PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	RUIJS, MBM; KEYSER, A; GABREELS, FJM; NOTERMANS, SLH				RUIJS, MBM; KEYSER, A; GABREELS, FJM; NOTERMANS, SLH			SOMATOSENSORY-EVOKED POTENTIALS AND COGNITIVE SEQUELAE IN CHILDREN WITH CLOSED HEAD-INJURY	NEUROPEDIATRICS			English	Article						SOMATOSENSORY EVOKED POTENTIAL; CLOSED HEAD-INJURY; COGNITIVE SEQUELAE	BRAIN-STEM RESPONSES; POSTTRAUMATIC AMNESIA; COMA; DYSFUNCTION; ADOLESCENTS; PROGNOSIS; SYMPTOMS	In search of a prognostic indicator for residual cognitive function loss in children after closed head-injury, the somatosensory evoked potential P300 has been studied in a prospective follow-up study of 17 patients with mild and moderately severe head-injuries. The P300 response was measured in the acute phase after patients regained consciousness. In addition the duration of coma and of post-traumatic amnesia were recorded. An age-matched control group of 20 healthy children supplied age-related normative evoked potential data. During a two-years follow-up period the presence of residual disorders in various faculties was evaluated at fixed time intervals after discharge. Correlation analyses revealed that, where the duration of coma and of post-traumatic amnesia qualify as general predictors of sequelae, the long-latency somatosensory evoked potential P300 correlated specifically with long-term deficits in the field of school performance.	CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CLIN NEUROPHYSIOL,6500 HB NIJMEGEN,NETHERLANDS		RUIJS, MBM (corresponding author), CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						BENNA P, 1982, ITAL J NEUROL SCI, V3, P281, DOI 10.1007/BF02043575; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; DRAKE ME, 1987, CLIN EVOKED POTENTIA, V5, P19; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SCHOENHUBER R, 1985, EVOKED POTENTIALS NE, P237; TEASDALE G, 1974, LANCET, V2, P81; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; ZENTNER J, 1988, EEG-EMG-Z ELEK ELEKT, V19, P267	26	7	7	0	3	HIPPOKRATES VERLAG GMBH	STITTGART	PO BOX 30 05 04 RUDIGERSTRASSE 14, 70469 STITTGART, GERMANY	0174-304X			NEUROPEDIATRICS	Neuropediatrics	DEC	1993	24	6					307	312		10.1055/s-2008-1071562			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	MP787	WOS:A1993MP78700003	8133975				2022-02-06	
J	DONDERS, J				DONDERS, J			WISC-R SUBTEST PATTERNS IN CHILDREN WITH TRAUMATIC BRAIN INJURY	CLINICAL NEUROPSYCHOLOGIST			English	Article							HEAD-INJURY; CLUSTERING PROCEDURES; PERFORMANCE; ADOLESCENTS; SEQUELAE	Subtypes of WISC-R subtest patterns were explored statistically in a sample of 96 children with traumatic brain injury. Four subtypes were identified by cluster analysis. Differences in level of performance as well as differences in pattern of performance contributed to the clustering process. Level of performance was meaningfully related to both premorbid variables and to length of coma. Several subtest patterns were found that did not resemble any of the subtypes known to be prevalent in the WISC-R standardization sample, suggesting that these patterns may be clinically significant in children with traumatic brain injury. Support for the reliability and validity of the clusters, as well as clinical and research implications, are discussed.	MARY FREE BED HOSP,GRAND RAPIDS,MI 49503								ADAMS KM, 1985, NEUROPSYCHOLOGY LEAR, P17; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BAYNE CK, 1980, PATTERN RECOGN, V12, P51, DOI 10.1016/0031-3203(80)90002-3; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DELUCA JW, **NON-TRADITIONAL**; DONDERS J, 1993, J CLIN PSYCHOL, V49, P255, DOI 10.1002/1097-4679(199303)49:2<255::AID-JCLP2270490220>3.0.CO;2-Q; Everitt B. S., 1980, CLUSTER ANAL; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; KAUFMAN AS, 1986, J LEARN DISABIL, V19, P145, DOI 10.1177/002221948601900303; KAUFMAN AS, 1975, J CONSULT CLIN PSYCH, V43, P135, DOI 10.1037/h0076502; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KUIPER FK, 1975, BIOMETRICS, V31, P777, DOI 10.2307/2529565; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Lorr M., 1983, CLUSTER ANAL SOCIAL; McDermott P.A., 1989, PSYCHOL ASSESSMENT J, V1, P292, DOI [https://doi.org/10.1037/1040-3590.1.4.292, DOI 10.1037/1040-3590.1.4.292]; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; NAGLIERI JA, 1981, PSYCHOL REP, V49, P891, DOI 10.2466/pr0.1981.49.3.891; OWNBY RL, 1985, J CONSULT CLIN PSYCH, V53, P531, DOI 10.1037/0022-006X.53.4.531; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Rourke B. P., 1985, NEUROPSYCHOLOGY LEAR; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; 1991, CSS STATISTICA; [No title captured]	38	7	7	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	OCT	1993	7	4					430	442		10.1080/13854049308401533			13	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ML701	WOS:A1993ML70100003					2022-02-06	
J	COOMBS, DW; COLBURN, RW; MCCARTHY, LE; DELEO, JA; HOOPES, PJ; TWITCHELL, BB				COOMBS, DW; COLBURN, RW; MCCARTHY, LE; DELEO, JA; HOOPES, PJ; TWITCHELL, BB			NEUROTOXICOLOGY OF CHRONIC INFUSION OF THE GANGLIOSIDE GM1 IN THE EWE - PHASE-I - INTRATHECAL ADMINISTRATION	ANESTHESIA AND ANALGESIA			English	Article							NERVE GROWTH-FACTOR; MONOSIALOGANGLIOSIDE; DISEASE; REGENERATION; PSYCHOSINE; MORPHINE; NEURONS; BRAIN; RAT	Gangliosides, including GM1, provide a measure of improved functional recovery after ischemic, toxic, and traumatic brain injuries in animal studies. Since systemically injected GM1 has provided equivocal results in a variety of human neurodegenerative conditions, the possibility exists that intrathecal or intracerebroventricular delivery might provide more effective concentrations along the neuroaxis. In preparation to consider clinical trials, the potential neurotoxicologic effects of chronic intrathecal GM1 were studied in ewes. Preliminary in vitro tests first demonstrated the stability and compatibility of GM1 in implanted pumps. Two groups of adult ewes were then implanted with either Therex or Infusaid continuous flow implantable pumps and chronic intrathecal catheters. Ewes were infused intrathecally with either preservative-free normal saline (n = 5) or GM1 (n = 7) 100 mug-10,000 mug/d for up to 24 wk. No abnormal behavioral responses were noted. Cerebrospinal fluid analyzed for GM1 concentrations by thin layer chromatography revealed no evidence of GM1 accumulation. After the animals were killed, spinal cords were removed, fixed, sectioned, and stained. Histologic analysis revealed no generalized pattern of neuronal damage, demyelination, gliosis, or axonopathy to distinguish intrathecal normal saline or GM1. In both treated and control groups, the only consistent finding was a pericatheter-associated compression of white matter with axonal dilation, vacuolation, and occasional neuronal loss. Catheter tracts in both groups were also associated with variable leptomeningeal fibroproliferative changes in adjacent dura and pia, at times in conjunction with more generalized duromeningeal thickening. In summary, chronic intrathecal GM1 in doses up to 10 mg/d had no definable neuropathologic consequences.	DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,HANOVER,NH 03756		COOMBS, DW (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,INST SPINAL DRUGS & NEUROTOXICOL,DEPT ANESTHESIOL,HANOVER,NH 03756, USA.						BELLATO P, 1989, CLIN TRIALS J, V26, P39; BRADLEY WG, 1990, MUSCLE NERVE, V13, P833, DOI 10.1002/mus.880130910; CAHN R, 1989, STROKE, V20, P652, DOI 10.1161/01.STR.20.5.652; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; COOMBS DW, UNPUB ACTA ANAESTHIO; COOMBS DW, 1993, IN PRESS REG ANAESTH; DIPATRE PL, 1989, BRAIN RES, V480, P219, DOI 10.1016/0006-8993(89)91585-0; DOHERTY P, 1985, J NEUROCHEM, V44, P1259, DOI 10.1111/j.1471-4159.1985.tb08752.x; FROMM C, 1993, ANESTH ANALG, V77, P501; GHIDONI R, 1986, FIDIA RES SERIES GAN, P183; GORIO A, 1980, BRAIN RES, V197, P236, DOI 10.1016/0006-8993(80)90451-5; HAYES RL, 1992, PAIN, V48, P391, DOI 10.1016/0304-3959(92)90089-T; HECKER JF, 1981, EXPT SURGERY SMALL R; ILYAS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1225, DOI 10.1073/pnas.81.4.1225; Kandel E.R., 1981, PRINCIPLES NEURAL SC, V1st ed.; LEDEEN RW, 1978, J SUPRAMOL STR CELL, V8, P1, DOI 10.1002/jss.400080102; LEDEEN RW, 1984, J NEUROSCI RES, V12, P147, DOI 10.1002/jnr.490120204; LEON A, 1990, STROKE, V21, P95; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIPARTITI M, 1991, EXP NEUROL, V113, P301, DOI 10.1016/0014-4886(91)90019-9; MCCARTHY L, 1990, JUL S AN PAIN ITS CO; NILSSON O, 1982, BIOCHIM BIOPHYS ACTA, V712, P453, DOI 10.1016/0005-2760(82)90272-7; NORTH RB, 1991, NEUROSURGERY, V29, P778, DOI 10.1227/00006123-199111000-00025; ONOFRIO BM, 1981, MAYO CLIN PROC, V56, P516; PESTRONK A, 1991, ADV NEUROL, V56, P427; SANDOFF K, 1985, NEUROBIOCHEMISTRY SE, P149; SCHENGRUND CL, 1990, BRAIN RES BULL, V24, P131, DOI 10.1016/0361-9230(90)90297-D; SVENNERHOLM L, 1990, ACTA NEUROL SCAND, V81, P48; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; SVENNERHOLM L, 1980, J LIPID RES, V21, P53; TOFFANO G, 1983, BRAIN RES, V261, P163, DOI 10.1016/0006-8993(83)91298-2; VAVORON M, 1988, P NATL ACAD SCI USA, V85, P7351; WEIGANDT H, 1985, NEW COMPREHENSIVE BI, P199	33	7	7	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	1993	77	3					507	515					9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	LW216	WOS:A1993LW21600015	7690199				2022-02-06	
J	DARBY, JM; NEMOTO, EM; YONAS, H; YAO, LP; MELICK, JA; BOSTON, JR				DARBY, JM; NEMOTO, EM; YONAS, H; YAO, LP; MELICK, JA; BOSTON, JR			LOCAL CEREBRAL BLOOD-FLOW MEASURED BY XENON-ENHANCED CT DURING CRYOGENIC BRAIN EDEMA AND INTRACRANIAL HYPERTENSION IN MONKEYS	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						COLD INJURY; COMPUTED TOMOGRAPHY; INTRACRANIAL PRESSURE; LOCAL CEREBRAL BLOOD FLOW; RHESUS MONKEY; XENON	SEVERE HEAD-INJURIES; COMPUTED-TOMOGRAPHY; STABLE XENON; CRANIECTOMY	We developed a closed-skull model of freeze injury-induced brain edema, a model classically thought to produce vasogenic edema, and observed the natural course of changes in edema and blood flow using xenon-enhanced computed tomography (CT) in five rhesus monkeys before and for up to 6 h post insult. Intracranial pressure (ICP) gradually rose throughout the duration of the experiment. CT scans and CBF images permitted direct observation of the evolution of the lesion and revealed early ischemia in the periphery of the injury zone that progressed over time in association with edema. Frequency histogram analysis of local CBF (lCBF) demonstrated subtle but potentially important changes in distribution of lCBF between and within hemispheres at various times post insult. Changes in lCBF distribution were phasic and dissociated from increases in ICP in the latter stages of injury. The Xe/CT CBF method can be used to evaluate the effects of injury and therapy on CBF in this and other models of acute brain injury.	PRESBYTERIAN UNIV HOSP,DEPT CRIT CARE MED,PITTSBURGH,PA 15261; PRESBYTERIAN UNIV HOSP,DEPT NEUROL SURG,PITTSBURGH,PA 15261		DARBY, JM (corresponding author), PRESBYTERIAN UNIV HOSP,DEPT ANESTHESIOL,648 SCAIFE HALL,PITTSBURGH,PA 15261, USA.				NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL27208-08] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL027208] Funding Source: NIH RePORTER		BRUCE DA, 1972, INTRACRANIAL PRESSUR, P85; CARSON RE, 1991, J CEREB BLOOD FLOW M, V11, pS45; CHRIST R, 1969, CEREBRAL BLOOD FLOW, P184; CLASEN RA, 1953, SURG GYNECOL OBSTET, V96, P605; CLASEN RA, 1981, J COMPUT ASSIST TOMO, V5, P313, DOI 10.1097/00004728-198106000-00001; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CZERNICKI Z, 1990, ACT NEUR S, V51, P407; DEWITT DS, 1989, STROKE, V20, P1716, DOI 10.1161/01.STR.20.12.1716; DUTREVOU MD, 1987, S AFR J SURG, V25, P95; FATOUROS PP, 1987, INVEST RADIOL, V22, P705, DOI 10.1097/00004424-198709000-00003; FORD I, 1991, J CEREBR BLOOD F MET, V11, pA89, DOI 10.1038/jcbfm.1991.43; FOX PT, 1991, J CEREBR BLOOD F MET, V11, pA79, DOI 10.1038/jcbfm.1991.41; FREI HJ, 1973, ACTA NEUROCHIR, V29, P15, DOI 10.1007/BF01414613; GABB MR, 1990, ADV NEUROL, V52, P247; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; HEIPERTZ R, 1968, SCAN J CLIN LAB IN S, V102; JOHNSON DW, 1991, AJNR, V12, P210; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LANGFITT TW, 1966, J NEUROSURG, V24, P975, DOI 10.3171/jns.1966.24.6.0975; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARMAROU A, 1976, DYNAMICS BRAIN EDEMA, P113; MILLER JD, 1976, DYNAMICS BRAIN EDEMA, P68; PAWLIK G, 1991, J CEREBR BLOOD F MET, V11, pA136, DOI 10.1038/jcbfm.1991.48; RAPOPORT SI, 1991, J CEREBR BLOOD F MET, V11, pA140, DOI 10.1038/jcbfm.1991.49; REULEN HJ, 1976, BRIT J ANAESTH, V48, P741, DOI 10.1093/bja/48.8.741; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; ROTTENBERG DA, 1991, J CEREBR BLOOD F MET, V11, pA1, DOI 10.1038/jcbfm.1991.30; SCHUTTA HS, 1966, J NEUROSURG, V24, P281; WALLENFANG T, 1975, CEREBRAL CIRCULATION, P99; WALLENFANG T, 1973, BRAIN EDEMA PATHOPHY, P176; YAMAMOTO L, 1976, DYNAMICS BRAIN EDEMA, P59	34	7	7	0	6	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	1993	13	5					763	772		10.1038/jcbfm.1993.97			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	LT800	WOS:A1993LT80000004	8360283	Bronze			2022-02-06	
J	GOLDMAN, H; MOREHEAD, M; MURPHY, S				GOLDMAN, H; MOREHEAD, M; MURPHY, S			USE OF ADRENOCORTICOTROPIC HORMONE ANALOG TO MINIMIZE BRAIN INJURY	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	SYMP ON NEUROTRAUMA : CONCEPTS, CURRENT PRACTICE AND EMERGING THERAPIES	JUN 11-12, 1992	DEARBORN, MI	WAYNE STATE UNIV SCH MED, DEPT EMERGENCY MED		BRAIN INJURY; ADRENOCORTICOTROPIC HORMONE; TRAUMA, CENTRAL NERVOUS SYSTEM		Study objectives: To investigate the effects of a vasoactive analog of adrenocorticotrophic hormone (GMM2) on time-dependent disturbances in regional cerebral blood flow, permeability-capillary surface area products, and intracranial pressure in a rat model of moderate concussion/brain injury. Setting and design: Regional permeability-capillary surface area products and cerebral blood flow were measured at two hours after trauma. Intracranial pressure was monitored for 120 hours after trauma. Subjects: Male Wistar rats (330 to 430 g) (regional cerebral blood flow studies, n = 35; permeability-capillary surface area product studies, n = 36; intracranial pressure studies, n = 32). interventions: Post-traumatic subcutaneous administration of nanomolar concentrations of GMM2 (31 nmol per rat). Measurements and main results: Untreated trauma acutely increased average brain permeability-capillary surface area products for sucrose and decreased average brain cerebral blood flow. Moreover, it produced marked and prolonged increases in intracranial pressure. Post-traumatic subcutaneous administration of nanomolar concentrations of GMM2 effectively reduced the early hypoperfusion, blood-brain barrier leakiness, and pathologic elevation of intracranial pressure. Conclusion: Post-traumatic administration of GMM2, in nanomolar amounts, can prevent or reverse significantly the serious cerebrovascular sequelae of moderate head injury in this animal model. In view of its potency, low toxicity, and other neuroprotective properties, in both rats and human beings, these data suggest that GMM2 may have considerable clinical benefits in the treatment of central nervous system trauma.			GOLDMAN, H (corresponding author), WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,540 E CANFIELD AVE,DETROIT,MI 48201, USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R24RR002022, R01RR002022] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [NIDRR G0087C2022] Funding Source: Medline			0	7	7	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					1035	1040		10.1016/S0196-0644(05)82747-7			6	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE338	WOS:A1993LE33800013	8389101				2022-02-06	
J	LAIDLAW, TM				LAIDLAW, TM			HYPNOSIS AND ATTENTION DEFICITS AFTER CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS			English	Article							HARVARD GROUP SCALE; HYPNOTIC-SUSCEPTIBILITY; FORM-A; NORMS	In a controlled study of patients attending a concussion clinic because of ongoing postconcussion symptoms, attention deficits were recorded in the head-injured group for the aspects of alertness, assessed by the Continuous Performance Test (CPT), and processing capacity, assessed by a version of the Paced Auditory Serial Addition Test (PASAT). Selective attention was intact. Hypnotizability was assessed by the Harvard Group Scale of Hypnotic Susceptibility, Form A (HGSHS:A), with normal means and standard deviations found in both the concussed and control groups. There was a significant correlation, however, between HGSHS:A scores and PASAT scores in the concussed group only The results of this preliminary study suggest that slower processing capacity after a closed head injury may predict higher hypnotizability and that hypnosis could be an appropriate rehabilitation technique for these patients who present with postconcussion symptoms.	UNIV AUCKLAND, DEPT PSYCHOL, AUCKLAND, NEW ZEALAND		LAIDLAW, TM (corresponding author), UNIV AUCKLAND, SCH MED, DEPT PSYCHIAT & BEHAV SCI, PRIVATE BAG 92019, AUCKLAND, NEW ZEALAND.						AS A, 1963, J ABNORM PSYCHOL, V66, P142, DOI 10.1037/h0045590; BARTIS SP, 1990, INT J CLIN EXP HYP, V38, P168, DOI 10.1080/00207149008414516; BERCH DB, 1984, SUSTAINED ATTENTION; BONGARTZ W, 1985, INT J CLIN EXP HYP, V33, P131, DOI 10.1080/00207148508406643; BRICKENKAMP R, 1975, AUFMERKSAMKEITS BEKA; BROUWER WH, 1985, LIMITATIONS ATTENTIO; CEDERCREUTZ C, 1976, INT J CLIN EXP HYP, V24, P195, DOI 10.1080/00207147608405607; CRAIG A, 1984, SUSTAINED ATTENTION; DAS JP, 1964, J ABNORM SOC PSYCH, V68, P72, DOI 10.1037/h0044222; Davies DR., 1982, PSYCHOL VIGILANCE; DEIKMAN AJ, 1971, ARCH GEN PSYCHIAT, V25, P481; DREARY IJ, 1991, PERSONALITY INDIVIDU, V12, P983; FARTHING GW, 1983, INT J CLIN EXP HYP, V31, P8, DOI 10.1080/00207148308407176; FARTHING GW, 1983, INT J CLIN EXP HYP, V31, P170, DOI 10.1080/00207148308406607; GRAHAM C, 1977, J ABNORM PSYCHOL, V86, P631, DOI 10.1037/0021-843X.86.6.631; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GUMMOW L, 1983, CLIN PSYCHOL REV, V3, P255, DOI 10.1016/0272-7358(83)90015-6; Hilgard E. R., 1965, HYPNOTIC SUSCEPTIBIL; Hilgard E. R., 1977, DIVIDED CONSCIOUSNES; Hilgard Josephine Rohrs, 1979, PERSONALITY HYPNOSIS, V2nd; HILGARD JR, 1974, INT J CLIN EXP HYP, V22, P138, DOI 10.1080/00207147408412993; Karlin R A, 1979, J Abnorm Psychol, V88, P92, DOI 10.1037/0021-843X.88.1.92; LAURENCE JR, 1982, INT J CLIN EXP HYP, V30, P167, DOI 10.1080/00207148208407381; Levin HS., 1982, NEUROBEHAVIORAL CONS; MCCONKEY KM, 1980, INT J CLIN EXP HYP, V28, P164, DOI 10.1080/00207148008409838; Moray N., 1969, ATTENTION SELECTIVE; MOSTOFSKY DT, 1970, ATTENTION CONT THEOR; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; Orne M T, 1977, Ann N Y Acad Sci, V296, P14, DOI 10.1111/j.1749-6632.1977.tb38158.x; PARASURAMAN R, 1984, SUSTAINED ATTENTION; PERRY C, 1979, J ABNORM PSYCHOL, V88, P592, DOI 10.1037/0021-843X.88.5.592; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; SAMPSON H, 1956, CAN J PSYCHOLOGY, V10, P219, DOI 10.1037/h0083679; SHEEHAN PW, 1979, INT J CLIN EXP HYP, V27, P294, DOI 10.1080/00207147908407568; Shor R. E., 1962, HARVARD GROUP SCALE; SHOR RONALD E., 1963, INTERNATL JOUR CLIN AND EXPTL HYPNOSIS, V11, P39; SPANOS NP, 1978, J ABNORM PSYCHOL, V87, P566, DOI 10.1037/0021-843X.87.5.566; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; VANNUYS D, 1973, INT J CLIN EXP HYP, V21, P59, DOI 10.1080/00207147308409306; WALLACE B, 1976, J ABNORM PSYCHOL, V85, P558, DOI 10.1037/0021-843X.85.6.558; Wood R. L., 1987, BRAIN INJURY REHABIL; ZOMEREN AHV, 1984, CLOSED HEAD INJURY	45	7	7	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7144	1744-5183		INT J CLIN EXP HYP	Int. J. Clin. Exp. Hypn.	APR	1993	41	2					97	111		10.1080/00207149308414541			15	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	KU544	WOS:A1993KU54400003	8468107				2022-02-06	
J	NIIHO, Y; YAMAZAKI, T; HOSONO, T; NAKAJIMA, Y; ISHIZAKI, M; KURASHIGE, T				NIIHO, Y; YAMAZAKI, T; HOSONO, T; NAKAJIMA, Y; ISHIZAKI, M; KURASHIGE, T			PHARMACOLOGICAL STUDIES ON SMALL PEPTIDE FRACTION DERIVED FROM SOYBEAN - THE EFFECTS OF SMALL PEPTIDE FRACTION DERIVED FROM SOYBEAN ON FATIGUE, OBESITY AND GLYCEMIA IN MICE	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						SOYBEAN; SMALL PEPTIDE; ANTIFATIGUE; ANTIOBESITY; HYPOGLYCEMIA; SPORTING MOVEMENT		The present research was an attempt to determine the pharmacological actions as for anti-fatigue, antiobesity and hypoglycemia of small peptide isolated from soybean in mice. Small peptide administration prevented the decrease in sporting movement induced by concussion stress for 3 h in mice. In addition, it should be noted that the recovery rate of fatigue in 60 min after small peptide administration was over one hundred percentage in comparison with that after pretreatment, while the equivalent dose administration of amino acid mixture with the same small peptide amino acid composition did not prevent the decrease in sporting movement. In goldthioglucose (500 mg/kg (i.p.))-induced obese mouse body weight gain, liver weight and body lipid level around uterine were significantly reduced by the chronicoral administration of small peptide (200, 1000 mg/kg). Administration in 1000 mg per kg of small peptide significantly lowerd hyperglycemia in 30 and 120 min after glucose (3 g/kg (p.o.)) administration, whereas the equivalent amino acid mixture showed no effect. In conclusion, it suggested that small peptide isolated from soybean might have some pharmacological effects of anti-fatigue, antiobesity, and hypoglycemia.			NIIHO, Y (corresponding author), OHTAS ISAN CO LTD, TUKUBA RES INST, 957 SHISHIKO, USHIKU, IBARAKI 30012, JAPAN.						ADIBI S, 1968, Clinical Research, V16, P446; ADIBI SA, 1974, GASTROENTEROLOGY, V67, P586; ASATOOR AM, 1972, GUT, V13, P95, DOI 10.1136/gut.13.2.95; BRECHER G, 1949, P SOC EXP BIOL MED, V70, P498; BROBECK JR, 1946, PHYSIOL REV, V26, P541, DOI 10.1152/physrev.1946.26.4.541; GATES RJ, 1977, HORM RES, V8, P189, DOI 10.1159/000178800; GRAFT IL, 1968, GUT, V9, P425; HAN PW, 1966, AM J PHYSIOL, V211, P229, DOI 10.1152/ajplegacy.1966.211.1.229; KIRIYAMA S., 1962, Japanese Journal of Nutrition, V20, P121; KIRIYAMA S, 1970, NEWER METHODS NUTRIT, V4, P37; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; MURLIN JR, 1953, J NUTR, V51, P149, DOI 10.1093/jn/51.2.149; NEWEY H, 1959, J PHYSIOL-LONDON, V145, P48, DOI 10.1113/jphysiol.1959.sp006125; TALOW MJ, 1970, CLIN SCI, V39, P18; YORK DA, 1972, ENDOCRINOLOGY, V90, P885, DOI 10.1210/endo-90-4-885	15	7	7	2	9	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	APR	1993	113	4					334	342		10.1248/yakushi1947.113.4_334			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	LA123	WOS:A1993LA12300007	8492298	Bronze			2022-02-06	
J	DONDERS, J				DONDERS, J			FACTOR STRUCTURE OF THE WISC-R IN CHILDREN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							HEAD-INJURY; 3RD FACTOR; POPULATION; COMPONENTS	The factor structure of the WISC-R was examined in a sample of 108 children with traumatic brain injury. Principal factor analysis of 11 WISC-R subtests yielded three factors, which were subjected to varimax rotation. The rotated factor pattern suggested the existence of a Verbal Comprehension factor, a Perceptual Organization factor, and a somewhat weaker third factor. The meaning and implications of this third factor are discussed.			DONDERS, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY S E,GRAND RAPIDS,MI 49503, USA.						CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Gorsuch R.L., 1983, FACTOR ANAL; GREENBERG RD, 1986, J PSYCHOEDUCATIONAL, V4, P123; KAUFMAN AS, 1986, J LEARN DISABIL, V19, P145, DOI 10.1177/002221948601900303; KAUFMAN AS, 1975, J CONSULT CLIN PSYCH, V43, P135, DOI 10.1037/h0076502; KROONENBERG PM, 1987, APPL PSYCH MEAS, V11, P195, DOI 10.1177/014662168701100209; MCMAHON RC, 1981, J CLIN PSYCHOL, V37, P408, DOI 10.1002/1097-4679(198104)37:2<408::AID-JCLP2270370235>3.0.CO;2-I; NAGLIERI JA, 1981, PSYCHOL REP, V49, P891, DOI 10.2466/pr0.1981.49.3.891; OWNBY RL, 1985, J CONSULT CLIN PSYCH, V53, P531, DOI 10.1037/0022-006X.53.4.531; PETERSEN CR, 1979, J CONSULT CLIN PSYCH, V47, P643; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; STEWART KJ, 1983, J CONSULT CLIN PSYCH, V51, P940; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; THINGSTROM DH, 1988, J CLIN PSYCHOL, V44, P799; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wielkiewicz R. M., 1990, PSYCHOL ASSESSMENT J, V2, P91; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	22	7	8	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAR	1993	49	2					255	260		10.1002/1097-4679(199303)49:2<255::AID-JCLP2270490220>3.0.CO;2-Q			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	KZ345	WOS:A1993KZ34500018	8486809				2022-02-06	
J	KAPLAN, SP				KAPLAN, SP			5-YEAR TRACKING OF PSYCHOSOCIAL CHANGES IN PEOPLE WITH SEVERE TRAUMATIC BRAIN INJURY	REHABILITATION COUNSELING BULLETIN			English	Article							HEAD-INJURY; PRACTICAL SCALE; REHABILITATION	The current study involved a group of 25 individuals with severe brain injury and their significant others, all of whom were interviewed 1, 3, and 5 years after injury. Results showed a trend of improvement in psychological and social functioning between 1 and 5 years. Physical capabilities were significantly improved between 1 and 3 years. Many participants continued to have deficits in certain psychosocial areas.			KAPLAN, SP (corresponding author), IIT,DEPT PSYCHOL,CHICAGO,IL 60616, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bond M R, 1979, Int Rehabil Med, V1, P155; BRACY O, 1985, COGNITIVE REHABILITA, V3, P33; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; COHEN J, 1985, J APPLIED REHABILITA, V16, P25; GRIFFITH E, 1985, REHABILITATION HEAD, P23; HEINEMANN A, 1989, DEC NAT HEAD INJ F M; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1985, REHABILITATION HEAD, P3; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; KAY T, 1986, ANNOTATED BIBLIO RES; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LEZAK MD, 1990, TRAUMATIC BRAIN INJU, P365; MAITZ E, 1989, DEC NAT HEAD INJ M C; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGATANO G, 1984, J NEUROL NEUROSUR PS, V47, P260; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RIMEL R, 1985, REHABILITATION HEAD; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; TEASDALE G, 1974, LANCET, V2, P81; TUKEY JW, 1953, UNPUB PROBLEM MULTIP; WESOLOWSKI MD, 1987, REHABIL COUNS BULL, V31, P17	30	7	7	0	0	AMER COUNSELING ASSOC	ALEXANDRIA	5999 STEVENSON AVE, ALEXANDRIA, VA 22304-3300	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	MAR	1993	36	3					151	159					9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KP087	WOS:A1993KP08700003					2022-02-06	
J	PEARSON, IY				PEARSON, IY			THE POTENTIAL ORGAN DONOR	MEDICAL JOURNAL OF AUSTRALIA			English	Article							BRAIN-STEM DEATH; ABC; DIAGNOSIS	The source of most organs for transplantation is the brain-dead cadaveric donor. The realistic potential donor is one for whom mechanical ventilation and other support, to the point of brain death, is provided in the best interests of that patient, and not solely for the purpose of organ donation. Brain death secondary to spontaneous intracranial haemorrhage now exceeds traumatic head injury as a source of organ donors in Australis. There are now few medical exclusions to organ donation. Age limits rise constantly. No patient should be excluded without referral to the transplant coordinator. Adequate medical support of the potential donor is no more than should be provided to the severely brain-injured patient. Haemodynamic and other organ support are as logically appropriate as ventilation and must be continued until confirmation of brain death. Support should cease only if organ donation will not occur. Australian State laws define brain death as irreversible cessation of all function of the brain of the person, but do not dictate the methods of confirmation. The prospect of organ donation should not be raised until brain death is confirmed. The over-riding principle is that the family always has the right to be asked. There is no other way for the family's and patient's wishes about organ donation to be known and respected. It is vital that the person who will ask be experienced, competent and committed. A dedicated medical, nursing and allied health team providing care of the family throughout the period is essential.	WESTMEAD HOSP, WESTMEAD, NSW, AUSTRALIA								[Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; [Anonymous], 1968, JAMA, V205, P337; BEECHER HK, 1969, NEW ENGL J MED, V281, P1070, DOI 10.1056/NEJM196911062811909; BLACK PM, 1978, NEW ENGL J MED, V299, P338, DOI 10.1056/NEJM197808172990705; BLACK PM, 1978, NEW ENGL J MED, V299, P393, DOI 10.1056/NEJM197808242990805; Diagnosis of death, 1979, BMJ-BRIT MED J, V1, P332; FEEST TG, 1990, LANCET, V335, P1133, DOI 10.1016/0140-6736(90)91134-V; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; PALLIS C, 1982, BRIT MED J, V285, P1720, DOI 10.1136/bmj.285.6356.1720; PALLIS C, 1983, BRIT MED J, V286, P39, DOI 10.1136/bmj.286.6358.39; PALLIS C, 1983, BRIT MED J, V286, P123, DOI 10.1136/bmj.286.6359.123; PALLIS C, 1982, BRIT MED J, V285, P1409, DOI 10.1136/bmj.285.6352.1409; PALLIS C, 1982, BMJ-BRIT MED J, V285, P1487, DOI 10.1136/bmj.285.6353.1487; PALLIS C, 1982, BRIT MED J, V285, P1558, DOI 10.1136/bmj.285.6354.1558; PALLIS C, 1982, BRIT MED J, V285, P1641, DOI 10.1136/bmj.285.6355.1641; PALLIS C, 1983, BRIT MED J, V286, P209, DOI 10.1136/bmj.286.6360.209; PALLIS C, 1983, BRIT MED J, V286, P284, DOI 10.1136/bmj.286.6361.284; Pallis C., 1983, BRIT MED J; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; 1977, HUMAN TISSUE TRANSPL	20	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	JAN 4	1993	158	1					45	47		10.5694/j.1326-5377.1993.tb121651.x			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KF084	WOS:A1993KF08400016	8417293				2022-02-06	
J	BASTIAANSE, R; NIJBOER, S; TACONIS, M				BASTIAANSE, R; NIJBOER, S; TACONIS, M			THE AUDITORY LANGUAGE COMPREHENSION PROGRAM - A DESCRIPTION AND CASE-STUDY	EUROPEAN JOURNAL OF DISORDERS OF COMMUNICATION			English	Article						APHASIA; THERAPY; AUDITORY COMPREHENSION	THERAPY; APHASIA	The Auditory Language Comprehension Programme is a Dutch therapy programme at the word level, especially developed for severely aphasic patients. The programme consists of 420 items divided over three parts. Each item consists of a larger word and three distractors. One spoken target word at a time is presented to the patient who has to choose one out of four pictures. The number of related distractors is varied: each part starts with items in which the distractors bear no resemblance to the target; later on, one, two and then all three distractors are related to the target. The nature of relatedness is dependent on the different levels in the programme. In part 1, the phonological level, there is a correspondence in sound; in part 2, the semantic level, a correspondence in meaning; in part 3, the complement, there is a phonological correspondence, a combination of phonological and semantic correspondence, or a lexical-morphological correspondence. The levels are hierarchically built, according to the principles of programmed instruction. In order to show how a therapist may apply this programme, a case study is presented. The patient, who developed aphasia after traumatic brain injury, was trained on the semantic level. Both his performance and our therapy methods will be described and evaluated.	REHABIL CTR HET ROESSINGH, DEPT SPEECH THERAPY & APHASIA TEAM, ENSCHEDE, NETHERLANDS		BASTIAANSE, R (corresponding author), UNIV GRONINGEN, DEPT LINGUIST, POB 716, 9700 AS GRONINGEN, NETHERLANDS.		Bastiaanse, Roelien/I-9209-2017	Bastiaanse, Roelien/0000-0002-4818-0763			AITCHISON J, 1987, WORDS MIND INTRO MEN; BASTIAANSE R, 1989, AUDITIEF TAALBEGRIPS; BASTIAANSE R, 1989, NEUROLOGISCHE TAALEN; BASTIAANSE R, 1992, 5TH INT APH REH C ZU; BASTIAANSE R, 1986, AUDITIEF TAALBEGRIPS; DEELMAN BG, 1981, SAN TEST EEN AFASIET; Ellis A., 1988, HUMAN COGNITIVE NEUR; HELMESTABROOKS N, 1982, J SPEECH HEAR DISORD, V47, P385, DOI 10.1044/jshd.4704.385; HOWARD D, 1985, COGN NEUROPSYCHOL, V2, P49, DOI 10.1080/02643298508252861; Howard D., 1988, MISSING MEANING COGN; JONES EV, 1986, BRIT J DISORD COMMUN, V21, P63; Kaplan E, 1983, BOSTON NAMING TEST; KOHNSTAMM GA, 1981, NIEUWE STREEFLIJST W; LAPOINTE LL, 1977, J SPEECH HEAR DISORD, V42, P90, DOI 10.1044/jshd.4201.90; Levelt W.J.M., 1989, SPEAKING INTENTION A; MARSHALL J, 1990, APHASIOLOGY, V4, P167, DOI 10.1080/02687039008249068; NICKELS L, 1991, BRIT J DISORD COMMUN, V26, P175; NICKELS L, 1992, COGNITIVE NEUROPSYCH, V9, P155, DOI 10.1080/02643299208252057; Parisi D, 1970, Cortex, V6, P204; Prins R S, 1980, Gerontologie, V11, P22; Shallice T, 1990, NEUROPSYCHOLOGY MENT; SPARKS RW, 1976, J SPEECH HEAR DISORD, V41, P287, DOI 10.1044/jshd.4103.287; VISCHBRINK E, 1989, NEUROLOGISCHE SPRAAK; WILSONH MS, 1979, WILSON EXPANDED SYNT; 1991, P BRIT APHASIOLOGY S	25	7	7	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-7273			EUR J DISORDER COMM	Eur. J. Disord. Commun.		1993	28	4					415	433					19	Communication; Rehabilitation	Social Science Citation Index (SSCI)	Communication; Rehabilitation	MM502	WOS:A1993MM50200007	8312656				2022-02-06	
J	CIRICILLO, SF; ANDREWS, BT; DAMRON, SL; PITTS, LH				CIRICILLO, SF; ANDREWS, BT; DAMRON, SL; PITTS, LH			SEVERITY AND OUTCOME OF INTRACRANIAL LESIONS IN PEDESTRIANS INJURED BY MOTOR-VEHICLES	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; DIFFUSE AXONAL INJURY; BRAIN-LESIONS; TRAUMA; COMA; CONSCIOUSNESS; PATHOLOGY; HEMATOMA; CHILDREN; SYSTEM	To evaluate the type and severity of intracranial lesions and the prognosis after closed head trauma in pedestrians injured by motor vehicles, we reviewed the cases of 225 consecutive patients who suffered major head injuries in collisions with motor vehicles. Patients in this series were comatose, had intracranial hematomas requiring surgical removal, or both. The initial Glasgow Coma Scale (GCS) score was 9-15 in 24% of patients, 6-8 in 32%, and 3-5 in 43%. Intracranial hypertension occurred in 40%. Diagnostic studies showed subdural hematomas in 45% of patients, epidural hematomas in 8%, intracerebral hematomas in 10%, and cerebral contusions in 9%. Clinically significant mass lesions were evacuated, and intracranial pressure was monitored and treated aggressively if elevated. After 6 months, 51% of the patients had died, 13% were vegetative or severely disabled, and 35% had a good outcome or moderate disability. These major head injuries in pedestrians struck by motor vehicles were usually severe, included a high incidence of intracranial hematomas and increased intracranial pressure, and frequently had poor outcomes.	UNIV CALIF SAN FRANCISCO, DEPT NEUROL SURG,EDITORIAL OFF,1360 9TH AVE, SUITE 210, SAN FRANCISCO, CA 94122 USA; SAN FRANCISCO GEN HOSP, INFECT DIS SERV, SAN FRANCISCO, CA 94110 USA								Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARANCIK JI, 1986, AM J EPIDEMIOL, V123, P846, DOI 10.1093/oxfordjournals.aje.a114314; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRAINARD BJ, 1989, ANN EMERG MED, V18, P881, DOI 10.1016/S0196-0644(89)80218-5; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; DERLET R W, 1989, Journal of Emergency Medicine, V7, P5; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GLANTZ SA, 1987, PRIMER BIOSTATISTICS, P122; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; TEASDALE G, 1974, LANCET, V2, P81; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; VESTRUP JA, 1989, J TRAUMA, V29, P741, DOI 10.1097/00005373-198906000-00007; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300	27	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1992	33	6					899	903		10.1097/00005373-199212000-00018			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	KF879	WOS:A1992KF87900018	1474635				2022-02-06	
J	HARTUNG, HJ; OLENIK, D				HARTUNG, HJ; OLENIK, D			PROGNOSTIC PARAMETERS OF SEVERE HEAD-INJURIES	ANAESTHESIST			German	Article						CEREBRAL TRAUMA; TRAUMATIC EDEMA; INTRACRANIAL PRESSURE; MORTALITY FACTORS; PROGNOSTIC PARAMETERS	OUTCOME PREDICTION; AGGRESSIVE TREATMENT; EMERGENCY CARE; MANAGEMENT; ADULT; COMA	Severe head injuries are still associated with a high mortality (30-60%). Depth and duration of coma are poor prognostic parameters because of therapeutic concepts such as sedation and mechanical ventilation. That is the reason why we looked for prognostic parameters that are independent of therapy and can be obtained during the normal routine at an ICU for head and trauma patients. Methods. The medical records of 59 patients with severe head injury were studied and analyzed by statistical means. Exclusion criteria were, e.g., thoracic trauma or abdominal injury. All data tested are parameters routinely measured at our ICU. The statistical analysis was based on calculation of the odd's ratio and its range of confidence. Results. We evaluated 16 parameters correlating to patient lethality. All of them can be obtained by routine diagnostic procedures, OP findings and intensive care monitoring. The relevant criteria that raise the mortality risk to 1.9-7.7 are: age, subdural hematoma, subarachnoid hemorrhage, brain edema, midline shift, pupillary reflexes, motoric answer to pain, hemisyndrome, intracranial pressure, heart rate, blood pressure, Conclusions. The evaluated risk factors permit early estimation of the patient's outcome independent of therapeutical interventions. Further studies are necessary to create a score on the basis of the parameters found.	UNIV HEIDELBERG, FAK KLIN MED MANNHEIM, INST ANASTHESIOL & OPERAT INTENS MED, W-6800 MANNHEIM 1, GERMANY								ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BECKER DP, 1976, INTRACRANIAL PRESSUR, V3, P97; BENZER A, 1987, NOTFALLMEDIZIN, V13, P41; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Braakman R, 1986, Acta Neurochir Suppl (Wien), V36, P112; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRAAKMAN R, 1985, CEREBRALE NOTFALL, P47; BYRNES DP, 1980, INTRACRANIAL PRESSUR, V4, P73; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; Eisenberg H M, 1988, Clin Neurosurg, V34, P572; FAUPEL G, 1980, NERVENARZT, V51, P91; FROWEIN R A, 1975, Aktuelle Traumatologie, V5, P203; FROWEIN RA, 1980, NEUROTRAUMATOLOGIE D, V8, P79; FROWEIN RA, 1982, SCHADELHIRN TRAUMA, P103; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GIBSON RM, 1989, LANCET, V2, P369; Habbema J D, 1979, Acta Neurochir Suppl (Wien), V28, P158; HANS P, 1989, J NEUROSURG, V71, P54, DOI 10.3171/jns.1989.71.1.0054; HEMMER M, 1988, UPDATE INTENSIVE CAR, V5, P537; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1976, LANCET, V1, P1031; KARIMINEJAD A, 1984, UNFALLHEILKUNDE PRAX, P176; Klun B, 1979, Acta Neurochir Suppl (Wien), V28, P134; KRETSCHMER H, 1985, SCHADEL HIRN VERLETZ, V16, P38; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LANKSCH W, 1981, MUNCHEN MED WOCHEN, V123, P556; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Miller J D, 1979, Acta Neurochir Suppl (Wien), V28, P86; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; OSSWALD PM, 1985, ANAESTHESIST, V34, P508; RICHLING B, 1980, NEUROTRAUMATOLOGIE D, V8, P87; RIFFEL B, 1989, ANAESTHESIST, V38, P51; SACHS L, 1984, ANGEWANDTE STATISTIK, P96; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHEIDEGGER D, 1988, UPDATE INTENSIVE CAR, V5, P545; SCHIRMER M, 1984, EINFUHRUNG NEUROCHIR, P145; SINGBARTL G, 1989, ANAESTHESIST, V38, P116; SINGBARTL G, 1987, ANAESTHESIST, V36, P321; SINGBARTL G, 1985, ANASTH INTENSIV NOTF, V20, P251, DOI 10.1055/s-2007-1003119; SOLLMANN WP, 1985, NEUROCHIRURGIA, V28, P46; Steifensand, 1987, THEORETICAL SURGERY, V1, P169; STEINBEREITHNER K, 1986, REIHE ANAESTHESIOLOG, V194, P95; STEINBEREITHNER K, 1984, INTENSIVSTATION PFLE, P486; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; WALTZER E, 1988, BIOMATHEMATIK MEDIZI, P116; [No title captured]	49	7	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	AUG	1992	41	8					468	473					6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JK219	WOS:A1992JK21900006	1524158				2022-02-06	
J	CATZ, A; SNIR, D; GROSWASSER, Z; MENDELSON, L; SOLZI, P				CATZ, A; SNIR, D; GROSWASSER, Z; MENDELSON, L; SOLZI, P			IS THE APPEARANCE OF PERIARTICULAR NEW BONE-FORMATION RELATED TO LOCAL NEUROLOGICAL DISABILITY	PARAPLEGIA			English	Article						LOCAL FACTORS; SENSORIMOTOR DISABILITY; PERIARTICULAR NEW BONE FORMATION; SPINAL CORD LESIONS; TRAUMATIC BRAIN INJURY		The present work examined the relationship between the appearance of periarticular new bone formation (PNBF) and the presence of local sensorimotor disability, and the relationship between PNBF and the severity of the motor disability. The study population consisted of 18 patients with spinal cord lesions and 18 patients with traumatic brain injury. The confinement of PNBF below the level of neurological deficit in patients with spinal cord lesions, and mainly to paralysed or paretic limbs in brain injured patients, indicates a possible causal relationship between the presence of sensorimotor disability and PNBF. On the other hand, the high incidence of bilateral PNBF in patients with incomplete spinal lesions and the appearance of PNBF in some nonplegic and even paretic limbs in the brain injured patients, demonstrates the lack of connection between the severity of the motor deficit and the risk of PNBF. It is suggested that local factors which are related to sensorimotor disability are probably involved in PNBF induction, but additional elements may also play a role in the induction of PNBF and in its propagation.			CATZ, A (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR,278 ACHUZA ST,POB 3,RAANANA 43100,ISRAEL.			Catz, Amiram/0000-0002-7879-2015				0	7	7	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia	MAY	1992	30	5					361	365		10.1038/sc.1992.83			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	JV191	WOS:A1992JV19100010	1598178	Bronze			2022-02-06	
J	DONDERS, J				DONDERS, J			VALIDITY OF 2 SHORT FORMS OF THE WISC-R IN CHILDREN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article								The validities of Kaufman's (1976) four-subtest short form and Kennedy and Elder's (1982) five-subtest short form for the WISC-R were evaluated in 98 children with traumatic brain injury. Both forms correlated highly with actual WISC-R FSIQ, and both forms had acceptable relationships to measures of injury severity. However, the Kaufman method had a larger standard error of measurement than did the Kennedy and Elder method, and the Kaufman method tended to overestimate actual FSIQ. It was concluded that the Kennedy and Elder short form for the WISC-R may be a relatively more accurate predictor of actual FSIQ in children with traumatic brain injury.			DONDERS, J (corresponding author), MARY FREE BED HOSP,DEPT PSYCHOL,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						BECK NC, 1983, J CONSULT CLIN PSYCH, V51, P864, DOI 10.1037/0022-006X.51.6.864; KAUFMAN AS, 1976, CONTEMP EDUC PSYCHOL, V1, P180, DOI 10.1016/0361-476X(76)90022-9; KENNEDY LP, 1982, J CLIN PSYCHOL, V38, P174, DOI 10.1002/1097-4679(198201)38:1<174::AID-JCLP2270380130>3.0.CO;2-C; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; SILVERSTEIN AB, 1974, PSYCHOL REP, V35, P817, DOI 10.2466/pr0.1974.35.2.817; SLATER EJ, 1988, J ADOLESCENT RES, V3, P217; TEASDALE G, 1974, LANCET, V2, P81; VOLLMERHAUSEN S, 1986, J CLIN PSYCHOL, V42, P347, DOI 10.1002/1097-4679(198603)42:2<347::AID-JCLP2270420222>3.0.CO;2-H; WATKINS CE, 1986, PROF PSYCHOL-RES PR, V17, P36; Wechsler D., 1974, WECHSLER INTELLIGENC	10	7	9	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAY	1992	48	3					364	370		10.1002/1097-4679(199205)48:3<364::AID-JCLP2270480315>3.0.CO;2-A			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HV121	WOS:A1992HV12100014	1602027				2022-02-06	
J	ESCHUN, G; PARKINSON, D; VRIEND, J				ESCHUN, G; PARKINSON, D; VRIEND, J			CHANGES IN HIPPOCAMPAL MONOAMINE CONCENTRATION FOLLOWING HALOTHANE ANESTHESIA AND CONCUSSION	SURGICAL NEUROLOGY			English	Article						CONCUSSION; HALOTHANE; MONOAMINES; HIPPOCAMPUS; MEMORY	KORSAKOFFS SYNDROME; MEMORY IMPAIRMENT; HEAD-INJURY; AMNESIA; ANTEROGRADE; SKILLS; TERM; RATS	The concentration of norepinephrine in the hippocampus of rats anesthetized with halothane (Wyeth-Ayerst, Philadelphia, Pa) is found to be markedly increased, presumably due to the stress of handling and administering the anesthetic. This increased norepinephrine concentration persists for about 50 minutes but is obliterated when the anesthetized rat is concussed. This 50-minute period corresponds to the time it takes for a rat (or human), comatose for 1-2 seconds following concussion, to regain normal memory. No changes in 3,4-dihydroxybenzeneacetic acid (DOPAC), 3-(3,4-dihydroxyphenyl) alanine (L-DOPA), and 3,4-dihydroxybenzylamine (DHBA) were noted. 5-Hydroxy indole acetic acid (HIAA) showed a depression at 5 minutes and again at 30 minutes, changes that were consistent but not considered statistically significant.	UNIV MANITOBA,FAC MED,WINNIPEG R3T 2N2,MANITOBA,CANADA				Vriend, Jerry/I-4354-2015	Vriend, Jerry/0000-0001-6435-755X			ABRAMS R, 1988, ELECTR CONVULSIVE TH, P135; AGRANOFF BW, 1988, BASIC NEUROCHEMISTRY, P925; Axelrod J, 1973, Harvey Lect, V67, P175; AXELROD J, 1971, ANN REV BIOCH, V40, P465; AXELROD J, 1957, SCIENCE, V1, P126; BARASH PG, 1989, CLIN ANESTH, P326; BEDFORD PD, 1955, LANCET, V2, P259; BINDER LM, 1987, J NEUROSURG, V67, P785; BRUCE DL, 1974, ANESTHESIOLOGY, V40, P453, DOI 10.1097/00000542-197405000-00010; CARLSSON A, 1973, P INT C PHARM, V4, P286; DAVISON LA, 1975, ANESTHESIOLOGY, V43, P313, DOI 10.1097/00000542-197509000-00008; DELANGE S, 1983, CAN ANAESTH SOC J, V30, P248; DIXON KC, 1962, LANCET, V2, P1359; ENZENAUER RW, 1989, JAMA-J AM MED ASSOC, V261, P1463, DOI 10.1001/jama.261.10.1463; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOTTESFELD Z, 1982, EXP NEUROL, V76, P168, DOI 10.1016/0014-4886(82)90110-8; HAYCOCK JW, 1977, EXP NEUROL, V54, P199, DOI 10.1016/0014-4886(77)90264-3; HUGHES D, 1988, ANAESTHESIA, V43, P114; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; JOHNSTON RR, 1972, ANESTHESIOLOGY, V36, P357, DOI 10.1097/00000542-197204000-00010; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; MERSKEY H, 1988, PSYCHIATRIC ILLNESS, P289; MILLER RD, 1968, ANESTHESIOLOGY, V29, P1153, DOI 10.1097/00000542-196811000-00012; MIZUMORI SJY, 1987, BEHAV NEUROSCI, V101, P782, DOI 10.1037/0735-7044.101.6.782; MUELLER RA, 1975, ANESTHESIOLOGY, V42, P143, DOI 10.1097/00000542-197502000-00006; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NEFF NH, 1969, MOL PHARMACOL, V5, P90; NGAI SH, 1989, ENZYMES ANESTHESIOLO, P238; PARKINSON D, 1988, SURG NEUROL, V30, P102, DOI 10.1016/0090-3019(88)90094-8; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1981, CLIN NEUROSURG, V29, P131; PARKINSON D, 1981, BRAIN RES, V225, P271; PARKINSON D, 1977, P MAYO CLIN, V52, P492; PARKINSON D, 1988, J AM ASS ANAT CINCIN, pA73; PEARCE RA, 1989, ANESTHESIOLOGY, V71, P591, DOI 10.1097/00000542-198910000-00019; PRICE HL, 1959, ANESTHESIOLOGY, V20, P563, DOI 10.1097/00000542-195909000-00001; REITAN JA, 1986, ANESTH ANALG, V65, P933; RISS J, 1983, ACTA ANAESTH SCAND, V27, P44; ROIZEN MF, 1988, MOL MECHANISMS ANEST, V2, P447; SHIMAMURA AP, 1986, BEHAV NEUROSCI, V100, P165, DOI 10.1037/0735-7044.100.2.165; SQUIRE LR, 1978, NEUROPSYCHOLOGIA, V16, P313, DOI 10.1016/0028-3932(78)90025-8; SQUIRE LR, 1982, J EXP PSYCHOL LEARN, V8, P560, DOI 10.1037/0278-7393.8.6.560; SQUIRE LR, 1981, ARCH GEN PSYCHIAT, V38, P89; SQUIRE LR, 1986, NEUROPSYCHOLOGICAL A, P268; STOELTING RK, 1975, ANESTH ANALG, V54, P422; SUCKLING CW, 1957, BR J ANAES, V28, P466; TAMURA R, 1990, NEUROSCI LETT, V109, P293, DOI 10.1016/0304-3940(90)90010-7; TARKKA M, 1985, ACTA ANAESTH SCAND, V29, P300, DOI 10.1111/j.1399-6576.1985.tb02204.x; THEYE RA, 1968, ANESTHESIOLOGY, V26, P1113; TOWNES BD, 1986, ANESTH ANALG, V65, P955	52	7	7	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	1992	37	2					101	105		10.1016/0090-3019(92)90184-O			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HB604	WOS:A1992HB60400004	1546372				2022-02-06	
J	RICHARDSON, JTE				RICHARDSON, JTE			IMAGERY MNEMONICS AND MEMORY REMEDIATION	NEUROLOGY			English	Article							BRAIN-DAMAGED PATIENTS; CLOSED-HEAD-INJURY; MENTAL-IMAGERY; VISUAL-IMAGERY; AMNESIA; RECALL; AID	This paper evaluates the claim that imagery mnemonic techniques are useful in remediation of memory disorders in brain-damaged patients. Clinical research has confirmed that such techniques can lead to improved performance on formal testing in a number of neurologic disease populations and following lesions of either the left or right hemisphere. However, those patients with more severe forms of amnesia and those with medial or bilateral damage do not improve unless the learning task is highly structured. Even among patients who show improvement on formal testing, there is little evidence that they maintain the use of these techniques in similar learning tasks or generalize the use to new learning situations. Imagery mnemonics also appear to be of little practical value in the daily activities that are of most concern to brain-damaged patients themselves. The effectiveness of imagery mnemonics appears to depend upon the patients' motivation and insight rather than upon their intelligence or educational level. Instead of training patients in specific mnemonic techniques, clinicians should promote the development of "metacognitive" skills and the acquisition of knowledge about domains of practical significance.			RICHARDSON, JTE (corresponding author), BRUNEL UNIV,DEPT HUMAN SCI,UXBRIDGE UB8 3PH,MIDDX,ENGLAND.			Richardson, John/0000-0002-6267-0603			BADDELEY AD, 1973, NEUROPSYCHOLOGIA, V11, P159, DOI 10.1016/0028-3932(73)90003-1; CERMAK L S, 1975, Cortex, V11, P163; CERMAK LS, 1976, NEUROPSYCHOLOGIA, V14, P311, DOI 10.1016/0028-3932(76)90025-7; CERMAK LS, 1980, NEW DIRECTIONS MEMOR, P507; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; CUTTING J, 1978, CORTEX, V14, P485, DOI 10.1016/S0010-9452(78)80024-0; DELEON JLM, 1974, DISS ABSTR INT, V35, pB3011; Denis M., 1984, TEXT, V4, P381; ERLICHMAN H, 1983, BRAIN COGNITION, V2, P55; FARAH MJ, 1984, COGNITION, V18, P245, DOI 10.1016/0010-0277(84)90026-X; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; GASPARRINI B, 1979, Journal of Clinical Neuropsychology, V1, P137, DOI 10.1080/01688637908414447; GASPARRINI WG, 1978, DISS ABTS INT B, V39, P379; GAZZANIGA MS, 1978, INTEGRATED MIND, P122; GIANNICI B, 1983, RELIAB ENG SYST SAFE, V5, P37, DOI 10.1016/0143-8174(83)90017-3; GIANUTSOS R, 1981, Journal of Clinical Neuropsychology, V3, P143, DOI 10.1080/01688638108403119; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GOLDENBERG G, 1989, BRAIN, V112, P305, DOI 10.1093/brain/112.2.305; GRIFFITH D, 1978, B PSYCHONOMIC SOC, V12, P347; JAFFE PG, 1975, J ABNORM PSYCHOL, V84, P559, DOI 10.1037/h0077128; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; KAPUR N, 1983, BRIT J PSYCHOL, V74, P409, DOI 10.1111/j.2044-8295.1983.tb01872.x; KATZ AN, 1987, IMAGERY RELATED MNEM, P177; KOSSLYN SM, 1985, J EXP PSYCHOL GEN, V114, P311, DOI 10.1037/0096-3445.114.3.311; KOVNER R, 1985, J CLIN EXP NEUROPSYC, V7, P395, DOI 10.1080/01688638508401272; KOVNER R, 1983, J CLIN NEUROPSYCHOL, V5, P65, DOI 10.1080/01688638308401151; LEVIN HS, 1982, NEUROBEBEHAVIORAL CO, P218; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; Ley R.G., 1983, IMAGERY CURRENT THEO, P252; MASTROPIERI MA, 1987, IMAGERY RELATED MNEM, P358; PARIS SG, 1974, AM J MENT DEF, V78, P714; PATTEN BM, 1972, ARCH NEUROL-CHICAGO, V26, P25, DOI 10.1001/archneur.1972.00490070043006; PATTEN BM, 1990, NEUROLOGY, V40, P346; Poon L., 1980, NEW DIRECTIONS MEMOR, P461; PRESSLEY M, 1982, CHILD DEV, V53, P296, DOI 10.1111/j.1467-8624.1982.tb01319.x; PRESSLEY M, 1982, REV EDUC RES, V52, P61, DOI 10.3102/00346543052001061; Pressley M., 1987, IMAGERY RELATED MNEM, P274; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; PRIGATANO GP, 1983, PERCEPT MOTOR SKILL, V56, P296, DOI 10.1177/003151258305600101; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P61; Richardson JT, 1987, IMAGINAL RELATED MNE, P303; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1991, IMAGERY AND COGNITION, P1; RICHARDSON JTE, 1987, BRIT J PSYCHOL, V78, P65, DOI 10.1111/j.2044-8295.1987.tb02226.x; RICHARDSON JTE, 1990, IMAGERY CURRENT DEV, P351; RICHARDSON JTE, 1989, PSYCHOL SURVEY, V7, P98; ROBERTSONTCHABO EA, 1980, NEW DIRECTIONS MEMOR, P511; Schacter DL, 1986, CLIN NEUROPSYCHOLOGY, P257; SHORE DL, 1979, DISS ABSTR INT, V40, pB1916; SIGNORET JL, 1976, NEURAL MECHANISMS LE, P67; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TURNURE JE, 1987, IMAGERY RELATED MNEM, P329; VOGEL CC, 1987, INT J NEUROSCI, V33, P237, DOI 10.3109/00207458708987408; WILSON B, 1982, CORTEX, V18, P581, DOI 10.1016/S0010-9452(82)80055-5; [No title captured]	57	7	7	0	4	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0028-3878			NEUROLOGY	Neurology	FEB	1992	42	2					283	286		10.1212/WNL.42.2.283			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HD792	WOS:A1992HD79200004	1736154				2022-02-06	
J	CHRISTENSEN, AL				CHRISTENSEN, AL			OUTPATIENT MANAGEMENT AND OUTCOME IN RELATION TO WORK IN TRAUMATIC BRAIN INJURY PATIENTS	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article						BRAIN INJURY; REHABILITATION; COGNITIVE TRAINING; PSYCHOTHERAPY; VOICE THERAPY; PHYSICAL TRAINING; RELATIVES		This paper reports on a holistic psychosocial rehabilitation program for post-acute brain-injury patients. Methods and rationale are described and follow-up data are reported on a group of patients with regard to return to employment or educational programs. The results generally give grounds for optimism concerning the effectiveness of psychosocial rehabilitation.			CHRISTENSEN, AL (corresponding author), UNIV COPENHAGEN,CTR REHABIL BRAIN DAMAGE,NJALSGADE 88,DK-2300 COPENHAGEN,DENMARK.							0	7	7	0	3	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1992				26			34	42					9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KG064	WOS:A1992KG06400004	1488639				2022-02-06	
J	NATIV, A				NATIV, A			BRAIN POTENTIALS ASSOCIATED WITH MOVEMENT IN TRAUMATIC BRAIN INJURY	PHYSICAL THERAPY			English	Article						CONTINGENT NEGATIVE VARIATION; MOVEMENT-RELATED POTENTIAL; TRAUMATIC BRAIN INJURY	MOTOR; FOOT; FINGER	Brain potentials may be used to assess the functional abnormalities that underlie impairments of movement. The purpose of this article is to illustrate the usefulness of examining these potentials. In addition to an overview of the topic, the article includes a report of a study demonstrating that there were differences between the brain potentials of five patients with traumatic brain injury and those of four healthy control subjects. All five patients were in the postacute phase of hemiplegia. Slow cortical potentials associated with simple goal-directed forearm and finger movements were recorded from frontal and parietal electrodes. Two seconds of movement-related electroencephalographic activity (movement-related potential) were recorded. The patients showed reduced brain potentials for movements associated with their paretic limb and, to a lesser extent, reduced brain potentials for movements associated with their nonparetic limb. The waveforms obtained from the patients were unusual, with uncharacteristic cross-cortical movement-related potential correlations associated with specific electrode configurations, as well as with specific movement conditions. Brain potentials associated with the fore-period interval of a simple reaction time paradigm were later recorded in two of the patients with traumatic brain injury and in a control subject to help determine the functional significance of the relative positivity apparent in their movement-related potential data. This preliminary study indicates that electroencephalographic potentials obtained during the preparation for and execution of movement can provide information regarding the basis for motor dysfunction.	DEPT REHABIL MED, NEUROMUSCULAR RETRAINING CLIN, MADISON, WI 53705 USA								BARRETT G, 1987, ELECTROENCEPHALOGR C, V63, P340; BASHORE T, 1984, ANN NY ACAD SCI, V425, P415; BRUNIA CHM, 1980, BIOL PSYCHOL, V11, P181, DOI 10.1016/0301-0511(80)90054-X; BRUNIA CHM, 1984, ANN NY ACAD SCI, V425, P434, DOI 10.1111/j.1749-6632.1984.tb23564.x; BRUNIA CHM, 1981, BIOL PSYCHOL, V13, P261; CHISHOLM RC, 1988, INT J NEUROSCI, V42, P131, DOI 10.3109/00207458808985768; DEECKE L, 1985, HUM NEUROBIOL, V4, P143; DEECKE L, 1984, ANN NY ACAD SCI, V425, P398, DOI 10.1111/j.1749-6632.1984.tb23562.x; Deecke L., 1977, PROG CLIN NEUROPHYS, P151; GHEZ C, 1981, PRINCIPLES NEURAL SC, P271; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; GRUNEWALDZUBERB.E, 1984, ANN NY ACAD SCI, V425, P406; JERGELOVA M, 1980, ACTIV NERV SUPER, V22, P233; KARRER R, 1976, DEV PSYCHOPHYSIOLOGY, P361; KORNHUBER HH, 1984, ANN NY ACAD SCI, V425, P398; KRISTEVA R, 1984, ANN NY ACAD SCI, V425, P477, DOI 10.1111/j.1749-6632.1984.tb23570.x; KRISTEVA R, 1980, MOTIVATION MOTOR SEN, P748; Kutas M., 1977, PROGR CLIN NEUROPHYS, P189; SEMMES J, 1968, NEUROPSYCHOLOGIA, V6, P11, DOI 10.1016/0028-3932(68)90035-3; Shibasaki H, 1980, Prog Brain Res, V54, P237, DOI 10.1016/S0079-6123(08)61632-5; SHIBASAKI H, 1986, BRAIN RES, V368, P361, DOI 10.1016/0006-8993(86)90582-2; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1; YORK D H, 1989, Society for Neuroscience Abstracts, V15, P397	23	7	7	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JAN	1991	71	1					48	59		10.1093/ptj/71.1.48			12	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	EQ550	WOS:A1991EQ55000006	1984251				2022-02-06	
J	MCGUIRE, BE				MCGUIRE, BE			COMPUTER-ASSISTED COGNITIVE REHABILITATION	IRISH JOURNAL OF PSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; BRAIN-DAMAGE; MEMORY; REMEDIATION; SKILL		HOMERTON HOSP,NEUROLOG REHABIL,LONDON,ENGLAND								BENYISHAY Y, 1981, INT J REHABIL RES, V4, P208, DOI 10.1097/00004356-198106000-00012; BRACY OL, 1984, OCT TEX STAT OCC THE; BRACY OL, 1983, COGNITIVE REHABILITA, V1, P7; CARTER L, 1980, CLIN NEUROPSYCHOLOGY, V2, P109; CARTER LT, 1983, AM J OCCUP THER, V37, P320, DOI 10.5014/ajot.37.5.320; CRAINE JF, 1982, COGNITIVE REHABILITA; DICKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333; ERICSSON KA, 1980, SCIENCE, V208, P1181, DOI 10.1126/science.7375930; EVANS CD, 1981, REHABILITATION HEAD; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GORDON WA, 1985, ARCH PHYS MED REHAB, V66, P353; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HARRIS JE, 1984, CLIN MANAGEMENT MEMO; JOHNSON R, 1985, OCCUPATIONAL THERAPY, V48, P46; KATZ RC, 1984, COGNITIVE REHABILITA, V2, P8; KERNER M, 1985, COGNITIVE REHABILITA, V3, P26; LYNCH WJ, 1983, COGN REHABIL, V1, P19; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; MALEC J, 1984, COGNITIVE REHABILITA, V2, P18; MOFFAT N, 1984, CLIN MANAGEMENT MEMO; MOYER SB, 1979, CORTEX, V15, P139, DOI 10.1016/S0010-9452(79)80015-5; PARENTE F, 1983, COGNITIVE REHABILITA, V1, P20; POLLACK IW, 1984, J MED SOC NEW JERSEY, V82, P311; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Robertson I, 1988, Brain Inj, V2, P151, DOI 10.3109/02699058809150939; ROBERTSON IH, IN PRESS ARCH PHYSIC; SENA DA, 1984, 92ND ANN CONV AM PSY; SIVAK M, 1984, INT J REHABILITATION, V4, P389; SMART S, 1988, CLIN REHABIL, V2, P61; STONEMAN R, 1985, OCCUPATIONAL THERAPY, V48, P163; SWEETMAN ML, 1987, THESIS PLYMOUTH POLY; THOMSEN I V, 1981, Journal of Clinical Neuropsychology, V3, P43, DOI 10.1080/01688638108403112; Towle D, 2016, CLIN REHABIL, V2, P303, DOI [10.1177/026921558800200406, DOI 10.1177/026921558800200406], DOI 10.1177/026921558800200406]; Wilson BA, 1984, CLIN MANAGEMENT MEMO; WILSON PB, 1983, COGNITIVE REHABILITA, V1, P9; YOUNG GC, 1983, J CLIN NEUROPSYCHOL, V5, P201, DOI 10.1080/01688638308401169; [No title captured]	38	7	8	0	2	PSYCHOLOGICAL SOC IRELAND	DUBLIN	TRINITY COLLEGE DEPT PSYCHOLOGY 25 WESTLAND ROW, DUBLIN 2, IRELAND	0303-3910			IRISH J PSYCHOL	Irish J. Psychol.		1990	11	4					299	308		10.1080/03033910.1990.10557810			10	Psychology	Social Science Citation Index (SSCI)	Psychology	FD341	WOS:A1990FD34100001					2022-02-06	
J	PRIGATANO, GP				PRIGATANO, GP			BRING IT UP IN MILIEU - TOWARD EFFECTIVE TRAUMATIC BRAIN INJURY REHABILITATION INTERACTION	REHABILITATION PSYCHOLOGY			English	Article											PRIGATANO, GP (corresponding author), ST JOSEPHS HOSP & MED CTR,BARROW NEUROL INST,350 W THOMAS RD,PHOENIX,AZ 85013, USA.						BENYISHAY Y, REHABILITATION ADULT; DILLER L, 1987, NEUROPSYCHOL REHABIL, P3; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; GANS JS, 1987, REHABIL PSYCHOL, P185; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Maslach C., 1982, BURNOUT COST CARING; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PRIGATANO GP, 1988, BNI Q, V4, P40; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; PRIGATANO GP, 1986, BNI Q, V2, P9; Stern PH, 1971, STROKE, V2, P213, DOI 10.1161/01.STR.2.3.213; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO	15	7	7	0	1	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					135	144		10.1037//0090-5550.34.2.135			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400013					2022-02-06	
J	SLATER, EJ; BASSETT, SS				SLATER, EJ; BASSETT, SS			ADOLESCENTS WITH CLOSED HEAD-INJURIES - A REPORT OF INITIAL COGNITIVE DEFICITS	AMERICAN JOURNAL OF DISEASES OF CHILDREN			English	Article											SLATER, EJ (corresponding author), UNIV MARYLAND MED SYST,DEPT PEDIAT,DIV ADOLESCENT MED,22 S GREENE ST,BALTIMORE,MD 21201, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-240510] Funding Source: Medline		Benton A.L., 1983, CONTRIBUTIONS NEUROP; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CICERONE KD, 1983, NEUROPSYCHOLOGIA, V21, P513, DOI 10.1016/0028-3932(83)90007-6; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Geisler F.H., 1987, TRAUMA EMERGENCY SUR, P919; Heaton R.K., 1981, WISCONSIN CARD SORTI; JENNETT B, 1979, J PEDIATR PSYCHOL, V4, P389; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; Reitan R., 1979, MANUAL ADM NEUROPSYC; RICHARDSON F, 1963, DEV MED CHILD NEUROL, V5, P471; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Sattler J. M., 1981, ASSESSMENT CHILDRENS; STERN B, 1985, SCAND J REHAB MED S, V12, P27; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	23	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0002-922X			AM J DIS CHILD	Am. J. Dis. Child.	OCT	1988	142	10					1048	1051		10.1001/archpedi.1988.02150100042022			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	Q3249	WOS:A1988Q324900019	3177300				2022-02-06	
J	RAO, N; JELLINEK, HM; HARBERG, JK				RAO, N; JELLINEK, HM; HARBERG, JK			THE ART OF MEDICINE - SUBJECTIVE MEASURES AS PREDICTORS OF OUTCOME IN STROKE AND TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article									MENTAL HLTH CTR DANE CTY,MADISON,WI 53703; UNIV WISCONSIN,DEPT ONCOL,MADISON,WI 53792; UNIV WISCONSIN,DEPT IND ENGN,MADISON,WI 53792; UNIV WISCONSIN,DEPT PREVENT MED,MADISON,WI 53792		RAO, N (corresponding author), MARIANJOY REHABIL CTR,POB 795,WHEATON,IL 60189, USA.						CHRISTIE D, 1982, J EPIDEMIOL COMMUN H, V36, P123, DOI 10.1136/jech.36.2.123; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DELISA JA, 1982, AM FAM PHYSICIAN, V26, P207; GIBSON CJ, 1974, ARCH PHYS MED REHAB, V55, P398; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GRESHAM GE, 1975, NEW ENGL J MED, V293, P954, DOI 10.1056/NEJM197511062931903; HARVEY RF, 1981, ARCH PHYS MED REHAB, V62, P456; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P87; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RAO N, 1984, ARCH PHYS MED REHAB, V65, P18; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SHAPIRO AR, 1977, NEW ENGL J MED, V296, P1509, DOI 10.1056/NEJM197706302962607; TEASDALE G, 1974, LANCET, V2, P81; TIMMING R, 1982, ARCH PHYS MED REHAB, V63, P154; TORKELSON RM, 1983, REHABIL PSYCHOL, V28, P169, DOI 10.1037/h0090992	20	7	7	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1988	69	3					179	182					4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	M5917	WOS:A1988M591700005	3348715				2022-02-06	
J	RING, IT; BERRY, G; DAN, NG; KWOK, B; MANDRYK, JA; NORTH, JB; SELECKI, BR; SEWELL, MF; SIMPSON, DA; STENING, WA; VANDERFIELD, GK				RING, IT; BERRY, G; DAN, NG; KWOK, B; MANDRYK, JA; NORTH, JB; SELECKI, BR; SEWELL, MF; SIMPSON, DA; STENING, WA; VANDERFIELD, GK			EPIDEMIOLOGY AND CLINICAL OUTCOMES OF NEUROTRAUMA IN NEW-SOUTH-WALES	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article											RING, IT (corresponding author), QUEENSLAND DEPT HLTH,CANC EPIDEMIOL & PREVENT UNIT,GPO BOX 48,BRISBANE,QLD 4001,AUSTRALIA.							0	7	7	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	JUL	1986	56	7					557	566		10.1111/j.1445-2197.1986.tb07099.x			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	D5284	WOS:A1986D528400006	3090991				2022-02-06	
J	OLBRICH, HM; LANCZOS, L; LODEMANN, E; ZERBIN, D; ENGELMEIER, MP; NAU, HE; SCHMITNEUERBURG, KP				OLBRICH, HM; LANCZOS, L; LODEMANN, E; ZERBIN, D; ENGELMEIER, MP; NAU, HE; SCHMITNEUERBURG, KP			EVENT-RELATED BRAIN POTENTIALS AND COGNITIVE IMPAIRMENT - A STUDY IN PATIENTS WITH BRAIN-TUMOR AND TRAUMATIC HEAD-INJURY	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article									UNIV ESSEN GESAMTHSCH, KLINIKUM, ALLGEMEINE PSYCHIAT KLIN, D-4300 ESSEN 1, FED REP GER; UNIV ESSEN GESAMTHSCH, KLINIKUM, NEUROCHIRURG KLIN, D-4300 ESSEN 1, FED REP GER; UNIV ESSEN GESAMTHSCH, KLINIKUM, UNFALLCHIRURG ABT, D-4300 ESSEN 1, FED REP GER								Baumler G., 1974, LGT3; Brickenkamp R., 1981, AUFMERKSAMKEITS BELA; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Brown W S, 1982, Bull Los Angeles Neurol Soc, V47, P91; BROWN WS, 1983, ELECTROEN CLIN NEURO, V55, P277, DOI 10.1016/0013-4694(83)90205-5; Callaway E, 1978, EVENT RELATED BRAIN; Donchin E., 1978, EVENT RELATED BRAIN, P349; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAILLARD AW, 1983, TUTORIALS EVENT RELA; GOODIN DS, 1978, ELECTROEN CLIN NEURO, V44, P447, DOI 10.1016/0013-4694(78)90029-9; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; HANSCH EC, 1982, ANN NEUROL, V11, P599, DOI 10.1002/ana.410110608; Horn W, 1983, LEISTUNGSPRUFSYSTEM; KARRER R, 1984, ANN NEW YORK ACADEMY, V425; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; McCarthy G., 1983, TUTORIALS ERP RES EN, P251; MULDER DW, 1974, HDB CLIN NEUROLOGY, V16, P727; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; RITTER W, 1983, PSYCHOPHYSIOLOGY, V20, P168, DOI 10.1111/j.1469-8986.1983.tb03283.x; Ritter W., 1983, TUTORIALS ERP RES EN, P143; Ruchkin D. S., 1983, TUTORIALS EVENT RELA, V10, P233, DOI 10.1016/S0166-41150862042-7; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; Syndulko K, 1982, Adv Neurol, V32, P279; TEASDALE G, 1974, LANCET, V2, P81; ZWANGWILL OL, 1976, HDB CLIN NEUROLOGY, V24, P477	27	7	7	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	JUN	1986	54	6					182	188		10.1055/s-2007-1001863			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	C8272	WOS:A1986C827200002	3721380				2022-02-06	
J	ELLIS, DW; ZAHN, BS				ELLIS, DW; ZAHN, BS			PSYCHOLOGICAL FUNCTIONING AFTER SEVERE CLOSED HEAD-INJURY	JOURNAL OF PERSONALITY ASSESSMENT			English	Article											ELLIS, DW (corresponding author), DEVEREUX FDN,BOX 400,DEVON,PA 19333, USA.						Exner J.E., 1974, RORSCHACH COMPREHENS, V1; Goldfried MR., 1971, RORSCHACH HDB CLIN R; LEZAK MD, 1976, NEUROPSYCHOLOGICAL A; *NAT HEAD INJ F, 1979, SIL EP; Piotrowski Z.A., 1957, PERCEPTANALYSIS; WEINER IB, 1977, RORSCHACH PSYCHOL; [No title captured]	7	7	7	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262	0022-3891			J PERS ASSESS	J. Pers. Assess.		1985	49	2					125	128		10.1207/s15327752jpa4902_3			4	Psychology, Clinical; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	AHD26	WOS:A1985AHD2600003	3998981				2022-02-06	
J	LILLEHEI, KO; HOFF, JT				LILLEHEI, KO; HOFF, JT			ADVANCES IN THE MANAGEMENT OF CLOSED HEAD-INJURY	ANNALS OF EMERGENCY MEDICINE			English	Article									UNIV MICHIGAN, NEUROSURG SECT, ANN ARBOR, MI 48109 USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 177601-5] Funding Source: Medline		ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; FADEN AI, 1982, NEUROLOGY, V32, P1083, DOI 10.1212/WNL.32.10.1083; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, HEAD INJURY, P83; HARRIS RJ, 1982, STROKE, V13, P759, DOI 10.1161/01.STR.13.6.759; HOFF JT, 1978, CRIT CARE MED, V6, P245, DOI 10.1097/00003246-197807000-00005; HOSSMANN KA, 1982, J CEREBR BLOOD F MET, V2, P275, DOI 10.1038/jcbfm.1982.30; JENNET B, 1981, MANAGEMENT HEAD INJU, P361; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; LJUNGGREN B, 1974, BRAIN RES, V77, P173, DOI 10.1016/0006-8993(74)90782-3; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; MARSHALL LF, 1982, CLIN NEUR, V29, P312; MARSHALL LF, 1982, HEAD INJURY, P129; Miller J, 1982, NEUROLOGICAL SURG, P1896; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; PEERLESS SJ, 1981, STROKE, V12, P558, DOI 10.1161/01.STR.12.5.558; PRITZ MB, 1978, NEUROSURGERY, V3, P364, DOI 10.1227/00006123-197811000-00006; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1974, LANCET, V2, P81; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; WATERS D, J NEUROSURG; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	35	7	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.		1985	14	8					789	795		10.1016/S0196-0644(85)80059-7			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ANA29	WOS:A1985ANA2900016	3896062				2022-02-06	
J	ODONNELL, JM; THOMPSON, DR; LAYTON, TR				ODONNELL, JM; THOMPSON, DR; LAYTON, TR			THE EFFECT OF HIGH-FREQUENCY JET VENTILATION ON INTRACRANIAL-PRESSURE IN PATIENTS WITH CLOSED HEAD-INJURIES	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									MERCY HOSP,DIV CRIT CARE MED,PITTSBURGH,PA 15219								COURNAND A, 1948, AM J PHYSIOL, V152, P162; JAMES HE, 1977, ACTA NEUROCHIR, V36, P189, DOI 10.1007/BF01405391; JENNETT B, 1981, CONT NEUROLOGY SERIE, V20; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Miller J D, 1975, Clin Neurosurg, V22, P76; PONTOPPIDAN H, 1977, ANESTHESIOLOGY, V47, P96, DOI 10.1097/00000542-197708000-00003; QUIST J, 1975, ANESTHESIOLOGY, V42, P45; SJOSTRAND U, 1980, CRIT CARE MED, V8, P345; SNYDER JV, 1980, ANESTHESIA NEUROSURG; TODD MM, 1981, ANESTHESIOLOGY, V54, P496, DOI 10.1097/00000542-198106000-00009	11	7	7	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care		1984	24	1					73	75					3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	SB068	WOS:A1984SB06800013	6363723				2022-02-06	
J	TORKELSON, RM; JELLINEK, HM; MALEC, JF; HARVEY, RF				TORKELSON, RM; JELLINEK, HM; MALEC, JF; HARVEY, RF			TRAUMATIC BRAIN INJURY - PSYCHOLOGICAL AND MEDICAL FACTORS RELATED TO REHABILITATION OUTCOME	REHABILITATION PSYCHOLOGY			English	Article									MT SINAI MED CTR,MILWAUKEE,WI 53233; MARIANJOY REHABIL HOSP,WHEATON,IL		TORKELSON, RM (corresponding author), UNIV WISCONSIN,DEPT REHABIL MED,MADISON,WI 53792, USA.						BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; DAHLSTROM WG, 1972, CLIN INTERPRETATION, V1; FAHY TJ, 1967, LANCET, V2, P475; HARVEY RF, 1981, ARCH PHYS MED REHAB, V62, P456; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KALSBEEK WD, 1980, J NEUROSURGERY S; Klove H, 1972, Scand J Rehabil Med, V4, P55; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; NAJENSON R, 1980, INT J REHABILITATION, V2, P17; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; *US DEP ED, 1981, PROGR HAND, V6, P1; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	13	7	7	0	1	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.		1983	28	3					169	176		10.1037/h0090992			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	RE938	WOS:A1983RE93800004					2022-02-06	
J	GOVONS, SR				GOVONS, SR			BRAIN CONCUSSION AND POSTURE KNOCKDOWN BLOW OF BOXING RING	CONFINIA NEUROLOGICA			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P7; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Magnus R, 1926, LANCET, V2, P531; Magnus R, 1926, LANCET, V2, P585; Miller GG, 1927, ARCH SURG-CHICAGO, V14, P891, DOI 10.1001/archsurg.1927.01130160100005; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SHERRINGTON CS, 1947, INTEGRATIVE ACTION N, P324; SHERRINGTON CS, 1947, INTEGRATIVE ACTION N, P1; SPIEGEL E, 1946, FED P, V5, P98; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	11	7	7	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0010-5678			CONFIN NEUROL			1968	30	2					77	&					0	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	B5590	WOS:A1968B559000002	5698579				2022-02-06	
J	BROWN, GW; BROWN, ML; HINES, HM				BROWN, GW; BROWN, ML; HINES, HM			EFFECTS OF EXPERIMENTAL CONCUSSION ON BLOOD FLOW, ARTERIAL PRESSURE AND CARDIAC RATE	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																	Batson OV, 1944, FED PROC, V3, P139; BROWN ML, 1952, AM J PSYCHIAT, V109, P27, DOI 10.1176/ajp.109.1.27; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dixon KC, 1940, LANCET, V2, P360; RICHARDSON AW, 1949, J LAB CLIN MED, V34, P1706; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; WALKER AE, 1945, RES PUBL A NERV MENT, V24, P437	7	7	7	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1952	170	2					294	300		10.1152/ajplegacy.1952.170.2.294			7	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	UK951	WOS:A1952UK95100006	12985894				2022-02-06	
J	SPIEGELADOLF, M; WYCIS, HT; SPIEGEL, EA				SPIEGELADOLF, M; WYCIS, HT; SPIEGEL, EA			CEREBROSPINAL FLUID STUDIES IN CEREBRAL CONCUSSION	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article																	Caspersson T., 1940, Journal of the Royal Microscopical Society, V60, P8; EULER H, 1946, ARK KEMI MIN GEOL A, V22; Gersh Isidore, 1943, JOUR CELL AND COMP PHYSIOL, V21, P253, DOI 10.1002/jcp.1030210305; GREENSTEIN JP, 1944, ADV PROTEIN CHEM, V1, P267; JAKOB A, 1913, HISTOLOGISCHE HISTOP, V5, P182; MILLER ES, 1937, QUANTITATIVE BIOL SP, P147; ROUSSY G, 1924, TRAITE PATHOLOGIE ME, V2, P759; SPIEGEL EA, 1946, ARCH PATHOL, V42, P175; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12, DOI 10.1152/ajplegacy.1946.146.1.12; Spiegel-Adolf M, 1937, P SOC EXP BIOL MED, V37, P92; Spiegel-Adolf M, 1939, P SOC EXP BIOL MED, V40, P398; Spiegel-Adolf Mona, 1946, CONFINIA NEUROL [BASEL], V7, P77; SPIEGELADOLF M, 1945, FED PROC, V4, P105; SPIEGELADOLF M, 1945, J OPT SOC AM, V35, P800; SPIEGELADOLF M, 1946, FED PROC, V5, P156; SPIEGELADOLF M, 1946, J PHYS CHEM-US, V50, P447, DOI 10.1021/j150450a001; SPIEGELADOLF M, 1945, J NEUROPATH EXP NEUR, V4, P277, DOI 10.1097/00005072-194504030-00007; SPIEGELADOLF M, 1939, CONFIN NEUROL, V2, P228; SPIEGELADOLF M, IN PRESS CEREBROSPIN; SPIEGELADOLF M, 1939, J NERV MENT DIS, V89, P311; SPIEGELADOLF M, 1938, ARCH NEUROL PSYCHIAT, V39, P881; SPIEGELADOLF M, 1939, CONFIN NEUROL, V2, P1; Wadsworth A, 1936, J PHYS CHEM-US, V40, P739, DOI 10.1021/j150375a006; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	24	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.		1947	106	3					359	368		10.1097/00005053-194710630-00011			10	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	UU559	WOS:A1947UU55900012	20270239				2022-02-06	
J	SAVAGE, O				SAVAGE, O			PULMONARY CONCUSSION - (BLAST) IN NON-THORACIC BATTLE WOUNDS	LANCET			English	Article																	ZUCKERMAN S., 1941, Proceedings of the Royal Society of Medicine, V31, P171; Bernal JD, 1941, NATURE, V147, P594, DOI 10.1038/147594a0; Hadfield G, 1940, LANCET, V2, P478; HADFIELD G, 1941, P ROY SOC MED, V34, P189; HADFIELD G, 1941, BRIT MED J, V2, P239; HADFIELD G, LANCET, V2, P197; HADFIELD G, 1941, BRIT MED J, V1, P77; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Nicholson WF, 1944, LANCET, V1, P299; OSBORN GR, 1943, LANCET, V2, P277; Wakeley Cecil P G, 1943, Glasgow Med J, V139, P91; Wiles P, 1944, LANCET, V1, P523; Zuckerman S, 1940, LANCET, V2, P219	13	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet		1945	248	APR7					424	429					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UB058	WOS:A1945UB05800002					2022-02-06	
J	Auster, LS; Willard, JH				Auster, LS; Willard, JH			Hydraulic abdominal concussion - The syndrome of intra abdominal underwater blast injury	JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0002-9955			J AMER MED ASSOC	J. Am. Med. Assoc.	JAN-APR	1943	121						995	999		10.1001/jama.1943.02840130009003			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V24LP	WOS:000201652500262					2022-02-06	
J	Wolff, K				Wolff, K			Fundamentals of the problem of spontaneous apoplectic brain haemorrhages. Angionecrosis in traumatic brain fractures, development over time of pro and regressive tissue changes in traumatically injured brain tissue, injuries to the vessel linings in striatum arteries, evidence of vessel ruptures. Part I.	BEITRAGE ZUR PATHOLOGISCHEN ANATOMIE UND ZUR ALLGEMEINEN PATHOLOGIE			German	Article																		0	7	7	0	0	GUSTAV FISCHER VERLAG JENA	JENA	VILLENGANG 2, D-07745 JENA, GERMANY	0366-2446			BEITR PATHOL ANAT AL			1932	89	2					249	310					62	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	V15YZ	WOS:000201078900001					2022-02-06	
J	Di Pietro, V; O'Halloran, P; Watson, CN; Begum, G; Acharjee, A; Yakoub, KM; Bentley, C; Davies, DJ; Iliceto, P; Candilera, G; Menon, DK; Cross, MJ; Stokes, KA; Kemp, SPT; Belli, A				Di Pietro, Valentina; O'Halloran, Patrick; Watson, Callum N.; Begum, Ghazala; Acharjee, Animesh; Yakoub, Kamal M.; Bentley, Conor; Davies, David J.; Iliceto, Paolo; Candilera, Gabriella; Menon, David K.; Cross, Matthew J.; Stokes, Keith A.; Kemp, Simon P. T.; Belli, Antonio			Unique diagnostic signatures of concussion in the saliva of male athletes: the Study of Concussion in Rugby Union through MicroRNAs (SCRUM)	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						trauma; concussion; brain; contact sports; diagnosis	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-MATRIX; TEMPORAL WINDOW; TRANSFER-RNA; IN-VITRO; BIOMARKERS; MILD; SERUM; VULNERABILITY; EXPRESSION	Objective To investigate the role of salivary small non-coding RNAs (sncRNAs) in the diagnosis of sport-related concussion. Methods Saliva was obtained from male professional players in the top two tiers of England's elite rugby union competition across two seasons (2017-2019). Samples were collected preseason from 1028 players, and during standardised head injury assessments (HIAs) at three time points (in-game, post-game, and 36-48 hours post-game) from 156 of these. Samples were also collected from controls (102 uninjured players and 66 players sustaining a musculoskeletal injury). Diagnostic sncRNAs were identified with next generation sequencing and validated using quantitative PCR in 702 samples. A predictive logistic regression model was built on 2017-2018 data (training dataset) and prospectively validated the following season (test dataset). Results The HIA process confirmed concussion in 106 players (HIA+) and excluded this in 50 (HIA-). 32 sncRNAs were significantly differentially expressed across these two groups, with let-7f-5p showing the highest area under the curve (AUC) at 36-48 hours. Additionally, a combined panel of 14 sncRNAs (let-7a-5p, miR-143-3p, miR-103a-3p, miR-34b-3p, RNU6-7, RNU6-45, Snora57, snoU13.120, tRNA18Arg-CCT, U6-168, U6-428, U6-1249, Uco22cjg1,YRNA_255) could differentiate concussed subjects from all other groups, including players who were HIA- and controls, immediately after the game (AUC 0.91, 95% CI 0.81 to 1) and 36-48 hours later (AUC 0.94, 95% CI 0.86 to 1). When prospectively tested, the panel confirmed high predictive accuracy (AUC 0.96, 95% CI 0.92 to 1 post-game and AUC 0.93, 95% CI 0.86 to 1 at 36-48 hours). Conclusions SCRUM, a large prospective observational study of non-invasive concussion biomarkers, has identified unique signatures of concussion in saliva of male athletes diagnosed with concussion.	[Di Pietro, Valentina; O'Halloran, Patrick; Watson, Callum N.; Davies, David J.; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Birmingham 9000, W Midlands, England; [Di Pietro, Valentina; Acharjee, Animesh; Yakoub, Kamal M.; Bentley, Conor; Davies, David J.; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Di Pietro, Valentina; O'Halloran, Patrick; Begum, Ghazala; Belli, Antonio] Birmingham Res Pk, BioHub, Marker Diagnost UK Ltd, Birmingham, W Midlands, England; [Acharjee, Animesh] Univ Birmingham, Ctr Computat Biol, Inst Canc & Genom Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Acharjee, Animesh] Univ Hosp Birmingham NHS Fdn Trust, Inst Translat Med, Birmingham, W Midlands, England; [Iliceto, Paolo; Candilera, Gabriella] S&P Stat & Psychometr Ltd, Rome, Italy; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Cross, Matthew J.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Cross, Matthew J.] Premier Rugby Ltd, London, England; [Stokes, Keith A.; Kemp, Simon P. T.] Rugby Football Union, London, England; [Kemp, Simon P. T.] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England		Di Pietro, V; Belli, A (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Birmingham 9000, W Midlands, England.	v.dipietro@bham.ac.uk; a.belli@bham.ac.uk	Acharjee, Animesh/AAC-7637-2019; Belli, Antonio/I-3799-2015	Acharjee, Animesh/0000-0003-2735-7010; Bentley, Conor/0000-0003-3021-4838; Di Pietro, Valentina/0000-0001-9430-4723; Belli, Antonio/0000-0002-3211-9933; O'Halloran, Patrick/0000-0002-1185-3485; Watson, Callum Nicholas/0000-0003-2511-5501	National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Rugby Football Union; Midland Neuroscience Teaching and Research Fund (MNTRF); Marker Diagnostics; National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC)	The study was funded by the National Institute for Health Research (NIHR), Medical Research Council (MRC), Rugby Football Union, Midland Neuroscience Teaching and Research Fund (MNTRF) and Marker Diagnostics. The NIHR, MRC and MNTRF had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. This study was supported by the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC). The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care or the other funders.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Berretta S, 2012, NEUROPHARMACOLOGY, V62, P1584, DOI 10.1016/j.neuropharm.2011.08.010; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hicks SD, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.197; Hicks SD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207758; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Jones CMC, 2020, BRAIN INJURY, V34, P407, DOI 10.1080/02699052.2020.1725123; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li HJ, 2018, NEUROPHARMACOLOGY, V137, P33, DOI 10.1016/j.neuropharm.2018.04.028; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miguel-Hidalgo JJ, 2017, PROG NEURO-PSYCHOPH, V79, P503, DOI 10.1016/j.pnpbp.2017.08.009; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Stokes KA, 2021, BRIT J SPORT MED, V55, P220, DOI [10.1136/bjsports-2019-101557, 10.1136/bjsports-2020-101983]; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Teng GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056709; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Yakoub KM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029883; Yakoub KM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024245; Zhao H, 2000, J CELL BIOCHEM, V76, P109, DOI 10.1002/(SICI)1097-4644(20000101)76:1<109::AID-JCB11>3.0.CO;2-K	45	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2021	55	24					1395	1404		10.1136/bjsports-2020-103274			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XK9EU	WOS:000727760100005	33757972	Green Published, hybrid			2022-02-06	
J	Edlow, BL; Sanz, LRD; Polizzotto, L; Pouratian, N; Rolston, JD; Snider, SB; Thibaut, A; Stevens, RD; Gosseries, O				Edlow, Brian L.; Sanz, Leandro R. D.; Polizzotto, Len; Pouratian, Nader; Rolston, John D.; Snider, Samuel B.; Thibaut, Aurore; Stevens, Robert D.; Gosseries, Olivia		Curing Coma Campaign Its Contribut	Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions	NEUROCRITICAL CARE			English	Article						Coma; Consciousness; Disorders of consciousness; Gap analysis; Precision medicine	TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE-STIMULATION; ULTRASONIC THALAMIC-STIMULATION; ALTERNATING-CURRENT STIMULATION; ANTERIOR FOREBRAIN MESOCIRCUIT; CALORIC VESTIBULAR REACTIONS; PLACEBO-CONTROLLED TRIAL; SPINAL-CORD STIMULATION; GLASGOW OUTCOME SCALE; VEGETATIVE STATE	Background/Objective For patients with disorders of consciousness (DoC) and their families, the search for new therapies has been a source of hope and frustration. Almost all clinical trials in patients with DoC have been limited by small sample sizes, lack of placebo groups, and use of heterogeneous outcome measures. As a result, few therapies have strong evidence to support their use; amantadine is the only therapy recommended by current clinical guidelines, specifically for patients with DoC caused by severe traumatic brain injury. To foster and advance development of consciousness-promoting therapies for patients with DoC, the Curing Coma Campaign convened a Coma Science Work Group to perform a gap analysis. Methods We consider five classes of therapies: (1) pharmacologic; (2) electromagnetic; (3) mechanical; (4) sensory; and (5) regenerative. For each class of therapy, we summarize the state of the science, identify gaps in knowledge, and suggest future directions for therapy development. Results Knowledge gaps in all five therapeutic classes can be attributed to the lack of: (1) a unifying conceptual framework for evaluating therapeutic mechanisms of action; (2) large-scale randomized controlled trials; and (3) pharmacodynamic biomarkers that measure subclinical therapeutic effects in early-phase trials. To address these gaps, we propose a precision medicine approach in which clinical trials selectively enroll patients based upon their physiological receptivity to targeted therapies, and therapeutic effects are measured by complementary behavioral, neuroimaging, and electrophysiologic endpoints. Conclusions This personalized approach can be realized through rigorous clinical trial design and international collaboration, both of which will be essential for advancing the development of new therapies and ultimately improving the lives of patients with DoC.	[Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, 175 Cambridge St Suite 300, Boston, MA 02114 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.] Harvard Med Sch, Charlestown, MA USA; [Sanz, Leandro R. D.; Thibaut, Aurore; Gosseries, Olivia] Univ Liege, GIGA, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Sanz, Leandro R. D.; Thibaut, Aurore; Gosseries, Olivia] Univ Hosp Liege, Ctr Cerveau, Liege, Belgium; [Polizzotto, Len] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Pouratian, Nader] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA USA; [Rolston, John D.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Rolston, John D.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT USA; [Snider, Samuel B.] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Snider, Samuel B.] Harvard Med Sch, Boston, MA 02115 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA		Edlow, BL (corresponding author), Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, 175 Cambridge St Suite 300, Boston, MA 02114 USA.	bedlow@mgh.harvard.edu		Hemphill, Claude/0000-0003-4019-7525	Neurocritical Care Society; National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS109627, RF1NS115268, K23NS114178]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2HD101400]; National Institutes of Health Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM135420]; University of Liege and University Hospital of Liege; Belgian National Fund for Scientific ResearchFonds de la Recherche Scientifique - FNRS; Generet Fund of the King Baudouin Foundation; Marie Sklodowska-Curie Actions [H2020-MSCA-IF-2016-ADOC-752686]; European Union's Horizon 2020 Framework Program for Research and Innovation under Specific Grant (Human Brain Project SGA3) [945539]; James S. McDonnell Foundation; Tiny Blue Dot Foundation; Mind Science Foundation; BIAL FoundationBial Foundation; AstraZeneca FoundationAstraZeneca	This work was supported by the Neurocritical Care Society, the National Institutes of Health National Institute of Neurological Disorders and Stroke (R21NS109627, RF1NS115268, K23NS114178), the National Institutes of Health Director's Office (DP2HD101400), the National Institutes of Health Institute of General Medical Sciences (R01GM135420), the University of Liege and University Hospital of Liege, the Belgian National Fund for Scientific Research (research fellow grant to LRDS and research associate mandate to OG), the Generet Fund of the King Baudouin Foundation, the Marie Sklodowska-Curie Actions (H2020-MSCA-IF-2016-ADOC-752686), the European Union's Horizon 2020 Framework Program for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the James S. McDonnell Foundation, the Tiny Blue Dot Foundation, the Mind Science Foundation, the BIAL Foundation, and the AstraZeneca Foundation.	Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Alkhachroum A, 2020, J NEUROL NEUROSUR PS, V91, P675, DOI 10.1136/jnnp-2019-322645; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Anderson CJ, 2020, BRAIN STIMUL, V13, P1040, DOI 10.1016/j.brs.2020.03.017; Anderson DN, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aae590; Anderson DN, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa14b; Arnts H, 2020, CORTEX, V132, P135, DOI 10.1016/j.cortex.2020.08.011; Arnts H, 2020, J NEUROTRAUM, V37, P2150, DOI 10.1089/neu.2020.7129; Ashkan K, 2017, NAT REV NEUROL, V13, P548, DOI 10.1038/nrneurol.2017.105; Asrican B, 2020, NEURON, V108, P349, DOI 10.1016/j.neuron.2020.07.039; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bai Y, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00473; Baloh RW, 2000, NEUROLOGY, V54, P2138, DOI 10.1212/WNL.54.11.2138; Barra ME, 2020, J INTENSIVE CARE MED, V35, P1196, DOI 10.1177/0885066619841603; Battistella G, 2017, BRAIN STRUCT FUNCT, V222, P2203, DOI 10.1007/s00429-016-1336-4; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Berkowitz AL, 2016, NEW ENGL J MED, V375, P196, DOI 10.1056/NEJMc1600188; Billot B, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117287; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blethyn Kate L., 2008, Thalamus & Related Systems, V4, P13, DOI 10.1017/S1472928807000325; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Bystritsky A, 2011, BRAIN STIMUL, V4, P125, DOI 10.1016/j.brs.2011.03.007; Cain JA, 2021, BRAIN STIMUL, V14, P301, DOI 10.1016/j.brs.2021.01.008; Carboncini MC, 2014, RESTOR NEUROL NEUROS, V32, P767, DOI 10.3233/RNN-140426; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Cavinato M, 2019, CLIN NEUROPHYSIOL, V130, P231, DOI 10.1016/j.clinph.2018.10.018; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; Chow SC, 2014, ANNU REV MED, V65, P405, DOI 10.1146/annurev-med-092012-112310; Chudy Darko, 2018, J Neurosurg, V128, P1189, DOI 10.3171/2016.10.JNS161071; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Clauss RP, 2011, MED HYPOTHESES, V77, P209, DOI 10.1016/j.mehy.2011.04.014; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Deco G, 2019, P NATL ACAD SCI USA, V116, P18088, DOI 10.1073/pnas.1905534116; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Dhamapurkar SK, 2017, DISABIL REHABIL, V39, P2633, DOI 10.1080/09638288.2016.1236414; Diamond BR, 2020, METHODSX, V7, DOI 10.1016/j.mex.2020.100994; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Drover JD, 2010, J COMPUT NEUROSCI, V28, P605, DOI 10.1007/s10827-010-0244-5; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; Duffley G, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab3c95; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2020, NEUROCRIT CARE, V33, P364, DOI 10.1007/s12028-020-01062-7; Edlow BL, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0254-8; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Eldabe S, 2016, PAIN MED, V17, P325, DOI 10.1093/pm/pnv025; Elias GJB, 2021, BRAIN, V144, P712, DOI 10.1093/brain/awaa374; Engel K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198529; Engelhardt J, 2018, STEREOT FUNCT NEUROS, V96, P364, DOI 10.1159/000494982; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225; Fins JJ, 2018, NEUROLOGY, V91, P471, DOI 10.1212/WNL.0000000000005927; Formisano R, 2019, EUR J PHYS REHAB MED, V55, P139, DOI 10.23736/S1973-9087.18.05441-2; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Fridman EA, 2019, BRAIN, V142, P1887, DOI 10.1093/brain/awz118; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Glass JD, 2016, NEUROLOGY, V87, P392, DOI 10.1212/WNL.0000000000002889; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Grabherr L, 2015, MULTISENS RES, V28, P653, DOI 10.1163/22134808-00002495; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hakon J, 2020, NEUROMODULATION, V23, P859, DOI 10.1111/ner.13148; Hannawi Y, 2020, NEUROCRIT CARE, V33, P358, DOI 10.1007/s12028-020-01065-4; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; Hazell AS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00118; He FP, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5036184; He RH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.583268; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrington TM, 2016, J NEUROPHYSIOL, V115, P19, DOI 10.1152/jn.00281.2015; Herrold Amy A, 2014, ScientificWorldJournal, V2014, P964578, DOI 10.1155/2014/964578; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Horn A, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117180; Horn A, 2019, CURR OPIN NEUROL, V32, P511, DOI 10.1097/WCO.0000000000000679; Horn A, 2019, NEUROIMAGE, V184, P293, DOI 10.1016/j.neuroimage.2018.08.068; Iglesias JE, 2018, NEUROIMAGE, V183, P314, DOI 10.1016/j.neuroimage.2018.08.012; Jang SH, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1607-9; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jensen A, 2013, Case Rep Transplant, V2013, P951827, DOI 10.1155/2013/951827; Johnson KA, 2020, BRAIN, V143, P2607, DOI 10.1093/brain/awaa188; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Kang YJ, 2017, J NEUROTRAUM, V34, P2823, DOI 10.1089/neu.2016.4852; Kenny JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131914; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Kletzel SL, 2020, J HEAD TRAUMA REHAB, V35, P430, DOI 10.1097/HTR.0000000000000636; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Kondziella D, 2021, NEUROCRIT CARE, V35, P27, DOI 10.1007/s12028-021-01246-9; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Kotchoubey B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01763; Kubanek J, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.11.FOCUS17621; Kundu B, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18168; Lant ND, 2016, NEUROIMAGE-CLIN, V10, P27, DOI 10.1016/j.nicl.2015.11.004; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lefaucheur JP, 2020, CLIN NEUROPHYSIOL, V131, P474, DOI 10.1016/j.clinph.2019.11.002; Legostaeva L, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050103; Lei J, 2015, J NEUROTRAUM, V32, P1584, DOI 10.1089/neu.2014.3768; Lemaire JJ, 2018, ANN CLIN TRANSL NEUR, V5, P1372, DOI 10.1002/acn3.648; Lempka SF, 2010, CLIN NEUROPHYSIOL, V121, P2128, DOI 10.1016/j.clinph.2010.04.026; Li XL, 2020, J NEUROSCI NURS, V52, P146, DOI 10.1097/JNN.0000000000000511; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Liu P, 2016, EUR NEUROL, V76, P1, DOI 10.1159/000447325; Loggini A, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105815; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Lozano AM, 2019, NAT REV NEUROL, V15, P148, DOI 10.1038/s41582-018-0128-2; Lutkenhoff ES, 2020, NEUROLOGY, V95, pE2398, DOI 10.1212/WNL.0000000000010825; Magee WL, 2015, ANN NY ACAD SCI, V1337, P256, DOI 10.1111/nyas.12633; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Margetis K, 2014, NEUROMODULATION, V17, P699, DOI 10.1111/ner.12147; Martens G, 2018, BRAIN STIMUL, V11, P982, DOI 10.1016/j.brs.2018.04.021; Martens G, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120162; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Mccoy TH, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu078; McGlothlin AE, 2014, JAMA-J AM MED ASSOC, V312, P1342, DOI 10.1001/jama.2014.13128; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Mensen A, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00062; Miller JP, 2016, NEUROMODULATION, V19, P373, DOI 10.1111/ner.12438; MINDERHOUD JM, 1976, ACTA NEUROCHIR, V34, P23, DOI 10.1007/BF01405860; Montgomery EB, 2006, CLIN NEUROPHYSIOL, V117, P2691, DOI 10.1016/j.clinph.2006.08.011; Monti MM, 2016, BRAIN STIMUL, V9, P940, DOI 10.1016/j.brs.2016.07.008; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nardone R, 2020, J NEURAL TRANSM, V127, P1209, DOI 10.1007/s00702-020-02233-8; Naro A, 2016, BRAIN TOPOGR, V29, P623, DOI 10.1007/s10548-016-0489-z; Naro A, 2015, NEUROREHAB NEURAL RE, V29, P603, DOI 10.1177/1545968314562114; Noe E, 2020, BRAIN STIMUL, V13, P427, DOI 10.1016/j.brs.2019.12.005; O'Kelly J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00884; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Pape TLB, 2020, J HEAD TRAUMA REHAB, V35, P371, DOI 10.1097/HTR.0000000000000634; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; Perlmutter JS, 2002, NEUROLOGY, V58, P1388, DOI 10.1212/WNL.58.9.1388; Perrin F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01102; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Pincherle A, 2019, ANN NEUROL, V85, P443, DOI 10.1002/ana.25417; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Pistoia F, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-014-0466-8; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Rezai AR, 2016, NEUROSURGERY, V79, P204, DOI 10.1227/NEU.0000000000001190; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; Rodriguez-Rojas R, 2013, BRAIN INJURY, V27, P1320, DOI 10.3109/02699052.2013.794961; Rossi S, 2021, CLIN NEUROPHYSIOL, V132, P269, DOI 10.1016/j.clinph.2020.10.003; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Sauerbeck AD, 2020, NEURON, V107, P257, DOI 10.1016/j.neuron.2020.04.012; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Schartner MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46421; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00297; Schnakers C, 2015, PM&R, V7, pS270, DOI 10.1016/j.pmrj.2015.09.016; Schweitzer JS, 2020, NEW ENGL J MED, V382, P1926, DOI 10.1056/NEJMoa1915872; Scott G, 2019, NEUROSCI CONSCIOUS, V5, DOI 10.1093/nc/niz003; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Siddiqi SH, 2020, AM J PSYCHIAT, V177, P435, DOI 10.1176/appi.ajp.2019.19090915; Sidhaye J, 2021, CELL DEATH DIFFER, V28, P52, DOI 10.1038/s41418-020-0566-4; Silva S, 2017, CRIT CARE MED, V45, pE763, DOI 10.1097/CCM.0000000000002379; Sironi VA, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00042; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Sokoliuk R, 2021, ANN NEUROL, V89, P646, DOI 10.1002/ana.25995; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Storm JF, 2017, J NEUROSCI, V37, P10882, DOI 10.1523/JNEUROSCI.1838-17.2017; Su JH, 2019, NEUROIMAGE, V194, P272, DOI 10.1016/j.neuroimage.2019.03.021; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Sutton JA, 2017, BRAIN INJURY, V31, P1019, DOI 10.1080/02699052.2017.1300836; Tang HL, 2019, CURR PHARM DESIGN, V25, P4208, DOI 10.2174/1381612825666191029101830; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Toffa DH, 2020, SEIZURE-EUR J EPILEP, V83, P104, DOI 10.1016/j.seizure.2020.09.027; Tononi G, 2016, NAT REV NEUROSCI, V17, P450, DOI 10.1038/nrn.2016.44; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; Tsubokawa T, 1990, Brain Inj, V4, P315; Tucker C, 2016, NEUROCRIT CARE, V24, P488, DOI 10.1007/s12028-015-0227-5; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; VANWEERDEN TW, 1975, CLIN NEUROL NEUROSUR, V78, P41, DOI 10.1016/S0303-8467(75)80006-0; Vanzan S, 2017, CLIN REHABIL, V31, P500, DOI 10.1177/0269215516646167; Victor JD, 2011, P NATL ACAD SCI USA, V108, P15631, DOI 10.1073/pnas.1012168108; Vilensky JA, 2002, SURG NEUROL, V58, P425, DOI 10.1016/S0090-3019(02)00920-5; Vogel D, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102271; Vorwerk J, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab35b1; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Wroblewski Bruno, 1993, Brain Injury, V7, P353, DOI 10.3109/02699059309034962; Wu M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/7089543; Xia XY, 2019, NEUROREPORT, V30, P1307, DOI 10.1097/WNR.0000000000001362; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Xu YY, 2019, NEUROMODULATION, V22, P347, DOI 10.1111/ner.12903; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yoo SS, 2011, NEUROREPORT, V22, P783, DOI 10.1097/WNR.0b013e32834b2957; Yu YT, 2017, BRAIN STIMUL, V10, P328, DOI 10.1016/j.brs.2016.12.004; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8; Zhang XY, 2021, NEURAL REGEN RES, V16, P1266, DOI 10.4103/1673-5374.301021; Zheng T, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00172	240	6	6	8	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUL	2021	35	SUPPL 1		1	SI		68	85		10.1007/s12028-021-01227-y			18	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TG3ZR	WOS:000671346400007	34236624	hybrid, Green Published			2022-02-06	
J	Robba, C; Graziano, F; Rebora, P; Elli, F; Giussani, C; Oddo, M; Meyfroidt, G; Helbok, R; Taccone, FS; Prisco, L; Vincent, JL; Suarez, JI; Stocchetti, N; Citerio, G				Robba, Chiara; Graziano, Francesca; Rebora, Paola; Elli, Francesca; Giussani, Carlo; Oddo, Mauro; Meyfroidt, Geert; Helbok, Raimund; Taccone, Fabio S.; Prisco, Lara; Vincent, Jean-Louis; Suarez, Jose, I; Stocchetti, Nino; Citerio, Giuseppe		SYNAPSE-ICU Investigators	Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU) : an international, prospective observational cohort study	LANCET NEUROLOGY			English	Article							CEREBRAL PERFUSION-PRESSURE; CONSENSUS CONFERENCE; NEUROCRITICAL CARE; MANAGEMENT; GUIDELINES; PROFESSIONALS; HYPERTENSION; HEMORRHAGE; MORTALITY; SOCIETY	Background The indications for intracranial pressure (ICP) monitoring in patients with acute brain injury and the effects of ICP on patients' outcomes are uncertain. The aims of this study were to describe current ICP monitoring practises for patients with acute brain injury at centres around the world and to assess variations in indications for ICP monitoring and interventions, and their association with long-term patient outcomes. Methods We did a prospective, observational cohort study at 146 intensive care units (ICUs) in 42 countries. We assessed for eligibility all patients aged 18 years or older who were admitted to the ICU with either acute brain injury due to primary haemo-rrhagic stroke (including intracranial haemorrhage or subarachnoid haemorrhage) or traumatic brain injury. We included patients with altered levels of consciousness at ICU admission or within the first 48 h after the brain injury, as defined by the Glasgow Coma Scale (GCS) eye response score of 1 (no eye opening) and a GCS motor response score of at least 5 (not obeying commands). Patients not admitted to the ICU or with other forms of acute brain injury were excluded from the study. Between-centre differences in use of ICP monitoring were quantified by using the median odds ratio (MOR). We used the therapy intensity level (TIL) to quantify practice variations in ICP interventions. Primary endpoints were 6 month mortality and 6 month Glasgow Outcome Scale Extended (GOSE) score. A propensity score method with inverse probability of treatment weighting was used to estimate the association between use of ICP monitoring and these 6 month outcomes, independently of measured baseline covariates. This study is registered with ClinicalTrial.gov, NCT03257904. Findings Between March 15, 2018, and April 30, 2019, 4776 patients were assessed for eligibility and 2395 patients were included in the study, including 1287 (54%) with traumatic brain injury, 587 (25%) with intracranial haemorrhage, and 521 (22%) with subarachnoid haemorrhage. The median age of patients was 55 years (IQR 39-69) and 1567 (65%) patients were male. Considerable variability was recorded in the use of ICP monitoring across centres (MOR 4.5, 95% CI 3.8-4.9 between two randomly selected centres for patients with similar covariates). 6 month mortality was lower in patients who had ICP monitoring (441/1318 [34%]) than in those who were not monitored (517/1049 [49%]; p<0.0001). ICP monitoring was associated with significantly lower 6 month mortality in patients with at least one unreactive pupil (hazard ratio [HR] 0.35, 95% CI 0.26-0.47; p<0.0001), and better neurological outcome at 6 months (odds ratio 0.38, 95% CI 0.26-0.56; p=0.0025). Median TIL was higher in patients with ICP monitoring (9 [IQR 7-12]) than in those who were not monitored (5 [3-8]; p<0.0001) and an increment of one point in TIL was associated with a reduction in mortality (HR 0.94, 95% CI 0.91-0.98; p=0.0011). Interpretation The use of ICP monitoring and ICP management varies greatly across centres and countries. The use of ICP monitoring might be associated with a more intensive therapeutic approach and with lower 6-month mortality in more severe cases. Intracranial hypertension treatment guided by monitoring might be considered in severe cases due to the potential associated improvement in long-term clinical results. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Robba, Chiara] IRCCS, Policlin San Martino, Anesthesia & Intens Care, Oncol & Neurosci, Genoa, Italy; [Robba, Chiara] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Graziano, Francesca; Rebora, Paola; Elli, Francesca; Giussani, Carlo; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Graziano, Francesca; Rebora, Paola] Univ Milano Bicocca, Bicocca Bioinformat Biostat & Bioimaging Ctr B4, Sch Med & Surg, Milan, Italy; [Giussani, Carlo] Azienda Sociosanit Terr Monza, Osped San Gerardo, Neurosurg, Monza, Italy; [Oddo, Mauro] CHUV Lausanne Univ Hosp, Dept Intens Care Med, Lausanne, Switzerland; [Meyfroidt, Geert] Univ Hosp, Dept Intens Care Med, Leuven, Belgium; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Innsbruck, Austria; [Taccone, Fabio S.; Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Prisco, Lara] Oxford Univ Hosp Trust, Nuffield Dept Clin Neurosci, Oxford, England; [Suarez, Jose, I] Johns Hopkins Univ, Div Neurosci Crit Care, Sch Med, Baltimore, MD USA; [Stocchetti, Nino] Univ Milan, Dept Physiopathol & Transplant, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Citerio, Giuseppe] Osped San Gerardo, Azienda Sociosanit Terr Monza, Neurointens Care Unit, Monza, Italy		Citerio, G (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.	giuseppe.citerio@unimib.it	Krieg, Sandro M./L-8902-2016; Elhadi, Muhammed/AAU-5641-2020; Ozair, Ahmad/B-9701-2018; GIUSSANI, CARLO GIORGIO/AAC-2941-2022; Galarza, Laura/ABB-2294-2020; MAKRIS, DEMOSTHENES/J-5953-2015; Lamperti, Massimo/AAD-4836-2022; Gritsan, Alexey/M-4261-2014	Krieg, Sandro M./0000-0003-4050-1531; Elhadi, Muhammed/0000-0001-6406-4212; Ozair, Ahmad/0000-0001-6570-4541; GIUSSANI, CARLO GIORGIO/0000-0002-9033-2927; Galarza, Laura/0000-0002-4658-748X; MAKRIS, DEMOSTHENES/0000-0003-1951-6421; Lamperti, Massimo/0000-0001-8270-2724; Gritsan, Alexey/0000-0002-0500-2887; Zerbi, Simone Maria/0000-0002-4957-3112; Shum, Hoi Ping/0000-0001-7002-3548; Idowu, Olufemi/0000-0001-9064-1562	University of Milano-Bicocca; European Society of Intensive Care Medicine	University of Milano-Bicocca and the European Society of Intensive Care Medicine.	Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Citerio G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026552; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Helbok R, 2011, NEUROCRIT CARE, V14, P162, DOI 10.1007/s12028-010-9472-9; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Magni F, 2015, STROKE, V46, P2464, DOI 10.1161/STROKEAHA.115.010219; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Seder DB, 2009, CLIN CHEST MED, V30, P103, DOI 10.1016/j.ccm.2008.11.004; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woods KS, 2021, PEDIATR CRIT CARE ME, V22, P135, DOI 10.1097/PCC.0000000000002618; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	31	6	6	4	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2021	20	7					548	558					11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD5TG	WOS:000687268300014	34146513	Green Submitted			2022-02-06	
J	Fletcher, JL; Dill, LK; Wood, RJ; Wang, S; Robertson, K; Murray, SS; Zamani, A; Semple, BD				Fletcher, Jessica L.; Dill, Larissa K.; Wood, Rhiannon J.; Wang, Sharon; Robertson, Kate; Murray, Simon S.; Zamani, Akram; Semple, Bridgette D.			Acute treatment with TrkB agonist LM22A-4 confers neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Tropomyosin-related kinase receptor; LM22A-4; Brain-derived neurotrophic factor; BDNF; Myelination; Inflammation; External capsule; Corpus callosum; Spectral confocal reflectance microscopy		Young children have a high risk of sustaining a traumatic brain injury (TBI), which can have debilitating life-long consequences. Importantly, the young brain shows particular vulnerability to injury, likely attributed to ongoing maturation of the myelinating nervous system at the time of insult. Here, we examined the effect of acute treatment with the partial tropomyosin receptor kinase B (TrkB) agonist, LM22A-4, on pathological and neurobehavioral outcomes after pediatric TBI, with the hypothesis that targeting TrkB would minimize tissue damage and support functional recovery. We focused on myelinated tracts-the corpus callosum and external capsules-based on recent evidence that TrkB activation potentiates oligodendrocyte remyelination. Male mice at postnatal day 21 received an experimental TBI or sham surgery. Acutely post-injury, extensive cell death, a robust glial response and disruption of compact myelin were evident in the injured brain. TBI or sham mice then received intranasal saline vehicle or LM22A-4 for 14 days. Behavior testing was performed from 4 weeks post-injury, and brains were collected at 5 weeks for histology. TBI mice showed hyperactivity, reduced anxiety-like behavior, and social memory impairments. LM22A-4 ameliorated the abnormal anxiolytic phenotype but had no effect on social memory deficits. Use of spectral confocal reflectance microscopy detected persistent myelin fragmentation in the external capsule of TBI mice at 5 weeks post-injury, which was accompanied by regionally distinct deficits in oligodendrocyte progenitor cells and post-mitotic oligodendrocytes, as well as chronic reactive gliosis and atrophy of the corpus callosum and injured external capsule. LM22A-4 treatment ameliorated myelin deficits in the perilesional external capsule, as well as tissue volume loss and the extent of reactive gliosis. However, there was no effect of this TrkB agonist on oligodendroglial populations detected at 5 weeks postinjury. Collectively, our results demonstrate that targeting TrkB immediately after TBI during early life confers neuroprotection and preserves myelin integrity, and this was associated with some improved neurobehavioral outcomes as the pediatric injured brain matures.	[Fletcher, Jessica L.; Wood, Rhiannon J.; Murray, Simon S.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia; [Dill, Larissa K.; Wang, Sharon; Robertson, Kate; Zamani, Akram; Semple, Bridgette D.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic, Australia		Semple, BD (corresponding author), Monash Univ, Alfred Ctr, Dept Neurosci, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Bridgette.Semple@monash.edu			National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia; Department of Anatomy and Neuroscience, The University of Melbourne; 2018 Melbourne Neuroscience Institute Fellowship	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) via a Career Development Fellowship and Project Grant to BDS, as well as project funding from the Department of Anatomy and Neuroscience, The University of Melbourne, to JF and BDS. JF was supported by a 2018 Melbourne Neuroscience Institute Fellowship. The authors also thank Dr. David Gonsalvez (School of Biomedical Sciences, Monash University) for assistance with SCoRe imaging, as well as the Monash Histology Platform and Monash Micro Imaging Platform at the Alfred Research Alliance and the Biological Optical Microscopy Platform (BOMP) at the University of Melbourne for their facilities and technical support.	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; Du YZ, 2006, J NEUROSCI RES, V84, P1692, DOI 10.1002/jnr.21080; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fletcher JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124131; Fletcher JL, 2018, J NEUROSCI, V38, P7088, DOI 10.1523/JNEUROSCI.0487-18.2018; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Gallucci M., 2020, GAMLJ GEN MIXED GEN; Geraghty AC, 2019, NEURON, V103, P250, DOI 10.1016/j.neuron.2019.04.032; Gonsalvez DG, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00275; Gorski JA, 2003, J NEUROSCI, V23, P6856; Govier-Cole A.E., ENEURO, V6; Gu F, 2020, CEREB CORTEX, V30, P5180, DOI 10.1093/cercor/bhz254; Gu F, 2018, NEUROBIOL DIS, V113, P45, DOI 10.1016/j.nbd.2018.01.018; Han J, 2012, STROKE, V43, P1918, DOI 10.1161/STROKEAHA.111.641878; Hill RA, 2019, GLIA, V67, P2008, DOI 10.1002/glia.23635; Hill RA, 2018, NAT NEUROSCI, V21, P683, DOI 10.1038/s41593-018-0120-6; Huang YY, 2020, ASN NEURO, V12, DOI 10.1177/1759091420957464; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marshall J., 2017, SCI REP-UK, V7; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Nguyen HTH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00205; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Park H.Y., INT J MOL MED, V33; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Rui TY, 2020, NEUROCHEM INT, V132, DOI 10.1016/j.neuint.2019.104606; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Schain AJ, 2014, NAT MED, V20, P443, DOI 10.1038/nm.3495; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Simmons DA, 2013, J NEUROSCI, V33, P18712, DOI 10.1523/JNEUROSCI.1310-13.2013; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Van't Veer A, 2009, J NEUROSCI RES, V87, P69, DOI 10.1002/jnr.21841; Warnock A, 2020, J NEUROTRAUM, V37, P739, DOI 10.1089/neu.2019.6890; Waterhouse EG, 2013, J MOL MED, V91, P1241, DOI 10.1007/s00109-013-1071-8; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wong AW, 2013, J NEUROSCI, V33, P4947, DOI 10.1523/JNEUROSCI.3990-12.2013; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xiao JH, 2012, J NEUROCHEM, V122, P1167, DOI 10.1111/j.1471-4159.2012.07871.x; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yin R, 2020, J PHARM PHARMACOL, V72, P539, DOI 10.1111/jphp.13233; Zamani A, 2020, J NEUROTRAUM, V37, P724, DOI 10.1089/neu.2019.6895	72	6	6	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2021	339								113652	10.1016/j.expneurol.2021.113652			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RF4OO	WOS:000634819800023	33609501	Green Submitted			2022-02-06	
J	Ge, XH; Tang, PY; Rong, YL; Jiang, DD; Lu, X; Ji, CY; Wang, JX; Huang, CY; Duan, A; Liu, Y; Chen, XL; Chen, XC; Xu, ZY; Wang, F; Wang, ZB; Li, XY; Zhao, W; Fan, J; Liu, W; Yin, GY; Cai, WH				Ge, Xuhui; Tang, Pengyu; Rong, Yuluo; Jiang, Dongdong; Lu, Xiao; Ji, Chengyue; Wang, Jiaxing; Huang, Chenyu; Duan, Ao; Liu, Yang; Chen, Xinglin; Chen, Xichen; Xu, Zhiyang; Wang, Feng; Wang, Zibin; Li, Xiaoyan; Zhao, Wene; Fan, Jin; Liu, Wei; Yin, Guoyong; Cai, Weihua			Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-kappa B signaling pathway in vascular endothelial cells after traumatic spinal cord injury	REDOX BIOLOGY			English	Article						Spinal cord injury; Blood-spinal-cord-barrier; miR-155/SOCS6/p65; Endothelial-to-mesenchymal transition; Mitochondria	TO-MESENCHYMAL TRANSITION; BRAIN-BARRIER PERMEABILITY; INFLAMMATORY RESPONSE; REGENERATION; EXPRESSION; MICROGLIA; FIBROSIS	Pathologically, blood-spinal-cord-barrier (BSCB) disruption after spinal cord injury (SCI) leads to infiltration of numerous peripheral macrophages into injured areas and accumulation around newborn vessels. Among the leaked macrophages, M1-polarized macrophages are dominant and play a crucial role throughout the whole SCI process. The aim of our study was to investigate the effects of M1-polarized bone marrow-derived macrophages (M1-BMDMs) on vascular endothelial cells and their underlying mechanism. Microvascular endothelial cell line bEnd.3 cells were treated with conditioned medium or exosomes derived from M1-BMDMs, followed by evaluations of endothelial-to-mesenchymal transition (EndoMT) and mitochondrial function. After administration, we found conditioned medium or exosomes from M1-BMDMs significantly promoted EndoMT of vascular endothelial cells in vitro and in vivo, which aggravated BSCB disruption after SCI. In addition, significant dysfunction of mitochondria and accumulation of reactive oxygen species (ROS) were also detected. Furthermore, bioinformatics analysis demonstrated that miR-155 is upregulated in both M1-polarized macrophages and microglia. Experimentally, exosomal transfer of miR-155 participated in M1-BMDMs-induced EndoMT and mitochondrial ROS generation in bEnd.3 cells, and subsequently activated the NF-.B signaling pathway by targeting downstream suppressor of cytokine signaling 6 (SOCS6), and suppressing SOCS6-mediated p65 ubiquitination and degradation. Finally, a series of rescue assay further verified that exosomal miR155/SOCS6/p65 axis regulated the EndoMT process and mitochondrial function in vascular endothelial cells. In summary, our work revealed a potential mechanism describing the communications between macrophages and vascular endothelial cells after SCI which could benefit for future research and aid in the development of potential therapies for SCI.	[Ge, Xuhui; Tang, Pengyu; Rong, Yuluo; Jiang, Dongdong; Ji, Chengyue; Wang, Jiaxing; Duan, Ao; Fan, Jin; Liu, Wei; Yin, Guoyong; Cai, Weihua] Nanjing Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Lu, Xiao] Nantong Univ, Dept Orthoped, Dongtai Hosp, Yancheng 224200, Jiangsu, Peoples R China; [Huang, Chenyu] Nanjing Med Univ, Nanjing Hosp 1, Dept Orthoped, Nanjing 210006, Jiangsu, Peoples R China; [Liu, Yang] Nanjing Med Univ, Dept Orthoped, Affiliated Wuxi 2 Peoples Hosp, Wuxi 214002, Jiangsu, Peoples R China; [Chen, Xinglin] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Xichen; Xu, Zhiyang; Wang, Feng; Wang, Zibin; Li, Xiaoyan; Zhao, Wene] Nanjing Med Univ, Dept Analyt, Nanjing 211166, Jiangsu, Peoples R China; [Chen, Xichen; Xu, Zhiyang; Wang, Feng; Wang, Zibin; Li, Xiaoyan; Zhao, Wene] Nanjing Med Univ, Testing Ctr, Nanjing 211166, Jiangsu, Peoples R China		Liu, W; Yin, GY; Cai, WH (corresponding author), Nanjing Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.	liuweiorth@njmu.edu.cn; guoyong_yin@sina.com; caiwhspine@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974335]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20181490]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [SJCX20_0475]; Six Talent Peaks Project in Jiangsu Province [TD-SWYY-010]; Wu Jieping Medical Foundation	This work was sponsored by the National Natural Science Foundation of China (Grant No.81974335); Natural Science Foundation of Jiangsu Province (Grant No. BK20181490); Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant No. SJCX20_0475); Six Talent Peaks Project in Jiangsu Province (Grant No. TD-SWYY-010), and Wu Jieping Medical Foundation (Grant No.320-2745-16-117).	Akhtar AZ, 2008, REV NEUROSCIENCE, V19, P47; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Andrabi SS, 2020, J CONTROL RELEASE, V317, P300, DOI 10.1016/j.jconrel.2019.12.001; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Bala S, 2016, J HEPATOL, V64, P1378, DOI 10.1016/j.jhep.2016.01.035; Bao QQ, 2018, ACS NANO, V12, P6794, DOI 10.1021/acsnano.8b01994; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Bischoff J, 2019, CIRC RES, V124, P1163, DOI 10.1161/CIRCRESAHA.119.314813; Cai HQ, 2020, MOL PSYCHIATR, V25, P761, DOI 10.1038/s41380-018-0235-x; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen JY, 2014, J PINEAL RES, V57, P340, DOI 10.1111/jpi.12173; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Faraco G, 2016, J CLIN INVEST, V126, P4674, DOI 10.1172/JCI86950; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Gaudet AD, 2016, J NEUROSCI, V36, P8516, DOI 10.1523/JNEUROSCI.0735-16.2016; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Hervera A, 2018, NAT CELL BIOL, V20, P307, DOI 10.1038/s41556-018-0039-x; Hong Y, 2020, CELL DEATH DIFFER, V27, P1633, DOI 10.1038/s41418-019-0447-x; Horner PJ, 1996, EXP NEUROL, V142, P226, DOI 10.1006/exnr.1996.0194; Huang MG, 2016, J CLIN INVEST, V126, P1801, DOI 10.1172/JCI84876; Jiang DD, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00665-8; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim B, 2018, J CLIN INVEST, V128, P4543, DOI 10.1172/JCI120912; Kobayakawa K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5086; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lee BK, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090843; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Li LM, 2020, NANO LETT, V20, P4298, DOI 10.1021/acs.nanolett.0c00929; Li ZL, 2020, J CLIN INVEST, V130, P1977, DOI 10.1172/JCI130308; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Liu W, 2019, J NEUROTRAUM, V36, P469, DOI 10.1089/neu.2018.5835; Liu X, 2017, BIOMATERIALS, V121, P64, DOI 10.1016/j.biomaterials.2017.01.006; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; Manetti M, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210229; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Mori MA, 2019, CELL METAB, V30, P656, DOI 10.1016/j.cmet.2019.07.011; Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Okada T, 2020, CURR NEUROPHARMACOL, V18, P1187, DOI 10.2174/1570159X18666200528143301; Qu SL, 2019, INT IMMUNOPHARMACOL, V67, P22, DOI 10.1016/j.intimp.2018.11.045; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Sabirzhanov B., BRAIN BEHAV IMMUN, P8073; Shenoy AK, 2016, J CLIN INVEST, V126, P4174, DOI 10.1172/JCI86623; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Teckchandani A, 2016, ELIFE, V5, DOI 10.7554/eLife.17440; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Vivinetto AL, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107834; Wang B, 2019, MOL BIOL EVOL, V36, P393, DOI 10.1093/molbev/msy230; Wang CX, 2017, MOL THER, V25, P192, DOI 10.1016/j.ymthe.2016.09.001; Wang JX, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00630-5; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xiong JH, 2018, MOL CELL, V69, P689, DOI 10.1016/j.molcel.2018.01.010; Yang Y., 2018, NEUROBIOL DIS, DOI [10.1016/j.nbd.2018.02.012,11495-110, DOI 10.1016/J.NBD.2018.02.012,11495-110]; Yeung D, 2008, ACTA NEUROPATHOL, V115, P635, DOI 10.1007/s00401-008-0364-4; Young W, 2002, PROG BRAIN RES, V137, P231; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9; Zhou X, 2020, NAT NEUROSCI, V23, P337, DOI 10.1038/s41593-020-0597-7	65	6	6	14	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	MAY	2021	41								101932	10.1016/j.redox.2021.101932			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RY1SN	WOS:000647697600003	33714739	Green Published, gold			2022-02-06	
J	Harrington, BM; Gretschel, A; Lombard, C; Lonser, RR; Vlok, AJ				Harrington, Bradley M.; Gretschel, Armin; Lombard, Carl; Lonser, Russell R.; Vlok, Adriaan J.			Complications, outcomes, and management strategies of non-missile penetrating head injuries	JOURNAL OF NEUROSURGERY			English	Article						non-missile penetrating head injury; outcome; surgery; treatment; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANEURYSMS	OBJECTIVE While high-velocity missile injury (gunshot) is associated with kinetic and thermal injuries, non-missile penetrating head injury (NMPHI) results in primary damage along the tract of the piercing object that can be associated with significant secondary complications. Despite the unique physical properties of NMPHI, factors associated with com- plications, expected outcomes, and optimal management have not been defined. In this study, the authors attempted to define those factors. METHODS Consecutive adult patients with NMPHI who presented to Tygerberg Academic Hospital (Cape Town, South Africa) in the period from August 1, 2011, through July 31, 2018, were enrolled in a prospective study using a defined treatment algorithm. Clinical, imaging, and laboratory data were analyzed. RESULTS One hundred ninety-two patients (185 males [96%], 7 females [4%]) with 192 NMPHIs were included in this analysis. The mean age at injury was 26.2 +/- 1.1 years (range 18-58 years). Thirty-four patients (18%) presented with the weapon in situ. Seventy-one patients (37%) presented with a Glasgow Coma Scale (GCS) score of 15. Weapons included a knife (156 patients [81%]), screwdriver (18 [9%]), nail gun (1 [0.5%]), garden fork (1 [0.5%]), barbeque fork (1 [0.5%]), and unknown (15 [8%]). The most common wound locations were temporal (74 [39%]), frontal (65 [34%]), and parietal (30 [16%]). The most common secondary complications were vascular injury (37 patients [19%]) and infection (27 patients [14%]). Vascular injury was significantly associated with imaging evidence of deep subarachnoid hemorrhage and an injury tract crossing vascular territory (p <= 0.05). Infection was associated with delayed referral (> 24 hours), lack of prophylactic antibiotic administration, and weapon in situ (p <= 0.05). A poorer outcome was associated with a stab depth > 50 mm, a weapon removed by the assailant, vascular injury, and eloquent brain involvement (p <= 0.05). Nineteen patients (10%) died from their injuries. The Glasgow Outcome Scale (GOS) score was linearly related to the admission GCS score (p < 0.001). One hundred forty patients (73%) had a GOS score of 4 or better at discharge. CONCLUSIONS The most common NMPHI secondary complications are vascular injury and infection, which are associated with specific NMPHI imaging and clinical features. Identifying these features and using a systematic management paradigm can effectively treat the primary injury, as well as diagnose and manage NMPHI-related complications, leading to a good outcome in the majority of patients.	[Harrington, Bradley M.; Gretschel, Armin; Vlok, Adriaan J.] Univ Stellenbosch, Div Neurosurg, Stellenbosch, South Africa; [Lombard, Carl] Univ Stellenbosch, Dept Global Hlth, Div Epidemiol & Biostat, Western Cape, South Africa; [Lonser, Russell R.] Ohio State Univ, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA		Vlok, AJ (corresponding author), Univ Stellenbosch, Western Cape, South Africa.	ianvlok@sun.ac.za					Abdulbaki A, 2012, CASE REP OPHTHALMOL, V2012, DOI 10.1155/2012/742186; Bruyn, 1975, HDB CLIN NEUROLOGY, P477; BULLOCK R, 1985, SURG NEUROL, V24, P555, DOI 10.1016/0090-3019(85)90273-3; Casler JD, 2005, LARYNGOSCOPE, V115, P16, DOI 10.1097/01.mlg.0000150681.68355.85; Chen PC, 2014, J KOREAN NEUROSURG S, V55, P293, DOI 10.3340/jkns.2014.55.5.293; Chowdhury FH, 2016, WORLD NEUROSURG, V94, P529, DOI 10.1016/j.wneu.2016.06.062; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Cychowska Magdalena, 2013, Arch Med Sadowej Kryminol, V63, P283; de Holanda LF, 2016, WORLD NEUROSURG, V90, P420, DOI 10.1016/j.wneu.2016.03.015; Del Castillo-Calcaneo JD, 2016, INT J SURG CASE REP, V23, P169, DOI 10.1016/j.ijscr.2016.04.037; DUTREVOU M, 1991, INJURY, V22, P237, DOI 10.1016/0020-1383(91)90053-H; Enicker B, 2014, INJURY, V45, P1355, DOI 10.1016/j.injury.2014.04.036; Estebanez G, 2015, CRANIOMAX TRAUM REC, V8, P356, DOI 10.1055/s-0035-1546813; Grossbach AJ, 2014, BRAIN INJURY, V28, P1617, DOI 10.3109/02699052.2014.934284; Ijaz L, 2014, J PEDIATR NEUROSCI, V9, P267, DOI 10.4103/1817-1745.147588; JENNETT B, 1975, LANCET, V1, P480; Kataria Rashim, 2011, Asian J Neurosurg, V6, P39, DOI 10.4103/1793-5482.85635; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Larson P S, 2000, Neurosurg Focus, V8, pe4; Li XS, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.11.125; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P231, DOI 10.3171/jns.2005.102.2.0231; Redekop G, 2001, J NEUROSURG, V95, P412, DOI 10.3171/jns.2001.95.3.0412; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; TEASDALE G, 1974, LANCET, V2, P81; VANDELLEN JR, 1978, SURG NEUROL, V10, P110	26	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2021	134	5					1658	1666		10.3171/2020.4.JNS20122			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RZ6HW	WOS:000648699900003	32559744	Bronze			2022-02-06	
J	Bonds, B; Dhanda, A; Wade, C; Diaz, C; Massetti, J; Stein, DM				Bonds, Brandon; Dhanda, Amit; Wade, Christine; Diaz, Carla; Massetti, Jennifer; Stein, Deborah M.			Prognostication of Mortality and Long-Term Functional Outcomes Following Traumatic Brain Injury: Can We Do Better?	JOURNAL OF NEUROTRAUMA			English	Article						prognostication; traumatic brain injury		Accurate prognostication of outcomes following traumatic brain injury (TBI) affects not only the aggressiveness of intervention and therapeutic decision-making but also clinicians' ability to provide reliable expectations. To investigate the relative ability of clinicians to accurately predict a patient's outcomes, compared with point-of-care prognostic models, we surveyed clinical providers of 86 patients with moderate-severe TBI at admission, Day 3, and Day 7 post-injury for a patient's predicted mortality and functional outcome at 6 months. The predicted mortality and functional outcomes were compared with actual occurrence of 14-day mortality and functional outcomes at six months. A prognostic score was then calculated utilizing the Corticoid Randomization After Significant Head Injury (CRASH) and International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) models and categorized as high, intermediate, and low likelihood of mortality or poor functional outcome, and compared with clinical predictions. Overall, clinicians of varying backgrounds showed an accurate prediction of survival (87.2-97.4%) but struggled in prognosticating poor functional outcomes (24.3-36.6%). These values did not statistically improve over 7 days. Stratified CRASH (87.2%) and IMPACT (84.9%) accuracy rates were statistically better than clinical judgment alone in predicting functional outcomes (p < 0.0001). Prognostic models calculated at admission showed to be potentially useful, in conjunction with clinical judgment, in accurately predicting both survival and 6-month functional outcomes.	[Bonds, Brandon; Dhanda, Amit; Wade, Christine; Diaz, Carla; Massetti, Jennifer; Stein, Deborah M.] Univ Maryland, Shock Trauma Anesthesia Res Organized Res Ctr, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Bonds, B (corresponding author), Univ Maryland, Shock Trauma Anesthesia Res Organized Res Ctr, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.	bbonds@stapa.umm.edu					Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; DeQuesada IM, 2014, SEMIN ROENTGENOL, V49, P64, DOI 10.1053/j.ro.2013.10.003; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Faul M, 2010, TRAUMATIC BRAIN INJU; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	22	6	6	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1168	1176		10.1089/neu.2014.3742			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500022	26230149				2022-02-06	
J	Schwab, N; Wennberg, R; Grenier, K; Tartaglia, C; Tator, C; Hazrati, LN				Schwab, Nicole; Wennberg, Richard; Grenier, Karl; Tartaglia, Carmela; Tator, Charles; Hazrati, Lili-Naz			Association of Position Played and Career Duration and Chronic Traumatic Encephalopathy at Autopsy in Elite Football and Hockey Players	NEUROLOGY			English	Article							HEAD IMPACTS; LEAGUE PLAYERS; DIVISION-I; CONCUSSIONS; AMERICAN; NHL; FREQUENCY; SIZE	Objective To determine whether an association exists between career duration or position played and the presence of chronic traumatic encephalopathy (CTE) at autopsy in a series of elite football and hockey players. Methods This retrospective cohort study analyzed postmortem brains of 35 former football or hockey players (29 professional, 6 university varsity/major junior), with the presence of CTE at autopsy as the primary outcome. Position played (highest level), age at retirement (indicator of lifetime exposure to sport), and hockey fighting/penalization histories (surrogate marker for role/style of play) were collected. A blinded neuropathologic evaluation of each participant was performed, providing an assessment for neurodegenerative diseases including CTE, based on the 2015 National Institute of Neurological Disorders and Stroke/National Institute of Biomedical Imaging and Bioengineeringconsensus paper. Results In total, 17 of 35 former players (48.6%) showed pathologic evidence of CTE. There was no correlation found between position played and CTE presence, nor between hockey fighting/ penalization histories and CTE, in either the football or hockey groups (p > 0.75, MannWhitney-Wilcoxon). Similarly, there was no association between age at retirement and CTE presence (p > 0.5, Mann-Whitney-Wilcoxon). In 24 of 35 cases (68.6%), other neuropathologies were present, 13 of 24 (54.2%) of which were coexistent with CTE. Conclusion In this cohort of 35 former collision sports athletes, no significant associations were found between career duration, position or role played, and CTE presence at autopsy. Although limited by the small and nonrepresentative sample studied, these findings suggest that nonsport factors may be important to understand differing susceptibilities among athletes to CTE.	[Schwab, Nicole; Grenier, Karl] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Wennberg, Richard; Tartaglia, Carmela; Tator, Charles] Toronto Western Hosp, Krembil Brain Inst, Canadian Concuss Ctr, Toronto, ON, Canada; [Wennberg, Richard; Tartaglia, Carmela] Toronto Western Hosp, Univ Hlth Network, Div Neurol, Toronto, ON, Canada; [Tator, Charles] Toronto Western Hosp, Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada; [Hazrati, Lili-Naz] Hosp Sick Children, Pathol, Toronto, ON, Canada; [Hazrati, Lili-Naz] Canadian Concuss Ctr, Toronto, ON, Canada		Hazrati, LN (corresponding author), Hosp Sick Children, Pathol, Toronto, ON, Canada.; Hazrati, LN (corresponding author), Canadian Concuss Ctr, Toronto, ON, Canada.	lili-naz.hazrati@sickkids.ca			Canadian Concussion Centre at the Toronto Western Hospital	Study funded by donations through the Canadian Concussion Centre at the Toronto Western Hospital.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anderson GR, 2019, SPORTS HEALTH, V11, P514, DOI 10.1177/1941738119849105; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Binney ZO, 2019, NEUROLOGY, V92, P43, DOI 10.1212/WNL.0000000000006699; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Gardner AJ, 2019, J ORTHOP SPORT PHYS, V49, P768, DOI 10.2519/jospt.2019.9105; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schwab N, 2018, J ALZHEIMERS DIS, V64, P1067, DOI 10.3233/JAD-180373; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	36	6	6	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 6	2021	96	14					E1835	E1843		10.1212/WNL.0000000000011668			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SL0UT	WOS:000656632400010	33627496	Green Published, hybrid			2022-02-06	
J	Wilson, L; Boase, K; Nelson, LD; Temkin, NR; Giacino, JT; Markowitz, AJ; Maas, A; Menon, DK; Teasdale, G; Manley, GT				Wilson, Lindsay; Boase, Kim; Nelson, Lindsay D.; Temkin, Nancy R.; Giacino, Joseph T.; Markowitz, Amy J.; Maas, Andrew; Menon, David K.; Teasdale, Graham; Manley, Geoffrey T.			A Manual for the Glasgow Outcome Scale-Extended Interview	JOURNAL OF NEUROTRAUMA			English	Article						clinical outcome assessment; Glasgow Outcome Scale-Extended; GOSE; traumatic brain injury		The Glasgow Outcome Scale-Extended (GOSE) has become one of the most widely used outcome instruments to assess global disability and recovery after traumatic brain injury. Achieving consistency in the application of the assessment remains a challenge, particularly in multi-center studies involving many assessors. We present a manual for the GOSE interview that is designed to support both single- and multi-center studies and promote inter-rater agreement. Many patients fall clearly into a particular category; however, patients may have outcomes that are on the borderline between adjacent categories, and cases can present other challenges for assessment. The Manual includes the general principles of assessment, advice on administering each section of the GOSE interview, and guidance on "borderline" and "difficult" cases. Finally, we discuss the properties of the GOSE, including strengths and limitations, and outline recommendations for assessor training, accreditation, and monitoring.	[Wilson, Lindsay] Univ Stirling, Sch Nat Sci, Div Psychol, Stirling FK9 4LA, Scotland; [Boase, Kim; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Harborview Med Ctr, Seattle, WA 98195 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Maas, Andrew] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew] Univ Antwerp, Edegem, Belgium; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Teasdale, Graham] Univ Glasgow, Mental Hlth & Wellbeing Inst Hlth & Wellbeing, Med Sch, Glasgow, Lanark, Scotland		Wilson, L (corresponding author), Univ Stirling, Sch Nat Sci, Div Psychol, Stirling FK9 4LA, Scotland.	l.wilson@stir.ac.uk	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	European Union 7th Framework program (CENTER-TBI, EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind and Integra LifeSciences Corporation; United States DoD-TBI Endpoints Development Initiative [W81XWH-14-2-0176]; TRACK-TBI Precision Medicine [W81XWH-18-2-0042]; TRACK-TBI NETWORK [W81XWH-15-9-0001]; NIH-NINDS-TRACK-TBI [U01NS086090]; Abbott Point of Care Inc. [A133407]; National Football League (NFL) Scientific Advisory Board-TRACK-TBI LONGITUDINAL [131769A]; United States Department of Energy precision medicine collaborationUnited States Department of Energy (DOE); NFL; NeuroTrauma Sciences LLC	The authors acknowledge support from the following sources: European Union 7th Framework program (CENTER-TBI, EC grant 602150), Hannelore Kohl Stiftung (Germany), OneMind and Integra LifeSciences Corporation; United States DoD-TBI Endpoints Development Initiative (Grant #W81XWH-14-2-0176), TRACK-TBI Precision Medicine (Grant #W81XWH-18-2-0042), and TRACK-TBI NETWORK (Grant #W81XWH-15-9-0001); NIH-NINDS-TRACK-TBI (Grant #U01NS086090); Abbott Point of Care Inc. (Grant #A133407); the National Football League (NFL) Scientific Advisory Board-TRACK-TBI LONGITUDINAL (Grant #131769A); United States Department of Energy precision medicine collaboration; additional support from NFL and NeuroTrauma Sciences LLC.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Ercole A, 2020, J CLIN TRANSL SCI, V4, P354, DOI 10.1017/cts.2020.24; FEINSTEIN AR, 1983, ANN INTERN MED, V99, P843, DOI 10.7326/0003-4819-99-6-843; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MacDonald D.F., CATASTROPHIC DEFINIT; MacDonald DF, USING MED RECOGNIZED; Manley G, J NEUROTRAUM; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; RANKIN J, 1957, Scott Med J, V2, P200; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	34	6	7	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2435	2446		10.1089/neu.2020.7527		APR 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000638036000001	33740873	hybrid, Green Submitted, Green Published			2022-02-06	
J	Zinger, A; Soriano, S; Baudo, G; De Rosa, E; Taraballi, F; Villapol, S				Zinger, Assaf; Soriano, Sirena; Baudo, Gherardo; De Rosa, Enrica; Taraballi, Francesca; Villapol, Sonia			Biomimetic Nanoparticles as a Theranostic Tool for Traumatic Brain Injury	ADVANCED FUNCTIONAL MATERIALS			English	Article						biomimicry; blood-brain barrier; inflammation; leukosomes; liposomes	BARRIER PERMEABILITY; EXTRACELLULAR VESICLES; UNITED-STATES; ACCUMULATION; EXPRESSION; ENDOTHELIUM; CLEARANCE; STROKE; IMPACT; DAMAGE	Traumatic brain injury (TBI) triggers both central and peripheral inflammatory responses. Existing pharmacological drugs are unable to effectively and quickly target the brain inflamed regions, setting up a major roadblock towards effective brain trauma treatments. Nanoparticles (NPs) have been used in multiple diseases as drug delivery tools with remarkable success due to their rapid diffusion and specificity in the target organ. Here, leukocyte-based biomimetic NPs are fabricated as a theranostic tool to directly access inflamed regions in a TBI mouse model. This NP systemic delivery is visualized using advanced in vivo imaging techniques, including intravital microscopy and in vivo imaging system. The results demonstrate selective targeting of NPs to the injured brain and increased NPs accumulation among the peripheral organs 24 h after TBI. Interestingly, increased microglial proliferation, decreased macrophage infiltration, and reduced brain lesion following the NPs treatments compared to sham vehicle-treated mice are also found. In summary, the results suggest that NPs represent a promising future theranostic tool for TBI treatment.	[Zinger, Assaf; Baudo, Gherardo; De Rosa, Enrica; Taraballi, Francesca] Houston Methodist Hosp, Ctr Musculoskeletal Regenerat, Houston Methodist Acad Inst, Dept Orthoped & Sports Med, Houston, TX 77030 USA; [Soriano, Sirena; Villapol, Sonia] Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA; [Soriano, Sirena; Villapol, Sonia] Houston Methodist Res Inst, Dept Neurosurg, Houston, TX 77030 USA; [Villapol, Sonia] Weill Cornell Med Coll, New York, NY 10065 USA		Zinger, A; Taraballi, F (corresponding author), Houston Methodist Hosp, Ctr Musculoskeletal Regenerat, Houston Methodist Acad Inst, Dept Orthoped & Sports Med, Houston, TX 77030 USA.; Villapol, S (corresponding author), Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA.; Villapol, S (corresponding author), Houston Methodist Res Inst, Dept Neurosurg, Houston, TX 77030 USA.; Villapol, S (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	ayzinger@houstonmethodist.org; ftaraballi2@houstonmethodist.org; svillapol@houstonmethodist.org		Villapol, Sonia/0000-0002-6174-4113	National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS106640]; TIRR Foundation through Mission Connect grant; Houston Methodist Research Institute	This work was supported by grants from the National Institute for Neurological Disorders and Stroke (NINDS), R21NS106640 (S.V.), TIRR Foundation through Mission Connect grant (S.V.), and funds from Houston Methodist Research Institute (S.V.). The authors thank Ms. Manuela Sushnitha, Ms. Shashi Krishnamurthy, Dr. Tomoyuki Naoi, and Ms. Eliana Stetco for their technical help. The authors are indebted to Dr. Gillian Hamilton for editing the text. They thank the Baylor College of Medicine Cryo-TEM Core Facility for electronic imaging support and the Pathology and Histology Core (HTAP). Figure 1 was created using Biorender.com.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aertker BM, 2019, J NEUROSCI RES, V97, P698, DOI 10.1002/jnr.24395; Al-Ahmady ZS, 2019, ACS NANO, V13, P12470, DOI 10.1021/acsnano.9b01808; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Allen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35497; Barrett JP, 2020, J NEUROSCI, V40, P2357, DOI 10.1523/JNEUROSCI.2516-19.2020; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Biegon A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.576366; Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chao DL, 2018, ADV MATER, V30, DOI 10.1002/adma.201803181; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Costantini TW, 2009, LIFE SCI, V84, P18, DOI 10.1016/j.lfs.2008.10.007; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; LUCAS D, 1964, AM J PSYCHOTHER, V18, P126, DOI 10.1176/appi.psychotherapy.1964.18.1.126; Lutton EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00582; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Martinez JO, 2018, THERANOSTICS, V8, P1131, DOI 10.7150/thno.22078; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Molinaro R, 2018, ADV MATER, V30, DOI 10.1002/adma.201702749; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Sharma S, 2020, ANN NEUROL, V87, P442, DOI 10.1002/ana.25675; Shoffstall K.T., 2012, BIOMACROMOLECULES, V13, P10293; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timm A, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.08.017; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang WX, 2021, NEURAL REGEN RES, V16, P514, DOI 10.4103/1673-5374.293149; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wicker E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5967816; Wu X, 2013, ANN ONCOL, V24, P2131, DOI 10.1093/annonc/mdt163; Yamamoto T, 2016, SCI TECHNOL ADV MAT, V17, P677, DOI 10.1080/14686996.2016.1240006; Yates AG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02723; Yong HYF, 2019, CELL MOL IMMUNOL, V16, P540, DOI 10.1038/s41423-019-0223-3; Zinger A, 2021, ACS NANO, V15, P6326, DOI 10.1021/acsnano.0c05792; Zinger A, 2020, ACS APPL BIO MATER, V3, P6737, DOI 10.1021/acsabm.0c00685; Zinger A, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10112172; Zinger A, 2018, ACS NANO, V12, P1482, DOI 10.1021/acsnano.7b07983	45	6	6	13	18	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	JUL	2021	31	30							2100722	10.1002/adfm.202100722		MAR 2021	12	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	TM5BP	WOS:000633496800001	34413716	hybrid, Green Published			2022-02-06	
J	Brett, BL; Walton, SR; Kerr, ZY; Nelson, LD; Chandran, A; Defreese, JD; Echemendia, RJ; Guskiewicz, KM; Meehan, WP; McCrea, MA				Brett, Benjamin L.; Walton, Samuel R.; Kerr, Zachery Y.; Nelson, Lindsay D.; Chandran, Avinash; Defreese, J. D.; Echemendia, Ruben J.; Guskiewicz, Kevin M.; Meehan, William P., III; McCrea, Michael A.			Distinct latent profiles based on neurobehavioural, physical and psychosocial functioning of former National Football League (NFL) players: an NFL-LONG Study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article								Objective To identify subgroups of former National Football League (NFL) players using latent profile analysis (LPA) and examine their associations with total years of participation (TYP) and self-reported lifetime sport-related concussion history (SR-CHx). Methods Former NFL players (N=686) aged 50-70 years, with an average 18.0 TYP (+/- 4.5) completed a questionnaire. SR-CHx distributions included: low (0-3; n=221); intermediate (4-8; n=209) and high (9+; n=256). LPA measures included: Quality of Life in Neurological Disorders Emotional-Behavioral Dyscontrol, Patient Reported Outcomes Measurement Information System Cognitive Function, Emotional Support, Self-Efficacy, Meaning and Purpose, Physical Function, Pain Interference, Participation in Social Roles and Activities, Anxiety, Depression, Fatigue, and Sleep Disturbance. Demographic, medical/psychiatric history, current psychosocial stressors, TYP and SR-CHx were compared across latent profiles (LPs). Results A five profile solution emerged: (LP1) global higher functioning (GHF; 26.5%); (LP2) average functioning (10.2%); (LP3) mild somatic (pain and physical functioning) concerns (22.0%); (LP4) somatic and cognitive difficulties with mild anxiety (SCA; 27.5%); LP5) global impaired functioning (GIF; 13.8%). The GIF and SCA groups reported the largest number ofe- medical/psychiatric conditions and higher psychosocial stressor levels. SR-CHx was associated with profile group (chi(2)(8)=100.38, p<0.001); with a higher proportion of GIF (72.6%) and SCA (43.1%) groups reporting being in the high SR-CHx category, compared with GHF (23.1%), average (31.4%) and somatic (27.8%) groups. TYP was not significantly associated with group (p=0.06), with greater TYP reported by the GHF group. Conclusions Five distinct profiles of self-reported functioning were identified among former NFL players. Several comorbid factors (ie, medical/psychiatric diagnoses and psychosocial stressors) and SR-CHx were associated with greater neurobehavioural and psychosocial dysfunction.	[Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Neurol, Milwaukee, WI 53226 USA; [Walton, Samuel R.; Kerr, Zachery Y.; Defreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Exercise & Sports Sci, Chapel Hill, NC 27515 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, NCAA Injury Surveillance Program, Indianapolis, IN USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates, State Coll, PA USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Med, Boston, MA USA		Brett, BL (corresponding author), Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA.	bbrett@mcw.edu		Brett, Benjamin/0000-0003-2849-4658; Walton, Samuel/0000-0003-2647-5701	National Football League (NFL)	This study (NFL-LONG) was funded by the National Football League (NFL).	Beutel TF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1956-8; Cappelleri JC, 2014, CLIN THER, V36, P648, DOI 10.1016/j.clinthera.2014.04.006; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Collins L.M., 2009, LATENT CLASS LATENT, VVolume 718; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Curtis R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05569; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Group PHOaPC , PROMIS 29 PROFILE V2; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Herzig L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-120; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; LoBue C, 2020, J NEUROL NEUROSUR PS, V91, P586, DOI 10.1136/jnnp-2019-321567; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Rasouli O, 2019, NEUROPSYCHOLOGY, V33, P658, DOI 10.1037/neu0000550; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Rose AJ, 2018, QUAL LIFE RES, V27, P2935, DOI 10.1007/s11136-018-1958-5; Salsman JM, 2019, QUAL LIFE RES, V28, P2513, DOI 10.1007/s11136-019-02198-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Smith GE, 1996, PSYCHOL AGING, V11, P272, DOI 10.1037/0882-7974.11.2.272; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; System P-ROMI, 2018, MEAN PURP BRIEF GUID; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350	39	6	6	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2021	92	3					282	290		10.1136/jnnp-2020-324244			9	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	QK1SE	WOS:000620160500011	33483350				2022-02-06	
J	Wang, WX; Prajapati, P; Vekaria, HJ; Spry, M; Cloud, AL; Sullivan, PG; Springer, JE				Wang, Wang-Xia; Prajapati, Paresh; Vekaria, Hemendra J.; Spry, Malinda; Cloud, Amber L.; Sullivan, Patrick G.; Springer, Joe E.			Temporal changes in inflammatory mitochondria-enriched microRNAs following traumatic brain injury and effects of miR-146a nanoparticle delivery	NEURAL REGENERATION RESEARCH			English	Article							BIOENERGETICS; DYSFUNCTION; NEUROINFLAMMATION; HOMEOSTASIS; EXPRESSION; MODEL; RNA	MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate post-transcriptional gene expression and contribute to all aspects of cellular function. We previously reported that the activities of several mitochondria-enriched miRNAs regulating inflammation (i.e., miR-142-3p, miR-142-5p, and miR-146a) are altered in the hippocampus at 3-12 hours following a severe traumatic brain injury. In the present study, we investigated the temporal expression profile of these inflammatory miRNAs in mitochondria and cytosol fractions at more chronic post-injury times following severe controlled cortical impact injury in rats. In addition, several inflammatory genes were analyzed in the cytosol fractions. The analysis showed that while elevated levels were observed in cytoplasm, the mitochondria-enriched miRNAs, miR-142-3p and miR-142-5p continued to be significantly reduced in mitochondria from injured hippocampi for at least 3 days and returned to near normal levels at 7 days post-injury. Although not statistically significant, miR-146a also remained at reduced levels for up to 3 days following controlled cortical impact injury, and recovered by 7 days. In contrast, miRNAs that are not enriched in mitochondria, including miR-124a, miR-150, miR-19b, miR-155, and miR-223 were either increased or demonstrated no change in their levels in mitochondrial fractions for 7 days. The one exception was that miR-223 levels were reduced in mitochondria at 1 day following injury. No major alterations were observed in sham operated animals. This temporal pattern was unique to mitochondria-enriched miRNAs and correlated with injury-induced changes in mitochondrial bioenergetics as well as expression levels of several inflammatory markers. These observations suggested a potential compartmental re-distribution of the mitochondria-enriched inflammatory miRNAs and may reflect an intracellular mechanism by which specific miRNAs regulate injury-induced inflammatory signaling. To test this, we utilized a novel peptide-based nanoparticle strategy for in vitro and in vivo delivery of a miR-146a mimic as a potential therapeutic strategy for targeting nuclear factor-kappaB inflammatory modulators in the injured brain. Nanoparticle delivery of miR-146a to BV-2 or SH-SY5Y cells significantly reduced expression of TNF receptor-associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1), two important modulators of the nuclear factor-kappaB (NF-kappa B) pro-inflammatory pathway. Moreover, injections of miR-146a containing nanoparticles into the brain immediately following controlled cortical impact injury significantly reduced hippocampal TNF receptor-associated factor 6 and interleukin-1 receptor-associated kinase 1 levels. Taken together, our studies demonstrate the subcellular alteration of inflammatory miRNAs after traumatic brain injury and establish proof of principle that nanoparticle delivery of miR-146a has therapeutic potential for modulating pro-inflammatory effectors in the injured brain. All of the studies performed were approved by the University of Kentucky Institutional Animal Care and Usage Committee (IACUC protocol # 2014-1300) on August 17, 2017.	[Wang, Wang-Xia] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Wang, Wang-Xia; Prajapati, Paresh; Vekaria, Hemendra J.; Spry, Malinda; Cloud, Amber L.; Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Wang, Wang-Xia] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA; [Prajapati, Paresh; Vekaria, Hemendra J.; Spry, Malinda; Cloud, Amber L.; Sullivan, Patrick G.; Springer, Joe E.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA		Wang, WX (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.; Wang, WX; Springer, JE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Wang, WX (corresponding author), Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA.; Springer, JE (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.	wwangc@uky.edu; jspring@uky.edu	Wang, Wang-Xia/AAD-6900-2019; Prajapati, Paresh/P-1058-2019	Prajapati, Paresh/0000-0002-3734-4662; Wang, Wang-Xia/0000-0002-8104-3779	Kentucky Spinal Cord and Head Injury Research Trust [15-12A]	This work is supported by a grant (15-12A) from the Kentucky Spinal Cord and Head Injury Research Trust to JES and WXW.	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Cui HC, 2015, PROG INFLAMM RES SER, P59, DOI 10.1007/978-3-319-13689-9_4; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Hata A, 2013, ANNU REV PHYSIOL, V75, P69, DOI 10.1146/annurev-physiol-030212-183737; Hou KK, 2013, ACS NANO, V7, P8605, DOI 10.1021/nn403311c; Hou KK, 2013, BIOMATERIALS, V34, P3110, DOI 10.1016/j.biomaterials.2013.01.037; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	53	6	6	3	48	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2021	16	3					514	522		10.4103/1673-5374.293149			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NZ5AQ	WOS:000577108400023	32985480	gold, Green Submitted, Green Published			2022-02-06	
J	Kawabori, M; Weintraub, AH; Imai, H; Zinkevych, I; McAllister, P; Steinberg, GK; Frishberg, BM; Yasuhara, T; Chen, JW; Cramer, SC; Achrol, AS; Schwartz, NE; Suenaga, J; Lu, DC; Semeniv, I; Nakamura, H; Kondziolka, D; Chida, D; Kaneko, T; Karasawa, Y; Paadre, S; Nejadnik, B; Bates, D; Stonehouse, AH; Richardson, RM; Okonkwo, DO				Kawabori, Masahito; Weintraub, Alan H.; Imai, Hideaki; Zinkevych, Iaroslav; McAllister, Peter; Steinberg, Gary K.; Frishberg, Benjamin M.; Yasuhara, Takao; Chen, Jefferson W.; Cramer, Steven C.; Achrol, Achal S.; Schwartz, Neil E.; Suenaga, Jun; Lu, Daniel C.; Semeniv, Ihor; Nakamura, Hajime; Kondziolka, Douglas; Chida, Dai; Kaneko, Takehiko; Karasawa, Yasuaki; Paadre, Susan; Nejadnik, Bijan; Bates, Damien; Stonehouse, Anthony H.; Richardson, R. Mark; Okonkwo, David O.			Cell Therapy for Chronic TBI Interim Analysis of the Randomized Controlled STEMTRA Trial	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FUGL-MEYER ASSESSMENT; STANDARDIZED APPROACH; UNITED-STATES; STROKE; RECOVERY	Objective To determine whether chronic motor deficits secondary to traumatic brain injury (TBI) can be improved by implantation of allogeneic modified bone marrow-derived mesenchymal stromal/stem cells (SB623). Methods This 6-month interim analysis of the 1-year double-blind, randomized, surgical sham-controlled, phase 2 Stem Cell Therapy for Traumatic Brain Injury (STEMTRA) trial (NCT02416492) evaluated safety and efficacy of the stereotactic intracranial implantation of SB623 in patients with stable chronic motor deficits secondary to TBI. Patients in this multicenter trial (n = 63) underwent randomization in a 1:1:1: 1 ratio to 2.5 x 10(6), 5.0 x 10(6), or 10 x 10(6) SB623 cells or control. Safety was assessed in patients who underwent surgery (n = 61), and efficacy was assessed in the modified intent-to-treat population of randomized patients who underwent surgery (n = 61; SB623 = 46, control = 15). Results The primary efficacy endpoint of significant improvement from baseline of Fugl-Meyer Motor Scale score at 6 months for SB623-treated patients was achieved. SB623-treated patients improved by (least square [LS] mean) 8.3 (standard error 1.4) vs 2.3 (standard error 2.5) for control at 6months, the LS mean difference was 6.0 (95% confidence interval 0.3-11.8, p = 0.040). Secondary efficacy endpoints improved from baseline but were not statistically significant vs control at 6 months. There were no dose-limiting toxicities or deaths, and 100% of SB623-treated patients experienced treatment-emergent adverse events vs 93.3% of control patients (p = 0.25). Conclusions SB623 cell implantation appeared to be safe and well tolerated, and patients implanted with SB623 experienced significant improvement from baseline motor status at 6 months compared to controls. Classification of Evidence This study provides Class I evidence that implantation of SB623 was well tolerated and associated with improvement in motor status.	[Kawabori, Masahito] Hokkaido Univ Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Weintraub, Alan H.] Rocky Mt Reg Brain Injury Systemand, Englewood, CO USA; [Weintraub, Alan H.] Univ Colorado, Sch Med, Englewood, CO USA; [Imai, Hideaki] JCHO Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Zinkevych, Iaroslav] Ukraine Presidential Hosp, Kiev, Ukraine; [McAllister, Peter] New England Inst Neurol & Headache, Stamford, CT USA; [McAllister, Peter] New England Inst Clin Res, Stamford, CT USA; [McAllister, Peter] Yale Univ, Dept Neurol, New Haven, CT USA; [McAllister, Peter] Quinnipiac Univ, Frank Netter Sch Med, Hamden, CT 06518 USA; [Steinberg, Gary K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Schwartz, Neil E.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Steinberg, Gary K.; Schwartz, Neil E.] Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA; Stanford Hlth Care, Stanford, CA USA; [Frishberg, Benjamin M.] Neurol Ctr Southern Calif, Carlsbad, CA USA; [Yasuhara, Takao] Okayama Univ, Dept Neurol Surg, Grad Sch Med, Okayama Univ Hosp, Okayama, Japan; [Chen, Jefferson W.] Univ Calif Irvine, Dept Neurol Surg, Sch Med, Irvine, CA 92717 USA; [Cramer, Steven C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Cramer, Steven C.] Calif Rehabil Inst, Los Angeles, CA USA; [Achrol, Achal S.] Loma Linda Univ, Dept Neurosurg, Med Ctr, Loma Linda, CA 92350 USA; [Suenaga, Jun] Yokohama City Univ, Dept Neurosurg, Sch Med, Yokohama, Kanagawa, Japan; [Lu, Daniel C.] Ronald Reagan UCLA Med Ctr, Dept Neurosurg, Los Angeles, CA USA; [Semeniv, Ihor] Clin Hosp Feofaniya, Kiev, Ukraine; [Nakamura, Hajime] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka, Japan; [Kondziolka, Douglas] NYU, Dept Neurosurg, New York, NY 10003 USA; NYU Langone Med Ctr, New York, NY USA; [Chida, Dai; Kaneko, Takehiko; Nejadnik, Bijan; Bates, Damien] SanBio Inc, Mountain View, CA USA; [Karasawa, Yasuaki] Univ Tokyo Hosp, Dept Neurosurg, Tokyo, Japan; [Paadre, Susan] Biostat Consulting Inc, Lexington, MA USA; [Stonehouse, Anthony H.] Watson & Stonehouse EnterprisesLLC, Pacific Grove, CA USA; [Richardson, R. Mark] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Richardson, R. Mark] Harvard Med Sch, Boston, MA 02115 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Kawabori, M (corresponding author), Hokkaido Univ Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan.	kawabori@med.hokudai.ac.jp	Richardson, Robert/AAY-4969-2021; Kawabori, Masahito/AAH-7117-2020	Kawabori, Masahito/0000-0002-3574-8380	SanBio, Inc.	This study was sponsored by SanBio, Inc.	Aizman I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt418; Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; HIXSON JE, 1990, J LIPID RES, V31, P545; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; National Institute of Neurological Disorders and Stroke, 2015, NINDS US MAN QUAL LI; Rehabilitation Measures Database, 2012, DIS RAT SCAL TBI; Rehabilitation Measures Database, 2014, 10 MET WALK TEST; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seledtsov VI, 2005, BIOMED PHARMACOTHER, V59, P415, DOI 10.1016/j.biopha.2005.01.012; Steinberg GK, 2019, J NEUROSURG, V131, P1462, DOI 10.3171/2018.5.JNS173147; Sullivan KJ, 2011, STROKE, V42, P427, DOI 10.1161/STROKEAHA.110.592766; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wechsler LR, 2018, STROKE, V49, P1066, DOI 10.1161/STROKEAHA.117.018290; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	29	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	FEB 23	2021	96	8					E1202	E1214		10.1212/WNL.0000000000011450			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SL0VV	WOS:000656635300025	33397772	hybrid, Green Published			2022-02-06	
J	Alyenbaawi, H; Kanyo, R; Locskai, LF; Kamali-Jamil, R; DuVal, MG; Bai, Q; Wille, H; Burton, EA; Allison, WT				Alyenbaawi, Hadeel; Kanyo, Richard; Locskai, Laszlo F.; Kamali-Jamil, Razieh; DuVal, Michele G.; Bai, Qing; Wille, Holger; Burton, Edward A.; Allison, W. Ted			Seizures are a druggable mechanistic link between TBI and subsequent tauopathy	ELIFE			English	Article							TRAUMATIC BRAIN-INJURY; SYNTHETIC TAU FIBRILS; PRION STRAINS; IN-VIVO; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; ADULT ZEBRAFISH; AGGREGATED TAU; BLOOD-FLOW	Traumatic brain injury (TBI) is a prominent risk factor for dementias including tauopathies like chronic traumatic encephalopathy (CTE). The mechanisms that promote prion-like spreading of Tau aggregates after TBI are not fully understood, in part due to lack of tractable animal models. Here, we test the putative role of seizures in promoting the spread of tauopathy. We introduce 'tauopathy reporter' zebrafish expressing a genetically encoded fluorescent Tau biosensor that reliably reports accumulation of human Tau species when seeded via intraventricular brain injections. Subjecting zebrafish larvae to a novel TBI paradigm produced various TBI features including cell death, post-traumatic seizures, and Tau inclusions. Bath application of dynamin inhibitors or anticonvulsant drugs rescued TBI-induced tauopathy and cell death. These data suggest a role for seizure activity in the prion-like seeding and spreading of tauopathy following TBI. Further work is warranted regarding anti-convulsants that dampen post-traumatic seizures as a route to moderating subsequent tauopathy.	[Alyenbaawi, Hadeel; Kanyo, Richard; Locskai, Laszlo F.; Kamali-Jamil, Razieh; Wille, Holger; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Alyenbaawi, Hadeel; Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Alyenbaawi, Hadeel] Majmaah Univ, Majmaah, Saudi Arabia; [Kanyo, Richard; Locskai, Laszlo F.; DuVal, Michele G.; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Kamali-Jamil, Razieh; Wille, Holger] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Bai, Qing; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Burton, Edward A.] Pittsburgh VA Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA		Allison, WT (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.; Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Burton, Edward/AAO-9677-2021; Wille, Holger/C-2280-2008; Burton, Edward/ABB-1324-2021; Allison, Ted/A-2612-2014	Wille, Holger/0000-0001-5102-8706; Burton, Edward/0000-0002-8072-4636; Allison, Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117	Alberta Innovates - Health Solutions; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Bio Solutions [201700005, 201700018]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS080881]; CurePSP [655-2018-06, 468-08]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [BX003168]; Majmaah University; Saudi Arabia Cultural Bureau in Ottawa	Alberta Innovates - Health Solutions Laszlo F Locskai Michele G DuVal; Natural Sciences and Engineering Research Council of Canada Laszlo F Locskai; Canadian Institutes of Health Research Michele G DuVal; Alberta Innovates Bio Solutions 201700005 Holger Wille; Alberta Innovates Bio Solutions 201700018 W Ted Allison; Anonymous Donors W Ted Allison; National Institutes of Health NS080881 Edward A Burton; CurePSP 655-2018-06 and 468-08 Edward A Burton; U.S. Department of Veterans Affairs BX003168 Edward A Burton; Majmaah University Hadeel Alyenbaawi; Saudi Arabia Cultural Bureau in Ottawa Hadeel Alyenbaawi	Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Ayers JI, 2018, BIOL PSYCHIAT, V83, P337, DOI 10.1016/j.biopsych.2017.04.003; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Balik-Meisner M, 2018, MAMM GENOME, V29, P90, DOI 10.1007/s00335-018-9735-x; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cho SJ, 2020, EPILEPSIA, V61, P1774, DOI 10.1111/epi.16589; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Colin M, 2020, ACTA NEUROPATHOL, V139, P3, DOI 10.1007/s00401-019-02087-9; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Demaegd K, 2018, CHEMBIOCHEM, V19, P2424, DOI 10.1002/cbic.201800288; DuVal MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092991; Ellis LD, 2012, BRAIN RES, V1449, P46, DOI 10.1016/j.brainres.2012.02.022; Englander Jeffrey, 2014, Arch Phys Med Rehabil, V95, P1223, DOI 10.1016/j.apmr.2013.06.002; Eskandari-Sedighi G, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0215-7; Evans LD, 2018, CELL REP, V22, P3612, DOI 10.1016/j.celrep.2018.03.021; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; Gutzman Jennifer H, 2009, J Vis Exp, DOI 10.3791/1218; Hanwell D, 2016, ZEBRAFISH, V13, pS153, DOI 10.1089/zeb.2016.1286; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kanyo R, 2020, EPILEPSIA, V61, P1678, DOI 10.1111/epi.16592; Kanyo R, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113283; Kasatkina LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34749; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kim YH, 2010, NEUROTOXICOL TERATOL, V32, P551, DOI 10.1016/j.ntt.2010.04.054; Kovacs A, 2017, PROCEEDINGS - 31ST EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2017, P355; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leighton PLA, 2018, J BIOL CHEM, V293, P12576, DOI 10.1074/jbc.RA117.001171; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Liu J, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0041-19.2019; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; LUNDH H, 1978, BRAIN RES, V153, P307, DOI 10.1016/0006-8993(78)90409-2; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; McCutcheon V, 2016, ZEBRAFISH, V13, P161, DOI 10.1089/zeb.2015.1188; McGeachie AB, 2013, ACS CHEM BIOL, V8, P1507, DOI 10.1021/cb400137p; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Menezes FP, 2014, PROG NEURO-PSYCHOPH, V55, P109, DOI 10.1016/j.pnpbp.2014.04.004; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Murakami T, 2006, AM J PATHOL, V169, P1365, DOI 10.2353/ajpath.2006.051250; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Orr ME, 2017, TRENDS PHARMACOL SCI, V38, P637, DOI 10.1016/j.tips.2017.03.011; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Pickett EK, 2017, SYNAPSE, V71, DOI 10.1002/syn.21965; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Pokrishevsky E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32835-y; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Russell W. M. S., 1959, PRINCIPLES HUMANE EX; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saleem S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0109-7; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Sanchez MP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041092; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Singh M, 2017, MOL PHARMACOL, V91, P123, DOI 10.1124/mol.116.105064; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Verweij FJ, 2019, DEV CELL, V48, P573, DOI 10.1016/j.devcel.2019.01.004; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Winter MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06646-6; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193	99	6	6	1	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	FEB 2	2021	10								e58744	10.7554/eLife.58744			33	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	QH1UT	WOS:000618063900001	33527898	gold, Green Published, Green Submitted			2022-02-06	
J	Das Gupta, S; Ciszek, R; Heiskanen, M; Lapinlampi, N; Kukkonen, J; Leinonen, V; Puhakka, N; Pitkanen, A				Das Gupta, Shalini; Ciszek, Robert; Heiskanen, Mette; Lapinlampi, Niina; Kukkonen, Janne; Leinonen, Ville; Puhakka, Noora; Pitkanen, Asla			Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						biomarker; microRNA; mild TBI; miR-9-3p; miR-136-3p; plasma; severe TBI	CEREBROSPINAL-FLUID; BLOOD BIOMARKERS; MICRORNA; SERUM; EXPRESSION; RAT; S100B; MIRNAS; MODELS; RNA	Noninvasive, affordable circulating biomarkers for difficult-to-diagnose mild traumatic brain injury (mTBI) are an unmet medical need. Although blood microRNA (miRNA) levels are reportedly altered after traumatic brain injury (TBI), their diagnostic potential for mTBI remains inconclusive. We hypothesized that acutely altered plasma miRNAs could serve as diagnostic biomarkers both in the lateral fluid percussion injury (FPI) model and clinical mTBI. We performed plasma small RNA-sequencing from adult male Sprague-Dawley rats (n = 31) at 2 days post-TBI, followed by polymerase chain reaction (PCR)-based validation of selected candidates. miR-9a-3p, miR-136-3p, and miR-434-3p were identified as the most promising candidates at 2 days after lateral FPI. Digital droplet PCR (ddPCR) revealed 4.2-, 2.8-, and 4.6-fold elevations in miR-9a-3p, miR-136-3p, and miR-434-3p levels (p < 0.01 for all), respectively, distinguishing rats with mTBI from naive rats with 100% sensitivity and specificity. DdPCR further identified a subpopulation of mTBI patients with plasma miR-9-3p (n = 7/15) and miR-136-3p (n = 5/15) levels higher than one standard deviation above the control mean at <2 days postinjury. In sTBI patients, plasma miR-9-3p levels were 6.5- and 9.2-fold in comparison to the mTBI and control groups, respectively. Thus, plasma miR-9-3p and miR-136-3p were identified as promising biomarker candidates for mTBI requiring further evaluation in a larger patient population.	[Das Gupta, Shalini; Ciszek, Robert; Heiskanen, Mette; Lapinlampi, Niina; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland; [Kukkonen, Janne; Leinonen, Ville] Kuopio Univ Hosp, Dept Neurosurg, Kuopio 70029, Finland; [Kukkonen, Janne; Leinonen, Ville] Univ Eastern Finland, Inst Clin Med, Kuopio 70210, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, Kuopio 70211, Finland.	shalini.gupta@uef.fi; robert.ciszek@uef.fi; mette.heiskanen@uef.fi; niina.lapinlampi@uef.fi; jannekuk@student.uef.fi; ville.leinonen@kuh.fi; noora.puhakka@uef.fi; asla.pitkanen@uef.fi		Lapinlampi, Niina/0000-0003-3210-6312; Heiskanen, Mette/0000-0003-1624-5240	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; European Union's Seventh Framework Programme (FP7/2007-2013) [602102]; National Institute of Neurological Disorders and Stroke (NINDS) Centres without Walls [U54 NS100064]	This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9) and by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602102 (EPITARGET), the National Institute of Neurological Disorders and Stroke (NINDS) Centres without Walls [grant number U54 NS100064].	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Andrade P, 2019, J NEUROTRAUM, V36, P1890, DOI 10.1089/neu.2018.6107; Anzai Y., 2011, IMAGING MED, V3, P153, DOI [10.2217/iim.11.11, DOI 10.2217/IIM.11.11]; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Chen M, 2020, EPILEPSY RES, V166, DOI 10.1016/j.eplepsyres.2020.106400; Chen WH, 2014, J NEURO-ONCOL, V120, P43, DOI 10.1007/s11060-014-1535-x; Chen YX, 2020, FASEB J, V34, P5348, DOI 10.1096/fj.201902463RR; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Das Gupta S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66072-z; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gao F, 2013, BIOCHEM BIOPH RES CO, V431, P610, DOI 10.1016/j.bbrc.2012.12.097; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ji QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163645; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Jung HJ, 2017, J GERONTOL A-BIOL, V72, P1483, DOI 10.1093/gerona/glx025; Kamnaksh A, 2019, EPILEPSY RES, V149, P92, DOI 10.1016/j.eplepsyres.2018.11.009; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kitahara Y, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109207; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lin YB, 2020, KIDNEY BLOOD PRESS R, V45, P477, DOI 10.1159/000505849; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Mainieri A, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0250-0; Manakov SA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00156; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Mazurek M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041507; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Ndode-Ekane XE, 2019, EPILEPSY RES, V151, P7, DOI 10.1016/j.eplepsyres.2019.01.006; Nowek Katarzyna, 2018, Oncotarget, V9, P20838, DOI 10.18632/oncotarget.24889; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Pardo PS, 2017, AGING-US, V9, P1012, DOI 10.18632/aging.101207; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Raheja R, 2018, MUSCLE NERVE, V58, P261, DOI 10.1002/mus.26106; Rau CS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0106-y; Ravanidis S, 2020, ANN CLIN TRANSL NEUR, V7, P1594, DOI 10.1002/acn3.51146; Ravanidis S, 2020, MOVEMENT DISORD, V35, P457, DOI 10.1002/mds.27928; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Selvamani A, 2014, CLIN SCI, V127, P77, DOI 10.1042/CS20130565; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Senyuk V, 2013, P NATL ACAD SCI USA, V110, P5594, DOI 10.1073/pnas.1302645110; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Shang FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22884; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sim SE, 2016, J NEUROSCI, V36, P8641, DOI 10.1523/JNEUROSCI.0630-16.2016; Siracusa J, 2016, AM J PATHOL, V186, P1313, DOI 10.1016/j.ajpath.2016.01.007; Sorensen SS, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0104-9; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thiele C., 2020, CUTPOINTR DETERMINE; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; Vuokila N, 2020, NEUROSCIENCE, V433, P21, DOI 10.1016/j.neuroscience.2020.02.045; Wang PC, 2020, INT J MED SCI, V17, P437, DOI 10.7150/ijms.39667; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu YW, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01949-x; Yan J, 2019, J NEUROCHEM, V150, P202, DOI 10.1111/jnc.14717; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Zhong Y, 2019, CANCER GENE THER, V26, P234, DOI 10.1038/s41417-018-0067-5	93	6	6	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2021	22	4							1563	10.3390/ijms22041563			27	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	QP6GI	WOS:000623932800001	33557217	Green Published			2022-02-06	
J	Liraz-Zaltsman, S; Friedman-Levi, Y; Shabashov-Stone, D; Gincberg, G; Atrakcy-Baranes, D; Joy, MT; Carmichael, ST; Silva, AJ; Shohami, E				Liraz-Zaltsman, Sigal; Friedman-Levi, Yael; Shabashov-Stone, Dalia; Gincberg, Galit; Atrakcy-Baranes, Dana; Joy, Mary Teena; Carmichael, S. Thomas; Silva, Alcino J.; Shohami, Esther			Chemokine Receptors CC Chemokine Receptor 5 and C-X-C Motif Chemokine Receptor 4 Are New Therapeutic Targets for Brain Recovery after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chemokine receptors; CCR5; CXCR4; TBI; temporal-profile	CLOSED-HEAD INJURY; FUNCTIONAL RECOVERY; NMDA RECEPTORS; NEUROINFLAMMATION; INFLAMMATION; ACTIVATION; EXPRESSION; MODEL; GLUTAMATE; PROMOTES	Recently, chemokine receptor CC chemokine receptor 5 (CCR5) was found to be a negative modulator of learning and memory. Its inhibition improved outcome after stroke and traumatic brain injury (TBI). To better understand its role after TBI and establish therapeutic strategies, we investigated the effect of reduced CCR5 signaling as a neuroprotective strategy and of the temporal changes of CCR5 expression after TBI in different brain cell types. To silence CCR5 expression, ccr5 short hairpin RNA (shRNA) or dsred shRNA (control) was injected into the cornu ammonis (CA) 1 and CA3 regions of the hippocampus 2 weeks before induction of closed-head injury in mice. Animals were then monitored for 32 days and euthanized at different time points to assess lesion area, inflammatory components of the glial response (immunohistochemistry; IHC), cytokine levels (enzyme-linked immunosorbent array), and extracellular signal-regulated kinase (ERK) phosphorylation (western blot). Fluorescence-activated cell sorting (FACS) analysis was performed to study post-injury temporal changes of CCR5 and C-X-C motif chemokine receptor 4 (CXCR4) expression in cortical and hippocampal cell populations (neurons, astrocytes, and microglia). Phosphorylation of the N-methyl-d-aspartate subunit 1 (NR1) subunit of N-methyl-d-aspartate (western blot) and cAMP-response-element-binding protein (CREB; IHC) were also assessed. The ccr5 shRNA mice displayed reduced lesion area, dynamic alterations in levels of inflammation-related CCR5 ligands and cytokines, and higher levels of phosphorylated ERK. The ccr5 shRNA also reduced astrocytosis in the lesioned and sublesioned cortex. FACS analysis revealed increased cortical CCR5 and CXCR4 expression in CD11b-positive cells, astrocytes, and neurons, which was most evident in cells expressing both receptors, at 3 and 11 days post-injury. The lowest levels of phosphorylated NR1 and phosphorylated CREB were found at day 3 post-injury, suggesting that this is the critical time point for therapeutic intervention.	[Liraz-Zaltsman, Sigal; Friedman-Levi, Yael; Shabashov-Stone, Dalia; Gincberg, Galit; Shohami, Esther] Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel; [Atrakcy-Baranes, Dana] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Liraz-Zaltsman, Sigal] Ono Acad Coll, Inst Hlth & Med Profess, Dept Sports Therapy, Qiryat Ono, Israel; [Joy, Mary Teena; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Liraz-Zaltsman, S (corresponding author), Sheba Med Ctr, Joseph Sagol Neurosci Ctr, IL-5265601 Tel Hashomer, Israel.	Sigal.lirazzaltsman@sheba.health.gov.il	Joy, Mary Teena/S-9605-2018; Silva, Alcino/ABD-7684-2021	Joy, Mary Teena/0000-0002-3120-2022; Silva, Alcino/0000-0002-1587-4558	Dr. Miriam and Sheldon Adelson Foundation (AMRF)	This study was supported by a grant from the Dr. Miriam and Sheldon Adelson Foundation (AMRF) to E.S., S.T.C., and A.J.S.	Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073; Eggers C, 2017, J NEUROL, V264, P1715, DOI 10.1007/s00415-017-8503-2; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gincberg G, 2018, CYTOTHERAPY, V20, P245, DOI 10.1016/j.jcyt.2017.11.008; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Victoria ECG, 2017, CURR NEUROVASC RES, V14, P125, DOI 10.2174/1567202614666170313113056; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Grossman R, 2012, CURR DRUG SAF, V7, P329, DOI 10.2217/FNL.12.25; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hosomi S, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.520; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kim S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1320-4; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lan YY, 2019, J CELL PHYSIOL, V234, P18748, DOI 10.1002/jcp.28514; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lunemann A, 2006, GLIA, V53, P412, DOI 10.1002/glia.20301; Middei S, 2012, LEARN MEMORY, V19, P330, DOI 10.1101/lm.025817.112; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ru WJ, 2016, J NEUROIMMUNE PHARM, V11, P182, DOI 10.1007/s11481-015-9644-7; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Umschweif G, 2014, J CEREBR BLOOD F MET, V34, P1381, DOI 10.1038/jcbfm.2014.93; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Wang H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0095-0; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zhou M, 2016, ELIFE, V5, DOI 10.7554/eLife.20985; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	53	6	6	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					2003	2017		10.1089/neu.2020.7015		JAN 2021	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000613465200001	33256497				2022-02-06	
J	Wu, JC; Li, H; He, JC; Tian, XC; Luo, SL; Li, JK; Li, W; Zhong, JJ; Zhang, HR; Huang, ZJ; Sun, XC; Jiang, T				Wu, Jingchuan; Li, Hui; He, Junchi; Tian, Xiaocui; Luo, Shuilian; Li, Jiankang; Li, Wei; Zhong, Jianjun; Zhang, Hongrong; Huang, Zhijian; Sun, Xiaochuan; Jiang, Tao			(Downregulation of microRNA-9-5p promotes synaptic remodeling in the chronic phase after traumatic brain injury)	CELL DEATH & DISEASE			English	Article							HYPERBARIC-OXYGEN THERAPY; CYLD REPRESSION; IN-VITRO; EXPRESSION; THROMBOSPONDINS; INFLAMMATION; BIOMARKERS; PROTEINS; PATHWAY; TAK1	The level of microRNA-9-5p (miRNA-9-5p) in brain tissues is significantly changed in the chronic phase after traumatic brain injury (TBI). However, the effect of miRNA-9-5p on brain function after TBI has not been elucidated. In this study, we used a controlled cortical impact (CCI) model to induce TBI in Sprague-Dawley rats. Brain microvascular endothelial cells (BMECs), astrocytes, and neurons were extracted from immature Sprague-Dawley rats and cocultured to reconstruct the neurovascular unit (NVU) in vitro. The results showed that downregulation of miRNA-9-5p in the chronic phase contributed to neurological function recovery by promoting astrocyte proliferation and increasing the release of astrocyte-derived neurotrophic factors around injured brain tissues after TBI. A dual-luciferase reporter assay validated that miRNA-9-5p was a post-transcriptional modulator of thrombospondin 2 (Thbs-2), and downregulation of miRNA-9-5p promoted Thbs-2 expression in astrocytes. Furthermore, we verified that Thbs-2 can promote Notch pathway activation by directly binding to Jagged and Notch. Through in vitro experiments, we found that the expression of synaptic proteins and the number of synaptic bodies were increased in neurons in the NVU, which was constructed using astrocytes pretreated with miRNA-9-5p inhibitor. Moreover, we also found that downregulation of miRNA-9-5p promoted Thbs-2 expression in astrocytes, which activated the Notch/cylindromatosis/transforming growth factor-beta -activated kinase 1 pathway in neurons and promoted the expression of synaptic proteins, including post-synaptic density protein 95 and synaptotagmin. Based on these results, miRNA-9-5p may be a new promising prognostic marker and treatment target for TBI.	[Wu, Jingchuan; Li, Hui; He, Junchi; Zhong, Jianjun; Zhang, Hongrong; Huang, Zhijian; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Wu, Jingchuan] Wuhan Brain Hosp, Gen Hosp YangTze River Shipping, Dept Neurosurg, Wuhan 430014, Hubei, Peoples R China; [Tian, Xiaocui] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Coll Pharm, Chongqing 400016, Yuzhong, Peoples R China; [Luo, Shuilian] Wuhan Univ, Zhongnan Hosp, Dept Ultrasound, Wuhan 430071, Peoples R China; [Li, Jiankang] City Univ Hong Kong, Dept Comp Sci, Kowloon, 83 Tat Chee Ave, Hong Kong, Peoples R China; [Li, Wei] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China; [Jiang, Tao] Capital Med Univ, Beijing TianTan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Jiang, Tao] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing TianTan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China.; Jiang, T (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.	sunxch1445@qq.com; zacharytaojiang@163.com		LI, Jiankang/0000-0002-5061-4460; Wu, Jingchuan/0000-0002-1213-4888; Jiang, Tao/0000-0002-8529-4487	Chongqing Key Laboratory of Ophthalmology and Laboratory Research Central, the First Affiliated Hospital of Chongqing Medical University; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071397]; Health Commission of Wuhan Municipality scientific research Funding [WX19Q17]; Health Commission of Hubei Province scientific research project [WJ2019H364]; Capital's Funds for Health Improvement and Research [CFH2018-2-2042]	We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology and Laboratory Research Central, the First Affiliated Hospital of Chongqing Medical University. We also acknowledge the assistant provided by Xiaoyun Dou (Institute of Life Sciences, Chongqing Medical University). This work was supported by grants from the National Natural Science Foundation of China (No. 82071397), Health Commission of Wuhan Municipality scientific research Funding (No. WX19Q17), Health Commission of Hubei Province scientific research project (No. WJ2019H364), and Capital's Funds for Health Improvement and Research (CFH2018-2-2042).	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Andersen AM, 2020, HEADACHE, V60, P1066, DOI 10.1111/head.13812; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Burnside MN, 2015, PEDIATR DEVEL PATHOL, V18, P59, DOI 10.2350/14-06-1516-CR.1; Chen H, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub2; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; D'Altri T, 2011, CELL CYCLE, V10, P1031, DOI 10.4161/cc.10.7.15067; De Luca C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041539; Delaloy C, 2008, NAT NEUROSCI, V11, P625, DOI 10.1038/nn0608-625; Delaloy C, 2010, CELL CYCLE, V9, P2913, DOI 10.4161/cc.9.15.12699; Du TJ, 2020, WORLD NEUROSURG, V139, pE553, DOI 10.1016/j.wneu.2020.04.083; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Gayen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072312; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Gonzales-Portillo B, 2019, BRAIN CIRC, V5, P101, DOI 10.4103/bc.bc_31_19; Hu Q, 2014, STROKE, V45, P1807, DOI 10.1161/STROKEAHA.114.005116; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kestner RI, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00280; Kim SK, 2017, GLIA, V65, P1719, DOI 10.1002/glia.23169; Kirk JA, 2016, J MOL CELL CARDIOL, V90, P102, DOI 10.1016/j.yjmcc.2015.12.009; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lekic T, 2010, J NEUROTRAUM, V27, P627, DOI 10.1089/neu.2009.1163; Li J, 2020, NEUROL SCI, V41, P2367, DOI 10.1007/s10072-020-04410-9; Li ZK, 2020, CELL CYCLE, V19, P24, DOI 10.1080/15384101.2019.1691763; Liu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246125; Miller GF, 2020, AM J PUBLIC HEALTH, V110, P897, DOI 10.2105/AJPH.2020.305622; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Mondello S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01326; Munakomi Sunil, 2020, Adv Exp Med Biol, V1279, P53, DOI 10.1007/5584_2020_529; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Sell SL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221163; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tian XC, 2016, J NEUROCHEM, V139, P757, DOI 10.1111/jnc.13833; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang PC, 2020, INT J MED SCI, V17, P437, DOI 10.7150/ijms.39667; Wen YT, 2018, BIOCHEM BIOPH RES CO, V503, P2312, DOI 10.1016/j.bbrc.2018.06.154; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wu JC, 2020, J NEUROCHEM, V153, P710, DOI 10.1111/jnc.14963; Zhou S, 2018, NEURAL REGEN RES, V13, P2134, DOI 10.4103/1673-5374.241462; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	51	6	6	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN 5	2021	12	1							9	10.1038/s41419-020-03329-5			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	PU7SQ	WOS:000609501400001	33414448	Green Published, gold			2022-02-06	
J	Alam, SI; Jo, MG; Park, TJ; Ullah, R; Ahmad, S; Rehman, SU; Kim, MO				Alam, Sayed Ibrar; Jo, Min Gi; Park, Tae Ju; Ullah, Rahat; Ahmad, Sareer; Rehman, Shafiq Ur; Kim, Myeong Ok			Quinpirole-Mediated Regulation of Dopamine D2 Receptors Inhibits Glial Cell-Induced Neuroinflammation in Cortex and Striatum after Brain Injury	BIOMEDICINES			English	Article						brain injury; quinpirole; dopamine D2 receptors; glial cell; neuroinflammation; neurodegeneration		Brain injury is a significant risk factor for chronic gliosis and neurodegenerative diseases. Currently, no treatment is available for neuroinflammation caused by the action of glial cells following brain injury. In this study, we investigated the quinpirole-mediated activation of dopamine D2 receptors (D2R) in a mouse model of traumatic brain injury (TBI). We also investigated the neuroprotective effects of quinpirole (a D2R agonist) against glial cell-induced neuroinflammation secondary to TBI in adult mice. After the brain injury, we injected quinpirole into the TBI mice at a dose of 1 mg/kg daily intraperitoneally for 7 days. Our results showed suppression of D2R expression and deregulation of downstream signaling molecules in ipsilateral cortex and striatum after TBI on day 7. Quinpirole administration regulated D2R expression and significantly reduced glial cell-induced neuroinflammation via the D2R/Akt/glycogen synthase kinase 3 beta (GSK3-beta) signaling pathway after TBI. Quinpirole treatment concomitantly attenuated increase in glial cells, neuronal apoptosis, synaptic dysfunction, and regulated proteins associated with the blood-brain barrier, together with the recovery of lesion volume in the TBI mouse model. Additionally, our in vitro results confirmed that quinpirole reversed the microglial condition media complex-mediated deleterious effects and regulated D2R levels in HT22 cells. This study showed that quinpirole administration after TBI reduced secondary brain injury-induced glial cell activation and neuroinflammation via regulation of the D2R/Akt/GSK3-beta signaling pathways. Our study suggests that quinpirole may be a safe therapeutic agent against TBI-induced neurodegeneration.	[Alam, Sayed Ibrar; Jo, Min Gi; Ullah, Rahat; Ahmad, Sareer; Rehman, Shafiq Ur; Kim, Myeong Ok] Gyeongsang Natl Univ, Div Life Sci & Appl Life Sci BK21 FOUR, Coll Nat Sci, Jinju 52828, South Korea; [Park, Tae Ju] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, MVLS, Glasgow G12 8QQ, Lanark, Scotland		Kim, MO (corresponding author), Gyeongsang Natl Univ, Div Life Sci & Appl Life Sci BK21 FOUR, Coll Nat Sci, Jinju 52828, South Korea.	ibrar@gnu.ac.kr; mingi.cho@gnu.ac.kr; 2358860p@student.gla.ac.uk; Rahatullah1414@gnu.ac.kr; sareer_50@gnu.ac.kr; shafiq.qau.edu@gmail.com; 2358860p@student.gla.ac.uk	Kim, Myeong Ok/AAS-1488-2021	Kim, Myeong Ok/0000-0003-4317-1072; Jo, Min Gi/0000-0002-2863-6989	Neurological Disorder Research Program of the National Research Foundation (NRF) - Korean Government (MSIT) [2020M3E5D9080660]	This research was supported by the Neurological Disorder Research Program of the National Research Foundation (NRF) funded by the Korean Government (MSIT) (2020M3E5D9080660).	Ahmad R, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100380; Alam SI, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020271; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Becker A, 2000, PHARMACOL BIOCHEM BE, V66, P425, DOI 10.1016/S0091-3057(99)00264-6; Bibb JA, 2005, CELL, V122, P153, DOI 10.1016/j.cell.2005.07.011; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Clement T, 2020, GLIA, V68, P528, DOI 10.1002/glia.23736; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Han X, 2017, BRIT J PHARMACOL, V174, P4751, DOI 10.1111/bph.14057; Huang JJ, 2013, PSYCHOPHARMACOLOGY, V227, P459, DOI 10.1007/s00213-013-2965-4; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Khan M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102504; Khlghatyan J, 2019, CEREB CORTEX, V29, P3813, DOI 10.1093/cercor/bhy261; Kim DW, 2007, NEUROCHEM RES, V32, P1460, DOI 10.1007/s11064-007-9332-y; KOLLER W, 1987, NEUROPHARMACOLOGY, V26, P1031, DOI 10.1016/0028-3908(87)90245-0; Kuric E, 2013, EXP NEUROL, V247, P202, DOI 10.1016/j.expneurol.2013.04.016; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Maixner Dylan Warren, 2013, J Pharm Pharmacol (Los Angel), V1, P001; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Nair VD, 2003, BIOCHEM J, V373, P25, DOI 10.1042/BJ20030017; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Qiu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0739-8; Rehman SU, 2019, MOL NEUROBIOL, V56, P2774, DOI 10.1007/s12035-018-1280-9; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Sellnow RC, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0653-7; Shah SA, 2017, MOL PSYCHIATR, V22, P407, DOI 10.1038/mp.2016.23; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tajiri N, 2014, BRAIN RES, V1559, P65, DOI 10.1016/j.brainres.2014.02.041; Takahashi H, 2008, J NEUROSCI, V28, P12032, DOI 10.1523/JNEUROSCI.3446-08.2008; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Ul Amin F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40753; Ullah R, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01989-w; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wallenquist U, 2012, RESTOR NEUROL NEUROS, V30, P9, DOI 10.3233/RNN-2011-0606; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792	55	6	6	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	JAN	2021	9	1							47	10.3390/biomedicines9010047			17	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	PV2PZ	WOS:000609836000001	33430188	Green Published, Green Accepted			2022-02-06	
J	Ansado, J; Chasen, C; Bouchard, S; Northoff, G				Ansado, Jennyfer; Chasen, Clelia; Bouchard, Stephane; Northoff, Georg			How brain imaging provides predictive biomarkers for therapeutic success in the context of virtual reality cognitive training	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						Virtual reality; Neurorehabilitation; fMRI; EEG; NIRS		As Virtual reality (VR) is increasingly used in neurological disorders such as stroke, traumatic brain injury, or attention deficit disorder, the question of how it impacts the brain's neuronal activity and function becomes essential. VR can be combined with neuroimaging to offer invaluable insight into how the targeted brain areas respond to stimulation during neurorehabilitation training. That, in turn, could eventually serve as a predictive marker for therapeutic success. Functional magnetic resonance imaging (fMRI) identified neuronal activity related to blood flow to reveal with a high spatial resolution how activation patterns change, and restructuring occurs after VR training. Portable and quiet, electroencephalography (EEG) conveniently allows the clinician to track spontaneous electrical brain activity in high temporal resolution. Then, functional near-infrared spectroscopy (fNIRS) combines the spatial precision level of fMRIs with the portability and high temporal resolution of EEG to constitute an ideal measuring tool in virtual environments (VEs). This narrative review explores the role of VR and concurrent neuroimaging in cognitive rehabilitation.	[Ansado, Jennyfer] Univ Cote dAzur, Dept Psychol, Campus St Jean dAngely,24 Av Diables Bleus, F-06357 Nice, France; [Chasen, Clelia] Inst Savoir Montfort, 713 Montreal Rd, Montreal, ON K1K OT2, Canada; [Chasen, Clelia; Bouchard, Stephane] Univ Quebec Outaouais, Clin Cybeipsychol, 283 Alexandre Tache Blvd, Gatineau, PQ J8X 3X7, Canada; [Bouchard, Stephane] Ctr Integre Sante & Serv Sociaux Outaouais, Gatineau, PQ, Canada; [Northoff, Georg] Royals Inst Mental Hlth Res, Mind Brain Imaging & Neuroeth, 1145 Carling Ave, Ottawa, ON K1Z 7K4, Canada		Ansado, J (corresponding author), Univ Cote dAzur, Dept Psychol, Campus St Jean dAngely,24 Av Diables Bleus, F-06357 Nice, France.	jennyfer.ansado@univ-cotedazur.fr			European UnionEuropean Commission [785907]; Canada-UK Artificial Intelligence (AI) Initiative [ES/T01279X/1]; UMRF; CIHRCanadian Institutes of Health Research (CIHR); uOBMRI; PSI; Chaire de recherche du Canada [(231039)A]	Georg Northoff has received funding from the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 785907 (Human Brain Project SGA2). Financial contribution to GN also comes from Canada-UK Artificial Intelligence (AI) Initiative `The self as agent-environment nexus: crossing disciplinary boundaries to help human selves and anticipate artificial selves' (ES/T01279X/1). GN is also grateful for funding provided by UMRF, uOBMRI, CIHR, and PSI.; Stephane Bouchard. Organisation name: Chaire de recherche du Canada Grant/Contract number: Chaire de recherche du Canada en cyberpsychologie clinique (#231039)A.	Ansado J, 2018, ANN REV CYBERTHERAPY, V16, P101; Beck L, 2010, CYBERPSYCH BEH SOC N, V13, P211, DOI 10.1089/cyber.2008.0343; Badia SBI, 2013, IEEE T NEUR SYS REH, V21, P174, DOI 10.1109/TNSRE.2012.2229295; Caglio M, 2012, NEUROCASE, V18, P123, DOI 10.1080/13554794.2011.568499; Cho BH, 2004, CYBERPSYCHOL BEHAV, V7, P519, DOI 10.1089/cpb.2004.7.519; Comani S, 2015, IEEE ENG MED BIO, P3925, DOI 10.1109/EMBC.2015.7319252; Holper L, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-57; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P2218, DOI 10.1016/j.apmr.2005.04.015; Kolvoort IR, 2020, HUM BRAIN MAPP, V41, P4355, DOI 10.1002/hbm.25129; Laver K, 2012, PRESENCE-TELEOP VIRT, V21, P183, DOI 10.1162/PRES_a_00098; Merians AS, 2009, STUD HEALTH TECHNOL, V145, P109, DOI 10.3233/978-1-60750-018-6-109; Northoff G, 2020, PHYS LIFE REV, V33, P34, DOI 10.1016/j.plrev.2019.05.002; Parnas J, 2020, SCHIZOPHR B; Prochnow D, 2013, EUR J NEUROSCI, V37, P1441, DOI 10.1111/ejn.12157; Rizzo A., 2019, VIRTUAL REALITY PSYC; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Sangani S, 2015, PROG BRAIN RES, V218, P313, DOI 10.1016/bs.pbr.2014.12.003; Steinisch M, 2013, IEEE T NEUR SYS REH, V21, P849, DOI 10.1109/TNSRE.2013.2267851; Teo WP, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00284; Wolff A, 2019, HUM BRAIN MAPP, V40, P789, DOI 10.1002/hbm.24412	20	6	6	6	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	JAN	2021	120						583	594		10.1016/j.neubiorev.2020.05.018			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	QB6VG	WOS:000614277700008	32533997				2022-02-06	
J	Khan, MI; Hasan, F; Al Mahmud, KA; Adnan, A				Khan, Md Ishak; Hasan, Fuad; Al Mahmud, Khandakar Abu Hasan; Adnan, Ashfaq			Domain focused and residue focused phosphorylation effect on tau protein: A molecular dynamics simulation study	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article							CEREBROSPINAL-FLUID LEVELS; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; ABNORMAL PHOSPHORYLATION; MICROTUBULE-BINDING; THREONINE 181; FORCE-FIELD; FETAL-TAU; BRAIN; STATE	Phosphorylation has been hypothesized to alter the ability of tau protein to bind with microtubules (MT), and pathological level of phosphorylation can incorporate formation of Paired Helical Filaments (PHF) in affected tau. Study of the effect of phosphorylation on different domains of tau (projection domain, microtubule binding sites and N-terminus tail) is important to obtain insight about tau neuropathology. In an earlier study, we have already obtained the mechanical properties and behavior of single tau and dimerized tau and observed tau-MT interaction for normal level of phosphorylation. This study attempts to obtain insights on the effect of phosphorylation on different domains of tau, using molecular dynamics (MD) simulation with the aid of CHARMM force field under high strain rate. It also determines the effect of residue focused phosphorylation on tau-MT interaction and tau accumulation tendency. The results show that for single tau protein, unfolding stiffness does not differ significantly due to phosphorylation, but stretching stiffness can be much higher than the normally phosphorylated protein. For dimerized tau protein, the stretching required to separate the protein forming the dimer is similar for phosphorylation in individual domains but is significantly less in case of phosphorylation in all domains. For tau-MT interaction simulations, it is found that for normal phosphorylation, the tau separation from MT occurs at higher strain for phosphorylation in projection domain and N-terminus tail, and earlier for phosphorylation in all domains altogether than the normal phosphorylation state. The residue focused phosphorylation study also shows that tau separates earlier from MT and shows stronger accumulation tendency at the phosphorylated state, while preserving the highly stretchable and flexible characteristic of tau. This study provides important insight on mechanochemical phenomena relevant to traumatic brain injury (TBI) scenario, where the result of mechanical loading and posttranslational modification as well as conformation decides the mechanical behavior.	[Khan, Md Ishak; Hasan, Fuad; Al Mahmud, Khandakar Abu Hasan; Adnan, Ashfaq] Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA		Adnan, A (corresponding author), Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA.	aadnan@uta.edu	Hasan, Fuad/ABC-9862-2020	Hasan, Fuad/0000-0003-1889-4877; Khan, Md Ishak/0000-0001-7680-9613	Computational Cellular Biology of Blast (C2B2) program through the Office of Naval Research (ONR) [N00014-18-1-2082]	This work has been funded by the Computational Cellular Biology of Blast (C2B2) program through the Office of Naval Research (ONR) (Award #N00014-18-1-2082-Dr. Timothy Bentley, Program Manager). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing HPC resources that have contributed to the research results reported within this paper. URL: http./E66666.tacc.utexas.edu.	Adnan A, 2018, J MECH BEHAV BIOMED, V86, P375, DOI 10.1016/j.jmbbm.2018.06.031; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; AVILA J, 1990, FASEB J, V4, P3284, DOI 10.1096/fasebj.4.15.2253844; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Battisti A, 2012, MOL SIMULAT, V38, P525, DOI 10.1080/08927022.2011.633347; BAUDIER J, 1987, J BIOL CHEM, V262, P17577; Becker JS, 2007, J ANAL ATOM SPECTROM, V22, P761, DOI 10.1039/b701440f; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Castro TG, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030116; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; Churcher I, 2006, CURR TOP MED CHEM, V6, P579, DOI 10.2174/156802606776743057; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cloots R.J.H., 2010, P IRCOBI C HANN GERM, P119; Dudek SM, 1995, DEV BRAIN RES, V90, P54, DOI 10.1016/0165-3806(96)83486-9; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Garver TD, 1996, J NEUROSCI RES, V44, P12, DOI 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L; Gladkevich A, 2007, PROG NEURO-PSYCHOPH, V31, P1347, DOI 10.1016/j.pnpbp.2007.06.005; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Haense C, 2008, EUR J NEUROL, V15, P1155, DOI 10.1111/j.1468-1331.2008.02274.x; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Jho YS, 2010, BIOPHYS J, V99, P2387, DOI 10.1016/j.bpj.2010.06.056; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kandimalla RJL, 2013, BIOL OPEN, V2, P1119, DOI 10.1242/bio.20135447; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KHAN MA, 2020, MULTISCALE SCI ENG, DOI DOI 10.1007/S11042-020-08806-9; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McQuaid MJ, 2004, J COMPUT CHEM, V25, P61, DOI 10.1002/jcc.10316; Mortazavi B, 2017, APPL ENERG, V202, P323, DOI 10.1016/j.apenergy.2017.05.175; Mortazavi B, 2015, CARBON, V85, P1, DOI 10.1016/j.carbon.2014.12.046; Mulder C, 2010, CLIN CHEM, V56, P248, DOI 10.1373/clinchem.2009.130518; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; ONO T, 1995, NEUROCHEM INT, V26, P205, DOI 10.1016/0197-0186(94)00135-H; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Pearce CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114292; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickhardt Marcus, 2005, Current Alzheimer Research, V2, P219, DOI 10.2174/1567205053585891; Ravaglia S, 2008, NEUROL SCI, V29, P417, DOI 10.1007/s10072-008-1023-1; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Rycroft C., 2009, VORO 3 DIMENSIONAL V, DOI [10.2172/946741, DOI 10.2172/946741]; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Senftle TP, 2016, NPJ COMPUT MATER, V2, DOI 10.1038/npjcompumats.2015.11; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Sochocka M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1520-6; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Wu YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29804-w; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; 2010, ARCT REG ANTARCT ISS, P1	92	6	6	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2021	113								104149	10.1016/j.jmbbm.2020.104149			19	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	PG3QM	WOS:000599653400002	33125954	Bronze			2022-02-06	
J	Moro, F; Fossi, F; Magliocca, A; Pascente, R; Sammali, E; Baldini, F; Tolomeo, D; Micotti, E; Citerio, G; Stocchetti, N; Fumagalli, F; Magnoni, S; Latini, R; Ristagno, G; Zanier, ER				Moro, Federico; Fossi, Francesca; Magliocca, Aurora; Pascente, Rosaria; Sammali, Eliana; Baldini, Federico; Tolomeo, Daniele; Micotti, Edoardo; Citerio, Giuseppe; Stocchetti, Nino; Fumagalli, Francesca; Magnoni, Sandra; Latini, Roberto; Ristagno, Giuseppe; Zanier, Elisa R.			Efficacy of acute administration of inhaled argon on traumatic brain injury in mice	BRITISH JOURNAL OF ANAESTHESIA			English	Article						argon; brain protection; neuroinflammation; neuroprotection; traumatic brain injury		Background: Whilst there has been progress in supportive treatment for traumatic brain injury (TBI), specific neuroprotective interventions are lacking. Models of ischaemic heart and brain injury show the therapeutic potential of argon gas, but it is still not known whether inhaled argon (iAr) is protective in TBI. We tested the effects of acute administration of iAr on brain oedema, tissue micro-environmental changes, neurological functions, and structural outcome in a mouse model of TBI. Methods: Anaesthetised adult C57BL/6J mice were subjected to severe TBI by controlled cortical impact. Ten minutes after TBI, the mice were randomised to 24 h treatments with iAr 70%/0 2 30% or air (iCtr). Sensorimotor deficits were evaluated up to 6 weeks post-TBI by three independent tests. Cognitive function was evaluated by Barnes maze test at 4 weeks. MRI was done to examine brain oedema at 3 days and white matter damage at 5 weeks. Microglia/macrophages activation and functional commitment were evaluated at 1 week after TBI by immunohistochemistry. Results: iAr significantly accelerated sensorimotor recovery and improved cognitive deficits 1 month after TBI, with less white matter damage in the ipsilateral fimbria and body of the corpus callosum. Early changes underpinning protection included a reduction of pericontusional vasogenic oedema and of the inflammatory response. iAr significantly reduced microglial activation with increases in ramified cells and the M2-like marker YM1. Conclusions: iAr accelerates recovery of sensorimotor function and improves cognitive and structural outcome 1 month after severe TBI in adult mice. Early effects include a reduction of brain oedema and neuroinflammation in the contused tissue.	[Moro, Federico; Fossi, Francesca; Pascente, Rosaria; Sammali, Eliana; Baldini, Federico; Zanier, Elisa R.] Ist Ric Farmacol Mario Negri IRCCS, Lab Acute Brain Injury & Therapeut Strategies, Dept Neurosci, Milan, Italy; [Fossi, Francesca] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Magliocca, Aurora; Fumagalli, Francesca; Latini, Roberto; Ristagno, Giuseppe] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Milan, Italy; [Tolomeo, Daniele; Micotti, Edoardo] Ist Ric Farmacol Mario Negri IRCCS, Lab Biol Neurodegenerat Disorders, Dept Neurosci, Milan, Italy; [Citerio, Giuseppe; Stocchetti, Nino; Ristagno, Giuseppe] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Magnoni, Sandra] Santa Chiara Hosp, Azienda Prov & Serv Sanit Prov Trento APSS, Trento, Italy		Zanier, ER (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Lab Acute Brain Injury & Therapeut Strategies, Dept Neurosci, Milan, Italy.	elisa.zanier@marionegri.it	Baldini, Federico/ABG-5630-2021; Micotti, Edoardo/J-9359-2018; Moro, Federico/AAG-1731-2021; Magnoni, Sandra/AAC-7479-2022; moro, federico/K-5644-2016	Baldini, Federico/0000-0002-9402-6775; Micotti, Edoardo/0000-0002-5995-2992; Moro, Federico/0000-0002-2682-5583; Magnoni, Sandra/0000-0002-1723-0844; moro, federico/0000-0002-2682-5583; Tolomeo, Daniele/0000-0002-5219-6397; Magliocca, Aurora/0000-0002-3908-3857			Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Badaut J, 2020, J NEUROSCI RES, V98, P129, DOI 10.1002/jnr.24415; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brucken A, 2015, NEUROCRIT CARE, V22, P112, DOI 10.1007/s12028-014-0029-1; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gardner AJ, 2018, BRIT J ANAESTH, V120, P453, DOI 10.1016/j.bja.2017.10.017; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hollig A, 2016, CRIT CARE MED, V44, pE520, DOI 10.1097/CCM.0000000000001561; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liu JJ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2493-7; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Perego C, 2016, NEUROBIOL DIS, V96, P284, DOI 10.1016/j.nbd.2016.09.017; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Trudell JR, 1998, ANESTH ANALG, V87, P411, DOI 10.1097/00000539-199808000-00034; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhao HL, 2016, ONCOTARGET, V7, P25640, DOI 10.18632/oncotarget.8241; Zhao HL, 2016, ANESTHESIOLOGY, V125, P180, DOI 10.1097/ALN.0000000000001128; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	39	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JAN	2021	126	1					256	264		10.1016/j.bja.2020.08.027			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QG0IO	WOS:000617270300063	32977957	Bronze, Green Submitted			2022-02-06	
J	Orr, R; Bogg, T; Fyffe, A; Lam, LT; Browne, GJ				Orr, Rhonda; Bogg, Tina; Fyffe, Andrew; Lam, Lawrence T.; Browne, Gary J.			Graded Exercise Testing Predicts Recovery Trajectory of Concussion in Children and Adolescents	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						head injury; mild traumatic brain injury; return to activity; youth; risk stratification		Objective: To determine whether graded exercise testing can predict recovery trajectory of concussion in children and adolescents. Design: Prospective study. Setting:Children's Hospital, Westmead, Australia. Participants:One hundred thirty-nine children aged 12 to 16 years at 5 to 7 days after an acute concussive injury. Intervention:Graded exercise testing on a treadmill at the subacute phase to assess symptom provocation and determine clinical recovery indicating readiness to commence a return to activity (RTA) protocol. Exercise time to symptom exacerbation and clinical recovery were measured. Main Outcome Measures: Standard concussion assessment and clinical testing (neurocognitive, vestibular/ocular, and balance) were conducted to determine major clinical drivers/indicators. Results: Participants (mean age 12.4 +/- 2.8 years, 73% male) had a confirmed sport-related concussion. The main clinical drivers identified on exercise testing were headache, balance, and vestibular dysfunction. Participants fell into 1 of 2 groups, exercise-tolerant (54%) and exercise-intolerant (46%). Exercise-tolerant patients showed mild clinical indicators, no symptom exacerbation during 10.3 +/- 3.3 minutes of exercise, were safely transitioned to a RTA protocol, and recovered within 10 days. Exercise-intolerant patients had high clinical indicators, significant symptom exacerbation at 4.2 +/- 1.6 minutes of exercise, and prolonged recovery of 45.6 days. No adverse effects from exercise were reported in either group. Combined use of provocative exercise and clinical testing was 93% predictive of outcome. Conclusions: Exercise testing during the subacute phase after a concussion can predict longer recovery. Exercise testing can identify a unique window where patients can be safely transitioned to activity, enabling clinicians to better inform patients and families, allocate resources and streamline care.	[Orr, Rhonda] Univ Sydney, Discipline Exercise & Sport Sci, Fac Hlth Sci, Childrens Hosp,Westmead Clin Sch, Sydney, NSW, Australia; [Orr, Rhonda] Univ Sydney, Discipline Emergency Med, Childrens Hosp, Westmead Clin Sch, Sydney, NSW, Australia; [Bogg, Tina; Fyffe, Andrew; Browne, Gary J.] Childrens Hosp Westmead, Royal Alexandra Hosp Children, Sydney Childrens Hosp Network, Childrens Hosp,Inst Sports Med, Sydney, NSW, Australia; [Lam, Lawrence T.] Univ Technol Sydney, Grad Sch Hlth, Fac Hlth, Sydney, NSW, Australia; [Browne, Gary J.] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia		Orr, R (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Childrens Hosp,Westmead Clin Sch, 75 East St, Lidcombe, NSW 2141, Australia.; Orr, R (corresponding author), Univ Sydney, Westmead Clin Sch, Discipline Emergency Med, Childrens Hosp, 75 East St, Lidcombe, NSW 2141, Australia.	rhonda.orr@sydney.edu.au	Orr, Rhonda/C-1817-2008				Ahmad F, 2001, J PEDIATR-US, V139, P284, DOI 10.1067/mpd.2001.115968; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BRUCE R A, 1963, Pediatrics, V32, P742; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Corbin-Berrigan LA, 2017, CLIN J SPORT MED, V27, P325, DOI 10.1097/JSM.0000000000000355; CUMMING GR, 1978, AM J CARDIOL, V41, P69, DOI 10.1016/0002-9149(78)90134-0; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kerrigan JM, 2017, CHILD NERV SYST, V33, P1669, DOI 10.1007/s00381-017-3537-4; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	49	6	6	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					23	30		10.1097/JSM.0000000000000683			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800008	30439726				2022-02-06	
J	Sakakura, K; Fujimoto, A; Arai, Y; Ichikawa, N; Sato, K; Baba, S; Inenaga, C; Matsumura, A; Ishikawa, E; Enoki, H; Okanishi, T				Sakakura, Kazuki; Fujimoto, Ayataka; Arai, Yoshifumi; Ichikawa, Naoki; Sato, Keishiro; Baba, Shimpei; Inenaga, Chikanori; Matsumura, Akira; Ishikawa, Eiichi; Enoki, Hideo; Okanishi, Tohru			Posttraumatic epilepsy may be a state in which underlying epileptogenicity involves focal cortical dysplasia	EPILEPSY & BEHAVIOR			English	Article						Traumatic brain injury-related epilepsy; Neuropathological findings; Epilepsy surgery; Focal cortical dysplasia	TRAUMATIC BRAIN-INJURY; INTRACTABLE EPILEPSY; SEIZURES; SURGERY; CLASSIFICATION; ULEGYRIA; CHILDREN; MODEL	Introduction: The occurrence rate of posttrauma epilepsy ranges widely from 1% to 30%. Little is known about the underlying epileptogenesis of traumatic brain injury (TBI)-related epilepsy (TRE), because no comparison between TRE and TBI without epilepsy has been performed in terms of neuropathology. Therefore, we postulated that different neuropathological factors may be present between TRE and TBI without epilepsy. The purpose of this study was to clarify differences between TRE and TBI without epilepsy. Methods: We studied patients who experienced severe head trauma and underwent brain surgery. The age range of the patients was 9-71 years old. Patients with medically resistant epilepsy were included in the Epilepsy group, and patients without epilepsy were included in the nonepilepsy group. Pathological findings, age, sex, and cause of head trauma were statistically compared between these two groups. Results: This study involved 10 patients, nine of whom met the inclusion criteria. Pathological findings for all patients in the Epilepsy group included focal cortical dysplasia (FCD) (p = 0.012). Conclusion: The difference between TRE and TBI without epilepsy was underlying FCD in patients with TRE. (C) 2020 Elsevier Inc. All rights reserved.	[Sakakura, Kazuki; Fujimoto, Ayataka; Ichikawa, Naoki; Sato, Keishiro; Baba, Shimpei; Enoki, Hideo; Okanishi, Tohru] Seirei Hamamatsu Gen Hosp, Comprehens Epilepsy Ctr, Shizuoka, Japan; [Inenaga, Chikanori] Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Shizuoka, Japan; [Arai, Yoshifumi] Seirei Hamamatsu Gen Hosp, Dept Pathol, Shizuoka, Japan; [Sakakura, Kazuki; Matsumura, Akira; Ishikawa, Eiichi] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki, Japan		Fujimoto, A (corresponding author), Seirei Hamamatsu Gen Hosp, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	afujimotoscienceacademy@gmail.com	Baba, Shimpei/M-9457-2019	Baba, Shimpei/0000-0002-0596-3338			Alexandre V, 2006, SEIZURE-EUR J EPILEP, V15, P420, DOI 10.1016/j.seizure.2006.05.005; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; CASCINO GD, 1993, EPILEPSY RES, V14, P175, DOI 10.1016/0920-1211(93)90022-Y; Cossu M, 2015, J NEUROSURG SCI, V59, P237; Diaz RJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E6; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; El Tahry R, 2017, ACTA NEUROL BELG, V117, P433, DOI 10.1007/s13760-017-0769-8; Esquenazi Y, 2016, WORLD NEUROSURG, V95, P276, DOI 10.1016/j.wneu.2016.08.041; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Hader WJ, 2004, J NEUROSURG, V100, P110, DOI 10.3171/ped.2004.100.2.0110; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Ho CSH, 2019, EPILEPSY BEHAV, V92, P306, DOI 10.1016/j.yebeh.2019.01.011; Immonen A, 2010, EPILEPSIA, V51, P2260, DOI 10.1111/j.1528-1167.2010.02720.x; Iuchi T, 2015, J CLIN NEUROSCI, V22, P87, DOI 10.1016/j.jocn.2014.05.036; JENNETT B, 1977, LANCET, V1, P878; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Josephson CB, 2016, NEUROLOGY, V86, P64, DOI 10.1212/WNL.0000000000002240; Kazemi H, 2012, INJURY, V43, P2132, DOI 10.1016/j.injury.2012.06.007; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kim HI, 2006, NEUROPATHOLOGY, V26, P236, DOI 10.1111/j.1440-1789.2006.00659.x; Kuchukhidze G, 2008, J NEUROL NEUROSUR PS, V79, P547, DOI 10.1136/jnnp.2007.118216; Lau T, 2014, SEIZURE-EUR J EPILEP, V23, P20, DOI 10.1016/j.seizure.2013.09.004; Luhmann HJ, 2016, J NEUROSCI METH, V260, P62, DOI 10.1016/j.jneumeth.2015.03.034; Masuda Yosuke, 2019, Surg Neurol Int, V10, P187, DOI 10.25259/SNI_241_2019; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Sahoo Sanjiv K, 2004, Curr Sports Med Rep, V3, P284; Sarnat HB, 2018, CLIN NEUROPATHOL, V37, P262, DOI 10.5414/NP301103; Shang-Guan HC, 2018, WORLD NEUROSURG, V120, pE984, DOI 10.1016/j.wneu.2018.08.208; Tai PC, 2004, CAN J NEUROL SCI, V31, P394, DOI 10.1017/S0317167100003516; Takayama Y, 2020, J NEUROSURG, V133, P1576, DOI 10.3171/2019.8.JNS191642; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	35	6	6	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JAN	2021	114		A						107352	10.1016/j.yebeh.2020.107352			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	PS6VB	WOS:000608063000010	32843304				2022-02-06	
J	Schneider, KJ; Nettel-Aguirre, A; Palacios-Derflingher, L; Mrazik, M; Brooks, BL; Woollings, K; Blake, T; McKay, C; Lebrun, C; Barlow, K; Taylor, K; Lemke, N; Meeuwisse, WH; Emery, CA				Schneider, Kathryn J.; Nettel-Aguirre, Alberto; Palacios-Derflingher, Luz; Mrazik, Martin; Brooks, Brian L.; Woollings, Kaikanani; Blake, Tracy; McKay, Carly; Lebrun, Constance; Barlow, Karen; Taylor, Kirsten; Lemke, Nicole; Meeuwisse, Willem H.; Emery, Carolyn A.			Concussion Burden, Recovery, and Risk Factors in Elite Youth Ice Hockey Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; ice hockey; youth; risk factor		Objective: To examine rates of concussion and more severe concussion (time loss of greater than 10 days) in elite 13- to 17-year-old ice hockey players. Methods:This is a prospective cohort study (Alberta, Canada). Bantam (13-14 years) and Midget (15-17 years) male and female elite (top 20% by division of play) youth ice hockey players participated in this study. Players completed a demographic and medical history questionnaire and clinical test battery at the beginning of the season. A previously validated injury surveillance system was used to document exposure hours and injury during one season of play (8 months). Players with a suspected ice hockey-related concussion were referred to the study sport medicine physicians for assessment. Time loss from hockey participation was documented on an injury report form. Results: Overall, 778 elite youth ice hockey players (659 males and 119 females; aged 13-17 years) participated in this study. In total, 143 concussions were reported. The concussion incidence rate (IR) was 17.60 concussions/100 players (95% CI, 15.09-20.44). The concussion IR was 1.31 concussions/1000 player-hours (95% CI, 1.09-1.57). Time loss of greater than 10 days was reported in 74% of cases (106/143), and 20% (n = 28) had time loss of greater than 30 days. Conclusions:Concussion is a common injury in elite youth ice hockey players. In this study population, a large proportion of concussions (74%) resulted in a time loss of greater than 10 days, possibly reflecting more conservative management or longer recovery in youth athletes.	[Schneider, Kathryn J.; Nettel-Aguirre, Alberto; Palacios-Derflingher, Luz; Woollings, Kaikanani; Blake, Tracy; McKay, Carly; Taylor, Kirsten; Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn J.; Nettel-Aguirre, Alberto; Emery, Carolyn A.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Cumming Sch Med, Calgary, AB, Canada; [Schneider, Kathryn J.; Meeuwisse, Willem H.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Nettel-Aguirre, Alberto; Palacios-Derflingher, Luz; Emery, Carolyn A.] Univ Calgary, Dept Community Hlth Sci, Fac Med, Calgary, AB, Canada; [Nettel-Aguirre, Alberto; Brooks, Brian L.; Barlow, Karen] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada; [Blake, Tracy] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [McKay, Carly] Univ Bath, Dept Hlth, Bath, Somerset, England; [Lebrun, Constance; Lemke, Nicole] Univ Alberta, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Lebrun, Constance] Univ Alberta, Fac Med & Dent, Dept Family Med, Edmonton, AB, Canada; [Barlow, Karen] Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia		Schneider, KJ (corresponding author), Univ Calgary, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014; Nettel-Aguirre, Alberto/ABB-9412-2021	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; McKay, Carly/0000-0001-7664-3211; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Max Bell Foundation; Alberta Innovates Health Solutions; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (Alberta Children's Hospital Foundation); Hotchkiss Brain Institute; International Olympic Committee; Hockey Calgary; Hockey Alberta; Hockey Quebec; Hockey Canada	The authors acknowledge the support of Max Bell Foundation, Alberta Innovates Health Solutions, Canadian Institutes of Health Research, the Alberta Children's Hospital Research Institute (Alberta Children's Hospital Foundation), and Hotchkiss Brain Institute. The Sport Injury Prevention Research Centre at the University of Calgary is one of the International Research Centres for the Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. This research would not have been possible without the support of Hockey Calgary, Hockey Alberta, Hockey Quebec, Hockey Canada, team therapists, team designates, coaches, players, and parents.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Canadian Heritage, 2013, SPORT PARTICIPATION; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hockey Canada, HOCK CAN 2014 2015 A; Kang J, 2014, INJURY PREV, V20, P177, DOI 10.1136/injuryprev-2012-040537; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	6	6	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					70	77		10.1097/JSM.0000000000000673			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800016	30300143				2022-02-06	
J	Gilmore, CS; Lim, KO; Garvin, MK; Wang, JK; Ledolter, J; Fenske, AL; Gentz, CL; Nellis, J; Armstrong, MT; Kardon, RH				Gilmore, Casey S.; Lim, Kelvin O.; Garvin, Mona K.; Wang, Jui-Kai; Ledolter, Johannes; Fenske, Alicia L.; Gentz, Carolyn L.; Nellis, Julie; Armstrong, Michael T.; Kardon, Randy H.			Association of Optical Coherence Tomography With Longitudinal Neurodegeneration in Veterans With Chronic Mild Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							NERVE-FIBER LAYER; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; RETINAL DAMAGE; HEAD TRAUMA; THICKNESS; DEMENTIA; MODEL; BIOMARKER	Question Do veterans with a history of mild traumatic brain injury show greater neurodegeneration over time compared with control veterans with no history of head injury? Findings In this longitudinal cohort study of 139 veterans with and without a history of mild traumatic brain injury, mild traumatic brain injury was associated with significantly greater thinning of the retinal nerve fiber layer over time. Meaning These findings suggest that structural neural loss in the visual system, as evidenced by thinning of the retinal nerve fiber layer, may be a useful biomarker of neurodegeneration following chronic mild traumatic brain injury. Importance Mild traumatic brain injury (TBI) may predispose individuals to progressive neurodegeneration. Objective To identify evidence of neurodegeneration through longitudinal evaluation of changes in retinal layer thickness using optical coherence tomography in veterans with a history of mild TBI. Design, Setting, and Participants This longitudinal cohort study evaluated veterans who were receiving services at the Minneapolis Veterans Affairs Health Care System. Symptomatic or mild TBI was diagnosed according to the Mayo TBI Severity Classification System. Participants in the age-matched control group had no history of TBI. Participants with any history or evidence of retinal or optic nerve disease that could affect retinal thickness were excluded. Data analysis was performed from July 2019 to February 2020. Exposures The presence and severity of mild TBI were determined through consensus review of self-report responses during the Minnesota Blast Exposure Screening Tool semistructured interview. Main Outcomes and Measures Change over time of retinal nerve fiber layer (RNFL) thickness. Results A total of 139 veterans (117 men [84%]; mean [SD] age, 49.9 [11.1] years) were included in the study, 69 in the TBI group and 70 in the control group. Veterans with mild TBI showed significantly greater RNFL thinning compared with controls (mean [SE] RNFL slope, -1.47 [0.24] mu m/y vs -0.31 [0.32] mu m/y; F-1,F-122 = 8.42; P = .004; Cohen d = 0.52). Functionally, veterans with mild TBI showed greater declines in visual field mean deviation (mean [SE] slope, -0.09 [0.14] dB/y vs 0.46 [0.23] dB/y; F-1,F-122 = 4.08; P = .046; Cohen d = 0.36) and pattern standard deviation (mean [SE] slope, 0.09 [0.06] dB/y vs -0.10 [0.07] dB/y; F-1,F-122 = 4.78; P = .03; Cohen d = 0.39) and high spatial frequency (12 cycles/degree) contrast sensitivity compared with controls. Cognitively, there was a significantly greater decrease in the number of errors over time during the Groton Maze Learning Test (GMLT) in controls compared with veterans with mild TBI (mean [SE] slope, -9.30 [1.48] errors/y vs -5.23 [1.24] errors/y; F-1,F-127 = 4.43; P = .04; Cohen d = 0.37). RNFL tissue loss was significantly correlated with both worsening performance on the GMLT over time (Spearman rho = -0.20; P = .03) and mild TBI severity (Spearman rho = -0.25; P = .006). The more severe the mild TBI (larger Minnesota Blast Exposure Screening Tool severity score), the faster the reduction in RNFL thickness (ie, the more negative the slope) across time. Conclusions and Relevance This cohort study found longitudinal evidence for significant, progressive neural degeneration over time in veterans with mild TBI, as indicated by greater RNFL tissue loss in patients with mild TBI vs controls, as well as measures of function. These results suggest that these longitudinal measures may be useful biomarkers of neurodegeneration. Changes in this biomarker may provide early detection of subsequent cognitive and functional deficits that may impact veterans' independence and need for care. This cohort study examines neurodegeneration through longitudinal evaluation of changes in retinal layer thickness using optical coherence tomography in veterans with a history of mild traumatic brain injury (TBI).	[Gilmore, Casey S.; Lim, Kelvin O.; Fenske, Alicia L.; Gentz, Carolyn L.; Armstrong, Michael T.] Minneapolis VA Healthcare Syst, One Vet Dr,4L-122, Minneapolis, MN 55417 USA; [Gilmore, Casey S.; Lim, Kelvin O.; Fenske, Alicia L.; Gentz, Carolyn L.; Armstrong, Michael T.] Def & Vet Brain Injury Ctr, Minneapolis, MN USA; [Lim, Kelvin O.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Garvin, Mona K.; Wang, Jui-Kai; Nellis, Julie; Kardon, Randy H.] Iowa City VA Healthcare Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Garvin, Mona K.; Wang, Jui-Kai; Ledolter, Johannes] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Ledolter, Johannes] Univ Iowa, Dept Business Analyt, Iowa City, IA USA; [Ledolter, Johannes] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA; [Nellis, Julie; Kardon, Randy H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA		Gilmore, CS (corresponding author), Minneapolis VA Healthcare Syst, One Vet Dr,4L-122, Minneapolis, MN 55417 USA.	casey.gilmore2@va.gov		Lim, Kelvin/0000-0002-2390-7268; Kardon, Randy/0000-0002-3173-7123	Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) [W81XWH-13-2-0095]; Department of Veterans Affairs CENC awardUS Department of Veterans Affairs [I01 CX001135]; Iowa City VA Center for the Prevention and Treatment of Visual Loss [C9251-C RX003002]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by grant funding from the Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) award W81XWH-13-2-0095 and Department of Veterans Affairs CENC award I01 CX001135, the Iowa City VA Center for the Prevention and Treatment of Visual Loss funded by Department of Veterans Affairs (Rehabilitation, Research, and Development) grant C9251-C RX003002, and the Defense and Veterans Brain Injury Center.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; Ahn J, 2018, NEUROLOGY, V91, pE1003, DOI 10.1212/WNL.0000000000006157; Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; Ann JK, 2018, KERALA J OPHTHALMOL, V30, P94, DOI [10.4103/kjo.kjo_40_18, DOI 10.4103/KJO.KJO_40_18]; Bailie J, 2017, ARCH CLIN NEUROPSYCH, V32, P660, DOI 10.1093/arclin/acx075.15; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chan JW, 2019, INVEST OPHTH VIS SCI, V60, P2005, DOI 10.1167/iovs.18-26094; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Childs C, 2018, EYE BRAIN, V10, P101, DOI 10.2147/EB.S183042; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; Costello F, 2018, EYE BRAIN, V10, P47, DOI 10.2147/EB.S139417; Decramer T, 2018, J NEUROL, V265, P41, DOI 10.1007/s00415-017-8661-2; den Haan Jurre, 2017, Alzheimers Dement (Amst), V6, P162, DOI 10.1016/j.dadm.2016.12.014; Dinkin M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0725-2; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Fry LE, 2018, PROG RETIN EYE RES, V65, P77, DOI 10.1016/j.preteyeres.2018.04.001; Greenberg Benjamin M, 2010, Ther Adv Neurol Disord, V3, P153, DOI 10.1177/1756285610368890; Grewal DS, 2012, J GLAUCOMA, V21, P214, DOI 10.1097/IJG.0b013e3182071cc7; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; La Morgia C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00710; Lamirel Cedric, 2009, Rev Neurol Dis, V6, pE105; Ledolter J, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.34; Leong D, 2018, J NEURO-OPHTHALMOL, V38, P285, DOI 10.1097/WNO.0000000000000572; Liao H, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00188; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; O'Leary N, 2012, EYE, V26, P1554, DOI 10.1038/eye.2012.202; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Pietrzak RH, 2008, ARCH CLIN NEUROPSYCH, V23, P433, DOI 10.1016/j.acn.2008.03.002; Pillay G, 2018, INDIAN J OPHTHALMOL, V66, P114, DOI 10.4103/ijo.IJO_539_17; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Salobrar-Garcia E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220535; Santos Claudia Y, 2018, Alzheimers Dement (Amst), V10, P196, DOI 10.1016/j.dadm.2018.01.003; Sari ES, 2015, J NEURO-OPHTHALMOL, V35, P117, DOI 10.1097/WNO.0000000000000203; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Yu JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085718; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1	54	6	6	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	DEC 22	2020	3	12							e2030824	10.1001/jamanetworkopen.2020.30824			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PL3XQ	WOS:000603059400008	33351088	Green Published, gold			2022-02-06	
J	Cui, WX; Wu, X; Shi, YW; Guo, W; Luo, JN; Liu, HX; Zheng, LL; Du, Y; Wang, P; Wang, Q; Feng, DY; Ge, SN; Qu, Y				Cui, Wenxing; Wu, Xun; Shi, Yingwu; Guo, Wei; Luo, Jianing; Liu, Haixiao; Zheng, Longlong; Du, Yong; Wang, Ping; Wang, Qiang; Feng, Dayun; Ge, Shunnan; Qu, Yan			20-HETE synthesis inhibition attenuates traumatic brain injury-induced mitochondrial dysfunction and neuronal apoptosis via the SIRT1/PGC-1 alpha pathway: A translational study	CELL PROLIFERATION			English	Article						20&#8208; HETE; apoptosis; mitochondrial dysfunction; SIRT1; traumatic brain injury	OXIDATIVE STRESS; 20-HYDROXYEICOSATETRAENOIC ACID; NEUROLOGICAL DETERIORATION; SMOOTH-MUSCLE; NEUROPROTECTION; PREDICTOR; DYNAMICS; TS-011; CELLS; SIRT1	Objectives 20-hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid catalysed by cytochrome P450 enzymes and plays an important role in cell death and proliferation. We hypothesized that 20-HETE synthesis inhibition may have protective effects in traumatic brain injury (TBI) and investigated possible underlying molecular mechanisms. Materials and methods Neurologic deficits, and lesion volume, reactive oxygen species (ROS) levels and cell death as assessed using immunofluorescence staining, transmission electron microscopy and Western blotting were used to determine post-TBI effects of HET0016, an inhibitor of 20-HETE synthesis, and their underlying mechanisms. Results The level of 20-HETE was found to be increased significantly after TBI in mice. 20-HETE synthesis inhibition reduced neuronal apoptosis, ROS production and damage to mitochondrial structures after TBI. Mechanistically, HET0016 decreased the Drp1 level and increased the expression of Mfn1 and Mfn2 after TBI, indicating a reversal of the abnormal post-TBI mitochondrial dynamics. HET0016 also promoted the restoration of SIRT1 and PGC-1 alpha in vivo, and a SIRT1 activator (SRT1720) reversed the downregulation of SIRT1 and PGC-1 alpha and the abnormal mitochondrial dynamics induced by 20-HETE in vitro. Furthermore, plasma 20-HETE levels were found to be higher in TBI patients with unfavourable neurological outcomes and were correlated with the GOS score. Conclusions The inhibition of 20-HETE synthesis represents a novel strategy to mitigate TBI-induced mitochondrial dysfunction and neuronal apoptosis by regulating the SIRT1/PGC-1 alpha pathway.	[Cui, Wenxing; Wu, Xun; Shi, Yingwu; Guo, Wei; Luo, Jianing; Liu, Haixiao; Zheng, Longlong; Du, Yong; Wang, Ping; Wang, Qiang; Feng, Dayun; Ge, Shunnan; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China		Ge, SN; Qu, Y (corresponding author), Tangdu Hosp, Dept Neurosurg, Xian 710038, Shaanxi, Peoples R China.	yanqu0123@fmmu.edu.cn; yanqu0123@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81630027]	National Natural Science Foundation of China, Grant/Award Number: 81630027	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmed ME, 2020, J NEUROTRAUM, V37, P1645, DOI 10.1089/neu.2019.6932; Bao YY, 2011, J CARDIOVASC PHARM, V57, P294, DOI 10.1097/FJC.0b013e3182073c78; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491; Donnelly MK, 2015, J CEREBR BLOOD F MET, V35, P1515, DOI 10.1038/jcbfm.2015.75; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Gao HF, 2020, INT J MOL MED, V45, P1121, DOI 10.3892/ijmm.2020.4479; Gui C, 2020, TOXICOL APPL PHARM, V388, DOI 10.1016/j.taap.2019.114874; Han XN, 2019, J CEREBR BLOOD F MET, V39, P1531, DOI 10.1177/0271678X18762645; Huang FF, 2017, ATHEROSCLEROSIS, V263, P184, DOI 10.1016/j.atherosclerosis.2017.06.012; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang S, 2017, J CARDIOVASC PHARM, V70, P94, DOI 10.1097/FJC.0000000000000499; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Kai J, 2020, FREE RADICAL BIO MED, V153, P89, DOI 10.1016/j.freeradbiomed.2020.03.031; Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022; Kizub IV, 2016, AM J PHYSIOL-LUNG C, V310, pL772, DOI 10.1152/ajplung.00377.2015; Kong XY, 2017, MOL NEUROBIOL, V54, P5277, DOI 10.1007/s12035-016-0073-2; Lakhkar A, 2016, AM J PHYSIOL-HEART C, V310, pH1107, DOI 10.1152/ajpheart.00961.2015; Li SY, 2019, CHEMOSPHERE, V234, P822, DOI 10.1016/j.chemosphere.2019.06.096; Ma JX, 2017, TOXICOL RES-UK, V6, P290, DOI 10.1039/c7tx00016b; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Marumo T, 2010, BRIT J PHARMACOL, V161, P1391, DOI 10.1111/j.1476-5381.2010.00973.x; Miyata N, 2005, J PHARMACOL EXP THER, V314, P77, DOI 10.1124/jpet.105.083964; O'Leary RA, 2018, J NEUROSURG SCI, V62, P542, DOI 10.23736/S0390-5616.18.04501-0; Qi J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00176; Renic M, 2012, AM J PHYSIOL-HEART C, V302, pH1285, DOI 10.1152/ajpheart.00340.2011; Shekhar S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184500; Tang BL, 2016, MOL CELLS, V39, P87, DOI 10.14348/molcells.2016.2318; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Viana MP, 2020, CELL SYST, V10, P287, DOI 10.1016/j.cels.2020.02.002; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Ward NC, 2011, CLIN SCI, V121, P501, DOI 10.1042/CS20110215; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Wu X, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12759; Yang ZJ, 2012, J NEUROCHEM, V121, P168, DOI 10.1111/j.1471-4159.2012.07666.x; Yi XY, 2017, J ATHEROSCLER THROMB, V24, P1258, DOI 10.5551/jat.41145; Yi XY, 2016, STROKE, V47, P3045, DOI 10.1161/STROKEAHA.116.015146; Yu P, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12362; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zhang HY, 2017, IEEE WINT CONF APPL, P37, DOI 10.1109/WACV.2017.12; Zhao HY, 2015, J CARDIOVASC PHARM, V66, P86, DOI 10.1097/FJC.0000000000000248; Zhu JC, 2015, DEV NEUROSCI-BASEL, V37, P376, DOI 10.1159/000369007; Zhu YH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4783602	49	6	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7722	1365-2184		CELL PROLIFERAT	Cell Prolif.	FEB	2021	54	2							e12964	10.1111/cpr.12964		DEC 2020	14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	QF0BC	WOS:000598267700001	33314534	Green Published, gold			2022-02-06	
J	Ashina, H; Iljazi, A; Amin, FM; Ashina, M; Lipton, RB; Schytz, HW				Ashina, Hakan; Iljazi, Afrim; Amin, Faisal M.; Ashina, Messoud; Lipton, Richard B.; Schytz, Henrik W.			Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study	JOURNAL OF HEADACHE AND PAIN			English	Article						Concussion; Head trauma; Diagnosis; Clinical characteristics	PREVENTIVE TREATMENT; NATURAL-HISTORY; PREVALENCE; ERENUMAB	Background Persistent post-traumatic headache (PTH) is a common sequela of mild traumatic brain injury (TBI) and retrospective assessments have found a migraine-like phenotype to be very frequent. This has raised a discussion of shared underlying mechanisms and whether persistent PTH is simply trauma-triggered migraine. Methods A 28-day prospective diary study with daily entries and acquisition of data on headache characteristics, associated symptoms, and acute medication use. A total of 64 patients with persistent PTH were enrolled from April 2019 to August 2019. Outcomes were the proportion of monthly headache days of any intensity that met the criteria for a migraine-like day or TTH-like day, as well as the corresponding figures for monthly headache days of moderate to severe intensity. Headache phenotypes were initially assigned based on diagnostic evaluation by semi-structured interview, whilst final headache phenotypes were assigned by diary review. Results After diary review, we found that monthly headache days were exclusively migraine-like in 24 of 64 patients (38%) and exclusively TTH-like days in 8 of 64 patients (13%). Considering only monthly headache days of moderate to severe intensity, the corresponding figures were 35 of 64 patients (55%) for migraine-like days and 8 of 64 patients (13%) for TTH-like days. The following headache phenotypes were assigned based on diary review: chronic migraine-like (n = 47, 73%), combined episodic migraine-like and chronic TTH-like (n = 9, 13%), and 'pure' chronic TTH-like (n = 8, 13%). Conclusions A migraine-like phenotype is common in patients most adversely affected by persistent PTH, although some patients did have a pure chronic TTH-like phenotype. At minimum, these findings suggest that persistent PTH is - at least in some - not 'trauma-triggered migraine'.	[Ashina, Hakan; Iljazi, Afrim; Amin, Faisal M.; Ashina, Messoud; Schytz, Henrik W.] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Danish Headache Ctr,Dept Neurol, Valdemar Hansen Vej 5, DK-2600 Copenhagen, Denmark; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lipton, Richard B.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA		Schytz, HW (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Danish Headache Ctr,Dept Neurol, Valdemar Hansen Vej 5, DK-2600 Copenhagen, Denmark.	hernik.winther.schytz.01@regionh.dk	Lipton, Richard Bruce/AAY-2818-2021	Ashina, Messoud/0000-0003-0951-5804; Ashina, Hakan/0000-0002-6268-727X; Schytz, Henrik Winther/0000-0002-6262-2986	Novartis Healthcare A/S	The study was supported by an investigator-initiated research grant from Novartis Healthcare A/S.	Ashina H, 2020, CEPHALALGIA, V40, P1276, DOI 10.1177/0333102420941115; Ashina H, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01136-z; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina M, 2020, NEW ENGL J MED, V383, P1866, DOI 10.1056/NEJMra1915327; Ashina M, 2020, CEPHALALGIA, V40, P241, DOI 10.1177/0333102420905132; Benemei S, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01135-0; Capi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072585; Chong CD, 2019, CEPHALALGIA, V39, P1121, DOI 10.1177/0333102418815650; Davis KD, 2020, NAT REV NEUROL, V16, P381, DOI 10.1038/s41582-020-0362-2; Detke HC, 2018, NEUROLOGY, V91, pE2211, DOI 10.1212/WNL.0000000000006640; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Ferrari MD, 2019, LANCET, V394, P1030, DOI 10.1016/S0140-6736(19)31946-4; GALLAI V, 1995, CEPHALALGIA, V15, P384, DOI 10.1046/j.1468-2982.1995.1505384.x; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lipton RB, 2020, NEUROLOGY, V94, pE1365, DOI 10.1212/WNL.0000000000009169; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mitsikostas DD, 2021, NAT REV NEUROL, V17, P133, DOI 10.1038/s41582-020-00431-2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Reuter U, 2018, LANCET, V392, P2280, DOI 10.1016/S0140-6736(18)32534-0; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Silberstein SD, 2017, NEW ENGL J MED, V377, P2113, DOI 10.1056/NEJMoa1709038; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stauffer VL, 2018, JAMA NEUROL, V75, P1080, DOI 10.1001/jamaneurol.2018.1212; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	38	6	6	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2020	21	1							134	10.1186/s10194-020-01202-6			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OT6EV	WOS:000590938300001	33213358	Green Published, gold			2022-02-06	
J	Dias, IR; Santos, CD; Magalhaes, CODE; de Oliveira, LRS; Peixoto, MFD; De Sousa, RAL; Cassilhas, RC				Dias, Isabella Rocha; Santos, Carina de Sousa; Diniz e Magalhaes, Caique Olegario; Sena de Oliveira, Lucas Renan; Dias Peixoto, Marco Fabricio; Leoni De Sousa, Ricardo Augusto; Cassilhas, Ricardo Cardoso			Does calorie restriction improve cognition?	IBRO REPORTS			English	Article						Calorie intake; Memory; Cognitive function; Aging; Neurodegenative diseases	TRAUMATIC BRAIN-INJURY; FOOD RESTRICTION; DIETARY RESTRICTION; OXIDATIVE STRESS; LIFE-SPAN; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; NEUROTROPHIC FACTOR; TREADMILL EXERCISE; O-GLCNACYLATION	Calorie restriction (CR) has been considered the most effective non-pharmacological intervention to counteract aging-related diseases and improve longevity. This intervention has shown beneficial effects in the prevention and treatment of several chronic diseases and functional declines related to aging, such as Parkinson's, Alzheimer's, and neuroendocrine disorders. However, the effects of CR on cognition show controversial results since its effects vary according to intensity, duration, and the period of CR. This review focuses on the main studies published in the last ten years regarding the consequences of CR on cognition in different neurological diseases and conditions of experimental animals. Also, possible CR mimetics are discussed. These findings highlight the potential beneficial effects of CR of up to 40 % on cognition when started early in life in non human animals.	[Dias Peixoto, Marco Fabricio; Cassilhas, Ricardo Cardoso] Fed Univ Valleys Jequitinhonha & Mucuri UFVJM, Dept Phys Educ, Diamantina, MG, Brazil; [Dias, Isabella Rocha; Diniz e Magalhaes, Caique Olegario; Sena de Oliveira, Lucas Renan; Dias Peixoto, Marco Fabricio; Leoni De Sousa, Ricardo Augusto; Cassilhas, Ricardo Cardoso] Univ Fed Vales Jequitinhonha & Mucuri, Grp Estudos Neuroplasticidade & Exercicio GENE, Neuroplastic & Exercise Study Grp, Diamantina, MG, Brazil; [Dias, Isabella Rocha; Santos, Carina de Sousa; Diniz e Magalhaes, Caique Olegario; Sena de Oliveira, Lucas Renan; Dias Peixoto, Marco Fabricio; Leoni De Sousa, Ricardo Augusto; Cassilhas, Ricardo Cardoso] Univ Fed Vales Jequitinhonha & Mucuri, Brazilian Soc Physiol, Multictr Post Grad Program Physiol Sci PMPGCF, Diamantina, MG, Brazil; [Dias Peixoto, Marco Fabricio; Cassilhas, Ricardo Cardoso] Univ Fed Vales Jequitinhonha & Mucuri, Post Grad Program Hlth Sci PPGCS, Diamantina, MG, Brazil		Cassilhas, RC (corresponding author), Dept Educ Fis, Rodovia MGT 367,Km 583,5000, BR-39100000 Diamantina, MG, Brazil.	rcassilhas@yahoo.com.br	DIAS PEIXOTO, MARCO FABRICIO/AAC-7943-2022; De Sousa, Ricardo Augusto Leoni/C-8540-2015; Cassilhas, Ricardo C./E-5920-2012; De Sousa, Ricardo Augusto Leoni/AAR-4540-2021	DIAS PEIXOTO, MARCO FABRICIO/0000-0003-3324-3634; De Sousa, Ricardo Augusto Leoni/0000-0003-2622-032X; Cassilhas, Ricardo C./0000-0001-6970-2551; De Sousa, Ricardo Augusto Leoni/0000-0003-2622-032X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [438498/2018-6]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-03855-16]	For the financial support, the authors are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant number 438498/2018-6; Chamada Universal) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), grant number APQ-03855-16. For the academic support, the authors are grateful to Department of Physical Education - Universidade Federal dos Vales do Jequitinhonha e Mucuri (UVFJM), and Laboratorio Experimental de Exercicio Fisico (LETFIs), UFVJM.	Akitake Y, 2015, NUTR RES, V35, P76, DOI 10.1016/j.nutres.2014.10.014; Arnoldussen IAC, 2014, EUR NEUROPSYCHOPHARM, V24, P1982, DOI 10.1016/j.euroneuro.2014.03.002; Babenko NA, 2014, ARCH GERONTOL GERIAT, V58, P420, DOI 10.1016/j.archger.2013.12.005; Bales CW, 2013, J CARDIOPULM REHABIL, V33, P201, DOI 10.1097/HCR.0b013e318295019e; Bar-Sela G, 2010, CURR MED CHEM, V17, P190, DOI 10.2174/092986710790149738; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bayliss JA, 2016, J NEUROSCI, V36, P3049, DOI 10.1523/JNEUROSCI.4373-15.2016; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Brownlow ML, 2014, BEHAV BRAIN RES, V271, P79, DOI 10.1016/j.bbr.2014.06.001; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Busch C., 2000, POPULATION ECOLOGY S, DOI [10.1071/AM01075_BR, DOI 10.1071/AM01075_BR]; Cassilhas RC, 2016, CELL MOL LIFE SCI, V73, P975, DOI 10.1007/s00018-015-2102-0; Chen GH, 2015, AGE, V37, DOI 10.1007/s11357-015-9839-0; Chouliaras L, 2011, BRAIN BEHAV IMMUN, V25, P616, DOI 10.1016/j.bbi.2010.11.016; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Costantini C, 2005, BIOCHEM J, V391, P59, DOI 10.1042/BJ20050700; Curi R., 2009, FISIOLOGIA BASICA; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; Delic V, 2015, MOL CELL NEUROSCI, V67, P46, DOI 10.1016/j.mcn.2015.06.001; Dhurandhar EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060437; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dong W, 2016, AGING CLIN EXP RES, V28, P303, DOI 10.1007/s40520-015-0398-0; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Fontana L, 2006, J CLIN ENDOCR METAB, V91, P3232, DOI 10.1210/jc.2006-0328; Fu Y, 2017, INT J DEV NEUROSCI, V60, P8, DOI 10.1016/j.ijdevneu.2017.03.010; GALEA LAM, 1994, BRAIN RES, V635, P18, DOI 10.1016/0006-8993(94)91419-2; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Grayson BE, 2014, INT J OBESITY, V38, P349, DOI 10.1038/ijo.2013.100; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Han XF, 2010, ACTA PHARMACOL SIN, V31, P1111, DOI 10.1038/aps.2010.146; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008; Jee YS, 2008, NEUROSCI LETT, V443, P188, DOI 10.1016/j.neulet.2008.07.078; Jeon BT, 2016, NEUROBIOL AGING, V44, P127, DOI 10.1016/j.neurobiolaging.2016.05.002; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Kaptan Z, 2015, BRAIN RES, V1618, P194, DOI 10.1016/j.brainres.2015.05.041; Kim H, 2016, J CEREBR BLOOD F MET, V36, P1098, DOI 10.1177/0271678X15606724; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Kishi T, 2012, IEEE ENG MED BIO, P6764, DOI 10.1109/EMBC.2012.6347547; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Kong WH, 2008, J AGR FOOD CHEM, V56, P2613, DOI 10.1021/jf073223i; Kuhla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068778; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047122; Li YG, 2011, J ETHNOPHARMACOL, V134, P961, DOI 10.1016/j.jep.2011.02.009; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Liu Y, 2017, BEHAV BRAIN RES, V331, P135, DOI 10.1016/j.bbr.2017.04.024; Llimona F., 2011, CO ATIVADOR TRANSCRI; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Martin SA, 2016, AGING CELL, V15, P100, DOI 10.1111/acel.12418; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; Mattson MP, 2014, J PARKINSON DIS, V4, P1, DOI 10.3233/JPD-130335; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McEwen BR, 2010, NEUROSCIENCE, V166, P263, DOI 10.1016/j.neuroscience.2009.11.076; Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069; Navarro-Cruz AR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8510761; Parikh I, 2016, AGING-US, V8, P2814, DOI 10.18632/aging.101094; Park JH, 2013, EUR J NEUROSCI, V37, P1987, DOI 10.1111/ejn.12249; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Porquet D, 2013, AGE, V35, P1851, DOI 10.1007/s11357-012-9489-4; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Rodriguez JS, 2012, REPROD SCI, V19, P493, DOI 10.1177/1933719111424439; Ruhlmann C, 2016, AGING-US, V8, P2777, DOI 10.18632/aging.101086; Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266; Sarker MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140431; Schleich CE, 2015, PHYSIOL BEHAV, V139, P150, DOI 10.1016/j.physbeh.2014.11.023; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Steinman MQ, 2011, EUR J NEUROSCI, V33, P361, DOI 10.1111/j.1460-9568.2010.07528.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Villain N, 2016, BEHAV BRAIN RES, V305, P157, DOI 10.1016/j.bbr.2016.02.037; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wei SG, 2014, REJUV RES, V17, P19, DOI 10.1089/rej.2013.1450; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Yamada Y, 2018, J GERONTOL A-BIOL, V73, P273, DOI 10.1093/gerona/glx059; Yang FY, 2014, BEHAV BRAIN RES, V264, P82, DOI 10.1016/j.bbr.2014.02.005; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang NN, 2016, CELL CYCLE, V15, P1009, DOI 10.1080/15384101.2016.1152427	100	6	7	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	DEC	2020	9						37	45		10.1016/j.ibror.2020.05.001			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	PT4YR	WOS:000608622700006	33336102	Green Published, gold			2022-02-06	
J	Graham, NSN; Jolly, A; Zimmerman, K; Bourke, NJ; Scott, G; Cole, JH; Schott, JM; Sharp, DJ				Graham, Neil S. N.; Jolly, Amy; Zimmerman, Karl; Bourke, Niall J.; Scott, Gregory; Cole, James H.; Schott, Jonathan M.; Sharp, David J.			Diffuse axonal injury predicts neurodegeneration after moderate-severe traumatic brain injury	BRAIN			English	Article						TBI; dementia; DAI; head injury		Traumatic brain injury is associated with elevated rates of neurodegenerative diseases such as Alzheimer's disease and chronic traumatic encephalopathy. In experimental models, diffuse axonal injury triggers post-traumatic neurodegeneration, with axonal damage leading to Wallerian degeneration and toxic proteinopathies of amyloid and hyperphosphorylated tau. However, in humans the link between diffuse axonal injury and subsequent neurodegeneration has yet to be established. Here we test the hypothesis that the severity and location of diffuse axonal injury predicts the degree of progressive post-traumatic neurodegeneration. We investigated longitudinal changes in 55 patients in the chronic phase after moderate-severe traumatic brain injury and 19 healthy control subjects. Fractional anisotropy was calculated from diffusion tensor imaging as a measure of diffuse axonal injury. Jacobian determinant atrophy rates were calculated from serial volumetric T-1 scans as a measure of measure post-traumatic neurodegeneration. We explored a range of potential predictors of longitudinal post-traumatic neurodegeneration and compared the variance in brain atrophy that they explained. Patients showed widespread evidence of diffuse axonal injury, with reductions of fractional anisotropy at baseline and follow-up in large parts of the white matter. No significant changes in fractional anisotropy over time were observed. In contrast, abnormally high rates of brain atrophy were seen in both the grey and white matter. The location and extent of diffuse axonal injury predicted the degree of brain atrophy: fractional anisotropy predicted progressive atrophy in both whole-brain and voxelwise analyses. The strongest relationships were seen in central white matter tracts, including the body of the corpus callosum, which are most commonly affected by diffuse axonal injury. Diffuse axonal injury predicted substantially more variability in white matter atrophy than other putative clinical or imaging measures, including baseline brain volume, age, clinical measures of injury severity and microbleeds (>50% for fractional anisotropy versus <5% for other measures). Grey matter atrophy was not predicted by diffuse axonal injury at baseline. In summary, diffusion MRI measures of diffuse axonal injury are a strong predictor of post-traumatic neurodegeneration. This supports a causal link between axonal injury and the progressive neurodegeneration that is commonly seen after moderate/severe traumatic brain injury but has been of uncertain aetiology. The assessment of diffuse axonal injury with diffusion MRI is likely to improve prognostic accuracy and help identify those at greatest neurodegenerative risk for inclusion in clinical treatment trials.	[Graham, Neil S. N.; Jolly, Amy; Zimmerman, Karl; Bourke, Niall J.; Scott, Gregory; Sharp, David J.] Imperial Coll London, Dept Brain Sci, Div Med, London, England; [Graham, Neil S. N.; Jolly, Amy; Zimmerman, Karl; Bourke, Niall J.; Scott, Gregory; Sharp, David J.] UK Dementia Res Inst, Ctr Care Res & Technol, London, England; [Cole, James H.; Schott, Jonathan M.] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England; [Cole, James H.] UCL, Ctr Med Image Comp, London, England; [Sharp, David J.] Imperial Coll London, Ctr Blast Injury Studies, London, England		Sharp, DJ (corresponding author), Imperial Coll London, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg, London W12 0NN, England.	david.sharp@imperial.ac.uk	Graham, Neil/AAN-2754-2021; Zimmerman, Karl/AAL-4988-2020; Schott, Jonathan/A-9065-2011	Graham, Neil/0000-0002-0183-3368; Zimmerman, Karl/0000-0003-1239-3414; Karikari, Thomas/0000-0003-1422-4358; Scott, Gregory/0000-0001-8063-5871; Schott, Jonathan/0000-0003-2059-024X; Jolly, Amy/0000-0002-7413-9772	Alzheimer's Research UK Clinical Research Fellowship [ARUKCRF2017A-1]; UK Dementia Research Institute (DRI) Care Research and Technology Centre; National Institute of Health Research (NIHR) ProfessorshipNational Institute for Health Research (NIHR) [NIHR-RP-011-048]; NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust; Medical Research Council through a Clinician Scientist Fellowship by the Centre for Blast Injury Studies, Imperial College London; ARUKAlzheimer's Research UK (ARUK) [ARUK-PG2017-1946]; Brain Research UK [UCC14191]; Weston Brain Institute [UB170045]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; British Heart FoundationBritish Heart Foundation; European UnionEuropean Commission [666992]; NIHR Clinical Lectureship [CL-2016-21-005]; UKRI Innovation Fellowship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This research was supported by an Alzheimer's Research UK Clinical Research Fellowship awarded to N.G. (ARUKCRF2017A-1), and by the UK Dementia Research Institute (DRI) Care Research and Technology Centre (N.G./D.J.S.), an National Institute of Health Research (NIHR) Professorship (NIHR-RP-011-048) awarded to D.J.S. and by the NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust. The research was also supported the Medical Research Council through a Clinician Scientist Fellowship awarded to D.J.S. who was also supported by the Centre for Blast Injury Studies, Imperial College London. J.M.S. acknowledges the support of the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Wolfson Foundation, ARUK (ARUK-PG2017-1946), Brain Research UK (UCC14191), Weston Brain Institute (UB170045), Medical Research Council, British Heart Foundation and European Union's Horizon 2020 research and innovation programme (Grant 666992). G.S. was supported by an NIHR Clinical Lectureship (CL-2016-21-005). J.C. is funded by a UKRI Innovation Fellowship. The authors would like to thank the participants in this research project.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Baddeley A, 1994, DOORS PEOPLE TEST TE; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Feeney C, 2017, ANN NEUROL, V82, P30, DOI 10.1002/ana.24971; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Ly M, 2014, HUM BRAIN MAPP, V35, P2044, DOI 10.1002/hbm.22311; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Poudel GR, 2020, ANN CLIN TRANSL NEUR, V7, P270, DOI 10.1002/acn3.50984; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D., 2011, WECHSLER ABBREVIATED; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784	53	6	6	2	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2020	143		12				3685	3698		10.1093/brain/awaa316			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QE0TH	WOS:000615920000028	33099608	Green Submitted			2022-02-06	
J	Tang, YL; Fang, LJ; Zhong, LY; Jiang, J; Dong, XY; Feng, Z				Tang, Yun-Liang; Fang, Long-Jun; Zhong, Ling-Yang; Jiang, Jian; Dong, Xiao-Yang; Feng, Zhen			Hub genes and key pathways of traumatic brain injury: bioinformatics analysis and in vivo validation	NEURAL REGENERATION RESEARCH			English	Article						bioinformatics; DEGs; differentially expressed genes; Gene Ontology; hub genes; inflammation; Kyoto Encyclopedia of Genes and Genomes; molecular mechanism; traumatic brain injury	NF-KAPPA-B; CEREBRAL-ISCHEMIA; INDUCED COMA; MECHANISMS; RATS; NEUROPROTECTION; EXPRESSION; METFORMIN; SUBUNIT	The exact mechanisms associated with secondary brain damage following traumatic brain injury (TBI) remain unclear; therefore, identifying the critical molecular mechanisms involved in TBI is essential. The mRNA expression microarray GSE2871 was downloaded from the Gene Expression Omnibus (GEO) repository. GSE2871 comprises a total of 31 cerebral cortex samples, including two post-TBI time points. The microarray features eight control and seven TBI samples, from 4 hours post-TBI, and eight control and eight TBI samples from 24 hours post-TBI. In this bioinformatics-based study, 109 and 66 differentially expressed genes (DEGs) were identified in a Sprague-Dawley (SD) rat TBI model, 4 and 24 hours post-TBI, respectively. Functional enrichment analysis showed that the identified DEGs were significantly enriched in several terms, such as positive regulation of nuclear factor-kappa B transcription factor activity, mitogen- activated protein kinase signaling pathway, negative regulation of apoptotic process, and tumor necrosis factor signaling pathway. Moreover, the hub genes with high connectivity degrees were primarily related to inflammatory mediators. To validate the top five hub genes, a rat model of TBI was established using the weight-drop method, and real-time quantitative polymerase chain reaction analysis of the cerebral cortex was performed. The results showed that compared with control rats, Tnf-alpha, c-Myc, Spp1, Cxcl10, Ptprc, Egf, Mmp9, and Lcn2 were upregulated, and Fn1 was downregulated in TBI rats. Among these hub genes, Fn1, c-Myc, and Ptprc may represent novel biomarkers or therapeutic targets for TBI. These identified pathways and key genes may provide insights into the molecular mechanisms of TBI and provide potential treatment targets for patients with TBI. This study was approved by the Experimental Animal Ethics Committee of the First Affiliated Hospital of Nanchang University, China (approval No. 003) in January 2016.	[Tang, Yun-Liang; Fang, Long-Jun; Zhong, Ling-Yang; Jiang, Jian; Dong, Xiao-Yang; Feng, Zhen] Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	fengzhen@email.ncu.edu.cn		Reis, AlessanRSS/0000-0001-8486-7469			Bachstetter AD, 2010, AGING DIS, V1, P199; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bottero V, 2018, J PARKINSON DIS, V8, P529, DOI 10.3233/JPD-181391; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng Z, 2016, NEURAL REGEN RES, V11, P951, DOI 10.4103/1673-5374.184494; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao N, 2020, J CEREBR BLOOD F MET, V40, P35, DOI 10.1177/0271678X19836412; Garcia-Gutierrez L, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030244; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Hui JL, 2020, PEERJ, V8, DOI 10.7717/peerj.8653; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Shen LJ, 2017, CLIN CHIM ACTA, V474, P130, DOI 10.1016/j.cca.2017.09.016; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Su DY, 2017, J NEUROIMMUNOL, V305, P35, DOI 10.1016/j.jneuroim.2017.01.015; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zhang L, 2017, FREE RADICAL RES, V51, P316, DOI 10.1080/10715762.2017.1311015; Zhu XC, 2015, MOL NEUROBIOL, V52, P375, DOI 10.1007/s12035-014-8866-7; Zollinger AJ, 2017, MATRIX BIOL, V60-61, P27, DOI 10.1016/j.matbio.2016.07.011	38	6	6	2	38	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2020	15	12					2262	2269		10.4103/1673-5374.284996			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MG0WP	WOS:000545755700020	32594047	gold, Green Published			2022-02-06	
J	Tseng, CT; Brougher, J; Gaulding, SJ; Hassan, BS; Thorn, CA				Tseng, Ching-Tzu; Brougher, Jackson; Gaulding, Solomon J.; Hassan, Bilaal S.; Thorn, Catherine A.			Vagus nerve stimulation promotes cortical reorganization and reduces task-dependent calorie intake in male and female rats	BRAIN RESEARCH			English	Article						Cortical plasticity; Motor cortex; Sex differences; Vagus nerve stimulation; Motor learning	SEX-DIFFERENCES; WEIGHT-LOSS; RECOVERY; CORTEX; STROKE	Numerous preclinical studies demonstrate that vagus nerve stimulation (VNS) paired with motor rehabilitation improves functional recovery after neural injuries such as stroke, traumatic brain injury, and spinal cord injury, in part by driving neural plasticity within the motor cortex. To date, these studies have been performed almost exclusively in female rats, however, the risk for neural injuries of all types is significantly higher among males than females. We therefore sought to determine whether VNS was equally effective at driving motor cortical plasticity in both sexes. Male and female rats were trained on a skilled lever press task prior to VNS electrode implantation. After recovery, rats received ten training sessions in which VNS, or sham stimulation, was paired with correct motor performance. At the completion of these treatment sessions, somatotopic mapping of motor cortex was performed. We found that performance on the lever task was similar between male and female rats, though on average, males performed more trials per training session, consistent with their larger size and higher caloric need. Training-paired VNS effectively induced cortical motor map reorganization in both male and female rats. Notably, we also found that VNS reduced lever-press associated caloric intake during treatment in both sexes. These VNS-driven effects were robust to behavioral and biological differences between male and female subjects. Taken together, our results suggest that, in both male and female rats, VNS simultaneously engages both pro-plasticity neuromodulation within the neocortex and satiety or reward-related networks that reduce task-associated caloric intake.	[Tseng, Ching-Tzu; Brougher, Jackson; Gaulding, Solomon J.; Hassan, Bilaal S.; Thorn, Catherine A.] Univ Texas Dallas, Sch Behav & Brain Sci, 800 W Campbell Rd, Richardson, TX 75080 USA		Thorn, CA (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	catherine.thorn@utdallas.edu		Hassan, Bilaal/0000-0003-0184-2907; Thorn, Catherine/0000-0002-6425-4814	University of Texas at Dallas; University of Texas Board of Regents	This work was funded by The University of Texas at Dallas and The University of Texas Board of Regents. We thank Kiree Gove for her artwork.	Bangasser DA, 2011, PHYSIOL BEHAV, V103, P342, DOI 10.1016/j.physbeh.2011.02.037; Banni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044813; Ben-Menachem E, 2005, EPILEPTIC DISORD, V7, pS22; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Berger-Sweeney J, 2003, NEUROSCI BIOBEHAV R, V27, P401, DOI 10.1016/S0149-7634(03)00070-8; BERGERSWEENEY J, 1995, BEHAV NEUROSCI, V109, P859, DOI 10.1037/0735-7044.109.5.859; Bodenlos Jamie S, 2014, J Diabetes Sci Technol, V8, P590, DOI 10.1177/1932296814525188; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Bonaz B, 2016, J PHYSIOL-LONDON, V594, P5781, DOI 10.1113/JP271539; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Centers for Disease Control and Prevention, 2014, CDC INJ CTR GET FACT, VFacts, P2009; Childs JE, 2019, BRAIN STIMUL, V12, P1448, DOI 10.1016/j.brs.2019.07.001; Childs JE, 2017, LEARN MEMORY, V24, P35, DOI 10.1101/lm.043539.116; Childs JE, 2015, JOVE-J VIS EXP, DOI 10.3791/53032; Chunchai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26866; Conner JM, 2010, CEREB CORTEX, V20, P2739, DOI 10.1093/cercor/bhq022; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; de Araujo IE, 2020, ANNU REV PSYCHOL, V71, P139, DOI 10.1146/annurev-psych-122216-011643; Detari L., 1983, ACTA PHYSL HUNGARICA; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fernandes AB, 2020, NEURON, V106, P778, DOI 10.1016/j.neuron.2020.03.009; Frokjaer J.B., 2016, NEUROGASTROENT MOTIL, DOI [10.1111/nmo.24032., DOI 10.1111/NMO.24032]; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Ganzer PD, 2018, ELIFE, V7, DOI 10.7554/eLife.32058; Groves DA, 2005, NEUROSCI LETT, V379, P174, DOI 10.1016/j.neulet.2004.12.055; Han WF, 2018, CELL, V175, P665, DOI [10.1016/j.cell.2018.08.049, 10.1016/j.cell.2018.10.018]; Hays SA, 2016, NEUROTHERAPEUTICS, V13, P382, DOI 10.1007/s13311-015-0417-z; Hays SA, 2014, STROKE, V45, P3097, DOI 10.1161/STROKEAHA.114.006654; Hays SA, 2013, J NEUROSCI METH, V214, P52, DOI 10.1016/j.jneumeth.2012.12.022; Hotta H, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00375; Hulsey DR, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112975; Hulsey DR, 2017, EXP NEUROL, V289, P21, DOI 10.1016/j.expneurol.2016.12.005; Hulsey DR, 2016, BRAIN STIMUL, V9, P174, DOI 10.1016/j.brs.2015.12.007; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Khodaparast N, 2016, NEUROREHAB NEURAL RE, V30, P676, DOI 10.1177/1545968315616494; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; LUQUE JM, 1992, DEV BRAIN RES, V67, P211, DOI 10.1016/0165-3806(92)90221-H; Maisiyiti A, 2019, EXPERT REV MED DEVIC, V16, P855, DOI 10.1080/17434440.2019.1673728; McClelland J, 2013, EUR EAT DISORD REV, V21, P436, DOI 10.1002/erv.2256; Meyers E.C., 2018, STROKE, DOI [10.1161/STROKEAHA.117, DOI 10.1161/STROKEAHA.117]; Meyers EC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13695-0; Meyers EE, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12718; Molina-Luna K, 2008, NEUROIMAGE, V40, P1748, DOI 10.1016/j.neuroimage.2007.11.018; Morrison RA, 2019, BRAIN STIMUL, V12, P256, DOI 10.1016/j.brs.2018.10.017; National Spinal Cord Injury Statistics C, 2015, SPIN CORD INJ FACTS; Noble LJ, 2019, PSYCHOPHARMACOLOGY, V236, P355, DOI 10.1007/s00213-018-4994-5; PAINTAL AS, 1973, PHYSIOL REV, V53, P159, DOI 10.1152/physrev.1973.53.1.159; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Pelot NA, 2018, BRAIN RES, V1693, P180, DOI 10.1016/j.brainres.2018.02.003; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Porter BA, 2012, CEREB CORTEX, V22, P2365, DOI 10.1093/cercor/bhr316; Pruitt DT, 2016, J NEUROTRAUM, V33, P871, DOI 10.1089/neu.2015.3972; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Rios MU, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2010019; Sanchez CA, 2020, JOVE-J VIS EXP, DOI 10.3791/61128; Stauss HM, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13953; STERN JE, 1994, J AUTONOM NERV SYST, V48, P45, DOI 10.1016/0165-1838(94)90158-9; Takase K, 2009, NEUROSCIENCE, V159, P7, DOI 10.1016/j.neuroscience.2008.12.039; Yin J, 2019, OBES SURG, V29, P2869, DOI 10.1007/s11695-019-03901-9; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1	63	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2020	1748								147099	10.1016/j.brainres.2020.147099			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC8TB	WOS:000579428000030	32896520	hybrid			2022-02-06	
J	Zhu, MM; Lin, JH; Qing, P; Pu, L; Chen, SL; Lin, SJ; Li, CL; Cao, LX; Zhang, YM				Zhu, Ming-min; Lin, Ji-huan; Qing, Peng; Pu, Liu; Chen, Shu-lian; Lin, Shu-jun; Li, Cheng-lu; Cao, Lu-xi; Zhang, Yi-min			Manual acupuncture relieves microglia-mediated neuroinflammation in a rat model of traumatic brain injury by inhibiting the RhoA/ROCK2 pathway	ACUPUNCTURE IN MEDICINE			English	Article						manual acupuncture; microglia; neuroinflammation; RhoA; ROCK2 signaling pathway; traumatic brain injury		Objective: To investigate the regulatory mechanism of manual acupuncture (MA) on microglial polarization-mediated neuroinflammation after traumatic brain injury (TBI), focusing on the RhoA/Rho-associated coiled coil-forming protein kinase (ROCK2) pathway. Methods: Sprague Dawley (SD) rats were used to generate a TBI model using Feeney's freefall epidural impact method. MA was performed on half of the TBI model rats, while the others remained untreated. Acupuncture was administered at GV15, GV16, GV20, GV26, and LI4. At the end of the intervention, rat brain tissue samples were collected, and the microglial M1 polarization status was observed by immunofluorescence labeling of CD86, an M1 microglia-specific protein. RhoA/ROCK2 signaling components were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting. An enzyme-linked immunosorbent assay (ELISA) was used to detect the expression levels of inflammatory factors. Results: Compared with normal rats, the CD86 expression density in the untreated TBI model rats was high and showed an aggregated expression pattern. The genes and proteins of the RhoA/ROCK2 signaling pathway were highly expressed, and inflammatory factors were significantly increased. The CD86 expression density in TBI rats after MA was reduced compared to that in untreated TBI rats and showed a scattered distribution. The expression of RhoA/ROCK2 signaling pathway genes and proteins was also significantly reduced, and inflammatory factors were decreased. Conclusion: These results show that MA may inhibit M1 polarization of microglia by regulating the RhoA/ROCK2 signaling pathway, thereby reducing neuroinflammation in TBI.	[Zhu, Ming-min; Lin, Ji-huan; Pu, Liu; Chen, Shu-lian; Lin, Shu-jun; Li, Cheng-lu; Cao, Lu-xi; Zhang, Yi-min] Jinan Univ, Tradit Chinese Med Coll, 601 Huangpu West Aveme, Guangzhou 510632, Guangdong, Peoples R China; [Qing, Peng] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China		Zhu, MM; Zhang, YM (corresponding author), Jinan Univ, Tradit Chinese Med Coll, 601 Huangpu West Aveme, Guangzhou 510632, Guangdong, Peoples R China.	rock3590@163.com; zhangymjnu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81704156]; Natural Science Foundation of Guang-dong ProvinceNational Natural Science Foundation of Guangdong Province [2016A030310093, 2017A030310024]; Administration of Traditional Chinese Medicine of Guangdong Province, China [20161067, 20181070]; Fundamental Research Funds for the Central Universities, ChinaFundamental Research Funds for the Central Universities [21616318]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by National Natural Science Foundation of China (grant no. 81704156), Natural Science Foundation of Guang-dong Province (grant no. 2016A030310093 and 2017A030310024), Administration of Traditional Chinese Medicine of Guangdong Province, China (grant no. 20161067 and 20181070), and the Fundamental Research Funds for the Central Universities, China (grant no. 21616318).	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Cao J, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00005; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fujita R, 2008, J NEUROCHEM, V107, P152, DOI 10.1111/j.1471-4159.2008.05599.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jiang ST, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2047412; Katsumoto A, 2014, J IMMUNOL, V193, P2615, DOI 10.4049/jimmunol.1400716; Lin SJ, 2018, ACUPUNCT MED, V36, P247, DOI 10.1136/acupmed-2017-011472; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Peng Chang-lin, 2010, Zhongguo Zhen Jiu, V30, P551; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Xu JX., 2014, J EMERG TRADIT CHIN, V04, P594; Yi Guo, 2016, EXPT ACUPUNCTURE; [Zhang Lihua 张丽华], 2016, [Journal of Acupuncture and Tuina Science, 针灸推拿医学], V14, P175; Zhang YM, 2016, ACUPUNCT MED, V34, P48, DOI 10.1136/acupmed-2014-010742; Zhang Yi-Min, 2013, Zhen Ci Yan Jiu, V38, P158	24	6	6	2	20	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0964-5284	1759-9873		ACUPUNCT MED	Acupunct. Med.	DEC	2020	38	6					426	434		10.1177/0964528420912248			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	PA8GG	WOS:000595867300007	32310010				2022-02-06	
J	Anderson, MI; Daher, M; Simpson, GK				Anderson, Malcolm, I; Daher, Maysaa; Simpson, Grahame K.			A predictive model of resilience among family caregivers supporting relatives with traumatic brain injury (TBI): A structural equation modelling approach	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; family caregivers; resilience; personality; psychological adjustment	QUALITY-OF-LIFE; SELF-EFFICACY; PSYCHOLOGICAL DISTRESS; FEMALE CAREGIVERS; PERCEIVED BURDEN; UNITED-STATES; MENTAL-HEALTH; INDIVIDUALS; PERSONALITY; NEEDS	Constructs from positive psychology were employed to create an explicit model of caregiver resilience. Predictive and mediating relationships among resilience and related variables (personality, coping, self-efficacy, hope, social support) were then tested for their association with burden and psychological adjustment among family members caring for relatives with severe TBI. Family participants (n = 131) from six rehabilitation units from New South Wales and Queensland completed assessments which elicited explanatory (Eysenck Personality Questionnaire, Ways of Coping Questionnaire), mediating (Connor-Davidson Resilience Scale, General Self-Efficacy Scale, Herth Hope Scale, Medical Outcome Study Social Support Survey), and caregiver outcome (Caregiver Burden Scale, Mental Health sub-Scale-SF36, General Health Questionnaire, and Positive and Negative Affect Scale) variables. Structural Equation Modeling (SEM) showed that resilience had a direct effect on positive affect in caregivers. Resilience also played a protective role in relation to two variables associated with caregiver vulnerability: an indirect association with caregiver burden mediated through social support; a direct effect on hope, which, in turn, was associated with positive mental health. Positive mental health then played a buffering role in relation to psychological distress and negative affect. Resilience, in combination with other psychological attributes, was associated with reduced morbidity among family caregivers after severe TBI.	[Anderson, Malcolm, I] Avondale Coll Higher Educ, Sydney, NSW, Australia; [Daher, Maysaa; Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Daher, Maysaa] NSW Hlth, Agcy Clin Innovat, Brain Injury Rehabil Directorate, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia		Anderson, MI (corresponding author), Avondale Coll Higher Educ, Sydney, NSW, Australia.	malcolm.anderson@avondale.edu.au		Simpson, Grahame/0000-0001-8156-9060			Access Economics, 2015, EC VALUE INFORMAL CA; Alfano D. P., 1994, APPL NEUROPSYCHOL, V1, P1; Anderson MI, 2015, ANNU REV NURS RES-SE, V33, P219, DOI 10.1891/0739-6686.33.219; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arbuckle J. L, 2016, AMOS 24 0 USERS GUID; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Campbell C H, 1988, Rehabil Nurs, V13, P320; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Chari AV, 2015, HEALTH SERV RES, V50, P871, DOI 10.1111/1475-6773.12238; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Ciarrochi J, 2015, J POSIT PSYCHOL, V10, P520, DOI 10.1080/17439760.2015.1015154; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Dillahunt-Aspillaga C., 2014, SGRJARC, V45, P25; Elliott TR, 2014, J CONSULT CLIN PSYCH, V82, P1072, DOI 10.1037/a0037593; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Eysenck H., 1991, EYSENCK PERSONALITY; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Folkman S., 1984, STRESS; Folkman S., 1988, MANUAL WAYS COPING Q; Frain J, 2014, REHABIL RES POL EDUC, V28, P91, DOI 10.1891/2168-6653.28.2.91; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gallagher D, 2011, AGING MENT HEALTH, V15, P663, DOI 10.1080/13607863.2011.562179; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Goldberg D., 1988, USERS GUIDE GEN HLTH; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hamill S. K., 2007, COLGATE U J SCI, V35, P115; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Ho R., 2014, HDB UNIVARIATE MULTI, V2nd ed.; HOOKER K, 1994, GERONTOLOGIST, V34, P386, DOI 10.1093/geront/34.3.386; IBM Corp, 2016, SPSS STAT WIND VERS; Jones K. F., REHABILITATION PSYCH; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Joreskog K. G., 1993, LISREL 8 USERS REFER; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim SK, 2017, INT PSYCHOGERIATR, V29, P227, DOI 10.1017/S1041610216001770; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Hayas CL, 2014, REHABIL PSYCHOL, V59, P193, DOI 10.1037/a0035622; Lightsey OR, 2006, COUNS PSYCHOL, V34, P96, DOI 10.1177/0011000005282369; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Lu W, 2014, PERS INDIV DIFFER, V63, P128, DOI 10.1016/j.paid.2014.01.015; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Nogales-Gonzalez C, 2015, AGING MENT HEALTH, V19, P1022, DOI 10.1080/13607863.2014.995593; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Ong HL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1616-z; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rabinowitz YG, 2007, J AGING HEALTH, V19, P946, DOI 10.1177/0898264307308559; Rabinowitz YG, 2009, ALZ DIS ASSOC DIS, V23, P389, DOI 10.1097/WAD.0b013e3181b6f74d; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Simpson G, 2016, J SOC WORK DISABIL R, V15, P213, DOI 10.1080/1536710X.2016.1220888; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Snyder C. R., 1996, J PERSONAL INTERPERS, V1, P1, DOI [10.1080/15325029608415455, DOI 10.1080/15325029608415455]; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Trujillo M, 2016, REHABIL PSYCHOL, V61, P389, DOI 10.1037/rep0000108; Vaidya J, 2003, HDB PSYCHOL RES METH, V2, P351, DOI DOI 10.1002/0471264385.WEI0214; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wu HC, 2011, J CLIN NURS, V20, P1906, DOI 10.1111/j.1365-2702.2010.03664.x; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	102	6	6	3	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 25	2020	30	10					1925	1946		10.1080/09602011.2019.1620787			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OK4VL	WOS:000584650000004	31132931				2022-02-06	
J	Lajud, N; Roque, A; Cheng, JP; Bondi, CO; Kline, AE				Lajud, Naima; Roque, Angelica; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.			Early Life Stress Preceding Mild Pediatric Traumatic Brain Injury Increases Neuroinflammation but Does Not Exacerbate Impairment of Cognitive Flexibility during Adolescence	JOURNAL OF NEUROTRAUMA			English	Article						attentional set shifting; controlled cortical impact; hypothalamic&#8211; pituitary&#8211; adrenal axis; interleukin-1&#946; maternal separation	CORTICOTROPIN-RELEASING HORMONE; PERIODIC MATERNAL SEPARATION; HIPPOCAMPAL NEUROGENESIS; INFLAMMATORY CYTOKINES; CORTICOSTERONE LEVELS; EXECUTIVE FUNCTION; CHILDHOOD ABUSE; MESSENGER-RNA; HPA AXIS; BEHAVIOR	Early life stress (ELS) followed by pediatric mild traumatic brain injury (mTBI) negatively impacts spatial learning and memory and increases microglial activation in adolescent rats, but whether the same paradigm negatively affects higher order executive function is not known. Hence, we utilized the attentional set-shifting test (AST) to evaluate executive function (cognitive flexibility) and to determine its relationship with neuroinflammation and hypothalamic-pituitary-adrenal (HPA) axis activity after pediatric mTBI in male rats. ELS was induced via maternal separation for 180 min per day (MS180) during the first 21 post-natal (P) days, while controls (CONT) were undisturbed. At P21, fully anesthetized rats received a mild controlled cortical impact (2.2 mm tissue deformation at 4 m/sec) or sham injury. AST was evaluated during adolescence on P35-P40 and cytokine expression and HPA activity were analyzed on P42. The data indicate that pediatric mTBI produced a significant reversal learning deficit on the AST versus sham (p < 0.05), but that the impairment was not exacerbated further by MS180. Additionally, ELS produced an overall elevation in set-loss errors on the AST, and increased hippocampal interleukin (IL)-1 beta expression after TBI. A significant correlation was observed in executive dysfunction and IL-1 beta expression in the ipsilateral pre-frontal cortex and hippocampus. Although the combination of ELS and pediatric mTBI did not worsen executive function beyond that of mTBI alone (p > 0.05), it did result in increased hippocampal neuroinflammation relative to mTBI (p < 0.05). These findings provide important insight into the susceptibility to incur alterations in cognitive and neuroimmune functioning after stress exposure and TBI during early life.	[Lajud, Naima; Roque, Angelica] Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Roque, Angelica; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA		Lajud, N (corresponding author), Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Lab Neurobiol Desarrollo, Morelia, Michoacan, Mexico.	naima.lajud@imss.gob.mx	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	CONACyT-FOSISS [FIS/IMSS/PROT/1769]; National Institutes of Health (NIH) grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, NS099674, NS084967, NS110609, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; University of Pittsburgh Medical Center (UPMC) Rehabilitation Institute; CONACYT (CVU) [509694/286252]; Programa Para La Formacion de Investigadores de la Coordinacion de Investigacion en Salud-IMSS; Programa de apoyo de estudios de posgrado (PAEP-UNAM)	Funding for this study was provided by grants CONACyT-FOSISS No. FIS/IMSS/PROT/1769 (N.L.A.), National Institutes of Health (NIH) grants HD069620, NS099674, and NS084967 (A.E.K.), and NS110609, NS094950, NS099683 (C.O.B.), the University of Pittsburgh Physicians /UPMC Academic Foundation, and the University of Pittsburgh Medical Center (UPMC) Rehabilitation Institute (C.O.B.). A.R. is a graduate student in la Programa de Doctorado en Ciencias Biomedicas- Universidad Nacional Autonoma de Mexico (UNAM) and is supported by CONACYT (CVU no. 509694/286252), Programa Para La Formacion de Investigadores de la Coordinacion de Investigacion en Salud-IMSS, and Programa de apoyo de estudios de posgrado (PAEP-UNAM) to conduct research in the Department of Physical Medicine & Rehabilitation and the Safar Center for Resuscitation Research at the University of Pittsburgh.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Avishai-Eliner S, 2001, ENDOCRINOLOGY, V142, P89, DOI 10.1210/en.142.1.89; Baudin A, 2012, NEUROBIOL LEARN MEM, V98, P207, DOI 10.1016/j.nlm.2012.08.004; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bolton JL, 2017, CURR OPIN BEHAV SCI, V14, P133, DOI 10.1016/j.cobeha.2016.12.012; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; Bremner JD, 2003, CHILD ADOL PSYCH CL, V12, P271, DOI 10.1016/S1056-4993(02)00098-6; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Brummelte S, 2010, DEV NEUROBIOL, V70, P714, DOI 10.1002/dneu.20805; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Bustin S, 2004, A Z QUANTITATIVE PCR; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Cotella EM, 2014, STRESS, V17, P235, DOI 10.3109/10253890.2014.910649; Daskalakis NP, 2014, PSYCHONEUROENDOCRINO, V39, P39, DOI 10.1016/j.psyneuen.2013.09.021; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diaz-Chavez A, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113318; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dube C, 2000, J CEREBR BLOOD F MET, V20, P1414, DOI 10.1097/00004647-200010000-00003; Francis DD, 2002, J NEUROSCI, V22, P7840; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim Christine, 2002, Semin Clin Neuropsychiatry, V7, P147, DOI 10.1053/scnp.2002.33127; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022; Kosari-Nasab M, 2019, BEHAV PHARMACOL, V30, P220, DOI 10.1097/FBP.0000000000000450; Kvichansky AA, 2019, BIOCHEMISTRY-MOSCOW+, V84, P905, DOI 10.1134/S0006297919080066; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Lukas M, 2010, NEUROPHARMACOLOGY, V58, P78, DOI 10.1016/j.neuropharm.2009.06.020; Lundberg S, 2017, HORM BEHAV, V87, P137, DOI 10.1016/j.yhbeh.2016.11.016; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Maghami S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204731; Majcher-Maslanka I, 2019, PHARMACOL REP, V71, P347, DOI 10.1016/j.pharep.2018.11.003; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marin MT, 2004, BRAIN RES, V1013, P83, DOI 10.1016/j.brainres.2004.04.003; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; Saavedra LM, 2017, NEUROIMMUNOMODULAT, V24, P242, DOI 10.1159/000485383; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Neumann ID, 2005, NEUROSCIENCE, V132, P867, DOI 10.1016/j.neuroscience.2005.01.034; Niesman PJ, 2018, NEUROSCI LETT, V665, P212, DOI 10.1016/j.neulet.2017.12.018; Njoku I, 2019, EXP NEUROL, V315, P32, DOI 10.1016/j.expneurol.2019.01.019; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Nylander I, 2013, PSYCHOPHARMACOLOGY, V229, P555, DOI 10.1007/s00213-013-3217-3; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Robinson S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00451; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Roque A, 2020, DEV PSYCHOBIOL, V62, P737, DOI 10.1002/dev.21947; Roque A, 2016, BRAIN BEHAV IMMUN, V55, P39, DOI 10.1016/j.bbi.2015.09.017; Ruiz R, 2018, PSYCHONEUROENDOCRINO, V96, P203, DOI 10.1016/j.psyneuen.2018.07.012; SAPOLSKY RM, 1992, NEUROBIOL AGING, V13, P171, DOI 10.1016/0197-4580(92)90025-S; Schmidt MV, 2008, J ENDOCRINOL, V197, P421, DOI 10.1677/JOE-07-0634; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Suri D, 2014, INT J NEUROPSYCHOPH, V17, P289, DOI 10.1017/S1461145713001004; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Tata DA, 2015, BEHAV BRAIN RES, V280, P51, DOI 10.1016/j.bbr.2014.11.033; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; Vargas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162665; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; World Health Organization, 2020, ADV CHILDH EXP INT Q; Zulma D, 2017, CURR PHARM DESIGN, V23, P6042, DOI 10.2174/1381612823666170224111641	85	6	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					411	421		10.1089/neu.2020.7354		NOV 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000590828200001	33040677				2022-02-06	
J	Barra, ME; Izzy, S; Sarro-Schwartz, A; Hirschberg, RE; Mazwi, N; Edlow, BL				Barra, Megan E.; Izzy, Saef; Sarro-Schwartz, Aliyah; Hirschberg, Ronald E.; Mazwi, Nicole; Edlow, Brian L.			Stimulant Therapy in Acute Traumatic Brain Injury: Prescribing Patterns and Adverse Event Rates at 2 Level 1 Trauma Centers	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						pharmacological stimulant; consciousness; coma; traumatic brain injury; intensive care unit	RECEPTOR OCCUPANCY; AMANTADINE; DOPAMINE-D-2; METHYLPHENIDATE; QUETIAPINE; DISORDERS; MODERATE; AROUSAL	Background/Objective: Pharmacological stimulant therapies are routinely administered to promote recovery in patients with subacute and chronic disorders of consciousness (DoC). However, utilization rates and adverse drug event (ADE) rates of stimulant therapies in patients with acute DoC are unknown. We aimed to determine the frequency of stimulant use and associated ADEs in intensive care unit (ICU) patients with acute DoC caused by traumatic brain injury (TBI). Methods: We retrospectively identified patients with TBI admitted to the ICU at 2 level 1 trauma centers between 2015 and 2018. Patients were included if they were stimulant naive at baseline and received amantadine, methylphenidate, or modafinil during ICU admission. Stimulant dose reduction or discontinuation during ICU admission was considered a surrogate marker of an ADE. Targeted chart review was performed to identify reasons for dose reduction or discontinuation. Results: Forty-eight of 608 patients with TBI received pharmacological stimulant therapy (7.9%) during the study period. Most patients were diagnosed with severe TBI at presentation (60.4%), although stimulants were also administered to patients with moderate (14.6%) and mild (25.0%) TBI. The median time of stimulant initiation was 11 days post-injury (range: 2-28 days). Median Glasgow Coma Scale score at the time of stimulant initiation was 9 (range: 4-15). Amantadine was the most commonly prescribed stimulant (85.4%) followed by modafinil (14.6%). Seven (14.6%) patients required stimulant dose reduction or discontinuation during ICU admission. The most common ADE resulting in therapy modification was delirium/agitation (n = 2), followed by insomnia (n = 1), anxiety (n = 1), and rash (n = 1); the reason for therapy modification was undocumented in 2 patients. Conclusions: Pharmacological stimulant therapy is infrequently prescribed but well tolerated in ICU patients with acute TBI at level 1 trauma centers. These retrospective observations provide the basis for prospective studies to evaluate the safety, optimal dose range, and efficacy of stimulant therapies in this population.	[Barra, Megan E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pharm, 55 Fruit St,GRB-005, Boston, MA 02114 USA; [Izzy, Saef; Sarro-Schwartz, Aliyah] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hirschberg, Ronald E.; Mazwi, Nicole] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02115 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		Barra, ME (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pharm, 55 Fruit St,GRB-005, Boston, MA 02114 USA.	mbarra@mgh.harvard.edu		Barra, Megan/0000-0002-7696-1540	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS094538] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER		[Anonymous], 2018, ZYPR OL; [Anonymous], 2003, SER QUET FUM; Borghol Amne, 2018, Innov Clin Neurosci, V15, P17; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Coulet A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33980-0; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; Gefvert O, 1998, PSYCHOPHARMACOLOGY, V135, P119, DOI 10.1007/s002130050492; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Gramish JA, 2017, CLIN NEUROPHARMACOL, V40, P212, DOI 10.1097/WNF.0000000000000242; Kane-Gill SL, 2012, CRIT CARE MED, V40, P823, DOI 10.1097/CCM.0b013e318236f473; Kapur S, 2000, ARCH GEN PSYCHIAT, V57, P553, DOI 10.1001/archpsyc.57.6.553; Maneewong J, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S128138; Masand PS, 2007, AM J HEALTH-SYST PH, V64, pS3, DOI 10.2146/ajhp060593; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mo Y, 2018, J CLIN PHARMACOL, V58, P152, DOI 10.1002/jcph.1002; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Mohamed IN, 2011, BRIT J CLIN PHARMACO, V71, P244, DOI 10.1111/j.1365-2125.2010.03816.x; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Patel MB, 2018, CRIT CARE MED, V46, P1832, DOI 10.1097/CCM.0000000000003349; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8; Zipursky RB, 2005, CAN J PSYCHIAT, V50, P462, DOI 10.1177/070674370505000806	34	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV	2020	35	11					1196	1202		10.1177/0885066619841603			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NV7TU	WOS:000574519800006	30966863	Green Accepted			2022-02-06	
J	Benjamini, D; Hutchinson, EB; Komlosh, ME; Comrie, CJ; Schwerin, SC; Zhang, GF; Pierpaoli, C; Basser, PJ				Benjamini, Dan; Hutchinson, Elizabeth B.; Komlosh, Michal E.; Comrie, Courtney J.; Schwerin, Susan C.; Zhang, Guofeng; Pierpaoli, Carlo; Basser, Peter J.			Direct and specific assessment of axonal injury and spinal cord microenvironments using diffusion correlation imaging	NEUROIMAGE			English	Article						DDCOSY; axonal injury; specificity; diffusion; correlation; distribution; MADCO; MRI; spectrum; Wallerian degeneration	BRAIN WHITE-MATTER; IN-VIVO; WATER DIFFUSION; WALLERIAN DEGENERATION; TENSOR MRI; MICROSCOPIC ANISOTROPY; TISSUE MICROSTRUCTURE; NMR; RELAXATION; MODEL	We describe a practical two-dimensional (2D) diffusion MRI framework to deliver specificity and improve sensitivity to axonal injury in the spinal cord. This approach provides intravoxel distributions of correlations of water mobilities in orthogonal directions, revealing sub-voxel diffusion components. Here we use it to investigate water diffusivities along axial and radial orientations within spinal cord specimens with confirmed, tract-specific axonal injury. First, we show using transmission electron microscopy and immunohistochemistry that tract-specific axonal beading occurs following Wallerian degeneration in the cortico-spinal tract as direct sequelae to closed head injury. We demonstrate that although some voxel-averaged diffusion tensor imaging (DTI) metrics are sensitive to this axonal injury, they are non-specific, i.e., they do not reveal an underlying biophysical mechanism of injury. Then we employ 2D diffusion correlation imaging (DCI) to improve discrimination of different water microenvironments by measuring and mapping the joint water mobility distributions perpendicular and parallel to the spinal cord axis. We determine six distinct diffusion spectral components that differ according to their microscopic anisotropy and mobility. We show that at the injury site a highly anisotropic diffusion component completely disappears and instead becomes more isotropic. Based on these findings, an injury-specific MR image of the spinal cord was generated, and a radiological-pathological correlation with histological silver staining % area was performed. The resulting strong and significant correlation (r = 0.70, p < 0.0001) indicates the high specificity with which DCI detects injury-induced tissue alterations. We predict that the ability to selectively image microstructural changes following axonal injury in the spinal cord can be useful in clinical and research applications by enabling specific detection and increased sensitivity to injury-induced microstructural alterations. These results also encourage us to translate DCI to higher spatial dimensions to enable assessment of traumatic axonal injury, and possibly other diseases and disorders in the brain.	[Benjamini, Dan; Komlosh, Michal E.; Basser, Peter J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20817 USA; [Benjamini, Dan; Komlosh, Michal E.; Schwerin, Susan C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Hutchinson, Elizabeth B.; Comrie, Courtney J.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA; [Schwerin, Susan C.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Zhang, Guofeng; Pierpaoli, Carlo] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20817 USA		Benjamini, D (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20817 USA.; Benjamini, D (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	dan.benjamini@nih.gov		Schwerin, Susan/0000-0001-5435-2448; Comrie, Courtney/0000-0002-7528-1607	Intramural Research Program (IRP) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [ZIAHD000266]; Center for Neuroregenerative Medicine (CNRM) under Henry Jackson Foundation (HJF)	This work was supported by funds provided by the Intramural Research Program (IRP) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant number ZIAHD000266) and the Center for Neuroregenerative Medicine (CNRM) under the auspices of the Henry Jackson Foundation (HJF).	Adler DH, 2018, P NATL ACAD SCI USA, V115, P4252, DOI 10.1073/pnas.1801093115; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anaby D, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4170; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Benjamini D, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4226; Benjamini D, 2019, MAGN RESON IMAGING, V56, P187, DOI 10.1016/j.mri.2018.12.001; Benjamini D, 2018, MICROPOR MESOPOR MAT, V269, P93, DOI 10.1016/j.micromeso.2017.02.001; Benjamini D, 2017, NEUROIMAGE, V163, P183, DOI 10.1016/j.neuroimage.2017.09.033; Benjamini D, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.158003; Benjamini D, 2016, J MAGN RESON, V271, P40, DOI 10.1016/j.jmr.2016.08.004; Benjamini D, 2016, NEUROIMAGE, V135, P333, DOI 10.1016/j.neuroimage.2016.04.052; Benjamini D, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4901134; Benjamini D, 2014, ACTA BIOMATER, V10, P2762, DOI 10.1016/j.actbio.2014.02.014; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Callaghan P.T., 2011, TRANSLATIONAL DYNAMI; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Callaghan PT, 2002, MAGN RESON CHEM, V40, pS15, DOI 10.1002/mrc.1122; Carroll S., 2009, ENCY NEUROSCIENCE, P485; Castellanos JL, 2002, APPL NUMER MATH, V43, P359, DOI 10.1016/S0168-9274(01)00179-9; Cory D.G., 1990, POLYM PREPR-ACS, P149; CVX Research, 2012, CVX MATL SOFTW DISC; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dhital B, 2018, NEUROIMAGE, V182, P398, DOI 10.1016/j.neuroimage.2017.10.051; Englund E, 2004, J NEUROL, V251, P350, DOI 10.1007/s00415-004-0318-2; Epstein CL, 2008, SIAM REV, V50, P504, DOI 10.1137/060657273; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; FORDHAM EJ, 1995, J MAGN RESON SER A, V113, P139, DOI 10.1006/jmra.1995.1073; Grant MC, 2008, LECT NOTES CONTR INF, V371, P95, DOI 10.1007/978-1-84800-155-8_7; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hutchinson E., 2019, IMPROVEMENTS SPECIFI; Hutchinson E., 2018, MRI MARKERS BRAIN IN; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Ianus A, 2016, NMR BIOMED, V29, P672, DOI 10.1002/nbm.3496; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kim D, 2017, MAGN RESON MED, V78, P2236, DOI 10.1002/mrm.26629; Koch MA, 2008, MAGN RESON MED, V60, P90, DOI 10.1002/mrm.21514; Komlosh ME, 2007, J MAGN RESON, V189, P38, DOI 10.1016/j.jmr.2007.07.003; Komlosh ME, 2017, J MAGN RESON, V275, P19, DOI 10.1016/j.jmr.2016.11.017; Komlosh ME, 2013, NEUROIMAGE, V78, P210, DOI 10.1016/j.neuroimage.2013.03.074; Komlosh ME, 2018, MICROPOR MESOPOR MAT, V269, P156, DOI 10.1016/j.micromeso.2017.05.030; KROEKER RM, 1986, J MAGN RESON, V69, P218, DOI 10.1016/0022-2364(86)90074-0; Kroenke CD, 2004, MAGN RESON MED, V52, P1052, DOI 10.1002/mrm.20260; LABADIE C, 1994, J MAGN RESON SER B, V105, P99, DOI 10.1006/jmrb.1994.1109; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Lawrenz M, 2015, MAGN RESON MED, V73, P773, DOI 10.1002/mrm.25140; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; Lawson C. L., 1974, SOLVING LEAST SQUARE; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee HH, 2018, NEUROIMAGE, V182, P500, DOI 10.1016/j.neuroimage.2017.12.038; Leow AD, 2009, MAGN RESON MED, V61, P205, DOI 10.1002/mrm.21852; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Martins JPD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.087601; MENON RS, 1991, MAGNET RESON MED, V20, P214, DOI 10.1002/mrm.1910200205; Mitchell J, 2012, PROG NUCL MAG RES SP, V62, P34, DOI 10.1016/j.pnmrs.2011.07.002; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Ozarslan E, 2013, NEUROIMAGE, V78, P16, DOI 10.1016/j.neuroimage.2013.04.016; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Palombo M., 2019, SANDI COMP BASED MOD; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Pas K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60092-5; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pfeuffer J, 1999, MAGN RESON MATER PHY, V8, P98; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prange M, 2009, J MAGN RESON, V196, P54, DOI 10.1016/j.jmr.2008.10.008; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Qiao Y, 2005, BIOPHYS J, V89, P2899, DOI 10.1529/biophysj.105.064709; Reiter DA, 2016, MAGN RESON MED, V76, P953, DOI 10.1002/mrm.25913; Ronen I, 2006, MAGN RESON IMAGING, V24, P61, DOI 10.1016/j.mri.2005.10.023; Scherrer B, 2016, MAGN RESON MED, V76, P963, DOI 10.1002/mrm.25912; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; Shemesh N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3285299; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Skinner NP, 2018, ANN NEUROL, V84, P37, DOI 10.1002/ana.25260; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Skinner NP, 2015, NMR BIOMED, V28, P1489, DOI 10.1002/nbm.3405; Slator PJ, 2019, MAGN RESON MED, V82, P95, DOI 10.1002/mrm.27733; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song YQ, 2002, J MAGN RESON, V154, P261, DOI 10.1006/jmre.2001.2474; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tax CMW, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116534; Teipel SJ, 2014, J ALZHEIMERS DIS, V41, P69, DOI 10.3233/JAD-131829; Thrane LW, 2019, J MAGN RESON, V303, P7, DOI 10.1016/j.jmr.2019.04.003; Topgaard D, 2002, J PHYS CHEM B, V106, P11887, DOI 10.1021/jp020130p; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Venkataramanan L, 2002, IEEE T SIGNAL PROCES, V50, P1017, DOI 10.1109/78.995059; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; VY, 1977, SOLUTIONS ILL POSED; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Williamson NH, 2019, ELIFE, V8, DOI 10.7554/eLife.51101; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009; Zong FR, 2017, MAGN RESON CHEM, V55, P498, DOI 10.1002/mrc.4492	118	6	6	3	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 1	2020	221								117195	10.1016/j.neuroimage.2020.117195			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PI0MO	WOS:000600795000060	32726643	Green Accepted, Green Submitted, gold			2022-02-06	
J	Costa, JMC; Fernandes, FAO; de Sousa, RJA				Costa, Jose M. C.; Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.			Prediction of subdural haematoma based on a detailed numerical model of the cerebral bridging veins	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						subdural Haematoma bridging veins; Finite element model; Brain injury; Tubular structure	RUPTURE; INJURY	Traumatic brain injury is one of the major causes of death and disability in the world. One of the most frequent and deadly injury resulted from a head trauma is acute subdural haematoma (ASDH), which consists on the rupture of a bridging vein (BV). Given the importance of this type of injury, it is necessary to correctly assess thresholds and damage criteria, which is difficult to perform on human cadavers or animals, due to ethical and economical issues. Finite element (FE) models are a very good and cost-effective alternative. Once properly validated, a finite element head model (FEHM) becomes a valuable tool, that can be used in the development of head protective gear as a design tool and in the reconstruction of head traumas by predicting brain injuries under impact conditions. The YEt Another Head Model (YEAHM) is one example of a FE model that can be used to assist/replace the experimental tests. In this study, the bridging veins model from YEAHM was improved and validated by comparing its results with others reported in literature and estimating the success rate. At the end, it was developed a pressurised tubular shaped FE model of BVs, considering the blood pressure in cerebral veins. Results showed a maximum success rate of 90%, which in comparison with other FE models available in the literature, presents an equal or even better ASDH prediction success rate.	[Costa, Jose M. C.; Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.] Univ Aveiro, Ctr Mech Technol & Automat, Mech Engn Dept, P-3810193 Aveiro, Portugal		Fernandes, FAO (corresponding author), Univ Aveiro, Ctr Mech Technol & Automat, Mech Engn Dept, P-3810193 Aveiro, Portugal.	fabiofernandes@ua.pt	de Sousa, Ricardo Alves/E-4405-2010; Lang, Steven/AAE-8102-2021; Fernandes, Fabio A.O./H-2680-2012	de Sousa, Ricardo Alves/0000-0002-5848-6424; Lang, Steven/0000-0003-1669-9146; Fernandes, Fabio A.O./0000-0001-9751-8807	FCT - Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and Technology [UIDB/00481/2020, UIDP/00481/2020]; Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement [CENTRO-01-0145-FEDER-022083]; Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [CEECIND/01192/2017]; Centro Portugal Regional Operational Programme (Centro2020) through the European Regional Development Fund [CENTRO-01-0145-FEDER-022083]	This work was supported by the projects UIDB/00481/2020 and UIDP/00481/2020 - FCT - Fundacao para a Ciencia e a Tecnologia; and CENTRO-01-0145-FEDER-022083 - Centro Portugal Regional Operational Programme (Centro2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund. The researcher under grant (CEECIND/01192/2017) would like to acknowledge the support given by Fundacao para a Ciencia e a Tecnologia (FCT).	Abaqus User's Manual, 2018, AB US MAN; Cui ZY, 2017, COMPUT METHOD BIOMEC, V20, P530, DOI 10.1080/10255842.2016.1255942; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Depreitere B., 2005, IUTAM S IMP BIOM FUN, V124; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Habibi R, 2017, LAB CHIP, V17, P3279, DOI 10.1039/c7lc00640c; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kapeliotis M, 2019, J BIOMECH, V92, P6, DOI 10.1016/j.jbiomech.2019.05.016; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mayo Foundation for Medical Education and Research, 2019, BLOOD PRESS CHART WH; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Neuroangioorg, 2020, YOUR NEUR ED INF SOU; Singh D, 2019, J BIOMECH, V92, P84, DOI 10.1016/j.jbiomech.2019.05.033; Takhounts EG, 2008, STAPP CAR C, V52, P1; The Physics Factbook, DENS BLOOD; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	24	6	6	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	NOV	2020	111								103976	10.1016/j.jmbbm.2020.103976			7	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	NW9WQ	WOS:000575370300005	32750673				2022-02-06	
J	Fuller, G; Sabir, L; Evans, R; Bradbury, D; Kuczawski, M; Mason, SM				Fuller, Gordon; Sabir, Lisa; Evans, Rachel; Bradbury, Daniel; Kuczawski, Maxine; Mason, Suzanne M.			Risk of significant traumatic brain injury in adults with minor head injury taking direct oral anticoagulants: a cohort study and updated meta-analysis	EMERGENCY MEDICINE JOURNAL			English	Article							EMERGENCY-DEPARTMENT; PREVALENCE; WARFARIN; TRENDS; SCANS; UK	Background Patients taking direct oral anticoagulants (DOACs) commonly undergo CT head imaging after minor head injury, regardless of symptoms or signs. However, the risk of intracranial haemorrhage (ICH) in such patients is unclear, and further research has been recommended by the UK National Institute for Health and Care Excellence head injury guideline group. Methods An observational cohort study was performed in the UK South Yorkshire major trauma centre between 26 June and 3 September 2018. Adult patients taking DOACs with minor head injury were prospectively identified, with case ascertainment supplemented by screening of radiology and ED information technology systems. Clinical and outcome data were subsequently collated from patient records. The primary endpoint was adverse outcome within 30 days, comprising: neurosurgery, ICH or death due to head injury. A previously published meta-analysis was updated with the current results and the findings of other recent studies. Results 148 patients with minor head injury were included (GCS 15, n=107, 72%; GCS 14, n=41, 28%). Patients were elderly (median 82 years) and most frequently injured from ground level falls (n=142, 96%). Overall risk of adverse outcome was 3.4% (5/148, 95% CI 1.4% to 8.0%). Five patients had ICH, of whom one died within 30 days. One patient was treated with prothrombin complex concentrate but no patient received critical care management or underwent neurosurgical intervention. Updated random effects meta-analysis, including the current results and two further recent studies, showed a weighted overall risk of adverse outcome of 3.2% (n=29/787, 95% CI 2.0% to 4.4%). Conclusions The risk of adverse outcome following mild head injury in patients taking DOACs appears low. These findings would support shared patient-clinician decision making, rather than routine imaging, following minor head injury while taking DOACs.	[Fuller, Gordon; Sabir, Lisa; Evans, Rachel; Kuczawski, Maxine; Mason, Suzanne M.] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield S10 2TG, S Yorkshire, England; [Bradbury, Daniel] Sheffield Teaching Hosp, Northern Gen Hosp, Emergency Dept, Sheffield, S Yorkshire, England		Fuller, G (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield S10 2TG, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Kuczawski, Maxine/0000-0002-0774-8113; Fuller, Gordon Ward/0000-0001-8532-3500; Sabir, Lisa/0000-0001-6488-3314; Mason, Suzanne/0000-0002-1701-0577			Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Borenstein M., 2009, INTRO META ANAL; Chenoweth JA, 2017, WEST J EMERG MED, V18, P794, DOI 10.5811/westjem.2017.5.33092; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; Hull A, 2015, PEDIATR EMERG CARE, V31, P759, DOI 10.1097/PEC.0000000000000467; Iorio A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h870; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Loo SY, 2017, BRIT J CLIN PHARMACO, V83, P2096, DOI 10.1111/bcp.13299; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; O'Neal WT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007943; Padalecki J, 2017, TURK J EMERG MED, V17, P16, DOI 10.1016/j.tjem.2016.09.009; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pirmohamed M, 2006, BRIT J CLIN PHARMACO, V62, P509, DOI 10.1111/j.1365-2125.2006.02806.x; Probst MA, 2020, ANN EMERG MED, V75, P354, DOI 10.1016/j.annemergmed.2019.10.004; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Spinola MB, 2019, AM J EMERG MED, V37, P1677, DOI 10.1016/j.ajem.2018.12.003; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stewart A, 2015, J CLIN PHARM THER, V40, P466, DOI 10.1111/jcpt.12291; Than M, 2013, INT J CARDIOL, V166, P752, DOI 10.1016/j.ijcard.2012.09.171; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wolfe Z, 2018, J THROMB HAEMOST, V16, P1296, DOI 10.1111/jth.14131	35	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2020	37	11					666	673		10.1136/emermed-2019-209307			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	OJ5LQ	WOS:000584003100003	32900858	Bronze			2022-02-06	
J	Kroshus, E; Cameron, KL; Coatsworth, JD; D'Lauro, C; Kim, E; Lee, K; Register-Mihalik, JK; Milroy, JJ; Roetert, EP; Schmidt, JD; Silverman, RD; Warmath, D; Wayment, HA; Hainline, B				Kroshus, Emily; Cameron, Kenneth L.; Coatsworth, J. Douglas; D'Lauro, Christopher; Kim, Eungjae; Lee, Katherine; Register-Mihalik, Johna K.; Milroy, Jeffery J.; Roetert, E. Paul; Schmidt, Julianne D.; Silverman, Ross D.; Warmath, Dee; Wayment, Heidi A.; Hainline, Brian			Improving concussion education: consensus from the NCAA-Department of Defense Mind Matters Research & Education Grand Challenge	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; consensus; implementation; education; knowledge translation	ICE HOCKEY; PREVENTION; SPORT; NORMS	Early disclosure of possible concussive symptoms has the potential to improve concussion-related clinical outcomes. The objective of the present consensus process was to provide useful and feasible recommendations for collegiate athletic departments and military service academy leaders about how to increase concussion symptom disclosure in their setting. Consensus was obtained using a modified Delphi process. Participants in the consensus process were grant awardees from the National Collegiate Athletic Association and Department of Defense Mind Matters Research & Education Grand Challenge and a multidisciplinary group of stakeholders from collegiate athletics and military service academies. The process included a combination of in-person meetings and anonymous online voting on iteratively modified recommendations for approaches to improve concussion symptom disclosure. Recommendations were rated in terms of their utility and feasibility in collegiate athletic and military service academy settings with a priori thresholds for retaining, discarding and revising statements. A total of 17 recommendations met thresholds for utility and feasibility and are grouped for discussion in five domains: (1) content of concussion education for athletes and military service academy cadets, (2) dissemination and implementation of concussion education for athletes and military service academy cadets, (3) other stakeholder concussion education, (4) team and unit-level processes and (5) organisational processes. Collectively, these recommendations provide a path forward for athletics departments and military service academies in terms of the behavioural health supports and institutional processes that are needed to increase early and honest disclosure of concussion symptoms and ultimately to improve clinical care outcomes.	[Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Dept Pediat, Seattle, WA USA; [Cameron, Kenneth L.] Keller Army Community Hosp, Orthopaed, West Point, NY USA; [Coatsworth, J. Douglas] Colorado State Univ, Human Dev & Family Studies, Ft Collins, CO 80523 USA; [D'Lauro, Christopher] US Air Force Acad, Behav Sci & Leadership, Colorado Springs, CO 80840 USA; [Kim, Eungjae] Emory Univ, Atlanta, GA 30322 USA; [Lee, Katherine] US Dept Def, Hlth Readiness & Policy Oversight, Hlth Affairs, Falls Church, VA USA; [Register-Mihalik, Johna K.] Univ N Carolina, Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Milroy, Jeffery J.] Univ North Carolina Greensboro, Publ Hlth Educ, Greensboro, NC USA; [Roetert, E. Paul; Hainline, Brian] Natl Collegiate Athlet Assoc, Indianapolis, IN USA; [Schmidt, Julianne D.] Univ Georgia, Kinesiol, Athens, GA 30602 USA; [Silverman, Ross D.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Warmath, Dee] Univ Georgia, Family & Consumer Sci, Athens, GA 30602 USA; [Wayment, Heidi A.] No Arizona Univ, Psychol Sci, Flagstaff, AZ 86011 USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	ekroshus@u.washington.edu	Warmath, Dee/AAK-5148-2021	Warmath, Dee/0000-0001-8301-1386; Silverman, Ross D./0000-0003-4492-3096; Coatsworth, J Douglas/0000-0003-0306-2760; D'Lauro, Christopher/0000-0003-0894-6602; Kroshus, Emily/0000-0002-7484-2601	NCAA-DoD Grand Alliance Mind Matters Challenge; National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense	This publication was made possible, in part, with support from the NCAA-DoD Grand Alliance Mind Matters Challenge, funded, in part by the National Collegiate Athletic Association and the Department of Defense.	Adler M., 1996, GAZING ORACLE DELPHI; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brook RH, 1995, RAND UCLA APPROPRIAT; Brown EC, 2011, J COMMUNITY PSYCHOL, V39, P183, DOI 10.1002/jcop.20426; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Dalkey N, 1969, EXPT STUDY GROUP OPI, P408, DOI 10.1016/S0016-3287(69)80025-X; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Finch CF, 2011, BRIT J SPORT MED, V45, P763, DOI 10.1136/bjsports-2011-090252; Foster CA., 2019, J CONCUSSION, V3, p2059700219882876, DOI [10.1177/2059700219882876, DOI 10.1177/2059700219882876]; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Glanz K, 2015, RES PRACTICE; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Hom MA, 2017, CLIN PSYCHOL REV, V53, P59, DOI 10.1016/j.cpr.2017.01.008; Jorm AF, 2015, AUST NZ J PSYCHIAT, V49, P887, DOI 10.1177/0004867415600891; Kroshus E, 2019, HEALTH EDUC BEHAV, V1090198119864621; Kroshus E, 2019, CLIN J SPORT MED; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Van Pelt KL, 2019, INJURY EPIDEMIOL, V6, DOI 10.1186/s40621-018-0178-3; Warmath D, 2019, SPORTS HEALTH, V11, P416, DOI 10.1177/1941738119856609; Wayment HA, 2020, HEALTH EDUC BEHAV, V47, P91, DOI 10.1177/1090198119879216; Wayment HA, 2019, MUSCULOSKEL SCI PRAC, V42, P186, DOI 10.1016/j.msksp.2019.04.003; Wayment HA, 2020, J AM COLL HEALTH, V68, P438, DOI 10.1080/07448481.2019.1577863; Weber ML, 2019, BRAIN INJURY, V33, P592, DOI 10.1080/02699052.2019.1568573; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015	46	6	6	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2020	54	22					1314	1320		10.1136/bjsports-2020-102185			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OK9GX	WOS:000584953300006	32912847	Bronze			2022-02-06	
J	Brenner, LA; Forster, JE; Stearns-Yoder, KA; Stamper, CE; Hoisington, AJ; Brostow, DP; Mealer, M; Wortzel, HS; Postolache, TT; Lowry, CA				Brenner, Lisa A.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Stamper, Christopher E.; Hoisington, Andrew J.; Brostow, Diana P.; Mealer, Meredith; Wortzel, Hal S.; Postolache, Teodor T.; Lowry, Christopher A.			Evaluation of an Immunomodulatory Probiotic Intervention for Veterans With Co-occurring Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; posttraumatic stress disorder (PTSD); probiotic; Veteran; gut-brain axis; Lactobacillus reuteri DSM 17938; microbiome	HELICOBACTER-PYLORI INFECTION; PSYCHOLOGICAL STRESS; PREDICTIVE-VALIDITY; SYMPTOMS; QUESTIONNAIRE; COLONIZATION; INFLAMMATION; CONCUSSION; ADHERENCE	Background: US military Veterans returned from Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) with symptoms associated with mild traumatic brain injury [mTBI; i.e., persistent post-concussive (PPC) symptoms] and posttraumatic stress disorder (PTSD). Interventions aimed at addressing symptoms associated with both physical and psychological stressors (e.g., PPC and PTSD symptoms) are needed. This study was conducted to assess the feasibility, acceptability, and safety of a probiotic intervention, as well as to begin the process of evaluating potential biological outcomes. Methods: A pilot randomized controlled trial was implemented among US military Veterans from recent conflicts in Iraq and Afghanistan. Those enrolled had clinically significant PPC and PTSD symptoms. Participants were randomized to intervention (Lactobacillus reuteri DSM 17938) or placebo supplementation (daily for 8 weeks +/- 2 weeks) at a 1:1 ratio, stratified by irritable bowel syndrome status. Thirty-one Veterans were enrolled and randomized (15 to the placebo condition and 16 to the probiotic condition). Results: Thresholds for feasibility, acceptability, and safety were met. Probiotic supplementation resulted in a decrease in plasma C-reactive protein (CRP) concentrations relative to the placebo group that approached statistical significance (p = 0.056). Although during the Trier Social Stress Test (TSST; administered post-supplementation) no between-group differences were found on a subjective measure of stress responsivity (Visual Analog Scale), there was a significantly larger increase in mean heart beats per minute between baseline and the math task for the placebo group as compared with the probiotic group (estimated mean change, probiotic 5.3 [95% Confidence Interval: -0.55, 11.0], placebo 16.9 [11.0, 22.7], p = 0.006). Conclusions: Findings from this trial support the feasibility, acceptability, and safety of supplementation with an anti-inflammatory/immunoregulatory probiotic, L. reuteri DSM 17938, among Veterans with PPC and PTSD symptoms. Moreover, results suggest that CRP may be a viable inflammatory marker of interest. A larger randomized controlled trial aimed at measuring both biological and clinical outcomes is indicated.	[Brenner, Lisa A.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Stamper, Christopher E.; Hoisington, Andrew J.; Brostow, Diana P.; Mealer, Meredith; Wortzel, Hal S.; Postolache, Teodor T.; Lowry, Christopher A.] Rocky Mt Reg Vet Affairs VA Med Ctr RMRVAMC, VA Rocky Mt Mental Illness Res Educ & Clin Ctr MI, Aurora, CO USA; [Brenner, Lisa A.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Stamper, Christopher E.; Hoisington, Andrew J.; Brostow, Diana P.; Mealer, Meredith; Lowry, Christopher A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Wortzel, Hal S.] Univ Colorado, Dept Psychiat & Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Forster, Jeri E.; Stearns-Yoder, Kelly A.; Stamper, Christopher E.; Hoisington, Andrew J.; Brostow, Diana P.; Postolache, Teodor T.; Lowry, Christopher A.] Mil & Veteran Microbiome Consortium Res & Educ, Aurora, CO USA; [Hoisington, Andrew J.] Air Force Inst Technol, Dept Syst Engn & Management, Wright Patterson AFB, OH USA; [Postolache, Teodor T.] Univ Maryland, Sch Med, Mood & Anxiety Program, Baltimore, MD 21201 USA; [Postolache, Teodor T.] Dept Vet Affairs, Vet Integrated Serv Network VISN MIRECC 5, Baltimore, MD USA; [Lowry, Christopher A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Anschutz Med Campus, Aurora, CO USA		Brenner, LA (corresponding author), Rocky Mt Reg Vet Affairs VA Med Ctr RMRVAMC, VA Rocky Mt Mental Illness Res Educ & Clin Ctr MI, Aurora, CO USA.; Brenner, LA (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA.; Brenner, LA (corresponding author), Univ Colorado, Dept Psychiat & Neurol, Anschutz Med Campus, Aurora, CO USA.; Brenner, LA (corresponding author), Mil & Veteran Microbiome Consortium Res & Educ, Aurora, CO USA.	lisa.brenner@va.gov		Postolache, Teodor/0000-0001-6056-4244	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I21 RX002232, NCT02723344]	This material was based upon work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Rehabilitation Research and Development Service (I21 RX002232, Biological Signature and Safety of an Immunomodulatory Probiotic Intervention for Veterans with Co-occurring Mild TBI and PTSD; ClinicalTrials.gov Identifier: NCT02723344). The views, opinions, and/or findings contained in this article are those of the author(s) and should not be construed as an official Department of Defense or Veterans Affairs position, policy, or decision unless so designated by other documentation.	Atkinson Mark J, 2004, Health Qual Life Outcomes, V2, P12, DOI 10.1186/1477-7525-2-12; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Betthauser LM, 2014, MED CARE, V52, pS50, DOI 10.1097/MLR.0000000000000219; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Buysse D J, 1989, Psychiatry Res, V28, P193; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Feeley N, 2009, CAN J NURS RES, V41, P84; Francavilla R, 2008, HELICOBACTER, V13, P127, DOI 10.1111/j.1523-5378.2008.00593.x; Francavilla R, 2014, J CLIN GASTROENTEROL, V48, P407, DOI 10.1097/MCG.0000000000000007; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gold SA, 2004, BIOL PSYCHOL, V67, P261, DOI 10.1016/j.biopsycho.2003.12.001; Guo G, 2009, STRESS, V12, P478, DOI 10.3109/10253890802642188; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Hoge C, 2015, JAMA INTERN MED, V175, P53, DOI 10.1001/jamainternmed.2014.3375; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanefsky R, 2019, PSYCHIAT RES, V279, P34, DOI 10.1016/j.psychres.2019.07.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; LEMYRE L, 1988, CAN J BEHAV SCI, V20, P302, DOI 10.1037/h0079945; Lemyre L, 2003, CAN FAM PHYS, V49, P66; Lesage FX, 2012, OCCUP MED-OXFORD, V62, P600, DOI 10.1093/occmed/kqs140; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Maguen S, 2014, DEPRESS ANXIETY, V31, P160, DOI 10.1002/da.22072; MANDAL S, 2015, MICROB ECOL HEALTH D, V0026; Mangalat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043910; Mazidi M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010020; Michopoulos V, 2017, NEUROPSYCHOPHARMACOL, V42, P254, DOI 10.1038/npp.2016.146; Mobini R, 2017, DIABETES OBES METAB, V19, P579, DOI 10.1111/dom.12861; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Preidis GA, 2012, J PEDIATR GASTR NUTR, V55, P299, DOI 10.1097/MPG.0b013e31824d2548; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rief W, 2009, GENERIC ASSESSMENT S; Rome Foundation, 2015, ROME III DISORDERS C; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thabane L., 2010, BMC MED RES METHODOL, V10; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; U.S. Department of Veterans Affairs, 2014, CLIN ADM PTSD SCAL D; VA/DoD, 2016, CLIN PRACT GUID MAN; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041; **DATA OBJECT**	64	6	6	4	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 20	2020	11								1015	10.3389/fneur.2020.01015			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OJ2VA	WOS:000583823300001	33192959	gold, Green Published			2022-02-06	
J	Zhao, YK; Zhao, J; Zhang, XY; Cheng, YY; Luo, D; Lee, SMY; Lao, LX; Rong, JH				Zhao, Yingke; Zhao, Jia; Zhang, Xiuying; Cheng, Yuanyuan; Luo, Dan; Lee, Simon Ming-Yuen; Lao, Lixing; Rong, Jianhui			Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP+-Induced Toxicity via Progesterone Receptor Signaling	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							TRAUMATIC BRAIN-INJURY; BDNF EXPRESSION; NERVOUS-SYSTEM; ESTROGEN; DISEASE; NEUROPROTECTION; MODEL; RATS	Background. Progesterone receptor (PR) modulates neuroprotective and regenerative responses in Parkinson's disease and related neurological diseases. Objectives. The present study was designed to determine whether botanical drug puerarin could exhibit neuroprotective and neurorestorative activities via PR signaling. Methods. The neuroprotective and neurotrophic activities of puerarin were investigated in MPTP-lesioned mice and MPP+-challenged primary rat midbrain neurons. Rotarod performance test and tail suspension test were used to assess motor functions. Tyrosine hydroxylase (TH) and PR were determined by immunostaining, Western blotting, and luciferase reporter assays. Neurite outgrowth was assessed by fluorescence staining and immunostaining. Results. Puerarin effectively ameliorated the MPTP-induced motor abnormalities in MPTP-lesioned mice and protected primary rat midbrain neurons against MPP+-induced toxicity via PR signaling although progesterone exhibited the neuroprotection. PR antagonist mifepristone (RU486) diminished the neuroprotection of puerarin in MPTP-lesioned mice and MPP+-induced primary rat midbrain neurons. Moreover, puerarin promoted the differentiation of primary rat midbrain neurons and potentiated NGF to induce neuritogenesis in PC12 cells. RU486 and PR-siRNA could inhibit the effect of puerarin. Puerarin and progesterone could enhance the PR promoter. Conclusion. Puerarin attenuated MPTP- and MPP+-induced toxicity and potentiated neurite outgrowth via PR. These results suggested that puerarin may become an alternative hormone for suppressing MPTP- and MPP+-induced toxicity in neurodegenerative diseases.	[Zhao, Yingke; Zhao, Jia; Zhang, Xiuying; Cheng, Yuanyuan; Luo, Dan; Lao, Lixing; Rong, Jianhui] Univ Hong Kong, Sch Chinese Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Zhao, Jia; Lao, Lixing] Univ Hong Kong Shenzhen Hosp, Dept Chinese Med, Shenzhen, Peoples R China; [Lee, Simon Ming-Yuen] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China; [Rong, Jianhui] Univ Hong Kong Shenzhen Inst Res & Innovat HKU SI, Shenzhen, Peoples R China		Rong, JH (corresponding author), Univ Hong Kong, Sch Chinese Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.; Rong, JH (corresponding author), Univ Hong Kong Shenzhen Inst Res & Innovat HKU SI, Shenzhen, Peoples R China.	zhao-yingke@outlook.com; zhaojia7@hku.hk; xyzh@connect.hku.hk; chengyuanyuan@gzucm.edu.cn; vivialuo@connect.hku.hk; simonlee@um.edu.mo; llao@vuim.edu; jrong@hkucc.hku.hk		RONG, Jianhui/0000-0002-3709-7315	General Research Fund (GRF) from the Research Grants Council of Hong Kong [17120915, 17146216, 17100317, 17119619]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81703726, 21778046]; Health and Medical Research Fund [15161731, 16171751, 17181231]; Science, Technology and Innovation Commission of Shenzhen Municipality (Basic Research Program, Free Exploration Project) [JCYJ20180306173835901]; Research and Cultivation Plan of High-Level Hospital Construction [HKUSZH201902040]; Midstream Research Programme for Universities (MRP) [053/18X]; University of Hong KongUniversity of Hong Kong [201611159156]	The authors are grateful to Mr. Wong Hei Kiu, Ms. Lee Wai Sin, and Mr. Shek Chun Shum for their technical assistance. This work was supported by General Research Fund (GRF) grants (17120915, 17146216, 17100317, and 17119619) from the Research Grants Council of Hong Kong, National Natural Science Foundation of China (Nos. 81703726 and 21778046), Health and Medical Research Fund (15161731, 16171751, and 17181231), Science, Technology and Innovation Commission of Shenzhen Municipality (Basic Research Program, Free Exploration Project JCYJ20180306173835901), Research and Cultivation Plan of High-Level Hospital Construction (HKUSZH201902040), Midstream Research Programme for Universities (MRP) (053/18X), and the Seed Funding (201611159156) for Basic Research Programme from University of Hong Kong.	Bourque M, 2019, NEUROPHARMACOLOGY, V147, P37, DOI 10.1016/j.neuropharm.2018.04.005; Bourque M, 2016, NEUROENDOCRINOLOGY, V103, P300, DOI 10.1159/000438789; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Burbulla LF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6870; Casas S, 2013, NEUROL RES, V35, P719, DOI 10.1179/1743132812Y.0000000142; Cheng YY, 2015, J NUTR BIOCHEM, V26, P146, DOI 10.1016/j.jnutbio.2014.09.012; Cheng YF, 2017, J MOL NEUROSCI, V61, P227, DOI 10.1007/s12031-016-0856-y; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Espinosa-Abascal T, 2016, INT J QUAL METH, V15; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Garg D, 2017, TRENDS ENDOCRIN MET, V28, P656, DOI 10.1016/j.tem.2017.05.006; Gonzalez SL, 2020, STEROIDS, V153, DOI 10.1016/j.steroids.2019.108525; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kataoka H, 2017, J NEUROL SCI, V377, P179, DOI 10.1016/j.jns.2017.04.025; Li L, 2017, BRAIN RES, V1657, P87, DOI 10.1016/j.brainres.2016.11.023; Li R, 2013, BRAIN RES, V1523, P1, DOI 10.1016/j.brainres.2013.05.046; Luo D, 2018, MOL NEUROBIOL, V55, P2258, DOI 10.1007/s12035-017-0486-6; Luo D, 2017, AGING-US, V9, P2068, DOI 10.18632/aging.101302; Pomata PE, 2000, DEV BRAIN RES, V120, P83, DOI 10.1016/S0165-3806(99)00181-9; Przedborski S, 2017, NAT REV NEUROSCI, V18, P251, DOI 10.1038/nrn.2017.25; Purandare N, 2018, J BIOL CHEM, V293, P6517, DOI 10.1074/jbc.RA117.001073; Qiu ZK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06552-x; Rudolph LM, 2016, J NEUROSCI, V36, P11449, DOI 10.1523/JNEUROSCI.2473-16.2016; Saha P, 2012, REPRODUCTION, V144, P633, DOI 10.1530/REP-11-0423; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Siani F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00306; Solanki I, 2016, NEUROCHEM INT, V95, P100, DOI 10.1016/j.neuint.2015.11.001; Srivastava P, 2016, ADV NEUROBIOL, V12, P107, DOI 10.1007/978-3-319-28383-8_7; Su AS, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108978; Tenkorang MA, 2018, STEROIDS, V133, P21, DOI 10.1016/j.steroids.2017.12.010; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wulsin AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00214; Yi HL, 2016, J CHEM NEUROANAT, V77, P60, DOI 10.1016/j.jchemneu.2016.05.005; Zhao J, 2019, CNS NEUROL DISORD-DR, V18, P103, DOI 10.2174/1871527317666181105093834; Zhao J, 2016, MOL NEUROBIOL, V53, P2200, DOI 10.1007/s12035-015-9195-1; Zhao J, 2015, CNS NEUROSCI THER, V21, P61, DOI 10.1111/cns.12334; Zhao YK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00496; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083; Zhu GQ, 2014, PHYTOTHER RES, V28, P179, DOI 10.1002/ptr.4975; Zhu XY, 2017, J NEUROSCI, V37, P10998, DOI 10.1523/JNEUROSCI.3874-16.2017	41	6	6	3	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	OCT 17	2020	2020								7635291	10.1155/2020/7635291			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OQ0CA	WOS:000588459300001	33123315	gold, Green Published			2022-02-06	
J	Bai, LJ; Bai, GH; Wang, S; Yang, XF; Gan, SQ; Jia, XY; Yin, B; Yan, ZH				Bai, Lijun; Bai, Guanghui; Wang, Shan; Yang, Xuefei; Gan, Shuoqiu; Jia, Xiaoyan; Yin, Bo; Yan, Zhihan			Strategic white matter injury associated with long-term information processing speed deficits in mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						DTI; information processing speed; mild traumatic brain injury; prognosis; serum inflammation cytokine	COGNITIVE IMPAIRMENT; BIDIRECTIONAL CHANGES; DYSFUNCTION; VALIDATION; ANISOTROPY; INTELLIGENCE; TRACTOGRAPHY; PREDICTION; BIOMARKERS; RECOVERY	Deficits in information processing speed (IPS) are among the earliest and most prominent cognitive manifestations in mild traumatic brain injury (mTBI). We investigated the impact of white matter fiber location on IPS outcome in an individual basis assessment. A total of 112 acute mild TBI with all CT negative underwent brain DTI and blood sampling for inflammation cytokines within 7 days postinjury and 72 age- and sex matched healthy controls with same assessments were enrolled. IPS outcome was assessed by the trail making test at 6-12 month postinjury in mild TBI. Fractional anisotropy (FA) features were extracted using a novel lesion-load analytical strategy to capture spatially heterogeneous white matter injuries and minimize implicit assumptions of uniform injury across diverse clinical presentations. Acute mild TBI exhibited a general pattern of increased and decreased FA in specific white matter tracts. The power of acute FA measures to identify patients developing IPS deficits with 92% accuracy and further improved to 96% accuracy by adding inflammation cytokines. The classifiers predicted individual's IPS and working memory ratings (r= .74 and .80, respectively,p< .001). The thalamo-cortical circuits and commissural tracts projecting or connecting frontal regions became important predictors. This prognostic model was also verified by an independent replicate sample. Our findings highlighted damage to frontal interhemispheric and thalamic projection fiber tracts harboring frontal-subcortical neuronal circuits as a predictor for processing speed performance in mild TBI.	[Bai, Lijun; Bai, Guanghui; Yan, Zhihan] Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China; [Bai, Lijun; Bai, Guanghui; Yin, Bo; Yan, Zhihan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China; [Bai, Lijun; Wang, Shan; Yang, Xuefei; Gan, Shuoqiu; Jia, Xiaoyan] Xi Jiaotong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Wenzhou, Peoples R China		Bai, LJ; Yan, ZH (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China.; Bai, LJ (corresponding author), Xi Jiaotong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China.; Bai, LJ; Yan, ZH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Peoples R China.	bailijun@xjtu.edu.cn; yanzhihanwz@163.com		Jia, Xiaoyan/0000-0002-3730-6877	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771914] Funding Source: Medline; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H180003] Funding Source: Medline		Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Briones TL, 2014, BRAIN BEHAV IMMUN, V35, P23, DOI 10.1016/j.bbi.2013.07.175; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cawley GC, 2006, IEEE IJCNN, P1661; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Fabri M, 2014, WORLD J RADIOL, V6, P895, DOI 10.4329/wjr.v6.i12.895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Floresco SB, 2003, J NEUROSCI, V23, P3930; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kochunov P, 2017, JAMA PSYCHIAT, V74, P958, DOI 10.1001/jamapsychiatry.2017.2228; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith Katherine, 2012, Nat Rev Neurol, V8, P474, DOI 10.1038/nrneurol.2012.164; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Taylor C, 2003, NY TIMES BK REV, P18; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Vapnik V., 2000, NATURE STAT LEARNING; Wang ZN, 2021, J NEUROTRAUM, V38, P464, DOI 10.1089/neu.2018.6196; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Xu H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00467	61	6	7	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	OCT 15	2020	41	15					4431	4441		10.1002/hbm.25135			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	NR5TL	WOS:000571625800019	32657510	gold, Green Published			2022-02-06	
J	Cusimano, MD; Saarela, O; Hart, K; Zhang, SD; McFaull, SR				Cusimano, Michael D.; Saarela, Olli; Hart, Kirsten; Zhang, Shudong; McFaull, Steven R.			A population-based study of fall-related traumatic brain injury identified in older adults in hospital emergency departments	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; TBI; falls; elderly; trends; hospitalization; emergency	AGE; MORBIDITY	OBJECTIVE The purpose of this study was to examine the population-based trends and factors associated with hospitalization of patients with traumatic brain injury (TBI) treated in the Emergency Department (ED) among those 65 years and older. The implications of these trends for neurosurgery and the broader society are discussed. METHOD With a national, mandatory reporting system of ED visits, the authors used Poisson regression controlling for age and sex to analyze trends in fall related TBI of those aged 65 years and older between 2002 and 2017. RESULTS The overall rate of ED visits for TBI increased by 78% - from 689.51 per 100,000 (95% CI 676.5-702.8) to 1229 per 100,000 (95% CI 1215-1243) between 2002 and 2017. Females consistently experienced higher rates of fall-related TBI than did males. All age groups 65 years and older experienced significant increases in fall-related TBI rate over the study period; however, the highest rates occurred among the oldest individuals (90+ and 85-89 years). The hospital admission rate increased with age and Charlson Comorbidity Index. Males experienced both a higher admission rate and a greater percentage change in admission rate than females. CONCLUSIONS Rates of ED visits for fall-related TBI, hospitalization, and in-ED mortality in those aged 65 years and older are increasing for both sexes. The increasing hospital admission rate is related to more advanced comorbidities, male sex, and increasing age. These findings have significant implications for neurosurgical resources; they emphasize that health professionals should work proactively with patients, families, and caregivers to clarify goals of care, and they also outline the need for more high-level and, preferably, randomized evidence to support outcomes-based decisions. Additionally, the findings highlight the urgent need for improved population-based measures for prevention in not only this age demographic but in younger ones, and the need for changes in the planning of health service delivery and long-term care.	[Cusimano, Michael D.; Hart, Kirsten; Zhang, Shudong] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.; Hart, Kirsten; Zhang, Shudong] Univ Toronto, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.; Saarela, Olli] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McFaull, Steven R.] Publ Hlth Agcy Canada, Ctr Surveillance & Appl Res, Injury Sect, Ottawa, ON, Canada		Cusimano, MD (corresponding author), Unity Hlth Toronto, Toronto, ON, Canada.	injuryprevention@smh.ca			Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946, MOP 123371]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 (M.D.C.), MOP 123371 (M.D.C.), and the Ontario Neurotrauma Foundation (M.D.C.).	Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; [Anonymous], 2012, CIHI DAT QUAL STUD 2; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Canadian Institute of Health Information (CIHI), DAT QUAL STUD EM DEP; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 2010, EXT CAUSINJ MORT MAT; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Faul M, 2010, TRAUMATIC BRAIN INJU; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Hanna A., 2009, POLICY CHRONIC DIS M; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Paganini-Hill A, 2017, AGE AGEING, V46, P951, DOI 10.1093/ageing/afx039; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; World Health Organization, 2016, AG HLTH FACT SHEET 4	21	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2020	49	4							E20	10.3171/2020.7.FOCUS20520			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OG2DX	WOS:000581702500020	33002878	gold			2022-02-06	
J	Gravesteijn, BY; Sewalt, CA; Nieboer, D; Menon, DK; Maas, A; Lecky, F; Klimek, M; Lingsma, HF				Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Nieboer, Daan; Menon, David Krishna; Maas, Andrew; Lecky, Fiona; Klimek, Markus; Lingsma, Hester Floor		CENTER-TBI Collaborators	Tracheal intubation in traumatic brain injury: a multicentre prospective observational study	BRITISH JOURNAL OF ANAESTHESIA			English	Article						effectiveness; Europe; neurological outcome; prehospital; tracheal intubation; traumatic brain injury	PREHOSPITAL ENDOTRACHEAL INTUBATION; POSITIVE-PRESSURE VENTILATION; RAPID-SEQUENCE INTUBATION; DECREASED SURVIVAL; HEAD-INJURY; CENTER-TBI; HYPOTENSION; GUIDELINES; MANAGEMENT; OUTCOMES	Background: We aimed to study the associations between pre- and in-hospital tracheal intubation and outcomes in traumatic brain injury (TBI), and whether the association varied according to injury severity. Methods: Data from the international prospective pan-European cohort study, Collaborative European NeuroTrauma Effectiveness Research for TBI (CENTER-TBI), were used (n=4509). For prehospital intubation, we excluded selfpresenters. For in-hospital intubation, patients whose tracheas were intubated on-scene were excluded. The association between intubation and outcome was analysed with ordinal regression with adjustment for the International Mission for Prognosis and Analysis of Clinical Trials in TBI variables and extracranial injury. We assessed whether the effect of intubation varied by injury severity by testing the added value of an interaction term with likelihood ratio tests. Results: In the prehospital analysis, 890/3736 (24%) patients had their tracheas intubated at scene. In the in-hospital analysis, 460/2930 (16%) patients had their tracheas intubated in the emergency department. There was no adjusted overall effect on functional outcome of prehospital intubation (odds ratio=1.01; 95% confidence interval, 0.79-1.28; P=0.96), and the adjusted overall effect of in-hospital intubation was not significant (odds ratio=0.86; 95% confidence interval, 0.65-1.13; P=0.28). However, prehospital intubation was associated with better functional outcome in patients with higher thorax and abdominal Abbreviated Injury Scale scores (P=0.009 and P=0.02, respectively), whereas inhospital intubation was associated with better outcome in patients with lower Glasgow Coma Scale scores (P=0.01): inhospital intubation was associated with better functional outcome in patients with Glasgow Coma Scale scores of 10 or lower. Conclusion: The benefits and harms of tracheal intubation should be carefully evaluated in patients with TBI to optimise benefit. This study suggests that extracranial injury should influence the decision in the prehospital setting, and level of consciousness in the in-hospital setting.	[Gravesteijn, Benjamin Yael; Klimek, Markus] Erasmus MC, Dept Anaesthesiol, Rotterdam, Netherlands; [Gravesteijn, Benjamin Yael; Sewalt, Charlie Aletta; Nieboer, Daan; Lingsma, Hester Floor] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Menon, David Krishna] Univ Cambridge, Dept Anaesthesiol, Cambridge, England; [Maas, Andrew] Univ Hosp Antwerp, Dept Neurosurg, Antwerp, Belgium; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res ScHARR, Fac Med Dent & Hlth, Emergency Med Res Sheffield EMRiS, Sheffield, S Yorkshire, England		Gravesteijn, BY (corresponding author), Erasmus MC, Dept Anaesthesiol, Rotterdam, Netherlands.; Gravesteijn, BY (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	b.gravesteijn@erasmusmc.nl	Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008; Oresic, Matej/K-7673-2016; Posti, Jussi P./Y-2908-2019; Ledoux, Didier/ABA-8401-2021; Vande Vyvere, Thijs/AAB-5180-2022; Lagares, Alfonso/B-2969-2011; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014; van der Jagt, Mathieu/G-1905-2017	Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Oresic, Matej/0000-0002-2856-9165; Posti, Jussi P./0000-0002-5925-5193; Ledoux, Didier/0000-0002-9314-6564; Vande Vyvere, Thijs/0000-0003-4032-5443; Lagares, Alfonso/0000-0003-3996-0554; Ercole, Ari/0000-0001-8350-8093; Sakowitz, Oliver/0000-0003-3248-6335; Radoi, Andreea/0000-0002-0677-3544; Raj, Rahul/0000-0003-4243-9591; Gratz, Johannes/0000-0001-8717-0544; Sanchez-Porras, Renan/0000-0002-9084-8114; Stewart, William/0000-0003-2199-2582; Rossi, Sandra/0000-0002-9963-8121; Dark, Paul/0000-0003-3309-0164; Parizel, Paul M./0000-0002-0221-2854; Newcombe, Virginia/0000-0001-6044-9035; Gomez, Pedro/0000-0002-4185-5238; Coles, Jonathan/0000-0003-4013-679X; Zeiler, Frederick/0000-0003-1737-0510; van der Naalt, Joukje/0000-0001-9873-2418; Della Corte, Francesco/0000-0003-1736-2318; Kondziella, Daniel/0000-0001-5562-9808; Gravesteijn, Benjamin/0000-0001-8096-5803; van der Jagt, Mathieu/0000-0003-2566-8325; Van Essen, Thomas/0000-0003-4657-5283	European Union 7th Framework Program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	European Union 7th Framework Program (EC Grant 602150). Additional funding from Hannelore Kohl Stiftung (Germany), OneMind (USA), and Integra LifeSciences Corporation (USA). The funders had no role in the study design, enrolment, collection of data, writing, or publication decisions.	Badjatia N, 2006, GUIDELINES PREHOSPIT; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Benjamin E, 2015, J TRAUMA ACUTE CARE, V79, P1030, DOI 10.1097/TA.0000000000000704; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; booksmedicos org, ADV TRAUM LIF SUPP A; BURNEY RG, 1975, ANESTH ANALG, V54, P687; Buuren, 2018, FLEXIBLE IMPUTATION; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cnossen MC, 2016, J NEUROTRAUMA, V14; Davis DP, 2011, PREHOSP EMERG CARE, V15, P18, DOI 10.3109/10903127.2010.514091; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Gravesteijn BY, 2020, ANAESTHESIA, V75, P45, DOI 10.1111/anae.14838; Green RS, 2017, J TRAUMA ACUTE CARE, V83, P569, DOI 10.1097/TA.0000000000001561; GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269; Haltmeier T, 2017, EUR J TRAUMA EMERG S, V43, P731, DOI 10.1007/s00068-016-0718-x; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Pape M, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0589-3; Salomone JP, 2005, J TRAUMA, V59, P1145; Shafi S, 2005, J TRAUMA, V59, P1140, DOI 10.1097/01.ta.0000196434.88182.77; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	39	6	6	4	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	OCT	2020	125	4					505	517		10.1016/j.bja.2020.05.067			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	NT0WX	WOS:000572673400042	32747075	Green Published, hybrid			2022-02-06	
J	Kerezoudis, P; Goyal, A; Puffer, RC; Parney, IF; Meyer, FB; Bydon, M				Kerezoudis, Panagiotis; Goyal, Anshit; Puffer, Ross C.; Parney, Ian F.; Meyer, Fredric B.; Bydon, Mohamad			Morbidity and mortality in elderly patients undergoing evacuation of acute traumatic subdural hematoma	NEUROSURGICAL FOCUS			English	Article						hematoma; trauma; subdural; epidural; craniotomy; elderly	BRAIN-INJURY; DISCHARGE; IMPACT; OLDER; AGE	OBJECTIVE Acute traumatic subdural hematoma (atSDH) can be a life-threatening neurosurgical emergency that necessitates immediate evacuation. The elderly population can be particularly vulnerable to tearing bridging veins. The aim of this study was to evaluate inpatient morbidity and mortality, as well as predictors of inpatient mortality, in a national trauma database. METHODS The authors queried the 2016-2017 National Trauma Data Bank registry for patients aged 65 years and older who had undergone evacuation of atSDH. Patients were categorized into three age groups: 65-74, 75-84, and 85+ years. A multivariable logistic regression model was fitted for inpatient mortality adjusting for age group, sex, race, presenting Glasgow Coma Scale (GCS) category (3-8, 9-12, and 13-15), Injury Severity Score, presence of coagulopathy, presence of additional hemorrhages (epidural hematoma [EN], intraparenchymal hematoma [IPH], and subarachnoid hemorrhage [SAH]), presence of midline shift > 5 mm, and pupillary reactivity (both, one, or none). RESULTS A total of 2508 patients (35% females) were analyzed. Age distribution was as follows: 990 patients at 65-74 years, 1096 at 75-84, and 422 at 85+. Midline shift > 5 mm was present in 72% of cases. With regard to additional hemorrhages, SAH was present in 21%, IPH in 10%, and EDH in 2%. Bilaterally reactive pupils were noted in 90% of patients. A major complication was observed in 14.4% of patients, and the overall mortality rate was 18.3%. In the multivariable analysis, the presenting GCS category was found to be the strongest predictor of postoperative inpatient mortality (3-8 vs 13-15: OR 3.63, 95% CI 2.68-4.92, p < 0.001; 9-12 vs 13-15: OR 2.64, 95% CI 1.79-3.90, p < 0.001; 30% of overall variation), followed by the presence of SAH (OR 2.86, 95% CI 2.21-3.70, p < 0.001; 25% of overall variation) and the presence of midline shift > 5 mm (OR 2.40, 95% CI 1.74-3.32, p < 0.001;11% of overall variation). Model discrimination was excellent (c-index 0.81). Broken down by age decile group, mortality increased from 8.0% to 15.4% for GCS 13-15 to around 36% for GCS 9-12 to almost as high as 60% for GCS 3-8, particularly in those aged 85 years and older. CONCLUSIONS The present results from a national trauma database will, the authors hope, assist surgeons in preoperative discussions with patients and their families with regard to expected postoperative outcomes following surgical evacuation of an atSDH.	[Kerezoudis, Panagiotis; Goyal, Anshit; Puffer, Ross C.; Parney, Ian F.; Meyer, Fredric B.; Bydon, Mohamad] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Kerezoudis, Panagiotis; Goyal, Anshit; Bydon, Mohamad] Mayo Clin, Neuroinformat Lab, Rochester, MN USA		Bydon, M (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	bydon.mohamad@mayo.edu					[Anonymous], TBI DAT STAT; [Anonymous], ANN CALL DAT NAT TRA; Baraniskin A, 2014, J NEUROL SURG PART A, V75, P31, DOI 10.1055/s-0032-1325629; Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249; Duff Diane, 2006, Axone, V27, P9; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Fantus RJ, 2018, BULLETIN; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gordy Stephanie, 2011, Int J Crit Illn Inj Sci, V1, P132, DOI 10.4103/2229-5151.84800; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrell FE Jr, 2017, REGRESSION MODELING; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Puffer RC, 2019, J NEUROSURG, V131, P596, DOI 10.3171/2018.2.JNS173138; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Schupper AJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000306; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417	31	6	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2020	49	4							E22	10.3171/2020.7.FOCUS20439			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OG2DX	WOS:000581702500022	33002870	gold			2022-02-06	
J	Lindsey, HM; Lalani, SJ; Mietchen, J; Gale, SD; Wilde, EA; Faber, J; MacLeod, MC; Hunter, JV; Chu, ZD; Aitken, ME; Ewing-Cobbs, L; Levin, HS				Lindsey, Hannah M.; Lalani, Sanam J.; Mietchen, Jonathan; Gale, Shawn D.; Wilde, Elisabeth A.; Faber, Jessica; MacLeod, Marianne C.; Hunter, Jill V.; Chu, Zili D.; Aitken, Mary E.; Ewing-Cobbs, Linda; Levin, Harvey S.			Acute pediatric traumatic brain injury severity predicts long-term verbal memory performance through suppression by white matter integrity on diffusion tensor imaging	BRAIN IMAGING AND BEHAVIOR			English	Article						Pediatric traumatic brain injury; Diffusion tensor imaging tractography; Fractional anisotropy; Injury severity; Verbal memory	EFFECT-SIZE MEASURES; HEAD-INJURY; CHILDRENS-VERSION; LEARNING-TEST; MEDIATION; MODERATE; COMA; SITUATIONS; PATHWAY; IMPACT	Mediation analysis was used to investigate the role of white matter integrity in the relationship between injury severity and verbal memory performance in participants with chronic pediatric traumatic brain injury (TBI). DTI tractography was used to measure fractional anisotropy (FA) within the corpus callosum, fornix, cingulum bundles, perforant pathways, and uncinate fasciculi. Injury severity was indexed using Glasgow Coma Scale (GCS) scores obtained at the time of the injury. Verbal memory was measured by performance on the long-delay free recall (LDFR) trial of the California Verbal Learning Test-Children's version. Participants were between the ages of 10-18 and included 21 children with TBI (injured before age 9) and 19 typically-developing children (TDC). Children with TBI showed lower FA across all pathways and poorer LDFR performance relative to TDC. Within the TBI group, mediation analysis revealed neither a significant total effect of GCS on LDFR nor significant direct effects of GCS on LDFR across pathways; however, the indirect effects of GCS on LDFR through FA of the corpus callosum, left perforant pathway, and left uncinate fasciculus were significant and opposite in sign to their respective direct effects. These results suggests that the predictive validity of GCS for LDFR is initially suppressed by the substantial variance accounted for by FA, which is uncorrelated with GCS, and the predictive validity of GCS increases only when FA is considered, and the opposing path is controlled. These findings illustrate the complex associations between acute injury severity, white matter pathways, and verbal memory several years following pediatric TBI.	[Lindsey, Hannah M.; Lalani, Sanam J.; Mietchen, Jonathan; Gale, Shawn D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Gale, Shawn D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Lindsey, Hannah M.; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Wilde, Elisabeth A.; Faber, Jessica; MacLeod, Marianne C.; Hunter, Jill V.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Hunter, Jill V.; Chu, Zili D.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Aitken, Mary E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Aitken, Mary E.] Arkansas Childrens Res Inst, Little Rock, AR USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA		Wilde, EA (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.	ewilde@bcm.edu	Lindsey, Hannah M./AAE-1243-2019; Aitken, Mary/ABG-6119-2021	Lindsey, Hannah M./0000-0003-3826-854X; Aitken, Mary/0000-0002-8318-9755; Lalani, Sanam/0000-0001-7429-2892	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS065937]	We wish to express our gratitude to our participants and their family members. The study was funded by the National Institute of Health grant R21 NS065937 ('Trauma to Developing Brain: Model Refinement and Therapeutic Intervention'; Levin, PI and Noble, PI). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Augustinack JC, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/fnhum.2010.000421985, 10.3389/fnhum.2010.00042]; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; CONGER AJ, 1974, EDUC PSYCHOL MEAS, V34, P35, DOI 10.1177/001316447403400105; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; Davis JA, 1985, LOGIC CAUSAL ORDER; de Heus P, 2012, BEHAV RES METHODS, V44, P213, DOI 10.3758/s13428-011-0141-5; Delis D, 1994, MANUAL CALIFORNIA VE; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fairchild AJ, 2009, BEHAV RES METHODS, V41, P486, DOI 10.3758/BRM.41.2.486; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Kalus P, 2006, NEUROIMAGE, V30, P713, DOI 10.1016/j.neuroimage.2005.10.035; Keselman HJ, 2008, PSYCHOL METHODS, V13, P110, DOI 10.1037/1082-989X.13.2.110; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Lajiness-O'Neill R, 2011, APPL NEUROPSYCHOL, V18, P298, DOI 10.1080/09084282.2011.595457; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; Mabbott DJ, 2009, BRAIN RES, V1294, P80, DOI 10.1016/j.brainres.2009.07.046; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Netsch T, 2001, INT C COMP VIS VANC; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Paulhus DL, 2004, MULTIVAR BEHAV RES, V39, P303, DOI 10.1207/s15327906mbr3902_7; Peng CYJ, 2014, J EXP EDUC, V82, P22, DOI 10.1080/00220973.2012.745471; Rogalski EJ, 2009, BEHAV NEUROL, V21, P51, DOI [10.3233/BEN-2009-0235, 10.1155/2009/408037]; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TEASDALE G, 1974, LANCET, V2, P81; Tofighi D, 2011, BEHAV RES METHODS, V43, P692, DOI 10.3758/s13428-011-0076-x; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2015, NEUROPSYCHOLOGICAL R; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2017, J INT NEUROPSYCH SOC, V23, P806, DOI 10.1017/S1355617717000686; Yu QW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00228	66	6	6	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2020	14	5					1626	1637		10.1007/s11682-019-00093-9			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OC9YM	WOS:000579512100030	31134584	Green Accepted			2022-02-06	
J	Martindale, SL; Ord, AS; Rowland, JA				Martindale, Sarah L.; Ord, Anna S.; Rowland, Jared A.			Influence of Blast Exposure on Cognitive Functioning in Combat Veterans	NEUROPSYCHOLOGY			English	Article						blast; veteran; cognition; posttraumatic stress disorder; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; OEF/OIF VETERANS; SLEEP QUALITY; IRAQI FREEDOM; SELF-REPORT; PERFORMANCE; PTSD; ASSOCIATIONS	Objective: We evaluated the contribution of blast-pressure severity to cognitive functioning beyond posttraumatic stress disorder (PTSD) severity and traumatic brain injury (TBI). Method: Post-9/11 veterans (N = 254, 86.22% male) completed the Wechsler Adult Intelligence Scale (WAIS-IV) and Trail Making Test (TMT). The Clinician-Administered PTSD Scale (CAPS-5), Mid-Atlantic MIRECC Assessment of TBI, and the Salisbury Blast Interview evaluated PTSD diagnosis/severity, deployment TBI history/severity, and blast-exposure history/severity, respectively. Results: Veterans with mild deployment TBI had overall significantly lower T scores on the WAIS-IV Verbal Comprehension Index (d = .13), Working Memory Index (d = .30), and Processing Speed Index (d = .25); the Trail Making Test A (TMT-A; d = .50); and the Trail Making Test B (TMT-B; d = .37). Mild deployment TBI was significantly associated with TMT-A (Delta R-2 = .05, p < .001) and TMT-B (Delta R-2 = .03, p = .001) performance. Blast-pressure severity moderated the association between mild deployment TBI and TMT-A (Delta R-2 = .02, p < .039, B = -2.01). Conclusion: Blast-pressure severity exacerbated the effects of mild TBI on a simple attention task, such that participants with TBI had gradual decrements in attention as blast severity increased. Veterans who incur a TBI and are exposed to blasts during deployment may experience persisting difficulties with cognitive functioning as a result of alterations in basic attention abilities.	[Martindale, Sarah L.] WG Bill Hefner VA Healthcare Syst, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Res & Acad Affairs Serv Line, Salisbury, NC 28144 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Ord, Anna S.; Rowland, Jared A.] WG Bill Hefner VA Healthcare Syst, MA MIRECC, Res & Acad Affairs Serv Line, Salisbury, NC 28144 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA		Martindale, SL (corresponding author), WG Bill Ilefncr VA Healthcare Syst, Midatlantic Mental Illness Res Educ & Clin Ctr, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018; Rowland, Jared A./AAN-3030-2021	Martindale, Sarah L/0000-0002-0059-3454; Rowland, Jared A./0000-0002-3655-3411	Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from the Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and the Department of Veterans Affairs CENC Award I01 CX001135. This work was also supported by resources of the W. G. (Bill) Hefner VA Healthcare System, MA-MIRECC, and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment (MIRT). The authors report no conflicts of interest. We thank the veterans and service members who contributed their time and effort to this research. We also thank Mary Peoples, David J. Curry, Christine Sortino, and Alana M. Higgins for their contributions to this project. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. For a comprehensive list of publications from the present study, please contact the corresponding author.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Boone K., 2002, THE B TEST; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Defense and Veterans Brain Injury Center, 2019, DOD NUMB TRAUM BRAIN; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; First M.B., 1996, STRUCTURED CLIN INTE; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Green P., 2004, TEST MANUAL MED SYMP; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hayes, 2018, INTRO MEDIATION MODE; Heaton R. K., 2004, REVISED COMPREHENSIV; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Martindale SL, 2017, REHABIL PSYCHOL, V62, P563, DOI 10.1037/rep0000159; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Martinson SJ, 2019, B ENTOMOL RES, V109, P141, DOI [10.1017/S0007485318000184, 10.1080/02699052.2018.1492741]; Miskey H.M., 2017, CURR TREAT OPTIONS P, V4, P254, DOI [10.1007/s40501-017-0120-2, DOI 10.1007/S40501-017-0120-2]; Nelson N.W., 2015, BRAIN NEUROTRAUMA MO, P451; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Reitan R, 1985, HALSTEAD REITAN NEUR; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Rowland JA, 2020, BRAIN INJURY, V34, P642, DOI 10.1080/02699052.2020.1729418; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Vogt D., 2012, MANUAL DEPLOYMENT RE; Wechsler, 1997, WECHSLER ADULT INTEL; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	59	6	6	1	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2020	34	7					735	743		10.1037/neu0000672			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	OF1GY	WOS:000580966700001	32673000	Bronze, Green Accepted			2022-02-06	
J	Prabhakaran, K; Gogna, S; Lombardo, G; Latifi, R				Prabhakaran, Kartik; Gogna, Shekhar; Lombardo, Gary; Latifi, Rifat			Venous Thromboembolism in Geriatric Trauma Patients-Risk Factors and Associated Outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article							DEEP-VEIN THROMBOSIS; PLASMA; GUIDELINES; FRAILTY; INJURY	Background: Venous thromboembolism (VTE) places elderly trauma patients at a high risk of morbidity. The purpose of this study was to determine the outcomes related to VTE in geriatric trauma patients, as well as to identify risk factors for the development of VTE in this population. We also assessed the impact of the type and timing of VTE prophylaxis, and the type of injuries, on development of VTE in geriatric trauma population. Methods: We performed a 2-year retrospective review from American College of Surgeons-Trauma Quality Improvement Project (ACS-TQIP) databank from 2014 to 2016. A total of 354,272 patients aged 65 y or older who developed VTE after trauma were included in the study. Results: Overall, 354,272 elderly trauma patients with complete records were identified from the year 2014 to 2016, and of this, 4290 (1.1%) patients developed in-hospital VTE. Male gender was more predominant in the VTE group (P < 0.001). Both the ICU length of stay and hospital length of stay (P < 0.001) were higher in the VTE group. Spine injury (P = 0.002), lower extremity injury (P 0.001), age category 75-84 y (P < 0.001), age >= 85 y (P < 0.001), frailty (P < 0.001), severe traumatic brain injury (TBI) (GCS3-8) (P < 0.001), ventilator days (P < 0.001), and transfusion of plasma products in first 24 h of admission (P < 0.001) were independent predictors of developing VTE after trauma in the elderly. Higher injury severity score, TBI, and transfusion of packed red blood cells within 24 h were associated with longer time to initiate VTE prophylaxis. Time to initiate chemical deep vein thrombosis prophylaxis was significantly longer in those patients that developed VTE (3.73 +/- 4.82 d), when compared with those patients without VTE ((1.81 +/- 2.53 d) (P < 0.001). Conclusions: Our study demonstrates that ICU and hospital length of stay were higher in VTE group. Frailty, severe TBI, spine injury, lower extremity injury, longer duration of mechanical ventilation, and transfusion of plasma products in the first 24 h of hospital admission were independent predictors of developing VTE after trauma in elderly. Type and timing of VTE prophylaxis were not significant independent predictors of developing VTE after trauma, while higher injury severity score, TBI, and transfusion of packed red blood cells within 24 h were associated with longer time to initiate VTE prophylaxis. Future multi-institutional prospective studies are warranted to gather more evidence on this topic. (c) 2020 Elsevier Inc. All rights reserved.	[Prabhakaran, Kartik; Gogna, Shekhar; Lombardo, Gary; Latifi, Rifat] New York Med Coll, Westchester Med Ctr, Dept Surg, Sect Trauma & Acute Care Surg, Valhalla, NY 10595 USA		Prabhakaran, K (corresponding author), New York Med Coll, Westchester Med Ctr, Dept Surg, 100 Woods Rd,Taylor Pavil,Off E150, Valhalla, NY 10595 USA.	Kartik.prabhakaran@wmchealth.org		Latifi, Rifat/0000-0003-1091-3682			Aronow WS, 2004, J GERONTOL A-BIOL, V59, P42; Azu MC, 2007, AM SURGEON, V73, P1228; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; U. S. Census Bureau, 2000, US CENS 2000; Van Gent JM, 2017, J TRAUMA ACUTE CARE, V83, P1154, DOI 10.1097/TA.0000000000001652; Velanovich V, 2013, J SURG RES, V183, P104, DOI 10.1016/j.jss.2013.01.021; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Weill-Engerer S, 2004, J AM GERIATR SOC, V52, P1299, DOI 10.1111/j.1532-5415.2004.52359.x; Zander AL, 2015, J TRAUMA ACUTE CARE, V78, P39, DOI 10.1097/TA.0000000000000480; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	17	6	6	2	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2020	254						327	333		10.1016/j.jss.2020.05.008			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	NK5PD	WOS:000566783600006	32521371				2022-02-06	
J	Tan, BT; Jiang, H; Moulson, AJ; Wu, XL; Wang, WC; Liu, J; Plunet, WT; Tetzlaff, W				Tan, Bo-Tao; Jiang, Hui; Moulson, Aaron J.; Wu, Xiao-Liang; Wang, Wen-Chun; Liu, Jie; Plunet, Ward T.; Tetzlaff, Wolfram			Neuroprotective effects of a ketogenic diet in combination with exogenous ketone salts following acute spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						axon; behavior; corticospinal tract; ketogenic diet; ketone supplementation; myelin; neuroprotection; spinal cord injury	BETA-HYDROXYBUTYRATE; FUNCTIONAL RECOVERY; STAIRCASE TEST; BRAIN; RESTRICTION; PERFORMANCE; PLASTICITY; NEURONS	We have previously shown that induction of ketosis by ketogenic diet (KD) conveyed neuroprotection following spinal cord injury in rodent models, however, clinical translation may be limited by the slow raise of ketone levels when applying KD in the acute post-injury period. Thus we investigated the use of exogenous ketone supplementation (ketone sodium, KS) combined with ketogenic diet as a means rapidly inducing a metabolic state of ketosis following spinal cord injury in adult rats. In uninjured rats, ketone levels increased more rapidly than those in rats with KD alone and peaked at higher levels than we previously demonstrated for the KD in models of spinal cord injury. However, ketone levels in KD + KS treated rats with SCI did not exceed the previously observed levels in rats treated with KD alone. We still demonstrated neuroprotective effects of KD + KS treatment that extend our previous neuroprotective observations with KD only. The results showed increased neuronal and axonal sparing in the dorsal corticospinal tract. Also, better performance of forelimb motor abilities were observed on the Montoya staircase (for testing food pellets reaching) at 4 and 6 weeks post-injury and rearing in a cylinder (for testing forelimb usage) at 6 and 8 weeks post-injury. Taken together, the findings of this study add to the growing body of work demonstrating the potential benefits of inducing ketosis following neurotrauma. Ketone salt combined with a ketogenic diet gavage in rats with acute spinal cord injury can rapidly increase ketone body levels in the blood and promote motor function recovery. This study was approved by the Animal Care Committee of the University of British Columbia (protocol No. A14-350) on August 31, 2015.	[Tan, Bo-Tao] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China; [Tan, Bo-Tao; Jiang, Hui; Moulson, Aaron J.; Liu, Jie; Plunet, Ward T.; Tetzlaff, Wolfram] Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Moulson, Aaron J.; Liu, Jie; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Jiang, Hui; Wu, Xiao-Liang] Southern Med Univ, Dept Spinal Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Wen-Chun] Gen Hosp Western Theater Command PLA, Dept Rehabil Med, Chengdu, Sichuan, Peoples R China		Tan, BT (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China.; Tan, BT (corresponding author), Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.	tanbotao@hospital.cqmu.edu.cn	Wu, Xiaoliang/AAD-2444-2021; Tetzlaff, Wolfram/AAY-4430-2020	Wu, Xiaoliang/0000-0001-8643-3840; Tan, Botao/0000-0001-8513-3416	Craig Neilsen Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); China Scholarship CouncilChina Scholarship Council [201508500102]; Blusson Integrated Cure Partnership; Rick Hansen Foundation	This study was supported by the Craig Neilsen Foundation (to WT), and the Canadian Institutes for Health Research (to WT). BTT was supported by the China Scholarship Council (No. 201508500102) and a visiting trainee stipend from the Blusson Integrated Cure Partnership. WT holds the John and Penny Ryan British Columbia Leadership Chair in Spinal Cord Research funded in part by the Rick Hansen Foundation.	Achanta LB, 2017, NEUROCHEM RES, V42, P35, DOI 10.1007/s11064-016-2099-2; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ahuja Christopher S, 2016, F1000Res, V5, DOI 10.12688/f1000research.7586.1; Ari C, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13961; Chen K, 2016, J NEUROTRAUM, V33, P1667, DOI 10.1089/neu.2015.4218; Clarke P, 2012, PROCEEDINGS OF THE ASME POWER CONFERENCE - 2011, VOL 1, P401; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Gomez-Pinilla F, 2011, PM&R, V3, pS111, DOI 10.1016/j.pmrj.2011.03.001; Hayta E, 2018, J CHEM NEUROANAT, V87, P25, DOI 10.1016/j.jchemneu.2017.08.001; Hilton BJ, 2017, NEUROSCI LETT, V652, P3, DOI 10.1016/j.neulet.2016.12.004; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Hilton BJ, 2013, J NEUROTRAUM, V30, P1070, DOI 10.1089/neu.2012.2734; Hug A, 2012, INT REV NEUROBIOL, V106, P173, DOI 10.1016/B978-0-12-407178-0.00008-9; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kesl SL, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0069-y; Koppel SJ, 2018, NEUROCHEM INT, V117, P114, DOI 10.1016/j.neuint.2017.05.019; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Levy RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001903.pub2; Lu Y, 2018, NEUROSCI LETT, V683, P13, DOI 10.1016/j.neulet.2018.06.016; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; McDougall A, 2018, BRAIN INJURY, V32, P416, DOI 10.1080/02699052.2018.1429025; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Murray AJ, 2016, FASEB J, V30, P4021, DOI 10.1096/fj.201600773R; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Nikkhah G, 1998, BEHAV BRAIN RES, V92, P85, DOI 10.1016/S0166-4328(97)00128-9; Offermanns S, 2015, TRENDS MOL MED, V21, P245, DOI 10.1016/j.molmed.2015.02.002; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pilla R., 2018, CANCER, V15, P16; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Plunet WT, 2010, ANN NY ACAD SCI, V1198, pE1, DOI 10.1111/j.1749-6632.2010.05564.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shaafi S, 2016, IRAN J NEUROL, V15, P63; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Simsek T, 2014, TURK J SURG, V30, P153, DOI 10.5152/UCD.2014.2653; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Stubbs BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00848; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang BH, 2018, BRAIN RES, V1678, P106, DOI 10.1016/j.brainres.2017.10.009; Wang XH, 2017, CELL, V171, P440, DOI 10.1016/j.cell.2017.08.014; Winesett SP, 2015, EXPERT REV NEUROTHER, V15, P621, DOI 10.1586/14737175.2015.1044982; Yarar-Fisher Ceren, 2018, Spinal Cord Ser Cases, V4, P88, DOI 10.1038/s41394-018-0121-4; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	54	6	6	0	16	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	OCT	2020	15	10					1912	1919		10.4103/1673-5374.280327			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	LE8AS	WOS:000526946300023	32246640	gold, Green Published			2022-02-06	
J	Funk, JR; Jadischke, R; Bailey, A; Crandall, J; McCarthy, J; Arbogast, K; Myers, B				Funk, James R.; Jadischke, Ron; Bailey, Ann; Crandall, Jeff; McCarthy, Joe; Arbogast, Kristy; Myers, Barry			Laboratory Reconstructions of Concussive Helmet-to-Helmet Impacts in the National Football League	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Brain injury; Crash test dummy; Hybrid III	HUMAN HEAD; INJURY	Seventeen concussive helmet-to-helmet impacts occurring in National Football League (NFL) games were analyzed using video footage and reconstructed by launching helmeted crash test dummies into each other in a laboratory. Helmet motion on-field and in the laboratory was tracked in 3D before, during, and after impact in multiple high frame rate video views. Multiple (3-10) tests were conducted for each of the 17 concussive cases (100 tests total) with slight variations in input conditions. Repeatability was assessed by duplicating one or two tests per case. The accuracy of the input conditions in each reconstruction was assessed based on how well the closing velocity, impact locations, and the path eccentricity of the dummy heads matched the video analysis. The accuracy of the reconstruction output was assessed based on how well the changes in helmet velocity (translational and rotational) from the impact matched the video analysis. The average absolute error in helmet velocity changes was 24% in the first test, 20% in the tests with the most accurate input configuration, and 14% in the tests with minimal error. Coefficients of variation in 22 repeated test conditions (1-2 per case) averaged 3% for closing velocity, 7% for helmet velocity changes, and 8% for peak head accelerations. Iterative testing was helpful in reducing error. A combination of sophisticated video analysis, articulated physical surrogates, and iterative testing was required to reduce the error to within half of the effect size of concussion.	[Funk, James R.; Bailey, Ann; Crandall, Jeff] Biocore LLC, 1627 Quail Run, Charlottesville, VA 22911 USA; [Jadischke, Ron; McCarthy, Joe] McCarthy Engn Inc, 2280 Ambassador Dr, Windsor, ON N9C 4E4, Canada; [Arbogast, Kristy] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Myers, Barry] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Funk, JR (corresponding author), Biocore LLC, 1627 Quail Run, Charlottesville, VA 22911 USA.	jfunk@biocorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. The authors acknowledge McCarthy Engineering Inc. for their technical and equipment support.	Bailey A, ANN BIOMEDICAL UNPUB; Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Baumgartner D, 2005, SOLID MECH APPL, V124, P195; Bonita R, 2006, BASIC EPIDEMIOLOGY, P45; Clark J. M, 2018, INT IRCOBI C; Cournoyer J, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1600004; DiMasi F, 1995, 808282 DOT HS US DEP; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Jadischke R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000362; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; King A. I, 2003, INT IRCOBI C; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Newman J., 1999, INT RES COUNC BIOM I, P17; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Newman KM, 2000, MINN REV, P223; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2014, INT IRCOBI C; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Society of Automotive Engineers, 1995, INSTR IMP TESTS 1; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zanetti K, 2013, INT IRCOBI C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	33	6	6	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2652	2666		10.1007/s10439-020-02632-8		SEP 2020	15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000574063200002	33000448				2022-02-06	
J	Fan, Y; Li, YL; Huang, SL; Xu, HL; Li, H; Liu, BX				Fan, Yue; Li, Yuanlong; Huang, Silin; Xu, Huali; Li, Hui; Liu, Beixing			Resveratrol-primed exosomes strongly promote the recovery of motor function in SCI rats by activating autophagy and inhibiting apoptosis via the PI3K signaling pathway	NEUROSCIENCE LETTERS			English	Article						Spinal cord injury; Microglia; Exosome drug loading; Autophagy; PI3K Signaling pathway; Apoptosis	SPINAL-CORD-INJURY; DELIVERY; RAPAMYCIN; PROTECTS; THERAPY; NEURONS	Spinal cord injury (SCI) is a traumatic condition of the central nervous system (CNS) that can cause paralysis of the limbs. The molecular mechanisms of neural repair following SCI remain unclear and no effective treatment for SCI currently exists, since drugs have difficulty crossing the blood-brain barrier (BBB). The present study aimed to investigate whether exosomes could be used as specific carriers of resveratrol for induction of neuronal autophagy both in vitro and in vivo for the treatment of SCI. The results indicate that exosomes are able to enhance the solubility of resveratrol and enhance penetration of the drug through the BBB, thereby increasing its concentration in the CNS. Exosomes derived from resveratrol-treated primary microglia (Exo + Res) assisted the rehabilitation of paralyzed limbs in rats. Restoration of neural function following SCI was mediated through increased induction of autophagy and inhibition of apoptosis of neurons both in vitro and in vivo via activation of the PI3K signaling pathway. The mechanism of action of Exo + Res may be associated with the PI3K inhibitor 3-methyladenine (3-MA) in primary spinal neurons. The results suggest that Exo + Res are highly effective at crossing the BBB with good stability, suggesting they have potential for enhancing targeted drug delivery and the recovery of neuronal function in SCI therapy, likely associated with the induction of autophagy and inhibition of apoptosis via the PI3K signaling pathway.	[Fan, Yue; Liu, Beixing] China Med Univ, Sch Basic Med, Shenyang, Liaoning, Peoples R China; [Li, Yuanlong; Li, Hui] Jinzhou Med Univ, Dept Orthoped, Affiliated Hosp 1, Jinzhou, Liaoning, Peoples R China; [Fan, Yue; Huang, Silin; Xu, Huali] Southern Med Univ, Shenzhen Hosp, Shenzhen, Peoples R China		Liu, BX (corresponding author), China Med Univ, Sch Basic Med, Shenyang, Liaoning, Peoples R China.; Li, YL (corresponding author), Jinzhou Med Univ, Dept Orthoped, Affiliated Hosp 1, Jinzhou, Liaoning, Peoples R China.	liyuanlong2015@foxmail.com			Bone and Cartilage Regeneration and Repair Professional Committee of the Chinese Shock Wave Medical Professional Committee; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2020A1515010090]	This work was supported by the Bone and Cartilage Regeneration and Repair Professional Committee of the Chinese Shock Wave Medical Professional Committee. Moreover, this word was supported by Natural Science Foundation of Guangdong Province (No: 2020A1515010090). We are very grateful to Professor Xifan Mei from Jinzhou Medical University, China for technical support.	Adamiak M, 2018, MOL THER, V26, P1635, DOI 10.1016/j.ymthe.2018.04.024; Chen S, 2015, MOL CELL BIOL, V35, P406, DOI 10.1128/MCB.01044-14; Cyranoski D, 2019, NATURE, V565, P544, DOI 10.1038/d41586-019-00178-x; Eckert MJ, 2017, SURG CLIN N AM, V97, P1031, DOI 10.1016/j.suc.2017.06.008; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; He ZZ, 2017, ARCH BIOCHEM BIOPHYS, V623, P1, DOI 10.1016/j.abb.2017.01.013; Huang HC, 2016, J MOL NEUROSCI, V58, P416, DOI 10.1007/s12031-015-0672-9; Kalani A, 2017, NEURAL REGEN RES, V12, P205, DOI 10.4103/1673-5374.200799; Kong FQ, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01735-2; Koritzinsky EH, 2017, J CELL PHYSIOL, V232, P1587, DOI 10.1002/jcp.25387; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Li XG, 2019, NEURAL REGEN RES, V14, P721, DOI 10.4103/1673-5374.247476; Li YL, 2019, NEUROCHEM RES, V44, P2007, DOI 10.1007/s11064-019-02838-w; Li YL, 2018, BIOL PHARM BULL, V41, P478, DOI 10.1248/bpb.b17-00768; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; O'Loughlin AJ, 2012, CURR GENE THER, V12, P262, DOI 10.2174/156652312802083594; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Reynolds JL, 2020, J NEUROIMMUNE PHARM, V15, P554, DOI 10.1007/s11481-019-09895-6; Rong YL, 2019, AGING-US, V11, P7723, DOI 10.18632/aging.102283; Rufino-Ramos D, 2017, J CONTROL RELEASE, V262, P247, DOI 10.1016/j.jconrel.2017.07.001; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Wang H, 2019, NANOSCALE, V11, P7481, DOI 10.1039/c9nr01255a; Wang N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00859; Wang P., 2017, CELL MOL NEUROBIOL; Wang ZY, 2017, NEUROSCI LETT, V656, P158, DOI 10.1016/j.neulet.2017.07.036; Warner N, 2017, SPINAL CORD, V55, P307, DOI 10.1038/sc.2016.107; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang HF, 2011, CELL MOL IMMUNOL, V8, P23, DOI 10.1038/cmi.2010.59; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027; Zhu SP, 2020, STEM CELL TRANSL MED, V9, P603, DOI 10.1002/sctm.19-0282	37	6	6	2	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 25	2020	736								135262	10.1016/j.neulet.2020.135262			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS7GQ	WOS:000572426200004	32682847				2022-02-06	
J	Kempuraj, D; Ahmed, ME; Selvakumar, GP; Thangavel, R; Raikwar, SP; Zaheer, SA; Iyer, SS; Govindarajan, R; Chandrasekaran, PN; Burton, C; James, D; Zaheer, A				Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Govindarajan, Raghav; Nattanmai Chandrasekaran, Premkumar; Burton, Casey; James, Donald; Zaheer, Asgar			Acute Traumatic Brain Injury-Induced Neuroinflammatory Response and Neurovascular Disorders in the Brain	NEUROTOXICITY RESEARCH			English	Article						Blood-brain barrier; Neuroinflammation; Tight junction proteins; Traumatic brain injury	MAST-CELLS; BARRIER DISRUPTION; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; MOUSE MODEL; DYSFUNCTION; EXPRESSION; CYTOKINES; PERICYTES; DAMAGE	Acute traumatic brain injury (TBI) leads to neuroinflammation, neurodegeneration, cognitive decline, psychological disorders, increased blood-brain barrier (BBB) permeability, and microvascular damage in the brain. Inflammatory mediators secreted from activated glial cells, neurons, and mast cells are implicated in the pathogenesis of TBI through secondary brain damage. Abnormalities or damage to the neurovascular unit is the indication of secondary injuries in the brain after TBI. However, the precise mechanisms of molecular and ultrastructural neurovascular alterations involved in the pathogenesis of acute TBI are not yet clearly understood. Moreover, currently, there are no precision-targeted effective treatment options to prevent the sequelae of TBI. In this study, mice were subjected to closed head weight-drop-induced acute TBI and evaluated neuroinflammatory and neurovascular alterations in the brain by immunofluorescence staining or quantitation by enzyme-linked immunosorbent assay (ELISA) procedure. Mast cell stabilizer drug cromolyn was administered to inhibit the neuroinflammatory response of TBI. Results indicate decreased level of pericyte marker platelet-derived growth factor receptor-beta (PDGFR-beta) and BBB-associated tight junction proteins junctional adhesion molecule-A (JAM-A) and zonula occludens-1 (ZO-1) in the brains 7 days after weight-drop-induced acute TBI as compared with the brains from sham control mice indicating acute TBI-associated BBB/tight junction protein disruption. Further, the administration of cromolyn drug significantly inhibited acute TBI-associated decrease of PDGFR-beta, JAM-A, and ZO-1 in the brain. These findings suggest that acute TBI causes BBB/tight junction damage and that cromolyn administration could protect this acute TBI-induced brain damage as well as its long-time consequences.	[Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Govindarajan, Raghav; Nattanmai Chandrasekaran, Premkumar; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, 1 Hosp Dr, Columbia, MO 65212 USA; [Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Zaheer, Asgar] Univ Missouri, Sch Med, Ctr Translat Neurosci, 1 Hosp Dr, Columbia, MO 65212 USA; [Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Zaheer, Asgar] US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO USA		Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Dept Neurol, 1 Hosp Dr, Columbia, MO 65212 USA.; Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, 1 Hosp Dr, Columbia, MO 65212 USA.; Kempuraj, D; Zaheer, A (corresponding author), US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	duraisamyk@health.missouri.edu; Zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570	Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048205]; VA Research Career Scientist Award	Research was sponsored by the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-14-2-0034. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Leonard Wood Institute, the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes, notwithstanding any copyright notation hereon. The authors express their gratitude for the Acute Effects of Neurotrauma Consortium in assisting and coordinating the conduct of this project at Fort Leonard Wood. This research was also supported by NIH grant AG048205 and the VA Research Career Scientist Award to Asgar Zaheer.	Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Ahmed ME, 2020, MOL NEUROBIOL, V57, P4438, DOI 10.1007/s12035-020-02040-y; Ahmed ME, 2020, J NEUROTRAUM, V37, P1645, DOI 10.1089/neu.2019.6932; Ahmed ME, 2019, MOL NEUROBIOL, V56, P6964, DOI 10.1007/s12035-019-1544-z; Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Arac A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00126; Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Charkviani M, 2019, EUR J NEUROSCI, V50, P2860, DOI 10.1111/ejn.14390; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Conti P, 2020, J BIOL REG HOMEOS AG, V34, P1623, DOI 10.23812/20-34-4EDIT-65; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Duan LH, 2018, NEURON, V100, P183, DOI 10.1016/j.neuron.2018.08.030; Forsythe P, 2019, TRENDS NEUROSCI, V42, P43, DOI 10.1016/j.tins.2018.09.006; Franza L, 2019, J BIOL REG HOMEOS AG, V33, P1321, DOI 10.23812/Editorial; Gallenga CE, 2019, J BIOL REG HOMEOS AG, V33, P1; Granucci EJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53982-w; Valle-Dorado MG, 2015, NEUROPHARMACOLOGY, V92, P49, DOI 10.1016/j.neuropharm.2014.12.032; He JT, 2020, J ALZHEIMERS DIS, V73, P39, DOI 10.3233/JAD-190764; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Jing Y, 2020, NEUROSCI BULL, V36, P625, DOI 10.1007/s12264-020-00471-0; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kempuraj D, 2020, NEUROSCIENTIST, V26, P134, DOI 10.1177/1073858419848293; Kempuraj D, 2020, NEUROSCIENTIST, V26, P402, DOI 10.1177/1073858420941476; Kempuraj D, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/4243953; Kempuraj D, 2020, CLIN THER, V42, P974, DOI 10.1016/j.clinthera.2020.02.018; Kempuraj D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00054; Kempuraj D, 2018, J ALZHEIMERS DIS, V66, P1117, DOI 10.3233/JAD-180786; Kempuraj D, 2019, MOL NEUROBIOL, V56, P1681, DOI 10.1007/s12035-018-1177-7; Kempuraj D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00703; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Komi DEA, 2020, CLIN REV ALLERG IMMU, V58, P342, DOI 10.1007/s12016-019-08769-2; Kritas SK, 2020, J BIOL REG HOMEOS AG, V34, P9, DOI 10.23812/20-Editorial-Kritas; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Li NN, 2017, BEHAV BRAIN RES, V322, P60, DOI 10.1016/j.bbr.2017.01.006; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mattila OS, 2011, STROKE, V42, P3600, DOI 10.1161/STROKEAHA.111.632224; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKittrick CM, 2015, J CEREBR BLOOD F MET, V35, P638, DOI 10.1038/jcbfm.2014.239; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moretti R, 2016, J NEUROSCI RES, V94, P1546, DOI 10.1002/jnr.23911; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Ocak U, 2019, BRAIN INJURY, V33, P723, DOI 10.1080/02699052.2018.1556807; Rafalski VA, 2018, NEURON, V100, P11, DOI 10.1016/j.neuron.2018.09.033; Raikwar SP, 2021, CELL MOL NEUROBIOL, V41, P1687, DOI 10.1007/s10571-020-00937-9; Raikwar SP, 2019, MOL NEUROBIOL, V56, P378, DOI 10.1007/s12035-018-1068-y; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Segovia-Oropeza M, 2020, J NEUROTRAUM, V37, P2595, DOI 10.1089/neu.2019.6975; Selvakumar GP, 2020, EXP NEUROBIOL, V29, P230, DOI 10.5607/en20017; Selvakumar GP, 2019, MOL NEUROBIOL, V56, P3865, DOI 10.1007/s12035-018-1340-1; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shen J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01133; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Tadepalli SA, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112268; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thangavel R, 2018, J ALZHEIMERS DIS, V61, P553, DOI 10.3233/JAD-170777; Yeung D, 2008, ACTA NEUROPATHOL, V115, P635, DOI 10.1007/s00401-008-0364-4; Zhang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19641-2; Zhang SS, 2016, BEHAV BRAIN RES, V298, P158, DOI 10.1016/j.bbr.2015.11.003; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524; Zysk M, 2019, J ALZHEIMERS DIS, V72, P161, DOI 10.3233/JAD-190572	72	6	6	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	APR	2021	39	2					359	368		10.1007/s12640-020-00288-9		SEP 2020	10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QS7JI	WOS:000571700500001	32955722	Green Published, Bronze			2022-02-06	
J	Reynier, KA; Alshareef, A; Sanchez, EJ; Shedd, DF; Walton, SR; Erdman, NK; Newman, BT; Giudice, JS; Higgins, MJ; Funk, JR; Broshek, DK; Druzgal, TJ; Resch, JE; Panzer, MB				Reynier, Kristen A.; Alshareef, Ahmed; Sanchez, Erin J.; Shedd, Daniel F.; Walton, Samuel R.; Erdman, Nicholas K.; Newman, Benjamin T.; Giudice, J. Sebastian; Higgins, Michael J.; Funk, James R.; Broshek, Donna K.; Druzgal, Thomas J.; Resch, Jacob E.; Panzer, Matthew B.			The Effect of Muscle Activation on Head Kinematics During Non-injurious Head Impacts in Human Subjects	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Muscle activation; Head kinematics; Injury prevention; Volunteer testing	CONCUSSION; FOOTBALL; STRENGTH; RISK; PLAYERS	In this study, twenty volunteers were subjected to three, non-injurious lateral head impacts delivered by a 3.7 kg padded impactor at 2 m/s at varying levels of muscle activation (passive, co-contraction, and unilateral contraction). Electromyography was used to quantify muscle activation conditions, and resulting head kinematics were recorded using a custom-fit instrumented mouthpiece. A multi-modal battery of diagnostic tests (evaluated using neurocognitive, balance, symptomatic, and neuroimaging based assessments) was performed on each subject pre- and post-impact. The passive muscle condition resulted in the largest resultant head linear acceleration (12.1 +/- 1.8 g) and angular velocity (7.3 +/- 0.5 rad/s). Compared to the passive activation, increasing muscle activation decreased both peak resultant linear acceleration and angular velocity in the co-contracted (12.1 +/- 1.5 g, 6.8 +/- 0.7 rad/s) case and significantly decreased in the unilateral contraction (10.7 +/- 1.7 g, 6.5 +/- 0.7 rad/s) case. The duration of angular velocity was decreased with an increase in neck muscle activation. No diagnostic metric showed a statistically or clinically significant alteration between baseline and post-impact assessments, confirming these impacts were non-injurious. This study demonstrated that isometric neck muscle activation prior to impact can reduce resulting head kinematics. This study also provides the data necessary to validate computational models of head impact.	[Reynier, Kristen A.; Alshareef, Ahmed; Shedd, Daniel F.; Giudice, J. Sebastian; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22903 USA; [Sanchez, Erin J.; Funk, James R.] Biocore LLC, Charlottesville, VA USA; [Walton, Samuel R.; Erdman, Nicholas K.; Higgins, Michael J.; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Newman, Benjamin T.; Druzgal, Thomas J.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Broshek, Donna K.] Univ Virginia, Neurocognit Assessment Lab, Charlottesville, VA USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22903 USA.	mpb2q@virginia.edu	Erdman, Nicholas/ABA-4554-2020; Broshek, Donna/ABA-4208-2021	Erdman, Nicholas/0000-0001-8109-7585; Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701	Football Research, Inc. (FRI); University of Virginia Brain Institute	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. The authors acknowledge the support from the University of Virginia Brain Institute.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Burnett A, 2007, J ELECTROMYOGR KINES, V17, P635, DOI 10.1016/j.jelekin.2006.06.003; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Eckersley C., 2017, INT RES COUNCIL BIOM, P685; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fahlstedt M., 2016, P 2016 IRCOBI C INT, P459; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Funk JR, 2015, J APPL BIOMECH, V31, P170, DOI 10.1123/jab.2014-0161; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gordon C.C., 2014, ANTHROPOMETRIC SURVE; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hendler E, 1974, SAE T, V83, P3682; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Lovell MR, 2011, IMMEDIATE POST CONCU; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Randolph C, 2005, J ATHL TRAINING, V40, P139; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Schneider L.W., 1983, ANTHROPOMETRY MOTOR; Stashuk D, 2001, J ELECTROMYOGR KINES, V11, P151, DOI 10.1016/S1050-6411(00)00050-X; Tagliabue P, 2003, NEUROSURGERY, V53, P796, DOI 10.1227/01.NEU.0000083559.68424.3F; Takhounts E.G., 2013, 57TH STAPP CAR CRASH; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Versace J, 1971, REV SEVERITY INDEX; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Walker L.B., 1973, 17 STAPP CAR CRASH C	39	6	6	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2020	48	12					2751	2762		10.1007/s10439-020-02609-7		SEP 2020	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PD4VU	WOS:000569292400003	32929556				2022-02-06	
J	Elbaum, T; Golan, L; Lupu, T; Wagner, M; Braw, Y				Elbaum, Tomer; Golan, Lior; Lupu, Tamar; Wagner, Michael; Braw, Yoram			Establishing supplementary response time validity indicators in the Word Memory Test (WMT) and directions for future research	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Feigned cognitive impairment; malingering; Performance Validity Test (PVT); response time; simulation; validation; Word Memory Test (WMT)	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; RECOGNITION MEMORY; INTRAINDIVIDUAL VARIABILITY; MILD; IMPAIRMENT; BELIEFS; BIAS	Response time (RT) measures in the Word Memory Test (WMT) offer to complement information derived from conventional accuracy measures. The current study aimed to validate the findings of Lupu, Elbaum, Wagner, and Braw in which RT variability was assessed, for the first time, in the WMT. A secondary aim was to suggest directions for the future research of RT measures in Forced-Choice Recognition Memory Performance Validity Tests (FCRM-PVTs). The study utilized a simulation research design, with participants performing the WMT's immediate recognition (IR) subtest (N = 59). Mean RTs and a scale which combines accuracy and RT measures, but not variability in RTs, possessed adequate discrimination capacity. Enhanced discrimination capacity was found after discarding the first items' RTs, though the IR-subtest's accuracy measure still showed superiority as a stand-alone validity indicator. The promise of RT measures may, therefore, lie in their ability to illuminate speed-accuracy tradeoffs among examinees with border-zone accuracy scores in FCRM-PVTs. They should, therefore, be regarded as complementary to conventional accuracy measures.	[Elbaum, Tomer; Golan, Lior; Lupu, Tamar; Braw, Yoram] Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel; [Elbaum, Tomer; Wagner, Michael] Ariel Univ, Dept Ind Engn & Management, Ariel, Israel		Braw, Y (corresponding author), Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel.	yoramb@ariel.ac.il		Elbaum, Tomer/0000-0002-4455-6153			Arnold NR, 2015, PSYCHOL RES-PSYCH FO, V79, P882, DOI 10.1007/s00426-014-0608-y; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Boussahba-Bravard M, 2018, ROUTL RES GEND HIST, P1; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Dutilh G., 2018, PSYCHONOMIC B REV, DOI [10.3758/s13423-017-1417-1422, DOI 10.3758/S13423-017-1417-1422]; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Faust D, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P1, DOI 10.1007/978-1-4614-0442-2_1; Forstmann BU, 2016, ANNU REV PSYCHOL, V67, P641, DOI 10.1146/annurev-psych-122414-033645; Frederick R. I, 2002, DETECTION RESPONSE B; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Gutierrez JM, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P151, DOI 10.1007/978-1-4614-0442-2_4; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Kanser RJ, 2018, The Clinical Neuropsychologist, V33, P1, DOI 10.1080/13854046.2018.1440006; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McGuire C, 2019, ARCH CLIN NEUROPSYCH, V34, P114, DOI 10.1093/arclin/acy012; Rogers R., 2011, RES METHODS FORENSIC, P1; Schmiedek F, 2007, J EXP PSYCHOL GEN, V136, P414, DOI 10.1037/0096-3445.136.3.414; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Suchotzki K, 2017, PSYCHOL BULL, V143, P428, DOI 10.1037/bul0000087; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Walczyk JJ, 2014, NEW IDEAS PSYCHOL, V34, P22, DOI 10.1016/j.newideapsych.2014.03.001	49	6	7	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 2	2020	27	5					403	413		10.1080/23279095.2018.1555161			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NC2YP	WOS:000561082300002	30724595				2022-02-06	
J	Han, Y; He, W; Shi, LL; Wu, H; Pan, D; Huang, HW				Han, Yong; He, Wei; Shi, Liangliang; Wu, He; Pan, Di; Huang, Hongwu			Helmet protective performance via reconstruction of electric two-wheeler rider's head-to-ground impact accidents	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						In-depth accidents reconstruction; head-ground impact; video information; helmet; risk of skull fracture; risk of brain injuries	BICYCLE HELMETS; INJURY RISK; AXONAL INJURY; WHITE-MATTER; KINEMATICS; COLLISIONS; BEHAVIOR; CRITERIA; VEHICLE; MOTION	Numerous studies, including epidemiological, experimental and simulation studies, have shown that helmets can provide good protection for the two-wheeler (TW) rider's head and reduce the casualty rate due to head injuries during an accident. The objective of this current study was to evaluate the protective performance of a helmet based on in-depth accident reconstructions of electric two-wheel (ETW) rider's head-to-ground impact validated by the video information that provide clear and complete kinematics of ETW rider. Furthermore, validated finite element (FE) models of the helmet and human head were used. Three real-world accident cases (Cases A, B and C) were evaluated, in which, the riders' head were injured by ground impact after collided by the vehicles. In Case A and Case B, the helmet could effectively reduce the risk of skull fracture to 46% and 4%, respectively; whereas the risk of a skull fracture was up to 94% in Case C. In addition, the helmet can slightly reduce the risk of DAI injuries to 39% in Case C, while the risk of concussion cannot be reduced in three cases. In the violent impact condition such as in Case C, the bottoming out of the liner foam makes helmet lose effective protection against skull fracture. The connection between the shell and liner foam largely affects the helmet's protection against the brain injuries such as DAIs and concussions. The findings point out the lack of protective performance of the helmet and further provide more comprehensive guidance on the safety design of the helmet.	[Han, Yong; He, Wei; Wu, He; Huang, Hongwu] Xiamen Univ Technol, Dept Vehicle & Traff Engn, Xiamen, Peoples R China; [Han, Yong; He, Wei; Shi, Liangliang; Wu, He; Pan, Di; Huang, Hongwu] Fujian Collaborat Innovat Ctr R&D Coach & Special, Xiamen, Peoples R China; [Shi, Liangliang; Pan, Di; Huang, Hongwu] Xiamen Univ, Xiamen, Peoples R China		Han, Y (corresponding author), Xiamen Univ Technol, Dept Vehicle & Traff Engn, Xiamen, Peoples R China.; Han, Y (corresponding author), Fujian Collaborat Innovat Ctr R&D Coach & Special, Xiamen, Peoples R China.	yonghanxmut@gmail.com					Aare Magnus, 2003, Inj Control Saf Promot, V10, P131, DOI 10.1076/icsp.10.3.131.14556; Aldman B, 1978, IRCOBI C P; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, SAE T, V103, P1708, DOI DOI 10.4271/942215; Bourdet N, 2012, INT J CRASHWORTHINES, V17, P51, DOI 10.1080/13588265.2011.625676; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Deck C, 2017, IRCOBI C P; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; Fahlstedt M, 2014, 3 INT CYCL SAF C ICS; Fahlstedt M, 2016, IRCOBI C P; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Fayon A, 1976, IRCOBI C P; Feist F, 2016, IRCOBI C P; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Fernandes FAO, 2013, IRCOBI C P; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P621, DOI 10.1080/13588265.2011.616078; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; [韩学源 Han Xueyuan], 2012, [汽车工程, Automotive Engineering], V34, P1145; Han Y, 2017, IRCOBI C P; [韩勇 Han Yong], 2018, [汽车安全与节能学报, Journal of Automotive Safety and Energy], V9, P386; Han Y, 2019, INT J CRASHWORTHINES, V24, P211, DOI 10.1080/13588265.2018.1429520; Hering AM, 2000, IRCOBI C P; Holbourn AHS, 1943, LANCET, V2, P438; Ito D, 2014, IRCOBI C P; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Kendall R, 2006, SAE 2006 WORLD C DET; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Q, 2018, GROUND LANDING MECH, DOI [10.4271/2018-01-1044, DOI 10.4271/2018-01-1044]; Maki T, 2001, JSAE REV, V22, P357, DOI 10.1016/S0389-4304(01)00112-6; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mclundie WM, 2007, THESIS; McNally DS, 2013, ACCIDENT ANAL PREV, V60, P15, DOI 10.1016/j.aap.2013.07.011; Medrano N, 2007, 2007 EUROPEAN CONFERENCE ON CIRCUIT THEORY AND DESIGN, VOLS 1-3, P200, DOI 10.1109/ECCTD.2007.4529571; Mertz HJ, 1996, SAE 1996 INT C EXH; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Nie J, 2015, TRAFFIC INJ PREV, V16, P76, DOI 10.1080/15389588.2014.881477; Nie J, 2014, ACCIDENT ANAL PREV, V71, P50, DOI 10.1016/j.aap.2014.04.021; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Ommaya AK, 1967, 11 STAPP CAR CRASH C; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Prasad P, 1985, SAE GOV IND M EXH; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shi LL, 2018, J SAFETY RES, V64, P37, DOI 10.1016/j.jsr.2017.12.004; Simms CK, 2006, INT J CRASHWORTHINES, V11, P345, DOI 10.1533/ijcr.2005.0109; Song Yi, 2009, Journal of South China University of Technology, V37, P140; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; World Health Organization, 2015, GLOB STAT REP ROAD S; Yong Han, 2018, International Journal of Vehicle Safety, V10, P212; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	64	6	6	4	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness	SEP 2	2020	25	5					493	504		10.1080/13588265.2019.1616886			12	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	NN6HB	WOS:000568886100003					2022-02-06	
J	Appelt, J; Baranowsky, A; Jahn, D; Yorgan, T; Kohli, P; Otto, E; Farahani, SK; Graef, F; Fuchs, M; Herrera, A; Amling, M; Schinke, T; Frosch, KH; Duda, GN; Tsitsilonis, S; Keller, J				Appelt, Jessika; Baranowsky, Anke; Jahn, Denise; Yorgan, Timur; Koehli, Paul; Otto, Ellen; Farahani, Saeed Khomeijani; Graef, Frank; Fuchs, Melanie; Herrera, Aaron; Amling, Michael; Schinke, Thorsten; Frosch, Karl-Heinz; Duda, Georg N.; Tsitsilonis, Serafeim; Keller, Johannes			The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing	EBIOMEDICINE			English	Article						Fracture; Bone regeneration; Osteoblasts; Osteoclasts; Neuropeptides; alpha CGRP; CRLR; Olcegepant	TRAUMATIC BRAIN-INJURY; EXTRACEREBRAL CIRCULATION; CGRP; DIFFERENTIATION; OSTEOBLASTS; MIGRAINE; EXPRESSION; PLASMA; FAMILY; RAT	Background: Impaired fracture healing represents an ongoing clinical challenge, as treatment options remain limited. Calcitonin gene-related peptide (CGRP), a neuropeptide targeted by emerging anti-migraine drugs, is also expressed in sensory nerve fibres innervating bone tissue. Method: Bone healing following a femoral osteotomy stabilized with an external fixator was analysed over 21 days in alpha CGRP-deficient and WT mice. Bone regeneration was evaluated by serum analysis, mu CT analysis, histomorphometry and genome-wide expression analysis. Bone-marrow-derived osteoblasts and osteoclasts, as well as the CGRP antagonist olcegepant were employed for mechanistic studies. Findings: WT mice with a femoral fracture display increased CGRP serum levels. alpha CGRP mRNA expression after skeletal injury is exclusively induced in callus tissue, but not in other organs. On protein level, CGRP and its receptor, calcitonin receptor-like receptor (CRLR) complexing with RAMP1, are differentially expressed in the callus during bone regeneration. On the other hand, alpha CGRP-deficient mice display pro-foundly impaired bone regeneration characterised by a striking reduction in the number of bone-forming osteoblasts and a high rate of incomplete callus bridging and non-union. As assessed by genome-wide expression analysis, CGRP induces the expression of specific genes linked to ossification, bone remodeling and adipogenesis. This suggests that CGRP receptor-dependent PPAR gamma signaling plays a central role in fracture healing. Interpretation: This study demonstrates an essential role of alpha CGRP in orchestrating callus formation and identifies CGRP receptor agonism as a potential approach to stimulate bone regeneration. Moreover, as novel agents blocking CGRP or its receptor CRLR are currently introduced clinically for the treatment of migraine disorders, their potential negative impact on bone regeneration warrants clinical investigation. (C) 2020 The Author(s). Published by Elsevier B.V.	[Appelt, Jessika; Jahn, Denise; Koehli, Paul; Otto, Ellen; Graef, Frank; Fuchs, Melanie; Tsitsilonis, Serafeim] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Appelt, Jessika; Jahn, Denise; Farahani, Saeed Khomeijani; Herrera, Aaron; Duda, Georg N.; Tsitsilonis, Serafeim] Charite Univ Med Berlin, Julius Wolff Inst Biomech & Musculoskeletal Regen, D-13353 Berlin, Germany; [Baranowsky, Anke; Frosch, Karl-Heinz; Keller, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Trauma & Orthoped Surg, D-20246 Hamburg, Germany; [Baranowsky, Anke; Yorgan, Timur; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany		Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Trauma & Orthoped Surg, D-20246 Hamburg, Germany.	j.keller@uke.de	; Duda, Georg/H-2085-2016	Otto, Ellen/0000-0001-9394-0066; Kohli, Paul/0000-0001-7473-6553; Graef, Frank/0000-0002-0435-9059; Jahn, Denise/0000-0001-8912-5851; Duda, Georg/0000-0001-7605-3908; Herrera Martin, Aaron Xerach/0000-0002-9780-1562	Else-Kroner-Fresenius-Stiftung [EKFS 2017_A22]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG KE 2179/2-1, TS 303/2-1]; Berlin Institute of Health (BIH)	This study was funded by grants to JK and ST by the Else-Kroner-Fresenius-Stiftung (EKFS 2017_A22), the Deutsche Forschungsgemeinschaft (DFG KE 2179/2-1; TS 303/2-1) and the Berlin Institute of Health (BIH).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aubdool AA, 2017, CIRCULATION, V136, P367, DOI 10.1161/CIRCULATIONAHA.117.028388; Ballica R, 1999, J BONE MINER RES, V14, P1067, DOI 10.1359/jbmr.1999.14.7.1067; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bussiere JL, 2019, REGUL TOXICOL PHARM, V106, P224, DOI 10.1016/j.yrtph.2019.05.013; BUZZI MG, 1991, NEUROPHARMACOLOGY, V30, P1193, DOI 10.1016/0028-3908(91)90165-8; Ceriani CEJ, 2019, HEADACHE, V59, P1597, DOI 10.1111/head.13661; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Deen M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0807-1; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Edvinsson L, 2018, NAT REV NEUROL, V14, P338, DOI 10.1038/s41582-018-0003-1; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Emeson R.B., 1992, ANN NY ACAD SCI, V657, P18; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; ESCOTT KJ, 1995, BRAIN RES, V669, P93, DOI 10.1016/0006-8993(94)01247-F; Finlay DB, 2020, BRIT J PHARMACOL, V177, P1472, DOI 10.1111/bph.14988; GALLAI V, 1995, CEPHALALGIA, V15, P384, DOI 10.1046/j.1468-2982.1995.1505384.x; GOADSBY PJ, 1988, ANN NEUROL, V23, P193, DOI 10.1002/ana.410230214; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Kitase Y, 2014, J DENT RES, V93, P1108, DOI 10.1177/0022034514553008; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Lipton RB, 2019, JAMA-J AM MED ASSOC, V322, P1887, DOI 10.1001/jama.2019.16711; Lu JT, 1999, MOL CELL NEUROSCI, V14, P99, DOI 10.1006/mcne.1999.0767; MACDONALD NJ, 1989, BRIT J CLIN PHARMACO, V28, P257, DOI 10.1111/j.1365-2125.1989.tb05424.x; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Mumme M, 2012, EUR CELLS MATER, V24, P224, DOI 10.22203/eCM.v024a16; Naot D, 2019, PHYSIOL REV, V99, P781, DOI 10.1152/physrev.00066.2017; Neagu TP, 2016, ROM J MORPHOL EMBRYO, V57, P1215; Negishi-Koga T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7637; Niedermair T, 2020, INT J MOL SCI, V21; Nilsson C, 2016, EUR J PHARMACOL, V773, P24, DOI 10.1016/j.ejphar.2016.01.003; Oni O O, 1990, J Orthop Trauma, V4, P441; Onuoha GN, 2001, PEPTIDES, V22, P1107, DOI 10.1016/S0196-9781(01)00434-X; Onuoha GN, 2000, NEUROPEPTIDES, V34, P116, DOI 10.1054/npep.2000.0803; Russow G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010083; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Scott LJ, 2020, DRUGS, V80, P323, DOI 10.1007/s40265-020-01264-5; Seeling M, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.06.26; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Sexton PM, 2008, CRIT CARE MED, V36, P1637, DOI 10.1097/CCM.0b013e318170a554; Sinder BP, 2017, J BONE MINER RES, V32, P2116, DOI 10.1002/jbmr.3196; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Staines KA, 2014, J BONE MINER METAB, V32, P240, DOI 10.1007/s00774-013-0493-2; Tepper SJ, 2018, HEADACHE, V58, P238, DOI 10.1111/head.13379; Tian G, 2013, ACTA PHARMACOL SIN, V34, P1467, DOI 10.1038/aps.2013.41; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9; Wang CC, 2019, AM J PATHOL, V189, P648, DOI 10.1016/j.ajpath.2018.11.019; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; Wang YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03899-z; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Yuan H, 2019, HEADACHE, V59, P20, DOI 10.1111/head.13583; Zhang YF, 2016, NAT MED, V22, P1160, DOI 10.1038/nm.4162; Zhou R, 2016, MOL MED REP, V13, P4689, DOI 10.3892/mmr.2016.5117; Zou R, 2010, ACTA PHARMACOL SIN, V31, P43, DOI 10.1038/aps.2009.174	66	6	7	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	SEP	2020	59								102970	10.1016/j.ebiom.2020.102970			14	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	NX1AN	WOS:000575450100013	32853990	Green Published, gold			2022-02-06	
J	Brett, BL; Zuckerman, SL; Terry, DP; Solomon, GS; Iverson, GL				Brett, Benjamin L.; Zuckerman, Scott L.; Terry, Douglas P.; Solomon, Gary S.; Iverson, Grant L.			Normative Data for the Sway Balance System	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; head injuries; concussion; sports medicine; balance	ERROR SCORING SYSTEM; SPORT-RELATED CONCUSSION; AGE-RELATED DIFFERENCES; POSTURAL-CONTROL; REACTION-TIME; BRAIN-INJURY; CHILDREN; STABILITY; VALUES; PERFORMANCE	Objective: Static balance, postural stability, and reaction time are commonly impaired after a sport-related concussion. The Sway Balance System assesses postural sway (ie, stability) and simple reaction time using the triaxial accelerometer built into iOS mobile devices. The purpose of this study was to provide normative data for children and adolescents and to examine for age and sex differences on the Sway Balance System. Design: Cross-sectional study. Setting: Middle and high schools across the United States. Participants: Participants were 3763 youth aged 9 to 21 years who completed the Sway Balance System Sports protocol in accordance with the company's recommended methods (ie, 1 acclimation trial and 2-3 baseline tests). Independent Variables: Age and sex. Main Outcome Measures: Sway Balance score (0-100) and Sway Reaction Time score (0-100). Statistical Analysis: A multivariate analysis of variance examined the effects of age and sex on balance and reaction time scores. Results: Sway Balance and Reaction Time scores significantly differed by age [F(10, 7494) = 39.68,P< 0.001, V = 0.10,eta(2)(p)= 0.05] and sex [F(4, 7494) = 55.29,P< 0.001, V = 0.06,eta(2)(p)= 0.03]. Post hoc analyses revealed that older groups generally had better scores than younger groups on all balance comparisons (ps < 0.001) and many reaction time comparisons. Girls performed better than boys on balance [F(2, 3747) = 53.79,P< 0.001,eta(2)(p)= 0.03] and boys had faster reaction times [F(2, 3747) = 37.11,P< 0.001,eta(2)(p)= 0.02]. Conclusions: Age and sex are important factors to consider when assessing Balance and Reaction Time scores using the Sway Balance System's Sports protocol in youth. We provide age- and sex-based normative values for the Sway Balance System, which will likely be helpful when using this technology to assess and manage concussions.	[Brett, Benjamin L.; Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Terry, Douglas P.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteen St, Charlestown, MA 02129 USA.	GIVERSON@mgh.harvard.edu			ImPACT Applications, Inc; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc)	G.L. Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injury (mTBI) and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc, CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc). He has received salary support from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. He acknowledges unrestricted philanthropic support from ImPACT Applications, Inc and theMooney-Reed Charitable Foundation. G.S. Solomon has been reimbursed by professional scientific bodies for discussing or presenting research relating to sportrelated concussion at meetings, scientific conferences, and symposiums. He is a consultant for the Nashville Predators, Tennessee Titans, and the athletic departments of Tennessee Tech University and the University of Tennessee, fees paid to institution. He is also a consultant to the National Football League Department of Health and Safety.	Alabdulwahab SS, 2016, J EXERC REHABIL, V12, P182, DOI 10.12965/jer.1632600.300; Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; Anderson SL, 2019, CLIN J SPORT MED, V29, P413, DOI 10.1097/JSM.0000000000000545; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fu ASN, 2005, AM J SPORT MED, V33, P1174, DOI 10.1177/0363546504271976; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Howells BE, 2011, KNEE SURG SPORT TR A, V19, P1168, DOI 10.1007/s00167-011-1444-x; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Keppel G., 1991, DESIGN ANAL RES HDB; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Kiselev S, 2009, J EXP CHILD PSYCHOL, V102, P150, DOI 10.1016/j.jecp.2008.02.002; Ku PX, 2012, J BIOMECH, V45, P1638, DOI 10.1016/j.jbiomech.2012.03.029; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Nuri L, 2013, EUR J SPORT SCI, V13, P431, DOI 10.1080/17461391.2012.738712; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Reynolds E, 2016, APPL NEUROPSYCH-CHIL, V5, P283, DOI 10.1080/21622965.2015.1057637; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	44	6	6	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					458	464		10.1097/JSM.0000000000000632			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300022	30113969				2022-02-06	
J	Clugston, JR; Chrisman, SPD; Houck, ZM; Asken, BM; Boone, JK; Buckley, TA; Hoffman, NL; Schmidt, JD; Kontos, AP; Jaffee, MS; Harmon, KG; Broglio, SP; McCrea, MA; McAllister, TW; Ortega, JD				Clugston, James R.; Chrisman, Sara P. D.; Houck, Zachary M.; Asken, Breton M.; Boone, Jonathan K.; Buckley, Thomas A.; Hoffman, Nicole L.; Schmidt, Julianne D.; Kontos, Anthony P.; Jaffee, Michael S.; Harmon, Kimberly G.; Broglio, Steven P.; McCrea, Michael A.; McAllister, Thomas W.; Ortega, Justus D.			King-Devick Test Time Varies by Testing Modality	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; oculomotor; vision testing; number-naming; saccades	CONCUSSION	Objective: To explore differences in baseline King-Devick Test (KD) completion time between 2 testing modalities: (1) spiral-bound paper cards (cards) and (2) iPad application (iPad). Design: Cross-sectional cohort analysis. Setting: National Collegiate Athlete Association (NCAA) institutions. Participants: Student athletes from 13 women's and 11 men's collegiate sports who completed KD baseline testing as part of their first year in the Concussion Assessment, Research and Education (CARE) Consortium from 2014 to 2016 (n = 2003, 52.2% male). Independent Variables: King-Devick Test modalities; cards or iPad. Main Outcome Measure: Baseline KD completion time (seconds). Results: Mean baseline KD completion time of the iPad modality group [42.8 seconds, 95% confidence interval (CI), 42.1-43.3] was 2.8 seconds (95% CI, 2.1-3.4) greater than the cards group (40.0 seconds, 95% CI, 39.7-40.3) (t(1, 1010.7) = -8.0,P< 0.001, Cohen'sd= 0.41). Conclusions: Baseline KD performance is slower when tested on an iPad than when tested on spiral-bound paper cards. The 2 KD modalities should not be used interchangeably in concussion assessments because differences in the modalities can lead to time differences similar in magnitude to those used to indicate concussion. From a research perspective, modality may influence interpretation and/or synthesis of findings across studies.	[Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL 32611 USA; [Clugston, James R.; Jaffee, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL 32611 USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Div Sports Hlth, Gainesville, FL 32611 USA; [Chrisman, Sara P. D.] Seattle Childrens Res Inst, Seattle, WA USA; [Chrisman, Sara P. D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Houck, Zachary M.; Asken, Breton M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Boone, Jonathan K.] Dept Athlet Training, Natl Football League, Miami Dolphins, Davie, FL USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Hoffman, Nicole L.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Harmon, Kimberly G.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Ortega, Justus D.] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA		Clugston, JR (corresponding author), Univ Florida, Dept Community Hlth & Family Med, Student Hlth Care Ctr, POB 117500, Gainesville, FL 32611 USA.	jayclug@ufl.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Asken, Breton/0000-0001-8419-142X; Chrisman, Sara/0000-0001-5373-7223; Ortega, Justus/0000-0002-9931-5605; Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity, Fort Detrick, MD [21702-5014]; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-142-0151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense forHealth Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-142-0151. Opinions, interpretations, conclusions, and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (DHP funds).	Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, CONCUSSION, V1, P1; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Raynowska J., 2015, ANN SPORTS MED RES, V2, P1051; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938	9	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					E139	E142		10.1097/JSM.0000000000000691			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300006	30358616				2022-02-06	
J	Elbin, RJ; Zuckerman, SL; Sills, AK; Crandall, JR; Lessley, DJ; Solomon, GS				Elbin, Robert J.; Zuckerman, Scott L.; Sills, Allen K.; Crandall, Jeff R.; Lessley, David J.; Solomon, Gary S.			Sensitivity and Specificity of On-Field Visible Signs of Concussion in the National Football League	NEUROSURGERY			English	Article						Sport-related concussion; Football; National Football League; Visible signs; Sensitivity and specificity; Mild traumatic brain injury; American football; Concussion; Sensitivity; Specificity	VIDEO ANALYSIS; NONDISCLOSURE; NHL	BACKGROUND: On-field visible signs (VS) are used to help identify sport-related concussion (SRC) in the National Football League (NFL). However, the predictive utility of a VS checklist for SRC is unknown. OBJECTIVE: To report the frequency, sensitivity, specificity, and predictive value of VS in a cohort of NFL athletes. METHODS: On-field VS ratings from 2 experts who independently reviewed video footage of a cohort of 251 injury plays that resulted in an SRC diagnosis (n = 211) and no diagnosis (n = 40) from the 2017 NFL season were examined. The frequency, sensitivity, specificity, and a receiver operating characteristic (ROC) curve with area under the curve (AUC) were calculated for each VS. RESULTS: Slow to get up (65.9%) and motor incoordination (28.4%) were the most frequent VS in concussed athletes, and slow to get up (60.0%) was the most common VS among nonconcussed athletes. The most sensitive VS was slow to get up (66%); the most specific signs in concussed NFL athletes were blank/vacant look and impact seizure (both 100%). Approximately 26% of concussed NFL players did not exhibit a VS, and the overall sensitivity and specificity for the VS checklist to detect SRC were 73% and 65%, respectively. The VS checklist demonstrated "poor"ability to discriminate between SRC and non-SRC groups (AUC = 0.66). CONCLUSION: In the NFL, the diagnosis of concussion cannot be made from on-field VS alone. The VS checklist is one part of the comprehensive sideline/acute evaluation of concussion, and the diagnosis remains a multimodal clinical decision.	[Elbin, Robert J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR USA; [Zuckerman, Scott L.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Vanderbilt Sports Concuss Ctr, Med Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Med Ctr North T-4224, Nashville, TN 37212 USA; [Sills, Allen K.; Solomon, Gary S.] Natl Football League, Player Hlth & Safety Dept, New York, NY USA; [Crandall, Jeff R.; Lessley, David J.] Biomech Consulting & Res LLC, Charlottesville, VA USA; [Solomon, Gary S.] Vanderbilt Univ, Dept Orthopaed Surg & Rehabil, Med Ctr, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Dept Psychiat & Behav Sci, Med Ctr, Nashville, TN 37212 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vumc.org					Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; NFL. Head Neck and Spine Committee, 2013, NFL HEAD NECK SPIN C; Tape TG, 2019, AREA ROC CURVE; Zuckerman SL, 2020, PHYSICIAN SPORTSMED, V48, P424, DOI 10.1080/00913847.2020.1731379	24	6	6	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2020	87	3					530	537		10.1093/neuros/nyaa072			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HM	WOS:000593120600061	32294198				2022-02-06	
J	Ruban, A; Daya, N; Schneider, ALC; Gottesman, R; Selvin, E; Coresh, J; Lazo, M; Koton, S				Ruban, Angela; Daya, Natalie; Schneider, Andrea L. C.; Gottesman, Rebecca; Selvin, Elizabeth; Coresh, Josef; Lazo, Mariana; Koton, Silvia			Liver Enzymes and Risk of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study	JOURNAL OF STROKE			English	Article						Stroke; Incidence; Liver enzymes; Atherosclerosis Risk in Communities; Gamma-glutamyltransferase; Aspartate aminotransferases; Alanine transaminase	GLUTAMATE-OXALOACETATE TRANSAMINASE; TRANSPEPTIDASE; TRANSFERASE; DISEASE	Background and Purpose Liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT], and gamma-glutamyl transpeptidase [GGT]) are glutamate-regulatory enzymes, and higher glutamate levels correlated with worse prognosis of patients with neurotrauma. However, less is known about the association between liver enzymes and incidence of stroke. We evaluated the association between serum levels of AST, ALT, and GGT and incidence of stroke in the Atherosclerosis Risk in Communities (ARIC) study cohort from 1990 to 1992 through December 31, 2016. Methods We included 12,588 ARIC participants without prevalent stroke and with data on liver enzymes ALT, AST, and GGT at baseline. We used multivariable Cox regression models to examine the associations between liver enzymes levels at baseline and stroke risk (overall, ischemic stroke, and intracerebral hemorrhage [ICH]) through December 31, 2016, adjusting for potential confounders. Results During a median follow-up time of 24.2 years, we observed 1,012 incident strokes (922 ischemic strokes and 90 ICH). In age, sex, and race-center adjusted models, the hazard ratios (HRs; 95% confidence intervals [Cls]) for the highest compared to lowest GGT quartile were 1.94 (95% CI, 1.64 to 2.30) for all incident stroke and 2.01 (95 0 /0 CI, 1.68 to 2.41) for ischemic stroke, with the results supporting a dose-response association (P for linear trend <0.001). Levels of AST were associated with increased risk of ICH, but the association was significant only when comparing the third quartile with the lowest quartile (adjusted HR, 1.82; 95% CI, 1.06 to 3.13). Conclusions Elevated levels of GGT (within normal levels), independent of liver disease, are associated with higher risk of incident stroke overall and ischemic stroke, but not ICH.	[Ruban, Angela; Koton, Silvia] Tel Aviv Univ, Sackler Fac Med, Dept Nursing, Tel Aviv, Israel; [Daya, Natalie; Gottesman, Rebecca; Selvin, Elizabeth; Coresh, Josef; Lazo, Mariana; Koton, Silvia] Johns Hopkins Univ, Dept Epidemiol, Sch Med, Baltimore, MD USA; [Schneider, Andrea L. C.; Gottesman, Rebecca] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Ruban, A (corresponding author), Tel Aviv Univ, Dept Nursing, Steyer Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel.; Ruban, A (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	angellruban@tauex.tau.ac.il	Gottesman, Rebecca/ABA-8468-2020		National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HHSN268201700001I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I, HHSN2682017000021]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL70825]; NIH/NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K24DK106414, R01DK089174]	The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I, HHSN2682017000021). Neurocognitive data is collected by U01 2U01HL096812, 2U01HL096814, 2U01HL096899, 2U01HL096902, 2U01HL096917 from the NIH (NHLBI, NINDS, NIA and NIDCD), and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. Dr. Selvin was supported by NIH/NIDDK K24DK106414 and R01DK089174 grants. Dr. Lazo was supported by NIH/NIDDK grant R01DK089174.	Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Chandra Ankush, 2017, Brain Circ, V3, P66, DOI 10.4103/bc.bc_12_17; da Silva-Candal A, 2018, ANN NEUROL, V84, P260, DOI 10.1002/ana.25286; Dufour DR, 2000, CLIN CHEM, V46, P2027; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Hanigan MH, 2014, ADV CANCER RES, V122, P103, DOI 10.1016/B978-0-12-420117-0.00003-7; Harrell FE Jr, 2017, REGRESSION MODELING; Jousilahti P, 2000, STROKE, V31, P1851, DOI 10.1161/01.STR.31.8.1851; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Kim HC, 2005, STROKE, V36, P1642, DOI 10.1161/01.STR.0000173404.37692.9b; Koga M, 2011, BIOCHEM BIOPH RES CO, V409, P596, DOI 10.1016/j.bbrc.2011.04.087; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Loomba R, 2013, J CLIN EXP HEPATOL, V3, P4, DOI 10.1016/j.jceh.2012.10.004; Ndrepepa G, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.12.27; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Shimizu Y, 2010, STROKE, V41, P385, DOI 10.1161/STROKEAHA.109.569061; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; van der Stel AX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00567; Weikert C, 2013, ATHEROSCLEROSIS, V228, P508, DOI 10.1016/j.atherosclerosis.2013.03.026; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yang W, 2018, ANN NEUROL, V83, P375, DOI 10.1002/ana.25158; Zheng Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003755	29	6	6	1	2	KOREAN STROKE SOC	SEOUL	C/O CHIN-SANG CHUNG, DEPT NEUROL, SAMSUNG MED CTR, SUNGKYUNKWAN UNIV, SCH MED, IRWON-RO, GANGNAM-GU, SEOUL, 135-710, SOUTH KOREA	2287-6391	2287-6405		J STROKE	J. Stroke	SEP	2020	22	3					357	+		10.5853/jos.2020.00290			14	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	NZ8LO	WOS:000577353300008	33053951	Green Published, gold			2022-02-06	
J	Williams, AM; Higgins, GA; Bhatti, UF; Biesterveld, BE; Dekker, SE; Kathawate, RG; Tian, YZ; Wu, ZY; Kemp, MT; Wakam, GK; Liu, BL; Li, YQ; Buller, B; Alam, HB				Williams, Aaron M.; Higgins, Gerald A.; Bhatti, Umar F.; Biesterveld, Ben E.; Dekker, Simone E.; Kathawate, Ranganath G.; Tian, Yuzi; Wu, Zhenyu; Kemp, Michael T.; Wakam, Glenn K.; Liu, Baoling; Li, Yongqing; Buller, Benjamin; Alam, Hasan B.			Early treatment with exosomes following traumatic brain injury and hemorrhagic shock in a swine model promotes transcriptional changes associated with neuroprotection	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Exosomes; mesenchymal stem cell-derived exosomes; neuroprotection; neurogenesis; neuroplasticity; neuroinflammation; traumatic brain injury; swine	VALPROIC ACID; CELLS; NEUROGENESIS; IMPROVEMENT; MODULATION; INTEGRITY; RECOVERY; GROWTH	BACKGROUND We have shown that administration of mesenchymal stem cell-derived exosomes (single dose given within 1 hour) in models of traumatic brain injury (TBI) and hemorrhagic shock is neuroprotective. The precise mechanisms responsible for the neuroprotection are not fully understood. This study was designed to investigate the transcriptomic changes in the brain that are associated with this treatment strategy. METHODS Yorkshire swine (40-45 kg) were subjected to a severe TBI (12-mm cortical impact) and hemorrhagic shock (40% estimated total blood volume). One hour into shock, animals were randomized (n = 5/cohort) to receive either lactated Ringer's (LR; 5 mL) or exosomes suspended in LR (LR + EXO; 1 x 10(13)exosome particles in 5 mL LR). Animals then underwent additional shock (1 hour) followed by normal saline resuscitation. After 6 hours of observation, brain swelling (% increase compared with the uninjured side) and lesion size (mm(3)) were assessed. Periinjured brain tissue was processed for RNA sequencing, analyzed with high through-put RNA sequencing data analysis, and results compared between control and experimental groups. RESULTS Exosome treatment significantly increased (p< 0.005) gene expression associated with neurogenesis, neuronal development, synaptogenesis, and neuroplasticity. It also significantly reduced (p< 0.005) genes associated with stroke, neuroinflammation, neuroepithelial cell proliferation, and nonneuronal cell proliferation contributing to reactive gliosis. Exosome treatment also significantly increased (p< 0.005) the genes that are associated with stability of blood-brain barrier. CONCLUSIONS Administration of a single dose of exosomes induces transcriptomic changes suggestive of neuroprotection. Their use as a treatment for TBI is promising and requires further investigation for human translation.	[Williams, Aaron M.; Bhatti, Umar F.; Biesterveld, Ben E.; Dekker, Simone E.; Kathawate, Ranganath G.; Tian, Yuzi; Wu, Zhenyu; Kemp, Michael T.; Wakam, Glenn K.; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Buller, Benjamin] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctt 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Buller, B (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Rm 3013,2799 W Grand Blvd, Detroit, MI 48202 USA.	bbuller1@hfhs.org; alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021	Kathawate, Ranganath/0000-0002-5090-5188	Massey Foundation TBI Research Grant	This study was supported by the Massey Foundation TBI Research Grant. A.M.W. and G.A.H. designate as co-first authors.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Andersson HC, 2011, NEUROL RES, V33, P614, DOI 10.1179/1743132810Y.0000000020; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8178; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crux S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199359; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Del Rio JA, 2007, CURR PHARM DESIGN, V13, P2485; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Gao WW, 2018, EXP NEUROL, V307, P99, DOI 10.1016/j.expneurol.2018.06.001; Ge XT, 2020, MOL THER, V28, P503, DOI 10.1016/j.ymthe.2019.11.017; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Jiao Y, 2018, J LEUKOCYTE BIOL, V103, P175, DOI 10.1189/jlb.3HI0517-173R; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lu YH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00209; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Varet H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157022; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Williams AM, 2020, J TRAUMA ACUTE CARE; Xian PP, 2019, THERANOSTICS, V9, P5956, DOI 10.7150/thno.33872; Xu HY, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920855; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Yuan XC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00319; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	48	6	6	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2020	89	3					536	543		10.1097/TA.0000000000002815			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NQ7RJ	WOS:000571066500029	32658440				2022-02-06	
J	Seo, JH; Dalal, MS; Calderon, F; Contreras, JE				Seo, Joon Ho; Dalal, Miloni S.; Calderon, Frances; Contreras, Jorge E.			Myeloid Pannexin-1 mediates acute leukocyte infiltration and leads to worse outcomes after brain trauma	JOURNAL OF NEUROINFLAMMATION			English	Article						Blood-brain barrier; Hemichannels; Inflammation; Pannexin; Traumatic brain injury	INFLAMMATORY RESPONSE; INJURY; DEFICIENCY; MICROGLIA; MONOCYTES; DYSFUNCTION; ANTAGONISM; MECHANISMS; CHANNELS; CELLS	Background Neuroinflammation is a major component of secondary damage after traumatic brain injury (TBI). We recently reported that pharmacological inhibition of Pannexin-1 (Panx1) channels markedly reduced the inflammatory response after TBI. Panx1 channels have been shown to be important conduits for adenosine 5 '-triphosphate (ATP) release and are associated with leukocyte infiltration and pyroptosis. Because Panx1 blockers significantly decrease ATP release and migration of activated microglia and other myeloid cells (such as monocyte-derived macrophages and dendritic cells) in vitro, we hypothesized that myeloid Panx1 channels play a specific role in immune cell infiltration promoting tissue damage following TBI. Methods The murine-controlled cortical impact (CCI) model was used on myeloid-specific Panx1 conditional knockout (Cx3cr1-Cre::Panx1(fl/fl)) mice to determine whether myeloid Panx1 mediates neuroinflammation and brain damage. Immune cell infiltration was measured using flow cytometry. Locomotor and memory functions were measured using the rotarod and Barnes maze test, respectively. The levels of biomarkers for tissue damage and blood-brain barrier leakage were measured using western blot and magnetic resonance imaging. Panx1 channel activity was measured with ex vivo dye uptake assays, using flow cytometry and confocal microscopy. Results CCI-injuredCx3cr1-Cre::Panx1(fl/fl)mice showed markedly reduced immune cell infiltration to the brain parenchyma compared withPanx1(fl/fl)mice. As expected, Panx1 dependent activity, assessed by dye uptake, was markedly reduced only in myeloid cells fromCx3cr1-Cre::Panx1(fl/fl)mice. The expression of biomarkers of tissue damage was significantly reduced in the CCI-injuredCx3cr1-Cre::Panx1(fl/fl)mice compared withPanx1(fl/fl)mice. In line with this, magnetic resonance imaging showed reduced blood-brain barrier leakage in CCI-injuredCx3cr1-Cre::Panx1(fl/fl)mice. There was also a significant improvement in motor and memory function inCx3cr1-Cre::Panx1(fl/fl)mice when compared withPanx1(fl/fl)mice within a week post-CCI injury. Conclusion Our data demonstrate that CCI-related outcomes correlate with Panx1 channel function in myeloid cells, indicating that activation of Panx1 channels in myeloid cells is a major contributor to acute brain inflammation following TBI. Importantly, our data indicate myeloid Panx1 channels could serve as an effective therapeutic target to improve outcome after TBI.	[Seo, Joon Ho; Dalal, Miloni S.; Calderon, Frances; Contreras, Jorge E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Med Sci Bldg 1-615,185 S Orange Ave, Newark, NJ 07103 USA		Contreras, JE (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Med Sci Bldg 1-615,185 S Orange Ave, Newark, NJ 07103 USA.	contrejo@njms.rutgers.edu			New Jersey Commission for Brain Injury Research [CBIR19IRG014]	This research was supported by the New Jersey Commission for Brain Injury Research (CBIR19IRG014 to J.E. Contreras).	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Alves M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00193; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Burma NE, 2017, NAT MED, V23, P355, DOI 10.1038/nm.4281; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Flores J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06449-x; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Garg C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1069-9; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Good ME, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96272; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanstein R, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00061; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Meaney David F, 2015, Handb Clin Neurol, V127, P105, DOI 10.1016/B978-0-444-52892-6.00007-6; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mousseau M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9846; Negron-Oyarzo I, 2018, P NATL ACAD SCI USA, V115, P7123, DOI 10.1073/pnas.1720117115; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; RUBIN TG, 2019, J EXP NEUROSCI, V0013; Saez PJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah7107; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Thompson RJ, 2015, J PHYSIOL-LONDON, V593, P3463, DOI 10.1113/jphysiol.2014.282426; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Velasquez S, 2016, J IMMUNOL, V196, P4338, DOI 10.4049/jimmunol.1502440; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Weaver JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42550; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Wu LY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00175; Yu YRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150606; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zhou LQ, 2018, MOL MED REP, V17, P5684, DOI 10.3892/mmr.2018.8624	59	6	6	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	AUG 20	2020	17	1							245	10.1186/s12974-020-01917-y			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	NL0SI	WOS:000567135500002	32819386	Green Submitted, gold, Green Published			2022-02-06	
J	Condon, TM; Sexton, RW; Wells, AJ; To, MS				Condon, Thomas M.; Sexton, Richard W.; Wells, Adam J.; To, Minh-Son			The weakness of fragility index exposed in an analysis of the traumatic brain injury management guidelines: A meta-epidemiological and simulation study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SAMPLE-SIZE; P VALUES; STATISTICAL SIGNIFICANCE; POWER; RISK	Objectives To perform fragility index (FI) analysis on the evidence that forms the basis of the guidelines for the management of severe traumatic brain injury (TBI), and develop a deeper understanding of the pitfalls associated with FI. Design Meta-epidemiological analysis and numerical simulations. Methods The Brain Trauma Foundation guidelines (4(th)edition) for management of severe TBI were used to identify relevant randomised controlled trials (RCTs). FI based on Fisher's exact test and relative risk was performed on eligible RCTs. The relationship between FI, event counts andPvalues was explored by exhaustively considering different combinations of outcomes for studies of total size ranging from 80 to 10000. Sample size calculations were also performed for a range of power, baseline risk and relative risk, to determine the influence of study design on FI. Results FI analysis of the severe TBI management guidelines revealed that most studies were associated with a low FI. In the majority of studies, FI was of a similar magnitude to the number lost to follow-up. The simulations revealed that while FI was inversely related toPvalue, a wide range of FI may be associated with a givenPvalue. FI is also affected by sample size, baseline risk and effect size. Sample size calculations suggest that aside from very high-powered studies, most are likely to yield low FI values in the range typically encountered in the literature. Conclusions Many studies are underpowered and are expected to be associated with a small FI. Furthermore, FI over-simplifies the complex, non-linear relationships between sample size, effect size andPvalue, which hinder comparisons of FI between studies. FI places undue importance on the "significance" ofPvalues and accordingly should only be used sparingly.	[Condon, Thomas M.] Royal Adelaide Hosp, Dept Intens Care Med, Adelaide, SA, Australia; [Sexton, Richard W.] Lyell McEwin Hosp, Dept Emergency Med, Elizabeth Vale, SA, Australia; [Wells, Adam J.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Wells, Adam J.] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA, Australia; [To, Minh-Son] Flinders Med Ctr, Div Surg & Perioperat Med, Bedford Pk, SA, Australia; [To, Minh-Son] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia		To, MS (corresponding author), Flinders Med Ctr, Div Surg & Perioperat Med, Bedford Pk, SA, Australia.; To, MS (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia.	Minh-Son.To@sa.gov.au		To, Minh-Son/0000-0002-8060-6218	Neurosurgical Research Foundation; Abbie Simpson Clinical Fellowship	Author AJW is supported by the Neurosurgical Research Foundation and is the recipient of the Abbie Simpson Clinical Fellowship.	Acuna SA, 2019, JAMA SURG, V154, P674, DOI [10.1001/jamasurg.2019.0568, 10.1001/jamasurg.2019.0567]; Ahmed W, 2016, CRIT CARE MED, V44, pE1142, DOI 10.1097/CCM.0000000000001976; Akobeng AK, 2005, ARCH DIS CHILD, V90, P840, DOI 10.1136/adc.2004.058222; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carter RE, 2017, EUR HEART J, V38, P346, DOI 10.1093/eurheartj/ehw495; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Crans GG, 2008, STAT MED, V27, P3598, DOI 10.1002/sim.3221; Del Paggio JC, 2019, LANCET ONCOL, V20, P1065, DOI 10.1016/S1470-2045(19)30338-9; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Docherty KF, 2017, EUR HEART J, V38, P338, DOI 10.1093/eurheartj/ehw427; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P201, DOI 10.1016/0895-4356(90)90186-S; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jakobsen JC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027092; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Kruse BC, 2017, DIABETES RES CLIN PR, V134, P91, DOI 10.1016/j.diabres.2017.10.007; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Matics TJ, 2017, J CLIN MED, V6, DOI 10.3390/jcm6080079; Mazzinari G, 2018, BRIT J ANAESTH, V120, P935, DOI 10.1016/j.bja.2018.01.012; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Sato K, 2019, J STROKE CEREBROVASC, V28, P1290, DOI 10.1016/j.jstrokecerebrovasdis.2019.01.015; Shen YF, 2019, NEUROSURG REV, V42, P9, DOI 10.1007/s10143-017-0870-8; Shochet LR, 2017, KIDNEY INT, V92, P1469, DOI 10.1016/j.kint.2017.05.011; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Tignanelli CJ, 2019, JAMA SURG, V154, P74, DOI 10.1001/jamasurg.2018.4318; To MS, 2020, J NEUROSURG, V132, P662, DOI 10.3171/2018.8.JNS172897; Nguyen TL, 2017, KIDNEY INT, V92, P1319, DOI 10.1016/j.kint.2017.06.021; Walsh M, 2014, J CLIN EPIDEMIOL, V67, P622, DOI 10.1016/j.jclinepi.2013.10.019; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WOODWARD M, 1992, J ROY STAT SOC D-STA, V41, P185	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2020	15	8							e0237879	10.1371/journal.pone.0237879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NF7CD	WOS:000563451300033	32810192	gold, Green Published			2022-02-06	
J	Tweedie, D; Karnati, HK; Mullins, R; Pick, CG; Hoffer, BJ; Goetzl, EJ; Kapogiannis, D; Greig, NH				Tweedie, David; Karnati, Hanuma Kumar; Mullins, Roger; Pick, Chaim G.; Hoffer, Barry J.; Goetzl, Edward J.; Kapogiannis, Dimitrios; Greig, Nigel H.			Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury	ELIFE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; GROWTH FACTOR-B; CLOSED-HEAD INJURY; C-REACTIVE PROTEIN; UP-REGULATION; CELL-DEATH; COGNITIVE DEFICITS; GENE-EXPRESSION; FRACTALKINE; NEURONS	Traumatic brain injury (TBI) is a serious global health problem, many individuals live with TBI-related neurological dysfunction. A lack of biomarkers of TBI has impeded medication development. To identify new potential biomarkers, we time-dependently evaluated mouse brain tissue and neuronally derived plasma extracellular vesicle proteins in a mild model of TBI with parallels to concussive head injury. Mice (CD-1, 30-40 g) received a sham procedure or 30 g weight-drop and were euthanized 8, 24, 48, 72, 96 hr, 7, 14 and 30 days later. We quantified ipsilateral cortical proteins, many of which differed from sham by 8 hours post-mTBI, particularly GAS-1 and VEGF-B were increased while CXCL16 reduced, 23 proteins changed in 4 or more of the time points. Gene ontology pathways mapped from altered proteins over time related to pathological and physiological processes. Validation of proteins identified in this study may provide utility as treatment response biomarkers.	[Tweedie, David; Karnati, Hanuma Kumar; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Mullins, Roger; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Sylvan Adams Sports Inst, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & SheldonG Adelson Chair & Ctr Biol Add, Tel Aviv, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA USA		Tweedie, D (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	tweedieda@grc.nia.nih.gov	karnati, Hanuma kumar/ABH-8371-2020; Kapogiannis, Dimitrios/AAW-4934-2020; Karnati, Hanuma kumar/V-2002-2019	karnati, Hanuma kumar/0000-0002-1259-6900; Kapogiannis, Dimitrios/0000-0003-2181-3118; Greig, Nigel/0000-0002-3032-1468; Mullins, Roger/0000-0002-0561-4402	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG000944, R56 AG057028]; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases; Ari and Regine Aprijaskis Fund	National Institutes of Health AG000944 Nigel H Greig National Institutes of Health R56 AG057028 Barry J Hoffer Ari and Regine Aprijaskis Fund Chaim G Pick Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases Chaim G Pick The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Bengzon J, 2003, ACTA NEUROCHIR, V145, P667, DOI 10.1007/s00701-003-0083-5; Bry M, 2014, PHYSIOL REV, V94, P779, DOI 10.1152/physrev.00028.2013; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2010, ALL DAT SOURC AR MAI; Cheng Y, 2019, J CELL PHYSIOL, V234, P14377, DOI 10.1002/jcp.28139; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gaetani P, 2013, J NEUROSURG SCI, V57, P55; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goetzl EJ, 2019, FASEB J, V33, P231, DOI 10.1096/fj.201801001; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Golden Nyoman, 2018, Open Access Maced J Med Sci, V6, P2239, DOI 10.3889/oamjms.2018.432; GREIG NH, 1988, J PHARMACOL EXP THER, V245, P574; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Ishikawa K, 1999, J TRAUMA, V46, P999, DOI 10.1097/00005373-199906000-00004; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; KALISS N, 1950, P SOC EXP BIOL MED, V75, P16, DOI 10.3181/00379727-75-18083; Kan AA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-207; Kiddle SJ, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.78; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Korley FK, 2018, J NEUROTRAUM, V36, P182, DOI DOI 10.1089/NEU.2017; Lauro C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00472; Lecca D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104528; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Maiorino C, 2013, GENE THER, V20, P487, DOI 10.1038/gt.2012.58; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mellstrom B, 2002, MOL CELL NEUROSCI, V19, P417, DOI 10.1006/mcne.2001.1092; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Olczak M, 2018, FOLIA NEUROPATHOL, V56, P97, DOI 10.5114/fn.2018.76613; Parolo S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194225; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Rosito M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00193; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shi M, 2016, ALZHEIMERS DEMENT, V12, P1125, DOI 10.1016/j.jalz.2016.04.003; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SONOBE Y, 2016, J BIOL CHEM, V291, P1257, DOI DOI 10.1097/01.WCB.0000134477.38980.38; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Sun XL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0643-2; Sun YJ, 2004, J CEREBR BLOOD F MET, V24, P1146, DOI 10.1097/01.WCB.0000134477.38980.38; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Tarozzo G, 2002, EUR J NEUROSCI, V15, P1663, DOI 10.1046/j.1460-9568.2002.02007.x; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Topcu I, 2013, TURK NEUROSURG, V23, P764, DOI 10.5137/1019-5149.JTN.7749-13.0; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Voyle N, 2015, J ALZHEIMERS DIS, V46, P947, DOI 10.3233/JAD-150020; Wang K, 2016, CELL MOL NEUROBIOL, V36, P603, DOI 10.1007/s10571-015-0241-3; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zarco N, 2012, APOPTOSIS, V17, P627, DOI 10.1007/s10495-011-0696-8; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang Y, 2018, CNS NEUROSCI THER, V24, P64, DOI 10.1111/cns.12774; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524	106	6	7	5	9	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	AUG 17	2020	9								e55827	10.7554/eLife.55827			29	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	NO2SA	WOS:000569333200001	32804078	Green Published, gold			2022-02-06	
J	Wallace, J; Moran, R; Beidler, E; Deitrick, JM; Shina, J; Covassin, T				Wallace, Jessica; Moran, Ryan; Beidler, Erica; McAllister Deitrick, Jamie; Shina, James; Covassin, Tracey			Disparities on Baseline Performance Using Neurocognitive and Oculomotor Clinical Measures of Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						socioeconomic status; race; baseline testing; ImPACT; King-Devick	KING-DEVICK TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TEST-RETEST RELIABILITY; AFRICAN-AMERICAN; ACADEMIC-ACHIEVEMENT; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; WHITE DIFFERENCES; ONLINE VERSION; READING LEVEL	Background: Given the high participation of Black/African American individuals in high school sports, especially high-risk sports for concussion, it is important to note if racial and socioeconomic status (SES) differences exist in baseline performance on clinical measures of concussion. Purpose: To explore the association between race and SES on baseline concussion assessments of neurocognitive performance and oculomotor function in adolescent athletes. Study Design: Cohort study (Diagnosis); Level of evidence, 3. Methods: A total of 564 high school athletes (mean +/- SD age, 15.33 +/- 1.1 years) completed the baseline Immediate Post-Concussion Assessment and Cognitive Test and King-Devick (KD) battery before the start of their competitive season. Race was defined as either White/non-Hispanic or Black/African American. SES status was determined by whether the individual's participating high school was a Title I or non-Title I school. A series of multivariable linear regression analyses were conducted to evaluate the association of computerized neurocognitive test scores (verbal memory, visual memory, motor processing speed, and reaction time), symptom severity scores, and KD scores by race and SES. Results: White/non-Hispanic individuals performed significantly better than Black/African American individuals on verbal memory (P< .01), visual memory (P< .01), visual motor processing speed (P< .01), and reaction time (P< .01) and had a lower symptom score (P< .01). Regarding SES, individuals from non-Title I schools performed better on visual memory (P= .05) and reaction time (P= .02) than individuals from Title I schools. Examination of cumulative KD test reading time revealed that there was no association between race on baseline reading times (P= .12). There was a significant association between cumulative reading time and SES (P= .02). Individuals from non-Title I schools performed significantly faster than individuals from Title I schools on KD test time. Conclusion: Overall, race and SES influence neurocognitive and oculomotor concussion baseline performance in high school athletes. These findings add to the growing literature on the influence of race and SES on neurocognitive and oculomotor function baseline concussion assessments; they highlight the necessity for individualized concussion baseline measurements or race-specific normative reference values.	[Wallace, Jessica; Moran, Ryan; Beidler, Erica; McAllister Deitrick, Jamie; Shina, James; Covassin, Tracey] Youngstown State Univ, Youngstown, OH 44555 USA; [Wallace, Jessica; Moran, Ryan] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane, Tuscaloosa, AL 35487 USA; [Wallace, Jessica] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [McAllister Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Conway, SC USA; [Shina, James] Youngstown State Univ, Youngstown, OH 44555 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu					[Anonymous], 2000, IMM OSTC ASS COGGN T; Bernstein JPK, 2021, APPL NEUROPSYCH-ADUL, V28, P627, DOI 10.1080/23279095.2019.1678159; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Byrd D, 2008, NEUROPSYCHOL REV, V18, P214, DOI 10.1007/s11065-008-9065-y; Castora-Binkley M, 2015, J GERONTOL B-PSYCHOL, V70, P512, DOI 10.1093/geronb/gbt112; CHEN TH, 1994, PERCEPT MOTOR SKILL, V79, P1683, DOI 10.2466/pms.1994.79.3f.1683; COAKLEY Jay, 2007, SPORTS SOC ISSUES CO; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Galetta KM, 2017, ALZ DIS ASSOC DIS, V31, P152, DOI 10.1097/WAD.0000000000000157; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldsmith PA, 2003, SOCIOL SPORT J, V20, P147, DOI 10.1123/ssj.20.2.147; Hollingshed AB., 2011, YALE J SOCIOLOGY, V8, P21; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Kush JC, 1997, ASSESSMENT, V4, P297, DOI 10.1177/107319119700400309; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; PANG Y, 2015, INVEST OPHTH VIS SCI, V56; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Pickett MW, 2012, AM BEHAV SCI, V56, P1581, DOI 10.1177/0002764212458282; Restrepo MA, 2006, LANG SPEECH HEAR SER, V37, P17, DOI 10.1044/0161-1461(2006/003); Rexrode BL, 2021, APPL NEUROPSYCH-CHIL, V10, P234, DOI 10.1080/21622965.2019.1671842; Rosen ML, 2018, NEUROIMAGE, V173, P298, DOI 10.1016/j.neuroimage.2018.02.043; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P921; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; U.S. Census Bureau, QUICKFACTS; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; WATSON BC, 1989, J NEGRO EDUC, V58, P309, DOI 10.2307/2295664; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Zahodne LB, 2017, PSYCHOL AGING, V32, P118, DOI 10.1037/pag0000154; ZUCKERMAN M, 1990, AM PSYCHOL, V45, P1297, DOI 10.1037/0003-066X.45.12.1297; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	49	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2020	48	11					2774	2782	0363546520946753	10.1177/0363546520946753		AUG 2020	9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	NI3RK	WOS:000567133500001	32804545				2022-02-06	
J	Tiernan, S; Meagher, A; O'Sullivan, D; O'Keeffe, E; Kelly, E; Wallace, E; Doherty, CP; Campbell, M; Liu, YZ; Domel, AG				Tiernan, Stephen; Meagher, Aidan; O'Sullivan, David; O'Keeffe, Eoin; Kelly, Eoin; Wallace, Eugene; Doherty, Colin P.; Campbell, Matthew; Liu, Yuzhe; Domel, August G.			Concussion and the severity of head impacts in mixed martial arts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Concussion; mixed martial arts; mild traumatic brain injury; linear acceleration; angular acceleration	PROFESSIONAL FOOTBALL; BRAIN-INJURY; ACCELERATION; PREDICTION; THRESHOLD; PLAYERS; BIOMECHANICS; KINEMATICS; DIRECTION; SYSTEM	Concern about the consequences of head impacts in US football has motivated researchers to investigate and develop instrumentation to measure the severity of these impacts. However, the severity of head impacts in unhelmeted sports is largely unknown as miniaturised sensor technology has only recently made it possible to measure these impacts in vivo. The objective of this study was to measure the linear and angular head accelerations in impacts in mixed martial arts, and correlate these with concussive injuries. Thirteen mixed martial arts fighters were fitted with the Stanford instrumented mouthguard (MiG2.0) participated in this study. The mouthguard recorded linear acceleration and angular velocity in 6 degrees of freedom. Angular acceleration was calculated by differentiation. All events were video recorded, time stamped and reported impacts confirmed. A total of 451 verified head impacts above 10g were recorded during 19 sparring events (n = 298) and 11 competitive events (n = 153). The average resultant linear acceleration was 38.0624.3g while the average resultant angular acceleration was 256761739 rad/s2. The competitive bouts resulted in five concussions being diagnosed by a medical doctor. The average resultant acceleration (of the impact with the highest angular acceleration) in these bouts was 86.7618.7g and 756163438 rad/s2. The average maximum Head Impact Power was 20.6kW in the case of concussion and 7.15kW for the uninjured athletes. In conclusion, the study recorded novel data for sub-concussive and concussive impacts. Events that resulted in a concussion had an average maximum angular acceleration that was 24.7% higher and an average maximum Head Impact Power that was 189% higher than events where there was no injury. The findings are significant in understanding the human tolerance to short-duration, high linear and angular accelerations.	[Tiernan, Stephen; Meagher, Aidan] Technol Univ Dublin, Dublin, Ireland; [O'Sullivan, David] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [O'Sullivan, David; O'Keeffe, Eoin; Campbell, Matthew] Pusan Natl Univ, Div Sports Sci, Busan 46241, South Korea; [Kelly, Eoin; Wallace, Eugene; Doherty, Colin P.] St James Hosp, Hlth Care Ctr, Dept Neurol, Hosp 5, Dublin, Ireland; [Doherty, Colin P.] Trinity Coll Dublin, Acad Unit Neurol, Biomed Sci Inst, Dublin, Ireland; [Liu, Yuzhe; Domel, August G.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		O'Sullivan, D (corresponding author), Pusan Natl Univ, Div Sports Sci, Busan 46241, South Korea.	davidosullivan@pusan.ac.kr		Doherty, Colin/0000-0002-8869-8567; Tiernan, Stephen/0000-0002-0658-7557	Financial Supporting Project of Long-term Overseas Dispatch of PNU's Tenure-track Faculty	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was, in part, supported by the Financial Supporting Project of Long-term Overseas Dispatch of PNU's Tenure-track Faculty.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; Bartsch A, 2013, DEFENSE SECUR SENS, V2013, P8723; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hoshizaki B, 2014, J NEUROL NEUROPHYSIO, V5, P1; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kendall Marshall Post Andrew GM, 2012, INT RES COUNC BIOM I; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mayer AR, 2012, J NEUROTRAUM, V32, P3833; McCrory P, 2017, BRIT J SPORT MED, V51, P699; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McGrew CA, 2019, CURR SPORT MED REP, V18, P20, DOI 10.1249/JSR.0000000000000555; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Newman J. A, 2000, 200001SC16 SAE; Newman KM, 2000, MINN REV, P223; Oeur A, 2014, AM SOC TEST MATER, V1552, P56, DOI 10.1520/STP155220120160; Paris AJ, 2010, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, 2010, P815; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; PELLMAN EJ, 2003, NEUROSURGERY, V53, P796; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shojaati M., 2003, P 3 SWISS TRANSP RES; Siegmund GP, 2015, INT IRCOBI C BIOM IN, P182; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	55	6	6	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	DEC	2020	234	12					1472	1483	0954411920947850	10.1177/0954411920947850		AUG 2020	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	OT0QZ	WOS:000560609800001	32799750	Green Submitted			2022-02-06	
J	Bartnik-Olson, BL; Alger, JR; Babikian, T; Harris, AD; Holshouser, B; Kirov, II; Maudsley, AA; Thompson, PM; Dennis, EL; Tate, DF; Wilde, EA; Lin, A				Bartnik-Olson, Brenda L.; Alger, Jeffry R.; Babikian, Talin; Harris, Ashley D.; Holshouser, Barbara; Kirov, Ivan I.; Maudsley, Andrew A.; Thompson, Paul M.; Dennis, Emily L.; Tate, David F.; Wilde, Elisabeth A.; Lin, Alexander			The clinical utility of proton magnetic resonance spectroscopy in traumatic brain injury: recommendations from the ENIGMA MRS working group	BRAIN IMAGING AND BEHAVIOR			English	Article						Magnetic resonance spectroscopy; Trauma; Brain injury; Concussion	DIFFUSE AXONAL INJURY; MEDIAL TEMPORAL-LOBE; SPORTS-RELATED CONCUSSION; COMMON DATA ELEMENTS; PRIMARY MOTOR CORTEX; ABUSIVE HEAD TRAUMA; ECHO TIME H-1-MRSI; N-ACETYLASPARTATE; METABOLITE CONCENTRATIONS; CORPUS-CALLOSUM	Proton (H-1) magnetic resonance spectroscopy provides a non-invasive and quantitative measure of brain metabolites. Traumatic brain injury impacts cerebral metabolism and a number of research groups have successfully used this technique as a biomarker of injury and/or outcome in both pediatric and adult TBI populations. However, this technique is underutilized, with studies being performed primarily at centers with access to MR research support. In this paper we present a technical introduction to the acquisition and analysis of in vivo(1)H magnetic resonance spectroscopy and review(1)H magnetic resonance spectroscopy findings in different injury populations. In addition, we propose a basic(1)H magnetic resonance spectroscopy data acquisition scheme (Supplemental Information) that can be added to any imaging protocol, regardless of clinical magnetic resonance platform. We outline a number of considerations for study design as a way of encouraging the use of(1)H magnetic resonance spectroscopy in the study of traumatic brain injury, as well as recommendations to improve data harmonization across groups already using this technique.	[Bartnik-Olson, Brenda L.; Holshouser, Barbara] Loma Linda Univ, Dept Radiol, Med Ctr, Loma Linda, CA 92350 USA; [Alger, Jeffry R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Alger, Jeffry R.] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Alger, Jeffry R.] NeuroSpectroScopics LLC, Los Angeles, CA USA; [Alger, Jeffry R.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Babikian, Talin] UCLA, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Babikian, Talin] UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Harris, Ashley D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Harris, Ashley D.] Univ Calgary, Alberta Childrens Hosp, Child & Adolescent Imaging Res Program, Res Inst, Calgary, AB, Canada; [Harris, Ashley D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kirov, Ivan I.] NYU, Bernard & Irene Schwartz Ctr Biomed Imaging, Ctr Adv Imaging Innovat & Res CAI2R, Dept Radiol,Sch Med, New York, NY USA; [Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Thompson, Paul M.; Dennis, Emily L.] USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Keck Sch Med, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Dennis, Emily L.; Tate, David F.; Wilde, Elisabeth A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Dennis, Emily L.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Tate, David F.; Wilde, Elisabeth A.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Lin, Alexander] Harvard Med Sch, Ctr Clin Spect, Brigham & Womens Hosp, Boston, MA 02115 USA		Bartnik-Olson, BL (corresponding author), Loma Linda Univ, Dept Radiol, Med Ctr, Loma Linda, CA 92350 USA.	bbartnik@llu.edu	Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021; Tate, David/G-5166-2011	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009; Kirov, Ivan/0000-0001-5641-8578; Bartnik-Olson, Brenda/0000-0002-1137-9437; Tate, David/0000-0003-0213-1920	Alzheimer's Disease Center at NYU Langone (NIH) [R01NS097494, R21NS112853, P41EB017183, P30AG008051];  [K99NS096116];  [R01EB016064];  [U54 EB020403];  [R01 MH116147];  [R56 AG058854];  [P41 EB015922];  [R01 MH111671];  [R01HD061504];  [W81XWH-15-1-0412];  [U01NS093334-02];  [R01NS100952-01A1]	K99NS096116 to Dr. Dennis. R01NS097494, R21NS112853, P41EB017183, pilot grant funding from the Alzheimer's Disease Center at NYU Langone (NIH award P30AG008051) to Dr. Kirov. R01EB016064 to Dr. Maudsley. U54 EB020403, R01 MH116147, R56 AG058854, P41 EB015922, R01 MH111671 to Dr. Thompson. R01HD061504 to Drs. Dennis, Babikian, and Alger. W81XWH-15-1-0412, U01NS093334-02, R01NS100952-01A1 to Dr. Lin.	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Alessandri B, 1999, ACT NEUR S, V75, P25; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ashwal S, 1997, ANN NEUROL, V41, P470, DOI 10.1002/ana.410410410; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bai Xue, 2017, Open J Radiol, V7, P35, DOI 10.4236/ojrad.2017.71004; Baker EH, 2008, J MAGN RESON IMAGING, V27, P489, DOI 10.1002/jmri.21285; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Barker P. B., 2010, CLIN MR SPECTROSCOPY; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Bednarik P, 2015, NMR BIOMED, V28, P685, DOI 10.1002/nbm.3309; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brown S, 2003, J NEUROPSYCH CLIN N, V15, P367, DOI 10.1176/appi.neuropsych.15.3.367; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cady EB, 1996, MAGN RESON MED, V36, P878, DOI 10.1002/mrm.1910360610; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Clark JF, 2006, MED HYPOTHESES, V67, P506, DOI 10.1016/j.mehy.2006.02.047; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Davitz MS, 2019, J MAGN RESON IMAGING, V50, P1424, DOI 10.1002/jmri.26718; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Deelchand DK, 2018, MAGN RESON MED, V79, P1241, DOI 10.1002/mrm.26788; Dennis E. L, 2019, BRAIN IMAGING BEHAV; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Duhaime AC, 2012, J NEUROTRAUM, V29, P629, DOI 10.1089/neu.2011.1927; Ebel A, 2003, MAGNET RESON MED, V49, P903, DOI 10.1002/mrm.10444; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Eylers VV, 2016, AM J NEURORADIOL, V37, P447, DOI 10.3174/ajnr.A4557; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; FRAHM J, 1989, MAGNET RESON MED, V11, P47, DOI 10.1002/mrm.1910110105; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 2017, NEUROLOGY, V89, P2151, DOI 10.1212/WNL.0000000000004666; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gasparovic C, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3914; Gasparovic C, 2011, MAGN RESON MED, V66, P324, DOI 10.1002/mrm.22858; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Goryawala MZ, 2018, MAGN RESON MED, V79, P2886, DOI 10.1002/mrm.26991; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hahnemann ML, 2015, EUR RADIOL, V25, P299, DOI 10.1007/s00330-014-3443-z; Hangel G, 2018, NEUROIMAGE, V168, P199, DOI 10.1016/j.neuroimage.2016.10.043; Harris AD, 2017, MAGN RESON MED, V77, P1377, DOI 10.1002/mrm.26619; Harris AD, 2015, J MAGN RESON IMAGING, V42, P1431, DOI 10.1002/jmri.24903; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hetherington HP, 1996, MAGNET RESON MED, V36, P21, DOI 10.1002/mrm.1910360106; Hoch SE, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3710; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Huppi P S, 2001, Semin Neonatol, V6, P195, DOI 10.1053/siny.2001.0039; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jaboski M, 2017, BMC BIOINFORMATICS, V18, P1; Jacob R, 2016, AM J NEURORADIOL, V37, P1944, DOI 10.3174/ajnr.A4817; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kimbrell T, 2005, PSYCHIAT RES-NEUROIM, V140, P91, DOI 10.1016/j.pscychresns.2005.07.001; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Kirov II, 2018, NEUROIMAG CLIN N AM, V28, P91, DOI 10.1016/j.nic.2017.09.007; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kontos AP, 2017, MIL MED, V182, P99, DOI 10.7205/MILMED-D-16-00177; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kyathanahally SP, 2018, MAGN RESON MED, V80, P851, DOI 10.1002/mrm.27096; Lam F, 2016, MAGN RESON MED, V76, P1059, DOI [10.1002/mrm.26460, 10.1002/mrm.26019]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence TP, 2019, BRAIN INJURY, V33, P854, DOI 10.1080/02699052.2019.1584332; Lefebvre G, 2018, J NEUROTRAUM, V35, P953, DOI 10.1089/neu.2017.5254; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Louis A, 2017, NEW HISP CULTUR LIT, P1; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mandl RC, 2012, HUM BRAIN MAPP, V33, P1503, DOI 10.1002/hbm.21302; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mariano L. J., 2017, 2017 IEEE APPL IM PA, P1; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2017, J NEUROIMAGING, V27, P562, DOI 10.1111/jon.12463; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean MA, 2000, MAGNET RESON MED, V44, P401, DOI 10.1002/1522-2594(200009)44:3<401::AID-MRM10>3.0.CO;2-W; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyer EJ, 2016, AM J NEURORADIOL, V37, P2273, DOI 10.3174/ajnr.A4886; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Panigrahy A, 2010, PEDIATR RADIOL, V40, P3, DOI 10.1007/s00247-009-1450-z; Parry L, 2004, CHILD NEUROPSYCHOL, V10, P248, DOI 10.1080/09297040490909279; Pfeiffer H, 2018, ARCH DIS CHILD, V103, P776, DOI 10.1136/archdischild-2017-313748; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Sabati M, 2015, MAGN RESON MED, V74, P1209, DOI 10.1002/mrm.25510; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Scheenen TWJ, 2008, MAGN RESON MED, V59, P1, DOI 10.1002/mrm.21302; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; SHANKAR RV, 2019, BIOMEDICINE, V32, DOI DOI 10.1002/NBM.4046; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Signoretti S, 2002, ACT NEUR S, V81, P373; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Spurny B, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00028; Srivastava A, 2017, I CONF VLSI DESIGN, P175, DOI 10.1109/VLSID.2017.18; StarLack J, 1997, MAGN RESON MED, V38, P311, DOI 10.1002/mrm.1910380222; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Su E., 2015, TRANSLATIONAL RES TR; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Terpstra M, 2016, MAGN RESON MED, V76, P1083, DOI 10.1002/mrm.26022; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Tomiyasu M, 2016, MAGN RESON IMAGING, V34, P1269, DOI 10.1016/j.mri.2016.07.006; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Wijnen JR, 2010, J MAGN RESON IMAGING, V31, P61, DOI 10.1002/jmri.21999; Wilson M, 2019, MAGN RESON MED, V82, P527, DOI 10.1002/mrm.27742; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Yahya A, 2007, J MAGN RESON, V188, P111, DOI 10.1016/j.jmr.2007.06.009; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Young K, 1998, MAGNET RESON MED, V40, P812, DOI 10.1002/mrm.1910400605	176	6	6	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					504	525		10.1007/s11682-020-00330-6		AUG 2020	22	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK3RJ	WOS:000559706400002	32797399	Green Accepted			2022-02-06	
J	Camara-Costa, H; Francillette, L; Opatowski, M; Toure, H; Brugel, D; Laurent-Vannier, A; Meyer, P; Dellatolas, G; Watier, L; Chevignard, M				Camara-Costa, Hugo; Francillette, Leila; Opatowski, Marion; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Meyer, Philippe; Dellatolas, Georges; Watier, Laurence; Chevignard, Mathilde			Participation seven years after severe childhood traumatic brain injury*	DISABILITY AND REHABILITATION			English	Article						Participation; severe traumatic brain injury; outcome; child; prospective cohort study	MULTIDIMENSIONAL FATIGUE SCALE; GLASGOW OUTCOME SCALE; GENERIC CORE SCALES; ADOLESCENT SCALE; CHILDRENS PARTICIPATION; PSYCHOMETRIC PROPERTIES; EXECUTIVE FUNCTION; SOCIAL COMPETENCE; PEDSQL(TM); RELIABILITY	Purpose: Participation in home, school and community activities is considered as the ultimate aim of rehabilitation. The aims of this study were to examine participation seven years post-severe childhood traumatic brain injury and factors associated with participation. Materials and methods: Participants were enrolled in theTraumatisme Grave de l'Enfant(Severe Childhood Injury) cohort study following severe accidental childhood traumatic brain injury. Participation seven years post-injury, was examined using parent- and self-report forms of the Child and Adolescent Scale of Participation among 37 patients [62% males, mean age 15.4 years (SD = 4.4), mean length of coma 6.68 days (SD = 4.96)] and 33 matched controls. Results: Parent reports indicated significantly lower participation among patients compared to controls, but the self-reports did not. In the traumatic brain injury group, parent-reported participation was variable, with 22% of the patients clearly showing greater restrictions than controls. Participation restrictions were significantly associated with injury severity, poor functional outcome one-year post-injury, executive and behavioral difficulties and higher fatigue levels seven years post-injury, but not with pre-injury nor family factors. Conclusions: Several years after severe childhood traumatic brain injury, participation appears to depend more on injury-related factors than on environmental factors. In self-reports assessments of participation, it could be difficult for children and adolescents to distinguish capacity from performance.	[Camara-Costa, Hugo; Dellatolas, Georges] Paris Saclay Univ, Paris Sud Univ, INSERM, CESP,UVSQ, Paris, France; [Camara-Costa, Hugo; Francillette, Leila; Chevignard, Mathilde] Sorbonne Univ, Lab Biomed Imaging LIB, Paris, France; [Opatowski, Marion; Watier, Laurence] Univ Paris Saclay, Inst Pasteur, Dept Biostat Biomath Pharmacoepidemiol & Infect D, INSERM,UVSQ, Paris, France; [Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Meyer, Philippe] Hop Necker Enfants Malad, Dept Paediat Anesthesiol, Paris, France; [Meyer, Philippe] Paris 5 Univ, Fac Med Rene Descartes, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, Clin Res Grp Cognit Handicap & Rehabil HanCRe, Paris, France		Camara-Costa, H (corresponding author), Univ Paris Saclay, Univ Paris SUD, UVSQ, CESP,INSERM,CESP INSERM U1018, 97 Blvd Port Royal, F-75014 Paris, France.	hugocamaracosta@gmail.com	Dellatolas, Georges/AAW-1377-2021; WATIER, Laurence/K-8213-2013	Camara-Costa, Hugo/0000-0002-3739-7190; WATIER, Laurence/0000-0002-4057-1102; Meyer, Philippe G/0000-0002-3829-6631			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2011, ARCH PHYS MED REHAB, V92, P765, DOI 10.1016/j.apmr.2010.12.029; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chamberon M, DISABIL REHABIL; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coster W, 2008, DISABIL REHABIL, V30, P639, DOI 10.1080/09638280701400375; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Gioia GA IP, 2000, BEHAV RATING INVENTO; Golos A, 2018, DEV NEUROREHABIL, V21, P431, DOI 10.1080/17518423.2017.1342711; Golos A, 2016, NEUROREHABILITATION, V38, P311, DOI 10.3233/NRE-161322; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hung AH, 2017, J DEV BEHAV PEDIATR, V38, P49, DOI 10.1097/DBP.0000000000000366; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Kapapa T, 2010, J CHILD NEUROL, V25, P409, DOI 10.1177/0883073809340697; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Lantagne A, 2018, J PEDIATR PSYCHOL, V43, P703, DOI 10.1093/jpepsy/jsy020; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McConachie H, 2006, DISABIL REHABIL, V28, P1157, DOI 10.1080/09638280500534507; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; Meadows EA, 2017, J INT NEUROPSYCH SOC, V23, P451, DOI 10.1017/S1355617717000352; Morris C, 2009, DEV MED CHILD NEUROL, V51, P92, DOI 10.1111/j.1469-8749.2008.03248.x; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Roth RM, 2015, ADAPTATION FRANCAISE; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Speranza M, 2012, CAN J PSYCHIAT, V57, P570, DOI 10.1177/070674371205700908; Statistical Analysis Software Institute Inc, 2004, SAS STAT 9 1 US GUID; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Thompson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157951; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2009, J HEALTH PSYCHOL, V14, P611, DOI 10.1177/1359105309103580; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2011, ECHELLE INTELLIGENCE, V4th ed.; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	77	6	6	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2402	2411		10.1080/09638288.2019.1594398			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000562793500003	30950661	Green Submitted			2022-02-06	
J	Pu, HJ; Zheng, X; Jiang, XY; Mu, HF; Xu, F; Zhu, W; Ye, Q; Jizhang, Y; Hitchens, TK; Shi, YJ; Hu, XM; Leak, RK; Dixon, CE; Bennett, MVL; Chen, J				Pu, Hongjian; Zheng, Xuan; Jiang, Xiaoyan; Mu, Hongfeng; Xu, Fei; Zhu, Wen; Ye, Qing; Jizhang, Yunneng; Hitchens, T. Kevin; Shi, Yejie; Hu, Xiaoming; Leak, Rehana K.; Dixon, C. Edward; Bennett, Michael V. L.; Chen, Jun			Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPAR gamma	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Traumatic brain injury; white matter injury; integrity; OPC differentiation; oligodendrogenesis; PPAR gamma	COGNITIVE IMPAIRMENT; GENE-EXPRESSION; IL-4; DIFFERENTIATION; ROSIGLITAZONE; INHIBITION; LINEAGE; MYELIN; DAMAGE; POLARIZATION	Long-term neurological recovery after severe traumatic brain injury (TBI) is strongly linked to the repair and functional restoration of injured white matter. Emerging evidence suggests that the anti-inflammatory cytokine interleukin-4 (IL-4) plays an important role in promoting white matter integrity after cerebral ischemic injury. Here, we report that delayed intranasal delivery of nanoparticle-packed IL-4 boosted sensorimotor neurological recovery in a murine model of controlled cortical impact, as assessed by a battery of neurobehavioral tests for up to five weeks. Post-injury IL-4 treatment failed to reduce macroscopic brain lesions after TBI, but preserved the structural and functional integrity of white matter, at least in part through oligodendrogenesis. IL-4 directly facilitated the differentiation of oligodendrocyte progenitor cells (OPCs) into mature myelin-producing oligodendrocytes in primary cultures, an effect that was attenuated by selective PPAR gamma inhibition. IL-4 treatment after TBI in vivo also failed to stimulate oligodendrogenesis or improve white matter integrity in OPC-specific PPAR gamma conditional knockout (cKO) mice. Accordingly, IL-4-afforded improvements in sensorimotor neurological recovery after TBI were markedly impaired in the PPAR gamma cKO mice compared to wildtype controls. These results support IL-4 as a potential novel neurorestorative therapy to improve white matter functionality and mitigate the long-term neurological consequences of TBI.	[Pu, Hongjian; Jiang, Xiaoyan; Xu, Fei; Ye, Qing; Shi, Yejie; Hu, Xiaoming; Dixon, C. Edward; Chen, Jun] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Pu, Hongjian; Zheng, Xuan; Jiang, Xiaoyan; Mu, Hongfeng; Xu, Fei; Zhu, Wen; Ye, Qing; Jizhang, Yunneng; Shi, Yejie; Hu, Xiaoming; Chen, Jun] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15213 USA; [Pu, Hongjian; Zheng, Xuan; Jiang, Xiaoyan; Mu, Hongfeng; Xu, Fei; Zhu, Wen; Ye, Qing; Jizhang, Yunneng; Shi, Yejie; Hu, Xiaoming; Chen, Jun] Univ Pittsburgh, Dept Neurol, 3500 Terrace St,S-507 BST, Pittsburgh, PA 15213 USA; [Hitchens, T. Kevin] Univ Pittsburgh, Anim Imaging Ctr, Sch Med, Pittsburgh, PA 15213 USA; [Hitchens, T. Kevin] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Leak, Rehana K.] Duquesne Univ, Sch Pharm, Grad Sch Pharmaceut Sci, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Bennett, Michael V. L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Chen, J (corresponding author), Univ Pittsburgh, Dept Neurol, 3500 Terrace St,S-507 BST, Pittsburgh, PA 15213 USA.	chenj2@upmc.edu	Leak, Rehana K/I-2607-2019; Shi, Yejie/E-5645-2015	Leak, Rehana K/0000-0003-2817-7417; Shi, Yejie/0000-0001-7502-9201; Mu, Hongfeng/0000-0003-4444-9590	US Department of Veterans Affairs (VA)US Department of Veterans Affairs [I01 BX003377]; American Heart AssociationAmerican Heart Association [17POST33661207]; Senior Research Career Scientist Award from the Department of Veterans AffairsUS Department of Veterans Affairs	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Merit Review grants from the US Department of Veterans Affairs (VA) (I01 BX003377) to JC; H.P. was supported by the American Heart Association Grant 17POST33661207. J.C. is the Richard King Mellon Professor of Neurology at the University of Pittsburgh and also supported by the Senior Research Career Scientist Award from the Department of Veterans Affairs. We thank Lesley M. Foley for technical assistance with MRI experiments and Patricia Strickler for administrative support.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alshweiat A, 2019, CURR MED CHEM, V26, P6459, DOI 10.2174/0929867326666190827151741; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bernardo A, 2017, BBA-MOL CELL BIOL L, V1862, P1013, DOI 10.1016/j.bbalip.2017.06.014; Bernardo A, 2013, BIOL CHEM, V394, P1607, DOI 10.1515/hsz-2013-0152; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; CHAO CC, 1993, J IMMUNOL, V151, P1473; Dai XJ, 2020, J CEREBR BLOOD F MET, V40, P639, DOI 10.1177/0271678X19830791; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Falcone M, 1998, J IMMUNOL, V160, P4822; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jiang XY, 2019, NEUROBIOL DIS, V126, P62, DOI 10.1016/j.nbd.2018.09.012; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kato M, 2002, JPN J CANCER RES, V93, P660, DOI 10.1111/j.1349-7006.2002.tb01304.x; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Monje M, 2018, ANNU REV NEUROSCI, V41, P61, DOI 10.1146/annurev-neuro-080317-061853; National Research Council, 2011, GUIDE CARE USE LAB A; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Paintlia AS, 2006, J IMMUNOL, V176, P4385, DOI 10.4049/jimmunol.176.7.4385; Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Ting SM, 2020, J CEREBR BLOOD F MET, V40, P513, DOI 10.1177/0271678X19838189; van Wageningen TA, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0850-z; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Ya JC, 2015, MOL MED REP, V12, P6591, DOI 10.3892/mmr.2015.4292; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yoshizaki K, 2008, EXP NEUROL, V210, P585, DOI 10.1016/j.expneurol.2007.12.005; Zhang J, 2019, J CEREBR BLOOD F MET, V39, P1394, DOI 10.1177/0271678X18785480; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330	54	6	6	2	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2021	41	3					511	529	0271678X20941393	10.1177/0271678X20941393		AUG 2020	19	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	QM6TT	WOS:000556872300001	32757740	Green Published			2022-02-06	
J	Amiresmaili, S; Khaksari, M; Shahrokhi, N; Abolhassani, M				Amiresmaili, Sedigheh; Khaksari, Mohammad; Shahrokhi, Nader; Abolhassani, Moslem			Evolution of TLR4 role in mediating the hepatoprotective effects of estradiol after traumatic brain injury in male rats	BIOCHEMICAL PHARMACOLOGY			English	Article						Traumatic brain injury; Estrogen receptors; TLR4; Hepato-protection; Oxidative stress; Pro-inflammatory cytokines (IL-17)	RECEPTOR 4 ANTAGONIST; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; LIVER-INJURY; INFLAMMATORY RESPONSE; ANTIOXIDANT ENZYMES; L. EXTRACT; ESTROGEN; 17-BETA-ESTRADIOL; TAK-242	Several studies have shown that 17 beta-estradiol (E2) exerted beneficial effects on liver disease, and it has a protective impact on brain damage after traumatic brain injury (TBI). TBI-induced liver injury is associated with the activation of TLR4. However, it remains unknown whether E2 can modulate TBI-induced liver injury through TLR4. The objective of this study was to determine the role of TLR4 in hepatoprotective mechanisms of E2 after TBI. Diffuse TBI induced by the Marmarou model in male rats. TAK-242 as a selective antagonist of TLR4 (3 mg/kg) and E2 (33.3 mu g/kg) were injected (i.p) respectively 30 min before and 30 min after TBI. The results showed that E2 and TAK-242 markedly inhibited TBI-induced liver injury, which was characterized by decreased aminotransferase activities, inhibition of the oxidative stress, and reduced levels of pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and IL-17 in the liver. We also found that TBI induced significant upregulation of TLR4 in the liver, with peak expression occurring 24 h after TBI, and that treatment with E2 significantly inhibited the upregulation of TLR4. Also, both classic [Estrogen receptors alpha (ER alpha) and beta (ER beta)] and non-classic (G protein-coupled estrogen receptor GPER) E2 receptors are involved in modulating the expression of TLR4. These results suggested that the hepatoprotective effects of estradiol after TBI may be mediated via the downregulation expression of TLR4.	[Amiresmaili, Sedigheh] Kerman Univ Med Sci, Fac Med, Dept Physiol, Kerman, Iran; [Amiresmaili, Sedigheh] Bam Univ Med Sci, Dept Physiol, Bam, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Neuroscince Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Abolhassani, Moslem] Kerman Univ Med Sci, Sch Med, Dept Clin Biochem, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Neuroscince Res Ctr, Inst Neuropharmacol, Kerman, Iran.; Khaksari, M (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Neuropharmacol, Kerman, Iran.	mkhaksari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281	Physiology Research Center of Kerman University of Medical Sciences (Kerman, Iran)	The present study was financially supported by the Physiology Research Center of Kerman University of Medical Sciences (Kerman, Iran).	Abbasloo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31866; Azizian H, 2018, INT IMMUNOPHARMACOL, V65, P190, DOI 10.1016/j.intimp.2018.10.009; Azizian H, 2018, BIOMED PHARMACOTHER, V108, P153, DOI 10.1016/j.biopha.2018.09.028; Badshah H, 2016, SCI REP, V6, P1, DOI DOI 10.1038/SREP24493; Bandegi AR, 2014, ADV PHARM BULL, V4, P493, DOI 10.5681/apb.2014.073; Bellanti F, 2013, REDOX BIOL, V1, P340, DOI 10.1016/j.redox.2013.05.003; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Caballero I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40981; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Carrillo-Sepulveda MA, 2015, J MOL MED, V93, P1341, DOI 10.1007/s00109-015-1318-7; Casillas-Ramirez A, 2006, LIFE SCI, V79, P1881, DOI 10.1016/j.lfs.2006.06.024; Chang CA, 2018, BIOMATERIALS, V159, P13, DOI 10.1016/j.biomaterials.2017.12.020; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hsieh YC, 2007, MOL IMMUNOL, V44, P2165, DOI 10.1016/j.molimm.2006.11.019; Hsieh YC, 2007, J CELL PHYSIOL, V211, P364, DOI 10.1002/jcp.20943; Hu LL, 2017, GRAEF ARCH CLIN EXP, V255, P2199, DOI 10.1007/s00417-017-3772-0; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khemili D, 2020, INFLAMMATION, V43, P155, DOI 10.1007/s10753-019-01105-y; Kunde SS, 2005, HEPATOLOGY, V42, P650, DOI 10.1002/hep.20818; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lin CL, 2009, J NEUROSURG, V111, P1014, DOI 10.3171/2009.3.JNS081660; Liu FY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1388-x; Liu M, 2018, ONCOTARGET, V9, P394, DOI 10.18632/oncotarget.23037; Lou YY, 2017, INT J BIOL SCI, V13, P434, DOI 10.7150/ijbs.18278; Luo CL, 2019, FREE RADICAL BIO MED, V130, P215, DOI 10.1016/j.freeradbiomed.2018.10.402; Maione F, 2009, BIOCHEM PHARMACOL, V77, P878, DOI 10.1016/j.bcp.2008.11.011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Moeinpour F, 2007, MOL IMMUNOL, V44, P3317, DOI 10.1016/j.molimm.2007.02.023; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Okada T, 2020, ACTA NEUROCHIR SUPPL, V127, P77, DOI 10.1007/978-3-030-04615-6_13; Oya S, 2014, AM J PHYSIOL-GASTR L, V306, pG244, DOI 10.1152/ajpgi.00366.2013; Pan LF, 2016, J SURG RES, V206, P298, DOI 10.1016/j.jss.2016.08.011; Pratap UP, 2016, BRAIN RES BULL, V124, P238, DOI 10.1016/j.brainresbull.2016.05.015; Raeiszadeh M, 2018, S AFR J BOT, V118, P144, DOI 10.1016/j.sajb.2018.07.006; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shao ZG, 2016, BIOMED PHARMACOTHER, V84, P495, DOI 10.1016/j.biopha.2016.09.036; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Shibata A, 2017, J AUTOIMMUN, V80, P28, DOI 10.1016/j.jaut.2017.01.007; Sobocanec S, 2015, LIFE SCI, V130, P57, DOI 10.1016/j.lfs.2015.03.014; Surico D, 2017, CELL PHYSIOL BIOCHEM, V42, P1051, DOI 10.1159/000478752; Toyoda Y, 2011, TOXICOL LETT, V204, P17, DOI 10.1016/j.toxlet.2011.03.031; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Wang S., 2014, J MOL NEUROSCI, V55, P141, DOI DOI 10.1007/S12031-014-0384-6; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523; Ye SX, 2019, MOLECULES, V24, DOI 10.3390/molecules24203731; Yucel A., 2012, J EXP INTEGR MED, V2, P1; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhang ZL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1246-x; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zhu Y, 2019, ANN HEPATOL, V18, P770, DOI 10.1016/j.aohep.2019.01.008	67	6	7	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	AUG	2020	178								114044	10.1016/j.bcp.2020.114044			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MO6UM	WOS:000551658300008	32445868				2022-02-06	
J	Armstrong, N; Rotundo, M; Aubrey, J; Tarzi, C; Cusimano, MD				Armstrong, Nicholas; Rotundo, Mario; Aubrey, Jason; Tarzi, Christopher; Cusimano, Michael D.			Characteristics of potential concussive events in three elite football tournaments	INJURY PREVENTION			English	Article						concussion; traumatic brain injury; enforcement; health education; physical medicine	TRAUMATIC BRAIN-INJURY; VIDEO ANALYSIS; HEAD; IMPACTS; EPIDEMIOLOGY; MECHANISMS; HOCKEY	Objective Identify patterns in the nature and characteristics of potential concussive events (PCEs) in football. Methods This study analysed the incidence and characteristics of PCEs that occurred during the 2014 and 2018 Federation Internationale de Football Association World Cups, and the 2016 UEFA Euro Cup. PCEs were defined as direct head collision incidents resulting in the athlete being unable to immediately resume play for at least 5 sec following impact. Results A total of 218 incidents were identified in 179 matches (1.22 per match, 36.91 per 1000 hours of exposure). The most common mechanism of PCE was elbow-to-head (28.7%, n=68). The frontal region was the most frequently affected location of impact with 22.8% (n=54). Conclusion Our study defined the identification, prevalence and nature of PCEs in professional international soccer tournaments. Our findings indicate the different contexts and mechanisms of head contact and contact to different regions of the head can be associated with varying signs of concussion. The results highlight targets for future injury prevention strategies.	[Armstrong, Nicholas; Rotundo, Mario; Aubrey, Jason; Tarzi, Christopher; Cusimano, Michael D.] St Michaels Hosp, Neurosurg, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Neurosurg, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca		Armstrong, Nicholas/0000-0002-9470-9437	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This work is supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Comper P, 2012, BRIT J SPORT MED, V47; Conder Robert L, 2015, N C Med J, V76, P89; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2017, JAMA-J AM MED ASSOC, V317, P2548, DOI 10.1001/jama.2017.6204; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Giza CC, 2018, JAMA PEDIATR, V172, P803, DOI 10.1001/jamapediatrics.2018.1645; Hardy, 2003, P INT RES C BIOM IMP; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Oehlert K, 2004, SPORTVERLETZ SPORTSC, V18, P80, DOI 10.1055/s-2004-813031; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	AUG	2020	26	4					334	338		10.1136/injuryprev-2019-043242			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NB9GN	WOS:000560823700007	31331934	Green Published, hybrid			2022-02-06	
J	Astarabadi, M; Khurrum, M; Asmar, S; Bible, L; Chehab, M; Castanon, L; Ditillo, M; Douglas, M; Joseph, B				Astarabadi, Mariam; Khurrum, Muhammad; Asmar, Samer; Bible, Letitia; Chehab, Mohamad; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal			The impact of non-neurological organ dysfunction on outcomes in severe isolated traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	105th Annual Scientific Clinical Congress of the American-College-of-Surgeons / 5th Annual Sessions of the Owen-H-Wangensteen-Scientific-Forum	OCT 27-31, 2019	San Francisco, CA	Amer Coll Surg, Owen H Wangensteen Sci Forum		Traumatic brain injury; non-neurological organ dysfunction; intensive care unit; multiple organ dysfunction scores	HEAD-INJURY; FAILURE; SCORE; COMPLICATIONS; SOFA; CARE; MODS	INTRODUCTION Organ dysfunction following traumatic brain injury (TBI) is common and has been associated with unpredictable outcomes. The aim of our study is to describe the incidence of non-neurological organ dysfunction (NNOD) and its impact on outcomes in patients with severe TBI admitted to our intensive care unit (ICU). METHODS We performed a 3-year (2015-2017) review of our Level 1 trauma center's prospectively maintained TBI database and included all adult (age >= 18y) patients with isolated severe TBI (head abbreviated injury severity (AIS) >= 3 and other AIS <3) and an ICU stay >48 hours. Organ dysfunction (OD) was measured by multiple organ dysfunction scores. Organ system failure was defined as a non-neurological component score of >= 3 on any day during the ICU stay. Outcomes measured were the incidence of NNOD and its effect on outcomes. Multivariate regression analysis was performed. RESULTS A total of 285 patients were included. The mean age was 48 22 years, 72% were males, median [IQR] Glasgow Coma Scale (GCS) was 8[5-10], and median Injury Severity Score (ISS) was 17[10-26]. Epidural hematoma was the most common intracranial hemorrhage (49%) followed by subdural hematoma (46%). The overall incidence of NNOD was 33%, with the most common dysfunctional organ system being the respiratory (23%) followed by the cardiovascular (12%) and hepatic system (8%). The overall in-hospital mortality rate was 19% (NNOD:36% vs. No-NNOD:9%, p< 0.01). On regression analysis, NNOD was associated with higher in-hospital mortality (aOR: 2.0 [1.6-2.7]), discharge to skilled nursing facility (SNF) (aOR: 1.8 [1.4-2.2]), and Glasgow Outcome Scale-Extended (GOS-E) <less than or equal to>4 (OR: 1.7 [1.3-2.3]) and p-values <0.01. CONCLUSION One in every three isolated severe TBI patients develop NNOD. NNOD is independently associated with worse outcomes. Understanding the mechanisms associated with NNOD in the setting of TBI may promote prevention practices and improve outcomes in TBI. LEVEL OF EVIDENCE Prognostic, level III.	[Astarabadi, Mariam; Khurrum, Muhammad; Asmar, Samer; Bible, Letitia; Chehab, Mohamad; Castanon, Lourdes; Ditillo, Michael; Douglas, Molly; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Ahl R, 2017, EUR J TRAUMA EMERG S, V43, P783, DOI 10.1007/s00068-017-0779-5; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Fan X, 2012, CHINESE MED J-PEKING, V125, P3430, DOI 10.3760/cma.j.issn.0366-6999.2012.19.013; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Kemp CD, 2008, AM SURGEON, V74, P866; Khwannimit Bodin, 2007, Journal of the Medical Association of Thailand, V90, P1074; Khwannimit Bodin, 2008, Journal of the Medical Association of Thailand, V91, P1336; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Wijayatilake DS, 2015, CURR OPIN ANESTHESIO, V28, P525, DOI 10.1097/ACO.0000000000000236; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	23	6	6	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2020	89	2					405	410		10.1097/TA.0000000000002771			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NA4GO	WOS:000559775000032	32744835				2022-02-06	
J	Davis, GA; Makdissi, M; Bloomfield, P; Clifton, P; Cowie, C; Echemendia, R; Falvey, EC; Fuller, GW; Green, GA; Harcourt, P; Hill, J; Leahy, K; Loosemore, MP; McCrory, P; McGoldrick, A; Meeuwisse, W; Moran, K; Nagahiro, S; Orchard, JW; Pugh, J; Raftery, M; Sills, AK; Solomon, GS; Valadka, AB				Davis, Gavin A.; Makdissi, Michael; Bloomfield, Paul; Clifton, Patrick; Cowie, Charlotte; Echemendia, Ruben; Falvey, Eanna C.; Fuller, Gordon Ward; Green, Gary Alan; Harcourt, Peter; Hill, Jerry; Leahy, Kevin; Loosemore, Mike P.; McCrory, Paul; McGoldrick, Adrian; Meeuwisse, Willem; Moran, Kevin; Nagahiro, Shinji; Orchard, John W.; Pugh, Jennifer; Raftery, Martin; Sills, Allen K.; Solomon, Gary S.; Valadka, Alex B.			Concussion Guidelines in National and International Professional and Elite Sports	NEUROSURGERY			English	Article						Concussion; Guidelines; Sport	CONSENSUS STATEMENT; AGREEMENT STATEMENT; ZURICH	The Berlin statement on sport-related concussion was published in 2017 using evidence-based recommendations. We aimed to examine (1) the implementation of, distribution and education based on the Berlin recommendations, and the development of sport-specific protocols/guidelines among professional and elite sports, (2) the implementation of guidelines at the community level, (3) translation of guidelines into different languages, and (4) research activities. Senior medical advisers and chief medical officers from Australian Football League, All Japan Judo Federation, British Horseracing Authority, Cricket Australia, Federation Equestre Internationale, Football Association, Gaelic Athletic Association, International Boxing Association, Irish Horseracing Regulatory Board, Major League Baseball, National Football League, National Hockey League, National Rugby League, and World Rugby completed a questionnaire. The results demonstrated that all 14 sporting organizations have published concussion protocols/guidelines based on the Berlin recommendations, including Recognize, Removal from play, Re-evaluation, Rest, Recovery, and Return to play. There is variable inclusion of Prolonged symptoms. Prevention and Risk reduction and Long-term effects are addressed in the guidelines, rules and regulations, and/or sport-specific research. There is variability in education programs, monitoring compliance with guidelines, and publication in other languages. All sporting bodies are actively involved in concussion research. We conclude that the Berlin recommendations have been included in concussion protocols/guidelines by all the sporting bodies, with consistency in the essential components of the recommendations, whilst also allowing for sport- and regional-specific variations. Education at the elite, community, and junior levels remains an ongoing challenge, and future iterations of guidelines may consider multiple language versions, and community- and junior-level guidelines.	[Davis, Gavin A.] Australian Football League Concuss Working Grp, Melbourne, Vic, Australia; [Makdissi, Michael; Clifton, Patrick; Harcourt, Peter] Australian Football League, Melbourne, Vic, Australia; [Bloomfield, Paul] Natl Rugby League, Sydney, NSW, Australia; [Cowie, Charlotte] St Georges Pk, Football Assoc, Needwood, England; [Echemendia, Ruben; Meeuwisse, Willem; Raftery, Martin] Natl Hockey League, New York, NY USA; [Falvey, Eanna C.] World Rugby, Dublin, Ireland; [Fuller, Gordon Ward] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Green, Gary Alan; Valadka, Alex B.] Major League Baseball, New York, NY USA; [Hill, Jerry] British Horseracing Author, London, England; [Leahy, Kevin; Moran, Kevin] Gael Athlet Assoc, Dublin, Ireland; [Loosemore, Mike P.] UCL, Fac Med Sci, Inst Sport Exercise & Hlth, Div Surg & Intervent Sci, London, England; [McCrory, Paul] Concuss Sport Grp, Zurich, Switzerland; [McGoldrick, Adrian; Pugh, Jennifer] Irish Horseracing Regulatory Body, The Curragh, Ireland; [Nagahiro, Shinji] All Japan Judo Federat, Tokyo, Japan; [Orchard, John W.] Univ Sydney, Sch Publ Hlth, Camperdown, NSW, Australia; [Sills, Allen K.; Solomon, Gary S.] Natl Football League, New York, NY USA		Davis, GA (corresponding author), Suite 53 Neurosurg,Wattletree Rd, Malvern, Vic 3144, Australia.	gavin.davis@me.com	Orchard, John W/AAY-7216-2020	Orchard, John W/0000-0003-3530-1711; makdissi, michael/0000-0003-0334-7133; Falvey, Eanna/0000-0003-3961-1805; Davis, Gavin/0000-0001-8293-4496; Fuller, Gordon Ward/0000-0001-8532-3500; McCrory, Paul/0000-0003-4850-0568	NFL; Boston Children's Hospital; National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Dr Echemendia is cochair of the NHL/NHLPA Concussion Subcommittee and receives remuneration as a consultant to the NHL, Major League Soccer, and Princeton University. He is a Co-PI on grant-funded research from the NFL and Boston Children's Hospital. Dr Fuller has received travel expenses from World Rugby to attend scientific meetings. Dr Solomon is a paid consultant to the National Football League. Dr Valadka is a paid consultant to Major League Baseball. DrDavis is an honorary member of the AFL ConcussionWorkingGroup Scientific Committee and has attended meetings organized by sporting organizations including the NFL, NRL, IIHF, and FIFA; however, he has not received any payment, research funding, or other monies from these groups other than for travel costs. Dr McCrory is a coinvestigator on competitive grants relating to mild TBI funded by several governmental and other organizations. He is funded under a Fellowship awarded by the National Health & Medical Research Council of Australia and is employed at the Florey Institute of Neuroscience and Mental Health. He has a clinical consulting practice in neurology, including medicolegal work. He has been reimbursed by the government, professional scien-tific bodies, and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, scientific conferences, and symposiums. He does not hold any individual shares in or receive monies from any company related to concussion or brain injury assessment or technology. He acknowledges unrestricted philanthropic support from CogState Inc (2001-2016). He is the chair of the scientific committees of the International Concussion and Head Injury Research Foundation in London and the Sports Surgery Clinic in Dublin. Dr Sills is an employee of the National Football League. Dr Orchard is ChiefMedical Officer of Cricket Australia. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079	8	6	6	2	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2020	87	2					418	425		10.1093/neuros/nyaa057			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OW8HL	WOS:000593120500101	32232354	Bronze			2022-02-06	
J	Lempke, LB; Johnson, RS; Schmidt, JD; Lynall, RC				Lempke, Landon B.; Johnson, Rachel S.; Schmidt, Julianne D.; Lynall, Robert C.			Clinical versus Functional Reaction Time: Implications for Postconcussion Management	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						DUAL-TASK; CONCUSSION; SPORTS MEDICINE; RESPONSE TIME; MOVEMENT TIME	COMPUTERIZED NEUROCOGNITIVE TEST; CONCUSSION-ASSESSMENT; PERFORMANCE; RELIABILITY; INJURY; EPIDEMIOLOGY; VALIDITY; DEFICITS; IMPACT; RETURN	Purpose This study aimed to examine the association between clinical and functional reaction time (RT) assessments with and without simultaneous cognitive tasks among healthy individuals. Methods Participants (n= 41, 49% female; 22.5 +/- 2.1 yr; 172.5 +/- 11.9 cm; 71.0 +/- 13.7 kg) completed clinical (drop stick, Stroop) and functional (gait, jump landing, single-leg hop, anticipated cut, unanticipated cut) RT assessments in random order. All RT assessments, except Stroop and unanticipated cut, were completed under single- (movement only) and dual-task conditions (movement and subtracting by 6s or 7s). Drop stick involved catching a randomly dropped rod embedded in a weighted disk. Stroop assessed RT via computerized neurocognitive testing. An instrumented walkway measured gait RT when center-of-pressure moved after random stimulus. All other functional RT assessments involved participants jumping forward and performing a vertical jump (jump landing), balancing on one leg (single-leg hop), or a 45 degrees cut in a known (anticipated cut) or unknown (unanticipated cut) direction. RT was determined when the sacrum moved following random visual stimulus. Pearson correlation coefficients and a 5 x 2 repeated-measures ANOVA compared RT assessments and cognitive conditions. Results Stroop RT outcomes did not significantly correlate with functional RT assessments (rrange = -0.10 to 0.24). A significant assessment by cognitive task interaction (F-4,F-160= 14.01;P< 0.001) revealed faster single-task RT among all assessments compared with dual-task (mean differences, -0.11 to -0.09 s;P< 0.001), except drop stick (P= 0.195). Single-leg hop (0.58 +/- 0.11 s) was significantly slower compared with jump landing (0.53 +/- 0.10 s), anticipated cut (0.49 +/- 0.09 s), gait (0.29 +/- 0.07 s), and drop stick (0.21 +/- 0.03 s;Pvalues <= 0.001). Dual-task assessments were significantly slower than single-task assessments (mean difference, 0.08 s;P< 0.001). Conclusions Clinical and functional RT assessments were not correlated with each other, suggesting that sport-like RT is not being assessed after concussion. Functional and dual-task RT assessments may add clinical value and warrant further exploration after concussion.	Univ Georgia, Dept Kinesiol, UGA Biomech Lab, Athens, GA 30602 USA; Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Lynall, RC (corresponding author), Ramsey Student Ctr, 330 River Rd, Athens, GA 30606 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	University of Georgia, College of Education	The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation, and do not constitute endorsement by the American College of Sports Medicine. This study was funded by the University of Georgia, College of Education.	Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; Blackburn JT, 2013, J ATHL TRAINING, V48, P764, DOI 10.4085/1062-6050-48.4.01; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; CNS Vital Signs, 2017, CNS VIT SIGNS BRIEF; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hinkle DE., 2003, APPL STAT BEHAV SCI, V5th; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, GAIT POSTURE, V52, P308, DOI 10.1016/j.gaitpost.2016.12.023; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Ramkumar PN, 2019, AM J SPORT MED, V47, P2287, DOI 10.1177/0363546519859542; Ross SE, 2008, J ATHL TRAINING, V43, P44, DOI 10.4085/1062-6050-43.1.44; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	42	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2020	52	8					1650	1657		10.1249/MSS.0000000000002300			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	MQ7TK	WOS:000553096300002	32053547	Bronze			2022-02-06	
J	Lengel, D; Huh, JW; Barson, JR; Raghupathi, R				Lengel, Dana; Huh, Jimmy W.; Barson, Jessica R.; Raghupathi, Ramesh			Progesterone treatment following traumatic brain injury in the 11-day-old rat attenuates cognitive deficits and neuronal hyperexcitability in adolescence	EXPERIMENTAL NEUROLOGY			English	Article						Pediatric TBI; Adolescence; Cognition; Risk-taking behavior; E/I balance; Neuronal excitability; Object recognition; Prefrontal cortex	MEDIAL PREFRONTAL CORTEX; OBJECT RECOGNITION; CONTUSION INJURY; TEMPORAL-ORDER; NERVOUS-SYSTEM; IMMATURE RAT; WATER MAZE; RECEPTORS; RECOVERY; AGE	Traumatic brain injury (TBI) in children younger than 4 years old results in cognitive and psychosocial deficits in adolescence and adulthood. At 4 weeks following closed head injury on postnatal day 11, male and female rats exhibited impairment in novel object recognition memory (NOR) along with an increase in open arm time in the elevated plus maze (EPM), suggestive of risk-taking behaviors. This was accompanied by an increase in intrinsic excitability and frequency of spontaneous excitatory post-synaptic currents (EPSCs), and a decrease in the frequency of spontaneous inhibitory post-synaptic currents in layer 2/3 neurons within the medial prefrontal cortex (PFC), a region that is implicated in both object recognition and risk-taking behaviors. Treatment with progesterone for the first week after brain injury improved NOR memory at the 4-week time point in both sham and brain-injured rats and additionally attenuated the injury-induced increase in the excitability of neurons and the frequency of spontaneous EPSCs. The effect of progesterone on cellular excitability changes after injury may be related to its ability to decrease the mRNA expression of the beta 3 subunit of the voltage-gated sodium channel and increase the expression of the neuronal excitatory amino acid transporter 3 in the medial PFC in sham- and brain-injured animals and also increase glutamic acid decarboxylase mRNA expression in sham- but not brain-injured animals. Progesterone treatment did not affect injury-induced changes in the EPM test. These results demonstrate that administration of progesterone immediately after TBI in 11-day-old rats reduces cognitive deficits in adolescence, which may be mediated by progesterone-mediated regulation of excitatory signaling mechanisms within the medial PFC.	[Lengel, Dana; Barson, Jessica R.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Grad Sch Biomed Sci & Profess Studies, Program Neurosci, Philadelphia, PA 19129 USA; [Barson, Jessica R.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rr79@drexel.edu	Raghupathi, Ramesh/AAX-5538-2021	Barson, Jessica/0000-0001-7227-5730	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD061963]; Pennsylvania Department of Health [SAP4100077079]	These studies were supported, in part, by grants from the National Institutes of Health HD061963 and a grant from the Pennsylvania Department of HealthSAP4100077079.	Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Allitt BJ, 2017, CELL TRANSPLANT, V26, P1202, DOI 10.1177/0963689717714326; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; Bjorn-Yoshimoto WE, 2016, NEUROCHEM INT, V98, P4, DOI 10.1016/j.neuint.2016.05.007; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Gonzalez-Orozco JC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00503; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cheng ZX, 2008, EXP NEUROL, V210, P128, DOI 10.1016/j.expneurol.2007.10.004; Choe MC, 2016, J CHILD NEUROL, V31, P109, DOI 10.1177/0883073815572685; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Frye CA, 2004, BRAIN RES, V1004, P116, DOI 10.1016/j.brainres.2004.01.020; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2009, ANIM BEHAV, V78, P279, DOI 10.1016/j.anbehav.2009.04.017; Geddes RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146419; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hanlon LA, 2019, EXP NEUROL, V316, P39, DOI 10.1016/j.expneurol.2019.04.004; Hannesson DK, 2004, BEHAV BRAIN RES, V153, P273, DOI 10.1016/j.bbr.2003.12.004; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2019, NEUROPHARMACOLOGY, V145, P153, DOI 10.1016/j.neuropharm.2018.06.025; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Knock GA, 2001, BIOL REPROD, V64, P1526, DOI 10.1095/biolreprod64.5.1526; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu LJ, 2012, NEURAL REGEN RES, V7, P2036, DOI 10.3969/j.issn.1673-5374.2012.26.005; MAJEWSKA MD, 1991, J ENDOCRINOL, V131, P427, DOI 10.1677/joe.0.1310427; Morales-Lazaro SL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00419; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; O'Donovan SM, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-017-0037-1; Pandey S, 2019, ADDICT BIOL, V24, P3, DOI 10.1111/adb.12546; Pati S, 2018, J BIOSCIENCES, V43, P85, DOI 10.1007/s12038-018-9732-y; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Pezze MA, 2015, PSYCHOPHARMACOLOGY, V232, P2669, DOI 10.1007/s00213-015-3903-4; PORTERFIELD SP, 1994, ENVIRON HEALTH PERSP, V102, P125, DOI 10.2307/3431829; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prouty EW, 2017, EUR J NEUROSCI, V45, P712, DOI 10.1111/ejn.13501; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Reznikov R, 2018, NEUROPSYCHOPHARMACOL, V43, P1099, DOI 10.1038/npp.2017.207; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2015, PEDIATR CRIT CARE ME, V16, P236, DOI 10.1097/PCC.0000000000000323; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Salvi SS, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00249; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; SMITH SS, 1987, BRAIN RES BULL, V18, P739, DOI 10.1016/0361-9230(87)90209-7; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Watson DJG, 2012, NEUROPSYCHOPHARMACOL, V37, P770, DOI 10.1038/npp.2011.254; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witkowski ED, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00166; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701	88	6	6	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2020	330								113329	10.1016/j.expneurol.2020.113329			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LW8YA	WOS:000539428100012	32335121	Green Accepted			2022-02-06	
J	Qi, BT; Jin, ST; Qian, HS; Zou, Y				Qi, Bote; Jin, Shuting; Qian, Hongsheng; Zou, Yu			Bibliometric Analysis of Chronic Traumatic Encephalopathy Research from 1999 to 2019	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						bibliometrics; CiteSpace; VOSviewer; chronic traumatic encephalopathy	BRAIN-INJURY; SPORT; TAU; PET; NEUROPATHOLOGY; EPIDEMIOLOGY; PATHOLOGY; DEMENTIA; SPECTRUM; DISEASE	Research on chronic traumatic encephalopathy (CTE) has increased over the past two decades. However, few studies have statistically analyzed these publications. In this work, we conducted a bibliometric analysis of studies on CTE to track research trends and highlight current research hotspots. Relevant original articles were obtained from the Web of Science Core Collection database between 1999 and 2019. CiteSpace and VOSviewer software were used to perform analysis and visualization of scientific productivity and emerging trends. Our results show that the publications related to CTE dramatically increased from four publications in 1999 to 160 publications in 2019. The United States dominated this field with 732 publications (75.934%), followed by Canada with 88 publications (9.129%). Most of related publications were published in the journals with a focus on molecular biology, immunology, neurology, sports and ophthalmology, as represented by the dual-map overlay. A total of 11 major clusters were explored based on the reference co-citation analysis. In addition, three predominant research topics were summarized by clustering high-frequency keywords: epidemiological, clinical and pathological studies. The research frontiers were the diagnosis of diseases using new neuroimaging techniques, and the investigation of the molecular mechanism of tau aggregation. This study provides researchers with valuable guidance in the selection of research topics.	[Qi, Bote; Zou, Yu] Zhejiang Univ, Coll Educ, Dept Sport & Exercise Sci, 886 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Jin, Shuting] Zhejiang Univ, Coll Comp Sci & Technol, 886 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Qian, Hongsheng] Cent China Normal Univ, Coll Phys Educ, 152 Luoyu Ave, Wuhan 430079, Peoples R China		Zou, Y (corresponding author), Zhejiang Univ, Coll Educ, Dept Sport & Exercise Sci, 886 Yuhangtang Rd, Hangzhou 310058, Peoples R China.	qibote@zju.edu.cn; stefanie.jinst@gmail.com; qianhsheng@126.com; zouyuzy@zju.edu.cn			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2020QNA245]; "Double First-Class" Construction Fund of Zhejiang University	This research was funded by the Fundamental Research Funds for the Central Universities (Grant No. 2020QNA245) and the "Double First-Class" Construction Fund of Zhejiang University.	Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CM, 2012, EXPERT OPIN BIOL TH, V12, P593, DOI 10.1517/14712598.2012.674507; Chen CM, 2009, J INFORMETR, V3, P191, DOI 10.1016/j.joi.2009.03.004; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goerlandt F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093255; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kepe V, 2013, J ALZHEIMERS DIS, V36, P145, DOI 10.3233/JAD-130032; Lim LJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020254; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Liu H, 2020, FUEL, V262, DOI 10.1016/j.fuel.2019.116598; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Smid LM, 2013, J ALZHEIMERS DIS, V36, P261, DOI 10.3233/JAD-122434; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Trujillo CM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701130; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Yi Fengyun, 2016, BMC Res Notes, V9, P221, DOI 10.1186/s13104-016-2026-2; Zhai F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113766; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zou YD, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016817	54	6	6	24	38	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	AUG	2020	17	15							5411	10.3390/ijerph17155411			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	MZ6FJ	WOS:000559220800001	32731338	Green Published, gold			2022-02-06	
J	Rao, R; Topiwala, A				Rao, Rahul; Topiwala, Anya			Alcohol use disorders and the brain	ADDICTION			English	Article						Alcohol; dementia; brain; hepatic encephalopathy; Korsakoff's syndrome; thiamine; Wernicke's encephalopathy	ENHANCES INFLAMMATORY MEDIATORS; COGNITIVE DECLINE; WERNICKES ENCEPHALOPATHY; HEPATIC-ENCEPHALOPATHY; WITHDRAWAL SEIZURES; ETHANOL INTAKE; RISK-FACTOR; CONSUMPTION; DEMENTIA; SHRINKAGE	A diagnosis of alcohol use disorder is associated with a higher risk of dementia, but a dose-response relationship between alcohol intake consumption and cognitive impairment remains unclear. Alcohol is associated with a range of effects on the central nervous system at different doses and acts on a number of receptors. Acute disorders include Wernicke's encephalopathy (WE), traumatic brain injury, blackouts, seizures, stroke and hepatic encephalopathy. The most common manifestations of chronic alcohol consumption are Korsakoff's syndrome (KS) and alcohol-related dementia (ARD). There is limited evidence for benefit from memantine in the treatment of ARD, but stronger evidence for the use of high-dose parenteral thiamine in the progression of neuropsychiatric symptoms for WE. Accumulating evidence exists for pharmacological treatment in the prevention of hepatic encephalopathy. Rehabilitation of people with ARD may take several years, and requires an approach that addresses physical and psychosocial factors.	[Rao, Rahul] Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, De Crespigny Pk, London SE5 8AF, England; [Rao, Rahul] South London & Maudsley NHS Fdn Trust, Psychol Med & Older Adults Directorate, London, England; [Topiwala, Anya] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Oxford, England		Rao, R (corresponding author), Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, De Crespigny Pk, London SE5 8AF, England.	tony.rao@kcl.ac.uk		Rao, Rahul/0000-0002-0262-5122			Abdou E, 2015, NEUROCHEM RES, V40, P353, DOI 10.1007/s11064-014-1430-z; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Ahluwalia V, 2015, LIVER TRANSPLANT, V21, P1123, DOI 10.1002/lt.24163; Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Alleman AM, 2014, SEMIN ULTRASOUND CT, V35, P153, DOI 10.1053/j.sult.2013.09.009; Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P112, DOI 10.1097/00000374-200101000-00016; Anderson BM, 2011, ALCOHOL CLIN EXP RES, V35, P156, DOI 10.1111/j.1530-0277.2010.01332.x; Angunawela II, 2001, INT J GERIATR PSYCH, V16, P338, DOI 10.1002/gps.338; Anstey KJ, 2018, NAT REV NEUROL, V14, P635, DOI 10.1038/s41582-018-0073-0; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Bjerring P. N., 2018, COCHRANE DB SYST REV, V12, P1; Blanco AM, 2007, FRONT BIOSCI-LANDMRK, V12, P2616, DOI 10.2741/2259; Blazer DG, 2011, AM J GERIAT PSYCHIAT, V19, P685, DOI 10.1097/JGP.0b013e3182006a96; Bleich S, 2006, EPILEPSIA, V47, P934, DOI 10.1111/j.1528-1167.2006.00560.x; Bleich S, 2003, NEUROSCI LETT, V335, P179, DOI 10.1016/S0304-3940(02)01194-1; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; BROWN ME, 1988, BIOL PSYCHIAT, V23, P507, DOI 10.1016/0006-3223(88)90023-6; Butterworth RE, 2000, J HEPATOL, V32, P171, DOI 10.1016/S0168-8278(00)80424-9; BUTTERWORTH RF, 1993, ALCOHOL CLIN EXP RES, V17, P1084, DOI 10.1111/j.1530-0277.1993.tb05668.x; Calhoun VD, 2004, HUM BRAIN MAPP, V21, P15, DOI 10.1002/hbm.10145; CARLEN PL, 1986, ALCOHOL CLIN EXP RES, V10, P226; Casadevall-Codina T, 2002, REV NEUROLOGIA, V35, P341, DOI 10.33588/rn.3504.2002050; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cheon Y, 2008, INT J NEUROPSYCHOPH, V11, P971, DOI 10.1017/S1461145708008663; Chou Wei-Po, 2019, Clin Nutr, V38, P1269, DOI 10.1016/j.clnu.2018.05.009; Cochrane M, 2005, ALCOHOL ALCOHOLISM, V40, P151, DOI 10.1093/alcalc/agh127; Cook C C, 2000, Alcohol Alcohol Suppl, V35, P19; Cook CCH, 1998, ALCOHOL ALCOHOLISM, V33, P317; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crome I., 2011, OUR INVISIBLE ADDICT, V1; Day E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004033.pub3; Diaz MR, 2016, ALCOHOL CLIN EXP RES, V40, P83, DOI 10.1111/acer.12940; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Doty P, 1997, DRUG ALCOHOL DEPEN, V47, P109, DOI 10.1016/S0376-8716(97)00094-X; FERRER I, 1984, NEUROPATH APPL NEURO, V10, P245, DOI 10.1111/j.1365-2990.1984.tb00357.x; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Gazdzinski S, 2005, DRUG ALCOHOL DEPEN, V78, P263, DOI 10.1016/j.drugalcdep.2004.11.004; Geibprasert S, 2010, EUR RADIOL, V20, P1492, DOI 10.1007/s00330-009-1668-z; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Gilman JM, 2012, ADDICT BIOL, V17, P465, DOI 10.1111/j.1369-1600.2011.00383.x; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; HANSEN LA, 1991, ARCH NEUROL-CHICAGO, V48, P939, DOI 10.1001/archneur.1991.00530210065025; HARPER CG, 1985, BRIT MED J, V290, P501, DOI 10.1136/bmj.290.6467.501; HARPER CG, 1986, J NEUROL NEUROSUR PS, V49, P341, DOI 10.1136/jnnp.49.4.341; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Harrison NL, 2017, NEUROPHARMACOLOGY, V122, P36, DOI 10.1016/j.neuropharm.2017.04.007; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; Iga JI, 2001, ALCOHOL ALCOHOLISM, V36, P553, DOI 10.1093/alcalc/36.6.553; JENSEN GB, 1993, LANCET, V342, P1201; Johnston C, 2007, J MED ETHICS, V33, P94, DOI 10.1136/jme.2006.016972; JONES A, 2019, WIRES FORENSIC SCI, V1; Kaji K., 2019, CLIN INVESTIGATION P, P533; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; Kuzma E, 2014, AM J GERIAT PSYCHIAT, V22, P1047, DOI 10.1016/j.jagp.2014.06.001; Langballe EM, 2015, EUR J EPIDEMIOL, V30, P1049, DOI 10.1007/s10654-015-0029-2; Lee H, 2009, INT J ENV RES PUB HE, V6, P2783, DOI 10.3390/ijerph6112783; Macrae R., 2003, M NEEDS PEOPLE ALCOH; Mahley RW, 1999, NEUROBIOL AGING, V20, P429, DOI 10.1016/S0197-4580(99)00081-0; Meda SA, 2009, HUM BRAIN MAPP, V30, P1257, DOI 10.1002/hbm.20591; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Millwood IY, 2019, LANCET, V393, P1831, DOI 10.1016/S0140-6736(18)31772-0; MORGAN MY, 1982, BRIT MED BULL, V38, P21, DOI 10.1093/oxfordjournals.bmb.a071727; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mullen KD, 2007, ALIMENT PHARM THER, V25, P11, DOI 10.1111/j.1746-6342.2006.03216.x; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; Naegele T, 2000, RADIOLOGY, V216, P683, DOI 10.1148/radiology.216.3.r00se27683; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nicolas JM, 2000, QJM-MON J ASSOC PHYS, V93, P449, DOI 10.1093/qjmed/93.7.449; Office of National Statistics (ONS), 2019, STAT ALC ENGL; Oscar-Berman M, 2012, NEUROPSYCHOL REV, V22, P154, DOI 10.1007/s11065-012-9198-x; Oslin D, 1998, INT J GERIATR PSYCH, V13, P203, DOI 10.1002/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B; Pelletier Stephanie, 2016, J Addict, V2016, P1539096, DOI 10.1155/2016/1539096; Peters R, 2008, AGE AGEING, V37, P505, DOI 10.1093/ageing/afn095; Pitel AL, 2015, NEUROSCI BIOBEHAV R, V54, P38, DOI 10.1016/j.neubiorev.2014.07.023; Plant M., 2000, WOMEN ALCOHOL REPORT; Poordad FF, 2007, ALIMENT PHARM THERAP, V25, P3, DOI 10.1111/j.1746-6342.2006.03215.x; Rao R, 2019, BMJ-BRIT MED J, V366, pI5112; Rao R., 2013, MENT HLTH SUBST USE, V6, P362; Rao R. T., 2010, MENTAL HLTH LATER LI, P108; Rao R, 2016, ADV DUAL DIAGN, V9, P154, DOI 10.1108/ADD-06-2016-0014; Rao R, 2015, LANCET PSYCHIAT, V2, P674, DOI 10.1016/S2215-0366(15)00215-1; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ridley NJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt157; Ritchie Karen, 2008, Handb Clin Neurol, V89, P845, DOI 10.1016/S0072-9752(07)01273-0; Rose ME, 2010, J ADDICT MED, V4, P61, DOI 10.1097/ADM.0b013e3181e1299d; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; Sabia S, 2014, NEUROLOGY, V82, P332, DOI 10.1212/WNL.0000000000000063; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Saxton J, 2000, J GERIATR PSYCH NEUR, V13, P141, DOI 10.1177/089198870001300308; SCHROTH G, 1988, NEURORADIOLOGY, V30, P385, DOI 10.1007/BF00404102; Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Squeglia LM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0689-y; Sripada CS, 2011, NEUROIMAGE, V55, P371, DOI 10.1016/j.neuroimage.2010.11.062; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Sullivan EV, 1996, ALCOHOL CLIN EXP RES, V20, P348, DOI 10.1111/j.1530-0277.1996.tb01651.x; The Royal College of Psychiatrists The Royal College of General Practitioners, 2014, ALC BRAIN DAM AD REF; Thomson AD, 2002, ALCOHOL ALCOHOLISM, V37, P513, DOI 10.1093/alcalc/37.6.513; TRABERT W, 1995, ACTA PSYCHIAT SCAND, V92, P87, DOI 10.1111/j.1600-0447.1995.tb09548.x; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Valles SL, 2004, BRAIN PATHOL, V14, P365; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; White AM, 2003, ALCOHOL RES HEALTH, V27, P186; Wijnia JW, 2010, MED HYPOTHESES, V75, P266, DOI 10.1016/j.mehy.2010.02.035; Wilhelm J, 2006, J NEURAL TRANSM, V113, P357, DOI 10.1007/s00702-005-0333-1; Wilson K, 2012, ALCOHOL ALCOHOLISM, V47, P304, DOI 10.1093/alcalc/agr167; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Ye JH, 2001, J PHARMACOL EXP THER, V296, P77; Zahr NM, 2010, NEUROPSYCHOL REV, V20, P280, DOI 10.1007/s11065-010-9141-y; Zubaran C, 1997, POSTGRAD MED J, V73, P27, DOI 10.1136/pgmj.73.855.27; Zuccoli G, 2010, AM J ROENTGENOL, V195, P1378, DOI 10.2214/AJR.09.4130	119	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-2140	1360-0443		ADDICTION	Addiction	AUG	2020	115	8					1580	1589		10.1111/add.15023			10	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	MF4JQ	WOS:000545311100021	32112474				2022-02-06	
J	Sigurdardottir, S; Andelic, N; Roe, C; Schanke, AK				Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie; Schanke, Anne-Kristine			Trajectory of 10-Year Neurocognitive Functioning After Moderate-Severe Traumatic Brain Injury: Early Associations and Clinical Application	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognitive impairment; Longitudinal; Recovery; Emotional distress; Rehabilitation; TBI	1-YEAR FOLLOW-UP; POSTTRAUMATIC AMNESIA; COGNITIVE RECOVERY; 1ST YEAR; IMPACT; DEPRESSION; MEMORY; PERFORMANCE; PREDICTORS; DISTRESS	Objective: This study aimed to explore the 10-year trajectories of neurocognitive domains after moderate-severe traumatic brain injury (TBI), to identify factors related to long-term neurocognitive functioning, and to investigate whether performance remained stable or changed over time. Method: Seventy-nine patients with moderate-severe TBI between the ages of 16 and 55 years were assessed at 3 months, 1, 5, and 10 years postinjury using neuropsychological tests and functional outcomes. Three hierarchical linear models were used to investigate the relationships of domain-specific neurocognitive trajectories (Memory, Executive function, and Reasoning) with injury severity, demographics, functional outcome at 3 months (Glasgow Outcome Scale-Extended) and emotional distress at 1 year (Symptom Checklist 90-Revised). Results: Education, injury severity measures, functional outcome, and emotional distress were significantly associated with both Memory and Executive function. Education and emotional distress were related to Reasoning. The interaction effects between time and these predictors in predicting neurocognitive trajectories were nonsignificant. Among patients with data at 1 and 10 year follow-ups (n= 47), 94-96% exhibited stable scores on Executive function and Reasoning tasks, and 83% demonstrated stable scores on Memory tasks. Significant memory decline was presented in 11% of patients. Conclusions: The findings highlight the differential contribution of variables in their relationships with long-term neurocognitive functioning after moderate-severe TBI. Injury severity was important for Memory outcomes, whereas emotional distress influenced all neurocognitive domains. Reasoning (intellectual) abilities were relatively robust after TBI. While the majority of patients appeared to be cognitively stable beyond the first year, a small subset demonstrated a significant memory decline over time.	[Sigurdardottir, Solrun; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway; [Andelic, Nada; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Div Clin Neurosci, Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	sosigu@ous-hf.no		Sigurdardottir, Solrun/0000-0002-7194-3570	Department of Research, Sunnaas Rehabilitation Hospital, Nesoddtangen; Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Norway	This study was funded by the Department of Research, Sunnaas Rehabilitation Hospital, Nesoddtangen, and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Norway. The authors are grateful to all the persons for their participation. Special thanks to Tone Jerstad (neuroradiologist, Oslo University Hospital, Ulleval, Oslo) for the CT assessments and Morten Hestnes (Trauma Register, Oslo University Hospital, Ulleval, Oslo) for the extraction of trauma scores.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 1991, NASSP B, V75, pv; [Anonymous], 2014, CITIES, V36, P1; [Anonymous], 2009, AFRICA CONFIDENTIAL, V50, P4; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL REV 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; D'Souza A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00353; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis LR., 1983, SCL 90 R ADM SCORING; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meyers JE., 1995, REY COMPLEX FIGURE T; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reitan R, 1985, HALSTEAD REITAN NEUR; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shields GS, 2016, EMOTION, V16, P792, DOI 10.1037/emo0000151; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Teague S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0586-7; TEASDALE G, 1974, LANCET, V2, P81; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29	78	6	6	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2020	26	7					654	667	PII S1355617720000193	10.1017/S1355617720000193			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	MY2TG	WOS:000558272100003	32098637				2022-02-06	
J	Wang, YY; Wang, GQ; Xu, DG; Jiang, BZ; Ge, ML; Wu, LM; Yang, CY; Mu, N; Wang, S; Chang, C; Chen, TN; Feng, H; Yao, JQ				Wang, Yuye; Wang, Guoqiang; Xu, Degang; Jiang, Bozhou; Ge, Meilan; Wu, Limin; Yang, Chuanyan; Mu, Ning; Wang, Shi; Chang, Chao; Chen, Tunan; Feng, Hua; Yao, Jianquan			Terahertz spectroscopic diagnosis of early blast-induced traumatic brain injury in rats	BIOMEDICAL OPTICS EXPRESS			English	Article							SHOCK-TUBES; MODEL	The early diagnosis of blast-induced traumatic brain injury (bTBI) is of great clinical significance for prognostication and treatment. Here, we report a new strategy for early bTBI diagnosis through serum and cerebrospinal fluid (CSF) based on terahertz time-domain spectroscopy (THz-TDS). The spectral differences of serum and CSF for different degrees of experimental bTBI in rats have been demonstrated in the early period. In addition, the THz spectra of total protein in the hypothalamus and hippocampus were investigated at different time points after blast exposure, which both showed clear differences with time increasing compared with that in the normal brain. This might help to explain the neurological symptoms caused by bTBI. Moreover, based on the THz absorption spectra of serum and CSF, the principal component analysis and machine learning algorithms were performed to automatically identify the degree of bTBI. The highest diagnostic accuracy was up to 95.5%. It is suggested that this method has potential as an alternative method for high-sensitive, rapid, label-free, economical and early diagnosis of bTBI. (C) 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Wang, Yuye; Wang, Guoqiang; Xu, Degang; Jiang, Bozhou; Ge, Meilan; Wu, Limin; Yao, Jianquan] Tianjin Univ, Sch Precis Instruments & Optoelect Engn, Inst Laser & Optoelect, Tianjin 300072, Peoples R China; [Wang, Yuye; Wang, Guoqiang; Xu, Degang; Jiang, Bozhou; Ge, Meilan; Wu, Limin; Yao, Jianquan] Tianjin Univ, Key Lab Optoelect Informat Technol, Minist Educ, Tianjin 300072, Peoples R China; [Yang, Chuanyan; Mu, Ning; Wang, Shi; Chen, Tunan; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Army Med Univ, Chongqing 400038, Peoples R China; [Yang, Chuanyan; Mu, Ning; Wang, Shi; Chen, Tunan; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Key Lab Neurotrauma, Army Med Univ, Chongqing 400038, Peoples R China; [Chang, Chao] Natl Innovat Inst Def Technol, Innovat Lab Terahertz Biophys, Beijing 100071, Peoples R China		Xu, DG (corresponding author), Tianjin Univ, Sch Precis Instruments & Optoelect Engn, Inst Laser & Optoelect, Tianjin 300072, Peoples R China.; Xu, DG (corresponding author), Tianjin Univ, Key Lab Optoelect Informat Technol, Minist Educ, Tianjin 300072, Peoples R China.	xudegang@tju.edu.cn; changc@xjtu.edu.cn; ctn_666@sina.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217; Mu, Ning/0000-0002-5195-4838	National Basic Research Program of China (973)National Basic Research Program of China [2015CB755403]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61771332, 61775160, 62011540006, U1837202]	The National Basic Research Program of China (973) (2015CB755403); National Natural Science Foundation of China (61771332, 61775160, 62011540006, U1837202).	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444; Bernier M, 2013, IEEE T THZ SCI TECHN, V3, P295, DOI 10.1109/TTHZ.2013.2247793; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Fan ST, 2016, PHOTONICS RES, V4, pA29, DOI 10.1364/PRJ.4.000A29; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hirori H, 2004, JPN J APPL PHYS 2, V43, pL1287, DOI 10.1143/JJAP.43.L1287; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liu HB, 2006, OPT EXPRESS, V14, P415, DOI 10.1364/OPEX.14.000415; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ning YL, 2015, CHIN J TRAUMATOL, V18, P187, DOI 10.1016/j.cjtee.2015.04.005; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Saggar M, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0384-19.2019; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Shi J, 2018, OPT EXPRESS, V26, P6371, DOI 10.1364/OE.26.006371; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yu S, 2009, CELL TRANSPLANT, V18, P241; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372	32	6	7	8	25	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	AUG 1	2020	11	8					4085	4098		10.1364/BOE.395432			14	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	NZ9XI	WOS:000577451600003	32923030	Green Published, gold			2022-02-06	
J	Giudice, JS; Alshareef, A; Wu, TT; Gancayco, CA; Reynier, KA; Tustison, NJ; Druzgal, TJ; Panzer, MB				Giudice, J. Sebastian; Alshareef, Ahmed; Wu, Taotao; Gancayco, Christina A.; Reynier, Kristen A.; Tustison, Nicholas J.; Druzgal, T. Jason; Panzer, Matthew B.			An Image Registration-Based Morphing Technique for Generating Subject-Specific Brain Finite Element Models	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Magnetic resonance imaging (MRI); Traumatic brain injury (TBI); Personalized medicine; Computational mechanics	TENSOR-BASED MORPHOMETRY; PROFESSIONAL FOOTBALL; DIFFUSION-TENSOR; INJURY; DEFORMATION; CONCUSSION; RESPONSES; HEAD; MRI; DIAGNOSIS	Finite element (FE) models of the brain are crucial for investigating the mechanisms of traumatic brain injury (TBI). However, FE brain models are often limited to a single neuroanatomy because the manual development of subject-specific models is time consuming. The objective of this study was to develop a pipeline to automatically generate subject-specific FE brain models using previously developed nonlinear image registration techniques, preserving both external and internal neuroanatomical characteristics. To verify the morphing-induced mesh distortions did not influence the brain deformation response, strain distributions predicted using the morphed model were compared to those from manually created voxel models of the same subject. Morphed and voxel models were generated for 44 subjects ranging in age, and simulated using head kinematics from a football concussion case. For each subject, brain strain distributions predicted by each model type were consistent, and differences in strain prediction was less than 4% between model type. This automated technique, taking approximately 2 h to generate a subject-specific model, will facilitate interdisciplinary research between the biomechanics and neuroimaging fields and could enable future use of biomechanical models in the clinical setting as a tool for improving diagnosis.	[Giudice, J. Sebastian; Alshareef, Ahmed; Wu, Taotao; Reynier, Kristen A.; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22901 USA; [Gancayco, Christina A.] Univ Virginia, Adv Res Comp, Charlottesville, VA USA; [Tustison, Nicholas J.; Druzgal, T. Jason] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA; [Panzer, Matthew B.] Univ Virginia, Brain Injury & Sports Concuss Ctr, Charlottesville, VA USA		Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22901 USA.	panzer@virginia.edu		Panzer, Matthew/0000-0002-4500-9442; Giudice, Sebastian/0000-0003-1074-4890	UVA Brain Institute and Achievement Rewards for College Scientists Foundation (ARCS)	The authors gratefully acknowledge the UVA Brain Institute and Achievement Rewards for College Scientists Foundation (ARCS) for supporting this research. We would also like to thank Grant Kim for his assistance. The authors are thankful to Dr. Alayna Panzer for her thorough revisions to the manuscript.	Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; [Anonymous], 2015, C TRAUM BRAIN INJ US; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Avants BB, 2006, MED IMAGE ANAL, V10, P397, DOI 10.1016/j.media.2005.03.005; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Crum WR, 2003, NEUROIMAGE, V20, P1425, DOI 10.1016/j.neuroimage.2003.07.014; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; de Grau S, 2020, P I MECH ENG P-J SPO, V234, P98, DOI 10.1177/1754337119871866; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Glaister J., 2017, AUTOMATIC FALX CEREB; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Reynier K., 2020, ANN BIOMED ENG; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Siegkas P, 2019, SCI REP, V9, P1; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Toga AW, 2001, IMAGE VISION COMPUT, V19, P3, DOI 10.1016/S0262-8856(00)00055-X; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z	61	6	6	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2020	48	10					2412	2424		10.1007/s10439-020-02584-z		JUL 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	NS0HW	WOS:000554028600002	32725547				2022-02-06	
J	Wettervik, TS; Engquist, H; Howells, T; Lenell, S; Rostami, E; Hillered, L; Enblad, P; Lewen, A				Wettervik, Teodor Svedung; Engquist, Henrik; Howells, Timothy; Lenell, Samuel; Rostami, Elham; Hillered, Lars; Enblad, Per; Lewen, Anders			Arterial Oxygenation in Traumatic Brain Injury-Relation to Cerebral Energy Metabolism, Autoregulation, and Clinical Outcome	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						autoregulation; energy metabolism; hyperoxia; neurointensive care; traumatic brain injury	SEVERE HEAD-INJURY; BLOOD-FLOW; TISSUE OXYGEN; PRESSURE REACTIVITY; PERFUSION-PRESSURE; INTRACEREBRAL MICRODIALYSIS; NORMOBARIC HYPEROXIA; NEUROINTENSIVE CARE; INSPIRED OXYGEN; MANAGEMENT	Background: Ischemic and hypoxic secondary brain insults are common and detrimental in traumatic brain injury (TBI). Treatment aims to maintain an adequate cerebral blood flow with sufficient arterial oxygen content. It has been suggested that arterial hyperoxia may be beneficial to the injured brain to compensate for cerebral ischemia, overcome diffusion barriers, and improve mitochondrial function. In this study, we investigated the relation between arterial oxygen levels and cerebral energy metabolism, pressure autoregulation, and clinical outcome. Methods: This retrospective study was based on 115 patients with severe TBI treated in the neurointensive care unit, Uppsala university hospital, Sweden, 2008 to 2018. Data from cerebral microdialysis (MD), arterial blood gases, hemodynamics, and intracranial pressure were analyzed the first 10 days post-injury. The first day post-injury was studied in particular. Results: Arterial oxygen levels were higher and with greater variability on the first day post-injury, whereas it was more stable the following 9 days. Normal-to-high mean pO(2)was significantly associated with better pressure autoregulation/lower pressure reactivity index (P= .02) and lower cerebral MD-lactate (P= .04) on day 1. Patients with limited cerebral energy metabolic substrate supply (MD-pyruvate below 120 mu M) and metabolic disturbances with MD-lactate-/pyruvate ratio (LPR) above 25 had significantly lower arterial oxygen levels than those with limited MD-pyruvate supply and normal MD-LPR (P= .001) this day. Arterial oxygenation was not associated with clinical outcome. Conclusions: Maintaining a pO(2)above 12 kPa and higher may improve oxidative cerebral energy metabolism and pressure autoregulation, particularly in cases of limited energy substrate supply in the early phase of TBI. Evaluating the cerebral energy metabolic profile could yield a better patient selection for hyperoxic treatment in future trials.	[Wettervik, Teodor Svedung; Howells, Timothy; Lenell, Samuel; Rostami, Elham; Hillered, Lars; Enblad, Per; Lewen, Anders] Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Lenell, Samuel/0000-0001-8914-5086; Svedung Wettervik, Teodor/0000-0002-4556-5721	Uppsala University Hospital (ALF grant, Swedish Research Council funding for clinical research in medicine)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported financially by the Uppsala University Hospital (ALF grant, ie, Swedish Research Council funding for clinical research in medicine). The data for this manuscript can be accessed upon request.	Alali AS, 2020, J NEUROSURG, V132, P537, DOI 10.3171/2018.10.JNS18964; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; GRAHAM DI, 1971, LANCET, V1, P265; Hoiland RL, 2016, AM J PHYSIOL-REG I, V310, pR398, DOI 10.1152/ajpregu.00270.2015; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2013, NEUROCRIT CARE, V19, P69, DOI 10.1007/s12028-013-9857-7; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Lazaridis C, 2017, J CRIT CARE, V37, P230, DOI 10.1016/j.jcrc.2016.09.027; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Sjoberg F, 1999, ACTA PHYSIOL SCAND, V165, P33; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Wettervik TS, 2020, WORLD NEUROSURG, V133, pE567, DOI 10.1016/j.wneu.2019.09.099; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	51	6	6	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	SEP	2021	36	9					1075	1083	0885066620944097	10.1177/0885066620944097		JUL 2020	9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TV4ZK	WOS:000553082200001	32715850	Green Published			2022-02-06	
J	Damiano, F; De Benedetto, GE; Longo, S; Giannotti, L; Fico, D; Siculella, L; Giudetti, AM				Damiano, Fabrizio; De Benedetto, Giuseppe E.; Longo, Serena; Giannotti, Laura; Fico, Daniela; Siculella, Luisa; Giudetti, Anna M.			Decanoic Acid and Not Octanoic Acid Stimulates Fatty Acid Synthesis in U87MG Glioblastoma Cells: A Metabolomics Study	FRONTIERS IN NEUROSCIENCE			English	Article						citric acid cycle; decanoic acid; lipid synthesis; metabolomics; octanoic acid	LIVER-MITOCHONDRIA; CHAIN; METABOLISM; PLASMA; OXIDATION; BINDING	Medium-chain fatty acids (MCFA) are dietary components with a chain length ranging from 6 to 12 carbon atoms. MCFA can cross the blood-brain barrier and in the brain can be oxidized through mitochondrial beta-oxidation. As components of ketogenic diets, MCFA have demonstrated beneficial effects on different brain diseases, such as traumatic brain injury, Alzheimer's disease, drug-resistant epilepsy, diabetes, and cancer. Despite the interest in MCFA effects, not much information is available about MCFA metabolism in the brain. In this study, with a gas chromatography-mass spectrometry (GC-MS)-based metabolomics approach, coupled with multivariate data analyses, we followed the metabolic changes of U87MG glioblastoma cells after the addition of octanoic (C8), or decanoic (C10) acids for 24 h. Our analysis highlighted significant differences in the metabolism of U87MG cells after the addition of C8 or C10 and identified several metabolites whose amount changed between the two groups of treated cells. Overall, metabolic pathway analyses suggested the citric acid cycle, Warburg effect, glutamine/glutamate metabolism, and ketone body metabolism as pathways influenced by C8 or C10 addition to U87MG cells. Our data demonstrated that, while C8 affected mitochondrial metabolism resulting in increased ketone body production, C10 mainly influenced cytosolic pathways by stimulating fatty acid synthesis. Moreover, glutamine might be the main substrate to support fatty acids synthesis in C10-treated cells. In conclusion, we identified a metabolic signature associated with C8 or C10 addition to U87MG cells that can be used to decipher metabolic responses of glioblastoma cells to MCFA treatment.	[Damiano, Fabrizio; Longo, Serena; Giannotti, Laura; Siculella, Luisa; Giudetti, Anna M.] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [De Benedetto, Giuseppe E.; Fico, Daniela] Univ Salento, Dept Cultural Heritage, Analyt & Isotop Mass Spectrometry Lab, Lecce, Italy		Siculella, L; Giudetti, AM (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	luisa.siculella@unisalento.it; anna.giudetti@unisalento.it	Giudetti, Anna Maria/ABF-4049-2021	LONGO, SERENA/0000-0001-8595-1259			Andersen JV, 2017, J CEREBR BLOOD F MET, V37, P1137, DOI 10.1177/0271678X16684154; ASHBROOK JD, 1972, J BIOL CHEM, V247, P7038; ASHBROOK JD, 1975, J BIOL CHEM, V250, P2333; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Boomgaarden I, 2009, BIOCHEM GENET, V47, P739, DOI 10.1007/s10528-009-9273-z; Bott AJ, 2019, CANCERS, V11, DOI 10.3390/cancers11060770; Bowman CE, 2017, CELL CHEM BIOL, V24, P673, DOI 10.1016/j.chembiol.2017.04.009; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CASADEIGARDINI A, 2020, CANCERS, V0012; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; De Castro F, 2018, MOLECULES, V23, DOI 10.3390/molecules23092301; Del Coco L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050720; Evans M, 2017, J PHYSIOL-LONDON, V595, P2857, DOI 10.1113/JP273185; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; GEELEN MJH, 1994, BIOCHEM J, V302, P141, DOI 10.1042/bj3020141; Girelli CR, 2016, PEERJ, V4, DOI 10.7717/peerj.2740; Giudetti AM, 2019, FASEB J, V33, P1428, DOI 10.1096/fj.201801130R; Giudetti AM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060817; HAIDUKEWYCH D, 1982, CLIN CHEM, V28, P642; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Jones PM, 2006, BIOCHEM BIOPH RES CO, V346, P193, DOI 10.1016/j.bbrc.2006.05.107; Khabbush A, 2017, EPILEPSIA, V58, P1423, DOI 10.1111/epi.13833; Klepper J, 2004, PROSTAG LEUKOTR ESS, V70, P321, DOI 10.1016/j.plefa.2003.07.004; Leaver HA, 2002, PROSTAG LEUKOTR ESS, V66, P19, DOI 10.1054/plef.2001.0336; Li RJ, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13140; Malapaka RRV, 2012, J BIOL CHEM, V287, P183, DOI 10.1074/jbc.M111.294785; Marten B, 2006, INT DAIRY J, V16, P1374, DOI 10.1016/j.idairyj.2006.06.015; NATHAN J, 2019, CUREUS, V0011; Nugent S, 2014, NEUROBIOL AGING, V35, P1386, DOI 10.1016/j.neurobiolaging.2013.11.027; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Romano A, 2017, FREE RADICAL BIO MED, V111, P281, DOI 10.1016/j.freeradbiomed.2016.12.046; Rusek M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163892; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Siculella L, 2006, J BIOL CHEM, V281, P19072, DOI 10.1074/jbc.M507237200; Sonnay S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00657; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; Thevenet J, 2016, FASEB J, V30, P1913, DOI 10.1096/fj.201500182; Vergara D, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7864316; Vergara D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00544; Vessey DA, 1999, BBA-GEN SUBJECTS, V1428, P455, DOI 10.1016/S0304-4165(99)00088-4; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI 10.1158/jcr.1925.148; Weber DD, 2020, MOL METAB, V33, P102, DOI 10.1016/j.molmet.2019.06.026; Weiss AKH, 2018, BIOCHEM J, V475, P3561, DOI 10.1042/BCJ20180750	48	6	6	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 23	2020	14								783	10.3389/fnins.2020.00783			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NB1WL	WOS:000560305200001	32792906	Green Published, gold			2022-02-06	
J	Lefkovits, AM; Hicks, AJ; Downing, M; Ponsford, J				Lefkovits, Aviva Margaret; Hicks, Amelia J.; Downing, Marina; Ponsford, Jennie			Surviving the "silent epidemic": A qualitative exploration of the long-term journey after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Qualitative; Long-term recovery	PSYCHOSOCIAL ADJUSTMENT; COGNITIVE IMPAIRMENT; PEOPLE; SELF; EXPERIENCE; NARRATIVES; OUTCOMES; ADULTS; PERSPECTIVES; INDIVIDUALS	Previous studies examining life after traumatic brain injury (TBI) have taken a predominantly short-term and quantitative perspective, with generally narrow focus, and have not specifically investigated changes in experienceover timepost-injury to gain a uniquely long-term perspective. This study therefore aimed to qualitatively explore the broad long-term experience of living for 10 years or more with TBI. Thirty participants completed semi-structured interviews investigating the impact of TBI on various life domains, the rehabilitation experience and support received, and overall perspectives of the long-term journey after TBI. Results demonstrated that: (a) although some participants reported full recovery, several experienced persistent physical, cognitive and emotional problems that impacted their independence, employment and interpersonal relationships; (b) early rehabilitation was very helpful, but some participants experienced difficulties accessing ongoing services; (c) family and social support were important to recovery; (d) most participants drew upon inner strength to find positives in their experience. These findings have identified factors that facilitate and impede long-term recovery from TBI, which may inform better support and care for injured individuals over the years after injury to improve their quality of life.	[Lefkovits, Aviva Margaret; Hicks, Amelia J.; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X; Hicks, Amelia/0000-0002-1152-0576	Transport Accident Commission	The present study forms part of a larger longitudinal study conducted at Monash Epworth Rehabilitation Research Centre, which has funding from the Transport Accident Commission. This funding was used to compensate participants financially.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Calhoun, 1995, TRAUMA TRANSFORMATIO; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; Cutler M, 2016, J SOC WORK DISABIL R, V15, P260, DOI 10.1080/1536710X.2016.1220879; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020672; KNAFL KA, 1984, RES NURS HEALTH, V7, P17, DOI 10.1002/nur.4770070105; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Libeson L, 2020, NEUROPSYCHOL REHABIL, V30, P412, DOI 10.1080/09602011.2018.1470987; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Schrank B, 2012, SOC SCI MED, V74, P554, DOI 10.1016/j.socscimed.2011.11.008; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Viera AJ, 2005, FAM MED, V37, P360; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359	51	6	6	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 26	2021	31	10					1582	1606		10.1080/09602011.2020.1787849		JUL 2020	25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WY2GK	WOS:000552767500001	32660336				2022-02-06	
J	Zhang, ZW; Liang, J; Yan, JX; Ye, YC; Wang, JJ; Chen, C; Sun, HT; Chen, F; Tu, Y; Li, XH				Zhang, Zhen-Wen; Liang, Jun; Yan, Jing-Xing; Ye, Yi-Chao; Wang, Jing-Jing; Chen, Chong; Sun, Hong-Tao; Chen, Feng; Tu, Yue; Li, Xiao-Hong			TBHQ improved neurological recovery after traumatic brain injury by inhibiting the overactivation of astrocytes	BRAIN RESEARCH			English	Article						Traumatic brain injury; TBHQ; Astrocyte; Activation; Nrf-2; Oxidative stress	SPINAL-CORD-INJURY; TERT-BUTYLHYDROQUINONE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; FUNCTIONAL RECOVERY; MODEL; INFLAMMATION; ACTIVATION; HEMORRHAGE; PROTECTS	Traumatic brain injury (TBI) is a major leading cause of death and long-term disability. Although astrocytes play a key role in neuroprotection after TBI in the early stage, the overactivation of astrocytes can lead to long-term functional deficits, and the underlying pathophysiological mechanisms remain unclear. In addition, it is unknown whether the nuclear factor erythroid 2-related factor2/haem oxygenase-1 (Nrf-2/HO-1) pathway could elicit a neuroprotective effect by decreasing astrocyte overactivation after TBI. We aimed to study the effects of tert-butylhydroquinone (TBHQ) in reducing astrocyte overactivation after TBI and explored the underlying mechanisms. We first established a controlled cortical impact (CCI) model in rats and performed Haematoxylin and eosin (H&E) staining to observe brain tissue damage. The cognitive function of rats was assessed by modified neurological severity scoring (mNSS) and Morris water maze (MWM) test. Astrocyte and microglia activation was detected by immunofluorescence staining. Oxidative stress conditions were investigated using Western blotting. An enzyme-linked immunosorbent assay (ELISA) was designed to assess the level of the proinflammatory factor tumour necrosis factor-alpha (TNF-alpha). Dihydroethidium (DHE) staining was used to detect reactive oxygen species (ROS). Apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The results showed that the administration of TBHQ ameliorated motor function and cognitive deficits and decreased the lesion volume. In addition, TBHQ significantly decreased astrocyte overactivation, diminished the pro-inflammatory phenotype M1 and inflammatory cytokines production after TBI, increased Nrf-2 nuclear accumulation, and enhanced the levels of the Nrf-2 downstream antioxidative genes HO-1 and NADPH-quinone oxidoreductase-1 (NQO-1). Furthermore, TBHQ treatment alleviated apoptosis and neuronal death in the cerebral cortex. Overall, our data indicated that the upregulation of Nrf-2 expression could enhance neuroprotection and decrease astrocyte overactivation and might represent a new theoretical basis for treating TBI.	[Zhang, Zhen-Wen] Gansu Univ Chinese Med, Coll Integrated Tradit Chinese & Western Med, Lanzhou 730000, Gansu, Peoples R China; [Zhang, Zhen-Wen; Yan, Jing-Xing; Chen, Feng] Gansu Univ Chinese Med, Affiliated Hosp, Lanzhou 730000, Gansu, Peoples R China; [Liang, Jun; Yan, Jing-Xing; Ye, Yi-Chao; Wang, Jing-Jing; Chen, Chong; Sun, Hong-Tao; Tu, Yue] Characterist Med Ctr PAPF, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China; [Li, Xiao-Hong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China		Tu, Y (corresponding author), Characterist Med Ctr PAPF, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China.; Li, XH (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China.	ytumail@vip.126.com; lixiaohong12@hotmail.com			National Nature Scientific Fund of China [81771350, 81771352, 81671222, 81772018, 81971782]; Nature Scientific Fund of Tianjin [18JCJQJC48500, 15ZXLCSY00040, 16JCYBJC27600, 16ZXHLSY00120]	This work was supported by the National Nature Scientific Fund of China (81771350, 81771352, 81671222, 81772018, 81971782) and the Nature Scientific Fund of Tianjin (18JCJQJC48500, 15ZXLCSY00040, 16JCYBJC27600, 16ZXHLSY00120).	Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; Bai J, 2017, TOXICOL LETT, V281, P1, DOI 10.1016/j.toxlet.2017.08.018; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eastman CL, 2019, NEUROPHARMACOLOGY; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao P, 2019, NEUROREPORT, V30, P389, DOI 10.1097/WNR.0000000000001210; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lee JH, 2015, AM J EMERG MED, V33, P1773, DOI 10.1016/j.ajem.2015.08.036; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee SH, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146405; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li TT, 2020, BRAIN RES, V1730, DOI 10.1016/j.brainres.2020.146651; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu FT, 2014, CNS NEUROSCI THER, V20, P778, DOI 10.1111/cns.12258; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ren C., 2019, BIOMATERIALS, V232; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sugiyama T, 2018, BRAIN RES, V1701, P137, DOI 10.1016/j.brainres.2018.08.021; Sukumari-Ramesh S, 2016, J MOL NEUROSCI, V58, P525, DOI 10.1007/s12031-016-0722-y; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang YC, 2011, J BIOL CHEM, V286, P21742, DOI 10.1074/jbc.M110.160697; Wang Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0104657, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0109571]; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ye F, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2075915; Zhang J, 2010, CYTOKINE, V52, P252, DOI 10.1016/j.cyto.2010.08.011; Zhang J, 2018, NEUROCHEM INT, V116, P1, DOI 10.1016/j.neuint.2018.03.004; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang Z, 2019, BRAIN RES BULL, V150, P42, DOI 10.1016/j.brainresbull.2019.05.005; Zhao R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/412576; Zou JY, 2016, BRAIN RES, V1637, P56, DOI 10.1016/j.brainres.2016.02.017; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190	65	6	6	4	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 15	2020	1739								146818	10.1016/j.brainres.2020.146818			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LN3CS	WOS:000532820500005	32275911				2022-02-06	
J	Waltzman, D; Womack, LS; Thomas, KE; Sarmiento, K				Waltzman, Dana; Womack, Lindsay S.; Thomas, Karen E.; Sarmiento, Kelly			Trends in Emergency Department Visits for Contact Sports-Related Traumatic Brain Injuries Among Children - United States, 2001-2018	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article							CONCUSSIONS		[Waltzman, Dana; Womack, Lindsay S.; Thomas, Karen E.; Sarmiento, Kelly] CDC, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30333 USA		Waltzman, D (corresponding author), CDC, Natl Ctr Injury Prevent & Control, Div Injury Prevent, Atlanta, GA 30333 USA.	DWaltzman@cdc.gov					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MOSES S, 2018, SPORTS CONTACT LEVEL; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Shanley E, 2021, CLIN J SPORT MED, V31, P120, DOI 10.1097/JSM.0000000000000711; The Aspen Institute, 2018, STAT PLAY 2018 TREND; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	10	6	6	1	2	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	JUL 10	2020	69	27					870	874		10.15585/mmwr.mm6927a4			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	MJ6RP	WOS:000548215500004	32644984	gold, Green Published			2022-02-06	
J	Saksvik, SB; Karaliute, M; Kallestad, H; Follestad, T; Asarnow, R; Vik, A; Haberg, AK; Skandsen, T; Olsen, A				Saksvik, Simen Berg; Karaliute, Migle; Kallestad, Havard; Follestad, Turid; Asarnow, Robert; Vik, Anne; Haberg, Asta Kristine; Skandsen, Toril; Olsen, Alexander			The Prevalence and Stability of Sleep-Wake Disturbance and Fatigue throughout the First Year after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						fatigue; hypersomnia; insomnia; mild traumatic brain injury; sleep-wake disturbances	DAYTIME SLEEPINESS; NORWEGIAN VERSION; RISK-FACTORS; DISORDERS; DEPRESSION; SEVERITY; INSOMNIA; SYMPTOMS; NEED; INTERVENTIONS	In this prospective, longitudinal study, we aimed to determine the prevalence and stability of sleep-wake disturbance (SWD) and fatigue in a large representative sample of patients (Trondheim mild traumatic brain injury [mTBI] follow-up study). We included 378 patients with mTBI (age 16-60), 82 matched trauma controls with orthopedic injuries, and 83 matched community controls. Increased sleep need, poor sleep quality, excessive daytime sleepiness, and fatigue were assessed at 2 weeks, 3 months, and 12 months after injury. Mixed logistic regression models were used to evaluate clinically relevant group differences longitudinally. Prevalence of increased sleep need, poor sleep quality, and fatigue was significantly higher in patients with mTBI than in both trauma controls and community controls at all time points. More patients with mTBI reported problems with excessive daytime sleepiness compared to trauma controls, but not community controls, at all time points. Patients with complicated mTBI (intracranial findings on computed tomography or magnetic resonance imaging) had more fatigue problems compared to those with uncomplicated mTBI, at all three time points. In patients with mTBI who experienced SWDs and fatigue 2 weeks after injury, around halfstillhad problems at 3 months and approximately one third at 12 months. Interestingly, we observed limited overlap between the different symptom measures; a large number of patients reported one specific problem with SWD or fatigue rather than several problems. In conclusion, our results provide strong evidence that mTBI contributes significantly to the development and maintenance of SWDs and fatigue.	[Saksvik, Simen Berg; Karaliute, Migle; Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway; [Kallestad, Havard] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Vik, Anne; Haberg, Asta Kristine; Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway; [Saksvik, Simen Berg; Skandsen, Toril; Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta Kristine] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Asarnow, Robert] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA		Olsen, A (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7491 Trondheim, Norway.	alexander.olsen@ntnu.no			Liaison Committee	The study was partly funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU; to S.B.S. and A.O.).	Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Aurora RN, 2011, SLEEP, V34, P1707, DOI 10.5665/sleep.1442; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Beiske KK, 2009, SLEEP BREATH, V13, P65, DOI 10.1007/s11325-008-0202-x; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crofford LJ, 2007, TRAUMA VIOLENCE ABUS, V8, P299, DOI 10.1177/1524838007303196; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Enders CK, 2017, BEHAV RES THER, V98, P4, DOI 10.1016/j.brat.2016.11.008; Engberg I, 2017, BMC PUBLIC HEALTH, V2014, P17, DOI DOI 10.1186/S12889-017-4623-Y; Gee B, 2019, SLEEP MED REV, V43, P118, DOI 10.1016/j.smrv.2018.09.004; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hoffman N.L., 2018, SLEEP, V42; Huang TY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/378726; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Jang SH, 2016, J NEUROL NEUROSUR PS, V87, P1260, DOI 10.1136/jnnp-2016-313093; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Khan S, 2020, CUREUS, V12, DOI 10.7759/cureus.6616; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Mollayeva T., 2017, NEUROPSYCHIATRY-LOND, V7, P86, DOI [DOI 10.4172/Neuropsychiatry, 10.4172/Neuropsychiatry.1000184, DOI 10.4172/NEUROPSYCHIATRY.1000184]; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Pallesen S, 2014, SLEEP MED, V15, P173, DOI 10.1016/j.sleep.2013.10.009; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2; Raikes AC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00468; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Shafi R, 2019, OCCUP ENVIRON MED, V76, P471, DOI 10.1136/oemed-2018-105621; Shekleton JA, 2010, SLEEP MED REV, V14, P47, DOI 10.1016/j.smrv.2009.06.001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shulman BS, 2015, J ORTHOP TRAUMA, V29, pE146, DOI 10.1097/BOT.0000000000000217; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Skorvanek M, 2015, ACTA NEUROL SCAND, V131, P80, DOI 10.1111/ane.12282; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Touitou Y, 2013, J PHYSIOL-PARIS, V107, P323, DOI 10.1016/j.jphysparis.2013.03.008; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wylde V, 2011, ORTHOP TRAUMATOL-SUR, V97, P139, DOI 10.1016/j.otsr.2010.12.003; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	84	6	6	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2528	2541		10.1089/neu.2019.6898		JUL 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000547880200001	32460623	hybrid, Green Submitted, Green Published			2022-02-06	
J	Bony, BA; Miller, HA; Tarudji, AW; Gee, CC; Sarella, A; Nichols, MG; Kievit, FM				Bony, Badrul Alam; Miller, Hunter A.; Tarudji, Aria W.; Gee, Connor C.; Sarella, Anandakumar; Nichols, Michael G.; Kievit, Forrest M.			Ultrasmall Mixed Eu-Gd Oxide Nanoparticles for Multimodal Fluorescence and Magnetic Resonance Imaging of Passive Accumulation and Retention in TBI	ACS OMEGA			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR DYSFUNCTION; DEMENTIA; DELIVERY; NEUROINFLAMMATION; SURFACE; DESIGN; RATS	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. TBI can have a long-term impact on the quality of life for survivors of all ages. However, there remains no approved treatment that improves outcomes following TBI, which is partially due to poor delivery of therapies into the brain. Therefore, there is a significant unmet need to develop more effective delivery strategies that increase the accumulation and retention of potentially efficacious treatments in the injured brain. Recent work has revealed that nanoparticles (NPs) may offer a promising approach for site-specific delivery; however, a detailed understanding of the specific NP properties that promote brain accumulation and retention are still being developed. Multimodal imaging plays a vital role in the understanding of physicochemical properties that initiate the uptake and accumulation of NPs in the brain at both high spatial (e.g., fluorescence imaging) and temporal (e.g., magnetic resonance imaging, MRI) frequency. However, many NP systems that are currently used in TBI only provide contrast in a single imaging modality limiting the imaging data that can be obtained, and those that offer multimodal imaging capabilities have complicated multistep synthesis methods. Therefore, the goal of this work was to develop an ultrasmall NP with simple fabrication capable of multimodal imaging. Here, we describe the development, characterization, accumulation, and retention of poly(ethylene glycol) (PEG)-coated europium-gadolinium (Eu-Gd) mixed magnetic NPs (MNPs) in a controlled cortical impact mouse model of TBI. We find that these NPs having an ultrasmall core size of 2 nm and a small hydrodynamic size of 13.5 nm can be detected in both fluorescence and MR imaging modalities and rapidly accumulate and are retained in injured brain parenchyma. These NPs should allow for further testing of NP physicochemical properties that promote accumulation and retention in TBI and other disease models.	[Bony, Badrul Alam; Miller, Hunter A.; Tarudji, Aria W.; Gee, Connor C.; Kievit, Forrest M.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA; [Sarella, Anandakumar] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; [Nichols, Michael G.] Creighton Univ, Dept Phys, Omaha, NE 68178 USA		Kievit, FM (corresponding author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.	fkievit2@unl.edu	BONY, BADRUL ALAM/J-4009-2019	BONY, BADRUL ALAM/0000-0001-5139-6541; Gee, Connor/0000-0002-5205-7557; Kievit, Forrest/0000-0002-9847-783X	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103480]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS109488]; Nebraska Settlement Biomedical Research Development Funds; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5P20RR016469]; National Institute for General Medical Science (NIGMS), a component of the National Institutes of Health (NIH) [8P20GM103427]; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1610400]; C.U. Medical School	F.M.K. acknowledges support from an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103480), grant funding from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01NS109488), and the Nebraska Settlement Biomedical Research Development Funds. Part of this research was conducted at the Integrative Biological Imaging Facility at Creighton University, Omaha, NE. This facility, supported by the C.U. Medical School, was constructed with support from grants from the National Center for Research Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (8P20GM103427), a component of the National Institutes of Health (NIH). This investigation is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS, NINDS, or NIH. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under the grant no. DGE-1610400 to H.A.M. We thank Brandon McDonald for his assistance in surgeries to generate CCI mice.	Badieirostami M, 2019, MRS ADV, V4, P2461, DOI 10.1557/adv.2019.242; Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Bharadwaj VN, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700668; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Bony BA, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11090473; Boyd BJ, 2015, J DRUG TARGET, V23, P847, DOI 10.3109/1061186X.2015.1034280; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cotton F.A., 1980, ADV INORGANIC CHEM, Vfourth; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Dong H, 2015, CHEM REV, V115, P10725, DOI 10.1021/acs.chemrev.5b00091; Elci SG, 2016, ACS NANO, V10, P5536, DOI 10.1021/acsnano.6b02086; Estandarte AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31417; Flores-Gonzalez MA, 2005, APPL PHYS A-MATER, V81, P1385, DOI 10.1007/s00339-005-3215-3; Gao J, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-017-2581-9; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; George MR, 2006, INORG CHEM, V45, P1739, DOI 10.1021/ic051461u; Hall E D, 1985, Cent Nerv Syst Trauma, V2, P75; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hug SJ, 2006, J ELECTRON SPECTROSC, V150, P208, DOI 10.1016/j.elspec.2005.05.006; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Kanaras AG, 2002, CHEM COMMUN, P2294, DOI 10.1039/b207838b; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/NNANO.2010.58, 10.1038/nnano.2010.58]; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kwon GS, 2003, CRIT REV THER DRUG, V20, P357, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Mutas M, 2018, NANOSCALE, V10, P20453, DOI 10.1039/c8nr06639f; Naczynski DJ, 2015, NANO LETT, V15, P96, DOI 10.1021/nl504123r; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Pelaz B, 2017, ACS NANO, V11, P2313, DOI 10.1021/acsnano.6b06040; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; Soderlind F, 2005, J COLLOID INTERF SCI, V288, P140, DOI 10.1016/j.jcis.2005.02.089; Suk JS, 2016, ADV DRUG DELIVER REV, V99, P28, DOI 10.1016/j.addr.2015.09.012; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; van Vlerken LE, 2007, PHARM RES-DORDR, V24, P1405, DOI 10.1007/s11095-007-9284-6; Wakefield G, 1999, J COLLOID INTERF SCI, V215, P179, DOI 10.1006/jcis.1999.6225; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Xu WL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03210; Yahav G, 2016, CYTOM PART A, V89A, P644, DOI 10.1002/cyto.a.22890; Yokel RA, 2020, NANOMEDICINE-UK, V15, P409, DOI 10.2217/nnm-2019-0169; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	52	6	6	0	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	JUL 7	2020	5	26					16220	16227		10.1021/acsomega.0c01890			8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	MK1JY	WOS:000548543800051	32656444	gold, Green Published			2022-02-06	
J	Simpson, GK; McRae, P; Hallab, L; Daher, M; Strettles, B				Simpson, Grahame K.; McRae, Philippa; Hallab, Lisa; Daher, Maysaa; Strettles, Barbara			Participation in competitive employment after severe traumatic brain injury: New employment versus return to previous (pre-injury) employment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Vocational rehabilitation; employment; traumatic brain injury; observational study; comorbidity	QUALITY-OF-LIFE; NEW-SOUTH-WALES; COMMUNITY INTEGRATION; WORK; MODERATE; OUTCOMES; REHABILITATION; COMORBIDITIES; STABILITY; WORKPLACE	There is limited literature comparing the clinical and employment characteristics of clients accessing new employment with those resuming previous employment. To address this gap, a multi-centre observational study was conducted of all active clients with severe TBI from the 11 community rehabilitation services (n = 588) of the New South Wales Brain Injury Rehabilitation Program. Demographic, injury, clinical and vocational data were collected by treating clinicians employing a purpose-designed protocol. New employment constituted almost 40% of competitive employment outcomes. Clients accessing new employment were significantly more likely to be younger, single, less educated, with more severe injuries and more likely to be displaying challenging behaviours than those resuming pre-injury work. Kaplan-Meier analyses found time to RTW was significantly longer for new employment. Stability of new employment was significantly poorer with jobs twice as likely to break down compared to previous employment. New employment positions were also more likely to be part-time and unskilled compared to previous employment. The results found that placement into new employment made a substantial contribution to employment outcomes after TBI but requires more intensive and tailored programmes to meet the multiple clinical and workplace challenges.	[Simpson, Grahame K.; McRae, Philippa; Hallab, Lisa; Daher, Maysaa; Strettles, Barbara] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [McRae, Philippa; Hallab, Lisa; Daher, Maysaa; Strettles, Barbara] NSW Agcy Clin Innovat, Brain Injury Rehabil Directorate, Sydney, NSW, Australia		McRae, P (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia.; McRae, P (corresponding author), NSW Agcy Clin Innovat, Brain Injury Rehabil Directorate, Sydney, NSW, Australia.	philippa.mcrae@health.nsw.gov.au		Simpson, Grahame/0000-0001-8156-9060	Lifetime Care & Support Authority (LTCSA); Motor Accidents Authority of NSW	This work was supported by the Lifetime Care & Support Authority (LTCSA) and Motor Accidents Authority of NSW (MAA).	Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Australian Bureau of Statistics, 2009, AUSTR NZ STANDARD CL; Australian Bureau of Statistics, 2013, LAB STAT CONC SOURC; Australian Bureau of Statistics, 2017, AUSTR DEM STAT FEAT; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Escorpizo R, 2015, HDB VOCATIONAL REHAB; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; O'Neil-Pirozzi T., 2004, STUDYING EMPLOYMENT; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; Tate RL, 2003, STUD NEUROPSYCHOL DE, P137; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107	47	6	6	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 2	2020	30	6					995	1012		10.1080/09602011.2018.1531769			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LU7DF	WOS:000537910900001	30404583				2022-02-06	
J	Kim, H; Langley, MR; Simon, WL; Yoon, H; Kleppe, L; Lanza, IR; LeBrasseur, NK; Matveyenko, A; Scarisbrick, IA				Kim, Ha Neui; Langley, Monica R.; Simon, Whitney L.; Yoon, Hyesook; Kleppe, Laurel; Lanza, Ian R.; LeBrasseur, Nathan K.; Matveyenko, Aleksey; Scarisbrick, Isobel A.			A Western diet impairs CNS energy homeostasis and recovery after spinal cord injury: Link to astrocyte metabolism	NEUROBIOLOGY OF DISEASE			English	Article						Astrogliosis; Myelin; Insulin; Spinal cord injury; Metformin; Western diet	TRAUMATIC BRAIN-INJURY; HIGH-FAT DIET; CEREBRAL GLUCOSE-METABOLISM; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; RAT MODEL; SIGNALING PATHWAYS; MULTIPLE-SCLEROSIS; DIABETES-MELLITUS; THROMBIN RECEPTOR	A diet high in fat and sucrose (HFHS), the so-called Western diet promotes metabolic syndrome, a significant co-morbidity for individuals with spinal cord injury (SCI). Here we demonstrate that the spinal cord of mice consuming HFHS expresses reduced insulin-like growth factor 1 (IGF-1) and its receptor and shows impaired tricarboxylic acid cycle function, reductions in PLP and increases in astrogliosis, all prior to SCI. After SCI, Western diet impaired sensorimotor and bladder recovery, increased microgliosis, exacerbated oligodendrocyte loss and reduced axon sprouting. Direct and indirect neural injury mechanisms are suggested since HFHS culture conditions drove parallel injury responses directly and indirectly after culture with conditioned media from HFHS-treated astrocytes. In each case, injury mechanisms included reductions in IGF-1R, SIRT1 and PGC-1 alpha and were prevented by metformin. Results highlight the potential for a Western diet to evoke signs of neural insulin resistance and injury and metformin as a strategy to improve mechanisms of neural neuroprotection and repair.	[Kim, Ha Neui; Langley, Monica R.; Simon, Whitney L.; Yoon, Hyesook; Kleppe, Laurel; LeBrasseur, Nathan K.; Scarisbrick, Isobel A.] Mayo Clin, Dept Phys Med & Rehabil, Grad Sch Biomed Sci, Rochester, MN 55905 USA; [Kim, Ha Neui; Langley, Monica R.; Yoon, Hyesook; Lanza, Ian R.; LeBrasseur, Nathan K.; Matveyenko, Aleksey; Scarisbrick, Isobel A.] Mayo Clin, Rehabil Med Res Ctr, Dept Physiol & Biomed Engn, Grad Sch Biomed Sci, Rochester, MN 55905 USA; [Scarisbrick, Isobel A.] Mayo Clin, Neurosci Program, Grad Sch Biomed Sci, Rochester, MN 55905 USA		Scarisbrick, IA (corresponding author), Mayo Clin Rochester, Neurobiol Dis Program, Phys Med & Rehabil, Rehabil Med Res Ctr, 642B Guggenhe Bldg,200 First St SW, Rochester, MN 55905 USA.	Scarisbrick.Isobel@mayo.edu		Kim, Haneui/0000-0002-5651-4727	Minnesota State Spinal Cord Injury and Traumatic Brain Injury Research Program; Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Metabolomics Core [U24DK100469, UL1TR000135]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [R01NS052741, RG4958]; Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology; Craig H. Neilsen Foundation	The work was supported by a grant from the Minnesota State Spinal Cord Injury and Traumatic Brain Injury Research Program, the Mayo Clinic Center for Biomedical Discovery and the Mayo Clinic Metabolomics Core (U24DK100469 and UL1TR000135). Portions of this work were also supported by R01NS052741, RG4958 from the National Multiple Sclerosis Society, a grant from the Craig H. Neilsen Foundation and the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology.	Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P1313, DOI 10.1016/j.bbadis.2014.05.007; Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; [Anonymous], 2017, SPIN CORD INJ FACTS; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; Berghoff SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14241; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Byrne F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/752481; Camacho A, 2013, EUR J NEUROSCI, V38, P2672, DOI 10.1111/ejn.12281; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Chesik D, 2007, INT REV NEUROBIOL, V79, P203, DOI 10.1016/S0074-7742(07)79009-8; Cuyas E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00657; de la Monte Suzanne M, 2012, Aging health, V8, P61; de Paleville DGLT, 2019, J SPINAL CORD MED, V42, P32, DOI 10.1080/10790268.2018.1449373; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Dutta T, 2016, J CLIN ENDOCR METAB, V101, P1023, DOI 10.1210/jc.2015-2640; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Farkas GJ, 2018, J SPINAL CORD MED, V41, P378, DOI 10.1080/10790268.2017.1357104; Frederick TJ, 2004, MOL CELL NEUROSCI, V25, P480, DOI 10.1016/j.mcn.2003.11.015; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fulton D, 2010, ASN NEURO, V2, DOI 10.1042/AN20090051; Gao Z, 2015, NEUROSCIENCE, V297, P11, DOI 10.1016/j.neuroscience.2015.03.031; Gater DR, 2019, J SPINAL CORD MED, V42, P86, DOI 10.1080/10790268.2017.1423266; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Gilbert O, 2014, ATHEROSCLEROSIS, V232, P305, DOI 10.1016/j.atherosclerosis.2013.11.028; Graham LC, 2019, NEUROBIOL AGING, V80, P154, DOI 10.1016/j.neurobiolaging.2019.03.018; Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Groah SL, 2011, J CARDIOPULM REHABIL, V31, P73, DOI 10.1097/HCR.0b013e3181f68aba; Guo Y, 2018, NEUROCHEM RES, V43, P1111, DOI 10.1007/s11064-018-2525-8; Gzielo K, 2017, CELL MOL NEUROBIOL, V37, P783, DOI 10.1007/s10571-016-0417-5; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Harris KK, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14207; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Hedstrom AK, 2014, NEUROLOGY, V82, P865, DOI 10.1212/WNL.0000000000000203; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HUITINGA I, 1995, CLIN EXP IMMUNOL, V100, P344; Inyang KE, 2019, PHARMACOL RES, V139, P1, DOI 10.1016/j.phrs.2018.10.027; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Ji Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01881; Jin YJ, 2016, NEURON, V91, P748, DOI 10.1016/j.neuron.2016.07.024; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Katoh H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00248; Kiebish MA, 2012, J LIPID RES, V53, P273, DOI 10.1194/jlr.M020628; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Langley MR, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165630; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; Lee YM, 2016, PHYSICIAN SPORTSMED, V44, P217, DOI 10.1080/00913847.2016.1216718; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin SY, 2005, BRAIN RES, V1063, P15, DOI 10.1016/j.brainres.2005.09.042; Liu YY, 2017, NEURON, V95, P817, DOI 10.1016/j.neuron.2017.07.037; Los DB, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.05.057; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Adami PVM, 2017, BBA-MOL BASIS DIS, V1863, P731, DOI 10.1016/j.bbadis.2016.12.014; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Min J, 2012, GLIA, V60, P1684, DOI 10.1002/glia.22387; Moore CD, 2018, J CLIN DENSITOM, V21, P329, DOI 10.1016/j.jocd.2017.06.001; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Mowery NT, 2009, J TRAUMA, V66, P145, DOI 10.1097/TA.0b013e3181938c5e; Muir E, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113032; Nash MS, 2016, ARCH PHYS MED REHAB, V97, P1696, DOI 10.1016/j.apmr.2016.07.002; Negrotto L, 2016, JAMA NEUROL, V73, P520, DOI 10.1001/jamaneurol.2015.4807; Ness JK, 2002, DEV NEUROSCI-BASEL, V24, P437, DOI 10.1159/000069050; Ng F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00064; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oliveira SR, 2014, NUTRITION, V30, P268, DOI 10.1016/j.nut.2013.08.001; Pardo PS, 2012, AGING-US, V4, P456, DOI 10.18632/aging.100470; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Penesova A, 2015, METAB BRAIN DIS, V30, P895, DOI 10.1007/s11011-015-9665-1; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Pukos N, 2019, GLIA, V67, P2178, DOI 10.1002/glia.23702; Qi BX, 2017, CELL MOL NEUROBIOL, V37, P1269, DOI 10.1007/s10571-016-0459-8; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Radulovic Maja, 2013, J Neuropathol Exp Neurol, V72, P1072, DOI 10.1097/NEN.0000000000000007; Saab AS, 2017, CURR OPIN NEUROBIOL, V47, P104, DOI 10.1016/j.conb.2017.09.013; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salkovic-Petrisic M, 2013, J NEURAL TRANSM, V120, P233, DOI 10.1007/s00702-012-0877-9; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schneider A, 2005, J CELL SCI, V118, P2415, DOI 10.1242/jcs.02365; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Song J, 2015, NEUROSCIENCE, V301, P26, DOI 10.1016/j.neuroscience.2015.05.072; Spann RA, 2017, PHYSIOL GENOMICS, V49, P519, DOI 10.1152/physiolgenomics.00078.2017; Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stassart RM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00467; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Stubbs CO, 2004, MED J AUSTRALIA, V181, P489, DOI 10.5694/j.1326-5377.2004.tb06406.x; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Taheri A, 2019, J NEUROL, V266, P1988, DOI 10.1007/s00415-019-09366-1; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Theriault P, 2016, ONCOTARGET, V7, P67808, DOI 10.18632/oncotarget.12179; Timmermans S, 2014, J NEUROIMMUNE PHARM, V9, P209, DOI 10.1007/s11481-013-9502-4; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; van Stee MF, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0738-4; Venkatesh K, 2019, CELL TISSUE RES, V377, P125, DOI 10.1007/s00441-019-03039-1; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011; Yahiro AM, 2020, J SPINAL CORD MED, V43, P485, DOI 10.1080/10790268.2018.1557864; Yoon H, 2017, GLIA, V65, P2070, DOI 10.1002/glia.23215; Yoon H, 2016, BBA-MOL BASIS DIS, V1862, P545, DOI 10.1016/j.bbadis.2016.01.019; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zeger M, 2007, GLIA, V55, P400, DOI 10.1002/glia.20469; Zhang D, 2017, J CELL MOL MED, V21, P3322, DOI 10.1111/jcmm.13235	132	6	6	3	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2020	141								104934	10.1016/j.nbd.2020.104934			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC0EQ	WOS:000542971000013	32376475	hybrid, Green Accepted			2022-02-06	
J	Le Fur, C; Camara-Costa, H; Francillette, L; Opatowski, M; Toure, H; Brugel, D; Laurent-Vannier, A; Meyer, P; Watier, L; Dellatolas, G; Chevignard, M				Le Fur, Clement; Camara-Costa, Hugo; Francillette, Leila; Opatowski, Marion; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Meyer, Philippe; Watier, Laurence; Dellatolas, Georges; Chevignard, Mathilde			Executive functions and attention 7 years after severe childhood traumatic brain injury: Results of the Traumatisme Grave de l'Enfant (TGE) cohort	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Severe traumatic brain injury; Child; Adolescent; Long-term outcome; Executive functions	QUALITY-OF-LIFE; MULTIDIMENSIONAL FATIGUE SCALE; PERFORMANCE-BASED MEASURES; BEHAVIOR RATING INVENTORY; GLASGOW OUTCOME SCALE; GENERIC CORE SCALES; YOUNG-CHILDREN; HEAD-INJURY; RECOVERY; VALIDITY	Objectives: Severe childhood traumatic brain injury (TBI) leads to long-standing executive function and attention deficits, with negative consequences for participation, academic outcome and independence. This study aimed to assess executive function and attention 7 years after severe childhood TBI in comparison with a matched control group and to investigate associated factors. Methods: Children (< 15 years) with severe accidental TBI consecutively admitted in a single trauma center over 3 years were included in the Traumatisme Grave de l'Enfant (TGE) prospective longitudinal study. Of the 81 children initially included, 65 survived. At 7 years post-TBI, executive functions and attention were assessed in 27 participants (42 % of the 65 survivors) by using a combination of computerized tasks from the Test of Attentional Performance (TAP) and the Behavioral Rating of Executive Functions (BRIEF) questionnaire. Patients were compared to a group of 27 typically developing controls who were matched for sex, age and parental education level. Results: Among the 27 participants, mean (SD) age at injury was 7.7 (4.6) years, and mean length of coma 5.6 (4.6) days. Regarding the TAP, the number of errors was significantly higher (P = 0.003) and reaction time marginally slower (P = 0.08) in the TBI than control group. The BRIEF questionnaire completed by parents indicated significantly more executive difficulties in the TBI than control group (Behavior Regulation Index, P = 0.005; Metacognitive index, P = 0.02; Global Executive Composite, P = 0.012). Correlations between BRIEF and TAP scores did not reach statistical significance. BRIEF total score was correlated moderately with length of coma (r = 0.40, P = 0.037), and TAP scores were correlated with the Full-Scale Intellectual Quotient (total number of errors: r = -0.48; P = 0.01; mean reaction time: r = -0.51; P = 0.009). Conclusions: Executive and attention deficits were evident 7 years after severe childhood TBI. Computerized tasks and questionnaires provide complementary and non-redundant information. Systematic long-term follow-up should be provided until the transition to adulthood, to assess ongoing development and to implement timely tailored interventions. (C) 2019 Elsevier Masson SAS. All rights reserved.	[Le Fur, Clement; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France; [Le Fur, Clement; Toure, Hanna; Brugel, Dominique; Laurent-Vannier, Anne; Chevignard, Mathilde] Hop St Maurice, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris SUD, Univ Paris Saclay, UVSQ, INSERM,UVSQ,CESP, Paris, France; [Camara-Costa, Hugo; Francillette, Leila; Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed LIB, Paris, France; [Opatowski, Marion; Watier, Laurence] Univ Paris Saclay, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, INSERM, UVSQ,Inst Pasteur, Paris, France; [Meyer, Philippe] Hop Necker Enfants Malad, Paediat Anesthesiol Dept, Paris, France; [Meyer, Philippe] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, GRC Handicap Moteur & Cognitif & Readaptat HaMCRe, Paris, France		Camara-Costa, H (corresponding author), INSERM, CESP, U1018, 97 Blvd Port Royal, F-75014 Paris, France.	hugocamaracosta@gmail.com	Meyer, Philippe/ABE-4242-2020; Dellatolas, Georges/AAW-1377-2021	Meyer, Philippe/0000-0002-3829-6631; Camara-Costa, Hugo/0000-0002-3739-7190	Departement de la Recherche Clinique et du Developpement, AP-HP (Paris) [PHRC 2003, AOM 03018]; French Ministry of Health; national institute for prevention and education for health; French Speaking Society of Research in Children with Disabilities (SFERHE); French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC); French Speaking Society of Physical Medicine and Rehabilitation (SOFMER)	The initial data collection for the initiation of the cohort study was funded by the Departement de la Recherche Clinique et du Developpement, AP-HP (Paris, No. PHRC 2003; AOM 03018). The 7-year follow-up study was co-funded by the French Ministry of Health general direction of health and direction of research, studies, assessment and statistics, by the national fund for health insurance of salaried workers, the national fund for health insurance of independent workers, by the national fund for solidarity and autonomy and by the national institute for prevention and education for health, in the call for research projects launched by the IReSP in 2011. In-depth analyses and manuscript preparation were also funded by two grants awarded to Hugo Camara-Costa: one grant from the French Speaking Society of Research in Children with Disabilities (SFERHE, www.sferhe.org) and one joint grant from the French Traumatic Brain Injury Society (France Traumatisme Cranien - FTC) and the French Speaking Society of Physical Medicine and Rehabilitation (SOFMER, www.sofmer.com).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2014, INTERD APPROACH KNOW, P7; Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; [Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Camara-Costa H, J HEAD TRAUMA REHABI; Camara-Costa H, 2020, DISABIL REHABIL, V42, P2402, DOI 10.1080/09638288.2019.1594398; Camara-Costa H, 2017, NEURO-ONCOL PRACT, V4, P161, DOI 10.1093/nop/npw028; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Coutinho V, 2017, APPL NEUROPSYCH-CHIL, V6, P255, DOI 10.1080/21622965.2016.1146141; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Emslie H., 2003, BEHAV ASSESSMENT DYS; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gilboa Y, 2017, NEUROPSYCHOL REHABIL, P1; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA, 2014, ADAPTATION FRANCAISE; Hope TL, 1999, J PSYCHOPATHOL BEHAV, V21, P349, DOI 10.1023/A:1022124900328; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Martin R., 1972, TEST COMMISSIONS EPR, V2nd; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Slomine B., 2018, COGNITIVE REHABILITA, P75, DOI [10.1017/9781316855683.006, DOI 10.1017/9781316855683.006]; Spagna A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00065; Speranza M, 2012, CAN J PSYCHIAT, V57, P570, DOI 10.1177/070674371205700908; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; van Zomeren AH, 1994, CLIN NEUROPSYCHOL AT, P250; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2009, J HEALTH PSYCHOL, V14, P611, DOI 10.1177/1359105309103580; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wechsler D., 2005, ECHELLE INTELLIGENCE; Wechsler D., 2011, ECHELLE INTELLIGENCE, V4th ed.; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zimmermann P., 2002, APPL NEUROPSYCHOLOGY; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	68	6	6	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2020	63	4					270	279		10.1016/j.rehab.2019.09.003			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MM6SJ	WOS:000550284400002	31605766	Bronze			2022-02-06	
J	Martens, G; Bodien, Y; Sheau, K; Christoforou, A; Giacino, JT				Martens, Geraldine; Bodien, Yelena; Sheau, Kristen; Christoforou, Andrea; Giacino, Joseph T.			Which behaviours are first to emerge during recovery of consciousness after severe brain injury?	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injury; Vegetative state; Minimally conscious state; Outcome	VISUAL PURSUIT; VEGETATIVE STATE; DISORDERS; SCALE; COMA; DIAGNOSIS; CHILDREN; SIGNS	Background: Early detection of consciousness after severe brain injury is critical for establishing an accurate prognosis and planning appropriate treatment. Objectives: To determine which behavioural signs of consciousness emerge first and to estimate the time course to recovery of consciousness in patients with severe acquired brain injury. Methods: Retrospective observational study using the Coma Recovery Scale-Revised and days to recovery of consciousness in 79 patients (51 males; 34 with traumatic brain injury; median [IQR] age 48 [26-61] years; median time since injury 26 [20-36] days) who transitioned from coma or unresponsive wakefulness syndrome (UWS)/vegetative state (VS) to the minimally conscious state (MCS) or emerged from MCS during inpatient rehabilitation. Results: Visual pursuit was the most common initial sign of MCS (41% of patients; 95% CI [30-52]), followed by reproducible command-following (25% [16-35]) and automatic movements (24% [ 15-33]). Ten other behaviours emerged first in less than 16% of cases. Median [IQR] time to recovery of consciousness was 44 [33-59] days. Etiology did not significantly affect time to recovered consciousness. Conclusion: Recovery of consciousness after severe brain injury is most often signalled by reemergence of visual pursuit, reproducible command-following and automatic movements. Clinicians should use assessment measures that are sensitive to these behaviours because early detection of consciousness is critical for accurate prognostication and treatment planning. (C) 2019 Elsevier Masson SAS. All rights reserved.	[Martens, Geraldine; Bodien, Yelena; Sheau, Kristen; Christoforou, Andrea; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Martens, Geraldine; Bodien, Yelena; Christoforou, Andrea; Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Martens, Geraldine] Univ Liege, Coma Sci Grp, GIGA Res, GIGA Consciousness, 11 Ave Hop, B-4000 Liege, Sart Tilman, Belgium; [Martens, Geraldine] Univ Hosp Liege, Ctr Integre Pluridisciplinaire Etud Cerveau Cogn, Ctr Cerveau2, Liege, Belgium; [Bodien, Yelena] Massachusetts Gen Hosp, Lab Neuroimaging Coma & Consciousness, Boston, MA 02114 USA; [Sheau, Kristen] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA		Martens, G (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.; Martens, G (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Martens, G (corresponding author), Univ Liege, Coma Sci Grp, GIGA Res, GIGA Consciousness, 11 Ave Hop, B-4000 Liege, Sart Tilman, Belgium.; Martens, G (corresponding author), Univ Hosp Liege, Ctr Integre Pluridisciplinaire Etud Cerveau Cogn, Ctr Cerveau2, Liege, Belgium.	geraldine.martens@uliege.be	Martens, Geraldine/ABF-1147-2020; Giacino, Joseph/AAF-1952-2021	Martens, Geraldine/0000-0001-7038-7165; Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0011]; Centre within the Administration for Community Living (ACL); Department of Health and Human Services (HHS); University of Liege (LEAR Foundation); Wallonia-Brussels Federation; Wallonie-Bruxelles International (WBI World); Tiny Blue Dot Foundation; James S. McDonnell Foundation	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (90DPTB0011), which is a Centre within the Administration for Community Living (ACL), Department of Health and Human Services (HHS), University of Liege (LEAR Foundation), the Wallonia-Brussels Federation, Wallonie-Bruxelles International (WBI World), Tiny Blue Dot Foundation and the James S. McDonnell Foundation.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato Sergio, 2017, J Neurotrauma, V34, P535, DOI 10.1089/neu.2016.4418; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Damasio A., 1999, FEELING WHAT HAPPENS; Di HB, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-147; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Dolce G, 2011, J NEUROTRAUM, V28, P1149, DOI 10.1089/neu.2010.1405; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 1999, NEUROPSYCHOL REHABIL, V9, P305, DOI 10.1080/096020199389392; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Naccache L, 2018, BRAIN, V141, P949, DOI 10.1093/brain/awx324; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Overbeek BUH, 2018, J NEUROL, V265, P1957, DOI 10.1007/s00415-018-8788-9; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Plum F, 1972, Contemp Neurol Ser, V10, P1; Remi J, 2011, NEUROLOGY, V77, P1453, DOI 10.1212/WNL.0b013e318232abe4; Sadleir LG, 2009, ARCH NEUROL-CHICAGO, V66, P729, DOI 10.1001/archneurol.2009.108; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Wannez S, 2017, BRAIN INJURY, V31, P1429, DOI 10.1080/02699052.2017.1376755; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wannez S, 2017, J NEUROL, V264, P928, DOI 10.1007/s00415-017-8469-0; Wannez S, 2018, NEUROPSYCHOL REHABIL, V28, P1350, DOI 10.1080/09602011.2017.1310656; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5	45	6	6	0	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2020	63	4					263	269		10.1016/j.rehab.2019.10.004			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MM6SJ	WOS:000550284400001	31783144	Bronze, Green Published			2022-02-06	
J	Savioli, G; Ceresa, IF; Ciceri, L; Sciutti, F; Belliato, M; Iotti, GA; Luzzi, S; Del Maestro, M; Mezzini, G; Lafe, E; Simoncelli, A; Ricevuti, G; Manzoni, F; Bressan, MA				Savioli, Gabriele; Ceresa, Iride Francesca; Ciceri, Luca; Sciutti, Fabio; Belliato, Mirko; Iotti, Giorgio Antonio; Luzzi, Sabino; Del Maestro, Mattia; Mezzini, Gianluca; Lafe, Elvis; Simoncelli, Anna; Ricevuti, Giovanni; Manzoni, Federica; Bressan, Maria Antonietta			Mild head trauma in elderly patients: experience of an emergency department	HELIYON			English	Article						Neurosurgery; Trauma; Emergency medicine; Internal medicine; Clinical research; Brain injury management; Elderly patients; Hemorrhage; Mild traumatic brain injury; Posttraumatic intracranial hemorrhage	BRAIN-INJURY; OLDER-ADULTS; EPIDEMIOLOGY; POPULATION; STRATEGIES; COMMUNITY	Introduction: We evaluated the risk profile of elderly patients who came to the emergency department for mild head trauma. The primary goal was to determine the difference in the incidence of posttraumatic intracranial hemorrhage (ICH) after minor head injury (MHI). The secondary objective was to assess worse outcome, such as: hospitalization rate, rate of re-admission, need of neurosurgery. We also assess the admission process times and length of hospital stay. The ultimate goal was to optimize the diagnostic-observational management of minor head trauma in elderly patients. Material and methods: We evaluated all patients with MHI who came to our emergency department during 2017 and 2018. All patients underwent computed tomography. Results: We enrolled 2325 patients, of whom 1094 were 75 years of age or older. The population was divided into two categories according to age: The "elderly population" was 75 or older, and the younger patients were younger than 75. The elderly population, in comparison with the younger patients, had a higher rate of ICH (12.1% versus 5.1%), a higher hospitalization rate (11.7% versus 5.5%), and a higher rate of readmission within 30 days (6.8% versus 3.2%). The elderly population also had longer admission process times (8 h, 25 min, versus 4 h, 09 min) and longer lengths of hospital stay (9 h, 41 min, versus 5 h, 29 min). Of the younger patients, 92% (versus 41% of the elderly population) did not take any drugs, 6% (versus 39%) were receiving antiplatelet therapy, 1% (versus 13%) took vitamin K antagonists, and 1% (versus 7%) took oral direct-acting anticoagulants. Logistic regression models revealed that a 1-year increase in age raised the risk of bleeding by 2% on average; this finding was statistically significant (odds ratio [OR], 1023/year, p < 0.001). The rate of ICH increased significantly after the age of 75, by 180% (OR, 2.82; p < 0.001). Conclusions: These data suggest that age is an independent risk factor for ICH, whereby the age of 75 entails a 180% increase in the risk of bleeding.	[Savioli, Gabriele; Ceresa, Iride Francesca; Ciceri, Luca; Bressan, Maria Antonietta] Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy; [Sciutti, Fabio; Belliato, Mirko; Iotti, Giorgio Antonio] Fdn IRCCS Policlin San Matteo, Intens Care Unit, Pavia, Italy; [Luzzi, Sabino; Del Maestro, Mattia] Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, Pavia, Italy; [Luzzi, Sabino; Mezzini, Gianluca] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, Pavia, Italy; [Lafe, Elvis; Simoncelli, Anna] Fdn IRCCS Policlin San Matteo, Neuro Radiodiagnost, Pavia, Italy; [Ricevuti, Giovanni] Univ Pavia, Geriatr Unit, Pavia, Italy; [Savioli, Gabriele] Univ Pavia, PhD Sch Expt Med, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy; [Manzoni, Federica] Fdn IRCCS Policlin San Matteo, Clin Epidemiol & Biometry Unit, Pavia, Italy		Savioli, G (corresponding author), Fdn IRCCS Policlin San Matteo, Emergency Dept, Pavia, Italy.; Savioli, G (corresponding author), Univ Pavia, PhD Sch Expt Med, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.	gabrielesavioli@gmail.com	Savioli, Gabriele/AAQ-2847-2021; Ceresa, Iride/AAP-9431-2021; Ricevuti, Giovanni/AAK-7707-2021; Luzzi, Sabino/AAE-8474-2021	Ricevuti, Giovanni/0000-0003-3422-2747; Savioli, Gabriele/0000-0002-8679-5435; belliato, mirko/0000-0002-3411-6293			Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Andelic N., 2012, LANCET NEUROL, V12; [Anonymous], 2019, 64 C NAZ SIGG ROM; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Del Maestro M, 2018, ACTA NEUROCHIR SUPPL, V129, P109, DOI 10.1007/978-3-319-73739-3_16; Farzaneh E, 2017, EMERG MED INT, V2017, DOI 10.1155/2017/1439486; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gallieni M, 2018, ACTA NEUROCHIR SUPPL, V129, P19, DOI 10.1007/978-3-319-73739-3_3; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Hosseininejad Seyed Mohammad, 2019, Mater Sociomed, V31, P186, DOI 10.5455/msm.2019.31.186-189; Intzitari M, 2007, J GERONTOL A-BIOL, V62, P837, DOI 10.1093/gerona/62.8.837; Lippi Giuseppe, 2013, Recenti Progressi in Medicina, V104, P120, DOI 10.1701/1255.13861; Lord S., 2001, INJ PREV, V9; Luzzi S, 2019, WORLD NEUROSURG; Luzzi S, 2019, WORLD NEUROSURG, V131, P10, DOI 10.1016/j.wneu.2019.07.152; Luzzi S, 2018, ACTA NEUROCHIR SUPPL, V129, P25, DOI 10.1007/978-3-319-73739-3_4; Luzzi S, 2018, WORLD NEUROSURG, V116, pE340, DOI 10.1016/j.wneu.2018.04.203; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Ouchi Y, 2017, GERIATR GERONTOL INT, V17, P1045, DOI 10.1111/ggi.13118; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ricci Alessandro, 2017, Surg Neurol Int, V8, P117, DOI 10.4103/sni.sni_50_17; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Suzuki T, 2018, GERIATR GERONTOL INT, V18, P667, DOI 10.1111/ggi.13266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Zoia Cesare, 2019, Surg Neurol Int, V10, P76, DOI 10.25259/SNI-132-2019	32	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	JUL	2020	6	7							e04226	10.1016/j.heliyon.2020.e04226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MY9LK	WOS:000558741400008	32671238	Green Published, gold			2022-02-06	
J	Starr, NE; Matthay, ZA; Fields, AT; Nunez-Garcia, B; Callcut, RA; Cohen, MJ; Kornblith, LZ				Starr, Nichole E.; Matthay, Zachary A.; Fields, Alexander T.; Nunez-Garcia, Brenda; Callcut, Rachael A.; Cohen, Mitchell J.; Kornblith, Lucy Zumwinkle			Identification of injury and shock driven effects on ex vivo platelet aggregometry: A cautionary tale of phenotyping	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	33rd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 14-18, 2020	Orlando, FL	Eastern Assoc Surg Trauma		Platelets; platelet activation; platelet aggregation; platelet function tests; trauma	TRAUMATIC BRAIN-INJURY; DYSFUNCTION; RESUSCITATION; COAGULOPATHY; COAGULATION; ACTIVATION; MODEL	BACKGROUND: Platelet behavior in trauma-induced coagulopathy is poorly understood. Injured patients have impaired platelet aggregation (dysfunction) in ex vivo agonist-stimulated platelet aggregometry (PA). However, PA assumes that platelets are inactivated before ex vivo stimulated aggregation, which may be altered by injury. We hypothesized that following trauma, platelet aggregation (area under the curve) is decreased regardless of injury burden, but that (1) minor injury is associated with an increased baseline electrical impedance, characteristic of a functional platelet phenotype (platelets that activate in response to injury), and that (2) severe injury is not associated with an increased baseline electrical impedance, characteristic of a dysfunctional phenotype (platelets that do not activate well in response to injury) compared with healthy controls. METHODS: Blood from 458 trauma patients and 30 healthy donors was collected for PA. Baseline electrical impedance (O); platelet aggregation stimulated by adenosine diphosphate, collagen, thrombin, and arachidonic acid; and rotational thromboelastometry were measured. Multivariate regression was performed to identify associations of PA measures with blood transfusion. RESULTS: Compared with healthy controls, injured patients had impaired platelet aggregation in response to ex vivo stimulation, regardless of injury burden. However, minorly injured patients had increased endogenous platelet activation (baseline electrical impedance, Omega: with shock, p = 0.012; without shock, p = 0.084), but severely injured patients did not have significant increases in endogenous platelet activation (baseline electrical impedance, Omega: with shock, p = 0.86; without shock, p = 0.37). For every 10 O increase in baseline electrical impedance, there was an 8% decrease in units of blood transfused in the first 24 h (-0.08; confidence interval, - 0.14 to - 0.02; p = 0.015). CONCLUSION: Injury and shock confer differential patterns of platelet aggregation in PA. Minor injury overestimates the presence of platelet dysfunction, while severe injury induces a truly dysfunctional phenotype-platelets that do not activate nor aggregate appropriately after injury. This is consequential in improving accurate phenotyping of postinjury platelet behavior for platelet-based therapeutics. (Copyright (C) 2020 Wolters Kluwer Health, Inc. All rights reserved.)	[Starr, Nichole E.; Matthay, Zachary A.; Fields, Alexander T.; Nunez-Garcia, Brenda; Callcut, Rachael A.; Kornblith, Lucy Zumwinkle] Univ Calif San Francisco, Dept Surg, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Cohen, Mitchell J.] Univ Colorado, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80202 USA		Kornblith, LZ (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Bldg 1,Ste 210,Box 1302, San Francisco, CA 94110 USA.	lucy.kornblith@ucsf.edu	Callcut, Rachael/ABE-1484-2021	Starr, Nichole/0000-0003-0714-5512	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23GM130892-01, UM1HL120877, K01ES026834, T32 DK007573]; DoDUnited States Department of Defense [W911QY-15-C-0044]; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [5TL1TR001871-04]	L.Z.K. is supported by NIH 1K23GM130892-01. M.J.C. is supported by NIH UM1HL120877 and DoD W911QY-15-C-0044. R.A.C. is supported by NIH K01ES026834 and DoD W911QY-15-C-0044. Z.A.M. is supported by The National Center for Advancing Translational Sciences of the NIH award 5TL1TR001871-04. N.E.S. is supported by NIH T32 DK007573 grant.	Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Cardenas JC, 2014, CURR OPIN HEMATOL, V21, P404, DOI 10.1097/MOH.0000000000000063; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Cohen MJ, 2016, INT J SURG, V33, P242, DOI 10.1016/j.ijsu.2016.05.037; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Kornblith LZ, 2019, J TRAUMA ACUTE CARE, V87, P1042, DOI 10.1097/TA.0000000000002459; Kornblith LZ, 2019, J THROMB HAEMOST, V17, P852, DOI 10.1111/jth.14450; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lee MY, 2017, J THROMB HAEMOST, V15, P2396, DOI 10.1111/jth.13863; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; St John AE, 2019, J THROMB HAEMOST, V17, P771, DOI 10.1111/jth.14414; Vulliamy P, 2019, P NATL ACAD SCI USA, V116, P17444, DOI 10.1073/pnas.1904978116; Vulliamy P, 2017, J TRAUMA ACUTE CARE, V83, P388, DOI 10.1097/TA.0000000000001520; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	27	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2020	89	1					20	28		10.1097/TA.0000000000002707			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	MJ2BL	WOS:000547897300007	32218020	Green Accepted			2022-02-06	
J	Wilhelm, J; Ptak, M; Fernandes, FAO; Kubicki, K; Kwiatkowski, A; Ratajczak, M; Sawicki, M; Szarek, D				Wilhelm, Johannes; Ptak, Mariusz; Fernandes, Fabio A. O.; Kubicki, Konrad; Kwiatkowski, Artur; Ratajczak, Monika; Sawicki, Marek; Szarek, Dariusz			Injury Biomechanics of a Child's Head: Problems, Challenges and Possibilities with a New aHEAD Finite Element Model	APPLIED SCIENCES-BASEL			English	Article						finite element head model; numerical model; biomechanics; head injury; injury criteria; TBI; DAI; brain; numerical simulation; aHEAD; vulnerable road user; paediatric model; child safety; head kinematics; gray and white matter	TRAUMATIC BRAIN-INJURY; FETAL DURA-MATER; MECHANICAL-BEHAVIOR; IMPACT; AGE; PATTERNS; INFANTS; WORLD; POPULATION; VALIDATION	Traumatic brain injury (TBI) is a major public health problem among children. The predominant causes of TBI in young children are motor vehicle accidents, firearm incidents, falls, and child abuse. The limitation of in vivo studies on the human brain has made the finite element modelling an important tool to study brain injury. Numerical models based on the finite element approach can provide valuable data on biomechanics of brain tissues and help explain many pathological conditions. This work reviews the existing numerical models of a child's head. However, the existing literature is very limited in reporting proper geometric representation of a small child's head. Therefore, an advanced 2-year-old child's head model, named aHEAD 2yo (aHEAD: advanced Head models for safety Enhancement And medical Development), has been developed, which advances the state-of-the-art. The model is one of the first published in the literature, which entirely consists of hexahedral elements for three-dimensional (3D) structures of the head, such as the cerebellum, skull, and cerebrum with detailed geometry of gyri and sulci. It includes cerebrospinal fluid as Smoothed Particle Hydrodynamics (SPH) and a detailed model of pressurized bringing veins. Moreover, the presented review of the literature showed that material models for children are now one of the major limitations. There is also no unambiguous opinion as to the use of separate materials for gray and white matter. Thus, this work examines the impact of various material models for the brain on the biomechanical response of the brain tissues during the mechanical loading described by Hardy et al. The study compares the inhomogeneous models with the separation of gray and white matter against the homogeneous models, i.e., without the gray/white matter separation. The developed model along with its verification aims to establish a further benchmark in finite element head modelling for children and can potentially provide new insights into injury mechanisms.	[Wilhelm, Johannes; Ptak, Mariusz; Sawicki, Marek] Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland; [Fernandes, Fabio A. O.] Univ Aveiro, TEMA Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, P-3810193 Aveiro, Portugal; [Kubicki, Konrad] Wroclaw Med Univ, Dept Neurosurg, PL-50556 Wroclaw, Poland; [Kwiatkowski, Artur] Prov Specialist Hosp Legnica, Dept Neurosurg, PL-59220 Legnica, Poland; [Ratajczak, Monika] Univ Zielona Gora, Fac Mech Engn, Prof Szafrana 4, PL-65516 Zielona Gora, Poland; [Szarek, Dariusz] Lower Silesia Specialist Hosp T Marciniak, Emergency Med Ctr, Dept Neurosurg, AE Fieldorfa 2, PL-54049 Wroclaw, Poland		Ptak, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland.	johannes.wilhelm@pwr.edu.pl; mariusz.ptak@pwr.edu.pl; fabiofernandes@us.pt; konrad.kubicki@umed.wroc.pl; artur.kwiatkowski@szptial.legnica.pl; m.ratajczak@iizp.uz.zgora.pl; sawicki.marek@pwr.edu.pl; d.szarek@szpital-marciniak.wroclaw.pl	Szarek, Dariusz/ABB-2655-2020; Ptak, Mariusz/B-1493-2013; Fernandes, Fabio A.O./H-2680-2012; Ratajczak, Monika/AAV-6979-2020; Wilhelm, Johannes/O-8330-2016; Sawicki, Marek/L-8103-2016	Ptak, Mariusz/0000-0001-8081-8336; Fernandes, Fabio A.O./0000-0001-9751-8807; Ratajczak, Monika/0000-0001-6980-315X; Wilhelm, Johannes/0000-0001-5114-5400; Sawicki, Marek/0000-0002-9649-8434; Kubicki, Konrad/0000-0002-6140-8363	National Centre for Research and Development of PolandNational Centre for Research & Development, Poland [LIDER/8/0051/L-8/16/NCBR/2017]	This research was co-funded by the National Centre for Research and Development of Poland, grant number LIDER/8/0051/L-8/16/NCBR/2017. www.aheadproject.org/	Arbogast K.B., 1995, P SAE SAE INT WARR P; Arkusz K, 2019, COMPUT METHOD BIOMEC, V22, P313, DOI 10.1080/10255842.2018.1553238; Baranowski P, 2015, ARCH CIV MECH ENG, V15, P361, DOI 10.1016/j.acme.2014.07.001; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; CDC, 2002, CDC TRAUM BRAIN INJ; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Cheng PX, 2020, J SAFETY RES, V72, P93, DOI 10.1016/j.jsr.2019.12.013; Chybowski L., 2020, SYST SAF HUM TECH FA, V2, P91, DOI [10.2478/czoto-2020-0012, DOI 10.2478/CZOTO-2020-0012]; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Crandall J.R., 2013, PEDIAT INJURY BIOMEC; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; Dehghani H, 2020, EUR J MECH A-SOLID, V83, DOI 10.1016/j.euromechsol.2020.103996; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Duck F.A., 1990, PHYS PROPERTIES TISS; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Fernandes F.A.O., 2017, ANALISE BIOMECANICA; Fernandes FAO, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25010012; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gelineau-Morel RN, 2019, PEDIATR REV, V40, P468, DOI 10.1542/pir.2018-0257; GHMBC, 2014, LLC US MAN M50 OCC V; Giordano C., 2016, IRCOBI C, P288; Gise R, 2018, J AAPOS, V22, P421, DOI 10.1016/j.jaapos.2018.07.351; Gomez-Gesteira M, 2012, COMPUT GEOSCI-UK, V48, P300, DOI 10.1016/j.cageo.2012.02.028; Grivna M, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0156-z; Hardy W.N., 2007, RESPONSE HUMAN CADAV; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Heron Melonie, 2018, Natl Vital Stat Rep, V67, P1; Hsia RY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227981; Huelke DF, 1998, P ANN C ASS, P93; Ibrahim NG, 2012, INT J DEV NEUROSCI, V30, P201, DOI 10.1016/j.ijdevneu.2011.10.007; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ivarsson B Johan, 2006, Traffic Inj Prev, V7, P290, DOI 10.1080/15389580600652283; Jamroziak K, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9132702; Karlinski J, 2019, ENERGIES, V12, DOI 10.3390/en12152971; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kemp A, 2016, ARCH DIS CHILD, V101, P929, DOI 10.1136/archdischild-2015-309078; Kendall M., 2012, IRCOBI C 2012 INT RE; King R, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101842; KRIEWALL TJ, 1983, J BIOMECH ENG-T ASME, V105, P71, DOI 10.1115/1.3138388; Lewartowska-Nyga Dorota, 2016, Dev Period Med, V20, P126; Li XG, 2019, FORENSIC SCI INT, V294, P173, DOI 10.1016/j.forsciint.2018.11.008; Li XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33393-z; Lindell B., 2009, CHIN J RADIOL HLTH, V8, P1; LLC Elemance Global Human Body Models Consortium, 2014, US MAN M50 OCC VERS; LLC Elemance-GHBMC Model, 2014, LLC EL GHBMC MOD GLO; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Mayer L, 2006, PEDIATR SURG INT, V22, P743, DOI 10.1007/s00383-006-1731-7; Meaney D.F., 1991, THESIS; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Miller K, 2019, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-030-04996-6; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Palka L, 2020, INJURY, V51, P1527, DOI 10.1016/j.injury.2020.03.057; Pike J.A., 2011, HEAD INJURY BIOMECHA, V2; Pitone ML, 2006, PEDIATR EMERG CARE, V22, P470, DOI 10.1097/01.pec.0000226869.41803.50; Post A., 2012, P IRCOBI C INT RES C; Post A, 2015, ACCIDENT ANAL PREV, V79, P33, DOI 10.1016/j.aap.2015.03.017; Prange M.T., 1999, PEDIAT ROTATIONAL IN; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ptak M., 2017, LECT NOTES MECH ENG; Ptak M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9051000; Ratajczak M., 2018, THESIS; Ratajczak M, 2020, ADV INTELL SYST, V1033, P308, DOI 10.1007/978-3-030-29885-2_28; Ratajczak M, 2019, MATERIALS, V12, DOI 10.3390/ma12020271; Raul JS, 2008, INT J LEGAL MED, V122, P337, DOI 10.1007/s00414-008-0242-6; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rusinski E., 2000, ADV FINITE ELEMENT M; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Shapiro JS, 2020, J NEUROTRAUM, V37, P1300, DOI 10.1089/neu.2019.6768; Slawinski G, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9194077; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; Sybilski K, 2019, ACTA BIOENG BIOMECH, V21, P169, DOI [10.37190/ABB-01421-2019-02, 10.5277/ABB-01421-2019-02]; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Toma M, 2018, BRAIN INJURY, V32, P1576, DOI 10.1080/02699052.2018.1502470; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Wade SL, 2020, J HEAD TRAUMA REHAB, V35, pE393, DOI 10.1097/HTR.0000000000000567; Waqas M, 2018, PEDIATR NEUROSURG, V53, P7, DOI 10.1159/000479561; Weavee JB, 2007, PROC SPIE, V6511, DOI 10.1117/12.713781; Whithey Donald A., 1992, J INT COMM RAD UNITS, P5; Wolaski W., 2019, PREDICTION CHILDS HE, P267; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278; Yang KH, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P111, DOI 10.1016/B978-0-12-809831-8.00003-9; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; 2011, BIOL MED PHYS BIOMED, P1	101	6	6	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	JUL	2020	10	13							4467	10.3390/app10134467			26	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Materials Science; Physics	MP6EM	WOS:000552295600001		Green Submitted			2022-02-06	
J	Korotkov, A; Puhakka, N; Das Gupta, S; Vuokila, N; Broekaart, DWM; Anink, JJ; Heiskanen, M; Karttunen, J; van Scheppingen, J; Huitinga, I; Mills, JD; van Vliet, EA; Pitkanen, A; Aronica, E				Korotkov, Anatoly; Puhakka, Noora; Das Gupta, Shalini; Vuokila, Niina; Broekaart, Diede W. M.; Anink, Jasper J.; Heiskanen, Mette; Karttunen, Jenni; van Scheppingen, Jackelien; Huitinga, Inge; Mills, James D.; van Vliet, Erwin A.; Pitkanen, Asla; Aronica, Eleonora			Increased expression of miR142 and miR155 in glial and immune cells after traumatic brain injury may contribute to neuroinflammation via astrocyte activation	BRAIN PATHOLOGY			English	Article						biomarker; gliosis; inflammation; microRNA; secondary injury; TBI	POSTTRAUMATIC EPILEPSY; CIRCULATING MICRORNAS; CORTICAL TUBERS; RAT; BIOMARKERS; HIPPOCAMPUS; MECHANISMS; REGULATORS; PROTEINS; MODELS	Traumatic brain injury (TBI) is associated with the pathological activation of immune-competent cells in the brain, such as astrocytes, microglia and infiltrating immune blood cells, resulting in chronic inflammation and gliosis. This may contribute to the secondary injury after TBI, thus understanding of these processes is crucial for the development of effective treatments of post-traumatic pathologies. MicroRNAs (miRNAs, miRs) are small noncoding RNAs, functioning as posttranscriptional regulators of gene expression. The increased expression of inflammation-associated microRNAs miR155 and miR142 has been reported after TBI in rats. However, expression of these miRNAs in the human brain post-TBI is not studied and their functions are not well understood. Moreover, circulating miR155 and miR142 are candidate biomarkers. Therefore, we characterized miR142 and miR155 expression in the perilesional cortex and plasma of rats that underwent lateral fluid-percussion injury, a model for TBI and in the human perilesional cortex post-TBI. We demonstrated higher miR155 and miR142 expression in the perilesional cortex of rats 2 weeks post-TBI. In plasma, miR155 was associated with proteins and miR142 with extracellular vesicles, however their expression did not change. In the human perilesional cortex miR155 was most prominently expressed by activated astrocytes, whereas miR142 was expressed predominantly by microglia, macrophages and lymphocytes. Pro-inflammatory medium from macrophage-like cells stimulated miR155 expression in astrocytes and overexpression of miR142 in these cells further potentiated a pro-inflammatory state of activated astrocytes. We conclude that miR155 and miR142 promote brain inflammation via astrocyte activation and may be involved in the secondary brain injury after TBI.	[Korotkov, Anatoly; Broekaart, Diede W. M.; Anink, Jasper J.; van Scheppingen, Jackelien; Mills, James D.; van Vliet, Erwin A.; Aronica, Eleonora] Univ Amsterdam, Amsterdam UMC, Amsterdam Neurosci, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Puhakka, Noora; Das Gupta, Shalini; Vuokila, Niina; Heiskanen, Mette; Karttunen, Jenni; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurol, FI-70211 Kuopio, Finland; [van Scheppingen, Jackelien; Huitinga, Inge] Netherlands Inst Neurosci, Dept Neuroimmunol, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [van Vliet, Erwin A.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Sci Pk 904, NL-1090 GE Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland SEIN, Heemstede, Netherlands		van Vliet, EA (corresponding author), Univ Amsterdam, Med Ctr, Locat Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.a.vanvliet@uva.nl		Korotkov, Anatoly/0000-0002-8313-6282; Huitinga, Ingeborg/0000-0002-4878-8920; van Vliet, Erwin/0000-0001-5747-3202; Broekaart, Diede/0000-0002-4842-0659; Karttunen, Jenni/0000-0002-0099-1305; Heiskanen, Mette/0000-0003-1624-5240; Vuokila, Niina/0000-0003-4976-6835	European UnionEuropean Commission [602102, 642881]; Dutch Epilepsy Foundation [16-05]	The authors are grateful to D. Khaan (Pathology, Amsterdam UMC, the Netherlands) and M. van der Poel (Neuroimmunology, Netherlands Institute for Neuroscience) for providing primary cell material and to Merja Lukkari and Jarmo Hartikainen (Neurobiology, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland) for technical assistance. The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement 602102 (EPITARGET; EAvV, EA), the Dutch Epilepsy Foundation, project 16-05 (DWMB, EAvV) and the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement no. 642881 (ECMED; AK, EA). We acknowledge the HIS Mouse Facility of the Amsterdam UMC and the Bloemenhove Clinic (Heemstede, the Netherlands) for providing fetal tissues.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Arruda LCM, 2015, BONE MARROW TRANSPL, V50, P380, DOI 10.1038/bmt.2014.277; Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; Bagla S, 2018, NEUROBIOL DIS, V109, P76, DOI 10.1016/j.nbd.2017.10.004; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Chaudhuri AD, 2013, FASEB J, V27, P3720, DOI 10.1096/fj.13-232678; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Huang LG, 2018, BRAIN RES, V1689, P109, DOI 10.1016/j.brainres.2017.11.019; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Karttunen J, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2018.1555410; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Korotkov A, 2020, GLIA, V68, P60, DOI 10.1002/glia.23700; Korotkov A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1245-y; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mandolesi G, 2017, J NEUROSCI, V37, P546, DOI [10.1523/JNEUROSCI.0851-16.2017, 10.1523/JNEUROSCI.0851-16.2016]; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mizee MR, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0418-8; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Pena-Llopis S, 2013, NAT PROTOC, V8, P2240, DOI 10.1038/nprot.2013.141; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sharma S, 2017, DEV COMP IMMUNOL, V77, P150, DOI 10.1016/j.dci.2017.08.001; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Slota JA, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020035; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Scheppingen J, 2016, GLIA, V64, P1066, DOI 10.1002/glia.22983; van Vliet EA, 2018, NEUROPATH APPL NEURO, V44, P91, DOI 10.1111/nan.12444; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju162	65	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	SEP	2020	30	5					897	912		10.1111/bpa.12865		JUN 2020	16	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	NK6MF	WOS:000543298300001	32460356	Green Published, hybrid			2022-02-06	
J	Vaudreuil, R; Langston, DG; Magee, WL; Betts, D; Kass, S; Levy, C				Vaudreuil, Rebecca; Langston, Diane G.; Magee, Wendy L.; Betts, Donna; Kass, Sara; Levy, Charles			Implementing music therapy through telehealth: considerations for military populations	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						Music therapy; creative arts therapies; telemedicine; telehealth; military; service members; veterans; traumatic brain injury; posttraumatic stress disorder; community reintegration	TRAUMATIC BRAIN-INJURY; ACTIVE-DUTY; VETERANS; HEALTH; IRAQ; CARE; TECHNOLOGY; STIGMA	Purpose: Telehealth provides psychotherapeutic interventions and psychoeducation for remote populations with limited access to in-person behavioural health and/or rehabilitation treatment. The United States Department of Defense and the Veterans Health Administration use telehealth to deliver primary care, medication management, and services including physical, occupational, and speech-language therapies for service members, veterans, and eligible dependents. While creative arts therapies are included in telehealth programming, the existing evidence base focuses on art therapy and dance/movement therapy, with a paucity of information on music therapy. Methods:Discussion of didactic and applied music experiences, clinical, ethical, and technological considerations, and research pertaining to music therapy telehealth addresses this gap through presentation of three case examples. These programmes highlight music therapy telehealth with military-connected populations on a continuum of clinical and community engagement: 1) collaboration between Berklee College of Music in Boston, MA and the Acoke Rural Development Initiative in Lira, Uganda; 2) the Semper Sound Cyber Health programme in San Diego, CA; and 3) the integration of music therapy telehealth into Creative Forces (R), an initiative of the National Endowment for the Arts. Results:These examples illustrate that participants were found to positively respond to music therapy and community music engagement through telehealth, and reported decrease in pain, anxiety, and depression; they endorsed that telehealth was not a deterrent to continued music engagement, requested continued music therapy telehealth sessions, and recommended it to their peers. Conclusions:Knowledge gaps and evolving models of creative arts therapies telehealth for military-connected populations are elucidated, with emphasis on clinical and ethical considerations. IMPLICATIONS FOR REHABILITATION Music therapy intervention can be successfully adapted to accommodate remote facilitation. Music therapy telehealth has yielded positive participant responses including decrease in pain, anxiety, and depression. Telehealth facilitation is not a deterrent to continued music engagement. Distance delivery of music through digital platforms can support participants on a clinic to community continuum.	[Vaudreuil, Rebecca; Langston, Diane G.; Betts, Donna; Kass, Sara] Natl Endowment Arts, Creat Forces NEA Mil Healing Arts Network, Washington, DC 20506 USA; [Langston, Diane G.; Levy, Charles] Malcom Randall VA Hosp, Phys Med & Rehabil, Gainesville, FL USA; [Magee, Wendy L.] Temple Univ, Boyer Coll Mus & Dance, Philadelphia, PA 19122 USA		Vaudreuil, R (corresponding author), Natl Endowment Arts, 400 7th St SW, Washington, DC 20506 USA.	Rebecca_vaudreuil@mail.harvard.edu	Magee, Wendy L./AAP-6839-2020	Magee, Wendy L./0000-0003-4350-1289; Vaudreuil, Rebecca/0000-0003-1108-5970	Creative Forces(R) : NEA Military Healing Arts Network, an initiative of the National Endowment for the Arts (NEA); U.S. Department of DefenseUnited States Department of Defense; U.S. Department of Veterans AffairsUS Department of Veterans Affairs	This paper was supported by funding from Creative Forces (R) : NEA Military Healing Arts Network, an initiative of the National Endowment for the Arts (NEA) in partnership with the U.S. Departments of Defense and Veterans Affairs and state and local arts agencies. The initiative seeks to improve the health, wellness, and quality of life for military and veteran populations exposed to trauma, as well as their families and caregivers. Administrative support for the initiative is provided by Americans for the Arts.	American Art Therapy Association, 2013, ETH PRINC ART THER; American Dance Therapy Association (ADTA), 2015, COD ETH STAND; American Music Therapy Association, 2019, COD OF ETH; American Music Therapy Association, 2014, MUS THER MIL POP STA; American Music Therapy Association, 2019, WHAT IS MUS THER; [Anonymous], 2015, MUS HEALS PROGR; [Anonymous], 2018, GETWELL NETWORK MY H; [Anonymous], DOD WORLDW NUMB TBI; [Anonymous], 2018, WILLIAM JOINER I STU; Art Therapy Credentials Board, 2013, COD ETH COND DISC PR; Baker F, 2009, BRIT J MUSIC THER, V23, P3, DOI 10.1177/135945750902300202; Bates D, 2014, MUSIC THER PERSPECT, V32, P136, DOI 10.1093/mtp/miu030; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Center for Military Health Policy Research (RAND), 2008, INVISIBLE WOUNDS WAR; Codding P, 2015, MUSIC THERAPY UGANDA, P1; Federal Office of Rural Health Policy. Health Resources and Services Administration, 2015, HLTH RES SERV ADM TE; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kong Ha-Kyung, 2016, AMIA Annu Symp Proc, V2016, P1870; Kvedar J, 2014, HEALTH AFFAIR, V33, P194, DOI 10.1377/hlthaff.2013.0992; Langston DG, 2018, P 5 INT C ASS MUS ME; Levy CE, 2018, ART PSYCHOTHER, V57, P20, DOI 10.1016/j.aip.2017.08.010; Levy CE, 2015, J REHABIL RES DEV, V52, P361, DOI 10.1682/JRRD.2014.10.0239; Lightstone AJ, 2015, ARTS HEALTH, V7, P123, DOI 10.1080/17533015.2015.1019895; National Endowment for the Arts, 2019, NAT END ARTS ANN EXP; National Endowment for the Arts, 2018, TEL MAN CREAT ARTS T; National Endowments for the Arts, 2019, CREAT FORC NEA MIL H; Resounding Joy Inc, 2018, SEMP SOUND MIL MUS T; Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8; Schneider M., 2017, CREATIVE FORCES NEA; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Spooner H, 2019, ART PSYCHOTHER, V62, P12, DOI 10.1016/j.aip.2018.11.012; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; Tanielian T., 2008, INVISIBLE WOUNDS WAR; The U.S Department of Veteran's Affairs, 2011, RUR VET TEL REH IN T; Turgoose D, 2018, J TELEMED TELECARE, V24, P575, DOI 10.1177/1357633X17730443; U.S. Department of Veterans Affairs, 2019, WHOL HLTH IN; UN Human Rights Council, 2016, PROM PROT ENJ HUM RI; VA Office of Information and Technology, 2017, HIST IT VA DAT FIL; Van Ast P., 2007, RURAL REMOTE HEALTH, V7, P623; Vaudreuil R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00119; Vaudreuil R, 2019, DISABIL REHABIL, V41, P2333, DOI 10.1080/09638288.2018.1462412; World Health Organization, 2010, TEL OPP DEV MEMB STA	43	6	6	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2020.1775312		JUN 2020	10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	ML6PE	WOS:000549584700001	32608282	Green Published, hybrid			2022-02-06	
J	Voormolen, DC; Cnossen, MC; Spikman, J; Polinder, S; Iverson, GL; de Koning, M; van der Naalt, J				Voormolen, Daphne C.; Cnossen, Maryse C.; Spikman, Joke; Polinder, Suzanne; Iverson, Grant L.; de Koning, Myrthe; van der Naalt, Joukje			Rating of pre-injury symptoms over time in patients with mild traumatic brain injury: the good-old-days bias revisited	BRAIN INJURY			English	Article						Traumatic brain injury; post-concussion symptom; post-concussion syndrome; good-old-days bias	POST-CONCUSSION SYMPTOMS; POSTCONCUSSION-LIKE SYMPTOMS; RISK-FACTORS; HEAD-INJURY; QUESTIONNAIRE; ASSOCIATION; PREVALENCE; RECALL; RATES	Objective Post-concussion syndrome (PCS) occurs following mild traumatic brain injury (mTBI). Patients with mTBI are often assessed using self-report instruments that rely on perception of current symptoms compared to how they felt and functioned pre-injury. The objective was to examine reliability of patients' post-injury reporting of their pre-injury symptoms. Methods We included two control groups (trauma patients without brain injury history and healthy controls) who were recruited at an outpatient surgical clinic and among the working and social environment of the researchers, respectively. The Head Injury Symptom Checklist (HISC) was used to assess pre-injury and current symptoms at four time points post injury. We included 836 patients with mTBIs, 191 trauma patients without brain injury history, and 100 healthy controls. Results Patients with mTBI reported significantly more pre-injury symptoms than both control groups (p< .001). Forty-five percent of patients with mTBI were inconsistent in their pre-injury ratings across four assessments. Patients with post-injury PCS reported much greater pre-injury symptoms and were more often inconsistent. Conclusion Accurately assessing PCS by comparing pre with post-injury complaints is difficult, and may have implications for diagnosis when using self-report instruments. Therefore, post-injury PCS diagnosis should be interpreted with caution and PCS should ideally be examined using clinical examination.	[Voormolen, Daphne C.; Cnossen, Maryse C.; Polinder, Suzanne] Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Spikman, Joke; de Koning, Myrthe; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Spikman, Joke] Univ Groningen, Dept Clin Neuropsychol, Groningen, Netherlands; [Iverson, Grant L.] Harvard Med Sch, Spaulding Res Inst, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA		Voormolen, DC (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.	d.voormolen@erasmusmc.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418; Iverson, Grant/0000-0001-7348-9570			Arciniegas DB, 2005, NEUROPSYCHIATR DIS T, V1; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; D'Souza A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00353; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Patten SB, 2012, SOC PSYCH PSYCH EPID, V47, P691, DOI 10.1007/s00127-011-0385-5; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; The National Institute of Neurological Disorders and Stroke (NINDS), 2015, NINDS COMM DAT EL TR; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Warren AM, 2015, J TRAUMA ACUTE CARE, V79, P1062, DOI 10.1097/TA.0000000000000875; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Yue JK, 2013, J NEUROTRAUM, DOI DOI 10.1089/NEU.2013.2970	38	6	6	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1001	1009		10.1080/02699052.2020.1761563		JUN 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000546476900001	32567367	Green Published, hybrid			2022-02-06	
J	Belding, JN; Fitzmaurice, S; Englert, RM; Koenig, HG; Thomsen, CJ; da Silva, LUO				Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Koenig, Hannah G.; Thomsen, Cynthia J.; da Silva, Lt Uade Olaghere			Self-Reported Concussion Symptomology during Deployment: Differences as a Function of Injury Mechanism and Low-Level Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						blast; concussion; deployment; low-level blast; TBI	TRAUMATIC BRAIN-INJURY; MILITARY; PATHOLOGY; OUTCOMES; IRAQ; TBI	Traumatic brain injury (TBI), which can result from either direct impact to the head or blast exposure, has been the leading cause of morbidity and mortality in recent military conflicts. However, little research has compared mTBIs by mechanism of injury. The present research addressed two research questions: (1) Are blast-related mTBIs (mbTBIs) associated with significantly more symptoms than impact-related mTBIs (miTBIs), and (2) are mTBIs associated with more self-reported symptoms among service members with higher (vs. lower) risk of low-level blast (LLB) exposure. We obtained data from 181,423 active duty enlisted United States Marines deployed between 2003 and 2012, who completed the Post-Deployment Health Assessment. We examined the self-reported symptoms of Marines who completed an mTBI screen and could be classified as at high or low risk for LLB exposure, using their military occupation as a proxy (n = 12,013). Symptoms were compared as a function of blast exposure (blast vs. impact), probable mTBI (yes vs. no), occupational risk of LLB (high vs. low), and symptom type (neurological vs. musculoskeletal vs. immunological). Overall, musculoskeletal symptoms were reported more frequently than neurological and immunological symptoms. However, Marines with probable mTBIs (regardless of mechanism of injury) and those with probable mbTBIs specifically reported more neurological symptoms, which rose to the level of musculoskeletal symptom reporting. Among Marines with probable mTBI, those with high risk of LLB exposure also reported significantly more neurological symptoms. Our results indicate that mbTBIs and miTBIs may be fundamentally different, and that LLB may increase susceptibility to injury.	[Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Koenig, Hannah G.] Leidos, San Diego, CA USA; [Belding, Jennifer N.; Fitzmaurice, Shannon; Englert, Robyn Martin; Koenig, Hannah G.; Thomsen, Cynthia J.; da Silva, Lt Uade Olaghere] Naval Hlth Res Ctr, San Diego, CA 92106 USA		Belding, JN (corresponding author), Naval Hlth Res Ctr, Hlth & Behav Sci Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	jennifer.n.belding.ctr@mail.mil			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [N1629]	This study was funded by the United States Army Medical Research and Materiel Command under work unit number N1629.	Agoston D, 2017, J NEUROTRAUM, V34, pS6, DOI 10.1089/neu.2017.5220; Belding J.N., 2019, MIL MED; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Gardner AJ, 2017, PHYS MED REH CLIN N, V28, P413, DOI 10.1016/j.pmr.2016.12.014; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Luse TM, 2016, MIL MED, V181, P123, DOI 10.7205/MILMED-D-15-00019; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nelson P.R., 2005, ANAL MEANS GRAPHICAL; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Ruscio BA, 2010, AM J PREV MED, V38, pS19, DOI 10.1016/j.amepre.2009.10.004; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith GS, 2000, AM J PREV MED, V18, P41, DOI 10.1016/S0749-3797(99)00171-3; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; United States Department of the Navy, 2015, MIL OCC SPEC MAN; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	41	6	6	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2219	2226		10.1089/neu.2020.6997		JUN 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000541873100001	32368945				2022-02-06	
J	Vaz, JR; Stergiou, N; Diniz, A; Dinis, R; Pezarat-Correia, P				Vaz, Joao R.; Stergiou, Nick; Diniz, Ana; Dinis, Ricardo; Pezarat-Correia, Pedro			Postural control is altered in females with excessive medial knee displacement	SPORTS BIOMECHANICS			English	Article; Early Access						Sports Medicine; valgus; balance; variability; entropy	CRUCIATE LIGAMENT INJURIES; INVERSION ANKLE SPRAINS; INTRINSIC RISK-FACTORS; SINGLE-LEG SQUAT; APPROXIMATE ENTROPY; NEUROMUSCULAR CONTROL; MOVEMENT VARIABILITY; PATELLOFEMORAL PAIN; CEREBRAL CONCUSSION; GENDER-DIFFERENCES	Knee valgus motion observed during landing tasks has been proposed as a predictor of future knee injury. It mainly involves excess motion in the frontal plane and is known to be greater in individuals with excessive medial knee displacement (MKD). This affects postural control during sports manoeuvres. Previous sports medicine-related research suggests that the nature of these fluctuations provide rich and more sensitive information to identify risk of (re)injury. We aimed to investigate the fluctuations of the centre of pressure (CoP) in individuals with and without excessive MKD. Twenty females (12 controls; 8 excessive MKD) were instructed to perform single-leg landing tasks from three different directions. The participants landed on a force plate and stayed still for 20 seconds. The fluctuations of the anterior-posterior and medial-lateral directions of the CoP were determined through the calculation of Sample Entropy. Mixed-model ANOVAs (3 [Landing Direction] x 2 [Group]) were used. We have found that only the entropy of the medial-lateral direction was different between groups. Individuals with excessive MKD exhibited an increase in entropy values, indicating greater randomness in CoP fluctuations. This suggests a decreased ability to adapt to environmental demands that likely result in an increased risk of injury.	[Vaz, Joao R.; Diniz, Ana; Dinis, Ricardo; Pezarat-Correia, Pedro] Univ Lisbon, Interdisciplinary Ctr Study Human Performance CIP, Fac Human Kinet, Lisbon, Portugal; [Vaz, Joao R.; Stergiou, Nick] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Stergiou, Nick] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE USA		Vaz, JR (corresponding author), Univ Lisbon, Interdisciplinary Ctr Study Human Performance CIP, Fac Human Kinet, Lisbon, Portugal.; Vaz, JR (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.	vazj@edu.ulisboa.pt	Diniz, Ana/F-4810-2010; Vaz, Joao R/AAH-7314-2019; Pezarat-Correia, Pedro/O-1661-2019	Diniz, Ana/0000-0002-1534-3423; Vaz, Joao R/0000-0001-9691-5456; Pezarat-Correia, Pedro/0000-0001-6154-5563	Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [PTDC/SAU-DES/31297/2017]; Center for Research in Human Movement Variability; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM109090, R15AG063106, R01NS114282]	Dr. Vaz was supported by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-DES/31297/2017). Dr. Stergiou was supported by the Center for Research in Human Movement Variability and the National Institutes of Health (P20GM109090, R15AG063106, and R01NS114282).	Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Azevedo AM, 2019, MED SCI SPORT EXER, V51, P539, DOI 10.1249/MSS.0000000000001817; Bell DR, 2008, ARCH PHYS MED REHAB, V89, P1323, DOI 10.1016/j.apmr.2007.11.048; Bollen S, 2000, BRIT J SPORT MED, V34, P227, DOI 10.1136/bjsm.34.3.227-a; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Carvalho-e-Silva APDC, 2016, KNEE, V23, P616, DOI 10.1016/j.knee.2016.04.013; de Noronha M, 2006, BRIT J SPORT MED, V40, P824, DOI 10.1136/bjsm.2006.029645; Decker LM, 2011, KNEE SURG SPORT TR A, V19, P1620, DOI 10.1007/s00167-011-1484-2; DuPrey KM, 2016, AM J SPORT MED, V44, P1487, DOI 10.1177/0363546516629635; Dusing SC, 2009, PHYS THER, V89, P1354, DOI 10.2522/ptj.20080361; FERRETTI A, 1992, AM J SPORT MED, V20, P203, DOI 10.1177/036354659202000219; Fewster KM, 2020, GAIT POSTURE, V78, pE1, DOI 10.1016/j.gaitpost.2017.06.005; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 2002, CLIN ORTHOP RELAT R, P76, DOI 10.1097/01.blo.0000026962.51742.99; Hollman JH, 2014, CLIN BIOMECH, V29, P468, DOI 10.1016/j.clinbiomech.2013.12.017; Hughes G, 2008, SPORT BIOMECH, V7, P333, DOI 10.1080/14763140802233215; Ireland ML, 2002, ORTHOP CLIN N AM, V33, P637, DOI 10.1016/S0030-5898(02)00028-7; Knapp D, 2011, J ATHL TRAINING, V46, P257, DOI 10.4085/1062-6050-46.3.257; Ko JH, 2018, J SPORT SCI, V36, P809, DOI 10.1080/02640414.2017.1343490; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Krosshaug T, 2016, AM J SPORT MED, V44, P874, DOI 10.1177/0363546515625048; LaPrade RF, 2012, J ORTHOP SPORT PHYS, V42, P221, DOI 10.2519/jospt.2012.3624; Lee SP, 2012, GAIT POSTURE, V36, P425, DOI 10.1016/j.gaitpost.2012.03.024; Liu K, 2016, SPORT BIOMECH, V15, P245, DOI 10.1080/14763141.2016.1158859; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McKeon PO, 2008, J ATHL TRAINING, V43, P305, DOI 10.4085/1062-6050-43.3.305; Moraiti CO, 2010, GAIT POSTURE, V32, P169, DOI 10.1016/j.gaitpost.2010.04.008; Moraiti CO, 2009, ARTHROSCOPY, V25, P742, DOI 10.1016/j.arthro.2009.01.016; Nakagawa TH, 2012, J ORTHOP SPORT PHYS, V42, P491, DOI 10.2519/jospt.2012.3987; Oliphant Jeff G., 1996, Journal of Athletic Training, V31, P245; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Oshima T, 2015, ORTHOP J SPORTS MED, V3, DOI [10.1177/232596711 5s00110, DOI 10.1177/2325967115S00110]; Padua DA, 2012, J ATHL TRAINING, V47, P525, DOI 10.4085/1062-6050-47.5.10; Patterson MR, 2013, KNEE, V20, P532, DOI 10.1016/j.knee.2013.07.008; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Post E. G., 2017, J SPORT REHABIL, V26, DOI [10.1073/pnas.88.6.2297, DOI 10.1073/PNAS.88.6.2297]; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sinsurin Komsak, 2013, Asian J Sports Med, V4, P195; Solomonow M, 2001, SCAND J MED SCI SPOR, V11, P64, DOI 10.1034/j.1600-0838.2001.011002064.x; Staynor JMD, 2017, SPORT BIOMECH, V16, P501, DOI 10.1080/14763141.2016.1246597; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stiffler MR, 2015, CLIN J SPORT MED, V25, P61, DOI 10.1097/JSM.0000000000000106; Terada M, 2019, MED SCI SPORT EXER, V51, P640, DOI 10.1249/MSS.0000000000001848; Trojian TH, 2006, BRIT J SPORT MED, V40, P610, DOI 10.1136/bjsm.2005.024356; Wang HK, 2006, ARCH PHYS MED REHAB, V87, P821, DOI 10.1016/j.apmr.2006.02.024; Webster KA, 2010, J ATHL TRAINING, V45, P580, DOI 10.4085/1062-6050-45.6.580; Wikstrom EA, 2008, J SCI MED SPORT, V11, P106, DOI 10.1016/j.jsams.2007.02.014; Wikstrom EA, 2006, CLIN J SPORT MED, V16, P311, DOI 10.1097/00042752-200607000-00005; Willems TM, 2005, SCAND J MED SCI SPOR, V15, P336, DOI 10.1111/j.1600-0838.2004.00428.x; Willems TM, 2005, AM J SPORT MED, V33, P415, DOI 10.1177/0363546504268137; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	66	6	6	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2020.1767187		JUN 2020	15	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	ME8QS	WOS:000544918500001	32546063				2022-02-06	
J	O'Connell, GC; Smothers, CG; Winkelman, C				O'Connell, Grant C.; Smothers, Christine G.; Winkelman, Chris			Bioinformatic analysis of brain-specific miRNAs for identification of candidate traumatic brain injury blood biomarkers	BRAIN INJURY			English	Article						Neurotrauma; microRNA; concussion; triage; cardiac dysfunction; arrhythmia	MICRORNAS; MILD; DYSFUNCTION; EXPRESSION; DIAGNOSIS; GENE	Background Detection of brain-specific miRNAs in the peripheral blood could serve as a surrogate marker of traumatic brain injury (TBI). Here, we systematically identified brain-enriched miRNAs, and tested their utility as TBI biomarkers in the acute phase of care. Methods Publically available microarray data generated from 29 postmortem human tissues were used to rank 1,364 miRNAs in terms of their degree of brain-specific expression. Levels of the top six ranked miRNAs were then prospectively measured in serum samples collected from 10 Patients with TBI at hospital admission, as well as from 10 controls. Results The top six miRNAs identified in our analysis (miR-124-3p, miR-219a-5p, miR-9-5p, miR-9-3p, miR-137, and miR-128-3p) were enriched 70 to 320-fold in brain relative to other tissues, and exhibited dramatically greater brain specificity compared to several miRNAs previously proposed as biomarkers. Furthermore, their levels were elevated in serum from patients with TBI compared to controls, and could collectively discriminate between groups with 90% sensitivity and 100% specificity. Interestingly, subsequent informatic pathway analysis revealed that their target transcripts were enriched for components of signaling pathways active in peripheral organs involved in common post-TBI complications. Conclusions The six candidate miRNAs identified in this preliminary study have promise as blood biomarkers of TBI, and could also be molecular contributors to systemic physiologic changes commonly observed post-injury.	[O'Connell, Grant C.; Smothers, Christine G.; Winkelman, Chris] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA		O'Connell, GC (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA.	grant.oconnell@case.edu		Smothers, Christine/0000-0002-8269-2375; O'Connell, Grant/0000-0002-2642-6670	FPB School of Nursing start-up funds issued to GCO	Work was funded via FPB School of Nursing start-up funds issued to GCO.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; [Anonymous], 2017, STROKE, V48, pe78; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dave VP, 2019, LAB INVEST, V99, P452, DOI 10.1038/s41374-018-0143-3; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fuller G, 2016, EUR J EMERG MED, V23, P61, DOI 10.1097/MEJ.0000000000000327; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Huang S, 2018, FASEB J, V32, P2315, DOI 10.1096/fj.201700673RERR; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI 10.2307/1390807; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; LaRocca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207785; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; O'Connell GC, 2018, TRANSL STROKE RES IN, DOI 10.1007/s12975-018-0623-1; O'Connell GC, 2017, GENOM DATA, V14, P47, DOI 10.1016/j.gdata.2017.08.006; Oliveira AC, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00059; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Scott Hannah, 2017, Neuronal Signal, V1, pNS20170112, DOI 10.1042/NS20170112; Srivastava PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-348; Szklarczyk D, 2019, NUCL ACIDS RES, V47, pD607; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Witkos TM, 2011, CURR MOL MED, V11, P93; Yan J, 2019, J NEUROCHEM, V150, P202, DOI 10.1111/jnc.14717; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	45	6	6	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					965	974		10.1080/02699052.2020.1764102		JUN 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000542690600001	32497449	Green Submitted			2022-02-06	
J	Brickell, TA; Wright, MM; Lippa, SM; Sullivan, JK; Bailie, JM; French, LM; Lange, RT				Brickell, Tracey A.; Wright, Megan M.; Lippa, Sara M.; Sullivan, Jamie K.; Bailie, Jason M.; French, Louis M.; Lange, Rael T.			Resilience is associated with health-related quality of life in caregivers of service members and veterans following traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						Caregiver; Resilience; Service member veteran; Military; Traumatic brain injury; Mental health	FAMILY-CENTERED PREVENTION; SPINAL-CORD-INJURY; ITEM BANK; OUTCOMES; INDIVIDUALS; CALIBRATION; CHILDREN; BURDEN; RISK; TBI	Purpose To examine factors related to resilience in military caregivers across caregiver health-related quality of life (HRQOL), caregiver sociodemographic variables, and service member/veteran (SMV) injury and health status. Methods Caregivers (N = 346, Female = 96.2%; Spouse = 91.0%; Age: M = 40.6 years, SD = 9.3) of SMVs following a mild, moderate, severe, or penetrating TBI were recruited from U.S. military treatment facilities and via community outreach. Caregivers completed select TBI-CareQOL and NIH Toolbox scales, the Caregiver Appraisal Scale, Caregiver Questionnaire, and Mayo-Portland Adaptability Inventory-4. Caregivers were divided into three groups using the TBI-QOL Resilience scale: (1) Low-Moderate Resilience (n = 125), (2) Moderate Resilience (n = 122), and (3) Moderate-High Resilience (n = 99). Results Factors related to low caregiver resilience were strain on employment, financial burden from out-of-pocket expenses, caring for children, less personal time, caring for both verbal and physical irritability, anger, and aggression, and lower SMV functional ability (all p's < .05). The Low-Moderate Resilience group had consistently worse HRQOL scores compared to the Moderate and Moderate-High Resilience groups (ps < .001; d = .50-1.60), with the exception of Caregiving Ideology. Conclusion Lower resilience among caregivers of SMVs following TBI is associated with poorer caregiver HRQOL. Programs aimed at promoting and maintaining resilience in military caregivers long-term is important for their own health, the health of the SMV, and the health of their children.	[Brickell, Tracey A.; Wright, Megan M.; Lippa, Sara M.; Sullivan, Jamie K.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA; [Brickell, Tracey A.; Wright, Megan M.; Lippa, Sara M.; Sullivan, Jamie K.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,4954 N Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bailie, Jason M.] Def & Vet Brain Injury Ctr, 2016 San Jacinto Rd, Camp Pendleton, CA 92055 USA; [Brickell, Tracey A.; Wright, Megan M.; Lippa, Sara M.; Sullivan, Jamie K.; Bailie, Jason M.; Lange, Rael T.] Gen Dynam Informat Technol, Silver Spring, MD 20910 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA.; Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,4954 N Palmer Rd, Bethesda, MD 20889 USA.; Brickell, TA (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.; Brickell, TA (corresponding author), Gen Dynam Informat Technol, Silver Spring, MD 20910 USA.	tbrickell@dvbic.org; megan.m.wright13.ctr@mail.mil; sara.m.lippa.ctr@mail.mil; Jamie.k.sullivan2.ctr@mail.mil; jason.m.bailie.ctr@mail.mil; louis.m.french.civ@mail.mil; rlange@dvbic.org		french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury Center (DVBC); DHA Contracting Office (CO-NCR) [HT0014, HT0014-19-C-0004]	This work is supported by the Defense and Veterans Brain Injury Center (DVBC). The views expressed in this manuscript are those of the authors and do not necessarily represent the official policy or position of the Defense Health Agency, Department of Defense, or any other U.S. government agency. This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014, and therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Per Title 17 U.S.C. 105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.DVBICinfo@mail.mil.	[Anonymous], 2006, SEC721 NDAA FY2007 L; Brickell TA, 2019, REHABIL PSYCHOL, V64, P366, DOI 10.1037/rep0000270; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P323, DOI 10.1037/rep0000295; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cozza SJ, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P259, DOI 10.1007/978-1-4419-7064-0_13; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Dreer LE, 2019, ARCH PHYS MED REHAB, V100, pS76, DOI 10.1016/j.apmr.2018.12.027; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gershon, 2012, NIH TOOLBOX TECHNICA; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Iverson G. L., 2016, BRAIN INJURY MED PRI, P470; Iverson GL, 2016, BRAIN INJURY MED PRI; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P., 2013, MIL MED, V16, P25; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; National Alliance for Caregiving, 2010, CAR VET SERV HOM; Patient-Reported Outcome Measurement Information System, 2013, INSTR DEV VAL SCI ST; Ramchand R., 2014, HIDDEN HEROES AM MIL; Rosenberg AR, 2013, J PALLIAT MED, V16, P645, DOI 10.1089/jpm.2012.0494; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Saltzman WR, 2011, CLIN CHILD FAM PSYCH, V14, P213, DOI 10.1007/s10567-011-0096-1; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Victorson D, 2015, J SPINAL CORD MED, V38, P366, DOI 10.1179/2045772315Y.0000000016	44	6	6	1	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2020	29	10					2781	2792		10.1007/s11136-020-02529-y		JUN 2020	12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	OA9CS	WOS:000537961000001	32500241				2022-02-06	
J	Mathieu, F; Guting, H; Gravesteijn, B; Monteiro, M; Ben Glocker; Kornaropoulos, EN; Kamnistas, K; Robertson, CS; Levin, H; Whitehouse, DP; Das, T; Lingsma, HF; Maegele, M; Newcombe, VFJ; Menon, DK				Mathieu, Francois; Gueting, Helge; Gravesteijn, Benjamin; Monteiro, Miguel; Ben Glocker; Kornaropoulos, Evgenios N.; Kamnistas, Konstantinos; Robertson, Claudia S.; Levin, Harvey; Whitehouse, Daniel P.; Das, Tilak; Lingsma, Hester F.; Maegele, Marc; Newcombe, Virginia F. J.; Menon, David K.		Collaborative European NeuroTrauma	Impact of Antithrombotic Agents on Radiological Lesion Progression in Acute Traumatic Brain Injury: A CENTER-TBI Propensity-Matched Cohort Analysis	JOURNAL OF NEUROTRAUMA			English	Article						anticoagulant; antiplatelet; intracranial hemorrhage; traumatic brain injury	PREINJURY WARFARIN; INTRACEREBRAL HEMORRHAGE; ANTIPLATELET AGENTS; HEAD-INJURY; RISK; OUTCOMES; ANTICOAGULATION; SEGMENTATION; CLOPIDOGREL; MORTALITY	An increasing number of elderly patients are being affected by traumatic brain injury (TBI) and a significant proportion are on pre-hospital antithrombotic therapy for cardio- or cerebrovascular indications. We have quantified the impact of antiplatelet/anticoagulant (APAC) agents on radiological lesion progression in acute TBI, using a novel, semi-automated approach to volumetric lesion measurement, and explored the impact of use on clinical outcomes in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. We used a 1:1 propensity-matched cohort design, matching controls to APAC users based on demographics, baseline clinical status, pre-injury comorbidities, and injury severity. Subjects were selected from a pool of patients enrolled in CENTER-TBI with computed tomography (CT) scan at admission and repeated within 7 days of injury. We calculated absolute changes in volume of intraparenchymal, extra-axial, intraventricular, and total intracranial hemorrhage (ICH) between scans, and compared volume of hemorrhagic progression, proportion of patients with significant degree of progression (>25% of initial volume), proportion with new ICH on follow-up CT, as well as clinical course and outcomes. A total of 316 patients were included (158 APAC users; 158 controls). The mean volume of progression was significantly higher in the APAC group for extra-axial (3.1 vs. 1.3 mL, p = 0.01), but not intraparenchymal (3.8 vs. 4.6 mL, p = 0.65), intraventricular (0.2 vs. 0.0 mL, p = 0.79), or total intracranial hemorrhage (ICH; 7.0 vs. 6.0 mL, p = 0.08). More patients had significant hemorrhage growth (54.1 vs. 37.0%, p = 0.003) and delayed ICH (4 of 18 vs. none; p = 0.04) in the APAC group compared with controls, but this was not associated with differences in length of stay (LOS), rates of neurosurgical intervention, mortality or Glasgow Outcome Scale Extended (GOS-E) score at 6 months. Pre-injury use of antithrombotic agents was associated with greater expansion of extra-axial lesions, higher rates of significant hemorrhagic progression, and higher risk of delayed traumatic ICH, but this was not associated with worse clinical course or functional outcomes.	[Mathieu, Francois] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Mathieu, Francois; Kornaropoulos, Evgenios N.; Whitehouse, Daniel P.; Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Dept Med, Cambridge, England; [Mathieu, Francois] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Das, Tilak] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Gueting, Helge; Maegele, Marc] Univ Witten Herdecke, Inst Res Operat Med IFOM, Witten, Germany; [Gravesteijn, Benjamin; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Monteiro, Miguel; Ben Glocker; Kamnistas, Konstantinos] Imperial Coll London, Biomed Image Anal Grp, London, England; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Maegele, Marc] Cologne Merheim Med Ctr, Dept Traumatol & Orthoped Surg, Cologne, Germany		Mathieu, F (corresponding author), Univ Cambridge, Div Anesthesia, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	fm494@cam.ac.uk	Posti, Jussi P./Y-2908-2019; Volovici, Victor/AAZ-8901-2020; Castano-Leon, Ana M/ABF-6322-2020; Monteiro, Miguel/AAE-6334-2021; Sahuquillo, Juan/B-3577-2008; Vande Vyvere, Thijs/AAB-5180-2022; Das, Tilak/AAY-5310-2020; Cooper, D. James/G-7961-2013; Raj, Rahul/K-7693-2012; Gomez, Pedro/E-2411-2014	Posti, Jussi P./0000-0002-5925-5193; Volovici, Victor/0000-0002-5798-5360; Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Vande Vyvere, Thijs/0000-0003-4032-5443; Das, Tilak/0000-0003-0655-412X; Cooper, D. James/0000-0002-5872-9051; Coles, Jonathan/0000-0003-4013-679X; Van Essen, Thomas/0000-0003-4657-5283; Sanchez-Porras, Renan/0000-0002-9084-8114; Newcombe, Virginia/0000-0001-6044-9035; Stewart, William/0000-0003-2199-2582; Raj, Rahul/0000-0003-4243-9591; Sakowitz, Oliver/0000-0003-3248-6335; Radoi, Andreea/0000-0002-0677-3544; Gomez, Pedro/0000-0002-4185-5238; Dark, Paul/0000-0003-3309-0164; Kondziella, Daniel/0000-0001-5562-9808; Whitehouse, Daniel/0000-0002-0216-1866; Kolias, Angelos/0000-0003-3992-0587; Zeiler, Frederick/0000-0003-1737-0510; Gravesteijn, Benjamin/0000-0001-8096-5803; Rossi, Sandra/0000-0002-9963-8121	European Union 7th Framework program (EC) [602150]; Cambridge Commonwealth Trust; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; NIHRNational Institute for Health Research (NIHR)	Data used in preparation of this article were obtained in the context of Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI), a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). FM has received salary support for dedicated research time from the Canada Cambridge Scholarship funded by the Cambridge Commonwealth Trust. VN is supported by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. These studies were also supported by infrastructure provided by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Center (BRC), a partnership between the Cambridge University Hospitals National Health Service (NHS) Foundation Trust and the University of Cambridge, funded by the NIHR. In addition, DKM was supported by an NIHR Senior Investigator Award.	Adelborg K, 2016, HEART, V102, P1883, DOI 10.1136/heartjnl-2016-309402; Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Cull JD, 2015, AM SURGEON, V81, P128; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fiez JA, 2000, HUM BRAIN MAPP, V9, P192, DOI 10.1002/(SICI)1097-0193(200004)9:4<192::AID-HBM2>3.0.CO;2-Y; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP AG 2017 HI; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	36	6	6	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2020	37	19					2069	2080		10.1089/neu.2019.6911		JUN 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NV1ON	WOS:000538187300001	32312149	Green Submitted			2022-02-06	
J	LoBue, C; Schaffert, J; Cullum, CM; Peters, ME; Didehbani, N; Hart, J; White, CL				LoBue, Christian; Schaffert, Jeff; Cullum, C. Munro; Peters, Matthew E.; Didehbani, Nyaz; Hart, John; White, Charles L.			Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							DISEASE; BRAIN	Objective To determine whether subjects with chronic traumatic encephalopathy (CTE) and dementia have distinct clinical features compared to subjects with pathologically confirmed Alzheimer's disease (AD). Methods Among 339 subjects assessed for CTE in the National Alzheimer's Coordinating Center dataset, 6 subjects with CTE and 25 subjects with AD neuropathologic change matched for age (5 years) and sex were identified. All subjects had a clinical diagnosis of dementia. Neurological examination, neuropsychological testing and emotional/behavioural data were compared between CTE and AD subjects at the time of dementia diagnosis and last clinical visit near death. Results A history of traumatic brain injury with loss of consciousness (LOC) was reported in one CTE and one AD subject; information about injuries without LOC or multiple injuries was unavailable. CTE and AD subjects did not differ significantly at the time of diagnosis or last visit on the Unified Parkinson's Disease Rating Scale-Motor Exam, global measures of cognitive functioning (Mini-Mental State Exam and Clinical Dementia Rating Scale), emotional/behaviour symptoms as assessed with the Neuropsychiatric Inventory questionnaire or across neuropsychological measures. All CTE participants had co-occurring neuropathologic processes, including AD and most had TAR DNA-binding protein 43 (TDP-43) neuropathology. Conclusions CTE pathology was rare in a large multicentre national dataset, and when present, was accompanied by AD and TDP-43 pathologies. CTE was not associated with a different clinical presentation from AD or with greater cognitive impairment or neurobehavioral symptoms. These findings suggest that CTE may not have a distinct clinical profile when other neuropathologic processes are coexistent with CTE pathology.	[LoBue, Christian; Schaffert, Jeff; Cullum, C. Munro; Didehbani, Nyaz; Hart, John] UT Southwestern Med Ctr, Psychiat, Dallas, TX USA; [LoBue, Christian; Cullum, C. Munro] UT Southwestern Med Ctr, Neurol Surg, Dallas, TX USA; [Cullum, C. Munro; Hart, John] UT Southwestern Med Ctr, Neurol & Neurotherapeut, Dallas, TX USA; [Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Psychiat & Behav Sci, Baltimore, MD USA; [Hart, John] Univ Texas Dallas, Sch Behav & Brain Sci, Callier Ctr, Dallas, TX USA; [White, Charles L.] UT Southwestern Med Ctr, Pathol, Dallas, TX USA		LoBue, C (corresponding author), UT Southwestern Med, Dallas, TX 75390 USA.	christian.lobue@utsw.edu	White, Charles L/AAJ-1858-2021; LoBue, Christian/M-4584-2017	White, Charles L/0000-0002-3870-2804; Peters, Matthew/0000-0002-5668-4566; LoBue, Christian/0000-0001-9671-5526; Hart, John/0000-0003-3919-8125; Schaffert, Jeff/0000-0002-8842-980X; Cullum, Munro/0000-0001-9706-5465	Texas Alzheimer's Research and Care Consortium (TARCC); Texas Institute for Brain Injury and Repair (TIBIR) in the Peter O'Donnell Brain Institute at University of Texas Southwestern Medical Center; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG 016976]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG 019610, P30 AG 013846, P50 AG 008702, P50 AG 025688, P50 AG 047266, P30 AG 010133, P50 AG 005146, P50 AG 005134, P50 AG 016574, P50 AG 005138, P30 AG 008051, P30 AG 013854, P30 AG 008017, P30 AG 010161, P50 AG 047366, P30 AG 010129];  [P50 AG 016573];  [P50 AG 005131];  [P50 AG 023501];  [P30 AG 035982];  [P30 AG 028383];  [P30 AG 053760];  [P30 AG 010124];  [P50 AG 005133];  [P50 AG 005142];  [P30 AG 012300];  [P30 AG 049638];  [P50 AG 005136];  [P50 AG 033514];  [P50 AG 005681];  [P50 AG 047270]	Financial support for this work was provided in part by the Texas Alzheimer's Research and Care Consortium (TARCC) and the Texas Institute for Brain Injury and Repair (TIBIR) in the Peter O'Donnell Brain Institute at University of Texas Southwestern Medical Center. The NACC database is funded by NIA/NIH Grant U01 AG 016976. NACC data are contributed by the NIA--funded ADCs: P30 AG 019610 (PI Eric Reiman, MD), P30 AG 013846 (PI Neil Kowall, MD), P50 AG 008702 (PI Scott Small, MD), P50 AG 025688 (PI Allan Levey, MD, PhD), P50 AG 047266 (PI Todd Golde, MD, PhD), P30 AG 010133 (PI Andrew Saykin, PsyD), P50 AG 005146 (PI Marilyn Albert, PhD), P50 AG 005134 (PI Bradley Hyman, MD, PhD), P50 AG 016574 (PI Ronald Petersen, MD, PhD), P50 AG 005138 (PI Mary Sano, PhD), P30 AG 008051 (PI Thomas Wisniewski, MD), P30 AG 013854 (PI M. Marsel Mesulam, MD), P30 AG 008017 (PI Jeffrey Kaye, MD), P30 AG 010161 (PI David Bennett, MD), P50 AG 047366 (PI Victor Henderson, MD, MS), P30 AG 010129 (PI Charles DeCarli, MD), P50 AG 016573 (PI Frank LaFerla, PhD), P50 AG 005131 (PI James Brewer, MD, PhD), P50 AG 023501 (PI Bruce Miller, MD), P30 AG 035982 (PI Russell Swerdlow, MD), P30 AG 028383 (PI Linda Van Eldik, PhD), P30 AG 053760 (PI Henry Paulson, MD, PhD), P30 AG 010124 (PI John Trojanowski, MD, PhD), P50 AG 005133 (PI Oscar Lopez, MD), P50 AG 005142 (PI Helena Chui, MD), P30 AG 012300 (PI Roger Rosenberg, MD), P30 AG 049638 (PI Suzanne Craft, PhD), P50 AG 005136 (PI Thomas Grabowski, MD), P50 AG 033514 (PI Sanjay Asthana, MD, FRCP), P50 AG 005681 (PI John Morris, MD) and P50 AG 047270 (PI Stephen Strittmatter, MD, PhD).	Besser LM, 2018, J NEUROPATH EXP NEUR, V77, P717, DOI 10.1093/jnen/nly049; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Connor DJ, 1998, ARCH NEUROL-CHICAGO, V55, P994, DOI 10.1001/archneur.55.7.994; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; Galioto R, 2015, EPILEPSY BEHAV, V51, P48, DOI 10.1016/j.yebeh.2015.06.035; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092	26	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2020	91	6					586	592		10.1136/jnnp-2019-321567			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	LW3RG	WOS:000539061900007	32332103	Bronze, Green Accepted			2022-02-06	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Perez-Cejas, A; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Caceres, JJ; Sole-Violan, J; Alvarez-Castillo, A; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Perez-Cejas, Antonia; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Caceres, Juan J.; Sole-Violan, Jordi; Alvarez-Castillo, Andrea; Jimenez, Alejandro; Garcia-Marin, Victor			Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						DNA and RNA oxidative damage; Traumatic brain injury; Mortality; Outcome	8-HYDROXY-2-DEOXYGUANOSINE LEVELS; STRESS; CLASSIFICATION; DISEASE; METAANALYSIS; SEVERITY; ACID; COMA	Background The hyperoxidative state in traumatic brain injury (TBI) could produce oxidative damage on the ribonucleic acid (RNA) and deoxyribonucleic acid (DNA). Oxidative damage to nucleic acids in TBI patients has been studied, and higher concentrations of 8-OHdG were found in postmortem brain samples of subjects who died following TBI than in subjects who died from sudden cardiac death. Thus, the objective of this study was to determine whether there is an association between serum DNA and RNA oxidative damage and mortality in TBI patients. Methods We included patients with severe isolated TBI defined as a lower score than 9 points in the Glasgow Coma Scale (GCS) and lower than 9 points in non-cranial aspects in the Injury Severity Score. We determined serum concentrations of the three oxidized guanine species (OGS) (8-OHdG from DNA, 8-hydroxyguanosine from RNA, and 8-hydroxyguanine from DNA or RNA) and malondialdehyde (to estimate lipid peroxidation) on the day of TBI. Mortality at 30 days was the end-point study. Results We found higher serum concentrations of OGS (p < 0.001) and malondialdehyde (p < 0.001) in non-surviving (n = 34) than in surviving patients (n = 90), an association between serum OGS levels and 30-day mortality after control for CGS, age, and computed tomography findings (OR = 1.397; 95% CI = 1.137-1.716; p = 0.001), and a positive correlation between serum levels of OGS and malondialdehyde (rho = 0.24; p = 0.01). Conclusions To our knowledge, our study is the largest series reporting data on DNA oxidative damage in TBI patients and is the first reporting DNA and RNA oxidative damage in TBI patients associating lipid peroxidation and mortality.	[Lorente, Leonardo; Alvarez-Castillo, Andrea] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Gonzalez-Rivero, Agustin F.; Perez-Cejas, Antonia] Hosp Univ Canarias, Lab Dept, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Physiology, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Arriba S-N, Brena Alta 38713, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Barranco Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Alvarez Castillo, Andrea Carolina/0000-0003-4063-9370; Jimenez-Sosa, Alejandro/0000-0001-8732-2616; Argueso, Monica/0000-0001-5917-1056			AbdulSalam SF, 2016, BIOCHEMISTRY-US, V55, P5341, DOI 10.1021/acs.biochem.6b00703; Abe N, 2018, GLIA, V66, P2158, DOI 10.1002/glia.23469; Aschbacher K, 2013, PSYCHONEUROENDOCRINO, V38, P1698, DOI 10.1016/j.psyneuen.2013.02.004; Atalay T, 2017, TURK NEUROSURG, V27, P924, DOI 10.5137/1019-5149.JTN.17249-16.2; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Di Minno A, 2017, NUTR METAB CARDIOVAS, V27, P201, DOI 10.1016/j.numecd.2016.10.009; Di Minno A, 2016, ANTIOXID REDOX SIGN, V24, P548, DOI 10.1089/ars.2015.6508; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Bernal EF, 2013, MED INTENSIVA, V37, P327, DOI 10.1016/j.medin.2012.05.015; Itoh T, 2013, J NEURAL TRANSM, V120, P767, DOI 10.1007/s00702-012-0918-4; Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Kino K, 2017, GENES ENVIRON, V39, DOI 10.1186/s41021-017-0081-0; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumagai Shunichi, 2003, Rinsho Byori, V51, P126; Li ZW, 2006, IUBMB LIFE, V58, P581, DOI 10.1080/15216540600946456; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; MALINS DC, 1991, CANCER RES, V51, P5430; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nunomura A, 2007, CURR MED CHEM, V14, P2968, DOI 10.2174/092986707782794078; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Paredes-Sanchez E, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/7916578; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shin CS, 2001, DIABETES CARE, V24, P733, DOI 10.2337/diacare.24.4.733; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; TEASDALE G, 1974, LANCET, V2, P81; Zhang GX, 2016, NEUROCHEM RES, V41, P2948, DOI 10.1007/s11064-016-2013-y	35	6	6	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2020	32	3					790	795		10.1007/s12028-019-00800-w			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LV6MP	WOS:000538548700018	31385181				2022-02-06	
J	Patterson, JT; Ishii, K; Tornetta, P; Leighton, RK; Friess, DM; Jones, CB; Levine, A; Maclean, JJ; Miclau, T; Mullis, BH; Obremskey, WT; Ostrum, RF; Reid, JS; Ruder, JA; Saleh, A; Schmidt, AH; Teague, DC; Tsismenakis, A; Westberg, JR; Morshed, S				Patterson, Joseph T.; Ishii, Keisuke; Tornetta, Paul, III; Leighton, Ross K.; Friess, Darin M.; Jones, Clifford B.; Levine, Ari; Maclean, Jeffrey J.; Miclau, Theodore, III; Mullis, Brian H.; Obremskey, William T.; Ostrum, Robert F.; Reid, J. Spence; Ruder, John A.; Saleh, Anas; Schmidt, Andrew H.; Teague, David C.; Tsismenakis, Antonios; Westberg, Jerald R.; Morshed, Saam			Open Reduction Is Associated With Greater Hazard of Early Reoperation After Internal Fixation of Displaced Femoral Neck Fractures in Adults 18-65 Years	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						adult; displaced; femoral neck fracture; outcomes; complications; avascular necrosis; malunion; nonunion; reoperation	SUBCAPITAL FRACTURES; PROPENSITY SCORE; HIP FRACTURE; YOUNG-ADULTS; COMPLICATIONS; OUTCOMES; CLASSIFICATION; QUALITY; AGES	Objectives: To determine (1) which factors are associated with the choice to perform an open reduction and (2) by adjusting for these factors, if the choice of reduction method is associated with reoperation. Design: Retrospective cohort study with radiograph and chart review. Setting: Twelve Level 1 North American trauma centers. Patients: Two hundred thirty-four adults 18-65 years of age with an isolated, displaced, OTA/AO type 31-B2 or type 31-B3 femoral neck fracture treated with internal fixation with minimum of 6-month follow-up or reoperation. Exclusion criteria were pathologic fractures, associated femoral head or shaft fractures, and primary arthroplasty. Intervention: Open or closed reduction technique during internal fixation. Main outcome: Cox proportional hazard of reoperation adjusting for propensity score for open reduction based on injury, demographic, and medical factors. Reduction quality was assessed by 3 senior orthopaedic traumatologists as "acceptable" or "unacceptable" on AP and lateral postoperative radiographs. Results: Median follow-up was 1.5 years. One hundred six (45%) patients underwent open reduction. Reduction quality was not significantly affected by open versus closed approach (71% vs. 69% acceptable,P= 0.378). The propensity to receive an open reduction was associated with study center; younger age; male sex; no history of injection drug use, osteoporosis, or cerebrovascular disease; transcervical fracture location; posterior fracture comminution; and surgery within 12 hours. A total of 35 (33%) versus 28 (22%) reoperations occurred after open versus closed reduction (P= 0.056). Open reduction was associated with a 2.4-fold greater propensity-adjusted hazard of reoperation (95% confidence interval 1.3-4.4,P= 0.004). A total of 35 (15%) patients underwent subsequent total hip arthroplasty or hemiarthroplasty. Conclusions: Open reduction of displaced femoral neck fractures in nonelderly adults is associated with a greater hazard of reoperation without significantly improving reduction. Prospective randomized trials are indicated to confirm a causative effect of open versus closed reduction on outcomes after femoral neck fracture.	[Patterson, Joseph T.; Ishii, Keisuke; Maclean, Jeffrey J.; Miclau, Theodore, III; Morshed, Saam] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Tornetta, Paul, III; Tsismenakis, Antonios] Boston Univ, Med Ctr, Dept Orthopaed Surg, Boston, MA USA; [Leighton, Ross K.] Dalhousie Univ, Div Orthopaed Surg, Halifax, NS, Canada; [Friess, Darin M.] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA; [Jones, Clifford B.] CORE Inst, Phoenix, AZ USA; [Levine, Ari; Saleh, Anas] Metrohlth Med Ctr, Dept Orthopaed, Cleveland, OH USA; [Mullis, Brian H.] Indiana Univ, Dept Orthopaed Surg, Indianapolis, IN 46204 USA; [Obremskey, William T.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Nashville, TN USA; [Ostrum, Robert F.] Cooper Univ Hlth Care, Cooper Bone & Joint Inst, Camden, NJ USA; [Reid, J. Spence] Penn State Hlth Milton S Hershey Med Ctr, Dept Orthopaed & Rehabil, Hershey, PA USA; [Ruder, John A.] Carolinas HealthCare Syst, Dept Orthopaed Surg, Charlotte, NC USA; [Schmidt, Andrew H.; Westberg, Jerald R.] Univ Minnesota, Dept Orthopaed Surg, Hennepin Healthcare, Minneapolis, MN USA; [Teague, David C.] Univ Oklahoma, Dept Orthoped Surg & Rehabil, Oklahoma City, OK USA		Morshed, S (corresponding author), Univ Calif San Francisco, Orthopaed Trauma Inst, Zuckerberg San Francisco Gen Hosp, 2550 23rd St,Bldg 9, San Francisco, CA 94110 USA.	saam.morshed@ucsf.edu					[Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2017, LANCET, V389, P1519, DOI DOI 10.1016/S0140-6736(17)30066-1; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bartonicek J, 2001, J ORTHOP TRAUMA, V15, P358, DOI 10.1097/00005131-200106000-00009; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; DEDRICK DK, 1986, J TRAUMA, V26, P932, DOI 10.1097/00005373-198610000-00013; GARDEN R S, 1971, Journal of Bone and Joint Surgery British Volume, V53, P183; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; Ghayoumi P, 2015, INJURY, V46, P467, DOI 10.1016/j.injury.2014.10.011; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; Karanicolas PJ, 2009, J ORTHOP TRAUMA, V23, P408, DOI 10.1097/BOT.0b013e31815ea017; Kellam JF, 2018, J ORTHOP TRAUMA, V32, pS1, DOI [10.1097/BOT.0000000000001063, 10.1097/BOT.0000000000001062]; Klinger C, 2016, ORTHOP P S7, V98B, P111; Kurylo JC, 2015, INJURY, V46, P441, DOI 10.1016/j.injury.2014.11.027; Lazaro LE, 2015, BONE JOINT J, V97B, P1204, DOI 10.1302/0301-620X.97B9.34704; Li MN, 2015, INJURY, V46, P453, DOI 10.1016/j.injury.2014.11.017; LINDEQUIST S, 1995, J ORTHOP TRAUMA, V9, P215, DOI 10.1097/00005131-199506000-00006; Liporace F, 2008, J BONE JOINT SURG AM, V90A, P1654, DOI 10.2106/JBJS.G.01353; Ly TV, 2008, J BONE JOINT SURG AM, V90A, P2254; Mir HR, 2011, J ORTHOP TRAUMA, V25, P714, DOI 10.1097/BOT.0b013e318212f82b; Orimo H, 2000, J BONE MINER METAB, V18, P126, DOI 10.1007/s007740050102; Panteli M, 2015, INJURY, V46, P445, DOI 10.1016/j.injury.2014.12.031; Putnam SM, 2019, J ORTHOP TRAUMA, V33, P111, DOI 10.1097/BOT.0000000000001377; Ray RI, 2015, INJURY, V46, P709, DOI 10.1016/j.injury.2014.11.005; ROBINSON CM, 1995, CLIN ORTHOP RELAT R, P238; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Samuel AM, 2016, J ORTHOP TRAUMA, V30, P89, DOI 10.1097/BOT.0000000000000456; SCHECK M, 1980, CLIN ORTHOP RELAT R, P138; Shah AK, 2002, CLIN ORTHOP RELAT R, P28; Slobogean GP, 2015, INJURY, V46, P435, DOI 10.1016/j.injury.2014.11.028; Slobogean GP, 2015, INJURY, V46, P484, DOI 10.1016/j.injury.2014.10.010; Spled K, 1935, SURG GYNECOL OBSTET, V60, P341; Sprague S, 2015, INJURY, V46, P507, DOI 10.1016/j.injury.2014.11.020; Steffen R, 2007, J BONE JOINT SURG BR, V89B, P1293, DOI 10.1302/0301-620X.89B10.18974; STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34, DOI 10.1302/0301-620X.77B1.7822393; TOOKE SMT, 1985, J BONE JOINT SURG AM, V67A, P1255, DOI 10.2106/00004623-198567080-00018; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Whiting PS, 2015, ARCH ORTHOP TRAUM SU, V135, P321, DOI 10.1007/s00402-015-2151-8; Yoon BH, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0157-9	41	6	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	JUN	2020	34	6					294	301		10.1097/BOT.0000000000001711			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	NP5QT	WOS:000570231400012	32079891				2022-02-06	
J	Plautz, WE; Matthay, ZA; Rollins-Raval, MA; Raval, JS; Kornblith, LZ; Neal, MD				Plautz, William E.; Matthay, Zachary A.; Rollins-Raval, Marian A.; Raval, Jay S.; Kornblith, Lucy Z.; Neal, Matthew D.			Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness	TRANSFUSION			English	Article							ACUTE KIDNEY INJURY; TRAUMATIC BRAIN-INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; VONWILLEBRAND-FACTOR; SYSTEMIC INFLAMMATION; CLEAVING PROTEASE; CLINICAL-PRACTICE; ADAMTS13 ACTIVITY; FACTOR MULTIMERS; RISK-FACTORS	The endothelial exocytosis of high-molecular-weight multimeric von Willebrand factor (vWF) may occur in critical illness states, including trauma and sepsis, leading to the sustained elevation and altered composition of plasma vWF. These critical illnesses involve the common process of sympathoadrenal activation and loss of the endothelial glycocalyx. As a prothrombotic and proinflammatory molecule that interacts with the endothelium, the alterations exhibited by vWF in critical illness have been implicated in the development and damaging effects of downstream pathologies, such as disseminated intravascular coagulation and systemic inflammatory response syndrome. Given the role of vWF in these pathologies, there has been a recent push to further understand how the molecule may be involved in the pathophysiology of related diseases, such as trauma-induced coagulopathy and acute renal injury, which are also known to develop secondarily to critical illness states. Elucidation of the role of vWF across the broader spectrum of generalized pathologies may provide a basis for the development of novel preventative and restorative measures, while also bolstering the scaffold of more widely used treatments, such as the administration of plasma-containing blood products.	[Plautz, William E.; Neal, Matthew D.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA 15213 USA; [Matthay, Zachary A.; Kornblith, Lucy Z.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Matthay, Zachary A.; Kornblith, Lucy Z.] Zuckerberg San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA; [Rollins-Raval, Marian A.; Raval, Jay S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA		Neal, MD (corresponding author), Univ Pittsburgh, Med Ctr, F1271 2 PUH 200 Lothrop St, Pittsburgh, PA 15213 USA.	wep20@pitt.edu					Alobaidi R, 2015, SEMIN NEPHROL, V35, P2, DOI 10.1016/j.semnephrol.2015.01.002; Ayme G, 2017, ARTERIOSCL THROM VAS, V37, P1736, DOI 10.1161/ATVBAHA.117.309319; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Budde U, 2006, SEMIN THROMB HEMOST, V32, P626, DOI 10.1055/s-2006-949668; Casonato A, 2001, CLIN APPL THROMB-HEM, V7, P81, DOI 10.1177/107602960100700201; Chen JM, 2018, BLOOD, V132, P141, DOI 10.1182/blood-2018-02-769000; Claus RA, 2009, THROMB HAEMOSTASIS, V101, P239, DOI 10.1160/TH08-03-0161; Cobo G, 2018, NEPHROL DIAL TRANSPL, V33, P35, DOI 10.1093/ndt/gfy175; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Curry N, 2015, BRIT J ANAESTH, V115, P76, DOI 10.1093/bja/aev134; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davenport RA, 2017, ANESTHESIOLOGY, V126, P115, DOI 10.1097/ALN.0000000000001428; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Droubatchevskaia N., 2007, BCMJ, V49, P441; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; Elterman Joel, 2015, J Trauma Acute Care Surg, V79, pS171, DOI 10.1097/TA.0000000000000572; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Furmaga W, 2015, CLIN CHIM ACTA, V440, P87, DOI 10.1016/j.cca.2014.10.045; Gonzalez E, 2014, SCAND J SURG, V103, P89, DOI 10.1177/1457496914531927; GRALNICK HR, 1988, AM J MED, V85, P806; Habe K, 2012, THROMB RES, V129, P598, DOI 10.1016/j.thromres.2011.10.011; Hardaway R M, 1995, J Intensive Care Med, V10, P145; Heegard KD, 2015, J TRAUMA ACUTE CARE, V78, P988, DOI 10.1097/TA.0000000000000607; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Hillgruber C, 2014, J INVEST DERMATOL, V134, P77, DOI 10.1038/jid.2013.292; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24; Hyseni A, 2014, BLOOD, V123, P2153, DOI 10.1182/blood-2013-08-508093; Johansson PI, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1756-4; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kornblith LZ, 2019, J THROMB HAEMOST, V17, P852, DOI 10.1111/jth.14450; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kruse-Jarres R, 2018, BLOOD, V131, P1292, DOI 10.1182/blood-2017-06-742692; Kumar MA, 2019, J NEUROTRAUM, V36, P222, DOI 10.1089/neu.2018.5696; Lai WH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0330-4; Lee K, 2014, BLOOD COAGUL FIBRIN, V25, P241, DOI 10.1097/MBC.0000000000000035; Leebeek FWG, 2016, NEW ENGL J MED, V375, P2067, DOI 10.1056/NEJMra1601561; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levi M, 2018, J THROMB HAEMOST, V16, P646, DOI 10.1111/jth.13953; Levi M, 2018, BLOOD, V131, P845, DOI 10.1182/blood-2017-10-804096; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P378, DOI 10.1055/s-0030-1254047; Lopes JA, 2009, INT J INFECT DIS, V13, P176, DOI 10.1016/j.ijid.2008.05.1231; Lopez JA, 2005, BLOOD COAGUL FIBRIN, V16, pS11, DOI 10.1097/01.mbc.0000167657.85143.ad; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Martini WZ, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0105-2; McBride D, 2019, J VET INTERN MED, V33, P2029, DOI 10.1111/jvim.15588; Miszta A, 2014, J BIOL CHEM, V289, P35979, DOI 10.1074/jbc.M114.591677; Moore HB, 2017, SHOCK, V48, P159, DOI 10.1097/SHK.0000000000000854; Myers SR, 2019, SURGERY, V166, P416, DOI 10.1016/j.surg.2019.04.014; Nascimento B, 2014, BRIT J ANAESTH, V113, P922, DOI 10.1093/bja/aeu158; Ng C, 2015, BLOOD, V125, P2029, DOI 10.1182/blood-2014-08-528398; Nguyen TC, 2008, CRIT CARE MED, V36, P2878, DOI 10.1097/CCM.0b013e318186aa49; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Ostrowski SR, 2017, J TRAUMA ACUTE CARE, V82, P293, DOI 10.1097/TA.0000000000001304; Padmanabhan A, 2019, J CLIN APHERESIS, V34, P171, DOI 10.1002/jca.21705; Peigne V, 2013, CRIT CARE, V17, DOI 10.1186/cc13115; Perkins ZB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211001; Peyvandi F, 2011, BLOOD TRANSFUS-ITALY, V9, pS3, DOI 10.2450/2011.002S; Pidcoke HF, 2013, TRANSFUSION, V53, p137S, DOI 10.1111/trf.12048; Pipe SW, 2016, BLOOD, V128, P2007, DOI 10.1182/blood-2016-04-713289; Plautz WE, 2019, AM SOC HEM ANN M; Plautz WE, 2019, SEVERE INJURY PRECIP; Qu LR, 2011, J CLIN APHERESIS, V26, P208, DOI 10.1002/jca.20296; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Raval JS, 2014, TRANSFUSION, V54, P2375, DOI 10.1111/trf.12794; Ruggeri ZM, 2000, J CLIN INVEST, V105, P699, DOI 10.1172/JCI9604; Russell RT, 2018, THROMB HAEMOSTASIS, V118, P676, DOI 10.1055/s-0038-1636528; Rusu L, 2015, ARTERIOSCLER THRO S1, V35, pA659; Rusu L, 2014, BLOOD, V123, P442, DOI 10.1182/blood-2013-03-489351; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Sandsmark DK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00246; Schillemans M, 2019, J THROMB HAEMOST, V17, P6, DOI 10.1111/jth.14322; Scott EA, 2007, TRANSFUSION, V47, P120, DOI 10.1111/j.1537-2995.2007.01074.x; Shashaty MGS, 2012, J CRIT CARE, V27, P496, DOI 10.1016/j.jcrc.2012.02.002; Skinner DL, 2014, INJURY, V45, P259, DOI 10.1016/j.injury.2013.07.013; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; WAGNER DD, 1991, MAYO CLIN PROC, V66, P621, DOI 10.1016/S0025-6196(12)60522-9; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Yazer Mark H, 2010, Korean J Hematol, V45, P152, DOI 10.5045/kjh.2010.45.3.152; Yokota Hiroyuki, 2007, Journal of Nippon Medical School, V74, P332, DOI 10.1272/jnms.74.332	96	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	JUN	2020	60			3	SI		S158	S166		10.1111/trf.15667		JUN 2020	9	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	LX8JE	WOS:000539452400001	32478907	Bronze			2022-02-06	
J	Savioli, G; Ceresa, IF; Luzzi, S; Gragnaniello, C; Lucifero, AG; Del Maestro, M; Marasco, S; Manzoni, F; Ciceri, L; Gelfi, E; Ricevuti, G; Bressan, MA				Savioli, Gabriele; Ceresa, Iride Francesca; Luzzi, Sabino; Gragnaniello, Cristian; Lucifero, Alice Giotta; Del Maestro, Mattia; Marasco, Stefano; Manzoni, Federica; Ciceri, Luca; Gelfi, Elia; Ricevuti, Giovanni; Bressan, Maria Antonietta			Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists	MEDICINA-LITHUANIA			English	Article						mild head trauma; anticoagulated patients; emergency department; direct anticoagulant drugs; DOAC; NOAC; new anticoagulant drugs; vitamin K antagonist anticoagulants; VKAs; mild head injury; minor head trauma; minor head injury; intracranial hemorrhage; surgery; ED revisit rates; intrahospital mortality; computed tomography; risk management; hemorrhage; observation	TERM MORTALITY TRENDS; BRAIN-INJURY; PREINJURY WARFARIN; ANTIPLATELET AGENTS; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; NATIONAL TRENDS; RISK; OUTCOMES; METAANALYSIS	Background and objectives: Anticoagulants are thought to increase the risks of traumatic intracranial injury and poor clinical outcomes after blunt head trauma. The safety of using direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) after intracranial hemorrhage (ICH) is unclear. This study aims to compare the incidence of post-traumatic ICH following mild head injury (MHI) and to assess the need for surgery, mortality rates, emergency department (ED) revisit rates, and the volume of ICH.Materials and Methods: This is a retrospective, single-center observational study on all patients admitted to our emergency department for mild head trauma from 1 January 2016, to 31 December 2018. We enrolled 234 anticoagulated patients, of which 156 were on VKAs and 78 on DOACs. Patients underwent computed tomography (CT) scans on arrival (T0) and after 24 h (T24). The control group consisted of patients not taking anticoagulants, had no clotting disorders, and who reported an MHI in the same period. About 54% in the control group had CTs performed.Results: The anticoagulated groups were comparable in baseline parameters. Patients on VKA developed ICH more frequently than patients on DOACs and the control group at 17%, 5.13%, and 7.5%, respectively. No significant difference between the two groups was noted in terms of surgery, intrahospital mortality rates, ED revisit rates, and the volume of ICH.Conclusions: Patients with mild head trauma on DOAC therapy had a similar prevalence of ICH to that of the control group. Meanwhile, patients on VKA therapy had about twice the ICH prevalence than that on the control group or patients on DOAC, which remained after correcting for age. No significant difference in the need for surgery was determined; however, this result must take into account the very small number of patients needing surgery.	[Savioli, Gabriele; Ceresa, Iride Francesca; Ciceri, Luca; Gelfi, Elia; Bressan, Maria Antonietta] Fdn IRCCS Policlin San Matteo, Emergency Dept, I-27100 Pavia, Italy; [Savioli, Gabriele; Del Maestro, Mattia] Univ Pavia, PhD Sch Expt Med Diagnost & Pediat Sci, Dept Clin Surg, I-27100 Pavia, Italy; [Luzzi, Sabino; Lucifero, Alice Giotta; Marasco, Stefano] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Neurosurg Unit, I-27100 Pavia, Italy; [Luzzi, Sabino; Del Maestro, Mattia] Fdn IRCCS Policlin San Matteo, Dept Surg Sci, Neurosurg Unit, I-27100 Pavia, Italy; [Gragnaniello, Cristian] Univ Illinois, Dept Neurol Surg, Chicago, IL 60656 USA; [Manzoni, Federica] Fdn IRCCS Policlin San Matteo, Clin Epidemiol & Biometry Unit, I-27100 Pavia, Italy; [Ricevuti, Giovanni] Univ Pavia, Dept Drug Sci, Pavia, Italy; [Ricevuti, Giovanni] St Camillus Int Univ Hlth Sci Rome Italy, I-27100 Pavia, Italy		Savioli, G (corresponding author), Fdn IRCCS Policlin San Matteo, Emergency Dept, I-27100 Pavia, Italy.; Savioli, G (corresponding author), Univ Pavia, PhD Sch Expt Med Diagnost & Pediat Sci, Dept Clin Surg, I-27100 Pavia, Italy.	gabrielesavioli@gmail.com; irideceresa@gmail.com; sabino.luzzi@unipv.it; cristian.neuro@gmail.com; alicelucifero@gmail.com; m.delmaestro@smatteo.pv.it; stefanom92@outlook.it; f.manzoni@smatteo.pv.it; luca.ciceri02@universitadipavia.it; gelfielia@gmail.com; giovanni.ricevuti@unipv.it; mita.bressan@gmail.com	Luzzi, Sabino/AAE-8474-2021; Ricevuti, Giovanni/AAK-7707-2021; Ceresa, Iride/AAP-9431-2021; Savioli, Gabriele/AAQ-2847-2021	Ricevuti, Giovanni/0000-0003-3422-2747; Savioli, Gabriele/0000-0002-8679-5435; Luzzi, Sabino/0000-0002-1381-8528			Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; Altiok E, 2018, DTSCH ARZTEBL INT, V115, P776, DOI 10.3238/arztebl.2018.0776; Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Arnaout MM, 2020, CLIN NEUROL NEUROSUR, V189, DOI 10.1016/j.clineuro.2019.105623; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Bellantoni G, 2019, eNeurologicalSci, V14, P31, DOI 10.1016/j.ensci.2018.11.021; Bergs J, 2016, INT EMERG NURS, V24, P74, DOI 10.1016/j.ienj.2015.05.004; Bouget J, 2020, BRIT J CLIN PHARMACO, V86, P2519, DOI 10.1111/bcp.14362; Brammen D, 2017, STUD HEALTH TECHNOL, V243, P132, DOI 10.3233/978-1-61499-808-2-132; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Caplan GA, 1998, AGE AGEING, V27, P697, DOI 10.1093/ageing/27.6.697; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Dixon J, 2000, BRIT MED J, V321, P315, DOI 10.1136/bmj.321.7257.315; Dwyer R, 2015, J AM MED DIR ASSOC, V16, P551, DOI 10.1016/j.jamda.2015.03.007; Dwyer R, 2014, AGE AGEING, V43, P759, DOI 10.1093/ageing/afu117; Elsawaf Y, 2020, WORLD NEUROSURG, V138, P9, DOI 10.1016/j.wneu.2020.02.065; Escobar C, 2019, REV ESP CARDIOL, V72, P305, DOI 10.1016/j.rec.2018.03.009; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Marques RSF, 2021, EUR J TRAUMA EMERG S, V47, P1461, DOI 10.1007/s00068-019-01172-8; Forero R, 2011, CRIT CARE, V15, DOI 10.1186/cc9998; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gindi M, 2005, AM J EMERG MED, V23, P120, DOI 10.1016/j.ajem.2004.03.015; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Huang JL, 2019, EUR J TRAUMA EMERG S, V45, P481, DOI 10.1007/s00068-018-0924-9; Huisman MV, 2016, AM J EMERG MED, V34, P46, DOI 10.1016/j.ajem.2016.09.053; Hullick C, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0279-1; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Jones P, 2010, EMERG MED AUSTRALAS, V22, P391, DOI 10.1111/j.1742-6723.2010.01330.x; Karve S, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/846163; Kim K, 2017, J MANAG CARE SPEC PH, V23, P57, DOI 10.18553/jmcp.2017.23.1.57; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Lorsbach M, 2021, MED KLIN-INTENSIVMED, V116, P345, DOI 10.1007/s00063-020-00661-8; Luzzi S, 2019, TURK NEUROSURG, V29, P875, DOI 10.5137/1019-5149.JTN.26052-19.2; Luzzi S, 2019, WORLD NEUROSURG, V131, P10, DOI 10.1016/j.wneu.2019.07.152; Luzzi S, 2019, WORLD NEUROSURG, V124, pE769, DOI 10.1016/j.wneu.2019.01.016; Luzzi S, 2018, ACTA NEUROCHIR SUPPL, V129, P25, DOI 10.1007/978-3-319-73739-3_4; Luzzi S, 2018, WORLD NEUROSURG, V116, pE340, DOI 10.1016/j.wneu.2018.04.203; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Markou M, 2021, EUR J TRAUMA EMERG S, V47, P565, DOI 10.1007/s00068-019-01228-9; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Nederpelt CJ, 2020, J TRAUMA ACUTE CARE, V88, P186, DOI 10.1097/TA.0000000000002518; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Neurochirurgia S.S.I.D., 2008, MINERVA ANESTESIOL, V74, P583; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Ntaios G, 2017, STROKE, V48, P2494, DOI 10.1161/STROKEAHA.117.017549; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Ricci Alessandro, 2017, Surg Neurol Int, V8, P117, DOI 10.4103/sni.sni_50_17; Richardson DB, 2002, MED J AUSTRALIA, V177, P492, DOI 10.5694/j.1326-5377.2002.tb04917.x; Rodriguez-Pascual C, 2018, J AM MED DIR ASSOC, V19, P936, DOI 10.1016/j.jamda.2018.04.017; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; SAVIOLI G, 2020, MEDICINA-LITHUANIA, V56, DOI DOI 10.3390/medicina56040205; Savioli G., 2020, HELIYON; SAVIOLI G, 2020, MEDICINA-LITHUANIA, V56, DOI DOI 10.3390/medicina56050251; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sercy E, 2020, BRAIN INJURY, V34, P556, DOI 10.1080/02699052.2020.1725981; Sesona ML, 2011, ASSIST INFERM RIC, V30, P117; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Singer AJ, 2017, J EMERG MED, V52, P1, DOI 10.1016/j.jemermed.2016.09.028; Spinola MB, 2019, AM J EMERG MED, V37, P1677, DOI 10.1016/j.ajem.2018.12.003; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuntz Mark, 2017, Prev Med Rep, V5, P183, DOI 10.1016/j.pmedr.2016.12.023; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Turcato G, 2019, J EMERG MED, V57, P817, DOI 10.1016/j.jemermed.2019.09.007; Tykocki T, 2016, WORLD NEUROSURG, V89, P497, DOI 10.1016/j.wneu.2016.01.063; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vinogradova Y, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2505; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	96	6	6	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	JUN	2020	56	6							308	10.3390/medicina56060308			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MN9TU	WOS:000551182800062	32585829	Green Published, gold			2022-02-06	
J	Weiss, C; Lendacki, FR; Rigby, PH; Wyrwicz, AM; Disterhoft, JF; Spiess, J				Weiss, Craig; Lendacki, Frances R.; Rigby, Paul H.; Wyrwicz, Alice M.; Disterhoft, John F.; Spiess, Joachim			Conditioned Contextual Freezing is A Neurobehavioral Biomarker of Axonal Injury Indicated by Reduced Fractional Anisotropy in A Mouse Model of Blast-Induced Mild Traumatic Brain Injury	SHOCK			English	Article						Delay fear conditioning; trace fear conditioning; declarative memory; non-declarative memory; post-concussion syndrome (PCS); post-traumatic stress disorder (PTSD)	PARKINSONS-DISEASE	Mild traumatic brain injury (TBI) is an important public health problem generated by closed head injury. This study is focused on the impact of blast-induced mild TBI on auditory trace and delay fear conditioning, models of declarative and non-declarative memory, respectively, and the correlation of conditioned freezing and fractional anisotropy, a measure of axonal state. A supersonic helium pressure wave was generated by a shock tube to blast 8-week-old male mice on Day 1 for 1.4 msec with an incident pressure of 16 psi, corresponding to a reflected pressure of 56.9 psi at the mouse head. On Day 3, the mice were subjected to auditory trace- or delay-fear conditioning. On Day 4, contextual freezing in the trained context, and precue and cued freezing in a novel context were determined. After cardiac perfusion on Day 5,ex vivoimages were obtained with diffusion tensor imaging at 14.1 Tesla. We observed that delay fear conditioning prevented or reversed the decrease in fractional anisotropy in both the medial and lateral corpus callosum suggesting axonal stabilization of potentially behavioral therapeutic significance. Moderately strong and statistically significant Pearson correlations were found between fractional anisotropy and contextual freezing in the medial and lateral corpus callosum of blasted and sham-blasted delay- or trace-fear conditioned mice. Thus, contextual freezing is a neurobehavioral biomarker for axonal injury in mild TBI and is a reliable and high-throughput behavioral assay for the evaluation of potential therapeutics to treat mild TBI.	[Weiss, Craig; Disterhoft, John F.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL USA; [Lendacki, Frances R.; Wyrwicz, Alice M.] NorthShore Univ Hlth Syst, Ctr Basic MR Res, Evanston, IL USA; [Rigby, Paul H.] L3 Appl Technol, San Diego, CA USA; [Spiess, Joachim] Cortrop Inc, Encinitas, CA 92024 USA; [Spiess, Joachim] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA		Spiess, J (corresponding author), Cortrop Inc, Encinitas, CA 92024 USA.	joachim.spiess@gmail.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1NS059879, S10RR13880, MH047340]; Max Planck SocietyMax Planck SocietyFoundation CELLEX	NIH grants RO1NS059879 (CW), S10RR13880 (AMW), MH047340 (JFD), and Max Planck Society (JS).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Balci F, 2009, P NATL ACAD SCI USA, V106, P2459, DOI 10.1073/pnas.0812709106; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Clark RE, 2002, TRENDS COGN SCI, V6, P524, DOI 10.1016/S1364-6613(02)02041-7; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Cui JX, 2016, J NEUROPHYSIOL, V116, P2892, DOI 10.1152/jn.00603.2016; D'Arceuil HE, 2007, NEUROIMAGE, V35, P553, DOI 10.1016/j.neuroimage.2006.12.028; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Ding AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051704; Fievisohn E, 2018, J BIOMECH ENG, V140, P1; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hazamy AA, 2017, BRAIN COGNITION, V113, P23, DOI 10.1016/j.bandc.2017.01.002; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Manhaes AC, 2003, NEUROSCI LETT, V348, P69, DOI 10.1016/S0304-3940(03)00746-8; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Mole JP, 2016, EUR RADIOL, V26, P3327, DOI 10.1007/s00330-015-4178-1; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Shults RA, 2004, J SAFETY RES, V35, P447, DOI 10.1016/j.jsr.2004.06.001; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Tasissa AF, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2015.0611; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	35	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2020	53	6					744	753		10.1097/SHK.0000000000001424			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	NG8WY	WOS:000564263300012	31689268	Green Accepted, hybrid			2022-02-06	
J	Zhang, JT; Czerpaniak, K; Huang, L; Liu, XM; Cloud, ME; Unsinger, J; Hotchkiss, RS; Li, DZ; Cao, YQ				Zhang, Jintao; Czerpaniak, Katherine; Huang, Liang; Liu, Xuemei; Cloud, Megan E.; Unsinger, Jacqueline; Hotchkiss, Richard S.; Li, Daizong; Cao, Yu-Qing			Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders	PAIN			English	Article						Low-dose interleukin-2; Regulatory T cell; Chronic migraine; Post-traumatic headache; Medication overuse headache; Mouse model; Facial skin hypersensitivity; Mechanical threshold	REGULATORY T-CELLS; MEDICATION-OVERUSE HEADACHE; NEUROPATHIC PAIN; RISK-FACTORS; ALLODYNIA; MIGRAINE; MECHANISMS; AUTOIMMUNE; INCREASES; DEPLETION	Headache disorders are highly prevalent and debilitating, with limited treatment options. Previous studies indicate that many proinflammatory immune cells contribute to headache pathophysiology. Given the well-recognized role of regulatory T (Treg) cells in maintaining immune homeostasis, we hypothesized that enhancing Treg function may be effective to treat multiple headache disorders. In a mouse model of chronic migraine, we observed that repeated nitroglycerin (NTG, a reliable trigger of migraine in patients) administration doubled the number of CD3(+) T cells in the trigeminal ganglia without altering the number of Treg cells, suggesting a deficiency in Treg-mediated immune homeostasis. We treated mice with low-dose interleukin-2 (ld-IL2) to preferentially expand and activate endogenous Treg cells. This not only prevented the development of NTG-induced persistent sensitization but also completely reversed the established facial skin hypersensitivity resulting from repeated NTG administration. The effect of ld-IL2 was independent of mouse sex and/or strain. Importantly, ld-IL2 treatment did not alter basal nociceptive responses, and repeated usage did not induce tolerance. The therapeutic effect of ld-IL2 was abolished by Treg depletion and was recapitulated by Treg adoptive transfer. Furthermore, treating mice with ld-IL2 1 to 7 days after mild traumatic brain injury effectively prevented as well as reversed the development of behaviors related to acute and chronic post-traumatic headache. In a model of medication overuse headache, Ld-IL2 completely reversed the cutaneous hypersensitivity induced by repeated administration of sumatriptan. Collectively, this study identifies ld-IL2 as a promising prophylactic for multiple headache disorders with a mechanism distinct from the existing treatment options.	[Zhang, Jintao; Czerpaniak, Katherine; Huang, Liang; Liu, Xuemei; Cloud, Megan E.; Unsinger, Jacqueline; Hotchkiss, Richard S.; Li, Daizong; Cao, Yu-Qing] Washington Univ, Sch Med, Dept Anesthesiol, 660 South Euclid,Box 8054, St Louis, MO 63110 USA; [Zhang, Jintao; Czerpaniak, Katherine; Huang, Liang; Liu, Xuemei; Cloud, Megan E.; Li, Daizong; Cao, Yu-Qing] Washington Univ, Sch Med, Pain Ctr, 660 South Euclid,Box 8054, St Louis, MO 63110 USA; [Huang, Liang] NYU, Grossman Sch Med, New York Univ Langone Hlth, Dept Anesthesiol, New York, NY USA; [Zhang, Jintao] Southern Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou, Peoples R China; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA		Cao, YQ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 South Euclid,Box 8054, St Louis, MO 63110 USA.; Cao, YQ (corresponding author), Washington Univ, Sch Med, Pain Ctr, 660 South Euclid,Box 8054, St Louis, MO 63110 USA.	caoy@anest.wustl.edu		Cloud, Megan/0000-0003-4087-6499	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS103350-02S1]	Supported by the National Institute of Neurological Disorders and Stroke grant NS103350-02S1 (to Y.-Q.C.).	Akerman S, 2019, BRAIN, V142, P103, DOI 10.1093/brain/awy313; Araldi D, 2017, NEUROSCIENCE, V344, P394, DOI 10.1016/j.neuroscience.2016.12.031; Arumugam M, 2016, J NEUROIMMUNOL, V290, P54, DOI 10.1016/j.jneuroim.2015.11.015; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Ben Aissa M, 2018, CEPHALALGIA, V38, P1471, DOI 10.1177/0333102417737778; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Bree D, 2019, PAIN, V160, P1050, DOI 10.1097/j.pain.0000000000001481; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Buonvicino D, 2018, PAIN, V159, P1980, DOI 10.1097/j.pain.0000000000001291; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2015, J CLIN INVEST, V125, P3226, DOI 10.1172/JCI80883; Constandil L, 2012, J PAIN, V13, P579, DOI 10.1016/j.jpain.2012.03.008; Dallel R, 2018, CEPHALALGIA, V38, P776, DOI 10.1177/0333102417714032; Dansokho C, 2016, BRAIN, V139, P1237, DOI 10.1093/brain/awv408; De Felice M, 2010, ANN NEUROL, V67, P325, DOI 10.1002/ana.21897; Demartini C, 2019, PROG NEUROBIOL, V177, P15, DOI 10.1016/j.pneurobio.2019.02.002; Di W, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0694-x; Diener HC, 2016, NAT REV NEUROL, V12, P575, DOI 10.1038/nrneurol.2016.124; Duffy SS, 2019, J NEUROSCI, V39, P2326, DOI 10.1523/JNEUROSCI.1815-18.2019; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Farkas S, 2016, J PHARMACOL TOX MET, V77, P33, DOI 10.1016/j.vascn.2015.09.006; Ferrari LF, 2016, NEUROSCIENCE, V317, P121, DOI 10.1016/j.neuroscience.2016.01.005; Fischer R, 2019, P NATL ACAD SCI USA, V116, P17045, DOI 10.1073/pnas.1902091116; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; Huang DY, 2016, PAIN, V157, P1744, DOI 10.1097/j.pain.0000000000000578; Johnson KW, 2019, CEPHALALGIA, V39, P1241, DOI 10.1177/0333102419844711; Kim SJ, 2018, BIOL PHARM BULL, V41, P172, DOI 10.1248/bpb.b17-00589; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Krukowski K, 2016, J NEUROSCI, V36, P11074, DOI 10.1523/JNEUROSCI.3708-15.2016; Kwilasz AJ, 2015, NEUROPHARMACOLOGY, V96, P55, DOI 10.1016/j.neuropharm.2014.10.020; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lees JG, 2015, CYTOKINE, V71, P207, DOI 10.1016/j.cyto.2014.10.028; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Liu XJ, 2014, CELL RES, V24, P1374, DOI 10.1038/cr.2014.106; Marone IM, 2018, BRAIN, V141, P2312, DOI 10.1093/brain/awy177; May A, 2016, NAT REV NEUROL, V12, P455, DOI 10.1038/nrneurol.2016.93; McIlvried LA, 2017, CEPHALALGIA, V37, P36, DOI 10.1177/0333102416637832; Melo-Carrillo A, 2019, CEPHALALGIA, V39, P1358, DOI 10.1177/0333102419873675; Moye LS, 2019, NEUROPHARMACOLOGY, V148, P77, DOI 10.1016/j.neuropharm.2018.12.017; Moye LS, 2019, CEPHALALGIA, V39, P77, DOI 10.1177/0333102418777507; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Nurkhametova D, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00326; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Rosenzwajg M, 2019, ANN RHEUM DIS, V78, P209, DOI 10.1136/annrheumdis-2018-214229; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Schain AJ, 2018, ANN NEUROL, V83, P508, DOI 10.1002/ana.25169; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sharabi A, 2018, NAT REV DRUG DISCOV, V17, P823, DOI 10.1038/nrd.2018.148; SHIMOMURA T, 1991, HEADACHE, V31, P310, DOI 10.1111/j.1526-4610.1991.hed3105310.x; Tahvildari M, 2016, TRANSPLANTATION, V100, P525, DOI 10.1097/TP.0000000000001044; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	58	6	6	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	JUN	2020	161	6					1381	1398		10.1097/j.pain.0000000000001818			18	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	LW6MA	WOS:000539257100026	32028334	Green Accepted			2022-02-06	
J	de Amorim, VCM; Oliveira, MS; da Silva, AB; David, JM; David, JPL; Costa, MDD; Butt, AM; da Silva, VDA; Costa, SL				Meira de Amorim, Vanessa Cristina; Oliveira Junior, Markley Silva; da Silva, Alessandra Bispo; David, Jorge M.; Lima David, Juceni Pereira; Dias Costa, Maria de Fatima; Butt, Arthur Morgan; Amaral da Silva, Victor Diogenes; Costa, Silvia Lima			Agathisflavone modulates astrocytic responses and increases the population of neurons in an in vitro model of traumatic brain injury	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Flavonoids; Agathisflavone; 6; 8"-Bisapigenin; NGF; GDNF	FIBRILLARY ACIDIC PROTEIN; CAESALPINIA-PYRAMIDALIS; NEUROTROPHIC FACTOR; NEURITIC OUTGROWTH; SCAR FORMATION; MECHANISMS; FLAVONOIDS; NEUROPROTECTION; BIFLAVONOIDS; INHIBITORS	Traumatic brain injury (TBI) is a critical health problem worldwide, with a high incidence rate and potentially severe long-term consequences. Depending on the level of mechanical stress, astrocytes react with complex morphological and functional changes known as reactive astrogliosis. In cases of severe tissue injury, astrocytes proliferate in the area immediately adjacent to the lesion to form the glial scar, which is a major barrier to neuronal regeneration in the central nervous system. The flavonoid agathisflavone has been shown to have neuroprotective, neurogenic, and immunomodulatory effects and could have beneficial effects in situations of TBI. In this study, we investigated the effects of agathisflavone on modulating the responses of astrocytes and neurons to injury, using the in vitro scratch wound model of TBI in primary cultures of rat cerebral cortex. In control conditions, the scratch wound induced an astroglial injury response, characterized by upregulation of glial fibrillary acidic protein (GFAP) and hypertrophy, together with the reduction in proportion of neurons within the lesion site. Treatment with agathisflavone (1 mu M) decreased astroglial GFAP expression and hypertrophy and induced an increase in the number of neurons and neurite outgrowth into the lesion site. Agathisflavone also induced increased expression of the neurotrophic factors NGF and GDNF, which are associated with the neuroprotective profile of glial cells. These results demonstrate that in an in vitro model of TBI, the flavonoid agathisflavone modulates the astrocytic injury response and glial scar formation, stimulating neural recomposition.	[Meira de Amorim, Vanessa Cristina; Oliveira Junior, Markley Silva; da Silva, Alessandra Bispo; Dias Costa, Maria de Fatima; Amaral da Silva, Victor Diogenes; Costa, Silvia Lima] Univ Fed Bahia, Inst Hlth Sci, Dept Biochem & Biophys, Av Reitor Miguel Calmon, BR-40100902 Salvador, BA, Brazil; [David, Jorge M.] Univ Fed Bahia, Inst Chem, Dept Gen & Inorgan Chem, R Barao de Jeremoabo, BR-40170115 Salvador, BA, Brazil; [Lima David, Juceni Pereira] Univ Fed Bahia, Fac Pharm, Dept Medicat, R Barao de Jeremoabo, BR-40170115 Salvador, BA, Brazil; [Butt, Arthur Morgan] Univ Portsmouth, Sch Pharm & Biomed Sci, Winston Churchill Ave, Portsmouth PO1 2UP, Hants, England		Costa, SL (corresponding author), Univ Fed Bahia, Inst Hlth Sci, Dept Biochem & Biophys, Av Reitor Miguel Calmon, BR-40100902 Salvador, BA, Brazil.	costasl@ufba.br	da Silva, Victor Diogenes Amaral/ABD-2609-2020; David, Juceni/AAX-8782-2020; Costa, Silvia Lima/A-5760-2008	da Silva, Victor Diogenes Amaral/0000-0001-8032-9663; David, Juceni/0000-0001-9405-2327; Costa, Silvia Lima/0000-0002-8975-3871	Coordination of Personnel Improvement of Higher Level (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.117666/2016-01]; Foundation for Research Support of the State of Bahia [INT 0016/2016]; National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [443723/2014-1, MCTI/CNPq/Universal 14/2014]; INCT/CNPq for Excitotoxicity and Neuroprotection; Laboratory of Neurochemistry and Cell Biology of the Federal University of Bahia; Postgraduate Program in Animal Science in the Tropics of the Federal University of Bahia; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [0001]	This work was supported by the Coordination of Personnel Improvement of Higher Level (CAPES, PGCI-Process No. 88881.117666/2016-01), the Foundation for Research Support of the State of Bahia (Process No. INT 0016/2016), the National Council for Scientific and Technological Development (CNPq, MCTI/CNPq/Universal 14/2014 Process 443723/2014-1), and the INCT/CNPq for Excitotoxicity and Neuroprotection. We would like to thank the Laboratory of Neurochemistry and Cell Biology and the Postgraduate Program in Animal Science in the Tropics of the Federal University of Bahia for the support and CAPES for the Master fellowships to VCMA (Process 0001).	Agra MD, 2008, REV BRAS FARMACOGN, V18, P472, DOI 10.1590/S0102-695X2008000300023; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Bahia MV, 2010, QUIM NOVA, V33, P1297, DOI 10.1590/S0100-40422010000600015; Bahia MV, 2005, J BRAZIL CHEM SOC, V16, P1402, DOI 10.1590/S0103-50532005000800017; Bankston AN, 2013, NEUROSCI BULL, V29, P216, DOI 10.1007/s12264-013-1321-3; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cepeda SB, 2020, J PHYSIOL BIOCHEM, V76, P99, DOI 10.1007/s13105-019-00722-3; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; de Amorim VCM, 2018, J PHARM PHARM SCI, V21, P376, DOI 10.18433/jpps30103; de Sousa LRF, 2015, EXP PARASITOL, V156, P42, DOI 10.1016/j.exppara.2015.05.016; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Diniz PBF, 2015, J ETHNOPHARMACOL, V168, P79, DOI 10.1016/j.jep.2015.03.054; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Grosso C, 2013, CURR MED CHEM, V20, P4694, DOI 10.2174/09298673113209990155; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Katano H, 1999, NEUROREPORT, V10, P2439, DOI 10.1097/00001756-199908200-00002; Konan NA, 2012, EXP TOXICOL PATHOL, V64, P435, DOI 10.1016/j.etp.2010.10.010; Kuipers SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep21222; Lane JT, 2014, TRANSL RES, V164, P193, DOI 10.1016/j.trsl.2014.06.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefrancois T, 1997, J NEUROSCI, V17, P4121; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Lin YM, 1997, J NAT PROD, V60, P884, DOI 10.1021/np9700275; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Andrade AWL, 2019, BIOMED PHARMACOTHER, V110, P68, DOI 10.1016/j.biopha.2018.11.050; Luine VN, 2014, HORM BEHAV, V66, P602, DOI 10.1016/j.yhbeh.2014.08.011; Macready AL, 2014, AM J CLIN NUTR, V99, P479, DOI 10.3945/ajcn.113.074237; Mendes CC, 2000, FITOTERAPIA, V71, P205, DOI 10.1016/S0367-326X(99)00145-8; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Paulsen BS, 2011, STEM CELLS DEV, V20, P1711, DOI 10.1089/scd.2010.0446; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Peluso I, 2015, CRIT REV FOOD SCI, V55, P383, DOI 10.1080/10408398.2012.656770; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi ZF, 2015, BIOMED ENVIRON SCI, V28, P199, DOI 10.3967/bes2015.026; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Souza CD, 2018, NEUROTOXICOLOGY, V65, P85, DOI 10.1016/j.neuro.2018.02.001; Su BYW, 2018, J ALTERN COMPLEM MED, V24, P850, DOI 10.1089/acm.2017.0118; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Taiwo BJ, 2017, BIOORGAN MED CHEM, V25, P2327, DOI 10.1016/j.bmc.2017.02.040; Takeuchi K, 2015, BRAIN RES, V1621, P222, DOI 10.1016/j.brainres.2014.11.016; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Velagapudi R, 2018, PHYTOTHER RES, V32, P1957, DOI 10.1002/ptr.6122; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Weber JT, 2012, EUR J PHARMACOL, V680, P55, DOI 10.1016/j.ejphar.2012.01.036; Wu L, 2012, J AGR FOOD CHEM, V60, P9377, DOI 10.1021/jf301787f; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173; Zhang H, 2016, CURR OPIN FOOD SCI, V8, P33, DOI 10.1016/j.cofs.2016.02.002	59	6	6	2	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	OCT	2020	393	10					1921	1930		10.1007/s00210-020-01905-2		MAY 2020	10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	NI8NY	WOS:000534872100003	32444988	Green Submitted			2022-02-06	
J	Pernici, CD; Rowe, RK; Doughty, PT; Madadi, M; Lifshitz, J; Murray, TA				Pernici, Chelsea D.; Rowe, Rachel K.; Doughty, P. Timothy; Madadi, Mahboubeh; Lifshitz, Jonathan; Murray, Teresa A.			Longitudinal optical imaging technique to visualize progressive axonal damage after brain injury in mice reveals responses to different minocycline treatments	SCIENTIFIC REPORTS			English	Article							MICROGLIAL ACTIVATION; NEUROFILAMENT COMPACTION; AXOTOMY; TRAUMA; INFLAMMATION; TRANSPORT; ATROPHY; STROKE; STATES	A high-resolution, three-dimensional, optical imaging technique for the murine brain was developed to identify the effects of different therapeutic windows for preclinical brain research. This technique tracks the same cells over several weeks. We conducted a pilot study of a promising drug to treat diffuse axonal injury (DAI) caused by traumatic brain injury, using two different therapeutic windows, as a means to demonstrate the utility of this novel longitudinal imaging technique. DAI causes immediate, sporadic axon damage followed by progressive secondary axon damage. We administered minocycline for three days commencing one hour after injury in one treatment group and beginning 72hours after injury in another group to demonstrate the method's ability to show how and when the therapeutic drug exerts protective and/or healing effects. Fewer varicosities developed in acutely treated mice while more varicosities resolved in mice with delayed treatment. For both treatments, the drug arrested development of new axonal damage by 30 days. In addition to evaluation of therapeutics for traumatic brain injury, this hybrid microlens imaging method should be useful to study other types of brain injury and neurodegeneration and cellular responses to treatment.	[Pernici, Chelsea D.; Doughty, P. Timothy; Murray, Teresa A.] Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Madadi, Mahboubeh] San Jose State Univ, Lucas Coll Business, Dept Mkt & Business Analyt, San Jose, CA 95192 USA		Murray, TA (corresponding author), Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.	bioengineer1@hotmail.com	Madadi, Mahboubeh/ABD-8071-2020	Murray, Teresa/0000-0002-8857-154X; Rowe, Rachel/0000-0002-9034-3159; Pernici, Chelsea/0000-0003-3531-7086	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS090131]; Phoenix Children's Hospital Mission Support funds	We thank Hunter Rasnic, Haley Alexander, Angelica Andrews, Cole Forbes, Amara Stokes, and Luke Seaton, Anassas Anderson, and Claire E. Jones of Louisiana Tech University (Ruston, Louisiana, USA) for performing blinded analysis of multiphoton images. We also thank Tabitha Rose Fox Green for blinded analysis of behavioral videos and Kelsey Newbold and J. Bryce Ortiz for blinded analyses of behavioral tests; TRFG and JBO are from the University of Arizona College of Medicine -Phoenix (Phoenix, Arizona, USA) and KN is from Arizona State University (Tempe, Arizona, USA). A National Institutes of Health grant (R21NS090131) to TAM supported this work. RKR was supported by Phoenix Children's Hospital Mission Support funds to the University of Arizona College of Medicine-Phoenix. The funding agencies were not involved in the study design; in the collection, analysis, and interpretation of data; and in writing this report and the decision to submit it for publication.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carter Rickey E, 2013, Diabetes, V62, pe15, DOI 10.2337/db13-0692; Cui LL, 2019, ANN NEUROL, V86, P5, DOI 10.1002/ana.25493; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kielian T, 2007, AM J PATHOL, V171, P1199, DOI 10.2353/ajpath.2007.070231; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lee SA, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.01465334723314, DOI 10.1371/JOURNAL.PONE.01465334723314]; Lee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146533; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Min YJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00511; Murray TA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021106; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pernici CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44174-7; Pierce JES, 1996, J NEUROSCI, V16, P1083; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor AN, 2018, J NEUROTRAUM, V35, P630, DOI 10.1089/neu.2017.5238; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Voziyanov V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00169; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; [No title captured]	63	6	6	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 8	2020	10	1							7815	10.1038/s41598-020-64783-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB2PG	WOS:000560354300004	32385407	gold, Green Published			2022-02-06	
J	Beadle, EJ; Ownsworth, T; Fleming, J; Shum, DHK				Beadle, Elizabeth Jane; Ownsworth, Tamara; Fleming, Jennifer; Shum, David H. K.			The nature of occupational gaps and relationship with mood, psychosocial functioning and self-discrepancy after severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; occupational participation; rehabilitation; self-discrepancy; psychosocial function	RANDOMIZED CONTROLLED-TRIAL; EVERYDAY LIFE; INTERVENTION; INDIVIDUALS; DEPRESSION; ANXIETY; HOME; REHABILITATION; TRANSITION; MEDIATION	Purpose: To examine the nature of occupational gaps and desired re-engagement following severe traumatic brain injury (TBI), and the relationship to mood, self-discrepancy, and psychosocial functioning. Materials and methods: Fifty-nine adults with severe TBI (73% male, M age = 36.50, SD = 12.54) were administered measures of past, current, and desired occupations (Occupational Gaps Questionnaire), mood (Depression Stress and Anxiety Scale - 21), and self-discrepancy (Head Injury Semantic Differential Scale - version 3). Psychosocial functioning was rated by relatives on the Sydney Psychosocial Reintegration Questionnaire. Results: Participants reported that they engaged in significantly fewer occupations than prior to their injury (p < 0.001). Further, they participated in fewer occupations than they desired (p < 0.001). Desired re-engagement was identified for 18 of the 30 occupations (e.g., working, sports, managing personal finances, and supporting others). A higher number of these re-engagement gaps was significantly related to greater anxiety (r = 0.30, p < 0.05) and lower psychosocial functioning (r = -0.29, p < 0.05). A mediation analysis revealed that re-engagement gaps were indirectly related to self-discrepancy through an association with anxiety. Conclusions: Occupational gaps are commonly experienced after severe traumatic brain injury. Lack of engagement in desired occupations is associated with greater anxiety and poorer psychosocial functioning. Anxiety regarding these gaps may contribute to negative comparisons between one's pre-injury and post-injury self. Identification of occupational gaps and their psychological impact may guide the focus of client-centred rehabilitation approaches.	[Beadle, Elizabeth Jane; Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Appl Psychol, Mt Gravatt, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Shum, David H. K.] Chinese Acad Sci, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, Inst Psychol, Beijing, Peoples R China		Beadle, EJ (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	elizabeth.beadle@griffithuni.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David H. K./0000-0002-4810-9262; Fleming, Jennifer/0000-0002-5603-2410			Aristotle J. L., 1998, NICOMACHEAN ETHICS; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Bellon M, 2015, BRAIN IMPAIR, V16, P131, DOI 10.1017/BrImp.2015.17; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Dumont Claire, 2005, Can J Occup Ther, V72, P222; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fines L., 1994, J COGNITIVE REHABILI, P10; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Goldstein K, 1942, EFFECTS BRAIN INJURY; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Hayes A, 2012, FAMILY MATTERS, P2; Hayes Andrew F., 2012, CISC VIS NETW IND GL; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Lovibond S. H., 1995, MANUAL DEPRESSION AN, V2; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth T, 2011, BRAIN IMPAIR, V12, P79; Pais C, 2017, NEUROPSYCHOL REHABIL, P1; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Reddy A, 2017, NEUROPSYCHOL REHABIL, V27, P1103, DOI 10.1080/09602011.2015.1114499; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Townend E, 2013, ENABLING OCCUPATION; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Wilcock A. A., 1999, AUST OCCUP THER J, V46, P1, DOI [10.1046/j.1440-1630.1999.00174.x, DOI 10.1177/000841749806500501]; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	58	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 7	2020	42	10					1414	1422		10.1080/09638288.2018.1527954			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	LN6FC	WOS:000533029800008	30668152				2022-02-06	
J	Keating, CE; Browne, KD; Duda, JE; Cullen, DK				Keating, Carolyn E.; Browne, Kevin D.; Duda, John E.; Cullen, D. Kacy			Neurons in Subcortical Oculomotor Regions are Vulnerable to Plasma Membrane Damage after Repetitive Diffuse Traumatic Brain Injury in Swine	JOURNAL OF NEUROTRAUMA			English	Article						microglia; NeuN; oculomotor; permeability; TBI	SPORT-RELATED CONCUSSION; CLOSED-HEAD INJURY; AXONAL INJURY; BASAL GANGLIA; ANIMAL-MODELS; EYE FIELD; PERMEABILITY; CALCIUM; DEGENERATION; CONNECTIONS	Oculomotor deficits, such as insufficiencies in accommodation, convergence, and saccades, are common following traumatic brain injury (TBI). Previous studies in patients with mild TBI attributed these deficits to insufficient activation of subcortical oculomotor nuclei, although the exact mechanism is unknown. A possible cause for neuronal dysfunction in these regions is biomechanically induced plasma membrane permeability. We used our established porcine model of head rotational TBI to investigate whether cell permeability changes occurred in subcortical oculomotor areas following single or repetitive TBI, with repetitive injuries separated by 15 min, 3 days, or 7 days. Swine were subjected to sham conditions or head rotational acceleration in the sagittal plane using a HYGE pneumatic actuator. Two hours prior to the final injury, the cell-impermeant dye Lucifer Yellow was injected into the ventricles to diffuse throughout the interstitial space to assess plasmalemmal permeability. Animals were sacrificed 15 min after the final injury for immunohistological analysis. Brain regions examined for cell membrane permeability included caudate, substantia nigra pars reticulata, superior colliculus, and cranial nerve oculomotor nuclei. We found that the distribution of permeabilized neurons varied depending on the number and spacing of injuries. Repetitive injuries separated by 15 min or 3 days resulted in the most permeability. Many permeabilized cells lost neuron-specific nuclear protein reactivity, although no neuronal loss occurred acutely after injury. Microglia contacted and appeared to begin phagocytosing permeabilized neurons in repetitively injured animals. These pathologies within oculomotor areas may mediate transient dysfunction and/or degeneration that may contribute to oculomotor deficits following diffuse TBI.	[Keating, Carolyn E.; Browne, Kevin D.; Duda, John E.; Cullen, D. Kacy] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Keating, Carolyn E.; Browne, Kevin D.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Duda, John E.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Univ Penn, 3320 Smith Walk,105E Hayden Hall, Philadelphia, PA 19104 USA.	dkacy@pennmedicine.upenn.edu			Department of Veterans Affairs (RRD Merit Review)US Department of Veterans Affairs [I01-RX001097]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS094340]; Department of Health of the Commonwealth of Pennsylvania (PA Consortium on TBI: PACT); Penn's University Research Foundation; Department of Veterans Affairs (BLRD Merit Review)US Department of Veterans Affairs [I01-BX003748]	Financial support was provided by the Department of Veterans Affairs (RR&D Merit Review I01-RX001097 & BLR&D Merit Review I01-BX003748), the National Institutes of Health (U01NS094340), the Department of Health of the Commonwealth of Pennsylvania (PA Consortium on TBI: PACT), and Penn's University Research Foundation. None of the funding sources aided in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Gupte R., 2019, J NEUROTRAUM, V29, P1; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; May P.J., 2014, ENCY NEUROSCIENCE, P351; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R., 2000, J NEUROTRAUMA, P17; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; ROYCE GJ, 1984, J COMP NEUROL, V226, P28, DOI 10.1002/cne.902260104; Seger CA, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00104; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tyler CW, 2015, I-PERCEPTION, V6, DOI 10.1177/2041669515613671; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; UPDYKE BV, 1993, J COMP NEUROL, V327, P159, DOI 10.1002/cne.903270202; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Womble MN, 2021, CLIN J SPORT MED, V31, pE193, DOI 10.1097/JSM.0000000000000761; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	67	6	6	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1918	1932		10.1089/neu.2019.6738		MAY 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000532139900001	32178582	Green Published			2022-02-06	
J	Chin, DL; Zeber, JE				Chin, David L.; Zeber, John E.			Mental Health Outcomes Among Military Service Members After Severe Injury in Combat and TBI	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; LONGITUDINAL ASSESSMENT; GENDER-DIFFERENCES; SHELL SHOCK; IRAQ; RISK; AFGHANISTAN; DEPLOYMENT; ASSOCIATION	Introduction Studies examining the mental health outcomes of military personnel deployed into combat zones have focused on the risk of developing post-traumatic stress disorder conferred by mild or moderate traumatic brain injury (TBI). However, other mental health outcomes among veterans who sustained critical combat injuries have not been described. Materials and Methods We examined the associations of moderate and severe TBI and combat injury with the risk for anxiety and mood disorders, adjustment reactions, schizophrenia and other psychotic disorders, cognitive disorders, and post-traumatic stress disorder. We conducted a retrospective cohort study of U.S. military service members critically injured in combat during military operations in Iraq and Afghanistan from February 1, 2002, to February 1, 2011. Health care encounters from (1) the Department of Defense (DoD) Trauma Registry (TR), (2) acute and ambulatory care in military facilities, and (3) civilian facilities are reimbursed by Tricare. Service members who sustained severe combat injury require critical care. We estimated the risk of mental health outcomes using risk-adjusted logit models for demographic and clinical factors. We explored the relationship between TBI and the total number of mental health diagnoses. Results Of the 4,980 subjects who met inclusion criteria, most injuries occurred among members of the Army (72%) or Marines (25%), with mean (SD) age of 25.5(6.1) years. The prevalence of moderate or severe TBI was 31.6% with explosion as the most common mechanism of injury (78%). We found 71% of the cohort was diagnosed with at least one poor mental health condition, and the adjusted risk conferred by TBI ranged from a modest increase for anxiety disorder (odds ratio, 1.27; 95% confidence interval [CI], 1.11-1.45) to a large increase for cognitive disorder (odds ratio, 3.24; 95% CI, 2.78-3.77). We found TBI was associated with an increased number of mental health diagnoses (incidence rate ratio, 1.52; 95% CI, 1.42-1.63). Conclusions Combat-associated TBI may have a broad effect on several mental health conditions among critically injured combat casualties. Early recognition and treatment for trauma-associated mental health are crucial to improving outcomes among service personnel as they transition to post-deployment care in the DoD, Department of Veterans Affairs, or community health systems.	[Chin, David L.; Zeber, John E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, 715 N Pleast St, Amherst, MA 01003 USA; [Zeber, John E.] Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA		Chin, DL (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, 715 N Pleast St, Amherst, MA 01003 USA.				United States Air Force, Office of the Surgeon General	The United States Air Force, Office of the Surgeon General. The funders played no role in study design, writing of the manuscript, or the decision to submit for publication.	Adams RS, 2016, J TRAUMA STRESS, V29, P356, DOI 10.1002/jts.22121; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carter-Visscher R, 2010, J TRAUMA STRESS, V23, P78, DOI 10.1002/jts.20481; Chase RP, 2015, SOC SCI MED, V147, P309, DOI 10.1016/j.socscimed.2015.11.015; Chu KM, 2021, ETHNIC HEALTH, V26, P235, DOI 10.1080/13557858.2018.1494823; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen GH, 2016, WOMEN HEALTH ISS, V26, P268, DOI 10.1016/j.whi.2016.01.001; DeBruyne NF, 2015, AM WAR MILITARY OPER; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Fischer H, 2010, DTIC DOCUMENT; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Ilie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188908; Institute of Medicine, 2013, RET HOM IR AFGH ASS, DOI [10.17226/13499, DOI 10.17226/13499]; Jacobson IG, 2015, J PSYCHIATR RES, V68, P30, DOI 10.1016/j.jpsychires.2015.05.015; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miles SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184265; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Minassian A, 2015, JAMA PSYCHIAT, V72, P979, DOI 10.1001/jamapsychiatry.2015.0922; Myers CS, 1915, LANCET, V1, P316; Perrin M, 2014, SOC PSYCH PSYCH EPID, V49, P447, DOI 10.1007/s00127-013-0762-3; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sbordone RJ, BRAIN INJ, V9, P405; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stewart IJ, 2014, MIL MED, V179, P370, DOI 10.7205/MILMED-D-13-00393; Sundin J, 2014, BRIT J PSYCHIAT, V204, P202, DOI 10.1192/bjp.bp.113.129569; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; Szeto HC, 2002, AM J MANAG CARE, V8, P37; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Vemula Radhika, 2007, J Healthc Qual, V29, P6; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	58	6	6	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2020	185	5-6					E711	E718		10.1093/milmed/usz440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LY4LU	WOS:000540501500033	31889174	hybrid			2022-02-06	
J	Ernst, W; Kneavel, ME				Ernst, William; Kneavel, Meredith E.			Development of a Peer Education Program to Improve Concussion Knowledge and Reporting in Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; Theory of Reasoned Action and Planned Behavior; student-athletes	SPORT-RELATED CONCUSSION; POSITION STATEMENT; MANAGEMENT; EPIDEMIOLOGY; SYMPTOMS; BEHAVIOR; TRENDS	Context: A novel peer concussion-education program (PCEP) was developed to enhance concussion knowledge and reporting among collegiate student-athletes. Objective: To describe the PCEP and its development and implementation. Design: Program development consisting of a literature review, focus group, and pilot implementation. Setting: Athletics department at a college participating at the National Collegiate Athletic Association Division II-sanctioned competition level. Patients or Other Participants: Fifteen student-athletes from the women's soccer and men's lacrosse teams participated in the focus group. Four peer concussion educators (PCEs) were debriefed after the pilot implementation of the PCEP with the women's soccer and men's lacrosse teams. Data Collection and Analysis: Focus-group data were analyzed qualitatively. The PCEs were debriefed, and responses were organized into recommendation types. Results: The literature review contributed information that supported the development of the PCEP's conceptual model. Focus-group results provided information used to train the PCEs and refine the PCEP's education modules. The pilot implementation and PCE debriefing supplied information used to further revise the education modules, PCE training, and PCEP implementation procedure. Conclusions: The PCEP was developed based on the Theory of Reasoned Action and Planned Behavior and uses a peer-mediated, cognitive-behavioral, and interdisciplinary model to enhance concussion knowledge of and reporting by collegiate student-athletes. After a focus-group discussion and pilot implementation, we revised the PCEP and its education modules and developed an online manual to facilitate broad dissemination.	[Ernst, William] Chestnut Hill Coll, 9601 Germantown Ave, Philadelphia, PA 19118 USA; [Kneavel, Meredith E.] La Salle Univ, Philadelphia, PA 19141 USA		Ernst, W (corresponding author), Chestnut Hill Coll, 9601 Germantown Ave, Philadelphia, PA 19118 USA.	ernstw@chc.edu	Kneavel, Meredith/ABG-5233-2021	Kneavel, Meredith/0000-0002-9820-6909	National Collegiate Athletic Association - US Department of Defense Mind Matters Educational Program Challenge Award from Indianapolis, IN	The development of the Peer Concussion Education Program was made possible, in part, with support from the National Collegiate Athletic Association - US Department of Defense Mind Matters Educational Program Challenge Award from Indianapolis, IN.	Adefolalu AO, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.762; [Anonymous], 2018, OPP RESH CULT CONC S; [Anonymous], 2015, MIND MATT CHALL; [Anonymous], 2017, HEADS YOUTH SPORTS; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Beattie J, 2013, PSYCHIATR REHABIL J, V36, P306, DOI 10.1037/prj0000031; BECK AT, 1970, BEHAV THER, V1, P184, DOI 10.1016/S0005-7894(70)80030-2; Bell L., 2014, SELF REPORTED CONCUS; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Creswell J.W., 2018, QUALITATIVE INQUIRY; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dart EH, 2014, SCHOOL PSYCHOL REV, V43, P367, DOI 10.17105/SPR-14-0009.1; Dawson P, 2014, REV EDUC RES, V84, P609, DOI 10.3102/0034654314540007; Ellis A., 1962, REASON EMOTION PSYCH; Fishbein M., 1975, BELIEF ATTITUDE INTE; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Knapp B., 2015, PLOS COMPUTATIONAL B, V11, P4, DOI DOI 10.1371/J0URNAL.PCBI.1004214; Kneavel M, 2021, J AM COLL HEALTH, V69, P435, DOI 10.1080/07448481.2019.1679816; Kneavel ME, 2020, J ATHL TRAINING, V55, P456, DOI 10.4085/1062-6050-0182.19; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lincoln Y.S., 2000, HDB QUALITATIVE RE E, P163; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McKenzie-Mohr D, 2000, AM PSYCHOL, V55, P531, DOI 10.1037/0003-066X.55.5.531; Morgan DL., 2019, BASIC ADV FOCUS GROU; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	40	6	6	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2020	55	5					448	455		10.4085/1062-6050-212-19			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4YN	WOS:000566738600002	32250640	Green Published, gold			2022-02-06	
J	Fonda, JR; Gradus, JL; Brogly, SB; McGlinchey, RE; Milberg, WP; Fredman, L				Fonda, Jennifer R.; Gradus, Jaimie L.; Brogly, Susan B.; McGlinchey, Regina E.; Milberg, William P.; Fredman, Lisa			Traumatic Brain Injury and Opioid Overdose Among Post-9/11 Veterans With Long-Term Opioid Treatment of Chronic Pain	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic pain; opioid overdose; traumatic brain injury; veterans	PRESCRIPTIONS; IRAQ; ASSOCIATION; DEPLOYMENT; PATTERNS; US	Objective: To evaluate the association between traumatic brain injury (TBI) and nonfatal opioid overdose, and the role of psychiatric conditions as mediators of this association. Setting: Post-9/11 veterans receiving care at national Department of Veterans Affairs (VA) facilities from 2007 to 2012. Participants: In total, 49 014 veterans aged 18 to 40 years receiving long-term opioid treatment of chronic noncancer pain. Design: Longitudinal cohort study using VA registry data. Main Measures: TBI was defined as a confirmed diagnosis (28%) according to VA comprehensive TBI evaluation; no TBI was defined as a negative primary VA TBI screen (ie, no head injury). Nonfatal opioid overdose was defined using ICD-9 (International Classification of Diseases, Ninth Revision) codes. We performed demographic-adjusted Cox proportional hazards regression. We quantified the impact of co-occurring and individual psychiatric conditions (mood, anxiety, substance use, and posttraumatic stress disorder) on this association using mediation analyses. Results: Veterans with TBI had more than a 3-fold increased risk of opioid overdose compared with those without (adjusted hazards ratio [aHR] = 3.22; 95% confidence interval [CI], 2.13-4.89). This association was attenuated in mediation analyses of any co-occurring psychiatric condition (aHR = 1.77; 95% CI, 1.25-2.52) and individual conditions (aHR range, 1.52-2.95). Conclusion: TBI status, especially in the context of comorbid conditions, should be considered in clinical decisions regarding long-term use of opioids in patients with chronic pain.	[Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Fonda, Jennifer R.; Gradus, Jaimie L.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Gradus, Jaimie L.; Brogly, Susan B.; Fredman, Lisa] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brogly, Susan B.] Queens Univ, Dept Surg, Kingston, ON, Canada; [McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Fonda, JR (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave 182-JP, Boston, MA 02130 USA.; Fonda, JR (corresponding author), VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave 182-JP, Boston, MA 02130 USA.	Jennifer.Fonda@va.gov	Fonda, Jennifer R./ABG-2890-2021	Fonda, Jennifer R./0000-0001-9482-2918	VA Boston Healthcare System and Translational Research Center for TBI and Stress Disorders, a VA Rehabilitation Research & Development Traumatic Brain Injury National Network Research Center [B9254-C]	VA Boston Healthcare System and Translational Research Center for TBI and Stress Disorders, a VA Rehabilitation Research & Development Traumatic Brain Injury National Network Research Center (grant B9254-C) are acknowledged for providing overall and infrastructural support. The authors thank Dr Alisa Lincoln who provided valuable insight into the preparation of the manuscript.	Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention, 2019, CALC TOT DAIL DOS OP; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P2295, DOI 10.1001/jama.2017.15971; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Epidemiology Program Post-Deployment Health Group, 2012, AN VA HLTH CAR UT OP; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Lange T, 2014, AM J EPIDEMIOL, V179, P513, DOI 10.1093/aje/kwt270; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Miller EA, 2012, SOC WORK PUBLIC HLTH, V27, P379, DOI 10.1080/19371910903176197; Morasco BJ, 2008, GEN HOSP PSYCHIAT, V30, P93, DOI 10.1016/j.genhosppsych.2007.12.004; National Center for Veterans Analysis and Statistics, 2016, UN VET US REP FY 201; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Rochon J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-9; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Warner Margaret, 2009, NCHS Data Brief, P1	29	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		209	217		10.1097/HTR.0000000000000546			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200005	31834063				2022-02-06	
J	Kim, JY; Yi, ES; Lee, H; Kim, JS; Jee, YS; Kim, SE; Kim, CJ; Ko, IG				Kim, Ji-Youn; Yi, Eun-Surk; Lee, Hyunju; Kim, Jun-Su; Jee, Yong-Seok; Kim, Sung Eun; Kim, Chang-Ju; Ko, Il-Gyu			Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats	INTERNATIONAL NEUROUROLOGY JOURNAL			English	Article						Multiple sclerosis; Experimental autoimmune encephalomyelitis; Swimming exercise; Inflammation; Demyelination	TRAUMATIC BRAIN-INJURY; TREADMILL EXERCISE; ANIMAL-MODEL; NEUROPROTECTION; ACTIVATION; RECEPTOR; MEMORY; CELLS; MICE	Purpose: Multiple sclerosis is an autoimmune disease that affects the central nerve system, resulting in cumulative loss of motor function. Multiple sclerosis is induced through multiple mechanisms and is caused by inflammation and demyelination. This study aims to evaluate the neuroprotective effect of swimming exercise in experimental autoimmune encephalomyelitis (EAE) rats, an animal model of multiple sclerosis. Methods: EAE was induced by an intradermal injection of 50-mu g purified myelin oligodendrocyte glycoprotein 33-55 (MOG(33-55)) dissolved in 200-mu L saline at the base of the tail. The rats in the swimming exercise group were made to swim for 30 minutes once pert a day for 26 consecutive days, starting 5 days after induction of EAE. To compare the effect of swimming exercise with interferon-beta, a drug for multiple sclerosis, interferon-beta was injected intraperitoneally into rats of the EAE-induced and interferon-beta-treated group during the exercise period. Results: Injection of MOG(33-55) caused weight loss, decreased clinical disability score, and increased level of pro-inflammatory cytokines and inflammatory mediators in the lumbar spinal cord. Loss of motor function and weakness increased demyelination score. Swimming exercise suppressed demyelination and expression of pro-inflammatory cytokines and inflammatory mediators. These changes promoted recovery of EAE symptoms such as body weight loss, motor dysfunction, and weakness. Swimming exercise caused the same level of improvement as interferon-beta treatment. Conclusions: The results of this experiment suggest the possibility of swimming exercise in urological diseases that are difficult to treat. Swimming exercises can be considered for relief of symptom in incurable multiple sclerosis.	[Kim, Ji-Youn; Yi, Eun-Surk] Gachon Univ, Dept Exercise Rehabil & Welf, Incheon, South Korea; [Lee, Hyunju] Jungwon Univ, Coll Med Hlth, Dept Hlth Adm, Goesan, South Korea; [Kim, Jun-Su] Eulji Univ, Coll Hlth Ind, Dept Sports & Outdoors, Seongnam, South Korea; [Jee, Yong-Seok] Hanseo Univ, Res Inst Sports & Ind Sci, Seosan, South Korea; [Kim, Sung Eun; Kim, Chang-Ju; Ko, Il-Gyu] Kyung Hee Univ, Coll Med, Dept Physiol, 26 Kyungheedae Ro, Seoul 02447, South Korea		Ko, IG (corresponding author), Kyung Hee Univ, Coll Med, Dept Physiol, 26 Kyungheedae Ro, Seoul 02447, South Korea.	rhdlfrb@hanmail.net	Kim, Chang-Ju/M-4216-2017	Kim, Chang-Ju/0000-0003-4749-5795; Jee, Yong-Seok/0000-0001-6797-0843; Ko, IL-Gyu/0000-0003-2696-6869; Yi, Eun Surk/0000-0002-9370-5231			Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Arnett HA, 2003, J NEUROSCI, V23, P9824; Bassi MS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00030; Bernardes D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0941-z; Bernardes D, 2013, J NEUROIMMUNOL, V264, P24, DOI 10.1016/j.jneuroim.2013.08.014; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Cervantes-Llanos M, 2018, LIFE SCI, V194, P130, DOI 10.1016/j.lfs.2017.12.032; Deforges S, 2009, J PHYSIOL-LONDON, V587, P3561, DOI 10.1113/jphysiol.2009.169748; Feng M, 2014, NEUROCHEM INT, V64, P64, DOI 10.1016/j.neuint.2013.11.007; Herold S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0317-0; Jeong H, 2019, INT NEUROUROL J, V23, pS93, DOI 10.5213/inj.1938218.109; Kaminska Joanna, 2017, Postepy Hig Med Dosw (Online), V71, P551; Kim JE, 2013, MOL MED REP, V8, P327, DOI 10.3892/mmr.2013.1518; Kim SE, 2019, INT NEUROUROL J, V23, pS40, DOI 10.5213/inj.1938048.024; Klaren RE, 2016, J NEUROSCI RES, V94, P907, DOI 10.1002/jnr.23783; Klaren RE, 2014, J NEUROIMMUNOL, V274, P14, DOI 10.1016/j.jneuroim.2014.06.014; Ko IG, 2019, J EXERC REHABIL, V15, P504, DOI 10.12965/jer.1938316.158; Kuerten S, 2008, ANN ANAT, V190, P1, DOI 10.1016/j.aanat.2007.11.001; Lee MJ, 2016, MOL NEUROBIOL, V53, P1977, DOI 10.1007/s12035-015-9131-4; Lubina-Dabrowska N, 2017, ARCH IMMUNOL THER EX, V65, P325, DOI 10.1007/s00005-017-0458-6; Lublin FD, 2005, NEUROL CLIN, V23, P1, DOI 10.1016/j.ncl.2004.09.003; Mastronardi FG, 2005, J NEUROSCI RES, V80, P301, DOI 10.1002/jnr.20420; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mifflin KA, 2017, J NEUROIMMUNOL, V305, P135, DOI 10.1016/j.jneuroim.2017.02.005; Patel DI, 2013, APPL PHYSIOL NUTR ME, V38, P194, DOI 10.1139/apnm-2012-0303; Pryor WM, 2015, J NEUROSCI RES, V93, P697, DOI 10.1002/jnr.23528; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rossi S, 2014, MULT SCLER J, V20, P304, DOI 10.1177/1352458513498128; Santana AJ, 2018, J EXERC REHABIL, V14, P24, DOI 10.12965/jer.1835138.569; Song SH, 2018, J EXERC REHABIL, V14, P911, DOI 10.12965/jer.1836508.254; Timoteo RP, 2019, J EXERC REHABIL, V15, P460, DOI 10.12965/jer.1938146.073; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Xie Y, 2019, J NEUROIMMUNOL, V328, P60, DOI 10.1016/j.jneuroim.2018.12.005; Yoon JR, 2018, J EXERC REHABIL, V14, P1032, DOI 10.12965/jer.1836446.223	35	6	6	0	0	KOREAN CONTINENCE SOC	YEONGOTONG-GU	DEPT UROLOGY, AJOU UNIV COLL MEDICINE, SAN 5 WONCHEN-DONG, YEONGOTONG-GU, SUWON 443-721, SOUTH KOREA	2093-4777	2093-6931		INT NEUROUROL J	Int. Neurourol. J.	MAY	2020	24			1			S39	S47		10.5213/inj.2040156.078			9	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	LU7RA	WOS:000537946800006	32482056	Green Published, gold			2022-02-06	
J	Matsushima, K; Hogen, R; Piccinini, A; Biswas, S; Khor, D; Delapena, S; Strumwasser, A; Inaba, K; Demetriades, D				Matsushima, Kazuhide; Hogen, Rachel; Piccinini, Alice; Biswas, Subarna; Khor, Desmond; Delapena, Samantha; Strumwasser, Aaron; Inaba, Kenji; Demetriades, Demetrios			Adjunctive use of hepatic angioembolization following hemorrhage control laparotomy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Conference of the Committe on Trauma of the American-College-of-Surgeons	DEC 03, 2016	Los Angeles, CA	Amer Coll Surg, Comm Trauma		Liver injury; angioembolization; adjunctive use; hemorrhage control surgery	ANGIOGRAPHIC EMBOLIZATION; DAMAGE CONTROL; TRAUMA; EXPERIENCE; MANAGEMENT; MORTALITY; INJURIES; OUTCOMES	BACKGROUND Severe liver injuries pose a challenge to trauma surgeons. While the use of hepatic angioembolization (HAE) has been evaluated as a component of the nonoperative management of liver injury, little is known about the efficacy of postoperative HAE in patients who require hemorrhage control laparotomy (HCL) for liver injury. The purpose of this study is to evaluate the impact of HAE following HCL on patient survival. METHODS This is a retrospective cohort study using the American College of Surgeons Trauma Quality Improvement Program database from January 2013 to December 2014. In propensity score matched (2:1) patients who underwent HCL-only or HCL + HAE, the impact of adjunctive use of HAE on patient survival was examined with the Cox proportional hazards regression analysis adjusting for transfusion requirement within 4 hours. We also performed a subgroup analysis in patients without severe traumatic brain injury (Abbreviated Injury Scale head <= 3). RESULTS A total of 1,675 patients met our inclusion criteria. Of those, 75 (4.5%) patients underwent HAE after HCL (median hours to HAE, 5 hours after admission). In 225 propensity score-matched patients, the use of HAE following HCL was significantly associated with improved 24-hour mortality, but not in-hospital mortality. In the subgroup of patients without severe traumatic brain injury (n = 189), we observed significant survival benefits (24-hour and in-hospital mortality) associated with the adjunctive use of HAE. CONCLUSION The results of our study suggest that the adjunctive use of HAE might improve survival of patients who require HCL for liver injury. Further prospective study to determine the indication for postoperative HAE is still warranted.	[Matsushima, Kazuhide; Hogen, Rachel; Piccinini, Alice; Biswas, Subarna; Khor, Desmond; Delapena, Samantha; Strumwasser, Aaron; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg, Los Angeles, CA 90007 USA		Matsushima, K (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Surg, 2051 Marengo St,Inpatient Tower C,C5L100, Los Angeles, CA 90033 USA.	kazuhide.matsushima@med.usc.edu					Asensio JA, 2003, J TRAUMA, V54, P647, DOI 10.1097/01.TA.0000054647.59217.BB; Bardes JM, 2018, J TRAUMA ACUTE CARE, V84, P893, DOI 10.1097/TA.0000000000001882; COGBILL TH, 1988, J TRAUMA, V28, P1433, DOI 10.1097/00005373-198810000-00004; Dabbs DN, 2009, J TRAUMA, V66, P621, DOI 10.1097/TA.0b013e31819919f2; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Duane TM, 2004, J TRAUMA, V57, P494, DOI 10.1097/01.TA.0000141026.20937.81; FELICIANO DV, 1986, J TRAUMA, V26, P738, DOI 10.1097/00005373-198608000-00010; Hagiwara A, 2002, J TRAUMA, V52, P1091, DOI 10.1097/00005373-200206000-00011; Johnson JW, 2002, J TRAUMA, V52, P1102, DOI 10.1097/00005373-200206000-00013; Kong YL, 2014, HEPATOB PANCREAT DIS, V13, P173, DOI 10.1016/S1499-3872(14)60027-8; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V79, P951, DOI 10.1097/TA.0000000000000692; MacKenzie S, 2004, INJURY, V35, P869, DOI 10.1016/j.injury.2003.07.004; Matsumoto S, 2018, J TRAUMA ACUTE CARE, V85, P290, DOI 10.1097/TA.0000000000001906; MAYS ET, 1972, J TRAUM, V12, P397, DOI 10.1097/00005373-197205000-00011; Misselbeck TS, 2009, J TRAUMA, V67, P769, DOI 10.1097/TA.0b013e3181b5ce7f; Mohr AM, 2003, J TRAUMA, V55, P1077, DOI 10.1097/01.TA.0000100219.02085.AB; PACHTER HL, 1992, ANN SURG, V215, P492, DOI 10.1097/00000658-199205000-00012; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SPECTOR N, 1957, ANN SURG, V145, P244, DOI 10.1097/00000658-195702000-00015; Stuart EA, 2008, STAT MED, V27, P2062, DOI 10.1002/sim.3207; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313	21	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2020	88	5					636	643		10.1097/TA.0000000000002591			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NE5OT	WOS:000562650900010	31977997				2022-02-06	
J	Narad, ME; Riemersma, J; Wade, SL; Smith-Paine, J; Morrison, P; Taylor, HG; Yeates, KO; Kurowski, BG				Narad, Megan E.; Riemersma, Jacqlyn; Wade, Shari L.; Smith-Paine, Julia; Morrison, Paige; Taylor, H. Gerry; Yeates, Keith Owen; Kurowski, Brad G.			Impact of Secondary ADHD on Long-Term Outcomes After Early Childhood Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ADHD; adolescents; attention problems; functional outcomes; pediatric traumatic brain injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; BEHAVIOR RATING INVENTORY; EXECUTIVE FUNCTION; PSYCHIATRIC-DISORDERS; YOUNG-CHILDREN; PEDIATRIC TBI; ADOLESCENTS 6; PREDICTORS; RECOVERY	Objective: To examine the impact of secondary attention-deficit/hyperactivity disorder (SADHD) on long-term global and executive functioning in adolescents after traumatic brain injury (TBI). Setting: Three tertiary cared children's hospitals and 1 general hospital. Participants: One hundred twenty children (TBI: n = 54; orthopedic injury: n = 66) without preinjury ADHD evaluated approximately 6.8 years postinjury. Design: Cross-sectional data analysis from a prospective, longitudinal study. Main Measures: Outcomes included functional impairment (Child and Adolescent Functional Assessment Scale) and executive functioning (Behavior Rating Inventory of Executive Function [BRIEF]). Results: SADHD moderated the association of injury type with the BRIEF-Behavioral Regulation Index (F-1,F-113 = 4.42, P = .04) and the Child and Adolescent Functional Assessment Scale (F-1,F-112 = 8.95, P = .003). TBI was only associated with poorer outcomes in the context of SADHD. SADHD was also associated with poorer outcomes on the BRIEF-Global Executive Composite (F-1,F-113 = 52.92, P < .0001) and BRIEF-Metacognitive Index scores (F-1,F-113 = 48.64, P < .0001) across groups. Adolescents with TBI had greater BRIEF-Global Executive Composite scores than those with orthopedic injury (F-1,F-113 = 5.00, P = .03). Conclusions: Although SADHD was associated with poorer functioning across groups, its adverse effects on behavioral regulation and overall functioning were amplified following TBI. TBI + SADHD may confer an elevated risk for significant impairments in early adolescence.	[Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wade, Shari L.; Smith-Paine, Julia; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Narad, Megan E.; Wade, Shari L.; Kurowski, Brad G.] Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Riemersma, Jacqlyn; Morrison, Paige] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Smith-Paine, Julia] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Biobehav Hlth Ctr, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020		Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research grant from the State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1F32HD088011-01]; Rehabilitation Research Experience for Medical Students; Mentored Patient-Oriented Research Career Development Award from the NICHD [K23 HD07468303]	This publication was supported by grant R01 HD42729 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and Trauma Research grant from the State of Ohio Emergency Medical Services. Additional support was provided through grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). Dr Narad was supported by grant 1F32HD088011-01 from the NICHD. Mss Riemersma and Morrison were supported by a grant from the Rehabilitation Research Experience for Medical Students. Dr Kurowski was supported by Mentored Patient-Oriented Research Career Development Award K23 HD07468303 from the NICHD. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bagwell CL, 2001, J AM ACAD CHILD PSY, V40, P1285, DOI 10.1097/00004583-200111000-00008; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Berger I, 2011, ISR MED ASSOC J, V13, P571; Biederman J, 2004, J CLIN PSYCHIAT, V65, P3; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; DuPaul G. J., 2003, ADHD SCH ASSESSMENT, V2nd; Eccles J. S., 1988, J EARLY ADOLESC, V8, P133, DOI DOI 10.1177/0272431688082003; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Garner AA, 2013, J DEV BEHAV PEDIATR, V34, P469, DOI 10.1097/DBP.0b013e3182a39890; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kurowski BG, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000432; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; LeBlond E, 2019, J INT NEUROPSYCH SOC, V25, P740, DOI 10.1017/S1355617719000444; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2012, PEDIAT FORENSIC NEUR, P258; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Nixon, 2001, CHILD ADOL MENT H-UK, V6, P172, DOI [10.1017/s1360641701002738, DOI 10.1017/S1360641701002738]; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Reddy LA, 2011, SCHOOL PSYCHOL QUART, V26, P45, DOI 10.1037/a0022585; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sharma A, 2014, ANN PHARMACOTHER, V48, P209, DOI 10.1177/1060028013510699; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Xue Y, 2004, J CLIN CHILD ADOLESC, V33, P516, DOI 10.1207/s15374424jccp3303_9; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	61	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E271	E279		10.1097/HTR.0000000000000550			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200010	31834065	Green Accepted			2022-02-06	
J	Ramsey, A; Blake, ML				Ramsey, Ashley; Blake, Margaret Lehman			Speech-Language Pathology Practices for Adults With Right Hemisphere Stroke: What Are We Missing?	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; IMPAIRED SELF-AWARENESS; COMPETENCE RATING-SCALE; COMMUNICATION-SKILLS; MEMORY REHABILITATION; ATTENTIONAL DEFICITS; UNILATERAL NEGLECT; EXECUTIVE FUNCTION; COGNITIVE DECLINE; CONNECTED SPEECH	Purpose: Limited evidence exists to guide the assessment and treatment of cognitive-communication disorders associated with right hemisphere stroke. The purpose of this study was to obtain information about speech-language pathologists' (SLPs') clinical practices and decision making for this population to understand what practices are being used and identify gaps in clinical practice. Method: A survey was distributed via online ASHA Communities for the Special Interest Groups and other social media platforms. Respondents included 143 SLPs from across the United States representing 3-50 years of experience and a wide range of practice settings. Survey questions probed assessment practices including how tests are selected, what tests are used to diagnose specific deficits, and how confident SLPs were in their diagnoses. Treatment decisions were queried for a small set of disorders. Results: SLPs routinely assess cognitive disorders using standardized tests. Communication disorders are less likely to be formally assessed. Three core right cerebral hemisphere deficits-anosognosia, aprosodia, and pragmatic deficits-are either not assessed or assessed only through observation by 80% of SLPs. Evidence-based treatments are commonly used for disorders of attention, awareness, and aprosodia. Conclusion: Communication disorders are less likely to be formally assessed than cognitive disorders, creating a critical gap in care that cannot be filled by other allied health professionals. Suggestions for free or low-cost resources for evaluating pragmatics, prosody, and awareness are provided to aid SLPs in filling this gap.	[Ramsey, Ashley; Blake, Margaret Lehman] Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA		Blake, ML (corresponding author), Univ Houston, Dept Commun Sci & Disorders, Houston, TX 77004 USA.	mtblake@uh.edu					Adamit T, 2015, DISABIL REHABIL, V37, P667, DOI 10.3109/09638288.2014.923523; Adamovich B. B., 1992, SCALES COGNITIVE ABI; Agis D, 2016, STROKE, V47, P1459, DOI 10.1161/STROKEAHA.115.012324; Alpers GW, 2008, LATERALITY, V13, P158, DOI 10.1080/13576500701779247; American Speech-Language-Hearing Association, ASHA COMM; Appelros P, 2003, DISABIL REHABIL, V25, P473, DOI 10.1080/0963828031000071714; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; Barker-Collo SL, 2010, TOP STROKE REHABIL, V17, P463, DOI 10.1310/tsr1706-463; Ben-David BM, 2011, BRAIN INJURY, V25, P206, DOI 10.3109/02699052.2010.536197; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Benton E, 1996, INT J REHABIL RES, V19, P47, DOI 10.1097/00004356-199603000-00005; Blake M.L., 2002, APHASIOLOGY, V16, P537, DOI [10.1080/02687030244000194, DOI 10.1080/02687030244000194]; Blake ML, 2007, AM J SPEECH-LANG PAT, V16, P331, DOI 10.1044/1058-0360(2007/037); Blake ML, 2015, NEUROPSYCHOL REHABIL, V25, P15, DOI 10.1080/09602011.2014.932290; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Blake ML, 2003, APHASIOLOGY, V17, P423, DOI 10.1080/02687030344000120; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Bowers D., 1991, FLORIDA AFFECT BATTE; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brasure M., 2012, PREPARED BY THE MINN; Bryan K. L., 1994, RIGHT HEMISPHERE LAN; Burns M., 1997, BURNS BRIEF INVENTOR; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cote H, 2007, APHASIOLOGY, V21, P739, DOI 10.1080/02687030701192331; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dara Chinar, 2014, J Neurol Transl Neurosci, V2, P1037; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffin JT, 2012, J CLIN EXP NEUROPSYC, V34, P864, DOI 10.1080/13803395.2012.690368; Ekman P., 2006, COMPREHENSIVE AFFECT; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Ferre P, 2012, FOLIA PHONIATR LOGO, V64, P199, DOI 10.1159/000340017; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godefroy O, 2009, EUR NEUROL, V61, P223, DOI 10.1159/000197107; Grabowska A, 2011, NEUROPSYCHOLOGIA, V49, P3327, DOI 10.1016/j.neuropsychologia.2011.08.006; Halper A. S., 2010, REHABILITATION I CHI; Hedna VS, 2013, J CLIN NEUROL, V9, P97, DOI 10.3988/jcn.2013.9.2.97; Helm-Estabrooks N, 2017, COGNITIVE LINGUISTIC; Hochstenbach J, 1998, J CLIN EXP NEUROPSYC, V20, P503, DOI 10.1076/jcen.20.4.503.1471; Hyndman D, 2008, J NEUROL NEUROSUR PS, V79, P656, DOI 10.1136/jnnp.2007.125609; Jehkonen M, 2001, ACTA NEUROL SCAND, V104, P136, DOI 10.1034/j.1600-0404.2001.00025.x; Joanette Y, 2015, MONTREAL PROTOCOL EV; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy MRT, 2000, AM J SPEECH-LANG PAT, V9, P72, DOI 10.1044/1058-0360.0901.72; Kertesz A., 2006, W APHASIA BATTERY RE; Kim J, 2007, CYBERPSYCHOL BEHAV, V10, P7, DOI 10.1089/cpb.2006.9998; Kleinman JT, 2007, BRAIN COGNITION, V64, P50, DOI 10.1016/j.bandc.2006.10.005; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Lehman Blake M, 2018, RIGHT HEMISPHERE DIS; Leon S. A., 2004, J REHABILITATION RES, V41, P93, DOI 10.1682/JRRD.2003.12.0182; Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968; Linscott R., 2018, PROFILE PRAGMATIC IM; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Mackenzie C, 1997, APHASIOLOGY, V11, P929, DOI 10.1080/02687039708249420; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; Miller LA, 2014, NEUROPSYCHOL REHABIL, V24, P721, DOI 10.1080/09602011.2014.894479; Milman L. H., 2012, SCALES COGNITIVE COM; Myers P.S., 1999, RIGHT HEMISPHERE DAM; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Park YH, 2015, J STROKE CEREBROVASC, V24, P554, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.033; Parola A, 2019, J NEUROLINGUIST, V51, P53, DOI 10.1016/j.jneuroling.2018.12.003; Pedroli E, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00226; Pimental P. A., 2000, MINIINVENTORY RIGHT; Portegies MLP, 2015, STROKE, V46, P252, DOI 10.1161/STROKEAHA.114.007385; Poulin V, 2012, TOP STROKE REHABIL, V19, P158, DOI 10.1310/tsr1902-158; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Randolph C., 1998, REPEATABLE BATTERY A; Robertson I., 1994, TEST EVERYDAY ATTENT; Rosenbek JC, 2006, J REHABIL RES DEV, V43, P379, DOI 10.1682/JRRD.2005.01.0029; Ross-Swain DG., 1996, ROSS INFORM PROCESSI; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Sohlberg M. M., 2011, ATTENTION PROCESS TR; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Tompkins C., 2013, APHASIA RELATED NEUR, P345; Tompkins C., 2013, APHASIA RELATED NEUR, P297; Tompkins C. A., 2013, CLIN APH C TUCS AZ; Tompkins CA, 2016, SEMIN SPEECH LANG, V37, P153, DOI 10.1055/s-0036-1583548; Vossel S, 2013, CORTEX, V49, P1782, DOI 10.1016/j.cortex.2012.12.011; Vuilleumier P, 2001, CORTEX, V37, P741, DOI 10.1016/S0010-9452(08)70629-4; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	93	6	6	3	7	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2020	29	2					741	759		10.1044/2020_AJSLP-19-00082			19	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MM5FZ	WOS:000550183600014	32330389				2022-02-06	
J	Taherian, M; Norenberg, MD; Panickar, KS; Shamaladevi, N; Ahmad, A; Rahman, P; Jayakumar, AR				Taherian, Mehran; Norenberg, Michael D.; Panickar, Kiran S.; Shamaladevi, Nagarajarao; Ahmad, Anis; Rahman, Purbasha; Jayakumar, Arumugam R.			Additive Effect of Resveratrol on Astrocyte Swelling Post-exposure to Ammonia, Ischemia and Trauma In Vitro	NEUROCHEMICAL RESEARCH			English	Article						Resveratrol; Astrocyte swelling; Ammonia; Ischemia; Brain trauma	OXYGEN-GLUCOSE DEPRIVATION; K-CL COTRANSPORTER-1; MITOCHONDRIAL DYSFUNCTION; THERAPEUTIC IMPLICATIONS; DIFFERENTIAL RESPONSE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; NEURAL CELLS; BRAIN-INJURY; EXPRESSION	Swelling of astrocytes represents a major component of the brain edema associated with many neurological conditions, including acute hepatic encephalopathy (AHE), traumatic brain injury (TBI) and ischemia. It has previously been reported that exposure of cultured astrocytes to ammonia (a factor strongly implicated in the pathogenesis of AHE), oxygen/glucose deprivation, or to direct mechanical trauma results in an increase in cell swelling. Since dietary polyphenols have been shown to exert a protective effect against cell injury, we examined whether resveratrol (RSV, 3,5,4 '-trihydroxy-trans-stilbene, a stilbenoid phenol), has a protective effect on astrocyte swelling following its exposure to ammonia, oxygen-glucose deprivation (OGD), or trauma in vitro. Ammonia increased astrocyte swelling, and pre- or post-treatment of astrocytes with 10 and 25 mu M RSV displayed an additive effect, while 5 mu M did not prevent the effect of ammonia. However, pre-treatment of astrocytes with 25 mu M RSV slightly, but significantly, reduced the trauma-induced astrocyte swelling at earlier time points (3 h), while post-treatment had no significant effect on the trauma-induced cell swelling at the 3 h time point. Instead, pre- or post-treatment of astrocytes with 25 mu M RSV had an additive effect on trauma-induced astrocyte swelling. Further, pre- or post-treatment of astrocytes with 5 or 10 mu M RSV had no significant effect on trauma-induced astrocyte swelling. When 5 or 10 mu M RSV were added prior to, or during the process of OGD, as well as post-OGD, it caused a slight, but not statistically significant decline in cell swelling. However, when 25 mu M RSV was added during the process of OGD, as well as after the cells were returned to normal condition (90 min period), such treatment showed an additive effect on the OGD-induced astrocyte swelling. Noteworthy, a higher concentration of RSV (25 mu M) exhibited an additive effect on levels of phosphorylated forms of ERK1/2, and p38(MAPK), as well as an increased activity of the Na+-K+-Cl- co-transporter-1 (NKCC1), factors known to induce astrocytes swelling, when the cells were treated with ammonia or after trauma or ischemia. Further, inhibition of ERK1/2, and p38(MAPK) diminished the RSV-induced exacerbation of cell swelling post-ammonia, trauma and OGD treatment. These findings strongly suggest that treatment of cultured astrocytes with RSV enhanced the ammonia, ischemia and trauma-induced cell swelling, likely through the exacerbation of intercellular signaling kinases and ion transporters. Accordingly, caution should be exercised when using RSV for the treatment of these neurological conditions, especially when brain edema is also suspected.	[Taherian, Mehran; Panickar, Kiran S.; Rahman, Purbasha; Jayakumar, Arumugam R.] Vet Affairs Med Ctr, R&D Serv, Neuropathol Sect, Gen Med Res, 1201 NW 16th St,Res 151,Room 314, Miami, FL 33125 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Neurol & Neurol Surg, Miami, FL USA; [Shamaladevi, Nagarajarao] GeneChem Diagnost Labs, Miami, FL USA; [Ahmad, Anis] Univ Miami, Sch Med, Dept Radiat Oncol, Sylvester Canc Ctr, Miami, FL USA; [Rahman, Purbasha] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA; [Jayakumar, Arumugam R.] Vet Affairs Med Ctr, South Florida VA Fdn Res & Educ Inc, Miami, FL 33125 USA		Jayakumar, AR (corresponding author), Vet Affairs Med Ctr, R&D Serv, Neuropathol Sect, Gen Med Res, 1201 NW 16th St,Res 151,Room 314, Miami, FL 33125 USA.	avrj_2000@yahoo.com			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [Merit Review] Funding Source: Medline		Bastianetto S, 2015, BBA-MOL BASIS DIS, V1852, P1195, DOI 10.1016/j.bbadis.2014.09.011; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bellaver B, 2015, NEUROCHEM RES, V40, P1600, DOI 10.1007/s11064-015-1636-8; Bellaver B, 2014, TOXICOL IN VITRO, V28, P479, DOI 10.1016/j.tiv.2014.01.006; Bobermin LD, 2018, NUTR NEUROSCI, V21, P276, DOI 10.1080/1028415X.2017.1284375; Bobermin LD, 2015, TOXICOL IN VITRO, V29, P2022, DOI 10.1016/j.tiv.2015.08.008; Bobermin LD, 2015, NEUROTOXICOLOGY, V49, P28, DOI 10.1016/j.neuro.2015.05.005; Bobermin LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052164; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chen Y, 2007, IN VIVO, V21, P365; Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; DUCIS I, 1989, BRAIN RES, V493, P362, DOI 10.1016/0006-8993(89)91171-2; Finnell JE, 2017, BRAIN BEHAV IMMUN, V59, P147, DOI 10.1016/j.bbi.2016.08.019; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Hajizadeh-Sharafabad F, 2019, BIOFACTORS, V45, P651, DOI 10.1002/biof.1531; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Jayakumar AR, 2018, NEUROCHEM RES, V43, P397, DOI 10.1007/s11064-017-2434-2; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jayakumar AR, 2006, NEUROCHEM INT, V48, P623, DOI 10.1016/j.neuint.2005.11.017; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar Arumugam R., 2016, Biology-Basel, V5, P48, DOI 10.3390/biology5040048; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Jayakumar AR, 2017, J NEUROCHEM, V140, P645, DOI 10.1111/jnc.13867; Jensen MD, 2009, NEUROCHEM INT, V55, P362, DOI 10.1016/j.neuint.2009.04.002; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kataria R, 2019, CURR TOP MED CHEM, V19, P116, DOI 10.2174/1568026619666190301173958; Kimura J, 2009, BIOL PHARM BULL, V32, P325, DOI 10.1248/bpb.32.325; Kitada M, 2013, DIABETES METAB J, V37, P315, DOI 10.4093/dmj.2013.37.5.315; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Kotwica Z, 1989, Zentralbl Neurochir, V50, P68; Kwon KJ, 2011, J PINEAL RES, V50, P110, DOI 10.1111/j.1600-079X.2010.00820.x; Lafrenaye AD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020330; Latronico T, 2013, TOXICOL SCI, V135, P218, DOI 10.1093/toxsci/kft146; Li WN, 2015, MOL MED REP, V12, P7756, DOI 10.3892/mmr.2015.4366; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Lopez MS, 2015, NEUROCHEM INT, V89, P75, DOI 10.1016/j.neuint.2015.08.009; Malaguarnera G, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030329; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; NORENBERG MD, 1991, NEUROCHEM RES, V16, P833, DOI 10.1007/BF00965694; Oomen CA, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.004.2009; Panickar KS, 2012, NEUROSCIENCE, V202, P87, DOI 10.1016/j.neuroscience.2011.11.051; Panickar KS, 2015, NUTR NEUROSCI, V18, P297, DOI 10.1179/1476830514Y.0000000127; Panickar Kiran S, 2010, Recent Pat CNS Drug Discov, V5, P99; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Panickar KS, 2005, NEUROSCIENCE, V135, P73, DOI 10.1016/j.neuroscience.2005.02.052; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Panickars KS, 2009, NUTR NEUROSCI, V12, P105, DOI 10.1179/147683009X423300; Pasantes-Morales H, 2012, NEUROCHEM RES, V37, P2379, DOI 10.1007/s11064-012-0777-2; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Quincozes-Santos A, 2009, NEUROTOX RES, V16, P30, DOI 10.1007/s12640-009-9042-0; Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; Romero-Perez AI, 1999, J AGR FOOD CHEM, V47, P1533, DOI 10.1021/jf981024g; Sadi G, 2015, GENE, V570, P213, DOI 10.1016/j.gene.2015.06.019; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Souza DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060282; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Vella RK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918123; Voloshyna I, 2012, J MED FOOD, V15, P763, DOI 10.1089/jmf.2012.0025; Wells AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130512; Wight RD, 2012, BIOCHEM BIOPH RES CO, V426, P112, DOI 10.1016/j.bbrc.2012.08.045; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009; Yang Y, 2013, NEUROBIOL AGING, V34, P2879, DOI 10.1016/j.neurobiolaging.2013.06.008; Yao Y, 2007, NEUROTOXICOLOGY, V28, P93, DOI 10.1016/j.neuro.2006.07.015; Zhang F, 2012, EXP BIOL MED, V237, P943, DOI 10.1258/ebm.2012.012044; Zhang H, 2016, MOL MED REP, V13, P224, DOI 10.3892/mmr.2015.4497; Zhou H, 2011, NEUROCHEM RES, V36, P17, DOI 10.1007/s11064-010-0254-8; Zhu XY, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0217-z	86	6	6	2	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2020	45	5					1156	1167		10.1007/s11064-020-02997-1			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LE0KF	WOS:000526413100017	32166573				2022-02-06	
J	Vuokila, N; Das Gupta, S; Huusko, R; Tohka, J; Puhakka, N; Pitkanen, A				Vuokila, Niina; Das Gupta, Shalini; Huusko, Riina; Tohka, Jussi; Puhakka, Noora; Pitkanen, Asla			Elevated Acute Plasma miR-124-3p Level Relates to Evolution of Larger Cortical Lesion Area after Traumatic Brain Injury	NEUROSCIENCE			English	Article						microRNA; miR-124-3p; plasma; prognostic biomarker; receiver operating characteristic curve; traumatic brain injury	POSTTRAUMATIC EPILEPSY; PATHOLOGICAL RESEARCH; MICRORNAS; EXPRESSION; BIOMARKERS; DIAGNOSIS; BARRIER; SERUM; MODEL; INFLAMMATION	Mechanisms initiated by traumatic brain injury (TBI), leading to the development of progressive secondary injury are poorly understood. MicroRNAs (miRNAs) have a proposed role in orchestrating the postinjury aftermath as a single miRNA can control the expression of several genes. We hypothesized that the post-injury level of circulating brain-enriched miR-124-3p explains the extent of post-TBI cortical lesion. Three separate cohorts of adult male Sprague-Dawley rats (total n = 57) were injured with lateral fluid-percussion- induced TBI. The miR-124-3p levels were measured in whole blood and/or plasma in cohorts 1 and 2 before TBI as well as at 2 d, 7 d, 2 months or 3 months post-TBI. The third cohort (22/57) was imaged with T2-weighted magnetic resonance imaging (MRI) at 2 months post-TBI to quantify cortical lesion area and perilesional T2-enhancement volume. Our data shows that miR-124-3p levels were elevated at 2 d post-TBI in both blood (FC 4.63, p < 0.01) and plasma (FC 1.39, p < 0.05) as compared to controls. Receiver operating curve (ROC) analysis indicated that plasma miR-124-3p level of 34 copies/mu l or higher differentiated TBI animals from controls [area under curve (AUC) 0.815, p < 0.05]. The data was validated in the third cohort (FC 1.68, p < 0.05). T2-weighted MRI revealed inter-animal differences in cortical lesion area. Linear regression analysis revealed that higher the plasma miR-124-3p level at 2 d post-TBI, larger the lesion area at chronic time point (R-2 = 0.327, p < 0.01). Our findings indicate that the extent of lateral fluid-percussion injury-induced chronic cortical pathology associated with the acutely elevated plasma miR-124-3p level. (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.	[Vuokila, Niina; Das Gupta, Shalini; Tohka, Jussi; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland; [Huusko, Riina] Nat Resources Inst Finland Luke, POB 413, FI-90014 Oulu, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Tohka, Jussi/D-2385-2013	Tohka, Jussi/0000-0002-1048-5860; Vuokila, Niina/0000-0003-4976-6835	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 317203]; European UnionEuropean Commission [602102]	We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance. This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909 and 317203) and by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602102 (EPITARGET).	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Andrade P, 2018, J NEUROSCI METH, V308, P330, DOI 10.1016/j.jneumeth.2018.08.028; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Becker C, 2015, ANN NEUROL, V78, P128, DOI 10.1002/ana.24414; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Carvalho-Gaspar M, 2005, J IMMUNOL METHODS, V301, P41, DOI 10.1016/j.jim.2005.03.003; Chen T, 2015, NEUROL SCI, V36, P131, DOI 10.1007/s10072-014-1895-1; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Devaux Y, 2016, JAMA CARDIOL, V1, P305, DOI 10.1001/jamacardio.2016.0480; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Huttunen JK, 2018, J NEUROTRAUM, V35, P2708, DOI 10.1089/neu.2017.5308; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Ji QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163645; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karttunen J, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2018.1555410; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leung LY, 2014, CLIN CHIM ACTA, V433, P139, DOI 10.1016/j.cca.2014.03.007; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Lunavat TR, 2015, RNA BIOL, V12, P810, DOI 10.1080/15476286.2015.1056975; Maria Bot Anna, 2013, PLOS ONE, V8; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Paxinos G, 2007, RAT BRAIN STEREOTACT; Pedroza-Torres A, 2016, GYNECOL ONCOL, V142, P557, DOI 10.1016/j.ygyno.2016.07.093; Peng J, 2013, J MOL NEUROSCI, V50, P291, DOI 10.1007/s12031-013-9953-3; Rainer TH, 2016, CLIN BIOCHEM, V49, P663, DOI 10.1016/j.clinbiochem.2016.02.016; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Savelyeva AV, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7404912; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Sorensen SS, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0104-9; Synnot A, 2015, J NEUROTRAUM; Takahashi I, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0161-7; Tang GS, 2015, MED SCI MONITOR, V21, P617, DOI 10.12659/MSM.891028; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tian Y, 2015, PANCREAS, V44, P23, DOI 10.1097/MPA.0000000000000204; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Yan Y, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00084	68	6	6	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 1	2020	433						21	35		10.1016/j.neuroscience.2020.02.045			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KZ9FS	WOS:000523565100003	32142864				2022-02-06	
J	Zhao, HL; Mo, MH; Miao, C; Li, L; Yang, H; Liu, Y; Yang, G				Zhao, Hongling; Mo, Menghui; Miao, Cheng; Li, Lei; Yang, Hui; Liu, Yi; Yang, Gang			Association of serum biomarker neurofilament light concentration with post -stroke depression: A preliminary study	GENERAL HOSPITAL PSYCHIATRY			English	Article						Axonal injury; Neurofilament light; Ischemic stroke; Depression	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; WHITE-MATTER INJURY; POSTSTROKE DEPRESSION; CEREBROSPINAL-FLUID; PROTEIN; DISEASE; CHAIN; NEURODEGENERATION; MARKER	Objective: To investigate serum neurofilament light (sNfL) levels in acute ischemic stroke and to assess whether sNfL are related to the severity of disease and a potential prognostic marker of post-stroke depression (PSD) during a 3-month follow-up period. Methods: This was a single-center prospective cohort study. The sNfL concentration was measured in baseline samples using the Simoa platform-Single Molecule Array technology. A psychiatrist administered the Structural Clinical Interview for Diagnostic and Statistical Manual IV to all patients and made a diagnosis of PSD 3 months after stroke. The logistic regression was used to examine the association between sNfL and PSD. Results: In total, 236 ischemic stroke cases were included and finished the follow-up. In the follow-up, 55 patients were defined as PSD, thus the incidence rate was 23.3% (95% confidence intervals [CI]: 17.9%-28.7%). Significant differences were observed between the sNfL levels in patients with PSD (124.8 pg/ml [interquartile range {IQR}: 59.6-159.2]) and in patients without PSD (35.9 pg/ml [IQR: 18.2-60.4]) levels (P < 0.001). After adjusting for age, family history of depression, marital status, National Institutes of Health and Stroke Scale score, C-reactive protein and homocysteine levels, sNfL levels independently predicted the development of poststroke depression. The crude and adjusted odds ratios [OR] (and 95%CI) of PSD associated with an IQR increase for sNfL were 3.38(2.29, 4.98) and 2.65(1.59, 4.04), respectively. According to receiver operating characteristic curves (ROC) curves, the cut-off value of sNfL to predict PSD was 111.4 pg/ml with an area under the curve (AUC) of 0.84(95% CI, 0.78-0.90) and with the highest sensitivity (61.8%) and specificity (95.4%). Conclusions: In this study, elevated level of sNfL is associated with higher risk of 3-month depression in patients with ischemic stroke and makes early diagnoses of depression. The study needs replication to ensure the validity of our preliminary results.	[Zhao, Hongling; Mo, Menghui; Miao, Cheng; Li, Lei; Yang, Hui; Liu, Yi] Cent Hosp Xinxiang City, Dept Ward Neurol 3, Xinxiang 453000, Henan, Peoples R China; [Yang, Gang] Shaoxing Univ, Zhuji Affiliated Hosp, Dept Neurosurg, Zhuji 311800, Zhejiang, Peoples R China		Yang, G (corresponding author), 9 Jianmin Rd,Taozhu St, Zhuji 311800, Zhejiang, Peoples R China.	zhanjone430@163.com					Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al Shweiki MHDR, 2019, J PSYCHIATR RES, V113, P137, DOI 10.1016/j.jpsychires.2019.03.019; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjornevik K, 2020, JAMA NEUROL, V77, P58, DOI 10.1001/jamaneurol.2019.3238; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROTT T, 1989, STROKE, V20, P871, DOI 10.1161/01.STR.20.7.871; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Chen Z, 2018, INT J CEREBROVASCULA, V26, P577; Cheng LS, 2018, MOL NEUROBIOL, V55, P2952, DOI 10.1007/s12035-017-0549-8; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Duering M, 2015, NEUROLOGY, V84, P1685, DOI 10.1212/WNL.0000000000001502; Eratne D, 2020, AUST NZ J PSYCHIAT, V54, P57, DOI 10.1177/0004867419857811; Firbank MJ, 2012, BRIT J PSYCHIAT, V201, P40, DOI 10.1192/bjp.bp.111.098897; FOURNIER LE, 2019, STROKE S1, V50; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Gu YY, 2019, NEUROSCI LETT, V690, P99, DOI 10.1016/j.neulet.2018.09.046; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Jakobsson J, 2014, NEUROPSYCHOPHARMACOL, V39, P2349, DOI 10.1038/npp.2014.81; Jimenez I, 2009, PSYCHOL MED, V39, P1201, DOI 10.1017/S0033291709005637; Kern S, 2019, JAMA NEUROL, V76, P187, DOI 10.1001/jamaneurol.2018.3459; Korley FK, 2019, STROKE, V50, P1669, DOI 10.1161/STROKEAHA.119.024941; Kuchcinski G, 2017, BRAIN, V140, P1932, DOI 10.1093/brain/awx114; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Lin JH, 2018, EPILEPSY BEHAV, V89, P148, DOI 10.1016/j.yebeh.2018.10.009; Lin YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35766-w; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; Lu XR, 2020, J AFFECT DISORDERS, V260, P695, DOI 10.1016/j.jad.2019.09.037; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2016, EMBO MOL MED, V8, P1184, DOI 10.15252/emmm.201606540; Mayeli M, 2019, J NEUROPATH EXP NEUR, V78, P709, DOI 10.1093/jnen/nlz054; Mielke MM, 2019, NEUROLOGY, V93, pE252, DOI 10.1212/WNL.0000000000007767; Onatsu J, 2019, J STROKE CEREBROVASC, V28, P2242, DOI 10.1016/j.jstrokecerebrovasdis.2019.05.008; Park GY, 2016, PSYCHIAT INVEST, V13, P659, DOI 10.4306/pi.2016.13.6.659; Pedergnana A, 2020, J PALEOLITH ARCHAEOL, V3, P225, DOI 10.1007/s41982-019-00039-z; Pujol-Calderon F, 2019, NEUROSCI LETT, V698, P58, DOI 10.1016/j.neulet.2018.12.042; Robinson RG, 2016, AM J PSYCHIAT, V173, P221, DOI 10.1176/appi.ajp.2015.15030363; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Spanier S, 2019, MED HYPOTHESES, V127, P159, DOI 10.1016/j.mehy.2019.03.022; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Tang WK, 2010, J NEUROL NEUROSUR PS, V81, P1312, DOI 10.1136/jnnp.2009.203141; Tiedt S, 2018, NEUROLOGY, V91, pE1338, DOI 10.1212/WNL.0000000000006282; Traenka C, 2015, CEREBROVASC DIS, V40, P222, DOI 10.1159/000440774; Tu WJ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1177-6; Tu WJ, 2014, CLIN SCI, V126, P339, DOI 10.1042/CS20130284; Uphaus T, 2019, STROKE, V50, P3077, DOI 10.1161/STROKEAHA.119.026410; Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Wu SM, 2019, LANCET NEUROL, V18, P394, DOI 10.1016/S1474-4422(18)30500-3; Xu HB, 2018, J STROKE CEREBROVASC, V27, P709, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.003; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001; Yasuno F, 2014, PSYCHOGERIATRICS, V14, P213, DOI 10.1111/psyg.12084; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037	68	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	MAY-JUN	2020	64						17	25		10.1016/j.genhosppsych.2020.01.006			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	LL5DJ	WOS:000531577200003	32078857				2022-02-06	
J	White, DL; Kunik, ME; Yu, H; Lin, HL; Richardson, PA; Moore, S; Sarwar, AI; Marsh, L; Jorge, RE				White, Donna L.; Kunik, Mark E.; Yu, Hong; Lin, Helen L.; Richardson, Peter A.; Moore, Suzanne; Sarwar, Aliya, I; Marsh, Laura; Jorge, Ricardo E.			Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury	ANNALS OF NEUROLOGY			English	Article							HEAD-INJURY; PTSD; NEURODEGENERATION; PREVALENCE; DIAGNOSIS; PATHOLOGY; LIFETIME; CRITERIA	Objective Determining if traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) are risk factors for Parkinson's disease (PD). This constitutes a research priority for the Veterans Administration (VA) with implications for screening policy and prevention. Methods Population-based, matched case-control study among veterans using VA health care facilities from October 1, 1999, to September 30, 2013. We identified 176,871 PD cases and 707,484 randomly selected PD-free matched controls. PD, TBI, and PTSD were ascertained by validated International Classification of Disease 9th revision (ICD)-9 code-based algorithms. We examined the association between both risk factors and PD using race-adjusted conditional logistic regression. Results The overall study cohort prevalence for TBImild, TBInon-mild, and PTSD was 0.65%, 0.69%, and 5.5%, respectively. Both TBI and PTSD were significantly associated with PD in single-risk factor race-adjusted analyses (conditional odds ratio [cOR] = 2.99; 95% confidence interval [CI]: 2.69-3.32), 3.82 (95% CI: 3.67-3.97), and 2.71 (95% CI: 2.66-2.77) for TBImild, TBInon-mild, and PTSD, respectively). There was suggestive positive interaction observed with comorbid PTSD/TBI in dual-risk factor analyses, with significant 2.69-fold and 3.70-fold excess relative PD risk in veterans with TBImild and TBInon-mild versus those without TBI when PTSD was present versus 2.17-fold and 2.80-fold excess risk when PTSD was absent. Interpretation Our study was the first to demonstrate that both TBI and PTSD are independently associated with increased relative PD risk in a diverse nationwide cohort of military service veterans, and the first to suggest a potential modest synergistic excess risk in those with comorbid TBI/PTSD. Longitudinal research is needed to confirm these suggestive findings. ANN NEUROL 2020	[White, Donna L.; Yu, Hong] Michael E DeBakey VA Hlth Serv Res Ctr Innovat IQ, Clin Epidemiol & Comparat Effectiveness Program, Dept Med, Houston, TX USA; [White, Donna L.; Kunik, Mark E.; Richardson, Peter A.] Baylor Coll Med, Dept Med, Sect Hlth Serv Res & Dev, Houston, TX 77030 USA; [White, Donna L.] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA; [Kunik, Mark E.; Lin, Helen L.; Marsh, Laura; Jorge, Ricardo E.] VA South Cent Mental Illness Res, Educ & Clin Ctr, Houston, TX USA; [Kunik, Mark E.; Marsh, Laura; Jorge, Ricardo E.] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX 77030 USA; [Kunik, Mark E.; Marsh, Laura; Jorge, Ricardo E.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Moore, Suzanne; Sarwar, Aliya, I] Michael E DeBakey VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Houston, TX 77030 USA; [Moore, Suzanne; Sarwar, Aliya, I] Michael E DeBakey VA Med Ctr, Neurol Care Line, Houston, TX 77030 USA; [Moore, Suzanne; Sarwar, Aliya, I] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA		Jorge, RE (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	ricardo.jorge@va.gov	White, Donna/AAZ-9349-2021	White, Donna/0000-0003-0297-2949	Houston VA Health Services Research and Development Center of Innovations [CIN13-413]; South-Central Mental Illness Research, Education (MIRECC); Department of Veterans AffairsUS Department of Veterans Affairs [CX001430, B9268-X]	This research was supported in part by the Houston VA Health Services Research and Development Center of Innovations (CIN13-413) and the South-Central Mental Illness Research, Education (MIRECC). Dr White and Dr Jorge received funding from the Department of Veterans Affairs (CX001430 and B9268-X, respectively).	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Camacho-Soto A, 2017, ANN NEUROL, V82, P744, DOI 10.1002/ana.25074; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Chan YLE, 2017, AM J GERIAT PSYCHIAT, V25, P917, DOI 10.1016/j.jagp.2017.03.012; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2017, J GERONTOL A-BIOL, V72, P1233, DOI 10.1093/gerona/glw341; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Health N.I.o, 2013, PARK DIS; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Holowka DW, 2014, J CONSULT CLIN PSYCH, V82, P569, DOI 10.1037/a0036347; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Lehavot K, 2018, AM J PREV MED, V54, pE1, DOI 10.1016/j.amepre.2017.09.008; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Milani ACC, 2017, PSYCHIAT CLIN NEUROS, V71, P154, DOI 10.1111/pcn.12473; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Nyam TTE, 2018, WORLD NEUROSURG, V113, pE328, DOI 10.1016/j.wneu.2018.02.027; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; SPIRO A, 1994, PSYCHOL AGING, V9, P17, DOI 10.1037/0882-7974.9.1.17; Statistics N.C.F.V.A.A, 2018, POP TABL TABL 1L VET; Statistics N.C.f.V.A.a, 2018, SEL VET HLTH ADM CHA; Svensson E, 2016, EUR J NEUROL, V23, P751, DOI 10.1111/ene.12933; Szumski NR, 2009, MOVEMENT DISORD, V24, P51, DOI 10.1002/mds.22283; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205	34	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUL	2020	88	1					33	41		10.1002/ana.25726		APR 2020	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MA5OV	WOS:000529267400001	32232880				2022-02-06	
J	Rickards, TA; Cranston, CC; McWhorter, J				Rickards, Tyler A.; Cranston, Christopher C.; McWhorter, Jessica			Persistent post-concussive symptoms: A model of predisposing, precipitating, and perpetuating factors	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Assessment; diagnosis; diagnosis; treatment	TRAUMATIC BRAIN-INJURY; GOOD-OLD-DAYS; POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; DAYS BIAS; PERFORMANCE VALIDITY; PUBLIC KNOWLEDGE; EARLY PREDICTORS	While the majority of individuals make full recovery within a short period following mild traumatic brain injury (mTBI), some continue to experience a more chronic course of symptoms termed persistent post-concussive symptoms (PPCS). Previous models and conceptualizations of PPCS have typically not differentiated the time at which factors present across the injury timeline spectrum or have considered a limited array of contributory factors. In the current review, PPCS are examined within the predisposing, precipitating, and perpetuating (PPP) model, which has been applied to explain other syndromes resulting in a clear framework to explain, disseminate, and further research the specified condition. Previous PPCS models are reviewed and integrated into this comprehensive model, as well. To do so, a literature review was completed which included previous PPP models applied to other conditions, other PPCS models, and more recent findings of factors related to PPCS. This new iteration and application of the PPP model more clearly, completely, and validly identifies contributing factors to PPCS. Future prevention, early identification, clearer questions for future research, and treatment of PPCS is possible with clarity provided by this model.	[Rickards, Tyler A.; McWhorter, Jessica] LifeBridge Hlth, Dept Neurol, Div Med Psychol, Baltimore, MD USA; [Cranston, Christopher C.] Johns Hopkins Med Psychiat & Behav Sci, Baltimore, MD USA		Rickards, TA (corresponding author), LifeBridge Hlth, Baltimore, MD 21215 USA.	tyler.rickards@gmail.com					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Braun B. G., 1985, CHILDHOOD ANTECEDENT, P37; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Crutchfield K., 2014, NEUROLOGY S, V82, P5; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Edmed SL, 2014, J CLIN EXP NEUROPSYC, V36, P221, DOI 10.1080/13803395.2013.877124; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Furger R. E., 2016, CONCUSSION, V1, pCNC11; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; GUTTMANN E, 1946, J MENT SCI, V92, P1; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holle D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142468; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2018, J NEUROTRAUM, V35, P1156, DOI 10.1089/neu.2017.5402; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kahn-Greene ET, 2006, PERS INDIV DIFFER, V41, P1433, DOI 10.1016/j.paid.2006.06.002; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lievesley K, 2014, CLIN PSYCHOL REV, V34, P233, DOI 10.1016/j.cpr.2014.02.002; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M., 2008, MILD TRAUMATIC BRAIN; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nebes RD, 2009, J GERONTOL B-PSYCHOL, V64, P180, DOI 10.1093/geronb/gbn037; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reuber M, 2007, PSYCHOSOMATICS, V48, P230, DOI 10.1176/appi.psy.48.3.230; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Rickards TA, 2018, APPL NEUROPSYCH-ADUL, V25, P219, DOI 10.1080/23279095.2017.1278602; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roth R. S., 2013, J PALLIATIVE CARE ME, V1, P2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruocco AC, 2007, BRAIN INJURY, V21, P1233, DOI 10.1080/02699050701716919; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Silver JM., 2013, MANAGEMENT ADULTS TR, P475; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; SULZBERGER MB, 1948, MED CLIN N AM, P669; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Tanielian T., 2008, INVISIBLE WOUNDS MEN; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Toyinbo PA, 2017, AM J EPIDEMIOL, V185, P135, DOI 10.1093/aje/kww074; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Varriano B, 2018, CAN J NEUROL SCI, V45, P636, DOI 10.1017/cjn.2018.322; Verploeg R.D., 2018, TXB CLIN NEUROPSYCHO, V2nd ed., P411; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; [No title captured]	126	6	6	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1748032		APR 2020	11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	LM1PF	WOS:000532024100001	32356498				2022-02-06	
J	Agtarap, S; Kramer, MD; Campbell-Sills, L; Yuh, E; Mukherjee, P; Manley, GT; McCrea, MA; Dikmen, S; Giacino, JT; Stein, MB; Nelson, LD				Agtarap, Stephanie; Kramer, Mark D.; Campbell-Sills, Laura; Yuh, Esther; Mukherjee, Pratik; Manley, Geoffrey T.; McCrea, Michael A.; Dikmen, Sureyya; Giacino, Joseph T.; Stein, Murray B.; Nelson, Lindsay D.		TRACK-TBI Investigators	Invariance of the Bifactor Structure of Mild Traumatic Brain Injury (mTBI) Symptoms on the Rivermead Postconcussion Symptoms Questionnaire Across Time, Demographic Characteristics, and Clinical Groups: A TRACK-TBI Study	ASSESSMENT			English	Article						mild TBI; bifactor; invariance; postconcussive symptoms; Rivermead Postconcussion Symptoms Questionnaire; traumatic brain injury	POST-CONCUSSION SYMPTOMS; COMMON DATA ELEMENTS; OF-FIT INDEXES; HEAD-INJURY; CONSTRUCT-VALIDITY; PREDICTORS; SENSITIVITY; PREVALENCE; CRITERIA; GENDER	This study aimed to elucidate the structure of the Rivermead Postconcussion Symptoms Questionnaire (RPQ) and evaluate its longitudinal and group variance. Factor structures were developed and compared in 1,011 patients with mild traumatic brain injury (mTBI; i.e., Glasgow Coma Scale score 13-15) from the Transforming Research and Clinical Knowledge in TBI study, using RPQ data collected at 2 weeks, and 3, 6, and 12 months postinjury. A bifactor model specifying a general factor and emotional, cognitive, and visual symptom factors best represented the latent structure of the RPQ. The model evinced strict measurement invariance over time and across sex, age, race, psychiatric history, and mTBI severity groups, indicating that differences in symptom endorsement were completely accounted for by these latent dimensions. While highly unidimensional, the RPQ has multidimensional features observable through a bifactor model, which may help differentiate symptom expression patterns in the future.	[Agtarap, Stephanie; Campbell-Sills, Laura; Stein, Murray B.] Naval Med Ctr, Def & Vet Brain Injury Ctr, San Diego, CA USA; [Kramer, Mark D.] Univ Minnesota, Minneapolis, MN USA; [Yuh, Esther; Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Dikmen, Sureyya] Univ Washington, Seattle, WA 98195 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Boston, MA 02114 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Ferguson, Adam/0000-0001-7102-1608; Agtarap, Stephanie/0000-0002-1188-0897; Hemphill, Claude/0000-0003-4019-7525; Badjatia, Neeraj/0000-0003-1509-9034	U.S. National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS1365885]; NeuroTrauma Sciences LLC; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R03NS100691, 1R01NS110856]; U.S. Department of Defense TBI Endpoints Development (TED) Initiative [W81XWH-14-2-0176]; OneMind; NeuroTrauma Sciences LLC.	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The TRACK-TBI study (PI: Manley) was funded by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (Grant #U01 NS1365885), OneMind, and NeuroTrauma Sciences LLC. This secondary data analysis project was supported by National Institutes of Health grants 1R03NS100691 and 1R01NS110856 (PI: Nelson) and the U.S. Department of Defense TBI Endpoints Development (TED) Initiative (Grant #W81XWH-14-2-0176; PI: Manley).	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Liu Y, 2017, PSYCHOL METHODS, V22, P486, DOI 10.1037/met0000075; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nelson LD, 2018, J INT NEUROPSYCH SOC, V24, P793, DOI 10.1017/S1355617718000462; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Reise SP, 2013, J PERS ASSESS, V95, P129, DOI 10.1080/00223891.2012.725437; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Savalei V, 2010, PSYCHOL METHODS, V15, P352, DOI 10.1037/a0020143; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	41	6	6	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	2021	28	6					1656	1670	1073191120913941	10.1177/1073191120913941		APR 2020	15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UH1XZ	WOS:000533014900001	32326739				2022-02-06	
J	Tate, RL; Wakim, D; Sigmundsdottir, L; Longley, W				Tate, Robyn L.; Wakim, Donna; Sigmundsdottir, Linda; Longley, Wendy			Evaluating an intervention to increase meaningful activity after severe traumatic brain injury: A single-case experimental design with direct inter-subject and systematic replications	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Apathy; Goal-setting; Meaningful occupation; Leisure; Single-case experimental design; Systematic replication	LEISURE ACTIVITIES; SELF-REGULATION; PARTICIPATION; SCALE; REHABILITATION; OUTCOMES; PEOPLE; AUTOCORRELATION; RECOMMENDATIONS; MANAGEMENT	Severe traumatic brain injury (sTBI) often results in significant morbidity, with fewer than 50% returning to work and only a minority resuming leisure and social activity. Yet few effective interventions are available for non-vocational activity. The aim of the study was to develop a new goal-directed intervention, the Programme for Engagement, Participation and Activities (PEPA), and evaluate its effect. The research design was a multiple-baseline design across behaviours, with direct inter-subject and systematic replications. Seven participants with sTBI, neurobehavioural impairment including apathy, inability to work, and limited leisure/social activities were categorised into two groups. Group 1 (n = 4) had cognitive impairments but were functionally independent. Systematic replication was conducted in a further three participants (group 2) with major neurobehavioural impairments and functional disability. Generalisation measures evaluated other life domains in group 1 participants (e.g., mood, community participation). Results of the weighted average Tau-U across the tiers was significant for six out of seven participants, with large effect sizes (>=.64) for five participants. Generalisation effects extended to other domains of life. The PEPA thus shows promise as an effective intervention to increase non-vocational activity and improve mental health outcomes in people with neurobehavioural disability after sTBI. These results add to the evidence for the effectiveness of goal-directed interventions.	[Tate, Robyn L.; Wakim, Donna; Sigmundsdottir, Linda; Longley, Wendy] Univ Sydney, Sydney Med Sch Northern, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Sigmundsdottir, Linda] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Sydney Med Sch Northern, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia.	rtate@med.usyd.edu.au	Longley, Wendy/AAN-6654-2021	Longley, Wendy/0000-0002-3434-8334	Lifetime Care and Support Authority, NSW, Australia; NHMRC Centre for Research Excellence in Psychosocial Recovery after TBINational Health and Medical Research Council of Australia	The study was funded by Lifetime Care and Support Authority, NSW, Australia and the NHMRC Centre for Research Excellence in Psychosocial Recovery after TBI.	Adiguzel, 2016, SINGLE CASE RES WEB; Agency for Clinical Innovation, 2013, GOAL TRAIN PART WORK; Agency for Clinical Innovation, 2013, INV VOC PROGR OUTC P; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Coopersmith S., 1981, SEI SELF ESTEEM INVE; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; DAVIS PK, 1994, J APPL BEHAV ANAL, V27, P553, DOI 10.1901/jaba.1994.27-553; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dorstyn D, 2014, TOP STROKE REHABIL, V21, P40, DOI 10.1310/tsr2101-40; Drummond A, 2001, CLIN REHABIL, V15, P647, DOI 10.1191/0269215501cr438oa; Evans JJ, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P49; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gast D. L., 2014, SINGLE CASE RES METH, P176, DOI DOI 10.4324/9780203521892-9; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Grace J, 2001, FRSBE FRONTAL SYSTEM; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; HOLLENBECK JR, 1989, J APPL PSYCHOL, V74, P18, DOI 10.1037/0021-9010.74.1.18; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; HUITEMA BE, 1991, PSYCHOL BULL, V110, P291, DOI 10.1037/0033-2909.110.2.291; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kazdin AE., 2011, SINGLE CASE RES DESI; Kiresuk TJ, 2014, GOAL ATTAINMENT SCAL; Krasny-Pacini A, 2016, ARCH PHYS MED REHAB, V97, P157, DOI 10.1016/j.apmr.2015.08.424; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Law M., 2014, CANADIAN OCCUPATIONA, V5th; Ledford JR, 2018, BRAIN IMPAIR, V19, P4, DOI 10.1017/BrImp.2017.16; Lee JB, 2018, AM J SPEECH-LANG PAT, V27, P495, DOI 10.1044/2017_AJSLP-16-0197; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Manolov R, 2017, BEHAV THER, V48, P97, DOI 10.1016/j.beth.2016.04.008; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Onghena P, 2018, BRAIN IMPAIR, V19, P33, DOI 10.1017/BrImp.2017.25; Ownsworth T., 2014, UNDERSTANDING TRAUMA, P235; Ownsworth T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P313; Parker RI, 2011, BEHAV MODIF, V35, P303, DOI 10.1177/0145445511399147; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell JM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020909; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Solanas A, 2010, PSICOLOGICA, V31, P357; Solhberg M. M., 2001, COGNITIVE REHABILITA; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate R. L., SINGLE CASE EXPT DES; Tate R. L., 2015, EXPANDED MANUAL CRIT; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tate RL, 2016, PHYS THER, V96, P932, DOI 10.1037/arc0000026.supp; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; Vannest KJ, 2015, J COUNS DEV, V93, P403, DOI 10.1002/jcad.12038; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wheeler S, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.713005; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization WHO, 2000, DIS ASS SCHED WHODAS; Zimmerman GL, 2000, AM FAM PHYSICIAN, V61, P1409	68	6	6	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 20	2020	30	4					641	672		10.1080/09602011.2018.1488746			32	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KY5YS	WOS:000522649700004	29985108				2022-02-06	
J	Ahmed, ME; Selvakumar, GP; Kempuraj, D; Raikwar, SP; Thangavel, R; Bazley, K; Wu, KT; Khan, O; Kukulka, K; Bussinger, B; Dubova, I; Zaheer, S; Govindarajan, R; Iyer, S; Burton, C; James, D; Zaheer, A				Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Kukulka, Klaudia; Bussinger, Bret; Dubova, Iuliia; Zaheer, Smita; Govindarajan, Raghav; Iyer, Shankar; Burton, Casey; James, Donald; Zaheer, Asgar			Neuroinflammation Mediated by Glia Maturation Factor Exacerbates Neuronal Injury in an in vitro Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ezrin; radixin; moesin proteins; glia maturation factor; neurodegeneration; neuroinflammation; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; KAPPA-B ACTIVITY; OXIDATIVE STRESS; EXPRESSION; PROTEINS; MICE; DEFICIENT; CORTEX; EZRIN	Traumatic brain injury (TBI) is the primary cause of death and disability affecting over 10 million people in the industrialized world. TBI causes a wide spectrum of secondary molecular and cellular complications in the brain. However, the pathological events are still not yet fully understood. Previously, we have shown that the glia maturation factor (GMF) is a mediator of neuroinflammation in neurodegenerative diseases. To identify the potential molecular pathways accompanying TBI, we used an in vitro cell culture model of TBI. A standardized injury was induced by scalpel cut through a mixed primary cell culture of astrocytes, microglia and neurons obtained from both wild type (WT) and GMF-deficient (GMF-KO) mice. Cell culture medium and whole-cell lysates were collected at 24, 48, and 72 h after the scalpel cuts injury and probed for oxidative stress using immunofluorescence analysis. Results showed that oxidative stress markers such as glutathione and glutathione peroxidase were significantly reduced, while release of cytosolic enzyme lactate dehydrogenase along with nitric oxide and prostaglandin E2 were significantly increased in injured WT cells compared with injured GMF-KO cells. In addition, injured WT cells showed increased levels of oxidation product 4-hydroxynonenal and 8-oxo-2 '-deoxyguanosine compared with injured GMF-KO cells. Further, we found that injured WT cells showed a significantly increased expression of glial fibrillary acidic protein, ionized calcium binding adaptor molecule 1, and phosphorylated ezrin/radixin/moesin proteins, and reduced microtubule associated protein expression compared with injured GMF-KO cells after injury. Collectively, our results demonstrate that GMF exacerbates the oxidative stress-mediated neuroinflammation that could be brought about by TBI-induced astroglial activation.	[Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Kukulka, Klaudia; Bussinger, Bret; Dubova, Iuliia; Zaheer, Smita; Govindarajan, Raghav; Iyer, Shankar; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO USA; [Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Bazley, Kieran; Wu, Kristopher; Khan, Osaid; Kukulka, Klaudia; Bussinger, Bret; Dubova, Iuliia; Zaheer, Smita; Govindarajan, Raghav; Iyer, Shankar; Zaheer, Asgar] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Kempuraj, Duraisamy; Raikwar, Sudhanshu P.; Thangavel, Ramasamy; Dubova, Iuliia; Iyer, Shankar; Zaheer, Asgar] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO USA		Zaheer, A (corresponding author), Univ Missouri, Sch Med, Ctr Translat Neurosci, Dept Neurol, Med Sci Bldg,M741A,1 Hosp Dr, Columbia, MO 65212 USA.	zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021; Ahmed, Mohammad Ejaz/AAU-5742-2020	Raikwar, Sudhanshu/0000-0001-8549-8570	Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048205]; VA Research Career Scientist Award	Research was sponsored by the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory and was accomplished under Cooperative Agreement NumberW911NF-14-2-0034.; This research also was supported by NIH grant AG048205 and VA Research Career Scientist Award to Asgar Zaheer.	Ahmed ME, 2019, MOL NEUROBIOL, V56, P6964, DOI 10.1007/s12035-019-1544-z; Ahmed ME, 2017, J ALZHEIMERS DIS, V60, P1143, DOI 10.3233/JAD-170634; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bonavolonta P, 2017, J CRANIO MAXILL SURG, V45, P1319, DOI 10.1016/j.jcms.2017.05.011; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; KAPLAN R, 1991, J NEUROCHEM, V57, P483, DOI 10.1111/j.1471-4159.1991.tb03777.x; Knoferl MW, 2001, SHOCK, V16, P479, DOI 10.1097/00024382-200116060-00013; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; LIM R, 1990, P NATL ACAD SCI USA, V87, P5233, DOI 10.1073/pnas.87.14.5233; Lim R, 2004, BRAIN RES, V1024, P225, DOI 10.1016/j.brainres.2004.08.003; Lindberg OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046380; Loov C, 2015, J NEUROTRAUM, V32, P244, DOI 10.1089/neu.2014.3517; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Maple-Grodem J, 2018, NEUROSCI LETT, V674, P123, DOI 10.1016/j.neulet.2018.03.036; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Park CO, 2001, YONSEI MED J, V42, P518, DOI 10.3349/ymj.2001.42.5.518; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Puttmann B, 2005, NEUROSIGNALS, V14, P85, DOI 10.1159/000086290; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Selvakumar GP, 2019, MOL NEUROBIOL, V56, P3865, DOI 10.1007/s12035-018-1340-1; Selvakumar GP, 2018, MOL NEUROBIOL, V55, P7132, DOI 10.1007/s12035-018-0882-6; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x; Zaheer A, 2001, NEUROCHEM RES, V26, P1293, DOI 10.1023/A:1014241300179; Zaheer A, 2007, BRAIN RES, V1144, P239, DOI 10.1016/j.brainres.2007.01.075; Zaheer A, 2006, NEUROCHEM RES, V31, P579, DOI 10.1007/s11064-006-9049-3; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	43	6	6	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1645	1655		10.1089/neu.2019.6932		APR 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000527380300001	32200671	Green Published			2022-02-06	
J	Zhang, Z; Ishrat, S; O'Bryan, M; Klein, B; Saraswati, M; Robertson, C; Kannan, S				Zhang, Zhi; Ishrat, Samiha; O'Bryan, Megan; Klein, Brandon; Saraswati, Manda; Robertson, Courtney; Kannan, Sujatha			Pediatric Traumatic Brain Injury Causes Long-Term Deficits in Adult Hippocampal Neurogenesis and Cognition	JOURNAL OF NEUROTRAUMA			English	Article						adult neurogenesis; cognition; inflammation; microglia; pediatric TBI	NEURAL STEM-CELLS; ENVIRONMENTAL ENRICHMENT; MICROGLIAL ACTIVATION; VENTRAL HIPPOCAMPUS; CRITICAL PERIOD; DENTATE GYRUS; INFLAMMATION; PROLIFERATION; RECOVERY; OUTCOMES	Young children who have sustained severe traumatic brain injury (TBI) can suffer from debilitating neurocognitive deficits. Impairment of adult hippocampal neurogenesis is associated with cognitive deficits and depression. Very few studies have investigated the adult hippocampal neurogenesis after pediatric TBI. Here, we evaluated long-term cognition, adult hippocampal neurogenesis, and microglial activation in a rabbit pediatric TBI model. On Post-natal Day 5-7 (P5-7), New Zealand white rabbits from the same litter were randomized into naive, sham (craniotomy alone), and TBI (controlled cortical impact). Bromodeoxyuridine (BrdU, 50 mg/kg, intraperitoneally) was administered at 1-month post-injury, once/daily for 5 consecutive days. Novel object recognition and spontaneous alternation in T-maze tests were performed at 2 months post-injury to measure the cognitive functions. The animals were euthanized after behavioral tests at 3 months of age to evaluate adult hippocampal neurogenesis and microglial activation. We found that: 1) pediatric TBI caused significant deficits in hippocampal dependent cognitive functions; 2) the survival rates of adult-born neurons at both ipsilateral and contralateral hippocampus significantly decreased in the TBI group; 3) TBI induced ectopic migration of adult-born neurons at the dorsal dentate gyrus in both ipsilateral and contralateral hippocampus; 4) TBI increased astrogenesis in the hilus of the dentate gyrus; and 5) TBI results in abnormal microglial activation. In conclusion, pediatric TBI causes prolonged neuroinflammation and dysregulation of the adult hippocampal neurogenesis through young adulthood, which might be responsible for the cognitive deficits. Protection of adult hippocampal neurogenesis may potentially improve outcomes.	[Zhang, Zhi; Ishrat, Samiha; O'Bryan, Megan; Klein, Brandon] Univ Michigan, Dept Nat Sci, 209 SFC,4901 Evergreen Rd, Dearborn, MI 48128 USA; [Saraswati, Manda; Robertson, Courtney; Kannan, Sujatha] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA		Zhang, Z (corresponding author), Univ Michigan, Dept Nat Sci, 209 SFC,4901 Evergreen Rd, Dearborn, MI 48128 USA.	zhizhan@umich.edu		Zhang, Zhi/0000-0001-6256-9516	Department of Natural Sciences, University of Michigan-Dearborn; "Stimulating and Advancing ACCM Research (StAAR Awards)'' from the Department of ACCM, Johns Hopkins School of Medicine	This project is supported in part by the Startup grant for Zhi Zhang from the Department of Natural Sciences, University of Michigan-Dearborn, and was previously supported in part by the "Stimulating and Advancing ACCM Research (StAAR Awards)'' grant for Zhi Zhang from the Department of ACCM, Johns Hopkins School of Medicine.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alvarez DD, 2016, SCIENCE, V354, P459, DOI 10.1126/science.aaf2156; Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bergami M, 2015, NEURON, V85, P710, DOI 10.1016/j.neuron.2015.01.001; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Ciurea A V, 2011, J Med Life, V4, P234; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; de Miranda AS, 2017, J NEUROL SCI, V372, P482, DOI 10.1016/j.jns.2016.10.052; Downes N, 2014, TOXICOL PATHOL, V42, P913, DOI 10.1177/0192623313503518; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Egeland M, 2015, NAT REV NEUROSCI, V16, P189, DOI 10.1038/nrn3855; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Huckleberry KA, 2018, NEUROPSYCHOPHARMACOL, V43, P2487, DOI 10.1038/s41386-018-0109-6; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kuhn HG, 2018, J NEUROSCI, V38, P10401, DOI 10.1523/JNEUROSCI.2144-18.2018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lowe A, 2015, NEUROSCI LETT, V593, P107, DOI 10.1016/j.neulet.2015.03.017; Matsuda T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7514; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morgan SC, 2004, J NEUROCHEM, V90, P89, DOI 10.1111/j.1471-4159.2004.02461.x; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Selvaraj P, 2019, J NEUROTRAUM, V36, P1655, DOI 10.1089/neu.2018.6226; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Tanti A, 2013, HIPPOCAMPUS, V23, P797, DOI 10.1002/hipo.22134; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toda T, 2019, MOL PSYCHIATR, V24, P67, DOI 10.1038/s41380-018-0036-2; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vay SU, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1261-y; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wadhwa M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0998-z; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wes PD, 2016, GLIA, V64, P197, DOI 10.1002/glia.22866; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang Z, 2019, J NEUROTRAUM, V36, P74, DOI 10.1089/neu.2017.5450; Zhang Z, 2016, NEUROBIOL DIS, V94, P116, DOI 10.1016/j.nbd.2016.06.010; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701; Zheng J, 2017, J NEUROSCI, V37, P4145, DOI 10.1523/JNEUROSCI.3333-16.2017; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006	92	6	7	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1656	1667		10.1089/neu.2019.6894		APR 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000526659700001	32079496				2022-02-06	
J	Timmer, ML; Jacobs, B; Schonherr, MC; Spikman, JM; van der Naalt, J				Timmer, Marlies L.; Jacobs, Bram; Schonherr, Marleen C.; Spikman, Jacoba M.; van der Naalt, Joukje			The Spectrum of Long-Term Behavioral Disturbances and Provided Care After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						behavioral disturbances; traumatic brain injury; outcome; return to work; discharge destinations; caregivers	MODERATE HEAD-INJURY; SELF-AWARENESS; EPIDEMIOLOGY; MILD; GUIDELINES; COMPLAINTS; DISORDERS; SEVERITY; PATHWAYS; IMPACT	Introduction: Behavioral disturbances are found in 50-60% of traumatic brain injury (TBI) survivors with an enormous impact on daily functioning and level of recovery. However, whether typical profiles can be distinguished and how these relate to provided care is unclear. The purpose of this study is to specify the characteristics of behavioral disturbances in patients with various severity of TBI and the impact on functional outcome. Furthermore, the pathways of care after hospital discharge for patients and their care givers are analyzed. Methods: We performed a retrospective cohort study comprising 226 patients with mild TBI (mTBI; n = 107) and moderate-to-severe TBI (mod/sevTBI; n = 119) treated at the outpatient clinic and/or rehabilitation center of our university hospital between 2010 and 2015. Inclusion criteria were: behavioral disturbances as determined with the Differential Outcome Scale and age >= 16 years. Functional outcome was determined by the Glasgow Outcome Scale Extended and return to work (RTW) at six months to one year post-injury. Behavioral impairments and pathway of care were derived from medical files and scored according to predefined criteria. Results: Overall 24% of patients showed serious behavioral disturbances; three times higher in mod/sevTBI (35%) compared to mTBI (13%). mTBI patients mostly showed irritation (82%) and anger (49%), while mod/sevTBI patients mostly showed irritation (65%) and disinhibition (55%). Most (92%) patients returned home, half of the patients did not RTW. Deficits in judgment and decision-making increased risk of no RTW 10-fold. One in ten patients was (temporarily) admitted to a nursing home or psychiatric institution. 13% Of caregivers received support for dealing with impairments of patients and 13% of the mTBI and 17% of the mod/sevTBI patients experienced relational problems. Conclusions: The spectrum of behavioral disturbances differs between TBI severity categories and serious behavioral disturbances are present in a quarter of patients. Only half of the patients resumed work regardless of severity of injury suggesting that particularly the presence and not the severity of long-term behavioral disturbances interferes with RTW. Most patients returned home despite these behavioral disturbances. These findings underline the importance of early identification and appropriate treatment of behavioral disturbances in TBI patients.	[Timmer, Marlies L.; Jacobs, Bram; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Schonherr, Marleen C.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763			Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Cristofori I, 2016, J NEUROSCI, V36, P2757, DOI 10.1523/JNEUROSCI.2975-15.2016; de Guise E, 2017, BRAIN INJURY, V31, P1061, DOI 10.1080/02699052.2017.1297485; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Diaz AP, 2014, CNS NEUROSCI THER, V20, P479, DOI 10.1111/cns.12256; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P68, DOI 10.1016/j.rehab.2015.10.007; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; Yang CC, 2013, BRAIN INJURY, V27, P1008, DOI 10.3109/02699052.2013.794975	37	6	6	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 7	2020	11								246	10.3389/fneur.2020.00246			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LH5WU	WOS:000528856100001	32318019	Green Published, gold			2022-02-06	
J	Boutte, AM; Hook, V; Thangavelu, B; Sarkis, GA; Abbatiello, BN; Hook, G; Jacobsen, JS; Robertson, CS; Gilsdorf, J; Yang, ZH; Wang, KKW; Shear, DA				Boutte, Angela M.; Hook, Vivian; Thangavelu, Bharani; Sarkis, George Anis; Abbatiello, Brittany N.; Hook, Gregory; Jacobsen, J. Steven; Robertson, Claudia S.; Gilsdorf, Janice; Yang, Zhihui; Wang, Kevin K. W.; Shear, Deborah A.			Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; cathepsin B; clinical TBI; cysteine protease; head trauma; penetrating ballistic-like brain injury; translational rodent models; traumatic brain injury	CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; COGNITIVE DEFICITS; NEURONAL LOSS; RISK-FACTOR; CYSTATIN-C; CELL-DEATH; MODEL; RAT	Cathepsin B (CatB), a lysosomal cysteine protease, is important to brain function and may have dual utility as a peripheral biomarker of moderate-severe traumatic brain injury (TBI). The present study determined levels of pro- and mature (mat) CatB protein as well as cysteine protease activity within the frontal cortex (FC; proximal injury site), hippocampus (HC; distal injury site), and cerebral spinal fluid (CSF) collected 1-7 days after craniotomy and penetrating ballistic-like brain injury (PBBI) in rats. Values were compared with naive controls. Further, the utility of CatB protein as a translational biomarker was determined in CSF derived from patients with severe TBI. Craniotomy increased matCatB levels in the FC and HC, and led to elevation of HC activity at day 7. PBBI caused an even greater elevation in matCatB within the FC and HC within 3-7 days. After PBBI, cysteine protease activity peaked at 3 days in the FC and was elevated at 1 day and 7 days, but not 3 days, in the HC. In rat CSF, proCatB, matCatB, and cysteine protease activity peaked at 3 days after craniotomy and PBBI. Addition of CA-074, a CatB-specific inhibitor, confirmed that protease activity was due to active matCatB in rat brain tissues and CSF at all time-points. In patients, CatB protein was detectable from 6 h through 10 days after TBI. Notably, CatB levels were significantly higher in CSF collected within 3 days after TBI compared with non-TBI controls. Collectively, this work indicates that CatB and its cysteine protease activity may serve as collective molecular signatures of TBI progression that differentially vary within both proximal and distal brain regions. CatB and its protease activity may have utility as a surrogate, translational biomarker of acute-subacute TBI.	[Boutte, Angela M.; Thangavelu, Bharani; Abbatiello, Brittany N.; Gilsdorf, Janice; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Hook, Vivian] Univ Calif San Diego, Dept Neurosci, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Sarkis, George Anis; Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Neuroprote & Biomarkers Res, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL USA; [Hook, Gregory; Jacobsen, J. Steven] Amer Life Sci Pharmaceut Inc, La Jolla, CA USA; [Robertson, Claudia S.] Ben Taub Gen Hosp, Ctr Neurosurg Intens Care, Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Sarkis, George Anis] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA		Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R41NS110147]	A.M. Boutte, B. Thangavelu, B.N. Abbatiello, J. Gilsdorf, and D.A. Shear were supported by the Combat Casualty Care Research Program. C.S. Robertson, Z. Yang, and K.K.W. Wang were supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (award #R01NS052831). V. Hook, G. Hook, and S. Jacobsen were supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (award #R41NS110147). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Anagli J, 2008, BIOCHEM BIOPH RES CO, V366, P86, DOI 10.1016/j.bbrc.2007.11.104; ASSFALGMACHLEIDT I, 1990, BIOL CHEM H-S, V371, P211; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Berry JN, 2012, NEUROSCIENCE, V222, P147, DOI 10.1016/j.neuroscience.2012.07.033; Boutte A, 2016, J NEUROTRAUM, V33, pA83; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Boutte AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022446; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Chan L, 2019, J NEUROTRAUM, V36, pA24; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Chung C, 2016, HUM MOL GENET, V25, P1434, DOI 10.1093/hmg/ddw025; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; DeDominicis K, 2017, J NEUROTRAUM, V34, pA19; Ding QX, 2018, NEUROSCI LETT, V678, P131, DOI 10.1016/j.neulet.2018.05.022; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gan L, 2004, J BIOL CHEM, V279, P23845; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Hsu A, 2018, J MOL NEUROSCI, V65, P420, DOI 10.1007/s12031-018-1110-6; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Madathil SK, 2015, J NEUROTRAUM, V32, pA96; Milton J, 2017, CUREUS, V9, DOI 10.7759/cureus.1342; Minokadeh A, 2010, MOL CELL NEUROSCI, V43, P98, DOI 10.1016/j.mcn.2009.10.001; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mountney A, 2016, J NEUROTRAUM, V33, P1492, DOI 10.1089/neu.2015.4139; Nagai A, 2000, NEUROLOGY, V55, P1828, DOI 10.1212/WNL.55.12.1828; Nakanishi H, 2003, AGEING RES REV, V2, P367, DOI 10.1016/S1568-1637(03)00027-8; Onatsu J, 2019, J STROKE CEREBROVASC, V28, P2242, DOI 10.1016/j.jstrokecerebrovasdis.2019.05.008; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; RYAN RE, 1995, J NEUROCHEM, V65, P1035; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Seyfried D, 1997, J NEUROSURG, V87, P716, DOI 10.3171/jns.1997.87.5.0716; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stoka V, 2016, AGEING RES REV, V32, P22, DOI 10.1016/j.arr.2016.04.010; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sundelof J, 2010, J ALZHEIMERS DIS, V22, P1223, DOI 10.3233/JAD-2010-101023; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; van Etten ES, 2017, NEUROLOGY, V88, P169, DOI 10.1212/WNL.0000000000003486; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xu M, 2014, GLIA, V62, P855, DOI 10.1002/glia.22645; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125	67	6	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1574	1586		10.1089/neu.2019.6537		APR 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000523350900001	31973644	Green Published			2022-02-06	
J	Brenner, EK; Grossner, EC; Johnson, BN; Bernier, RA; Soto, J; Hillary, FG				Brenner, Einat K.; Grossner, Emily C.; Johnson, Benjamin N.; Bernier, Rachel A.; Soto, Jose; Hillary, Frank G.			Race and ethnicity considerations in traumatic brain injury research: Incidence, reporting, and outcome	BRAIN INJURY			English	Article						Race; ethnicity; brain injury; TBI; outcome	UNITED-STATES; COUNSELING PSYCHOLOGY; RACIAL DISPARITIES; HEALTH; REHABILITATION; CARE; MODERATE; EPIDEMIOLOGY; TBI; ACCULTURATION	Primary Objective: This study has three goals: to determine whether there is a higher rate of traumatic brain injury (TBI) for people of color (POC), whether TBI studies report racial/ethnic demographics, and whether there is a discrepancy in discharge destinations between Whites and POC. We examined whether 1) a higher percentage of POC would sustain head injuries than expected, 2) the majority of TBI studies examined (>50%) would not include racial/ethnic demographics, and 3) Whites would be discharged to further treatment over POC. Research Design: Retrospective study and literature review. Methods and Procedures: Data from the Pennsylvania Trauma System Foundation was used to determine the number of POC with TBI using X-2 analysis, as well as where patients with TBI were being discharged using a configural frequency analysis. PubMed was used for the literature search to examine the frequency of reporting race/ethnicity in TBI literature. Main Outcomes and Results: Results demonstrated that Blacks sustain more TBIs than would be expected (p < .05), the majority of scientific studies (78%) do not report racial/ethnic demographic information, and Whites are discharged to further care more often than POC. Conclusions: These findings highlight differences in incidence and treatment of TBI between White individuals and POC, raising important considerations for providers and researchers.	[Brenner, Einat K.; Grossner, Emily C.; Johnson, Benjamin N.; Bernier, Rachel A.; Soto, Jose; Hillary, Frank G.] Penn State Univ, Dept Psychol, State Coll, PA USA		Hillary, FG (corresponding author), Penn State Univ, 140 Moore Bldg, University Pk, PA 16801 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186	Pennsylvania Trauma Systems Foundation	Pennsylvania Trauma Systems Foundation.	Alban RF, 2010, AM SURGEON, V76, P1108; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2007, J HEAD TRAUMA REHAB, V22, P73, DOI 10.1097/01.HTR.0000265094.98940.e0; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arvinen-Barrow M, 2013, PSYCHOL SPORT INJURY, P117; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Baldwin G, 2016, NEUROREHABILITATION, V39, P345, DOI 10.3233/NRE-161366; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benkert R, 2009, J NURS SCHOLARSHIP, V41, P211, DOI 10.1111/j.1547-5069.2009.01273.x; Bernier RA, 2016, BRAIN INJURY, V30, P414, DOI 10.3109/02699052.2015.1127998; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Cassidy LD, 2003, J PEDIATR SURG, V38, P482, DOI 10.1053/jpsu.2003.50084; Cooper RS, 2018, JAMA-J AM MED ASSOC, V320, P1531, DOI 10.1001/jama.2018.10960; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Delgado-Romero EA, 2005, COUNS PSYCHOL, V33, P419, DOI 10.1177/0011000004268637; Duany J, 2005, NEITHER ENEMIES NOR FRIENDS: LATINOS, BLACKS, AFRO-LATINOS, P173; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Farmer MM, 2005, SOC SCI MED, V60, P191, DOI 10.1016/j.socscimed.2004.04.026; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Golash-Boza T, 2008, ETHNIC RACIAL STUD, V31, P899, DOI 10.1080/01419870701568858; GRAHAM S, 1992, AM PSYCHOL, V47, P629, DOI 10.1037/0003-066X.47.5.629; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Koshy Susan, 1998, DIASPORA, V7, P285, DOI DOI 10.1353/DSP.1998.0013; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lopez IH, 2005, DAEDALUS-US, V134, P42, DOI 10.1162/0011526053124479; Lott JT, 1998, ASIAN AM RACIAL CATE, V2; Lu FJH, 2013, J ATHL TRAINING, V48, P92, DOI 10.4085/1062-6050-48.1.03; Lum TY, 2010, J IMMIGR MINOR HEALT, V12, P743, DOI 10.1007/s10903-008-9225-4; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maina IW, 2018, SOC SCI MED, V199, P219, DOI 10.1016/j.socscimed.2017.05.009; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Nakagawa Kazuma, 2013, Hawaii J Med Public Health, V72, P129; PA Trauma Systems Foundation, 2015, OP MAN DAT BAS COLL; PONTEROTTO JG, 1988, J COUNS PSYCHOL, V35, P410, DOI 10.1037/0022-0167.35.4.410; Putnam M, 2003, J REHABIL, V69, P37; Shommu NS, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0298-8; Sifers SK, 2002, J PEDIATR PSYCHOL, V27, P19, DOI 10.1093/jpepsy/27.1.19; Smedley A, 2005, AM PSYCHOL, V60, P16, DOI 10.1037/0003-066X.60.1.16; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stemmler M., 2014, PERSON CTR METHODS C; Suinn RM, 2010, ASIAN AM J PSYCHOL, V1, P5, DOI 10.1037/a0018798; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; U.S. Census Bureau, 2018, QUICKFACTS PENNS; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	52	6	6	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					801	810		10.1080/02699052.2020.1741033		APR 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000523345200001	32228303				2022-02-06	
J	Gan, DQ; Wu, SL; Chen, B; Zhang, JJ				Gan, Daqing; Wu, Shuilong; Chen, Bing; Zhang, Jingjing			Application of the Zebrafish Traumatic Brain Injury Model in Assessing Cerebral Inflammation	ZEBRAFISH			English	Article						zebrafish; traumatic brain injury; microglia; inflammation; Cytidine 5 '-Diphosphocholine	MACROPHAGE POLARIZATION; CDP-CHOLINE; WILD-TYPE; INCREASE; INTERLEUKIN-1; ACTIVATION; RESPONSES; PROTECTS; MUTANT; ROLES	Traumatic brain injury (TBI) is a major public and socioeconomic problem throughout the world. The establishment of an effective and cost-effective TBI model for developing new therapeutic agents is challenging. Microglia are considered the resident macrophages of the central nervous system (CNS) that normally do not enter the brain. As the primary mediators of the innate immune response in the CNS, microglia play a critical role in neuroinflammation and secondary injury after TBI. In this study, we established an in vivo TBI zebrafish model using Tg(coro1a:EGFP) line where the green fluorescent protein-labeled microglia were present. We demonstrated that microglia accumulated rapidly in response to neuronal injuries. To clear away injured neurons and restore the CNS homeostasis, activated microglia secreted two types of functional cytokines, including pro-inflammatory interleukins (IL) of IL-1 beta and IL-6 and anti-inflammatory factors of IL-4 and IL-10 in the lesioned larvae. Cytidine 5 '-Diphosphocholine (CDP-choline), as an effective and clinical neuroprotective drug, could further activate microglia, expressing high levels of il-1 beta, il-6, il-4, and il-10 in the TBI model. Moreover, CDP-choline reduced neuronal apoptosis and promoted neuronal proliferation around the lesioned site. Based on these results, the TBI model established in this study represents a suitable model for developing new therapeutic agents for CNS-associated diseases.	[Gan, Daqing; Wu, Shuilong; Chen, Bing; Zhang, Jingjing] Guangdong Med Univ, Affiliated Hosp, 57 Renmin Dadao Nan, Xiashan 524001, Zhanjiang, Peoples R China		Zhang, JJ (corresponding author), Guangdong Med Univ, Affiliated Hosp, 57 Renmin Dadao Nan, Xiashan 524001, Zhanjiang, Peoples R China.	jingjing.zhang@live.com					Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Alvarez XA, 1997, METHOD FIND EXP CLIN, V19, P201; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Fadl AA, 2007, MICROB PATHOGENESIS, V42, P193, DOI 10.1016/j.micpath.2007.02.002; Haffter P, 1996, DEVELOPMENT, V123, P1; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hedl M, 2016, CELL REP, V16, P2442, DOI 10.1016/j.celrep.2016.07.060; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Li Q, 2019, BIOSCI BIOTECH BIOCH, V83, P675, DOI 10.1080/09168451.2018.1553608; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Morton CC, 2013, J LIPID RES, V54, P3373, DOI 10.1194/jlr.M041434; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ogryzko NV, 2014, DIS MODEL MECH, V7, P259, DOI 10.1242/dmm.013029; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pousset F, 1999, GLIA, V26, P12, DOI 10.1002/(SICI)1098-1136(199903)26:1<12::AID-GLIA2>3.0.CO;2-S; Rema V, 2008, NEUROSCIENCE, V155, P556, DOI 10.1016/j.neuroscience.2008.04.017; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Stewart AM, 2015, MOL PSYCHIATR, V20, P2, DOI 10.1038/mp.2014.128; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; Stewart AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00014; Teather LA, 2003, PROG NEURO-PSYCHOPH, V27, P711, DOI 10.1016/S0278-5846(03)00086-1; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; Tsukada J, 1996, MOL CELL BIOL, V16, P2183; Unlu S, 2007, MOL IMMUNOL, V44, P3364, DOI 10.1016/j.molimm.2007.02.016; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wu SY, 2017, FRONT BIOSCI-LANDMRK, V22, P1805	44	6	6	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	APR 1	2020	17	2					73	82		10.1089/zeb.2019.1793			10	Developmental Biology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Zoology	KX9KQ	WOS:000522194500001	31825288				2022-02-06	
J	Gao, L; Smielewski, P; Li, P; Czosnyka, M; Ercole, A				Gao, Lei; Smielewski, Peter; Li, Peng; Czosnyka, Marek; Ercole, Ari			Signal Information Prediction of Mortality Identifies Unique Patient Subsets after Severe Traumatic Brain Injury: A Decision-Tree Analysis Approach	JOURNAL OF NEUROTRAUMA			English	Article						complexity; decision tree analysis; signal information; TBI	APPROXIMATE ENTROPY; INTERNATIONAL MISSION; EXTERNAL VALIDATION; TIME-SERIES; COMPLEXITY; PRESSURE; PROGNOSIS; MODELS; CARE; CONNECTIVITY	Nonlinear physiological signal features that reveal information content and causal flow have recently been shown to be predictors of mortality after severe traumatic brain injury (TBI). The extent to which these features interact together, and with traditional measures to describe patients in a clinically meaningful way remains unclear. In this study, we incorporated basic demographics (age and initial Glasgow Coma Scale [GCS]) with linear and non-linear signal information based features (approximate entropy [ApEn], and multivariate conditional Granger causality [GC]) to evaluate their relative contributions to mortality using cardio-cerebral monitoring data from 171 severe TBI patients admitted to a single neurocritical care center over a 10 year period. Beyond linear modelling, we employed a decision tree analysis approach to define a predictive hierarchy of features. We found ApEn (p = 0.009) and GC (p = 0.004) based features to be independent predictors of mortality at a time when mean intracranial pressure (ICP) was not. Our combined model with both signal information-based features performed the strongest (area under curve = 0.86 vs. 0.77 for linear features only). Although low "intracranial" complexity (ApEn-ICP) outranked both age and GCS as crucial drivers of mortality (fivefold increase in mortality where ApEn-ICP <1.56, 36.2% vs. 7.8%), decision tree analysis revealed clear subsets of patient populations using all three predictors. Patients with lower ApEn-ICP who were >60 years of age died, whereas those with higher ApEn-ICP and GCS >= 5 all survived. Yet, even with low initial intracranial complexity, as long as patients maintained robust GC and "extracranial" complexity (ApEn of mean arterial pressure), they all survived. Incorporating traditional linear and novel, non-linear signal information features, particularly in a framework such as decision trees, may provide better insight into "health" status. However, caution is required when interpreting these results in a clinical setting prior to external validation.	[Gao, Lei] Harvard Med Sch, Dept Anesthesiol, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gao, Lei; Li, Peng] Harvard Med Sch, Div Sleep & Circadian Disorders, Brigham & Womens Hosp, Boston, MA 02114 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Neurosci Crit Care Unit, Dept Anesthesia, Hills Rd, Cambridge, England		Gao, L (corresponding author), Harvard Med Sch, Dept Anesthesiol Crit Care & Pain Med, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	lgao@bwh.harvard.edu	Gao, Lei/AAL-1683-2020; Ercole, Ari/B-6288-2009; Li, Peng/I-6362-2012	Gao, Lei/0000-0003-1476-1460; Ercole, Ari/0000-0001-8350-8093; Li, Peng/0000-0002-4684-4909	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007592] Funding Source: Medline		Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Ding M., 2006, HDB TIME SERIES ANAL, V437, P826, DOI DOI 10.1002/9783527609970.CH17; Duggento A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0185; Gao L, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz034; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Kass GV., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Li P, 2019, NEUROBIOL AGING, V83, P21, DOI 10.1016/j.neurobiolaging.2019.08.023; Li P, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0650-5; Li P, 2016, IEEE T BIO-MED ENG, V63, P2231, DOI 10.1109/TBME.2016.2515543; Li P, 2015, MED BIOL ENG COMPUT, V53, P77, DOI 10.1007/s11517-014-1216-0; Li Y, 2019, IEEE ACCESS, V7, P53115, DOI 10.1109/ACCESS.2019.2911555; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mashour GA, 2017, ANESTHESIOLOGY, V126, P366, DOI 10.1097/ALN.0000000000001510; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI [10.4249/scholarpedia.1667, DOI 10.4249/SCHOLARPEDIA.1667]; Seth A., 2009, GRANGER CAUSAL CONNE, P1; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shanahan E, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz103.37; Shi B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50358-y; Soehle M, 2013, J CLIN MONIT COMPUT, V27, P395, DOI 10.1007/s10877-012-9427-0; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; West J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046111	46	6	6	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					1011	1019		10.1089/neu.2019.6631			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000524528800010	31744382	Green Published, Green Submitted			2022-02-06	
J	Isaev, NK; Stelmashook, EV; Genrikhs, EE				Isaev, Nickolay K.; Stelmashook, Elena, V; Genrikhs, Elisaveta E.			Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer's disease	REVIEWS IN THE NEUROSCIENCES			English	Article						Alzheimer's diseases; copper ions; traumatic brain injury; zinc ions	CEREBELLAR GRANULE NEURONS; AMYLOID-BETA; IN-VITRO; SPATIAL MEMORY; ZN2+ TOXICITY; TAU; DEATH; MITOCHONDRIA; DEFICIENCY; PATHOLOGY	The disruption of homeostasis of zinc (Zn2+) and copper (Cu2+) ions in the central nervous system is involved in the pathogenesis of many neurodegenerative diseases, such as amyotrophic lateral sclerosis, Wilson's, Creutzfeldt-Jakob, Parkinson's, and Alzheimer's diseases (AD), and traumatic brain injury (TBI). The last two pathological conditions of the brain are the most common; moreover, it is possible that TBI is a risk factor for the development of AD. Disruptions of Zn2+ and Cu2+ homeostasis play an important role in the mechanisms of pathogenesis of both TBI and AD. This review attempts to summarize and systematize the currently available research data on this issue. The neurocytotoxicity of Cu2+ and Zn2+, the synergism of the toxic effect of calcium and Zn2+ ions on the mitochondria of neurons, and the interaction of Zn2+ and Cu2+ with beta-amyloid (Abeta) and tau protein are considered.	[Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, Biol Fac, NA Belozersky Inst Phys Chem Biol, Moscow 119991, Russia; [Isaev, Nickolay K.; Stelmashook, Elena, V; Genrikhs, Elisaveta E.] Res Ctr Neurol, Moscow 125367, Russia		Isaev, NK (corresponding author), Moscow MV Lomonosov State Univ, Biol Fac, NA Belozersky Inst Phys Chem Biol, Moscow 119991, Russia.; Isaev, NK (corresponding author), Res Ctr Neurol, Moscow 125367, Russia.	isaev@genebee.msu.ru	Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Isaev, Nikolay K/B-4194-2012	Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]	This work was done with the financial support from the Russian Science Foundation project no. 16-15-10108, Funder Id: http://dx.doi.org/10.13039/501100006769.	Ackerman CM, 2018, J BIOL CHEM, V293, P4628, DOI 10.1074/jbc.R117.000176; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Blakemore LJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00297; Brown AM, 2000, J BIOL CHEM, V275, P13441, DOI 10.1074/jbc.275.18.13441; Caporale T, 2009, EXP NEUROL, V218, P228, DOI 10.1016/j.expneurol.2009.04.003; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; Craven KM, 2018, J ALZHEIMERS DIS, V64, P617, DOI 10.3233/JAD-180151; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Del Rio MJ, 2004, ARCH MED RES, V35, P185, DOI 10.1016/j.arcmed.2004.01.001; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Eom JW, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0194-6; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FUJIMOTO Y, 1984, RES COMMUN CHEM PATH, V44, P495; Gandhi J, 2019, REV NEUROSCIENCE, V30, P339, DOI 10.1515/revneuro-2016-0035; Gazaryan IG, 2007, J BIOL CHEM, V282, P24373, DOI 10.1074/jbc.M611376200; Gerber H, 2017, J BIOL CHEM, V292, P3751, DOI 10.1074/jbc.M116.754101; Giacconi R, 2017, EUR J NUTR, V56, P2457, DOI 10.1007/s00394-016-1281-2; GOLDSTEIN IM, 1982, ANN NY ACAD SCI, V389, P368, DOI 10.1111/j.1749-6632.1982.tb22150.x; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hellmich HL, 2008, NEUROSCI LETT, V440, P155, DOI 10.1016/j.neulet.2008.05.068; Hosseini MJ, 2014, CELL BIOCHEM BIOPHYS, V70, P367, DOI 10.1007/s12013-014-9922-7; Hu JY, 2017, BBA-MOL BASIS DIS, V1863, P414, DOI 10.1016/j.bbadis.2016.11.022; Huat TJ, 2019, J MOL BIOL, V431, P1843, DOI 10.1016/j.jmb.2019.01.018; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Isaev NK, 2019, REV NEUROSCIENCE, V30, P573, DOI 10.1515/revneuro-2018-0084; Isaev NK, 2016, REV NEUROSCIENCE, V27, P849, DOI 10.1515/revneuro-2016-0036; Isaev NK, 2016, TOXICOL LETT, V250, P29, DOI 10.1016/j.toxlet.2016.04.002; Isaev NK, 2012, BRAIN RES BULL, V87, P80, DOI 10.1016/j.brainresbull.2011.10.017; Isaev NK, 2010, CELL MOL NEUROBIOL, V30, P877, DOI 10.1007/s10571-010-9516-x; Isaev NK, 2004, NEUROREPORT, V15, P2227, DOI 10.1097/00001756-200410050-00017; Ivanova-Smolenskaya I.A., 2006, NERVES, V4, P13; James SA, 2012, FREE RADICAL BIO MED, V52, P298, DOI 10.1016/j.freeradbiomed.2011.10.446; Jembrek MJ, 2014, BIOMETALS, V27, P1303, DOI 10.1007/s10534-014-9792-x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kapkaeva MR, 2017, EXP TOXICOL PATHOL, V69, P259, DOI 10.1016/j.etp.2017.01.011; Kerbler GM, 2015, NEUROIMAGE-CLIN, V7, P105, DOI 10.1016/j.nicl.2014.11.015; Kiedrowski L, 2012, J NEUROCHEM, V121, P438, DOI 10.1111/j.1471-4159.2012.07695.x; Kim SW, 2016, NEUROPHARMACOLOGY, V105, P411, DOI 10.1016/j.neuropharm.2016.02.001; Lee M.C., 2018, SCI REP, V8; Li DD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00300; Li GZ, 2018, BIOL TRACE ELEM RES, V184, P442, DOI 10.1007/s12011-017-1162-4; Li Y.V., 2016, ER GOLGI APPARATUS, V8, P35; Lin XM, 2016, TOXICOL LETT, V263, P16, DOI 10.1016/j.toxlet.2016.10.009; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Liu Y, 2019, ACCOUNTS CHEM RES, V52, P2026, DOI 10.1021/acs.accounts.9b00248; Lozier ER, 2012, TOXICOL LETT, V208, P36, DOI 10.1016/j.toxlet.2011.10.003; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Mohr I, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.02.48; Myers SA, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/167503; Najem D, 2014, REV NEUROSCIENCE, V25, P509, DOI 10.1515/revneuro-2013-0050; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nations SP, 2008, NEUROLOGY, V71, P639, DOI 10.1212/01.wnl.0000312375.79881.94; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Olesen RH, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.83; OTEIZA PI, 1995, J NUTR, V125, P823; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pointer CB, 2017, CELL MOL NEUROBIOL, V37, P1161, DOI 10.1007/s10571-016-0458-9; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Railey AM, 2011, J ALZHEIMERS DIS, V24, P375, DOI 10.3233/JAD-2011-101452; Railey AM, 2010, PHYSIOL BEHAV, V100, P95, DOI 10.1016/j.physbeh.2010.01.040; Reddy PVB, 2008, LAB INVEST, V88, P816, DOI 10.1038/labinvest.2008.49; Reiss AB, 2018, REV NEUROSCIENCE, V29, P613, DOI 10.1515/revneuro-2017-0063; Saghazadeh A, 2017, REV NEUROSCIENCE, V28, P783, DOI 10.1515/revneuro-2017-0015; Sandusky-Beltran LA, 2017, BEHAV BRAIN RES, V333, P179, DOI 10.1016/j.bbr.2017.07.007; Sanford L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45844-2; SARIS NEL, 1994, FEBS LETT, V356, P195, DOI 10.1016/0014-5793(94)01256-3; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Sensi SL, 2018, TRENDS PHARMACOL SCI, V39, P1049, DOI 10.1016/j.tips.2018.10.001; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Seth R, 2015, J TRACE ELEM MED BIO, V30, P59, DOI 10.1016/j.jtemb.2014.10.010; Sharonova IN, 1998, EUR J NEUROSCI, V10, P522, DOI 10.1046/j.1460-9568.1998.00057.x; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silachev DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051553; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Stelmashook EV, 2019, B EXP BIOL MED+, V167, P455, DOI 10.1007/s10517-019-04548-3; Stelmashook EV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1176, DOI 10.1134/S0006297917100108; Stelmashook EV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P899, DOI 10.1134/S0006297916080113; Stelmashook EV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1065, DOI 10.1134/S000629791508012X; Stelmashook EV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P391, DOI 10.1134/S0006297914050022; Stelmashook E.V., 2019, B EXP BIOL MED; Su XY, 2007, BIOCHEM BIOPH RES CO, V358, P661, DOI 10.1016/j.bbrc.2007.04.191; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Sul JW, 2016, ARCH PHARM RES, V39, P1151, DOI 10.1007/s12272-016-0814-9; Sun KJ, 2013, BRAIN RES, V1506, P132, DOI 10.1016/j.brainres.2013.02.011; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Takeda A, 2017, J NEUROSCI, V37, P7253, DOI 10.1523/JNEUROSCI.0954-17.2017; Tanaka K, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00058; Telianidis J, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00044; Tian K, 2018, J INORG BIOCHEM, V179, P54, DOI 10.1016/j.jinorgbio.2017.11.014; Trombley PQ, 1996, J NEUROPHYSIOL, V76, P2536, DOI 10.1152/jn.1996.76.4.2536; Ventriglia M, 2015, J ALZHEIMERS DIS, V46, P75, DOI 10.3233/JAD-141296; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wang ZX, 2015, J ALZHEIMERS DIS, V47, P565, DOI 10.3233/JAD-143108; Ward RJ, 2012, CURR MED CHEM, V19, P2760; Weiser T, 1996, BRAIN RES, V742, P211, DOI 10.1016/S0006-8993(96)01009-8; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Whitfield DR, 2018, INT J GERIATR PSYCH, V33, P1146, DOI 10.1002/gps.4908; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JS, 2017, METALLOMICS, V9, P1106, DOI 10.1039/c7mt00074j; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Zhao LW, 2018, ANN CLIN LAB SCI, V48, P446; Zhou LX, 2007, PEPTIDES, V28, P2229, DOI 10.1016/j.peptides.2007.08.022; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	120	6	6	4	26	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2020	31	3					233	243		10.1515/revneuro-2019-0052			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC4UT	WOS:000525321900001	31747384				2022-02-06	
J	Koval, RR; Zalesky, CC; Moran, TP; Ratcliff, JJ; Wright, DW				Koval, Rachel R.; Zalesky, C. Christopher; Moran, Tim P.; Ratcliff, Jonathan J.; Wright, David W.			Concussion Care in the Emergency Department: A Prospective Observational Brief Report	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MANAGEMENT	Study objective: Emergency physicians are often the initial-and only-clinical providers for patients who have sustained a mild traumatic brain injury. This prospective observational study seeks to examine the practice patterns of clinicians in an academic Level I trauma center as they relate to the evaluation of patients who were presumed to be at high risk for mild traumatic brain injury. Specifically, we describe the frequency of a documented mild traumatic brain injury evaluation, diagnosis, and discharge education. Methods: This pilot study took place in a single academic Level I trauma and emergency care center during a 4-week period. Patients were identified by triage nurses, who determined whether they responded affirmatively to 2 questions that indicated a potential risk for mild traumatic brain injury. Data were abstracted from emergency department clinician documentation on identified patients to describe the frequency of a documented mild traumatic brain injury evaluation (history and physical examination), diagnosis, and discharge education among those who were identified to be at risk for a mild traumatic brain injury. Results: Ninety-eight subjects were included in the present study. Documentation of a mild traumatic brain injury evaluation was present for less than 50% of patients, a final diagnosis of mild traumatic brain injury was included for 36 (37%; 95% confidence interval 27.8% to 46.7%), and discharge education was provided to 15 (15%; 95% confidence interval 9.2% to 21.4%). Of the 36 patients who received a documented mild traumatic brain injury diagnosis, 15 (41.5%; 95% confidence interval 26.7% to 57.9%) received mild traumatic brain injury-specific discharge education. Conclusion: This study suggests that the majority of patients at high risk for mild traumatic brain injury have no documentation of an evaluation for one. Also, patients with a mild traumatic brain injury diagnosis were unlikely to receive appropriate discharge education about it. Education and standardization are needed to ensure that patients at risk for mild traumatic brain injury receive appropriate evaluation and care.	[Koval, Rachel R.; Moran, Tim P.; Ratcliff, Jonathan J.; Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Zalesky, C. Christopher] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA		Koval, RR (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.	rachel.koval@emory.edu		Moore, Jasmine/0000-0002-5265-9574			Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Defense and Veterans Brain Injury Center, ICD 10 DIAGN COD GUI; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gioia G, ACUTE CONCUSSION EVA; Patrick Sean P, 2017, AEM Educ Train, V1, P346, DOI 10.1002/aet2.10053; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	12	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	APR	2020	75	4					483	490		10.1016/j.annemergmed.2019.08.419			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KW6NN	WOS:000521281600006	31685254				2022-02-06	
J	Pipkorn, B; Iraeus, J; Lindkvist, M; Puthan, P; Bunketorp, O				Pipkorn, Bengt; Iraeus, Johan; Lindkvist, Mats; Puthan, Pradeep; Bunketorp, Olle			Occupant injuries in light passenger vehicles-A NASS study to enable priorities for development of injury prediction capabilities of human body models	ACCIDENT ANALYSIS AND PREVENTION			English	Article						NASS; Body region; AIS2+; Injuries; Frontal; Oblique; Side; Impact		To prioritize how the development of mathematical human body models for injury prediction in crash safety analysis should be made, the most frequent injuries in the NASS CDS data from 2000 to 2015 were analyzed. The crashes were divided into seven types, from front to side. Non-minor injuries (AIS2+) were analyzed in two steps. In the first step, a grouping was made according to the AIS definition of body regions: head, face, neck, thorax, abdomen and pelvic contents, spine, upper extremities (including shoulder girdle) and lower extremities (including pelvis). In a second step, the body regions were divided in organs, parts of the spine, and parts of the extremities. The three most often injured anatomical structures of each body region were estimated for drivers and front seat passengers in each type of crash. For drivers, an injury risk greater than 2.4 % was found for the lower extremities (pelvis) and the head (concussion) in side oblique near side impacts, for the head in frontal oblique near side impacts (concussion) and for the lower extremities (ankle joint) in frontal impacts. For passengers, an injury risk greater than 2.4 % was found for the thorax (lungs) in side near side impacts, for the head (concussion) in front oblique near side impacts, and for the thorax (sternum) and the upper extremities (wrist, hand) in frontal impacts. Future development of human body models should focus on injuries to the head, thorax and the lower extremities. More specifically, it should focus on concussion in all impact directions and on rib and pelvic fractures in side near side impacts and in side oblique near side impacts.	[Pipkorn, Bengt] Autoliv Res, SE-44783 Vargarda, Sweden; [Iraeus, Johan] Chalmers Univ Technol, Stockholm, Sweden; [Lindkvist, Mats] Umea Univ, Umea, Sweden; [Puthan, Pradeep] Autoliv, Mysuru, India; [Bunketorp, Olle] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, Gothenburg, Sweden		Pipkorn, B (corresponding author), Autoliv Res, SE-44783 Vargarda, Sweden.	bengt.pipkorn@autoliv.com	Iraeus, Johan/AAM-9246-2021	Iraeus, Johan/0000-0001-9360-0707; PUTHAN PISHARAM, PRADEEP/0000-0003-4131-7023	SAFER; FFI (Strategic Vehicle Research and Innovation); VINNOVAVinnova; Swedish Transport Administration; Swedish Energy AgencySwedish Energy AgencyMaterials & Energy Research Center (MERC); Chalmers University of Technology; Autoliv Research; Sahlgrenska University Hospital; Volvo Cars	The project was carried out at SAFER -Vehicle and Traffic Safety Centre at Chalmers, Sweden, and financed by the industrial project partners, SAFER and FFI (Strategic Vehicle Research and Innovation), VINNOVA, the Swedish Transport Administration, the Swedish Energy Agency. The project partners are Chalmers University of Technology, Autoliv Research, Sahlgrenska University Hospital and Volvo Cars.	[Anonymous], 1980, J224 SAE; Elemance, 2018, VIRT HUM BOD MOD; Foster J.K., 1977, STAPP CAR CRASH J, V31; Guleyupoglu B, 2018, TRAFFIC INJ PREV, V19, pS37, DOI 10.1080/15389588.2017.1395873; Iraeus J., 2015, ACCIDENT ANAL PREVEN; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klinich K.D., 2016, IRCOBI C P; Kononen DW, 2011, ACCIDENT ANAL PREV, V43, P112, DOI 10.1016/j.aap.2010.07.018; Lowne R., 1987, ELEVENTH INT TECHNIC, P1987; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Neilson L., 1985, 10 INT TECHN C EXP S, P1985; Ostling M., 2018, AIRB 2018 C NOV 26 2; Page M., 2001, 17 ENH SAF VEH C; Parent D., 2013, 23RD ENHANCED SAFETY; Rouhana S.W., 2003, 27 STAPP CAR CRASH C; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Toyota Central R&D Labs. INC, 2018, HUM BOD MOD INJ AN T; van Ratingen M, 2016, CHIN J TRAUMATOL, V19, P63, DOI 10.1016/j.cjtee.2015.11.016; Weaver A., 2013, 57 AAAM ANN C ANN AD; Weaver AA, 2015, TRAFFIC INJ PREV, V16, pS108, DOI 10.1080/15389588.2015.1012664	20	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	APR	2020	138								105443	10.1016/j.aap.2020.105443			17	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	LU1ME	WOS:000537525400004	32059123	Green Published			2022-02-06	
J	Qiu, XC; Ping, SN; Kyle, M; Longo, J; Chin, L; Zhao, LR				Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Longo, John; Chin, Lawrence; Zhao, Li-Ru			S100 Calcium-Binding Protein A9 Knockout Contributes to Neuroprotection and Functional Improvement after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neurogenesis; neuroinflammation; neuroprotection; S100a9; traumatic brain injury	PRO-INFLAMMATORY S100A9; CHRONIC NEURODEGENERATION; DISEASE; NEUROGENESIS; MECHANISMS; EXPRESSION; PLASTICITY; MRP-14; REORGANIZATION; DEGENERATION	S100 calcium-binding protein A9 (S100a9), a proinflammatory protein, has been shown to be involved in the development of neuroinflammatory disorders and neurodegenerative diseases. Upregulation of S100a9 in the brain during acute brain injury has been proposed to be associated with acute neuroinflammation. However, it remains unclear whether eliminating S100a9 expression will show beneficial outcomes after traumatic brain injury (TBI). Using S100a9 knockout mice, this study has demonstrated that S100a9 deletion ameliorates post-TBI anxiety, improves TBI-impaired motor and cognitive function, reduces lesion size, prevents perilesional neuron loss and neurodegeneration, diminishes neuroinflammation and TBI-induced neurogenesis, and enhances perilesional expression of neuroplasticity protein. These findings suggest that S100a9 plays a detrimental role in TBI. Genetic deletion of S100a9 enhances neuroprotection and improves functional outcome after TBI. This study sheds light on the pathological involvement of S100a9 in TBI, which would provide a new therapeutic target to minimize TBI-induced brain damage.	[Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Longo, John; Chin, Lawrence; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, 750 East Adams St, Syracuse, NY 13210 USA; [Zhao, Li-Ru] Syracuse VA Med Ctr, VA Hlth Care Upstate New York, Syracuse, NY USA		Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 East Adams St, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu			RRD VA [I01 RX002125] Funding Source: Medline		Alexaki VI, 2017, THROMB HAEMOSTASIS, V117, P636, DOI 10.1160/TH16-06-0434; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chang K.-A., 2009, ALZHEIMERS DEMENT, V5, P481; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Denstaedt SJ, 2018, J IMMUNOL, V200, P3188, DOI 10.4049/jimmunol.1700834; Ehara A, 2009, ACTA HISTOCHEM CYTOC, V42, P171, DOI 10.1267/ahc.09018; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Gruden MA, 2016, BEHAV BRAIN RES, V306, P106, DOI 10.1016/j.bbr.2016.03.016; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Holahan MR, 2015, RES REP BIOCHEM, V5, P137, DOI 10.2147/RRBC.S73846; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Horvath I, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1210-9; Horvath I, 2016, ACS CHEM NEUROSCI, V7, P34, DOI 10.1021/acschemneuro.5b00265; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kim HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088924; Lassmann H, 1997, J NEURAL TRANSM-SUPP, P183; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shoichet Molly S., 2008, P221; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Spampanato J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041029; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Ulfig N, 1998, CELL TISSUE RES, V291, P433, DOI 10.1007/s004410051013; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Vogl T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5593; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zacks JM, 2016, CORTEX, V74, P233, DOI 10.1016/j.cortex.2015.11.002; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003	72	6	6	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					950	965		10.1089/neu.2018.6170			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000524528800004	31621496				2022-02-06	
J	Rizk, T; Turtzo, LC; Cota, M; Van Der Merwe, AJ; Latour, L; Whiting, MD; Chan, LT				Rizk, Theresa; Turtzo, L. Christine; Cota, Martin; Van Der Merwe, Andre J.; Latour, Lawrence; Whiting, Mark D.; Chan, Leighton			Traumatic microbleeds persist for up to five years following traumatic brain injury despite resolution of other acute findings on MRI	BRAIN INJURY			English	Article						Traumatic brain injury; microbleed; MRI; neuroimaging; biomarker	SUSCEPTIBILITY-WEIGHTED MRI; MILITARY SERVICE MEMBERS; DIFFUSE AXONAL INJURY; CEREBRAL MICROBLEEDS; PREVALENCE; STROKE	Objective: The primary objective of this study was to track the incidence and progression of traumatic microbleeds (TMBs) for up to five years following traumatic brain injury (TBI). Methods: Thirty patients with mild, moderate, or severe TBI received initial MRI within 48 h of injury and continued in a longitudinal study for up to five years. The incidence and progression of MRI findings was assessed across the five year period. In addition to TMBs, we noted the presence of other imaging findings including diffusion weighted imaging (DWI) lesions, extra-axial and intraventricular hemorrhage, hematoma, traumatic meningeal enhancement (TME), fluid-attenuated inversion recovery (FLAIR) hyperintensities, and encephalomalacia. Results: TMBs were observed in 60% of patients at initial presentation. At one-year follow-up, TMBs were more persistent than other neuroimaging findings, with 83% remaining visible on MRI. In patients receiving serial MRI 2-5 years post-injury, acute TMBs were visible on all follow-up scans. In contrast, most other imaging markers of TBI had either resolved or evolved into ambiguous abnormalities on imaging by one year post-injury. Conclusions: These findings suggest that TMBs may serve as a uniquely persistent indicator of TBI and reinforce the importance of acute post-injury imaging for accurate characterization of persistent imaging findings.	[Rizk, Theresa; Chan, Leighton] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Turtzo, L. Christine; Latour, Lawrence] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cota, Martin; Van Der Merwe, Andre J.; Latour, Lawrence; Whiting, Mark D.; Chan, Leighton] Ctr Neurosci & Regenerat Med, Rockville, MD USA		Chan, LT (corresponding author), NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA.	chanle@cc.nih.gov	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263; Rizk, Theresa/0000-0002-0600-8834	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	This work was supported by the Center for Neuroscience and Regenerative Medicine.	Akoudad S, 2015, CIRCULATION, V132, P509, DOI 10.1161/CIRCULATIONAHA.115.016261; Akoudad S, 2013, NEUROLOGY, V81, P1930, DOI 10.1212/01.wnl.0000436609.20587.65; Andreasen SH, 2020, J NEUROTRAUM, V37, P581, DOI 10.1089/neu.2019.6608; Brundel M, 2012, J ALZHEIMERS DIS, V31, P259, DOI 10.3233/JAD-2012-120364; Department of Veterans Affairs/Department of Defense, 2016, VA DOD CLIN PRACT GU; Ding J, 2017, NEUROLOGY, V88, P2089, DOI 10.1212/WNL.0000000000003983; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Lotan E, 2018, AM J NEURORADIOL, V39, P1222, DOI 10.3174/ajnr.A5688; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martinez-Ramirez S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt263; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Toth A, 2019, J NEUROTRAUM, V36, P1670, DOI 10.1089/neu.2018.6004; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	40	6	6	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					775	783		10.1080/02699052.2020.1725835		APR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000523342600001	32228304	Green Accepted			2022-02-06	
J	Shi, QX; Chen, B; Nie, C; Zhao, ZP; Zhang, JH; Si, SY; Cui, SJ; Gu, JW				Shi, Quan-xing; Chen, Bing; Nie, Chuang; Zhao, Zhi-ping; Zhang, Jun-hai; Si, Shao-yan; Cui, Shao-jie; Gu, Jian-wen			A novel model of blast induced traumatic brain injury caused by compressed gas produced sustained cognitive deficits in rats: involvement of phosphorylation of tau at the Thr205 epitope	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Blast; Cognitive function; Tau; Rat	AMYLOID-BETA; ACCUMULATION; INCREASES; PROTEIN; TBI	Improvised explosive devices (IEDs) represent the leading causes for casualties among civilians and soldiers in the present war (including counter-terrorism). Traumatic brain injury (TBI) caused by IEDs results in different degrees of impairment of cognition and behavior, but the exact brain pathophysiological mechanism following exposure to blast has not been clearly investigated. Here, we sought to establish a rat model of closed-head blast injury using compressed gas to deliver a single blast only to the brain without systemic injuries. The cognitive functions of these bTBI models were assessed by Morris Water Maze test (MWM test). The HE staining, flow cytometry, ELISA and Western Blotting were used to measure the effects of shock wave on general histology, regulatory T (Treg) cells percentage, inflammatory reactions, the expression and phosphorylation level of tau, respectively. In addition, the brain water content and 24 -h mortality were also assessed. As the distance from the blast source increased, the input pressure did not change, the overpressure decreased, and the mortality decreased. Receiver operating characteristic (ROC) curves for predicting 24 -h mortality using peak overpressure fits with the following areas under ROC curves: 0.833. In 2 weeks after blast injury, cognitive tests revealed significantly decreased performance at 20 cm distance from the blast (about 136.44 kPa) as demonstrated by increased escape latency in the acquisition phase, and decreased crossing numbers in the probe phase of MWM test. Interestingly, a single blast exposure (at 20 cm) lead to significantly increased tau phosphorylation at the Thr205 epitope but not at the Ser404 and Ser262 epitopes at 12 h, 24 h, 3d, and 7d after blast injury. Blast decreased the percentage of CD4 +T cells, CD8 + T cells, Treg cells and lymphocytes at different time points after blast injury, and blast increased the percentage of neutrophils at 12 h after blast injury and significantly increased IL-6 production at 12 h, 24 h and 3d after blast injury. In addition, blast lead to an increase of brain edema at 24 h and 3d after blast injury. However, no obvious alterations in brain gross pathology were found acutely in the blast-exposed rats. In conclusion, we established a rat model of simple craniocerebral blast injury characterized by impairment of cognitive function, Thr205 phosphorylation of tau, decreased Treg cells and increased inflammatory reactions and brain edema. We expect this model may help clarify the underlying mechanism after blast injury and possibly serve as a useful animal model in the development of novel therapeutic and diagnostic approaches.	[Shi, Quan-xing] Third Mil Med Univ, Dept Grad Sch, Army Mil Med Univ, Chongqing 400038, Peoples R China; [Chen, Bing] Univ Chinese Acad Sci, Savaid Med Coll, Beijing 100101, Peoples R China; [Nie, Chuang] Chinese Peoples Liberat Army, Dept Ophthalmol, Hosp 306, Beijing 100101, Peoples R China; [Zhao, Zhi-ping] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100101, Peoples R China; [Shi, Quan-xing; Zhang, Jun-hai; Cui, Shao-jie; Gu, Jian-wen] Chinese Peoples Liberat Army, Dept Neurosurg, 306th Hosp, Beijing 100101, Peoples R China; [Si, Shao-yan] 306th Hosp, Dept Pathol & Expt Med, Beijing 100101, Peoples R China		Gu, JW (corresponding author), Chinese Peoples Liberat Army, Dept Neurosurg, 306th Hosp, Beijing 100101, Peoples R China.	gujianwen196606@163.com			Logistics Research Projects of the Chinese People's Liberation Army [BWS16J035, BWS12J019]; Research Project of the 306th Hospital of PLA in 2019 [19ZX26]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31770386]	We thank Dr. Ning Jiang and Prof. Li-na Qu for their technical support on Morris water maze experiment. We thank Ying-ying Wu and Ran Duan for their technical support on flow cytometry. The present study was supported by the Logistics Research Projects of the Chinese People's Liberation Army (BWS16J035, BWS12J019), the Research Project of the 306th Hospital of PLA in 2019 (19ZX26) and the National Natural Science Foundation of China (31770386).	Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dong LM, 2019, NUTR NEUROSCI, V22, P235, DOI [10.1080/1028415X.2017.1373928, 10.1080/1028415x.2017.1373928]; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu C, 2018, PHYTOTHER RES, V32, P1056, DOI 10.1002/ptr.6044; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; Ma Y, 2014, NEUROCHEM RES, V39, P1809, DOI 10.1007/s11064-014-1395-y; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Ning YL, 2015, CHIN J TRAUMATOL, V18, P204, DOI 10.1016/j.cjtee.2015.10.003; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Panigrahi B, 2018, PROC IEEE MICR ELECT, P10, DOI 10.1109/MEMSYS.2018.8346468; Popivanov G, 2014, J ROY ARMY MED CORPS, V160, P52, DOI 10.1136/jramc-2013-000132; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Shi QX, 2013, AM J THER, V20, P493, DOI 10.1097/MJT.0b013e3182456676; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang JH, 2018, EXP THER MED, V16, P93, DOI 10.3892/etm.2018.6146; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98; Zhou Y, 2018, CHINESE MED J-PEKING, V131, P2447, DOI 10.4103/0366-6999.243558	47	6	6	3	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR	2020	157						149	161		10.1016/j.brainresbull.2020.02.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT9ML	WOS:000519336000017	32044361				2022-02-06	
J	Vishwanath, M; Jafarlou, S; Shin, I; Lim, MM; Dutt, N; Rahmani, AM; Cao, H				Vishwanath, Manoj; Jafarlou, Salar; Shin, Ikhwan; Lim, Miranda M.; Dutt, Nikil; Rahmani, Amir M.; Cao, Hung			Investigation of Machine Learning Approaches for Traumatic Brain Injury Classification via EEG Assessment in Mice	SENSORS			English	Article						electroencephalogram (EEG); machine learning (ML); traumatic brain Injury (TBI)	MODEL	Due to the difficulties and complications in the quantitative assessment of traumatic brain injury (TBI) and its increasing relevance in today's world, robust detection of TBI has become more significant than ever. In this work, we investigate several machine learning approaches to assess their performance in classifying electroencephalogram (EEG) data of TBI in a mouse model. Algorithms such as decision trees (DT), random forest (RF), neural network (NN), support vector machine (SVM), K-nearest neighbors (KNN) and convolutional neural network (CNN) were analyzed based on their performance to classify mild TBI (mTBI) data from those of the control group in wake stages for different epoch lengths. Average power in different frequency sub-bands and alpha:theta power ratio in EEG were used as input features for machine learning approaches. Results in this mouse model were promising, suggesting similar approaches may be applicable to detect TBI in humans in practical scenarios.	[Vishwanath, Manoj; Shin, Ikhwan; Dutt, Nikil; Cao, Hung] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA 92607 USA; [Jafarlou, Salar] Erik Jonsson Sch Engn & Comp Sci, Dallas, TX 75201 USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Behav Neurosci, Med, Portland, OR 97239 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Dutt, Nikil; Rahmani, Amir M.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92607 USA; [Rahmani, Amir M.] Univ Calif Irvine, Sch Nursing, Irvine, CA 92607 USA; [Cao, Hung] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92607 USA		Cao, H (corresponding author), Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA 92607 USA.; Cao, H (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92607 USA.	manojv@uci.edu; salarjafarlou@gmail.com; ikhwans@uci.edu; lmir@ohsu.edu; dutt@ics.uci.edu; a.rahmani@uci.edu; hungcao@uci.edu		Cao, Hung/0000-0003-4197-7208; rahmani, mohammad/0000-0002-7408-7992	NSF CAREER AwardNational Science Foundation (NSF)NSF - Office of the Director (OD) [1917105]; Henry Samueli School of Engineering at UC Irvine	This work is supported by the NSF CAREER Award #1917105 (H.C.) and the setup fund from the Henry Samueli School of Engineering at UC Irvine (H.C.).	Abe S, 2005, ADV PATTERN RECOGNIT; Acharya UR, 2018, COMPUT BIOL MED, V100, P270, DOI 10.1016/j.compbiomed.2017.09.017; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Jafarlou S, 2019, ARXIV191007047; Jamaludin Z, 2019, INTELLIGENT MANUFACT; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Lawhern VJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8c; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1017/S1472928803000074; Perez L, 2017, EFFECTIVENESS DATA A; Peterson, 2009, SCHOLARPEDIA, V4, DOI DOI 10.4249/SCHOLARPEDIA.1883; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Simonyan K., 2014, ARXIV, DOI DOI 10.1109/CVPR.2015.7298594; Srivastava N, 2014, J MACH LEARN RES, V15, P1929	27	6	6	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	APR	2020	20	7							2027	10.3390/s20072027			10	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	LT5KW	WOS:000537110500223	32260320	Green Published, gold			2022-02-06	
J	Singh, S; Hearps, SJC; Borland, ML; Dalziel, SR; Neutze, J; Donath, S; Cheek, JA; Kochar, A; Gilhotra, Y; Phillips, N; Williams, A; Lyttle, MD; Bressan, S; Hoch, JS; Oakley, E; Holmes, JF; Kuppermann, N; Babl, FE				Singh, Sonia; Hearps, Stephen J. C.; Borland, Meredith L.; Dalziel, Stuart R.; Neutze, Jocelyn; Donath, Susan; Cheek, John A.; Kochar, Amit; Gilhotra, Yuri; Phillips, Natalie; Williams, Amanda; Lyttle, Mark D.; Bressan, Silvia; Hoch, Jeffrey S.; Oakley, Ed; Holmes, James F.; Kuppermann, Nathan; Babl, Franz E.		Paediat Res Emergency Dept	The Effect of Patient Observation on Cranial Computed Tomography Rates in Children With Minor Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							EMERGENCY-DEPARTMENT; RADIATION-EXPOSURE; INJURY; CT	Background Management of children with minor blunt head trauma often includes a period of observation to determine the need for cranial computed tomography (CT). Our objective was to estimate the effect of planned observation on CT use for each Pediatric Emergency Care Applied Research Network (PECARN) traumatic brain injury (TBI) risk group among children with minor head trauma. Methods This was a secondary analysis of a prospective observational study at 10 emergency departments (EDs) in Australia and New Zealand, including 18,471 children < 18 years old, presenting within 24 hours of blunt head trauma, with Glasgow Coma Scale scores of 14 to 15. The planned observation cohort was defined by those with planned observation and no immediate plan for cranial CT. The comparison cohort included the rest of the patients who were either not observed or for whom a decision to obtain a cranial CT was made immediately after ED assessment. The outcome clinically important TBI (ciTBI) was defined as death due to head trauma, neurosurgery, intubation for > 24 hours for head trauma, or hospitalization for >= 2 nights in association with a positive cranial CT scan. We estimated the odds of cranial CT use with planned observation, adjusting for patient characteristics, PECARN TBI risk group, history of seizure, time from injury, and hospital clustering, using a generalized linear model with mixed effects. Results The cranial CT rate in the total cohort was 8.6%, and 0.8% had ciTBI. The planned observation group had 4,945 (27%) children compared to 13,526 (73%) in the no planned observation group. Cranial CT use was significantly lower with planned observation (adjusted odds ratio [OR] = 0.2, 95% confidence interval [CI] = 0.1 to 0.1), with no difference in missed ciTBI rates. There was no difference in the odds of cranial CT use with planned observation for the group at very low risk for ciTBI (adjusted OR = 0.9, 95% CI = 0.5 to 1.4). Planned observation was associated with significantly lower cranial CT use in patients at intermediate risk (adjusted OR = 0.2, 95% CI = 0.2 to 0.3) and high risk (adjusted OR = 0.1, 95% CI = 0.0 to 0.1) for ciTBI. Conclusions Even in a setting with low overall cranial CT rates in children with minor head trauma, planned observation was associated with decreased cranial CT use. This strategy can be safely implemented on selected patients in the PECARN intermediate- and higher-risk groups for ciTBI.	[Singh, Sonia; Hearps, Stephen J. C.; Donath, Susan; Cheek, John A.; Williams, Amanda; Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Singh, Sonia; Donath, Susan; Cheek, John A.; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Singh, Sonia] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Borland, Meredith L.] Perth Childrens Hosp, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Dalziel, Stuart R.] Starship Childrens Hlth, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Auckland, New Zealand; [Cheek, John A.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Kochar, Amit] Womens & Childrens Hosp, Adelaide, SA, Australia; [Gilhotra, Yuri; Phillips, Natalie] Queensland Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Hoch, Jeffrey S.; Holmes, James F.] Univ Calif Davis, Dept Publ Hlth Sci, Div Hlth Policy & Management, Davis, CA 95616 USA; [Hoch, Jeffrey S.] Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Singh, S (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Singh, S (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.; Singh, S (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.	singhsd@student.unimelb.edu.au		Donath, Susan/0000-0003-2489-3977; Singh, Sonia/0000-0003-2430-0262; Lyttle, Mark/0000-0002-8634-7210; Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council (Centre of Research Excellence for Pediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Australian Government Research Training Program scholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; PREDICT CRE Research Higher Degree scholarship; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Pediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. SS is supported by an Australian Government Research Training Program scholarship, and a PREDICT CRE Research Higher Degree scholarship. FEB's time was partly funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia, and an NHMRC Practitioner Fellowship, Canberra, Australia. SRD's time was partly funded by the Health Research Council of New Zealand (HRC13/556). The authors have no potential conflicts to disclose.	American Academy of Pediatrics, 2013, CHOOS WIS 10 THINGS; American College of Emergency Physicians, 2013, CHOOS WIS 10 THINGS; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Coon ER, 2018, PEDIAT EMERG CARE; Crowe LM, 2018, ARCH PHYS MED REHAB, V99, P1360, DOI 10.1016/j.apmr.2017.12.026; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Forero R, 2019, EMERG MED AUSTRALAS, V31, P58, DOI 10.1111/1742-6723.13151; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Jones P, 2017, NEW ZEAL MED J, V130, P15; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Smith-Bindman R, 2019, JAMA-J AM MED ASSOC, V322, P843, DOI 10.1001/jama.2019.11456; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; von Elm E, 2007, BMJ-BRIT MED J, V335, P806	33	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	SEP	2020	27	9					832	843		10.1111/acem.13942		MAR 2020	12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NN7QZ	WOS:000521629500001	32064711	Green Published			2022-02-06	
J	Ouyang, LF; Mu, XY; Wang, JY; Li, QF; Gao, YL; Liu, HL; Sun, S; Ren, QJ; Yan, RJ; Wang, JY; Liu, Q; Sun, YM; Liu, CL; He, H; Long, W; Zhang, XD				Ouyang, Lufei; Mu, Xiaoyu; Wang, Junying; Li, Qifeng; Gao, Yalong; Liu, Haile; Sun, Si; Ren, Qinjuan; Yan, Ruijuan; Wang, Jingya; Liu, Qiang; Sun, Yuanming; Liu, Changlong; He, Hua; Long, Wei; Zhang, Xiao-Dong			Carbon dot targeting to nitrogen signaling molecules for inhibiting neuronal death	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; SIRNA DELIVERY; SUPEROXIDE-DISMUTASE; CERIA NANOPARTICLES; IN-VIVO; EFFICIENT; PROTECT; NEUROINFLAMMATION; NEUROPROTECTION	Free radical-induced oxidative damage and nitrosative stress have been identified as key factors in neuroinflammation responses after traumatic brain injury (TBI), with which reactive oxygen and nitrogen species (RONS), especially nitrogen signaling molecules, are strongly associated. Here, we prepared ultrasmall carbon dot (CD) by using a simple and facile method. In vitro assessment experiments show that the antioxidative CD exhibits an ultrahigh target-scavenging effect for nitrogen signaling molecules, especially the highly reactive (NO)-N-center dot and ONOO-. However, CD can only partially eliminate conventional oxygen radials such as O-2(center dot-) and (OH)-O-center dot, indicating CD has a preference for RNS modulation. Moreover, in vitro cell experiments and in vivo mice experiments reveal that CD can reduce the reactive oxygen species (ROS) level and lipid peroxidation, enhance superoxide dismutase (SOD) activity and GSSG level, and further improve the survival rate of neuron cells and TBI mice. These results declare that antioxidative CD could serve as an effective therapeutic for TBI.	[Ouyang, Lufei; Mu, Xiaoyu; Wang, Junying; Liu, Haile; Sun, Si; Ren, Qinjuan; Yan, Ruijuan; Liu, Changlong; Zhang, Xiao-Dong] Tianjin Univ, Sch Sci, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China; [Li, Qifeng; Gao, Yalong] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Li, Qifeng; Gao, Yalong] Tianjin Med Univ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Gen Hosp, Tianjin 300052, Peoples R China; [Wang, Jingya; Liu, Qiang; Sun, Yuanming; Long, Wei] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Mol Nucl Med, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China; [He, Hua] China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China; [He, Hua] China Univ Petr East China, Ctr Bioengn & Biotechnol, Qingdao 266580, Peoples R China; [Zhang, Xiao-Dong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Int Joint Res Ctr Neural Engn, Tianjin 300072, Peoples R China		Zhang, XD (corresponding author), Tianjin Univ, Sch Sci, Tianjin Key Lab Low Dimens Mat Phys & Preparing T, Tianjin 300350, Peoples R China.; Long, W (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Mol Nucl Med, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.; He, H (corresponding author), China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao 266580, Peoples R China.; He, H (corresponding author), China Univ Petr East China, Ctr Bioengn & Biotechnol, Qingdao 266580, Peoples R China.; Zhang, XD (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin Int Joint Res Ctr Neural Engn, Tianjin 300072, Peoples R China.	huahe@upc.edu.cn; longway@irm-cams.ac.cn; xiaodongzhang@tju.edu.cn	Nanozymes, Nanozymes/D-8197-2019; Zhang, Xiaodong/F-4665-2015	Zhang, Xiaodong/0000-0002-7212-0138	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91859101, 81971744, U1932107, 81471786]; National Natural Science Foundation of Tianjin [19JCZDJC34000]; Innovation Foundation of Tianjin University	This work was financially supported by the National Natural Science Foundation of China (Grant No. 91859101, 81971744, U1932107, and 81471786) and the National Natural Science Foundation of Tianjin (No. 19JCZDJC34000), the Innovation Foundation of Tianjin University.	Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Dai C, 2017, ACS NANO, V11, P9467, DOI 10.1021/acsnano.7b05215; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Fan KL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03903-8; Fan L, 2018, ACS APPL MATER INTER, V10, P4502, DOI 10.1021/acsami.7b17916; Gaudin A, 2014, NAT NANOTECHNOL, V9, P1054, DOI [10.1038/NNANO.2014.274, 10.1038/nnano.2014.274]; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heckman KL, 2013, ACS NANO, V7, P10582, DOI 10.1021/nn403743b; Huang YY, 2016, ANGEW CHEM INT EDIT, V55, P6646, DOI 10.1002/anie.201600868; Huo MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00424-8; Jalilov AS, 2017, ACS NANO, V11, P2024, DOI 10.1021/acsnano.6b08211; Jiang B, 2018, NAT PROTOC, V13, P1506, DOI 10.1038/s41596-018-0001-1; Kang JY, 2016, ADV MATER, V28, P7962, DOI 10.1002/adma.201600634; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Knott AB, 2009, ANTIOXID REDOX SIGN, V11, P541, DOI [10.1089/ars.2008.2234, 10.1089/ARS.2008.2234]; Kozielski KL, 2014, ACS NANO, V8, P3232, DOI 10.1021/nn500704t; Kwon EJ, 2016, ACS NANO, V10, P7926, DOI 10.1021/acsnano.6b03858; Kwon HJ, 2018, ANGEW CHEM INT EDIT, V57, P9408, DOI 10.1002/anie.201805052; Kwon HJ, 2016, ACS NANO, V10, P2860, DOI 10.1021/acsnano.5b08045; Li F, 2017, ANGEW CHEM INT EDIT, V56, P9910, DOI 10.1002/anie.201705989; Li J, 2018, BIOMATERIALS, V170, P147, DOI 10.1016/j.biomaterials.2018.04.015; Li SS, 2019, ANGEW CHEM INT EDIT, V58, P12624, DOI 10.1002/anie.201904751; Lin H, 2017, NANO LETT, V17, P384, DOI 10.1021/acs.nanolett.6b04339; Liu HL, 2019, ADV MATER, V31, DOI 10.1002/adma.201901015; Liu YL, 2017, J AM CHEM SOC, V139, P856, DOI 10.1021/jacs.6b11013; Lv W, 2018, ACS NANO, V12, P5417, DOI 10.1021/acsnano.8b00477; Mu XY, 2019, NANO LETT, V19, P4527, DOI 10.1021/acs.nanolett.9b01333; Mu XY, 2019, ACS NANO, V13, P1870, DOI 10.1021/acsnano.8b08045; Pei P, 2019, BIOMATERIALS, V188, P74, DOI 10.1016/j.biomaterials.2018.10.010; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Samuel ELG, 2015, P NATL ACAD SCI USA, V112, P2343, DOI 10.1073/pnas.1417047112; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Soh M, 2017, ANGEW CHEM INT EDIT, V56, P11399, DOI 10.1002/anie.201704904; Sun CX, 2019, BIOMATERIALS, V225, DOI 10.1016/j.biomaterials.2019.119514; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Vernekar AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6301; Wang FM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03617-x; Wang H, 2019, CHEM SCI, V10, P3770, DOI 10.1039/c8sc04961k; Wang L, 2019, POLYM CHEM-UK, V10, P2039, DOI 10.1039/c9py00171a; Wang ZZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05798-x; Wu JJX, 2019, CHEM SOC REV, V48, P1004, DOI 10.1039/c8cs00457a; Xie JN, 2019, ACS APPL MATER INTER, V11, P2579, DOI 10.1021/acsami.8b00949; Xu BL, 2019, ANGEW CHEM INT EDIT, V58, P4911, DOI 10.1002/anie.201813994; Xu C, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.88; Xu JL, 2016, ADV FUNCT MATER, V26, P4124, DOI 10.1002/adfm.201504416; Xu ZB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06164-7; Yan RJ, 2019, ACS NANO, V13, P11552, DOI 10.1021/acsnano.9b05075; Yao J, 2018, CHEM SCI, V9, P2927, DOI 10.1039/c7sc05476a; Yin WY, 2018, NANOSCALE, V10, P1517, DOI 10.1039/c7nr07927c; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang FR, 2019, ADV SCI, V6, DOI 10.1002/advs.201901378; Zhang L, 2019, MATER HORIZONS, V6, P1682, DOI 10.1039/c9mh00339h; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang XD, 2016, ACS NANO, V10, P4511, DOI 10.1021/acsnano.6b00321; Zhou RY, 2019, BIOMATERIALS, V189, P11, DOI 10.1016/j.biomaterials.2018.10.016	60	6	6	0	29	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B	MAR 21	2020	8	11					2321	2330		10.1039/c9tb02447f			10	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	KW7NH	WOS:000521370900012	32100792				2022-02-06	
J	Metti, A; Schwab, K; Finkel, A; Pazdan, R; Brenner, L; Cole, W; Terrio, H; Scher, AI				Metti, Andrea; Schwab, Karen; Finkel, Alan; Pazdan, Renee; Brenner, Lisa; Cole, Wesley; Terrio, Heidi; Scher, Ann I.			Posttraumatic vs nontraumatic headaches: A phenotypic analysis in a military population	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NATURAL-HISTORY; SERVICE MEMBERS; EPIDEMIOLOGY; PREVALENCE; SOLDIERS; DIAGNOSIS; COHORT	ObjectiveTo describe and compare phenotypic features of posttraumatic headaches (PTH) and headaches unrelated to concussion.MethodsParticipants are a random sample of recently deployed soldiers from the Warrior Strong cohort, consisting of soldiers with (n = 557) and without (n = 1,030) a history of a recent mild traumatic brain injury (mTBI; concussion). mTBI+ soldiers were subdivided as PTH+ (n = 230) and PTH- (n = 327). Headache classification was based on a detailed phenotypic questionnaire. Medical encounters for headache were documented for the year after deployment.ResultsThe findings here are limited to the soldiers with headaches, consisting of 94% of the mTBI+ soldiers and 76% of the mTBI- soldiers. Other than headache duration, all headache/migraine features were more common or more severe in the PTH+ group compared to the nonconcussed group (mTBI-) and compared to the concussed group with nontraumatic headaches (PTH-). Headaches were largely similar in the mTBI- and PTH- groups. The features most specific to PTH+ included allodynia, visual aura, sensory aura, daily headache, and continuous headache. Medical consultation for headache was most common in the PTH+ group (62%) vs the PTH- group (20%) or the mTBI- group (13%) (p < 0.008).ConclusionsIn this cohort of recently deployed soldiers, PTHs are more severe, frequent, and migraine-like and more often associated with medical consultation compared to headaches presumed unrelated to concussion. Future observational studies are needed to verify and characterize the PTH phenotype, which could be followed by treatment trials with appropriate and possibly novel outcomes for prespecified subgroups.ClinicalTrials.gov identifierNCT01847040.	[Metti, Andrea] Metti Consulting Co, Pittsburgh, PA USA; [Schwab, Karen; Finkel, Alan; Pazdan, Renee] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Schwab, Karen] 9Line LLC, Tampa, FL USA; [Finkel, Alan] Carolina Headache Inst, Durham, NC USA; [Brenner, Lisa] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa] Marcus Inst Brain Hlth, Aurora, CO USA; [Brenner, Lisa] VHA Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Finkel, Alan; Cole, Wesley] Womack Army Med Ctr, Ft Bragg, NC USA; [Terrio, Heidi] Evans Army Community Hosp, Colorado Springs, CO USA; [Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Scher, AI (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	ann.scher@usuhs.edu		Scher, Ann/0000-0003-4599-9834	Congressionally Directed Medical Research ProgramsUnited States Department of Defense; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Defense Medical Research and Development Program; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Military Clinical Neuroscience Center of Excellence	Primary funding for the study was provided by the Congressionally Directed Medical Research Programs. Additional support was provided by the Center for Neuroscience and Regenerative Medicine, Defense Medical Research and Development Program, Defense and Veterans Brain Injury Center, and Military Clinical Neuroscience Center of Excellence.	AMSARA, 2017, DIS EV SYST AN RES A; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Lake Alvin E 3rd, 2005, Curr Pain Headache Rep, V9, P4, DOI 10.1007/s11916-005-0067-7; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Serrano D, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0787-1; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; van Reekum R, 2013, BRAIN INJURY, V27, P1210, DOI 10.3109/02699052.2013.801515	24	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 17	2020	94	11					E1137	E1146		10.1212/WNL.0000000000008935			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LJ6FX	WOS:000530260000014	31924681				2022-02-06	
J	Asken, BM; Yang, ZH; Xu, HY; Weber, AG; Hayes, RL; Bauer, RM; DeKosky, ST; Jaffee, MS; Wang, KKW; Clugston, JR				Asken, Breton M.; Yang, Zhihui; Xu, Haiyan; Weber, Arthur G.; Hayes, Ronald L.; Bauer, Russell M.; DeKosky, Steven T.; Jaffee, Michael S.; Wang, Kevin K. W.; Clugston, James R.			Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; brain injury; concussion; multiplex; traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD BIOMARKERS	We prospectively evaluated serum concentrations of glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase L1 (UCH-L1), total tau (T-Tau), and neurofilament light (NF-L) from collegiate athletes at baseline and acutely after sport-related concussion (SRC) using the Quanterix Neurology 4Plex "B" (N4PB) multiplex assay. Uninjured controls were matched on age, sex, race, sport, and concussion history. Clinical outcomes included acute symptom severity, balance, rapid automated naming, computerized cognitive testing, and recovery duration. Baseline (n = 110; median [interquartile range] age = 19 [18-20] years, 54% male, 61% white/Caucasian) and post-SRC (n = 36; median [interquartile range] age = 19 [18-20] years, 50% male, 61% white/Caucasian) blood samples were analyzed. We observed post-SRC elevations from baseline for GFAP (p = 0.001, d = 1.7), T-Tau (p = 0.004, d = 1.3), and NF-L (p = 0.010, d = 1.1). GFAP (area under the curve [AUC] = 0.958, 95% confidence interval [CI] 0.927-0.989, p < 0.001) and NF-L (AUC = 0.904, 95% CI 0.851-0.957, p < 0.001) accurately discriminated SRC from control cases. There were no associations between biomarker concentrations and clinical measurements post-SRC or recovery duration. These findings suggest that, using the multiplex assay, GFAP, T-Tau, and NF-L elevate from baseline acutely after SRC, and both GFAP and NF-L excellently distinguished concussed from control cases. Serum biomarker changes do not necessarily correspond with clinical measurements or recovery duration.	[Asken, Breton M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94138 USA; [Asken, Breton M.; Bauer, Russell M.] Univ Florida, Dept Clin, Gainesville, FL USA; [Asken, Breton M.; Bauer, Russell M.] Univ Florida, Dept Hlth Psychol, Gainesville, FL USA; [Yang, Zhihui; Xu, Haiyan; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Gainesville, FL USA; [DeKosky, Steven T.; Jaffee, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Family Med, Gainesville, FL USA; [Weber, Arthur G.; Hayes, Ronald L.] Banyan Biomarkers Inc, San Diego, CA USA		Asken, BM (corresponding author), UCSF, Memory & Aging Ctr, 675 Nelson Rising Lane,Suite 190, San Francisco, CA 94138 USA.	Breton.Asken@ucsf.edu		Clugston, James/0000-0002-2103-1039	University of Florida Department of Emergency Medicine; GE; NFL; Banyan Biomarkers, Inc.; United States Army Medical Research and Material Command (USAMRMC) [W81XWH-06-1-0517]	Departmental funding (University of Florida Department of Emergency Medicine) obtained by K.K.W.W. supported Quanterix N4PB assay costs. Prior biomarker analyses (singleplex assays) were supported by funds provided in a grant from the Head Health Initiative, a collaboration between GE and the NFL, Banyan Biomarkers, Inc., and the United States Army Medical Research and Material Command (USAMRMC) under contract W81XWH-06-1-0517.	Asken BM, 2019, JAMA NEUROL, V76, P515, DOI 10.1001/jamaneurol.2019.0125; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bigler ED, 2018, NEUROLOGY, V91, P1035, DOI 10.1212/WNL.0000000000006609; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Casaletto KB, 2018, CYTOKINE, V111, P481, DOI 10.1016/j.cyto.2018.05.032; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01367; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; ImPACT Applications I., 2016, IMPACT ADM INT MAN; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Keshavan Ashvini, 2018, Alzheimers Dement (Amst), V10, P448, DOI 10.1016/j.dadm.2018.06.001; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Korley FK, 2018, J NEUROTRAUM, V36, P182, DOI DOI 10.1089/NEU.2017; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lenhard W., 2016, CALCULATION EFFECT S; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Scaccianoce S, 2004, BRAIN RES, V1004, P208, DOI 10.1016/j.brainres.2004.01.028; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Wood MD, 2011, RADIOPROTECTION, V46, pS85, DOI 10.1051/radiopro/20116728s; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	50	6	6	2	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1537	1545		10.1089/neu.2019.6831		MAR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525039200001	32024456				2022-02-06	
J	McIntyre, M; Ehrlich, C; Kendall, E				McIntyre, Michelle; Ehrlich, Carolyn; Kendall, Elizabeth			Informal care management after traumatic brain injury: perspectives on informal carer workload and capacity	DISABILITY AND REHABILITATION			English	Article						Informal care; traumatic brain injury; caregiving; burden of treatment; qualitative study	BIOGRAPHICAL DISRUPTION; CAREGIVERS; BURDEN; PREDICTORS; DISTRESS; REHABILITATION; SATISFACTION; ADJUSTMENT; EVERYDAY; DYNAMICS	Purpose: Much of the support required to live in the community post-traumatic brain injury (TBI) is provided by informal carers. Understanding the nature of caregiving work is important to better support informal carers. This study explored the work being performed by informal carers, and factors impacting on their capacity to manage the workload. Method: Participants comprised 21 dyads each consisting of an adult with moderate to severe TBI and a nominated carer. Thematic analysis was done on semi-structured interviews with injured participants and carers during the 12-month period post-discharge from hospital. Results: Results revealed two main themes and eight subcategories: (1) The nature of informal care: describing informal care management work, (personal assistant work; care provider work; family support work; and emotional self-regulation work), and (2) Mediating factors that impacted people's capacity to manage workload (carer intrinsic factors; injured person characteristics; family circumstances; and changes over time.) Conclusion: Rehabilitation providers supporting people following TBI need to focus on broad family contexts; understand the nature of work being undertaken, and carer capacity to carry out that work; and be aware of the unique and changing circumstances of families to better support informal carers.	[McIntyre, Michelle] Synapse Australia Ltd Brisbane, Brisbane, Qld, Australia; [McIntyre, Michelle; Ehrlich, Carolyn; Kendall, Elizabeth] Griffith Univ, Hopkins Ctr, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia		McIntyre, M (corresponding author), Synapse Australia, 1-262 Montague Rd, West End, Qld 4101, Australia.	mmcintyre@synapse.org.au		Kendall, Elizabeth/0000-0003-2399-1460	Griffith Health Institute	This research was funded by a grant received from Griffith Health Institute.	ABS Survey of Disability, 2015, ABS SURV DIS AG CAR; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Chleboun S, 2011, QUAL REP, V16, P764; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Cutler M, 2016, J SOC WORK DISABIL R, V15, P260, DOI 10.1080/1536710X.2016.1220879; Deloitte Access Economics, 2015, EC VAL INF CAR AUSTR; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Hammell KW, 2004, QUALITATIVE RES EVID; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levine C, 1999, NEW ENGL J MED, V340, P1587, DOI 10.1056/NEJM199905203402013; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; Milbourn BT, 2014, CAN J OCCUP THER, V81, P144, DOI 10.1177/0008417414533315; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perry BL, 2012, AM J SOCIOL, V118, P134, DOI 10.1086/666377; Pescosolido BA, 2006, J HEALTH SOC BEHAV, V47, P189, DOI 10.1177/002214650604700301; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Rogers A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-19; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; ter Meulen R, 2012, BIOETHICS, V26, P361, DOI 10.1111/j.1467-8519.2012.01992.x; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wittenberg-Lyles E, 2014, HEALTH COMMUN, V29, P901, DOI 10.1080/10410236.2013.815111	36	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAR 12	2020	42	6					754	762		10.1080/09638288.2018.1508511			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KU7LG	WOS:000519894000002	30326760	Green Accepted			2022-02-06	
J	Lai, CQ; Ibrahim, H; Abd Hamid, AI; Abdullah, MZ; Azman, A; Abdullah, JM				Lai, Chi Qin; Ibrahim, Haidi; Abd Hamid, Aini Ismafairus; Abdullah, Mohd Zaid; Azman, Azlinda; Abdullah, Jafri Malin			Detection of Moderate Traumatic Brain Injury from Resting-State Eye-Closed Electroencephalography	COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE			English	Article							EARLY-DIAGNOSIS; HEAD-INJURY; EEG; CLASSIFICATION; DISTURBANCES	Traumatic brain injury (TBI) is one of the injuries that can bring serious consequences if medical attention has been delayed. Commonly, analysis of computed tomography (CT) or magnetic resonance imaging (MRI) is required to determine the severity of a moderate TBI patient. However, due to the rising number of TBI patients these days, employing the CT scan or MRI scan to every potential patient is not only expensive, but also time consuming. Therefore, in this paper, we investigate the possibility of using electroencephalography (EEG) with computational intelligence as an alternative approach to detect the severity of moderate TBI patients. EEG procedure is much cheaper than CT or MRI. Although EEG does not have high spatial resolutions as compared with CT and MRI, it has high temporal resolutions. The analysis and prediction of moderate TBI from EEG using conventional computational intelligence approaches are tedious as they normally involve complex preprocessing, feature extraction, or feature selection of the signal. Thus, we propose an approach that uses convolutional neural network (CNN) to automatically classify healthy subjects and moderate TBI patients. The input to this computational intelligence system is the resting-state eye-closed EEG, without undergoing preprocessing and feature selection. The EEG dataset used includes 15 healthy volunteers and 15 moderate TBI patients, which is acquired at the Hospital Universiti Sains Malaysia, Kelantan, Malaysia. The performance of the proposed method has been compared with four other existing methods. With the average classification accuracy of 72.46%, the proposed method outperforms the other four methods. This result indicates that the proposed method has the potential to be used as a preliminary screening for moderate TBI, for selection of the patients for further diagnosis and treatment planning.	[Lai, Chi Qin; Ibrahim, Haidi; Abdullah, Mohd Zaid] Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia; [Abd Hamid, Aini Ismafairus; Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kota Baharu 16150, Kelantan, Malaysia; [Azman, Azlinda] Univ Sains Malaysia, Sch Social Sci, George Town 11800, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Sch Med Sci, Brain & Behav Cluster, Kota Baharu 16150, Kelantan, Malaysia		Ibrahim, H (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.	haidi_ibrahim@ieee.org	Abdullah, J/C-2828-2011; Ibrahim, Haidi/B-3131-2011	Abdullah, J/0000-0002-0258-7410; Ibrahim, Haidi/0000-0002-6401-1791	Ministry of Higher Education (MOHE), Malaysia, via Trans-Disciplinary Research Grant Scheme (TRGS) [203\PELECT\6768002]	This research is supported by the Ministry of Higher Education (MOHE), Malaysia, via Trans-Disciplinary Research Grant Scheme (TRGS) with grant number 203\PELECT\6768002.	Albert B, 2016, PROCEDIA COMPUT SCI, V96, P703, DOI 10.1016/j.procs.2016.08.253; Amin SU, 2019, IEEE ACCESS, V7, P18940, DOI 10.1109/ACCESS.2019.2895688; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; BASAR E, 1976, BIOL CYBERN, V25, P27; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.2307/2335441; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Goldberg Scott A, 2015, Handb Clin Neurol, V127, P367, DOI 10.1016/B978-0-444-52892-6.00023-4; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hine G. E., 2017, P 2017 INT C BIOM SP, P1, DOI DOI 10.23919/BIOSIG.2017.8053519; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Islam MK, 2016, NEUROPHYSIOL CLIN, V46, P287, DOI 10.1016/j.neucli.2016.07.002; Khan S., 2018, GUIDE CONVOLUTIONAL, V8, P1, DOI 10.2200/S00822ED1V01Y201712COV015; Kuhn M., 2013, APPL PREDICTIVE MODE, V26; Lai CQ, 2019, PROCEEDINGS OF 2019 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND ELECTRICAL ENGINEERING TECHNOLOGY (EEET 2019), P99, DOI 10.1145/3362752.3362758; Lai CQ, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/7895924; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masters D., 2018, REVISITING SMALL BAT; McBride J, 2013, IEEE T BIO-MED ENG, V60, P90, DOI 10.1109/TBME.2012.2223698; McNerney MW, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0187-y; Mudigere D, 2016, LARGE BATCH TRAINING; Muhammad K, 2018, IEEE ACCESS, V6, P18174, DOI 10.1109/ACCESS.2018.2812835; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reeves T. M., 2012, ELECTROPHYSIOLOGICAL; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Sehgal A, 2018, IEEE ACCESS, V6, P9017, DOI 10.1109/ACCESS.2018.2800728; Smith LN, 2017, IEEE WINT CONF APPL, P464, DOI 10.1109/WACV.2017.58; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Walsh T., 2011, FLEXIBLE HIGH PERFOR, P1237; Wen ZY, 2017, 2017 INTERNATIONAL CONFERENCE ON SECURITY, PATTERN ANALYSIS, AND CYBERNETICS (SPAC), P672, DOI 10.1109/SPAC.2017.8304360; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yang S, 2018, PATTERN ANAL APPL, V21, P105, DOI 10.1007/s10044-016-0569-4	46	6	7	1	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-5265	1687-5273		COMPUT INTEL NEUROSC	Comput. Intell. Neurosci.	MAR 11	2020	2020								8923906	10.1155/2020/8923906			10	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	KY1XH	WOS:000522364400002	32256555	Green Published, gold			2022-02-06	
J	Han, XJ; Chai, Z; Ping, XJ; Song, LJ; Ma, CG; Ruan, YW; Jin, XM				Han, Xinjia; Chai, Zhi; Ping, Xingjie; Song, Li-Juan; Ma, Cungen; Ruan, Yiwen; Jin, Xiaoming			In vivo Two-Photon Imaging Reveals Acute Cerebral Vascular Spasm and Microthrombosis After Mild Traumatic Brain Injury in Mice	FRONTIERS IN NEUROSCIENCE			English	Article						cerebral cortex; vasculature; blood circulation; mild traumatic brain injury; two-photon imaging	CAPILLARY BLOOD-FLOW; PATHOPHYSIOLOGY; SPORT; CONSEQUENCES; MICROSCOPY; MICROCIRCULATION; SUSCEPTIBILITY; ABNORMALITIES; MICROVESSELS; ASSOCIATION	Mild traumatic brain injury (mTBI), or concussion, is reported to interfere with cerebral blood flow and microcirculation in patients, but our current understanding is quite limited and the results are often controversial. Here we used longitudinal in vivo two-photon imaging to investigate dynamic changes in cerebral vessels and velocities of red blood cells (RBC) following mTBI. Closed-head mTBI induced using a controlled cortical impact device resulted in a significant reduction of dwell time in a Rotarod test but no significant change in water maze test. Cerebral blood vessels were repeatedly imaged through a thinned skull window at baseline, 0.5, 1, 6 h, and 1 day following mTBI. In both arterioles and capillaries, their diameters and RBC velocities were significantly decreased at 0.5, 1, and 6 h after injury, and recovered in 1 day post-mTBI. In contrast, decreases in the diameter and RBC velocity of venules occurred only in 0.5-1 h after mTBI. We also observed formation and clearance of transient microthrombi in capillaries within 1 h post-mTBI. We concluded that in vivo two-photon imaging is useful for studying earlier alteration of vascular dynamics after mTBI and that mTBI induced reduction of cerebral blood flow, vasospasm, and formation of microthrombi in the acute stage following injury. These changes may contribute to early brain functional deficits of mTBI.	[Han, Xinjia; Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Han, Xinjia; Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Han, Xinjia] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Obstet & Gynecol, Guangzhou, Peoples R China; [Han, Xinjia; Ruan, Yiwen] Jinan Univ, GHM Inst CNS Regenerat GHMICR, Guangzhou, Peoples R China; [Chai, Zhi; Song, Li-Juan; Ma, Cungen] Shaanxi Univ Chinese Med, Coll Basic Med, Neurobiol Res Ctr, Shanxi Key Lab Innovat Drugs Serious Illness, Jinzhong, Peoples R China; [Ruan, Yiwen] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China		Jin, XM (corresponding author), Indiana Univ Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Jin, XM (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.; Ruan, YW (corresponding author), Jinan Univ, GHM Inst CNS Regenerat GHMICR, Guangzhou, Peoples R China.; Ruan, YW (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.	tyiwen@jnu.edu.cn; xijin@iupui.edu	ping, xingjie/AAW-4597-2020		Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [A70-1-079438, A70-3-079971, A70-4-079956]; China's National 111 project [B14036]; Guangzhou Women and Children's Medical Center [3001008-04]	This work was supported in part by the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (A70-1-079438, A70-3-079971, and A70-4-079956) to XJ. This work was also supported by funding from the China's National 111 project (Grant number B14036) to YR and postdoctoral research start-up funding (3001008-04) from Guangzhou Women and Children's Medical Center.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clevenger AC, 2015, J NEUROTRAUM, V32, P120, DOI 10.1089/neu.2014.3570; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Drew PJ, 2010, NAT METHODS, V7, P981, DOI [10.1038/nmeth.1530, 10.1038/NMETH.1530]; Drew PJ, 2010, J COMPUT NEUROSCI, V29, P5, DOI 10.1007/s10827-009-0159-1; Fehnel Corey R, 2014, R I Med J (2013), V97, P45; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; GARCIA JH, 1994, AM J PATHOL, V145, P728; Gattinoni L, 2019, INTENS CARE MED, V45, P1686, DOI 10.1007/s00134-019-05695-x; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Huang JY, 2014, CNS NEUROSCI THER, V20, P816, DOI 10.1111/cns.12268; Ishikawa M, 2016, J NEUROL SCI, V368, P326, DOI 10.1016/j.jns.2016.06.067; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038590; Kontos H A, 1981, Trans Am Clin Climatol Assoc, V92, P111; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Lang W, 2002, CLIN CHEM LAB MED, V40, P404, DOI 10.1515/CCLM.2002.065; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Li BQ, 2019, ELIFE, V8, DOI 10.7554/eLife.42299; Lu XC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01261; Maeda T, 1997, ACT NEUR S, V70, P102; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ogami K, 2017, WORLD NEUROSURG, V101, DOI 10.1016/j.wneu.2017.03.039; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; ROSENBLUM WI, 1982, TEX HEART I J, V9, P345; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/nnano.2009.303, 10.1038/NNANO.2009.303]; Shih AY, 2012, JOVE-J VIS EXP, DOI 10.3791/3742; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; Small DM, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.020901; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Sunwoo J, 2011, IEEE ENG MED BIO, P174, DOI 10.1109/IEMBS.2011.6089922; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12972-6; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075	73	6	6	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 10	2020	14								210	10.3389/fnins.2020.00210			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC8UI	WOS:000525607400001	32210758	Green Published, gold			2022-02-06	
J	Soni, N; Vegh, V; To, XV; Mohamed, AZ; Borges, K; Nasrallah, FA				Soni, Neha; Vegh, Viktor; To, Xuan Vinh; Mohamed, Abdalla Z.; Borges, Karin; Nasrallah, Fatima A.			Combined Diffusion Tensor Imaging and Quantitative Susceptibility Mapping Discern Discrete Facets of White Matter Pathology Post-injury in the Rodent Brain	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; diffusion tensor imaging; track-based spatial statistics; quantitative susceptibility mapping; myelin; gliosis; contralateral	CONTROLLED CORTICAL IMPACT; TRAUMATIC AXONAL INJURY; NEUROPROTECTIVE ACTIONS; VOXELWISE ANALYSIS; IN-DIFFUSION; MOUSE MODEL; RAT MODEL; MRI; DETECTS; IRON	Early loss of white matter microstructure integrity is a significant cause of long-term neurological disorders following traumatic brain injury (TBI). White matter abnormalities typically involve axonal loss and demyelination. In-vivo imaging tools to detect and differentiate such microstructural changes are not well-explored. This work utilizes the conjoint potential offered by advanced magnetic resonance imaging techniques, including quantitative susceptibility mapping (QSM) and diffusion tensor imaging (DTI), to discern the underlying white matter pathology at specific time points (5 h, 1, 3, 7, 14, and 30 days) post-injury in the controlled cortical impact mouse model. A total of 42 animals were randomized into six TBI groups (n = 6 per group) and one sham group (n = 6). Histopathology was performed to validate in-vivo findings by performing myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) immunostaining for the assessment of changes to myelin and astrocytes. After 5 h of injury radial diffusivity (RD) was increased in white matter without a significant change in axial diffusivity (AxD) and susceptibility values. After 1 day post-injury RD was decreased. AxD and susceptibility changes were seen after 3 days post-injury. Susceptibility increases in white matter were observed in both ipsilateral and contralateral regions and persisted for 30 days. In histology, an increase in GFAP immunoreactivity was observed after 3 days post-injury and remained high for 30 days in both ipsilateral and contralateral white matter regions. A loss in MBP signal was noted after 3 days post-injury that continued up to 30 days. In conclusion, these results demonstrate the complementary ability of DTI and QSM in discerning the micro-pathological processes triggered following TBI. While DTI revealed acute and focal white matter changes, QSM mirrored the temporal demyelination in the white matter tracts and diffuse regions at the chronic state.	[Soni, Neha; To, Xuan Vinh; Mohamed, Abdalla Z.; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Vegh, Viktor] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Borges, Karin] Univ Queensland, Sch Biomed Sci, Fac Med, Brisbane, Qld, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.nasrallah@uq.edu.au	Mohamed, Abdalla/ABG-8718-2021; Mohaned, Abdalla/AAL-8721-2020; Borges, Karin/B-4276-2011; Mohaned, Abdalla/ABF-9320-2021; Nasrallah, Fatima/N-3398-2016	Mohaned, Abdalla/0000-0003-4499-672X; Borges, Karin/0000-0001-7448-0770; Mohaned, Abdalla/0000-0003-4499-672X; Nasrallah, Fatima/0000-0002-7385-9559; To, Xuan Vinh/0000-0002-6527-7356	Motor Accident Insurance Commission (MAIC) [2014000857]; Queensland Government, Australia	We thank the Motor Accident Insurance Commission (MAIC) (Grant: 2014000857), the Queensland Government, Australia for the research grant to FN to support this work.	Acosta-Cabronero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081093; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Basarslan SK, 2015, ULUS TRAVMA ACIL CER, V21, P235, DOI 10.5505/tjtes.2015.66502; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Campbell GR, 2012, MITOCHONDRION, V12, P173, DOI 10.1016/j.mito.2011.03.007; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Clark A, 2018, TRAUMA NEUROLOGICAL; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Heath F, 2018, DEV NEUROBIOL, V78, P136, DOI 10.1002/dneu.22552; Heidari M, 2016, MOL PSYCHIATR, V21, P1599, DOI 10.1038/mp.2015.192; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kim HG, 2017, NEUROIMAGE-CLIN, V16, P429, DOI 10.1016/j.nicl.2017.08.019; Koch KM, 2018, AM J NEURORADIOL, V39, P1215, DOI 10.3174/ajnr.A5692; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Soni N, 2019, J NEUROTRAUM, V36, P1306, DOI 10.1089/neu.2018.5972; Sood S, 2017, MAGN RESON MED, V77, P1946, DOI 10.1002/mrm.26281; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Sukstanskii AL, 2014, MAGN RESON MED, V71, P345, DOI 10.1002/mrm.24629; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Watson C, 2017, NEUROIMAGE, V157, P275, DOI 10.1016/j.neuroimage.2017.05.057; Weber AM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00575; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; Zhang Jiangyang, 2010, Imaging Med, V2, P623, DOI 10.2217/iim.10.60; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324; Ziser L, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3877	84	6	6	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 6	2020	11								153	10.3389/fneur.2020.00153			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB4FR	WOS:000524591900001	32210907	Green Published, gold			2022-02-06	
J	Oyegbile, TO; Dougherty, A; Tanveer, S; Zecavati, N; Delasobera, BE				Oyegbile, Temitayo Oyefunmike; Dougherty, Andrew; Tanveer, Sarah; Zecavati, Nassim; Delasobera, Bronson Elizabeth			High Sleep Disturbance and Longer Concussion Duration in Repeat Concussions	BEHAVIORAL SLEEP MEDICINE			English	Article							GENDER-DIFFERENCES; SYMPTOMS; IMPACT; QUALITY; INJURY	Objectives: The relationship between repeated concussions and sleep disturbance is yet to be fully understood. The objective of this study was to examine the relationship between sleep disturbance, concussion duration, and repeated concussions by assessing postconcussive symptoms and cognition. Methods: Subjects (ages 13-33 years) underwent postconcussion cognitive function evaluation and reported postconcussion symptoms including severity of disturbed sleep (drowsiness, trouble falling asleep, sleeping more than usual, and sleeping less than usual), mood disturbance (sadness, irritability, nervousness, and emotional lability), and headache. Data on cognitive function and concussive symptoms were collected for 430 subjects after first concussion, 192 subjects after second concussion, and 118 subjects after three or more concussions. A subset of subjects (119) were monitored longitudinally to assess concussion duration. Analyses included group comparisons, regression, and correlation; data were adjusted for age and gender. Results: Sleep disturbance differed significantly by group (mean[SEM]: 1st concussion = 2.56[0.2]; 2nd concussion = 3.65[0.34]; 3+ concussions = 4.32[0.43]). Concussion history predicts concussion duration (R-2 = 0.20, F[1,116] = 27.33, p < 0.001). Furthermore, trouble falling asleep (beta = 0.15) and sleeping less than usual (beta = 0.15) predicted concussion duration (R-2 = 0.062, F[1,116] = 3.15, p = 0.047). Reported sleep disturbance after repeated concussions was higher in patients with higher headache (F[2,732] = 3.15, p = 0.043) and mood disturbance (F[2,733] = 3.35, p = 0.036) severity. In addition, after repeated concussions, the positive correlation between sleep disturbance and cognitive dysfunction strengthened. Conclusions: History of repeated concussion is associated with longer concussion duration and higher reported sleep disturbance. Furthermore, those with sleep disturbance after repeated concussion exhibit more severe headaches, mood disturbance, and cognitive dysfunction.	[Oyegbile, Temitayo Oyefunmike; Dougherty, Andrew; Zecavati, Nassim; Delasobera, Bronson Elizabeth] MedStar Georgetown Univ Hosp, Dept Pediat & Neurol, Washington, DC 20016 USA; [Tanveer, Sarah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Publ Hlth, Baltimore, MD USA; MedStar Georgetown Univ Hosp, Washington, DC 20016 USA; Medstar Natl Rehabil Hosp Syst, Washington, DC USA		Oyegbile, TO (corresponding author), MedStar Georgetown Univ Hosp, Pediat Neurol Sleep Med & Epilepsy, 4200 Wisconsin Ave NW, Washington, DC 20016 USA.	Too3@georgetown.edu	Tanveer, Sarah/AAK-1470-2020	Tanveer, Sarah/0000-0002-6408-9855			Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Beebe DW, 2018, CLIN J SPORT MED, V28, P395, DOI 10.1097/JSM.0000000000000454; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Oyegbile TO, 2018, J CHILD NEUROL, V33, P383, DOI 10.1177/0883073818759436; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030	19	6	7	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-2002	1540-2010		BEHAV SLEEP MED	Behav. Sleep Med.	MAR 3	2020	18	2					241	248		10.1080/15402002.2019.1578223			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	KF0MF	WOS:000508944600007	30784317				2022-02-06	
J	Bitchell, CL; Mathema, P; Moore, IS				Bitchell, Charlotte Leah; Mathema, Prabhat; Moore, Isabel S.			Four-year match injury surveillance in male Welsh professional Rugby Union teams	PHYSICAL THERAPY IN SPORT			English	Article						Rugby Union; Injury; Incidence; Burden	MUSCLE INJURIES; ELITE; FOOTBALL; EPIDEMIOLOGY; DEMANDS; EVENTS; RISK	Objectives: To report match injury incidence, burden and mechanism over a four-year period in professional male Welsh Regional Rugby Union. Design: Descriptive; Longitudinal. Setting: Welsh Regional Rugby Union. Participants: Four Welsh Regional male Rugby Union teams. Main Outcome Measures: All time-loss injuries sustained between July 1, 2012 and June 30, 2016. Incidence (injuries/1000 h), severity (mean and median days lost per injury), burden (days-lost/1000 h) and proportions (%) were calculated. Results: The overall injury incidence and burden was 99.1 injuries/1000 h and 2570.3 days-lost/1000 h. Concussion represented the highest incidence and burden of all specific injuries, with increases in burden from 2012/13 (86.5 days-lost/1000 h) to 2015/16 (302.4 days-lost/1000 h). Acromio-clavicular (AC) joint injuries increased in burden from 2012/13 to 2015/16 (71.3 vs 130.6 days-lost/1000 h). However, anterior thigh haematomas decreased in incidence (8.2 vs 2.4 injuries/1000 h) and burden (48.6 vs 17.7 days lost/1000 h) across the same period. Tackle events contributed to the highest proportion of match injuries (being tackled: 20-31%, tackling: 30-42%). Conclusions: Injury incidence was higher than previously reported for professional Rugby Union. Decreases in anterior thigh haematoma and increases in concussion and AC joint injuries were shown, identifying a change in contact-related match injury risk. (C) 2019 Elsevier Ltd. All rights reserved.	[Bitchell, Charlotte Leah; Moore, Isabel S.] Cardiff Metropolitan Univ, Cyncoed Campus,Cyncoed Rd, Cardiff CF23 6XD, Wales; [Mathema, Prabhat] Welsh Rugby Union, Natl Ctr Excellence, Vale Hotel CF72 8JY, Hensol, Wales		Bitchell, CL (corresponding author), Cardiff Sch Sport & Hlth Sci, Cyncoed Campus, Cardiff CF23 6XD, Wales.	st20019889@outlook.cardiffmet.ac.uk; pmathema@wru.wales; imoore@cardiffmet.ac.uk			Knowledge Economy Skills Scholarships (KESS 2); Welsh Government's European Social Fund (ESF) convergence programme for West Wales and the Valleys	The lead author (CLB) was funded by the Knowledge Economy Skills Scholarships (KESS 2). The KESS 2 is a pan-Wales higher level skills initiative led by Bangor University on behalf of the HE sector in Wales. It is part funded by the Welsh Government's European Social Fund (ESF) convergence programme for West Wales and the Valleys.	Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Crossley M, 2017, THEAT MAKERS, P1; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Ekstrand J, 2013, BRIT J SPORT MED, V47, P732, DOI 10.1136/bjsports-2013-092394; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2018, SPORTS MED, V48, P1597, DOI 10.1007/s40279-018-0913-5; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Holtzhausen LJ, 2006, SAMJ S AFR MED J, V96, P1260; John C, 2013, PEZZULLO BIOSTATISTI; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Owen SM, 2015, J SPORT SCI, V33, P2061, DOI 10.1080/02640414.2015.1028086; Pulling C, 2015, INT J PERF ANAL SPOR, V15, P217, DOI 10.1080/24748668.2015.11868788; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Ranson C, J SPORTS SCI; Ranson C, 2013, BRIT J SPORT MED, V47, P637, DOI 10.1136/bjsports-2012-091783; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Rugby Football Union (England), 2016, INJURY PREV, V22, P188; Team R.C., 2013, R LANG ENV STAT COMP; Toohey LA, 2018, SPORTS MED, V48, P2199, DOI 10.1007/s40279-018-0879-3; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Walden M., 2005, INJURIES SWEDISH ELI, P118; Williams S, 2017, SPORTS MED, V47, P2395, DOI 10.1007/s40279-017-0721-3; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, HEAD INJ ASS HIA PRO, V1-2	34	6	6	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAR	2020	42						26	32		10.1016/j.ptsp.2019.12.001			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KS7NE	WOS:000518492600004	31869752	Green Accepted			2022-02-06	
J	Kanser, RJ; Bashem, JR; Patrick, SD; Hanks, RA; Rapport, LJ				Kanser, Robert J.; Bashem, Jesse R.; Patrick, Sarah D.; Hanks, Robin A.; Rapport, Lisa J.			Detecting Feigned Traumatic Brain Injury With Eye Tracking During a Test of Performance Validity	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; performance validity; eye tracking; malingering	RECOGNITION MEMORY TEST; RESPONSE BIAS; IMPAIRMENT; CHOICE; TIME; STRATEGIES; FIXATIONS; INTACT	Objective: Eye-tracking is a promising technology to enhance assessment of performance validity. Research has established that ocular behaviors are reliable biomarkers of (un)conscious cognitive processes, and they have distinguished deceptive from honest responding in experimental paradigms. This study examined the incremental utility of eye-tracking on a clinical performance validity test (PVT) in distinguishing adults with verified TBI from adults coached to feign cognitive impairment. Method: Participants were 49 adults with moderate-to-severe TBI (FBI), 47 healthy adults coached to simulate TBI (SIM), and 67 healthy comparisons providing full effort (HC). A PVT linked to eye-tracking was completed in the context of a full neuropsychological battery. Results: Kruskal-Wallis tests revealed that eye-tracking indices did not differ among the groups during presentation of stimulus items but did differ during forced-choice trials. Compared to TBI and HC, SIM had significantly more transitions, fixations, and time spent looking at correct and incorrect response options. Logistic regressions and ROC curve analyses showed that accuracy was the best predictor of SIM versus HC. For SIM versus TBI, eye-tracking indices exceeded accuracy in distinguishing the groups. Eye-tracking added incremental predictive value to accuracy for both SIM-HC and SIM-TBI discriminations. Conclusion: Eye-tracking indicated that persons feigning TBI showed multiple signs of greater cognitive effort than persons with verified TBI and healthy comparisons. In the comparison of greatest interest (SIM vs. TBI) eye-tracking best predicted group status and yielded excellent discrimination when combined with accuracy. Eyetracking may be an important complement to traditional accuracy scores on PVTs.	[Kanser, Robert J.; Patrick, Sarah D.; Rapport, Lisa J.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Bashem, Jesse R.] VA San Diego Healthcare Syst, Dept Psychiat, San Diego, CA USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Bashem, Jesse/0000-0002-0328-6388; Rapport, Lisa/0000-0001-8014-9523; Kanser, Robert/0000-0001-8229-1857	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IFOO92]; Blue Cross Blue Shield of Michigan (Kanser) [2365.SAP]; Wayne State University	This research was supported by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; Rapport, 90IFOO92), Blue Cross Blue Shield of Michigan (Kanser, 2365.SAP) and Wayne State University dissertation awards. We thank Carole Koviak and Robert Kotasek of the Southeastern Michigan Traumatic Brain Injury Model System; Shoshana Krohner, Barret Vermilion and Monica De Iorio for their invaluable help and support in data collection.	Althoff R, 1999, CURRENT OCULOMOTOR RESEARCH, P293; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Antoniades CA, 2015, EYE, V29, P200, DOI 10.1038/eye.2014.276; Barry DM, 2016, ARCH CLIN NEUROPSYCH, V31, P963, DOI 10.1093/arclin/acw070; Bashem J. R., 2017, J INT NEUROPSYCH SOC, V23, P32; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bittencourt J, 2013, NEUROPSYCH DIS TREAT, V9, P1393, DOI 10.2147/NDT.S45931; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Cook AE, 2012, J EXP PSYCHOL-APPL, V18, P301, DOI 10.1037/a0028307; Davis JJ, 2018, J CLIN EXP NEUROPSYC, V40, P1013, DOI 10.1080/13803395.2018.1472221; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Duchowski AT, 2002, BEHAV RES METH INS C, V34, P455, DOI 10.3758/BF03195475; Elhai JD, 2007, J PERS ASSESS, V88, P328, DOI 10.1080/00223890701332136; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Green P., 2003, WORD MEMORY TEST WIN; Griffin ZM, 2006, J EXP PSYCHOL LEARN, V32, P943, DOI 10.1037/0278-7393.32.4.943; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hosmer D.W., 2000, APPL LOGISITIC REGRE; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Jennett B, 1981, MANAGEMENT HEAD INJU; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Mahoney EJ, 2018, J APPL RES MEM COGN, V7, P441, DOI 10.1016/j.jarmac.2018.05.004; Manns JR, 2000, P NATL ACAD SCI USA, V97, P12375, DOI 10.1073/pnas.220398097; Millen AE, 2017, Q J EXP PSYCHOL, V70, P930, DOI 10.1080/17470218.2016.1172093; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Proudfoot JG, 2016, J MANAGE INFORM SYST, V33, P332, DOI 10.1080/07421222.2016.1205929; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI [10.4135/9781412984997, DOI 10.4135/9781412984997]; Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2009, NEUROPSYCHOLOGIA, V47, P338, DOI 10.1016/j.neuropsychologia.2008.09.006; Schwedes C, 2012, MEM COGNITION, V40, P642, DOI 10.3758/s13421-011-0173-1; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shum DHK, 2004, ARCH CLIN NEUROPSYCH, V19, P817, DOI 10.1016/j.acn.2003.10.002; Snyder KA, 2008, PSYCHON B REV, V15, P315, DOI 10.3758/PBR.15.2.315; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tabachnick BG., 2012, USING MULTIVARIATE S; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tobii Technology, 2006, TOB TX300 US MAN; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; Vakil E, 2019, J CLIN EXP NEUROPSYC, V41, P644, DOI 10.1080/13803395.2019.1604946; Vrij A, 2011, CURR DIR PSYCHOL SCI, V20, P28, DOI 10.1177/0963721410391245; Warrington E, 1984, RECOGNITION MEMORY T, V1; WechslerD, 2001, WECHSLER TEST ADULT; Whitehead JC, 2018, J CLIN EXP NEUROPSYC, V40, P904, DOI 10.1080/13803395.2018.1444737	63	6	6	2	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2020	34	3					308	320		10.1037/neu0000613			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KQ1TA	WOS:000516711300006	31944789				2022-02-06	
J	Knoll, RM; Herman, SD; Lubner, RJ; Babu, AN; Wong, K; Sethi, RKV; Chen, JX; Rauch, SD; Remenschneider, AK; Jung, DH; Kozin, ED				Knoll, Renata M.; Herman, Seth D.; Lubner, Rory J.; Babu, Ashwin N.; Wong, Kevin; Sethi, Rosh K. V.; Chen, Jenny X.; Rauch, Steven D.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.			Patient-reported auditory handicap measures following mild traumatic brain injury	LARYNGOSCOPE			English	Article						Mild traumatic brain injury; concussion; auditory symptoms; head injury	HEARING-LOSS; HEAD-INJURY; PSYCHIATRIC-DISORDERS; BLAST; TINNITUS; CONCUSSION; DIZZINESS; SYMPTOMS; VETERANS; ENCEPHALOPATHY	Objectives/Hypothesis Few studies have specifically addressed auditory complaints in patients with nonblast mild traumatic brain injury (mTBI). Herein, we aimed to investigate auditory symptoms in patients following mTBI using patient-reported outcome measures. Study Design Retrospective analysis of prospectively collected data in a tertiary-care hospital. Methods The patients included those with mTBI (cases) and those without mTBI (controls). Individuals (>= 18 years old) with and without mTBI were screened. Exclusion criteria included history of otologic disorders, blast injury, or occupational noise exposure. Primary outcomes included the Hearing Handicap Inventory for Adults (HHIA), Tinnitus Handicap Inventory (THI), and Hyperacusis Questionnaire (HQ). Secondary outcomes included subjective auditory complaints. Results From September 2017 to September 2018, 52 patients with mTBI and 55 controls met inclusion and exclusion criteria. The mean time between mTBI and survey intake was 70.6 months. The mean age and gender were 51.5 years old and 73% female in the mTBI group, and 46.1 years old and 56.3% female in the control group (P = .112 and P = .105, respectively). Patients with mTBI reported hyperacusis (67.3% of all mTBI patients), hearing loss (61.5%), and tinnitus (61.5%), compared to 8.3%, 12.7%, and 16.4%, respectively, for control subjects (P < .0001). The mean HHIA score in the mTBI group was 38.3 versus 8.5 in controls (P = .002). The mean THI score was 27.4 in the mTBI group and 3.1 in controls (P < .0001). The mean HQ score was 26.5 in mTBI group and 7.3 in controls (P = .001). Conclusions Auditory symptoms and associated handicap were common in patients with nonblast mTBI compared to age-matched controls. Findings have implications for the pathophysiology and management of symptoms in this patient population. Level of Evidence 3 Laryngoscope, 130:761-767, 2020	[Knoll, Renata M.; Lubner, Rory J.; Sethi, Rosh K. V.; Chen, Jenny X.; Rauch, Steven D.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA USA; [Knoll, Renata M.; Lubner, Rory J.; Sethi, Rosh K. V.; Chen, Jenny X.; Rauch, Steven D.; Jung, David H.; Kozin, Elliott D.] Harvard Med Sch, Dept Otolaryngol, Boston, MA USA; [Herman, Seth D.; Remenschneider, Aaron K.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Lubner, Rory J.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Babu, Ashwin N.] Massachusetts Gen Hosp, Dept Sports Med, Boston, MA 02114 USA; [Wong, Kevin] Mt Sinai Med Ctr, Dept Otolaryngol, Box 1189, New York, NY 10029 USA; [Remenschneider, Aaron K.] Univ Massachusetts, Med Ctr, Dept Otolaryngol, Worcester, MA USA		Kozin, ED (corresponding author), 243 Charles St, Boston, MA 02114 USA.	elliott_kozin@meei.harvard.edu	Chen, Jenny X./AAR-9523-2021	Lubner, Rory/0000-0001-9884-2799; Chen, Jenny X/0000-0002-2992-4771; Trakimas, Danielle/0000-0003-1974-1880; Remenschneider, Aaron/0000-0003-0989-6264	Hearing Health Foundation Funding Source: Medline		[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Assi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28312-1; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Chandrasekhar SS, 2013, NEUROREHABILITATION, V32, P445, DOI 10.3233/NRE-130867; Chen JX, 2018, AM J OTOLARYNG, V39, P338, DOI 10.1016/j.amjoto.2018.01.018; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; COHEN H, 1992, OTOLARYNG HEAD NECK, V107, P638, DOI 10.1177/019459989210700505; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Emerson LP, 2011, INDIAN J OTOLARYNGOL, V63, P45, DOI 10.1007/s12070-011-0117-x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Henry JA, 2012, J REHABIL RES DEV, V49, P1025, DOI 10.1682/JRRD.2010.07.0125; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Ishai R, 2018, OTOLARYNG HEAD NECK, V159, P526, DOI 10.1177/0194599818769861; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Karch Stephanie J, 2016, US Army Med Dep J, P52; KERR AG, 1978, PRACTITIONER, V221, P677; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; KIMURA RS, 1982, AM J OTOLARYNG, V3, P447, DOI 10.1016/S0196-0709(82)80023-9; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Leo P, 2016, EPIDEMIOLOGY TRANSLA; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Linck A., 1921, Z OHRENH; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; McKee AC, 2017, JAMA-J AM MED ASSOC, V318, P2353, DOI 10.1001/jama.2017.16687; Millspaugh J., 1937, US NAVAL MED B, V35, pe303; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; NEWMAN CW, 1991, EAR HEARING, V12, P355, DOI 10.1097/00003446-199110000-00009; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Saito Y, 1986, Auris Nasus Larynx, V13 Suppl 1, pS69; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; Shangkuan WC, 2017, LARYNGOSCOPE, V127, P2627, DOI 10.1002/lary.26567; Singh D, 1968, J Laryngol Otol, V82, P1017, DOI 10.1017/S0022215100069802; Singh G, 2013, INDIAN J OTOLARYNGOL, V65, pS498, DOI 10.1007/s12070-011-0404-6; SPILLANE J D, 1962, Br Med J, V2, P1205; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TETER DL, 1970, LARYNGOSCOPE, V80, P1122, DOI 10.1288/00005537-197007000-00010; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Voss O., 1936, SURG SKULL BASE FRAC; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; Wittmaack K., 1932, ARCH F OHRENH, V131, P59; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; ZIV M, 1973, MIL MED, V138, P811, DOI 10.1093/milmed/138.12.811; [No title captured]; [No title captured]; [No title captured]; [No title captured]	77	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAR	2020	130	3					761	767		10.1002/lary.28034			7	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Otorhinolaryngology	KM6CF	WOS:000514225500036	31066921				2022-02-06	
J	Lalonde, G; Bernier, A; Beaudoin, C; Gravel, J; Beauchamp, MH				Lalonde, Gabrielle; Bernier, Annie; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.			Factors contributing to parent-child interaction quality following mild traumatic brain injury in early childhood	JOURNAL OF NEUROPSYCHOLOGY			English	Article						concussion; paediatric; parent-child interaction; social skills; traumatic brain injury	MUTUALLY RESPONSIVE ORIENTATION; POST-CONCUSSIVE SYMPTOMS; MOTHER-CHILD; HEAD-INJURY; BEHAVIOR PROBLEMS; POSTCONCUSSION SYNDROME; DYADIC ADJUSTMENT; YOUNG-CHILDREN; SLEEP; STRESS	There is emerging evidence that parent-child interactions are affected by early childhood traumatic brain injury (TBI). These findings are of functional importance when considering the high prevalence of TBI in early childhood alongside evidence that young children exposed to positive relationships with their parents early in life exhibit better social functioning concurrently and longitudinally. Given that the overall quality of parent-child interactions is the result of both parent and child emotional and behavioural dispositions, it remains unclear which parental or child-related factors contribute to the quality of interactions post-TBI. The aim of this study was to investigate the factors that contribute to the quality of parent-child interactions following early childhood TBI. The sample included 68 children (18-60 months at recruitment) with accidental, uncomplicated mild TBI (mTBI). The quality of parent-child interactions was assessed 6 months post-injury using the Mutually Responsive Orientation scale, an observational measure of the dyadic quality of parent-child exchanges. Potential contributing factors were assessed among parental factors (e.g., age, socioeconomic status, family burden, parental stress, marital satisfaction) and child-related factors (e.g., age, sex, symptoms, fatigue, adaptive/behavioural skills). Socioeconomic status, child post-concussive symptoms, and child sleep problems were found to be significant independent contributing factors to parent-child interactions six months post-injury. This study provides the first evidence that both parental and child factors relate to the quality of parent-child interactions following mTBI, thus contributing to a better understanding of the scope and complexity of factors that play a role in childrens' recovery.	[Lalonde, Gabrielle; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Lalonde, Gabrielle; Bernier, Annie; Beaudoin, Cindy; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Vile, Montreal, PQ H3C 3J7, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Vile, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Beauchamp, Miriam/0000-0002-8637-6361			Abidin, 1995, PARENTING STRESS IND; ABIDIN RR, 1992, J CLIN CHILD PSYCHOL, V21, P407, DOI 10.1207/s15374424jccp2104_12; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson VA, 2000, BRAIN INJURY, V14, P679; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barroso NE, 2016, PSYCHOL ASSESSMENT, V28, P1331, DOI 10.1037/pas0000257; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beaudoin C., 2017, 12 WORLD C BRAIN INJ; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Belsky J., 1988, CLIN IMPLICATIONS AT, P45; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bernier A, 2010, CHILD DEV, V81, P1739, DOI 10.1111/j.1467-8624.2010.01507.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bornstein MH, 2012, AM J COMMUN PSYCHOL, V50, P89, DOI 10.1007/s10464-011-9479-1; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Camberis AL, 2016, INFANCY, V21, P396, DOI 10.1111/infa.12116; Carr A, 2012, DEV PSYCHOL, V48, P543, DOI 10.1037/a0025888; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Crnic K., 2002, HDB PARENTING VOLUME, P243; Crnic KA, 2005, INFANT CHILD DEV, V14, P117, DOI 10.1002/icd.384; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dahl RE, 2007, J FAM PSYCHOL, V21, P1, DOI 10.1037/0893-3200.21.1.1; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; De Falco S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00898; Deater-Deckard K, 1998, CLIN PSYCHOL-SCI PR, V5, P314, DOI 10.1111/j.1468-2850.1998.tb00152.x; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Deonandan R., 2000, CHRONIC DIS CANADA, V21, P1; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Faul M, 2010, TRAUMATIC BRAIN INJU; Francis, 2007, SENSORIA, V3, P76; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Haskett ME, 2006, J CLIN CHILD ADOLESC, V35, P302, DOI 10.1207/s15374424jccp3502_14; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayes C.D., 1987, RISKING FUTURE ADOLE, P174; Hoff E., 2019, HDB PARENTING BIOL E, P231; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kelly JP, 2001, J ATHL TRAINING, V36, P249; KLEBANOV PK, 1994, J MARRIAGE FAM, V56, P441, DOI 10.2307/353111; Kochanska G, 2005, J CHILD PSYCHOL PSYC, V46, P19, DOI 10.1111/j.1469-7610.2004.00348.x; Kochanska G, 2000, CHILD DEV, V71, P417, DOI 10.1111/1467-8624.00154; Kochanska G, 2008, CHILD DEV, V79, P30, DOI 10.1111/j.1467-8624.2007.01109.x; Kouros CD, 2014, J FAM PSYCHOL, V28, P315, DOI 10.1037/a0036804; Krishnakumar A, 2000, FAM RELAT, V49, P25, DOI 10.1111/j.1741-3729.2000.00025.x; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Martin J, 2007, PEDIATRICS, V119, P947, DOI 10.1542/peds.2006-2569; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McLoyd VC, 1998, STUDYING MINORITY ADOLESCENTS, P251; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meltzer LJ, 2007, J FAM PSYCHOL, V21, P67, DOI 10.1037/0893-3200.21.1.67; Meltzer LJ, 2011, PEDIATR CLIN N AM, V58, P765, DOI 10.1016/j.pcl.2011.03.010; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Nelson JA, 2009, J FAM PSYCHOL, V23, P671, DOI 10.1037/a0015977; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Paniak C, 2000, BRAIN INJURY, V14, P219; Peterson CC, 2004, J PEDIATR PSYCHOL, V29, P331, DOI 10.1093/jpepsy/jsh037; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Repetti R. L., 1987, APPLIED SOCIAL PSYCH, V7, P98; Repetti RL, 2015, J MARRIAGE FAM, V77, P126, DOI 10.1111/jomf.12143; Rook S, 2016, PEDIAT PAIN LETT, V18, P9; Sabourin S, 2005, PSYCHOL ASSESSMENT, V17, P15, DOI 10.1037/1040-3590.17.1.15; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thomson RM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-247; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Varni JW, 2004, J RHEUMATOL, V31, P2494; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	106	6	6	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2020	14	1					98	120		10.1111/jnp.12179			23	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KT2TC	WOS:000518867500007	30779296				2022-02-06	
J	Molteni, E; Colombo, K; Pastore, V; Galbiati, S; Recla, M; Locatelli, F; Galbiati, S; Fedeli, C; Strazzer, S				Molteni, Erika; Colombo, Katia; Pastore, Valentina; Galbiati, Susanna; Recla, Monica; Locatelli, Federica; Galbiati, Sara; Fedeli, Claudia; Strazzer, Sandra			Joint Neuropsychological Assessment through Coma/Near Coma and Level of Cognitive Functioning Assessment Scales Reduces Negative Findings in Pediatric Disorders of Consciousness	BRAIN SCIENCES			English	Article						pediatric brain injury; vegetative state; unresponsive wakefulness syndrome; minimally conscious state; early intensive neuropsychological assessment; Coma; Near Coma Scale; Level of Cognitive Functioning Assessment Scale	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS; IMPAIRED CONSCIOUSNESS; YOUNG-ADULTS; HEAD-INJURY; CHILDREN; RECOVERY; STATE; PAIN	The present study aimed to: (a) characterize the emergence to a conscious state (CS) in a sample of children and adolescents with severe brain injury during the post-acute rehabilitation and through two different neuropsychological assessment tools: the Rappaport Coma/Near Coma Scale (CNCS) and Level of Cognitive Functioning Assessment Scale (LOCFAS); (b) compare the evolution in patients with brain lesions due to traumatic and non-traumatic etiologies; and (c) describe the relationship between the emergence to a CS and some relevant clinical variables. In this observational prospective longitudinal study, 92 consecutive patients were recruited. Inclusion criteria were severe disorders of consciousness (DOC), Glasgow Coma Scale (GCS) score <= 8 at insult, age 0 to 18 years, and direct admission to inpatient rehabilitation from acute care. The main outcome measures were CNCS and LOCFAS, both administered three and six months after injury. The cohort globally shifted towards milder DOC over time, moving from overall 'moderate/near coma' at three months to 'near/no coma' at six months post-injury. The shift was captured by both CNCS and LOCFAS. CNCS differentiated levels of coma at best, while LOCFAS was superior in characterizing the emergence from coma. Agreement between scales was fair, and reduced negative findings at less than 10%. Patients with traumatic brain injury (TBI) vs. non-traumatic brain injury (NTBI) were older and had neurosurgical intervention more frequently. No relation between age and the level of consciousness was found overall. Concurrent administration of CNCS and LOCFAS reduced the rate of false negatives and better detected signs of arousal and awareness. This provides indication to administer both tools to increase measurement precision.	[Molteni, Erika] Kings Coll London, Sch Biomed Engn & Imaging Sci, London SE1 7EU, England; [Molteni, Erika] Kings Coll London, Ctr Med Engn, London SE1 7EU, England; [Colombo, Katia; Pastore, Valentina; Galbiati, Susanna; Recla, Monica; Fedeli, Claudia] IRCCS Eugenio Medea, Neurophysiatr Dept, Neuropsychol & Cognit Behav Serv, Sci Inst, I-23842 Bosisio Parini, Italy; [Locatelli, Federica; Galbiati, Sara; Strazzer, Sandra] IRCCS Eugenio Medea, Neurophysiatr Dept, Sci Inst, I-23842 Bosisio Parini, Italy		Molteni, E (corresponding author), Kings Coll London, Sch Biomed Engn & Imaging Sci, London SE1 7EU, England.; Molteni, E (corresponding author), Kings Coll London, Ctr Med Engn, London SE1 7EU, England.; Colombo, K (corresponding author), IRCCS Eugenio Medea, Neurophysiatr Dept, Neuropsychol & Cognit Behav Serv, Sci Inst, I-23842 Bosisio Parini, Italy.	erika.molteni@kcl.ac.uk; katia.colombo@lanostrafamiglia.it; valentina.pastore@lanostrafamiglia.it; susanna.galbiati@lanostrafamiglia.it; monica.recla@lanostrafamiglia.it; federica.locatelli@lanostrafamiglia.it; sara.galbiati@lanostrafamiglia.it; claudia.fedeli@lanostrafamiglia.it; sandra.strazzer@lanostrafamiglia.it	Galbiati, Sara/AAA-7115-2020; Strazzer, Sandra/AAH-5712-2019; Galbiati, Susanna/AAH-6883-2019; Recla, Monica/ABG-1905-2020; Colombo, Katia/ABE-5754-2020; Molteni, Erika/P-4564-2016	Galbiati, Sara/0000-0001-6810-359X; Strazzer, Sandra/0000-0001-8414-6565; Galbiati, Susanna/0000-0001-7209-4251; Recla, Monica/0000-0002-3001-8872; Colombo, Katia/0000-0002-5390-106X; Molteni, Erika/0000-0001-7773-8140	'KCL-Medical Research Council Skills Development Scheme' funds; NIHR BRC based at Guy's and St Thomas Trust and King's College London (KCL); Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z];  [07/08-CE];  [61/10-CE];  [027/15];  [05/19-CE]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Project ex art. 56 L 289/2002, funds year 2005 to Scientific Institute `IRCCS E. Medea' (PS-RIABIL Ex56/05/14 approved on 15 February 2008 and prot 07/08-CE); Ricerca Corrente years 2010-2012 (ID RC 2010 approved on 20 April 2010 and prot 61/10-CE), 2015-2016 (ID 027/15 approved on 24 March 2015 and prot 027/15), and 2019-2020 (ID n. 607 Rev.1-version n.1/25.02.2019 approved on 7 March 2019 and prot N. 05/19-CE) to Scientific Institute `IRCCS E. Medea', awarded to Sandra Strazzer and Valentina Pastore as Principal Investigators; `KCL-Medical Research Council Skills Development Scheme' funds awarded to Erika Molteni, NIHR BRC based at Guy's and St Thomas Trust and King's College London (KCL) and TheWellcome/EPSRC Centre for Medical Engineering (WT 203148/Z/16/Z).	Alvarez G, 2019, ARCH PHYS MED REHAB, V100, P687, DOI 10.1016/j.apmr.2018.12.022; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Aubinet C, 2018, HUM BRAIN MAPP, V39, P4519, DOI 10.1002/hbm.24303; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Bates D, 2003, CLIN MED, V3, P249; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Bruno M.A., 2009, P 19 M EUR NEUR SOC; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Corrigan J.D., 2010, J HEAD TRAUMA REHAB, V21, P375; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Flannery J, 1998, Rehabil Nurs, V23, P88; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hagen C., COMMUN DISORD SERV; Haley SM, 2004, PEDIATR NEUROL, V31, P333, DOI 10.1016/j.pediatrneurol.2004.05.002; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Melotte E, 2018, J NEUROL, V265, P954, DOI 10.1007/s00415-018-8794-y; Molteni E, 2019, BRAIN INJURY, V33, P517, DOI 10.1080/02699052.2019.1565899; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Peterson A, 2015, NEUROIMAGE-CLIN, V7, P588, DOI 10.1016/j.nicl.2015.02.008; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Philbin M K, 2000, J Perinatol, V20, pS68; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Rappaport M., COMA NEAR COMA SCALE; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2015, PM&R, V7, pS270, DOI 10.1016/j.pmrj.2015.09.016; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Slomine BS, 2019, BRAIN INJURY, V33, P1640, DOI 10.1080/02699052.2019.1658221; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; TEASDALE G, 1974, LANCET, V2, P81; Villa F, 2015, J CHILD NEUROL, V30, P1125, DOI 10.1177/0883073814553798; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	50	6	6	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAR	2020	10	3							162	10.3390/brainsci10030162			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LB0FS	WOS:000524314600044	32178348	Green Published, gold			2022-02-06	
J	Moulahoum, H; Zamani, FG; Timur, S; Zihnioglu, F				Moulahoum, Hichem; Zamani, Faezeh; Timur, Suna; Zihnioglu, Figen			Metal Binding Antimicrobial Peptides in Nanoparticle Bio-functionalization: New Heights in Drug Delivery and Therapy	PROBIOTICS AND ANTIMICROBIAL PROTEINS			English	Article						Antimicrobial peptides; Metal ions; Histidine-rich peptides; Histatins; Bio-functionalized nanoparticles; Brain diseases	CELL-PENETRATING PEPTIDE; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ANTIBACTERIAL PEPTIDES; MULTIDRUG-RESISTANCE; AMPHIPHILIC PEPTIDE; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; RECENT PROGRESS; CANCER-THERAPY	Peptides are considered very important due to the diversity expressed through their amino acid sequence, structure variation, large spectrum, and their essential role in biological systems. Antimicrobial peptides (AMPs) emerged as a potent tool in therapy owing to their antimicrobial properties but also their ability to trespass the membranes, specificity, and low toxicity. They comprise a variety of peptides from which specific amino acid-rich peptides are of interest to the current review due to their features in metal interaction and cell penetration. Histidine-rich peptides such as Histatins belong to the metal binding salivary residing peptides with efficient antibacterial, antifungal, and wound-healing activities. Furthermore, their ability to activate in acidic environment attracted the attention to their potential in therapy. The current review covers the current knowledge about AMPs and critically assess the potential of associating with metal ions both structurally and functionally. This review provides interesting hints for the advantages provided by AMPs and metal ions in biomedicine, making use of their direct properties in brain diseases therapy or in the creation of new bio-functionalized nanoparticles for cancer diagnosis and treatment.	[Moulahoum, Hichem; Zamani, Faezeh; Timur, Suna; Zihnioglu, Figen] Ege Univ, Fac Sci, Biochem Dept, TR-35100 Izmir, Turkey		Moulahoum, H; Zihnioglu, F (corresponding author), Ege Univ, Fac Sci, Biochem Dept, TR-35100 Izmir, Turkey.	hic_moul@hotmail.com; figen.zihnioglu@ege.edu.tr	Moulahoum, Hichem/AAA-7571-2022; Zihnioglu, Figen/AAG-4834-2021; Ghorbanizamani, Faezeh/ABE-3800-2021	Moulahoum, Hichem/0000-0003-3934-6415; Ghorbanizamani, Faezeh/0000-0001-8541-0540			Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Alies B, 2012, CHEM-EUR J, V18, P1161, DOI 10.1002/chem.201102746; Auld DS, 2001, ZINC COORDINATION SP; Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; Barondeau DP, 2004, CURR OPIN STRUC BIOL, V14, P765, DOI 10.1016/j.sbi.2004.10.012; Berkessel A, 1999, ANGEW CHEM INT EDIT, V38, P102, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<102::AID-ANIE102>3.0.CO;2-H; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Chen W, 2006, APPL SURF SCI, V253, P1762, DOI 10.1016/j.apsusc.2006.03.012; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chiu LS, 2017, MOL NEUROBIOL, V54, P7838, DOI 10.1007/s12035-016-0287-3; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Conde R., 2012, ANTIMICROBIAL AGENTS, P51; Conklin SE, 2017, BIOCHEMISTRY-US, V56, P4244, DOI 10.1021/acs.biochem.7b00348; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; Davoudi Z, 2014, ASIAN PAC J CANCER P, V15, P4353, DOI 10.7314/APJCP.2014.15.10.4353; de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; Dharap SS, 2003, J CONTROL RELEASE, V91, P61, DOI 10.1016/S0168-3659(03)00209-8; Dinca A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020263; Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Fei LK, 2014, BIOMATERIALS, V35, P4082, DOI 10.1016/j.biomaterials.2014.01.047; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Ginotra YP, 2012, INORG CHEM, V51, P7960, DOI 10.1021/ic301244x; Gogoladze G, 2014, FEMS MICROBIOL LETT, V357, P63, DOI 10.1111/1574-6968.12489; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Grogan J, 2001, FEBS LETT, V491, P76, DOI 10.1016/S0014-5793(01)02157-3; Guo ZR, 2016, BIOMED REP, V4, P528, DOI 10.3892/br.2016.639; Gusman H, 2001, BBA-PROTEIN STRUCT M, V1545, P86, DOI 10.1016/S0167-4838(00)00265-X; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harding MM, 2010, CRYSTALLOGR REV, V16, P247, DOI 10.1080/0889311X.2010.485616; Harford C, 1997, ACCOUNTS CHEM RES, V30, P123, DOI 10.1021/ar9501535; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Helmfors H, 2015, ANAL BIOCHEM, V484, P136, DOI 10.1016/j.ab.2015.05.023; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XF, 1999, BIOCHEMISTRY-US, V38, P2160, DOI 10.1021/bi982587o; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Huang YZ, 2013, ADV DRUG DELIVER REV, V65, P1299, DOI 10.1016/j.addr.2012.11.007; Imamura Y, 2009, J BIOCHEM, V145, P279, DOI 10.1093/jb/mvn165; JAHDE E, 1982, CANCER RES, V42, P1498; Jiang TY, 2012, BIOMATERIALS, V33, P9246, DOI 10.1016/j.biomaterials.2012.09.027; Jiang ZW, 2015, CHEM SOC REV, V44, P4264, DOI 10.1039/c4cs00387j; Kato T, 2016, BIOORGAN MED CHEM, V24, P2681, DOI 10.1016/j.bmc.2016.04.031; Khurshid Z, 2017, SAUDI PHARM J, V25, P25, DOI 10.1016/j.jsps.2016.04.027; Koh I, 2006, J PHYS CHEM B, V110, P1553, DOI 10.1021/jp0556310; Kulon K, 2008, J INORG BIOCHEM, V102, P960, DOI 10.1016/j.jinorgbio.2007.12.021; Kurowska E, 2011, J INORG BIOCHEM, V105, P1220, DOI 10.1016/j.jinorgbio.2011.06.002; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lakatos A, 2012, DALTON T, V41, P1713, DOI 10.1039/c1dt10989h; Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003; Li LY, 2004, INT J RADIAT ONCOL, V58, P1215, DOI 10.1016/j.ijrobp.2003.10.057; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Liang J, 2014, COLLOID SURFACE B, V114, P398, DOI 10.1016/j.colsurfb.2013.10.037; Licini G, 2003, ANGEW CHEM INT EDIT, V42, P4572, DOI 10.1002/anie.200301668; Lin CJ, 2010, BRAIN RES BULL, V82, P235, DOI 10.1016/j.brainresbull.2010.06.003; Lindgren M, 2006, BIOCHEM PHARMACOL, V71, P416, DOI 10.1016/j.bcp.2005.10.048; Loboda D, 2018, NEW J CHEM, V42, P7560, DOI 10.1039/c7nj04709f; Masood F, 2016, MAT SCI ENG C-MATER, V60, P569, DOI 10.1016/j.msec.2015.11.067; Melino S, 1999, BIOCHEMISTRY-US, V38, P9626, DOI 10.1021/bi990212c; Melino S, 2006, BIOCHEMISTRY-US, V45, P15373, DOI 10.1021/bi0615137; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003; Mishra B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00221; Missailidis S, 2005, J IMMUNOL METHODS, V296, P45, DOI 10.1016/j.jim.2004.10.011; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Mitra A, 2005, J CONTROL RELEASE, V102, P191, DOI 10.1016/j.jconrel.2004.09.023; Monje M, 2012, BEHAV BRAIN RES, V227, P376, DOI 10.1016/j.bbr.2011.05.012; Monsuez JJ, 2010, INT J CARDIOL, V144, P3, DOI 10.1016/j.ijcard.2010.03.003; Morales-Avila E, 2017, J NANOMATER, V2017, DOI 10.1155/2017/5831959; Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Pokorny A, 2005, BIOCHEMISTRY-US, V44, P9538, DOI 10.1021/bi0506371; Pokorny A, 2004, BIOCHEMISTRY-US, V43, P8846, DOI 10.1021/bi0497087; Porciatti E, 2010, INORG CHEM, V49, P8690, DOI 10.1021/ic902547t; Puri S, 2015, J DENT RES, V94, P201, DOI 10.1177/0022034514556709; Puri S, 2014, EUKARYOT CELL, V13, P958, DOI 10.1128/EC.00095-14; Rajchakit U, 2017, BIOCONJUGATE CHEM, V28, P2673, DOI 10.1021/acs.bioconjchem.7b00368; Sankararamakrishnan R, 2005, PROTEINS, V58, P211, DOI 10.1002/prot.20265; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Shi KR, 2015, J CONTROL RELEASE, V217, P138, DOI 10.1016/j.jconrel.2015.09.009; Song SJ, 2017, BIOCONJUGATE CHEM, V28, P2266, DOI 10.1021/acs.bioconjchem.7b00247; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Sousa MH, 2001, J MAGN MAGN MATER, V225, P67, DOI 10.1016/S0304-8853(00)01229-4; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; TANNOCK IF, 1989, CANCER RES, V49, P4373; Tay WM, 2009, BIOORG MED CHEM LETT, V19, P6709, DOI 10.1016/j.bmcl.2009.09.119; Tie SL, 2006, COLLOID SURFACE A, V273, P75, DOI 10.1016/j.colsurfa.2005.08.027; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; TROXLER RF, 1990, J DENT RES, V69, P2, DOI 10.1177/00220345900690010101; Turk BE, 2003, CURR OPIN CHEM BIOL, V7, P84, DOI 10.1016/S1367-5931(02)00004-2; Vargas JR, 2014, MOL PHARMACEUT, V11, P2553, DOI 10.1021/mp500161z; Viota JL, 2010, J COLLOID INTERF SCI, V344, P144, DOI 10.1016/j.jcis.2009.11.061; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; von zur Muhlen C, 2007, ATHEROSCLEROSIS, V193, P102, DOI 10.1016/j.atherosclerosis.2006.08.048; Wampler HP, 2009, MICRON, V40, P444, DOI 10.1016/j.micron.2009.01.002; Wang FH, 2014, J CONTROL RELEASE, V174, P126, DOI 10.1016/j.jconrel.2013.11.020; Wang G, 2010, ADV M C M, P1, DOI 10.1079/9781845936570.0000; WANG G, 2019, ANTIMICROBIAL PEPTID; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang GS, 2010, ANTIMICROB AGENTS CH, V54, P1343, DOI 10.1128/AAC.01448-09; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Wuerges J, 2004, P NATL ACAD SCI USA, V101, P8569, DOI 10.1073/pnas.0308514101; Xing G, 2001, CURR OPIN CHEM BIOL, V5, P196, DOI 10.1016/S1367-5931(00)00190-3; Yang XW, 2012, J PROTEOME RES, V11, P306, DOI 10.1021/pr200782u; Yao Jia, 2017, PeerJ, V5, pe3429, DOI 10.7717/peerj.3429; Zaro JL, 2012, J CONTROL RELEASE, V158, P357, DOI 10.1016/j.jconrel.2012.01.039; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang W, 2011, BIOCONJUGATE CHEM, V22, P1410, DOI 10.1021/bc200138d; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	126	6	6	3	29	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1867-1306	1867-1314		PROBIOTICS ANTIMICRO	Probiotics Antimicrob. Proteins	MAR	2020	12	1					48	63		10.1007/s12602-019-09546-5			16	Biotechnology & Applied Microbiology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Microbiology	KU2KO	WOS:000519537600006	31001788				2022-02-06	
J	Pinquart, M				Pinquart, Martin			Posttraumatic Stress Symptoms and Disorders in Children and Adolescents with Chronic Physical Illnesses: a Meta-Analysis	JOURNAL OF CHILD & ADOLESCENT TRAUMA			English	Article						Posttraumatic stress disorder; Pediatric medical traumatic stress; Chronic illness; Meta-analysis; Burn; Cancer; Heart disease; Traumatic brain injury	CHILDHOOD-CANCER; SOCIAL SUPPORT; MOTHERS; SURVIVORS; DEPRESSION; FAMILIES; PARENTS; IMPACT; GROWTH	The aim of the present meta-analysis was to compare levels of posttraumatic stress symptoms (PTSS) and the prevalence of posttraumatic stress disorders (PTSD) in individuals with and without pediatric chronic physical illnesses, and to analyze correlates of these symptoms. In total, 150 studies were identified that provided relevant data. On average, 11.5% of the participants with pediatric chronic physical illnesses met the criteria of PTSD (Odds Ratio 2.70). PTSS were also more common in this group than in control groups without chronic physical illnesses. While the PTSS levels did not differ across physical diseases, we found positive associations of PTSS with illness severity and duration/intensity of treatment, as well as negative associations with duration of illness, time since last treatment, treatment adherence, and family functioning. We conclude that individuals with pediatric chronic physical illnesses who experienced traumatic events should be screened for PTSS and receive psychological interventions when needed.	[Pinquart, Martin] Philipps Univ, Dept Psychol, Gutenbergstr 18, D-35032 Marburg, Germany		Pinquart, M (corresponding author), Philipps Univ, Dept Psychol, Gutenbergstr 18, D-35032 Marburg, Germany.	pinquart@staff.uni-marburg.de					Achenbach T., 1991, INTEGRATIVE GUIDE 19; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Barakat LR, 2006, SOC BEHAV PERSONAL, V34, P999, DOI 10.2224/sbp.2006.34.8.999; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; BUCKLEY TC, 2004, ASSESSING PSYCHOL TR, P00441; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Drotar, 2006, TRAUMATOLOGY, V12, P148, DOI [DOI 10.1177/1534765606294562, 10.77/1534765606294562]; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ferro MA, 2009, EPILEPSIA, V50, P2344, DOI 10.1111/j.1528-1167.2009.02276.x; Frederick C., 1992, CHILDHOOD POSTTRAUMA; Graziano S, 2016, J CHILD HEALTH CARE, V20, P174, DOI 10.1177/1367493514563854; Gustafson, 1996, ADAPTATION CHRONIC C; Higgins, 2005, COMPREHENSIVE META A; Higgins PT, 2009, COCHRANE HDB SYSTEMA; Jalmsell L, 2015, DEATH STUD, V39, P111, DOI 10.1080/07481187.2014.913086; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kazak AE, 2004, J FAM PSYCHOL, V18, P493, DOI 10.1037/0893-3200.18.3.493; Kazak AE, 1997, J CONSULT CLIN PSYCH, V65, P120, DOI 10.1037/0022-006X.65.1.120; Kerkar N, 2006, J PEDIATR GASTR NUTR, V43, P629, DOI 10.1097/01.mpg.0000239735.87111.ba; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; La Greca A, 2004, MANUAL SELF CARE INV; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; Le Brocque RM, 2010, J PEDIATR PSYCHOL, V35, P637, DOI 10.1093/jpepsy/jsp050; Lipsey M.W., 2001, PRACTICAL META ANAL; Meentken MG, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00020; Moos R., 1994, FAMILY ENV SCALE MAN; Morina N, 2016, CLIN PSYCHOL REV, V47, P41, DOI 10.1016/j.cpr.2016.05.006; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Rodriguez N SA, 1998, UCLA POSTTRAUMATIC S; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Tillery R, 2016, J PEDIATR PSYCHOL, V41, P290, DOI 10.1093/jpepsy/jsv091; Weiss Daniel S., 1997, P399; Werba BE, 2007, PEDIATR BLOOD CANCER, V48, P673, DOI 10.1002/pbc.21184; Yalug I, 2011, NEUROL PSYCHIAT BR, V17, P27, DOI 10.1016/j.npbr.2011.02.007; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	42	6	6	3	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1936-1521	1936-153X		J CHILD ADOLES TRAUM	J. Child Adolesc. Trauma	MAR	2020	13	1					1	10		10.1007/s40653-018-0222-z			10	Family Studies; Social Work	Emerging Sources Citation Index (ESCI)	Family Studies; Social Work	KX0PR	WOS:000521586500001	32318223	Green Published			2022-02-06	
J	Shepherd, D; Landon, J; Kalloor, M; Barker-Collo, S; Starkey, N; Jones, K; Ameratunga, S; Theadom, A				Shepherd, Daniel; Landon, Jason; Kalloor, Mathew; Barker-Collo, Suzanne; Starkey, Nicola; Jones, Kelly; Ameratunga, Shanthi; Theadom, Alice		BIONIC Res Grp	The association between health-related quality of life and noise or light sensitivity in survivors of a mild traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						Health-related quality of life; Brain injury; Noise sensitivity; Light sensitivity	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; 1ST YEAR; VISUAL IMPAIRMENTS; NEW-ZEALAND; POPULATION; PREDICTORS; VETERANS; RECOVERY	PurposeSensory impairment is a common aftereffect of mild traumatic brain injury (TBI); however, their influence upon treatment outcomes and quality of life has yet to be investigated. This study sought to determine the effects of noise and light sensitivity upon the quality of life of individuals diagnosed with a TBI.MethodsA cross-sectional adult sample obtained from a longitudinal study (n=293) provided measures of light and noise sensitivity and quality of life 12 months post injury. Sensitivities were taken from the Rivermead Post-concussion Symptoms Questionnaire, while quality of life was estimated using the Short-Form 36 health survey (SF-36).ResultsApproximately 42% of participants reported ongoing difficulties with noise and light sensitivity. Additionally, those reporting sensory difficulties also reported lower SF-36 domain and composite scores compared to those reporting no such symptoms. After controlling for known co-factors, hierarchical multiple regression analyses indicated that the combination of light and noise sensitivity explained between 8 and 35% of the variance in SF-36 scores.ConclusionsLight and noise sensitivity appear to degrade the quality of life of those with a mild TBI. Our findings challenge contemporary rehabilitation practices that tend to sideline sensory complaints and instead focus on the remediation of acute TBI symptoms.	[Shepherd, Daniel; Landon, Jason; Kalloor, Mathew; Theadom, Alice] Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Jones, Kelly] Auckland Univ Technol, Sch Publ Hlth, Private Bag 92006, Auckland 1142, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand		Shepherd, D (corresponding author), Auckland Univ Technol, Dept Psychol, Private Bag 92006, Auckland 1142, New Zealand.	daniel.shepherd@aut.ac.nz		Shepherd, Daniel/0000-0001-7089-7130			Assi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28312-1; Brotherton H, 2015, AUDIOL NEURO-OTOL, V20, P273, DOI 10.1159/000430459; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hallberg LRM, 2005, SCAND J CARING SCI, V19, P410, DOI 10.1111/j.1471-6712.2005.00361.x; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Job R.F. Soames, 1999, Noise Health, V1, P57; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Martenson ME, 2016, PAIN, V157, P868, DOI 10.1097/j.pain.0000000000000450; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Measuring health states, 2007, PUBLIC HLTH INTELLIG, V42; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Olofsson A, 2020, SCAND J OCCUP THER, V27, P194, DOI 10.1080/11038128.2018.1495762; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pryor J, 2004, DISABIL REHABIL, V26, P974, DOI 10.1080/09638280410001702397; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shepherd D, 2015, INT J ENV RES PUB HE, V12, P5284, DOI 10.3390/ijerph120505284; Shepherd D, 2013, INT J ENV RES PUB HE, V10, P1284, DOI 10.3390/ijerph10041284; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593, DOI DOI 10.7717/PEERJ.5676; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Ware J.E., 1994, SF 36 PHYS MENTAL SU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Welch D, 2013, NOISE HEALTH, V15, P224, DOI 10.4103/1463-1741.113513; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241	42	6	6	1	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	MAR	2020	29	3					665	672		10.1007/s11136-019-02346-y			8	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	KU3QF	WOS:000519625600001	31667708				2022-02-06	
J	Teymoori, A; Gorbunova, A; Haghish, FE; Real, R; Zeldovich, M; Wu, YJ; Polinder, S; Asendorf, T; Menon, D; von Steinbuechel, N				Teymoori, Ali; Gorbunova, Anastasia; Haghish, Fardzadeh E.; Real, Ruben; Zeldovich, Marina; Wu, Yi-Jhen; Polinder, Suzanne; Asendorf, Thomas; Menon, David; von Steinbuechel, Nicole		CTR-TBI Investigators	Factorial Structure and Validity of Depression (PHQ-9) and Anxiety (GAD-7) Scales after Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						depression; anxiety; bifactorial model; validity; comorbidity	GLASGOW COMA SCALE; HOSPITAL ANXIETY; LIFETIME PREVALENCE; MENTAL-DISORDERS; BIFACTOR MODEL; CENTER-TBI; COMORBIDITY; CARE; ASSOCIATION; MULTICENTER	Background: The dimensionality of depression and anxiety instruments have recently been a source of controversy. Objectives and Design: In a European-wide sample of patients after Traumatic Brain Injury (TBI), we aim to examine the factorial structure, validity, and association of the Patient Health Questionnaire for depression (PHQ-9) and the Generalized Anxiety Disorder (GAD-7) instruments. This study is based on longitudinal observational data. We conducted analyses of factorial structure and discriminant validity of outcomes six-months after TBI. We also examined the prevalence, co-occurrence, and changes of scores on the PHQ-9 and GAD-7 at 3-, 6-, and 12-month post-TBI assessments. Participants: At six-months post-TBI assessment, 2137 (738 (34.5%) women) participants completed the PHQ-9 and GAD-7 questionnaires. For the longitudinal analysis, we had 1922 participants (672 (35.0%) women). Results: The results of exploratory factor analysis suggested a general latent construct underlying both PHQ-9 and GAD-7 measures. Confirmatory factor analyses showed a slight improvement in the fit indices for the bifactorial model. The Omega hierarchical test clearly differentiated two subfactors of PHQ-9 and GAD-7 items over and above the underlying general factor; however, most of the variance (85.0%) was explained by the general factor and the explained variance of the subfactors was small. The PHQ-9 and GAD-7 performed similarly in detecting post-traumatic stress disorder (PTSD). As defined by conventional cut-offs, depression and anxiety have different prevalence rates in the sample. The scales also differed in their relationships with the short form of health survey (SF-36v2) subscales. The longitudinal analysis showed high stability of depression and anxiety symptoms: 49-67% of the post-TBI patients with comorbid depression and anxiety reported the persistence of the symptoms over time. Discussion: The factorial structure analysis favors a general latent construct underlying both depression and anxiety scales among patients after TBI. We discuss the implications our findings and future research directions.	[Teymoori, Ali] Helmut Schmidt Univ, Dept Social Psychol, D-22043 Hamburg, Germany; [Teymoori, Ali; Gorbunova, Anastasia; Haghish, Fardzadeh E.; Real, Ruben; Zeldovich, Marina; Wu, Yi-Jhen; Asendorf, Thomas; von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands; [Asendorf, Thomas] Georg August Univ, Inst Med Stat, Med Ctr, D-37073 Gottingen, Germany; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 157, Cambridge CB2 0QQ, England		Teymoori, A (corresponding author), Helmut Schmidt Univ, Dept Social Psychol, D-22043 Hamburg, Germany.; Teymoori, A (corresponding author), Georg August Univ, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	ali.teymoori@uqconnect.edu.au; Anastasia.Gorbunova@med.uni-goettingen.de; haghish.ebad-fardzadeh@med.uni-goettingen.de; r.real@web.de; marina.zeldovich@med.uni-goettingen.de; yi-jhen.wu@med.uni-goettingen.de; s.polinder@erasmusmc.nl; thomas.asendorf@med.uni-goettingen.de; dkm13@wbic.cam.ac.uk; nvsteinbuechel@med.uni-goettingen.de	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Menon, David/0000-0002-3228-9692; Teymoori, Ali/0000-0003-2227-7361	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); One Mind (USA); Integra Life Sciences Corporation (USA); Neurotrauma Sciences (USA)	The European Union Seventh Framework program (EC grant 602150) supported the CENTER-TBI study. The Hannelore Kohl Stiftung (Germany), One Mind (USA), Integra Life Sciences Corporation (USA), and Neurotrauma Sciences (USA) were additional funding parties.	Acquadro C., 2012, LINGUISTIC VALIDATIO; Barkin R L, 2000, Am J Ther, V7, P205, DOI 10.1097/00045391-200007030-00008; Bonifay W, 2017, CLIN PSYCHOL SCI, V5, P184, DOI 10.1177/2167702616657069; Boothroyd L., 2018, HLTH PRIMARY CARE, V2, P1; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buckby JA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-50; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Byrne B. M., 2016, STRUCTURAL EQUATION, V3rd; Caci H, 2003, PSYCHIAT RES, V118, P89, DOI 10.1016/S0165-1781(03)00044-1; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chen FF, 2012, J PERS, V80, P219, DOI 10.1111/j.1467-6494.2011.00739.x; Cohen J., 2013, STAT POWER ANAL BEHA; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Cummings CM, 2014, PSYCHOL BULL, V140, P816, DOI 10.1037/a0034733; DOBSON KS, 1985, CLIN PSYCHOL REV, V5, P307, DOI 10.1016/0272-7358(85)90010-8; Dunbar M, 2000, BRIT J CLIN PSYCHOL, V39, P79, DOI 10.1348/014466500163121; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Garber J, 2010, CLIN PSYCHOL-SCI PR, V17, P293, DOI 10.1111/j.1468-2850.2010.01221.x; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Hinz A, 2001, PSYCHOTHER PSYCH MED, V51, P193, DOI 10.1055/s-2001-13279; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iani L, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-84; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kline P., 2014, EASY GUIDE FACTOR AN; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2016, PSYCHOSOM MED, V78, P716, DOI 10.1097/PSY.0000000000000322; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kruger-Gottschalk A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1541-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McCrum-Gardner E, 2008, BRIT J ORAL MAX SURG, V46, P38, DOI 10.1016/j.bjoms.2007.09.002; MENDELS J, 1972, ARCH GEN PSYCHIAT, V27, P649; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Norton S, 2013, J PSYCHOSOM RES, V74, P74, DOI 10.1016/j.jpsychores.2012.10.010; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Parker G, 1999, J AFFECT DISORDERS, V52, P11, DOI 10.1016/S0165-0327(98)00084-6; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Rodriguez A, 2016, PSYCHOL METHODS, V21, P137, DOI 10.1037/met0000045; Rodriguez A, 2016, J PERS ASSESS, V98, P223, DOI 10.1080/00223891.2015.1089249; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teymoori A, 2020, J AFFECT DISORDERS, V262, P278, DOI 10.1016/j.jad.2019.10.035; Toft T, 2005, PSYCHOL MED, V35, P1175, DOI 10.1017/S0033291705004459; Ware Jr J.E., 2007, USERS MANUAL SF 36V2; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	6	7	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAR	2020	9	3							873	10.3390/jcm9030873			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LF2UT	WOS:000527278800262	32210017	Green Published, gold			2022-02-06	
J	Townsend, JM; Sali, G; Homburg, HB; Cassidy, NT; Sanders, ME; Fung, KM; Andrews, BT; Nudo, RJ; Bohnstedt, BN; Detamore, MS				Townsend, Jakob M.; Sali, Goksel; Homburg, Hannah B.; Cassidy, Nina T.; Sanders, Megan E.; Fung, Kar-Ming; Andrews, Brian T.; Nudo, Randolph J.; Bohnstedt, Bradley N.; Detamore, Michael S.			Thiolated bone and tendon tissue particles covalently bound in hydrogels for in vivo calvarial bone regeneration	ACTA BIOMATERIALIA			English	Article						Calvarial bone; Hyaluronic acid; Hydrogel; Thiolated bone; Thiolated tendon	HYALURONIC-ACID; DECOMPRESSIVE CRANIECTOMY; EXTRACELLULAR-MATRIX; COLLOIDAL GELS; INJECTABLE HYDROGEL; BEHAVIOR; HEMICRANIECTOMY; COMPLICATION; PLACEMENT; SCAFFOLDS	Bone regeneration of large cranial defects, potentially including traumatic brain injury (TBI) treatment, presents a major problem with non-crosslinking, clinically available products due to material migration outside the defect. Commercial products such as bone cements are permanent and thus not conducive to bone regeneration, and typical commercial bioactive materials for bone regeneration do not crosslink. Our previous work demonstrated that non-crosslinking materials may be prone to material migration following surgical placement, and the current study attempted to address these problems by introducing a new hydrogel system where tissue particles are themselves the crosslinker. Specifically, a pentenoate-modified hyaluronic acid (PHA) polymer was covalently linked to thiolated tissue particles of demineralized bone matrix (TDBM) or devitalized tendon (TDVT), thereby forming an interconnected hydrogel matrix for calvarial bone regeneration. All hydrogel precursor solutions exhibited sufficient yield stress for surgical placement and an adequate compressive modulus post-crosslinking. Critical-size calvarial defects were filled with a 4% PHA hydrogel containing 10 or 20% TDBM or TDVT, with the clinical product DBX (R) being employed as the standard of care control for the in vivo study. At 12 weeks, micro-computed tomography analysis demonstrated similar bone regeneration among the experimental groups, TDBM and TDVT, and the standard of care control DBX (R). The group with 10% TDBM was therefore identified as an attractive material for potential calvarial defect repair, as it additionally exhibited a sufficient initial recovery after shearing (i.e., > 80% recovery). Future studies will focus on applying a hydrogel in a rat model for treatment of TBI. Statement of Significance Non-crosslinking materials may be prone to material migration from a calvarial bone defect following surgical placement, which is problematic for materials intended for bone regeneration. Unfortunately. typical crosslinking materials such as bone cements are permanent and thus not conducive to bone regeneration, and typical bioactive materials for bone regeneration such as tissue matrix are not crosslinked in commercial products. The current study addressed these problems by introducing a new biomaterial where tissue particles are themselves the crosslinker in a hydrogel system. The current study successfully demonstrated a new material based on pentenoate-modified hyaluronic acid with thiolated demineralized bone matrix that is capable of rapid crosslinking, with desirable paste-like rheology of the precursor material for surgical placement, and with bone regeneration comparable to a commercially available standard-of-care product. Such a material may hold promise for a single-surgery treatment of severe traumatic brain injury (TBI) following hemicraniectomy. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Townsend, Jakob M.; Cassidy, Nina T.; Sanders, Megan E.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Sali, Goksel; Homburg, Hannah B.; Bohnstedt, Bradley N.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurosurg, Oklahoma City, OK USA; [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Andrews, Brian T.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66103 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66103 USA		Detamore, MS (corresponding author), Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.	detamore@ou.edu		Andrews, Brian/0000-0003-3994-6808	Growth Fund program of the University of Oklahoma Office of Technology Development	The authors would like to thank the Stephenson Cancer Tissue Pathology Core at the University of Oklahoma Health Sciences Center for generously providing histology services. The authors would also like to thank Drs. Hong Liu and Yuhua Li for help with microcomputed tomography of the rat skulls. Research reported in this publication was supported by the Growth Fund program of the University of Oklahoma Office of Technology Development.	Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Beck EC, 2016, ACTA BIOMATER, V38, P94, DOI 10.1016/j.actbio.2016.04.019; Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5; Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Horcajo CB, 2018, CYTOTHERAPY, V20, P314, DOI 10.1016/j.jcyt.2017.11.012; Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Chen CL, 2019, J BIOMED MATER RES B, V107, P529, DOI 10.1002/jbm.b.34144; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.TEA.2012.0733, 10.1089/ten.tea.2012.0733]; Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.teb.2014.0419, 10.1089/ten.TEB.2014.0419]; Gao XL, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9051013; Honeybul S, 2017, J REHABIL MED, V49, P204, DOI 10.2340/16501977-2209; Kamal M, 2019, J BIOMED MATER RES B, V107, P773, DOI 10.1002/jbm.b.34171; Kim D, 2019, INT J BIOL MACROMOL, V134, P749, DOI 10.1016/j.ijbiomac.2019.04.184; Kim YS, 2019, BIOENG TRANSL MED, V4, P83, DOI 10.1002/btm2.10110; Kiyotake EA, 2019, ACTA BIOMATER, V95, P176, DOI 10.1016/j.actbio.2019.01.041; Ko E, 2016, ACS APPL MATER INTER, V8, P22819, DOI 10.1021/acsami.6b05358; Koga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147235; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lang J, 2016, IDEGGYOGY SZEMLE, V69, P227, DOI 10.18071/isz.69.0227; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Moringlane RB, 2017, NEUROSURG REV, V40, P655, DOI 10.1007/s10143-017-0823-2; Omary R, 2013, J MOL NEUROSCI, V49, P157, DOI 10.1007/s12031-012-9922-2; Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068; Poldervaart MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177628; Rindone AN, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801565; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Tang ZM, 2019, BIOMATERIALS, V194, P57, DOI 10.1016/j.biomaterials.2018.12.015; Aroni MAT, 2019, CLIN ORAL INVEST, V23, P1605, DOI 10.1007/s00784-018-2588-6; Tiwari S, 2019, INT J BIOL MACROMOL, V121, P556, DOI 10.1016/j.ijbiomac.2018.10.049; Townsend J.M., 2017, DEV BIOMATERIALS CAL; Townsend JM, 2019, PROG POLYM SCI, V91, P126, DOI 10.1016/j.progpolymsci.2019.01.003; Townsend JM, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aaad77; Townsend JM, 2018, ACTA BIOMATER, V71, P148, DOI 10.1016/j.actbio.2018.02.013; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]; Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yin S, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801433; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	47	6	6	5	34	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	MAR 1	2020	104						66	75		10.1016/j.actbio.2019.12.035			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	KR0ZF	WOS:000517348400006	31904561	Bronze			2022-02-06	
J	Williams, RM; Ehde, DM; Day, M; Turner, AP; Hakimian, S; Gertz, K; Ciol, M; McCall, A; Kincaid, C; Pettet, MW; Patterson, D; Suri, P; Jensen, MP				Williams, Rhonda M.; Ehde, Dawn M.; Day, Melissa; Turner, Aaron P.; Hakimian, Shahin; Gertz, Kevin; Ciol, Marcia; McCall, Alisha; Kincaid, Carrie; Pettet, Mark W.; Patterson, David; Suri, Pradeep; Jensen, Mark P.			The chronic pain skills study: Protocol for a randomized controlled trial comparing hypnosis, mindfulness meditation and pain education in Veterans	CONTEMPORARY CLINICAL TRIALS			English	Article						Chronic pain; Hypnosis; Mindfulness meditation; Complementary and integrative medicine	TRAUMATIC BRAIN-INJURY; COGNITIVE THERAPY; SELF-HYPNOSIS; MULTIPLE-SCLEROSIS; MANAGEMENT; HEALTH; PSYCHOTHERAPY; INTERVENTION; METAANALYSIS; PREVALENCE	Objectives: To describe the protocol of a randomized controlled trial to evaluate the effectiveness and mechanisms of three behavioral interventions. Methods: Participants will include up to 343 Veterans with chronic pain due to a broad range of etiologies, randomly assigned to one of three 8-week manualized in-person group treatments: (1) Hypnosis (HYP), (2) Mindfulness Meditation (MM), or (3) Education Control (EDU). Projected outcomes: The primary aim of the study is to compare the effectiveness of HYP and MM to EDU on average pain intensity measured pre- and post-treatment. Additional study aims will explore the effectiveness of HYP and MM compared to EDU on secondary outcomes (i.e., pain interference, sleep, depression, anxiety and PTSD), and the maintenance of effects at 3- and 6-months post-treatment. Participants will have electroencephalogram (EEG) assessments at pre- and post-treatment to determine if the power of specific brain oscillations moderate the effectiveness of HYP and MM (Study Aim 2) and examine brain oscillations as possible mediators of treatment effects (exploratory aim). Additional planned exploratory analyses will be performed to identify possible treatment mediators (i.e., pain acceptance, catastrophizing, mindfulness) and moderators (e.g., hypnotizability, treatment expectations, pain type, cognitive function). Setting: The study treatments will be administered at a large Veterans Affairs Medical Center in the northwest United States. The treatments will be integrated within clinical infrastructure and delivered by licensed and credentialed health care professionals.	[Williams, Rhonda M.; Turner, Aaron P.; McCall, Alisha; Kincaid, Carrie; Suri, Pradeep] VA Puget Sound Hlth Care Syst, 1660 S Columbian Way,RCS 117, Seattle, WA 98108 USA; [Williams, Rhonda M.; Ehde, Dawn M.; Turner, Aaron P.; Gertz, Kevin; Ciol, Marcia; Patterson, David; Suri, Pradeep; Jensen, Mark P.] Univ Washington, Dept Rehabil Med, Sch Med, Ninth & Jefferson Bldg,Box 359612, Seattle, WA 98104 USA; [Day, Melissa] Univ Queensland, Fac Hlth & Behav Sci, Sch Psychol, St Lucia Campus, Brisbane, Qld 4072, Australia; [Hakimian, Shahin] Univ Washington, Harborview Med Ctr, Dept Neurol, Sch Med, 325 Ninth Ave,Box 359745, Seattle, WA 98104 USA; [Pettet, Mark W.] Univ Washington, Integrated Brain Imaging Ctr, Dept Radiol, 1959 NE Pacific St,Box 357115, Seattle, WA 98195 USA		Williams, RM (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way,RCS 117, Seattle, WA 98108 USA.	Rhonda.Williams1@va.gov	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003; Ciol, Marcia/0000-0001-6406-4706; Hakimian, Shahin/0000-0002-1310-2773	National Center for Complementary and Integrative Health [1R01AT008336-01]; University of WashingtonUniversity of Washington	This work was supported by the National Center for Complementary and Integrative Health (Grant #1R01AT008336-01, awarded to CoPrincipal Investigators Mark Jensen, PhD, and Rhonda Williams, PhD). The sponsor did not participate in study design, implementation of any part of the study, or any dissemination decisions or activities. This work was also supported in part with resources and facilities at VA Puget Sound Health Care System and the University of Washington. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. This trial is registered in Clinical Trials.gov (NCT02653664).	Adachi T, 2014, INT J CLIN EXP HYP, V62, P1, DOI 10.1080/00207144.2013.841471; Anamkath NS, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/3941682; Andersen SR, 2013, ACTA ONCOL, V52, P336, DOI 10.3109/0284186X.2012.745948; Bawa FLM, 2015, BRIT J GEN PRACT, V65, pE387, DOI 10.3399/bjgp15X685297; Becker PM, 2015, SLEEP MED CLIN, V10, P85, DOI 10.1016/j.jsmc.2014.11.003; Becker WC, 2018, J GEN INTERN MED, V33, pS11, DOI 10.1007/s11606-018-4345-6; Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Bennett MI, 2005, J PAIN, V6, P149, DOI 10.1016/j.jpain.2004.11.007; Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; Brugnoli MP, 2018, ANN PALLIAT MED, V7, P17, DOI 10.21037/apm.2017.10.03; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chamine I, 2018, J CLIN SLEEP MED, V14, P271, DOI 10.5664/jcsm.6952; Cherkin DC, 2016, JAMA-J AM MED ASSOC, V315, P1240, DOI 10.1001/jama.2016.2323; Cook KF, 2012, ARCH PHYS MED REHAB, V93, P1289, DOI 10.1016/j.apmr.2011.11.022; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; DAVIDSON RJ, 1977, INT J CLIN EXP HYP, V25, P291, DOI 10.1080/00207147708415986; Day MA, 2017, COMPLEMENT THER MED, V33, P94, DOI 10.1016/j.ctim.2017.06.009; Day MA, 2015, J PAIN, V16, P947, DOI 10.1016/j.jpain.2015.07.003; Day MA, 2014, J PAIN, V15, P691, DOI 10.1016/j.jpain.2014.03.003; Day MA, 2014, CLIN J PAIN, V30, P152, DOI 10.1097/AJP.0b013e318287a1dc; de Jong M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00967; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ehde DM, 2015, ARCH PHYS MED REHAB, V96, P1945, DOI 10.1016/j.apmr.2015.07.015; Ehde DM, 2004, REHABIL PSYCHOL, V49, P254, DOI 10.1037/0090-5550.49.3.254; Eisendrath SJ, 2016, PSYCHOTHER PSYCHOSOM, V85, P99, DOI 10.1159/000442260; Elbers S, 2018, EUR J PAIN, V22, P1577, DOI 10.1002/ejp.1253; Elkins G, 2007, INT J CLIN EXP HYP, V55, P275, DOI 10.1080/00207140701338621; Farrar, 2001, CLIN IMPORTANCE CHAN; Federal Pain Research Strategy, 2017, INT PAIN RES COORD C; Fortin Martin, 2005, Health Qual Life Outcomes, V3, P74, DOI 10.1186/1477-7525-3-74; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Geneen LJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0120-5; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hayes Andrew F, 2017, Behav Res Ther, V98, P39, DOI 10.1016/j.brat.2016.11.001; HEIMBERG RG, 1990, COGNITIVE THER RES, V14, P1, DOI 10.1007/BF01173521; Helmes E, 2017, AGING MENT HEALTH, V21, P272, DOI 10.1080/13607863.2015.1111862; Hilgard E. R., 1965, HYPNOTIC SUSCEPTIBIL; Hilton L, 2017, ANN BEHAV MED, V51, P199, DOI 10.1007/s12160-016-9844-2; Holt C.S., 1990, BEHAV THER, V13, P213; Institute of Medicine, 2013, COGN REH THER TRAUM; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Jensen M, 2006, J BEHAV MED, V29, P95, DOI 10.1007/s10865-005-9031-6; Jensen M.P., 2011, TREATMENTS WORK HYPN; Jensen MP, 2008, INT J CLIN EXP HYP, V56, P156, DOI 10.1080/00207140701849486; Jensen MP, 2006, INT J CLIN EXP HYP, V54, P432, DOI 10.1080/00207140600856798; Jensen MP, 2017, NEUROSCI CONSCIOUS, V3, DOI 10.1093/nc/nix004; Jensen MP, 2016, J PAIN, V17, P529, DOI 10.1016/j.jpain.2016.02.001; Jensen MP, 2015, AM J CLIN HYPN, V57, P230, DOI [10.1080/00029157.2014.976786, 10.1080/00029157.2015.985573]; Jensen MP, 2014, PAIN MED, V15, P2055, DOI 10.1111/pme.12546; Jensen MP, 2015, INT J CLIN EXP HYP, V63, P34, DOI 10.1080/00207144.2014.961875; Jensen MP, 2014, NAT REV NEUROL, V10, P167, DOI 10.1038/nrneurol.2014.12; Jensen MP, 2010, MEDICAL HYPNOSIS PRIMER: CLINICAL AND RESEARCH EVIDENCE, P25; Jensen MP, 2011, PAIN, V152, P717, DOI 10.1016/j.pain.2010.09.002; Jensen MP, 2011, INT J CLIN EXP HYP, V59, P45, DOI 10.1080/00207144.2011.522892; Jensen MP, 2009, PAIN, V146, P235, DOI 10.1016/j.pain.2009.06.027; Jensen MP, 2009, INT J CLIN EXP HYP, V57, P239, DOI 10.1080/00207140902881007; Jensen MP, 2009, INT J CLIN EXP HYP, V57, P198, DOI 10.1080/00207140802665476; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Joypaul S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223306; Kabat-Zin J., 2013, FULL CATASTROPHE LIV; Kazdin AE, 2009, PSYCHOTHER RES, V19, P418, DOI 10.1080/10503300802448899; Kennedy J, 2014, J PAIN, V15, P979, DOI 10.1016/j.jpain.2014.05.009; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lomas T, 2015, NEUROSCI BIOBEHAV R, V57, P401, DOI 10.1016/j.neubiorev.2015.09.018; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; Milliken G. A., 2009, ANAL MESSY DATA, V2nd; Nahin RL, 2017, J PAIN, V18, P247, DOI 10.1016/j.jpain.2016.10.021; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; O'Toole SK, 2016, J TRAUMA STRESS, V29, P97, DOI 10.1002/jts.22077; Perry C., 1992, MEASUREMENT HYPNOTIC, P235; Rollnick S, 2013, MOTIVATIONAL INTERVI; Rotaru TS, 2016, INT J CLIN EXP HYP, V64, P116, DOI 10.1080/00207144.2015.1099406; Schramm PJ, 2016, SLEEP MED, V17, P57, DOI 10.1016/j.sleep.2015.09.022; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Scott W, 2015, J PAIN, V16, P518, DOI 10.1016/j.jpain.2015.02.007; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thompson T, 2019, NEUROSCI BIOBEHAV R, V99, P298, DOI 10.1016/j.neubiorev.2019.02.013; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Weitzenhoffer A., 1963, STANFORD HYPNOTIC SU; Wurtzen H, 2013, EUR J CANCER, V49, P1365, DOI 10.1016/j.ejca.2012.10.030; Yapko M, 2001, AM J CLIN HYPN, V44, P97, DOI 10.1080/00029157.2001.10403465; Zeidan F, 2016, ANN NY ACAD SCI, V1373, P114, DOI 10.1111/nyas.13153	91	6	6	4	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAR	2020	90								105935	10.1016/j.cct.2020.105935			12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	LG2DF	WOS:000527917400006	31926321	Green Accepted			2022-02-06	
J	Zamani, A; Powell, KL; May, A; Semple, BD				Zamani, Akram; Powell, Kim L.; May, Ashleigh; Semple, Bridgette D.			Validation of reference genes for gene expression analysis following experimental traumatic brain injury in a pediatric mouse model	BRAIN RESEARCH BULLETIN			English	Article						Development; Traumatic brain injury; Pediatric; Reference genes; qPCR; House-keeping gene	POLYMERASE-CHAIN-REACTION; MESSENGER-RNA; QUANTITATIVE PCR; RAT-BRAIN; TRANSCRIPTION; NORMALIZATION; VULNERABILITY; MATURATION; SELECTION; RECOVERY	Quantitative polymerase chain reaction (qPCR) is the gold standard method in targeted analysis of messenger RNA (mRNA) levels in a tissue. To minimize methodological errors, a reference gene (or a combination of reference genes) is routinely used for normalization to account for technical variables such as RNA quality and sample size. While presumed to have stable expression, reference genes in the brain can change during normal development, as well as in response to injury, such as traumatic brain injury (TBI). This study is the first to evaluate the stability of reference genes in a controlled cortical impact (CCI) model in the pediatric mouse brain, using two methods of qPCR normalization for optimal reference gene selection. Three week old mice were subjected to unilateral CCI at two severity of injuries (mild or severe), compared to sham controls. At 1 and 8 weeks post-injury, the ipsilateral hemisphere was analyzed to determine reference gene stability. Five commonly-used reference genes were compared: tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein zeta (Ywhaz), cyclophilin A (Ppia), hypoxanthine phosphoribosyl transferase (Hprt), glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and beta-actin (Actb). Ppia and Hprt were chosen as the most stable combination of genes using GeNORM software analysis. These results highlight the instability of several commonly used reference genes after TBI, and provide a selection of validated genes for future gene expression analyses in the injured pediatric mouse brain.	[Zamani, Akram; Powell, Kim L.; May, Ashleigh; Semple, Bridgette D.] Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia; [Powell, Kim L.; Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia		Zamani, A (corresponding author), Monash Univ, Dept Neurosci, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	akram.zamani@monash.edu		, Ashleigh/0000-0001-5522-2776	Monash UniversityMonash University; National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia	The authors acknowledge funding support from Monash University (BDS and KLP), and the National Health and Medical Research Council of Australia (NHMRC) (Project Grant and Career Development Fellowship to BDS).	Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Biervert C, 2001, NEUROSCI LETT, V315, P25, DOI 10.1016/S0304-3940(01)02312-6; BLATTI SP, 1988, P NATL ACAD SCI USA, V85, P1119, DOI 10.1073/pnas.85.4.1119; BOND JF, 1983, MOL CELL BIOL, V3, P1333, DOI 10.1128/MCB.3.8.1333; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Cho YE, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00168; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Franz G, 1999, J NEUROCHEM, V73, P1615, DOI 10.1046/j.1471-4159.1999.0731615.x; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Ketheeswaranathan P, 2011, BRAIN RES, V1418, P93, DOI 10.1016/j.brainres.2011.08.029; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Remans T, 2014, PLANT CELL, V26, P3829, DOI 10.1105/tpc.114.130641; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xu DC, 2018, DEV NEUROBIOL, V78, P39, DOI 10.1002/dneu.22558; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	58	6	6	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAR	2020	156						43	49		10.1016/j.brainresbull.2019.12.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KO0AE	WOS:000515207600006	31904409				2022-02-06	
J	Kim, TJ; Park, SH; Jeong, HB; Ha, EJ; Cho, WS; Kang, HS; Kim, JE; Ko, SB				Kim, Tae Jung; Park, Soo-Hyun; Jeong, Hae-Bong; Ha, Eun Jin; Cho, Won Sang; Kang, Hyun-Seung; Kim, Jung Eun; Ko, Sang-Bae			Neurological Pupil Index as an Indicator of Neurological Worsening in Large Hemispheric Strokes	NEUROCRITICAL CARE			English	Article						Neurological pupil index; Neurological worsening; Large hemispheric stroke	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; QUANTITATIVE PUPILLOMETRY; TRANSTENTORIAL HERNIATION; INTRACRANIAL-PRESSURE; DECOMPRESSIVE SURGERY; MALIGNANT INFARCTION; MIDLINE SHIFT; DETERIORATION; MULTICENTER	Background/Objective Cerebral herniation due to brain edema is the major cause of neurological worsening in patients suffering large hemispheric strokes. In this study, we investigated whether quantitative pupillary response could help identify the neurological worsening due to brain swelling in patients with large hemispheric strokes. Methods Quantitative pupillary assessment using an automated pupillometer (NPi-100) was performed between April 2017 and August 2019 for patients suffering large hemispheric strokes. Consecutive pupillary responses were measured every 2 or 4 h as a part of routine clinical care. We compared the mean neurological pupil index (NPi) values, NPi value at the time of neurological deterioration, and percentage change in NPi from the immediate previous value between patients with and without neurological worsening. Results In this study, 2442 quantitative pupillary assessments were performed (n = 30; mean age, 67.9 years; males, 60.0%). Among the included patients, 10 (33.3%) experienced neurological worsening. Patients with neurological worsening had a significantly lower mean value of NPi and a sudden decrease in the NPi value as compared to those without neurological worsening during the whole monitoring period (3.88 +/- 0.65 vs. 4.45 +/- 0.46, P < 0.001; and 29.5% vs. 11.1%, P = 0.006, respectively). All patients with NPi values below 2.8 showed neurological deterioration. Conclusions Quantitative monitoring of the pupillary response using an automated pupillometer could be a useful and noninvasive tool for detecting neurological deterioration due to cerebral edema in large hemispheric stroke patients.	[Kim, Tae Jung; Jeong, Hae-Bong; Ko, Sang-Bae] Seoul Natl Univ Hosp, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea; [Kim, Tae Jung; Ha, Eun Jin; Ko, Sang-Bae] Seoul Natl Univ Hosp, Dept Crit Care Med, 101 Daehak Ro, Seoul, South Korea; [Park, Soo-Hyun] Inha Univ Hosp, Dept Neurol, Incheon, South Korea; [Ha, Eun Jin; Cho, Won Sang; Kang, Hyun-Seung; Kim, Jung Eun] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea		Ko, SB (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea.; Ko, SB (corresponding author), Seoul Natl Univ Hosp, Dept Crit Care Med, 101 Daehak Ro, Seoul, South Korea.	sangbai1378@gmail.com		Ko, Sang-Bae/0000-0002-9429-9597	 [0620160820]	This study was supported by the Youhan Pharmacy (No. 0620160820). The funding organizations had no role in the study or in the preparation of this report.	Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Fan JS, 2017, POSTGRAD MED J, V93, P349, DOI 10.1136/postgradmedj-2016-134463; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heimburger D, 2016, RESUSCITATION, V103, P88, DOI 10.1016/j.resuscitation.2016.02.026; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jia L, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1183-y; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kim TJ, 2018, ACUTE CRIT CARE, V33, P57, DOI 10.4266/acc.2017.00213; Knight Patrick H, 2015, Int J Crit Illn Inj Sci, V5, P256, DOI 10.4103/2229-5151.170840; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Lord AS, 2015, STROKE, V46, P647, DOI 10.1161/STROKEAHA.114.007704; McNett M, 2017, J NEUROSCI NURS, V49, P229, DOI 10.1097/JNN.0000000000000290; Mendelow AD, 2005, LANCET, V365, P387; Natzeder S, 2019, J NEUROSURG ANESTH, V31, P428, DOI 10.1097/ANA.0000000000000553; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Osman M, 2019, J STROKE CEREBROVASC, V28, P1902, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.055; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Park JG, 2015, J KOREAN NEUROSURG S, V58, P363, DOI 10.3340/jkns.2015.58.4.363; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Rollins MD, 2014, ANESTHESIOLOGY, V121, P1037, DOI 10.1097/ALN.0000000000000384; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Shoyombo I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25477-7; Siegler JE, 2016, J STROKE, V18, P203, DOI 10.5853/jos.2016.00073; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Stevens AR, 2019, BRAIN INJURY, V33, P1032, DOI 10.1080/02699052.2019.1605621; Suys T, 2014, NEUROCRIT CARE, V21, P300, DOI 10.1007/s12028-014-9981-z; Tamura T, 2018, RESUSCITATION, V131, P108, DOI 10.1016/j.resuscitation.2018.06.027; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Yamamoto H, 1998, ARCH NEUROL-CHICAGO, V55, P481, DOI 10.1001/archneur.55.4.481; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	40	6	6	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					575	581		10.1007/s12028-020-00936-0		FEB 2020	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000516453200004	32096118				2022-02-06	
J	O'Keeffe, F; Dunne, J; Nolan, M; Cogley, C; Davenport, J				O'Keeffe, Fiadhnait; Dunne, Johann; Nolan, Maeve; Cogley, Clodagh; Davenport, John			"The things that people can't see" The impact of TBI on relationships: an interpretative phenomenological analysis	BRAIN INJURY			English	Article						Traumatic brain injury; qualitative research; relationships following TBI; interpretive phenomenological analysis	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; RELATIONSHIP SATISFACTION; QUALITATIVE-ANALYSIS; EXPERIENCES; ADJUSTMENT; CAREGIVERS; DISTRESS; RECOVERY; DISEASE	Objective: To explore the impact of TBI on couple relationships, from the perspective of both injured and uninjured partners in the relationship. Method: In-depth, semi-structured interviews were conducted with six uninjured women and five of their male partners living with TBI for between four and eight years who had attended a tertiary neurorehabilitation service. The principles of Interpretative Phenomenological Analysis (IPA) were used to analyze the data. Results: The three major themes emerged. Broken Bonds: "those special things just between the two of us" captures the emotional fallout from TBI on each individual and on the relationship; New Dynamics: "like oil and water" describes the effect of individual changes on relationship dynamics in general, on sexuality, conflict and family life; Moving Forward Together: "We figure it out" describes coping strategies in maintaining relationships post-TBI including hope, time, understanding TBI and positive reappraisal. Conclusions: This research provides an in-depth, phenomenological account of couples' experiences of the impact of TBI on relationships, including the perspectives of both TBI survivors and their partners. The three major themes that emerged capture the stresses that impinge on relationships post-TBI and confirms the importance of supportive clinical interventions for couples as an essential component of neurorehabilitation.	[O'Keeffe, Fiadhnait; Dunne, Johann; Davenport, John] Trinity Coll Dublin, Coll Green, Sch Psychol, Dublin 2, Ireland; [O'Keeffe, Fiadhnait; Nolan, Maeve] Natl Rehabil Hosp, Dept Clin Psychol, Dun Laoghaire, Co Dublin, Ireland; [O'Keeffe, Fiadhnait; Cogley, Clodagh] St Vincents Univ Hosp, Dept Psychol, Dublin 4, Ireland; [O'Keeffe, Fiadhnait] Univ Coll Dublin, Sch Psychol, Dublin 4, Ireland		O'Keeffe, F (corresponding author), Trinity Coll Dublin, Coll Green, Sch Psychol, Dublin 2, Ireland.	fiokeeffe@gmail.com		Cogley, Clodagh/0000-0003-1801-6230			ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Arguello JL, 2013, THESIS, P83; Backhaus S, 2016, BRAIN INJURY, V30, P975, DOI 10.3109/02699052.2016.1147601; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Boss P., 1999, AMBIGUOUS LOSS LEARN; Bowen C., 2010, RELATIONAL APPROACH; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brunsden C, 2017, NEUROPSYCHOL REHABIL, V27, P937, DOI 10.1080/09602011.2015.1109525; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Folkman S., 1984, STRESS; Gilbert P., 2000, OVERCOMING DEPRESSIO; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; Green R-J, 2008, CLIN HDB COUPLE THER, P662; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Kabat-Zinn J., 2005, COMING OUR SENSES HE; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Larkin M, 2019, QUAL RES PSYCHOL, V16, P182, DOI 10.1080/14780887.2018.1540655; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LINGE FR, 1990, CAN J PSYCHOL, V44, P116, DOI 10.1037/h0084383; Littleton H, 2007, J TRAUMA STRESS, V20, P977, DOI 10.1002/jts.20276; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Moskowitz JT, 2003, DEATH STUD, V27, P471, DOI 10.1080/07481180390197624; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Oyebode J, 2003, ADV PSYCHIAT TREATME, V9, P45, DOI DOI 10.1192/APT.9.1.45; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Prendergast S, 2012, THESIS, DOI [10.1094/PDIS-11-11-0999-PDN, DOI 10.1094/PDIS-11-11-0999-PDN]; Seamark DA, 2004, PALLIATIVE MED, V18, P619, DOI 10.1191/0269216304pm928oa; Shaver P.R., 2007, ATTACHMENT ADULTHOOD; Smith J. A., 2012, INTERPRETATIVE PHENO; Smith LJ, 2017, MED HEALTH CARE PHIL, V20, P13, DOI 10.1007/s11019-016-9716-3; Soundy A, 2013, HEALTH PSYCHOL REV, V7, P177, DOI 10.1080/17437199.2011.568856; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wahl A, 1999, QUAL LIFE RES, V8, P427, DOI 10.1023/A:1008944108101; Wang S, 2017, NEUROIMAGE, V157, P439, DOI 10.1016/j.neuroimage.2017.05.056; Wawrziczny E, 2016, DEMENTIA-LONDON, V15, P1082, DOI 10.1177/1471301214554720; Weatherhead S., 2014, NARRATIVE APPROACHES; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; Wilson-Barnett J, 1980, Nursing (Lond), P432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Yeates G, 2013, NEURO DISABILITY PSY, V1, P108; Yeates G.N., 2013, NEURODISABILITY PSYC, V1, P151	59	6	6	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					496	507		10.1080/02699052.2020.1725641		FEB 2020	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000514786100001	32070149				2022-02-06	
J	Fung, FW; Jacobwitz, M; Parikh, DS; Vala, L; Donnelly, M; Fan, JX; Xiao, R; Topjian, AA; Abend, NS				Fung, France W.; Jacobwitz, Marin; Parikh, Darshana S.; Vala, Lisa; Donnelly, Maureen; Fan, Jiaxin; Xiao, Rui; Topjian, Alexis A.; Abend, Nicholas S.			Development of a model to predict electroencephalographic seizures in critically ill children	EPILEPSIA			English	Article						critical care; EEG monitoring; electroencephalogram; pediatric; seizure; status epilepticus	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; ELECTROGRAPHIC SEIZURES; CONSENSUS STATEMENT; COMATOSE CHILDREN; ADULTS; COMMON; PROBABILITY; TERMINOLOGY	Objective Electroencephalographic seizures (ESs) are common in encephalopathic critically ill children, but ES identification with continuous electroencephalography (EEG) monitoring (CEEG) is resource-intense. We aimed to develop an ES prediction model that would enable clinicians to stratify patients by ES risk and optimally target limited CEEG resources. We aimed to determine whether incorporating data from a screening EEG yielded better performance characteristics than models using clinical variables alone. Methods We performed a prospective observational study of 719 consecutive critically ill children with acute encephalopathy undergoing CEEG in the pediatric intensive care unit of a quaternary care institution between April 2017 and February 2019. We identified clinical and EEG risk factors for ES. We evaluated model performance with area under the receiver-operating characteristic (ROC) curve (AUC), validated the optimal model with the highest AUC using a fivefold cross-validation, and calculated test characteristics emphasizing high sensitivity. We applied the optimal operating slope strategy to identify the optimal cutoff to define whether a patient should undergo CEEG. Results The incidence of ES was 26%. Variables associated with increased ES risk included age, acute encephalopathy category, clinical seizures prior to CEEG initiation, EEG background, and epileptiform discharges. Combining clinical and EEG variables yielded better model performance (AUC 0.80) than clinical variables alone (AUC 0.69; P < .01). At a 0.10 cutoff selected to emphasize sensitivity, the optimal model had a sensitivity of 92%, specificity of 37%, positive predictive value of 34%, and negative predictive value of 93%. If applied, the model would limit 29% of patients from undergoing CEEG while failing to identify 8% of patients with ES. Significance A model employing readily available clinical and EEG variables could target limited CEEG resources to critically ill children at highest risk for ES, making CEEG-guided management a more viable neuroprotective strategy.	[Fung, France W.; Jacobwitz, Marin; Parikh, Darshana S.; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Parikh, Darshana S.; Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Vala, Lisa; Donnelly, Maureen; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Neurodiagnost, Philadelphia, PA 19104 USA; [Fan, Jiaxin; Xiao, Rui; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Abend, Nicholas S.] Univ Penn, Perelman Sch Med, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA		Fung, FW (corresponding author), CHOP Neurol, CTRB 10009,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	fungf@email.chop.edu		Abend, Nicholas/0000-0001-6166-2663	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02NS096058]	Dr Abend is funded by National Institutes of Health (NIH) K02NS096058.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P251, DOI 10.1097/WNP.0000000000000459; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P246, DOI 10.1097/WNP.0000000000000458; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Children's Hospital of Philadelphia, 2019, CRIT CAR PATHW EEG M; Fernandez IS, 2014, J PEDIATR-US, V164, P339, DOI 10.1016/j.jpeds.2013.09.032; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Newey CR, 2018, J CLIN NEUROPHYSIOL, V35, P325, DOI 10.1097/WNP.0000000000000475; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Fernandez IS, 2018, SEIZURE-EUR J EPILEP, V54, P19, DOI 10.1016/j.seizure.2017.11.013; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Sansevere AJ, 2019, J CLIN NEUROPHYSIOL, V36, P186, DOI 10.1097/WNP.0000000000000574; Sansevere AJ, 2017, J CLIN NEUROPHYSIOL, V34, P421, DOI 10.1097/WNP.0000000000000379; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; Vlachy J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00303; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Yang A, 2015, SEIZURE-EUR J EPILEP, V25, P104, DOI 10.1016/j.seizure.2014.09.013	50	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAR	2020	61	3					498	508		10.1111/epi.16448		FEB 2020	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV6TM	WOS:000514396300001	32077099				2022-02-06	
J	Mahmood, A; Needham, K; Shakur-Still, H; Davies, D; Belli, A; Jamaluddin, SF; Harris, T; Mohamed, FL; Leech, C; Lotfi, H; Moss, P; Hopkins, P; Wong, D; Kendall, J; Boyle, A; Wilson, M; Darwent, M; Roberts, I				Mahmood, Abda; Needham, Kelly; Shakur-Still, Haleema; Davies, David; Belli, Antonio; Jamaluddin, Sabariah Faizah; Harris, Tim; Mohamed, Fatahul Laham; Leech, Caroline; Lotfi, Hamzah; Moss, Phil; Hopkins, Phillip; Wong, Darin; Kendall, Jason; Boyle, Adrian; Wilson, Mark; Darwent, Melanie; Roberts, Ian		CRASH-3 Intracranial Bleeding Mech	Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Tranexamic acid	INTRACEREBRAL HEMORRHAGE	Purpose The CRASH-3 trial is a randomised trial of tranexamic acid (TXA) on death and disability in patients with traumatic brain injury (TBI). It is based on the hypothesis that early TXA treatment can prevent deaths from post-traumatic intracranial bleeding. The results showed that timely TXA treatment reduces head injury deaths in patients with reactive pupils and those with a mild to moderate GCS at baseline. We examined routinely collected CT scans in a sample of 1767 CRASH-3 trial patients to explore if, why, and how patients are affected by TXA. Methods The CRASH-3 IBMS is an explanatory study nested within the CRASH-3 trial. We measured the volume of intracranial bleeding on CT scans using established methods (e.g. ABC/2). Results Patients with any un-reactive pupil had a median intracranial bleeding volume of 60 ml (IQR 18-101 ml) and patients with reactive pupils had a median volume of 26 ml (IQR 1-55 ml). Patients with severe GCS had median intracranial bleeding volume of 37 ml (IQR 3-75 ml) and patients with moderate to mild GCS had a median volume of 26 ml (IQR 0.4-50 ml). For every hour increase from injury to the baseline scan, the risk of new bleeding on a further scan decreased by 12% (adjusted RR = 0.88 [95% CI 0.80-0.96], p = 0.0047). Conclusion Patients with reactive pupils and/or mild to moderate GCS may have benefited from TXA in the CRASH-3 trial because they had less intracranial bleeding at baseline. However, because bleeding occurs soon after injury, treatment delay reduces the benefit of TXA.	[Mahmood, Abda; Needham, Kelly; Shakur-Still, Haleema] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Clin Trials Unit, Keppel St, London WC1E 7HT, England; [Davies, David; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Jamaluddin, Sabariah Faizah] Hosp Sungai Buloh, Emergency Dept, Jalan Hosp, Sungai Buloh 47000, Selangor, Malaysia; [Harris, Tim] Barts Hlth NHS Trust, Dept Emergency Med, Royal London Hosp, London E1 1BB, England; [Mohamed, Fatahul Laham] Hosp Sultanah Bahiyah, Emergency Dept, Km 6,Jalan Langgar, Alor Setar 05460, Kedah, Malaysia; [Leech, Caroline] Univ Hosp Coventry & Warwickshire NHS Trust, Emergency Dept, Univ Hosp Coventry, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England; [Lotfi, Hamzah] Hosp Sultanah Nur Zahirah, Emergency Dept, Jalan Sultan Mahmud, Terengganu 20400, Malaysia; [Moss, Phil] St Georges Univ Hosp NHS Fdn Trust, St Georges Hosp, Emergency Dept, Blackshaw Rd, London SW17 0QT, England; [Hopkins, Phillip] Kings Coll Hosp NHS Fdn Trust, Emergency Dept, Denmark Hill, London SE5 9RS, England; [Wong, Darin] Penang Gen Hosp, Emergency Dept, Jalan Residensi, George Town 10990, Pulau Pinang, Malaysia; [Kendall, Jason] North Bristol NHS Trust, Emergency Dept, Southmead Hosp, Southmead Rd, Bristol BS10 5NB, Avon, England; [Boyle, Adrian] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Emergency Dept, Hills Rd, Cambridge CB2 0QQ, England; [Wilson, Mark] Imperial Coll NHS Trust, St Marys Hosp, Div Med, Neurosurg Emergencies & Neurotrauma, Praed St, London W2 1NY, England; [Darwent, Melanie] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Emergency Dept, Headley Way, Oxford OX3 9DU, England; [Roberts, Ian] London Sch Hyg & Trop Med, Fac Epidemiol Populat Hlth, Clin Trials Unit, Keppel St, London WC1E 7HT, England		Mahmood, A (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Clin Trials Unit, Keppel St, London WC1E 7HT, England.		JAMALUDDIN, SABARIAH FAIZAH/AAY-2902-2020; Belli, Antonio/I-3799-2015; Needham, Kelly/C-8298-2019; Jamaluddin, Sabariah/ABB-6372-2020	Belli, Antonio/0000-0002-3211-9933; Needham, Kelly/0000-0003-2340-5994; Mahmood, Abda/0000-0002-3267-4590; Boyle, Adrian/0000-0002-9009-5423; Wilson, Mark/0000-0002-2346-4911; JAMALUDDIN, SABARIAH/0000-0002-3788-7915	London School of Hygiene and Tropical Medicine [EPAA6020]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	The CRASH-3 explanatory study is funded by the London School of Hygiene and Tropical Medicine (Grant reference EPAA6020).	CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Gaillard F, 2019, INTRACRANIAL HAEMORR; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts Ian, 1800, Wellcome Open Res, V3, P86, DOI 10.12688/wellcomeopenres.14700.1; Tuhrim S, 2008, NEW ENGL J MED, V358, P2174, DOI 10.1056/NEJMe0801856	13	6	6	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2021	47	1			SI		261	268		10.1007/s00068-020-01316-1		FEB 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QA9JI	WOS:000516324700002	32076783	Green Published, hybrid			2022-02-06	
J	Giudice, JS; Caudillo, A; Mukherjee, S; Kong, KV; Park, G; Kent, R; Panzer, MB				Giudice, J. Sebastian; Caudillo, Adrian; Mukherjee, Sayak; Kong, Kevin; Park, Gwansik; Kent, Richard; Panzer, Matthew B.			Finite Element Model of a Deformable American Football Helmet Under Impact	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						American football; Safety; Research and development; Parametric investigation; Concussion		Despite the use of helmets in American football, brain injuries are still prevalent. To reduce the burden of these injuries, novel impact mitigation systems are needed. The Vicis Zero1 (VZ1) American football helmet is unique in its use of multi-directional buckling structures sandwiched between a deformable outer shell and a stiff inner shell. The objective of this study was to develop a model of the VZ1 and to assess this unique characteristic for its role in mitigating head kinematics. The VZ1 model was developed using a bottom-up framework that emphasized material testing, constitutive model calibration, and component-level validation. Over 50 experimental tests were simulated to validate the VZ1 model. CORrelation and Analysis (CORA) was used to quantify the similarity between experimental and model head kinematics, neck forces, and impactor accelerations and forces. The VZ1 model demonstrated good correlation with an overall mean CORA score of 0.86. A parametric analysis on helmet compliance revealed that the outer shell and column stiffness influenced translational head kinematics more than rotational. For the material parameters investigated, head linear acceleration ranged from 80 to 220 g, whereas angular velocity ranged from 37 to 40 rad/s. This helmet model is open-source and serves as an in silico design platform for helmet innovation.	[Giudice, J. Sebastian; Caudillo, Adrian; Mukherjee, Sayak; Kong, Kevin; Kent, Richard; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22901 USA; [Park, Gwansik; Kent, Richard] Biomech Consulting & Res Biocore LLC, Charlottesville, VA USA		Panzer, MB (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22901 USA.	panzer@virginia.edu		Giudice, Sebastian/0000-0003-1074-4890	Football Research, Inc. (FRI)	The research presented in this paper was made possible by a Grant from Football Research, Inc. (FRI). The views expressed are solely those of the authors and do not represent those of FRI or any of their affiliates or funding sources. The authors would like to thank our collaborators in the ``Engineering Roadmap: Numerical Crowdsourcing Project'' for their support and feedback of this work (Teams from Wake Forest University, University of Waterloo, and KTH Royal Institute of Technology). The authors also acknowledge the Virginia Tech Helmet Lab and BioKinetics and Associates, Ltd. for generating the pendulum and linear impactor test data. Finally, the authors would like to thank Dr. Lee Gabler, Dr. Anne Bailey, and Dr. Wei Zeng for their feedback.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Corrales MA, 2019, ANN BIOMED ENG, V48, P1; Decker W, 2020, ANN BIOMED ENG, V48, P258, DOI 10.1007/s10439-019-02345-7; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gehre C., 2009, 21 INT TECHN C ENH S 21 INT TECHN C ENH S; Gessel LM, 2009, YB SPORTS MED, V2009, P19, DOI [10.1016/S0162-0908(08)79294-8, DOI 10.1016/S0162-0908(08)79294-8]; Giudice J. S, 2018, IRCOBI C P; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Hallquist J., 2007, LS DYNA KEYWORD USER; Hallquist JO, 2006, LS DYNA THEORY MANUA, V3, P25; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Holbourn AHS, 1943, LANCET, V2, P438; Joodaki H, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043038; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; National Football League (NFL), 2017, 2017 HELM LAB TEST P; Panzer MB, 2018, J NEUROTRAUM, V35, pA148; SAE, 1998, US MAN 50 PERC MAL H; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Withnall, 2017, NFL LINEAR IMPACTOR	23	6	6	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAY	2020	48	5					1524	1539		10.1007/s10439-020-02472-6		FEB 2020	16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	LC7DL	WOS:000515948200002	32034610				2022-02-06	
J	MacQueen, R; Fisher, P; Williams, D				MacQueen, Ruth; Fisher, Paul; Williams, Deirdre			A qualitative investigation of masculine identity after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Masculine identity; Neurorehabilitation; Adjustment	INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS; MEN; SELF; EXPERIENCE; GENDER; EXPLORATION; RISK; ABI	Men are twice as likely as women to experience a traumatic brain injury (TBI), suggesting that aspects of masculine identity contribute to how people acquire their brain injuries. Research also suggests that masculine identity impacts on how people manage their health experiences. The current study aimed to explore the experience of masculine identity following TBI. Individual interviews were conducted with 10 men aged 21-67 years who had experienced a TBI. All were living in the community. Interpretative phenomenological analysis was used to consider lived experiences and to explore the meaning of the TBI experience in relation to masculine identity. Three superordinate themes emerged from the analysis: doing life and relationships differently, self-perceptions and the perceived view of others, and managing the impact of TBI as a man. These themes are considered in relation to how participants' experiences interacted with dominant social ideals of masculine identity. The findings highlighted how masculine identity may be a valuable aspect of self in considering threats to and reconstruction of self-identity after TBI. Aspects of gender identity should be considered in order to promote engagement, support adjustment and achieve meaningful outcomes in rehabilitation.	[MacQueen, Ruth; Fisher, Paul; Williams, Deirdre] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [MacQueen, Ruth] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Fisher, Paul] Norfolk Community Hlth & Care NHS Trust, Norwich, Norfolk, England		MacQueen, R (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.; MacQueen, R (corresponding author), Univ East Anglia, Dept Clin Psychol, Norwich Med Sch, Elizabeth Fry Bldg, Norwich NR4 7PA, Norfolk, England.	ruth.macqueen@nhs.net					Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Andrewes HE, 2014, BRAIN INJURY, V28, P965, DOI 10.3109/02699052.2014.888764; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Clifton, 2006, QUALITATIVE RES PSYC, V3, P102, DOI [DOI 10.1191/1478088706QP0620A, 10.1191/1478088706qp062oa, DOI 10.1191/1478088706QP062OA]; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Cullen B, 2018, NEUROPSYCHOL REHABIL, V28, P17, DOI 10.1080/09602011.2015.1131722; Ervik B, 2012, EUR J ONCOL NURS, V16, P103, DOI 10.1016/j.ejon.2011.04.005; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gerschick TJ, 2000, SIGNS, V25, P1263, DOI 10.1086/495558; GILBERT P, 2007, THERAPEUTIC RELATION, P00122; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Good GE, 2006, PSYCHOL MEN MASCULIN, V7, P165, DOI DOI 10.1037/1524-9220.7.3.165; Good GE, 2008, REHABIL PSYCHOL, V53, P39, DOI 10.1037/0090-5550.53.1.39; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Headway, 2014, KEY FACTS STAT; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Hutchinson S. L., 2000, Therapeutic Recreation Journal, V34, P42; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Jetten J., 2012, SOCIAL CURE IDENTITY; Jones J. A., 2011, DISABILITY REHABILIT, V33, P17; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kingerlee R, 2012, PSYCHOL PSYCHOTHER-T, V85, P83, DOI 10.1111/j.2044-8341.2011.02017.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Meyers N. M., 2012, THESIS; Morriss E, 2013, AUST J REHABIL COUNS, V19, P119, DOI 10.1017/jrc.2013.15; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Rashid T, 2013, CURRENT PSYCHOTHERAP, P461; Robertson S, 2010, SOCIOL HEALTH ILL, V32, P695, DOI 10.1111/j.1467-9566.2010.01249.x; Rodham K, 2015, INT J SOC RES METHOD, V18, P59, DOI 10.1080/13645579.2013.852368; Roe D, 2014, J CLIN PSYCHOL, V70, P303, DOI 10.1002/jclp.22050; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Shakespeare T, 1999, SEX DISABIL, V17, P53, DOI 10.1023/A:1021403829826; Shinebourne, 2011, EXISTENTIAL ANAL, V22, P16; Smith J.A., 2009, INTERPRETATIVE PHENO; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Smith JA, 2011, HEALTH PSYCHOL REV, V5, P9, DOI 10.1080/17437199.2010.510659; Sullivan CT, 2014, J REHABIL MED, V46, P424, DOI 10.2340/16501977-1788; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Thompson, 2008, QUAL RES PSYCHOL, V5, P214, DOI [10.1080/14780880802314304, DOI 10.1080/14780880802314304]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tyerman A., 2009, PSYCHOL APPROACHES R; Wilson NJ, 2012, INTELLECT DEV DISAB, V50, P261, DOI 10.1352/1934-9556-50.3.261; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Yardley L., 2008, QUALIT PSYCHOL PRACT, V2, P235; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	53	6	6	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2020	30	2					298	314		10.1080/09602011.2018.1466714			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KQ4EM	WOS:000516877900009	29712508	Green Accepted			2022-02-06	
J	Zhang, J; Li, YY; Wang, C; Wang, YY; Zhang, YY; Huang, LQ; Zhang, ZH				Zhang, Jie; Li, Yiyi; Wang, Chao; Wang, Yaya; Zhang, Yangyang; Huang, Liqin; Zhang, Zhaohui			Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						LPA; LPA1; LPA2; MAPK; apoptosis; mitochondrial dysfunction	PROTEIN-COUPLED RECEPTOR; MITOCHONDRIA; GPR92	Lysophosphatidic acid is a small extracellular signaling molecule, which is elevated in pathological conditions such as ischemic stroke and traumatic brain injury (TBI). LPA regulates the survival of neurons in various diseases. However, the molecular mechanisms underlying LPA-induced neuronal death remain unclear. Here we report that LPA activates LPA1 and LPA2 receptors, and the downstream MAPK pathway to induce the apoptosis of PC12 cells through mitochondrial dysfunction. LPA elicits the activation of ERK1/2, p38, and JNK pathways, decreases the expression of Bcl2, promotes the translocation of Bax, and enhances the activation of caspase-3, resulting in mitochondrial dysfunction and cell apoptosis. This process can be blocked by LPA1 receptor antagonist and LPA2 receptor antagonist and MAPK pathway inhibitors. Our results indicate that LPA1 receptor, LPA2 receptor and MAPK pathway play a critical role in LPA-induced neuronal injury. LPA receptors and MAPK pathways may be novel therapeutic targets for ischemic stroke and TBI, where excessive LPA signaling exist.	[Zhang, Jie; Li, Yiyi; Wang, Chao; Wang, Yaya; Zhang, Yangyang; Huang, Liqin; Zhang, Zhaohui] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Peoples R China		Zhang, ZH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan, Peoples R China.	zhzhqing1990@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671051]	This study was supported by the National Natural Science Foundation of China (Grant no. 81671051) to ZZ.	Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; Han F., 2019, BRAIN SCI ADV, V5, P21, DOI [10.1177/2096595819896178, DOI 10.1177/2096595819896178]; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hollville E, 2019, FEBS J, V286, P3276, DOI 10.1111/febs.14970; Huang CP, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1258-0; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee JH, 2019, BBA-MOL BASIS DIS, V1865, P1332, DOI 10.1016/j.bbadis.2019.02.001; Li N, 2017, APOPTOSIS, V22, P1296, DOI 10.1007/s10495-017-1399-6; Li ZG, 2008, NEUROL RES, V30, P366, DOI 10.1179/174313208X300369; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Lopez-Serrano C, 2019, BRAIN BEHAV IMMUN, V76, P258, DOI 10.1016/j.bbi.2018.12.007; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Meng LX, 2019, J ALZHEIMERS DIS, V67, P515, DOI 10.3233/JAD-180798; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Park S, 2018, J CELL PHYSIOL, V233, P8597, DOI 10.1002/jcp.26540; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Ramesh S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071827; Rogers LC, 2018, REDOX BIOL, V15, P380, DOI 10.1016/j.redox.2018.01.002; Steiner MR, 2000, ANN NY ACAD SCI, V905, P132; Wang C, 2018, EXP NEUROL, V306, P1, DOI 10.1016/j.expneurol.2018.04.010; Wu PY, 2018, CANCERS, V10, DOI 10.3390/cancers10110413; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Zaman S, 2014, LEUKEMIA LYMPHOMA, V55, P1980, DOI 10.3109/10428194.2013.855307	30	6	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	FEB 6	2020	13								16	10.3389/fnmol.2020.00016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KO9MU	WOS:000515871700001	32116549	Green Published, gold			2022-02-06	
J	Hambock, M; Hosmann, A; Seemann, R; Wolf, H; Schachinger, F; Hajdu, S; Widhalm, H				Hamboeck, Martina; Hosmann, Arthur; Seemann, Rudolf; Wolf, Harald; Schachinger, Florian; Hajdu, Stefan; Widhalm, Harald			The impact of implant material and patient age on the long-term outcome of secondary cranioplasty following decompressive craniectomy for severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Implant material; Long-term outcome; Secondary cranioplasty; Traumatic brain injury	INFECTION; CHILDREN; SURGERY	Background Secondary cranioplasty (CP) is considered to support the neurological recovery of patients after decompressive craniectomy (DC), but the treatment success might be limited by complications associated to confounders, which are not yet fully characterized. The aim of this study was to identify the most relevant factors based on the necessity to perform revision surgeries. Methods Data from 156 patients who received secondary CP following DC for severe traumatic brain injury (TBI) between 1984 and 2015 have been retrospectively analyzed and arranged into cohorts according to the occurrence of complications requiring surgical intervention. Results Cox regression analysis revealed a lower revision rate in patients with polymethylmethacrylate (PMMA) implants than in patients with autologous calvarial bone (ACB) implants (HR 0.2, 95% CI 0.1 to 1.0, p = 0.04). A similar effect could be observed in the population of patients aged between 18 and 65 years, who had a lower risk to suffer complications requiring surgical treatment than individuals aged under 18 or over 65 years (HR 0.4, 95% CI 0.2 to 0.9, p = 0.02). Revision rates were not influenced by the gender (p = 0.88), timing of the CP (p = 0.53), the severity of the TBI (p = 0.86), or the size of the cranial defect (p = 0.16). Conclusions In this study, the implant material and patient age were identified as the most relevant parameters independently predicting the long-term outcome of secondary CP. The use of PMMA was associated with lower revision rates than ACB and might provide a therapeutic benefit for selected patients with traumatic cranial defects.	[Hamboeck, Martina] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria; [Hosmann, Arthur] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Seemann, Rudolf] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria; [Wolf, Harald; Schachinger, Florian; Hajdu, Stefan; Widhalm, Harald] Med Univ Vienna, Dept Orthoped & Traumatol, Clin Div Traumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria		Widhalm, H (corresponding author), Med Univ Vienna, Dept Orthoped & Traumatol, Clin Div Traumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	harald.widhalm@meduniwien.ac.at	Widhalm, Harald/ABE-8863-2020	Hosmann, Arthur/0000-0001-7396-4239; Widhalm, Harald/0000-0001-9739-6176	Medical University of Vienna	Open Access funding provided by Medical University of Vienna.	Bhaskar IP, 2011, ANZ J SURG, V81, P137, DOI 10.1111/j.1445-2197.2010.05584.x; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Honeybul S, 2018, ACTA NEUROCHIR, V160, P885, DOI 10.1007/s00701-018-3514-z; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Im SH, 2012, J KOREAN NEUROSURG S, V52, P396, DOI 10.3340/jkns.2012.52.4.396; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lee S. H., 2014, J NEUROTRAUM, V10, P10, DOI [1410.13004/kjnt.2014.10.1.1027169026, DOI 10.13004/kjnt.2014.10.1.10]; Paredes I, 2016, J NEUROTRAUM, V33, P1586, DOI 10.1089/neu.2015.4261; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; PROLO DJ, 1991, CLIN ORTHOP RELAT R, P270; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zhang J, 2017, J NEUROSURG, V127, P1449, DOI 10.3171/2016.8.JNS16204	25	6	6	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2020	162	4					745	753		10.1007/s00701-020-04243-7		FEB 2020	9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KT9YD	WOS:000515840600001	32025876	Green Published, hybrid			2022-02-06	
J	Hess, MC; Swedler, DI; Collins, CS; Ponce, BA; Brabston, EW				Hess, Matthew C.; Swedler, David, I; Collins, Christine S.; Ponce, Brent A.; Brabston, Eugene W.			Descriptive Epidemiology of Injuries in Professional Ultimate Frisbee Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; American Ultimate Disc League; flying disc; AUDL-ISP; athletic injuries	MENS SOCCER INJURIES; HIGH-SCHOOL; SURVEILLANCE SYSTEM; SPORTS; PREVENTION; FOOTBALL; PLAYERS; HEALTH; RATES; TEAM	Context: Injuries in professional ultimate Frisbee (ultimate) athletes have never been described. Objective: To determine injury rates, profiles, and associated factors using the first injury-surveillance program for professional ultimate. Design: Descriptive epidemiology study. Setting: American Ultimate Disc League professional ultimate teams during the 2017 season. Patients or Other Participants: Sixteen all-male teams. Main Outcome Measure(s): Injury incidence rates (IRs) were calculated as injuries per 1000 athlete-exposures (AEs). Incidence rate ratios were determined to compare IRs with 95% confidence intervals, which were used to calculate differences. Results: We observed 299 injuries over 8963 AEs for a total IR of 33.36 per 1000 AEs. Most injuries affected the lower extremity (72%). The most common injuries were thigh-muscle strains (12.7%) and ankle-ligament sprains (11.4%). Running was the most frequent injury mechanism (32%). Twenty-nine percent of injuries involved collisions; however, the concussion rate was low (IR =0.22 per 1000 AEs). Injuries were more likely to occur during competition and in the second half of games. An artificial turf playing surface did not affect overall injury rates (Mantel-Haenszel incidence rate ratio = 1.28; 95% confidence interval = 0.99, 1.67). Conclusions: To our knowledge, this is the first epidemiologic study of professional ultimate injuries. Injury rates were comparable with those of similar collegiate- and professional-level sports.	[Hess, Matthew C.; Collins, Christine S.; Ponce, Brent A.; Brabston, Eugene W.] Univ Alabama Birmingham, Sch Med, Dept Orthopaed Surg, Orthopaed Specialties Bldg,1313 13th St South, Birmingham, AL 35205 USA; [Swedler, David, I] Pacific Inst Res & Evaluat, Calverton, MD USA		Hess, MC (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Orthopaed Surg, Orthopaed Specialties Bldg,1313 13th St South, Birmingham, AL 35205 USA.	mattcharleshess@gmail.com		Tajudin, Muhd/0000-0001-7026-4173; Collins, Christine/0000-0001-6220-578X			Agel J, 2007, J ATHL TRAINING, V42, P270; Akinbola M, 2015, INT J SPORTS PHYS TH, V10, P75; [Anonymous], 2017 AUDL RUL; [Anonymous], ULT AIM GAM; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Chan ZYS, 2018, AM J SPORT MED, V46, P388, DOI 10.1177/0363546517736277; Clifton DR, 2017, AM J SPORT MED, V45, P417, DOI 10.1177/0363546516667914; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Finch CF, 2017, AM J SPORT MED, V45, P1921, DOI 10.1177/0363546517691943; Finch CF, 2014, BRIT J SPORT MED, V48, P1276, DOI 10.1136/bjsports-2012-091729; Hamilton GM, 2011, CLIN J SPORT MED, V21, P508, DOI 10.1097/JSM.0b013e31822e8619; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; History of ultimate, HIST ULT; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; McGuine TA, 2012, AM J SPORT MED, V40, P49, DOI 10.1177/0363546511422332; Meyers MC, 2017, AM J SPORT MED, V45, P708, DOI 10.1177/0363546516671715; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Reynolds Kristen H, 2006, WMJ, V105, P46; Riva D, 2016, J STRENGTH COND RES, V30, P461, DOI 10.1519/JSC.0000000000001097; Russell M, 2015, SPORTS MED, V45, P353, DOI 10.1007/s40279-014-0297-0; Swedler DI, 2015, J ATHL TRAINING, V50, P419, DOI 10.4085/1062-6050-49.3.73; Thacker SB, 2007, J ATHL TRAINING, V42, P171; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; USA ultimate: club division, US ULT CLUB DIV; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645; Yen LE, 2010, CLIN J SPORT MED, V20, P300, DOI 10.1097/JSM.0b013e3181ea8b1c	31	6	6	5	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2020	55	2					195	204		10.4085/1062-6050-269-18			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM1GV	WOS:000513866900010	31895593	gold, Green Published			2022-02-06	
J	Hofman, M; Andruszkow, H; Kobbe, P; Poeze, M; Hildebrand, F				Hofman, Martijn; Andruszkow, Hagen; Kobbe, Philipp; Poeze, Martijn; Hildebrand, Frank			Incidence of post-traumatic pneumonia in poly-traumatized patients: identifying the role of traumatic brain injury and chest trauma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						TBI; Chest injury; Poly-trauma; Pneumonia; Mortality	VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; FAILURE ASSESSMENT SCORE; SEVERITY SCORE; RISK-FACTORS; COMPLICATIONS; EPIDEMIOLOGY; MORTALITY; INFECTIONS; POLYTRAUMA	Purpose Traumatic brain injury (TBI) and chest trauma are common injuries in severely injured patients. Both entities are well known to be associated with severe post-traumatic complications, including pneumonia, a common complication with a significant impact on the further clinical course. However, the relevance of TBI, chest trauma and particularly their combination as risk factors for the development of pneumonia and its impact on outcomes are not fully elucidated. Methods A retrospective analysis of poly-traumatized patients treated between 2010 and 2015 at a level I trauma centre was performed. Inclusion criteria were: Injury Severity Score >= 16 and age >= 18 years. TBI and chest trauma were classified according to the Abbreviated Injury Scale. Complications (i.e. acute respiratory distress syndrome (ARDS), multi-organ dysfunction syndrome (MODS) and pneumonia) were documented by a review of the medical records. The primary outcome parameter was in-hospital mortality. Results Over the clinical course, 19.9% of all patients developed pneumonia, and in-hospital mortality was 25.3%. Pneumonia (OR 5.142, p = 0.001) represented the strongest independent predictor of in-hospital mortality, followed by the combination of chest injury and TBI (OR 3.784, p = 0.008) and TBI (OR 3.028, p = 0.010). Chest injury alone, the combination of chest injury and TBI, and duration of ventilation were independent predictors of pneumonia [resp. OR 4.711 (p = 0.004), OR 4.193 (p = 0.004), OR 1.002 (p < 0.001)]. Conclusions Chest trauma alone and especially its combination with TBI represent high-risk injury patterns for the development of pneumonia, which forms the strongest predictor of mortality in poly-traumatized patients.	[Hofman, Martijn; Andruszkow, Hagen; Kobbe, Philipp; Hildebrand, Frank] Univ Aachen Med Ctr, Dept Orthped Trauma, Reconstruct Surg, Pauwelsstrasse 30, DE-52074 Aachen, Germany; [Poeze, Martijn] Maastricht Univ Med Ctr, Dept Surg, Div Trauma Surg, P. Debyelaan 25, NL-6229 HX Maastricht, Netherlands		Hofman, M (corresponding author), Univ Aachen Med Ctr, Dept Orthped Trauma, Reconstruct Surg, Pauwelsstrasse 30, DE-52074 Aachen, Germany.	mhofman@ukaachen.de		Hofman, Martijn/0000-0003-2204-1949			Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Buki A, 2012, CURR GERIATR REP, V1, P159, DOI 10.1007/s13670-012-0016-3; Calhoon J H, 1997, Chest Surg Clin N Am, V7, P199; Chen J, 2014, SURGERY, V156, P988, DOI 10.1016/j.surg.2014.06.045; Chrysou K, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0384-y; Cook A, 2010, J TRAUMA, V69, P1083, DOI 10.1097/TA.0b013e3181f9fb51; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dai DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074204; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Evans Charlesnika T, 2012, Top Spinal Cord Inj Rehabil, V18, P300, DOI 10.1310/sci1804-300; Fiebich BL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00260; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Grubmuller M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0469-7; Haenel J B, 1996, Respir Care Clin N Am, V2, P401; Hildebrand F, 2005, INJURY, V36, P293, DOI 10.1016/j.injury.2004.08.012; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Kristiansen T, 2014, INJURY, V45, P23, DOI 10.1016/j.injury.2013.07.007; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P83, DOI 10.1016/j.accpm.2017.11.006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Mangram AJ, 2015, AM J SURG, V210, P1056, DOI 10.1016/j.amjsurg.2015.06.029; Mondello S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/473419; O'Grady NP, 2012, JAMA-J AM MED ASSOC, V307, P2534, DOI 10.1001/jama.2012.6445; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Para RA, 2018, J EMERG TRAUMA SHOCK, V11, P288, DOI 10.4103/JETS.JETS_34_17; Park Hyun Oh, 2017, Korean J Thorac Cardiovasc Surg, V50, P346, DOI 10.5090/kjtcs.2017.50.5.346; Prin I., 2013, INJ EPIDEMIOL, V3, P18, DOI DOI 10.1186/S40621-016-0084-5; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trupka A, 1997, UNFALLCHIRURG, V100, P469, DOI 10.1007/s001130050144; Vecsei V., 2005, EUR J TRAUMA, V31, P239; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walaszek Marta, 2016, Przegl Epidemiol, V70, P15; Wang KW, 2013, J NEUROSURG, V118, P358, DOI 10.3171/2012.10.JNS127; Yucel N, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/6461072; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	48	6	6	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2020	46	1					11	19		10.1007/s00068-019-01179-1			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KN0GN	WOS:000514517700003	31270555	Green Published, Bronze			2022-02-06	
J	Iacono, D; Lee, P; Edlow, BL; Gray, N; Fischl, B; Kenney, K; Lew, HL; Lozanoff, S; Liacouras, P; Lichtenberger, J; Dams-O'Connor, K; Cifu, D; Hinds, SR; Perl, DP				Iacono, Diego; Lee, Patricia; Edlow, Brian L.; Gray, Nichelle; Fischl, Bruce; Kenney, Kimbra; Lew, Henry L.; Lozanoff, Scott; Liacouras, Peter; Lichtenberger, John; Dams-O'Connor, Kristen; Cifu, David; Hinds, Sidney R.; Perl, Daniel P.			Early-Onset Dementia in War Veterans: Brain Polypathology and Clinicopathologic Complexity	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain co-occurring pathologies; Chronic stress; Combat-TBI; Histologic distribution; Short- and long-terms neuropsychiatric manifestations in veterans; War settings	NATIONAL INSTITUTE; SUICIDE ATTEMPTS; ASSOCIATION; INJURY; IRAQ; US; AFGHANISTAN; DISEASE; GUIDELINES; DIAGNOSIS	The neuropathology associated with cognitive decline in military personnel exposed to traumatic brain injury (TBI) and chronic stress is incompletely understood. Few studies have examined clinicopathologic correlations between phosphorylated-tau neurofibrillary tangles, beta-amyloid neuritic plaques, neuroinflammation, or white matter (WM) lesions, and neuropsychiatric disorders in veterans. We describe clinicopathologic findings in 4 military veterans with early-onset dementia (EOD) who had varying histories of blunt- and blast-TBI, cognitive decline, behavioral abnormalities, post-traumatic stress disorder, suicidal ideation, and suicide. We found that pathologic lesions in these military-EOD cases could not be categorized as classic Alzheimer's disease (AD), chronic traumatic encephalopathy, traumatic axonal injury, or other wellcharacterized clinicopathologic entities. Rather, we observed a mixture of polypathology with unusual patterns compared with pathologies found in AD or other dementias. Also, ultrahigh resolution ex vivo MRI in 2 of these 4 brains revealed unusual patterns of periventricular WM injury. These findings suggest that military-EOD cases are associated with atypical combinations of brain lesions and distribution rarely seen in nonmilitary populations. Future prospective studies that acquire neuropsychiatric data before and after deployments, as well as genetic and environmental exposure data, are needed to further elucidate clinicopathologic correlations in military-EOD.	[Iacono, Diego; Lee, Patricia; Gray, Nichelle; Liacouras, Peter; Perl, Daniel P.] USU, CNRM, Brain Tissue Repository & Neuropathol Core, Bethesda, MD USA; [Iacono, Diego; Kenney, Kimbra] USU, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD USA; [Iacono, Diego; Perl, Daniel P.] USU, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD USA; [Iacono, Diego; Lee, Patricia; Gray, Nichelle] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD USA; [Iacono, Diego] NINDS, Neurodegenerat Clin, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, Boston, MA 02114 USA; [Edlow, Brian L.; Fischl, Bruce] Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02114 USA; [Edlow, Brian L.; Fischl, Bruce] Harvard Med Sch, Boston, MA 02115 USA; [Fischl, Bruce] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Fischl, Bruce] MIT, Harvard MIT Program Hlth Sci & Technol HST, CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA; [Lozanoff, Scott] Univ Hawaii, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA; [Lee, Patricia; Liacouras, Peter; Lichtenberger, John] USU, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, Bethesda, MD USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Cifu, David] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Cifu, David] CENC, Dept Vet Affairs, Richmond, VA USA; [Hinds, Sidney R.] US Army, DoD Brain Hlth Res Program, Blast Injury Res Program Coordinating Off, Res & Technol,Med Res & Mat Command, Ft Detrick, MD USA; [Hinds, Sidney R.] CENC, Ft Detrick, MD USA		Iacono, D (corresponding author), USU, F Edward Hebert Sch Med, Dept Neurol, Pathol Neuropathol,Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), USU, F Edward Hebert Sch Med, CNRM, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	diego.iacono.ctr@usuhs.edu	Iacono, Diego/K-8203-2016	Iacono, Diego/0000-0001-5511-0950; Cifu, David/0000-0003-1600-9387	Brain Tissue Repository and Neuropathology Core, CNRM, USU [308049-4.01-60855]; CENC [W81XWH-13-2-0095]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, U01NS086625]; National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01NS086625, K01HD074651]; James S. McDonnell Foundation; National Institutes of Health shared instrumentation grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR023401, 1S10RR019307, 1S10RR023043]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, 1R01EB023281, R01EB006758, R21EB018907, R01EB019956]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5R01AG008122, R01AG016495]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1-R21-DK-108277-01]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS0525851, R21NS072652, R01NS070963, R01NS083534, 5U01NS086625]; NIH Blueprint for Neuroscience Research, part of the multi-institutional Human Connectome ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01-MH093765]	This study was supported by the Brain Tissue Repository and Neuropathology Core, CNRM, USU award no. 308049-4.01-60855 and CENC grant award W81XWH-13-2-0095. Support was also provided by the National Institute of Neurological Disorders and Stroke (K23NS094538, U01NS086625), National Institute of Child Health and Development (U01NS086625; K01HD074651), and the James S. McDonnell Foundation. This research also utilized resources provided by National Institutes of Health shared instrumentation grants 1S10RR023401, 1S10RR019307, and 1S10RR023043. Additional support was provided in part by the National Institute for Biomedical Imaging and Bioengineering (P41EB015896, 1R01EB023281, R01EB006758, R21EB018907, R01EB019956), the National Institute on Aging (5R01AG008122, R01AG016495), the National Institute of Diabetes and Digestive and Kidney Diseases (1-R21-DK-108277-01), the National Institute for Neurological Disorders and Stroke (R01NS0525851, R21NS072652, R01NS070963, R01NS083534, 5U01NS086625), and by the NIH Blueprint for Neuroscience Research (5U01-MH093765), part of the multi-institutional Human Connectome Project.	Bourn LE, 2016, J PSYCHOSOM RES, V82, P35, DOI 10.1016/j.jpsychores.2016.01.009; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P183, DOI 10.1136/jramc-2018-000971; Brennan J, 2013, LARYNGOSCOPE, V123, P2411, DOI 10.1002/lary.24096; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Courtet P, 2016, WORLD J BIOL PSYCHIA, V17, P564, DOI 10.3109/15622975.2015.1054879; de la Monte SM, 2014, ACTA NEUROPATHOL, V127, P71, DOI 10.1007/s00401-013-1233-3; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Escher CM, 2019, J NEURAL TRANSM, V126, P1155, DOI 10.1007/s00702-019-01988-z; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iacono D, 2016, JOVE-J VIS EXP, DOI 10.3791/54602(2016); Jacobowitz DM, 2015, J PRIMATOLOGY, V04, P125; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kruger J, 2012, ALZ DIS ASSOC DIS, V26, P272, DOI 10.1097/WAD.0b013e318231e6c7; Leonard BE, 2006, NEUROIMMUNOMODULAT, V13, P268, DOI 10.1159/000104854; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Masellis M, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt197; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Picard C, 2011, ALZ DIS ASSOC DIS, V25, P203, DOI 10.1097/WAD.0b013e3182056be7; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sassi C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.026; Snyder HM, 2018, ALZHEIMERS DEMENT, V14, P1651, DOI 10.1016/j.jalz.2018.08.011; Suzuki H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00031; Teissier A, 2015, CELL REP, V13, P1965, DOI 10.1016/j.celrep.2015.10.061; Tripathy A, 2019, J ALZHEIMERS DIS, V67, P1277, DOI 10.3233/JAD-181039; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P1022, DOI 10.1001/jamapsychiatry.2018.2069; Ursano RJ, 2017, MIL MED, V182, DOI 10.7205/MILMED-D-16-00270; Ursano RJ, 2015, JAMA PSYCHIAT, V72, P917, DOI 10.1001/jamapsychiatry.2015.0987; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Williams JL, 2017, MIL MED, V182, pE1645, DOI 10.7205/MILMED-D-16-00221; Wong TH, 2019, NEUROBIOL AGING, V73, DOI 10.1016/j.neurobiolaging.2018.08.016	37	6	6	2	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2020	79	2					144	162		10.1093/jnen/nlz122			19	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology	KX0OV	WOS:000521584300002	31851313	hybrid, Green Published			2022-02-06	
J	Iverson, GL; Ivins, BJ; Karr, JE; Crane, PK; Lange, RT; Cole, WR; Silverberg, ND				Iverson, Grant L.; Ivins, Brian J.; Karr, Justin E.; Crane, Paul K.; Lange, Rael T.; Cole, Wesley R.; Silverberg, Noah D.			Comparing Composite Scores for the ANAM4 TBI-MIL for Research in Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Assessment; Norms/normative studies	MULTIVARIATE BASE RATES; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; ADVANCED CLINICAL INTERPRETATION; COGNITIVE IMPAIRMENT; OEF/OIF VETERANS; BLAST EXPOSURE; CONCUSSION; OUTCOMES; HETEROGENEITY; METAANALYSIS	Objective: The Automated Neuropsychological Assessment Metrics (Version 4) Traumatic Brain Injury Military (ANAM4 TBI-MIL) is commonly administered among U.S. service members both pre-deployment and following TBI. The current study used the ANAM4 TBI-MIL to develop a cognition summary score for TBI research and clinical trials, comparing eight composite scores based on their distributions and sensitivity/specificity when differentiating between service members with and without mild TBI (MTBI). Method: Male service members with MTBI (n = 56; Mdn = 11 days-since-injury) or no self-reported TBI history (n = 733) completed eight ANAM4 TBI-MIL tests. Their throughput scores (correct responses/minute) were used to calculate eight composite scores: the overall test battery mean (OTBM); global deficit score (GDS); neuropsychological deficit score-weighted (NDS-W); low score composite (LSC); number of scores <50th, <= 16th percentile, or <= 5th percentile; and the ANAM Composite Score (ACS). Results: The OTBM and ACS were normally distributed. Other composites had skewed, zero-inflated distributions (62.9% had GDS = 0). All composites differed significantly between participants with and without MTBI (p < .001), with deficit scores showing the largest effect sizes (d = 1.32-1.47). The Area Under the Curve (AUC) was lowest for number of scores <= 5th percentile (AUC = 0.653) and highest for the LSC, OTBM, ACS, and NDS-W (AUC = 0.709-0.713). Conclusions: The ANAM4 TBI-MIL has no well-validated composite score. The current study examined multiple candidate composite scores, finding that deficit scores showed larger group differences than the OTBM, but similar AUC values. The deficit scores were highly correlated. Future studies are needed to determine whether these scores show less redundancy among participants with more severe TBIs.	[Iverson, Grant L.; Karr, Justin E.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.] Spaulding Rehabil Hosp, Boston, MA 02129 USA; [Iverson, Grant L.; Karr, Justin E.] Home Base, Boston, MA 02129 USA; [Ivins, Brian J.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Karr, Justin E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02129 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Cole, Wesley R.] Def & Vet Brain Injury Ctr, Ft Bragg, NC 28310 USA; [Cole, Wesley R.] Intrepid Spirit, Ft Bragg, NC 28310 USA; [Cole, Wesley R.] Womack Army Med Ctr, Ft Bragg, NC 28310 USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC V5Z 2G9, Canada		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			U.S. Department of Defense as part of the TBI Endpoints Development Initiative [W81XWH-14-2-0176]; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [W91YTZ-13-C-0015]; General Dynamics Information Technology [W91YTZ-13-C-0015]	This work was funded by the U.S. Department of Defense as part of the TBI Endpoints Development Initiative with a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials (subaward from W81XWH-14-2-0176). Noah Silverberg receives research salary support from a Health Professional Investigator Award from the Michael Smith Foundation for Health Research. Brian Ivins and Rael Lange receive research salary support from the Defense and Veterans Brain Injury Center through a contract with General Dynamics Information Technology (W91YTZ-13-C-0015).	Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bieliauskas LA, 2006, J CLIN EXP NEUROPSYC, V28, P1346, DOI 10.1080/13803390500473720; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Burnham SC, 2015, J ALZHEIMERS DIS, V46, P1079, DOI 10.3233/JAD-143015; Butowski N, 2012, CURR OPIN NEUROL, V25, P780, DOI 10.1097/WCO.0b013e328359b45e; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cattie JE, 2012, J NEUROPSYCH CLIN N, V24, P331, DOI 10.1176/appi.neuropsych.11080192; Center for the Study of Human Operator Performance, 2007, AUT NEUR ASS METR VE; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cognitive Science Research Center, 2011, ANAM4 EFF MEAS QUICK; Cognitive Science Research Center, 2012, ANAM4 MIL ADM MAN; Cognitive Science Research Center, 2009, MIL NORM REF DAT MIL; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cysique LA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0298-0; Decloedt EH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005401; Donohue Michael C, 2017, Alzheimers Dement (N Y), V3, P123, DOI 10.1016/j.trci.2016.12.001; Dretsch MN, 2015, J NEUROTRAUM, V32, P1217, DOI 10.1089/neu.2014.3637; Haensel A, 2009, SLEEP BREATH, V13, P35, DOI 10.1007/s11325-008-0198-2; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Hinds S., 2015, NEUROCOGNITIVE ASSES; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Iverson GL, 2013, PRACT RESOUR MENT, P485, DOI 10.1016/B978-0-12-386934-0.00010-9; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Karr JE, 2018, CLIN NEUROPSYCHOL, V32, P42, DOI 10.1080/13854046.2017.1334828; Karr JE, 2017, ARCH CLIN NEUROPSYCH, V32, P297, DOI 10.1093/arclin/acw105; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; KENDLER KS, 1994, ARCH GEN PSYCHIAT, V51, P456; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; McIntyre RS, 2014, INT J NEUROPSYCHOPH, V17, P1557, DOI 10.1017/S1461145714000546; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; National Institute of Neurological Disorders and Stroke, 2012, NINDS COMM DAT EL; Proctor SP, 2015, MIL MED, V180, P660, DOI 10.7205/MILMED-D-14-00298; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Reichenberg A, 2009, SCHIZOPHRENIA BULL, V35, P1022, DOI 10.1093/schbul/sbn044; Reitan R, 1985, HALSTEAD REITAN NEUR; Robertson KR, 2016, AIDS, V30, P2315, DOI 10.1097/QAD.0000000000001189; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Russell E. W., 2011, SCI FDN NEUROPSYCHOL; Russell E. W., 1970, ASSESSMENT BRAIN DAM; RUSSELL EW, 1984, J CONSULT CLIN PSYCH, V52, P717, DOI 10.1037/0022-006X.52.4.717; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stricker NH, 2010, J INT NEUROPSYCH SOC, V16, P813, DOI 10.1017/S1355617710000652; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vardy J, 2007, J CLIN ONCOL, V25, P2455, DOI 10.1200/JCO.2006.08.1604; Vellas B, 2015, J Prev Alzheimers Dis, V2, P128; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Wolfson, 1993, HALSTEAD REITAN NEUR	70	6	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2020	35	1					56	69		10.1093/arclin/acz021			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN8GI	WOS:000569024700006	31063188	Bronze			2022-02-06	
J	Johnson, BD; Sackett, JR; Schlader, ZJ; Leddy, JJ				Johnson, Blair D.; Sackett, James R.; Schlader, Zachary J.; Leddy, John J.			Attenuated Cardiovascular Responses to the Cold Pressor Test in Concussed Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						heart rate; blood pressure; mild traumatic brain injury; autonomic nervous system	METABOLIC BRAIN VULNERABILITY; SYMPATHETIC-NERVE ACTIVITY; HEART-RATE-VARIABILITY; TEMPORAL WINDOW; ACTIVATION; IMPACTS; INJURY; SEASON	Context: Cardiovascular responses to the cold pressor test (CPT) provide information regarding sympathetic function. Objective: To determine if recently concussed collegiate athletes had blunted cardiovascular responses during the CPT. Design: Cross-sectional study. Setting: Laboratory. Patients or Other Participants: A total of 10 symptomatic concussed collegiate athletes (5 men, 5 women; age = 20 +/- 2 years) who were within 7 days of diagnosis and 10 healthy control individuals (5 men, 5 women; age = 24 +/- 4 years). Intervention(s): The participants' right hands were submerged in agitated ice water for 120 seconds (CPT). Main Outcome Measure(s): Heart rate and blood pressure were continuously measured and averaged at baseline and every 30 seconds during the CPT. Results: Baseline heart rate and mean arterial pressure were not different between groups. Heart rate increased throughout 90 seconds of the CPT (peak increase at 60 seconds = 16 +/- 13 beats/min; P < .001) in healthy control participants but remained unchanged in concussed athletes (peak increase at 60 seconds = 7 +/- 10 beats/min; P = .08). We observed no differences between groups for the heart rate response (P > .28). Mean arterial pressure was elevated throughout the CPT starting at 30 seconds (5 +/- 7 mm Hg; P = .048) in healthy control individuals (peak increase at 120 seconds = 26 +/- 9 mm Hg; P < .001). Mean arterial pressure increased in concussed athletes at 90 seconds (8 +/- 8 mm Hg; P = .003) and 120 seconds (12 +/- 8 mm Hg; P < .001). Healthy control participants had a greater increase in mean arterial pressure starting at 60 seconds (P < .001) and throughout the CPT than concussed athletes (peak difference at 90 seconds = 25 +/- 10 mm Hg and 8 +/- 8 mm Hg, respectively; P < .001). Conclusions: Recently concussed athletes had blunted cardiovascular responses to the CPT, which indicated sympathetic dysfunction.	[Johnson, Blair D.; Sackett, James R.; Schlader, Zachary J.] Univ Buffalo, Ctr Res & Educ Special Environm, Dept Exercise & Nutr Sci, 208A Kimball Tower, Buffalo, NY 14214 USA; [Leddy, John J.] Univ Buffalo, Dept Orthopaed & Sports Med, Buffalo, NY 14214 USA		Johnson, BD (corresponding author), Univ Buffalo, Ctr Res & Educ Special Environm, Dept Exercise & Nutr Sci, 208A Kimball Tower, Buffalo, NY 14214 USA.	blairjoh@buffalo.edu		Johnson, Blair/0000-0002-1731-4415	National Center for Advancing Translational Sciences of the National Institutes of Health Pilot Grants Award Program [UL1TR001412]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]	This study was supported by Grant No. UL1TR001412 from the National Center for Advancing Translational Sciences of the National Institutes of Health Pilot Grants Award Program (Dr Johnson) and Grant No. 1R01NS094444 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (Dr Leddy). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Ali A, 2016, J CLIN DIAGN RES, V10; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dishman RK, 2002, PSYCHOPHYSIOLOGY, V39, P568, DOI 10.1017/S0048577202394071; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Greaney JL, 2015, J HUM HYPERTENS, V29, P402, DOI 10.1038/jhh.2014.106; Greaney JL, 2015, AM J PHYSIOL-HEART C, V308, pH816, DOI 10.1152/ajpheart.00867.2014; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Holwerda SW, 2016, AM J PHYSIOL-HEART C, V310, pH300, DOI 10.1152/ajpheart.00636.2015; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Joyner MJ, 2016, J PHYSIOL-LONDON, V594, P4009, DOI 10.1113/JP271875; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Monahan KD, 2013, J PHYSIOL-LONDON, V591, P2937, DOI 10.1113/jphysiol.2013.251298; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Okada Y, 2016, HYPERTENSION, V67, P951, DOI 10.1161/HYPERTENSIONAHA.115.06700; Patel HM, 2013, J APPL PHYSIOL, V115, P90, DOI 10.1152/japplphysiol.00089.2013; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; SEALS DR, 1991, HYPERTENSION, V17, P36, DOI 10.1161/01.HYP.17.1.36; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Usselman CW, 2015, HYPERTENSION, V66, P858, DOI 10.1161/HYPERTENSIONAHA.115.05964; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; VICTOR RG, 1987, HYPERTENSION, V9, P429, DOI 10.1161/01.HYP.9.5.429; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2	39	6	7	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2020	55	2					124	131		10.4085/1062-6050-573-18			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM1GV	WOS:000513866900003	31909640	Green Published, gold			2022-02-06	
J	Nakase-Richardson, R; Schwartz, DJ; Drasher-Phillips, L; Ketchum, JM; Calero, K; Dandah, MN; Monden, KR; Bell, K; Magalang, U; Hoffman, JM; Whyte, J; Bogner, J; Zeitzer, JM				Nakase-Richardson, Risa; Schwartz, Daniel J.; Drasher-Phillips, Leah; Ketchum, Jessica M.; Calero, Karel; Dandah, Marie N.; Monden, Kimberley R.; Bell, Kathleen; Magalang, Ulysses; Hoffman, Jeanne M.; Whyte, John; Bogner, Jennifer; Zeitzer, Jamie M.			Comparative Effectiveness of Sleep Apnea Screening Instruments During Inpatient Rehabilitation Following Moderate to Severe TBI	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Comparative effectiveness research; Mass screening; Rehabilitation; Sensitivity and specificity; Sleep apnea syndromes	TRAUMATIC BRAIN-INJURY; GALVESTON ORIENTATION; QUESTIONNAIRE; DEPRIVATION; GUIDELINE; COGNITION; STROKE; SCALE; RISK	Objective: To determine the diagnostic sensitivity and specificity and comparative effectiveness of traditional sleep apnea screening tools in traumatic brain injury (TBI) neurorehabilitation admissions. Design: Prospective diagnostic comparative effectiveness trial of sleep apnea screening tools relative to the criterion standard, attended level 1 polysomnography including encephalography. Setting: Six TBI Model System Inpatient Rehabilitation Centers. Participants: Between May 2017 and February 2019, 449 of 896 screened were eligible for the trial with 345 consented (77% consented). Additional screening left 263 eligible for and completing polysomnography with final analyses completed on 248. Intervention: Not applicable. Main Outcome Measures: Area under the curve (AUC) of screening tools relative to total apnea hypopnea index >= 15 (AHI, moderate to severe apnea) measured at a median of 47 days post-TBI (interquartile range, 29-47). Results: The Berlin high-risk score (receiving operating curve [ROC] AUC =0.634) was inferior to the Multivariable Apnea Prediction Index (MAPI) (ROC AUC=0.780) (P=.0211; CI, 0.018-0.223) and Snoring, Tired, Observed, Blood Pressure, Body Mass Index, Age, Neck Circumference, and Gender (STOPBANG) score (ROC AUC=0.785) (P=.001; CI, 0.063-0.230), both of which had comparable AUC (P=.7245; CI, -0.047 to 0.068). Findings were similar for AHI >= 30 (severe apnea); however, no differences across scales was observed at AHI >= 5. The pattern was similar across TBI severity subgroups except for posttraumatic amnesia (PTA) status wherein the MAPI outperformed the Berlin. Youden's index to determine risk yielded lower sensitivities but higher specificities relative to non-TBI samples. Conclusion: This study is the first to provide clinicians with data to support a choice for which sleep apnea screening tools are more effective during inpatient rehabilitation for TBI (STOPBANG, MAPI vs Berlin) to help reduce comorbidity and possibly improve neurologic outcome. (C) 2019 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.	[Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Schwartz, Daniel J.; Calero, Karel] Univ S Florida, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Schwartz, Daniel J.; Calero, Karel] James A Haley Vet Hosp, Med Serv, Tampa, FL 33612 USA; [Drasher-Phillips, Leah] James A Haley Vet Hosp, Res & Dev Serv, Tampa, FL 33612 USA; [Ketchum, Jessica M.; Monden, Kimberley R.] Craig Hosp, Res Dept, Englewood, CO USA; [Dandah, Marie N.] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Dandah, Marie N.] Baylor Scott & White Med Ctr, Plano, TX USA; [Monden, Kimberley R.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Bell, Kathleen] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Magalang, Ulysses] Ohio State Univ, Wexner Med Ctr, Neurosci Res Inst, Columbus, OH 43210 USA; [Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bogner, Jennifer] Ohio State Univ, Div Rehabil Psychol, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Zeitzer, Jamie M.] Stanford Univ, Dept Psychiat & Behav Serv, Stanford, CA 94305 USA; [Zeitzer, Jamie M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin, Palo Alto, CA USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma TBI Rehabil Mail Code 117, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Zeitzer, Jamie M/A-1168-2007; Monden, Kimberley/AAE-9831-2020; Zeitzer, Jamie/AAO-2103-2020	Zeitzer, Jamie M/0000-0001-6174-5282; Monden, Kimberley/0000-0002-5207-0452; Zeitzer, Jamie/0000-0001-6174-5282; Bell, Kathleen/0000-0002-0928-2046	Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [CER-I511-33005]; VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W91YTZ 13 C 0015, HT0014 19 C 0004]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DFTB0008, 90DPT80004-02]	Supported by Patient-Centered Outcomes Research Institute (award no. CER-I511-33005); the VHA Central Office VA TBI Model Systems Program of Research; and a subcontract from General Dynamics Information Technology (W91YTZ 13 C 0015, HT0014 19 C 0004) from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (grant nos. 90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DFTB0008, 90DPT80004-02). The statements presented in this publication are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors, or the Methodology Committee.	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Balk EM, 2012, FUTURE RES NEEDS DIA; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2019, J HEAD TRAUMA REHABI; Brown RM, 2018, BRAIN INJURY, V32, P986, DOI 10.1080/02699052.2018.1468575; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Deflandre E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196270; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flanagan SR, 2015, BRAIN INJ PROF, V12, P8; Gamaldo C, 2018, J CLIN SLEEP MED, V14, P1239, DOI 10.5664/jcsm.7232; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Khot S, 2019, STROKE, V50, P1895, DOI 10.1161/STROKEAHA.119.024795; Kuczynski W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43199-2; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Silva MA, 2018, BRAIN INJURY, V32, P994, DOI 10.1080/02699052.2018.1468576; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; TEASDALE G, 1974, LANCET, V2, P81; The National Data and Statistical Center, DAT EM PTA; Vaughn BV, 2008, CHEST, V134, P1310, DOI 10.1378/chest.08-0812; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilson Georgina, 2014, Sleep Disord, V2014, P945287, DOI 10.1155/2014/945287; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	45	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2020	101	2					283	296		10.1016/j.apmr.2019.09.019			14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KM6CP	WOS:000514226500014	31705855	hybrid			2022-02-06	
J	Qi, R; Wang, XJ				Qi, Ruo; Wang, Xinjun			Inhibition of miR-429 improves neurological recovery of traumatic brain injury mice and attenuates microglial neuroinflammation	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Microglia; miR-429; Neuroinflammation; Traumatic brain injury; DUSP1	DUSP1; MAPK; PHOSPHATASE; CONTRIBUTES; APOPTOSIS; TARGET	Background: Neuroinflammation is a common therapeutic target for traumatic brain injury (TBI) due to its contribution to delayed secondary cell death and has the potential to occur for years after the initial insult. Previous studies demonstrate that miR-429 is up-regulated in the brain lesions of TBI mice, while its role in regulating neuroinflammation and brain injury remains largely unknown. Method: The expression of miR-429 in LPS-activated microglia and microglia in TBI model was detected by RTPCR. The effects of miR-429 inhibitors on LPS-activated microglia in vitro as well as neurological recovery and post-traumatic neuroinflammatory response in TBI model mice were detected in vivo. Results: LPS and TBI significantly induce the up-expression of miR-429, inflammatory cytokines, MAPK-p38 and phosphorylated NF-kappa B in microglia, which were all inhibited by miR-429 inhibitors. Meanwhile, miR-429 inhibitors also attenuated the neurological impairment in TBI mice. Btoinformatics analysis showed that miR-429 could target and inhibit the expression of dual specificity protein phosphatase 1 (DUSP1), thus inhibiting the expression of MAPK-p38 and phosphorylated NF-kappa B. Conclusion: miR-429 plays a pro-inflammatory role in activated microglia by targeting DUSP1 signaling pathway. Inhibiting miR-429 can attenuate the inflammatory response of microglia and TBI-mediated brain damage.	Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China; Zhengzhou Univ, Dept Ophthalmol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China		Wang, XJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, 3 Kangfuqian St, Zhengzhou, Henan, Peoples R China.	pangmengj41@163.com					Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Choi MJ, 2017, BIOCHEM PHARMACOL, V144, P120, DOI 10.1016/j.bcp.2017.07.021; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Di Pietro V., 2017, J NEUROTRAUMA, V34; Fang X, 2017, NEUROSCI BULL, V33, P603, DOI 10.1007/s12264-017-0153-y; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gang L, 2017, AM J TRANSL RES, V9, P5388; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kim H, 2017, 2017 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY & SIGNAL/POWER INTEGRITY (EMCSI), P591, DOI 10.1109/ISEMC.2017.8077937; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lin X, 2014, CURR MED CHEM, V21, P4405, DOI 10.2174/0929867321666140915143040; Ma J, 2016, AM J TRANSL RES, V8, P1895; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Quintanilha BJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111168; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Senfter Daniel, 2016, BioMolecular Concepts, V7, P311, DOI 10.1515/bmc-2016-0020; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shen JL, 2016, CANCER MED-US, V5, P2061, DOI 10.1002/cam4.772; Lopes LJS, 2017, MOL CARCINOGEN, V56, P1630, DOI 10.1002/mc.22619; Wang J, 2016, AUTOPHAGY, V12, P1791, DOI 10.1080/15548627.2016.1203483; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Xiao J, 2015, BIOCHEM J, V471, P281, DOI 10.1042/BJ20131510; Yan XT, 2018, J CELL PHYSIOL, V233, P4815, DOI 10.1002/jcp.26284; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Zhang XY, 2014, CANCER RES, V74, P7191, DOI 10.1158/0008-5472.CAN-14-1379; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	33	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	FEB	2020	79								106091	10.1016/j.intimp.2019.106091			8	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	KN3PW	WOS:000514753800030	31896511				2022-02-06	
J	Quarrie, K; Gianotti, S; Murphy, I				Quarrie, Ken; Gianotti, Simon; Murphy, Ian			Injury Risk in New Zealand Rugby Union: A Nationwide Study of Injury Insurance Claims from 2005 to 2017	SPORTS MEDICINE			English	Article							OPERATIONAL DEFINITION; CONSENSUS STATEMENT; SCHOOL RUGBY; CONCUSSION; EPIDEMIOLOGY; LEAGUE; METAANALYSIS; MANAGEMENT; TACKLE; RETURN	ObjectivesThe Accident Compensation Corporation is a compulsory, 24-h, no-fault personal injury insurance scheme in New Zealand. The purpose of this large-scale retrospective cohort study was to use Accident Compensation Corporation records to provide information about rugby injury epidemiology in New Zealand, with a focus on describing differences in risk by age and gender.MethodsA total of 635,657 rugby injury claims were made to the Accident Compensation Corporation for players aged 5-40 years over the period 2005-2017. Information about player numbers and estimates of player exposure was obtained from New Zealand Rugby, the administrative organisation for rugby in New Zealand.ResultsOver three quarters of claims (76%) were for soft-tissue injuries, with 11% resulting from fractures or dislocations, 6.7% from lacerations, 3.1% from concussions and 2.0% from dental injuries. Body regions injured included shoulder (14%), knee (14%), wrist/hand (13%), neck/spine (13%), head/face (12%), leg (11%) and ankle (10%). The probability of a player making at least one injury claim in a season (expressed as a percentage) was calculated under the assumption that the incidence of claims follows a Poisson distribution. Players aged 5-6 years had a probability of making at least one claim per season of 1.0%, compared to 8.3% for players aged 7-12 years, 35% for age 13-17 years, 53% for age 18-20 years, 57% for age 21-30 years and 47% for age 31-40 years. The overall probability of making at least one claim per season across all age groups was 29%. The relative claim rate for adults (players aged 18 years and over) was 3.92 (90% confidence interval 3.90-3.94) times that of children. Ten percent of players were female, and they sustained 6% of the injuries. Overall, the relative claim rate for female players was 0.57 times that of male players (90% confidence interval 0.56-0.58). The relative claim rate of female to male players tended to increase with age. There were very few female players aged over 30 years; however, those who did play had higher claim rates than male players of the same age group (1.49; 90% confidence interval 1.45-1.53).ConclusionsInjuries resulting from rugby are distributed across the body, and most of the claims are for soft-tissue injuries. Rates of injury increase rapidly through the teenage years until the early 20 s; for male players they then decrease until the mid-30 s. For female players, the injury rate does not decrease as players move into their 30 s. Combining Accident Compensation Corporation injury claim data with national player registration data provides useful information about the risks faced by New Zealand's community rugby players, and the insights derived are used in the development of rugby injury prevention programme content.	[Quarrie, Ken; Murphy, Ian] New Zealand Rugby, Wellington, New Zealand; [Gianotti, Simon] Accid Compensat Corp, Wellington, New Zealand		Quarrie, K (corresponding author), New Zealand Rugby, Wellington, New Zealand.	ken.quarrie@nzrugby.co.nz		Quarrie, Ken/0000-0003-1703-8489			Aman M, 2018, SCAND J MED SCI SPOR, V28, P1147, DOI 10.1111/sms.12956; Aman M, 2019, KNEE SURG SPORT TR A, V27, P1000, DOI 10.1007/s00167-018-5225-7; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Carter M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h26; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Freitag A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1587; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; King D, 2019, J SCI MED SPORT, V22, P532, DOI 10.1016/j.jsams.2018.10.015; King D, 2011, INT J SPORTS MED, V32, P287, DOI 10.1055/s-0030-1270486; King DA, 2010, BRIT J SPORT MED, V44, P1016, DOI 10.1136/bjsm.2009.064683; King DA, 2009, BRIT J SPORT MED, V43, P595, DOI 10.1136/bjsm.2009.061481; King DA, 2011, J SCI MED SPORT, V14, P126, DOI 10.1016/j.jsams.2010.10.001; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; New Zealand Rugby, 2003, SMALL BLACKS DEV MOD; Oudshoorn Bodil Yucki, 2017, BMJ Open Sport Exerc Med, V3, pe000239, DOI 10.1136/bmjsem-2017-000239; Parekh N, 2012, BRIT J SPORT MED, V46, P611, DOI 10.1136/bjsports-2011-090431; Pollock AM, 2017, BRIT J SPORT MED, V51, P1113, DOI 10.1136/bjsports-2016-096996; Quarrie KL, 2017, BRIT J SPORT MED, V51, P1134, DOI 10.1136/bjsports-2017-098013; Quarrie KL, 2014, BRIT J SPORT MED, V48, P1589, DOI 10.1136/bjsports-2014-094112; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Schneiders AG, 2009, PHYS THER SPORT, V10, P85, DOI 10.1016/j.ptsp.2009.05.001; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Rugby, 2017, WORLD RUGB PLAYER NU; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4	43	6	6	3	9	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	FEB	2020	50	2					415	428		10.1007/s40279-019-01176-9			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KS9EP	WOS:000518611100012	31506903	Green Published, hybrid			2022-02-06	
J	van Gent, JAN; van Essen, TA; Bos, MHA; Cannegieter, SC; van Dijck, JTJM; Peul, WC				van Gent, Jort A. N.; van Essen, Thomas A.; Bos, Mettine H. A.; Cannegieter, Suzanne C.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.			Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Coagulopathy; Progression of hemorrhagic injury; Time course; Mortality	HEAD TRAUMA; COAGULATION DISORDERS; TISSUE FACTOR; PROTEIN-C; PROGRESSION; HYPOPERFUSION; MODERATE	Background Traumatic brain injury is associated with high rates of mortality and morbidity. Trauma patients with a coagulopathy have a 10-fold increased mortality risk compared to patients without a coagulopathy. The aim of this study was to identify the incidence of coagulopathy and relate early coagulopathy to clinical outcome in patients with traumatic intracranial hemorrhages. Methods Between September 2015 and December 2016, 108 consecutive cranial trauma patients with traumatic intracranial hemorrhages were included in this study. To assess the relationship between patients with a coagulopathy and outcome, a chi-squared test was performed. Results A total of 29 out of the 108 patients (27%) with a traumatic intracranial hemorrhage developed a coagulopathy within 72 h after admission. Overall, a total of 22 patients (20%) died after admission of which ten were coagulopathic at emergency department presentation. Early coagulopathy in patients with traumatic brain injury is associated with progression of hemorrhagic injury (odds ratio 2.4 (95% confidence interval 0.8-8.0)), surgical intervention (odds ratio 2.8 (95% confidence interval 0.87-9.35)), and increased in-hospital mortality (odds ratio 23.06 (95% confidence interval 5.5-95.9)). Conclusion Patients who sustained a traumatic intracranial hemorrhage remained at risk for developing a coagulopathy until 72 h after trauma. Patients who developed a coagulopathy had a worse clinical outcome than patients who did not develop a coagulopathy.	[van Gent, Jort A. N.; van Essen, Thomas A.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Leiden Univ, Med Ctr, UNCH, Dept Neurosurg, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [van Gent, Jort A. N.; van Essen, Thomas A.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.] HAGA Teaching Hosp, The Hague, Netherlands; [van Gent, Jort A. N.; van Essen, Thomas A.; van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Haaglanden Med Ctr, The Hague, Netherlands; [Bos, Mettine H. A.; Cannegieter, Suzanne C.] Leiden Univ, Med Ctr, Div Thrombosis & Hemostasis, Leiden, Netherlands; [van Dijck, Jeroen T. J. M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands		van Gent, JAN (corresponding author), Leiden Univ, Med Ctr, UNCH, Dept Neurosurg, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.; van Gent, JAN (corresponding author), HAGA Teaching Hosp, The Hague, Netherlands.; van Gent, JAN (corresponding author), Haaglanden Med Ctr, The Hague, Netherlands.	J.A.N.van_Gent@lumc.nl; T.A.van_Essen@lumc.nl; M.H.A.Bos@lumc.nl; S.C.Cannegieter@lumc.nl; J.T.J.M.van_Dijck@lumc.nl; W.C.Peul@lumc.nl	Bos, Mettine/S-5317-2016; van Dijck, Jeroen/AAM-4123-2021	Bos, Mettine/0000-0002-8164-817X; van Dijck, Jeroen/0000-0002-9893-632X; Van Essen, Thomas/0000-0003-4657-5283	Hersenstichting [602150] Funding Source: Medline		Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Daabiss M, 2011, INDIAN J ANAESTH, V55, P111, DOI 10.4103/0019-5049.79879; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giesen PLA, 2000, SEMIN THROMB HEMOST, V26, P379, DOI 10.1055/s-2000-8456; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rezaie AR, 2001, J BIOL CHEM, V276, P15567, DOI 10.1074/jbc.C100123200; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	32	6	6	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2020	162	2					329	336		10.1007/s00701-019-04111-z			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KV1ES	WOS:000520167600016	31741112	hybrid, Green Published			2022-02-06	
J	Wang, K; Jing, Y; Xu, C; Zhao, JW; Gong, QY; Chen, SW				Wang, Kai; Jing, Yao; Xu, Chen; Zhao, Jianwei; Gong, Qiuyuan; Chen, Shiwen			HIF-1 alpha and VEGF Are Involved in Deferoxamine-Ameliorated Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Controlled cortical impact; Deferoxamine; Hypoxia-inducible factor 1 alpha; Traumatic brain injury; Vascular endothelial growth factor	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ANGIOGENESIS; NEUROGENESIS; EXPRESSION; RATS; HEMORRHAGE; PROTECTION; STROKE	Background: Deferoxamine (DFX) has been reported to have neuroprotective effect. This study aimed to investigate the neuroprotective effect of DFX and its effect on hypoxia-inducible factor 1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) in rats after traumatic brain injury (TBI). Materials and methods: Rats were randomly divided into sham operation, TBI + DFX, and TBI + vehicle groups. The rats in the TBI + DFX group were intraperitoneally injected with DFX 2 and 6 h after injury, thereafter once every 12 h. The rats in the TBI + vehicle group were intraperitoneally injected with saline at the same time points. At 6, 12, 24, and 48 h after TBI, 6 rats in each group were euthanized, and the brains were harvested. The expression of HIF-1 alpha and VEGF in the pericontusional area was detected using real-time polymerase chain reaction and Western blot analysis. TBI-induced apoptosis was investigated using the TdT-mediated dUTP nick-end labeling (TUNEL) method. Three days after TBI, the density of microvessels was examined via immunohistochemical staining. Results: DFX treatment upregulated the expression of HIF-1 alpha and VEGF after TBI. DFX treatment reduced apoptosis and improved the neurobehavioral score after TBI. The density of microvessels was higher in the TBI + DFX group than that in the TBI + vehicle group 3 d after TBI. Conclusions: DFX can stimulate angiogenesis, inhibit apoptosis, and play a protective role after TBI. The protective effect of DFX may, at least in part, be through upregulating the expression of HIF-1 alpha and its downstream target gene VEGF. (C) 2019 Elsevier Inc. All rights reserved.	[Wang, Kai; Jing, Yao; Xu, Chen; Zhao, Jianwei; Gong, Qiuyuan; Chen, Shiwen] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China; [Wang, Kai] Xuzhou Med Univ, Dept Neurosurg, Affiliated Huaian Hosp, Huaian, Peoples R China; [Wang, Kai] Second Peoples Hosp Huaian, Huaian, Peoples R China		Chen, SW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Sch Med, Dept Neurosurg, Shanghai 200233, Peoples R China.	chenshiwen@126.com			project of Shanghai Science and Technology Commission [19ZR1438600]	Authors' contributions: Kai Wang, Yao Jing, and Shiwen Chen designed the study; Chen Xu, Jianwei Zhao, and Qiuyuan Gong participated in the experimental design; Kai Wang, Yao Jing, and Chen Xu conducted the experiments. Jianwei Zhao and Qiuyuan Gong participated in the animal experiments. Shiwen Chen provided all the funds. Kai Wang and Yao Jing conducted data analysis and drafted the paper. All authors read and approved the final manuscript. This work was supported by the project of Shanghai Science and Technology Commission (19ZR1438600).	Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hatakeyama T, 2011, ACTA NEUROCHIR SUPPL, V111, P185, DOI 10.1007/978-3-7091-0693-8_31; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Kletkiewicz H, 2016, NEUROSCI LETT, V628, P116, DOI 10.1016/j.neulet.2016.06.022; Lee JY, 2011, ACTA NEUROCHIR SUPPL, V112, P101, DOI 10.1007/978-3-7091-0661-7_18; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; Liu JB, 2011, INJURY, V42, P742, DOI 10.1016/j.injury.2010.08.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Mericli AF, 2015, PLAST RECONSTR SURG, V136, p125E, DOI 10.1097/PRS.0000000000001386; Mu DZ, 2005, EXP NEUROL, V195, P407, DOI 10.1016/j.expneurol.2005.06.001; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Shi FP, 2018, IRAN J BASIC MED SCI, V21, P318, DOI 10.22038/IJBMS.2018.27267.6657; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100818; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wu XY, 2018, BRAIN RES BULL, V139, P133, DOI 10.1016/j.brainresbull.2018.02.018; Xie P, 2017, ACTA PHYSIOL, V221, P98, DOI 10.1111/apha.12874; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhang R, 2014, BRAIN RES, V1583, P23, DOI 10.1016/j.brainres.2014.08.016; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	32	6	7	0	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2020	246						419	426		10.1016/j.jss.2019.09.023			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JW1BS	WOS:000502794400049	31630885				2022-02-06	
J	McGlynn, J; Boneau, RD; Richardson, BK				McGlynn, Joseph; Boneau, Rebecca D.; Richardson, Brian K.			"It Might Also Be Good for Your Brain": Cognitive and Social Benefits That Motivate Parents to Permit Youth Tackle Football	JOURNAL OF SPORT & SOCIAL ISSUES			English	Article						youth football; concussions; sport socialization; risk; theory of planned behavior	SPORT-RELATED CONCUSSION; PLANNED BEHAVIOR; HEALTH-PROMOTION; UNITED-STATES; BELIEFS; FANS; SOCIALIZATION; PERSPECTIVE; PREVENTION; PSYCHOLOGY	Concussions in youth sports are a rising health concern. Between 1.7- and 3-million concussions occur each year in youth sport and recreation settings. This qualitative study investigated how parents assess the physical and social risks of allowing their children to participate in tackle football. Semi-structured interviews were conducted with 12 sets of parents (N = 24) who had permitted their middle school aged children to play on tackle football teams. Guided by the theory of planned behavior, findings illustrate the complex risk decisions parents must make regarding football participation. Although parents in our study acknowledged the risk of concussions, they identified cognitive and social benefits of football participation that shaped positive attitudes toward football outcomes. Participants also noted social factors that limited control over their children's football participation, including community pressures. The findings indicate key factors that motivate football enrollment, as parents must consider competing goals for their child of protection and development. Future research directions, theoretical implications, and practical applications are discussed.	[McGlynn, Joseph; Richardson, Brian K.] Univ North Texas, Dept Commun Studies, 1155 Union Circle 305268, Denton, TX 76203 USA; [Boneau, Rebecca D.] Univ North Texas, Denton, TX 76203 USA		McGlynn, J (corresponding author), Univ North Texas, Dept Commun Studies, 1155 Union Circle 305268, Denton, TX 76203 USA.	Joseph.McGlynn@unt.edu		McGlynn III, Joseph/0000-0002-8869-0629			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2015, HEALTH PSYCHOL REV, V9, P131, DOI 10.1080/17437199.2014.883474; Andrews KR, 2010, J HEALTH COMMUN, V15, P95, DOI 10.1080/10810730903460567; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Banks SP, 2000, J SOC PERS RELAT, V17, P299, DOI 10.1177/0265407500173001; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Binney ZO, 2019, NEUROLOGY, V92, P43, DOI 10.1212/WNL.0000000000006699; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Busselle R, 2009, MEDIA PSYCHOL, V12, P321, DOI 10.1080/15213260903287259; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Charmaz K., 2014, BROKERAGE CLOSURE IN; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Conine C. S., 2016, REPUBLIC FOOTBALL LE; Cooke R, 2016, HEALTH PSYCHOL REV, V10, P148, DOI 10.1080/17437199.2014.947547; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Cranmer GA, 2018, COMMUN SPORT, V6, P349, DOI 10.1177/2167479517714458; Cranmer GA, 2017, COMMUN Q, V65, P125, DOI 10.1080/01463373.2016.1197292; Creswell J., 2009, RES DESIGN, V3rd; Creswell J. W., 2016, QUAL INQ; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Diamond AB, 2015, CURR SPORT MED REP, V14, P320, DOI 10.1249/JSR.0000000000000169; Donovan-Kicken E, 2012, WESTERN J COMM, V76, P127, DOI 10.1080/10570314.2011.653856; Dorsch TE, 2015, SPORT EXERC PERFORM, V4, P19, DOI 10.1037/spy0000025; Duckworth AL, 2011, EDUC PSYCHOL-UK, V31, P17, DOI 10.1080/01443410.2010.506003; Dungan J, 2015, CURR OPIN PSYCHOL, V6, P129, DOI 10.1016/j.copsyc.2015.07.005; Dunn JS, 2003, AM BEHAV SCI, V46, P1359, DOI 10.1177/0002764203046010006; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; Fisher J., 2018, HIGH SCH FOOTBALL TE; Fredricks JA, 2005, J SPORT EXERCISE PSY, V27, P3, DOI 10.1123/jsep.27.1.3; French DP, 2012, BRIT J HEALTH PSYCH, V17, P1, DOI 10.1111/j.2044-8287.2010.02010.x; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Glaser B., 1967, DISCOVERY GROUNDED T; Guadagno RE, 2010, SOC INFLUENCE, V5, P152, DOI 10.1080/15534510903332378; Hull K, 2015, J SPORT SOC ISSUES, V39, P78, DOI 10.1177/0193723514558928; KASSING JW, 2004, ANN INT COMMUNICATIO, V28, P373, DOI DOI 10.1080/23808985.2004.11679040; Kremer-Sadlik T, 2007, DISCOURSE SOC, V18, P35, DOI 10.1177/0957926507069456; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Kroshus E, 2017, J LAW MED ETHICS, V45, P421, DOI 10.1177/1073110517737542; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lindlof T. R., 2002, QUALITATIVE RES METH; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McGlynn J, 2019, HEALTH COMMUN, V34, P689, DOI 10.1080/10410236.2018.1431025; Messner MA, 1994, SEX VIOLENCE POWER S; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Nadesan M., 2016, CRISIS COMMUNICATION; National Federation of State High School Associations, 2018, 2017 2018 ANN REP; Nickerson R. S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Niederdeppe J, 2011, HUM COMMUN RES, V37, DOI 10.1111/j.1468-2958.2011.01409.x; Peter J., 2017, US TODAY SPORTS 0129; Pilon M., 2013, NY TIMES, pB13; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reynolds JP, 2018, SOC SCI MED, V218, P1, DOI 10.1016/j.socscimed.2018.09.037; Richardson BK, 2012, COMMUN STUD, V63, P172, DOI 10.1080/10510974.2011.624396; Richardson BK, 2011, MANAGE COMMUN Q, V25, P121, DOI 10.1177/0893318910380344; Rigby J, 2013, J ATHL TRAINING, V48, P636, DOI 10.4085/1062-6050-48.3.10; Robbins R, 2019, J HEALTH COMMUN, V24, P84, DOI 10.1080/10810730.2019.1581305; Rugg A, 2019, J SPORT SOC ISSUES, V43, P69, DOI 10.1177/0193723518823332; Saldana J., 2015, THINKING QUALITATIVE; Sanderson J, 2020, COMMUN SPORT, V8, P72, DOI 10.1177/2167479518818185; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Sports & Fitness Industry Association, 2019, 2019 SPORTS FITN LEI; Tamminen KA, 2017, SPORT EXERC PERFORM, V6, P325, DOI 10.1037/spy0000093; Tracy S.J., 2013, QUALITATIVE RES METH; Tseng YF, 2018, PSYCHOL HEALTH MED, V23, P270, DOI 10.1080/13548506.2017.1378820; University of Pittsburgh Medical Center, 2019, UPMC SPORTS MED CONC; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Weinberg R, 2013, J CLIN SPORT PSYCHOL, V7, P41, DOI 10.1123/jcsp.7.1.41; Weiner B., 2006, SOCIAL MOTIVATION JU; Young, 2004, SPORTING BODIES DAMA, P59	81	6	6	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-7235	1552-7638		J SPORT SOC ISSUES	J. Sport Soc. Issues	JUN	2020	44	3					261	282	0193723520903226	10.1177/0193723520903226		JAN 2020	22	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	LG6XE	WOS:000510345500001					2022-02-06	
J	Wallace, EJ; Mathias, JL; Ward, L; Fripp, J; Rose, S; Pannek, K				Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn; Fripp, Jurgen; Rose, Stephen; Pannek, Kerstin			A fixel-based analysis of micro- and macro-structural changes to white matter following adult traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						adults; diffusion-weighted imaging; fixel-based analysis; neuroimaging; traumatic brain injury	FIBER DENSITY; DIFFUSION MRI; DTI	Diffusion tensor imaging is often used to assess white matter (WM) changes following traumatic brain injury (TBI), but is limited in voxels that contain multiple fibre tracts. Fixel-based analysis (FBA) addresses this limitation by using a novel method of analysing high angular resolution diffusion-weighted imaging (HARDI) data. FBA examines three aspects of each fibre tract within a voxel: tissue micro-structure (fibre density [FD]), tissue macro-structure (fibre-bundle cross section [FC]) and a combined measure of both (FD and fibre-bundle cross section [FDC]). This study used FBA to identify the location and extent of micro- and macro-structural changes in WM following TBI. A large TBI sample (N-mild = 133, Nmoderate-severe = 29) and control group (healthy and orthopaedic; N = 107) underwent magnetic resonance imaging with HARDI and completed reaction time tasks approximately 7 months after their injury (range: 98-338 days). The TBI group showed micro-structural differences (lower FD) in the corpus callosum and forceps minor, compared to controls. Subgroup analyses revealed that the mild TBI group did not differ from controls on any fixel metric, but the moderate to severe TBI group had significantly lower FD, FC and FDC in multiple WM tracts, including the corpus callosum, cerebral peduncle, internal and external capsule. The moderate to severe TBI group also had significantly slower reaction times than controls, but the mild TBI group did not. Reaction time was not related to fixel findings. Thus, the WM damage caused by moderate to severe TBI manifested as fewer axons and a reduction in the cross-sectional area of key WM tracts.	[Wallace, Erica J.; Mathias, Jane L.; Ward, Lynn] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Fripp, Jurgen; Rose, Stephen; Pannek, Kerstin] CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia		Mathias, JL (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia.	a1064843@adelaide.edu.au	Fripp, Jurgen/A-8763-2011; Pannek, Kerstin/C-8059-2011	Fripp, Jurgen/0000-0001-9705-0079; Pannek, Kerstin/0000-0002-6512-7630; Rose, Stephen/0000-0003-1558-6297	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [519220]	National Health and Medical Research Council, Grant/Award Number: 519220	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Aralasmak A, 2006, J COMPUT ASSIST TOMO, V30, P695, DOI 10.1097/01.rct.0000226397.43235.8b; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fortin JP, 2017, NEUROIMAGE, V161, P149, DOI 10.1016/j.neuroimage.2017.08.047; Froeling M., 2016, DIFFUSION TENSOR IMA, P175; Gajamange S, 2018, NEUROIMAGE-CLIN, V17, P60, DOI 10.1016/j.nicl.2017.09.027; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Strauss Sara, 2015, Top Magn Reson Imaging, V24, P353, DOI 10.1097/RMR.0000000000000071; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Toothaker L.E., 1993, MULTIPLE COMP PROCED; Tournier J.-Donald, 2019, MRTRIX3 FAST FLEXIBL, DOI [10.1101/551739, DOI 10.1101/551739]; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tournier JD, 2014, INTRO DIFFUSION TENS, P65, DOI DOI 10.1016/B978-0-12-398398-5.00008-4; Vaughan DN, 2017, ANN NEUROL, V81, P240, DOI 10.1002/ana.24848; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wallace E. J., 2019, WHITE MATTER C UNPUB; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Zhu YN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/548392	49	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUN 1	2020	41	8					2187	2197		10.1002/hbm.24939		JAN 2020	11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	LI9GA	WOS:000510063200001	31999046	Green Published, gold			2022-02-06	
J	Bedry, T; Tadele, H				Bedry, Tuji; Tadele, Henok			Pattern and Outcome of Pediatric Traumatic Brain Injury at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia: Observational Cross-Sectional Study	EMERGENCY MEDICINE INTERNATIONAL			English	Article							KWAZULU-NATAL PROVINCE; DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; EMERGENCY-DEPARTMENT; RISK-FACTORS; MORTALITY; CHILDREN; PATHOPHYSIOLOGY; EPIDEMIOLOGY; MANAGEMENT	Background. Traumatic brain injury (TBI) is the most common cause of death/disability in children. The Glasgow coma scale and other parameters are used for treatment/follow-up of TBI. Childhood TBI data are scarce from sub-Saharan Africa. The study aimed to determine the pattern and predictors of the TBI outcome in Southern Ethiopia. Methods. An observational cross-sectional study was conducted from September 2017 to September 2018 at Hawassa University Hospital. Structured questionnaires were used for data collection. Significant associations were declared at a P value of Results. There were 4,258 emergency room (ER) visits during the study period, and TBI contributed to 317 (7.4%) cases. The mean age of study subjects was 7.66 +/- 3.88 years. Boys, predominantly above 5 years of age, comprise 218 (68.8%) of the study subjects with a male to female ratio of 2.2 : 1. Pedestrian road traffic accidents (RTA), 120 (37.9%), and falls, 104 (32.8%), were the commonest causes of TBI. Mild, moderate, and severe TBI were documented in 231 (72.9%), 61 (19.2%), and 25 (7.9%) of cases, respectively. Most of the TBI cases presented within 24 hrs of injury, 258 (81.4%). Recovery with no neurologic deficit, 267 (84.2%); focal neurologic deficit, 30 (9.5%); depressed mentation, 10 (3.2%); and death, 10 (3.2%), were documented. Signs of increased intracranial pressure (ICP) at admission [AOR: 1.415 (95% CI: 1.4058-9.557)], severe TBI [AOR: 2.553 (95% CI: 1.965-4.524)], presence of hyperglycemia [AOR: 2.318 (95% CI: 1.873-7.874)], and presence of contusion, diffuse axonal injury (DAI), or intracranial bleeding on the head computed tomography (CT) scan [AOR: 2.45 (95% CI: 1.811-7.952)] predicted poor TBI outcome. Conclusion. TBI contributed to 7.4% of pediatric ER visits. Pedestrian RTA and falls, early presentation (<24 hours of injury), and mild form of TBI among boys were the most common documented patterns. ICP, hyperglycemia, severe TBI, and presence of contusion, DAI, or intracranial bleeding on head CT predicted poor outcome. Strategies to ensure road safety and to prevent falls and animal-related injuries and TBI follow-up for ICP and glycemic controls are recommended.	[Bedry, Tuji] Dire Dawa Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Dire Dawa, Ethiopia; [Tadele, Henok] Addis Ababa Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Addis Ababa, Ethiopia		Tadele, H (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Addis Ababa, Ethiopia.	henny_2007@yahoo.com	Tadele, Henok/AAV-2366-2021	Tadele, Henok/0000-0002-9400-6563	Hawassa University, School of Graduate Studies	The authors thank all health professionals who cared for our study subjects. The authors also thank Nina Gerlach for her editorial assistance. Funding was received from Hawassa University, School of Graduate Studies.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Avraham JB, 2019, INJURY PREV, V25, P136, DOI 10.1136/injuryprev-2017-042435; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P198, DOI 10.4103/0974-2700.82206; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; Balijepalli C, 2017, CLIN EPIDEMIOL, V9, P291, DOI 10.2147/CLEP.S129268; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Buitendag JJP, 2017, SAMJ S AFR MED J, V107, P777, DOI [10.7196/SAMJ.2017.v107i9.12394, 10.7196/samj.2017.v107i9.12394]; Chichom-Mefire A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180784; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Corwin DJ, 2017, PEDIATR EMERG CARE, V33, P643, DOI 10.1097/PEC.0000000000001252; Danisman B, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0010-0; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Emejulu JKC, 2010, NIGER J CLIN PRACT, V13, P276; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Fink EL, 2018, PEDIATR CRIT CARE ME, V19, P649, DOI 10.1097/PCC.0000000000001554; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Getachew S, 2016, PUBLIC HEALTH ACTION, V6, P66, DOI 10.5588/pha.15.0082; Ghaffarpasand Fariborz, 2013, Bull Emerg Trauma, V1, P135; Gupta PP, 2017, J NEPAL MED ASSOC, V56, P331, DOI 10.31729/jnma.3096; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Hill CS, 2018, PEDIATR EMERG CARE, V34, P426, DOI [10.1097/PEC.0000000000000845, 10.1097/pec.0000000000000845]; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Leaman AM, 2006, ARCH DIS CHILD, V91, P374; Li QF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194692; Mahdian M, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.4(2)2015.28465; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Mossop D, 2005, ANN ROY COLL SURG, V87, P188, DOI 10.1308/1478708051630; Nnadi MON, 2014, J PEDIATR NEUROSCI, V9, P237, DOI 10.4103/1817-1745.147577; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Punchak M, 2018, WORLD NEUROSURG, V114, pE396, DOI 10.1016/j.wneu.2018.02.191; Samuels J, 2018, J CLIN HYPERTENS, V20, P837, DOI 10.1111/jch.13285; Satapathy Mani Charan, 2016, Int J Crit Illn Inj Sci, V6, P16, DOI 10.4103/2229-5151.177359; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Siesjo BK, 2008, J NEUROSURG, V108, P616, DOI 10.3171/JNS/2008/108/3/0616; Syrmos N, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/209750; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Vavilala MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189296; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Webster J, 2015, SAMJ S AFR MED J, V105, P195, DOI 10.7196/SAMJ.9014; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; World Health Organisation, 2008, WORLD REPORT CHILD I; World Health Organization, 2004, REH PERS TRAUM BRAIN; Yates D, 2007, BMJ-BRIT MED J, V335, P719, DOI 10.1136/bmj.39331.702951.47; Yattoo GH, 2009, INT J HEALTH SCI-IJH, V3, P59	58	6	6	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.	JAN 29	2020	2020								1965231	10.1155/2020/1965231			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KM7FU	WOS:000514306900001	32399303	gold, Green Published			2022-02-06	
J	Osis, SL; Diccini, S				Osis, Sibila Lilian; Diccini, Solange			Incidence and risk factors associated with pressure injury in patients with traumatic brain injury	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						nursing; pressure injury; pressure ulcer; risk factors; traumatic brain injuries	BRADEN SCALE; ULCER; NUTRITION	Aim To identify the prevalence of pressure injury in patients diagnosed with traumatic brain injury and analyse the risk factors involved during hospitalization. Methods This was a prospective study evaluating patients who were diagnosed with traumatic brain injury between November 2013 and September 2014. Patient characteristics, clinical and metabolic factors and therapeutic interventions, were evaluated within 30 days of hospital admission. Results Most of the 240 patients included in the study were male, young, and non-Caucasian. The incidence of pressure injury was 18.8%. In terms of severity classification, the incidence of pressure injury was 2.7%, 23.2%, and 42.6% in mild, moderate, and severe traumatic brain injury, respectively. Pressure injury development was more likely in the first 10 days of hospitalization. A moderate or severe traumatic brain injury classification, the use of noradrenaline, and older age were pressure injury risk factors. The presence of pressure injury was associated with mortality within 30 days of hospitalization (P < .001). Conclusion The incidence of pressure injury was high in patients diagnosed with traumatic brain injury, especially in those whose injury was classified as severe. Older age, noradrenaline use, and a classification of moderate or severe traumatic brain injury were identified as pressure injury risk factors.	[Osis, Sibila Lilian] State Univ Amazonas, Brazilian Assoc Crit Care Nurses, Sch Nursing, Manaus, Amazonas, Brazil; [Diccini, Solange] Univ Fed Sao Paulo, Sch Nursing, Sao Paulo, Brazil		Osis, SL (corresponding author), Univ Estado Amazonas, Escola Super Ciencias Saude, Ave Carvalho Leal 1777, BR-69065001 Manaus, Amazonas, Brazil.	sosis@uea.edu.br	Osis, Sibila Lilian/AAW-5999-2021	OSIS, SIBILA/0000-0002-9312-850X			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BERGSTROM N, 1987, NURS CLIN N AM, V22, P417; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Coleman S, 2013, INT J NURS STUD, V50, P974, DOI 10.1016/j.ijnurstu.2012.11.019; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cox J, 2014, CRIT CARE NURSE, V34, P15, DOI 10.4037/ccn2014950; Cox J, 2013, OSTOMY WOUND MANAG, V59, P50; Cox J, 2011, AM J CRIT CARE, V20, P364, DOI 10.4037/ajcc2011934; Crozeta K., 2009, THESIS; Alchorne MMDA, 2008, AN BRAS DERMATOL, V83, P7, DOI 10.1590/S0365-05962008000100002; Dealey C, 2015, INT WOUND J, V12, P309, DOI 10.1111/iwj.12107; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Diccini S, 2009, ACTA PAUL ENFERM, V22, P205, DOI 10.1590/S0103-21002009000200014; Fernandes LM, 2008, REV LAT-AM ENFERM, V16, P973, DOI 10.1590/S0104-11692008000600006; Fife C, 2001, CRIT CARE MED, V29, P283, DOI 10.1097/00003246-200102000-00011; Flattau A, 2014, INT WOUND J, V11, P14, DOI 10.1111/j.1742-481X.2012.01032.x; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haesler E., 2014, PREV TREATM PRESS UL; Hyun S, 2013, AM J CRIT CARE, V22, P514, DOI 10.4037/ajcc2013991; Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 TAB 31; Klein K, 2015, CRIT CARE MED, V43, P865, DOI 10.1097/CCM.0000000000000787; Majdan M, 2013, EUR J PUBLIC HEALTH, V23, P682, DOI 10.1093/eurpub/cks074; Manzano F, 2010, J CRIT CARE, V25, P469, DOI 10.1016/j.jcrc.2009.09.002; Morgado Fabiana Lenharo, 2011, Radiol Bras, V44, P35, DOI 10.1590/S0100-39842011000100010; National Pressure Ulcer Advisory Panel, 2007, PRESS ULC STAG REV N; Posthauer ME, 2015, ADV SKIN WOUND CARE, V28, P175, DOI 10.1097/01.ASW.0000461911.31139.62; Rogenski Noemi Marisa Brunet, 2005, Rev. Latino-Am. Enfermagem, V13, P474, DOI 10.1590/S0104-11692005000400003; Scarlatti Kelly Cristina, 2011, Rev. esc. enferm. USP, V45, P1372; Subhas K, 2011, ANAEST INTENS CARE M, V12, P201, DOI 10.1016/j.mpaic.2011.02.001; Szubski CR, 2014, AM J CRIT CARE, V23, pE46, DOI 10.4037/ajcc2014985; TEASDALE G, 1974, LANCET, V2, P81; Thompson H. J., 2012, NURSING MANAGEMENT A; VanGilder C, 2008, OSTOMY WOUND MANAG, V54, P40; World Health Organization, 2006, DEP MENT HLTH SUBST; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	37	6	6	7	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	JUN	2020	26	3							e12821	10.1111/ijn.12821		JAN 2020	9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	ME3QW	WOS:000509810700001	31994827	hybrid			2022-02-06	
J	D'Souza, MM; Kumar, M; Choudhary, A; Kaur, P; Kumar, P; Rana, P; Trivedi, R; Sekhri, T; Singh, AK				D'Souza, Maria M.; Kumar, Mukesh; Choudhary, Ajay; Kaur, Prabhjot; Kumar, Pawan; Rana, Poonam; Trivedi, Richa; Sekhri, Tarun; Singh, Ajay K.			Alterations of connectivity patterns in functional brain networks in patients with mild traumatic brain injury: A longitudinal resting-state functional magnetic resonance imaging study	NEURORADIOLOGY JOURNAL			English	Article						Mild traumatic brain injury; resting-state functional MRI; post-concussion symptoms; neurocognitive deficits	HEAD-INJURY; STRUCTURAL CONNECTIVITY; INDEPENDENT COMPONENT; DEFAULT NETWORK; WORKING-MEMORY; ATTENTION; RECOVERY; DEFICITS; ROBUST; FMRI	Aim In the present study, we aimed to characterise changes in functional brain networks in individuals who had sustained uncomplicated mild traumatic brain injury (mTBI). We assessed the progression of these changes into the chronic phase. We also attempted to explore how these changes influenced the severity of post-concussion symptoms as well as the cognitive profile of the patients. Methods A total of 65 patients were prospectively recruited for an advanced magnetic resonance imaging (MRI) scan within 7 days of sustaining mTBI. Of these, 25 were reassessed at 6 months post injury. Differences in functional brain networks were analysed between cases and age- and sex-matched healthy controls using independent component analysis of resting-state functional MRI. Results Our study revealed reduced functional connectivity in multiple networks, including the anterior default mode network, central executive network, somato-motor and auditory network in patients who had sustained mTBI. A negative correlation between network connectivity and severity of post-concussive symptoms was observed. Follow-up studies performed 6 months after injury revealed an increase in network connectivity, along with an improvement in the severity of post-concussion symptoms. Neurocognitive tests performed at this time point revealed a positive correlation between the functional connectivity and the test scores, along with a persistence of negative correlation between network connectivity and post-concussive symptom severity. Conclusion Our results suggest that uncomplicated mTBI is associated with specific abnormalities in functional brain networks that evolve over time and may contribute to the severity of post-concussive symptoms and cognitive deficits.	[D'Souza, Maria M.; Kumar, Mukesh; Kaur, Prabhjot; Kumar, Pawan; Rana, Poonam; Trivedi, Richa; Sekhri, Tarun] Inst Nucl Med & Allied Sci, Delhi, India; [Choudhary, Ajay] RML Hosp, Dept Neurosurg, New Delhi, India; [Singh, Ajay K.] DRDO, DGLS, New Delhi, India		D'Souza, MM (corresponding author), INMAS, Div NMR, Brig SK Majumdar Marg, Delhi 110054, India.	mmathew@inmas.drdo.in			Defence Research and Development Organization (DRDO), IndiaDefence Research & Development Organisation (DRDO) [INM-322]	We thank Dr Subash Khushu for his guidance in execution of this study. This work was performed as a part of the Defence Research and Development Organization (DRDO), India, sponsored R&D project INM-322.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Braunlich K, 2015, NEUROIMAGE, V107, P146, DOI 10.1016/j.neuroimage.2014.11.051; Bressler SL, 2006, INT J PSYCHOPHYSIOL, V60, P139, DOI 10.1016/j.ijpsycho.2005.12.008; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dwarka P, 1990, HDB PGI BATTERY BRAI, P172; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Reineberg AE, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01600; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith S.M., 2009, NEUROIMAGE, V47, pS148; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sporns O., 2011, NETWORKS BRAIN; Storti SF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00072; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Washington Stuart D, 2015, Int J Med Biol Front, V21, P207; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	57	6	6	2	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1971-4009	2385-1996		NEURORADIOL J	Neuradiology J.	APR	2020	33	2					186	197	1971400920901706	10.1177/1971400920901706		JAN 2020	12	Neuroimaging	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	LA1RS	WOS:000510340900001	31992126	Green Published			2022-02-06	
J	Gomez, A; Dian, J; Zeiler, FA				Gomez, A.; Dian, J.; Zeiler, F. A.			Continuous and entirely non-invasive method for cerebrovascular reactivity assessment: technique and implications	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Autoregulation; Cerebrovascular reactivity; NIRS; Non-invasive; TCD	TRAUMATIC BRAIN-INJURY; MULTIDISCIPLINARY CONSENSUS CONFERENCE; AUTOREGULATION MEASUREMENT TECHNIQUES; CEREBRAL PERFUSION-PRESSURE; TRANSCRANIAL DOPPLER; SUBARACHNOID HEMORRHAGE; PART I; INDEXES; STATEMENT; RETURN	Continuous cerebrovascular reactivity assessment in traumatic brain injury (TBI) has been limited by the need for invasive monitoring of either cerebral physiology or arterial blood pressure (ABP). This restricts the application of continuous measures to the acute phase of care, typically in the intensive care unit. It remains unknown if ongoing impairment of cerebrovascular reactivity occurs in the subacute and long-term phase, and if it drives ongoing morbidity in TBI. We describe an entirely non-invasive method for continuous assessment of cerebrovascular reactivity. We describe the technique for entirely non-invasive continuous assessment of cerebrovascular reactivity utilizing near-infrared spectroscopy (NIRS) and robotic transcranial Doppler (rTCD) technology, with details provided for NIRS. Recent advances in continuous high-frequency non-invasive ABP measurement, combined with NIRS or rTCD, can be employed to derive continuous and entirely non-invasive cerebrovascular reactivity metrics. Such non-invasive measures can be obtained during any aspect of patient care post-TBI, and even during outpatient follow-up, avoiding classical intermittent techniques and costly neuroimaging based metrics obtained only at specialized centers. This combination of technology and signal analytic techniques creates avenues for future investigation of the long-term consequences of cerebrovascular reactivity, integrating high-frequency non-invasive cerebral physiology, neuroimaging, proteomics and clinical phenotype at various stages post-injury.	[Gomez, A.; Dian, J.; Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, F. A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England.	gomeza35@myumanitoba.ca; jdian@manitoba-physicians.ca; Frederick.Zeiler@umanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510	National Institutes of Health NIH R03 project grant, through the National Institute of Neurological Disease and Stroke (NINDS) [R03 NS114335-01]; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation (HSCF) Winnipeg	This work is supported by the National Institutes of Health NIH R03 project grant (R03 NS114335-01), through the National Institute of Neurological Disease and Stroke (NINDS). FAZ is also supported by the University of Manitoba VPRI Research Investment Fund (RIF), University of Manitoba Rudy Falk Clinician-Scientist Professorship, the Health Sciences Centre Foundation (HSCF) Winnipeg.	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski Karol P, 1800, Neurosurgery, V62 Suppl 1, P180, DOI 10.1227/NEU.0000000000000808; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Li K, 2019, WORLD NEUROSURG, V126, P513, DOI 10.1016/j.wneu.2019.03.083; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sharma S, 2020, ACTA NEUROCHIR SUPPL, V127, P201, DOI 10.1007/978-3-030-04615-6_32; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zeiler FA, 2018, CRIT ULTRASOUND J, V10, DOI 10.1186/s13089-018-0097-0; Zeiler FA, 2018, NEUROCRIT CARE, V28, P194, DOI 10.1007/s12028-017-0472-x; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2019, J NEUROTRAUM, V36, P713, DOI 10.1089/neu.2018.5987; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2149, DOI 10.1007/s00701-018-3687-5; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	39	6	6	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	APR	2021	35	2					307	315		10.1007/s10877-020-00472-4		JAN 2020	9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QT9AY	WOS:000515595000002	31989415				2022-02-06	
J	Clark, JA; Chuckowree, JA; Dyer, MS; Dickson, TC; Blizzard, CA				Clark, J. A.; Chuckowree, J. A.; Dyer, M. S.; Dickson, T. C.; Blizzard, C. A.			Epothilone D alters normal growth, viability and microtubule dependent intracellular functions of cortical neurons in vitro	SCIENTIFIC REPORTS			English	Article							PERIPHERAL NEUROPATHY; TARGETING AGENTS; MOUSE MODEL; TRANSPORT; BINDING; STABILIZATION; INITIATION; EXPRESSION; PACLITAXEL; STOP/MAP6	Brain penetrant microtubule stabilising agents (MSAs) are being increasingly validated as potential therapeutic strategies for neurodegenerative diseases and traumatic injuries of the nervous system. MSAs are historically used to treat malignancies to great effect. However, this treatment strategy can also cause adverse off-target impacts, such as the generation of debilitating neuropathy and axonal loss. Understanding of the effects that individual MSAs have on neurons of the central nervous system is still incomplete. Previous research has revealed that aberrant microtubule stabilisation can perturb many neuronal functions, such as neuronal polarity, neurite outgrowth, microtubule dependant transport and overall neuronal viability. In the current study, we evaluate the dose dependant impact of epothilone D, a brain penetrant MSA, on both immature and relatively mature mouse cortical neurons in vitro. We show that epothilone D reduces the viability, growth and complexity of immature cortical neurons in a dose dependant manner. Furthermore, in relatively mature cortical neurons, we demonstrate that while cellularly lethal doses of epothilone D cause cellular demise, low sub lethal doses can also affect mitochondrial transport over time. Our results reveal an underappreciated mitochondrial disruption over a wide range of epothilone D doses and reiterate the importance of understanding the dosage, timing and intended outcome of MSAs, with particular emphasis on brain penetrant MSAs being considered to target neurons in disease and trauma.	[Clark, J. A.; Chuckowree, J. A.; Dyer, M. S.; Dickson, T. C.; Blizzard, C. A.] Univ Tasmania, Menzies Inst Med Res, 17 Liverpool St, Hobart, Tas 7000, Australia		Blizzard, CA (corresponding author), Univ Tasmania, Menzies Inst Med Res, 17 Liverpool St, Hobart, Tas 7000, Australia.	Catherine.Blizzard@utas.edu.au		Chuckowree, Jyoti/0000-0002-1245-1402; Dyer, Marcus/0000-0002-7752-2988	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [D0018642]; Motor Neurone Disease Research Institute of Australia (MNDRIA) top-up scholarship [K0020795]; Masonic Centenary Medical Research Foundation of Tasmania [D0019780]	This work was supported by the National Health and Medical Research Council (NHMRC) [D0018642], the Motor Neurone Disease Research Institute of Australia (MNDRIA) top-up scholarship [K0020795], and the Masonic Centenary Medical Research Foundation of Tasmania [D0019780].	ALLEN C, 1974, J MOL BIOL, V90, P381, DOI 10.1016/0022-2836(74)90381-7; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Athamneh AIM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07402-6; Baas PW, 2016, CYTOSKELETON, V73, P442, DOI 10.1002/cm.21286; Baas PW, 2013, BRAIN, V136, P2937, DOI 10.1093/brain/awt153; Baas PW, 2011, DEV NEUROBIOL, V71, P403, DOI 10.1002/dneu.20818; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Benbow SJ, 2016, NEUROTOX RES, V29, P299, DOI 10.1007/s12640-015-9580-6; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Brill MS, 2016, NEURON, V92, P845, DOI 10.1016/j.neuron.2016.09.049; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2011, PHARMACOL RES, V63, P341, DOI 10.1016/j.phrs.2010.12.002; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carlson K, 2011, CLIN BREAST CANCER, V11, P73, DOI 10.1016/j.clbc.2011.03.006; Cartelli D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01837; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cheng KL, 2008, BIOL-TARGETS THER, V2, P789; Chuckowree JA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00223; Clark JA, 2018, NEUROPATH APPL NEURO, V44, P590, DOI 10.1111/nan.12473; Dent EW, 2017, MOL BIOL CELL, V28, P1, DOI 10.1091/mbc.E15-11-0769; Dent EW, 2014, J NEUROCHEM, V129, P235, DOI 10.1111/jnc.12621; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eira J, 2016, PROG NEUROBIOL, V141, P61, DOI 10.1016/j.pneurobio.2016.04.007; Fanara P, 2010, NEUROSCIENCE, V168, P167, DOI 10.1016/j.neuroscience.2010.03.031; Fanara P, 2007, J BIOL CHEM, V282, P23465, DOI 10.1074/jbc.M703434200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fournet V, 2012, J NEUROCHEM, V123, P982, DOI 10.1111/jnc.12027; Golovyashkina N, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0049-0; Gonzalez-Perez Oscar, 2012, Biol Biomed Rep, V2, P59; Gu Jiaping, 2009, Open Neurosci J, V3, P128; Nguyen HTN, 2018, BIOCHEM BIOPHYS REP, V16, P24, DOI 10.1016/j.bbrep.2018.09.004; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kihlmark M, 2001, J CELL SCI, V114, P3643; Kleele T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5827; Kole K, 2018, NEUROSCI BIOBEHAV R, V84, P100, DOI 10.1016/j.neubiorev.2017.11.015; Konner J, 2012, INVEST NEW DRUG, V30, P2294, DOI 10.1007/s10637-011-9765-7; Lee F. Y, 2011, GOOGLE PATENTS; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Lefevre J, 2013, J BIOL CHEM, V288, P24910, DOI 10.1074/jbc.M113.457267; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Pacheco A, 2016, BRAIN RES BULL, V126, P300, DOI 10.1016/j.brainresbull.2016.07.013; Sakakibara A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130061; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shemesh OA, 2010, ACTA NEUROPATHOL, V119, P235, DOI 10.1007/s00401-009-0586-0; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Slaughter T, 2003, J NEUROCYTOL, V32, P399, DOI 10.1023/B:NEUR.0000011334.70648.87; van Beuningen SFB, 2015, NEURON, V88, P1208, DOI 10.1016/j.neuron.2015.11.012; Volle J, 2013, SCHIZOPHRENIA BULL, V39, P969, DOI 10.1093/schbul/sbs113; Wang WZ, 2008, INT J CLIN EXP MED, V1, P145; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zheng XL, 2017, INT J CLIN PHARM TH, V55, P753, DOI 10.5414/CP202995; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	65	6	6	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 22	2020	10	1							918	10.1038/s41598-020-57718-z			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA4XE	WOS:000559820700012	31969604	gold, Green Published, Green Accepted			2022-02-06	
J	Lu, ZF; Zhang, D; Cui, KF; Fu, XJ; Man, J; Lu, H; Yu, L; Gao, YF; Liu, XL; Liao, LH; Li, X; Liu, C; Zhang, YX; Zhang, Z; Wang, JP				Lu, Zhengfang; Zhang, Di; Cui, Kefei; Fu, Xiaojie; Man, Jiang; Lu, Hong; Yu, Lie; Gao, Yufeng; Liu, Xianliang; Liao, Linghui; Li, Xiang; Liu, Chang; Zhang, Yongxin; Zhang, Zhen; Wang, Jianping			Neuroprotective Action of Teriflunomide in a Mouse Model of Transient Middle Cerebral Artery Occlusion	NEUROSCIENCE			English	Article						ischemic stroke; neuroinflammation; blood-brain barrier; neurogenesis	BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; PERICYTES; NEUROGENESIS; DISRUPTION; INTEGRITY; INJURY; DAMAGE; EDEMA; CELLS	Teriflunomide has been reported to inhibit microglial activation in experimental models of traumatic brain injury. However, its roles in ischemic stroke and underlying mechanisms of action are still undiscovered. In this study, we investigated the effects of teriflunomide on brain edema, neurologic deficits, infarct volume, neuroinflammation, blood-brain barrier (BBB) permeability, and neurogenesis in a mouse model of transient middle cerebral artery occlusion (tMCAO). tMCAO mice treated with teriflunomide showed lower brain water content on day 3, milder neurologic deficits and smaller infarct volume on day 7 than those treated with vehicle. Additionally, mice received teriflunomide had fewer activated Iba-1-positive microglia and lower protein levels of interleukin-1 beta(IL-1 beta) cyclooxygenase-2 (COX-2), and 3-Nitrotyrosine (3-NT) compared with those received vehicle on day 3. Further, teriflunomide alleviated Evans blue dye leakage, increased pericyte coverage and protein levels of platelet derived growth factor B (PDGFB), platelet-derived growth factor receptor beta (PDGFR beta) and Bcl2, and decreased the number of PDGFR beta/matrix metalloproteinase 9 (MMP9)-positive cells. Moreover, teriflunomide reduced the loss of zonula occludens-1 (ZO-1) and occludin. Finally, teriflunomide significantly upregulated the number of 5-bromo-20-deoxyuridine (BrdU)/doublecortin (DCX)-positive cells and expression of mammalian achaete-scute homolog 1 (Mash1), DCX and Pbx1 in subventricular zone (SVZ) on day 7 after stroke. Our results indicate that teriflunomide exhibits protective roles in ischemic stroke by inhibiting neuroinflammation, alleviating BBB disruption and enhancing neurogenesis. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Lu, Zhengfang; Zhang, Di; Man, Jiang; Gao, Yufeng; Liu, Xianliang; Liao, Linghui; Li, Xiang; Liu, Chang; Zhang, Yongxin; Zhang, Zhen; Wang, Jianping] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China; [Cui, Kefei] Zhengzhou Univ, Dept Ultrasound, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Fu, Xiaojie] Zhengzhou Univ, Dept Neurointervent, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Lu, Hong; Yu, Lie] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China		Wang, JP (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China.	wjpwfy666@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771247, 81571137]	This work was supported by the National Natural Science Foundation of China [grant numbers 81771247, 81571137]. ZL and JW designed the study. ZL, DZ, JM, XL, YZ and ZZ performed the experiments. KC, HL, XF, LY, YG, and CL analyzed the data. ZL, DZ, XL and LL arranged the figures. ZL wrote the drafting, and DZ and JW revised the drafting. All the authors approved the final version of the manuscript.	Ambrosius B, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0829-2; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Berthiaume AA, 2018, CELL REP, V22, P8, DOI 10.1016/j.celrep.2017.12.016; Bertrand L, 2019, BRAIN, V142, P502, DOI 10.1093/brain/awy339; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Chen CY, 2018, BRAIN BEHAV IMMUN, V69, P255, DOI 10.1016/j.bbi.2017.11.019; Chen JN, 2017, P NATL ACAD SCI USA, V114, pE7622, DOI 10.1073/pnas.1710848114; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Corada M, 2019, CIRC RES, V124, P511, DOI 10.1161/CIRCRESAHA.118.313316; Dhanesha N, 2019, STROKE, V50, P1201, DOI 10.1161/STROKEAHA.118.023697; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Grebbin BM, 2016, DEVELOPMENT, V143, P2281, DOI 10.1242/dev.128033; Groh J, 2017, MOL THER, V25, P1889, DOI 10.1016/j.ymthe.2017.04.021; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Malone K, 2019, IMMUNOL CELL BIOL, V97, P5, DOI 10.1111/imcb.12191; Marques BL, 2019, SEMIN CELL DEV BIOL; Nakano T, 2018, J STROKE CEREBROVASC, V27, P758, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.010; Nakazato R, 2017, J NEUROSCI, V37, P10052, DOI 10.1523/JNEUROSCI.3639-16.2017; Nirwane A, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0676-8; Ozen I, 2018, STROKE, V49, P2182, DOI 10.1161/STROKEAHA.118.020124; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Perez-Hernandez M, 2017, NEUROPHARMACOLOGY, V118, P157, DOI 10.1016/j.neuropharm.2017.03.019; Petrovic-Djergovic D, 2016, CIRC RES, V119, P142, DOI 10.1161/CIRCRESAHA.116.308022; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Qiu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0739-8; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Ruhnau J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5140679; Shichita T, 2017, NAT MED, V23, P723, DOI 10.1038/nm.4312; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tang X, 2018, MOL NEUROBIOL, V55, P2911, DOI 10.1007/s12035-017-0556-9; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tseng KY, 2018, MOL THER, V26, P238, DOI 10.1016/j.ymthe.2017.09.019; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Wang JP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1226-1; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2017, BEHAV BRAIN RES, V316, P145, DOI 10.1016/j.bbr.2016.09.007; Wang J, 2016, MOL NEUROBIOL, V53, P5367, DOI 10.1007/s12035-015-9464-z; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xu HC, 2017, BLOOD, V130, P11, DOI 10.1182/blood-2016-10-747089; Zhao BB, 2018, J CELL BIOCHEM, V119, P5382, DOI 10.1002/jcb.26685	43	6	7	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 21	2020	428						228	241		10.1016/j.neuroscience.2019.12.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK6ZP	WOS:000512888300023	31887363				2022-02-06	
J	Liu, GZ; Chen, C; Kong, N; Tian, R; Li, YY; Li, Z; Wang, KZ; Yang, P				Liu, Guan-Zhi; Chen, Chen; Kong, Ning; Tian, Run; Li, Yi-Yang; Li, Zhe; Wang, Kun-Zheng; Yang, Pei			Identification of potential miRNA biomarkers for traumatic osteonecrosis of femoral head	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						biomarkers; microRNA expression; traumatic osteonecrosis of the femoral head; weighted gene co-expression network analysis	AVASCULAR NECROSIS; INTERNAL-FIXATION; GROWTH-FACTOR; STEM-CELLS; APOPTOSIS; DIFFERENTIATION; ACTIVATOR; HIP	Traumatic osteonecrosis of femoral head (TONFH) is a common orthopedic disease caused by physical injury in hip. However, the unclear pathogenesis mechanism of TONFH and lacking of simple noninvasive early diagnosis method cause the necessity of hip replacement for most patients with TONFH. In this study, we aimed to identify circulating microRNAs (miRNAs) by integrated bioinformatics analyses as potential biomarker of TONFH. mRNA expression profiles were downloaded from the Gene Expression Omnibus database. Then we combined two miRNA screen methods: Weighted gene co-expression network analysis and fold change based differentially expressed miRNAs analysis. As a result, we identified 14 key miRNAs as potential biomarkers for TONFH. Besides, 302 target genes of these miRNAs were obtained and the miRNA-mRNA interaction network was constructed. Furthermore, the results of Kyoto Encyclopedia of Gene and Genome pathway analysis, Gene Ontology function analysis, protein-protein interaction (PPI) network analysis and PPI network module analysis showed close correlation between these 14 key miRNAs and TONFH. Then we established receiver operating characteristic curves and identified 6-miRNA signature with highly diagnosis value including miR-93-5p (area under the curve [AUC] = 0.93), miR-1324 (AUC = 0.92), miR-4666a-3p (AUC = 0.92), miR-5011-3p (AUC = 0.92), and miR-320a (AUC = 0.89), miR-185-5p (AUC = 0.89). Finally, the results of quantitative real-time polymerase chain reaction confirmed the significantly higher expression of miR-93-5p and miR-320a in the serum of patients with ONFH. These circulating miRNAs could serve as candidate early diagnosis markers and potential treatment targets of TONFH.	[Liu, Guan-Zhi; Kong, Ning; Tian, Run; Li, Yi-Yang; Li, Zhe; Wang, Kun-Zheng; Yang, Pei] Xi An Jiao Tong Univ, Affiliated Hosp 2, Bone & Joint Surg Ctr, Xian 710004, Peoples R China; [Chen, Chen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian, Peoples R China		Yang, P (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Bone & Joint Surg Ctr, Xian 710004, Peoples R China.	yangpei@vip.163.com	Kong, Ning/O-4314-2018	Kong, Ning/0000-0002-1385-0333; Liu, Guanzhi/0000-0003-1626-5006	Key Project for Science Research and Development of Shaanxi Province [2017SF-212]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672173]	Key Project for Science Research and Development of Shaanxi Province, Grant/Award Number: 2017SF-212; National Natural Science Foundation of China, Grant/Award Number: 81672173	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075; Cui Q, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1428-1; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P79, DOI 10.1016/j.otsr.2010.06.014; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hensel Janine, 2018, Oncotarget, V9, P28877, DOI 10.18632/oncotarget.25608; Huang GY, 2018, GENE, V652, P39, DOI 10.1016/j.gene.2018.01.090; Huang JH, 2016, CELL PHYSIOL BIOCHEM, V38, P40, DOI 10.1159/000438607; Huang L, 2018, J BIOCHEM, V163, P243, DOI 10.1093/jb/mvx076; Issa K, 2013, BONE JOINT J, V95B, P46, DOI 10.1302/0301-620X.95B11.32644; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar S, 2017, PROG MOL BIOL TRANSL, V146, P47, DOI 10.1016/bs.pmbts.2016.12.013; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li Z, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12405; Li Z, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12418; Medda S, 2019, J ORTHOP TRAUMA, V33, pS1, DOI 10.1097/BOT.0000000000001369; Mont MA, 2015, J BONE JOINT SURG AM, V97A, P1604, DOI 10.2106/JBJS.O.00071; Nie ZG, 2019, BIOCHEM BIOPH RES CO, V511, P693, DOI 10.1016/j.bbrc.2019.02.118; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Papakostidis C, 2015, INJURY, V46, P459, DOI 10.1016/j.injury.2014.12.025; Qi XY, 2015, J INT MED RES, V43, P3, DOI 10.1177/0300060514554724; Quan HY, 2018, CELL PHYSIOL BIOCHEM, V46, P401, DOI 10.1159/000488474; Sun DP, 2018, EXP THER MED, V16, P3261, DOI 10.3892/etm.2018.6534; Tao SC, 2017, THERANOSTICS, V7, P733, DOI 10.7150/thno.17450; Tomlinson RE, 2016, CELL REP, V16, P2723, DOI 10.1016/j.celrep.2016.08.002; Watanabe Y, 2007, J ORTHOP TRAUMA, V21, P456, DOI 10.1097/BOT.0b013e318126bb56; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu ZF, 2015, INT J MOL MED, V36, P1264, DOI 10.3892/ijmm.2015.2340; Zhang B, 2017, EUR REV MED PHARMACO, V21, P3754; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y., 2017, P INT MULT ENG COMP, V2, P1; Zlotorowicz M, 2013, BONE JOINT J, V95B, P1453, DOI 10.1302/0301-620X.95B11.32383	37	6	6	7	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	NOV	2020	235	11					8129	8140		10.1002/jcp.29467		JAN 2020	12	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	NR9KG	WOS:000507630900001	31951022				2022-02-06	
J	Rusiecki, J; Levin, LI; Wang, L; Byrne, C; Krishnamurthy, J; Chen, LG; Galdzicki, Z; French, LM				Rusiecki, Jennifer; Levin, Lynn, I; Wang, Li; Byrne, Celia; Krishnamurthy, Jayasree; Chen, Ligong; Galdzicki, Zygmunt; French, Louis M.			Blast traumatic brain injury and serum inflammatory cytokines: a repeated measures case-control study among US military service members	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; TBI; Cytokines; Inflammation; Operation Iraqi freedom; Operation enduring freedom; Protein; Microarray; Military	ACUTE-PHASE RESPONSE; CEREBROSPINAL-FLUID; GLYMPHATIC PATHWAY; TNF-ALPHA; BIOMARKERS; EXPOSURE; BLOOD; IL-6; INTERLEUKIN-6; STABILITY	Background There is a paucity of human data on exposure to blast traumatic brain injury (bTBI) and the corresponding systemic cytokine immune response at later time points (i.e., months, years) post-injury. Methods We conducted a repeated measures, case-control study, examining associations of serum levels of pro- and anti-inflammatory cytokines, measured both pre- and post-deployment with having mild and moderate/severe bTBI. Utilizing serum from the Department of Defense Serum Repository cytokines were measured via an ELISA-based array for 15 cytokines. We compared pre- vs. post-levels among mild cases, moderate/severe cases, and controls and carried out case-control comparisons, using paired t- tests and generalized linear models. Results The average time between bTBI and post-deployment/bTBI serum among cases was 315.8 days. From pre- to post-deployment/bTBI, levels of interleukin 8 (IL-8) were decreased among both mild cases (mu = - 83.43 pg/ml; s.e. = 21.66) and moderate/severe cases (mu = - 107.67 pg/ml; s.e. = 28.74 pg/ml), while levels increased among controls (mu = 32.86 pg/ml; s.e. = 30.29). The same pattern occurred for matrix metallopeptidase 3 (MMP3), with levels decreasing for moderate/severe cases (mu = - 3369.24 pg/ml; s.e. = 1701.68) and increasing for controls (mu = 1859.60 pg/ml; s.e. = 1737.51) from pre- to post-deployment/bTBI. Evidence was also suggestive of case-control differences, from pre- to post-deployment/bTBI for interleukin 1 alpha (IL-1 alpha), interleukin 4 (IL-4), and interleukin 6 (IL-6) among moderate/severe cases. Conclusion The findings of this longitudinal study indicate that in the chronic phase of bTBI, levels of IL-8 and MMP3 may be substantially lower than pre-injury. These results need confirmation in other studies, potentially those that account for treatment differences, which was not possible in our study.	[Rusiecki, Jennifer; Wang, Li; Byrne, Celia; Chen, Ligong] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Levin, Lynn, I] Walter Reed Army Inst Res, Stat & Epidemiol Branch, Silver Spring, MD USA; [Krishnamurthy, Jayasree] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Pediat, Bethesda, MD USA; [Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA		Rusiecki, J (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.	jennifer.rusiecki@usuhs.edu		french, louis/0000-0002-9451-0604	Department of Defense (DOD) Psychological Health/Traumatic Brain Injury (PH/TBI) Research Programs of the Office of the Congressionally Directed Medical Research Programs (CDMRP) [PT073882]; U.S. Department of DefenseUnited States Department of Defense [308430 USUHS]; Collaborative Health Initiative Research Program (NHLBI/NIH); Collaborative Health Initiative Research Program (USUHS)	This study was funded by a Department of Defense (DOD) Psychological Health/Traumatic Brain Injury (PH/TBI) Research Programs of the Office of the Congressionally Directed Medical Research Programs (CDMRP) Grant: PT073882. This grant funded the collection and analysis of the data. This research was partially supported (ZG) by a grant from U.S. Department of Defense, Program Project 308430 USUHS and Collaborative Health Initiative Research Program (NHLBI/NIH and USUHS).	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; AFHSC, 2013, DOD TBI STAT 2000 20; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Bingham D, 2013, J NEUROIMMUNOL, V256, P28, DOI 10.1016/j.jneuroim.2012.12.009; Calvalido J, 2016, VET IMMUNOL IMMUNOP, V182, P106, DOI 10.1016/j.vetimm.2016.10.009; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Graham C, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1154-3; Ha SK, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2819; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Institute S, 2012, THESAS SYST WIND 9; Keustermans GCE, 2013, METHODS, V61, P10, DOI 10.1016/j.ymeth.2013.04.005; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nathan DE, 2016, BRAIN CONNECT, V6, P389, DOI 10.1089/brain.2015.0403; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Surbatovic M, 2007, MIL MED, V172, P190, DOI 10.7205/MILMED.172.2.190; Talsky A., 2011, BRIT COLOMBIA MED J, V53, P26; Wang J, 2015, INT J CLIN EXP PATHO, V8, P4099; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamaguchi K, 2017, INT J MOL MED, V39, P687, DOI 10.3892/ijmm.2017.2875; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	66	6	6	3	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 13	2020	17	1							20	10.1186/s12974-019-1624-z			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology	KX6ML	WOS:000521993200001	31931830	Green Published, gold			2022-02-06	
J	Yu, SS; Xin, WQ; Jiang, QL; Li, AX				Yu, Shashuang; Xin, Wenqi; Jiang, Qiliang; Li, Aixiang			Propofol exerts neuroprotective functions by down-regulating microRNA-19a in glutamic acid-induced PC12 cells	BIOFACTORS			English	Article						AMPK pathway; cerebral injury; microRNA-19a; mTOR pathway; Propofol	POST-CONDITIONING PROTECTS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; AUTOPHAGY; MTOR; LUNG; EXPRESSION; DAMAGE	Background Propofol, a kind of intravenous sedative drug, is certified that exerts anti-inflammation and antitumor functions. However, the influence of propofol in cerebral injury and the corresponding mechanism remains unexplained, that our article focuses on. Methods PC12 cells were treated with propofol and exposed in glutamic acid (Glu) solutions. Cell viability, apoptotic potential, apoptosis-related and autophagy-linked proteins were tested via CCK-8, flow cytometry, and western blot assays. Reverse transcription-quantitative real-time PCR was utilized to test miR-19a expression in Glu-stimulated cells. Next, miR-19a mimic transfection was used to assess the effects of miR-19a on cell apoptosis and autophagy in Glu or propofol treated cells. Finally, western blot was performed to test AMPK and mTOR pathways. Results Glu exposure promoted cell apoptosis and autophagy of PC12 cells, while propofol attenuated cell apoptosis and autophagy triggered by Glu. Additionally, propofol decreased the miR-19a expression in Glu-stimulated PC12 cells. Meanwhile, over-expression of miR-19a reversed the effects of propofol on Glu-induced cell apoptosis and autophagy. Moreover, propofol potentiated AMPK and mTOR pathways in Glu-stimulated PC12 cells via impeding miR-19a expression. Conclusions These finding revealed that propofol relieved Glu-triggered apoptosis and autophagy of PC12, and activated AMPK and mTOR pathways by suppressing miR-19a expression.	[Yu, Shashuang; Xin, Wenqi; Jiang, Qiliang; Li, Aixiang] Henan Univ, Huaihe Hosp, Dept Anesthesiol, 8 Baobei Rd, Kaifeng 475000, Peoples R China		Li, AX (corresponding author), Henan Univ, Huaihe Hosp, Dept Anesthesiol, 8 Baobei Rd, Kaifeng 475000, Peoples R China.	aixiang0079@163.com					Alletag MJ, 2012, PEDIATR EMERG CARE, V28, P1391, DOI 10.1097/PEC.0b013e318276fde2; Arias-Perez A, 2018, SILICO DETECTION FIS; BORGEAT A, 1990, ANESTH ANALG, V71, P511; Boyarinov G. A., 2017, Sudebno-Meditsinskaya Ekspertiza, V60, P4, DOI 10.17116/sudmed20176014-7; Braz MG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001266; Carteron L, 2017, MINERVA ANESTESIOL, V83, P412, DOI 10.23736/S0375-9393.16.11696-7; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen JL, 2017, J CELL MOL MED, V21, P3679, DOI 10.1111/jcmm.13278; Chidambaran V, 2015, CNS DRUGS, V29, P543, DOI 10.1007/s40263-015-0259-6; Gao WW, 2017, ACTA CIR BRAS, V32, P376, DOI 10.1590/s0102-865020170050000007; Ge XL, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0160-2; Gong LC, 2019, EXP MOL PATHOL, V111, DOI 10.1016/j.yexmp.2019.104325; Guo JY, 2016, GENE DEV, V30, P1704, DOI 10.1101/gad.283416.116; Hao W, 2017, CELL BIOL INT, V41, P495, DOI 10.1002/cbin.10745; Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268; He MW, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0660-z; Hu M, 2012, ANTICANCER RES, V32, P4385; Islam MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051405; Ji FT, 2015, MOL MED REP, V12, P2049, DOI 10.3892/mmr.2015.3585; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Ludka FK, 2016, J PSYCHIATR RES, V82, P50, DOI 10.1016/j.jpsychires.2016.07.004; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Mayor D, 2018, NEUROPHARMACOLOGY, V134, P178, DOI 10.1016/j.neuropharm.2017.11.050; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Park HA, 2017, CELL DEATH DIFFER, V24, P1963, DOI 10.1038/cdd.2017.123; Prentice H, 2017, ADV EXP MED BIOL, V975, P207, DOI 10.1007/978-94-024-1079-2_18; Shan MH, 2017, FREE RADICAL BIO MED, V110, P432, DOI 10.1016/j.freeradbiomed.2017.05.021; Shi SS, 2014, NEUROCHEM RES, V39, P793, DOI 10.1007/s11064-014-1272-8; Siddiqui RA, 2005, BREAST CANCER RES, V7, pR645, DOI 10.1186/bcr1036; Stepulak A, 2014, J NEURAL TRANSM, V121, P933, DOI 10.1007/s00702-014-1182-6; Sun B, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0054-1; Wang JQ, 2018, ANTI-CANCER AGENT ME, V18, P156, DOI 10.2174/1871520617666170912120327; Wu WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132499; Yang NL, 2017, ONCOL REP, V37, P2611, DOI 10.3892/or.2017.5514; Yu Y, 2015, CHINESE MED J-PEKING, V128, P919, DOI 10.4103/0366-6999.154298; Zhang LM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-66; Zhang R, 2013, CHINESE MED J-PEKING, V126, P1884, DOI 10.3760/cma.j.issn.0366-6999.20130095; Zheng GD, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187655, 10.1590/1414-431x20187655]	44	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-6433	1872-8081		BIOFACTORS	Biofactors	NOV	2020	46	6					934	942		10.1002/biof.1607		JAN 2020	9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	PH2LJ	WOS:000506070500001	31913544				2022-02-06	
J	Tapiainen, V; Lavikainen, P; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM				Tapiainen, Vesa; Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija			The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						Alzheimer's disease; antipsychotics; dementia; risk factors; traumatic brain injury	HIP FRACTURE; DRUG-USE; OLDER; PREVALENCE; DIAGNOSIS; DEMENTIA; REGISTER; PEOPLE; FALLS	BACKGROUND/OBJECTIVES Antipsychotic use is associated with risk of falls among older persons, but we are not aware of previous studies investigating risk of head injuries. We studied the association of antipsychotic use and risk of head injuries among community dwellers with Alzheimer's disease (AD). DESIGN Nationwide register-based cohort study. SETTING Medication Use and Alzheimer's Disease (MEDALZ) cohort, Finland. PARTICIPANTS The MEDALZ cohort includes Finnish community dwellers who received clinically verified AD diagnosis in 2005 to 2011. Incident antipsychotic users were identified from the Prescription Register and matched with nonusers by age, sex, and time since AD diagnosis (21 795 matched pairs). Persons with prior head injury or history of schizophrenia were excluded. MEASUREMENTS Outcomes were incident head injuries (International Classification of Diseases, Tenth Revision [ICD-10] codes S00-S09) and traumatic brain injuries (TBIs; ICD-10 codes S06.0-S06.9) resulting in a hospital admission (Hospital Discharge Register) or death (Causes of Death Register). Inverse probability of treatment (IPT) weighted Cox proportional hazard models were used to assess relative risks. RESULTS Antipsychotic use was associated with an increased risk of head injuries (event rate per 100 person-years = 1.65 [95% confidence interval {CI} = 1.50-1.81] for users and 1.26 [95% CI = 1.16-1.37] for nonusers; IPT-weighted hazard ratio [HR] = 1.29 [95% CI = 1.14-1.47]) and TBIs (event rate per 100 person-years = 0.90 [95% CI = 0.79-1.02] for users and 0.72 [95% CI = 0.65-0.81] for nonusers; IPT-weighted HR = 1.22 [95% CI = 1.03-1.45]). Quetiapine users had higher risk of TBIs (IPT-weighted HR = 1.60 [95% CI = 1.15-2.22]) in comparison to risperidone users. CONCLUSIONS These findings imply that in addition to previously reported adverse events and effects, antipsychotic use may increase the risk of head injuries and TBIs in persons with AD. Therefore, their use should be restricted to most severe neuropsychiatric symptoms, as recommended by the AGS Beers Criteria (R). Additionally, higher relative risk of TBIs in quetiapine users compared to risperidone users should be confirmed in further studies.	[Tapiainen, Vesa; Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Hartikainen, Sirpa; Tolppanen, Anna-Maija] Univ Eastern Finland, Sch Pharm, POB 1627, Kuopio 70211, Finland; [Tapiainen, Vesa; Koponen, Marjaana; Taipale, Heidi; Hartikainen, Sirpa; Tolppanen, Anna-Maija] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Koponen, Marjaana] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Parkville, Vic, Australia; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Tanskanen, Antti] Natl Inst Hlth & Welf, Impact Assessment Unit, Helsinki, Finland		Tapiainen, V (corresponding author), Univ Eastern Finland, Sch Pharm, POB 1627, Kuopio 70211, Finland.	vesa.tapiainen@gmail.com	Tapiainen, Vesa/AAM-5440-2020	Lavikainen, Piia/0000-0003-3560-8860	Academy of FinlandAcademy of FinlandEuropean Commission [307232, 295334]; University of Eastern Finland; Finnish Medical Society Duodecim [2660]	A.M.T. is funded by the Academy of Finland (grants 307232 and 295334), which also paid V.T.'s salary. A.M.T. acknowledges strategic funding from the University of Eastern Finland. V.T. received a grant from the Finnish Medical Society Duodecim (grant 2660).	Alzheimer's Disease International, WORLD ALZHEIMER REPO; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P886; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; [Anonymous], 2017, MEM DIS CURR CAR GUI; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Azermai M, 2012, AGEING RES REV, V11, P78, DOI 10.1016/j.arr.2011.07.002; Bakken MS, 2016, J AM GERIATR SOC, V64, P1203, DOI 10.1111/jgs.14162; Carton L, 2015, CURR PHARM DESIGN, V21, P3280, DOI 10.2174/1381612821666150619092903; de Vries M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.013; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Finnish Medical Society Duodecim, 2010, MEM DIS CURR CAR GUI; Fraser LA, 2015, JAMA INTERN MED, V175, P450, DOI 10.1001/jamainternmed.2014.6930; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Harvey L, 2016, ARCH GERONTOL GERIAT, V67, P61, DOI 10.1016/j.archger.2016.06.014; Harvey L, 2016, INJURY, V47, P226, DOI 10.1016/j.injury.2015.09.021; Huybrechts KF, 2012, J AM GERIATR SOC, V60, P420, DOI 10.1111/j.1532-5415.2011.03853.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilmaniemi S, 2019, J EPIDEMIOL COMMUN H, V73, P451, DOI 10.1136/jech-2018-211960; Jalbert JJ, 2010, J AM MED DIR ASSOC, V11, P120, DOI 10.1016/j.jamda.2009.10.001; Koponen M, 2017, J CLIN PSYCHIAT, V78, pE257, DOI 10.4088/JCP.15m10458; Koponen M, 2015, BRIT J PSYCHIAT, V207, P444, DOI 10.1192/bjp.bp.114.162834; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Langlois J, 2004, TRAUMATIC BRAIN INJU, P55; Lehtola S, 2006, ARCH GERONTOL GERIAT, V42, P217, DOI 10.1016/j.archger.2005.07.002; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Population Register Centre, PERS ID COD; Pratt N, 2011, DRUG SAFETY, V34, P567, DOI 10.2165/11588470-000000000-00000; Rigler SK, 2013, J AM GERIATR SOC, V61, P715, DOI 10.1111/jgs.12216; Rikala M, 2010, DRUG AGING, V27, P337, DOI 10.2165/11315960-000000000-00000; Taipale H, 2016, CLIN EPIDEMIOL, V8, P363, DOI 10.2147/CLEP.S116160; Taipale H, 2014, EUR NEUROPSYCHOPHARM, V24, P1729, DOI 10.1016/j.euroneuro.2014.10.004; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; Tolppanen AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012100; WHO Collaborating Center for Drug Statistics Methodology. Norwegian Institute of Public Health, AN THER CHEM CLASS S AN THER CHEM CLASS S; WHO Collaborating Centre for Drug Statistics Methodology, DEF DAIL DOS	39	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAR	2020	68	3					595	602		10.1111/jgs.16275		JAN 2020	8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	KR9ZS	WOS:000505979300001	31912482				2022-02-06	
J	Dehghanian, F; Soltani, Z; Khaksari, M				Dehghanian, Fatemeh; Soltani, Zahra; Khaksari, Mohammad			Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Mesenchymal stem cells; Traumatic brain injury; Apoptosis; Inflammation	TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; MOUSE MODEL; NEUROPROTECTION; TRANSPLANTATION; PATHOPHYSIOLOGY; ACTIVATION; EXPRESSION; ISCHEMIA; CALCIUM	Traumatic brain injury (TBI), a leading cause of morbidity and mortality throughout the world, will probably become the third cause of death in the world by the year 2020. Lack of effective treatments approved for TBI is a major health problem. TBI is a heterogeneous disease due to the different mechanisms of injury. Therefore, it requires combination therapies or multipotential therapy that can affect multiple targets. In recent years, mesenchymal stem cells (MSCs) transplantation has considered one of the most promising therapeutic strategies to repair of brain injuries including TBI. In these studies, it has been shown that MSCs can migrate to the site of injury and differentiate into the cells secreting growth factors and anti-inflammatory cytokines. The reduction in brain edema, neuroinflammation, microglia accumulation, apoptosis, ischemia, the improvement of motor and cognitive function, and the enhancement in neurogenesis, angiogenesis, and neural stem cells survival, proliferation, and differentiation have been indicated in these studies. However, translation of MSCs research in TBI into a clinical setting will require additional preclinical trials.	[Dehghanian, Fatemeh] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Dehghanian, Fatemeh] Bam Univ Med Sci, Bam, Iran; [Soltani, Zahra] Kerman Univ Med Sci, Fac Med, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Fac Med, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran.	soltaniy@yahoo.com	Haddad, Mohammad Khaksari/AAB-9025-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Soltani, Zahra/0000-0002-8423-6189			Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Butovsky O, 2007, MOL CELL NEUROSCI, V35, P490, DOI 10.1016/j.mcn.2007.04.009; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen DY, 2013, BIOMATERIALS, V34, P1995, DOI 10.1016/j.biomaterials.2012.11.045; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Dehghan F, 2018, INFLAMMOPHARMACOLOGY, V26, P1017, DOI 10.1007/s10787-017-0417-1; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dodson MV, 2010, INT J BIOL SCI, V6, P465; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gennai G, 2005, LESSICO INTERCULTURA; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Gibb SL, 2015, STEM CELLS, V33, P3530, DOI 10.1002/stem.2189; Gincberg G, 2018, CYTOTHERAPY, V20, P245, DOI 10.1016/j.jcyt.2017.11.008; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Herson PS, 1999, J BIOL CHEM, V274, P833, DOI 10.1074/jbc.274.2.833; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hofer HR, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0394-0; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Khaksari M, 2018, IRAN J BASIC MED SCI, V21, P615, DOI 10.22038/IJBMS.2018.26586.6512; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kobeissy F, 2015, BRAIN NEUROTRAUMA MO; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Koutsoudaki PN, 2016, GLIA, V64, P763, DOI 10.1002/glia.22959; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Li G, 2018, TURK NEUROSURG, V28, P696, DOI 10.5137/1019-5149.JTN.20829-17.1; Liao YWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076090; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marshall LF, 2000, HEAD INJURY RECENT P; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Morganti-Kossmann C, 2010, ELSEV INSIGHT, P193, DOI 10.1016/B978-0-12-384691-4.00010-9; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Ooi YY, 2010, INT IMMUNOPHARMACOL, V10, P1532, DOI 10.1016/j.intimp.2010.09.001; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Qi LF, 2018, J CRANIOFAC SURG, V29, P1689, DOI 10.1097/SCS.0000000000005042; Racay P, 2009, NEUROCHEM RES, V34, P1469, DOI 10.1007/s11064-009-9934-7; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Rossetti MF, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12402; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schneider C. M., 2019, PRINCIPLES REGENERAT, P369; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Skendelas JP, 2015, CURRENT PHYS MED REH, V3, P115, DOI [10.1007/s40141-015-0091-4, DOI 10.1007/S40141-015-0091-4]; Soltani Z, 2017, BRAIN INJURY, V31, P16, DOI 10.1080/02699052.2016.1213421; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wan Jiangbo, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1730; Wang SY, 2013, INT J DEV NEUROSCI, V31, P30, DOI 10.1016/j.ijdevneu.2012.09.004; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu JG, 2016, INT J CLIN EXP MED, V9, P12649; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhao K, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2153629; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	125	6	6	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2020	70	5					677	688		10.1007/s12031-019-01475-w		JAN 2020	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LC8FQ	WOS:000505463700004	31897971				2022-02-06	
J	Bahado-Singh, RO; Vishweswaraiah, S; Er, A; Aydas, B; Turkoglu, O; Taskin, BD; Duman, M; Yilmaz, D; Radhakrishna, U				Bahado-Singh, Ray O.; Vishweswaraiah, Sangeetha; Er, Anil; Aydas, Buket; Turkoglu, Onur; Taskin, Birce D.; Duman, Murat; Yilmaz, Durgul; Radhakrishna, Uppala			Artificial Intelligence and the detection of pediatric concussion using epigenomic analysis	BRAIN RESEARCH			English	Article						Pediatric concussion; Methylation; Illumina Infinium MethylationEPIC BeadChip assay; Epigenetics; Artificial Intelligence; Biomarkers	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; LONG NONCODING RNA; NEUROTROPHIC FACTOR; DNA METHYLATION; CEREBRAL-CORTEX; CELL-VOLUME; INOSITOL; RECEPTOR; PROTEIN	Concussion, also referred to as mild traumatic brain injury (mTBI) is the most common type of traumatic brain injury. Currently concussion is an area of intense scientific interest to better understand the biological mechanisms and for biomarker development. We evaluated whole genome-wide blood DNA cytosine ('CpG') methylation in 17 pediatric concussion isolated cases and 18 unaffected controls using Illumina Infinium Methylation EPIC assay. Pathway analysis was performed using Ingenuity Pathway Analysis to help elucidate the epigenetic and molecular mechanisms of the disorder. Area under the receiver operating characteristics (AUC) curves and FOR p-values were calculated for mTBI detection based on CpG methylation levels. Multiple Artificial Intelligence (AI) platforms including Deep Learning (DL), the newest form of AI, were used to predict concussion based on i) CpG methylation markers alone, and ii) combined epigenetic, clinical and demographic predictors. We found 449 CpG sites (473 genes), those were statistically significantly methylated in mTBI compared to controls. There were four CpGs with excellent individual accuracy (AUC >= 0.90-1.00) while 119 displayed good accuracy (AUC >= 0.80-0.89) for the prediction of mTBI. The CpG methylation changes a 10% were observed in many CpG loci after concussion suggesting biological significance. Pathway analysis identified several biologically important neurological pathways that were perturbed including those associated with: impaired brain function, cognition, memory, neurotransmission, intellectual disability and behavioral change and associated disorders. The combination of epigenomic and clinical predictors were highly accurate for the detection of concusion using Al techniques. Using DL/AI, a combination of epigenomic and clinical markers had sensitivity and specificity >= 95% for prediction of mTBI. In this novel study, we identified significant methylation changes in multiple genes in response to mTBI. Gene pathways that were epigenetically dysregulated included several known to be involved in neurological function, thus giving biological plausibility to our findings.	[Bahado-Singh, Ray O.; Vishweswaraiah, Sangeetha; Turkoglu, Onur; Radhakrishna, Uppala] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 West 13 Mile Rd, Royal Oak, MI 48073 USA; [Er, Anil; Duman, Murat; Yilmaz, Durgul] Dokuz Eylul Univ, Dept Pediat, Div Pediat Emergency Care, Izmir, Turkey; [Aydas, Buket] Albion Coll, Dept Math & Comp Sci, Albion, MI 49224 USA; [Taskin, Birce D.] Ankara Childrens Hematol & Oncol Training & Res H, Dept Pediat Neurol, Ankara, Turkey		Radhakrishna, U (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 West 13 Mile Rd, Royal Oak, MI 48073 USA.	Uppala.radhakrishna@beaumont.edu	er, anil/AAA-6676-2022; Er, Anil/AAA-6661-2022	Er, Anil/0000-0003-3452-5123; Duman, Murat/0000-0001-6767-5748; Vishweswaraiah, Sangeetha/0000-0001-5681-5143			Adlakha YK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-33; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Alakwaa FM, 2018, J PROTEOME RES, V17, P337, DOI 10.1021/acs.jproteome.7b00595; Altorok N., 2014, ANN RHEUM DIS; Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Anderson T, 1995, COMPETING IN THE GLOBAL MARKETPLACE: A DECISION SCIENCE VIEWPOINT - DECISION SCIENCES INSTITUTE THIRD INTERNATIONAL MEETING, P187; Bai ZX, 2014, ALZ DIS ASSOC DIS, V28, P226, DOI 10.1097/WAD.0000000000000022; Bennett ER, 2016, FRONTIERS NEUROSCIEN; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bortell N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0825-6; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Candel A., 2018, DEEP LEARNING; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cases O, 2013, J BIOL CHEM, V288, P16655, DOI 10.1074/jbc.M113.451070; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chenn Anjen, 2008, Organogenesis, V4, P76; Chhabra R, 2015, CHEMBIOCHEM, V16, P195, DOI 10.1002/cbic.201402449; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cook Rebecca S, 2006, J Trauma Nurs, V13, P58; Coutton C, 2015, EUR J PEDIATR, V174, P75, DOI 10.1007/s00431-014-2367-6; Cui D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051315; Daca-Roszak P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2202-0; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Davis KN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148558; de Mooij-van Malsen A, 2009, BIOL PSYCHIAT, V66, P1123, DOI 10.1016/j.biopsych.2009.06.016; Di Zazzo Erika, 2013, Biology (Basel), V2, P107, DOI 10.3390/biology2010107; Dunkhase E, 2016, GENOM DATA, V10, P22, DOI 10.1016/j.gdata.2016.08.017; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Fregeac J, 2016, NEUROSCI BIOBEHAV R, V71, P729, DOI 10.1016/j.neubiorev.2016.10.018; Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.32; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Ghanemi A, 2015, SAUDI PHARM J, V23, P115, DOI 10.1016/j.jsps.2013.07.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gong YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115016; Gordon-Weeks PR, 2014, J NEUROCHEM, V129, P206, DOI 10.1111/jnc.12502; Guijarro P, 2013, DEV NEUROBIOL, V73, P871, DOI 10.1002/dneu.22107; Guil AFN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08140-5; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; Hicks SD, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00176; Homayouni R, 2000, CURR BIOL, V10, pR331, DOI 10.1016/S0960-9822(00)00459-0; Huang JH, 2013, ANAL CHIM ACTA, V804, P70, DOI 10.1016/j.aca.2013.10.003; Huang TN, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00406; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Kamat PK, 2015, METHOD ENZYMOL, V555, P207, DOI 10.1016/bs.mie.2014.11.025; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kasumu AW, 2012, J NEUROSCI, V32, P12786, DOI 10.1523/JNEUROSCI.1643-12.2012; Kelsom C, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-19; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leenen FAD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0256-8; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liland KH, 2011, TRAC-TREND ANAL CHEM, V30, P827, DOI 10.1016/j.trac.2011.02.007; Lin Wan-Hsin, 2009, Open Neurosci J, V3, P54; Lipovich L, 2014, CEREB CORTEX, V24, P1451, DOI 10.1093/cercor/bhs414; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; Mahmoudi E, 2017, MOL PSYCHIATR, V22, P44, DOI 10.1038/mp.2016.150; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Navarro JC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00494; Nystuen AM, 2015, NEURAL REGEN RES, V10, P1928, DOI 10.4103/1673-5374.169631; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oliver PL, 2015, CEREB CORTEX, V25, P3572, DOI 10.1093/cercor/bhu196; Osaki G, 2011, BRAIN RES, V1386, P58, DOI 10.1016/j.brainres.2011.02.025; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Podvin S., 2016, JSM ALZHEIMERS DIS R, V3; Poomipark Natwadee, 2016, Asian Pac J Cancer Prev, V17, P3213; Radhakrishna U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154010; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Saneyoshi T, 2012, CYTOSKELETON, V69, P545, DOI 10.1002/cm.21037; Sato Y, 2019, GENE EXPR PATTERNS, V34, DOI 10.1016/j.gep.2019.119070; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sims R., NAT GENET; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Spensberger D, 2008, FEBS LETT, V582, P2761, DOI 10.1016/j.febslet.2008.06.056; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Tilley SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176953; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Veerappa AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090391; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Wright Carrie, 2013, Frontiers in Genetics, V4, P58, DOI 10.3389/fgene.2013.00058; Yan Y, 2016, NEUROPHARMACOLOGY, V107, P227, DOI 10.1016/j.neuropharm.2016.03.050; Yang F, 2018, AM J CANCER RES, V8, P636; Ypsilanti AR, 2016, J COMP NEUROL, V524, P609, DOI 10.1002/cne.23866; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhong QS, 2014, J NEUROSCI RES, V92, P619, DOI 10.1002/jnr.23339; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	116	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 1	2020	1726								146510	10.1016/j.brainres.2019.146510			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW8WN	WOS:000503327300010	31628932				2022-02-06	
J	Bodien, YG; Martens, G; Ostrow, J; Sheau, K; Giacino, JT				Bodien, Yelena G.; Martens, Geraldine; Ostrow, Joseph; Sheau, Kristen; Giacino, Joseph T.			Cognitive impairment, clinical symptoms and functional disability in patients emerging from the minimally conscious state	NEUROREHABILITATION			English	Article						Brain injury; traumatic brain injury; consciousness; confusion	TRAUMATIC BRAIN-INJURY; ACUTE CONFUSION; POSTTRAUMATIC CONFUSION; RATING-SCALE; AMNESIA; RELIABILITY; EMERGENCE; SEVERITY; RECOVERY; CRITERIA	BACKGROUND: Although emergence from the minimally conscious state (eMCS) is associated with symptoms including disorientation, memory and attention impairment, restlessness, and significant functional disability, the neurobehavioral profile of eMCS has not been empirically characterized. OBJECTIVE: Determine degree of cognitive impairment, presence of clinical symptoms and functional disability at time eMCS in patients with traumatic and non-traumatic brain injury (TBI, nTBI). METHODS: Retrospective observational study of 169 adults (median [interquartile range] age: 51 [29, 62] years; male: 116; TBI: 103) who emerged from MCS based on the Coma Recovery Scale-Revised while in an inpatient Disorders of Consciousness program. Outcome measures include the Confusion Assessment Protocol (CAP) and Disability Rating Scale (DRS). RESULTS: CAP administration was attempted in 54 subjects. Twenty-eight subjects had valid scores on all CAP items, with a median [interquartile range] of 4 [3-5] symptoms of confusion. Scores in 93% of this subsample were consistent with an acute confusional state. The most common symptoms were cognitive impairment (98% of subjects), disorientation (93%), and agitation (69%). The median DRS score upon emergence from MCS was 14.5 [13, 16], indicating severe disability (n = 140). CONCLUSIONS: eMCS is associated with an acute confusional state and severe disability. This finding may inform the lower boundary of confusion as well as approach to treatment and caregiver education.	[Bodien, Yelena G.; Martens, Geraldine; Ostrow, Joseph; Sheau, Kristen; Giacino, Joseph T.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Bodien, Yelena G.] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Martens, Geraldine] Univ Liege, Dept Neurol, Liege, Belgium; [Martens, Geraldine] Univ Liege, GIGA Res, Coma Sci Grp, GIGA Consciousness, Liege, Belgium; [Martens, Geraldine] Univ Hosp Liege, Liege, Belgium		Bodien, YG (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	ybodien@mgh.harvard.edu	Martens, Geraldine/ABF-1147-2020; Giacino, Joseph/AAF-1952-2021	Martens, Geraldine/0000-0001-7038-7165; Giacino, Joseph/0000-0002-7916-9698	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (NIDILRR) [90DP0039]; James S. McDonnell Foundation; Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [EU-H2020-fetopen-ga686764]; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [EU-H2020-fetflagship-hbpsga1-ga720270]; DOCMA project [EU-H2020MSCA-RISE-778234]; IAP research network of the Belgian Government (Belgian Science Policy)Belgian Federal Science Policy Office [P7/06]; Wallonie-Bruxelles International (WBI.World); Wallonia-Brussels Federation Travel Grant; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0039]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; U.S. Department of DefenseUnited States Department of Defense; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); University Hospital of Li`ege	Y. Bodien: National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (NIDILRR grant number 90DP0039), James S. McDonnell Foundation. J. Ostrow: None. K. Sheau: None. G. Martens: University and University Hospital of Li`ege, the Belgian National Funds for Scientific Research (FRS-FNRS), European Commission: Luminous project (EU-H2020-fetopen-ga686764); Human Brain Project (EU-H2020-fetflagship-hbpsga1-ga720270); DOCMA project (EU-H2020MSCA-RISE-778234), IAP research network P7/06 of the Belgian Government (Belgian Science Policy), Wallonie-Bruxelles International (WBI.World), Wallonia-Brussels Federation Travel Grant. J. Giacino: National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0039), James S. McDonnell Foundation, National Institutes of Health, U.S. Department of Defense, the National Institute of Neurological Disorders and Stroke.	Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Russell W Ritchie, 1932, Edinb Med J, V39, pT25; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M., 2013, J HEAD TRAUMA REHABI; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]	24	6	6	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	1					65	74		10.3233/NRE-192860			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NT8RU	WOS:000573205100007	32039868	Bronze			2022-02-06	
J	Bottlang, M; Rouhier, A; Tsai, S; Gregoire, J; Madey, SM				Bottlang, Michael; Rouhier, Alexandra; Tsai, Stanley; Gregoire, Jordan; Madey, Steven M.			Impact Performance Comparison of Advanced Bicycle Helmets with Dedicated Rotation-Damping Systems	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Bicycle helmet; Rotation-damping system; Brain injury; Concussion; Oblique impact; Impact testing; Rotational acceleration; Slip liner	BRAIN-INJURY; HYBRID-III; HEAD-INJURY; REAL-WORLD; BIOMECHANICS; RISK; ACCELERATION; ASSOCIATIONS; EFFICACY; DAMAGE	Bicycle helmets effectively mitigate skull fractures, but there is increasing concern on their effectiveness in mitigating traumatic brain injury (TBI) caused by rotational head acceleration. Bicycle falls typically involve oblique impacts that induce rotational head acceleration. Recently, bicycle helmet with dedicated rotation-damping systems have been introduced to mitigate rotational head acceleration. This study investigated the impact performance of four helmets with different rotation-damping systems in comparison to a standard bicycle helmet without a rotation-damping system. Impact performance was tested under oblique impact conditions by vertical drops of a helmeted headform onto an oblique anvil at 6.2 m/s impact speed. Helmet performance was quantified in terms of headform kinematics, corresponding TBI risk, and resulting brain strain. Of the four rotation-damping systems, two systems significantly reduced rotational head acceleration, TBI risk, and brain strain compared to the standard bicycle helmet. One system had no significant effect on impact performance compared to control helmets, and one system significantly increase linear and rotational head acceleration by 62 and 61%, respectively. In conclusion, results revealed significant differences in the effectiveness between rotation-damping systems, whereby some rotation-damping systems significantly reduced rotational head acceleration and associated TBI risk.	[Bottlang, Michael; Rouhier, Alexandra; Tsai, Stanley; Gregoire, Jordan; Madey, Steven M.] Legacy Res Inst, Biomech Lab, Portland, OR 97232 USA		Bottlang, M (corresponding author), Legacy Res Inst, Biomech Lab, Portland, OR 97232 USA.	mbottlan@lhs.org		Rouhier, Alexandra/0000-0001-7644-516X	National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [SB1NS074734]; Research Foundation of the Legacy Health System	This research was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under Award Number SB1NS074734. Additional support was provided by the Research Foundation of the Legacy Health System. Some of the authors (MB, SMM) are co-inventors of helmet technology. However, their technology was not included in this research to preclude the potential for conflict of interest.	Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; [Anonymous], 2016, CONSUMER REPORTS; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bland M. L., 2018, BICYCLE HELMET STAR, P1; Bland M. L., 2018, J BIOMECH ENG, DOI [10.1115/1.40, DOI 10.1115/1.40]; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; CPSC, 2015, NAT EL INJ SURV SYST; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; ECE, 1999, R2205 ECE; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P245, DOI 10.1016/j.aap.2012.12.003; Fahlstedt M., 2014, INT SAF C 18 19 BIV; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Gaither TW, 2018, INJURY PREV, V24, P135, DOI 10.1136/injuryprev-2016-042281; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Holbourn AHS, 1943, LANCET, V2, P438; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klug C., 2015, INT RES COUNC BIOM I; Laituri Tony R, 2016, Stapp Car Crash J, V60, P301; McIntosh AS, 2013, J AUSTRALAS COLL ROA, V24, P11; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McKenzie B., 2014, AM COMMUNITY SURVEY, P1; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Otte D, 1989, SAE T, V98, P1606; Overton T. L., 2016, J EPIDEMIOL PUBLIC H, DOI [10.16966/2471-8211.103, DOI 10.16966/2471-8211.103]; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; SAE, 2007, J21101 SAE; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stigson H., 2017, FOLKSAM; Stigson H., 2017, P INT RES COUNCIL BI, P13; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Wen LM, 2008, PREV MED, V46, P29, DOI 10.1016/j.ypmed.2007.08.009; Willinger R., 2014, P INT CYCL SAF C 18; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	56	6	6	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					68	78		10.1007/s10439-019-02328-8			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	KI8PN	WOS:000511620300009	31342338	Green Published, hybrid			2022-02-06	
J	Hellewell, SC; Nguyen, VPB; Jayasena, RN; Welton, T; Grieve, SM				Hellewell, Sarah C.; Nguyen, Vy P. B.; Jayasena, Ruchira N.; Welton, Thomas; Grieve, Stuart M.			Characteristic patterns of white matter tract injury in sport-related concussion: An image based meta-analysis	NEUROIMAGE-CLINICAL			English	Article						Brain concussion; Brain injuries; Brain; Meta-analysis; Diffusion tensor imaging; Fractional anisotropy; Athletic injuries	TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR; FOOTBALL PLAYERS; FIBER DENSITY	Sports-related concussion (SRC) is sustained by millions of people per year, yet the spatiotemporal patterns of white matter (WM) injury remain poorly understood. Several SRC studies have implemented the standardised approach Tract-Based Spatial Statistics (TBSS). The aim of this image-based meta-analysis was to identify consensus patterns of SRC-related WM injury across TBSS studies. We included studies comparing the diffusion MRI measurement fractional anisotropy (FA) in SRC or subconcussive injury vs. controls using TBSS, as FA is the most frequently examined diffusion tensor imaging metric. Authors of eligible studies were contacted to request unthresholded statistical map outputs from TBSS, and image-based meta-analyses were performed using Seed-Based D-Mapping. Eight studies contributed to our meta-analyses, comprising 174 SRC or subconcussive injury participants and 160 controls. Our primary meta-analysis (n = 8), encompassing subjects with acute SRC (n = 2), chronic SRC(n = 4) and subconcussive injuries (n = 2) revealed dominant bilateral increased FA in the superior longitudinal fasciculus (SLF) and internal capsule. Subconcussive injury was associated with small clusters of increased and decreased FA in the arcuate fasciculus compared to control. In acute SRC, we found diffuse foci of raised FA at WM/grey matter border-zone associated with the bilateral SLF and right inferior fronto-occipital fasciculus. In contrast, chronic SRC had a pattern of deep WM alteration, asymmetrically located in the right optic radiations and arcuate fasciculus. Our findings represent the most powerful analysis of TBSS data in SRC, supporting the use of this approach to analyse diffusion data. TBSS is sensitive to WM abnormalities resulting from SRC or subconcussive injury over a range of temporal and clinical scenarios. Our data show spatially concordant patterns of WM injury unique to subconcussive, acute and chronic phases, highlighting the future utility of diffusion MRI for concussion diagnosis.	[Hellewell, Sarah C.; Nguyen, Vy P. B.; Jayasena, Ruchira N.; Welton, Thomas; Grieve, Stuart M.] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney Translat Imaging Lab, Camperdown, NSW 2006, Australia; [Grieve, Stuart M.] Royal Prince Alfred Hosp, Dept Radiol, Sydney, NSW, Australia		Grieve, SM (corresponding author), Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney Translat Imaging Lab, Camperdown, NSW 2006, Australia.	stuart.grieve@sydney.edu.au	Welton, Thomas/AAF-7805-2021; Grieve, Stuart/A-5093-2012	Welton, Thomas/0000-0002-9503-2093; Hellewell, Sarah/0000-0002-2179-2209; Grieve, Stuart/0000-0002-2712-157X	NHMRCNational Health and Medical Research Council of Australia [1130609]	This study is funded by NHMRC Grant 1130609. The funder had no role in writing, content or decision to submit this manuscript for publication.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Callaghan F, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0140-8; Churchill N.W., 2019, NEUROLOGY, DOI [10.1212/WNL., DOI 10.1212/WNL]; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003007; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kimura-Ohba S, 2016, J CEREBR BLOOD F MET, V36, P1731, DOI 10.1177/0271678X16630556; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kmet L.M., 2004, H I 13 EDMONT ALTA A; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lyon M, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101668; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McCrory P., 2017, BRIT J SPORT MED, V51, P1473; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Parazzini C, 2002, AM J NEURORADIOL, V23, P1669; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Radua J, 2012, EUR PSYCHIAT, V27, P605, DOI 10.1016/j.eurpsy.2011.04.001; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Salimi-Khorshidi G, 2009, NEUROIMAGE, V45, P810, DOI 10.1016/j.neuroimage.2008.12.039; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Smith Douglas H, 2016, Bridge (Wash D C), V46, P79; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stojanovski S, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102102; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wells G.S.B., 2012, NEWCASTLE OTTAWA SCA; Welton T, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101953; Welton T, 2015, RADIOLOGY, V275, P89, DOI 10.1148/radiol.14140925; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00868; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422	54	6	6	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	26								102253	10.1016/j.nicl.2020.102253			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LN7YO	WOS:000533149400070	32278315	Green Published, gold			2022-02-06	
J	Jullienne, A; Hamer, M; Haddad, E; Morita, A; Gifford, P; Hartman, R; Pearce, WJ; Tang, JP; Zhang, JH; Obenaus, A				Jullienne, Amandine; Hamer, Mary; Haddad, Elizabeth; Morita, Alexander; Gifford, Peter; Hartman, Richard; Pearce, William J.; Tang, Jiping; Zhang, John H.; Obenaus, Andre			Acute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article; Proceedings Paper	17th International Conference on Brain Edema and Cellular Injury	DEC 08-10, 2017	Guangzhou, PEOPLES R CHINA			controlled cortical impact; edema; extracellular matrix protein; Heme oxygenase-1; microglial activation; T2 mapping	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; EXPRESSION; HEME; MECHANISMS; RECOVERY; NEURONS; PATHWAY; DISEASE; LIGAND	Intranasal recombinant osteopontin (OPN) has been shown to be neuroprotective in different models of acquired brain injury but has never been tested after traumatic brain injury (TBI). We used a model of moderate-to-severe controlled cortical impact in male adult Sprague Dawley rats and tested our hypothesis that OPN treatment would improve neurological outcomes, lesion and brain tissue characteristics, neuroinflammation, and vascular characteristics at 1 day post-injury. Intranasal OPN administered 1 hr after the TBI did not improve neurological score, lesion volumes, blood-brain barrier, or vascular characteristics. When assessing neuroinflammation, we did not observe any effect of OPN on the astrocyte reactivity but discovered an increased number of activated microglia within the ipsilateral hemisphere. Moreover, we found a correlation between edema and heme oxygenase-1 (HO-1) expression which was decreased in OPN-treated animals, suggesting an effect of OPN on the HO-1 response to injury. Thus, OPN may increase or accelerate the microglial response after TBI, and early response of HO-1 in modulating edema formation may limit the secondary consequences of TBI at later time points. Additional experiments and at longer time points are needed to determine if intranasal OPN could potentially be used as a treatment after TBI where it might be beneficial by activating protective signaling pathways.	[Jullienne, Amandine; Hamer, Mary; Morita, Alexander; Obenaus, Andre] Loma Linda Univ, Dept Basic Sci, Loma Linda, CA 92350 USA; [Hamer, Mary; Haddad, Elizabeth; Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Morita, Alexander; Obenaus, Andre] Univ Calif Riverside, UCR IMDB, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Gifford, Peter; Hartman, Richard; Pearce, William J.; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA USA; [Pearce, William J.] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Dept Anesthesiol, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Dept Neurosurg, Loma Linda, CA USA		Obenaus, A (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.	obenausa@uci.edu	Jullienne, Amandine/H-3081-2019	Jullienne, Amandine/0000-0001-9458-055X; Haddad, Elizabeth/0000-0002-7622-9085; Tang, Jiping/0000-0002-2392-9280; Pearce, William/0000-0002-5331-5677; Zhang, John H./0000-0002-4319-4285; , Andre/0000-0003-0081-6950	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL135786] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD083132] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS082184] Funding Source: Medline		Albertsson AM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0197-0; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Faul M, 2010, TRAUMATIC BRAIN INJU; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ghosh N, 2014, MED IMAGE ANAL, V18, P1059, DOI 10.1016/j.media.2014.05.002; Ghosh N, 2011, J MAGN RESON IMAGING, V33, P772, DOI 10.1002/jmri.22488; Gong L, 2018, NEUROPHARMACOLOGY, V138, P160, DOI 10.1016/j.neuropharm.2018.06.009; Iwanaga Y, 2008, NEUROPATH APPL NEURO, V34, P145, DOI 10.1111/j.1365-2990.2007.00877.x; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kim MD, 2004, J NEUROIMMUNOL, V151, P78, DOI 10.1016/j.jneuroim.2004.02.014; Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; Obenaus A., 2015, ENCY MENTAL HLTH, P329; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Sharp FR, 2013, TRANSL STROKE RES, V4, P685, DOI 10.1007/s12975-013-0271-4; Shin T, 2012, ACTA HISTOCHEM, V114, P749, DOI 10.1016/j.acthis.2012.08.004; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Tambuyzer BR, 2012, CELL BIOL INT, V36, P1233, DOI 10.1042/CBI20120172; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Tustison NJ, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00039; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wu J, 2016, STROKE, V47, P1319, DOI 10.1161/STROKEAHA.115.011552; Wung JK, 2007, CURR ALZHEIMER RES, V4, P67, DOI 10.2174/156720507779939869; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yu H. Y., 2017, WETLANDS ECOLOGY MAN, V3, P1; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	44	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2020	98	1					141	154		10.1002/jnr.24405			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	JM0CE	WOS:000495891200013	30892744	Green Accepted			2022-02-06	
J	Patel, JB; Wilson, SH; Oakes, TR; Santhanam, P; Weaver, LK				Patel, J. B.; Wilson, S. H.; Oakes, T. R.; Santhanam, P.; Weaver, L. K.			Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							GEOMETRICALLY ACCURATE; SERVICE MEMBERS; UNITED-STATES; SEGMENTATION; HEAD; SYMPTOMS	BACKGROUND AND PURPOSE: Routine MR imaging findings are frequently normal following mild traumatic brain injury and have a limited role in diagnosis and management. Advanced MR imaging can assist in detecting pathology and prognostication but is not readily available outside research settings. However, 3D isotropic sequences with ?1-mm(3) voxel size are available on community MR imaging scanners. Using such sequences, we compared radiologists? findings and quantified regional brain volumes between a mild traumatic brain injury cohort and non-brain-injured controls to describe structural imaging findings associated with mild traumatic brain injury. MATERIALS AND METHODS: Seventy-one military personnel with persistent symptoms and 75 controls underwent 3T MR imaging. Three neuroradiologists interpreted the scans using common data elements. FreeSurfer was used to quantify regional gray and white matter volumes. RESULTS: WM hyperintensities were seen in 81% of the brain-injured group versus 60% of healthy controls. The odds of ?1 WM hyperintensity in the brain-injured group was about 3.5 times the odds for healthy controls (95% CI, 1.58?7.72; P?=?.002) after adjustment for age. A frontal lobe-only distribution of WM hyperintensities was more commonly seen in the mild traumatic brain injury cohort. Furthermore, 7 gray matter, 1 white matter, and 2 subcortical gray matter regions demonstrated decreased volumes in the brain-injured group after multiple-comparison correction. The mild traumatic brain injury cohort showed regional parenchymal volume loss. CONCLUSIONS: White matter findings are nonspecific and therefore a clinical challenge. Our results suggest that prior trauma should be considered in the differential diagnosis of multifocal white matter abnormalities with a clinical history of mild traumatic brain injury, particularly when a frontal predilection is observed.	[Patel, J. B.; Oakes, T. R.; Santhanam, P.] Lovelace Biomed Res, Albuquerque, NM USA; [Patel, J. B.] VA Maryland Hlth Care Syst, Baltimore, MD USA; [Wilson, S. H.] Emmes, Rockville, MD USA; [Weaver, L. K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, L. K.] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, L. K.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Oakes, T. R.] Univ Wisconsin, Madison, WI USA		Weaver, LK (corresponding author), Intermt LDS Hosp Hyperbar Med, 8th Ave & C St, Salt Lake City, UT 84143 USA.	lindell.weaver@imail.org			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	This work was supported by the United States Army Medical Research and Materiel Command Contract No. W81XWH-15-D-0039-0003.	Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Bumb JM, 2012, CLIN NEURORADIOL, V22, P69, DOI 10.1007/s00062-011-0110-5; Burrowes SAB, 2020, BRAIN IMAGING BEHAV, V14, P1651, DOI 10.1007/s11682-019-00095-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; DCoE Clinical Recommendation, 2013, NEUR FOLL MILD TRAUM; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; HOLM S, 1979, SCAND J STAT, V6, P65; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nolte I, 2010, CLIN NEUROL NEUROSUR, V112, P204, DOI 10.1016/j.clineuro.2009.11.010; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Reneman L, 2012, AM J NEURORADIOL, V33, P1971, DOI 10.3174/ajnr.A3217; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Weaver LK, 2019, UNDERSEA HYPERBAR M, V46, P341; Weaver LK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01030; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P489; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	37	6	6	0	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	2020	41	1					92	99		10.3174/ajnr.A6346			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KE4ZI	WOS:000508565000017	31896572	Green Published, hybrid			2022-02-06	
J	Rasheed, W; Tang, TB				Rasheed, Waqas; Tang, Tong Boon			Anomaly Detection of Moderate Traumatic Brain Injury Using Auto-Regularized Multi-Instance One-Class SVM	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Neural imaging; medical diagnosis; machine learning; neurorehabilitation; anomaly detection	FUNCTIONAL CONNECTIVITY; MACHINE; MILD; MAGNETOENCEPHALOGRAPHY; SUPPORT	Detection and quantification of functional deficits due to moderate traumatic brain injury (mTBI) is crucial for clinical decision-making and timely commencement of functional therapy. In this work, we explore magnetoencephalography (MEG) based functional connectivity features i.e. magnitude squared coherence(MSC) and phase lag index (PLI) to quantify synchronized brain activity patterns as a means to detect functional deficits. We propose a multi-instance one-class support vector machine (SVM) model generated from a healthy control population. Any dispersion from the decision boundary of the model would be identified as an anomaly instance of mTBI case (Glasgow Coma Scale, GCS score between 9 and 13). The decision boundary was optimized by considering the closest anomaly (GCS = 13) from the negative class as a support vector. Validated against magnetic resonance imaging (MRI) data, the proposed model at high beta band yielded an accuracy of 94.19% and a sensitivity of 90.00%, when tested with our mTBI dataset. The results support the suggestion of multi-instance one-class SVM for the detection of mTBI.	[Rasheed, Waqas; Tang, Tong Boon] Univ Teknol PETRONAS, Dept Elect & Elect Engn, CISIR, Seri Iskandar 32610, Perak, Malaysia		Tang, TB (corresponding author), Univ Teknol PETRONAS, Dept Elect & Elect Engn, CISIR, Seri Iskandar 32610, Perak, Malaysia.	iwaqas@gmail.com; tongboon.tang@utp.edu.my		Tang, Tong Boon/0000-0002-5721-6828	Ministry of Education MalaysiaMinistry of Education, Malaysia [FRGS/1/2014/TK03/UTP/02/02]; National HICoE Grant	This work was supported in part by the Ministry of Education Malaysia under Grant FRGS/1/2014/TK03/UTP/02/02 and in part by the National HICoE Grant to Centre for Intelligent Signal and Imaging Research (CISIR).	Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; BARTLETT MS, 1948, NATURE, V161, P686, DOI 10.1038/161686a0; BARTLETT MS, 1950, BIOMETRIKA, V37, P1; Bounsiar A., 2014, P INT C INF SCI APPL, P1, DOI DOI 10.1109/ICISA.2014.6847419; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Carling K, 2000, COMPUT STAT DATA AN, V33, P249, DOI 10.1016/S0167-9473(99)00057-2; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Gautam C, 2017, NEUROCOMPUTING, V261, P126, DOI 10.1016/j.neucom.2016.04.070; Gravetter F. J., 2016, STAT BEHAV SCI, P79; Gribkoff VK, 2017, NEUROPHARMACOLOGY, V120, P11, DOI 10.1016/j.neuropharm.2016.03.021; Hooker James Stewart, 2015, N C Med J, V76, P101; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Keller CJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0528; Kennedy K, 2010, LECT NOTES ARTIF INT, V6206, P174; Lazzaretti AE, 2015, LECT NOTES COMPUT SC, V9370, P103, DOI 10.1007/978-3-319-24261-3_9; Liu F, 2017, ECOL MODEL, V353, P37, DOI 10.1016/j.ecolmodel.2016.09.004; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; Mavroforakis ME, 2006, IEEE T NEURAL NETWOR, V17, P671, DOI 10.1109/TNN.2006.873281; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Mohammad-Rezazadeh I, 2016, CURR OPIN NEUROL, V29, P137, DOI 10.1097/WCO.0000000000000301; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Nunez P. L., 2009, ELECT FIELDS BRAIN N; O'Reilly C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175870; Oliva JT, 2017, IEEE IJCNN, P2956, DOI 10.1109/IJCNN.2017.7966222; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Parker JL, 2010, J PHARM PHARM SCI, V13, P191, DOI 10.18433/J39014; Rasheed W, 2017, COMPUT BIOL MED, V89, P573, DOI 10.1016/j.compbiomed.2017.05.005; Retico A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00306; Riley RD, 2015, STAT MED, V34, P2081, DOI 10.1002/sim.6471; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; SchOlkopf B., 2002, LEARNING KERNELS SUP; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Sweet A., 2013, THESIS; TEASDALE G, 1974, LANCET, V2, P81; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Umile EM, 1998, BRAIN INJURY, V12, P577; Veniero D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00477; Wang RF, 2015, COGN NEURODYNAMICS, V9, P291, DOI 10.1007/s11571-014-9325-x; Wang SQ, 2018, PATTERN RECOGN, V74, P198, DOI 10.1016/j.patcog.2017.09.012; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; White H., 2016, TRAUMATIC BRAIN INJU, P210; Wylie G., 2017, COGN AFFECT BEHAV NE, P1; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	47	6	6	1	19	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	JAN	2020	28	1					83	93		10.1109/TNSRE.2019.2948798			11	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	KE2FZ	WOS:000508375400009	31647439				2022-02-06	
J	Rowland, B; Savarraj, JPJ; Karri, J; Zhang, X; Cardenas, J; Choi, HA; Holcomb, JB; Wade, CE				Rowland, Bradley; Savarraj, Jude P. J.; Karri, Jay; Zhang, Xu; Cardenas, Jessica; Choi, H. Alex; Holcomb, John B.; Wade, Charles E.			Acute Inflammation in Traumatic Brain Injury and Polytrauma Patients Using Network Analysis	SHOCK			English	Article						Inflammation; network analysis; traumatic brain injury	HEMORRHAGIC PROGRESSION; PATTERNS; RESPONSES; PATHOPHYSIOLOGY; CONSEQUENCES; EXPRESSION; CHEMOKINES; PLASMA	Introduction: Traumatic brain injury (TBI) is associated with secondary injury to the central nervous system (CNS) via inflammatory mechanisms. The combination of polytrauma and TBI further exacerbates the inflammatory response to injury; however, combined injury phenomena have not been thoroughly studied. In this study, we examined the inflammatory differences between patients with TBI versus patients with polytrauma, but no TBI (polytrauma). We hypothesize that patients with TBI have a heightened early inflammatory response compared with polytrauma. Methods: We conducted a single-center retrospective study of a cohort of patients with polytrauma, who were enrolled in the PROPPR study. These patients had blood samples prospectively collected at eight time points in the first 3 days of admission. Using radiological data to determine TBI, our polytrauma cohort was dichotomized into TBI (n = 30) or polytrauma (n = 54). Inflammatory biomarkers were measured using ELISA. Data across time were compared for TBI versus polytrauma groups using Wilcoxon rank-sum test. Network analysis techniques were used to systematically characterize the inflammatory responses at admission. Results: Patients with TBI (51.6%) had a higher 30-day mortality compared with polytrauma (16.9%) (P<0.001). Expression levels of IL6, IL8, and CCL2 were elevated from the 2-h through 24-h time points, becoming significant at the 6-h time point (IL6, IL8, and CCL2;P<0.05) (Fig. 2). CSF3 showed a similar pattern, but did not attain significance. TBI and polytrauma networks underwent diverging trends from admission to the 6-h time point. Conclusion: Patients with TBI demonstrated upregulations in proinflammatory cytokines IL6, IL8, and CCL2. Utilizing informatics methods, we were able to identify temporal differences in network trends, as well as uncharacterized cytokines and chemokines in TBI. These data suggest TBI induces a distinct inflammatory response and pathologically heightened inflammatory response in the presence of polytrauma and may propagate worsened patient outcomes including mortality.	[Rowland, Bradley; Karri, Jay; Zhang, Xu; Cardenas, Jessica; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA; [Savarraj, Jude P. J.; Choi, H. Alex] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX 77030 USA		Wade, CE (corresponding author), Ctr Translat Injury Res CETIR, Dept Surg, 6431 Fannin St MSB 5-204, Houston, TX 77030 USA.	Charles.e.wade@uth.tmc.edu	Savarraj, Jude/AAJ-4969-2021	Savarraj, Jude/0000-0003-0194-0734; holcomb, john/0000-0001-8312-9157	NHLBI grant [U01HL077863]; William Stamps Farish Fund; Howell Family Foundation; James H. "Red'' Duke Professorship	This work was funded by NHLBI grant U01HL077863, theWilliam Stamps Farish Fund, the Howell Family Foundation and the James H. "Red'' Duke Professorship.	An G, 2012, INT J BURNS TRAUMA, V2, P1; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bethel-Brown C., 2012, J NEUROINFLAMM, V9, P1; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Garcia-Bonilla L, 2015, J NEUROSCI, V35, P14783, DOI 10.1523/JNEUROSCI.2980-15.2015; Rojas-Zuleta WG, 2017, METHODS MOL BIOL, V1585, P21, DOI 10.1007/978-1-4939-6877-0_2; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lamparello AJ, 2019, J AM COLL SURGEONS, V228, P148, DOI 10.1016/j.jamcollsurg.2018.10.019; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Rau C, 2018, PLOS ONE, V13, P1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yang J, 2016, FRONT NEUROSCI, V10, P1; Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	50	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2020	53	1					24	34		10.1097/SHK.0000000000001349			11	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	NF5LS	WOS:000563338600004	30939502	Green Accepted, Bronze			2022-02-06	
J	Sacramento, CB; Sondhi, D; Rosenberg, JB; Chen, A; Giordano, S; Pey, E; Lee, V; Stiles, KM; Havlicek, DF; Leopold, PL; Kaminsky, SM; Crystal, RG				Sacramento, Chester Bittencourt; Sondhi, Dolan; Rosenberg, Jonathan B.; Chen, Alvin; Giordano, Stephanie; Pey, Eduard; Lee, Vladlena; Stiles, Katie M.; Havlicek, David F.; Leopold, Philip L.; Kaminsky, Stephen M.; Crystal, Ronald G.			Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy	HUMAN GENE THERAPY			English	Article						traumatic brain injury (TBI); tauopathy; AAV gene therapy; anti-pTau antibody; vector-mediated CNS delivery	BRAIN-INJURY; MOUSE MODEL; ADENOASSOCIATED VIRUS; IN-VIVO; INHIBITION; ANTIBODIES; PATHOLOGY; DISEASE; MICE; HYPERPHOSPHORYLATION	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder caused by repetitive trauma to the central nervous system (CNS) suffered by soldiers, contact sport athletes, and civilians following accident-related trauma. CTE is a CNS tauopathy, with trauma-induced inflammation leading to accumulation of hyperphosphorylated forms of the microtubule-binding protein Tau (pTau), resulting in neurofibrillary tangles and progressive loss of neurons. At present, there are no therapies to treat CTE. We hypothesized that direct CNS administration of an adeno-associated virus (AAV) vector coding for an anti-pTau antibody would generate sufficient levels of anti-pTau in the CNS to suppress pTau accumulation thus interrupting the pathogenic process. Using a serotype AAVrh.10 gene transfer vector coding for a monoclonal antibody directed against pTau, we demonstrate the feasibility of this strategy in a murine CTE model in which pTau accumulation was elicited by repeated traumatic brain injury (TBI) using a closed cortical impact procedure over 5 days. Direct delivery of AAVrh.10 expression vectors coding for either of the two different anti-pTau antibodies to the hippocampus of these TBI mice significantly reduced pTau levels across the CNS. Using doses that can be safely scaled to humans, the data demonstrate that CNS administration of AAVrh.10anti-pTau is effective, providing a new strategy to interrupt the CTE consequences of TBI.	[Sacramento, Chester Bittencourt; Sondhi, Dolan; Rosenberg, Jonathan B.; Chen, Alvin; Giordano, Stephanie; Pey, Eduard; Lee, Vladlena; Stiles, Katie M.; Havlicek, David F.; Leopold, Philip L.; Kaminsky, Stephen M.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Genet Med, 1300 York Ave,Box 164, New York, NY 10065 USA		Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Genet Med, 1300 York Ave,Box 164, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Stiles, Katie M/ABG-7505-2021	Stiles, Katie/0000-0001-9082-1002			Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Agadjanyan MG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0172-1; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Allen B, 2002, J NEUROSCI, V22, P9340; Anand K, 2015, EXPERT OPIN INV DRUG, V24, P1355, DOI 10.1517/13543784.2015.1075002; Banks SJ, 2017, NEUROGERIATRICS CLIN; Barr W. B., 2019, HDB NEUROPSYCHOLOGY, P727, DOI 10.1007/978-3-319-93497-6_43; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Brody DL, 2018, ANN INTERN MED, V168, P285, DOI 10.7326/M17-2707; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; De BP, 2018, HUM GENE THER METHOD, V29, P146, DOI 10.1089/hgtb.2017.246; De BP, 2006, MOL THER, V13, P67, DOI 10.1016/j.ymthe.2005.09.003; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Deverman BE, 2018, NAT REV DRUG DISCOV, V17, P768, DOI 10.1038/nrd.2018.158; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Herskovits AZ, 2006, NEUROBIOL DIS, V23, P398, DOI 10.1016/j.nbd.2006.04.004; Ikonomovic MD, 2019, NEUROPHARMACOLOGY, V145, P160, DOI 10.1016/j.neuropharm.2018.06.021; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee SH, 2016, CELL REP, V16, P1690, DOI 10.1016/j.celrep.2016.06.099; Liu WC, 2016, J NEUROSCI, V36, P12425, DOI 10.1523/JNEUROSCI.2016-16.2016; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medina M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041160; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nagamatsu RN, 2019, TEXTILES, IDENTITY AND INNOVATION: DESIGN THE FUTURE, P9; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perea JR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00172; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; [Prevention CfDCa NCfIPaCDoUI Prevention], 2015, NCFIPACDOUI PREV; Rosenberg JB, 2018, HUM GENE THER CL DEV, V29, P24, DOI 10.1089/humc.2017.231; Rosenberg JB, 2014, HUM GENE THER CL DEV, V25, P164, DOI 10.1089/humc.2013.239; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sevin C, 2018, 14 ANN WORLD S WORLD, P129; Shahpasand K, 2018, HUM VACC IMMUNOTHER, V14, P277, DOI 10.1080/21645515.2017.1393594; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shively SB, 2017, MIL MED, V182, P1461, DOI 10.7205/MILMED-D-16-00239; Sigurdsson EM, 2018, J ALZHEIMERS DIS, V64, pS555, DOI 10.3233/JAD-179937; Sondhi D, 2012, HUM GENE THER METHOD, V23, P324, DOI 10.1089/hgtb.2012.120; Stoller KP, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0028-0; Tardieu M, 2017, LANCET NEUROL, V16, P712, DOI 10.1016/S1474-4422(17)30169-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thwaite R, 2015, GENE THER, V22, P196, DOI 10.1038/gt.2014.103; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yu YJ, 2013, NEUROTHERAPEUTICS, V10, P459, DOI 10.1007/s13311-013-0187-4; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	76	6	6	2	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	JAN 1	2020	31	1-2					57	69		10.1089/hum.2019.174			13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	KE4LW	WOS:000508529800009	31608704	Bronze			2022-02-06	
J	Seelig, J; Heller, RA; Hackler, J; Haubruck, P; Moghaddam, A; Biglari, B; Schomburg, L				Seelig, Julian; Heller, Raban Arved; Hackler, Julian; Haubruck, Patrick; Moghaddam, Arash; Biglari, Bahram; Schomburg, Lutz			Selenium and copper status - potential signposts for neurological remission after traumatic spinal cord injury	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Trace element; Traumatic spinal cord injury; Neurological remission; Trauma; Selenium; Copper; Selenoprotein P; Ceruloplasmin	BRAIN-INJURY; TRACE-ELEMENTS; CELL-DEATH; SELENOPROTEINS; EXPRESSION; INFLAMMATION; DYSFUNCTION; FERROPTOSIS; METABOLISM; PREVENTION	Introduction: Traumatic Spinal Cord Injury (TSCI) is a severe incident resulting in loss of motor and sensory function caused by complex pathological mechanisms including massive oxidative stress and extensive inflammatory processes. The essential trace elements selenium (Se) and copper (Cu) play crucial roles as part of the antioxidant defense. Hypothesis: Remission after TSCI is associated with characteristic dynamics of early changes in serum Cu and Se status. Study design: Single-center prospective observational study. Patients and methods: Serum samples from TSCI patients were analyzed (n = 52); 21 recovered and showed a positive abbreviated injury score (AIS) conversion within 3 months (G1), whereas 21 had no remission (G0). Ten subjects with vertebral fractures without neurological impairment served as control (C). Different time points (at admission, and after 4, 9, 12, and 24 h) were analyzed for total serum Se and Cu concentrations by total reflection X-ray fluorescence, and for Selenoprotein P (SELENOP) and Ceruloplasmin (CP) by sandwich ELISA. Results: At admission, CP and SELENOP concentrations were higher in the remission group (G1) than in the non-remission group (G0). Within 24 h, there were marginal changes in Se, SELENOP, Cu and CP concentrations in the groups of controls (C) and G0. In contrast, these parameters decreased significantly in G1. Binary logistic regression analysis including Cu and Se levels at admission in combination with Se and CP levels after 24 h allowed a prediction for potential remission, with an area under the curve (AUC) of 87.7% (CI: 75.1%-100.0%). Conclusion: These data indicate a strong association between temporal changes of the Se and Cu status and the clinical outcome after TSCI. The dynamics observed may reflect an ongoing redistribution of the trace elements in favor of a better anti-inflammatory response and a more successful neurological regeneration.	[Seelig, Julian; Heller, Raban Arved; Hackler, Julian; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany; [Seelig, Julian; Heller, Raban Arved; Hackler, Julian; Schomburg, Lutz] Humboldt Univ, Freie Univ Berlin, Augustenburger Pl 1, D-13353 Berlin, Germany; [Seelig, Julian; Heller, Raban Arved; Hackler, Julian; Schomburg, Lutz] Berlin Inst Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany; [Heller, Raban Arved; Haubruck, Patrick] Heidelberg Univ Hosp, Heidelberg Trauma Res Grp, Dept Trauma & Reconstruct Surg, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Heidelberg, Germany; [Haubruck, Patrick] Univ Sydney, Raymond Purves Bone & Joint Res Labs, Kolling Inst Med Res, Inst Bone & Joint Res, St Leonards, NSW 2065, Australia; [Moghaddam, Arash] Hosp Aschaffenburg Alzenau, Aschaffenburg Trauma & Orthoped Res Grp, Ctr Orthoped Trauma Surg & Sports Med, Aschaffenburg, Germany; [Biglari, Bahram] BG Trauma Ctr Ludwigshafen, Dept Paraplegiol, Ludwigshafen, Germany		Schomburg, L (corresponding author), Charite Univ Med Berlin, Inst Expt Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.; Schomburg, L (corresponding author), Humboldt Univ, Freie Univ Berlin, Augustenburger Pl 1, D-13353 Berlin, Germany.; Schomburg, L (corresponding author), Berlin Inst Hlth, Augustenburger Pl 1, D-13353 Berlin, Germany.	Lutz.Schomburg@charite.de	Heller, Raban/P-4152-2019; Seelig, Julian/AAU-6678-2021	Heller, Raban/0000-0001-8006-9742; Schomburg, Lutz/0000-0001-9445-1555	Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge )German Research Foundation (DFG) [Scho 849/6-1]	We thank Katja Schreiber, Vartiter Seher and Gabriele Boehm for excellent technical assistance, and Dr. Waldemar B. Minich, Dr. Eddy Rijntjes and Dr. Kostja Renko for helpful advice. The research was funded by the Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge, Scho 849/6-1).	AlHuthaifi F, 2017, J SPINAL CORD MED, V40, P282, DOI 10.1080/10790268.2016.1238184; Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Avery JC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091203; Badhiwala JH, 2019, J NEUROSURG-SPINE, V30, P1, DOI 10.3171/2018.9.SPINE18682; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Benstoem C, 2015, NUTRIENTS, V7, P3094, DOI 10.3390/nu7053094; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Burk RF, 2014, FASEB J, V28, P3579, DOI 10.1096/fj.14-252874; Burns AS, 2017, GLOB SPINE J, V7, p175S, DOI 10.1177/2192568217703084; Che M., 2016, DRUG DISCOV TODAY, V21; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Chen XB, 2015, EUR REV MED PHARMACO, V19, P4434; Choo AMT, 2009, J NEUROSCI METH, V181, P6, DOI 10.1016/j.jneumeth.2009.04.007; Ellwanger JH, 2016, AN ACAD BRAS CIENC, V88, P1655, DOI 10.1590/0001-3765201620150595; Estevez AO, 2014, NEUROTOXICOLOGY, V41, P28, DOI 10.1016/j.neuro.2013.12.012; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Ferbert T, 2017, J NEUROTRAUM, V34, P607, DOI 10.1089/neu.2015.4294; Guengerich FP, 2018, J BIOL CHEM, V293, P4603, DOI 10.1074/jbc.TM118.002255; Hachem LD, 2017, J SPINAL CORD MED, V40, P665, DOI 10.1080/10790268.2017.1329076; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Heller RA, 2019, J TRACE ELEM MED BIO, V51, P141, DOI 10.1016/j.jtemb.2018.10.006; Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071; Hybsier S, 2017, REDOX BIOL, V11, P403, DOI 10.1016/j.redox.2016.12.025; Inesi G, 2017, IUBMB LIFE, V69, P211, DOI 10.1002/iub.1590; IYENGAR V, 1988, CLIN CHEM, V34, P474; Kaler SG, 2013, HAND CLINIC, V113, P1745, DOI 10.1016/B978-0-444-59565-2.00045-9; Khalili H, 2017, INJURY, V48, P1922, DOI 10.1016/j.injury.2017.07.005; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Kuhbacher M, 2009, J NEUROCHEM, V110, P133, DOI 10.1111/j.1471-4159.2009.06109.x; Kwon BK, 2015, EXP NEUROL, V269, P154, DOI 10.1016/j.expneurol.2015.04.008; Macklin RA, 2017, J NEUROTRAUM, V34, P1778, DOI 10.1089/neu.2016.4433; MITCHELL JD, 1986, J NEUROL NEUROSUR PS, V49, P211, DOI 10.1136/jnnp.49.2.211; Moghaddam A, 2017, SPINAL CORD, V55, P8, DOI 10.1038/sc.2016.104; Moghaddam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159764; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Montes S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/147251; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pillai R, 2014, IUBMB LIFE, V66, P229, DOI 10.1002/iub.1262; Pitts MW, 2014, BIOL TRACE ELEM RES, V161, P231, DOI 10.1007/s12011-014-0060-2; R.D.C. Team, 2015, R FOUND STAT COMPUT, V1; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Savaskan NE, 2007, FREE RADICAL BIO MED, V43, P191, DOI 10.1016/j.freeradbiomed.2007.03.033; Savic G, 2018, SPINAL CORD, V56, P2, DOI 10.1038/sc.2017.98; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schweizer U, 2011, CURR OPIN PEDIATR, V23, P429, DOI 10.1097/MOP.0b013e32834877da; Steinbrenner H, 2015, ADV NUTR, V6, P73, DOI 10.3945/an.114.007575; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; Venables WN., 2013, MODERN APPL STAT S P; Vinceti M, 2014, TOXICOL LETT, V230, P295, DOI 10.1016/j.toxlet.2013.11.016; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Y, 2018, J NEUROSCI RES, V96, P1265, DOI 10.1002/jnr.24221; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Yan J, 1998, J NEUROSCI, V18, P8682; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zohrabian VM, 2016, BRIT J NEUROSURG, V30, P204, DOI 10.3109/02688697.2015.1056089	62	6	6	1	2	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.	JAN	2020	57						124	133		10.1016/j.jtemb.2019.126415			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	LB1OP	WOS:000524405300018	31685353				2022-02-06	
J	Smith, KD; Chen, T; Gan, RZ				Smith, Kyle D.; Chen, Tao; Gan, Rong Z.			Hearing Damage Induced by Blast Overpressure at Mild TBI Level in a Chinchilla Model	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				TRAUMATIC BRAIN-INJURY; ACUTE OTITIS-MEDIA; AUDITORY-SYSTEM; MEMBRANE	Introduction The peripheral auditory system and various structures within the central auditory system are vulnerable to blast injuries, and even blast overpressure is at relatively mild traumatic brain injury (TBI) level. However, the extent of hearing loss in relation to blast number and time course of post-blast is not well understood. This study reports the progressive hearing damage measured in chinchillas after multiple blast exposures at mild TBI levels (103-138 kPa or 15-20 psi). Materials and Methods Sixteen animals (two controls) were exposed to two blasts and three blasts, respectively, in two groups with both ears plugged with foam earplugs to prevent the eardrum from rupturing. Auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) were measured in pre- and post-blasts. Immunohistochemical study of chinchilla brains were performed at the end of experiment. Results Results show that the ABR threshold and DPOAE level shifts in 2-blast animals were recovered after 7 days. In 3-blast animals, the ABR and DPOAE shifts remained at 26 and 23 dB, respectively after 14 days. Variation of auditory cortex damage between 2-blast and 3-blast was also observed in immunofluorescence images. Conclusions This study demonstrates that the number of blasts causing mild TBI critically affects hearing damage.	[Smith, Kyle D.; Chen, Tao; Gan, Rong Z.] Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave, Norman, OK 73019 USA		Smith, KD (corresponding author), Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave, Norman, OK 73019 USA.				U.S. Army Medical Research and Material Command (USAMRMC) Military Operational Medicine Research Program [W81XWH-14-1-0228]	This work was supported by U.S. Army Medical Research and Material Command (USAMRMC) Military Operational Medicine Research Program, Contract No. W81XWH-14-1-0228.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Chen T, 2019, HEARING RES, V378, P33, DOI 10.1016/j.heares.2019.01.010; Cho S., 2013, PLOS ONE, V8, P1, DOI DOI 10.1186/1556-276X-8-491; Daniel SJ, 2007, LARYNGOSCOPE, V117, P2201, DOI 10.1097/MLG.0b013e318148b275; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Engles WG, 2017, ANN BIOMED ENG, V45, P2383, DOI 10.1007/s10439-017-1870-0; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Guan XY, 2017, HEARING RES, V350, P22, DOI 10.1016/j.heares.2017.04.003; Guan XY, 2011, HEARING RES, V277, P96, DOI 10.1016/j.heares.2011.03.003; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Henry KS, 2011, HEARING RES, V280, P236, DOI 10.1016/j.heares.2011.06.002; Hickman T.T., 2018, SCI REP-UK, V8, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jiang SY, 2016, INT J PEDIATR OTORHI, V88, P74, DOI 10.1016/j.ijporl.2016.06.049; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Munjal SK, 2010, J NEUROTRAUM, V27, P309, DOI 10.1089/neu.2009.0957; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Saunders GH, 2009, NOISE HEALTH, V11, P14, DOI 10.4103/1463-1741.45308; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Wells TS, 2015, NOISE HEALTH, V17, P34, DOI 10.4103/1463-1741.149574; Yang JL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091861; Zhong ZW, 2014, HEARING RES, V309, P55, DOI 10.1016/j.heares.2013.11.006	27	6	6	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			248	255		10.1093/milmed/usz309			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600036	32074377	Bronze			2022-02-06	
J	Stovell, MG; Mada, MO; Carpenter, TA; Yan, JL; Guilfoyle, MR; Jalloh, I; Welsh, KE; Helmy, A; Howe, DJ; Grice, P; Mason, A; Giorgi-Coll, S; Gallagher, CN; Murphy, MP; Menon, DK; Hutchinson, PJ; Carpenter, KLH				Stovell, Matthew G.; Mada, Marius O.; Carpenter, T. Adrian; Yan, Jiun-Lin; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Welsh, Karen E.; Helmy, Adel; Howe, Duncan J.; Grice, Peter; Mason, Andrew; Giorgi-Coll, Susan; Gallagher, Clare N.; Murphy, Michael P.; Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.			Phosphorus spectroscopy in acute TBI demonstrates metabolic changes that relate to outcome in the presence of normal structural MRI	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article; Proceedings Paper	Journal-of-Cerebral-Blood-Flow-and-Metabolism (JCBFM) Symposium at International Symposium on Cerebral Blood Flow, Metabolism and Function (BRAIN)	JUL 07, 2019	Yokohama, JAPAN	Journal Cerebral Blood Flow & Metab		P-31 magnetic resonance spectroscopy; adenosine triphosphate; clinical outcome; pH; traumatic brain injury (human)	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; SEVERE HEAD-INJURY; ENERGY-METABOLISM; CEREBRAL-ISCHEMIA; INTRACELLULAR PH; CREATINE-KINASE; DYSFUNCTION; ASTROCYTES; DIFFUSION	Metabolic dysfunction is a key pathophysiological process in the acute phase of traumatic brain injury (TBI). Although changes in brain glucose metabolism and extracellular lactate/pyruvate ratio are well known, it was hitherto unknown whether these translate to downstream changes in ATP metabolism and intracellular pH. We have performed the first clinical voxel-based in vivo phosphorus magnetic resonance spectroscopy (P-31 MRS) in 13 acute-phase major TBI patients versus 10 healthy controls (HCs), at 3T, focusing on eight central 2.5 x 2.5 x 2.5 cm(3) voxels per subject. PCr/gamma ATP ratio (a measure of energy status) in TBI patients was significantly higher (median = 1.09) than that of HCs (median = 0.93) (p < 0.0001), due to changes in both PCr and ATP. There was no significant difference in PCr/gamma ATP between TBI patients with favourable and unfavourable outcome. Cerebral intracellular pH of TBI patients was significantly higher (median = 7.04) than that of HCs (median = 7.00) (p = 0.04). Alkalosis was limited to patients with unfavourable outcome (median = 7.07) (p < 0.0001). These changes persisted after excluding voxels with > 5% radiologically visible injury. This is the first clinical demonstration of brain alkalosis and elevated PCr/gamma ATP ratio acutely after major TBI. P-31 MRS has potential for non-invasively assessing brain injury in the absence of structural injury, predicting outcome and monitoring therapy response.	[Stovell, Matthew G.; Yan, Jiun-Lin; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Helmy, Adel; Giorgi-Coll, Susan; Gallagher, Clare N.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Mada, Marius O.; Carpenter, T. Adrian; Welsh, Karen E.; Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Yan, Jiun-Lin] Chang Gung Univ, Keelung Chang Gung Mem Hosp, Dept Neurosurg, Coll Med, Taoyuan, Taiwan; [Howe, Duncan J.; Grice, Peter; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge, England; [Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England		Stovell, MG; Carpenter, KLH (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	mgs48@cam.ac.uk; klc1000@wbic.cam.ac.uk	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Stovell, Matthew/0000-0002-4172-4617; Hutchinson, Peter/0000-0002-2796-1835	CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline; Department of HealthEuropean Commission [HTA/13/15/02, NIHR-RP-R3-12-013] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0600986, MR/N025792/1, G0802251, MC_UU_00015/3, MC_U105663142, MC_PC_17156] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [110159/Z/15/Z, 110158/Z/15/Z] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251, G1002277, MC_PC_17156, MR/N025792/1, MC_UU_00015/3, G0600986, MC_U105663142] Funding Source: UKRI		Alves PM, 2000, NMR BIOMED, V13, P438, DOI 10.1002/nbm.665; Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226; Berg J.M, 2002, BIOCHEMISTRY-US; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1989, J NEUROSCI, V9, P2011; Chiche J, 2012, INT J CANCER, V130, P1511, DOI 10.1002/ijc.26125; CHOPP M, 1990, J CEREBR BLOOD F MET, V10, P860, DOI 10.1038/jcbfm.1990.142; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; de Graaf RA, 2007, VIVO NMR SPECTROSCOP; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; ELEFF SM, 1990, ANN NEUROL, V27, P626, DOI 10.1002/ana.410270607; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 2007, J CEREBR BLOOD F MET, V27, P646, DOI 10.1038/sj.jcbfm.9600383; Gabr RE, 2011, AM J PHYSIOL-CELL PH, V301, pC234, DOI 10.1152/ajpcell.00500.2010; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hattori N, 2003, J NUCL MED, V44, P1709; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hertz L, 2015, METAB BRAIN DIS, V30, P317, DOI 10.1007/s11011-014-9536-1; Hetherington HP, 2001, MAGNET RESON MED, V45, P46, DOI 10.1002/1522-2594(200101)45:1<46::AID-MRM1008>3.0.CO;2-N; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; LEVINE SR, 1992, RADIOLOGY, V185, P537, DOI 10.1148/radiology.185.2.1410369; Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1; Lodish H., 2000, MOL CELL BIOL; LOIKE JD, 1984, J EXP MED, V159, P746, DOI 10.1084/jem.159.3.746; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MADSHUS IH, 1988, BIOCHEM J, V250, P1, DOI 10.1042/bj2500001; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Mason GF, 1998, MAGN RESON MED, V39, P346, DOI 10.1002/mrm.1910390303; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Nicholson C, 2011, COMPUT VIS SCI, V14, P309, DOI 10.1007/s00791-012-0185-9; Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686; NILSSON L, 1974, J NEUROCHEM, V23, P29, DOI 10.1111/j.1471-4159.1974.tb06912.x; NILSSON L, 1970, ACTA PHYSIOL SCAND, V80, P235, DOI 10.1111/j.1748-1716.1970.tb04787.x; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PETROFF OAC, 1984, ANN NEUROL, V16, P169, DOI 10.1002/ana.410160203; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; PRICHARD JW, 1983, P NATL ACAD SCI-BIOL, V80, P2748, DOI 10.1073/pnas.80.9.2748; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; Ren JM, 2015, NMR BIOMED, V28, P1455, DOI 10.1002/nbm.3384; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; SAUTER A, 1993, J BIOL CHEM, V268, P13166; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schneider GH, 1998, ACT NEUR S, V71, P62; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Sonnay S, 2017, J NEUROSCI RES, V95, P2297, DOI 10.1002/jnr.24032; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stovell MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29255-3; STUBBS M, 1984, BIOCHEM J, V224, P241, DOI 10.1042/bj2240241; SWAIN JA, 1991, ANN THORAC SURG, V51, P105, DOI 10.1016/0003-4975(91)90460-8; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; TAKAMI H, 1988, J BIOCHEM, V104, P35, DOI 10.1093/oxfordjournals.jbchem.a122417; Theparambil SM, 2016, J BIOL CHEM, V291, P19108, DOI 10.1074/jbc.M116.730143; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Weigand MA, 1999, ANESTHESIOLOGY, V91, P414, DOI 10.1097/00000542-199908000-00015; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wood ET, 2012, J NEUROSCI, V32, P6665, DOI 10.1523/JNEUROSCI.0044-12.2012; Zollner JP, 2015, STROKE, V46, P441, DOI 10.1161/STROKEAHA.114.007896; zur Nedden S, 2012, ADENOSINE, P109; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	92	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2020	40	1					67	84		10.1177/0271678X18799176			18	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	JX2IE	WOS:000503564000007	30226401	Green Published, hybrid			2022-02-06	
J	Sugiyama, K; Fujita, H; Nishimura, S				Sugiyama, Kazuhiro; Fujita, Hiroshi; Nishimura, Shigeko			Effects of in-house cryoprecipitate on transfusion usage and mortality in patients with multiple trauma with severe traumatic brain injury: a retrospective cohort study	BLOOD TRANSFUSION			English	Article						multiple trauma; resuscitation; mortality; hypofibrinogenaemia	FIBRINOGEN SUPPLEMENTATION; REPLACEMENT THERAPY; HEMORRHAGE; PLASMA; OUTCOMES	Background - Hypofibrinogenaemia is a common complication of multiple trauma with severe traumatic brain injury (Abbreviated Injury Scale score of the head >= 4; body >= 3). In Japan, neither fibrinogen concentrate nor cryoprecipitate is permitted to treat acquired hypofibrinogenaemia with the purpose of rapidly restoring a haemostatic level of fibrinogen. The aim of this study was to investigate transfusion usage and mortality in patients with multiple trauma and severe traumatic brain injury who were given a cryoprecipitate prepared in-house, comparing those administered the product early or later. Material and methods - We prepared and produced cryoprecipitate from fresh-frozen plasma beginning in March 2013. We performed a retrospective cohort study of patients admitted to our single tertiary medical centre with severe multiple trauma with traumatic brain injury from March 2013 to June 2018, sorting them into those given the cryoprecipitate infusion within 90 minutes of admission (Early group) and those given it more than 90 minutes after admission (Late group). Clinical outcomes were compared between the two groups using chi-square or Fisher's exact tests and the Wilcoxon test as appropriate. Results - There were 26 and 16 patients in the Early and Late groups, respectively. The 24-hour mortality tended to be lower in the Early group than in the Late group (8 vs 13%, respectively). The patients were more severely anaemic and thrombocytopenic after haemostatic therapy in the Late group than in the Early group. Transfusion usage in the Early group was lower than that in the Late group (red blood cells: 7 +/- 1 units vs 17 +/- 3 units, p<0.05; fresh-frozen plasma: 9 +/- 1 units vs 16 +/- 3 units, p<0.05; platelet concentrate: 3 +/- 1 units vs 15 +/- 4 units, p<0.05, respectively). Discussion - Early administration of an in-house cryoprecipitate may reduce transfusion usage in patients with multiple trauma with severe traumatic brain injury.	[Sugiyama, Kazuhiro] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan; [Fujita, Hiroshi; Nishimura, Shigeko] Tokyo Metropolitan Bokutoh Hosp, Dept Transfus Med, Tokyo, Japan		Fujita, H (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Transfus Med, Tokyo, Japan.	hiroshi_fujita@tmhp.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064			Banerjee A, 2018, J TRAUMA ACUTE CARE, V84, P929, DOI 10.1097/TA.0000000000001878; Callum JL, 2009, TRANSFUS MED REV, V23, P177, DOI 10.1016/j.tmrv.2009.03.001; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Collins PW, 2014, BRIT J ANAESTH, V113, P585, DOI 10.1093/bja/aeu086; Curry N, 2015, BRIT J ANAESTH, V115, P76, DOI 10.1093/bja/aev134; Curry N, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2086-x; Cushing MM, 2017, TRANSFUSION, V57, P2502, DOI 10.1111/trf.14259; Freedman M, 2010, TRANSFUS APHER SCI, V43, P179, DOI 10.1016/j.transci.2010.07.004; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Inokuchi K, 2017, ACUTE MED SURG, V4, P271, DOI 10.1002/ams2.268; Kahn S, 2015, INTENS CARE MED, V41, P239; Ketchum L, 2006, J TRAUMA, V60, pS51, DOI 10.1097/01.ta.0000199432.88847.0c; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levy JH, 2015, BLOOD, V125, P1387, DOI 10.1182/blood-2014-08-552000; McQuilten ZK, 2017, BRIT J HAEMATOL, V179, P131, DOI 10.1111/bjh.14804; Mori, 2016, JAPANESE J TRANSF CE, V62, P664; Nascimento B, 2014, BRIT J ANAESTH, V113, P922, DOI 10.1093/bja/aeu158; Nascimento B, 2011, TRANSFUSION MED, V21, P394, DOI 10.1111/j.1365-3148.2011.01098.x; Nishimura S., 2017, JPN J TRANSF CELL TH, V63, P23; Pantanowitz L, 2003, AM J CLIN PATHOL, V119, P874, DOI 10.1309/56MQVQAQG8YU90X9; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052; Takayama W, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2022-0; Winearls J, 2017, INJURY, V48, P230, DOI 10.1016/j.injury.2016.12.012	28	6	6	0	0	SIMTIPRO SRL	MILAN	VIA DESIDERIO 21, MILAN, 20131, ITALY	1723-2007			BLOOD TRANSFUS-ITALY	Blood Transf.	JAN-FEB	2020	18	1					6	12		10.2450/2019.0198-18			7	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	KS0VG	WOS:000518029300003	30747700				2022-02-06	
J	Wang, H; Zhou, XM; Xu, WD; Tao, T; Liu, GJ; Gao, YY; Lu, Y; Wu, LY; Yu, Z; Yuan, B; Hang, CH; Li, W				Wang, Han; Zhou, Xiao-Ming; Xu, Wei-Dong; Tao, Tao; Liu, Guang-Jie; Gao, Yong-Yue; Lu, Yue; Wu, Ling-Yun; Yu, Zhu; Yuan, Bin; Hang, Chun-Hua; Li, Wei			Inhibition of Elevated Hippocampal CD24 Reduces Neurogenesis in Mice With Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						CD24; Traumatic brain injury; SHP-2; Neurogenesis; Cognitive function	NEURONAL REGENERATION; MOLECULE L1; EXPRESSION; CELLS; DIFFERENTIATION; PROLIFERATION; ANTIGEN; RODENT; GROWTH; SHP2	In the adult rodents' brain, CD24 expression is restricted to immature neurons located in the neurogenesis areas. Our previous studies have confirmed that CD24 expression could be markedly elevated in the cerebral cortex after traumatic brain injury (TBI) both in humans and in mice. Although there is a close relationship between CD24 and neurogenesis, it remains unknown about the specific role of CD24 in neurogenesis areas after TBI. Here, the expression of CD24 was detected in the ipsilateral hippocampus by the Western blotting and real-time quantitative polymerase chain reaction. RNA interference was applied to investigate the effects of CD24 on post-traumatic neurogenesis. Brain sections were labeled with CD24 and doublecortin (DCX) via immunofluorescence. The Morris water maze test was used to assess cognitive functions. The results indicated that both mRNA and protein levels of CD24 were markedly elevated in the hippocampus after TBI. Meanwhile, TBI could cause a decrease of DCX-positive cells in the dentate gyrus of the hippocampus. Downregulation of CD24 significantly inhibited the phosphorylation of Src homology region 2-containing protein tyrosine phosphatase 2 in the ipsilateral hippocampus. Meanwhile, inhibition of CD24 could reduce the number of DCX-positive cells in the dentate gyrus area and impair cognitive functions of the TBI mice. These data suggested that hippocampal expression of CD24 might positively regulate neurogenesis and improve cognitive functions after TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Wang, Han; Liu, Guang-Jie; Gao, Yong-Yue; Lu, Yue; Wu, Ling-Yun; Hang, Chun-Hua; Li, Wei] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Han; Xu, Wei-Dong] Southern Med Univ Guangzhou, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhou, Xiao-Ming] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tao, Tao; Yuan, Bin] Nanjing Med Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Yu, Zhu] Xuancheng Renjie Hosp, Dept Neurosurg, Xuancheng, Anhui, Peoples R China		Hang, CH; Li, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	hang_neurosurgery@163.com; lwxzlw@126.com	Li, Wei/ABE-4301-2021	LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401029, 81870922, 81771291]; Medical Science and technology development Foundation, Nanjing Department of Health [JQX18001]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [021414380361]	This work was supported by grants from National Natural Science Foundation of China (No. 81401029 for W.L., No. 81870922 for W.L., No. 81771291 for C.-H.H.), Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (No. JQX18001 for W.L.) and Fundamental Research Funds for the Central Universities (No. 021414380361 for W.L.).	Ahmed MAH, 2010, INFLAMM BOWEL DIS, V16, P795, DOI 10.1002/ibd.21134; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Chazal G, 2000, J NEUROSCI, V20, P1446; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gilliam DT, 2017, NEUROBIOL DIS, V99, P133, DOI 10.1016/j.nbd.2016.12.011; Huang SX, 2018, NEUROCHEM RES, V43, P1814, DOI 10.1007/s11064-018-2597-5; Jankovski A, 1996, J COMP NEUROL, V371, P376; KADMON G, 1995, EUR J NEUROSCI, V7, P993, DOI 10.1111/j.1460-9568.1995.tb01087.x; Kan C, 2018, STEM CELLS INT, V2018, P1; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Li N, 2018, CELL MOL IMMUNOL, V15, P79, DOI 10.1038/cmi.2017.47; Li SM, 2016, MOL BIOL+, V50, P22, DOI [10.1134/S0026893316010118, 10.7868/S0026898416010110]; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Nestl A, 2001, CANCER RES, V61, P1569; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Yoneyama M, 2014, J PHARMACOL SCI, V124, P99, DOI 10.1254/jphs.13201FP; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	34	6	6	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2020	245						321	329		10.1016/j.jss.2019.07.082			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JT4CK	WOS:000500939000042	31421380				2022-02-06	
J	Zhang, B; Zhu, XL; Wang, L; Hou, ZG; Hao, SY; Yang, MS; Gao, F; Liu, BY				Zhang, Bin; Zhu, Xueli; Wang, Liang; Hou, Zonggang; Hao, Shuyu; Yang, Mengshi; Gao, Fei; Liu, Baiyun			Inadequate Expression and Activation of Mineralocorticoid Receptor Aggravates Spatial Memory Impairment after Traumatic Brain Injury	NEUROSCIENCE			English	Article						Traumatic brain injury; Fludrocortisone; Mineralocorticoid receptor; Apoptosis	CONTROLLED CORTICAL IMPACT; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; STRESS; GLUCOCORTICOIDS; DEFICIENCY; CARE	The administration of glucocorticoids (GCs) for the treatment of traumatic brain injury (TBI) is controversial. Both protective and deleterious effects of GCs on the brain have been reported in previous studies, while the mechanisms are unclear. Most experimental studies have reported glucocorticoid receptor (GR)-mediated deleterious effects after TBI. Sufficient mineralocorticoid receptor (MR) activation was reported to be indispensable for normal function and survival of hippocampal neurons, but changes in MR expression and activation and the roles of MRs in the survival of neurons after TBI remain unclear. We hypothesized that inadequate MR expression and activation caused by TBI aggravates posttraumatic hippocampal apoptosis but that restoration by restoring MRs promotes the survival of neurons. Using a rat controlled cortical impact model, we examined plasma corticosterone, MR expression and activation, neuronal apoptosis in the hippocampus, and spatial memory on day 3 after injury with and without fludrocortisone (1 mg/kg) treatment. Plasma corticosterone levels were significantly reduced after TBI. In addition, both MR expression and activation were inhibited. Fludrocortisone treatment significantly increased both the expression and activation of MRs, reduced the number of apoptotic neurons and cell loss in the ipsilateral hippocampus, and subsequently improved spatial memory. Its protective effects were counteracted by the MR antagonist spironolactone. The results suggest that adequate expression and activation of MRs is crucial for the survival of neurons after TBI and that fludrocortisone protects hippocampal neurons via promoting MR expression and activation. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhang, Bin; Hou, Zonggang; Hao, Shuyu; Yang, Mengshi; Gao, Fei; Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 Nan Si Huan W Rd, Beijing 100070, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Liang] Tianjin Fifth Ctr Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhu, Xueli] Capital Med Univ, Beijing Tian Tan Hosp, Dept Ultrasound, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 Nan Si Huan W Rd, Beijing 100070, Peoples R China.	liubaiyun1212@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]	This work was supported by a research grant from the National Natural Science Foundation of China (No. 81771327). The authors would like to acknowledge the efforts of all the staff who contributed to this study.	Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; Beaton A, 2015, INT INDIG POLICY J, V6, DOI 10.18584/iipj.2015.6.3.1; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Bourke CH, 2012, HORM BEHAV, V62, P210, DOI 10.1016/j.yhbeh.2012.02.024; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Clark R, 2005, J NEUROCHEM, V74, P740; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Dalla C, 2005, NEUROSCIENCE, V135, P703, DOI 10.1016/j.neuroscience.2005.06.068; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; de Kloet ER, 2005, NEUROSCI BIOBEHAV R, V29, P271, DOI 10.1016/j.neubiorev.2004.10.008; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Edwards P, 2005, LANCET, V365, P1957; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gesmundo I, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00066; Gobiet W, 1976, INTRACRANIAL PRESSUR, P231; Gray JD, 2017, NAT REV ENDOCRINOL, V13, P661, DOI 10.1038/nrendo.2017.97; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Herman JP, 1998, J NEUROSCI, V18, P7462; Herman JP, 1999, ENDOCRINOLOGY, V140, P3981, DOI 10.1210/en.140.9.3981; Joels M, 2012, CELL CALCIUM, V51, P277, DOI 10.1016/j.ceca.2011.11.002; Kanatsou S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00132; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Munier M, 2012, ENDOCRINOLOGY, V153, P1330, DOI 10.1210/en.2011-1436; Qiu Guang, 2007, Neurosci Bull, V23, P131, DOI 10.1007/s12264-007-0019-9; Quinn M, 2014, ANN NY ACAD SCI, V1317, P1, DOI 10.1111/nyas.12425; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; SECKL JR, 1992, NEUROENDOCRINOLOGY, V55, P621, DOI 10.1159/000126180; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Sheline YI, 2019, BIOL PSYCHIAT, V85, P436, DOI 10.1016/j.biopsych.2019.01.011; Souza RR, 2014, NEUROPHARMACOLOGY, V79, P201, DOI 10.1016/j.neuropharm.2013.11.017; Sze C, 2013, MEDIAT INFLAMM, V2013, P1; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Yang S, 2013, J BIOL CHEM, V288, P25; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	53	6	6	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 1	2020	424						1	11		10.1016/j.neuroscience.2019.10.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JZ5OJ	WOS:000505150700001	31734415				2022-02-06	
J	Alosco, ML; Tripodis, Y; Koerte, IK; Jackson, JD; Chua, AS; Mariani, M; Haller, O; Foley, EM; Martin, BM; Palmisano, J; Singh, B; Green, K; Lepage, C; Muehlmann, M; Makris, N; Cantu, RC; Lin, AP; Coleman, M; Pasternak, O; Mez, J; Bouix, S; Shenton, ME; Stern, RA				Alosco, Michael L.; Tripodis, Yorghos; Koerte, Inga K.; Jackson, Jonathan D.; Chua, Alicia S.; Mariani, Megan; Haller, Olivia; Foley, Eimear M.; Martin, Brett M.; Palmisano, Joseph; Singh, Bhupinder; Green, Katie; Lepage, Christian; Muehlmann, Marc; Makris, Nikos; Cantu, Robert C.; Lin, Alexander P.; Coleman, Michael; Pasternak, Ofer; Mez, Jesse; Bouix, Sylvain; Shenton, Martha E.; Stern, Robert A.			Interactive Effects of Racial Identity and Repetitive Head Impacts on Cognitive Function, Structural MRI-Derived Volumetric Measures, and Cerebrospinal Fluid Tau and A beta	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						American football; biomarkers; chronic traumatic encephalopathy; cognitive function; concussion; magnetic resonance imaging; race; subconcussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL LEAGUE PLAYERS; PROFESSIONAL SOCCER PLAYERS; OLDER AFRICAN-AMERICANS; HIGH-SCHOOL FOOTBALL; ALZHEIMERS-DISEASE; 1ST EXPOSURE; LATER-LIFE; ASSOCIATION; DEMENTIA	Background Factors of increased prevalence among individuals with Black racial identity (e.g., cardiovascular disease, CVD) may influence the association between exposure to repetitive head impacts (RHI) from American football and later-life neurological outcomes. Here, we tested the interaction between racial identity and RHI on neurobehavioral outcomes, brain volumetric measures, and cerebrospinal fluid (CSF) total tau (t-tau), phosphorylated tau (p-tau(181)), and A beta(1)(-)(42) in symptomatic former National Football League (NFL) players. Methods 68 symptomatic male former NFL players (ages 40-69; n = 27 Black, n = 41 White) underwent neuropsychological testing, structural MRI, and lumbar puncture. FreeSurfer derived estimated intracranial volume (eICV), gray matter volume (GMV), white matter volume (WMV), subcortical GMV, hippocampal volume, and white matter (WM) hypointensities. Multivariate generalized linear models examined the main effects of racial identity and its interaction with a cumulative head impact index (CHII) on all outcomes. Age, years of education, Wide Range Achievement Test, Fourth Edition (WRAT-4) scores, CVD risk factors, and APOE epsilon 4 were included as covariates; eICV was included for MRI models. P-values were false discovery rate adjusted. Results Compared to White former NFL players, Black participants were 4 years younger (p = 0.04), had lower WRAT-4 scores (mean difference = 8.03, p = 0.002), and a higher BMI (mean difference = 3.09, p = 0.01) and systolic blood pressure (mean difference = 8.15, p = 0.03). With regards to group differences on the basis of racial identity, compared to White former NFL players, Black participants had lower GMV (mean adjusted difference = 45649.00, p = 0.001), lower right hippocampal volume (mean adjusted difference = 271.96, p = 0.02), and higher p-tau(181)/t-tau ratio (mean adjusted difference = -0.25, p = 0.01). There was not a statistically significant association between the CHII with GMV, right hippocampal volume, or p-tau(181)/t-tau ratio. However, there was a statistically significant Race x CHII interaction for GMV (b = 2206.29, p = 0.001), right hippocampal volume (b = 12.07, p = 0.04), and p-tau(181)/t-tau ratio concentrations (b = -0.01, p = 0.004). Conclusion Continued research on racial neurological disparities could provide insight into risk factors for long-term neurological disorders associated with American football play.	[Alosco, Michael L.; Tripodis, Yorghos; Mariani, Megan; Haller, Olivia; Foley, Eimear M.; Martin, Brett M.; Palmisano, Joseph; Cantu, Robert C.; Mez, Jesse; Stern, Robert A.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA; [Alosco, Michael L.; Tripodis, Yorghos; Mariani, Megan; Haller, Olivia; Foley, Eimear M.; Martin, Brett M.; Palmisano, Joseph; Cantu, Robert C.; Mez, Jesse; Stern, Robert A.] Boston Univ, CTE Ctr, Sch Med, Boston, MA 02215 USA; [Alosco, Michael L.; Mariani, Megan; Haller, Olivia; Cantu, Robert C.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Tripodis, Yorghos; Chua, Alicia S.; Singh, Bhupinder] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Koerte, Inga K.; Green, Katie; Lepage, Christian; Muehlmann, Marc; Makris, Nikos; Coleman, Michael; Pasternak, Ofer; Bouix, Sylvain; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, cBRAIN, Munich, Germany; [Jackson, Jonathan D.] Massachusetts Gen Hosp, CARE Res Ctr, Boston, MA 02114 USA; [Martin, Brett M.; Palmisano, Joseph] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA USA; [Muehlmann, Marc] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Makris, Nikos; Coleman, Michael; Pasternak, Ofer; Bouix, Sylvain; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Morphometr Anal, Boston, MA 02114 USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Neural Syst Invest, Boston, MA 02114 USA; [Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Dept Radiol, Boston, MA 02115 USA; [Shenton, Martha E.] US Dept Vet Affairs, VA Boston Healthcare Syst, Brockton, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Alosco, ML (corresponding author), Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA.; Alosco, ML (corresponding author), Boston Univ, CTE Ctr, Sch Med, Boston, MA 02215 USA.	malosco@bu.edu	Koerte, Inga Katharina/AAW-3031-2021; , Bob/ABA-8507-2020	Foley, Eimear M./0000-0002-3603-3774	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078337, U01NS093334, K23AG046377, K23NS102399, P30AG013846]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS102399] Funding Source: NIH RePORTER	This work was supported by grant funding from the NIH (R01NS078337; U01NS093334; K23AG046377; K23NS102399; P30AG013846).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Allison R, 2018, INT REV SOCIOL SPORT, V53, P615, DOI 10.1177/1012690216674936; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Baker JG, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000420; Barnes LL, 2014, HEALTH AFFAIR, V33, P580, DOI 10.1377/hlthaff.2013.1353; Barnes LL, 2012, CURR ALZHEIMER RES, V9, P734, DOI 10.2174/156720512801322627; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Brewster P, 2019, ALZHEIMERS DEMENT, V15, P995, DOI 10.1016/j.jalz.2018.07.221; Brickman AM, 2008, ARCH NEUROL-CHICAGO, V65, P1053, DOI 10.1001/archneur.65.8.1053; Byrd GS, 2011, J NATL MED ASSOC, V103, P480, DOI 10.1016/S0027-9684(15)30361-8; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cherry JD, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0619-9; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Deters KD, 2017, J ALZHEIMERS DIS, V58, P1245, DOI 10.3233/JAD-161114; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Filshtein TJ, 2019, J ALZHEIMERS DIS, V68, P145, DOI 10.3233/JAD-180992; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Graff-Radford NR, 2016, ALZHEIMERS DEMENT, V12, P669, DOI 10.1016/j.jalz.2016.03.004; Gross AL, 2015, PSYCHOL AGING, V30, P863, DOI 10.1037/pag0000032; Grossman M, 2014, JAMA NEUROL, V71, P442, DOI 10.1001/jamaneurol.2013.6064; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hill CV, 2015, ETHNIC DIS, V25, P245, DOI 10.18865/ed.25.3.245; Hohman TJ, 2016, ALZHEIMERS DEMENT, V12, P233, DOI 10.1016/j.jalz.2015.02.012; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Howard G, 2018, JAMA-J AM MED ASSOC, V320, P1338, DOI 10.1001/jama.2018.13467; Jackson CL, 2013, J OBES, V2013, DOI 10.1155/2013/140743; Jefferson AL, 2013, J ALZHEIMERS DIS, V36, P597, DOI 10.3233/JAD-130287; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lapchick R., 2017, 2017 RACIAL GENDER R 2017 RACIAL GENDER R; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Lincoln AE, 2018, MED SCI SPORT EXER, V50, P486, DOI 10.1249/MSS.0000000000001466; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Liu SY, 2015, J INT NEUROPSYCH SOC, V21, P677, DOI 10.1017/S1355617715000806; Logue MW, 2014, ALZHEIMERS DEMENT, V10, P609, DOI 10.1016/j.jalz.2014.06.010; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meeter LHH, 2018, NEUROLOGY, V90, pE1231, DOI 10.1212/WNL.0000000000005261; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2017, ALZHEIMERS DEMENT, V13, P119, DOI 10.1016/j.jalz.2016.09.002; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris AA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008250; Morris JC, 2019, JAMA NEUROL, V76, P264, DOI 10.1001/jamaneurol.2018.4249; NCAA (National Collegiate Athletics Association, 2018, NCAA DEM DAT; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Potter GG, 2009, ALZHEIMERS DEMENT, V5, P445, DOI 10.1016/j.jalz.2009.04.1234; Racine Annie M, 2016, Alzheimers Dement (Amst), V2, P27; Rajan KB, 2019, J AM GERIATR SOC, V67, P734, DOI 10.1111/jgs.15727; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Riudavets MA, 2006, J NEUROPATH EXP NEUR, V65, P1143, DOI 10.1097/01.jnen.0000248548.20799.a3; Rogers April J, 2017, J Sleep Disord Ther, V6, DOI 10.4172/2167-0277.1000278; Sabir MG, 2014, J AGING STUD, V29, P142, DOI 10.1016/j.jaging.2013.11.005; Samus QM, 2015, AM J GERIAT PSYCHIAT, V23, P698, DOI 10.1016/j.jagp.2015.01.005; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Sencakova D, 2001, ARCH NEUROL-CHICAGO, V58, P1593, DOI 10.1001/archneur.58.10.1593; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tosto G, 2015, ALZHEIMERS DEMENT, V11, P1510, DOI 10.1016/j.jalz.2015.05.014; Verney SP, 2019, INT J GERIATR PSYCH, V34, P563, DOI 10.1002/gps.5051; Waldstein SR, 2017, PSYCHOSOM MED, V79, P327, DOI 10.1097/PSY.0000000000000408; Weuve J, 2018, EPIDEMIOLOGY, V29, P151, DOI [10.1097/EDE.0000000000000747, 10.1097/ede.0000000000000747]; Wilkins CH, 2006, ARCH NEUROL-CHICAGO, V63, P87, DOI 10.1001/archneur.63.1.87; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Yu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180356; Yu L, 2017, NEUROLOGY, V88, P661, DOI 10.1212/WNL.0000000000003614; Zahodne LB, 2017, PSYCHOL AGING, V32, P118, DOI 10.1037/pag0000154; Zahodne LB, 2016, J AM GERIATR SOC, V64, P959, DOI 10.1111/jgs.14113; Zahodne LB, 2015, CURR ALZHEIMER RES, V12, P632, DOI 10.2174/1567205012666150530203214; Zivadinov R, 2018, J HEAD TRAUMA REHAB, V33, pE24, DOI 10.1097/HTR.0000000000000422	107	6	6	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 20	2019	13								440	10.3389/fnhum.2019.00440			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	KA0NG	WOS:000505497200001	31920598	Green Published, gold			2022-02-06	
J	Russell, NH; Black, RT; Lee, NN; Doperalski, AE; Reeves, TM; Phillips, LL				Russell, Nicholas H.; Black, Raiford T.; Lee, Nancy N.; Doperalski, Adele E.; Reeves, Thomas M.; Phillips, Linda L.			Time-dependent hemeoxygenase-1, lipocalin-2 and ferritin induction after non-contusion traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Hemoxygenase-1; Lipocalin 2; Ferritin; Metalloproteinase	GELATINASE-ASSOCIATED LIPOCALIN; FOCAL CEREBRAL-ISCHEMIA; HEME OXYGENASE-1 EXPRESSION; FLUID PERCUSSION INJURY; MATRIX METALLOPROTEINASES; BARRIER DISRUPTION; SPINAL-CORD; LESIONAL ACCUMULATION; VASCULAR INJURY; IRON	Traumatic brain injury (TBI) often presents with focal contusion and parenchymal bleeds, activating heme oxygenase (HO) to degrade released hemoglobin. Here we show that diffuse, midline fluid percussion injury causes time-dependent induction of HO-1 and iron binding proteins within both hemorrhagic neocortex and non-hemorrhagic hippocampus. Rats subjected to midline fluid percussion injury (FPI) survived 1-15d postinjury and tissue was collected for Western blot and immunohistochemical assays. HO-1 was elevated 1d after FPI, peaked at 3d, and returned to control baseline 7-15d. Iron management proteins lipocalin 2 (LCN2) and ferritin (FTL) exhibited distinct postinjury time courses, where peak LCN2 response preceded, and FTL followed that of HO-1. LCN2 elevation supported not only its role in iron transport, but also mediation of matrix metalloproteinase 9 (MMP9) activity. Upregulation of FTL for intracellular iron sequestration was delayed relative to both HO-1 and LCN2 induction. In the neocortex IBA-1+ microglia around the injury core expressed HO-1, but astrocytes co-localized with HO-1 in perilesional parenchyma. Non-hemorrhagic dentate gyrus showed predominant HO-1 labeling in hilar microglia and in molecular layer astrocytes. At 1d postinjury, LCN2 and HO-1 co-localized in a subpopulation of reactive glia within both brain regions. Notably, FTL was distributed within cells around injured vessels, damaged subcortical white matter, and along vessels of the hippocampal fissure. Together these results confirm that even the moderate, non-contusional insult of diffuse midline FPI can significantly activate postinjury HO-1 heme processing pathways and iron management proteins. Moreover, this activation is time-dependent and occurs in the absence of overt hemorrhage.	[Russell, Nicholas H.; Black, Raiford T.; Lee, Nancy N.; Doperalski, Adele E.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Med Coll Virginia Campus, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	Linda.Phillips@vcuhealth.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 044372, NS 056247, NS 057758]; NIH-NCI Cancer Center Grant [P30 CA016059]	This work was supported by the National Institutes of Health (grants NS 044372, NS 056247, NS 057758). The authors also wish to thank Frances White for guidance on confocal imaging. Microscopy was performed at the VCU Microscopy Facility, supported, in part, by funding from NIH-NCI Cancer Center Grant P30 CA016059.	Ahuja M, 2016, J NEUROSCI, V36, P6332, DOI 10.1523/JNEUROSCI.0426-16.2016; Alfieri A, 2013, FREE RADICAL BIO MED, V65, P1012, DOI 10.1016/j.freeradbiomed.2013.08.190; Angelova DM, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030067; Antonopoulos CN, 2016, CURR PHARM DESIGN, V22, P680, DOI 10.2174/1381612822666151204000458; Aoyama T, 2017, LAB INVEST, V97, P890, DOI 10.1038/labinvest.2017.44; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bouchet S, 2014, CANCERS, V6, P796, DOI 10.3390/cancers6020796; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Castellani Rudy J, 2016, Open Neurol J, V10, P136; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen-Roetling J, 2017, CURR PHARM DESIGN, V23, P2226, DOI 10.2174/1381612822666161027150616; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cousar JL, 2006, DEV NEUROSCI-BASEL, V28, P342, DOI 10.1159/000094160; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; Flower DR, 1996, BIOCHEM J, V318, P1; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Maass NF, 2012, ATENEA-CONCEPC, P187; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Iorio-Morin C, 2018, J NEUROTRAUM, V35, P1882, DOI 10.1089/neu.2018.5872; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kelly-Cobbs AI, 2013, AM J PHYSIOL-HEART C, V304, pH806, DOI 10.1152/ajpheart.00720.2012; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kobata H, 2017, NEUROL MED-CHIR, V57, P410, DOI 10.2176/nmc.oa.2017-0056; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Lee S, 2015, CRIT REV IMMUNOL, V35, P77, DOI 10.1615/CritRevImmunol.2015012127; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Li N, 2013, J NEPHROL, V26, P1083, DOI 10.5301/jn.5000282; Lin WS, 2017, HEART, V103, P1286, DOI 10.1136/heartjnl-2016-310451; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Linder MC, 2013, NUTRIENTS, V5, P4022, DOI 10.3390/nu5104022; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu YQ, 2013, NEUROREPORT, V24, P281, DOI 10.1097/WNR.0b013e32835f2810; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Lu XP, 2014, NEUROBIOL DIS, V70, P245, DOI 10.1016/j.nbd.2014.06.005; Mautes AEM, 2000, BRAIN RES, V883, P233, DOI 10.1016/S0006-8993(00)02846-8; McCarthy RC, 2018, J BIOL CHEM, V293, P7853, DOI 10.1074/jbc.RA118.001949; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Nairz M, 2017, PFLUG ARCH EUR J PHY, V469, P397, DOI 10.1007/s00424-017-1944-8; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ni W, 2015, J CEREBR BLOOD F MET, V35, P1454, DOI 10.1038/jcbfm.2015.52; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nitti M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082260; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Orihara Yoshiyuki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS278; OSHAUGHNESSY MC, 1966, J CLIN PATHOL, V19, P364, DOI 10.1136/jcp.19.4.364; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Peres CMA, 2018, J NEUROSURG, V128, P1044, DOI 10.3171/2016.11.JNS161398; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Powell MA, 2018, NEUROSCIENCE, V371, P106, DOI 10.1016/j.neuroscience.2017.11.045; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Ren JW, 2011, NEUROCHEM RES, V36, P2352, DOI 10.1007/s11064-011-0561-8; Richmon JD, 1998, BRAIN RES, V780, P108, DOI 10.1016/S0006-8993(97)01314-0; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sakoda E, 2008, NEUROSCI LETT, V440, P160, DOI 10.1016/j.neulet.2008.04.082; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Saw CLL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-39; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Seo JH, 2012, CURR PHARM DESIGN, V18, P3645; Shi BZ, 2012, ACTA NEUROCHIR, V154, P1081, DOI 10.1007/s00701-012-1335-z; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; STRASSMANN G, 1949, ARCH PATHOL, V47, P205; Suchdev PS, 2017, AM J CLIN NUTR, V106, p1626S, DOI 10.3945/ajcn.117.155937; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; Wang L., 2017, BIOSCIENCE REP, V6, P37; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Weinzierl M, 2003, NEUROSCI LETT, V336, P13, DOI 10.1016/S0304-3940(02)01233-8; Winter WE, 2014, LABMEDICINE, V45, P92, DOI 10.1309/LMF28S2GIMXNWHMM; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Wunder Christian, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P199; Xing CH, 2017, PROG NEUROBIOL, V152, P181, DOI 10.1016/j.pneurobio.2016.04.004; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Yamauchi T, 2004, J NEUROTRAUM, V21, P1017, DOI 10.1089/0897715041651042; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zhang B, 2013, MOL MED REP, V8, P681, DOI 10.3892/mmr.2013.1523; Zhang MJ, 2014, J NEUROSCI, V34, P1903, DOI 10.1523/JNEUROSCI.4043-13.2014; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao JB, 2016, J NEUROL SCI, V368, P392, DOI 10.1016/j.jns.2016.07.060; Zhao JB, 2016, ACTA NEUROCHIR SUPPL, V121, P291, DOI 10.1007/978-3-319-18497-5_50; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhou Y., 2019, INT J NEUROSCI, V16, P1	113	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 15	2019	1725								146466	10.1016/j.brainres.2019.146466			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JN9ZS	WOS:000497248100012	31539545	hybrid			2022-02-06	
J	Greig, NH; Lecca, D; Hsueh, SC; Nogueras-Ortiz, C; Kapogiannis, D; Tweedie, D; Glotfelty, EJ; Becker, RE; Chiang, YH; Hoffer, BJ				Greig, Nigel H.; Lecca, Daniela; Hsueh, Shih-Chang; Nogueras-Ortiz, Carlos; Kapogiannis, Dimitrios; Tweedie, David; Glotfelty, Elliot J.; Becker, Robert E.; Chiang, Yung-Hsiao; Hoffer, Barry J.			(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						neurodegeneration; neuroinflammation; phenserine; preprogrammed neuronal cell death; traumatic brain injury	LONG-TERM POTENTIATION; ANIMAL-MODELS; COGNITIVE DEFICITS; PIFITHRIN-ALPHA; PHENSERINE; DEMENTIA; RISK; IMPACT; EPIDEMIOLOGY; TRANSLATION	Aim Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality of both young adults and the elderly, and is a key contributing factor in about 30% of all injury-associated deaths occurring within the United States of America. Albeit substantial impact has been made to improve our comprehension of the mechanisms that underpin the primary and secondary injury stages initiated by a TBI incident, this knowledge has yet to successfully translate into the development of an effective TBI pharmacological treatment. Developing consent suggests that a TBI can concomitantly trigger multiple TBI-linked cascades that then progress in parallel and, if correct, the multifactorial nature of TBI would make the discovery of a single effective mechanism-targeted drug unlikely. Discussion We review recent data indicating that the small molecular weight drug (-)-phenserine tartrate (PhenT), originally developed for Alzheimer's disease (AD), effectively inhibits a broad range of mechanisms pertinent to mild (m) and moderate (mod)TBI, which in combination underpin the ensuing cognitive and motor impairments. In cellular and animal models at clinically translatable doses, PhenT mitigated mTBI- and modTBI-induced programmed neuronal cell death (PNCD), oxidative stress, glutamate excitotoxicity, neuroinflammation, and effectively reversed injury-induced gene pathways leading to chronic neurodegeneration. In addition to proving efficacious in well-characterized animal TBI models, significantly mitigating cognitive and motor impairments, the drug also has demonstrated neuroprotective actions against ischemic stroke and the organophosphorus nerve agent and chemical weapon, soman. Conclusion In the light of its tolerability in AD clinical trials, PhenT is an agent that can be fast-tracked for evaluation in not only civilian TBI, but also as a potentially protective agent in battlefield conditions where TBI and chemical weapon exposure are increasingly jointly occurring.	[Greig, Nigel H.; Lecca, Daniela; Hsueh, Shih-Chang; Tweedie, David; Glotfelty, Elliot J.; Becker, Robert E.] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Hsueh, Shih-Chang; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Nogueras-Ortiz, Carlos; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Glotfelty, Elliot J.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Becker, Robert E.] Aristea Translat Med Corp, Park City, UT USA; [Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurosurg, Sch Med, Cleveland, OH 44106 USA		Greig, NH (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.; Hoffer, BJ (corresponding author), Case Western Reserve Univ, Dept Neurosurg, Sch Med, Cleveland, OH 44106 USA.	Greign@grc.nia.nih.gov; bjh82@case.edu	Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Greig, Nigel/0000-0002-3032-1468; Glotfelty, Elliot/0000-0001-5125-8720	Intramural Research Program, National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG000333]; Ministry of Science and Technology TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3, MOST108-2321-B-038-008]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56 AG057028]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	Intramural Research Program, National Institute on Aging, NIH, Grant/Award Number: AG000333; Ministry of Science and Technology Taiwan, Grant/Award Number: MOST104-2923-B-038-001-MY3 and MOST108-2321-B-038-008; National Institutes of Health, Grant/Award Number: R56 AG057028	Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; Becker RE, 2018, CURR ALZHEIMER RES, V15, P883, DOI 10.2174/1567205015666180110120026; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Borlongan CV, 1995, RESTOR NEUROL NEUROS, V9, P15, DOI 10.3233/RNN-1995-9103; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Defense and Veterans Brain Injury Centre (DVBIC), DOD NUMB TRAUM BRAIN; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2017, J GERONTOL A-BIOL, V72, P1233, DOI 10.1093/gerona/glw341; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goetzl EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00452; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P275; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Hsueh SC, 2019, CELL TRANSPLANT, V28, P1183, DOI 10.1177/0963689719854693; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Klein J, 2007, EXPERT OPIN INV DRUG, V16, P1087, DOI 10.1517/13543784.16.7.1087; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lecca D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104528; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mikkilineni S, 2012, PARKINSONS DIS, V2012, P5; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Nordberg A, 2015, J ALZHEIMERS DIS, V47, P691, DOI 10.3233/JAD-132474; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Pulliam L, 2019, J NEUROVIROL, V25, P702, DOI 10.1007/s13365-018-0695-4; Radomski MV, 2018, MIL MED, V183, pE214, DOI 10.1093/milmed/usx045; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reale M, 2014, CURR ALZHEIMER RES, V11, P608, DOI 10.2174/1567205010666131212113218; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Vespa PM, 2016, JAMA NEUROL, V73, P504, DOI 10.1001/jamaneurol.2016.0251; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang J, 2016, VIROL J, V13, P1, DOI [10.1186/s12985-015-0456-4, DOI 10.1186/S12985-015-0456-4]; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2020	26	6			SI		636	649		10.1111/cns.13274		DEC 2019	14	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy	LQ8CX	WOS:000501998700001	31828969	Green Published, gold			2022-02-06	
J	Wan, GH; Wang, LL; Zhang, GH; Zhang, J; Lu, YL; Li, J; Yi, XH				Wan, Guohua; Wang, Linlin; Zhang, Guanhong; Zhang, Jian; Lu, Yanli; Li, Jun; Yi, Xinhao			Effects of probiotics combined with early enteral nutrition on endothelin-1 and C-reactive protein levels and prognosis in patients with severe traumatic brain injury	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article; Early Access						Probiotic; enteral nutrition; inflammatory factor; severe traumatic brain injury; endothelin-1; C-reactive protein	OUTCOMES; MORTALITY; DEFICITS; DISEASES; THERAPY; SUPPORT	Objective To investigate the effects of probiotics combined with early enteral nutrition on levels of endothelin-1 (ET-1), C-reactive protein (CRP), and inflammatory factors, and on the prognosis of patients with severe traumatic brain injury (TBI). Methods We enrolled 76 adults with severe TBI. The patients were divided randomly into two equal groups administered enteral nutrition with and without probiotics, respectively. Demographic and clinical data including age, sex, Glasgow Coma Scale score, Sequential Organ Failure Score, Acute Physiology, Chronic Health Score, hospitalization, mortality, and infections were recorded. Results Serum levels of inflammatory factors gradually decreased with increasing treatment time in both groups. However, ET-1 at 15 days, and interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha, and CRP at 7 and 15 days decreased significantly more in the combined treatment group. Hospitalization duration and pulmonary infection rates were also significantly reduced in the combined compared with the enteral nutrition alone group. GCS scores at 15 days were significantly lower in the combined compared with the enteral nutrition group. Conclusion Probiotics combined with early enteral nutrition could reduce serum levels of ET-1, CRP, and IL-6, IL-10, and TNF-alpha, and could thus improve the recovery of patients with severe TBI.	[Wan, Guohua; Wang, Linlin; Lu, Yanli] Shengli Oilfield Cent Hosp, Dept Nutr, 31 Jinan Rd, Dongying 257034, Peoples R China; [Zhang, Guanhong] Shengli Oilfield Cent Hosp, Joint Surg, Dongying, Peoples R China; [Zhang, Jian] Shengli Oilfield Cent Hosp, Hepatobiliary Surg, Dongying, Peoples R China; [Li, Jun] Shengcai Hosp, Shengli Petr Adm, Sinopec Grp, Dept Surg, Dongying, Peoples R China; [Yi, Xinhao] Shengli Oilfield Cent Hosp, Sci Educ Sect, Dongying, Peoples R China		Lu, YL (corresponding author), Shengli Oilfield Cent Hosp, Dept Nutr, 31 Jinan Rd, Dongying 257034, Peoples R China.	xiaoy261@tom.com					American Society for P Enteral Nutrition Board of D., 2009, JPEN J PARENTER ENTE, V33, P255, DOI [10.1177/0148607109333115, DOI 10.1177/0148607109333115]; Bengmark S, 2001, CLIN NUTR, V20, P11, DOI 10.1054/clnu.2000.0111; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Chapple LAS, 2016, CLIN NUTR, V35, P1315, DOI 10.1016/j.clnu.2016.02.009; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Milajerdi A, 2019, EUR J NUTR, DOI [10.1007/ s00394-019-01931-8, DOI 10.1007/S00394-019-01931-8.[EPUB]; Rey C, 2013, CRIT CARE, V17, DOI 10.1186/cc13064; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Seron-Arbeloa C, 2011, CLIN NUTR, V30, P346, DOI 10.1016/j.clnu.2010.11.004; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Timmerman KL, 2015, EUR J APPL PHYSIOL, V115, P111, DOI 10.1007/s00421-014-2997-4; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	26	6	6	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.											0300060519888112	10.1177/0300060519888112		DEC 2019	9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	JT3OV	WOS:000500903600001	31802692	gold, Green Published			2022-02-06	
J	Khosroshahi, SF; Duckworth, H; Galvanetto, U; Ghajari, M				Khosroshahi, Siamak Farajzadeh; Duckworth, Harry; Galvanetto, Ugo; Ghajari, Mazdak			The effects of topology and relative density of lattice liners on traumatic brain injury mitigation	JOURNAL OF BIOMECHANICS			English	Article						TBI; Helmet; Graded lattice; Additive manufacturing; FEM; PPE	OPTIMIZATION; HEAD; MECHANISMS; BODY	This paper evaluates the effects of topology and relative density of helmet lattice liners on mitigating Traumatic Brain Injury (TBI). Finite Element (FE) models of new lattice liners with prismatic and tetrahedral topologies were developed. A typical frontal head impact in motorcycle accidents was simulated, and linear and rotational accelerations of the head were recorded. A high-fidelity FE model of TBI was loaded with the accelerations to predict the brain response during the accident. The results show that prismatic lattices have better performance in preventing TBI than tetrahedral lattices and EPS that is typically used in helmets. Moreover, varying the cell size through the thickness of the liner improves its performance, but this effect was marginal. The relative density also has a significant effect, with lattices with lower relative densities providing better protection. Across different lattices studied here, the prismatic lattice with a relative density of 6% had the best performance and reduced the peak linear and rotational accelerations, Head Injury Criterion (HIC), brain strain and strain rate by 48%, 37%, 49%, 32% and 65% respectively, compared to the EPS liner. These results can be used to guide the design of lattice helmet liners for better mitigation of TBI. (C) 2019 Elsevier Ltd. All rights reserved.	[Khosroshahi, Siamak Farajzadeh; Duckworth, Harry; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London, England; [Galvanetto, Ugo] Univ Padua, Dept Ind Engn, Padua, Italy		Khosroshahi, SF (corresponding author), Imperial Coll Rd, London SW7 1AL, England.	s.f.khosroshahi@imperial.ac.uk		Ghajari, Mazdak/0000-0001-5678-5124; Duckworth, Harry/0000-0002-0367-0486; Farajzadeh Khosroshahi, Siamak/0000-0003-4476-2579	ECCELLENZA programme of the CARIPARO foundation under the REDIPhE projectFondazione Cariparo; EU-COST association [TU-1407]; UK Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [2024686] Funding Source: UKRI	The research leading to these results has received funding from the ECCELLENZA programme of the CARIPARO foundation under the REDIPhE project, the EU-COST association action number TU-1407 and the UK Engineering and Physical Sciences Research Council (EPSRC) funding.	Arora R, 2005, PHYTOTHER RES, V19, P1, DOI 10.1002/ptr.1605; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Du YX, 2017, ADV ENG SOFTW, V112, P211, DOI 10.1016/j.advengsoft.2017.04.011; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P621, DOI 10.1080/13588265.2011.616078; Gibson LI, 1999, SOLID STATE SCI SERI; Holbourn AHS, 1943, LANCET, V2, P438; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Khosroshahi SF, 2018, MATER TODAY COMMUN, V14, P312, DOI 10.1016/j.mtcomm.2018.02.002; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu YP, 2010, SCI RES ESSAYS, V5, P1052; LSTC, 2014, LS DYNA KEYW US MAN; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Mohsenizadeh M, 2018, MATER DESIGN, V139, P521, DOI 10.1016/j.matdes.2017.11.037; Moura R.T., 2010, P IMPLAST 2010 C; Ozdemir Z, 2017, INT J IMPACT ENG, V102, P1, DOI 10.1016/j.ijimpeng.2016.11.016; Piantini S., 2016, IRCOBI C MAL SPAIN; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Qiu WG, 2019, TUNN UNDERGR SP TECH, V87, P100, DOI 10.1016/j.tust.2019.02.008; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Sanami M, 2014, PROCEDIA ENGINEER, V72, P453, DOI 10.1016/j.proeng.2014.06.079; Schaedler B.T.A., 2014, DESIGNING METALLIC M, P276, DOI [10.1002/adem.201300206, DOI 10.1002/ADEM.201300206]; Soe SP, 2015, INT J ADV MANUF TECH, V79, P1975, DOI 10.1007/s00170-015-6972-y; Song J, 2019, COMPOS PART B-ENG, V160, P402, DOI 10.1016/j.compositesb.2018.12.027; THUMS, 2015, AM50 OCC MOD AC VERS; Wang YQ, 2019, EXTREME MECH LETT, V29, DOI 10.1016/j.eml.2019.03.004; Whyte T, 2016, J NEUROTRAUM, V33, P1802, DOI 10.1089/neu.2015.4208; Wu ZJ, 2019, COMPUT METHOD APPL M, V345, P602, DOI 10.1016/j.cma.2018.11.003; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249	36	6	6	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	DEC 3	2019	97								109376	10.1016/j.jbiomech.2019.109376			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	JW2LU	WOS:000502890000012	31627837				2022-02-06	
J	Brett, BL; Mummareddy, N; Kuhn, AW; Yengo-Kahn, AM; Zuckerman, SL				Brett, Benjamin L.; Mummareddy, Nishit; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Zuckerman, Scott L.			The Relationship Between Prior Concussions and Depression Is Modified by Somatic Symptomatology in Retired NFL Athletes	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; EXTREMITY MUSCULOSKELETAL INJURY; PHYSICAL-ACTIVITY; PRIMARY-CARE; PSYCHOMETRIC EVALUATION; INVENTORY-II; OLDER-ADULTS; RISK; PAIN; INFLAMMATION	A positive relationship between sport-related concussion (SRC) history and depressive symptoms in retired National Football League (NFL) athletes has been observed, with self-rated physical functioning identified as a confounding factor. The authors examined the influence of somatic symptom endorsement on the relationship between SRC history and self-reported depressive symptom severity in retired NFL athletes. Forty-three former NFL athletes completed self-report inventories of depression (with the Beck Depression Inventory II) and somatic symptoms (with the adjusted Patient Health Questionnaire-15). A moderation analysis examined the influence of somatic symptoms on the relationship between SRC history and depressive symptom severity. SRC history and somatic symptoms accounted for a significant amount of depressive symptomology. SRC history was not significantly associated with depressive symptom severity at low levels of somatic symptoms but was significant at the mean and high levels. The effect of somatic symptoms on depressive symptoms was nearly twice that of SRC history. The relationship between SRC and depression is complex, and treatment of depression in retired athletes should address comorbid somatic symptoms.	[Brett, Benjamin L.; Mummareddy, Nishit; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Yengo-Kahn, Aaron M.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.; Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.	scott.zuckerman@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Yengo-Kahn, Aaron/AAV-7647-2020	Kuhn, Andrew W/0000-0003-1836-7575; Yengo-Kahn, Aaron/0000-0002-5989-3064			Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Association A.P, 2013, DIAGN STAT MAN MENT; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Backmand H, 2003, INT J SPORTS MED, V24, P609; Becofsky K, 2013, ARTHRITIS, DOI 10.1155/2013/525761; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bosley BN, 2004, J AM GERIATR SOC, V52, P247, DOI 10.1111/j.1532-5415.2004.52063.x; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cera N, 2014, NEUROPSYCH DIS TREAT, V10, P1093, DOI 10.2147/NDT.S54423; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Domb BG, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114534824; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Geerlings SW, 2002, SOC PSYCH PSYCH EPID, V37, P23, DOI 10.1007/s127-002-8210-2; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Hayes A.F., 2017, INTRO MEDIATION MODE; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Kaplan MS, 2001, AM J PREV MED, V21, P306, DOI 10.1016/S0749-3797(01)00364-6; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kohler O, 2016, CURR NEUROPHARMACOL, V14, P732, DOI 10.2174/1570159X14666151208113700; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LIPOWSKI ZJ, 1990, PSYCHOSOMATICS, V31, P13, DOI 10.1016/S0033-3182(90)72212-8; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Maes M, 2012, PROG NEURO-PSYCHOPH, V36, P169, DOI 10.1016/j.pnpbp.2011.09.006; Morin CM, 1998, CLIN J PAIN, V14, P311, DOI 10.1097/00002508-199812000-00007; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Scott A, 2004, BRIT J SPORT MED, V38, P372, DOI 10.1136/bjsm.2004.011312; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Subica AM, 2014, PSYCHOL ASSESSMENT, V26, P1106, DOI 10.1037/a0036998; Suzuki S, 2017, J PAIN RES, V10, P1411, DOI 10.2147/JPR.S137482; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; West S. G., 1991, MULTIPLE REGRESSION; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zheng C, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0054-4	56	6	6	0	189	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2019	31	1					17	24		10.1176/appi.neuropsych.18040080			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	HU7CS	WOS:000465439300003	30187822	Bronze			2022-02-06	
J	Brignone, MS; Lanciotti, A; Serafini, B; Mallozzi, C; Sbriccoli, M; Veroni, C; Molinari, P; Elorza-Vidal, X; Petrucci, TC; Estevez, R; Ambrosini, E				Brignone, Maria Stefania; Lanciotti, Angela; Serafini, Barbara; Mallozzi, Cinzia; Sbriccoli, Marco; Veroni, Caterina; Molinari, Paola; Elorza-Vidal, Xabier; Petrucci, Tamara Corinna; Estevez, Raul; Ambrosini, Elena			Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals	MOLECULAR NEUROBIOLOGY			English	Article						Leukodystrophy; Neuroinflammation; Neurodegeneration; IL-1 beta; pERK; Astrocytosis	TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; PHARMACOLOGICAL TARGET; MULTIPLE-SCLEROSIS; KINASE PATHWAY; IN-VITRO; ALZHEIMERS; INTERLEUKIN-1; EXPRESSION; IL-1-BETA	Megalencephalic leukoencephalopathy with subcortical cysts protein-1 (MLC1) is a membrane protein expressed by perivascular astrocytes. MLC1 mutations cause MLC, an incurable leukodystrophy characterized by macrocephaly, brain edema, cysts, myelin vacuolation, and astrocytosis, leading to cognitive/motor impairment and epilepsy. Although its function is unknown, MLC1 favors regulatory volume decrease after astrocyte osmotic swelling and down-regulates intracellular signaling pathways controlling astrocyte activation and proliferation. By combining analysis of human brain tissues with in vitro experiments, here we investigated MLC1 role in astrocyte activation during neuroinflammation, a pathological condition exacerbating patient symptoms. MLC1 upregulation was observed in brain tissues from multiple sclerosis, Alzheimer's, and Creutzfeld-Jacob disease, all pathologies characterized by strong astrocytosis and release of inflammatory cytokines, particularly IL-1 beta. Using astrocytoma lines overexpressing wild-type (WT) or mutated MLC1 and astrocytes from control and Mlc1 knock-out (KO) mice, we found that IL-1 beta stimulated WT-MLC1 plasma membrane expression in astrocytoma cells and control primary astrocytes. In astrocytoma, WT-MLC1 inhibited the activation of IL-1 beta-induced inflammatory signals (pERK, pNF-kB) that, conversely, were constitutively activated in mutant expressing cells or abnormally upregulated in KO astrocytes. WT-MLC1(+) cells also expressed reduced levels of the astrogliosis marker pSTAT3. We then monitored MLC1 expression timing in a demyelinating/remyelinating murine cerebellar organotypic culture model where, after the demyelination and release of inflammatory cytokines, recovery processes occur, revealing MLC1 upregulation in these latter phases. Altogether, these findings suggest that by modulating specific pathways, MLC1 contributes to restore astrocyte homeostasis after inflammation, providing the opportunity to identify drug target molecules to slow down disease progression.	[Brignone, Maria Stefania; Lanciotti, Angela; Serafini, Barbara; Mallozzi, Cinzia; Sbriccoli, Marco; Veroni, Caterina; Petrucci, Tamara Corinna; Ambrosini, Elena] Ist Super Sanita, Dept Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy; [Molinari, Paola] Ist Super Sanita, Dept FARVA, Viale Regina Elena 299, I-00161 Rome, Italy; [Elorza-Vidal, Xabier; Estevez, Raul] Univ Barcelona, IDIBELL Inst Neurosci, Dept Ciencies Fisiol, Unitat Fisiol, Lhospitalet De Llobregat, Spain; [Estevez, Raul] ISCIII, Ctr Invest Red Enfermedades Raras CIBERER, Valenciana, Spain		Ambrosini, E (corresponding author), Ist Super Sanita, Dept Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	elena.ambrosini@iss.it	Estevez, Raul/D-8610-2015; Veroni, Caterina/AAA-5454-2021; brignone, maria stefania/J-6421-2016; , Angela/J-6431-2016	Estevez, Raul/0000-0003-1579-650X; Veroni, Caterina/0000-0002-6043-1051; Serafini, Barbara/0000-0002-6853-1161; brignone, maria stefania/0000-0002-5174-9973; , Marco/0000-0001-6458-7523; Elorza-Vidal, Xabier/0000-0001-9163-6079; ambrosini, elena/0000-0002-4458-3442; , Angela/0000-0003-1615-1770	Italian Ministry of Health, Ricerca FinalizzataMinistry of Health, Italy [GR-2013-02355882]; European Leukodystrophies Association (ELA) [ELA 2016-002F3, ELA2012-014C2B]; TELETHONFondazione Telethon [GEP14134]; Spanish Ministerio de Ciencia e Innovacion (MICINN)Spanish Government [SAF2015-70377]; Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [SGR2014-1178]; ICREA Academia prizeICREA	This work was supported by Italian Ministry of Health, Ricerca Finalizzata, (Grant N. GR-2013-02355882 to A. L.); European Leukodystrophies Association (ELA) (Grant N. ELA 2016-002F3 to M.S. B and ELA2012-014C2B to R.E.); TELETHON (Grant N. GEP14134 to E.A.); Spanish Ministerio de Ciencia e Innovacion (MICINN) (SAF2015-70377 to R.E.); and the Generalitat de Catalunya (SGR2014-1178 to R.E.), (ERARE to R.E.). R.E. is a recipient of an ICREA Academia prize.	AGRESTI C, 1991, DEV BIOL, V144, P16, DOI 10.1016/0012-1606(91)90474-H; Aguzzi A, 2017, J EXP MED, V214, P3477, DOI 10.1084/jem.20172045; Alam Q, 2016, CURR PHARM DESIGN, V22, P541, DOI 10.2174/1381612822666151125000300; Ambrosini E, 2008, MOL CELL NEUROSCI, V37, P480, DOI 10.1016/j.mcn.2007.11.003; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Avila-Munoz E, 2014, AGEING RES REV, V18, P29, DOI 10.1016/j.arr.2014.07.004; Barateiro A, 2016, MOL NEUROBIOL, V53, P3976, DOI 10.1007/s12035-015-9336-6; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Brignone MS, 2014, NEUROBIOL DIS, V66, P1, DOI 10.1016/j.nbd.2014.02.003; Brignone MS, 2011, HUM MOL GENET, V20, P90, DOI 10.1093/hmg/ddq435; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; Bugiani M, 2003, NEUROPEDIATRICS, V34, P211; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Cheng PP, 2013, INT J DEV NEUROSCI, V31, P783, DOI 10.1016/j.ijdevneu.2013.09.008; Duarri A, 2011, NEUROBIOL DIS, V43, P228, DOI 10.1016/j.nbd.2011.03.015; Dubey M, 2018, ANN NEUROL, V83, P636, DOI 10.1002/ana.25190; Dubey M, 2015, ANN NEUROL, V77, P114, DOI 10.1002/ana.24307; Eleuteri C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45780; Vidal XE, 2018, NEUROBIOL DIS, V119, P88, DOI 10.1016/j.nbd.2018.07.031; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Estevez R, 2018, EUR J MED GENET, V61, P50, DOI 10.1016/j.ejmg.2017.10.013; Ferrer I, 2017, BRAIN PATHOL, V27, P645, DOI 10.1111/bpa.12538; Fields J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056891; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Gao WL, 2014, NEUROSCI LETT, V562, P54, DOI 10.1016/j.neulet.2014.01.018; Gomez-Arboledas A, 2018, GLIA, V66, P637, DOI 10.1002/glia.23270; Griffin WST, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-5; Guillot-Sestier MV, 2017, J NEURAL TRANSM VIEN; Hamilton EMC, 2018, NEUROLOGY, V90, pE1395, DOI 10.1212/WNL.0000000000005334; Heneka MT, 2017, BRAIN PATHOL, V27, P220, DOI 10.1111/bpa.12483; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Iwasaki Y, 2013, NEUROPATHOLOGY, V33, P561, DOI 10.1111/neup.12012; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Lanciotti A, 2016, HUM MOL GENET, V25, P1543, DOI 10.1093/hmg/ddw032; Lanciotti A, 2013, TRANSL NEUROSCI, V4, P144, DOI 10.2478/s13380-013-0118-1; Lanciotti A, 2012, HUM MOL GENET, V21, P2166, DOI 10.1093/hmg/dds032; Lanciotti A, 2010, NEUROBIOL DIS, V37, P581, DOI 10.1016/j.nbd.2009.11.008; Lassmann H, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028936; Leegwater PAJ, 2002, HUM GENET, V110, P279, DOI 10.1007/s00439-002-0682-x; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lewicki H, 2003, J VIROL, V77, P3799, DOI 10.1128/JVI.77.6.3799-3808.2003; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lindemann C, 2011, ACTA NEUROPATHOL, V122, P241, DOI 10.1007/s00401-011-0832-0; Liu SJ, 2015, MOL NEUROBIOL, V51, P743, DOI 10.1007/s12035-014-8764-z; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; Meini A, 2008, BRIT J PHARMACOL, V153, P1706, DOI 10.1038/bjp.2008.40; MejaskiBosnjak V, 1997, PEDIATR NEUROL, V16, P347, DOI 10.1016/S0887-8994(97)00044-1; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Nadjar A, 2005, NEUROSCIENCE, V134, P921, DOI 10.1016/j.neuroscience.2005.04.035; Neprasova H, 2007, PFLUG ARCH EUR J PHY, V453, P839, DOI 10.1007/s00424-006-0151-9; Okazaki R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0690-8; Parker LC, 2002, BRIT J PHARMACOL, V136, P312, DOI 10.1038/sj.bjp.0704715; Pasantes-Morales H, 2012, NEUROCHEM RES, V37, P2379, DOI 10.1007/s11064-012-0777-2; Pascual-Castroviejo I, 2005, NEUROLOGIA, V20, P33; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Petrini S, 2013, MOL CELL NEUROSCI, V56, P307, DOI 10.1016/j.mcn.2013.07.001; Rao KVR, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-66; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Ridder MC, 2011, BRAIN, V134, P3342, DOI 10.1093/brain/awr255; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Rubio-Perez J. M., 2012, THESCIENTIFICWORLDJO, V2012, P2012, DOI DOI 10.1100/2012/756357; Sirisi S, 2017, HUM MOL GENET, V26, P2436, DOI 10.1093/hmg/ddx134; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922; Sticozzi C, 2013, NEUROSCIENCE, V252, P367, DOI 10.1016/j.neuroscience.2013.07.061; Stoeck K, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0170-y; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Summers L, 2010, MOL CELL NEUROSCI, V44, P272, DOI 10.1016/j.mcn.2010.03.013; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Toutounchian JJ, 2017, GENESIS, V55, DOI 10.1002/dvg.23071; Tzour A, 2017, J PHYSIOL-LONDON, V595, P713, DOI 10.1113/JP272547; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; Van Everbroeck B, 2002, NEUROBIOL AGING, V23, P59, DOI 10.1016/S0197-4580(01)00236-6; vanderKnaap MS, 1996, ACTA NEUROPATHOL, V92, P206, DOI 10.1007/s004010050510; Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011; Wang TY, 2015, BIOMED REP, V3, P141, DOI 10.3892/br.2014.401; Wei TJ, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00528; Yalcinkaya C, 2003, SEIZURE-EUR J EPILEP, V12, P388, DOI 10.1016/S1059-1311(02)00350-3; Yang ZY, 2018, PHARMACOGN MAG, V14, P134, DOI 10.4103/pm.pm_218_17; Yi MN, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0973-8; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zetterstrom M, 1998, ANN NY ACAD SCI, V856, P48, DOI 10.1111/j.1749-6632.1998.tb08311.x	96	6	6	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2019	56	12					8237	8254		10.1007/s12035-019-01657-y			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JK5CI	WOS:000494860800022	31209783				2022-02-06	
J	Brigode, W; Cohan, C; Beattie, G; Victorino, G				Brigode, William; Cohan, Caitlin; Beattie, Genna; Victorino, Gregory			Alcohol in Traumatic Brain Injury: Toxic or Therapeutic?	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	14th Annual American Academic Surgical Congress (ASC) of Society-of-University-Surgeons (SUS)/Association-for-Academic-Surgery (AAS)	FEB 04-09, 2019	Houston, TX	Soc Univ Surg, Assoc Acad Surg		Trauma; Traumatic brain injury; Alcohol	SERUM ETHANOL LEVELS; GLASGOW COMA SCALE; MORTALITY; INTOXICATION; ASSOCIATION; EXPRESSION; SEVERITY; SURVIVAL; MODERATE; IMPACT	Background: Alcohol (EtOH) poses a challenge in traumatic brain injuries (TBIs) given its metabolic and neurologic impact. Studies have had opposing results regarding mortality and complication rates in the intoxicated TBI patient. We hypothesized that trauma mechanism, brain injury severity, and blood alcohol concentration (BAC) would influence the impact of EtOH on mortality in TBI. Methods: We performed a single-institution retrospective review of consecutive adult trauma patients tested for EtOH and a diagnosis of TBI. The primary outcome was mortality, and secondary outcomes included infectious complications. The primary analysis included univariate and multivariate regression comparing mortality between intoxicated and sober patients, at different values of BAC, different brain injury severities, and among mechanisms of trauma. Results: Admission EtOH was assessed in 583 patients with TBI, with 256 testing positive for EtOH and 327 testing negative. Overall, EtOH was associated with lower mortality on univariate analysis (4.7% versus 8.9%, P = 0.05) but not on multivariate analysis (P = 0.21). There was no effect of EtOH on mortality when patients were stratified by brain injury severity or among penetrating trauma victims. However, EtOH was associated with lower overall infectious complications on univariate and multivariate regression. Finally, EtOH was predictive of mortality with an area under the receiver operator characteristic curve of 0.83. Conclusions: We found that EtOH is not associated with mortality in the patient with TBI, suggesting no causative effect. However, EtOH showed some predictability of mortality based on a receiver operator characteristic analysis. Interestingly, EtOH was associated with lower infectious complications, suggesting an immunomodulatory effect of EtOH in TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Brigode, William; Cohan, Caitlin; Beattie, Genna; Victorino, Gregory] Univ Calif San Francisco, Dept Surg, Oakland, CA USA		Brigode, W (corresponding author), Dept Surg, 1411 E 31st St, Oakland, CA 94602 USA.	William.Brigode@alamedahealthsystem.org		Brigode, William/0000-0002-3872-662X			Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Chandrasekar A, 2018, J NEUROTRAUM, V24, P1; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Fabbri A, 2002, EMERG MED J, V19, P210, DOI 10.1136/emj.19.3.210; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; He M, 2013, CHIN J TRAUMATOL, V16, P136, DOI 10.3760/cma.j.issn.1008-1275.2013.03.002; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Ronning P, 2015, BRAIN INJURY, V29, P1648, DOI 10.3109/02699052.2015.1075154; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736	29	6	6	2	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2019	244						196	204		10.1016/j.jss.2019.06.043			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	JG3EL	WOS:000491957000029	31299436				2022-02-06	
J	Caine, A; Brash, R; De Risio, L; Van Dijk, J; Cherubini, GB; Dennis, R				Caine, Abby; Brash, Robert; De Risio, Luisa; Van Dijk, Jan; Cherubini, Giunio Bruto; Dennis, Ruth			MRI in 30 cats with traumatic brain injury	JOURNAL OF FELINE MEDICINE AND SURGERY			English	Article						Traumatic brain injury; magnetic resonance imaging; TBI; MRI	HEAD TRAUMA; DOGS; MANAGEMENT; SEIZURES	Objectives The aim of this study was to evaluate the MRI findings in cats following traumatic brain injury (TBI), and establish which features identified might correlate with prognosis. Methods The magnetic resonance images of 30 cats with clinical signs attributed to the brain following TBI were retrospectively reviewed to assess the imaging features seen and their correlation with outcome. Results Twenty-one of 30 cats had a good outcome (full recovery or minor ongoing neurological deficits); the other nine either died or had ongoing neurological deficits that significantly affected quality of life. There was evidence of parenchymal injury in only 20/30 cats, including 8/9 that had a poor outcome. The frequency of bilateral or multifocal parenchymal lesions on T2-weighted imaging, and mass effect, particularly caudal transtentorial herniation, was statistically significantly higher in patients with a poorer outcome. Extra-axial haemorrhage was not identified. Concurrent soft tissue injury was noted in all cats, with a poorer prognosis statistically associated with a peripharyngeal pattern of injury and orbital trauma. Conclusions and relevance The number of cases with MRI-identified brain pathology, the patterns of injuries identified and the specific imaging features that appear to have effects on prognosis differ in this series of cats from those published in similar case series of dogs. Further work is needed to establish if cat-specific guidelines are needed to assess brain MRI following trauma.	[Caine, Abby] Dick White Referrals, Dept Imaging, Six Mile Bottom, Cambs, England; [Brash, Robert; Dennis, Ruth] Anim Hlth Trust, Dept Imaging, Newmarket, Suffolk, England; [De Risio, Luisa] Anim Hlth Trust, Dept Neurol, Newmarket, Suffolk, England; [Van Dijk, Jan] Anim Hlth Trust, Ctr Prevent Med, Newmarket, Suffolk, England; [Cherubini, Giunio Bruto] Dick White Referrals, Dept Neurol, Six Mile Bottom, Cambs, England		Caine, A (corresponding author), Stn Farm,London Rd, Six Mile Bottom CB8 0UH, Cambs, England.	ac@dwr.co.uk	Caine, Abby/ABA-3944-2020; De Risio, Luisa/ABB-3561-2020; Cherubini, Giunio Bruto/AAR-9744-2021	De Risio, Luisa/0000-0001-9005-4165; Cherubini, Giunio Bruto/0000-0002-0189-382X; Caine, Abby/0000-0003-0496-2648			Adamantos S, 2011, J FELINE MED SURG, V13, P806, DOI 10.1016/j.jfms.2011.09.002; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Bhateja A, 2009, INDIAN J NEUROTRAUM, V6, P115, DOI 10.1016/S0973-0508(09)80004-X; Edlow BL, 2015, CURR TRAUMA REP, V1, P133, DOI 10.1007/s40719-015-0018-7; Firsching R, 2008, ACTA NEUROCHIR SUPPL, V102, P237, DOI 10.1007/978-3-211-85578-2_45; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Friedenberg SG, 2012, JAVMA-J AM VET MED A, V241, P1479, DOI 10.2460/javma.241.11.1479; Grohmann KS, 2012, JAVMA-J AM VET MED A, V241, P1467, DOI 10.2460/javma.241.11.1467; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kuo KW, 2018, VET CLIN N AM-SMALL, V48, P111, DOI 10.1016/j.cvsm.2017.08.005; LANG DA, 1991, ACTA NEUROCHIR, V109, P5, DOI 10.1007/BF01405689; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Yanai H, 2015, JAVMA-J AM VET MED A, V246, P1222, DOI 10.2460/javma.246.11.1222	14	6	6	1	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1098-612X	1532-2750		J FELINE MED SURG	J. Feline Med. Surg.	DEC	2019	21	12					1111	1119		10.1177/1098612X18819162			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	JQ9OV	WOS:000499267800006	30565962				2022-02-06	
J	Chell, J; Brandani, CE; Fraschetti, S; Chakraverty, J; Camomilla, V				Chell, Jasper; Brandani, Carola Elea; Fraschetti, Stefano; Chakraverty, Joe; Camomilla, Valentina			Limitations of the European barrier crash testing regulation relating to occupant safety	ACCIDENT ANALYSIS AND PREVENTION			English	Article						HIC; ASI; THIV; TBI; EN 1317; Biomechanics	SEVERITY; RISK; INJURIES	The safety of roadside restraint systems in Europe is ensured by the EN 1317 regulation. The ability of the barrier to mitigate injury to the occupants of vehicles is tested according to two occupant injury metrics: Acceleration Severity Index (ASI) and Theoretical Head Impact Velocity (THIV). Both metrics aim to predict occupant head injury from vehicle kinematics, despite the potential to easily measure actual head kinematics from instrumented Anthropomorphic Test Dummies, a non-instrumented version of which is already required according to the regulation. Retrospective data provided by AISICO S.r.l. for 33 certificated barrier tests, where acceleration of the dummy's head had also been recorded, were re-analysed. ASI and THIV were compared with Head Injury Criterion (HIC15) and Neck injury Criterion (N-ij), as well as corresponding Real Head Impact Velocity (RHIV) values. Three barriers presented HIC15 values above the threshold used in crashworthiness testing, two of which corresponded to fatal injury according to the Abbreviated Injury Scale. One barrier presented an N-ij value corresponding to a 30% risk of neck injury. RHIV values were above the regulation threshold in 15% of tests, but were not significantly different from the corresponding THIV values. It was concluded that vehicle kinematics do not accurately predict head kinematics during barrier testing. The presented data indicate the current EN 1317 regulation was not capable of detecting all potential dangerous outcomes, with the potential to underestimate occupant risk. Further investigation is necessary to devise suitable indices based on actual head and neck data. These data would be obtained from a dummy instrumented with both a head accelerometer and neck load cell and, possibly, a gyroscope. To consistently test the true worst-case scenario, the tested side window should be closed and non-reinforced.	[Chell, Jasper; Chakraverty, Joe] Univ Bath, Dept Hlth, Bath, Avon, England; [Chell, Jasper; Brandani, Carola Elea; Fraschetti, Stefano; Chakraverty, Joe; Camomilla, Valentina] Univ Rome Foro Ital, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy; [Chell, Jasper; Chakraverty, Joe; Camomilla, Valentina] Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy; [Brandani, Carola Elea; Fraschetti, Stefano] AISICO Srl, Res & Dev Div, Rome, Italy		Camomilla, V (corresponding author), Univ Rome Foro Ital, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Rome, Italy.; Camomilla, V (corresponding author), Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy.	valentina.camomilla@uniroma4.it	Camomilla, Valentina/N-8934-2013	Camomilla, Valentina/0000-0002-7452-120X			Abraham N, 2016, INT J CRASHWORTHINES, V21, P211, DOI 10.1080/13588265.2016.1164444; Abu-Zidan FM, 2015, INJURY, V46, P136, DOI 10.1016/j.injury.2014.10.066; [Anonymous], 2018, ROAD SAF DAT SHOW IP; [Anonymous], 2016, MAN ASS SAF HARDW MA; Atahan AO, 2018, ACCIDENT ANAL PREV, V116, P103, DOI 10.1016/j.aap.2017.04.005; Bingham CR, 2014, J ADOLESCENT HEALTH, V54, pS3, DOI 10.1016/j.jadohealth.2014.02.015; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Deakin N.D, 2017, J CONCUSSION, V1; Delhaye A, 2015, INFRASTRUCTURE DELIV; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Gabauer D, 2005, 19 INT TECHN C ENH S, P6; Gabauer DJ, 2008, ACCIDENT ANAL PREV, V40, P548, DOI 10.1016/j.aap.2007.08.011; Gadd C, 1961, NATL RES COUNCIL PUB, P141; Garcia J, 2009, IMPROVING MOTORCYCLI; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Hollowell WT, 1998, REV POTENTIAL TEST P; International Organization for Standardization (ISO), 2015, 6487 ISO; Kleinberger M, 1998, DEV IMPROVED INJURY; Lee C, 2008, ACCIDENT ANAL PREV, V40, P1703, DOI 10.1016/j.aap.2008.06.006; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mellander H, 1986, HIC HEAD INJURY CRIT; Mertz HJ, 1997, P 41 STAPP CAR CRASH; Montella A, 2004, P 2 INT C NEW TECHN; Mueller B, 2015, ENHANC SAF VEH, P1; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Paterson J, 2016, HDB TEEN NOVICE DRIV; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Prasad P, 1985, SAE GOV IND M EXP; Ray MH, 2000, TRANSPORT RES REC, P67; Ren Z, 2005, ENG FAIL ANAL, V12, P963, DOI 10.1016/j.engfailanal.2004.12.033; Roque C, 2013, IATSS RES, V37, P21, DOI 10.1016/j.iatssr.2013.04.002; Ross H.E.J, 1993, 350 NAT COOP HIGHW R; Seiffert U, 2003, AUTOMOTIVE SAFETY HD; Services U.S.D. of H.& H, 2017, TRAUM BRAIN INJ CONC; Shojaati M., 2003, P 3 SWISS TRANSP RES; Silvestri-Dobrovolny C, 2016, ATLAS201612 U MICH; Sturt R, 2009, INT J CRASHWORTHINES, V14, P165, DOI 10.1080/13588260802614365; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; UNI CEN/TS, 131782012 UNI CENTS; UNI EN, 2010, 131712010 UNI EN; UNI EN, 2000, 131712000 UNI EN; Wong E, 2016, ENCY CLIN NEUROPSYCH; Yeung E, 1996, PHYSIOTHERAPY, V82, P286, DOI [10.1016/S0031-9406(05)66847-2, DOI 10.1016/S0031-9406(05)66847-2]; Yoganandan N., 2014, ACCIDENTAL INJURY BI; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	47	6	6	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	DEC	2019	133								105239	10.1016/j.aap.2019.07.015			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	JL4AC	WOS:000495472400006	31563016				2022-02-06	
J	Chiu, LS; Anderton, RS; Cross, JL; Clark, VW; Knuckey, NW; Meloni, BP				Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.			Poly-arginine Peptide R18D Reduces Neuroinflammation and Functional Deficits Following Traumatic Brain Injury in the Long-Evans Rat	INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS			English	Article						Neuroprotection; Arginine-rich; Peptide; TBI; Inflammation	TNF-ALPHA; RICH PEPTIDES; MIMETIC PEPTIDE; INHIBITION; IL-6; OUTCOMES; PATHOPHYSIOLOGY; INFLAMMATION; RECEPTOR; PATHWAY	We have previously demonstrated that the poly-arginine peptide R18 can improve histological and functional outcomes following traumatic brain injury (TBI) in the Sprague-Dawley rat. Since D-enantiomer peptides are often exploited in pharmacology for their increased stability and potency, the present study compared the effects of R18 and its D-enantiomer, R18D, following TBI in the Long-Evans rat. Following a closed-head impact delivered via a weight-drop apparatus, peptide was administered at a dose of 1000 nmol/kg at 30 min after TBI. Treatment with R18D, but not R18 resulted in significant reductions in sensorimotor (p = 0.026) and vestibulomotor (p = 0.049) deficits as measured by the adhesive tape removal and rotarod tests. Furthermore, treatment with R18 and R18D resulted in a significant reduction in brain protein levels of the astrocytic marker, glial fibrillary acidic protein (p = 0.019 and 0.048, respectively). These results further highlight the beneficial effects of poly-arginine peptides in TBI, however additional studies are required to confirm these positive effects.	[Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] QEII Med Ctr, Perron Inst Neurol & Translat Sci, 8 Verdun St,RR Block, Nedlands, WA 6009, Australia; [Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Sir Charles Gairdner Hosp, QEII Med Ctr, Dept Neurosurg, Nedlands, WA, Australia; [Anderton, Ryan S.] Univ Notre Dame Australia, Sch Heath Sci, Fremantle, WA 6160, Australia; [Anderton, Ryan S.] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA 6160, Australia		Chiu, LS (corresponding author), QEII Med Ctr, Perron Inst Neurol & Translat Sci, 8 Verdun St,RR Block, Nedlands, WA 6009, Australia.; Chiu, LS (corresponding author), Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia.	lishan.chiu@research.uwa.edu.au	Chiu, Li Shan/AAQ-5330-2020	Chiu, Li Shan/0000-0002-5601-7739; Anderton, Ryan/0000-0003-0568-9794	Neurotrauma Research Program of Western Australia; Insurance Commission of Western Australia; Brain Foundation (Australia); Perron Institute for Neurological and Translational Science at Sir Charles Gairdner Hospital; Department of Neurosurgery at Sir Charles Gairdner Hospital	This study was supported by grants from the Neurotrauma Research Program of Western Australia, Insurance Commission of Western Australia, and Brain Foundation (Australia). Financial support was also provided by the Perron Institute for Neurological and Translational Science and the Department of Neurosurgery at Sir Charles Gairdner Hospital. We thank Jim Litis for providing a student PhD scholarship for Li Shan Chiu. The authors would also like to thank Professor Frank Mastaglia for his assistance in the preparation of this manuscript.	ABADJI V, 1994, J MED CHEM, V37, P1889, DOI 10.1021/jm00038a020; Anbanandam A, 2008, J MOL BIOL, V384, P219, DOI 10.1016/j.jmb.2008.09.021; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chen YT, 2015, J CEREBR BLOOD F MET, V35, P739, DOI 10.1038/jcbfm.2015.16; Chiu LS, 2017, TRANSL NEUROSCI, V8, P147, DOI 10.1515/tnsci-2017-0021; Chiu LS, 2017, MOL NEUROBIOL, V54, P7838, DOI 10.1007/s12035-016-0287-3; Chiu LS, 2016, EXPERT REV NEUROTHER, V16, P361, DOI 10.1586/14737175.2016.1150180; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Edwards AB, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0352-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fotin-Mleczek M, 2005, J CELL SCI, V118, P3339, DOI 10.1242/jcs.02460; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gaczynska M, 2003, BIOCHEMISTRY-US, V42, P8663, DOI 10.1021/bi034784f; Gao YH, 2000, J CLIN INVEST, V106, P439, DOI 10.1172/JCI9826; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gu Q, 2013, NEUROCHEM INT, V63, P535, DOI 10.1016/j.neuint.2013.09.017; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Kloss A, 2009, EUR J PHARM BIOPHARM, V72, P219, DOI 10.1016/j.ejpb.2008.10.016; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Lightfoot AP, 2015, REDOX BIOL, V6, P253, DOI 10.1016/j.redox.2015.08.007; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; MacDougall G, 2017, J MOL NEUROSCI, V61, P235, DOI 10.1007/s12031-016-0861-1; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meloni BP, 2017, NEUROMOL MED, V19, P271, DOI 10.1007/s12017-017-8441-2; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Milani D, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/2372710; Milani D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193884; Milani D, 2017, NEUROSCI RES, V114, P9, DOI 10.1016/j.neures.2016.09.002; Milani D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0253-z; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Ramos-Molina B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130417; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Wang YF, 2011, MOL THER, V19, P1849, DOI 10.1038/mt.2011.82; Wei XL, 2014, MOL PHARMACEUT, V11, P3261, DOI 10.1021/mp500086e; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang Y, 2016, PEPTIDES, V75, P96, DOI 10.1016/j.peptides.2015.11.002; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	61	6	6	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1573-3149	1573-3904		INT J PEPT RES THER	Int. J. Pept. Res. Ther.	DEC	2019	25	4					1563	1572		10.1007/s10989-018-09799-8			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JG9WT	WOS:000492427400029		Green Accepted			2022-02-06	
J	Clugston, JR; Houck, ZM; Asken, BM; Boone, JK; Kontos, AP; Buckley, TA; Schmidt, JD; Chrisman, SPD; Hoffman, NL; Harmon, KG; Kaminski, TW; Collins, MW; McAllister, TW; McCrea, MA; Broglio, SP; Ortega, JD				Clugston, James R.; Houck, Zachary M.; Asken, Breton M.; Boone, Jonathan K.; Kontos, Anthony P.; Buckley, Thomas A.; Schmidt, Julianne D.; Chrisman, Sara P. D.; Hoffman, Nicole L.; Harmon, Kimberly G.; Kaminski, Thomas W.; Collins, Michael W.; McAllister, Thomas W.; McCrea, Michael A.; Broglio, Steven P.; Ortega, Justus D.			Relationship Between the King-Devick Test and Commonly Used Concussion Tests at Baseline	JOURNAL OF ATHLETIC TRAINING			English	Article						oculomotor evaluation; saccades; rapid number naming; symptoms; cognition; balance; vestibular system	VISUAL SCREENING TOOL; ASSOCIATIONS; VISION; STATEMENT; YOUTH	Context: Comprehensive assessments are recommended to evaluate sport-related concussion (SRC). The degree to which the King-Devick (KD) test adds novel information to an SRC evaluation is unknown. Objective: To describe relationships at baseline among the KD and other SRC assessments and explore whether the KD provides unique information to a multimodal baseline concussion assessment. Design: Cross-sectional study. Setting: Five National Collegiate Athletic Association institutions participating in the Concussion Assessment, Research and Education (CARE) Consortium. Patients or Other Participants: National Collegiate Athletic Association student-athletes (N = 2258, age = 20 +/- 1.5 years, 53.0% male, 68.9% white) in 11 men's and 13 women's sports. Main Outcome Measure(s): Participants completed baseline assessments on the KD and (1) the Symptom Inventory of the Sport Concussion Assessment Tool-3rd edition, (2) the Brief Symptom Inventory-18, (3) the Balance Error Scoring System, (4) the Standardized Assessment of Concussion (SAC), (5) the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test battery, and (6) the Vestibular/Ocular Motor Screening tool during their first year in CARE. Correlation coefficients between the KD and the 6 other concussion assessments in isolation were determined. Assessments with p magnitude >0.1 were included in a multivariate linear regression analysis to evaluate their relative association with the KD. Results: Scores for SAC concentration, ImPACT visual motor speed, and ImPACT reaction time were correlated with the KD (p = -0.216, -0.276, and 0.164, respectively) and were thus included in the regression model, which explained 16.8% of the variance in baseline KD time (P < .001, Cohen f(2) = 0.20). Better SAC concentration score (beta = -.174, P < .001), ImPACT visual motor speed (beta = -.205, P < .001), and ImPACT reaction time (beta = .056, P .020) were associated with faster baseline KD performance, but the effect sizes were small. Conclusions: Better performance on cognitive measures involving concentration, visual motor speed, and reaction time was weakly associated with better baseline KD performance. Symptoms, psychological distress, balance, and vestibular-oculomotor provocation were unrelated to KD performance at baseline. The findings indicate limited overlap at baseline among the CARE SRC assessments and the KD.	[Clugston, James R.] Univ Florida, Dept Neurol, Dept Community Hlth & Family Med, Gainesville, FL 32611 USA; [Clugston, James R.] Univ Florida, Div Sports Hlth, Univ Athlet Assoc, Gainesville, FL 32611 USA; [Houck, Zachary M.; Asken, Breton M.] Univ Florida, Dept Clin Psychol, Gainesville, FL 32611 USA; [Boone, Jonathan K.] Natl Football League, Miami Dolphins, Dept Athlet Training, Davie, FL USA; [Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15260 USA; [Buckley, Thomas A.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Chrisman, Sara P. D.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Chrisman, Sara P. D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Harmon, Kimberly G.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Hoffman, Nicole L.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Ortega, Justus D.] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA		Clugston, JR (corresponding author), Univ Florida, Student Hlth Care Ctr, Dept Community Hlth & Family Med, 280 Fletcher Dr, Gainesville, FL 32611 USA.	jayclug@ufl.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Chrisman, Sara/0000-0001-5373-7223; Ortega, Justus/0000-0002-9931-5605; Clugston, James/0000-0002-2103-1039	Grand Alliance CARE Consortium - NCAA; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This publication was made possible, in part, by support from the Grand Alliance CARE Consortium, funded by the NCAA and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds). This research was also supported in part by a grant to Dr Kontos at the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1).	Asken BM, 2016, ATHL TRAIN SPORTS HL, V8, P145; Barth JT, 1989, MILD HEAD INJURY, P257; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chrisman SPD, 2019, ANN BIOMED ENG, V47, P2122, DOI 10.1007/s10439-018-02150-8; Clark JF, 2017, CLIN J SPORT MED, V27, P457, DOI 10.1097/JSM.0000000000000381; Clugston JR, 2020, CLIN J SPORT MED, V30, pE139, DOI 10.1097/JSM.0000000000000691; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Devick S., 2010, KING DEVICK TEST; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lovell M, 2000, IMPACT IMMEDIATE POS; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Department of Health, 2017, IMPL SUMM REP DEPUY, P1; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Vander Vegt CB, 2019, MED SCI SPORT EXER, V51, P264, DOI 10.1249/MSS.0000000000001789; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	35	6	6	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2019	54	12					1247	1253		10.4085/1062-6050-455-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JW6PV	WOS:000503172400004	31584854	Green Published, gold			2022-02-06	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Gonzalez-Rivero, AF; Argueso, M; Ramos, L; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Argueso, Monica; Ramos, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Brain trauma; Injury; Mortality; Patients; Substance P	FUNCTIONAL DEFICITS; TACHYKININS; NEUROPEPTIDES; INTERLEUKIN-6; INFLAMMATION; ANTAGONISTS; ASTROCYTES; RECEPTORS; CYTOKINES; ALPHA	BACKGROUND: Substance P is a neuropeptide belonging to the tachykinin family and is involved in neuroinflammation. In a previous study by our team, we found higher serum substance P levels on day 1 of traumatic brain injury (TBI) in nonsurviving than in surviving patients. Thus, the objective of this study was to determine whether serum substance P levels during the first week of TBI could predict early mortality. METHODS: This was a multicenter, observational, and prospective study. We included patients with an isolated severe TBI, defining isolated as <9 points in non-cranial aspects of Injury Severity Score and severe as <9 points of Glasgow Coma Scale. We determined serum substance P concentrations at days 1, 4, and 8 of TBI. We performed receiver operating characteristic analyses to determine the capacity of serum substance P levels at day 1, 4, and 8 of TBI to predict 30-day mortality. RESULTS: Nonsurviving (n = 34) compared with surviving patients (n = 90) had greater serum substance P levels on day 1 (P < 0.001), 4 (P < 0.001), and 8 (P < 0.001) of TBI. The areas under curve of serum substance P concentrations at days 1, 4, and 8 of TBI to predict 30-day mortality were 76% (P < 0.001), 87% (P < 0.001), and 89% (P < 0.001), respectively. CONCLUSIONS: The new finding of our study is that the presence of elevated serum substance P levels during the first week of TBI is associated with increased mortality.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.] Hosp Univ Canarias, Lab Dept, Santa Cruz De Tenerife, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Santa Cruz De Tenerife, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Santa Cruz De Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Santa Cruz De Tenerife, Spain.	lorentemartin@msn.com		Argueso, Monica/0000-0001-5917-1056; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain) [OA18/011]	This study was supported by a grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Ameliorate JL, 2017, MAGNESIUM RES, V30, P88, DOI 10.1684/mrh.2017.0427; ANSEL JC, 1993, J IMMUNOL, V150, P4478; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z; Corrigan F, 2016, BRIT J PHARMACOL, V173, P703, DOI 10.1111/bph.13155; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; Graham GJ, 2004, BLOOD, V104, P1058, DOI 10.1182/blood-2003-11-3979; Jones S, 2008, BLOOD, V111, P605, DOI 10.1182/blood-2007-07-103424; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P529, DOI 10.1111/j.1365-3083.1990.tb02801.x; Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MARRIOTT DR, 1991, J NEUROCHEM, V56, P259, DOI 10.1111/j.1471-4159.1991.tb02590.x; Marriott I, 2004, FRONT BIOSCI, V9, P2153, DOI 10.2741/1377; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Palma C, 1997, GLIA, V21, P183, DOI 10.1002/(SICI)1098-1136(199710)21:2<183::AID-GLIA2>3.0.CO;2-8; PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B; Satake H, 2006, CURR DRUG TARGETS, V7, P963, DOI 10.2174/138945006778019273; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; TEASDALE G, 1974, LANCET, V2, P81; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Walsh DA, 2006, CURR DRUG TARGETS, V7, P1031, DOI 10.2174/138945006778019291; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	37	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2019	132						E613	E617		10.1016/j.wneu.2019.08.064			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN5VR	WOS:000496966300073	31442647				2022-02-06	
J	Morris, MC; Bercz, A; Niziolek, GM; Kassam, F; Veile, R; Friend, LA; Pritts, TA; Makley, AT; Goodman, MD				Morris, Mackenzie C.; Bercz, Aron; Niziolek, Grace M.; Kassam, Farzaan; Veile, Rose; Friend, Lou Ann; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.			UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma	JOURNAL OF SURGICAL RESEARCH			English	Article						UGH-L1; TBI; Hemorrhagic shock; Trauma	NEURON-SPECIFIC ENOLASE; GLYCOCALYX DEGRADATION; TERMINAL HYDROLASE; PLASMA SYNDECAN-1; PROTEIN; HEAD; S100B; GFAP; MARKER; MODEL	Background: Several serum biomarkers have been studied to diagnose incidence and severity of traumatic brain injury (TBI), but a reliable biomarker in TBI has yet to be identified. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) has been proposed as a biomarker in clinical and preclinical studies, largely in the setting of isolated TBI or concussion. The aim of this study was to evaluate the performance of UGH-L1 as a serum biomarker in the setting of polytrauma and TBI. Methods: Multiple variations of murine TBI and polytrauma models were used to evaluate serum biomarkers. The different models included TBI with and without hemorrhagic shock and resuscitation, isolated extremity vascular ligation, extremity ischemia/reperfusion, and blunt tail injury. Blood was drawn at intervals after injury, and serum levels of neuronspecific enolase, UGH-L1, creatine kinase, and syndecan-1 were evaluated by enzyme-linked immunosorbent assay. Results: UGH-L1 levels were not significantly different between TBI, tail injury, and sham TBI. By contrast, neuron-specific enolase levels were increased in TBI mice compared with tail injury and sham TBI mice. UGH-L1 levels increased regardless of TBI status at 30 min and 4 h after hemorrhagic shock and resuscitation. In mice that underwent femoral artery cannulation followed by hemorrhagic shock/resuscitation, UGH-L1 levels were significantly elevated compared with shock sham mice at 4 h (3158 +/- 2168 pg/mL, 4 h shock versus 0 +/- 0 pg/mL, 4 h shock sham; P < 0.01) and at 24 h (3253 +/- 2954 pg/mL, 24 h shock versus 324 +/- 482 pg/mL, 24 h shock sham; P = 0.03). No differences were observed in UGH-L1 levels between the sham shock and the arterial ligation, vein ligation, or extremity ischemia/reperfusion groups at any time point. Similar to UGH-L1, creatine kinase was elevated only after shock compared with sham mice at 4, 24, and 72 h after injury. Conclusions: Our study demonstrates that UGH-L1 is not a specific marker for TBI but is elevated in models that induce central and peripheral nerve ischemia. Given the increase in UGH-L1 levels observed after hemorrhagic shock, we propose that UGH-L1 may be a useful adjunct in quantifying severity of shock or global ischemia rather than as a specific marker of TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Morris, Mackenzie C.; Bercz, Aron; Niziolek, Grace M.; Kassam, Farzaan; Veile, Rose; Friend, Lou Ann; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Sect Gen Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Pritts, Timothy/0000-0003-2495-3255	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008478] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008478] Funding Source: NIH RePORTER		[Anonymous], 2018, RATES TBI RELATED EM; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gelderblom M, 2013, NEUROBIOL DIS, V59, P177, DOI 10.1016/j.nbd.2013.07.017; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Puskarich MA, 2016, J CRIT CARE, V36, P125, DOI 10.1016/j.jcrc.2016.06.027; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; THOMAS D G T, 1978, Lancet, V1, P113; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Valdez C, 2013, J TRAUMA ACUTE CARE, V74, P441, DOI 10.1097/TA.0b013e31827a0a36; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075	32	6	6	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2019	244						63	68		10.1016/j.jss.2019.06.023			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JG3EL	WOS:000491957000009	31279265	Green Accepted			2022-02-06	
J	Thastum, MM; Rask, CU; Naess-Schmidt, ET; Tuborgh, A; Jensen, JS; Svendsen, SW; Nielsen, JF; Schroder, A				Thastum, Mille Moeller; Rask, Charlotte Ulrikka; Naess-Schmidt, Erhard Trillingsgaard; Tuborgh, Astrid; Jensen, Jens Sondergaard; Svendsen, Susanne Wulff; Nielsen, Jorgen Feldbaek; Schroder, Andreas			Novel interdisciplinary intervention, GAIN, vs. enhanced usual care to reduce high levels of post -concussion symptoms in adolescents and young adults 2-6 months post -injury: A randomised trial	ECLINICALMEDICINE			English	Article						Brain concussion; Cognitive behavioural therapy; Graded exercise therapy; Illness perceptions; Intervention; Mild traumatic brain injury; Post-concussion syndrome; Rivermead Post-Concussion; Symptoms Questionnaire		Background: Evidence for effective interventions to prevent long-term sequelae after concussion is sparse. This study aimed to test the efficacy of Get going After concussIoN (GAIN), an interdisciplinary, individually-tailored intervention of 8 weeks duration based on gradual return to activities and principles from cognitive behavioural therapy. Methods: We conducted an open-label, parallel-group randomised trial in a hospital setting in Central Denmark Region. Participants were 15 -30-year-old patients with high levels of post-concussion symptoms (PCS) 2-6 months post-concussion (i.e., a score >= 20 on the Rivermead Post-concussion Symptoms Questionnaire (RPQ)). They were randomly assigned (1:1) to either enhanced usual care (EUC) or GAIN+EUC. Masking of participants and therapists was not possible. The primary outcome was change in RPQ-score from baseline to 3-month FU. All analyses were done on an intention-to-treat basis using linear mixed-effects models. This trial is registered with ClinicalTrials.gov, number NCT02337101. Findings: Between March 1, 2015, and September 1, 2017, we included 112 patients. Patients allocated to GAIN+EUC (n=57) reported a significantly larger reduction of PCS than patients allocated to EUC (n=55) with a mean adjusted difference in improvement of 7.6 points (95% confidence interval (CI) 2.0-13.1, p=0.008), Cohen's d=0.5 (95% CI 0.1-0.9). Number needed to treat for prevention of one additional patient with RPQ >20 at 3-month FU was 3.6 (95% CI 2.2-113). No adverse events were observed. Interpretation: Compared with EUC, GAIN+EUC was associated with a larger reduction of post-concussion symptoms at 3 -month FU. (C) 2019 Published by Elsevier Ltd.	[Thastum, Mille Moeller; Jensen, Jens Sondergaard; Schroder, Andreas] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Noerrebrogade 44, DK-8000 Aarhus, Denmark; [Rask, Charlotte Ulrikka; Tuborgh, Astrid] Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Res Unit, Psychiat, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Svendsen, Susanne Wulff; Nielsen, Jorgen Feldbaek] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Svendsen, Susanne Wulff; Nielsen, Jorgen Feldbaek] Aarhus Univ, Univ Res Clin, Aarhus, Denmark		Thastum, MM (corresponding author), Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Noerrebrogade 44, DK-8000 Aarhus, Denmark.	Mille.Moeller.Thastum@auh.rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Nass-Schmidt, Erhard/AAP-8212-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Nass-Schmidt, Erhard/0000-0002-2539-0362	Central Denmark Region; foundation "Public Health in Central Denmark Region -a collaboration between municipalities and the region"	MMT, AT, and AS received grants from Central Denmark Region during the conduct of the study. In addition, MMT received grants from the foundation "Public Health in Central Denmark Region -a collaboration between municipalities and the region". ETN reports nonfinancial support from Central Denmark Region during the conduct of the study. CUR, JFN, SWS, and JSJ declare no competing interests.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, pS28; Christensen KS, 2005, FAM PRACT, V22, P448, DOI 10.1093/fampra/cmi025; Christensen SS, 2015, J PSYCHOSOM RES, V78, P363, DOI 10.1016/j.jpsychores.2014.12.005; Eigthark Andersson E, 2007, ACTA NEUROCHIR WIEN, V149; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fink P, 1999, J PSYCHOSOM RES, V46, P261, DOI 10.1016/S0022-3999(98)00092-0; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hagger MS, 2017, PSYCHOL BULL, V143, P1117, DOI 10.1037/bul0000118; Henningsen P, 2018, PSYCHOSOM MED, V80, P422, DOI 10.1097/PSY.0000000000000588; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2017, LANCET NEUROL, V16, P494, DOI 10.1016/S1474-4422(17)30171-0; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934	33	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-5370		ECLINICALMEDICINE	EClinicalMedicine	DEC	2019	17								100214	10.1016/j.eclinm.2019.11.007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ9IC	WOS:000646535900014	31891145	Green Published, gold			2022-02-06	
J	Thompson, LW; Bass, KD; Agyei, JO; Naseem, HUR; Borngraber, E; Wang, JF; Reynolds, RM				Thompson, LaVerne W.; Bass, Kathryn D.; Agyei, Justice O.; Naseem, Hibbut-Ur-Rauf; Borngraber, Elizabeth; Wang, Jiefei; Reynolds, Renee M.			Incidence of nonaccidental head trauma in infants: a call to revisit prevention strategies	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						nonaccidental head trauma; shaken baby syndrome; abusive head trauma; traumatic brain injury	PROGRAM; NURSES	OBJECTIVE Traumatic brain injury is a major sequela of nonaccidental trauma (NAT) that disproportionately affects young children and can have lasting sequelae. Considering the potentially devastating effects, many hospitals develop parent education programs to prevent NAT. Despite these efforts, NAT is still common in Western New York. The authors studied the incidence of NAT following the implementation of the Western New York Shaken Baby Syndrome Education Program in 1998. METHODS The authors performed a retrospective chart review of children admitted to our pediatric hospital between 1999 and 2016 with ICD-9-CM and ICD-10-CM codes for types of child abuse and intracranial hemorrhage. Data were also provided by the Safe Babies New York program, which tracks NAT in Western New York. Children with a diagnosis of abuse at 0-24 months old were included in the study. Children who suffered a genuine accidental trauma or those with insufficient corroborating evidence to support the NAT diagnosis were excluded. RESULTS A total of 107 children were included in the study. There was a statistically significant rise in both the incidence of NAT (p = 0.0086) and the incidence rate of NAT (p = 0.0235) during the study period. There was no significant difference in trendlines for annual NAT incidence between sexes (y-intercept p = 0.5270, slope p = 0.5263). When stratified by age and sex, each age group had a distinct and statistically significant incidence of NAT (y-intercept p = 0.0069, slope p = 0.0374). CONCLUSIONS Despite educational interventions targeted at preventing NAT, there is a significant rise in the trend of newly reported cases of NAT, indicating a great need for better injury prevention programming.	[Thompson, LaVerne W.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Bass, Kathryn D.; Naseem, Hibbut-Ur-Rauf; Borngraber, Elizabeth] Univ Buffalo, Dept Pediat Surg, Buffalo, NY USA; [Agyei, Justice O.; Reynolds, Renee M.] Univ Buffalo, Dept Neurosurg, Buffalo, NY USA; [Wang, Jiefei] Univ Buffalo, Dept Biostat, Buffalo, NY USA		Reynolds, RM (corresponding author), Kaleida Hlth, Oishei Childrens Outpatient Ctr Conventus, Buffalo, NY 14203 USA.	rreynolds@kaleidahealth.org					Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; American Community Survey, NEW YORK COUNT HLTH; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Bishaw A, ACS02 US CENS BUR; Bishaw A, POVERTY 1999 CENSUS; Boop S, 2016, J NEUROSURG-PEDIATR, V18, P542, DOI 10.3171/2016.1.PEDS15583; BRAZELTON TB, 1962, PEDIATRICS, V29, P579; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Crouch JL, 2008, CHILD ABUSE NEGLECT, V32, P702, DOI 10.1016/j.chiabu.2007.11.002; Deyo G, 2008, CHILD ABUSE NEGLECT, V32, P1017, DOI 10.1016/j.chiabu.2008.02.006; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; HUNZIKER UA, 1986, PEDIATRICS, V77, P641; John R, OSHEI CHILDRENS HOSP; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Koh E, 2017, J FAM ISSUES, V38, P607, DOI 10.1177/0192513X15576963; Kurth E, 2011, MIDWIFERY, V27, P187, DOI 10.1016/j.midw.2009.05.012; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Long T, 2001, J ADV NURS, V34, P155, DOI 10.1046/j.1365-2648.2001.01740.x; Lopes NRL, 2013, J PEDIAT-BRAZIL, V89, P426, DOI 10.1016/j.jped.2013.01.011; New York State Department of Health, TABL 7 LIV BIRTHS RE; New York State Department of Health, LIV BIRTHS MOTH AG R; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Ornstein AE, 2016, PAED CHILD HEALT-CAN, V21, P74, DOI 10.1093/pch/21.2.74; Parrish J, 2013, INT J CIRCUMPOL HEAL, V72, P472, DOI 10.3402/ijch.v72i0.21216; Rideout L, 2016, J TRAUMA NURS, V23, P125, DOI 10.1097/JTN.0000000000000206; Scribano PV, 2013, CHILD ABUSE NEGLECT, V37, P771, DOI 10.1016/j.chiabu.2013.04.011; Shanahan ME, 2013, PEDIATRICS, V132, pE1546, DOI 10.1542/peds.2013-2049; Smith KM, 2008, MCN-AM J MATERN-CHIL, V33, P371, DOI 10.1097/01.NMC.0000341258.26169.d4; STJAMESROBERTS I, 1991, J CHILD PSYCHOL PSYC, V32, P951; US Department of Health & Human Services ACF, 2014, CHILD MALTREATMENT; US Department of Health & Human Services Office of the Assistant Secretary for Planning and Evaluation, COMP 2016 POV GUID C; Zolotor AJ, 2015, JAMA PEDIATR, V169, P1126, DOI 10.1001/jamapediatrics.2015.2690	32	6	6	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2019	24	6					689	696		10.3171/2019.7.PEDS195			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	JS4IV	WOS:000500271300009	31629317				2022-02-06	
J	van Erp, WS; Aben, AML; Lavrijsen, JCM; Vos, PE; Laureys, S; Koopmans, RTCM				van Erp, Willemijn S.; Aben, Anoek M. L.; Lavrijsen, Jan C. M.; Vos, Pieter E.; Laureys, Steven; Koopmans, Raymond T. C. M.			Unexpected emergence from the vegetative state: delayed discovery rather than late recovery of consciousness	JOURNAL OF NEUROLOGY			English	Article						Consciousness disorders (MeSH); Persistent vegetative state (MeSH); Neurological rehabilitation (MeSH)	DISORDERS; COMA; WAKEFULNESS	Background The vegetative state, also known as the unresponsive wakefulness syndrome, is one of the worst possible outcomes of acquired brain injury and confronts rehabilitation specialists with various challenges. Emergence to (minimal) consciousness is classically considered unlikely beyond 3-6 months after non-traumatic or 12 months after traumatic etiologies. A growing body of evidence suggests that these timeframes are too narrow, but evidence regarding chances of recovery is still limited. Objective To identify the moment of recovery of consciousness in documented cases of late emergence from a vegetative state. Methods Four cases of apparent late recovery of consciousness, identified within a prospective cohort study, were studied in-depth by analyzing medical, paramedical and nursing files and interviewing the patients' families about their account of the process of recovery. Results All patients were found to have shown signs of consciousness well within the expected time frame (5 weeks-2 months post-ictus). These behaviors, however, went unnoticed or were misinterpreted, leading to a diagnostic delay of several months to over 5 years. Absence of appropriate diagnostics, the use of erroneous terminology, sedative medication but also patient-related factors such as hydrocephalus, language barriers and performance fluctuations are hypothesized to have contributed to the delay. Conclusions Delayed recognition of signs of consciousness in patients in a vegetative state may not only lead to suboptimal clinical care, but also to distorted prognostic figures. Discriminating late recovery from the delayed discovery of consciousness, therefore, is vital to both clinical practice and science.	[van Erp, Willemijn S.; Aben, Anoek M. L.; Lavrijsen, Jan C. M.; Koopmans, Raymond T. C. M.] Radboud Univ Nijmegen, Dept Primary & Community Care, Radboud Inst Hlth Sci, Med Ctr,Radboudumc, ELG 117,Postbus 9101, NL-6500 HB Nijmegen, Netherlands; [van Erp, Willemijn S.; Laureys, Steven] Univ Liege, Coma Sci Grp, GIGA Consciousness, Liege, Belgium; [Vos, Pieter E.] Slingeland Ziekenhuis, Dept Neurol, Doetinchem, Netherlands; [Koopmans, Raymond T. C. M.] Joachim Anna, Ctr Specialized Geriatr Care, Nijmegen, Netherlands		van Erp, WS (corresponding author), Radboud Univ Nijmegen, Dept Primary & Community Care, Radboud Inst Hlth Sci, Med Ctr,Radboudumc, ELG 117,Postbus 9101, NL-6500 HB Nijmegen, Netherlands.; van Erp, WS (corresponding author), Univ Liege, Coma Sci Grp, GIGA Consciousness, Liege, Belgium.	Willemijn.vanerp@radboudumc.nl	Laureys, Steven/AAN-2097-2021; Koopmans, R.T.C.M./H-8062-2014; Lavrijsen, Jan/L-4477-2015; Laureys, Steven/A-3349-2011; van Erp, Willemijn S/P-6195-2015	Laureys, Steven/0000-0002-3096-3807; van Erp, Willemijn S/0000-0002-9167-4136			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2018, NEUROLOGY, V8, P0000000000005926; JENNETT B, 1972, LANCET, V1, P734; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Pickard JD, 2005, NEUROPSYCHOL REHABIL, V15, P224, DOI 10.1080/09602010443000614; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; van Erp WS, 2014, EUR J NEUROL, V21, P1361, DOI 10.1111/ene.12483; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1332, DOI 10.4065/81.10.1332; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1155, DOI 10.4065/81.9.1155; Yelden K, 2018, DISABIL REHABIL, V40, P2433, DOI 10.1080/09638288.2017.1339209	21	6	8	2	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	DEC	2019	266	12					3144	3149		10.1007/s00415-019-09542-3			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM2BJ	WOS:000496025500027	31541340	Green Published, hybrid			2022-02-06	
J	Wood, T; Nance, E				Wood, Thomas; Nance, Elizabeth			Disease-directed engineering for physiology-driven treatment interventions in neurological disorders	APL BIOENGINEERING			English	Article							TRAUMATIC BRAIN-INJURY; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; SEX-DIFFERENCES; ALZHEIMERS-DISEASE; SUPEROXIDE-DISMUTASE; GENDER-DIFFERENCES; THERAPEUTIC HYPOTHERMIA; EXTRACELLULAR-MATRIX; BARRIER PERMEABILITY; COGNITIVE FUNCTION	Neurological disease is killing us. While there have long been attempts to develop therapies for both acute and chronic neurological diseases, no current treatments are curative. Additionally, therapeutic development for neurological disease takes 15 years and often costs several billion dollars. More than 96% of these therapies will fail in late stage clinical trials. Engineering novel treatment interventions for neurological disease can improve outcomes and quality of life for millions; however, therapeutics should be designed with the underlying physiology and pathology in mind. In this perspective, we aim to unpack the importance of, and need to understand, the physiology of neurological disease. We first dive into the normal physiological considerations that should guide experimental design, and then assess the pathophysiological factors of acute and chronic neurological disease that should direct treatment design. We provide an analysis of a nanobased therapeutic intervention that proved successful in translation due to incorporation of physiology at all stages of the research process. We also provide an opinion on the importance of keeping a high-level view to designing and administering treatment interventions. Finally, we close with an implementation strategy for applying a disease-directed engineering approach. Our assessment encourages embracing the complexity of neurological disease, as well as increasing efforts to provide system-level thinking in our development of therapeutics for neurological disease. (C) 2019 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license.	[Wood, Thomas] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wood, Thomas] Inst Human & Machine Cognit, Pensacola, FL 32502 USA; [Nance, Elizabeth] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Nance, Elizabeth] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Nance, Elizabeth] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA		Nance, E (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.; Nance, E (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.; Nance, E (corresponding author), Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA.	eanance@uw.edu	Wood, Tommy/AAC-8252-2019; Nance, Elizabeth/AAJ-4445-2020	Wood, Tommy/0000-0002-1130-2720; Nance, Elizabeth/0000-0001-7167-7068	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1R35GM124677-01]	This work was supported by the National Institute of General Medical Sciences (No. 1R35GM124677-01). The views expressed in this article do not represent the views of the NIH, and are solely the views of the authors.	Adeoye O, 2014, STROKE, V45, P3019, DOI 10.1161/STROKEAHA.114.006293; Alabas OA, 2012, EUR J PAIN, V16, P1211, DOI 10.1002/j.1532-2149.2012.00121.x; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Anderton BH, 2002, MECH AGEING DEV, V123, P811, DOI 10.1016/S0047-6374(01)00426-2; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Baldwin G, 2015, C TRAUM BRAIN INJ US; Barnette AR, 2009, PEDIATR RES, V66, P80, DOI 10.1203/PDR.0b013e3181a291d9; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Becker JB, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0087-5; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bickel Ulrich, 2005, NeuroRx, V2, P15, DOI 10.1602/neurorx.2.1.15; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690; Brothers HM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00118; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Burke MK, 2009, AM J PHYSIOL-REG I, V296, pR1847, DOI 10.1152/ajpregu.90551.2008; Cai ZY, 2018, J ALZHEIMERS DIS, V63, P1223, DOI 10.3233/JAD-180098; Carroll WM, 2019, LANCET NEUROL, V18, P418, DOI 10.1016/S1474-4422(19)30029-8; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Cherry Brandon H, 2015, World J Crit Care Med, V4, P1, DOI 10.5492/wjccm.v4.i1.1; Chiyo PI, 2015, ECOL EVOL, V5, P5216, DOI 10.1002/ece3.1769; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Curtis C, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1422; Davis SR, 2015, LANCET DIABETES ENDO, V3, P980, DOI 10.1016/S2213-8587(15)00284-3; de Jong FJ, 2009, NEUROBIOL AGING, V30, P600, DOI 10.1016/j.neurobiolaging.2007.07.019; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Deloose E, 2012, NAT REV GASTRO HEPAT, V9, P271, DOI 10.1038/nrgastro.2012.57; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Diaz J, 2017, DEV NEUROSCI-BASEL, V39, P257, DOI 10.1159/000454949; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; DODSON RF, 1977, J NEUROL SCI, V33, P161, DOI 10.1016/0022-510X(77)90190-3; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Duarte-Guterman P, 2015, HORM BEHAV, V74, P37, DOI 10.1016/j.yhbeh.2015.05.024; Duyk G, 2003, SCIENCE, V302, P603, DOI 10.1126/science.1090521; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Eliot L, 2016, J NEUROSCI, V36, P11823, DOI 10.1523/JNEUROSCI.1391-16.2016; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Engin AB, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-017-0199-z; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Febo Marcelo, 2011, Front Psychiatry, V2, P43, DOI 10.3389/fpsyt.2011.00043; Field M.J., 2004, ETHICAL CONDUCT CLIN; Fineschi V, 2017, MEDIAT INFLAMM, P11; Galinsky R, 2017, DEV NEUROSCI-BASEL, V39, P7, DOI 10.1159/000452859; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Gibson CL, 2016, J CEREBR BLOOD F MET, V36, P487, DOI 10.1177/0271678X15616782; Glynn N, 2019, PITUITARY, V22, P249, DOI 10.1007/s11102-019-00938-y; Golde TE, 2018, SCIENCE, V362, P1250, DOI 10.1126/science.aau0437; Goldstein JM, 2013, AM J MED GENET B, V162, P698, DOI 10.1002/ajmg.b.32159; Gosztyla ML, 2018, J ALZHEIMERS DIS, V62, P1495, DOI 10.3233/JAD-171133; Green T, 2019, NEUROPSYCHOPHARMACOL, V44, P9, DOI 10.1038/s41386-018-0153-2; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gunn AJ, 2007, CLIN OBSTET GYNECOL, V50, P636, DOI 10.1097/GRF.0b013e31811ebe68; Gurvich C, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8090163; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamidi Vida, 2018, J Clin Med Res, V10, P88, DOI 10.14740/jocmr3168w; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039; Hayder M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002212; Heintz-Buschart A, 2018, MOVEMENT DISORD, V33, P88, DOI 10.1002/mds.27105; Hekler EB, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1366-x; Hekler EB, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8622; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Hua JT, 2016, COGN BEHAV NEUROL, V29, P122, DOI 10.1097/WNN.0000000000000104; Huffman DM, 2016, J GERONTOL A-BIOL, V71, P1395, DOI 10.1093/gerona/glw106; Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010; Irvine K, 2012, J CLIN EXP NEUROPSYC, V34, P989, DOI 10.1080/13803395.2012.712676; Itoh Y, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0036-8; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; JAIN RK, 1987, CANCER RES, V47, P3039; Perez-Alvarez MJ, 2016, CURR PHARM DESIGN, V22, P1334, DOI 10.2174/138161282210160304112834; Joseph A, 2018, NANO RES, V11, P5670, DOI 10.1007/s12274-018-2104-y; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kalsbeek MJT, 2016, MOL CELL ENDOCRINOL, V438, P27, DOI 10.1016/j.mce.2016.09.028; Kang EJ, 2013, NEUROBIOL DIS, V52, P204, DOI 10.1016/j.nbd.2012.12.007; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kim HJ, 2012, BRAIN, V135, P2865, DOI 10.1093/brain/aws208; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kotliar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13349-5; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157; Lauterbach MD, 2001, NEUROPSYCHOLOGY, V15, P411, DOI 10.1037/0894-4105.15.3.411; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Lee JE, 2017, J AM COLL NUTR, V36, P150, DOI 10.1080/07315724.2016.1255160; Lei J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06113-2; Leng O, 2019, THYROID RES, V12, DOI 10.1186/s13044-019-0063-3; Lepelletier FX, 2017, NEUROPATH APPL NEURO, V43, P167, DOI 10.1111/nan.12295; Lesniak WG, 2013, MOL PHARMACEUT, V10, P4560, DOI 10.1021/mp400371r; Leung V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197882; Li YL, 2018, FRONT PLANT SCI, V9, DOI [10.3389/fpls.2018.00190, 10.3389/fphar.2018.01341]; Liu FD, 2009, STROKE, V40, P1842, DOI 10.1161/STROKEAHA.108.538686; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lobo RA, 2017, NAT REV ENDOCRINOL, V13, P220, DOI 10.1038/nrendo.2016.164; Mailing LJ, 2019, EXERC SPORT SCI REV, V47, P75, DOI 10.1249/JES.0000000000000183; Makin S, 2018, NATURE, V559, pS4, DOI 10.1038/d41586-018-05719-4; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Martinez MN, 2011, AAPS J, V13, P632, DOI 10.1208/s12248-011-9303-8; Mastorakos P, 2017, J CONTROL RELEASE, V262, P37, DOI 10.1016/j.jconrel.2017.07.009; Matias I, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00059; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; MAVELLI I, 1982, BIOCHEM J, V204, P535, DOI 10.1042/bj2040535; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Miller G, 2010, SCIENCE, V329, P502, DOI 10.1126/science.329.5991.502; Minghetti L, 2013, J MATERN-FETAL NEO M, V26, P259, DOI 10.3109/14767058.2012.733751; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Nahum-Shani I, 2018, ANN BEHAV MED, V52, P446, DOI 10.1007/s12160-016-9830-8; Nance E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1004-5; Nance E, 2016, BIOMATERIALS, V101, P96, DOI 10.1016/j.biomaterials.2016.05.044; Nance E, 2015, J CONTROL RELEASE, V214, P112, DOI 10.1016/j.jconrel.2015.07.009; Nance E, 2014, ACS NANO, V8, P10655, DOI 10.1021/nn504210g; Nemeth CL, 2017, NANOMED-NANOTECHNOL, V13, P2359, DOI 10.1016/j.nano.2017.06.014; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nino DF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0237; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Ono KE, 2016, AM J SPORT MED, V44, pNP31, DOI 10.1177/0363546516651048; Palmer C, 1996, PEDIATR RES, V39, P379; Pankevich DE, 2014, NEURON, V84, P546, DOI 10.1016/j.neuron.2014.10.007; Panza F, 2019, IMMUNOTHERAPY-UK, V11, P3, DOI 10.2217/imt-2018-0119; Park MK, 2003, J NEUROENDOCRINOL, V15, P289, DOI 10.1046/j.1365-2826.2003.01010.x; Parker CC, 2014, NEUROPHARMACOLOGY, V76, P250, DOI 10.1016/j.neuropharm.2013.05.047; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Platt TL, 2013, BBA-MOL BASIS DIS, V1832, P1437, DOI 10.1016/j.bbadis.2013.04.017; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Renolleau S, 2008, NEUROSCIENTIST, V14, P46, DOI 10.1177/1073858407308889; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Ricciarelli R, 2017, CURR NEUROPHARMACOL, V15, P926, DOI 10.2174/1570159X15666170116143743; Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0; Rivers Jack R, 2013, Curr Drug Discov Technol, V10, P177; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; SAMII A, 1994, AM J PHYSIOL, V267, pE124, DOI 10.1152/ajpendo.1994.267.1.E124; Samuels MH, 2014, CURR OPIN ENDOCRINOL, V21, P377, DOI 10.1097/MED.0000000000000089; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Scott TJ, 2014, ANN NY ACAD SCI, V1313, P17, DOI 10.1111/nyas.12417; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sethi MK, 2017, ANAL BIOANAL CHEM, V409, P379, DOI 10.1007/s00216-016-9900-6; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shansky RM, 2016, J NEUROSCI, V36, P11817, DOI 10.1523/JNEUROSCI.1390-16.2016; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039; SHEDLOFSKY SI, 1994, J CLIN INVEST, V94, P2209, DOI 10.1172/JCI117582; Shetty P, 2018, AM J LIFESTYLE MED, V12, P391, DOI 10.1177/1559827618766468; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith E. S., ADV DRUG DELIVERY RE; Smith Quentin R, 2003, Methods Mol Med, V89, P209; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; TAGAYA M, 1992, LIFE SCI, V51, P253, DOI 10.1016/0024-3205(92)90083-2; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tan ZS, 2009, J ALZHEIMERS DIS, V16, P503, DOI 10.3233/JAD-2009-0991; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004; Thoresen M, 2005, CURR OPIN NEUROL, V18, P111, DOI 10.1097/01.wco.0000162850.44897.c6; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Tioseco JA, 2006, PEDIATR CRIT CARE ME, V7, P40, DOI 10.1097/01.PCC.0000192341.67078.61; Traudt CM, 2013, DEV NEUROSCI-BASEL, V35, P491, DOI 10.1159/000355460; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Tufts Center for the Study of Drug Development, 2018, TUFTS CSDD IMP REP; Turk BR, 2018, ANN NEUROL, V84, P452, DOI 10.1002/ana.25303; Tyagi Vineet, 2017, Rev Urol, V19, P16; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Voskuhl RR, 2012, NAT REV NEUROL, V8, P255, DOI 10.1038/nrneurol.2012.43; Wallisch JS, 2017, CRIT CARE MED, V45, P744, DOI 10.1097/CCM.0000000000002240; Wassink G, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0916-0; Wassink G, 2018, J PHYSIOL-LONDON, V596, P5641, DOI 10.1113/JP274928; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Wilson JL, 2018, EXP BIOL MED, V243, P1125, DOI 10.1177/1535370218813974; Wing Benjamin H, 2017, Open Neuroimag J, V11, P58, DOI 10.2174/1874440001711010058; Wood T, 2019, DEV NEUROSCI-BASEL, V40, P475, DOI 10.1159/000498968; Wright ML, 2018, BIOL RES NURS, V20, P513, DOI 10.1177/1099800418784202; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; You YY, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0435-17.2018; Zhang C, 2017, J CONTROL RELEASE, V263, P112, DOI 10.1016/j.jconrel.2017.03.007; Zhang F, 2017, J CONTROL RELEASE, V249, P173, DOI 10.1016/j.jconrel.2017.01.032; Zhang F, 2016, J CONTROL RELEASE, V237, P61, DOI 10.1016/j.jconrel.2016.06.046; Zhang F, 2015, BIOMATERIALS, V52, P507, DOI 10.1016/j.biomaterials.2015.02.053; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	228	6	6	0	0	AIP Publishing	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2473-2877			APL BIOENG	APL Bioeng.	DEC	2019	3	4							040901	10.1063/1.5117299			20	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JZ1ZS	WOS:000504903300002	31673672	gold, Green Published			2022-02-06	
J	Li, FF; Lu, LY; Chen, HY; Wang, P; Chen, YC; Zhang, H; Yin, XD				Li, Fengfang; Lu, Liyan; Chen, Huiyou; Wang, Peng; Chen, Yu-Chen; Zhang, Hong; Yin, Xindao			Disrupted brain functional hub and causal connectivity in acute mild traumatic brain injury	AGING-US			English	Article						mild traumatic brain injury; resting-state fMRI; degree centrality; Granger causality analysis; causal connectivity	MONTREAL COGNITIVE ASSESSMENT; PREFRONTAL CORTEX; CONCUSSION; OUTCOMES; FMRI; ABNORMALITIES; NETWORKS; MEMORY; MRI	There have been an increasing number of functional magnetic resonance imaging (fMRI) reports on brain abnormalities in mild traumatic brain injury (mTBI) at different phases. However, the neural bases and cognitive impairment after acute mTBI are unclear. This study aimed to identify brain functional hubs and connectivity abnormalities in acute mTBI patients and their correlations with deficits in cognitive performance. Within seven days after brain injury, mTBI patients (n=55) and age-, sex-, and educational -matched healthy controls (HCs) (n=41) underwent resting-state fMRI scans and cognitive assessments. We derived functional connectivity (FC) strength of the whole-brain network using degree centrality (DC) and performed Granger causality analysis (GCA) to analyze causal connectivity patterns in acute mTBI. Compared with HCs, acute mTBI patients had significantly decreased network centrality in the left middle frontal gyrus (MFG). Additionally, acute mTBI showed decreased inflows from the left MFG to bilateral middle temporal gyrus (MTG), left medial superior frontal gyrus (mSFG), and left anterior cingulate cortex (ACC). Correlation analyses revealed that changes in network centrality and causal connectivity were associated with deficits in cognitive performance in mTBI. Our findings may help to provide a new perspective for understanding the neuropathophysiological mechanism of acute cognitive impairment after mTBI.	[Li, Fengfang; Lu, Liyan; Chen, Huiyou; Wang, Peng; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhang, Hong] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China.; Zhang, H (corresponding author), Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China.	chenyuchen1989@126.com; yayiba2063@163.com; y.163yy@163.com			Nanjing Medical University [2017NJMU124]; Jiangsu Provincial Special Program of Medical Science [BE2017614]; Youth Medical Talents of Jiangsu Province [QNRC2016062]; 14th "Six Talent Peaks" Project of Jiangsu Province [YY-079]; Nanjing Outstanding Youth Fund [JQX17006]; 333 High-level Talents Training Project of Jiangsu Province	This work was funded by the Nanjing Medical University grant (No.2017NJMU124), Jiangsu Provincial Special Program of Medical Science (BE2017614), Youth Medical Talents of Jiangsu Province (No. QNRC2016062), 14th "Six Talent Peaks" Project of Jiangsu Province (No. YY-079), Nanjing Outstanding Youth Fund (No. JQX17006), and 333 High-level Talents Training Project of Jiangsu Province.	Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Chen HJ, 2015, EUR J RADIOL, V84, P2287, DOI 10.1016/j.ejrad.2015.08.005; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen YC, 2020, BRAIN IMAGING BEHAV, V14, P917, DOI 10.1007/s11682-019-00162-z; Clark RE, 2018, CURR TOP BEHAV NEURO, V37, P13, DOI 10.1007/7854_2017_481; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Funahashi S, 2013, J PHYSIOL-PARIS, V107, P471, DOI 10.1016/j.jphysparis.2013.05.001; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Huang MX, 2019, CEREB CORTEX, V29, P1953, DOI 10.1093/cercor/bhy075; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iwabuchi SJ, 2017, PSYCHOL MED, V47, P1300, DOI 10.1017/S0033291716003469; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Kaltiainen H, 2019, J NEUROTRAUM, V36, P2222, DOI 10.1089/neu.2018.6306; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Li Lianyang, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3165, DOI 10.1109/EMBC.2018.8513045; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rockswold SB, 2019, J NEUROTRAUM, V36, P1099, DOI 10.1089/neu.2018.5796; Santhanam P, 2019, BRAIN RES, V1711, P77, DOI 10.1016/j.brainres.2019.01.015; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Wang S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00107; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	51	6	7	0	11	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	NOV 30	2019	11	22					10684	10696		10.18632/aging.102484			13	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology; Geriatrics & Gerontology	JR5SE	WOS:000499683800047	31754082	gold, Green Published			2022-02-06	
J	Qiao, F; Jiang, F				Qiao, Fei; Jiang, Fei			Closed reduction of severely displaced radial neck fractures in children	BMC MUSCULOSKELETAL DISORDERS			English	Article						Radial neck fracture; Percutaneous leverage; Intramedullary pinning	PERCUTANEOUS REDUCTION; IONIZING-RADIATION; MANAGEMENT; FIXATION; OSTEOSYNTHESIS; EXPOSURE; HEAD	Background Severely displaced radial neck fractures in skeletally immature children are rare and can be difficult to reduce. The purpose of this study is to evaluate the results using our reduction maneuver. Methods From October 2011 to December 2015, 26 children with radial neck fractures(O'Brien type II, III and Judet type III, IV) were treated at our institute. All patients underwent percutaneous K-wire leverage and radial intramedullary pinning in an average surgery time of 35 mins (15-80 min). The injured arm was immobilized at the functional position with plaster for 4-6 weeks, evaluated clinically and radiologically. The Metaizeau classification and Mayo elbow performance score were used to evaluate the radiological and clinical results, respectively. Percutaneous K-wire leverage and radial intramedullary pinning were performed for 26 patients. No patients were treated with open reduction. Twenty four patients were followed up for a mean of 33 (range 12-53 months) months. Results There were 15 girls and 9 boys with ages ranging from 1.5 to 12 years and an average age of 7.2 years. Percutaneous K-wire leverage reduction and intramedullary pinning were successfully used in an average total surgery time of 35 mins (range 15-80 min). In total, 2 cases (O'Brien type III and Judet type IVb, angulation = 90 degrees) needed the additional maneuver. Bone union was achieved in all patients within a mean time of 4.2 weeks. The clinical results were evaluated basing on the Mayo elbow performance score, and there were 23 excellent results and one good result. There were no refractures and no incidences of nonunion, suture infection, iatrogenic radial nerve injury, asymptomatic enlargements of the radial head or growth arrest in the proximal radial epiphysis. Conclusion Our modified percutaneous leverage technique with radial intramedullary fixation may be successfully used to avoid open reduction.	[Qiao, Fei; Jiang, Fei] Dalian Childrens Hosp, Dept Pediat Orthopaed, 154 Zhongshan Rd, Dalian 116012, Peoples R China		Jiang, F (corresponding author), Dalian Childrens Hosp, Dept Pediat Orthopaed, 154 Zhongshan Rd, Dalian 116012, Peoples R China.	feijiangdalian@163.com			Medical Science Research Project of Dalian [1711063]; Orthopedics trust	Our author (Fei Qiao) received funding from The Medical Science Research Project of Dalian (number 1711063) and the Orthopedics trust to undertake the work contained within this manuscript. These funders had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Bither Nitin, 2015, Eur J Orthop Surg Traumatol, V25, P99, DOI 10.1007/s00590-014-1452-x; BIYANI A, 1994, INJURY, V25, P169, DOI 10.1016/0020-1383(94)90155-4; Cha SM, 2012, INT ORTHOP, V36, P803, DOI 10.1007/s00264-011-1387-3; Cossio A, 2014, INJURY, V45, pS80, DOI 10.1016/j.injury.2014.10.028; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Eberl R, 2010, EUR J PEDIATR SURG, V20, P250, DOI 10.1055/s-0030-1249104; Endele SM, 2010, J PEDIATR ORTHOP B, V19, P246, DOI 10.1097/BPB.0b013e32833918c0; Falciglia F, 2014, J PEDIATR ORTHOPED, V34, P756, DOI 10.1097/BPO.0000000000000299; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; Javed A, 2001, J BONE JOINT SURG BR, V83B, P542, DOI 10.1302/0301-620X.83B4.10945; JUDET J, 1962, Ann Chir, V16, P1377; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; Klitscher D, 2009, J PEDIATR ORTHOPED, V29, P698, DOI 10.1097/BPO.0b013e3181b76895; Koslowsky TC, 2011, CLIN ANAT, V24, P721, DOI 10.1002/ca.21206; Lee JE, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1891-8; Maempel JF, 2016, ANN ROY COLL SURG, V98, P483, DOI 10.1308/rcsann.2016.0215; Martus JE, 2018, J PEDIATR ORTHOPED, V38, P249, DOI 10.1097/BPO.0000000000000810; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Nawabi DH, 2006, J PEDIATR ORTHOPED, V26, P278, DOI 10.1097/01.bpo.0000218536.97351.ca; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Okcu G, 2007, ULUS TRAVMA ACIL CER, V13, P122; Patel NG, 2014, ANN ROY COLL SURG, V96, P190, DOI 10.1308/003588414X13814021677313; PESUDO JV, 1982, CLIN ORTHOP RELAT R, P215; Ron E, 2002, PEDIATR RADIOL, V32, P232, DOI 10.1007/s00247-002-0672-0; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Sirois ZJ, 2019, J AM ACAD ORTHOP SUR, V27, pE414, DOI 10.5435/JAAOS-D-17-00668; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760, DOI 10.1302/0301-620X.74B5.1527130; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; Tarallo L, 2013, J ORTHOP TRAUMATOL, V14, P291, DOI 10.1007/s10195-013-0252-0; Ugutmen E, 2010, J PEDIATR ORTHOP B, V19, P289, DOI 10.1097/BPB.0b013e32833918a0; Wilkins KE, 1996, FRACTURES CHILDREN, P586; WOOD S K, 1969, Journal of Bone and Joint Surgery British Volume, V51, P707; Zhang FY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002346; Zimmerman RM, 2013, J BONE JOINT SURG AM, V95A, P1825, DOI 10.2106/JBJS.L.01130	36	6	6	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	NOV 27	2019	20	1							567	10.1186/s12891-019-2947-8			8	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	JR9MD	WOS:000499939500005	31775704	Green Published, gold			2022-02-06	
J	Steppacher, I; Fuchs, P; Kaps, M; Nussbeck, FW; Kissler, J				Steppacher, Inga; Fuchs, Peter; Kaps, Michael; Nussbeck, Fridtjof W.; Kissler, Johanna			A tree of life? Multivariate logistic outcome-prediction in disorders of consciousness	BRAIN INJURY			English	Article						Disorders of consciousness; unresponsive wakefulness syndrome; minimal consciousness state; logistic outcome-prediction	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; FOLLOW-UP; RECOVERY; COMA; WITHDRAWAL	Background: Clinical outcome of patients with disorders of consciousness (DOC) is seen as generally very poor. Here, we specify individual outcome chances for patients with DOC on the basis of clinical and event-related-potentials (ERPs) data and identify subgroups, who vary substantially regarding their outcome chances. Methods: We employed data from 102 patients and used standard clinical protocol data (age, etiology, diagnosis, gender), sensory (N100, Mismatch-Negativity) and cognitive (P300, N400) ERPs to predict patients' recovery rates. Results: Two significant prediction models emerged: In both, subgroups of patients with good (51%, tree 1) to very good recovery chances (97%, tree 2) could be identified. The first model was obtained from standard clinical data. The second model included cognitive ERPs and resulted in considerably better patient classification. Moreover, when taking cognitive ERPs into account, the standard protocol data did not add further significant information, neither did sensory ERPs. Conclusion: The presented information about outcome chances of individual patients with DOC will be vital for these patients and critical for clinical professionals who have to direct specialized treatments and council relatives. Legal guardians and families, in turn, need to know what to expect in the future in order to prepare for the challenges ahead.	[Steppacher, Inga; Fuchs, Peter; Nussbeck, Fridtjof W.; Kissler, Johanna] Univ Bielefeld, Dept Psychol, Bielefeld, Germany; [Steppacher, Inga] Univ Goettingen, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Kaps, Michael] Kliniken Schmieder, Lurija Inst, Allensbach, Germany		Steppacher, I; Kissler, J (corresponding author), Univ Bielefeld, Dept Psychol, Bielefeld, Germany.	Inga.Steppacher@med.uni-goettingen.de; Johanna.Kissler@Uni-Bielefeld.de	Nussbeck, Fridtjof/I-8938-2016	Nussbeck, Fridtjof/0000-0003-4002-8916	Baden-Wurttemberg Ministry of Science and Culture	This work was supported by the Baden-Wurttemberg Ministry of Science and Culture.	Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bruno MA, 2011, J NEUROL; Childs NL, 1996, BRIT MED J, V313, P944; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; CRISCI C, 1995, J MED ETHICS, V21, P277, DOI 10.1136/jme.21.5.277; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI 10.2307/1390807; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; Johnson NE, 2016, STAGING BECKETT IN IRELAND AND NORTHERN IRELAND, P185; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kochanek PM, 2013, LANCET NEUROL, V12, P1132, DOI 10.1016/S1474-4422(13)70245-X; Kotchoubey B, 2005, PROG BRAIN RES, V150, P427, DOI 10.1016/S0079-6123(05)50030-X; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; PAGNI CA, 1977, ACTA NEUROCHIR, V36, P37, DOI 10.1007/BF01405985; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Steppacher I, 2016, ANN CLIN TRANSL NEUR, V3, P61, DOI 10.1002/acn3.269; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; Therneau T, 2018, RIPLEY MB PACKAGE RP; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Voss A, 1993, SPECTRUM NEUROREHABI, P112	34	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					399	406		10.1080/02699052.2019.1695289		NOV 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000498111700001	31760831	Green Submitted			2022-02-06	
J	Jorwal, P; Sikdar, SK				Jorwal, Pooja; Sikdar, Sujit Kumar			Lactate reduces epileptiform activity through HCA1 and GIRK channel activation in rat subicular neurons in an in vitro model	EPILEPSIA			English	Article						GIRK; HCA1; lactate; subiculum	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR LACTATE; PYRAMIDAL NEURONS; HUMAN HIPPOCAMPUS; PROTEIN; INHIBITION; SEIZURES; GLUCOSE; CORTEX; EXPRESSION	Objective Much evidence suggests that the subiculum plays a significant role in the regulation of epileptic activity. Lactate acts as a neuroprotective agent against many conditions that cause brain damage. During epileptic seizures, lactate formation reaches up to similar to 6 mmol/L in the brain. We investigated the effect of lactate on subicular pyramidal neurons after induction of epileptiform activity using 4-aminopyridine (4-AP-0Mg(2+)) in an in vitro epilepsy model in rats. The signaling mechanism associated with the suppression of epileptiform discharges by lactate was also investigated. Methods We used patch clamp electrophysiology recordings on rat subicular neurons of acute hippocampal slices. Immunohistochemistry was used for demonstrating the expression of hydroxycarboxylic acid receptor 1 (HCA1) in the subiculum. Results Our study showed that application of 6 mmol/L lactate after induction of epileptiform activity reduced spike frequency (control 2.5 +/- 1.23 Hz vs lactate 1.01 +/- 0.91 Hz, P = .049) and hyperpolarized the subicular neurons (control -51.8 +/- 1.9 mV vs lactate -57.2 +/- 3.56 mV, P = .002) in whole cell patch-clamp experiments. After confirming the expression of HCA1 in subicular neurons, we demonstrated that lactate-mediated effect occurs via HCA1 by using its specific agonist. All values are mean +/- SD. Electrophysiological recordings revealed the involvement of G beta gamma and intracellular cAMP in the lactate-induced effect. Furthermore, current-clamp and voltage-clamp experiments showed that the G protein-coupled inwardly rectifying potassium (GIRK) channel blocker tertiapin-Q, negated the lactate-induced inhibitory effect, which confirmed that lactate application results in outward GIRK current. Significance Our finding points toward the potential role of lactate as an anticonvulsant by showing lactate-induced suppression of epileptiform activity in subicular neurons. The study gives a different insight by suggesting importance of endogenous metabolite and associated signaling factors, which can aid in improving the present therapeutic approach for treating epilepsy.	[Jorwal, Pooja; Sikdar, Sujit Kumar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India		Sikdar, SK (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sks@iisc.ac.in			Department of Biotechnology, India (DBT)Department of Biotechnology (DBT) India; University Grants Commission (University Grants Commission India) [F-5-14/2012/SAP-II]; Department of Science and Technology, Ministry of Science and Technology (DST)Department of Science & Technology (DOST), Philippines [SR/FIST/LSII-039/2015(C)]; DBT-IISc Partnership Program for Advanced Research in Biological Sciences Bioengineering	Department of Biotechnology, India (DBT); University Grants Commission (University Grants Commission India), Grant/Award Number: F-5-14/2012/SAP-II; Department of Science and Technology, Ministry of Science and Technology (DST), Grant/Award Number: SR/FIST/LSII-039/2015(C)&Gdt. 1/6/2016; DBT-IISc Partnership Program for Advanced Research in Biological Sciences & Bioengineering	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Beland-Millar A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00007; Benini R, 2005, J PHYSIOL-LONDON, V566, P885, DOI 10.1113/jphysiol.2005.088708; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Brand CS, 2015, MOL PHARMACOL, V88, P758, DOI 10.1124/mol.115.099556; Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Cortes-Campos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062532; DURING MJ, 1994, J NEUROCHEM, V62, P2356; EBIHARA S, 1992, BRIT J PHARMACOL, V106, P823, DOI 10.1111/j.1476-5381.1992.tb14419.x; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; FERNANDEZ E, 1986, BIOCHEM J, V234, P489, DOI 10.1042/bj2340489; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Franco Rafael, 2018, BioMolecular Concepts, V9, P143, DOI 10.1515/bmc-2018-0013; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Ghatak S, 2016, J PHYSIOL-LONDON, V594, P59, DOI 10.1113/JP270706; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; HARADA M, 1993, HORM METAB RES, V25, P560, DOI 10.1055/s-2007-1002177; Herrera-Lopez G, 2018, HIPPOCAMPUS, V28, P557, DOI 10.1002/hipo.22958; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; KAKEHATA S, 1993, J PHYSIOL-LONDON, V463, P227, DOI 10.1113/jphysiol.1993.sp019592; Karschin C, 1996, J NEUROSCI, V16, P3559; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lei QB, 2003, MOL CELLS, V15, P1; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Madaan A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.072; Mazarati A, 2006, J PHARMACOL EXP THER, V318, P700, DOI 10.1124/jpet.106.104703; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Mullner C, 2003, BIOPHYS J, V84, P1399; Oses JP, 2019, EPILEPSY RES, V152, P35, DOI 10.1016/j.eplepsyres.2019.03.007; Pandey A, 2014, J PHYSIOL-LONDON, V592, P3537, DOI 10.1113/jphysiol.2014.273367; Pei Q, 1999, NEUROSCIENCE, V90, P621, DOI 10.1016/S0306-4522(98)00453-9; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; RUTECKI PA, 1987, J NEUROPHYSIOL, V57, P1911, DOI 10.1152/jn.1987.57.6.1911; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Sah N, 2011, NEUROSCIENCE, V199, P74, DOI 10.1016/j.neuroscience.2011.10.008; Sah N, 2013, EUR J NEUROSCI, V38, P2542, DOI 10.1111/ejn.12262; Shen Z, 2015, CNS NEUROSCI THER, V21, P271, DOI 10.1111/cns.12362; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slais K, 2008, EXP NEUROL, V209, P145, DOI 10.1016/j.expneurol.2007.09.008; Spauschus A, 1996, J NEUROSCI, V16, P930; Srinivas KV, 2008, EUR J NEUROSCI, V28, P2195, DOI 10.1111/j.1460-9568.2008.06519.x; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Stafstrom Carl E, 2005, Epilepsy Curr, V5, P121; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Toyoda I, 2013, J NEUROSCI, V33, P11100, DOI 10.1523/JNEUROSCI.0472-13.2013; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Witkowski G, 2012, J PHYSIOL PHARMACOL, V63, P457; YAMAGUCHI S, 1992, EPILEPSY RES, V11, P9, DOI 10.1016/0920-1211(92)90016-M; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111	55	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	DEC	2019	60	12					2370	2385		10.1111/epi.16389		NOV 2019	16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MG3ZV	WOS:000497892700001	31755997				2022-02-06	
J	van Markus-Doornbosch, F; van der Holst, M; de Kloet, AJ; Vlieland, TPMV; Meesters, JJL				van Markus-Doornbosch, Frederike; van der Holst, Menno; de Kloet, Arend J.; Vlieland, Thea P. M. Vliet; Meesters, Jorit J. L.			Fatigue, Participation and Quality of Life in Adolescents and Young Adults with Acquired Brain Injury in an Outpatient Rehabilitation Cohort	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Fatigue; participation; quality of life; acquired brain injury; adolescents and young adults	MULTIDIMENSIONAL FATIGUE; PSYCHOMETRIC PROPERTIES; CHILDREN; HEALTH; RELIABILITY; SCALE; YOUTH; FEASIBILITY; SURVIVORS; VALIDITY	Purpose: To study the association between fatigue and participation and QoL after acquired brain injury (ABI) in adolescents and young adults (AYAs). Materials & Methods: Cross-sectional study with AYAs aged 14-25 years, diagnosed with ABI. The PedsQL (TM) Multidimensional Fatigue Scale, Child & Adolescent Scale of Participation, and PedsQL (TM) 4.0 Generic Core Scales were administered. Results: Sixty-four AYAs participated in the study, 47 with traumatic brain injury (TBI). Median age at admission was 17.6 yrs, 0.8 yrs since injury. High levels of fatigue (median 44.4 (IQR 34.7, 59.7)), limited participation (median 82.5 (IQR 68.8, 92.3)), and diminished QoL (median 63.0 (IQR 47.8, 78.3)) were reported. More fatigue was significantly associated with more participation restrictions (beta 0.64, 95%CI 0.44, 0.85) and diminished QoL (beta 0.87, 95%CI 0.72, 1.02). Conclusions: AYAs with ABI reported high levels of fatigue, limited participation and diminished quality of life with a significant association between fatigue and both participation and QoL. Targeting fatigue in rehabilitation treatment could potentially improve participation and QoL.	[van Markus-Doornbosch, Frederike; van der Holst, Menno; de Kloet, Arend J.; Vlieland, Thea P. M. Vliet; Meesters, Jorit J. L.] Basalt Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands; [van Markus-Doornbosch, Frederike; van der Holst, Menno; Vlieland, Thea P. M. Vliet; Meesters, Jorit J. L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [de Kloet, Arend J.; Meesters, Jorit J. L.] The Hague Univ Appl Sci, The Hague, Netherlands		van Markus-Doornbosch, F (corresponding author), Basalt Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	f.vanmarkus@BasaltRevalidatie.nl	van der Holst, Menno/AAL-5791-2021; Vlieland, Thea Vliet/AAJ-8119-2020; van der Holst, Menno/AAO-3512-2020	van der Holst, Menno/0000-0002-0797-5711; Vlieland, Thea Vliet/0000-0001-6322-3859; de Kloet, Arend/0000-0001-9066-5601	Hersenstichting [PZ2015.01.10]; Revalidatiefonds [R2014124]	This work was supported by the Hersenstichting [PZ2015.01.10]; Revalidatiefonds [R2014124].	Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Berrin SJ, 2007, J PEDIATR PSYCHOL, V32, P330, DOI 10.1093/jpepsy/jsl017; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Calman K, 1987, DEFINITIONS DIMENSIO, P81; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cavallo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104642; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Eddy L, 2007, J SPEC PEDIATR NURS, V12, P105, DOI 10.1111/j.1744-6155.2007.00099.x; Eiser C, 2013, EUR J PEDIATR, V172, P1299, DOI 10.1007/s00431-013-2049-9; Engel-Yeger B, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5472018; Engelen V, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-68; Ezekiel L, 2019, ARCH PHYS MED REHAB, V100, P945, DOI 10.1016/j.apmr.2018.06.017; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gedaly-Duff V, 2006, ONCOL NURS FORUM, V33, P641, DOI 10.1188/06.ONF.641-646; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Gordijn MS, 2013, PEDIATR BLOOD CANCER, V60, P479, DOI 10.1002/pbc.24261; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Greenham M, 2018, DEV NEUROPSYCHOL, V43, P312, DOI 10.1080/87565641.2018.1440557; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gupta P, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0808-0; Haverman L, 2014, QUAL LIFE RES, V23, P2841, DOI 10.1007/s11136-014-0734-4; Imms C, 2016, DEV MED CHILD NEUROL, V58, P29, DOI 10.1111/dmcn.12932; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Knight SJ, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00302; Kristiansen I, 2019, J NEURO-ONCOL, V142, P203, DOI 10.1007/s11060-018-03085-9; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Limperg PF, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-9; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Scales PC, 2016, APPL DEV SCI, V20, P150, DOI 10.1080/10888691.2015.1082429; Simonetti BG, 2013, DEV MED CHILD NEUROL, V55, P65, DOI 10.1111/dmcn.12015; SPSS, 2016, STAT WIND VERS 22 0; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Wilkinson J, 2018, NEUROPSYCHOL REV, V28, P73, DOI 10.1007/s11065-018-9370-z; Yeh CH, 2008, BRIT J CANCER, V99, P23, DOI 10.1038/sj.bjc.6604434	63	6	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	JUL 3	2020	23	5					328	335		10.1080/17518423.2019.1692948		NOV 2019	8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	NE8KF	WOS:000497272200001	31746261	hybrid			2022-02-06	
J	Jaiswal, S; Knutsen, AK; Wilson, CM; Fu, AH; Tucker, LB; Kim, Y; Bittner, KC; Whiting, MD; McCabe, JT; Dardzinski, BJ				Jaiswal, Shalini; Knutsen, Andrew K.; Wilson, Colin M.; Fu, Amanda H.; Tucker, Laura B.; Kim, Yeonho; Bittner, Katie C.; Whiting, Mark D.; McCabe, Joseph T.; Dardzinski, Bernard J.			Mild traumatic brain injury induced by primary blast overpressure produces dynamic regional changes in [F-18]FDG uptake	BRAIN RESEARCH			English	Article						Blast; Mild traumatic brain injury; Positron emission tomography; Fluorodeoxyglucose	OXIDATIVE STRESS; GLUCOSE-UPTAKE; MOUSE MODEL; EXPOSURE; RATS; PATHOPHYSIOLOGY; CONCUSSION; POTASSIUM; RELEASE; SYSTEM	Changes in F-18-fluorodeoxyglucose ([F-18]FDG) measured by positron emission tomography (PET) can be used for the noninvasive detection of metabolic dysfunction following mild traumatic brain injury (mTBI). This study examined the time course of metabolic changes induced by primary blast injury by measuring regional [F-18]FDG uptake. Adult, male rats were exposed to blast overpressure (15 psi) or sham injury, and [F-18]FDG uptake was measured before injury and again at 1-3 h and 7 days post-injury, using both volume-of-interest (VOI) and voxel-based analysis. VOI analysis revealed significantly increased [F-18]FDG uptake in corpus callosum and amygdala at both 1-3 h and 7 days following blast, while a transient decrease in uptake was observed in the midbrain at 1-3 h only. Voxel-based analysis revealed similar significant differences in uptake between sham and blast-injured rats at both time points. At 1-3 h post-injury, clusters of increased uptake were found in the amygdala, somatosensory cortex, and corpus callosum, while regions of decreased uptake were observed in midbrain structures (inferior colliculus, ventrolateral tegmental area) and dorsal auditory cortex. At day 7, a region of increased uptake in blast-injured rats was found in a cluster centered on the cortex-amygdala transition zone, while no regions of decreased uptake were observed. These results suggest that a relatively mild primary blast injury results in altered brain metabolism in multiple brain regions and that post-injury time of assessment is an important factor in observing regional changes in [F-18]FDG uptake.	[Jaiswal, Shalini; Knutsen, Andrew K.; Dardzinski, Bernard J.] USUHS, CNRM, Translat Imaging Core, Bethesda, MD USA; [Wilson, Colin M.] Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA; [Fu, Amanda H.; Tucker, Laura B.; Kim, Yeonho; McCabe, Joseph T.] USUHS, CNRM, Dept Anat Physiol & Genet, Bethesda, MD USA; [Fu, Amanda H.; Tucker, Laura B.; Kim, Yeonho; McCabe, Joseph T.] USUHS, CNRM, Preclin Studies Core, Bethesda, MD USA; [Bittner, Katie C.; Whiting, Mark D.] USUHS, CNRM, Bethesda, MD USA; [Dardzinski, Bernard J.] USUHS, Dept Radiol & Radiol Sci, Bethesda, MD USA		Dardzinski, BJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	bernard.dardzinski@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative Medicine, Department of Defense [G189AU]	This work was supported by the Center for Neuroscience and Regenerative Medicine, Department of Defense [grant # G189AU].	Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Baker MS, 2014, MIL MED, V179, P348, DOI 10.7205/MILMED-D-13-00471; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Buck D, 2012, J NUCL MED, V53, P1269, DOI 10.2967/jnumed.111.102608; Cadiz-Moretti B, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00125; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Divani AA, 2018, J NEUROTRAUM, V35, P187, DOI 10.1089/neu.2017.5208; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Greer N., 2016, PREVALENCE AND EPIDE; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Masri S, 2018, NEUROSCIENCE, V379, P428, DOI 10.1016/j.neuroscience.2018.03.041; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Ratliff WA, 2019, EXP NEUROL, V315, P9, DOI 10.1016/j.expneurol.2019.01.020; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Vlachos I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001104; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Williams JL, 2017, MIL MED, V182, pE1645, DOI 10.7205/MILMED-D-16-00221; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	46	6	6	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2019	1723								146400	10.1016/j.brainres.2019.146400			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE3XG	WOS:000490627600019	31445032	Bronze			2022-02-06	
J	Hwang, F; McGreevy, CM; Pentakota, SR; Verde, D; Park, JH; Berlin, A; Glass, NE; Livingston, DH; Mosenthal, A				Hwang, Franchesca; McGreevy, Christopher M.; Pentakota, Sri Ram; Verde, Davis; Park, Joo Hye; Berlin, Ana; Glass, Nina E.; Livingston, David H.; Mosenthal, Anne			Sarcopenia is Predictive of Functional Outcomes in Older Trauma Patients	CUREUS			English	Article						geriatric trauma; trauma icu; sarcopenia; mortality; functional outcomes; glasgow outcome scale; older trauma patients	MORTALITY; FRAILTY; AGE	Introduction: Older patients are more vulnerable to poor outcomes after trauma than younger patients. Sarcopenia, loss of skeletal mass, is prevalent in trauma patients admitted to the intensive care unit (ICU), and it has been shown to correlate with adverse outcomes, such as mortality and ICU days. Yet, little is known whether it predicts other outcomes. We hypothesized that sarcopenia independently predicts poor functional outcomes in older trauma patients admitted to the ICU. Methods: We performed a retrospective review of patients aged >55 admitted to a surgical ICU in a Level I trauma center for two years. Sarcopenic status was determined by measuring total skeletal muscle cross-sectional area at the L3 level on admission computed tomography (CT), normalized for height with sex-specific cutoffs. Primary outcome measures were in-hospital mortality, functional outcomes measured by the Glasgow Outcome Scale (GOS) at discharge, and discharge disposition. Multivariable logistic regression was used to determine predictors of primary outcomes. Results: Out of 230 patients, 32% were sarcopenic. The overall mortality was 20%, and 30% were discharged with poor functional outcomes. A higher proportion of sarcopenic patients among survivors had poor functional outcomes at discharge (55% vs. 30%, p=0.002). Sarcopenia was not predictive of inhospital mortality but was an independent predictor of poor functional outcomes at discharge (OR 2.6; 95% confidence interval [CI] 1.3-5.5), adjusting for age, Glasgow Coma Scale (GCS) on admission, diagnosis of traumatic brain injury (TBI), Injury Severity Score (ISS), and the number of life-limiting illnesses. Conclusions: Sarcopenia is prevalent in geriatric trauma ICU patients and is an independent predictor of poor functional outcomes. Assessing for sarcopenia has an important potential as a prognostic tool in older trauma patients.	[Hwang, Franchesca] Rutgers New Jersey Med Sch, Gen Surg, Newark, NJ 07103 USA; [McGreevy, Christopher M.] Univ Penn, Breast Surg, Philadelphia, PA 19104 USA; [Pentakota, Sri Ram; Glass, Nina E.; Livingston, David H.; Mosenthal, Anne] Rutgers New Jersey Med Sch, Surg, Newark, NJ USA; [Verde, Davis] Columbia Univ, Anesthesiol, New York, NY USA; [Park, Joo Hye] Univ Southern Calif, Internal Med, Keck Sch Med, Los Angeles, CA USA; [Berlin, Ana] Columbia Univ, Surg, New York, NY USA		Hwang, F (corresponding author), Rutgers New Jersey Med Sch, Gen Surg, Newark, NJ 07103 USA.	hwangjf@njms.rutgers.edu	Berlin, Ana/M-1146-2016; Pentakota, Sri Ram/ABB-8001-2020	Pentakota, Sri Ram/0000-0001-6872-1507; Glass, Nina/0000-0002-6821-4289	New Jersey Medical School Hispanic Center of Excellence, Health Resources and Services Administration [D34HP26020]; Patient Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [PCORI-1502-27462]; Auen Foundation	Support for this publication was provided by the New Jersey Medical School Hispanic Center of Excellence, Health Resources and Services Administration through Grant D34HP26020 (Dr. Berlin), by the Patient Centered Outcomes Research Institute through Grant PCORI-1502-27462 (Dr. Mosenthal), and by the Auen Foundation (Dr. Hwang).	Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Ebbeling L, 2014, EUR J TRAUMA EMERG S, V40, P57, DOI 10.1007/s00068-013-0313-3; Fairchild B, 2015, WORLD J SURG, V39, P373, DOI 10.1007/s00268-014-2785-7; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kaplan SJ, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.4604; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P805, DOI 10.1097/TA.0000000000000989; Maxwell CA, 2016, J TRAUMA ACUTE CARE, V80, P195, DOI 10.1097/TA.0000000000000929; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; National Trauma Data Bank, 2015, ANN REPORT; Ottochian M, 2009, INJURY, V40, P354, DOI 10.1016/j.injury.2008.10.015; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Roubenoff R, 2001, JAMA-J AM MED ASSOC, V286, P1230, DOI 10.1001/jama.286.10.1230; Yoo T, 2017, SURGERY, V162, P377, DOI 10.1016/j.surg.2017.03.014	17	6	6	1	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV 14	2019	11	11							e6154	10.7759/cureus.6154			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JN2XG	WOS:000496763200004	31890363	Green Published, gold			2022-02-06	
J	Bailie, JM; Remigio-Baker, RA; Cole, WR; McCulloch, KL; Ettenhofer, ML; West, T; Stuessi, K; Qashu, FM; Gregory, E				Bailie, Jason M.; Remigio-Baker, Rosemay A.; Cole, Wesley R.; McCulloch, Karen L.; Ettenhofer, Mark L.; West, Therese; Stuessi, Keith; Qashu, Felicia M.; Gregory, Emma			Use of the Progressive Return to Activity Guidelines May Expedite Symptom Resolution After Concussion for Active Duty Military	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						traumatic brain injury; concussion; progressive return to activity; medical education; military training	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; PHYSICAL-ACTIVITY; REST; RECOVERY; CARE; ASSOCIATION; INVENTORY; IMPACT	Background: Clinical recommendations for concussion management encourage reduced cognitive and physical activities immediately after injury, with graded increases in activity as symptoms resolve. Empirical support for the effectiveness of such recommendations is needed. Purpose: To examine whether training medical providers on the Defense and Veterans Brain Injury Center's Progressive Return to Activity Clinical Recommendation (PRA-CR) for acute concussion improves patient outcomes. Study Design: Cohort study; Level of evidence, 2. Methods: This study was conducted from 2016 to 2018 and compared patient outcomes before and after medical providers received an educational intervention (ie, provider training). Patients, recruited either before or after intervention, were assessed at <= 72 hours, 1 week, 1 month, 3 months, and 6 months after a concussion. The participant population included 38 military medical providers and 106 military servicemembers with a diagnosed concussion and treated by one of the military medical providers: 58 patient participants received care before the intervention (ie, provider training) and 48 received care after intervention. The primary outcome measure was the Neurobehavioral Symptom Inventory. Results: The patients seen before and after the intervention were predominantly male (89.7% and 93.8%, respectively) of military age (mean +/- SD, 26.62 +/- 6.29 years and 25.08 +/- 6.85 years, respectively) and a mean +/- SD of 1.92 +/- 0.88 days from injury. Compared with patients receiving care before intervention, patients receiving care after intervention had smaller increases in physical activities (difference in mean change; 95% CI, 0.39 to 6.79) and vestibular/balance activities (95% CI, 0.79 to 7.5) during the first week of recovery. Although groups did not differ in symptoms at <= 72 hours of injury (d = 0.22; 95% CI, -2.21 to 8.07), the postintervention group reported fewer symptoms at 1 week (d = 0.61; 95% CI, 0.52 to 10.92). Postintervention patients who completed the 6-month study had improved recovery both at 1 month (d = 1.55; 95% CI, 5.33 to 15.39) and 3 months after injury (d = 1.10; 95% CI, 2.36 to 11.55), but not at 6 months (d = 0.35; 95% CI, 5.34 to 7.59). Conclusion: Training medical providers on the PRA-CR for management of concussion resulted in expedited recovery of patients.	[Bailie, Jason M.; Remigio-Baker, Rosemay A.; Cole, Wesley R.; McCulloch, Karen L.; Ettenhofer, Mark L.; West, Therese; Stuessi, Keith; Qashu, Felicia M.; Gregory, Emma] Naval Med Ctr San Diego, San Diego, CA USA; [Bailie, Jason M.; Remigio-Baker, Rosemay A.; Cole, Wesley R.; Ettenhofer, Mark L.; Gregory, Emma] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Bailie, Jason M.; Remigio-Baker, Rosemay A.] Naval Hosp Camp Pendleton, Camp Pendleton, CA USA; [Bailie, Jason M.] Gen Dynam Hlth Solut, Fairfax, VA USA; [Remigio-Baker, Rosemay A.; McCulloch, Karen L.] Venesco, Chantilly, VA USA; [Cole, Wesley R.] Womack Army Med Ctr, Ft Bragg, NC USA; [McCulloch, Karen L.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Ettenhofer, Mark L.] Amer Hosp Serv Grp, Exton, PA USA; [West, Therese] US Army Med Res & Mat Command, Ft Detrick, MD USA; [Qashu, Felicia M.] NIH, Bldg 10, Bethesda, MD 20892 USA		Bailie, JM (corresponding author), Def & Vet Brain Injury Ctr Intrepid Spirit 7, Naval Hosp Camp Pendleton, 2016 Jacinto Rd, Camp Pendleton, CA 92055 USA.	jason.m.bailie.ctr@mail.mil			Defense Health Program 6.7 [6.7_14_C2_I_14_J9_1077]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was support by the Defense Health Program 6.7 (award number: 6.7_14_C2_I_14_J9_1077) and the Defense and Veterans Brain Injury Center. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, PROGR RET ACT FOLL M; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2015, OXFORD HDB SPORTS RE, DOI [10.1093/oxfordhb/9780199896585.013.17, DOI 10.1093/OXFORDHB/9780199896585.013.17]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prince J, 2020, J SPORT REHABIL, V29, P122, DOI 10.1123/jsr.2018-0224; Remigio-Baker RA, 2020, J HEAD TRAUMA REHAB, V35, P92, DOI 10.1097/HTR.0000000000000498; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Schmidt J, 2018, J NEUROL PHYS THER, V42, P155, DOI 10.1097/NPT.0000000000000226; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Strelzik J, 2017, PEDIATR ANN, V46, pE139, DOI 10.3928/19382359-20170320-02; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Varner CE, 2017, ACAD EMERG MED, V24, P75, DOI 10.1111/acem.13073; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	44	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2019	47	14					3505	3513	0363546519883259	10.1177/0363546519883259		NOV 2019	9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	JT2LZ	WOS:000498316700001	31718246	Bronze			2022-02-06	
J	Nelson, LD; Brett, BL; Magnus, BE; Balsis, S; McCrea, MA; Manley, GT; Temkin, N; Dikmen, S				Nelson, Lindsay D.; Brett, Benjamin L.; Magnus, Brooke E.; Balsis, Steve; McCrea, Michael A.; Manley, Geoffrey T.; Temkin, Nancy; Dikmen, Sureyya			Functional Status Examination Yields Higher Measurement Precision of Functional Limitations after Traumatic Injury than the Glasgow Outcome Scale-Extended: A Preliminary Study	JOURNAL OF NEUROTRAUMA			English	Article						FSE; GOSE; IRT; outcome measurement; TBI	CLINICAL-TRIALS; BRAIN-INJURY; RECOMMENDATIONS; EXPERIENCE	The Glasgow Outcome Scale-Extended (GOSE) is one of the most widely used measures of functional limitations after traumatic brain injury (TBI), and is the primary outcome measure used in clinical trials of acute TBI treatment. However, the GOSE appears insensitive to the full spectrum of TBI-related functional limitations, which may limit its potential to capture treatment effects or correlate with other variables that impact outcome. The Functional Status Examination (FSE) was designed to improve on the assessment of injury-related functional limitations using a standardized assessment and wider possible score range. The aim of this pilot study was to employ item response theory (IRT) to test the hypothesis that the FSE yields more precise estimation of functional outcome than the GOSE. Traumatically injured patients (n = 100, 77 TBI, 23 orthopedic injuries) were interviewed at 3 months post-injury using both the GOSE and FSE structured interviews. IRT was used to quantify and compare the tests' information functions, which reflect the degree to which each instrument precisely measures functional limitations across the severity spectrum. Findings were consistent with predictions: the FSE yielded stronger measurement of functional limitations (i.e., higher test information) across a wider range of severity than the GOSE, whether scoring the GOSE from all interview items or using the traditional GOSE overall score. Although the FSE appears to be a promising alternative measure to the GOSE, further research is needed to cross-validate these findings in a larger sample and understand how to best deploy it in clinical and translational research.	[Nelson, Lindsay D.; Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Magnus, Brooke E.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Balsis, Steve] Univ Massachusetts Lowell, Dept Psychol, Boston, MA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Ctr Trauma, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu		Magnus, Brooke/0000-0001-6905-972X	Medical College of Wisconsin Center for Advancing Population Science; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS110856]; United States Army Medical Research Acquisition Activity (USAMRRA) [W81XWH-13-1-0441]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR001436]	This pilot study was funded by the Medical College of Wisconsin Center for Advancing Population Science. Data analyses and manuscript preparation were supported by National Institutes of Health (NIH) grant R01NS110856 and United States Army Medical Research Acquisition Activity (USAMRRA) grant W81XWH-13-1-0441. Study data were collected and managed using REDCap electronic data capture tools hosted at the Medical College of Wisconsin, which was supported by National Institutes of Health grant UL1TR001436. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Army and do not necessarily represent the official views of the NIH.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Altman D.G., 1990, PRACTICAL STAT MED R; [Anonymous], 2017, IRTPRO WIND VERS 4 2; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Balsis S, 2018, ASSESSMENT, V25, P360, DOI 10.1177/1073191117745125; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.3102/10769986022003265; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S, 2019, J NEUROTRAUM, V36, P2423, DOI 10.1089/neu.2018.6198; Hays RD, 2000, MED CARE, V38, P28; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Naggara O, 2011, AM J NEURORADIOL, V32, P437, DOI 10.3174/ajnr.A2425; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ranson J, 2019, J NEUROTRAUM, V36, P2493, DOI 10.1089/neu.2018.5998; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	22	6	7	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					675	679		10.1089/neu.2019.6719		NOV 2019	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000496153100001	31663425	Green Published			2022-02-06	
J	Drake, SA; Holcomb, JB; Yang, YJ; Thetford, C; Myers, L; Brock, M; Wolf, DA; Persse, D; Naik-Mathuria, BJ; Wade, CE; Harting, MT				Drake, Stacy A.; Holcomb, John B.; Yang, Yijiong; Thetford, Caitlin; Myers, Lauren; Brock, Morgan; Wolf, Dwayne A.; Persse, David; Naik-Mathuria, Bindi J.; Wade, Charles E.; Harting, Matthew T.			Establishing a regional pediatric trauma preventable/potentially preventable death rate	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pediatric trauma; Mortality data; Injury; Trauma systems; Pediatric trauma death	PREHOSPITAL DEATHS; MORTALITY; INJURY; EPIDEMIOLOGY; HEMORRHAGE; OUTCOMES; IMPACT; TIME; ROOM; CARE	Purpose Although trauma is the leading cause of death for the pediatric population, few studies have addressed the preventable/potentially preventable death rate (PPPDR) attributable to trauma. Methods This is a retrospective study of trauma-related death records occurring in Harris County, Texas in 2014. Descriptive and Chi-squared tests were conducted for two groups, pediatric and adult trauma deaths in relation to demographic characteristics, mechanism of injury, death location and survival time. Results There were 105 pediatric (age < 18 years) and 1738 adult patients. The PPPDR for the pediatric group was 21.0%, whereas the PPPDR for the adult group was 37.2% (p = 0.001). Analysis showed fewer preventable/potentially preventable (P/PP) deaths resulting from any blunt trauma mechanism in the pediatric population than in the adult population (19.6% vs. 48.4%, p < 0.001). Amongst the pediatric population, P/PP traumatic brain injury (TBI) were more common in the youngest age range (age 0-5) vs. the older (6-12 years) pediatric and adolescent (13-17 years) patients. Conclusion Our results identify areas of opportunities for improving pediatric trauma care. Although the overall P/PP death rate is lower in the pediatric population than the adult, opportunities for improving initial acute care, particularly TBI, exist.	[Drake, Stacy A.] Texas A&M Univ, Houston, TX 77030 USA; [Holcomb, John B.] Univ Alabama Birmingham, Birmingham, AL USA; [Yang, Yijiong] Univ Texas Hlth Sci Ctr Houston, Cizik Sch Nursing, Houston, TX 77030 USA; [Thetford, Caitlin; Naik-Mathuria, Bindi J.] Baylor Coll Med, Houston, TX 77030 USA; [Myers, Lauren; Naik-Mathuria, Bindi J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Brock, Morgan] Lyndon B Johnson Gen Hosp, Houston, TX USA; [Brock, Morgan; Harting, Matthew T.] Childrens Mem Hermann Hosp, Houston, TX USA; [Wolf, Dwayne A.] Harris Cty Inst Forens Sci, Houston, TX USA; [Persse, David] Dept Hlth & Human Serv City Houston, Houston, TX USA; [Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Wade, Charles E.; Harting, Matthew T.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA		Drake, SA (corresponding author), Texas A&M Univ, Houston, TX 77030 USA.	sadrake@tamu.edu; jbholcomb@uabmc.edu; Yijiong.Yang@uth.tmc.edu; crthetford@gmail.com; Lauren.Myers2391@gmail.com; Morgan.N.Brock@gmail.com; Dwayne.Wolf@ifs.hctx.net; David.Persse@houstontx.gov; bjnaikma@texaschildrens.org; Charles.E.Wade@uth.tmc.edu; Matthew.T.Harting@uth.tmc.edu		holcomb, john/0000-0001-8312-9157; Harting, Matthew/0000-0002-8929-8311	UTHealth Cizik School of Nursing PARTNERS Grant; UTHealth Center for Translational Injury Research (CeTIR)	The study was in part funded from two internal UTHealth sources: UTHealth Cizik School of Nursing PARTNERS Grant and Center for Translational Injury Research (CeTIR). No external funding was utilized for this manuscript. The authors have indicated they have no financial relationships relevant to this article to disclose.	Alarhayem AQ, 2016, AM J SURG, V212, P1101, DOI 10.1016/j.amjsurg.2016.08.018; Barmparas G, 2017, INT J SURG, V43, P137, DOI 10.1016/j.ijsu.2017.05.068; Center for Disease Prevention and Control, 2014, 10 LEAD CAUS DEATH A; Diamond IR, 2009, J TRAUMA, V66, P1189, DOI 10.1097/TA.0b013e31819adbb3; Drake SA, 2019, AM J FOREN MED PATH, V40, P108, DOI 10.1097/PAF.0000000000000455; Drake SA, 2020, ANN SURG, V271, P375, DOI 10.1097/SLA.0000000000002999; Drake Stacy A, 2017, Trauma Surg Acute Care Open, V2, pe000106, DOI 10.1136/tsaco-2017-000106; DYKES EH, 1989, J TRAUMA, V29, P724, DOI 10.1097/00005373-198906000-00004; DYKES EH, 1989, J PEDIATR SURG, V24, P107, DOI 10.1016/S0022-3468(89)80312-4; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Esposito TJ, 1999, J TRAUMA, V47, P243, DOI 10.1097/00005373-199908000-00004; Holcomb JB, 2018, CRIT CARE MED, V46, P447, DOI 10.1097/CCM.0000000000002915; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kotwal RS, 2017, J TRAUMA ACUTE CARE, V82, pS9, DOI 10.1097/TA.0000000000001428; Kuo LE, 2017, SURGERY, V161, P782, DOI 10.1016/j.surg.2016.08.017; Matsumoto S, 2018, SURG TODAY, V48, P1004, DOI 10.1007/s00595-018-1687-y; Maxson T, 2017, J AM COLL SURGEONS, V224, P489, DOI 10.1016/j.jamcollsurg.2016.12.042; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Montmany S, 2016, INJURY, V47, P669, DOI 10.1016/j.injury.2015.11.028; National Academeies of Science Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; National Institute of Child Health and Human Development, 2016, WHAT CAUS PED INJ; Nordin A, 2018, J PEDIATR SURG, V53, P1020, DOI 10.1016/j.jpedsurg.2018.02.036; Oliver GJ, 2017, INJURY, V48, P978, DOI 10.1016/j.injury.2017.01.039; Oliver GJ, 2017, INJURY, V48, P985, DOI 10.1016/j.injury.2017.02.026; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Parikh Kavita, 2017, Hosp Pediatr, V7, P303, DOI 10.1542/hpeds.2016-0146; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sleet David A, 2011, MMWR Suppl, V60, P78; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Spinella PC, 2017, CURR OPIN HEMATOL, V24, P529, DOI 10.1097/MOH.0000000000000386; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae	32	6	6	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	FEB	2020	36	2					179	189		10.1007/s00383-019-04597-9		NOV 2019	11	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	KT5HK	WOS:000495051100003	31701301				2022-02-06	
J	Liu, HL; Liu, SW; Tian, XC; Wang, Q; Rao, JY; Wang, YC; Xiang, F; Zheng, H; Xu, L; Dong, Z				Liu, Hailin; Liu, Shengwei; Tian, Xiaocui; Wang, Qian; Rao, Jiangyan; Wang, Yucun; Xiang, Fei; Zheng, Hang; Xu, Lu; Dong, Zhi			Bexarotene Attenuates Focal Cerebral Ischemia-Reperfusion Injury via the Suppression of JNK/Caspase-3 Signaling Pathway	NEUROCHEMICAL RESEARCH			English	Article						Ischemia; reperfusion; Bexarotene; Apolipoprotein-E; Apoptosis; Neuroprotection	E-DEFICIENT MICE; BEHAVIORAL DEFICITS; BRAIN-INJURY; APOLIPOPROTEIN; MOTOR; INFLAMMATION; ACTIVATION; APOPTOSIS; CASPASE-3; PROTECTS	Apolipoprotein E (APOE) is implicated not only in chronic degenerative neurological diseases, such as Alzheimer's disease, but also in acute brain disorders, including traumatic brain injury. Bexarotene, a selective agonist of the retinoid X receptor, has been reported to enhance markedly the expression of APOE. Previous studies have indicated that bexarotene exerts neuroprotective effects in animal models of ischemic stroke by modulating the peripheral immune response and autophagy. However, the role of this drug in neuronal apoptosis and the potential mechanisms involved have yet to be elucidated. The present study employed transient middle cerebral artery occlusion (t-MCAO) as a model of acute cerebral ischemia/reperfusion injury. The experiments were performed in wild-type C57BL/6 mice and APOE gene knockout (APOE-KO) mice. After t-MCAO, mice received intraperitoneal injection of bexarotene (5 mg/kg) or an equal volume of the vehicle. The outcome measurements included neurological deficits, learning ability, spatial memory, infarct volume, histopathology, magnitude of apoptosis, and the level of expression of proteins of the JNK/caspase-3 signaling pathway. The obtained results demonstrated that bexarotene administration significantly improved neurological function, learning ability, and spatial memory in C57BL/6 mice, but not in APOE-KO mice. Infarct volume, tissue damage, neuronal apoptosis rate, and the expression of proteins involved in the JNK/caspase-3 signaling pathway were markedly increased after t-MCAO in both C57BL/6 and APOE-KO mice. Importantly, bexarotene treatment significantly ameliorated all these changes in C57BL/6, but not in APOE-KO mice. In conclusion, bexarotene markedly alleviates the neurological deficits, improves the histological outcome, and inhibits cell apoptosis in mice after t-MCAO. This effect is mediated, at least in part, by up-regulation of APOE. Thus, bexarotene may be a candidate drug for the treatment of cerebral ischemia patients.	[Liu, Hailin; Liu, Shengwei; Tian, Xiaocui; Wang, Qian; Rao, Jiangyan; Wang, Yucun; Xiang, Fei; Zheng, Hang; Dong, Zhi] Chongqing Med Univ, Coll Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Xu, Lu] Chongqing Med & Pharmaceut Coll, Sch Pharm, Chongqing 41331, Peoples R China; [Liu, Hailin] First Peoples Hosp Chongqing Liangjiang New Dist, Dept Pharm, Chongqing 401121, Peoples R China		Dong, Z (corresponding author), Chongqing Med Univ, Coll Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.; Xu, L (corresponding author), Chongqing Med & Pharmaceut Coll, Sch Pharm, Chongqing 41331, Peoples R China.	xulu8792@163.com; 100798@cqmu.edu.cn		Liu, Shengwei/0000-0002-2102-3434	Chongqing Science Technology Commission of China [cstc2015zdcy-ztzx120003, CSTC 2016jcyjA0268, CSTC2018jcyjAX0821]; Chongqing Municipal Health Bureau [2014-2-223]	This study was supported by research grants from the Chongqing Science Technology Commission of China (Grants Nos. cstc2015zdcy-ztzx120003, CSTC 2016jcyjA0268, and CSTC2018jcyjAX0821) and the Chongqing Municipal Health Bureau (Grant No. 2014-2-223).	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bachmeier C, 2013, J MOL NEUROSCI, V49, P270, DOI 10.1007/s12031-012-9866-6; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Certo M, 2015, PHARMACOL RES, V102, P298, DOI 10.1016/j.phrs.2015.10.009; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Fonarow GC, 2010, CIRCULATION, V121, P879, DOI 10.1161/CIRCULATIONAHA.109.892497; Fuentes D, 2018, BEHAV SCI, V8, DOI 10.3390/bs8030033; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Huuskonen MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33176; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Liu B, 2016, MOL MED REP, V14, P4144, DOI 10.3892/mmr.2016.5785; Liu GY, 2013, BIOMED REP, V1, P861, DOI 10.3892/br.2013.153; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Luo Y, 2017, ONCOTARGET, V8, P35558, DOI 10.18632/oncotarget.16009; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Na KS, 2007, MOL CELLS, V24, P261; Osada N, 2009, NEUROCHEM INT, V54, P403, DOI 10.1016/j.neuint.2009.01.010; Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003; Pineiro R, 2000, STROKE, V31, P672, DOI 10.1161/01.STR.31.3.672; Riancho J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00250; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Sapkota A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171479; Sugo N, 2002, STROKE, V33, P1660, DOI 10.1161/01.STR.0000016967.76805.BF; Tachibana M, 2016, EXP NEUROL, V277, P1, DOI 10.1016/j.expneurol.2015.12.003; Thirugnanachandran T, 2018, INT J STROKE, V13, P277, DOI 10.1177/1747493017743056; Tunctan B, 2018, INFLAMMATION, V41, P337, DOI 10.1007/s10753-017-0691-5; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122744; Yang LY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0772-7; Yang YM, 2013, CARBOHYD POLYM, V98, P1383, DOI 10.1016/j.carbpol.2013.07.045; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003	41	6	8	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2019	44	12					2809	2820		10.1007/s11064-019-02902-5		NOV 2019	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KJ8LT	WOS:000493787700001	31680194				2022-02-06	
J	Alashram, AR; Annino, G; Mercuri, NB				Alashram, Anas R.; Annino, Giuseppe; Mercuri, Nicola Biagio			Rhythmic auditory stimulation in gait rehabilitation for traumatic brain and spinal cord injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Rhythmic auditory stimulation; Spinal cord injury; Traumatic brain injury; Gait; Rehabilitation		Walking impairments consider one from common secondary impairments post-traumatic brain injury (TBI) and spinal cord injury (SCI). As the evidence showed that RAS is effective in improving the gait ability in those with other neurological disorders, we propose that RAS is also effective in those with TBI and SCI. The aim was to test our hypothesis. Two pilot studies were included. In the first study, eight individuals with TBI participated in RAS experimental 1. Besides, five individuals participated in RAS experimental 2. In the second study, seventeen individuals with incomplete SCI participated RAS intervention. The included studies reported beneficial effects of RAS on gait ability in TBI and SCI population. Specifically, in the walking pattern aspect post-TBI, the cadence post thoracic incomplete SCI, besides, velocity and stride length post cervical incomplete SCI. Despite no confirmed conclusion that can be drawn, the initial findings of the existing evidence on the influences of RAS on gait ability in individuals with TBI and SCI are promising. Special attention should be given by researchers to conduct more researches on this topic to confirm using this approach in clinical practice in the future. (C) 2019 Elsevier Ltd. All rights reserved.	[Alashram, Anas R.; Mercuri, Nicola Biagio] Univ Roma Tor Vergata, Fac Med & Surg, Sch Neurosci, Rome, Italy; [Annino, Giuseppe; Mercuri, Nicola Biagio] Univ Roma Tor Vergata, Dept Med Syst, Rome, Italy; [Annino, Giuseppe] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy; [Mercuri, Nicola Biagio] IRCSS Fdn Santa Lucia, Rome, Italy		Alashram, AR (corresponding author), Via Cambridge 115, Rome, Italy.	anasradihassan.alashram@students.uniroma2.eu; mercurin@med.uniroma2.it	Mercuri, Nicola Biagio/K-5348-2016; Alashram, Anas/AAU-4481-2021	Mercuri, Nicola Biagio/0000-0001-6700-7491; Alashram, Anas/0000-0002-3066-3943			de I'Etoile SK, 2008, INT J REHABIL RES, V31, P155, DOI 10.1097/MRR.0b013e3282fc0f44; Ghai S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38723-3; Ghai S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00386; Ghai S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16232-5; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Lunenburger L, 2006, WILEY ENCY BIOMED EN, DOI [10.1002/9780471740360.ebs1393, DOI 10.1002/9780471740360.EBS1393]; Thaut MH, 1999, MOVEMENT DISORD, V14, P808, DOI 10.1002/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J; Thaut MH, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01185; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263	10	6	6	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2019	69						287	288		10.1016/j.jocn.2019.08.080			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JP5SV	WOS:000498325100054	31451378				2022-02-06	
J	Anehosur, V; Kulkarni, K; Shetty, S; Kumar, N				Anehosur, Venkatesh; Kulkarni, Kaustubh; Shetty, Spoorti; Kumar, Niranjan			Clinical outcomes of endoscopic vs retromandibular approach for the treatment of condylar fractures-a randomized clinical trial	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							ASSISTED OPEN REDUCTION; MANDIBULAR CONDYLE; INTERNAL-FIXATION; EXTRAORAL APPROACH; RIGID FIXATION	Objective. Condylar fractures remain the most controversial topic in maxillofacial trauma. Open reduction and internal fixation (ORIF) with use of an extraoral approach has certain benefits over the nonsurgical treatment. Concerns, however, remain about the risk of facial nerve injury, postoperative facial nerve weakness, and facial scarring when operating in this region despite the various extraoral approaches that have been developed. The recently popularized endoscope-assisted open reduction and internal fixation (EAORIF) is claimed to provide better results because it is minimally invasive, provides excellent visibility, and eliminates surgical scarring and the risk of facial nerve injury. This study, therefore, aims to compare the retromandibular (extraoral) approach and EAORIF for the treatment of condylar fractures. Study Design. A prospective analysis of 32 cases of condylar fractures that reported to the SDM Craniofacial Centre (Dharwad, India) was carried out. Sixteen patients had been treated with the retromandibular (RM) approach, and 16 had undergone EAORIF in the period from 2012- 2017. Patients were evaluated for clinical parameters, such as fracture site, displacement, and surgical duration, as well as for functional parameters, such as occlusion, maximum interincisal opening, deviation of mouth on lateral movements, temporomandibular joint (TMJ) pain and clicking, and facial nerve weakness. Statistical significance was elicited with P <.05. Results. The patients subjected to either approach had suffered fractures of the low condylar neck and the subcondyle. Maximum interincisal opening, mandibular deviation, occlusion, and TMJ function at postoperative month 6 were comparable between the groups. Although no permanent facial nerve injury was seen in this study, the incidence of transient facial nerve weakness was higher in the RM group (56.25%) compared with the EAORIF group (6.25%) (P =.036). The surgical time was longer in the EAORIF group (RM: 107 +/- 19.7 minutes and EAORIF: 155 +/- 18.2 minutes) (P =.04). The rest of the parameters were comparable between both groups. Conclusions. Although there is consensus on closed reduction in pediatric and adult condylar head fractures, the role of a surgical approach to treatment of displaced condylar neck and subcondylar fractures remains controversial. In our study, both surgical approaches were found to be suitable for the treatment of these fractures.	[Anehosur, Venkatesh; Kulkarni, Kaustubh; Shetty, Spoorti] SDM Coll Dent Sci & Hosp, Craniofacial Unit, Dharwad 580009, Karnataka, India; [Kumar, Niranjan] SDM Coll Dent Sci & Hosp, Craniofacial Unit, Dept Plast Surg, Dharwad, Karnataka, India		Anehosur, V (corresponding author), SDM Coll Dent Sci & Hosp, Craniofacial Unit, Dharwad 580009, Karnataka, India.	venkyrao12@yahoo.co.in	ANEHOSUR, VENKATESH/AAW-8384-2021; Kumar, Niranjan/ABD-5036-2021	Kumar, Niranjan/0000-0002-0384-6859			ALEXANDER R, 1994, J ORAL MAXIL SURG, V52, P808, DOI 10.1016/0278-2391(94)90223-2; Baker AW, 1998, INT J ORAL MAX SURG, V27, P258, DOI 10.1016/S0901-5027(05)80507-7; Boehle AP, 2015, J CRANIO MAXILL SURG, V43, P224, DOI 10.1016/j.jcms.2014.11.010; Colletti G, 2014, J CRANIO MAXILL SURG, V42, pE186, DOI 10.1016/j.jcms.2013.08.005; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Handschel J, 2012, J CRANIO MAXILL SURG, V40, pE397, DOI 10.1016/j.jcms.2012.02.012; Hwang NH, 2016, J CRANIOFAC SURG, V27, P1170, DOI 10.1097/SCS.0000000000002774; Jensen T, 2006, J ORAL MAXIL SURG, V64, P1771, DOI 10.1016/j.joms.2005.12.069; Kang SH, 2012, OR SURG OR MED OR PA, V113, P201, DOI 10.1016/j.tripleo.2011.02.005; Lee C, 1998, PLAST RECONSTR SURG, V102, P1434, DOI 10.1097/00006534-199810000-00016; Lo J, 2006, J ORAL MAXIL SURG, V64, P1443, DOI 10.1016/j.joms.2006.05.029; Meyer C, 2006, J CRANIO MAXILL SURG, V34, P173, DOI 10.1016/j.jcms.2005.09.005; Meyer C, 2007, J CRANIOMAXILLOFAC S, V35, pY90; Mueller Reid V, 2006, Facial Plast Surg Clin North Am, V14, P1; Nogami S, 2012, J CRANIOFAC SURG, V23, P1815, DOI 10.1097/SCS.0b013e3182710393; RAVEH J, 1989, J ORAL MAXIL SURG, V47, P120, DOI 10.1016/S0278-2391(89)80100-4; Schmelzeisen R, 2009, J ORAL MAXIL SURG, V67, P147, DOI 10.1016/j.joms.2008.09.019; Schon R, 2002, INT J ORAL MAX SURG, V31, P237, DOI 10.1054/ijom.2001.0213; You HJ, 2016, INT J ORAL MAX SURG, V45, P284, DOI 10.1016/j.ijom.2015.11.005; ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8	21	6	6	4	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	NOV	2019	128	5					479	484		10.1016/j.oooo.2018.12.007			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	JM7WA	WOS:000496419000008	31227460				2022-02-06	
J	Armstead, WM; Vavilala, MS				Armstead, William M.; Vavilala, Monica S.			Propranolol protects cerebral autoregulation and reduces hippocampal neuronal cell death through inhibition of interleukin-6 upregulation after traumatic brain injury in pigs	BRITISH JOURNAL OF ANAESTHESIA			English	Article						beta blockers; catecholamine; traumatic brain injury; cerebral autoregulation; histopathology; interleukin-6; neuroinflammation; propranolol	BETA-BLOCKER EXPOSURE; CARDIAC DYSFUNCTION; NITROUS-OXIDE; CHILDREN	Background: Traumatic brain injury (TBI) is associated with reduced cerebral blood flow and impaired autoregulation after TBI, which may lead to poor outcome. Clinical evidence has implicated neurological injuries and associated neuroinflammation as causes of cardiac dysfunction. Studies on newborn pigs show an association of elevated catecholamines with a sex-dependent impairment of cerebral autoregulation after TBI. One strategy to decrease sympathetic hyperactivity is pharmacological intervention with beta blockade. We tested the hypothesis that propranolol would prevent the impairment of cerebral autoregulation and tissue changes after TBI via inhibition of interleukin-6 (IL-6) upregulation. Methods: Using newborn pigs of both sexes equipped with a closed cranial window, TBI was induced via lateral fluid percussion injury. Propranolol was administered at 1 h post-TBI. Analyses included cerebral autoregulation (pial artery reactivity) before and 4 h post-TBI, CSF IL-6 analysed (enzyme-linked immunosorbent assay), and histopathology at 4 h post-TBI. Results: Propranolol administration prevented impairment of hypotensive dilation in both male and female newborn pigs after fluid percussion injury, which was paralleled by reduced upregulation of IL-6 in the CSF. Moreover, propranolol prevented neuronal cell death in cornu amonis (CA)1 and CA3 hippocampus equivalently in male and female pigs after TBI. Papaverine-induced dilation was unchanged by TBI and propranolol. Conclusions: These data indicate that sympathetic hyperactivity noted after TBI can be limited by propranolol administration to result in improved brain outcome post-injury via block of IL-6 upregulation, and this effect is irrespective of sex.	[Armstead, William M.] Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anaesthesiol Paediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; Armstead, WM (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	National Institutes of Health (R01 NS090998).	[Anonymous], TITLE ERROR; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bedford NM, 1999, ANESTH ANALG, V89, P170; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Curvello V, 2019, NEUROCRIT CARE, V30, P467, DOI 10.1007/s12028-018-0638-1; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Genet GF, 2018, J TRAUMA ACUTE CARE, V84, P89, DOI 10.1097/TA.0000000000001708; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Hekierski H, 2019, J NEUROTRAUM, V36, P630, DOI 10.1089/neu.2018.5824; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy Vijay, 2015, Int J Crit Illn Inj Sci, V5, P103, DOI 10.4103/2229-5151.158409; Krishnamoorthy V, 2015, PEDIATR CRIT CARE ME, V16, pE107, DOI 10.1097/PCC.0000000000000397; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lewis PR, 2016, J TRAUMA ACUTE CARE, V80, P643, DOI 10.1097/TA.0000000000000957; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Loftus TJ, 2016, SHOCK, V46, P341, DOI 10.1097/SHK.0000000000000636; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104	31	6	7	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	NOV	2019	123	5					610	617		10.1016/j.bja.2019.07.017			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JD4NR	WOS:000489956100021	31542162	Green Published, Bronze			2022-02-06	
J	Auxemery, Y				Auxemery, Y.			Towards a new nosography of post-traumatic psychic disorders: Interests and limits	EUROPEAN JOURNAL OF TRAUMA & DISSOCIATION			French	Article						Psychological trauma; Post-traumatic stress disorder; Post traumatic psychic disorders; Nosography; Anthropology; Sociology		Background. - Post-traumatic stress disorder is not just about post-traumatic stress disorder! The complexity of the psychic consequences of psychological trauma often results in delayed care and/or partial compensation for the damage suffered. Providing for severe clinical presentations, the interlinking of many symptoms is sometimes confusing to such an extent that the traumatic origin of the suffering remains masked by other more apparent difficulties. However, only the precise recognition of the clinical situation as a whole picture make it possible to implement the most appropriate and most diligent care in order to improve the prognosis. Objectives. - Our objectives are to formalize a global and precise clinical analysis, useful to the clinical activity of care and expert as well as to clinical research and, more generally, to the conception that we can have of the psychic traumatism as its clinical consequences. We especially wish to specify the links and sequencing of the symptoms at the semiological level. Finally, it is a question of proposing a classification in didactic format to reach the greatest number of caregivers and clinical researchers. Methodology. - From a socio-anthropological point of view, we address the origin and definitional modifications of "post-traumatic stress disorder'' in the diagnostic and statistical classification of psychic disorders, from DSM-I to DSM-5, in order to better understand the current description and to define its limits. Then, based on our clinical experience enriched with data from international literature, we propose a precise definition of psychic trauma followed by a new nosography of post-traumatic psychic disorders, new in the sense that it appears more detailed and dynamic than all those brought to our knowledge. Results. - After defining the psychic trauma, the immediate clinical reaction and the chronic cardinal symptoms, we detail the mood, anxious and psychotic clinical forms of post-traumatic psychic disorders. We mention somatoform expressions, psychosomatic and somatic consequences (with implications of possible traumatic brain injury), before specifying the traumatic impact on instinctual functions, behaviors, personality organization, and coping abilities (professional and private). Discussion. - Let us never forget that the vast majority of scientific research has, in the medical-psychological field, aimed at facilitating the therapeutic course. Here, closer to each patient, a classification-only approach seems insufficient. This is why we associate other semiological clinical evaluations with other perspectives such as the dimensional and psychodynamic approaches. From classificatory generalities to a singular clinical situation, from global principles referenced to stress to an approach centered on the trauma experienced by an individual, two worlds can meet on the side of subjectivity. If one of the initial objectives of the international classifications was to reduce the "diagnostic subjectivity'' in psychiatry, the nosographic entities nevertheless remain changeable from one reprint to another, reflecting what we call the "societal subjectivity''. The validity of diagnoses could still increase in the future by the characterization of biomarkers, although we cannot know if the clinical approach would be truly upset. The current clinical practice is always resulting from the transmission of knowledge from one generation of practitioners to another and, in the same therapist, from a changing experience according to the patients encountered. The issues are vast and the so-called "scientific'' methodology with reference to the uses of the moment could appear insufficient. Beyond a virtual psychiatry, whether it is solely administrative or neurobiological alone, our models must also be useful both for the transmission of clinical experience and for a revision of the paradigms of scientific research. (C) 2019 Elsevier Masson SAS. All rights reserved.	[Auxemery, Y.] Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France		Auxemery, Y (corresponding author), Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France.	yann.auxemery@intradef.gouv.fr					Ahern J, 2004, J NERV MENT DIS, V192, P217, DOI 10.1097/01.nmd.0000116465.99830.ca; Ahl R, 2017, INJURY, V48, P101, DOI 10.1016/j.injury.2016.10.041; Alarcon RD, 1999, PSYCHIATRY, V62, P114, DOI 10.1080/00332747.1999.11024860; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIGN STAT MAN MENT D; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1952, DIAGN STAT MAN MENT; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; [Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; Auxemery Y, 2015, ENCEPHALE, V41, P346, DOI 10.1016/j.encep.2014.07.005; Auxemery Y, 2011, ENCEPHALE, V37, P433, DOI 10.1016/j.encep.2010.12.001; Auxemery Y, 2015, EVOL PSYCHIATR, V80, P659, DOI 10.1016/j.evopsy.2014.05.001; Auxemery Y, 2014, ANN MED-PSYCHOL, V172, P519, DOI 10.1016/j.amp.2012.04.007; Auxemery Y, 2014, EVOL PSYCHIATR, V79, P287, DOI 10.1016/j.evopsy.2014.01.002; Auxemery Y, 2014, EVOL PSYCHIATR, V79, P79, DOI 10.1016/j.evopsy.2013.07.002; Auxemery Y, 2012, MED HYPOTHESES, V79, P667, DOI 10.1016/j.mehy.2012.08.005; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brewerton TD, 2017, EAT WEIGHT DISORD-ST, V22, P241, DOI 10.1007/s40519-016-0355-8; Breyer BN, 2016, J TRAUMA STRESS, V29, P229, DOI 10.1002/jts.22097; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Crocq L., 1999, PSYCHOL TRAUMAS WAR; David D, 1999, J CLIN PSYCHIAT, V60, P29, DOI 10.4088/JCP.v60n0106; Deb S, 1999, AM J PSYCHIAT, V156, P374; Ducrocq F, 2001, ENCEPHALE, V27, P159; El-Hage W, 2006, PRESSE MED, V35, P1683, DOI 10.1016/S0755-4982(06)74881-3; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fostick L, 2012, WORLD J BIOL PSYCHIA, V13, P312, DOI 10.3109/15622975.2011.607848; Fox GC, 1999, BRIT J PSYCHIAT, V174, P560, DOI 10.1192/S0007125000262703; Freeman D, 2013, PSYCHOL MED, V43, P2673, DOI 10.1017/S003329171300038X; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Harder LH, 2011, J NERV MENT DIS, V199, P940, DOI 10.1097/NMD.0b013e3182392bfb; Hartman D, 2001, POSTGRAD MED J, V77, P244, DOI 10.1136/pmj.77.906.244; Hartung, 2015, INTERVENTIONS IMPROV; Hippocrates, 1923, CORPUS HIPPROCRATICU; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krakow B, 2000, COMPR PSYCHIAT, V41, P49, DOI 10.1016/S0010-440X(00)90131-7; Lin KH, 2016, OCCUP MED-OXFORD, V66, P514, DOI 10.1093/occmed/kqw036; Lucretius K., 1910, RERUM NATURE NATURE; McKinney JM, 2017, J AFFECT DISORDERS, V214, P100, DOI 10.1016/j.jad.2017.03.008; Mol SSL, 2005, BRIT J PSYCHIAT, V186, P494, DOI 10.1192/bjp.186.6.494; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Orr SP, 2000, J AFFECT DISORDERS, V61, P225, DOI 10.1016/S0165-0327(00)00340-2; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Ouimette P, 2010, ADDICT BEHAV, V35, P64, DOI 10.1016/j.addbeh.2009.08.009; Pivar IL, 2004, J ANXIETY DISORD, V18, P745, DOI 10.1016/j.janxdis.2003.09.005; POLLOCK DA, 1990, AM J PSYCHIAT, V147, P772; Price M, 2015, J AFFECT DISORDERS, V186, P149, DOI 10.1016/j.jad.2015.06.012; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Reuber M, 2004, J NEUROL NEUROSUR PS, V75, P743, DOI 10.1136/jnnp.2003.013821; Richman H, 1997, Depress Anxiety, V6, P70, DOI 10.1002/(SICI)1520-6394(1997)6:2<70::AID-DA3>3.0.CO;2-9; Roelofs K, 2005, J NERV MENT DIS, V193, P508, DOI 10.1097/01.nmd.0000172472.60197.4d; Roley ME, 2015, J AFFECT DISORDERS, V180, P116, DOI 10.1016/j.jad.2015.04.006; Romano H, 2010, ANN MED-PSYCHOL, V168, P416, DOI 10.1016/j.amp.2010.04.014; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seedat S, 2003, J NERV MENT DIS, V191, P675, DOI 10.1097/01.nmd.0000092177.97317.26; Sellbom M, 2009, J TRAUMA STRESS, V22, P471, DOI 10.1002/jts.20452; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Silove D, 2010, J TRAUMA STRESS, V23, P169, DOI 10.1002/jts.20490; SOLOMON Z, 1989, PSYCHIATRY, V52, P428, DOI 10.1080/00332747.1989.11024467; STENGEL E., 1959, BULL WORLD HEALTH ORGAN, V21, P601; Sundquist K, 2016, J PSYCHOSOM RES, V86, P60, DOI 10.1016/j.jpsychores.2016.05.007; Swearingen JM, 2017, MIL MED, V182, P258, DOI 10.7205/MILMED-D-16-00107; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Teng EJ, 2015, J ANXIETY DISORD, V33, P1, DOI 10.1016/j.janxdis.2015.04.002; Tsai J, 2014, J CLIN PSYCHIAT, V75, P276, DOI 10.4088/JCP.13m08466; Vierling V, 2015, PRESSE MED, V44, pE339, DOI 10.1016/j.lpm.2015.04.039; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Waddington A, 2003, ENCEPHALE, V29, P20; Yehuda R, 2015, J SEX MED, V12, P1107, DOI 10.1111/jsm.12856; Zayfert C, 2005, J NERV MENT DIS, V193, P93, DOI 10.1097/01.nmd.0000152795.47479.d9; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	86	6	6	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7499			EUR J TRAUMA DISSOC	Eur. J. Trauma Dissociation	NOV	2019	3	4					245	256		10.1016/j.ejtd.2019.02.002			12	Psychology, Clinical; Psychiatry	Emerging Sources Citation Index (ESCI)	Psychology; Psychiatry	VJ9GI	WOS:000646084600006					2022-02-06	
J	Clifford, RE; Baker, D; Risbrough, VB; Huang, MX; Yurgil, KA				Clifford, Royce E.; Baker, Dewleen; Risbrough, Victoria B.; Huang, Mingxiong; Yurgil, Kate A.			Impact of TBI, PTSD, and Hearing Loss on Tinnitus Progression in a US Marine Cohort	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; VETERANS; PREVALENCE; DEPLOYMENT; CRITERION; PERSONNEL; PROGRAM; MEMORY; ADULTS	Introduction: Mild TBI (TBI) is associated with up to a 75.7% incidence of tinnitus, and 33.0% of tinnitus patients at the US Veterans Administration carry a diagnosis of post-traumatic stress syndrome (PTSD). Yet factors contributing to new onset or exacerbation of tinnitus remain unclear. Materials and Methods: Here we measure intermittent and constant tinnitus at two time points to ascertain whether pre-existing or co-occurring traumatic brain injury (TBI), hearing loss, or post-traumatic stress disorder (PTSD) predicts new onset, lack of recovery and/or worsening of tinnitus in 2,600 United States Marines who were assessed before and after a combat deployment. Results: Ordinal regression revealed that constant tinnitus before deployment was likely to continue after deployment (odds ratio [OR] = 28.62, 95% confidence interval [CI]: 9.84,83.26). Prior intermittent tinnitus increased risk of post-deployment constant tinnitus (OR = 4.95, CI: 2.97,8.27). Likelihood of tinnitus progression increased with partial PTSD (OR = 2.39, CI: 1.50,3.80) and TBI (OR = 1.59, CI: 1.13,2.23), particularly for blast TBI (OR = 2.01, CI: 1.27,3.12) and moderate to severe TBI (OR = 2.57, CI: 1.46,4.51). Tinnitus progression also increased with low frequency hearing loss (OR = 1.94, CI: 1.05,3.59), high frequency loss (OR = 3.01, CI: 1.91,4.76) and loss across both low and high frequency ranges (OR = 5.73, CI: 2.67,12.30). Conclusions: Screening for pre-existing or individual symptoms of PTSD, TBI, and hearing loss may allow for more focused treatment programs of comorbid disorders. Identification of those personnel vulnerable to tinnitus or its progression may direct increased acoustic protection for those at risk.	[Clifford, Royce E.; Baker, Dewleen; Risbrough, Victoria B.; Yurgil, Kate A.] VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Clifford, Royce E.; Baker, Dewleen; Risbrough, Victoria B.; Yurgil, Kate A.] Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Clifford, Royce E.] Harvard Univ, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Baker, Dewleen; Risbrough, Victoria B.] Univ Calif San Diego, Dept Psychiat, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Yurgil, Kate A.] Loyola Univ New Orleans, Dept Psychol Sci, 6363 St Charles Ave,Box 194, New Orleans, LA 70118 USA		Clifford, RE (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.; Clifford, RE (corresponding author), Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.; Clifford, RE (corresponding author), Harvard Univ, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.		Clifford, Royce/X-8799-2019; Baker, Dewleen/O-4957-2019	Clifford, Royce/0000-0002-5515-4336; Baker, Dewleen/0000-0002-1736-9838	CDMRP Grant [MR141217]; VA Center for Excellence in Stress and Mental Health, San Diego, CA	This research was supported by a grant from CDMRP Grant Number MR141217 and VA Center for Excellence in Stress and Mental Health, San Diego, CA. The sponsors had no role in data collection or manuscript preparation.	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; [Anonymous], 2017, ANN BEN REP FY2017; Araneda R, 2015, RESTOR NEUROL NEUROS, V33, P67, DOI 10.3233/RNN-140433; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; Balaban C, 2011, INT STAT OF THE SCI; Elgoyhen AB, 2015, NAT REV NEUROSCI, V16, P632, DOI 10.1038/nrn4003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Cox RC, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0773-y; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Defense and Veterans Brain Injury Center Working Group, 2006, AC MAN MILD TRAUM BR; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gopinath B, 2010, EAR HEARING, V31, P407, DOI 10.1097/AUD.0b013e3181cdb2a2; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Henry James A, 2008, Trends Amplif, V12, P170, DOI 10.1177/1084713808319941; Hoffer Michael E, 2013, Int Tinnitus J, V18, P6, DOI 10.5935/0946-5448.20130002; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; Karch Stephanie J, 2016, US Army Med Dep J, P52; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; Malakouti Seyed, 2011, Int Tinnitus J, V16, P118; Masino C, 2014, TELEMED E-HEALTH, V20, P1150, DOI 10.1089/tmj.2013.0350; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Myers PJ, 2014, J REHABIL RES DEV, V51, P609, DOI 10.1682/JRRD.2013.08.0189; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Phillips JS, 2018, LARYNGOSCOPE, V128, P217, DOI 10.1002/lary.26607; Rikkert M, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1512248; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Shah A, 2014, LARYNGOSCOPE, V124, P272, DOI 10.1002/lary.24169; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Simonetti P, 2015, INT ARCH OTORHINOLAR, V19, P259, DOI 10.1055/s-0035-1548671; Swan A, 2015, J HEAD TRAUMA REHAB, V30, pE109; Vanneste S, 2016, BRAIN RES, V1642, P170, DOI 10.1016/j.brainres.2016.03.016; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wallhausser-Franke E, 2013, SLEEP MED REV, V17, P65, DOI 10.1016/j.smrv.2012.04.003; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Wingfield A, 2007, J GERONTOL A-BIOL, V62, P1294, DOI 10.1093/gerona/62.11.1294; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	48	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2019	184	11-12					839	846		10.1093/milmed/usz016			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KG8TE	WOS:000510223200053	30793178	hybrid			2022-02-06	
J	Gardner, AJ; Quarrie, KL; Iverson, GL				Gardner, Andrew J.; Quarrie, Kenneth L.; Iverson, Grant L.			The Epidemiology of Sport-Related Concussion: What the Rehabilitation Clinician Needs to Know	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						athletes; concussion; epidemiology; injury surveillance; management	TRAUMATIC BRAIN-INJURY; MEDICINE POSITION STATEMENT; NCAA DIVISION I; HIGH-SCHOOL; UNITED-STATES; RUGBY UNION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; OPERATIONAL DEFINITION	SYNOPSIS: Sport-related concussion is common in full-contact and collision sports. Epidemiology studies use different types of surveillance systems and concussion definitions. Concussion incidence rates vary across age, sex, sport, and level of competition. Incidence rates are increasing, likely due to higher rates of reporting following improved knowledge and increased regulations. In this review, we summarize 7 key concepts related to concussion epidemiology: concussion definition, changes in concussion knowledge, reliability and accuracy of injury surveillance systems, conservative management and return to play, reliability of self-report, incidence of concussion across levels of play, and understanding the behaviors of players, coaches, and medical personnel from a multidisciplinary management perspective.	[Gardner, Andrew J.] Hunter New England Local Hlth Dist, Sports Concuss Program, New Lambton, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW 2208, Australia; [Quarrie, Kenneth L.] New Zealand Rugby, Wellington, New Zealand; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Res Inst, Concuss Res Program,Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp, Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Traumat Brain Injury Program, Boston, MA USA		Gardner, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW 2208, Australia.	Andrew.Gardner@newcastle.edu.au		Gardner, Andrew/0000-0001-5031-5586	National Football League; National Health and Medical Research Council Early Career FellowshipNational Health and Medical Research Council of Australia; Hunter New England Local Health District Partnerships, Innovation and Research Unit-Health Research and Translation Centre clinical research fellowship scheme; University of Newcastle's Priority Research Centre for Stroke and Brain Injury; Australian Football League; NSW Sporting Injuries Committee; Brain Foundation (Australia); Hunter Medical Research Institute; ImPACT Applications, Inc; CNS Vital Signs, LLC; PAR, Inc.; Mooney-Reed Charitable Foundation Trust; Spaulding Research Institute	This commentary was funded in part by the National Football League for a program of research titled "The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-term Effects." Unrestricted philanthropic support was provided by ImPACT Applications, Inc, the Mooney-Reed Charitable Foundation Trust, and the Spaulding Research Institute. Dr Gardner is currently funded through a National Health and Medical Research Council Early Career Fellowship; the Hunter New England Local Health District Partnerships, Innovation and Research Unit-Health Research and Translation Centre clinical research fellowship scheme; and the University of Newcastle's Priority Research Centre for Stroke and Brain Injury. Dr Gardner has a clinical practice in neuropsychology involving individuals who have sustained sport-related concussion (including current and former athletes). He has operated as a contracted concussion consultant to Rugby Australia since July 2016. Dr Gardner has received travel funding from the Australian Football League to present at the Concussion in Football Conference in 2013 and 2017. Previous grant funding was received from the NSW Sporting Injuries Committee; the Brain Foundation (Australia); and the Hunter Medical Research Institute, supported by Jennie Thomas and by Anne Greaves. Dr Quarrie is employed as the Senior Scientist at New Zealand Rugby. Dr Iverson has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild traumatic brain injuries. He has received research funding from several test publishing companies, including ImPACT Applications, Inc; CNS Vital Signs, LLC; and PAR, Inc. He receives royalties from the sales of a computerized neuropsychological test (Wisconsin Card Sorting Test-64 Card Version).	Adams I D, 1977, Br J Sports Med, V11, P4; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Blake TA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022735; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks, 2018, ENGLAND PROFESSIONAL; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Campbell-McGovern C, 2018, INJURY PREV, V24, P319, DOI 10.1136/injuryprev-2018-042831; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Comstock RD, 2016, SUMMARY REPORT NATL; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; DAVIES JE, 1978, BRIT MED J, V2, P1759, DOI 10.1136/bmj.2.6154.1759; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dixon G, 1993, NZ J SPORTS MED, V21, P18; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kuhn Andrew W, 2016, Concussion, V1, pCNC1, DOI 10.2217/cnc.15.1; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Langley J, 2004, INJURY PREV, V10, P69, DOI 10.1136/ip.2003.003715; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; O'Rourke KP, 2007, INJURY, V38, P104, DOI 10.1016/j.injury.2006.06.010; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Quarrie KL, 2014, BRIT J SPORT MED, V48, P1589, DOI 10.1136/bjsports-2014-094112; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; ROUX CE, 1987, S AFR MED J, V71, P307; Sarac N, 2017, PHYSICIAN SPORTSMED, V45, P458, DOI 10.1080/00913847.2017.1386068; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Sharp JCM, 2001, BRIT J SPORT MED, V35, P34, DOI 10.1136/bjsm.35.1.34; SMITHERS M, 1985, MED J AUSTRALIA, V142, P457, DOI 10.5694/j.1326-5377.1985.tb113452.x; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Targett SGR, 1998, CLIN J SPORT MED, V8, P280, DOI 10.1097/00042752-199810000-00005; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Yard EE, 2006, J ATHL TRAINING, V41, P325; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	94	6	6	1	9	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					768	778		10.2519/jospt.2019.9105			11	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100002	31672116				2022-02-06	
J	Jiang, F; Jaja, BNR; Kurpad, SN; Badhiwala, JH; Aarabi, B; Grossman, RG; Harrop, JS; Guest, JD; Schar, RT; Shaffrey, CI; Boakye, M; Toups, EG; Wilson, JR; Fehlings, MG				Jiang, Fan; Jaja, Blessing N. R.; Kurpad, Shekar N.; Badhiwala, Jetan H.; Aarabi, Bizhan; Grossman, Robert G.; Harrop, James S.; Guest, Jim D.; Schar, Ralph T.; Shaffrey, Chris, I; Boakye, Max; Toups, Elizabeth G.; Wilson, Jefferson R.; Fehlings, Michael G.		North Amer Clinical Trials Network	Acute Adverse Events After Spinal Cord Injury and Their Relationship to Long-term Neurologic and Functional Outcomes: Analysis From the North American Clinical Trials Network for Spinal Cord Injury	CRITICAL CARE MEDICINE			English	Article						adverse events; complications; functional recovery; neurologic recovery; North American Clinical Trials Network; spinal cord injury	METHYLPREDNISOLONE SODIUM SUCCINATE; TRAUMATIC BRAIN-INJURY; RESPIRATORY COMPLICATIONS; RISK-FACTORS; INPATIENT COMPLICATIONS; PRACTICE GUIDELINE; FRACTURE FIXATION; UNITED-STATES; CRITICAL-CARE; ACUTE-PHASE	Objectives: There are few contemporary, prospective multicenter series on the spectrum of acute adverse events and their relationship to long-term outcomes after traumatic spinal cord injury. The goal of this study is to assess the prevalence of adverse events after traumatic spinal cord injury and to evaluate the effects on long-term clinical outcome. Design: Multicenter prospective registry. Setting: Consortium of 11 university-affiliated medical centers in the North American Clinical Trials Network. Patients: Eight-hundred one spinal cord injury patients enrolled by participating centers. Interventions: Appropriate spinal cord injury treatment at individual centers. Measurements and Main Results: A total of 2,303 adverse events were recorded for 502 patients (63%). Penalized maximum logistic regression models were fitted to estimate the likelihood of neurologic recovery (ASIA Impairment Scale improvement >= 1 grade point) and functional outcomes in subjects who developed adverse events at 6 months postinjury. After accounting for potential confounders, the group that developed adverse events showed less neurologic recovery (odds ratio, 0.55; 95% CI, 0.32-0.96) and was more likely to require assisted breathing (odds ratio, 6.55; 95% CI, 1.17-36.67); dependent ambulation (odds ratio, 7.38; 95% CI, 4.35-13.06) and have impaired bladder (odds ratio, 9.63; 95% CI, 5.19-17.87) or bowel function (odds ratio, 7.86; 95% CI, 4.31-14.32) measured using the Spinal Cord Independence Measure subscores. Conclusions: Results from this contemporary series demonstrate that acute adverse events are common and are associated with worsened long-term outcomes after traumatic spinal cord injury.	[Jiang, Fan; Jaja, Blessing N. R.; Badhiwala, Jetan H.; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto Western Hosp, Toronto, ON, Canada; [Jiang, Fan] Univ Toronto, Toronto Western Hosp, Div Orthopaed Surg, Toronto, ON, Canada; [Jaja, Blessing N. R.; Schar, Ralph T.; Wilson, Jefferson R.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Kurpad, Shekar N.] Med Coll Wisconsin, Div Neurosurg, Milwaukee, WI 53226 USA; [Aarabi, Bizhan] Univ Maryland, Div Neurosurg, Shock Trauma, Baltimore, MD 21201 USA; [Grossman, Robert G.; Toups, Elizabeth G.] Methodist Hosp, Div Neurosurg, 6535 Fannin, Houston, TX 77030 USA; [Harrop, James S.] Thomas Jefferson Univ Hosp, Div Neurosurg, Philadelphia, PA 19107 USA; [Guest, Jim D.] Univ Miami, Div Neurosurg, Miami, FL USA; [Shaffrey, Chris, I] Univ Virginia, Div Neurosurg, Chalottesville, VA USA; [Boakye, Max] Univ Louisville, Div Neurosurg, Louisville, KY 40292 USA		Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto Western Hosp, Toronto, ON, Canada.	michael.fehlings@uhn.ca	Schar, Ralph T./P-3895-2019	Schar, Ralph T./0000-0001-8998-9668; Guest, James/0000-0003-0931-0286	Christopher Reeve Foundation; InSightec; North American Clinical Trials Network (NACTN); California Institute of Regenerative MedicineCalifornia Institute for Regenerative Medicine; AbbvieAbbVie; NACTN; Zimmer-Biomet; MedtronicMedtronic; NuVasive; EOS; SiemensSiemens AG; Department of Defense Joint Warfare Medical Research Program grantUnited States Department of Defense; Fortuna Fix; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	Christopher Reeve Foundation supports the North American Clinical Trials Network for the Treatment of Spinal Cord Injury and the AOSpine Spinal Cord Injury Knowledge Forum.; Dr. Grossman received funding from InSightec. Dr. Guest's institution received funding from North American Clinical Trials Network (NACTN); he received funding from the California Institute of Regenerative Medicine and Abbvie; and he received support for article research from NACTN. Dr. Shaffrey's institution received funding from NACTN and Zimmer-Biomet, and he received funding from Medtronic, NuVasive, EOS, and Siemens. Dr. Toups's institution received funding from the Department of Defense Joint Warfare Medical Research Program grant. Dr. Fehlings received funding from Fortuna Fix; he disclosed that the Christopher Reeve Foundation supports the NACTN for the Treatment of Spinal Cord Injury; and he would like to acknowledge support from the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the DeZwirek Family Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aarabi B, 2012, J NEUROSURG-SPINE, V17, P38, DOI 10.3171/2012.4.AOSPINE1295; Aito S, 2007, SPINAL CORD, V45, P627, DOI 10.1038/sj.sc.3102018; Aito S, 2003, SPINAL CORD, V41, P629, DOI 10.1038/sj.sc.3101513; Boakye M, 2008, J NEUROTRAUM, V25, P173, DOI 10.1089/neu.2007.0395; Bourassa-Moreau E, 2013, J TRAUMA ACUTE CARE, V74, P849, DOI 10.1097/TA.0b013e31827e1381; Brienza D, 2018, SPINAL CORD, V56, P28, DOI 10.1038/sc.2017.96; Burns SP, 2004, SPINAL CORD, V42, P450, DOI 10.1038/sj.sc.3101600; Cardozo CP, 2007, J SPINAL CORD MED, V30, P307, DOI 10.1080/10790268.2007.11753945; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Catz Amiram, 2002, Harefuah, V141, P1025; Chamberlain JD, 2015, NEUROEPIDEMIOLOGY, V44, P182, DOI 10.1159/000382079; Chen YY, 2005, ARCH PHYS MED REHAB, V86, P1208, DOI 10.1016/j.apmr.2004.12.023; Chipman JG, 2004, J TRAUMA, V56, P52, DOI 10.1097/01.TA.0000108630.34225.85; Cotton BA, 2005, J TRAUMA, V59, P1400, DOI 10.1097/01.ta.0000196005.49422.e6; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; Dimar JR, 2010, J TRAUMA, V69, P1497, DOI 10.1097/TA.0b013e3181cc853b; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Fehlings MG, 2017, GLOB SPINE J, V7, p195S, DOI 10.1177/2192568217706367; Fehlings MG, 2017, GLOB SPINE J, V7, p203S, DOI 10.1177/2192568217703085; Fehlings MG, 2017, GLOB SPINE J, V7, p116S, DOI 10.1177/2192568217706366; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Garcia-Arguello LY, 2017, SPINAL CORD, V55, P526, DOI 10.1038/sc.2016.173; Ge L, 2018, WORLD NEUROSURG, V111, pE411, DOI 10.1016/j.wneu.2017.12.008; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hadley MN, 2002, NEUROSURGERY, V50, pS63; Haisma JA, 2007, J REHABIL MED, V39, P393, DOI 10.2340/16501977-0067; Hamid R, 2018, WORLD J UROL, V36, P1517, DOI 10.1007/s00345-018-2301-z; Hartkopp A, 1997, SPINAL CORD, V35, P76, DOI 10.1038/sj.sc.3100351; Ito Y, 2009, SPINE, V34, P2121, DOI 10.1097/BRS.0b013e3181b613c7; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Jones TS, 2015, AM J SURG, V209, P363, DOI 10.1016/j.amjsurg.2014.07.016; Kerwin AJ, 2008, J TRAUMA, V65, P824, DOI 10.1097/TA.0b013e318182af7b; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Lavis Timothy, 2019, Phys Med Rehabil Clin N Am, V30, P55, DOI 10.1016/j.pmr.2018.08.010; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Marion TE, 2017, J NEUROTRAUM, V34, P2883, DOI 10.1089/neu.2016.4933; Matsumoto T, 2001, SPINE, V26, P426, DOI 10.1097/00007632-200102150-00020; Mchenry TP, 2006, J BONE JOINT SURG AM, V88A, P997, DOI 10.2106/JBJS.E.00560; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1402, DOI 10.1016/S0003-9993(99)90251-4; Mitchell R, 2018, SPINE J, V18, P1172, DOI 10.1016/j.spinee.2017.11.013; New PW, 2010, SPINE, V35, P796, DOI 10.1097/BRS.0b013e3181be76f5; O'Connor PJ, 2006, ACCIDENT ANAL PREV, V38, P71, DOI 10.1016/j.aap.2005.03.025; Ploumis A, 2009, J BONE JOINT SURG AM, V91A, P2568, DOI 10.2106/JBJS.H.01411; Regan MA, 2009, ARCH PHYS MED REHAB, V90, P213, DOI 10.1016/j.apmr.2008.08.212; Ropper Alexander E, 2015, Pract Neurol, V15, P266, DOI 10.1136/practneurol-2015-001094; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Schilero GJ, 2018, CLIN CHEST MED, V39, P411, DOI 10.1016/j.ccm.2018.02.002; Schwartzbauer G, 2016, SEMIN NEUROL, V36, P577, DOI 10.1055/s-0036-1592189; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Sewell MD, 2018, WORLD NEUROSURG, V118, pE161, DOI 10.1016/j.wneu.2018.06.146; Spinal Cord Injury (SCI), 2016, J SPINAL CORD MED, V39, P493, DOI [10.1080/10790268.2016.1210925, DOI 10.1080/10790268.2016.1210925]; Street JT, 2015, SPINE J, V15, P923, DOI 10.1016/j.spinee.2013.06.051; TATOR CH, 1993, PARAPLEGIA, V31, P700, DOI 10.1038/sc.1993.112; Wannapakhe J, 2015, J SPINAL CORD MED, V38, P84, DOI 10.1179/2045772313Y.0000000173; Wilson JR, 2017, GLOB SPINE J, V7, p95S, DOI 10.1177/2192568217701716; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P46, DOI 10.3171/2012.4.AOSPINE1246; Yue JK, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17396	62	6	6	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2019	47	11					E854	E862		10.1097/CCM.0000000000003937			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD1HE	WOS:000489725000001	31389834				2022-02-06	
J	Le Prell, CG; Hammill, TL; Murphy, WJ				Le Prell, Colleen G.; Hammill, Tanisha L.; Murphy, William J.			Noise-induced hearing loss and its prevention: Integration of data from animal models and human clinical trials	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; TEMPORARY THRESHOLD SHIFT; NUTRITION EXAMINATION SURVEY; PORTABLE LISTENING DEVICES; HIGH-FREQUENCY AUDIOMETRY; INTENSIVE IMPULSE NOISE; ACUTE ACOUSTIC TRAUMA; BRAIN-STEM RESPONSE; GUINEA-PIG COCHLEA; POP-ROCK MUSICIANS	Animal models have been used to gain insight into the risk of noise-induced hearing loss (NIHL) and its potential prevention using investigational new drug agents. A number of compounds have yielded benefit in pre-clinical (animal) models. However, the acute traumatic injury models commonly used in pre-clinical testing are fundamentally different from the chronic and repeated exposures experienced by many human populations. Diverse populations that are potentially at risk and could be considered for enrollment in clinical studies include service members, workers exposed to occupational noise, musicians and other performing artists, and children and young adults exposed to non-occupational (including recreational) noise. Both animal models and clinical populations were discussed in this special issue, followed by discussion of individual variation in vulnerability to NIHL. In this final contribution, study design considerations for NIHL otoprotection in pre-clinical and clinical testing are integrated and broadly discussed with evidence-based guidance offered where possible, drawing on the contributions to this special issue as well as other existing literature. The overarching goals of this final paper are to (1) review and summarize key information across contributions and (2) synthesize information to facilitate successful translation of otoprotective drugs from animal models into human application.	[Le Prell, Colleen G.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75080 USA; [Hammill, Tanisha L.] Def Hlth Agcy, Dept Def, Falls Church, VA 22042 USA; [Murphy, William J.] NIOSH, Div Field Studies & Engn, Cincinnati, OH 45226 USA		Le Prell, CG (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75080 USA.	colleen.leprell@utdallas.edu			USAMRAA [W81XWH-19-C-0054, JPC-8/SRMRP W81XWH1820014]; NIH-NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1R01DC014088]; 3M Inc.3M; Emilie and Phil Schepps Professorship in Hearing Science; Sound Pharmaceuticals, Inc.; Edison Pharmaceuticals, Inc.; Hearing Health Science, Inc; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC014088] Funding Source: NIH RePORTER	C.G.L. is currently supported by USAMRAA Grant Nos. W81XWH-19-C-0054, JPC-8/SRMRP W81XWH1820014, NIH-NIDCD 1R01DC014088, 3M Inc., and the Emilie and Phil Schepps Professorship in Hearing Science. C.G.L. has previously received contract funding and/or clinical trial material from industry partners including Sound Pharmaceuticals, Inc., Edison Pharmaceuticals, Inc., and Hearing Health Science, Inc. The authors gratefully acknowledge administrative support provided by J. R. Stefanson (HCE), and the editorial support of Liz Bury, Kelly Quigley, and James Lynch (Acoustical Society of America). The authors thank Chris Spankovich for helpful comments and suggestions on an earlier version of this manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the U.S. Department of Defense, Centers for Disease Control and Prevention, or the National Institute for Occupational Safety and Health.	Abaamrane L, 2009, HEARING RES, V247, P137, DOI 10.1016/j.heares.2008.11.005; Abaamrane L, 2011, EUR ARCH OTO-RHINO-L, V268, P987, DOI 10.1007/s00405-011-1487-0; ABEL SM, 1980, J OTOLARYNGOL, V9, P256; ABEL SM, 1982, J ACOUST SOC AM, V71, P708, DOI 10.1121/1.387547; ABEL SM, 1991, J OTOLARYNGOL, V20, P46; Ackermann BJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00973; Adelman C, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-14; American Academy of Audiology, 2009, POS STAT CLIN PRACT; [Anonymous], 1979, JAMA-J AM MED ASSOC, V241, P2055; [Anonymous], 2010, DEP DEF INSTR NUMBER; [Anonymous], 1994, ASHA S12, V36, P11; ARLINGER S, 1992, SCAND AUDIOL, V21, P123, DOI 10.3109/01050399209045992; ATTIAS J, 1994, AM J OTOLARYNG, V15, P26, DOI 10.1016/0196-0709(94)90036-1; Attias Joseph, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P119; Auchter M, 2014, AM J AUDIOL, V23, P211, DOI 10.1044/2014_AJA-14-0001; AXELSSON A, 1978, ACTA OTO-LARYNGOL, V85, P225, DOI 10.3109/00016487809121444; AXELSSON A, 1995, EAR HEARING, V16, P245, DOI 10.1097/00003446-199506000-00001; Barbee Christi M, 2018, Semin Hear, V39, P172, DOI 10.1055/s-0038-1641743; Barlow Nathan, 2016, Seminars in Hearing, V37, P84, DOI 10.1055/s-0035-1570335; Beach EF, 2012, J HEALTH PSYCHOL, V17, P237, DOI 10.1177/1359105311412839; Beach EF, 2017, MED PROBL PERFORM AR, V32, P101, DOI 10.21091/mppa.2017.2017; Beach EF, 2016, GLOB HEALTH PROMOT, V23, P45, DOI 10.1177/1757975914558887; Behar A, 2018, NOISE HEALTH, V20, P42, DOI 10.4103/nah.NAH_39_17; Berger EH, 2019, J ACOUST SOC AM, V146, P3873, DOI 10.1121/1.5132712; Bevis ZL, 2014, NOISE HEALTH, V16, P127, DOI 10.4103/1463-1741.132101; Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; Bielefeld EC, 2019, J ACOUST SOC AM, V146, P3790, DOI 10.1121/1.5132285; Bielefeld EC, 2013, J AM ACAD AUDIOL, V24, P461, DOI 10.3766/jaaa.24.6.3; Bielefeld EC, 2011, NEUROSCI RES, V71, P348, DOI 10.1016/j.neures.2011.07.1836; Bockstael A, 2015, NOISE HEALTH, V17, P198, DOI 10.4103/1463-1741.160688; Bockstael A, 2011, J ACOUST SOC AM, V129, P3702, DOI 10.1121/1.3575599; Boger Marlene Escher, 2017, Int Tinnitus J, V20, P88, DOI 10.5935/0946-5448.20160017; Bogoch II, 2005, CAN J PUBLIC HEALTH, V96, P69, DOI 10.1007/BF03404022; BOHNE BA, 1977, AM FAM PHYSICIAN, V15, P117; Borchgrevink HM, 1996, SCIENTIFIC BASIS OF NOISE-INDUCED HEARING LOSS, P299; Bramhall N, 2019, HEARING RES, V377, P88, DOI 10.1016/j.heares.2019.02.016; Bramhall NF, 2019, J ACOUST SOC AM, V146, P3849, DOI 10.1121/1.5132708; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Brown AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122982; Brungart DS, 2004, J ACOUST SOC AM, V116, P1897, DOI 10.1121/1.1786812; Burns W, 1970, HEARING NOISE IND; Burton JA, 2019, J ACOUST SOC AM, V146, P3770, DOI 10.1121/1.5132709; Campbell K, 2016, OTOL NEUROTOL, V37, pE263, DOI 10.1097/MAO.0000000000001135; Campbell KCM, 2016, PHASE 2 CLIN TRIALS; Canlon B, 1998, NEUROREPORT, V9, P269, DOI 10.1097/00001756-199801260-00017; CANLON B, 1995, HEARING RES, V84, P112, DOI 10.1016/0378-5955(95)00020-5; Canlon B, 1997, Ear Nose Throat J, V76, P248; Canlon B, 1999, HEARING RES, V127, P158, DOI 10.1016/S0378-5955(98)00170-1; Cantley LF, 2019, J ACOUST SOC AM, V146, P4044, DOI 10.1121/1.5132542; Cantley LF, 2015, INT J AUDIOL, V54, pS30, DOI 10.3109/14992027.2014.981305; Cantley LF, 2015, SCAND J WORK ENV HEA, V41, P75, DOI 10.5271/sjweh.3450; CARDER HM, 1972, J SPEECH HEAR RES, V15, P603, DOI 10.1044/jshr.1503.603; Casali JG, 2010, INT J ACOUST VIB, V15, P168; Casali JG, 2010, INT J ACOUST VIB, V15, P187; Casali JG, 2009, NOISE HEALTH, V11, P69, DOI 10.4103/1463-1741.48564; Casto KL, 2012, MIL MED, V177, P1114, DOI 10.7205/MILMED-D-12-00184; Cha J, 2015, INT J AUDIOL, V54, P984, DOI 10.3109/14992027.2015.1080863; Chan P, 2016, MIL MED, V181, P59, DOI 10.7205/MILMED-D-15-00139; Chasin M., 2010, HEAR MUSIC HEARING L; Chesky K, 2000, MED PROBL PERFORM AR, V15, P35; Chi FL, 2011, J LARYNGOL OTOL, V125, P673, DOI 10.1017/S0022215111000028; CHUNG DY, 1979, J AM AUDITORY SOC, V5, P11; Clasing JE, 2014, INT J AUDIOL, V53, pS43, DOI 10.3109/14992027.2013.860489; Clifford RE, 2019, J ACOUST SOC AM, V146, P4007, DOI 10.1121/1.5132552; Coleman JKM, 2007, HEARING RES, V226, P70, DOI 10.1016/j.heares.2006.05.006; Cousins RPC, 2019, J ACOUST SOC AM, V146, P3652, DOI 10.1121/1.5132706; Davis RI, 1996, SCIENTIFIC BASIS OF NOISE-INDUCED HEARING LOSS, P134; Davis RI, 2012, NOISE HEALTH, V14, P330, DOI 10.4103/1463-1741.104903; Decory L., 1992, NOISE INDUCED HEARIN, P229; Deiters K. K., 2019, SASRAC TECHNICAL REP; Deiters KK, 2019, J ACOUST SOC AM, V146, P3993, DOI 10.1121/1.5132705; Derebery MJ, 2012, OTOL NEUROTOL, V33, P1136, DOI 10.1097/MAO.0b013e31825f2328; Dille MF, 2010, J ACOUST SOC AM, V128, P1163, DOI 10.1121/1.3473693; Dobie R. A, 2015, MED LEGAL EVALUATION, P83; Dobie RA, 2017, INT J AUDIOL, V56, P74, DOI 10.1080/14992027.2016.1255359; Dobie RA, 2015, AM J IND MED, V58, P1311, DOI 10.1002/ajim.22534; Dolan Thomas G, 2005, Am J Audiol, V14, P80, DOI 10.1044/1059-0889(2005/007); Doosti A, 2014, NOISE HEALTH, V16, P223, DOI 10.4103/1463-1741.137057; Duan ML, 2004, HEARING RES, V192, P1, DOI 10.1016/j.heares.2004.02.005; DUNN DE, 1991, J ACOUST SOC AM, V90, P1979, DOI 10.1121/1.401677; Earshen J. J., 1986, NOISE HEARING CONSER, P41; El Dib RP, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-151; Environmental Protection Agency, 1974, 550974004 EPA; ERLANDSSON B, 1987, ACTA OTO-LARYNGOL, V103, P204, DOI 10.3109/00016488709107785; Escabi CD, 2019, J ACOUST SOC AM, V146, P3692, DOI 10.1121/1.5132553; Estill CF, 2017, J SAFETY RES, V60, P35, DOI 10.1016/j.jsr.2016.11.005; Feder K, 2019, J ACOUST SOC AM, V146, P3934, DOI 10.1121/1.5132949; Federman J, 2008, J SPEECH LANG HEAR R, V51, P147, DOI 10.1044/1092-4388(2008/011); Fetoni AR, 2014, NEUROSCI RES, V81-82, P30, DOI 10.1016/j.neures.2014.01.006; Flamme G. A., 2019, J OCCUP ENV MED; Flamme GA, 2017, INT J AUDIOL, V56, P52, DOI 10.1080/14992027.2016.1257164; Flamme GA, 2014, INT J AUDIOL, V53, pS5, DOI 10.3109/14992027.2013.857435; Fontana JM, 2019, J ACOUST SOC AM, V146, P3960, DOI 10.1121/1.5132290; Fraenkel Rachel, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P95; Franze A, 2003, INT J AUDIOL, V42, P227, DOI 10.3109/14992020309101318; Frye MD, 2019, J ACOUST SOC AM, V146, P4020, DOI 10.1121/1.5132545; Fulbright Angela N. C., 2017, Seminars in Hearing, V38, P298, DOI 10.1055/s-0037-1606325; Giguere C, 2016, INT J AUDIOL, V55, pS30, DOI 10.3109/14992027.2015.1129460; Giguere C, 2015, INT J AUDIOL, V54, pS9, DOI 10.3109/14992027.2014.973540; Girard SA, 2015, INJURY PREV, V21, pE88, DOI 10.1136/injuryprev-2013-040828; Gittleman SN, 2019, J ACOUST SOC AM, V146, P3800, DOI 10.1121/1.5133393; Gordon JS, 2017, HEARING RES, V349, P21, DOI 10.1016/j.heares.2016.11.014; GOWER DW, 1994, HUM FACTORS, V36, P350, DOI 10.1177/001872089403600214; Graydon K, 2019, J LARYNGOL OTOL, V133, P18, DOI 10.1017/S0022215118001275; Grinn S. K, 2019, THESIS; Grinn SK, 2019, J ACOUST SOC AM, V146, P3967, DOI 10.1121/1.5132546; Grinn SK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00465; Grose JH, 2017, TRENDS HEAR, V21, DOI 10.1177/2331216517737417; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Halevi-Katz DN, 2015, NOISE HEALTH, V17, P158, DOI 10.4103/1463-1741.155848; HALLMO P, 1995, SCAND AUDIOL, V24, P47, DOI 10.3109/01050399509042209; Hamernik RP, 1999, HEARING RES, V137, P127, DOI 10.1016/S0378-5955(99)00131-8; Hamernik RP, 2003, J ACOUST SOC AM, V114, P386, DOI 10.1121/1.1582446; Hammill T. L., 2017, THESIS; Harding GW, 2004, J ACOUST SOC AM, V115, P2207, DOI 10.1121/1.1689961; Harris KC, 2005, HEARING RES, V208, P14, DOI 10.1016/j.heares.2005.04.009; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Haupt H, 2003, ORL-J OTO-RHIN-LARYN, V65, P134, DOI 10.1159/000072250; Haupt H, 2002, MAGNESIUM RES, V15, P17; Hecht QA, 2019, J ACOUST SOC AM, V146, P3839, DOI 10.1121/1.5132710; Heinrich UR, 2008, LARYNGOSCOPE, V118, P837, DOI 10.1097/MLG.0b013e31816381ae; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; HENSELMAN LW, 1994, HEARING RES, V78, P1, DOI 10.1016/0378-5955(94)90038-8; Hetu R, 1995, J Am Acad Audiol, V6, P378; Hickox AE, 2017, HEARING RES, V349, P164, DOI 10.1016/j.heares.2016.12.010; Hight NG, 2003, HEARING RES, V179, P21, DOI 10.1016/S0378-5955(03)00067-4; Hiselius P, 2015, INT J AUDIOL, V54, pS3, DOI 10.3109/14992027.2014.973539; Hoffman HJ, 2017, JAMA OTOLARYNGOL, V143, P274, DOI 10.1001/jamaoto.2016.3527; Holt AG, 2019, J ACOUST SOC AM, V146, P3681, DOI 10.1121/1.5131344; HORMANN H, 1970, PSYCHOL FORSCH, V33, P289, DOI 10.1007/BF00424556; Huttunen KH, 2011, NOISE HEALTH, V13, P176, DOI 10.4103/1463-1741.77210; ISO, 2013, AC EST NOIS IND HEAR; Jadhav R, 2015, J AGROMEDICINE, V20, P434, DOI 10.1080/1059924X.2015.1075450; Jansen EJM, 2009, INT ARCH OCC ENV HEA, V82, P153, DOI 10.1007/s00420-008-0317-1; Jantzen MG, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00171; Jiang W, 2016, INT J AUDIOL, V55, P197, DOI 10.3109/14992027.2015.1122237; Jin SH, 2013, AM J AUDIOL, V22, P26, DOI 10.1044/1059-0889(2012/11-0030); Johannesen PT, 2019, HEARING RES, V374, P35, DOI 10.1016/j.heares.2019.01.017; Jokel C, 2019, J ACOUST SOC AM, V146, P3832, DOI 10.1121/1.5134069; Joubaud T, 2017, J ACOUST SOC AM, V141, P2637, DOI 10.1121/1.4979693; Kamerer AM, 2019, J ACOUST SOC AM, V146, P3947, DOI 10.1121/1.5132291; Kansu L, 2011, OTOL NEUROTOL, V32, P919, DOI 10.1097/MAO.0b013e3182267e06; Kardous Chucri A, 2003, Appl Occup Environ Hyg, V18, P629, DOI 10.1080/10473220301409; KARLSSON K, 1983, SCAND AUDIOL, V12, P257, DOI 10.3109/01050398309044429; Kerr MJ, 2017, AM J IND MED, V60, P569, DOI 10.1002/ajim.22627; Kil J, 2017, LANCET, V390, P969, DOI 10.1016/S0140-6736(17)31791-9; Konrad-Martin D, 2016, OTOL NEUROTOL, V37, pE286, DOI 10.1097/MAO.0000000000001134; Konrad-Martin D, 2012, INT J AUDIOL, V51, pS51, DOI 10.3109/14992027.2011.635713; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Kopke R, 2015, HEARING RES, V323, P40, DOI 10.1016/j.heares.2015.01.002; Korres GS, 2008, B-ENT, V4, P147; Korres GS, 2009, NOISE HEALTH, V11, P103, DOI 10.4103/1463-1741.50695; Kramer S, 2006, J AM ACAD AUDIOL, V17, P265, DOI 10.3766/jaaa.17.4.5; Kraus N, 2014, J NEUROSCI, V34, P11913, DOI 10.1523/JNEUROSCI.1881-14.2014; Kujawa SG, 1999, J NEUROPHYSIOL, V82, P863, DOI 10.1152/jn.1999.82.2.863; Kujawa SG, 2019, HEARING RES, V377, P44, DOI 10.1016/j.heares.2019.03.003; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Laitinen H, 2008, INT J AUDIOL, V47, P160, DOI 10.1080/14992020801886770; Laitinen Heli M, 2003, Appl Occup Environ Hyg, V18, P177, DOI 10.1080/10473220301356; Lamm K, 2004, HNO, V52, P301, DOI 10.1007/s00106-003-1042-4; Lankford JE, 2016, INT J AUDIOL, V55, pS51, DOI 10.3109/14992027.2015.1131851; Le Prell CG, 2011, NOISE HEALTH, V13, P432, DOI 10.4103/1463-1741.90317; Le Prell C. G., 2013, OTOL NEUROTOL, P268; Le Prell C. G., 2019, ADV AUDIOLOGY SPEECH, V2, P233; Le Prell CG, 2019, J ACOUST SOC AM, V146, P3646, DOI 10.1121/1.5133385; Le Prell Colleen G., 2019, Seminars in Hearing, V40, P162, DOI 10.1055/s-0039-1684045; Le Prell CG, 2019, INT J AUDIOL, V58, pS3, DOI 10.1080/14992027.2018.1534010; Le Prell CG, 2016, AUDIOLOGY NEUROTOL E, V6, P20, DOI 10.1159/000446600; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Le TN, 2017, J OTOLARYNGOL-HEAD N, V46, DOI 10.1186/s40463-017-0219-x; LEBO CP, 1967, CALIF MED, V107, P378; Lee K, 2019, INT J AUDIOL, V58, pS65, DOI 10.1080/14992027.2018.1532118; Lee K, 2017, INT J AUDIOL, V56, P22, DOI 10.1080/14992027.2016.1256505; Lee K, 2016, INT J AUDIOL, V55, pS21, DOI 10.3109/14992027.2015.1129073; Lee L. T., 1999, SMJ, V40, P571; Leensen MCJ, 2011, INT ARCH OCC ENV HEA, V84, P577, DOI 10.1007/s00420-010-0606-3; Leensen MCJ, 2015, INT ARCH OCC ENV HEA, V88, P45, DOI 10.1007/s00420-014-0932-y; LEI SF, 1994, J ACOUST SOC AM, V96, P1435, DOI 10.1121/1.410287; Lempert B, 2019, J ACOUST SOC AM, V145, P3640, DOI 10.1121/1.5111862; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Lie A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011923; Lim D. J., 1982, NEW PERSPECTIVES NOI, P23; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; Lin CY, 2009, HEARING RES, V257, P8, DOI 10.1016/j.heares.2009.07.008; Lindblad AC, 2011, NOISE HEALTH, V13, P392, DOI 10.4103/1463-1741.90293; LINDEMAN HE, 1976, AUDIOLOGY, V15, P348; LINDGREN F, 1983, EAR HEARING, V4, P197, DOI 10.1097/00003446-198307000-00004; LIPSCOMB DM, 1969, ARCH OTOLARYNGOL, V90, P545; LIPSCOMB DM, 1969, CLIN PEDIATR, V8, P63, DOI 10.1177/000992286900800205; Lobarinas E, 2016, INT J AUDIOL, V55, pS59, DOI 10.3109/14992027.2015.1122241; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; LONSBURYMARTIN BL, 1987, J ACOUST SOC AM, V81, P1507, DOI 10.1121/1.394503; Markou K, 2001, SCAND AUDIOL, V30, P180, DOI 10.1080/010503901300007461; Markou Konstantinos, 2004, Kulak Burun Bogaz Ihtis Derg, V12, P107; Masterson EA, 2015, AM J IND MED, V58, P392, DOI 10.1002/ajim.22429; MCBRIDE D, 1992, BRIT MED J, V305, P1561, DOI 10.1136/bmj.305.6868.1561; McGregor KD, 2018, INT J AUDIOL, V57, pS42, DOI 10.1080/14992027.2017.1416189; McMillan GP, 2012, INT J AUDIOL, V51, P689, DOI 10.3109/14992027.2012.688143; Mehrparvar AH, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.9628; Meinke Deanna K., 2017, Seminars in Hearing, V38, P267, DOI 10.1055/s-0037-1606323; Meinke DK, 2014, INT J AUDIOL, V53, pS16, DOI 10.3109/14992027.2013.865845; Meinke DK, 2013, INT J AUDIOL, V52, pS9, DOI 10.3109/14992027.2012.745650; Mendes Maria Helena, 2007, Rev. soc. bras. fonoaudiol., V12, P63, DOI 10.1590/S1516-80342007000100012; Mercier Vlasta, 2002, Noise Health, V4, P47; Mick P, 2018, EAR HEARING, V39, P631, DOI 10.1097/AUD.0000000000000535; Mills J. H, 1976, EFFECTS NOISE HEARIN, P265; MOODY DB, 1978, ARCH OTO-RHINO-LARYN, V220, P47, DOI 10.1007/BF00456301; Moon CIS, 2007, MIL MED, V172, P421; Moon IS, 2011, J OCCUP ENVIRON HYG, V8, P618, DOI 10.1080/15459624.2011.609013; Muller M, 2017, HNO, V65, pS59, DOI 10.1007/s00106-016-0266-z; Muller M, 2016, HNO, V64, P831, DOI 10.1007/s00106-016-0256-1; Murphy WJ, 2007, J OCCUP ENVIRON HYG, V4, P688, DOI 10.1080/15459620701537390; Murphy WJ, 2019, J ACOUST SOC AM, V146, P3868, DOI 10.1121/1.5132286; Murphy WJ, 2018, INT J AUDIOL, V57, pS28, DOI 10.1080/14992027.2017.1407459; Murphy WJ, 2017, INT J AUDIOL, V56, P1, DOI 10.1080/14992027.2016.1271145; Murphy WJ, 2016, INT J AUDIOL, V55, P688, DOI 10.1080/14992027.2016.1204470; Naert G, 2019, J ACOUST SOC AM, V146, P3743, DOI 10.1121/1.5132711; National Occupational Research Agenda (NORA) Hearing Loss Prevention Cross-Sector Council, 2019, NAT OCC RES AG HEAR; Neitzel RL, 2019, J ACOUST SOC AM, V146, P3911, DOI 10.1121/1.5132287; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Nelson JT, 2017, HEARING RES, V349, P13, DOI 10.1016/j.heares.2016.10.005; Nielsen D. W., 1986, BASIC APPL ASPECTS N, P281; NIOSH (National Institute for Occupational Safety and Health), 1998, DHHS NIOSH PUBLICATI, DOI DOI 10.26616/NIOSHPUB98126; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Norin JA, 2011, EAR HEARING, V32, P642, DOI 10.1097/AUD.0b013e31821478c8; O'Brien I, 2015, ANN OCCUP HYG, V59, P265, DOI 10.1093/annhyg/meu092; O'Brien I, 2014, J OCCUP ENVIRON HYG, V11, P450, DOI 10.1080/15459624.2013.875187; Obeling Lise, 1999, Noise Health, V1, P43; Ohlemiller KK, 2019, J ACOUST SOC AM, V146, P3668, DOI 10.1121/1.5132550; OKADA H, 1991, ACTA OTO-LARYNGOL, P61; Opperman DA, 2006, OTOLARYNG HEAD NECK, V134, P667, DOI 10.1016/j.otohns.2005.11.039; OSTRI B, 1989, SCAND AUDIOL, V18, P243, DOI 10.3109/01050398909042202; Palmer KT, 2015, OCCUP ENVIRON MED, V72, P195, DOI 10.1136/oemed-2014-102422; Park Y, 2017, J AM ACAD AUDIOL, V28, P295, DOI 10.3766/jaaa.16011; Passchier-Vermeer W., 1968, 35 I PUBL HLTH ENG; Pawlaczyk-Luszczynska M, 2011, INT J OCCUP SAF ERGO, V17, P255, DOI 10.1080/10803548.2011.11076892; PEKKARINEN E, 1990, AUDIOLOGY, V29, P286; Peng JH, 2007, NEUROREPORT, V18, P1167, DOI 10.1097/WNR.0b013e32820049a8; PILGRAMM M, 1985, ARCH OTO-RHINO-LARYN, V241, P247, DOI 10.1007/BF00453696; Portnuff CDF, 2019, INT J AUDIOL, V58, pS33, DOI 10.1080/14992027.2018.1532119; Portnuff CDF, 2016, ADOLESC HEALTH MED T, V7, P27, DOI 10.2147/AHMT.S74103; Portnuff CDF, 2011, J AM ACAD AUDIOL, V22, P663, DOI 10.3766/jaaa.22.10.5; Prendergast G, 2017, HEARING RES, V356, P74, DOI 10.1016/j.heares.2017.10.007; Prendergast G, 2017, HEARING RES, V344, P68, DOI 10.1016/j.heares.2016.10.028; Psillas G, 2008, EUR ARCH OTO-RHINO-L, V265, P1465, DOI 10.1007/s00405-008-0689-6; Radziwon KE, 2019, J ACOUST SOC AM, V146, P3733, DOI 10.1121/1.5132292; Ramakers GGJ, 2016, JAMA OTOLARYNGOL, V142, P551, DOI 10.1001/jamaoto.2016.0225; Reavis KM, 2008, EAR HEARING, V29, P875, DOI 10.1097/AUD.0b013e318181ad99; Reavis KM, 2011, EAR HEARING, V32, P61, DOI 10.1097/AUD.0b013e3181e8b6a7; REDDELL RC, 1972, CALIF MED, V116, P1; Riga M, 2010, MED SCI MONITOR, V16, pCR352; RINTELMANN WF, 1968, ARCH OTOLARYNGOL, V88, P377; Roberts B, 2019, J ACOUST SOC AM, V146, P3922, DOI 10.1121/1.5132540; Robinson G, 2003, NOISE MANUAL, P567; Rosowski JJ, 2019, J ACOUST SOC AM, V146, P3978, DOI 10.1121/1.5132288; ROYSTER JD, 1991, J ACOUST SOC AM, V89, P2793, DOI 10.1121/1.400719; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; Santoni CB, 2010, BRAZ J OTORHINOLAR, V76, P454, DOI 10.1590/S1808-86942010000400009; Saunders J. C., 1982, NEW PERSPECTIVES NOI, P229; Sayler SK, 2019, EAR HEARING, V40, P680, DOI 10.1097/AUD.0000000000000650; Scheibe F, 2002, MAGNESIUM RES, V15, P27; Schmidt JH, 2014, EAR HEARING, V35, P448, DOI 10.1097/AUD.0000000000000029; Schmidt JH, 2019, EAR HEARING, V40, P88, DOI 10.1097/AUD.0000000000000594; Schulz TY, 2011, NOISE HEALTH, V13, P152, DOI 10.4103/1463-1741.77216; Seever Katie L, 2018, Semin Hear, V39, P210, DOI 10.1055/s-0038-1641744; Seixas NS, 2012, OCCUP ENVIRON MED, V69, P643, DOI 10.1136/oemed-2011-100578; Seixas NS, 2004, OCCUP ENVIRON MED, V61, P899, DOI 10.1136/oem.2003.009209; Semeraro HD, 2015, NOISE HEALTH, V17, P98, DOI 10.4103/1463-1741.153401; Sendowski I, 2006, HEARING RES, V221, P119, DOI 10.1016/j.heares.2006.08.010; Sheffield B, 2017, INT J AUDIOL, V56, P34, DOI 10.1080/14992027.2016.1255360; Shuster BZ, 2019, J ACOUST SOC AM, V145, P3656, DOI 10.1121/1.5111870; Sisto R, 2007, J ACOUST SOC AM, V122, P387, DOI 10.1121/1.2737668; Skellett RA, 1998, HEARING RES, V116, P21, DOI 10.1016/S0378-5955(97)00199-8; Skoe E, 2018, HEARING RES, V361, P80, DOI 10.1016/j.heares.2018.01.005; Slater J, 2018, J COGNITIVE NEUROSCI, V30, P14, DOI 10.1162/jocn_a_01189; Slater J, 2017, EUR J NEUROSCI, V45, P952, DOI 10.1111/ejn.13535; Sliwinska-Kowalska M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101139; Spankovich C, 2019, J ACOUST SOC AM, V146, P4033, DOI 10.1121/1.5132707; Spankovich C, 2017, EAR HEARING, V38, P724, DOI 10.1097/AUD.0000000000000457; Stewart Michael, 2002, J Am Acad Audiol, V13, P160; Strait DL, 2015, DEV COGN NEUROS-NETH, V12, P94, DOI 10.1016/j.dcn.2015.01.001; Strasser H, 2003, Noise Health, V5, P75; Suckfuell M, 2007, ACTA OTO-LARYNGOL, V127, P938, DOI 10.1080/00016480601110212; Suter AH, 2007, HDB NOISE VIBRATION, P377; Suter Alice H, 2017, Semin Hear, V38, P225, DOI 10.1055/s-0037-1603726; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Talcott KA, 2012, INT J AUDIOL, V51, pS20, DOI 10.3109/14992027.2011.631591; Themann CL, 2019, J ACOUST SOC AM, V146, P3879, DOI 10.1121/1.5134465; Tierney AT, 2015, P NATL ACAD SCI USA, V112, P10062, DOI 10.1073/pnas.1505114112; Trevino M, 2019, J ACOUST SOC AM, V146, P3710, DOI 10.1121/1.5132950; Tufts JB, 2011, NOISE HEALTH, V13, P26, DOI 10.4103/1463-1741.73998; Tufts JB, 2009, J AM ACAD AUDIOL, V20, P539, DOI 10.3766/jaaa.20.9.3; Valderrama JT, 2018, HEARING RES, V365, P36, DOI 10.1016/j.heares.2018.06.003; Voix J, 2009, INT J OCCUP SAF ERGO, V15, P211, DOI 10.1080/10803548.2009.11076802; Wada T, 2017, ACTA OTO-LARYNGOL, V137, pS48, DOI 10.1080/00016489.2017.1297899; Wagoner L, 2007, J OCCUP ENVIRON HYG, V4, P114, DOI 10.1080/15459620601126377; Wall AT, 2019, J ACOUST SOC AM, V146, P3863, DOI 10.1121/1.5132289; Wang J, 2018, PHYSIOL REV, V98, P2477, DOI 10.1152/physrev.00053.2017; Ward W. D, 1991, AUD ENG SOC NEW YORK; Wartinger F, 2019, J ACOUST SOC AM, V146, P3906, DOI 10.1121/1.5132541; Watts KL, 2018, MIL MED, V183, P231, DOI 10.1093/milmed/usx177; Wenmaekers R, 2017, J ACOUST SOC AM, V142, P3154, DOI 10.1121/1.5012689; White-Schwoch T, 2013, J NEUROSCI, V33, P17667, DOI 10.1523/JNEUROSCI.2560-13.2013; WHO, 2015, HEAR LOSS DUE RECR E; Woodcock K, 2008, INT J REHABIL RES, V31, P297, DOI 10.1097/MRR.0b013e3282fb7d4d; Xie HW, 2016, EAR HEARING, V37, P312, DOI 10.1097/AUD.0000000000000251; Xiong M, 2015, EUR ARCH OTO-RHINO-L, V272, P2153, DOI 10.1007/s00405-014-3093-4; Xiong Min, 2012, Clin Med Insights Ear Nose Throat, V5, P25, DOI 10.4137/CMENT.S10711; Xiong M, 2012, ACTA OTO-LARYNGOL, V132, P467, DOI 10.3109/00016489.2011.643457; Xiong M, 2011, ACTA OTO-LARYNGOL, V131, P1069, DOI 10.3109/00016489.2011.591823; Xiong M, 2011, ACTA OTO-LARYNGOL, V131, P809, DOI 10.3109/00016489.2011.568524; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Zaccardi T., 2019, NHCA SPECTRUM, V36, P42; Zaccardi T., 2018, NHCA SPECTRUM, V35, P40; Zander MF, 2008, NOISE HEALTH, V10, P14, DOI 10.4103/1463-1741.39004; Zhai SQ, 2004, ACTA OTO-LARYNGOL, V124, P124, DOI 10.1080/00016480310015939; Zhang JS, 2019, J ACOUST SOC AM, V146, P3811, DOI 10.1121/1.5132551; Zhao YM, 2010, EAR HEARING, V31, P527, DOI 10.1097/AUD.0b013e3181d94e68; Zhou YD, 2013, AUDIOL NEURO-OTOL, V18, P89, DOI 10.1159/000345208; Zhou YD, 2009, ACTA OTO-LARYNGOL, V129, P602, DOI 10.1080/00016480802342424	320	6	6	0	7	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	NOV	2019	146	5					4051	4074		10.1121/1.5132951			24	Acoustics; Audiology & Speech-Language Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Acoustics; Audiology & Speech-Language Pathology	KG8WP	WOS:000510232400084	31795668	Bronze, Green Published			2022-02-06	
J	Miranda, SP; Schaefer, KG; Vates, GE; Gormley, WB; Buss, MK				Miranda, Stephen P.; Schaefer, Kristen G.; Vates, G. Edward; Gormley, William B.; Buss, Mary K.			Palliative Care and Communication Training in Neurosurgery Residency: Results of a Trainee Survey	JOURNAL OF SURGICAL EDUCATION			English	Article						Survey; palliative care; communication; neurosurgery; residency; education	OF-LIFE DISCUSSIONS; INTENSIVE-CARE; NONTECHNICAL SKILLS; MORAL DISTRESS; ILL PATIENTS; END; SURGEONS; PREFERENCES; PERFORMANCE; IMPROVEMENT	OBJECTIVE: Neurosurgeons care for critically ill patients near the end of life, yet little is known about how well their training prepares them for this role. We surveyed a random sample of neurosurgery residents to describe the quantity and quality of teaching activities related to serious illness communication and palliative care, and resident attitudes and perceived preparedness to care for seriously ill patients. METHODS: A previously validated survey instrument was adapted to reflect required communication and palliative care competencies in the 2015 the Accreditation Council for Graduate Medical Education (ACGME) Milestones for Neurological Surgery. The survey was reviewed for content validity by independent faculty neurosurgeons, piloted with graduating neurosurgical residents, and distributed online in August 2016 to neurosurgery residents in the United States using the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Joint Section on Neurotrauma and Critical Care email listserv. Multiple choice and Likert scale responses were analyzed using descriptive statistics. RESULTS: Sixty-two responses were recorded between August 2016 and October 2016. Most respondents reported no explicit teaching on: explaining risks and benefits of intubation and ventilation (69%), formulating prognoses in neurocritical care (60%), or leading family meetings (69%). Compared to performing craniotomies, respondents had less frequent practice leading discussions about withdrawing life-sustaining treatment (61% vs. 90%, p < 0.01, "weekly or more frequently"), and were less often observed (18% vs. 87%, p < 0.01) and given feedback on their performance (11% vs. 58%, p < 0.01). Nearly all respondents (95%) felt "prepared to discuss withdrawing life-sustaining treatments," however half (48%) reported they "would benefit from more communication training during residency." Most (87%) reported moral distress, agreeing that they "participated in operations and worried whether surgery aligned with patient goals." CONCLUSIONS: Residents in our sample reported limited formal training, and relatively less observation and feedback, on required ACGME competencies in palliative care and communication. Most reported preparedness in this domain, but many were receptive to more training. Better quality and more consistent palliative care education in neurosurgery residency could improve competency and help ensure that neurosurgical care aligns with patient goals. ((C) 2019 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.)	[Miranda, Stephen P.] Hosp Univ Penn, Dept Neurosurg, Third Floor,Silverstein Pavil,3400 Spruce St, Philadelphia, PA 19103 USA; [Miranda, Stephen P.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Schaefer, Kristen G.] Brigham & Womens Hosp, Div Palliat Med, 75 Francis St, Boston, MA 02115 USA; [Schaefer, Kristen G.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Schaefer, Kristen G.; Gormley, William B.; Buss, Mary K.] Harvard Med Sch, Boston, MA 02115 USA; [Vates, G. Edward] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Gormley, William B.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Buss, Mary K.] Beth Israel Deaconess Med Ctr, Div Gen Med, Sect Palliat Care, Boston, MA 02215 USA		Miranda, SP (corresponding author), Hosp Univ Penn, Dept Neurosurg, Third Floor,Silverstein Pavil,3400 Spruce St, Philadelphia, PA 19103 USA.	stephen.miranda@uphs.upenn.edu					Aoun SG, 2012, NEUROSURGERY, V71, pN15, DOI 10.1227/01.neu.0000419709.17781.8a; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Bradley CT, 2010, AM J SURG, V200, P542, DOI 10.1016/j.amjsurg.2009.12.014; Busl KM, 2015, J NEUROSURG ANESTH, V27, P31, DOI 10.1097/ANA.0000000000000085; Buss MK, 2011, CANCER-AM CANCER SOC, V117, P4304, DOI 10.1002/cncr.25952; Buss Mary Kathleen, 2005, J Palliat Med, V8, P363, DOI 10.1089/jpm.2005.8.363; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chen XD, 2015, AM J SURG, V209, P15, DOI 10.1016/j.amjsurg.2014.07.018; Childers JW, 2017, J ONCOL PRACT, V13, P700, DOI 10.1200/JOP.2016.018796; Chipman JG, 2011, AM J SURG, V201, P492, DOI 10.1016/j.amjsurg.2010.02.006; Cooper Z, 2014, ANN SURG, V260, P949, DOI 10.1097/SLA.0000000000000721; Dudzinski DM, 2016, J MED ETHICS, V42, P321, DOI 10.1136/medethics-2015-103156; Dzeng E, 2016, J GEN INTERN MED, V31, P93, DOI 10.1007/s11606-015-3505-1; Falcone JL, 2014, J SURG EDUC, V71, P309, DOI 10.1016/j.jsurg.2013.09.020; Fontes Ricardo B V, 2014, J Surg Educ, V71, pe83, DOI 10.1016/j.jsurg.2014.06.016; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Haglund MM, 2015, J SURG EDUC, V72, P394, DOI 10.1016/j.jsurg.2014.11.014; Harnof S, 2013, ISR MED ASSOC J, V15, P489; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Hull L, 2012, J AM COLL SURGEONS, V214, P214, DOI 10.1016/j.jamcollsurg.2011.10.016; King JT, 2005, J NEUROL NEUROSUR PS, V76, P550, DOI 10.1136/jnnp.2004.051649; Kirkman MA, 2013, J SURG EDUC, V70, P309, DOI 10.1016/j.jsurg.2012.11.011; Klaristenfeld DD, 2007, ANN SURG ONCOL, V14, P1801, DOI 10.1245/s10434-006-9324-1; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Mathew Jacob Eapen, 2015, J Anaesthesiol Clin Pharmacol, V31, P49, DOI 10.4103/0970-9185.150540; Minor S, 2009, AM J SURG, V197, P814, DOI 10.1016/j.amjsurg.2008.04.015; Nakagawa S, 2015, JAMA INTERN MED, V175, P1268, DOI 10.1001/jamainternmed.2015.2220; Pernar LIM, 2012, J AM COLL SURGEONS, V214, P231, DOI 10.1016/j.jamcollsurg.2011.11.002; Rodriguez-Paz JM, 2009, QUAL SAF HEALTH CARE, V18, P63, DOI 10.1136/qshc.2007.023903; Rozmovits L, 2010, J NEURO-ONCOL, V96, P241, DOI 10.1007/s11060-009-9955-8; Schaefer KG, 2014, ACAD MED, V89, P1024, DOI 10.1097/ACM.0000000000000271; Scheunemann LP, 2011, CHEST, V139, P543, DOI 10.1378/chest.10-0595; Schmitz CC, 2008, SIMUL HEALTHC, V3, P224, DOI 10.1097/SIH.0b013e31817e6149; Selden NR, 2012, NEUROSURGERY, V70, P971, DOI 10.1227/NEU.0b013e31823d7a45; Spetzler Robert F, 2011, Asian J Neurosurg, V6, P6, DOI 10.4103/1793-5482.85627; Webb TP, 2008, J SURG EDUC, V65, P91, DOI 10.1016/j.jsurg.2007.12.004; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wu X, 2014, PATIENT PREFER ADHER, V8, P883, DOI 10.2147/PPA.S45488; Yule S, 2015, J SURG EDUC, V72, P1124, DOI 10.1016/j.jsurg.2015.06.012	43	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1931-7204	1878-7452		J SURG EDUC	J. Surg. Educ.	NOV-DEC	2019	76	6					1691	1702		10.1016/j.jsurg.2019.06.010			12	Education, Scientific Disciplines; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Surgery	JV5QO	WOS:000502420200031	31239231				2022-02-06	
J	Pacheco, JM; Hines-Lanham, A; Stratton, C; Mehos, CJ; McCurdy, KE; Pinkowski, NJ; Zhang, HK; Shuttleworth, CW; Morton, RA				Pacheco, Johann M.; Hines-Lanham, Ashlyn; Stratton, Claire; Mehos, Carissa J.; McCurdy, Kathryn E.; Pinkowski, Natalie J.; Zhang, Haikun; Shuttleworth, C. William; Morton, Russell A.			Spreading Depolarizations Occur in Mild Traumatic Brain Injuries and Are Associated with Postinjury Behavior	ENEURO			English	Article						cerebral blood flow; closed skull impact; concussion; cortical spreading depression; electrophysiology; laser speckle contrast imaging	CEREBRAL-BLOOD-FLOW; CORTICAL DEPRESSION; PERIINFARCT DEPOLARIZATIONS; EXTRACELLULAR POTASSIUM; FUNCTIONAL MRI; IN-VITRO; C-FOS; CONCUSSION; PROPAGATION; MECHANISMS	Millions of people suffer mild traumatic brain injuries (mTBIs) every year, and there is growing evidence that repeated injuries can result in long-term pathology. The acute symptoms of these injuries may or may not include the loss of consciousness but do include disorientation, confusion, and/or the inability to concentrate. Most of these acute symptoms spontaneously resolve within a few hours or days. However, the underlying physiological and cellular mechanisms remain unclear. Spreading depolarizations (SDs) are known to occur in rodents and humans following moderate and severe TBIs, and SDs have long been hypothesized to occur in more mild injuries. Using a closed skull impact model, we investigated the presence of SDs immediately following a mTBI. Animals remained motionless for multiple minutes following an impact and once recovered had fewer episodes of movement. We recorded the defining electrophysiological properties of SDs, including the large extracellular field potential shifts and suppression of high-frequency cortical activity. Impact-induced SDs were also associated with a propagating wave of reduced cerebral blood flow (CBF). In the wake of the SD, there was a prolonged period of reduced CBF that recovered in approximately 90 min. Similar to SDs in more severe injuries, the impact-induced SDs could be blocked with ketamine. Interestingly, impacts at a slower velocity did not produce the prolonged immobility and did not initiate SDs. Our data suggest that SDs play a significant role in mTBIs and SDs may contribute to the acute symptoms of mTBIs.	[Pacheco, Johann M.; Hines-Lanham, Ashlyn; Stratton, Claire; Mehos, Carissa J.; McCurdy, Kathryn E.; Pinkowski, Natalie J.; Zhang, Haikun; Shuttleworth, C. William; Morton, Russell A.] Univ New Mexico, Dept Neurosci, Sch Med, Albuquerque, NM 87131 USA		Morton, RA (corresponding author), Univ New Mexico, Dept Neurosci, Sch Med, Albuquerque, NM 87131 USA.	ramorton@salud.unm.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P20GM109089, NS106901]; University of New Mexico Health Sciences Center Undergraduate Pipeline Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS106901] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health Grant 1P20GM109089 and NS106901 and by the University of New Mexico Health Sciences Center Undergraduate Pipeline Network.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Bouley J, 2019, J NEUROTRAUM, V36, P1008, DOI 10.1089/neu.2018.5844; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; BURES J, 1960, J NEUROPHYSIOL, V23, P225, DOI 10.1152/jn.1960.23.3.225; BURESOVA O, 1956, Cesk Fysiol, V5, P352; Cao Y, 1999, ARCH NEUROL-CHICAGO, V56, P548, DOI 10.1001/archneur.56.5.548; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chen SP, 2017, BRAIN, V140, P1643, DOI 10.1093/brain/awx085; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Denny-Brown D E, 1941, Proc R Soc Med, V34, P691; Dietrich WD, 2000, J CEREBR BLOOD F MET, V20, P103, DOI 10.1097/00004647-200001000-00014; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Ebine T, 2016, NEUROSCI RES, V112, P57, DOI 10.1016/j.neures.2016.06.001; Enger R, 2015, CEREB CORTEX, V25, P4469, DOI 10.1093/cercor/bhv054; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; FIFKOVA E, 1961, EXPERIENTIA, V17, P572, DOI 10.1007/BF02156433; Forcione M, 2018, J IMAGING, V4, DOI 10.3390/jimaging4040059; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; GUEDES RCA, 1992, BRAZ J MED BIOL RES, V25, P393; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hermann DM, 1999, NEUROSCIENCE, V88, P599, DOI 10.1016/S0306-4522(98)00249-8; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hosseini-Zare MS, 2017, EXP NEUROL, V295, P155, DOI 10.1016/j.expneurol.2017.05.002; Jones A, 2017, CLIN EXP EMERG MED, V4, P121, DOI 10.15441/ceem.17.226; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAUBE H, 1994, EUR NEUROL, V34, P30, DOI 10.1159/000117004; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kinder HA, 2019, J NEUROTRAUM, V36, P2930, DOI 10.1089/neu.2018.6303; Koide M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/819340; KRIVANEK J, 1961, J NEUROCHEM, V6, P183, DOI 10.1111/j.1471-4159.1961.tb13463.x; KUBOTA M, 1989, Neurosurgical Review, V12, P393, DOI 10.1007/BF01790681; Kucharz K, 2018, BRAIN, V141, P1049, DOI 10.1093/brain/awy036; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindquist BE, 2017, J CEREBR BLOOD F MET, V37, P1656, DOI 10.1177/0271678X16650696; Lindquist BE, 2014, J CEREBR BLOOD F MET, V34, P1779, DOI 10.1038/jcbfm.2014.146; Luhmann HJ, 1997, J NEUROPHYSIOL, V78, P1212, DOI 10.1152/jn.1997.78.3.1212; Main BS, 2017, JOVE-J VIS EXP, V124; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; MARTIN H, 1994, NEUROSCI LETT, V180, P285, DOI 10.1016/0304-3940(94)90540-1; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; MAXSON SC, 1977, PHARMACOL BIOCHEM BE, V6, P349, DOI 10.1016/0091-3057(77)90035-1; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; Miao P, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625231; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MONAKHOV KK, 1962, PHYSIOL BOHEMOSLOV, V11, P269; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mulherkar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11113-3; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Oliveira-Ferreira AI, 2020, J CEREBR BLOOD F MET, V40, P1274, DOI 10.1177/0271678X19861604; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RASHIDYPOUR A, 1995, BRAIN RES, V693, P64, DOI 10.1016/0006-8993(95)00692-J; Reinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; RUEDIGER W, 1962, Acta Biol Med Ger, V9, P371; Sachs Frederick, 2015, World J Neurol, V5, P74, DOI 10.5316/wjn.v5.i3.74; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Santos E, 2016, J CEREBR BLOOD F MET, V36, P2051, DOI 10.1177/0271678X16671317; Shen H, 2011, BRAIN RES, V1368, P248, DOI 10.1016/j.brainres.2010.10.014; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; TSCHIRGI RD, 1957, AM J PHYSIOL, V190, P557, DOI 10.1152/ajplegacy.1957.190.3.557; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Ward A A Jr, 1964, Clin Neurosurg, V12, P95; WARD R, 1971, EXP NEUROL, V31, P437, DOI 10.1016/0014-4886(71)90246-9; Watanabe N, 2002, J SOC TOHO U, V49, P23; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; Yang O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528610; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZACHAR J, 1958, Cesk Fysiol, V7, P189; ZACHAR J, 1961, ELECTROEN CLIN NEURO, V13, P896, DOI 10.1016/0013-4694(61)90195-X	116	6	6	2	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	NOV-DEC	2019	6	6							0070-19.2019	10.1523/ENEURO.0070-19.2019			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KA2LT	WOS:000505629700008	31748237	Green Published, gold			2022-02-06	
J	Reneker, JC; Babl, R; Pannell, WC; Adah, F; Flowers, MM; Curbow-Wilcox, K; Lirette, S				Reneker, Jennifer C.; Babl, Ryan; Pannell, W. Cody; Adah, Felix; Flowers, Meredith M.; Curbow-Wilcox, Kimberly; Lirette, Seth			Sensorimotor training for injury prevention in collegiate soccer players: An experimental study	PHYSICAL THERAPY IN SPORT			English	Article						Physical therapy; Concussion; Injury prevention; Population health	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; VESTIBULAR REHABILITATION; POSTURAL CONTROL; HIGH-SCHOOL; DIZZINESS; RELIABILITY; STABILITY; SYMPTOMS; BALANCE	Objectives: Deliver a sensorimotor training intervention; quantify the change in clinical measurements of sensorimotor control; and compare injury rate to a historical control. Design: One-arm experimental pilot; Level 3. Setting: NCAA Division II university athletic facilities. Participants: 75 collegiate soccer players (38 males; 37 females) were enrolled, including 30 (40%) with history of concussion, and participated in eight training sessions. Outcomes: Change in pre-to post-intervention for: static balance on the Sway app, near-point convergence, self-reported symptoms on the Post-Concussion Symptom Scale, cervical flexor neuromotor control/endurance, measured by the Cranial-Cervical Flexion Test and Joint Position Error test, and gaze stability on the Dynamic Visual Acuity Test. Injury incidence rate in 2018 was calculated using the number of traumatic injuries across the season and athlete exposure counts, as compared to a historical control. Results: Significant improvements were obtained in static balance, cervical flexor neuromotor control/endurance, and near-point convergence (p-values<0.01-0.03). Increases in symptom report (p = 0.02) and a decline in dynamic gaze stability (p < 0.01) were observed. There were 11.8 injuries/1000 athlete exposures in 2017 and 8.9 injuries/1000 athlete exposures in 2018 after the treatment (p = 0.18). Conclusion: This intervention holds promise as a preventive strategy for sports-injury as a comprehensive population-based intervention. (C) 2019 Elsevier Ltd. All rights reserved.	[Reneker, Jennifer C.; Babl, Ryan; Pannell, W. Cody; Adah, Felix; Flowers, Meredith M.; Curbow-Wilcox, Kimberly; Lirette, Seth] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA		Reneker, JC (corresponding author), 2500 North State St, Jackson, MS 30216 USA.	JReneker@umc.edu	Reneker, Jennifer/N-2038-2016	Reneker, Jennifer/0000-0003-3617-5681	Neuro Institute at the University of Mississippi Medical Center (UMMC)	This work was funded by an intramural grant from the Neuro Institute at the University of Mississippi Medical Center (UMMC).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bachero-Mena B, 2021, J STRENGTH COND RES, V35, P1905, DOI 10.1519/JSC.0000000000003066; Bourgeois FA, 2017, SPORTS, V5, DOI 10.3390/sports5040083; Brett B. L, 2018, CLIN J SPORT MED, V29, P413; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Clark JF, 2015, JOVE-J VIS EXP, DOI 10.3791/52648; Cone BL, 2015, GAIT POSTURE, V41, P711, DOI 10.1016/j.gaitpost.2015.01.030; Dick R, 2007, J ATHL TRAINING, V42, P173; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Downward P, 2018, EUR J PUBLIC HEALTH, V28, P99, DOI 10.1093/eurpub/ckx063; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Emery CA, 2015, BRIT J SPORT MED, V49, P865, DOI 10.1136/bjsports-2015-094639; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Gopfert A, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000346; Herdman SJ, 2014, VESTIBULAR REHABILIT; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huebner BJ, 2019, INT J SPORTS PHYS TH, V14, P127, DOI 10.26603/ijspt20190127; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004441.pub2; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Moral-Munoz JA, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0970-1; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Yoo S, 2018, J SPORT SCI MED, V17, P445; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	53	6	6	1	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	NOV	2019	40						184	192		10.1016/j.ptsp.2019.09.012			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JQ1ZA	WOS:000498750100024	31590121				2022-02-06	
J	Zasler, N; Haider, MN; Grzibowski, NR; Leddy, JJ				Zasler, Nathan; Haider, Mohammad N.; Grzibowski, Nicholas R.; Leddy, John J.			Physician Medical Assessment in a Multidisciplinary Concussion Clinic	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; concussion; concussive brain injury; physical examination	IMMEDIATE POST-CONCUSSION; COGNITIVE TESTING IMPACT; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; DIAGNOSTIC VALIDITY; STRESS-DISORDER; BLOOD-PRESSURE; SYMPTOM SCALE; TEST BATTERY	Concussive brain injury (CBI) is encountered by clinicians in sports medicine, pediatrics, neurosurgery, neurology, physiatry, and primary care. There is no gold standard diagnostic test for CBI, nor is there consensus on what neuromusculoskeletal physical examination tests should be performed on patients who have sustained CBI. This article presents an approach to the history and physical examination of the patient who has sustained a CBI that is based on a review of the literature evidence and the authors' extensive experience with this patient population. Suggested components include an elemental neurological examination that emphasizes the oculomotor/ophthalmologic and vestibular systems, as well as appropriate musculoskeletal assessment of the craniocervical and upper shoulder girdle complex. The use of supplementary tests for CBI, including assessment of exercise tolerance using the Buffalo Concussion Treadmill Test and tests of neurocognitive function, can aid in the differential diagnosis of CBI. The proposed protocol is envisioned for initial and follow-up assessments in the clinic after CBI, as well as for those with more protracted signs or symptoms. If symptoms persist beyond 2 weeks in adults or 4 weeks in adolescents, then referral to a multidisciplinary center that focuses on CBI is recommended.	[Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Haider, Mohammad N.; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthopaed & Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA; [Haider, Mohammad N.; Grzibowski, Nicholas R.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA		Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthopaed & Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arciniegas, 2019, TXB TRAUMATIC BRAIN, P677; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; Briere J, 2016, PSYCHOL TRAUMA-US, V8, P439, DOI 10.1037/tra0000107; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen J, 2019, J SPORT REHABIL, V28, P735, DOI 10.1123/jsr.2018-0166; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Connery AK, 2016, PHYS MED REH CLIN N, V27, P475, DOI 10.1016/j.pmr.2015.12.001; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Dessy AM, 2015, CONT NEUROSURGERY, V37, P1; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goldberg G, 2013, PM&R, V5, P890, DOI 10.1016/j.pmrj.2013.08.599; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Haider MN, 2018, BRAIN INJURY, V32, P809, DOI 10.1080/02699052.2018.1469045; Hall TM, 2008, J MANIP PHYSIOL THER, V31, P293, DOI 10.1016/j.jmpt.2008.03.012; Hammond FM, 2012, BRAIN INJURY MED PRI; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Huddleston-Slater JJR, 2002, J ORAL REHABIL, V29, P873; Hutting N, 2013, PHYS THER, V93, P1686, DOI 10.2522/ptj.20130186; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kaale BR, 2008, MANUAL THER, V13, P397, DOI 10.1016/j.math.2007.03.007; Kallioinen N, 2017, J HYPERTENS, V35, P421, DOI 10.1097/HJH.0000000000001197; KAMEI T, 1988, ACTA OTO-LARYNGOL, P108; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kutcher JS, 2010, SPORTS HEALTH, V2, P197, DOI 10.1177/1941738109357305; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Low PA, 2008, CLIN AUTON RES, V18, P8, DOI 10.1007/s10286-007-1001-3; Luedtke K, 2016, MANUAL THER, V23, P17, DOI 10.1016/j.math.2016.02.010; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCambridge TM, 2007, NEW ENGL J MED, V356, P1788; McCrory P, 2009, BR J SPORTS MED S1, V43, pi85; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Meyer RA., 1990, CLIN METHODS HIST PH, V3rd; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Osmotherly PG, 2012, PHYS THER, V92, P718, DOI 10.2522/ptj.20110261; Ostadimoghaddam H, 2017, CLIN EXP OPTOM, V100, P255, DOI 10.1111/cxo.12471; Pearlman R C, 1976, J Am Audiol Soc, V2, P1; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Pineau H, 2015, BEHAV SCI-BASEL, V5, P43, DOI 10.3390/bs5010043; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reiter Evan R, 2012, Int Neurotrauma Lett, V23; Rubio-Ochoa J, 2016, MANUAL THER, V21, P35, DOI 10.1016/j.math.2015.09.008; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shawkat FS, 2000, BRIT J OPHTHALMOL, V84, P175, DOI 10.1136/bjo.84.2.175; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slavin-Mulford J, 2012, J PERS ASSESS, V94, P593, DOI 10.1080/00223891.2012.681817; Snyder JJ, 2009, PSYCHIAT RES, V170, P256, DOI 10.1016/j.psychres.2008.11.008; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Tong HC, 2002, SPINE, V27, P156; UITVLUGT G, 1988, ARTHRITIS RHEUM, V31, P918, DOI 10.1002/art.1780310715; Viirre E, 2005, LARYNGOSCOPE, V115, P184, DOI 10.1097/01.mlg.0000150707.66569.d4; WHITING AS, 1992, AM FAM PHYSICIAN, V45, P1125; Zasler ND, 2013, MANAGEMENT ADULTS WI	92	6	6	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					409	418		10.1097/HTR.0000000000000524			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200012	31479079	Green Accepted			2022-02-06	
J	Zhang, JS				Zhang, Jinsheng			Blast-induced tinnitus: Animal models	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							DORSAL COCHLEAR NUCLEUS; TRAUMATIC BRAIN-INJURY; SPONTANEOUS NEURAL ACTIVITY; RESONANCE-IMAGING MEMRI; ACOUSTIC-TRAUMA; AUDITORY-CORTEX; HEARING-LOSS; HOMEOSTATIC PLASTICITY; INFERIOR COLLICULUS; DETECTION DEFICITS	Blast-induced tinnitus is a prevalent problem among military personnel and veterans, as blast-related trauma damages the vulnerable microstructures within the cochlea, impacts auditory and non-auditory brain structures, and causes tinnitus and other disorders. Thus far, there is no effective treatment of blast-induced tinnitus due to an incomplete understanding of its underlying mechanisms, necessitating development of reliable animal models. This article focuses on recent animal studies using behavioral, electrophysiological, imaging, and pharmacological tools. The mechanisms underlying blast-induced tinnitus are largely similar to those underlying noise-induced tinnitus: increased spontaneous firing rates, bursting, and neurosynchrony, Mn++ accumulation, and elevated excitatory synaptic transmission. The differences mainly lie in the data variability and time course. Noise trauma-induced tinnitus mainly originates from direct peripheral deafferentation at the cochlea, and its etiology subsequently develops along the ascending auditory pathways. Blast trauma-induced tinnitus, on the other hand, results from simultaneous impact on both the peripheral and central auditory systems, and the resultant maladaptive neuroplasticity may also be related to the additional traumatic brain injury. Consequently, the neural correlates of blast-induced tinnitus have different time courses and less uniform manifestations of its neural correlates. (C) 2019 Acoustical Society of America.	[Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, 60 Farnsworth St, Detroit, MI 48202 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031, W81XWH-15-1-0357]	This work was supported by the Department of Defense (Grant Award Nos. W81XWH-11-2-0031 and W81XWH-15-1-0357). The author thanks MD/Ph.D. student Ethan Firestone for his assistance in the preparation of Fig. 16.	AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8; Andersson G, 2009, J AM ACAD AUDIOL, V20, P315, DOI 10.3766/jaaa.20.5.5; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Bartels H, 2007, OTOL NEUROTOL, V28, P178, DOI 10.1097/MAO.0b013e31802b3248; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Berger JI, 2013, J NEUROSCI METH, V213, P188, DOI 10.1016/j.jneumeth.2012.12.023; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Brozoski T, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00009; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Cacace A. T, 2004, TINNITUS THEORY MANA, P162; Cacace AT, 2014, HEARING RES, V311, P49, DOI 10.1016/j.heares.2014.02.003; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chang YM, 2004, NEUROREPORT, V15, P1699, DOI 10.1097/01.wnr.0000134584.10207.1a; Charriaut-Marlangue C, 2014, STROKE, V45, P850, DOI 10.1161/STROKEAHA.113.003606; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen GD, 2012, BRAIN RES, V1485, P63, DOI 10.1016/j.brainres.2012.03.016; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; De Ridder D, 2006, ORL-J OTO-RHIN-LARYN, V68, P48, DOI 10.1159/000090491; DECKER MW, 1995, NEUROBIOL LEARN MEM, V64, P156, DOI 10.1006/nlme.1995.1055; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Engler H, 2011, BRAIN BEHAV IMMUN, V25, P1384, DOI 10.1016/j.bbi.2011.04.005; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Eyre H, 2012, PSYCHONEUROENDOCRINO, V37, P1397, DOI 10.1016/j.psyneuen.2012.03.019; Fetoni AR, 2019, FREE RADICAL BIO MED, V135, P46, DOI 10.1016/j.freeradbiomed.2019.02.022; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Fraticelli-Torres A. I., 2010, ETHNIC DIS, V20; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Gunbey HP, 2017, CLIN NEURORADIOL, V27, P221, DOI 10.1007/s00062-015-0473-0; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Hebert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037733; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Heffner HE, 2005, BEHAV NEUROSCI, V119, P734, DOI 10.1037/0735-7044.119.3.734; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; Heffner HE, 2011, BEHAV RES METHODS, V43, P577, DOI 10.3758/s13428-011-0061-4; Henry JA, 2009, J REHABIL RES DEV, V46, P619, DOI 10.1682/JRRD.2008.11.0157; Hesser H, 2009, BEHAV RES THER, V47, P523, DOI 10.1016/j.brat.2009.02.002; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Hui IR, 2006, NEUROBIOL LEARN MEM, V86, P160, DOI 10.1016/j.nlm.2006.02.002; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Kallakuri S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193389; Kaltenbach JA, 1996, AUDIT NEUROSCI, V3, P57; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kepecs A, 2003, NETWORK-COMP NEURAL, V14, P103, DOI 10.1088/0954-898X/14/1/306; Kizawa K, 2010, NEUROSCIENCE, V165, P1323, DOI 10.1016/j.neuroscience.2009.11.048; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kopke R. D., 2019, ASS RES OTOLARYNGOL, V42, P45; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Krishnan A, 2009, AUDIOL NEURO-OTOL, V14, P88, DOI 10.1159/000158537; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2012, EXPERT OPIN PHARMACO, V13, P2495, DOI 10.1517/14656566.2012.739608; Lanting CP, 2008, ACTA OTO-LARYNGOL, V128, P415, DOI 10.1080/00016480701793743; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lanting CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110704; Leaver AM, 2016, HEARING RES, V334, P49, DOI 10.1016/j.heares.2015.08.005; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lewis J E, 2002, J Am Acad Audiol, V13, P339; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Liang JF, 2017, HEARING RES, V354, P48, DOI 10.1016/j.heares.2017.08.003; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1979, ACTA OTO-LARYNGOL, V88, P161, DOI 10.3109/00016487909137156; Liberman T, 2009, BRAIN RES, V1298, P69, DOI 10.1016/j.brainres.2009.08.061; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lobarinas E, 2015, JARO-J ASSOC RES OTO, V16, P263, DOI 10.1007/s10162-014-0500-x; Lobarinas Edward, 2008, Seminars in Hearing, V29, P333, DOI 10.1055/s-0028-1095893; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Lutz J, 2007, ACAD RADIOL, V14, P692, DOI 10.1016/j.acra.2007.02.014; Ma WLD, 2006, HEARING RES, V216, P176, DOI 10.1016/j.heares.2006.03.011; Mahmood G, 2014, NEUROSCIENCE, V269, P367, DOI 10.1016/j.neuroscience.2014.03.020; Manzoor NF, 2013, HEARING RES, V295, P114, DOI 10.1016/j.heares.2012.04.003; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Marks KL, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aal3175; Masri S, 2018, NEUROSCIENCE, V379, P428, DOI 10.1016/j.neuroscience.2018.03.041; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229, DOI 10.1152/jn.1998.80.5.2229; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Okuyucu S, 2009, J LARYNGOL OTOL, V123, P718, DOI 10.1017/S002221510900423X; Olmestig JNE, 2017, CELL SIGNAL, V38, P39, DOI 10.1016/j.cellsig.2017.06.015; Ouyang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04941-w; Pace E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166346; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Pautler Robia G, 2006, Methods Mol Med, V124, P365; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pieper J., 2019, J HEAD TRAUMA REHABI; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Poremba A, 1997, J NEUROSCI, V17, P8645; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Rahman MU, 2001, CURR OPIN RHEUMATOL, V13, P184, DOI 10.1097/00002281-200105000-00006; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Robertson D, 2013, HEARING RES, V295, P124, DOI 10.1016/j.heares.2012.02.002; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schaette R, 2006, EUR J NEUROSCI, V23, P3124, DOI 10.1111/j.1460-9568.2006.04774.x; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Sederholm F, 2013, BRAIN RES, V1510, P48, DOI 10.1016/j.brainres.2013.03.013; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shaw E. A. G., 1974, HDB SENSORY PHYSL; Shulman, 1995, Int Tinnitus J, V1, P13; Shulman Abraham, 2014, Int Tinnitus J, V19, P10, DOI 10.5935/0946-5448.20140003; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Song AW, 2003, NEUROIMAGE, V20, P955, DOI 10.1016/S1053-8119(03)00292-1; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; SOUSSI T, 1994, ACTA OTO-LARYNGOL, V114, P135, DOI 10.3109/00016489409126031; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Stolzberg D, 2013, J NEUROSCI METH, V219, P224, DOI 10.1016/j.jneumeth.2013.07.021; Stuhmiller J.H., 1991, CONVENTIONAL WARFARE, P241; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VBA, 2013, ANN BEN REP VET BEN; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Wang WH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000307; Weinberg MS, 2013, EXP NEUROL, V247, P429, DOI 10.1016/j.expneurol.2013.01.011; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; Wu C, 2016, J NEUROSCI, V36, P2068, DOI 10.1523/JNEUROSCI.3960-15.2016; Wu LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000167; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yang S, 2013, RESTOR NEUROL NEUROS, V31, P99, DOI 10.3233/RNN-120248; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zhang JS, 2016, HEARING RES, V334, P7, DOI 10.1016/j.heares.2015.08.006; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813; Zhang Shu-jun, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P844; Zheng Y, 2011, NEUROSCIENCE, V193, P143, DOI 10.1016/j.neuroscience.2011.07.026; Zheng Y, 2011, NEUROSCIENCE, V186, P48, DOI 10.1016/j.neuroscience.2011.04.052; Zheng Y, 2011, NEUROSCIENCE, V180, P75, DOI 10.1016/j.neuroscience.2011.02.040; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282; Zuo HY, 2017, J NEUROSCI METH, V291, P227, DOI 10.1016/j.jneumeth.2017.08.029	179	6	6	1	7	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	NOV	2019	146	5					3811	3831		10.1121/1.5132551			21	Acoustics; Audiology & Speech-Language Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Acoustics; Audiology & Speech-Language Pathology	KG8WP	WOS:000510232400063	31795642	hybrid			2022-02-06	
J	Lee, DC; Vali, K; Baldwin, SR; Divino, JN; Feliciano, JL; Fequiere, JR; Fernandez, MA; Frageau, JC; Longo, FK; Madhoun, SS; Mingione, VP; O'Toole, TR; Ruiz, MG; Tanner, GR				Lee, Derek C.; Vali, Krishna; Baldwin, Shane R.; Divino, Jeffrey N.; Feliciano, Justin L.; Fequiere, Jesus R.; Fernandez, Mirella A.; Frageau, James C.; Longo, Frank K.; Madhoun, Salaheddine S.; Mingione, Pasquale, V; O'Toole, Timothy R.; Ruiz, Maria G.; Tanner, Geoffrey R.			Dietary Supplementation With the Ketogenic Diet Metabolite Beta-Hydroxybutyrate Ameliorates Post-TBI Aggression in Young-Adult Male Drosophila	FRONTIERS IN NEUROSCIENCE			English	Article						ketogenic diet (KD); traumatic brain injuries (TBI); aggression; Drosophila; chronic traumatic encephalopathies (CTE); KATP channel; neuroprotection	TRAUMATIC BRAIN-INJURY; K-ATP; KETONE-BODIES; LIFE-SPAN; FOOTBALL; MODEL; ENCEPHALOPATHY; CONCUSSION; ALZHEIMERS; JUVENILE	Traumatic brain injury (TBI), caused by repeated concussive head trauma can induce chronic traumatic encephalopathy (CTE), a neurodegenerative disease featuring behavioral symptoms ranging from cognitive deficits to elevated aggression. In a Drosophila model, we used a high-impact trauma device (Katzenberger et al., 2013, 2015) to induce TBI-like symptoms and to study post-TBI behavioral outcomes. Following TBI, aggression in banged male flies was significantly elevated as compared with that in unbanged flies. These increases in aggressive behavior were not the result of basal motility changes, as measured by a negative geotaxis assay. In addition, the increase in post-TBI aggression appeared to be specific to concussive trauma: neither cold exposure nor electric shock-two alternate types of trauma-significantly elevated aggressive behavior in male-male pairs. Various forms of dietary therapy, especially the high-fat, low-carbohydrate ketogenic diet (KD), have recently been explored for a wide variety of neuropathies. We thus hypothesized that putatively neuroprotective dietary interventions might be able to suppress post-traumatic elevations in aggressive behavior in animals subjected to head-trauma-inducing strikes, or "bangs". We supplemented a normal high-carbohydrate Drosophila diet with the KD metabolite beta-hydroxybutyrate (beta-HB)-a ketone body (KB). Banged flies raised on a KB-supplemented diet exhibited a marked reduction in aggression, whereas aggression in unbanged flies was equivalent whether dieted with KB supplements or not. Pharmacological blockade of the ATP-sensitive potassium (K-ATP) channel abrogated KB effects reducing post-TBI aggression while pharmacological activation mimicked them, suggesting a mechanism by which KBs act in this model. KBs did not significantly extend lifespan in banged flies, but markedly extended lifespan in unbanged flies. We have thus developed a functional model for the study of post-TBI elevations of aggression. Further, we conclude that dietary interventions may be a fruitful avenue for further exploration of treatments for TBI- and CTE-related cognitive-behavioral symptoms.	[Lee, Derek C.; Vali, Krishna; Baldwin, Shane R.; Divino, Jeffrey N.; Feliciano, Justin L.; Fequiere, Jesus R.; Fernandez, Mirella A.; Frageau, James C.; Longo, Frank K.; Madhoun, Salaheddine S.; Mingione, Pasquale, V; O'Toole, Timothy R.; Ruiz, Maria G.; Tanner, Geoffrey R.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Lee, Derek C.; Vali, Krishna; Frageau, James C.; O'Toole, Timothy R.; Tanner, Geoffrey R.] Connecticut Inst Brain & Cognit Sci, Storrs, CT 06269 USA		Tanner, GR (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.; Tanner, GR (corresponding author), Connecticut Inst Brain & Cognit Sci, Storrs, CT 06269 USA.	geoffrey.tanner@uconn.edu		Lee, Derek/0000-0003-3935-225X	UConn Department of Physiology and Neurobiology; UConn Office of Undergraduate Research (OUR); UConn McNair Scholars Program; Connecticut Institute for the Brain and Cognitive Sciences (IBaCS)	This work was supported by laboratory start-up funding from the UConn Department of Physiology and Neurobiology (to GT), the UConn Office of Undergraduate Research (OUR) supply grants (to SB, DL, and SM), and the UConn McNair Scholars Program (to JLF and MF). This work was also supported by Undergraduate Fellowship grants (to DL, KV, JCF, and TO'T), a Graduate Fellowship grant (to DL) and a Large Collaborative Seed Grant (to GT as Co-PI) from the Connecticut Institute for the Brain and Cognitive Sciences (IBaCS).	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; APPLETON DB, 1974, EPILEPSIA, V15, P211, DOI 10.1111/j.1528-1157.1974.tb04943.x; Bailey EE, 2005, EPILEPSY BEHAV, V6, P4, DOI 10.1016/j.yebeh.2004.10.006; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Davis SM, 2018, GENETICS, V208, P273, DOI 10.1534/genetics.117.300292; DEVIVO DC, 1978, ANN NEUROL, V3, P331, DOI 10.1002/ana.410030410; Edwards C, 2014, AGING-US, V6, P621, DOI 10.18632/aging.100683; Elamin M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00263; Fogle KJ, 2016, J NEUROGENET, V30, P247, DOI 10.1080/01677063.2016.1252765; FOSTER DW, 1967, J CLIN INVEST, V46, P1283, DOI 10.1172/JCI105621; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Katzenberger R. J, 2015, JOVE-J VIS EXP, V100; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Koenig JB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126506; Li JL, 2017, EPILEPSY RES, V133, P6, DOI 10.1016/j.eplepsyres.2017.04.003; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martinez CC, 2007, EPILEPSIA, V48, P187, DOI 10.1111/j.1528-1167.2006.00911.x; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masino S., 2012, Jasper's Basic Mechanisms of the Epilepsies, V4th; McDonald TJW, 2017, EPILEPSY CURR, V17, P346, DOI 10.5698/1535-7597.17.6.346; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ruskin DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065021; Simeone TA, 2017, NEUROCHEM RES, V42, P2011, DOI 10.1007/s11064-017-2253-5; Stubbs BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00848; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiele EA, 2003, EPILEPSIA, V44, P26, DOI 10.1046/j.1528-1157.44.s7.4.x; Thiele EA, 2013, J CHILD NEUROL, V28, P1054, DOI 10.1177/0883073813488827; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2017, IUBMB LIFE, V69, P305, DOI 10.1002/iub.1627; Wilder RM, 1921, MAYO CLIN B, V2, P307; Yang HJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00585; Yellen G, 2008, EPILEPSIA, V49, P80, DOI 10.1111/j.1528-1167.2008.01843.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	57	6	6	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 30	2019	13								1140	10.3389/fnins.2019.01140			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO2QX	WOS:000497428600001	31736687	Green Published, gold			2022-02-06	
J	Syed, UE; Kamal, A				Syed, Umm Eman; Kamal, Anila			Video game-based and conventional therapies in patients of neurological deficits: an experimental study	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Virtual Reality (VR); MIRA (Medical Interactive Rehabilitation Assistant); physical disability; mental health; self-esteem; motivation	VIRTUAL ENVIRONMENTS; FUNCTIONAL RECOVERY; BALANCE SCALE; REHABILITATION; EXERCISE; STROKE	Purpose: In the past few years, medicine has upgraded its therapeutic techniques and practices, with the use of various modern methods that are due to advancement in technology and sciences. It is recognized that the physical health of the patients is significantly associated to their mental state, their motivation and engagement in overcoming the illness. This paper presents experimental comparison between virtual reality (VR) technology and conventional mode of therapy for physical rehabilitation among patients of neurological deficits. The objective was to explore the effectiveness of VR during physical interactions with different game-like virtual environment and potentially leading to increased mental health (i.e., lower depression, anxiety and stress), self-esteem, social support and intrinsic motivation (task-based competence, choice and interest). Method: The study sample consisted of thirty-four subjects with Cerebral palsy (CP), Traumatic brain injury (TBI), Spinal cord injury, Stroke and Parkinson's disease; divided into two experimental groups virtual reality exercise group (n = 17), and conventional therapy group (n = 17); who have upper- or lower-limb impairment. Results: The outcome measures revealed significant differences across pretest and post-test conditions of both the experimental groups. Findings emerged from the study showed noticeable effectiveness of virtual-reality based rehabilitation in TBI, stroke and CP patients. Relationships between study variables and demographic variables (age and gender) were also presented. Conclusion: This study opens the way for future researchers, psychologists, physiotherapist and other practitioners to do more extensive work in the domain of virtual reality with different sample, constructs and approaches. IMPLICATIONS FOR REHABILITATION It has become increasing important to introduce new state-to-art technologies in domain of rehabilitation. People are reluctant to use all the traditional modes of treatment. As these conventional ways of treatment are least motivating and interesting to indulge the patients without force and burden. It is evident in the present study that addition of virtual reality-based exercise increases the self-motivated balance during functional task in contrast to conventional and task-dependent training participants. This study opens the way for future researchers to do more extensive work in this domain.	[Syed, Umm Eman; Kamal, Anila] Quaid i Azam Univ, Natl Inst Psychol, Islamabad, Pakistan		Kamal, A (corresponding author), Quaid I Azam Univ, Natl Inst Psychol, New Campus,Shahadra Rd Off Main Murree Rd, Islamabad, Pakistan.	dranilakamal@gmail.com					Agosto D., 2004, TEACHER LIB, V31, P8; Bao X, 2013, NEURAL REGEN RES, V8, P2904, DOI 10.3969/j.issn.1673-5374.2013.31.003; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Beaton D E, 2001, J Hand Ther, V14, P128; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; Biddle SJH, 2000, INT J SPORT PSYCHOL, V31, P290; Boulos MNK, 2012, GAMES HEALTH J, V1, P326, DOI 10.1089/g4h.2012.0041; Burdea G., 2002, 1 INT WORKSH VIRT RE; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; Byrne BM., 2013, STRUCTURAL EQUATION, DOI [10.4324/9781410600219, DOI 10.4324/9781410600219]; Carron AV, 1996, J SPORT EXERCISE PSY, V18, P1, DOI 10.1123/jsep.18.1.1; Cheung KL, 2014, VIRTUAL REALITY PHYS, DOI DOI 10.1023/B:NERV.0000009483.91468.FB; Clin A, 2011, STUDIA U BABES BOLYA, V56; Clin A, 2011, STUD U BABES BOLYAI, V56, P63; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; Grodal T, 2000, LEA COMMUN SER, P197; Hagger MS, 2009, BRIT J HEALTH PSYCH, V14, P189, DOI 10.1348/135910708X397034; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Holden MK, 2002, HUM FAC ER, P999; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Hutchison D, 2007, SOC STUD, V98, P35, DOI DOI 10.3200/TSSS.98.1.35-40; Jaffe DL, 2004, J REHABIL RES DEV, V41, P283, DOI 10.1682/JRRD.2004.03.0283; Jimison HB, 2013, 35 ANN INT C IEEE EN; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Law M, 2005, OCCUPATIONAL THERAPY, V5, P53; Lightheart VL, 2010, PSYCHOL EMOT MOTIV A, P157; Llorens R, 2015, ARCH PHYS MED REHAB, V96, P418, DOI 10.1016/j.apmr.2014.10.019; Lohse K, 2013, J NEUROL PHYS THER, V37, P166, DOI 10.1097/NPT.0000000000000017; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Palacios-Navarro G, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0289-0; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rosenberg M., 1965, SOC ADOLESCENT SELF; Russoniello C., 2009, J CYBERTHERAPY REHAB, V2, P53, DOI DOI 10.1086/662615; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryan RM., 2008, EUR HLTH PSYCHOL, V10, P2, DOI DOI 10.1080/17509840701827437; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; SLUIJS EM, 1991, PATIENT EDUC COUNS, V17, P191, DOI 10.1016/0738-3991(91)90060-I; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Ustinova KI, 2013, 2013 INT C VIRT REH; Usuda S, 1998, STROKE, V10, P53; Webster JS, 2001, ARCH PHYS MED REHAB, V82, P769, DOI 10.1053/apmr.2001.23201; WEISMAN S, 1983, GERONTOLOGIST, V23, P361, DOI 10.1093/geront/23.4.361; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644	49	6	6	3	29	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.	APR 3	2021	16	3					332	339		10.1080/17483107.2019.1679266		OCT 2019	8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	RS4ZH	WOS:000494405300001	31684776				2022-02-06	
J	McGuine, TA; Pfaller, A; Kliethermes, S; Schwarz, A; Hetzel, S; Hammer, E; Broglio, S				McGuine, Timothy A.; Pfaller, Adam; Kliethermes, Stephanie; Schwarz, Allison; Hetzel, Scott; Hammer, Erin; Broglio, Steven			The Effect of Sport-Related Concussion Injuries on Concussion Symptoms and Health-Related Quality of Life in Male and Female Adolescent Athletes: A Prospective Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; high school; HRQoL; prospective	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SEX; EPIDEMIOLOGY; RELIABILITY; MANAGEMENT; CHILDREN; DURATION; VALIDITY; OUTCOMES	Background: Sport-related concussions (SRCs) are associated with short-term disablement, characterized as increased concussion symptoms and lower health-related quality of life (HRQoL). However, there are limited longitudinal data detailing how an SRC affects disablement beyond short-term injury recovery. Purpose: To longitudinally assess the effect of SRCs on symptoms and HRQoL in high school athletes through the 12 months after injury. Study Design: Cohort study; Level of evidence, 2. Methods: The 125 participants included high school athletes who sustained an SRC (female patients, 36%; mean +/- SD age, 15.9 +/- 1.1 years). The Post-concussion Symptom Scale (PCSS) from the Sport Concussion Assessment Tool-3 and the Pediatric Quality of Life Inventory 4.0 (PedsQL) were completed at enrollment and repeated at 24 to 72 hours (onset) and at 7 days (D7) after the SRC; on the date of return to play (RTP); and at 3, 6, and 12 months (M12) after the SRC. Scores at each time point were compared with the athletes' own baseline via linear mixed models for repeated measures, controlling for age, sex, and history of previous SRC and with patient as a random effect. Results: Relative to baseline, female patients reported higher PCSS symptom and severity scores at onset (P < .001) and D7 (P < .001), while scores were not higher (P > .05) for RTP through M12. As compared with baseline, male patients reported higher PCSS scores at onset (P < .001) and D7 (P = .003) and severity scores at onset (P < .001) and D7 (P = .016), while the symptom and severity scores were not higher (P > .05) at RTP through M12. Female participants reported lower PedsQL physical scores at onset (P = .006), while scores were not lower (P > .05) from D7 through M12. Female psychosocial scores were not lower (P > .05) at any time after the SRC, while the total PedsQL score was lower at onset (P = .05) but not from D7 through M12. Male physical scores were lower at onset (P < .001) and D7 (P = .001) but not lower (P > .05) from RTP through M12. Male psychosocial and PedsQL scores were unchanged (P > .05) from baseline at onset through M12. Conclusion: After an SRC, high school athletes reported initial disablement (increased symptoms and lower HRQoL) through their RTP. However, after RTP, no similar disablement was detected through 12 months after injury.	[McGuine, Timothy A.; Pfaller, Adam; Kliethermes, Stephanie; Schwarz, Allison; Hetzel, Scott; Hammer, Erin; Broglio, Steven] Univ Wisconsin, Madison, WI USA; [McGuine, Timothy A.; Kliethermes, Stephanie; Schwarz, Allison; Hammer, Erin] Univ Wisconsin, Dept Orthoped & Rehabil, Div Sports Med, Med Fdn Centennial Bldg,1685 Highland Ave, Madison, WI 53705 USA; [Pfaller, Adam] Ohio State Univ, Dept Family Med, Columbus, OH 43210 USA; [Hetzel, Scott] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Broglio, Steven] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		McGuine, TA (corresponding author), Univ Wisconsin, Dept Orthoped & Rehabil, Div Sports Med, Med Fdn Centennial Bldg,1685 Highland Ave, Madison, WI 53705 USA.	mcguine@ortho.wisc.edu			National Athletic Trainers' Association Research and Education Foundation; AOSSM	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded by the National Athletic Trainers' Association Research and Education Foundation. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Houston MN, 2016, J ATHL TRAINING, V51, P442, DOI 10.4085/1062-6050-51.7.03; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kelly JP, 1997, NEUROLOGY, V48, P581; Leach CA, 2013, ATHL TRAIN SPORTS HL, V5, P115; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TV, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000394; McLeod TV, 2018, RETURN PLAY FOOTBALL, P723; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; R Core Team, 2016, R LANG ENV STAT COMP; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wisconsin Interscholastioc Athletic Association, WIAA CONC POL; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	36	6	6	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2019	47	14					3514	3520	0363546519880175	10.1177/0363546519880175		OCT 2019	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JT2LZ	WOS:000492611300001	31647876				2022-02-06	
J	Marceaux, JC; Soble, JR; O'Rourke, JJF; Swan, AA; Wells, M; Amuan, M; Sagiraju, HKR; Eapen, BC; Pugh, MJ				Marceaux, Janice C.; Soble, Jason R.; O'Rourke, Justin J. F.; Swan, Alicia A.; Wells, Margaret; Amuan, Megan; Sagiraju, Hari Krishna Raju; Eapen, Blessen C.; Pugh, Mary Jo			Validity of early-onset dementia diagnoses in VA electronic medical record administrative data	CLINICAL NEUROPSYCHOLOGIST			English	Article						Dementia; epidemiology; health administrative data; TBI; veterans	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE COMPLAINTS; VETERANS; RISK; PERFORMANCE; PREVALENCE; CONCUSSION; DISEASE; PTSD; IRAQ	Objective: To determine the validity of diagnoses indicative of early-onset dementia (EOD) obtained from an algorithm using administrative data, we examined Veterans Health Administration (VHA) electronic medical records (EMRs). Method: A previously used method of identifying cases of dementia using administrative data was applied to a random sample of 176 cases of Post-9/11 deployed veterans under 65 years of age. Retrospective, cross-sectional examination of EMRs was conducted, using a combination of administrative data, chart abstraction, and review/consensus by board-certified neuropsychologists. Results: Approximately 73% of EOD diagnoses identified using existing algorithms were identified as false positives in the overall sample. This increased to approximately 76% among those with mental health conditions and approximately 85% among those with mild traumatic brain injury (TBI; i.e. concussion). Factors related to improved diagnostic accuracy included more severe TBI, diagnosing clinician type, presence of neuroimaging data, absence of a comorbid mental health condition diagnosis, and older age at time of diagnosis. Conclusions: A previously used algorithm for detecting dementia using VHA administrative data was not supported for use in the younger adult samples and resulted in an unacceptably high number of false positives. Based on these findings, there is concern for possible misclassification in population studies using similar algorithms to identify rates of EOD among veterans. Further, we provide suggestions to develop an enhanced algorithm for more accurate dementia surveillance among younger populations.	[Marceaux, Janice C.; Soble, Jason R.; O'Rourke, Justin J. F.] South Texas Vet Hlth Care Syst San Antonio, Psychol Serv, San Antonio, TX USA; [Marceaux, Janice C.] Univ Texas San Antonio, Dept Neurol, Hlth Sci Ctr, San Antonio, TX USA; [Soble, Jason R.] Univ Illinois, Coll Med, Neuropsychiat Inst, Psychiat & Neurol, Chicago, IL USA; [Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Wells, Margaret; Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Amuan, Megan; Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT USA; [Sagiraju, Hari Krishna Raju; Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA; [Eapen, Blessen C.] UT Hlth San Antonio, Dept Rehabil Med, San Antonio, TX USA		Marceaux, JC (corresponding author), South Texas Vet Hlth Care Syst, Neuropsychol Consult Serv, Psychol Serv 116B, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	Janice.Marceaux@va.gov	Swan, Alicia A/O-3536-2018	Swan, Alicia A/0000-0003-2412-0499; Sagiraju, Hari Krishna Raju/0000-0002-9719-9380	VA Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I21 RX002060-01]; Brain Sentinel LLC	This work was supported by VA Rehabilitation Research and Development Service under Grant number I21 RX002060-01. The primary investigator also received research funding from Brain Sentinel LLC.	Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Department of Veterans Affairs and Department of Defense, 2018, VA DOD CLIN PRACT GU; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greenwald JL, 2017, MED CARE, V55, P261, DOI 10.1097/MLR.0000000000000651; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jaakkimainen RL, 2016, J ALZHEIMERS DIS, V54, P337, DOI 10.3233/JAD-160105; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Mawanda F, 2017, J AM GERIATR SOC, V65, P1043, DOI 10.1111/jgs.14756; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Military Health System, 2018, SURV CAS DEF 13 0 NE; Omino R, 2017, DIGEST DIS SCI, V62, P1180, DOI 10.1007/s10620-017-4503-4; Paulsen JS, 2011, CURR NEUROL NEUROSCI, V11, P474, DOI 10.1007/s11910-011-0215-x; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Salem LC, 2014, DEMENT GER COGN D EX, V4, P31, DOI 10.1159/000358050; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vieira Renata Teles, 2013, Clin Pract Epidemiol Ment Health, V9, P88, DOI 10.2174/1745017901309010088; Yaffe K, 2015, AM J GERIAT PSYCHIAT, V23, P651, DOI 10.1016/j.jagp.2015.02.008; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	37	6	6	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1175	1189		10.1080/13854046.2019.1679889		OCT 2019	15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000492093900001	31645200				2022-02-06	
J	Schweser, F; Kyyriainen, J; Preda, M; Pitkanen, A; Toffolo, K; Poulsen, A; Donahue, K; Levy, B; Poulsen, D				Schweser, Ferdinand; Kyyriainen, Jenni; Preda, Marilena; Pitkanen, Asla; Toffolo, Kathryn; Poulsen, Austin; Donahue, Kaitlynn; Levy, Benett; Poulsen, David			Visualization of thalamic calcium influx with quantitative susceptibility mapping as a potential imaging biomarker for repeated mild traumatic brain injury	NEUROIMAGE			English	Article						Repeated mild traumatic brain injury; Calcium; Quantitative susceptibility mapping; QSM; MRI; Biomarker; Fluid percussion injury; Rats	LATERAL FLUID-PERCUSSION; MAGNETIC-SUSCEPTIBILITY; HEMORRHAGES; RAT; CALCIFICATIONS; IRON	A key event in the pathophysiology of traumatic brain injury (TBI) is the influx of substantial amounts of Ca2+ into neurons, particularly in the thalamus. Detection of this calcium influx in vivo would provide a window into the biochemical mechanisms of TBI with potentially significant clinical implications. In the present work, our central hypothesis was that the Ca2+ influx could be imaged in vivo with the relatively recent MRI technique of quantitative susceptibility mapping (QSM). Wistar rats were divided into five groups: naive controls, sham-operated experimental controls, single mild TBI, repeated mild TBI, and single severe TBI. We employed the lateral fluid percussion injury (FPI) model, which replicates clinical TBI without skull fracture, performed 9.4 Tesla MRI with a 3D mull-echo gradient-echo sequence at weeks 1 and 4 post-injury, computed susceptibility maps using V-SHARP and the QUASAR-HEIDI technique, and performed histology. Sham, experimental controls animals, and injured animals did not demonstrate calcifications at 1 week after the injury. At week 4, calcifications were found in the ipsilateral thalamus of 25-50% of animals after a single TBI and 83% of animals after repeated mild TBI. The location and appearance of calcifications on stained sections was consistent with the appearance on the in vivo susceptibility maps (correlation of volumes: r = 0.7). Our findings suggest that persistent calcium deposits represent a primary pathology of repeated injury and that FPI-QSM has the potential to become a sensitive tool for studying pathophysiology related to mild TBI in vivo.	[Schweser, Ferdinand; Preda, Marilena] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, 875 Ellicott St, Buffalo, NY 14203 USA; [Schweser, Ferdinand; Preda, Marilena] SUNY Buffalo, Clin & Translat Sci Inst, Ctr Biomed Imaging, Buffalo, NY USA; [Kyyriainen, Jenni; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FI-70211 Kuopio, Finland; [Toffolo, Kathryn; Poulsen, Austin; Donahue, Kaitlynn; Levy, Benett; Poulsen, David] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY USA		Schweser, F (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, 875 Ellicott St, Buffalo, NY 14203 USA.	schweser@buffalo.edu	Schweser, Ferdinand/Q-6932-2019	Schweser, Ferdinand/0000-0003-0399-9211	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	Research reported in this publication was funded by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001412 (F.S.) and Academy of Finland Grants 272249 and 273909 (A.P.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Chang SX, 2016, J MAGN RESON IMAGING, V44, P420, DOI 10.1002/jmri.25143; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Ciraci S, 2017, DIAGN INTERV IMAG, V98, P707, DOI 10.1016/j.diii.2017.05.004; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kim S, 2009, NMR BIOMED, V22, P303, DOI 10.1002/nbm.1324; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ozbay PS, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3550; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Reichenbach JR, 2015, CLIN NEURORADIOL, V25, P225, DOI 10.1007/s00062-015-0432-9; Robinson S, 2011, MAGN RESON MED, V65, P1638, DOI 10.1002/mrm.22753; Schweser F, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3999; Schweser F, 2016, Z MED PHYS, V26, P6, DOI 10.1016/j.zemedi.2015.10.002; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Shah RN, 2017, CURR RADIOL REP, V5, P5, DOI [10.1007/s40134-017-0210-3, DOI 10.1007/S40134-017-0210-3]; Smith D, 2018, EPILEPSY RES, V147, P87, DOI 10.1016/j.eplepsyres.2018.09.005; Straub S, 2017, J MAGN RESON IMAGING, V45, P889, DOI 10.1002/jmri.25385; Sun HF, 2016, MAGN RESON MED, V76, P781, DOI 10.1002/mrm.25919; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Wu B, 2012, NEUROIMAGE, V59, P297, DOI 10.1016/j.neuroimage.2011.07.019; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055	41	6	6	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 15	2019	200						250	258		10.1016/j.neuroimage.2019.06.024			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IR6VU	WOS:000481579300021	31201986	Green Accepted			2022-02-06	
J	Weinstein, AA; Estep, JM; de Avila, L; Curry, M; Golabi, P; Escheik, C; Birerdinc, A; Stepanova, M; Price, JK; Gerber, L; Younossi, ZM				Weinstein, Ali A.; Estep, J. Michael; de Avila, Leyla; Curry, Michael; Golabi, Pegah; Escheik, Carey; Birerdinc, Aybike; Stepanova, Maria; Price, Jillian K.; Gerber, Lynn; Younossi, Zobair M.			Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Memory; Executive function; Cognitive performance; Cytokines; Hepatitis C	VERBAL-LEARNING TEST; QUALITY-OF-LIFE; KYNURENINE PATHWAY METABOLITES; TRAUMATIC BRAIN-INJURY; EXTRAHEPATIC MANIFESTATIONS; CONSTRUCT-VALIDITY; NORMATIVE DATA; VIRUS; MEMORY; TRAIL	An important extrahepatic consequence of Hepatitis C is its adverse impact on the central nervous system and cognitive performance. We aimed to determine whether there is a significant relationship between selected neurotransmitters and cytokines and cognitive performance in patients with Chronic Hepatitis C before and after achieving sustained virologic response (SVR). Pre-SVR, elevated kynurenine was associated with increased immediate and delayed visual memory, whereas post-SVR the positive associations are between kynurenine and immediate and delayed verbal memory. TGF-B was consistently negatively associated with both immediate and delayed visual memory pre- and post-SVR. These concomitant changes may have important clinical relevance.	[Weinstein, Ali A.; Estep, J. Michael; de Avila, Leyla; Golabi, Pegah; Escheik, Carey; Birerdinc, Aybike; Price, Jillian K.; Gerber, Lynn; Younossi, Zobair M.] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA; [Weinstein, Ali A.; Gerber, Lynn] George Mason Univ, Ctr Study Chron Illness & Disabil, Fairfax, VA 22030 USA; [Curry, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Stepanova, Maria] Ctr Outcomes Res Liver Dis, Washington, DC USA; [Gerber, Lynn; Younossi, Zobair M.] Inova Fairfax Med Campus, Dept Med, Ctr Liver Dis, Falls Church, VA USA		Younossi, ZM (corresponding author), Inova Fairfax Hosp, Betty & Guy Beatty Ctr Integrated Res, 3300 Gallows Rd, Falls Church, VA 22042 USA.	zobair.younossi@inova.org		Weinstein, Ali/0000-0002-3371-6086	Gilead SciencesGilead Sciences; Betty and Guy Beatty Center for Integrated Research	This research did not receive any specific grant from funding agencies in the public, commercial, or not -for-profit sectors. The clinical trial in which data from this study was collected was funded by Gilead Sciences. Data collection, analysis, and manuscript preparation was supported by the Betty and Guy Beatty Center for Integrated Research.	Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Cacoub P, 2014, DIGEST LIVER DIS, V46, pS165, DOI 10.1016/j.dld.2014.10.005; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Caneda Marco Aurélio G. de, 2018, Dement. neuropsychol., V12, P205, DOI 10.1590/1980-57642018dn12-020014; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fletcher NF, 2012, J VIRAL HEPATITIS, V19, P301, DOI 10.1111/j.1365-2893.2012.01591.x; Giil LM, 2017, J ALZHEIMERS DIS, V60, P495, DOI 10.3233/JAD-170485; Gill K, 2016, HEPATOL INT, V10, P415, DOI 10.1007/s12072-015-9684-3; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hilsabeck RC, 2003, J INT NEUROPSYCH SOC, V9, P847, DOI 10.1017/S1355617703960048; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hilsabeck RC, 2010, J NEUROIMMUNOL, V221, P53, DOI 10.1016/j.jneuroim.2010.01.017; Huckans M, 2009, J INT NEUROPSYCH SOC, V15, P69, DOI 10.1017/S1355617708090085; Jacola LM, 2014, J CLIN EXP NEUROPSYC, V36, P875, DOI 10.1080/13803395.2014.953039; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Kuhn T, 2017, J NEUROVIROL, V23, P593, DOI 10.1007/s13365-017-0533-0; Kuslansky G, 2004, ARCH CLIN NEUROPSYCH, V19, P89, DOI 10.1016/S0887-6177(02)00217-2; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Monaco S, 2015, WORLD J GASTROENTERO, V21, P11974, DOI 10.3748/wjg.v21.i42.11974; Monaco S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236148; Muir RT, 2015, STROKE, V46, P2755, DOI 10.1161/STROKEAHA.115.009936; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Perry W, 2008, DIGEST DIS SCI, V53, P307, DOI 10.1007/s10620-007-9896-z; Platzer M, 2017, PSYCHONEUROENDOCRINO, V81, P144, DOI 10.1016/j.psyneuen.2017.04.015; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Woods SP, 2005, ARCH CLIN NEUROPSYCH, V20, P1061, DOI 10.1016/j.acn.2005.06.007; Young KD, 2016, BRAIN BEHAV IMMUN, V56, P335, DOI 10.1016/j.bbi.2016.04.007; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1599, DOI 10.1053/j.gastro.2016.02.039; Younossi ZM, 2017, CLIN GASTROENTEROL H, V15, P421, DOI 10.1016/j.cgh.2016.10.037	40	6	6	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	OCT 15	2019	335								577022	10.1016/j.jneuroim.2019.577022			6	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology	IY0RN	WOS:000486100500006	31445380				2022-02-06	
J	Stillman, AM; Madigan, N; Torres, K; Swan, N; Alexander, MP				Stillman, Alexandra M.; Madigan, Nancy; Torres, Karen; Swan, Natasha; Alexander, Michael P.			Subjective Cognitive Complaints in Concussion	JOURNAL OF NEUROTRAUMA			English	Article						cognition; concussion; depression; mild traumatic brain injury	BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; FUNCTION-ADULT VERSION; HIGH-SCHOOL; MILD; ASSOCIATION; PERFORMANCE; MEDICATION; DEPRESSION; STATEMENT	Studies of symptoms after concussion have been focused heavily on athletic and military populations; generalizability to "civilians" has not recently been demonstrated. We selected cognitive symptoms as an important target to assess because of impact on school and employment. We evaluated cognitive complaints in a highly symptomatic (Rivermead Post-Concussion Symptoms Questionnaire [PCSQ], mean [M] = 29.5) civilian sample (n = 100; age: M = 41.4; 36 male/64 female; days post-injury: range 14-154, M = 51.4) of consecutive referrals to a concussion specialty clinic. The Behavior Rating of Executive Functions-Adult version (BRIEF-A) was used to assess subjective cognitive symptoms. Independent variables were prior neurologic and psychiatric history, current neurological symptoms, objective neuropsychological tests and several measures of depression (Beck Depression Inventory, Second Edition [BDI2]), anxiety (Beck Anxiety Inventory), and stress (Post-Traumatic Stress Checklist-Civilian form). No demographic characteristic, injury measure, or past or current neurological history had any association with cognitive symptoms. Prior psychiatric history (57% of patients) was associated with abnormal BRIEF-A. Cognitive tests were overall in the average range, with only mild and sporadic associations with BRIEF-A elevations. All psychological measures showed significant associations with BRIEF-A elevations. Regression analyses for the BRIEF-A revealed depression was the significant contributor (BDI2, beta = 0.73) with prior psychiatric history (beta = 0.16) and age (beta = 0.14) accounting to a lesser extent. In this civilian cohort, subjective cognitive symptoms appear to be due to psychological distress (in particular, depression) and prior psychiatric history more than actual cognitive impairment or other presenting symptoms. These findings illuminate the importance of early diagnosis and treatment of mood/emotional symptoms after injury.	[Stillman, Alexandra M.; Madigan, Nancy; Alexander, Michael P.] Harvard Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Torres, Karen] Univ Washington, Sch Med, Seattle, WA USA; [Swan, Natasha] Integrated Base Operat Support Team, Anchorage, AK USA		Stillman, AM (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	astillma@bidmc.harvard.edu					Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; Axelrod BN, 1998, ARCH CLIN NEUROPSYCH, V13, P543, DOI 10.1016/S0887-6177(97)00044-9; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Donders J, 2017, CHILD NEUROPSYCHOL, V23, P554, DOI 10.1080/09297049.2016.1161015; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gasparini CF, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-016-0711-0; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; Lovstad M, 2012, BRAIN COGNITION, V80, P237, DOI 10.1016/j.bandc.2012.07.008; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Scheenen ME, 2017, CLIN REHABIL, V31, P1019, DOI 10.1177/0269215516687101; Shin MS, 2004, NEUROPSYCHOLOGY, V18, P665, DOI 10.1037/0894-4105.18.4.665; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254	28	6	6	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					305	311		10.1089/neu.2018.5925		OCT 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489027500001	31407632				2022-02-06	
J	Eakman, AM; Kinney, AR; Reinhardt, R				Eakman, Aaron M.; Kinney, Adam R.; Reinhardt, Rebecca			Participation, Meaningful Activity, and Social Support Among US Student Service Members/Veterans	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						assessment; veterans; community participation; social participation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DISABILITY-AND-HEALTH; COMMUNITY REINTEGRATION; INTERNATIONAL-CLASSIFICATION; OCCUPATIONAL PERFORMANCE; MILITARY PERSONNEL; VETERANS; SEVERITY; VALIDITY	Student service members/veterans (SSM/Vs) may experience diminished social support and meaningful activity due to health-related sequelae, in turn threatening their community reintegration. Social and community participation may foster both social support and meaningful activity. This study assessed whether social and community participation explained social support and meaningful activity and evaluated the psychometric properties of the Veterans' Social and Community Participation Assessment (VSCPA). Online surveys generated responses to the VSCPA, indicators of social support, meaningful activity, health-related challenges, and demographic characteristics. Multiple regression models explored predictors of social support and meaningful activity. The VSCPA comprised three components: active community participation, familial and household participation, and social participation. These components exhibited positive associations with social support and meaningful activity and negative relationships with health-related sequelae. Targeting social and community participation among SSM/Vs may be a fruitful means by which occupational therapists bolster social support and meaningful activity.	[Eakman, Aaron M.; Kinney, Adam R.; Reinhardt, Rebecca] Colorado State Univ, Ft Collins, CO 80523 USA		Eakman, AM (corresponding author), Colorado State Univ, Dept Occupat Therapy, Coll Hlth & Human Sci, Campus Delivery 1573, Ft Collins, CO 80523 USA.	aaron.eakman@colostate.edu			New Start for Student Veterans (NSSV) program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for the current study was provided through philanthropic support of the New Start for Student Veterans (NSSV) program by a private donor.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; CATE C, 2016, SVA SPOTLIGHT, V2, P1; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Cogan AM, 2014, OTJR-OCCUP PART HEAL, V34, P150, DOI 10.3928/15394492-20140617-01; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Coster W, 2008, DISABIL REHABIL, V30, P639, DOI 10.1080/09638280701400375; Dutra ST, 2016, OCCUP THER MENT HEAL, V32, P146, DOI 10.1080/0164212X.2015.1104274; Eakman AM, 2018, J OCCUP SCI, V25, P346, DOI 10.1080/14427591.2018.1492958; Eakman AM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016519; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Eakman AM, 2011, OTJR-OCCUP PART HEAL, V31, P23, DOI 10.3928/15394492-20100122-02; Eakman AM, 2015, OCCUPATIONAL THERAPY, P313; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Elnitsky CA, 2017, AM J ORTHOPSYCHIAT, V87, P114, DOI 10.1037/ort0000244; Fritz HA, 2015, DISABIL REHABIL, V37, P1501, DOI 10.3109/09638288.2014.967415; Goldberg B., 2002, OCCUP THER MENT HEAL, V18, P17, DOI [10.1300/J004v18n02_03, DOI 10.1300/J004V18N02_03, DOI 10.1300/J004V18N02_]; Grant-Vallone E., 2003, J COLL STUD RETENT R, V5, P255, DOI [DOI 10.2190/C0T7-YX50-F71V-00CW, 10.2190/C0T7-YX50-F71V-00CW]; Hawkins BL, 2018, ARCH PHYS MED REHAB, V99, pS65, DOI 10.1016/j.apmr.2017.07.018; Hawkins BL, 2015, J REHABIL RES DEV, V52, P527, DOI 10.1682/JRRD.2014.08.0196; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kim Y, 2013, STUDENT VETERANS SER; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kinney AR, 2017, J POSTSECOND EDUC DI, V30, P345; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Litz B. T., 2009, EFFECTIVE TREATMENTS; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; McBain L., 2012, SOLDIER STUDENT; Murray C, 2013, SOC PSYCHOL EDUC, V16, P277, DOI 10.1007/s11218-012-9204-4; Norman SB, 2015, J REHABIL RES DEV, V52, P701, DOI 10.1682/JRRD.2015.01.0013; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Radomski MV, 2014, AM J OCCUP THER, V68, P379, DOI 10.5014/ajot.2014.013060; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Rogers CM, 2014, AM J OCCUP THER, V68, P395, DOI 10.5014/ajot.2014.011221; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Shallcross SL, 2016, J TRAUMA STRESS, V29, P167, DOI 10.1002/jts.22086; Speicher SM, 2014, AM J OCCUP THER, V68, P412, DOI 10.5014/ajot.2014.011304; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson B., 2004, EXPLORATORY CONFIRMA; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wenger JW, 2018, EXAMINATION RECENT D; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; Wilcock A. A., 2008, WILLARD SPACKMANS OC, P541; World Health Organization, 2007, INT CLASS FUNCT DIS	52	6	6	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	OCT	2019	39	4					222	231		10.1177/1539449219833351			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	JA5VP	WOS:000487911200006	30852944				2022-02-06	
J	Grossner, EC; Bernier, RA; Brenner, EK; Chiou, KS; Hong, J; Hillary, FG				Grossner, Emily C.; Bernier, Rachel A.; Brenner, Einat K.; Chiou, Kathy S.; Hong, Justin; Hillary, Frank G.			Enhanced Default Mode Connectivity Predicts Metacognitive Accuracy in Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury (TBI); metacognition; resting state functional connectivity; DMN	PREFRONTAL CORTEX; NEURAL BASIS; NETWORK; AWARENESS; CONFIDENCE; MEMORY; PERFORMANCE; CINGULATE; COGNITION; BENEFITS	Objective: To examine the role that intrinsic functional networks, specifically the default mode network, have on metacognitive accuracy for individuals with moderate to severe traumatic brain injury (TBI). Method: A sample of 44 individuals (TBI, n = 21; healthy controls [HCs], n = 23) were included in the study. All participants underwent an MRI scan and completed neuropsychological testing. Metacognitive accuracy was defined as participants' ability to correctly judge their item-by-item performance on an abstract reasoning task. Metacognitive values were calculated using the signal detection theory approach of area under the receiver operating characteristic curve. Large-scale subnetworks were created using Power's 264 Functional Atlas. The graph theory metric of network strength was calculated for six subsystem networks to measure functional connectivity. Results: There were significant interactions between head injury status (TBI or HC) and internetwork connectivity between the anterior default mode network (DMN) and salience network on metacognitive accuracy (R-2 = 0.13, p=.047) and between the posterior DMN and salience network on metacognitive accuracy (R-2 = 0.15, p=.038). There was an interpretable interaction between head injury status and internetwork connectivity between the attention network and salience network on metacognitive accuracy (R-2 = 0.13, p=.067). In all interactions, higher connectivity predicted better metacognitive accuracy in the TBI group, but this relationship was reversed for the HC group. Conclusion: Enhanced connectivity to both anterior and posterior regions within the DMN facilitates metacognitive accuracy postinjury. These findings are integrated into a larger literature examining network plasticity in TBI.	[Grossner, Emily C.; Bernier, Rachel A.; Brenner, Einat K.; Hillary, Frank G.] Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16801 USA; [Grossner, Emily C.; Bernier, Rachel A.; Brenner, Einat K.] Penn State Univ, Social Life & Engn Imaging Ctr, University Pk, PA 16801 USA; [Chiou, Kathy S.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Hong, Justin] Penn State Univ, Univ Hershey Med Ctr, University Pk, PA 16801 USA; [Hillary, Frank G.] Penn State Univ, Hershey Med Ctr, University Pk, PA 16801 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16801 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Hong, Justin/0000-0002-1675-6094; Bernier, Rachel/0000-0002-2759-9186	National Center for Advancing Translational Sciences through the Clinical Translational Science Institute [NIHUL Tr000127]; Social Life and Engineering Sciences Imaging Center; Social Sciences Research Institute at the Pennsylvania State University, University Park; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002014] Funding Source: NIH RePORTER	This research was supported by the National Center for Advancing Translational Sciences (NIHUL Tr000127) through the Clinical Translational Science Institute, the Social Life and Engineering Sciences Imaging Center, and the Social Sciences Research Institute at the Pennsylvania State University, University Park.	Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERNIER RA, 2017, FRONT NEUROL, V8, P1; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Chiou KS, 2012, J INT NEUROPSYCH SOC, V18, P379, DOI 10.1017/S1355617711001846; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Daselaar SM, 2015, CEREB CORTEX, V25, P983, DOI 10.1093/cercor/bht289; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming Stephen M, 2014, Front Hum Neurosci, V8, P443, DOI 10.3389/fnhum.2014.00443; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Grossner EC, 2018, NEUROPSYCHOLOGY, V32, P484, DOI 10.1037/neu0000446; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hillary F, 2001, ARCH CLIN NEUROPSYCH, V16, P171, DOI 10.1016/S0887-6177(00)00050-0; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kim H, 2009, BRAIN RES, V1282, P103, DOI 10.1016/j.brainres.2009.05.080; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; Menon V., 2015, BRAIN MAPPING, V2, P597, DOI 10.1016/B978-0-12-397025-1.00052-X; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Paul EJ, 2015, CORTEX, V71, P306, DOI 10.1016/j.cortex.2015.07.028; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rueda MR, 2012, DEV COGN NEUROS-NETH, V2, pS192, DOI 10.1016/j.dcn.2011.09.004; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Roy A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00146; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sinanaj I, 2015, CONSCIOUS COGN, V36, P327, DOI 10.1016/j.concog.2015.07.012; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; TEASDALE G, 1974, LANCET, V2, P81; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; Valk SL, 2016, HUM BRAIN MAPP, V37, P3388, DOI 10.1002/hbm.23247; XIA M, 2013, PLOS ONE, V8; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001	61	6	7	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2019	33	7					922	933		10.1037/neu0000559			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JA7EA	WOS:000488003100002	31094553	Green Accepted, Bronze			2022-02-06	
J	Techar, K; Nguyen, A; Lorenzo, RM; Yang, SM; Thielen, B; Cain-Nielsen, A; Hemmila, MR; Tignanelli, CJ				Techar, Kristina; Nguyen, Arthur; Lorenzo, Regina M.; Yang, Simon; Thielen, Brian; Cain-Nielsen, Anne; Hemmila, Mark R.; Tignanelli, Christopher J.			Early Imaging Associated With Improved Survival in Older Patients With Mild Traumatic Brain Injuries	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma systems improvement; TBI; Head CT imaging; Quality improvement; Quality metrics	GERIATRIC TRAUMA; AMERICAN-COLLEGE; SURGEONS COMMITTEE; AGE; MANAGEMENT; MORTALITY; OUTCOMES; WARFARIN; RISK	Background: Traumatic brain injury (TBI) is a leading cause of trauma-related death and disability. Computed tomography (CT) imaging of the head is essential for diagnosis of intracranial hemorrhage. This study aimed to identify optimal time to imaging and its impact on mortality for older patients with mild TBIs. Materials and methods: State-wide quality collaborative data were used from level I-II trauma centers. Inclusion criteria were ICD-9/10 codes for head trauma, age >= 50, admission/emergency department Glasgow Coma Scale >= 14, injury severity score <= 20, nonfull trauma activation, and head CT imaging time between 5 and 90 min of arrival. Locally weighted scatterplot smoothing plot data were used to dichotomize patients into early and late head CT imaging cohorts. Multivariable logistic regression and negative binomial models were used to evaluate the effect of early verses late head CT on clinical outcomes. The primary outcome was in-hospital mortality. Results: Mortality nadired at 35 min. Each 1-min delay in CT imaging resulted in a 2% increase in mortality (P = 0.002). Early patients had significantly reduced in-hospital mortality (P = 0.03), shorter emergency department length of stay (P < 0.001), and were more likely to receive fresh frozen plasma within 4 h if anticoagulated (P = 0.03). Teaching, high-volume, and level 2 trauma centers were all less likely to provide early head CTs (all P < 0.05). Conclusions: Delay in head CT imaging in the setting of potential mild TBI was associated with an increase in mortality. A delay in diagnosis cascades into delays in delivery of therapeutic interventions. Head CT within 35 min should be evaluated as a quality metric for older patients with mild TBI. (C) 2019 Published by Elsevier Inc.	[Techar, Kristina; Nguyen, Arthur; Lorenzo, Regina M.; Yang, Simon; Thielen, Brian] Univ Minnesota, Med Sch, Minneapolis, MN 55455 USA; [Cain-Nielsen, Anne] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Cain-Nielsen, Anne; Hemmila, Mark R.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Tignanelli, Christopher J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Tignanelli, Christopher J.] North Mem Hlth Hosp, Dept Surg, Robbinsdale, MN USA; [Tignanelli, Christopher J.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55455 USA		Tignanelli, CJ (corresponding author), Univ Minnesota, Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA.	ctignane@umn.edu		Tignanelli, Christopher/0000-0002-8079-5565			Baltazar GA, 2017, PRAGMAT OBS RES, V8, P43, DOI 10.2147/POR.S127710; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P91; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Garwe T, 2017, PREHOSP EMERG CARE, V21, P734, DOI 10.1080/10903127.2017.1332123; Gateno J, 2013, J ORAL MAXIL SURG, V71, P1900, DOI 10.1016/j.joms.2013.06.218; Goodmanson NW, 2012, SURGERY, V152, P668, DOI 10.1016/j.surg.2012.08.017; Gowing R, 2007, CAN J SURG, V50, P437; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Hemmila MR, 2017, J TRAUMA ACUTE CARE, V82, P867, DOI 10.1097/TA.0000000000001401; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; McKinley BA, 2000, ARCH SURG-CHICAGO, V135, P688, DOI 10.1001/archsurg.135.6.688; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Oliphant BW, 2019, J TRAUMA ACUTE CARE, V86, P1, DOI 10.1097/TA.0000000000002062; Rehn M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-4; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Rogers A, 2012, AM SURGEON, V78, P711; Saab M, 1996, J ACCID EMERG MED, V13, P208; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Scalea TM, 1990, J TRAUMA, V30, P34; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P273, DOI 10.1097/TA.0000000000001743; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745; Tignanelli CJ, 2018, JAMA SURG; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167	35	6	6	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2019	242						4	10		10.1016/j.jss.2019.04.006			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IM4EZ	WOS:000477948800003	31059948				2022-02-06	
J	Weber, ML; Bacon, CEW; McLeod, TV				Weber, Michelle L.; Bacon, Cailee E. Welch; McLeod, Tamara Valovich			School Nurses' Management and Collaborative Practices for Student-Athletes Following Sport-Related Concussion	JOURNAL OF SCHOOL NURSING			English	Article						sport-related concussion; secondary school; concussion management team; concussion management practices	ACADEMIC ACCOMMODATIONS; PERCEPTIONS; STATEMENT; FAMILIARITY; REST	The purpose of this study was to examine school nurses' management and collaboration with health-care providers (HCPs) for student-athletes following a concussion. Secondary school nurses accessed an online survey titled the Beliefs, Attitudes, and Knowledge of Pediatric Athletes with Concussions (access rate = 15.6%; n = 1,246/8,000). Approximately 40% of schools where nurses were employed administered baseline and postinjury concussion assessments. No significant differences were found between employment model (single vs. multiple sites) in regard to conducting baseline (p = .908) administration at their site; however, those employed at a single school more frequently offered postinjury assessments at their site than those at multiple sites (p = .019). School nurses most frequently reported relationships with an athletic trainer (38.8%, n = 483/1,246) compared to other HCPs. A concussion management team, including school nurses, and other recommended members should develop comprehensive concussion management plans. Plans should comprise of multiple concussion assessments to aid in the return-to-learn/play processes.	[Weber, Michelle L.] Univ Georgia, Athens, GA 30602 USA; [Bacon, Cailee E. Welch; McLeod, Tamara Valovich] AT Still Univ, Mesa, AZ USA		Bacon, CEW (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2014, HIGH SCH PARTICIPATI; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Davis GA, 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097492childscat5, DOI 10.1136/BJSPORTS-2017-097492CHILDSCAT5]; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pennington N, 2010, J SCH NURS, V26, P26, DOI 10.1177/1059840509341881; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider KH, 2017, J SCH NURS, V33, P364, DOI 10.1177/1059840516686842; Schneider KH, 2016, J SCH NURS, V32, P234, DOI 10.1177/1059840515607344; Shumaker L., 2016, J ATHL TRAINING, V51, pS222; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Weber ML, 2015, J ATHL TRAINING, V50, pS178; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465	37	6	6	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	OCT	2019	35	5					378	387		10.1177/1059840518774391			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IW9CX	WOS:000485292000008	29772943				2022-02-06	
J	Yu, MM; Wang, ML; Yang, DX; Wei, XE; Li, WB				Yu, Mengmeng; Wang, Mingliang; Yang, Dianxu; Wei, Xiaoer; Li, Wenbin			Dynamics of blood brain barrier permeability and tissue microstructure following controlled cortical impact injury in rat: A dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging study	MAGNETIC RESONANCE IMAGING			English	Article						Traumatic brain injury; Blood-brain barrier; Diffusion kurtosis imaging; Dynamic contrast-enhanced MRI; Thalamus	COGNITIVE IMPAIRMENT; DISRUPTION; MRI	Objective: The blood-brain barrier (BBB) and cerebral tissue microstructure can be impaired following traumatic brain injury (TBI), However, the spatiotemporal changes of BBB leakage and tissue microstructure are not completely understood. In this study, we evaluated the spatiotemporal changes of BBB leakage and tissue microstructure using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion kurtosis imaging (DKI) in controlled cortical impact (CCI) rats. Materials and methods: The DCE-MRI parameters volume transfer coefficient (K-trans) and DKI parameters were longitudinally measured in bilateral cortex, hippocampus, thalamus and corpus callosum (CC) at baseline (DO), acute stage (D1, D3), and subacute stage (D7, D14 and D28) post-injury. Immunohistochemistry analysis was performed at D28 after MRI scanning. Repeated-measures ANOVA was used to assess the temporal changes of MRI parameters. Results: K-trans abnormality was only localized to ipsilateral perilesional cortex with a significant temporal change (F = 144.2, p < 0.0001). Compared to baseline, increased mean kurtosis (MK) was observed in ipsilateral regions of cortex and hippocampus and CC for all the time points (p < 0.05 for all). Increased MK was also observed in ipsilateral thalamus (p = 0.005) at subacute stage but not at acute stage while no change was observed with MD and FA (p > 0.05 for both). In ipsilateral cortex, the overall K-trans value of D0, D1, D3, D7, D14, and D28 post-injury were significantly correlated with MK value (r = 0.84, p < 0.0001). The CCI group showed higher staining of glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba-1) and lower staining of neuron-specific nuclear protein (NeuN) and myelin basic protein (MBP) in ipsilateral regions of cortex, hippocampus, thalamus and CC (p < 0.05 for all) as compared to control group. There were no significant differences in the contralateral regions by immunohistochemistry. Conclusion: The BBB disruption reflected by K-trans correlated well with MK value in ipsilateral cortex. In addition, MK could detect the delayed microstructural changes in thalamus. DCE-MRI and DKI could be used to assess the BBB breakdown and cerebral microstructural changes of TBI.	[Yu, Mengmeng; Wang, Mingliang; Wei, Xiaoer; Li, Wenbin] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Yang, Dianxu] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Li, Wenbin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar 844000, Xinjiang, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	liwenbin@stju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Shanghai Key Discipline of Medical Imaging [2017ZZ02005]	This study was funded by the National Natural Science Foundation of China (grant number: 81271540), Natural Science Foundation of Xinjiang Province (grant number: 2016D01C083) and Shanghai Key Discipline of Medical Imaging (grant number: 2017ZZ02005).	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Wang ML, 2018, NEUROSCIENCE, V392, P180, DOI 10.1016/j.neuroscience.2018.09.030; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	36	6	6	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	OCT	2019	62						1	9		10.1016/j.mri.2019.01.017			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	IR8XQ	WOS:000481725200001	30660704				2022-02-06	
J	Hoffman, AN; Lam, J; Hovda, DA; Giza, CC; Fanselow, MS				Hoffman, Ann N.; Lam, Jamie; Hovda, David A.; Giza, Christopher C.; Fanselow, Michael S.			Sensory sensitivity as a link between concussive traumatic brain injury and PTSD	SCIENTIFIC REPORTS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ACOUSTIC STARTLE RESPONSE; LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CONTEXTUAL FEAR; LATE-ONSET; PLASTICITY; MEMORY; RISK; DEPRESSION	Traumatic brain injury (TBI) is one of the most common injuries to military personnel, a population often exposed to stressful stimuli and emotional trauma. Changes in sensory processing after TBI might contribute to TBI-post traumatic stress disorder (PTSD) comorbidity. Combining an animal model of TBI with an animal model of emotional trauma, we reveal an interaction between auditory sensitivity after TBI and fear conditioning where 75 dB white noise alone evokes a phonophobia-like phenotype and when paired with footshocks, fear is robustly enhanced. TBI reduced neuronal activity in the hippocampus but increased activity in the ipsilateral lateral amygdala (LA) when exposed to white noise. The white noise effect in LA was driven by increased activity in neurons projecting from ipsilateral auditory thalamus (medial geniculate nucleus). These data suggest that altered sensory processing within subcortical sensory-emotional circuitry after TBI results in neutral stimuli adopting aversive properties with a corresponding impact on facilitating trauma memories and may contribute to TBI-PTSD comorbidity.	[Hoffman, Ann N.; Hovda, David A.; Giza, Christopher C.] Univ Calif Los Angeles, Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hoffman, Ann N.; Lam, Jamie; Fanselow, Michael S.] Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA; [Hoffman, Ann N.; Hovda, David A.; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, Med & Mol Pharmacol, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA; [Fanselow, Michael S.] Univ Calif Los Angeles, Psychiat & Biobehav Sci, Los Angeles, CA USA; [Hoffman, Ann N.; Fanselow, Michael S.] Univ Calif Los Angeles, Staglin Ctr Brain & Behav Hlth, Los Angeles, CA 90095 USA		Hoffman, AN (corresponding author), Univ Calif Los Angeles, Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Psychol, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA.; Hoffman, AN (corresponding author), Univ Calif Los Angeles, Staglin Ctr Brain & Behav Hlth, Los Angeles, CA 90095 USA.	hoffmana7@ucla.edu		Giza, Christopher/0000-0002-5721-2667	UCLA Depression Grand Challenge Fellowship Fund; Staglin Center for Brain and Behavioral Health; UCLA Brain Injury Research Center; Centre for NeuroSkills; Joseph Drown Foundation; UCLA Steve Tisch BrainSPORT; Easton Labs for Brain Health;  [F32NS098694];  [R01MH062122];  [1PO1NS058489];  [1R01NS27544]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS098694] Funding Source: NIH RePORTER	This work was supported in part by F32NS098694: AH; R01MH062122: MF; UCLA Depression Grand Challenge Fellowship Fund: MF; Staglin Center for Brain and Behavioral Health: MF; UCLA Brain Injury Research Center; 1PO1NS058489: DH, CG; 1R01NS27544: DH, CG; Centre for NeuroSkills: DH; Joseph Drown Foundation, UCLA Steve Tisch BrainSPORT: CG; Easton Labs for Brain Health. The authors would like to thank Yan Cai, Zach Pennington, Michael Conoscenti, and Sonya Watson for technical assistance.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; Bernier BE, 2017, J NEUROSCI, V37, P6359, DOI 10.1523/JNEUROSCI.3029-16.2017; BORSZCZ GS, 1989, J EXP PSYCHOL ANIM B, V15, P54, DOI 10.1037/0097-7403.15.1.54; Carpenter-Thompson JR, 2014, BRAIN RES, V1567, P28, DOI 10.1016/j.brainres.2014.04.024; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; Cushman JD, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00003; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fadok JP, 2017, NATURE, V542, P96, DOI 10.1038/nature21047; Fanselow MS, 2010, TRENDS COGN SCI, V14, P7, DOI 10.1016/j.tics.2009.10.008; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1980, J EXP PSYCHOL ANIM B, V6, P65, DOI 10.1037/0097-7403.6.1.65; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gouty-Colomer LA, 2016, MOL PSYCHIATR, V21, P364, DOI 10.1038/mp.2015.18; Green SA, 2017, AUTISM RES, V10, P801, DOI 10.1002/aur.1726; Green SA, 2013, J AM ACAD CHILD PSY, V52, P1158, DOI 10.1016/j.jaac.2013.08.004; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P177, DOI 10.1037/0735-7044.108.1.177; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; Hoffman AN, 2019, BEHAV PHARMACOL, V30, P115, DOI 10.1097/FBP.0000000000000461; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; LEATON RN, 1990, J EXP PSYCHOL ANIM B, V16, P279, DOI 10.1037/0097-7403.16.3.279; LEDOUX JE, 1987, J COMP NEUROL, V264, P123, DOI 10.1002/cne.902640110; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Papesh MA, 2019, J NEUROTRAUM, V36, P702, DOI 10.1089/neu.2018.5801; Park S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31069; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rescorla R., 1972, THEORY PAVLOVIAN CON; Rescorla R. A., 1972, PSYCHOL LEARNING MOT, V6; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Temple MD, 2003, J NEUROSCI, V23, P2779; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang GW, 2018, NEURON, V97, P406, DOI 10.1016/j.neuron.2017.12.010; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	79	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 25	2019	9								13841	10.1038/s41598-019-50312-y			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JA1OP	WOS:000487586600032	31554865	Green Published, gold			2022-02-06	
J	Guilhaume-Correa, F; Cansler, SM; Shalosky, EM; Goodman, MD; Evanson, NK				Guilhaume-Correa, Fernanda; Cansler, Shelby M.; Shalosky, Emily M.; Goodman, Michael D.; Evanson, Nathan K.			Greater neurodegeneration and behavioral deficits after single closed head traumatic brain injury in adolescent versus adult male mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						adolescent; memory; neurodegeneration; neuroinflammation; RRID; AB_10641962; RRID; AB_10013382; RRID; AB_2307443; traumatic brain injury	COGNITIVE DEFICITS; UNITED-STATES; MOTOR; RATS; LOCALIZATION; MORTALITY; RECOVERY; VISITS; COSTS	Traumatic brain injury (TBI) is a major public health concern affecting 2.8 million people per year in the United States, of whom about 1 million are children under 19 years old. Animal models of TBI have been developed and used in multiple ages of animals, but direct comparisons of adult and adolescent populations are rare. The current studies were undertaken to directly compare outcomes between adult and adolescent male mice, using a closed head, single-impact model of TBI. Six-week-old adolescent and 9-week-old adult male mice were subjected to mild-moderate TBI. Histological measures for neurodegeneration, gliosis, and microglial neuroinflammation, and behavioral tests of locomotion and memory were performed. Adolescent TBI mice have increased mortality (X-2 = 20.72, p < 0.001) compared to adults. There is also evidence of hippocampal neurodegeneration in adolescents that is not present in adults. Hippocampal neurodegeneration correlates with histologic activation of microglia, but not with increased astrogliosis. Adults and adolescents have similar locomotion deficits after TBI that recover by 16 days postinjury. Adolescents have memory deficits as evidenced by impaired novel object recognition between 3-4 and 4-16 days postinjury (F-1,F-26 = 5.23, p = 0.031) while adults do not. In conclusion, adults and adolescents within a close age range (6-9 weeks) respond to TBI differently. Adolescents are more severely affected by mortality, neurodegeneration, and inflammation in the hippocampus compared to adults. Adolescents, but not adults, have worse memory performance after TBI that lasts at least 16 days postinjury.	[Guilhaume-Correa, Fernanda; Cansler, Shelby M.; Evanson, Nathan K.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Shalosky, Emily M.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA; [Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA		Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	Nathan.evanson@cchmc.org		Evanson, Nathan/0000-0003-2474-9764; Hetzer, Shelby/0000-0002-6497-378X; Guilhaume Correa, Fernanda/0000-0002-3878-5283	National Center for Medical Rehabilitation Research [HD001097]; Cincinnati Children's Hospital Medical Center	National Center for Medical Rehabilitation Research, Grant/Award Number: HD001097; Cincinnati Children's Hospital Medical Center, Grant/Award Number: Procter Scholar Award	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kokras N, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00088; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Maga AM, 2016, J AM ASSOC LAB ANIM, V55, P131; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25475-9	48	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2020	98	3					557	570		10.1002/jnr.24535		SEP 2019	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KB5FV	WOS:000487361900001	31541497	Green Accepted, Green Submitted			2022-02-06	
J	Bertalan, G; Boehm-Sturm, P; Schreyer, S; Morr, AS; Steiner, B; Tzschatzsch, H; Braun, J; Guo, J; Sack, I				Bertalan, Gergely; Boehm-Sturm, Philipp; Schreyer, Stefanie; Morr, Anna-Sophie; Steiner, Barbara; Tzschaetzsch, Heiko; Braun, Juergen; Guo, Jing; Sack, Ingolf			The influence of body temperature on tissue stiffness, blood perfusion, and water diffusion in the mouse brain	ACTA BIOMATERIALIA			English	Article						Multifrequency MRE; Tomoelastography; Perfusion; Diffusion; Brain stiffness; Temperature; Hypothermia; Mouse	MAGNETIC-RESONANCE ELASTOGRAPHY; IN-VIVO; THERAPEUTIC HYPOTHERMIA; CEREBRAL-ISCHEMIA; MR ELASTOGRAPHY; SUPRANUCLEAR PALSY; FLOW; DISEASE; MODEL; TOMOELASTOGRAPHY	While hypothermia of the brain is used to reduce neuronal damage in patients with conditions such as traumatic brain injury or stroke, little is known about how temperature affects the biophysical properties of in vivo brain tissue. Therefore, we measured shear wave speed (SWS), apparent diffusion coefficient (ADC), and cerebral blood flow (CBF) in the mouse brain at different body temperatures to investigate the relationship between temperature and tissue stiffness, water diffusion, and blood perfusion in the living brain. Multifrequency magnetic resonance elastography (MRE), diffusion-weighted imaging (DWI), and arterial spin labeling (ASL) were performed in seven mice while increasing and recording body temperature from hypothermia (28-30 degrees C) to normothermia (36-38 degrees C). SWS, ADC, and CBF were analyzed in regions of whole brain, cortex, hippocampus, and diencephalon. Our results show that SWS decreases while ADC and CBF increase from hypothermia to normothermia (whole brain SWS: -6.2%, ADC: +34.0%, CBF: +80.2%; cortex SWS: -10.1%, ADC: +30.9%, CBF: +82.4%; all p > 0.05). We found a significant inverse correlation between SWS and both ADC and CBF in all analyzed regions except diencephalon (whole brain SWS-ADC: r = -0.8, p < 0.005; SWS-CBF: r = -0.84, p < 0.005; cortex SWS-ADC: r = -0.74, p < 0.05; SWS-CBF: r = -0.65, p < 0.05). These results show that in vivo brain stiffness is inversely correlated with temperature, extracellular water mobility, and microvascular blood flow. Regional differences indicate that cortical areas are more markedly affected by hypothermia than central regions such as diencephalon. Temperature should be considered as a confounder in elastographic measurements, especially in preclinical settings. Statement of Significance Hibernating mammals lower their body temperature and metabolic activity. A hypothermic state can also be induced for medical purposes to reduce the risk of neural damage in patients with neurological disease or injury. However, little is known how physical soft-tissue properties of the in-vivo brain such as water diffusion, blood perfusion or mechanical parameters correlate with each other when temperature changes. Our study demonstrates for the first time that those quantitative imaging markers are tightly linked to changes in body temperature. While water diffusion and blood perfusion are reduced during hypothermia, brain stiffness significantly increases, suggesting that multiparametric quantitative MRI should be used for the noninvasive assessment of brain metabolic activity. (C) 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Bertalan, Gergely; Morr, Anna-Sophie; Tzschaetzsch, Heiko; Guo, Jing; Sack, Ingolf] Charite Univ Med Berlin, Dept Radiol, Charitepl 1, D-10117 Berlin, Germany; [Boehm-Sturm, Philipp] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Boehm-Sturm, Philipp] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Boehm-Sturm, Philipp] Charite Univ Med Berlin, NeuroCure Cluster Excellence, Berlin, Germany; [Boehm-Sturm, Philipp] Charite Univ Med Berlin, Charite Core Facil Expt MRI 7T, Berlin, Germany; [Schreyer, Stefanie; Steiner, Barbara] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Braun, Juergen] Charite Univ Med Berlin, Inst Med Informat, Berlin, Germany		Guo, J (corresponding author), Charite Univ Med Berlin, Dept Radiol, Charitepl 1, D-10117 Berlin, Germany.	Jing.guo@charite.de		Guo, Jing/0000-0002-1170-8157; Boehm-Sturm, Philipp/0000-0001-8777-4823; Schreyer, Stefanie/0000-0002-8331-0789; Braun, Jurgen/0000-0001-5183-7546	German Research FoundationGerman Research Foundation (DFG) [Sa901/16, Sa901/17, Ste1450/8-1, GRK2260 BIOQIC, SFB1340]; German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01E00801]; European Union's Horizon 2020 Program [668039]; German Research Foundation (Cluster of Excellence Exc 257 NeuroCURE)German Research Foundation (DFG)	Support from the German Research Foundation (Sa901/16, Sa901/17, Ste1450/8-1, GRK2260 BIOQIC, SFB1340 "Matrix in Vision" and Cluster of Excellence Exc 257 NeuroCURE), from the German Federal Ministry of Education and Research (BMBF; 01E00801, Center for Stroke Research Berlin) as well as from the European Union's Horizon 2020 Program (ID 668039, EU FORCE - Imaging the Force of Cancer) is gratefully acknowledged.	Al Amrani F, 2017, PEDIATR NEUROL, V73, P20, DOI 10.1016/j.pediatrneurol.2017.04.025; Alomair OI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130133; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Baron CA, 2015, STROKE, V46, P2136, DOI 10.1161/STROKEAHA.115.008815; Bertalan G, 2019, MAGN RESON MED, V81, P2676, DOI 10.1002/mrm.27586; BICHER HI, 1980, RADIOLOGY, V137, P523, DOI 10.1148/radiology.137.2.7433686; Chisholm KI, 2016, J CEREBR BLOOD F MET, V36, P1955, DOI 10.1177/0271678X15606457; Cinar Y, 2001, AM J HYPERTENS, V14, P433, DOI 10.1016/S0895-7061(00)01260-7; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Constantinides Christakis, 2011, ILAR J, V52, pe21; Dietrich WD, 2009, CRIT CARE MED, V37, pS238, DOI 10.1097/CCM.0b013e3181aa5d85; Dittmann F, 2018, MAGN RESON MED, V79, P1325, DOI 10.1002/mrm.26769; Dittmann F, 2017, MAGN RESON MED, V78, P976, DOI 10.1002/mrm.26484; Dittmann F, 2016, MAGN RESON MED, V76, P1116, DOI 10.1002/mrm.26006; Fehlner A, 2015, J MAGN RESON IMAGING; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Garcia SRM, 2018, MAGN RESON MED, V79, P2126, DOI 10.1002/mrm.26892; Garcia SRM, 2016, INVEST RADIOL, V51, P591, DOI 10.1097/RLI.0000000000000271; Gerischer LM, 2018, NEUROIMAGE-CLIN, V18, P485, DOI 10.1016/j.nicl.2017.12.023; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Harada M, 2002, NMR BIOMED, V15, P69, DOI 10.1002/nbm.759; HASEGAWA Y, 1994, J CEREBR BLOOD F MET, V14, P383, DOI 10.1038/jcbfm.1994.49; Helfenstein C, 2015, J BIOMECH, V48, P30, DOI 10.1016/j.jbiomech.2014.11.011; Hetzer S., 2017, J CEREB BLOOD FLOW M; Hetzer S, 2019, J CEREBR BLOOD F MET, V39, P2445, DOI 10.1177/0271678X18799241; Hirsch S, 2014, MAGN RESON MED, V71, P267, DOI 10.1002/mrm.24674; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Hong JM, 2014, STROKE, V45, P134, DOI 10.1161/STROKEAHA.113.003143; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jamin Y, 2015, CANCER RES, V75, P1216, DOI 10.1158/0008-5472.CAN-14-1997; JIANG Q, 1994, J CEREBR BLOOD F MET, V14, P732, DOI 10.1038/jcbfm.1994.94; Juge L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148652; Klatt D, 2015, J MAGN RESON IMAGING, V42, P297, DOI 10.1002/jmri.24806; Klatt D, 2013, PHYS MED BIOL, V58, P8663, DOI 10.1088/0031-9155/58/24/8663; Klein C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092582; Knight JRP, 2015, BIOCHEM J, V465, P227, DOI 10.1042/BJ20141014; Kober F, 2008, NMR BIOMED, V21, P781, DOI 10.1002/nbm.1253; Kozak LR, 2010, ACTA PAEDIATR, V99, P237, DOI 10.1111/j.1651-2227.2009.01528.x; Kwan S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/653727; Le Bihan D, 2014, EMBO MOL MED, V6, P569, DOI 10.1002/emmm.201404055; Lee YK, 2017, NEURORADIOL J, V30, P28, DOI 10.1177/1971400916678229; Leithner C, 2008, EXP NEUROL, V210, P118, DOI 10.1016/j.expneurol.2007.10.003; Lipp A, 2018, EUR RADIOL, V28, P3347, DOI 10.1007/s00330-017-5269-y; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Lizarbe B, 2013, NEUROIMAGE, V64, P448, DOI 10.1016/j.neuroimage.2012.09.033; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Manduca A., 2017, P 1 INT MRE WORKSH B, P12; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; Millward JM, 2015, NMR BIOMED, V28, P831, DOI 10.1002/nbm.3319; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Munder T, 2018, J MAGN RESON IMAGING, V47, P105, DOI 10.1002/jmri.25741; Murphy MC, 2016, NEUROIMAGE-CLIN, V10, P283, DOI 10.1016/j.nicl.2015.12.007; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Oosterlinck WW, 2011, MAGN RESON MED, V66, P802, DOI 10.1002/mrm.23060; Park JS, 2015, RESUSCITATION, V88, P132, DOI 10.1016/j.resuscitation.2014.11.031; Parker KJ, 2015, PHYS MED BIOL, V60, P4227, DOI 10.1088/0031-9155/60/11/4227; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Porcari P, 2016, NMR BIOMED, V29, P1577, DOI 10.1002/nbm.3610; Reynaud O, 2016, MAGN RESON MED, V76, P237, DOI 10.1002/mrm.25865; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Rossmanna Christian, 2014, Critical Reviews in Biomedical Engineering, V42, P467, DOI 10.1615/CritRevBiomedEng.2015012486; S. IEC (Geneva, 2015, 606012332010 S IEC; Sack I, 2018, QUANTIFICATION BIOPH; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Streitberger KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110588; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; T. b. t. foundation, 2007, J NEUROTRAUM, V24, pS21; Tajima G, 2007, J TRAUMA, V62, P36, DOI 10.1097/TA.0b013e31802dd73c; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Tzschatzsch H, 2016, MED IMAGE ANAL, V30, P1, DOI 10.1016/j.media.2016.01.001; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; vanderToorn A, 1996, MAGN RESON MED, V36, P914, DOI 10.1002/mrm.1910360614; Vorisek I, 2017, J NEUROSCI RES, V95, P1474, DOI 10.1002/jnr.23965; Wang C, 2016, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2016/06/006; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Xiong BY, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00128; Yenari MA, 2000, BRAIN RES, V885, P208, DOI 10.1016/S0006-8993(00)02942-5; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371	83	6	6	3	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	SEP 15	2019	96						412	420		10.1016/j.actbio.2019.06.034			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IY1DX	WOS:000486132900033	31247381				2022-02-06	
J	Yalcin, E; Beker, MC; Turkseven, S; Caglayan, B; Gurel, B; Kilic, U; Caglayan, AB; Kalkan, R; Baykal, AT; Kelestemur, T; Kilic, E				Yalcin, Esra; Beker, Mustafa C.; Turkseven, Seyma; Caglayan, Berrak; Gurel, Busra; Kilic, Ulkan; Caglayan, Ahmet B.; Kalkan, Rabia; Baykal, Ahmet T.; Kelestemur, Taha; Kilic, Ertugrul			Evidence that melatonin downregulates Nedd4-1 E3 ligase and its role in cellular survival	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Melatonin; Ubiquitin proteosome system; Nedd4-1; Proteomic; Proteasome; Ubiquitin	TISSUE-PLASMINOGEN ACTIVATOR; UBIQUITIN-PROTEASOME SYSTEM; REDUCES OXIDATIVE STRESS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; KAPPA-B ACTIVATION; DELAYED TREATMENT; HEME OXYGENASE-1; NUCLEAR IMPORT; RAT MODEL	Indolamine melatonin structurally resembles non-covalent proteasome inhibitors; however, the role of ubiquitin proteasome system (UPS) in neuronal survival and how melatonin carries out UPS inhibition remain largely unknown. With the use of melatonin treated cells, we evaluated the expression of Nedd4-1, an E3 ligase, how melatonin regulates its activity and its relationship with neuronal survival. Nedd4-1 was upregulated in the hypoxic condition in both control and Nedd4-1 overexpressed cells and melatonin treatment reversed its expression in both normoxic and hypoxic conditions, which was associated with increased cellular survival. Melatonin had no effect on the expression of Nedd4-1 at mRNA level. However, when melatonin was administered along with protein synthesis inhibitor cycloheximide, protein level of Nedd4-1 was further reduced, indicating that melatonin possibly downregulates Nedd4-1 after its synthesis. Notably, co-immunoprecipitation analyses followed by Liquid chromatography Mass Spectrometry (LC-MS/MS) revealed that melatonin may dissociate ribosomal proteins, such as RS19, RL23A, and nucleophosmin from Nedd4-1, while 40S ribosomal protein S7 and 60S ribosomal protein L35 came into contact with Nedd4-1 upon melatonin treatment. By using IPA analyses, we obtained further data indicated novel target molecules of melatonin in hypoxic conditions, including OTOF, SF3B2, IPO5, ST13, FGFR3, Mxl/Mx2, playing roles in RNA splicing and trafficking, growth factor and interferon signaling. Here, we described a new insight into the role of melatonin in UPS functioning by proposing a molecular mechanism through which melatonin regulates Nedd4-1.	[Yalcin, Esra; Beker, Mustafa C.; Kelestemur, Taha; Kilic, Ertugrul] Istanbul Medipol Univ, Sch Med, Dept Physiol, Istanbul, Turkey; [Yalcin, Esra; Beker, Mustafa C.; Turkseven, Seyma; Caglayan, Berrak; Caglayan, Ahmet B.; Kelestemur, Taha; Kilic, Ertugrul] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Turkseven, Seyma] Imperial Coll London, Div Computat & Syst Med, Dept Surg & Canc, London, England; [Caglayan, Berrak] Istanbul Medipol Univ, Int Sch Med, Dept Med Biol, Istanbul, Turkey; [Gurel, Busra; Baykal, Ahmet T.] Acibadern Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey; [Kilic, Ulkan; Kalkan, Rabia] Univ Hlth Sci, Sch Med, Dept Med Biol, Istanbul, Turkey; [Caglayan, Ahmet B.] Istanbul Medipol Univ, Int Sch Med, Dept Physiol, Istanbul, Turkey		Kilic, E (corresponding author), Istanbul Medipol Univ, Dept Physiol, Regenerat & Restorat Med Res Ctr, Ekinciler Cad 19, TR-34810 Istanbul, Turkey.	ekilic@medipol.edu.tr	Baykal, Ahmet T/C-3948-2013; Kilic, Ertugrul/W-4563-2018; Beker, Mustafa Caglar/ABH-2222-2020; Gurel, Busra/AAD-6244-2020	Baykal, Ahmet T/0000-0002-8814-7351; Kilic, Ertugrul/0000-0001-6494-8923; Caglayan, Berrak/0000-0002-5072-132X; Gurel, Busra/0000-0001-9779-1467; Yalcin, Esra/0000-0002-1064-7989; Beker, Mustafa/0000-0002-9476-8488; caglayan, ahmet burak/0000-0002-6242-3709; Kelestemur, Taha/0000-0003-3616-1204	Turkish Academy of Sciences (TUBA)Turkish Academy of Sciences	This work was funded by Turkish Academy of Sciences (TUBA).	An H, 2014, MOL BIOSYST, V10, P1643, DOI 10.1039/c3mb70572b; Beker MC, 2015, ONCOTARGET, V6, P30604, DOI 10.18632/oncotarget.5773; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; Bilokapic S, 2012, CURR OPIN CELL BIOL, V24, P86, DOI 10.1016/j.ceb.2011.12.011; Bruck R, 2004, J HEPATOL, V40, P86, DOI 10.1016/S0168-8278(03)00504-X; Caglayan B, 2017, EXP NEUROL, V296, P23, DOI 10.1016/j.expneurol.2017.06.024; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Cazevieille C, 1997, BRAIN RES, V768, P120, DOI 10.1016/S0006-8993(97)00611-2; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Ding QX, 2006, FASEB J, V20, P1055, DOI 10.1096/fj.05-5495com; Doeppner TR, 2012, BRAIN, V135, P3282, DOI 10.1093/brain/aws269; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Donovan P, 2013, INT J BIOCHEM CELL B, V45, P706, DOI 10.1016/j.biocel.2012.12.006; Esparza JL, 2005, J PINEAL RES, V39, P129, DOI 10.1111/j.1600-079X.2005.00225.x; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Genin E, 2010, CURR TOP MED CHEM, V10, P232, DOI 10.2174/156802610790725515; Guo YC, 2010, J HUAZHONG U SCI-MED, V30, P1, DOI 10.1007/s11596-010-0101-9; Harms C, 2000, FASEB J, V14, P1814, DOI 10.1096/fj.99-0899com; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Joshi KK, 2011, J MOL BIOL, V410, P383, DOI 10.1016/j.jmb.2011.05.005; Kang JW, 2014, CELL PHYSIOL BIOCHEM, V33, P23, DOI 10.1159/000356647; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Keller JN, 2000, J NEUROSCI RES, V61, P436, DOI 10.1002/1097-4547(20000815)61:4<436::AID-JNR10>3.0.CO;2-Z; Kilic U, 2017, REDOX BIOL, V12, P657, DOI 10.1016/j.redox.2017.04.006; Kim H, 2014, 2014 EIGHTH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NETWORKS-ON-CHIP (NOCS), P9, DOI 10.1109/NOCS.2014.7008756; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kwon KJ, 2011, J PINEAL RES, V50, P110, DOI 10.1111/j.1600-079X.2010.00820.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Miller JW, 1996, FREE RADICAL BIO MED, V21, P241, DOI 10.1016/0891-5849(96)00033-0; Mohseni M, 2012, MUTAT RES-FUND MOL M, V738, P19, DOI 10.1016/j.mrfmmm.2012.08.006; Morrione A, 1996, CANCER RES, V56, P3165; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Nopparat C, 2010, J PINEAL RES, V49, P382, DOI 10.1111/j.1600-079X.2010.00805.x; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Park JW, 2009, J PINEAL RES, V46, P415, DOI 10.1111/j.1600-079X.2009.00678.x; Pei Z, 2003, J PINEAL RES, V34, P194, DOI 10.1034/j.1600-079X.2003.00026.x; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006; Reiter RJ, 2010, CURR NEUROPHARMACOL, V8, P194, DOI 10.2174/157015910792246236; Santoro R, 2012, ONCOGENE, V31, P2931, DOI 10.1038/onc.2011.469; Sinha B, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12443; Taglialatela G, 1998, NEUROREPORT, V9, P489, DOI 10.1097/00001756-199802160-00024; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Vriend J, 2015, MOL CELL ENDOCRINOL, V417, P1, DOI 10.1016/j.mce.2015.09.001; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Vriend J, 2015, J PINEAL RES, V58, P1, DOI 10.1111/jpi.12189; Vriend J, 2014, LIFE SCI, V115, P8, DOI 10.1016/j.lfs.2014.08.024; Vriend J, 2014, CELL MOL LIFE SCI, V71, P3409, DOI 10.1007/s00018-014-1659-3; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Williams AJ, 2005, PHARMACOL BIOCHEM BE, V81, P182, DOI 10.1016/j.pbb.2005.03.011; Williams AJ, 2004, STROKE, V35, P1186, DOI 10.1161/01.STR.0000125721.10606.dc; Williams AJ, 2003, J CEREBR BLOOD F MET, V23, P75, DOI 10.1097/01.WCB.0000039285.37737.C2; Won J., 2015, FASEB J, V29; Yerlikaya A, 2012, PROTEIN PEPTIDE LETT, V19, P1330, DOI 10.2174/092986612803521657; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yoo YM, 2010, J PINEAL RES, V48, P204, DOI 10.1111/j.1600-079X.2010.00744.x; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207; Zhang L, 2010, STROKE, V41, P1001, DOI 10.1161/STROKEAHA.109.577288	73	6	6	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	SEP 15	2019	379								114686	10.1016/j.taap.2019.114686			10	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	IU3AF	WOS:000483450400018	31325559				2022-02-06	
J	Harada, GK; Rugg, CM; Arshi, A; Vail, J; Hame, SL				Harada, Garrett K.; Rugg, Caitlin M.; Arshi, Armin; Vail, Jeremy; Hame, Sharon L.			Multiple Concussions Increase Odds and Rate of Lower Extremity Injury in National Collegiate Athletic Association Athletes After Return to Play	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussion; general sports trauma; football (American); injury prevention	MUSCULOSKELETAL INJURY; SURVEILLANCE SYSTEM; SPORTS; RISK; EPIDEMIOLOGY; DEFICITS; TRENDS	Background: Concussion in collegiate athletics is one of the most prevalent sport-related injuries in the United States, with recent studies suggesting persistent deficits in neuromuscular control after a concussion and an associated increase in risk of lower extremity injury. Purpose: To expand on the relationship between concussion and lower extremity injury by examining the effect of multiple concussions (MC) on rate and odds of future lower extremity injury in collegiate athletes after return to play (RTP) compared with matched controls. Study Design: Cohort study; Level of evidence, 3. Methods: From 2001 to 2016, 48 National Collegiate Athletic Association Division I athletes sustaining multiple concussions at a single institution were identified. Athletes with multiple concussions (MC) were matched directly to athletes with a single concussion (SC) and to athletes with no concussion history (NC) by sex, sport, position, and games played. Incidence of, time to, and location of lower extremity injury were recorded for each group after RTP from their first reported concussion until completion of their collegiate career. Logistic regression was used to analyze odds ratios (ORs) for sustaining lower extremity injury, whereas time to injury was summarized by use of Kaplan-Meier curves and log rank test analysis. Results: The incidence of lower extremity injury after RTP was significantly greater (P = .049) in the MC cohort (36/48, 75%) than in SC athletes (25/48 = 52%) and NC athletes (27/48 = 56%). Similarly, odds of lower extremity injury were significantly greater in the MC cohort than in SC athletes (OR, 3.00; 95% CI, 1.26-7.12; P = .01) and NC athletes (OR, 1.66; 95% CI, 1.07-2.56; P = .02). Time to lower extremity injury was significantly shorter in the MC group compared with matched controls (P = .01). No difference was found in odds of lower extremity injury or time to lower extremity injury between SC and NC athletes. Conclusion: Collegiate athletes with MC were more likely to sustain a lower extremity injury after RTP in a shorter time frame than were the matched SC and NC athletes. This may suggest the presence of a cohort more susceptible to neuromuscular deficits after concussion or more injury prone due to player behavior, and it may imply the need for more stringent RTP protocols for athletes experiencing MC.	[Harada, Garrett K.; Rugg, Caitlin M.; Arshi, Armin; Vail, Jeremy; Hame, Sharon L.] Univ Calif Los Angeles, Los Angeles, CA USA; [Harada, Garrett K.; Arshi, Armin; Hame, Sharon L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 10833 Le Conte Ave,76-126 CHS, Los Angeles, CA 90095 USA; [Rugg, Caitlin M.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA; [Vail, Jeremy] Univ Calif Los Angeles, Dept Athlet, Los Angeles, CA USA		Harada, GK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 10833 Le Conte Ave,76-126 CHS, Los Angeles, CA 90095 USA.	garrett.harada@gmail.com					Agel J, 2007, J ATHL TRAINING, V42, P270; Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Clark D, 2012, NEUROLOGY, V78, pE140, DOI 10.1212/WNL.0b013e31825bc685; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; Doherty C, 2017, HUM MOVEMENT SCI, V52, P160, DOI 10.1016/j.humov.2017.02.005; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Krill ML, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118790552; Lu LH, 2000, NEUROLOGY, V55, P596, DOI 10.1212/WNL.55.4.596; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Teng PSP, 2017, KNEE, V24, P547, DOI 10.1016/j.knee.2017.01.014; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	29	6	6	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2019	47	13					3256	3262	0363546519872502	10.1177/0363546519872502		SEP 2019	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JI9IR	WOS:000491816500001	31513431				2022-02-06	
J	Anstey, JR; Taccone, FS; Udy, AA; Citerio, G; Duranteau, J; Ichai, C; Badenes, R; Prowle, JR; Ercole, A; Oddo, M; Schneider, AG; van der Jagt, M; Wolf, S; Helbok, R; Nelson, DW; Skrifvars, MB; Harrois, A; Presneill, J; Cooper, DJ; Bailey, M; Bellomo, R				Anstey, James R.; Taccone, Fabio S.; Udy, Andrew A.; Citerio, Giuseppe; Duranteau, Jacques; Ichai, Carole; Badenes, Rafael; Prowle, John R.; Ercole, Ari; Oddo, Mauro; Schneider, Antoine G.; van der Jagt, Mathieu; Wolf, Stefan; Helbok, Raimund; Nelson, David W.; Skrifvars, Marius B.; Harrois, Anatole; Presneill, Jeffrey; Cooper, D. Jamie; Bailey, Michael; Bellomo, Rinaldo		TBI Collaborative	Early Osmotherapy in Severe Traumatic Brain Injury: An International Multicenter Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						hypertonic saline; mannitol; mortality; osmotherapy; traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; HYPERTONIC SALINE; MANNITOL; EQUIOSMOLAR; MANAGEMENT; CONSENSUS	The optimal osmotic agent to treat intracranial hypertension in patients with severe traumatic brain injury (TBI) remains uncertain. We aimed to test whether the choice of mannitol or hypertonic saline (HTS) as early (first 96 h) osmotherapy in these patients might be associated with a difference in mortality. We retrospectively analyzed data from 2015 from 14 tertiary intensive care units (ICUs) in Australia, UK, and Europe treating severe TBI patients with intracranial pressure (ICP) monitoring and compared mortality in those who received mannitol only versus HTS only. We performed multi-variable analysis adjusting for site and illness severity (Injury Severity Score, extended IMPACT score, and mean ICP over the first 96 h) using Cox proportional hazards regression. We collected data on 262 patients and compared patients who received early osmotherapy with mannitol alone (n = 46) with those who received HTS alone (n = 46). Mannitol patients were older (median age, 49.2 (19.2) vs. 40.5 (16.8) years; p = 0.02), with higher Injury Severity Scores (42 (15.9) vs. 32.1 [11.3]; p = 0.001), and IMPACT-TBI predicted 6-month mortality (34.5% [23-46] vs. 25% [13-38]; p = 0.02), but had similar APACHE-II scores, and mean and maximum ICPs over the first 96 h. The unadjusted hazard ratio for in-hospital mortality in patients receiving only mannitol was 3.35 (95% confidence interval [CI], 1.60-7.03; p = 0.001). After adjustment for key mortality predictors, the hazard ratio for in-hospital mortality in patients receiving only mannitol was 2.64 (95% CI, 0.96-7.30; p = 0.06). The choice of early osmotherapy in severe TBI patients may affect survival, or simply reflect clinician beliefs about their different roles, and warrants controlled investigation.	[Anstey, James R.; Harrois, Anatole; Presneill, Jeffrey; Bellomo, Rinaldo] Royal Melbourne Hosp, Intens Care Unit, Parkville, Vic 3050, Australia; [Taccone, Fabio S.] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Udy, Andrew A.; Cooper, D. Jamie] Alfred Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Citerio, Giuseppe] Univ Milano Bicocca Neurointens Care, San Gerardo Hosp, ASST Monza, Sch Med & Surg, Monza, Italy; [Duranteau, Jacques; Harrois, Anatole] CHU Bicetre, Dept Anesthesia & Surg Intens Care, Le Kremlin Bicetre, France; [Ichai, Carole] Univ Cote Azur, CHU Nice, Hop Pasteur 2, Serv Reanimat Polyvalente, Nice, France; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Prowle, John R.] Royal London Hosp, Barts Hlth NHS Trust, Adult Crit Care Unit, Whitechapel Rd, London, England; [Ercole, Ari] Cambridge Univ Hosp NHS Fdn Trust, Neurosci & Trauma Crit Care Unit, Cambridge, England; [Oddo, Mauro; Schneider, Antoine G.] Univ Lausanne, CHUV, Fac Biol & Med, Dept Med Surg Intens Care Med, Lausanne, Switzerland; [van der Jagt, Mathieu] Erasmus MC, Univ Med Ctr, Dept Intens Care, Rotterdam, Netherlands; [Wolf, Stefan] Charite, Neuro Intens Care Unit 102i, Dept Neurosurg, CCM, Berlin, Germany; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Neurocrit Care Unit, Innsbruck, Austria; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Skrifvars, Marius B.] Helsinki Univ Hosp, Div Intens Care, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Marius B.] Helsinki Univ Hosp, Dept Emergency Med & Serv, Helsinki, Finland; [Skrifvars, Marius B.] Univ Helsinki, Helsinki, Finland; [Cooper, D. Jamie; Bailey, Michael; Bellomo, Rinaldo] Monash Univ, ANZIC RC, Sch Publ Hlth & Preventat Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Bailey, Michael] Univ Melbourne, Dept Med & Radiol, Parkville, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Anstey, JR (corresponding author), Royal Melbourne Hosp, Intens Care Unit, Parkville, Vic 3050, Australia.	james.anstey@mh.org.au	Cooper, D. James/G-7961-2013; Prowle, John/D-5014-2009; Ercole, Ari/B-6288-2009; Helbok, Raimund/AAA-8361-2021; Badenes, Rafael/K-6628-2019; Schneider, Antoine/L-2480-2019; van der Jagt, Mathieu/G-1905-2017	Cooper, D. James/0000-0002-5872-9051; Prowle, John/0000-0002-5002-2721; Ercole, Ari/0000-0001-8350-8093; Badenes, Rafael/0000-0001-7017-0150; Schneider, Antoine/0000-0003-0576-7094; Nelson, David/0000-0003-2530-8207; van der Jagt, Mathieu/0000-0003-2566-8325; Harrois, Anatole/0000-0002-5098-4656			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Deng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04627-3; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002032; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wijayatilake DS, 2015, J NEUROSURG ANESTH, V27, P241, DOI 10.1097/ANA.0000000000000143	15	6	6	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6399		SEP 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IX9PE	WOS:000486020900001	31286839	Green Submitted, Green Published			2022-02-06	
J	Karri, J; Zhang, B; Li, S				Karri, Jay; Zhang, Bei; Li, Sheng			Phenol Neurolysis for Management of Focal Spasticity in the Distal Upper Extremity	PM&R			English	Article							BOTULINUM-TOXIN; NERVE BLOCK; ULTRASOUND; STROKE; BLIND	Background When managing patients with focal spasticity, phenol neurolysis is often avoided largely because of its presumed poor adverse effect profile. It is suggested that dysesthesias may be more common with phenol neurolysis of the mixed sensorimotor nerves (eg, radial, median, and ulnar nerves) compared to neurolysis of pure motor nerves. However, these risks may be mitigated with precise localization of pure motor branches by ultrasound and electrical stimulation (EStim). Objective To explore practice patterns of phenol neurolysis to distal upper extremity mixed sensorimotor nerves with ultrasound and EStim guidance. Design A retrospective analysis of all neurolysis procedure records at a single institution from January 2013 to February 2018. Demographic and clinical variables including primary neurological diagnosis, concurrent spasticity treatments, nerves injected, phenol dosage and adverse events were abstracted from the electronic medical records. Participants 57 patients who received phenol neurolysis with ultrasound and EStim guidance for spasticity management to radial, median, or ulnar nerves. Main Outcome Measures Reported adverse effects. Results A total of 57 patients who collectively received neurolysis to 139 nerves across 102 encounters, met inclusion criteria. Most prevalent diagnoses included traumatic brain injury (N = 27, 47.4%) and stroke (N = 18, 31.6%), with a smaller subset having spinal cord injury (N = 10, 17.5%). Most patients received concomitant chemodenervation with botulinum toxin (N = 44, 77.2%). The average phenol dosage per nerve was 1.8 mL, with a range of 0.5-9.0 mL. Reported adverse effects included three cases of prolonged pain, but no dysesthesias were reported during the follow-up period (>40 days). Conclusions Phenol neurolysis with ultrasound and EStim guidance was successfully and safely used to manage focal spasticity in the distal upper extremity. Level of Evidence III.	[Karri, Jay] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Karri, Jay; Zhang, Bei; Li, Sheng] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, McGovern Med Sch, Houston, TX 77030 USA; [Zhang, Bei; Li, Sheng] TIRR Mem Hermann Hosp, TIRR Mem Hermann Res Ctr, Houston, TX USA		Li, S (corresponding author), 1333 Moursund St, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021				Deltombe T, 2004, ARCH PHYS MED REHAB, V85, P54, DOI 10.1016/S0003-9993(03)00405-2; Demir Y, 2018, SPINAL CORD, V56, P907, DOI 10.1038/s41393-018-0142-7; Francisco GE, 2016, PHYS MED REHABILITAT, P487; Francisco GE, 2012, STROKE, V43, P3132, DOI 10.1161/STROKEAHA.111.639831; Gooch JL, 2004, ARCH PHYS MED REHAB, V85, P1121, DOI 10.1016/j.apmr.2003.09.032; Gracies JM, 1997, MUSCLE NERVE, pS61; Karri J, 2017, J REHABIL MED, V49, P482, DOI 10.2340/16501977-2239; Kaymak B, 2019, EUR J PHYS REHAB MED, V55, P522, DOI 10.23736/S1973-9087.18.05295-4; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Lam K, 2015, J AM MED DIR ASSOC, V16, P238, DOI 10.1016/j.jamda.2014.10.005; Lee DG, 2012, NEUROREHABILITATION, V31, P373, DOI [10.3233/NRE-2012-0806, 10.3233/NRE-2012-00806]; Lee J, 2008, EUR RADIOL, V18, P1506, DOI 10.1007/s00330-008-0909-x; Matsumoto ME, 2018, PM&R, V10, P357, DOI 10.1016/j.pmrj.2017.09.006; Pierson SH, 1997, MUSCLE NERVE, pS36; Ploypetch T, 2015, PM&R, V7, P1073, DOI 10.1016/j.pmrj.2015.05.020	15	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	MAR	2020	12	3					246	250		10.1002/pmrj.12217		SEP 2019	5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KU9FC	WOS:000486292000001	31278847				2022-02-06	
J	Davies, MAM; Kerr, ZY; DeFreese, JD; Arden, NK; Marshall, SW; Guskiewicz, KM; Padua, DA; Pietrosimone, B				Davies, Madeleine A. M.; Kerr, Zachary Y.; DeFreese, J. D.; Arden, Nigel K.; Marshall, Stephen W.; Guskiewicz, Kevin M.; Padua, Darin A.; Pietrosimone, Brian			Prevalence of and Risk Factors for Total Hip and Knee Replacement in Retired National Football League Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; osteoarthritis; NFL; hip replacement; knee replacement; injury	ANTERIOR CRUCIATE LIGAMENT; DATA-COLLECTION PROCEDURES; SOCCER PLAYERS; UNITED-STATES; RECURRENT CONCUSSION; CONSENSUS STATEMENT; INJURY DEFINITIONS; JOINT REPLACEMENT; PHYSICAL-ACTIVITY; SPORTS INJURIES	Background: Osteoarthritis is a substantial cause of disability. Joint replacement prevalence relates to the burden of severe osteoarthritis, and identifying risk factors for end-stage disease may indicate intervention opportunities. American football has high youth and elite participation, and determining risk factors for severe osteoarthritis may support future morbidity prevention. Purpose: To (1) determine the prevalence of hip and knee replacement in retired National Football League (NFL) athletes, (2) examine risk factors for replacement, and (3) identify the association between knee injuries and knee replacement. Study Design: Case-control study; Level of evidence, 3. Methods: Retired NFL athletes who participated in a general health survey were included. This historical cohort included those playing between 1929 and 2001. The association between self-reported playing or injury history, and replacement after retirement, was assessed with prevalence ratios (PRs). Models were adjusted for potential confounders of age and weight. Results: Data for 2432 retired male NFL players (69.3% response rate) who had participated in football for a mean 15.2 years were included, in which 277 players reported replacement after retirement (11.4%). More participants reported knee replacement (7.7%) than hip replacement (4.6%). The majority of participants reported previous severe knee injury (53%), and the most prevalent was meniscal tear (32.2%). In multivariable models, age (10-year increase, PR, 2.23; 95% CI, 1.99-2.51), current weight (PR, 1.10; 95% CI, 1.06-1.14), and reporting 1 (PR, 1.78; 95% CI, 1.14-2.77), 2 (PR, 1.91; 95% CI, 1.16-3.15), or >= 3 knee injuries (PR, 3.44; 95% CI, 2.33-5.09) were associated with knee replacement. Age (10-year increase, PR, 1.86; 95% CI, 1.59-2.18), linemen (PR, 1.62; 95% CI, 1.03-2.55), and reporting 1 (PR, 1.72; 95% CI, 1.05-2.80), 2 (PR, 2.77 95% CI, 1.58-4.84), or >= 3 (PR, 2.44; 95% CI, 1.52-3.91) hip injuries were associated with hip replacement. Each reported knee injury type was cross-sectionally associated with replacement after retirement (P < .05). Conclusion: Knee replacement was more prevalent than hip replacement. Risk factors differed between the hip and the knee, with age and severe joint injury associated with hip and knee replacement, weight with knee replacement, and playing position associated with hip replacement. Joint injury and weight management may be prevention opportunities to reduce morbidity and end-stage osteoarthritis in this population.	[Davies, Madeleine A. M.; Kerr, Zachary Y.; DeFreese, J. D.; Arden, Nigel K.; Marshall, Stephen W.; Guskiewicz, Kevin M.; Padua, Darin A.; Pietrosimone, Brian] Univ N Carolina, Chapel Hill, NC 27515 USA; [Davies, Madeleine A. M.] Univ Bath, Dept Hlth, Wessex House 6-01, Bath BA2 7AY, Avon, England; [Davies, Madeleine A. M.; Arden, Nigel K.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England; [Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Padua, Darin A.; Pietrosimone, Brian] Univ N Carolina, MOT Sci Inst, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Davies, MAM (corresponding author), Univ Bath, Dept Hlth, Wessex House 6-01, Bath BA2 7AY, Avon, England.	m.davies@bath.ac.uk		Davies, Madeleine/0000-0002-6047-7340	National Football League Players Association; National Football League Charities; Centers for Disease Control and Prevention's National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE14002479]; Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis; National Operating Committee on Standards for Athletic Equipment; Medtronic IncMedtronic; Martek Biosciences Inc	The Center for the Study of Retired Athletes and its associated studies are funded in part by the National Football League Players Association, National Football League Charities, and several foundations and corporations, such as the National Operating Committee on Standards for Athletic Equipment, Medtronic Inc, and Martek Biosciences Inc. This study was not funded solely by any one of these entities. S.W.M. is partly supported by award R49/CE14002479 from the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control to the University of North Carolina Injury Prevention Research Center. The Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis provided fellowship funding to support this collaborative study. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	[Anonymous], 2017, BOD MASS IND BMI; [Anonymous], INJ DAT; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Ayers DC, 2014, J BONE JOINT SURG AM, V96A, P1567, DOI 10.2106/JBJS.N.00641; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Bennell K, 2012, NAT REV RHEUMATOL, V8, P747, DOI 10.1038/nrrheum.2012.119; Blanco FJ, 2012, NAT REV RHEUMATOL, V8, P130, DOI 10.1038/nrrheum.2012.11; Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Chen A, 2012, ARTHRITIS, DOI 10.1155/2012/698709; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Crowninshield RD, 2006, CLIN ORTHOP RELAT R, P266, DOI 10.1097/01.blo.0000188066.01833.4f; Davies M, 2017, SCI REP, V7, P1; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Esser S, 2011, CURR PAIN HEADACHE R, V15, P423, DOI 10.1007/s11916-011-0225-z; Fernandes GS, 2018, BRIT J SPORT MED, V52, P678, DOI 10.1136/bjsports-2017-097503; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Fitzgerald B, 1980, Br J Sports Med, V14, P97; Flugsrud GB, 2002, ARTHRITIS RHEUM, V46, P675, DOI 10.1002/art.10115; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hunter DJ, 2009, J ANAT, V214, P197, DOI 10.1111/j.1469-7580.2008.01013.x; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Knoop J, 2011, ARTHRIT CARE RES, V63, P1535, DOI 10.1002/acr.20571; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Kuijt MTK, 2012, J SCI MED SPORT, V15, P480, DOI 10.1016/j.jsams.2012.02.008; KUJALA UM, 1995, ARTHRITIS RHEUM, V38, P539, DOI 10.1002/art.1780380413; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Langley J, 2004, INJURY PREV, V10, P69, DOI 10.1136/ip.2003.003715; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Liu B, 2007, J CLIN EPIDEMIOL, V60, P1190, DOI 10.1016/j.jclinepi.2007.02.007; Lohkamp M, 2017, SCAND J MED SCI SPOR, V27, P1038, DOI 10.1111/sms.12846; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Losina E, 2013, ARTHRIT CARE RES, V65, P703, DOI 10.1002/acr.21898; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.101958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.01958]; LOTZ MK, 2010, ARTHRITIS RES THER, V12, DOI DOI 10.1186/AR3046; Luc B, 2014, J ATHL TRAINING, V49, P806, DOI 10.4085/1062-6050-49.3.35; MacLean JGB, 2012, BRIT J SPORT MED, V46, P591, DOI 10.1136/bjsports-2011-090183; MORETZ JA, 1984, AM J SPORT MED, V12, P298, DOI 10.1177/036354658401200410; NEYRET P, 1993, AM J SPORT MED, V21, P455, DOI 10.1177/036354659302100322; Ratzlaff C, 2012, OSTEOARTHR CARTILAGE, V20, P1568, DOI 10.1016/j.joca.2012.08.017; Robertsson O, 2010, ACTA ORTHOP, V81, P82, DOI 10.3109/17453671003685442; Rogers LQ, 2002, OSTEOARTHR CARTILAGE, V10, P617, DOI 10.1053/joca.2002.0802; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; Roos H, 1998, CLIN SPORT MED, V17, P819, DOI 10.1016/S0278-5919(05)70122-8; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Saxon L, 1999, SPORTS MED, V28, P123, DOI 10.2165/00007256-199928020-00005; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; van der Esch M, 2015, OSTEOARTHR CARTILAGE, V23, P544, DOI 10.1016/j.joca.2015.01.006; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Whittaker JL, 2015, OSTEOARTHR CARTILAGE, V23, P1122, DOI 10.1016/j.joca.2015.02.021; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	59	6	6	3	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2019	47	12					2863	2870	0363546519870804	10.1177/0363546519870804		SEP 2019	8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JE3YH	WOS:000487149900001	31498654				2022-02-06	
J	Miansari, M; Mehta, MD; Schilling, JM; Kurashina, Y; Patel, HH; Friend, J				Miansari, Morteza; Mehta, Meghna D.; Schilling, Jan M.; Kurashina, Yuta; Patel, Hemal H.; Friend, James			Inducing Mild Traumatic Brain Injury in C. elegans via Cavitation-Free Surface Acoustic Wave-Driven Ultrasonic Irradiation	SCIENTIFIC REPORTS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CAENORHABDITIS-ELEGANS; EXPERIMENTAL-MODELS; BLAST; MECHANISMS; HEALTH; RISK	Mild traumatic brain injury is an all-too-common outcome from modern warfare and sport, and lacks a reproducible model for assessment of potential treatments and protection against it. Here we consider the use of surface acoustic wave (SAW) irradiation of C. elegans worms-without cavitation-as a potential, ethically reasonable animal-on-a-chip model for inducing traumatic brain injury in an animal, producing significant effects on memory and learning that could prove useful in a model that progress from youth to old age in but a few weeks. We show a significant effect by SAW on the ability of worms to learn post-exposure through associative learning chemotaxis. At higher SAW intensity, we find immediate, thorough, but temporary paralysis of the worms. We further explore the importance of homogeneous exposure of the worms to the SAW-driven ultrasound, an aspect poorly controlled in past efforts, if at all, and demonstrate the absence of cavitation through a change in fluids from a standard media for the worms to the exceedingly viscous polyvinyl alcohol. Likewise, we demonstrate that acoustic streaming, when present, is not directly responsible for paralysis nor learning disabilities induced in the worm, but is beneficial at low amplitudes to ensuring homogeneous ultrasound exposure.	[Miansari, Morteza; Kurashina, Yuta; Friend, James] Univ Calif San Diego, Dept Mech & Aerosp Engn, Ctr Med Devices, Medically Adv Devices Lab, 9500 Gilman Dr MC0411, La Jolla, CA 92093 USA; [Miansari, Morteza] Babol Noshirvani Univ Technol, Dept Mech Engn, POB 484, Babol Sar, Iran; [Miansari, Morteza] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Canc Med, Babol Sar, Iran; [Mehta, Meghna D.; Schilling, Jan M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, 9500 Gilman Dr MC0801, La Jolla, CA 92093 USA; [Kurashina, Yuta] Tokyo Inst Technol, Sch Mat & Chem Technol, Yokohama, Kanagawa 4259, Japan		Friend, J (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, Ctr Med Devices, Medically Adv Devices Lab, 9500 Gilman Dr MC0411, La Jolla, CA 92093 USA.	jfriend@eng.ucsd.edu	Kurashina, Yuta/S-4155-2019; Friend, James/AAP-9697-2021	Kurashina, Yuta/0000-0003-3752-7204; 	University of CaliforniaUniversity of California System; NANO3 facility at UC San Diego; NIH Office of Research Infrastructure ProgramsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P40 OD010440]; National Science FoundationNational Science Foundation (NSF) [ECCS-1542148]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-GM121318-01]; W.M. Keck FoundationW.M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM121318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P40OD010440] Funding Source: NIH RePORTER	The authors are grateful to the University of California and the NANO3 facility at UC San Diego for provision of funds and facilities in support of this work. Some C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was performed in part at the San Diego Nanotechnology Infrastructure (SDNI) of UCSD, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (Grant ECCS-1542148). The authors are also grateful for the support of this work by NIH Grant T32-GM121318-01. The work presented here was generously supported in part by a research grant from the W.M. Keck Foundation.	Ahmed T, 2016, MOBISYS'16: COMPANION COMPANION PUBLICATION OF THE 14TH ANNUAL INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P7, DOI 10.1145/2938559.2948838; Alvarez L, 2008, NY TIMES, pA1; Angstman NB, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00012; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baasch T, 2018, BIOPHYS J, V115, P1817, DOI 10.1016/j.bpj.2018.08.048; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRENNER S, 1974, GENETICS, V77, P71; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Collignon S, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201704359; Connacher W, 2018, LAB CHIP, V18, P1952, DOI 10.1039/c8lc00112j; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Delius M, 1991, LITHOTRIPSY RELATED, P27; Dentry MB, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013203; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Ding XY, 2012, P NATL ACAD SCI USA, V109, P11105, DOI 10.1073/pnas.1209288109; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P832; Friend J, 2011, REV MOD PHYS, V83, P647, DOI 10.1103/RevModPhys.83.647; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gruber J, 2015, ANTIOXID REDOX SIGN, V23, P256, DOI 10.1089/ars.2014.6210; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; HAYAKAWA K, 1989, IEEE 1989 ULTRASONICS SYMPOSIUM : PROCEEDINGS, VOLS 1 AND 2, P969, DOI 10.1109/ULTSYM.1989.67133; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hobert O., WORMBOOK; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hope IA, 1999, C ELEGANS PRACTICAL; Ibsen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9264; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kauffman A, 2011, JOVE-J VIS EXP, DOI 10.3791/2490; Kazanis I, 2005, BRAIN RES REV, V50, P377, DOI 10.1016/j.brainresrev.2005.09.003; KURITA T, 1992, PATTERN RECOGN, V25, P1231, DOI 10.1016/0031-3203(92)90024-D; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Manvelyan H, 2006, Georgian Med News, P13; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NOLTINGK BE, 1950, P PHYS SOC LOND B, V63, P674, DOI 10.1088/0370-1301/63/9/305; Nussbaum-Krammer CI, 2015, JOVE-J VIS EXP, DOI 10.3791/52321; Porta-de-laRiva M, 2012, J VISUALIZED EXPT JO, V4019; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; San-Miguel A, WORMBOOK; SCHELLING G, 1994, BIOPHYS J, V66, P133, DOI 10.1016/S0006-3495(94)80758-1; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber K. H, 2006, THE JOURNAL OF NEURO; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan JZ, 2015, LAB CHIP, V15, P2790, DOI 10.1039/c5lc00305a; Zhou W, 2017, LAB CHIP, V17, P1725, DOI 10.1039/c7lc00163k	72	6	6	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 4	2019	9								12775	10.1038/s41598-019-47295-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IU6NU	WOS:000483703800044	31485018	gold, Green Published			2022-02-06	
J	Whiteside, DM; Caraher, K; Hahn-Ketter, A; Gaasedelen, O; Basso, MR				Whiteside, Douglas M.; Caraher, Kristen; Hahn-Ketter, Amanda; Gaasedelen, Owen; Basso, Michael R.			Classification accuracy of individual and combined executive functioning embedded performance validity measures in mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Executive function; logistic regression; mild traumatic brain injury; performance validity tests	CARD SORTING TEST; MALINGERING DETECTION; TEST-II; INDICATORS; VALIDATION; DERIVATION; ISSUES; TRAIL; BIAS	The development of more sophisticated performance validity measures is important due to concerns with coaching as well as providing clinicians with a greater variety of options when assessing performance validity. Examinees with noncredible performance may find it more difficult to elude detection by PVTs derived from arithmetical summation or logistic regression. The present study evaluated the classification accuracy of several executive functioning (EF) variables as PVTs both individually and when combined into derived variables. The current study evaluated a simple mathematic summation of embedded PVT scores and a logistic regression-based formula based on embedded PVTs from executive function measures. A total of 155 consecutive patients completed neuropsychological evaluation after sustaining a mild traumatic brain injury (MTBI) were studied and were placed into a PVT-PASS (N = 95, mean age = 44.9, SD = 12.55, mean education = 13.45, SD = 2.23, 38% male, 97% Caucasian) or PVT-FAIL group (N = 60, mean age = 44.1, SD = 15.47, mean education = 13.05, SD = 2.58, 55% male, 92% Caucasian). Trail Making Test B, Wisconsin Card Sorting Test, and Stroop Color Word Test were summed and also used in logistic regression to predict whether patients had credible performance. Both the mathematical summation and the logistic regression methods achieved excellent classification accuracy (summation AUC = .79; logistic regression AUC = .82) with higher sensitivity than individual PVTs.	[Whiteside, Douglas M.; Caraher, Kristen; Gaasedelen, Owen] Univ Iowa, Dept Psychiat, Iowa City, IA USA; [Hahn-Ketter, Amanda] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Basso, Michael R.] Univ Tulsa, Psychol, Tulsa, OK 74104 USA		Whiteside, DM (corresponding author), Univ Iowa, Psychiat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	douglas-whiteside@uiowa.edu	Whiteside, Douglas/AAK-6396-2020; Basso, Michael/S-9587-2019	Caraher, Kristen/0000-0003-2590-3022; Whiteside, Douglas/0000-0002-8454-4413; Basso, Michael/0000-0002-0217-662X			Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Golden CJ, 1978, STROOP COLOR WORD TE; Golden CJ., 2002, STROOP COLOR WORD TE; Green P., 2003, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K. W., 2007, ASSESSMENT MALINGERE, P171; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Harrell FE Jr, 2017, REGRESSION MODELING; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Menard S.W., 1995, APPL LOGISTIC REGRES; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Reitan RM, 1992, TRAIL MAKING TEST MA; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Steyeberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet J. J., 2007, ASSESSMENT FEIGNED C, P153; Tombaugh T.N., 1996, TEST MEMORY MALINGER; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Victor T.L., 2013, MILD TRAUMATIC BRAIN, P269; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	51	6	6	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 3	2019	26	5					472	481		10.1080/23279095.2018.1443935			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IQ1YZ	WOS:000480547500006	29521533				2022-02-06	
J	Rigon, A; Schwarb, H; Klooster, N; Cohen, NJ; Duff, MC				Rigon, Arianna; Schwarb, Hillary; Klooster, Nathaniel; Cohen, Neal J.; Duff, Melissa C.			Spatial relational memory in individuals with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Spatial memory; relational memory; traumatic brain injury; declarative memory; hippocampus	DECLARATIVE MEMORY; HIPPOCAMPAL DAMAGE; VISCOELASTICITY; RECONSTRUCTION; CONNECTIVITY; NAVIGATION; INTEGRITY; DEFICITS; MODERATE; COMPLEX	Introduction: Relational memory is the ability to bind arbitrary relations between elements of experience into durable representations and the flexible expression of these representations. It is well known that individuals with traumatic brain injury (TBI) have declarative memory impairments, but less is known about how TBI affects relational memory binding, the deficit at the heart of declarative, or relational, memory impairment. The aim of the current study is to examine such deficits. Method: We used a spatial reconstruction task (SRT) with 29 individuals with TBI and 23 normal comparison (NC) participants to investigate four different types of spatial relations: (A) identity-location relations, i.e., the relationship between a specific item and its known location; (B) item-item relations, or the relationship between one item and another; (C) item-display relations, or the relationship between an item and its position in the display; and (D) compound-item relations, i.e., relations that involve combinations of A, B, and C. Results: Our data revealed that individuals with TBI showed impairments in learning identity-location relations and increased compound errors compared to NCs. We also found evidence that when item identity is disregarded, individuals with TBI do not perform differently from NCs. An exploratory analysis revealed that while relational memory performance was significantly correlated with scores on the California Verbal Learning Test (CVLT), more participants with TBI exhibited impairment on the SRT than of the CVLT. Conclusions: Our findings show that relational memory is impaired following TBI, and provide preliminary evidence for an easy-to-administer task with increased sensitivity to memory impairment.	[Rigon, Arianna; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA; [Rigon, Arianna] Marshall Univ, Dept Commun Disorders, Huntington, WV USA; [Schwarb, Hillary; Cohen, Neal J.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Klooster, Nathaniel] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	arianna.rigon@vanderbilt.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD071844] Funding Source: Medline; ACL HHS [90SFGE0012] Funding Source: Medline		Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Beadle JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00069; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Clark R, 2017, HIPPOCAMPUS, V27, P716, DOI 10.1002/hipo.22727; Cohen, 2001, CONDITIONING CONSCIO; Costa PJ, 2014, J BIOPHARM STAT, V24, P1115, DOI 10.1080/10543406.2014.926366; Davidson PSR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00531; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Gean AD, 1994, IMAGING HEAD TRAUMA; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Horecka KM, 2018, HIPPOCAMPUS, V28, P164, DOI 10.1002/hipo.22819; Kessels RPC, 2002, J CLIN EXP NEUROPSYC, V24, P115, DOI 10.1076/jcen.24.1.115.967; Konkel A, 2009, FRONT NEUROSCI-SWITZ, V3, P166, DOI 10.3389/neuro.01.023.2009; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Postma A, 2008, NEUROSCI BIOBEHAV R, V32, P1339, DOI 10.1016/j.neubiorev.2008.05.001; Postma A, 2018, EXP BRAIN RES, V236, P1861, DOI 10.1007/s00221-018-5266-7; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Rubin RD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070082; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Schwarb H, 2017, NEUROIMAGE, V153, P179, DOI 10.1016/j.neuroimage.2017.03.061; Schwarb H, 2016, NEUROIMAGE, V132, P534, DOI 10.1016/j.neuroimage.2016.02.059; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skidmore Elizabeth R, 2015, Curr Phys Med Rehabil Rep, V3, P99; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Spreng RN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00437; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Voss JL, 2011, P NATL ACAD SCI USA, V108, pE402, DOI 10.1073/pnas.1100225108; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; Yee LTS, 2014, HIPPOCAMPUS, V24, P154, DOI 10.1002/hipo.22211	56	6	6	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2020	42	1					14	27		10.1080/13803395.2019.1659755		SEP 2019	14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KA8MP	WOS:000484739100001	31475607	Green Accepted			2022-02-06	
J	Anderson, SL; Gatens, D; Glatts, C; Russo, SA				Anderson, Stevi L.; Gatens, Dustin; Glatts, Colette; Russo, Stephen A.			Normative Data Set of SWAY Balance Mobile Assessment in Pediatric Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; balance; pediatrics; normative; assessment; reaction time	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; REACTION-TIME; NEUROPSYCHOLOGICAL ASSESSMENT; POSTURAL STABILITY; HIGH-SCHOOL; CONCUSSION; SPORT; GENDER; RELIABILITY	Objective: To examine and describe normative values for an objective, mobile measure of postural stability commonly used in concussion assessments, SWAY Balance (SWAY Medical, Tulsa, Oklahoma). Design: Retrospective analysis of baseline balance assessments in a healthy pediatric population. Setting: Baseline assessments completed by certified athletic trainers at an outpatient concussion center or sports medicine offices in Philadelphia, PA and surrounding suburban Pennsylvania and New Jersey or during an athletic trainer's baseline assessment of collegiate athletes at a National Collegiate Athletic Association (NCAA) Division-II University in Fort Lauderdale, FL. Participants: Test results of a sample of 466 athletes aged 5 to 18 years were included. Interventions: The SWAY Balance test was administered using a mobile device on all participants as part of a standard preseason, baseline evaluation, following the standard evaluation protocol. Main Outcome Measures: Baseline SWAY Balance mobile assessment balance and reaction time scores, age and sex effects, were examined. Results: Normative scores are described, with results stratified into 4 age groups (5-9, 10-12, 13-17, and 18 years old). Balance scores, overall and within each individual stance score, improved with the age of the participants. Sex effects on balance were only seen in single-leg stances, with females outperforming males. Reaction time was found to be faster in males and improved with age, peaking at 13 to 17 years old and slowing in 18-year-olds. Conclusions: Normative, age-specific SWAY Balance test results provided are of clinical use as references in the concussion assessments of pediatric athletes.	[Anderson, Stevi L.; Glatts, Colette; Russo, Stephen A.] Jefferson Comprehens Concuss Ctr, 4050 S 26th St,Suite 140, Philadelphia, PA 19112 USA; [Gatens, Dustin] Nova Southeastern Univ, Dept Athlet, Ft Lauderdale, FL 33314 USA		Anderson, SL (corresponding author), Jefferson Comprehens Concuss Ctr, 4050 S 26th St,Suite 140, Philadelphia, PA 19112 USA.	Stevi.Anderson@rothmaninstitute.com					Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bellis CJ, 1933, P SOC EXP BIOL MED, V30, P801; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Coleman J, 2014, CONCUSSION DIAGNOSIS; Collins MW, 2015, NEUROSURGERY, V2016, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Gribble PA, 2009, J SPORT REHABIL, V18, P240, DOI 10.1123/jsr.18.2.240; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kiselev S, 2009, J EXP CHILD PSYCHOL, V102, P150, DOI 10.1016/j.jecp.2008.02.002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Mormile MEE, 2018, J SPORT REHABIL, V27, P16, DOI 10.1123/jsr.2016-0140; Moser RS, 2017, APPL NEUROPSYCH-CHIL, V6, P166, DOI 10.1080/21622965.2016.1138310; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Owen A, TWOWAY ANOVA SPSS ST; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Reynolds E, 2016, APPL NEUROPSYCH-CHIL, V5, P283, DOI 10.1080/21622965.2015.1057637; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Silverman IW, 2006, SEX ROLES, V54, P57, DOI 10.1007/s11199-006-8869-6; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Steinberg N, 2016, PERCEPT MOTOR SKILL, V122, P256, DOI 10.1177/0031512516628989; Sway, 2013, SWAY INN MED TECHN F; Tabachnick B.G., 2013, USING MULTIVARIATE S; Whyte E, 2015, J ATHL TRAINING, V50, P392, DOI 10.4085/1062-6050-49.6.08; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	50	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2019	29	5					413	420		10.1097/JSM.0000000000000545			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	KG1HH	WOS:000509692100011	31460955				2022-02-06	
J	Armstrong, E; Coffin, J; McAllister, M; Hersh, D; Katzenellenbogen, JM; Thompson, SC; Ciccone, N; Flicker, L; Cross, N; Arabi, L; Woods, D; Hayward, C				Armstrong, Elizabeth; Coffin, Juli; McAllister, Meaghan; Hersh, Deborah; Katzenellenbogen, Judith M.; Thompson, Sandra C.; Ciccone, Natalie; Flicker, Leon; Cross, Natasha; Arabi, Linda; Woods, Deborah; Hayward, Colleen			'I've got to row the boat on my own, more or less': aboriginal australian experiences of traumatic brain injury	BRAIN IMPAIRMENT			English	Article						Aboriginal; Indigenous; traumatic brain injury; acquired communication disorder; rehabilitation; health worker	HOSPITALIZATION; TRANSITION; DISORDERS; AMERICAN; PEOPLE; CARE	Background: The overarching cultural context of the brain injury survivor, particularly that related to minority peoples with a history of colonisation and discrimination, has rarely been referred to in the research literature, despite profoundly influencing a person's recovery journey in significant ways, including access to services. This study highlights issues faced by Australian Aboriginal traumatic brain injury (TBI) survivors in terms of real-life consequences of the high incidence of TBI in this population, current treatment and long-term challenges. Method: A case study approach utilised qualitative interview and file review data related to five male Aboriginal TBI survivors diagnosed with acquired communication disorders. The five TBI survivors were from diverse areas of rural and remote Western Australia, aged between 19 and 48 years at the time of injury, with a range of severity. Case Reports: Common themes included: significant long-term life changes; short-term and long-term dislocation from family and country as medical intervention and rehabilitation were undertaken away from the person's rural/remote home; family adjustments to the TBI including permanent re-location to a metropolitan area to be with their family member in residential care; challenges related to lack of formal rehabilitation services in rural areas; poor communication channels; poor cultural security of services; and lack of consistent follow-up. Discussion and Conclusion: These case reports represent some of the first documented stories of Aboriginal Australian TBI survivors. They supplement available epidemiological data and highlight different contexts for Aboriginal people after TBI, contributing to an overall profile that is relevant for rehabilitation service planning.	[Armstrong, Elizabeth; McAllister, Meaghan; Hersh, Deborah; Ciccone, Natalie; Cross, Natasha; Arabi, Linda] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Coffin, Juli] Notre Dame Univ, Nulungu Res Inst, Broome, WA, Australia; [Katzenellenbogen, Judith M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Katzenellenbogen, Judith M.] Telethon Inst Child Hlth Res, Perth, WA, Australia; [Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, WA, Australia; [Flicker, Leon] Univ Western Australia, Ctr Med Res, Perth, WA, Australia; [Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, WA, Australia; [Hayward, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitfin, Perth, WA, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia.	b.armstrong@ecu.edu.au	; Thompson, Sandra/H-5955-2014	Flicker, Leon/0000-0002-3650-0475; Thompson, Sandra/0000-0003-0327-7155; Armstrong, Elizabeth/0000-0003-4469-1117; Ciccone, Natalie/0000-0002-1822-7217; Katzenellenbogen, Judith/0000-0001-5287-5819; Hersh, Deborah/0000-0003-2466-0225	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1046228]	The study was funded by National Health and Medical Research Council Project Grant #1046228.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Baxter P, 2008, QUAL REP, V13, P544; Blackmer J, 1999, BRAIN INJURY, V13, P627; Bohanna I, 2018, BRAIN IMPAIR, V19, P246, DOI 10.1017/BrImp.2018.1; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Chase SE., 2005, HDB QUALITATIVE RES, V3rd edn, P651; Coffin J., 2018, POSITIONING ABORIGIN, DOI [10.6084/m9.figshare.7180823, DOI 10.6084/M9.FIGSHARE.7180823]; Creswell J.W ., 2007, QUAL INQ; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Hines M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2721-2; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2015, AUST HEALTH REV, V39, P429, DOI 10.1071/AH14102; Katzenellenbogen JM, 2015, HEART, V101, P712, DOI 10.1136/heartjnl-2014-306678; Keightley M, 2011, BRAIN INJURY, V25, P142, DOI 10.3109/02699052.2010.541898; Kelly J., 2012, MANAGING 2 WORLDS TO; Kelly J, 2014, AUST J RURAL HEALTH, V22, P109, DOI 10.1111/ajr.12094; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; Lewis FD, 2017, NEUROREHABILITATION, V40, P401, DOI 10.3233/NRE-161427; Linton KF, 2015, BRAIN INJURY, V29, P639, DOI 10.3109/02699052.2014.989406; McDonald S, 2014, SOCIAL COMMUNICATION; McKenna B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2221-4; O'Reilly K, 2018, DISABIL REHABIL, V40, P2331, DOI 10.1080/09638288.2017.1334838; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Queensland Government (Writer) & A B I O Service (Director), 2017, MY COMM MY FAM 3 IND; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Taylor S. J., 1994, CHALLENGES SERVICE S, P43; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; World Health Organization, 2007, INT CLASS FUNCT DIS	39	6	6	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2019	20	2			SI		120	136	PII S1443964619000196	10.1017/BrImp.2019.19			17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IU7UQ	WOS:000483789200003					2022-02-06	
J	Beez, T; Munoz-Bendix, C; Ahmadi, SA; Steiger, HJ; Beseoglu, K				Beez, Thomas; Munoz-Bendix, Christopher; Ahmadi, Sebastian Alexander; Steiger, Hans-Jakob; Beseoglu, Kerim			From decompressive craniectomy to cranioplasty and beyond-a pediatric neurosurgery perspective	CHILDS NERVOUS SYSTEM			English	Article						Intracranial hypertension; Cranial reconstruction; Bone flap resorption	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; MALIGNANT INFARCTION; HEMICRANIECTOMY; CHILDREN; TRIAL; MULTICENTER	Purpose Decompressive craniectomy (DC) is an established neurosurgical emergency technique. Patient selection, optimal timing, and technical aspects related to DC and subsequent cranioplasty remain subjects of debate. For children, the overall degree of evidence is low, compared with randomized controlled trials (RCTs) in adults. Methods Here, we present a detailed retrospective analysis of pediatric DC, covering the primary procedure and cranioplasty. Results are analyzed and discussed in the light of modern scientific evidence, and conclusions are drawn to stimulate future research. Results The main indication for DC in children is traumatic brain injury (TBI). Primary and secondary DC is performed with similar frequency. Outcome appears to be better than that in adults, although long-term complications (especially bone flap resorption after autologous cranioplasty) are more common in children. Overt clinical signs of cerebral herniation prior to DC are predictors of poor outcome. Conclusions We conclude that DC is an important option in the armamentarium to treat life-threatening intracranial hypertension, but further research is warranted, preferentially in a multicenter prospective registry.	[Beez, Thomas; Munoz-Bendix, Christopher; Ahmadi, Sebastian Alexander; Steiger, Hans-Jakob; Beseoglu, Kerim] Heinrich Heine Univ, Med Fac, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany		Beez, T (corresponding author), Heinrich Heine Univ, Med Fac, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	thomas.beez@med.uni-duesseldorf.de	Munoz-Bendix, Christopher/A-1943-2014; Steiger, Hans-Jakob/AAN-8307-2021; Beez, Thomas/ABG-7004-2021	Steiger, Hans-Jakob/0000-0002-8249-2998; Beez, Thomas/0000-0002-8715-5237; Munoz-Bendix, Christopher/0000-0002-2414-2463			Ardissino M, 2019, CHILD NERV SYST, V35, P209, DOI 10.1007/s00381-018-3977-5; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Fiaschi P, 2016, J NEUROSURG-PEDIATR, V17, P705, DOI 10.3171/2015.10.PEDS15489; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Frassanito P, 2018, CHILD NERV SYST, V34, P2283, DOI 10.1007/s00381-018-3905-8; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson P, 2015, RANDOMISED EVALUATIO; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim DJ, 2012, J NEUROTRAUM, V29, P1354, DOI 10.1089/neu.2011.2018; Klieverik VM, 2019, CHILD NERV SYST, V35, P1481, DOI 10.1007/s00381-018-4025-1; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Korhonen TK, 2019, ACTA NEUROCHIR, V161, P473, DOI 10.1007/s00701-018-03791-3; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Lee SK, 2012, J KOREAN NEUROSURG S, V51, P86, DOI 10.3340/jkns.2012.51.2.86; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Manfiotto M, 2017, CHILD NERV SYST, V33, P1751, DOI 10.1007/s00381-017-3542-7; Rabinstein AA, 2011, LANCET NEUROL, V10, P593, DOI 10.1016/S1474-4422(11)70122-3; Ramaswamy V, 2008, J CHILD NEUROL, V23, P889, DOI 10.1177/0883073808314960; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Smith SE, 2011, DEV MED CHILD NEUROL, V53, P29, DOI 10.1111/j.1469-8749.2010.03775.x; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Waqas M, 2017, PEDIATR NEUROSURG, V52, P77, DOI 10.1159/000452808; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4	34	6	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2019	35	9					1517	1524		10.1007/s00381-019-04303-z			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IR9HA	WOS:000481753100015	31327037				2022-02-06	
J	Chung, S; Wang, X; Fieremans, E; Rath, JF; Amorapanth, P; Foo, FYA; Morton, CJ; Novikov, DS; Flanagan, SR; Lui, YW				Chung, S.; Wang, X.; Fieremans, E.; Rath, J. F.; Amorapanth, P.; Foo, F-Y A.; Morton, C. J.; Novikov, D. S.; Flanagan, S. R.; Lui, Y. W.			Altered Relationship between Working Memory and Brain Microstructure after Mild Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							SUPERIOR LONGITUDINAL FASCICULUS; INDIVIDUAL-DIFFERENCES; DIFFUSIONAL KURTOSIS; SPATIAL STATISTICS; NETWORKS; CONNECTIVITY; VARIABILITY; DYSFUNCTION; ANISOTROPY; ABILITIES	The authors investigated how working memory deficits relate to detectable WM microstructural injuries to discover robust biomarkers that allow early identification of patients with mild traumatic brain injury at the highest risk of working memory impairment. Multi-shell diffusion MR imaging was performed on a 3T scanner with 5 b-values. Diffusion metrics of fractional anisotropy, diffusivity and kurtosis (mean, radial, axial), and WM tract integrity were calculated. Auditory-verbal working memory was assessed using the Wechsler Adult Intelligence Scale. ROI analysis found a significant positive correlation between axial kurtosis and Digit Span Backward in mild traumatic brain injury mainly present in the right superior longitudinal fasciculus, which was not observed in healthy controls. BACKGROUND AND PURPOSE: Working memory impairment is one of the most troubling and persistent symptoms after mild traumatic brain injury (MTBI). Here we investigate how working memory deficits relate to detectable WM microstructural injuries to discover robust biomarkers that allow early identification of patients with MTBI at the highest risk of working memory impairment. MATERIALS AND METHODS: Multi-shell diffusion MR imaging was performed on a 3T scanner with 5 b-values. Diffusion metrics of fractional anisotropy, diffusivity and kurtosis (mean, radial, axial), and WM tract integrity were calculated. Auditory-verbal working memory was assessed using the Wechsler Adult Intelligence Scale, 4th ed, subtests: 1) Digit Span including Forward, Backward, and Sequencing; and 2) Letter-Number Sequencing. We studied 19 patients with MTBI within 4 weeks of injury and 20 healthy controls. Tract-Based Spatial Statistics and ROI analyses were performed to reveal possible correlations between diffusion metrics and working memory performance, with age and sex as covariates. RESULTS: ROI analysis found a significant positive correlation between axial kurtosis and Digit Span Backward in MTBI (Pearson r = 0.69, corrected P = .04), mainly present in the right superior longitudinal fasciculus, which was not observed in healthy controls. Patients with MTBI also appeared to lose the normal associations typically seen in fractional anisotropy and axonal water fraction with Letter-Number Sequencing. Tract-Based Spatial Statistics results also support our findings. CONCLUSIONS: Differences between patients with MTBI and healthy controls with regard to the relationship between microstructure measures and working memory performance may relate to known axonal perturbations occurring after injury.	[Chung, S.; Wang, X.; Fieremans, E.; Morton, C. J.; Novikov, D. S.; Lui, Y. W.] NYU, Sch Med, Ctr Adv Imaging Innovat & Res, New York, NY USA; [Chung, S.; Wang, X.; Fieremans, E.; Morton, C. J.; Novikov, D. S.; Lui, Y. W.] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, Dept Radiol, New York, NY USA; [Rath, J. F.; Amorapanth, P.; Flanagan, S. R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Foo, F-Y A.] New York Univ Langone Hlth, Dept Neurol, New York, NY USA		Chung, S (corresponding author), 660 1st Ave,4th Floor, New York, NY 10016 USA.	sohae.chung@nyulangone.org	Rath, Joseph F./C-4823-2008; Wang, Xiuyuan/A-7500-2013	Rath, Joseph F./0000-0003-2933-6299; Amorapanth, Prin/0000-0002-4260-7826; Novikov, Dmitry/0000-0002-4213-3050; Wang, Xiuyuan/0000-0001-6356-3386; Fieremans, Els/0000-0002-1384-8591; Flanagan, Steven/0000-0001-9005-5897; Chung, Sohae/0000-0002-1132-900X	National Institutes of Health/National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS039135-11, R21 NS090349]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER	This work was supported, in part, by grant funding from the National Institutes of Health/National Institute for Neurological Disorders and Stroke: R01 NS039135-11 and R21 NS090349. This work was also performed under the rubric of the Center for Advanced Imaging Innovation and Research (www.cai2r.net), a National Institute of Biomedical Imaging and Bioengineering, Biomedical Technology Resource Center (NIH P41 EB017183).	Andersson G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30961-1; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bluhm RL, 2011, HUM BRAIN MAPP, V32, P1029, DOI 10.1002/hbm.21090; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chechlacz M, 2015, J NEUROSCI, V35, P10647, DOI 10.1523/JNEUROSCI.0210-15.2015; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Chung S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21428-4; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collier Q, 2015, MAGN RESON MED, V73, P2174, DOI 10.1002/mrm.25351; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; FISHER RA, 1948, STAT METHODS RES WOR; Frye RE, 2010, DEV MED CHILD NEUROL, V52, P760, DOI 10.1111/j.1469-8749.2010.03633.x; Golestani AM, 2014, J NEUROSCI, V34, P14913, DOI 10.1523/JNEUROSCI.2317-14.2014; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jensen JH, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3689; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kayser A., 2018, WORKING MEMORY CLIN, P180; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lazar M, 2017, NEUROSCIENTIST, V23, P197, DOI 10.1177/1073858416634298; Long YC, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00391; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sandry J, 2016, ARCH PHYS MED REHAB, V97, P1026, DOI 10.1016/j.apmr.2015.10.109; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Wechsler D., 2008, WECHSLER ADULT INTEL; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	54	6	6	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2019	40	9					1438	1444		10.3174/ajnr.A6146			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IV8MJ	WOS:000484519300004	31371359	Green Published, hybrid			2022-02-06	
J	Garg, K; Singh, PM; Singla, R; Aggarwal, A; Borle, A; Singh, M; Chandra, PS; Kale, SS; Mahapatra, AK				Garg, Kanwaljeet; Singh, Preet M.; Singla, Raghav; Aggarwal, Ankita; Borle, Anuradha; Singh, Manmohan; Chandra, P. Sarat; Kale, Shashank S.; Mahapatra, Ashok K.			Role of Decompressive Craniectomy in Traumatic Brain Injury - A Meta-analysis of Randomized Controlled Trials	NEUROLOGY INDIA			English	Article						Craniectomy; decompressive; outcome; traumatic brain injury	REFRACTORY INTRACRANIAL HYPERTENSION; SEVERE HEAD-INJURY; GUIDELINES; MANAGEMENT; CHILDREN; PRESSURE	Objective: Several studies have indicated that decompressive craniectomy (DC) for traumatic brain injury (TBI) is lifesaving. However, there is lack of level 1 evidence to define the role of DC in TBI. We performed a meta-analysis of all the randomized controlled trials (RCTs) published so far on the role of DC in adult patients with TBI. Materials and Methods: A systematic literature search was performed for articles published until September of 2016 for RCTs of DC in adult patients with TBI. The primary end-point was mortality at six-months. We also evaluated the overall adverse outcomes at six months. Assessment of risk of bias of the RCTs was also performed. Results: Three trials evaluating adult population satisfied the eligibility criteria. Pooled analysis involved 285 and 288 patients in DC group and control groups respectively. Patients undergoing DC for TBI had a lower mortality association of nearly 50 percent. However, patients surviving DC were more likely to have a poor neurological outcome compared to patients undergoing medical management. Conclusion: Based on the available RCTs on DC in TBI, the results of our meta-analysis show that there is a mortality benefit of performing a DC over the best medical management in adult patients. Furthermore, surviving following DC, a greater incidence of a poor neurological outcome is noted. In the event of small number of high-quality RCTs, our results must be interpreted with caution.	[Garg, Kanwaljeet; Singla, Raghav; Singh, Manmohan; Chandra, P. Sarat; Kale, Shashank S.; Mahapatra, Ashok K.] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Singh, Preet M.; Borle, Anuradha] All India Inst Med Sci, Dept Anaesthesia, New Delhi, India; [Aggarwal, Ankita] All India Inst Med Sci, Dept Radiodiag, New Delhi, India		Garg, K (corresponding author), All India Inst Med Sci, Cardioneuro Ctr, Room 716, New Delhi, India.	gargneuro@hotmail.com	Garg, Kanwaljeet/AAS-7965-2021	Singla, Raghav/0000-0003-4426-5089			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang WTW, 2014, EMERG MED CLIN N AM, V32, P889, DOI 10.1016/j.emc.2014.07.008; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Gurusamy KS, 2009, BRIT J SURG, V96, P342, DOI 10.1002/bjs.6558; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lundh A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-22; Moein H, 2012, NEUROSURG QUART, V22, P149, DOI 10.1097/WNQ.0b013e318240f1e0; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Suehiro E, 2017, J NEUROTRAUMA; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor A, CHILDS NERVSYST, V17, P154; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	6	6	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2019	67	5					1225	1232	PMID 31744947	10.4103/0028-3886.271260			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF9GU	WOS:000509547500008	31744947				2022-02-06	
J	Goldsworthy, R; Donders, J				Goldsworthy, Rachael; Donders, Jacobus			MMPI-2-RF Patterns After Traumatic Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						traumatic brain injury; MMPI-2-RF; concussion; premorbid mental health; coping strategies	VALIDITY SCALES; DISORDER; SCORES; ABUSE; RBS	Individuals who sustain traumatic brain injury (FBI) may report various cognitive, emotional, and somatic symptoms. To formally assess the possibility of subtypes of symptom profiles following TBI, we examined patterns of Minnesota Multiphasic Personality Inventory-2-Restructured form (MMPI-2-RF) restructured clinical scales in 201 persons with TBI. 1 to 12 months post injury. We also evaluated how these patterns varied according to injury, demographic, and premorbid variables. Cluster analysis identified 4 distinct MMPI-2-RF profiles. Clusters I and 4 differed primarily in overall profile elevation, while Clusters 2 and 3 varied in pattern. Although Cluster 1 endorsed the most distress across clinical scales, they were also most likely to have highly elevated Symptom Validity scales. In addition, they had relatively greater prevalence of prior personal and substance abuse histories than Cluster 4. In contrast, Cluster 4 did not endorse any significant elevations on clinical scales, even though it comprised relatively more patients with positive neuroimaging findings. Cluster 2 was predominantly female and endorsed prominent somatization on the MMPI-2-RF, whereas Cluster 3 was predominantly male, and their MMPI-2-RF pattern was characterized by subclinical levels of guardedness and restlessness. Compared with Cluster 2, Cluster 3 had relatively greater proportions of participants with positive neuroimaging findings as well as prior substance abuse histories. The present study is consistent with research that suggests that subjective symptom reporting following TBI is associated to a considerable degree with premorbid factors.	[Goldsworthy, Rachael; Donders, Jacobus] Mary Free Bed Rehabil Hosp, 235 Wealthy St South East, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, 235 Wealthy St South East, Grand Rapids, MI 49503 USA.	Jacobus.Donders@MaryFreeBed.com			Campbell Foundation; Mary Free Bed Fund	The authors gratefully acknowledge the financial support of the Campbell Foundation and Mary Free Bed Fund, without which the present study could not have been completed. Part of this study's findings were presented as a poster during the 16th meeting of the American Academy of Clinical Neuropsychology in San Diego, California (June 21, 2018).	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Sarstedt M, 2014, CONCISE GUIDE MARKET, P273, DOI DOI 10.1007/978-3-642-53965-9; SAS, 2012, STAT AN SYST US GUID; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stucky KJ, 2014, NEUROPSYCHOLOGY STUD, P432; Tellegen, 2008, MINNESOTA MULTIPHASI; Thaler NS, 2015, APPL NEUROPSYCH-CHIL, V4, P20, DOI 10.1080/21622965.2013.790820; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Whiffen VE, 2005, TRAUMA VIOLENCE ABUS, V6, P24, DOI 10.1177/1524838004272543; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	39	6	6	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2019	31	9					1145	1153		10.1037/pas0000742			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	IS9TG	WOS:000482490200007	31219277				2022-02-06	
J	Hsueh, SC; Lecca, D; Greig, NH; Wang, JY; Selman, W; Hoffer, BJ; Miller, JP; Chiang, YH				Hsueh, Shih-Chang; Lecca, Daniela; Greig, Nigel H.; Wang, Jia-Yi; Selman, Warren; Hoffer, Barry J.; Miller, Jonathan P.; Chiang, Yung-Hsiao			(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice	CELL TRANSPLANTATION			English	Article						phenserine; traumatic brain injury; controlled cortical impact; contusion volume; behavioral impairment; neuroinflammation	ALZHEIMER DRUG PHENSERINE; AMYLOID-BETA PEPTIDE; BODY SWING TEST; HEAD-INJURY; VENTRICULAR ENLARGEMENT; PARKINSONS-DISEASE; PRECURSOR PROTEIN; ACETYLCHOLINESTERASE; PATHOPHYSIOLOGY; INHIBITORS	Traumatic brain injury (TBI), a major cause of mortality and morbidity, affects 10 million people worldwide, with limited treatment options. We have previously shown that (-)-phenserine (Phen), an acetylcholinesterase inhibitor originally designed and tested in clinical phase III trials for Alzheimer's disease, can reduce neurodegeneration after TBI and reduce cognitive impairments induced by mild TBI. In this study, we used a mouse model of moderate to severe TBI by controlled cortical impact to assess the effects of Phen on post-trauma histochemical and behavioral changes. Animals were treated with Phen (2.5 mg/kg, IP, BID) for 5 days started on the day of injury and the effects were evaluated by behavioral and histological examinations at 1 and 2 weeks after injury. Phen significantly attenuated TBI-induced contusion volume, enlargement of the lateral ventricle, and behavioral impairments in motor asymmetry, sensorimotor functions, motor coordination, and balance functions. The morphology of microglia was shifted to an active from a resting form after TBI, and Phen dramatically reduced the ratio of activated to resting microglia, suggesting that Phen also mitigates neuroinflammation after TBI. While Phen has potent anti-acetylcholinesterase activity, its (+) isomer Posiphen shares many neuroprotective properties but is almost completely devoid of anti-acetylcholinesterase activity. We evaluated Posiphen at a similar dose to Phen and found similar mitigation in lateral ventricular size increase, motor asymmetry, motor coordination, and balance function, suggesting the improvement of these histological and behavioral tests by Phen treatment occur via pathways other than anti-acetylcholinesterase inhibition. However, the reduction of lesion size and improvement of sensorimotor function by Posiphen were much smaller than with equivalent doses of Phen. Taken together, these results show that post-injury treatment with Phen over 5 days significantly ameliorates severity of TBI. These data suggest a potential development of this compound for clinical use in TBI therapy.	[Hsueh, Shih-Chang; Wang, Jia-Yi; Hoffer, Barry J.; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Hsueh, Shih-Chang; Wang, Jia-Yi; Hoffer, Barry J.; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Hsueh, Shih-Chang; Selman, Warren; Hoffer, Barry J.; Miller, Jonathan P.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, 11100 Euclid Ave, Cleveland, OH 44106 USA; [Lecca, Daniela; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan		Miller, JP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosurg, 11100 Euclid Ave, Cleveland, OH 44106 USA.; Chiang, YH (corresponding author), Taipei Med Univ, 252 Wu Hsing St, Taipei 110, Taiwan.	jonathan.miller@uhhospitals.org; ychiang@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56 AG057028] Funding Source: Medline		Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Barger SW, 2004, FRONT BIOSCI-LANDMRK, V9, P3286, DOI 10.2741/1481; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barrientos RM, 2015, NEUROSCIENCE, V309, P84, DOI 10.1016/j.neuroscience.2015.03.007; Bengtsson M, 2016, J REHABIL MED, V48, P1, DOI 10.2340/16501977-2040; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; GREIG NH, 1995, MED RES REV, V15, P3, DOI 10.1002/med.2610150103; Greig Nigel H., 2005, Current Alzheimer Research, V2, P275; Greig NH, 2014, ANN NEUROL, V76, P629, DOI 10.1002/ana.24254; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haam J, 2017, J NEUROCHEM, V142, P111, DOI 10.1111/jnc.14052; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Klein J, 2007, EXPERT OPIN INV DRUG, V16, P1087, DOI 10.1517/13543784.16.7.1087; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marcet Paul, 2017, Neuroimmunol Neuroinflamm, V4, P82, DOI 10.20517/2347-8659.2017.07; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mikkilineni S, 2012, PARKINSONS DIS, V2012, P5; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reale M, 2014, CURR ALZHEIMER RES, V11, P608, DOI 10.2174/1567205010666131212113218; Roghani M, 2002, PHYSIOL BEHAV, V76, P507, DOI 10.1016/S0031-9384(02)00753-9; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Solito E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00014; Teich Andrew F, 2018, Alzheimers Dement (N Y), V4, P37, DOI 10.1016/j.trci.2017.12.001; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Toth A, 2015, J NEUROTRAUM, V32, P1307, DOI 10.1089/neu.2014.3696; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu QS, 2001, J MED CHEM, V44, P4062, DOI 10.1021/jm010080x; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	67	6	6	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	SEP	2019	28	9-10					1183	1196		10.1177/0963689719854693			14	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	JA5VZ	WOS:000487912200011	31177840	Green Published, gold			2022-02-06	
J	Jones, JW; Sarkar, C; Lipinski, MM; Kane, MA				Jones, Jace W.; Sarkar, Chinmoy; Lipinski, Marta M.; Kane, Maureen A.			Detection and Structural Characterization of Ether Glycerophosphoethanolamine from Cortical Lysosomes Following Traumatic Brain Injury Using UPLC-HDMSE	PROTEOMICS			English	Article						data independent tandem mass spectrometry; ether lipids; glycerophosphoethanolamine; lipid structure; lysosomes; traveling wave ion mobility; traumatic brain injury; UPLC-HDMSE	TANDEM MASS-SPECTROMETRY; COLLISION CROSS-SECTION; ION MOBILITY; LIQUID-CHROMATOGRAPHY; LIPID-COMPOSITION; GLYCEROPHOSPHOLIPIDS; MOUSE; IDENTIFICATION; PLASMALOGENS; CURVATURE	The use of ultra performance liquid chromatography coupled to data independent tandem mass spectrometry with traveling wave ion mobility for detection and structural identification of ether-linked glycerophosphoethanolamine is described. The experimental design generates 4D data (chromatographic retention time, precursor accurate mass, drift time with associated calculated collisional cross-section, and time-aligned accurate mass diagnostic product ions) for each ionization mode. Confident structure identification depends on satisfying 4D data confirmation in both positive and negative ion mode. Using this methodology, a number of ether-linked glycerophosphoethanolamine lipids are structurally elucidated from mouse brain lysosomes. It is further determined that several ether-linked glycerophosphoethanolamine structures are differentially abundant between lysosomes isolated from mouse cortex following traumatic brain injury as compared to that of sham animals. The combined effort of aligning multi-dimensional mass spectrometry data with a well-defined traumatic brain injury model lays the foundation for gaining mechanistic insight in the role lysosomal membrane damage plays in neuronal cell death following brain injury.	[Jones, Jace W.; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Sarkar, Chinmoy; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA		Kane, MA (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	mkane@rx.umaryland.edu	Sarkar, Chinmoy/AAI-2461-2019	Jones, Jace/0000-0003-0460-0380	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091218, R01NS094527] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS 091218, R01 NS091218, R01 NS094527] Funding Source: Medline		Berry KAZ, 2017, ANAL CHEM, V89, P916, DOI 10.1021/acs.analchem.6b04047; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795; Deeley JM, 2009, ANAL CHEM, V81, P1920, DOI 10.1021/ac802395d; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Farooqui AA, 1995, BRAIN RES REV, V21, P152, DOI 10.1016/0165-0173(95)00008-9; Fhaner Cassie J, 2013, Mass Spectrom (Tokyo), V2, pS0015, DOI 10.5702/massspectrometry.S0015; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Guan ZZ, 1996, J NEUROCHEM, V66, P277; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; HAN XL, 1992, BIOPHYS J, V63, P309, DOI 10.1016/S0006-3495(92)81616-8; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P2065, DOI 10.1016/j.jasms.2007.08.019; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Jones JW, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3822; Kliman M, 2011, BBA-MOL CELL BIOL L, V1811, P935, DOI 10.1016/j.bbalip.2011.05.016; Kyle JE, 2016, ANALYST, V141, P1649, DOI 10.1039/c5an02062j; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lisa M, 2011, J CHROMATOGR A, V1218, P5146, DOI 10.1016/j.chroma.2011.05.081; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Paglia G, 2015, ANAL CHEM, V87, P1137, DOI 10.1021/ac503715v; PALTAUF F, 1994, CHEM PHYS LIPIDS, V74, P101, DOI 10.1016/0009-3084(94)90054-X; Rosenberger TA, 2002, J LIPID RES, V43, P59; Rudiger M, 2000, CRIT CARE MED, V28, P1572, DOI 10.1097/00003246-200005000-00052; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sindelar PJ, 1999, FREE RADICAL BIO MED, V26, P318, DOI 10.1016/S0891-5849(98)00221-4; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Zhou ZW, 2017, ANAL CHEM, V89, P9559, DOI 10.1021/acs.analchem.7b02625	39	6	6	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	SEP	2019	19	18			SI				1800297	10.1002/pmic.201800297			8	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IX8DW	WOS:000485916400005	30790445	Green Accepted			2022-02-06	
J	Leeper, CM; Strotmeyer, SJ; Neal, MD; Gaines, BA				Leeper, Christine M.; Strotmeyer, Stephen J.; Neal, Matthew D.; Gaines, Barbara A.			Window of Opportunity to Mitigate Trauma-induced Coagulopathy Fibrinolysis Shutdown not Prevalent Until 1 Hour Post-injury	ANNALS OF SURGERY			English	Article; Proceedings Paper	139th Annual Meeting of the American-Surgical-Association (ASA)	APR 11-13, 2019	Dallas, TX	Amer Surg Assoc		coagulopathy; fibrinolysis; pediatric; trauma	ADMISSION RAPID THROMBELASTOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; MORTALITY; CHILDREN; COAGULATION; INJURY; TIME; DEFINITION; OUTCOMES	Objective: The aim of this study was to delineate the kinetics of coagulation dysregulation after injury in children. Summary Background Data: Trauma-induced coagulopathy is common and portends poor outcomes in severely-injured children. Transfer to pediatric trauma centers is common; time from injury to laboratory testing is therefore highly variable. Methods: Records of severely injured children age <18 years with rapid thromboelastography (TEG) on arrival and documented time of injury were queried. Standard definitions of hyperfibrinolysis (LY30 >= 3), fibrinolysis shutdown (SD; LY30 <= 0.8), and physiologic (LY30 = 0.9-2.9) were applied. Abbreviated Injury Scale score >= 3 defined severe traumatic brain injury (TBI). Variables of interest included demographics, injury mechanism, medications, mortality, and functional disability. Wilcoxon rank-sum and Kruskal-Wallis testing were utilized for skewed continuous data, and Chi-square or Fisher exact test was used for categorical data. To determine independent predictors of SD, multivariable logistic regression modeling was performed using the time from injury variable as well as variables determined a priori to be clinically relevant contributors to the development of SD (TBI, injury mechanism, and age). Results: A total of 285 patients were included: median (interquartile range) age = 11 (6-15), injury severity score = 17 (10-25), 75% blunt mechanism, 32% severe TBI, 11% mortality, 28% functional disability. None received antifibrinolytics or blood products before TEG testing. Physiologic phenotype was predominant within 1 hour of injury (51%); beyond 1 hour, fibrinolysis SD was the predominant phenotype (1-3 hours = 46%, >3 hours = 59%). Patients with TBI had significant increase in incidence of fibrinolysis SD beyond 1 hour after injury as compared to non-TBI patients. Physiologic fibrinolysis was associated with survival at all timepoints (P = 0.005). Conclusions: Fibrinolysis SD is a reactive, compensatory mechanism that is evident soon after injury. There appears to be an early and brief window of opportunity for intervention to mitigate the progression to TIC. Further studies should focus on understanding the dynamic events occurring immediately after injury to identify specific targets for intervention.	[Leeper, Christine M.; Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15260 USA; [Strotmeyer, Stephen J.; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Leeper, CM (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15260 USA.	leepercm@upmc.edu					Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cardenas JC, 2019, SHOCK, V51, P273, DOI 10.1097/SHK.0000000000001160; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gall LS, 2018, ANN SURG; Gomez-Builes JC, 2018, ANESTH ANALG, V127, P840, DOI 10.1213/ANE.0000000000003341; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; Leeper CM, 2018, SURGERY, V163, P827, DOI 10.1016/j.surg.2017.09.031; Leeper CM, 2017, ANN SURG, V266, P508, DOI 10.1097/SLA.0000000000002355; Leeper CM, 2017, J TRAUMA ACUTE CARE, V82, P27, DOI 10.1097/TA.0000000000001308; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Liras IN, 2017, J AM COLL SURGEONS, V224, P625, DOI 10.1016/j.jamcollsurg.2016.12.046; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore HB, 2017, J TRAUMA ACUTE CARE, V83, P1014, DOI 10.1097/TA.0000000000001718; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Nicolau-Raducu R, 2019, LIVER TRANSPLANT, V25, P380, DOI 10.1002/lt.25394; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Roberts DJ, 2019, J TRAUMA ACUTE CARE, V86, P206, DOI 10.1097/TA.0000000000002099; Schmitt FCF, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0499-6; Semeraro F, 2018, CRIT CARE MED, V46, pe221, DOI 10.1097/CCM.0000000000002919; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	38	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2019	270	3					528	534		10.1097/SLA.0000000000003464			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	JT9QZ	WOS:000501317200015	31305285				2022-02-06	
J	Meulenbroek, P; Cherney, LR				Meulenbroek, Peter; Cherney, Leora R.			The Voicemail Elicitation Task: Functional Workplace Language Assessment for Persons With Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							FACTORS PREDICTING RETURN; COMMUNICATION ABILITY; WORK; OUTCOMES; ADULTS; SKILLS; EMPLOYABILITY; EMPLOYMENT; STABILITY; VALIDITY	Purpose: Politeness markers (PMs) are words that enhance cooperativity in dialogue and are an essential component of professional/work communication. Persons with moderate/severe traumatic brain injury (TBI) underuse PMs in connected speech and have employment stability issues. The voicemail elicitation task (VET) is a standardized computerized language sampling procedure measuring PM rate in role-play tasks. Our purpose is to provide preliminary data establishing the potential of a screening assessment tool for professional/work communication. Method: We measured VET performance using spoken PMs per minute (PMpM). We present data from 63 persons. Forty-three participants with TBI (22-65 years old, >= 1-year postinjury) worked in midlevel jobs before their injury and attempted work return after injury at the same job level. Twenty participants with TBI did not maintain work > 1 year (unstably employed), and 23 did maintain work for >= 1 year (stably employed). Twenty controls without history of neurological impairment working at the same job level also completed the VET protocol. We analyzed the data using between-group comparison with 1-way analysis of variance and post hoc analysis. We used receiver operating characteristic curve analysis to calculate sensitivity and specificity, as well as an optimal cutoff value for a screening measure. Results: Group differences, F(2, 60) = 19.59, p = .0001, eta(2) = .376, were identified between unstably employed persons with TBI performing with lower PMpM scores than the stably employed TBI group and the control group. Receiver operating characteristic curve analysis indicated a cutoff score of 11.55 PMpM. There was acceptable specificity (0.700, 95% CI [0.499, 0.901]) and sensitivity (0.696, 95% CI [0.508, 0.883]) for a screening tool indicating further assessment of social communication. Conclusion: The VET holds promise as a clinical screening tool to identify persons at risk for social communication-related job instability after TBI and the need for a more comprehensive social communication assessment.	[Meulenbroek, Peter] Univ Kentucky, Coll Hlth Sci, Lexington, KY 40506 USA; [Cherney, Leora R.] Shirley Ryan AbilityLab, Chicago, IL USA; [Cherney, Leora R.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Meulenbroek, P (corresponding author), Univ Kentucky, Coll Hlth Sci, Lexington, KY 40506 USA.	meulenbroek@uky.edu		Meulenbroek, Peter/0000-0003-4233-9910	National Institute on Disability, Independent Living, and Rehabilitation Research Advanced Rehabilitation Research Training Grant [H133P120013/90AR5015]; National Institute on Disability, Independent Living, and Rehabilitation Research Mary E. Switzer Merit Research Fellowship [90SF0006]; National Institutes of Health/National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31DC011462]	This study was supported by National Institute on Disability, Independent Living, and Rehabilitation Research Advanced Rehabilitation Research Training Grant H133P120013/90AR5015 awarded to Cherney, National Institute on Disability, Independent Living, and Rehabilitation Research Mary E. Switzer Merit Research Fellowship 90SF0006 awarded to Meulenbroek, and National Institutes of Health/National Institute on Deafness and Other Communication Disorders F31DC011462 awarded to Meulenbroek. The authors would like to thank Phillip Gribble for valuable feedback and input on the methods incorporated in this article, Lyn S. Turkstra for feedback and support with development of this instrument, Sheila MacDonald for feedback on the acceptability during instrument development, and Emma Edgar for transcription and transcription reliability.	[Anonymous], 1975, DO THINGS WORDS, V2nd; Bach Kent, 1982, LINGUISTIC COMMUNICA; Bargiela-Chiappini Francesca, 2006, J POLITENESS RES, V2, P7, DOI DOI 10.1515/PR.2006.002; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bureau of Labor Statistics, 2012, SECTOR EMPLOYMENT SH; BURTON LF, 1987, J REHABIL, V53, P71; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cherney L. R, 1998, ANALYZING DISCOURSE; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Culpeper Jonathan, 2011, HDB PRAGMATICS, P393, DOI DOI 10.1017/CB09780511975752; DeKay SH, 2012, BUS PROF COMMUN Q, V75, P449, DOI 10.1177/1080569912458966; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Drew P, 1992, TALK WORK INTERACTIO; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Grice H. P, 1975, SYNTAX SEMANTICS, V3, P719; Guo YE, 2008, BRAIN INJURY, V22, P83, DOI 10.1080/02699050701824150; Haffey W.J., 1991, J HEAD TRAUMA REHAB, V6, P24; Halliday G. M., 2004, INTRO FUNCTIONAL GRA; Handford M, 2010, THE LANGUAGE OF BUSI; Holmes J, 2003, RES LANG SOC INTERAC, V36, P65, DOI 10.1207/S15327973RLSI3601_4; Holmes J, 2003, P IEEE PPIC JUN; House J., 1981, CONVERSATIONAL ROUTI, P157; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Isaki E, 2000, BRAIN INJURY, V14, P441; Johnson R, 1987, Int Disabil Stud, V9, P49; KEYTON J, 2013, INT J BUSINESS COMMU, V50, P152, DOI DOI 10.1177/0021943612474990; Koester, 2006, INVESTIGATING WORKPL; KOESTER A, 2010, WORKPLACE DISCOURSE; Levinson, 1987, POLITENESS SOME UNIV; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; National Center for O*NET Development, 2017, JOB ZONE THREE MEDIU; National Center for O*NET Development, 2018, O NET ONLINE HELP JO; Phillips B. N., 2015, REHABILITATION COUNS, V60, P16; Portney L, 2009, FDN CLIN RES APPL PR, P3; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Safont-Jorda Pilar, 2005, RAEL REV ELECT LINGU, V4, P1; Schnurr S., 2013, EXPLORING PROFESSION; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Sigurdardottir S, 2018, NEUROPSYCHOLOGICAL R, DOI 10.1080/09602011.2018.1462719; Sohlberg M. M, INT J LANGUAGE COMMU, V21, P128, DOI 10.1080/17549507.2019.1583281; Stergiou-Kita M, 2012, DISABIL REHABIL, V34, P179, DOI 10.3109/09638288.2011.591881; Terkourafi Marina, 2005, J POLITENESS RES-LAN, V1, P237, DOI DOI 10.1515/JPLR.2005.1.2.237; Thuesen F, 2017, WORK EMPLOY SOC, V31, P937, DOI 10.1177/0950017016656321; Thurman D. J, 2007, BRAIN INJURY MED PRI, P44; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Trosborg A., 1995, INTERLANGUAGE PRAGMA; Turkstra LS, 2017, DISABIL REHABIL, V39, P1872, DOI 10.1080/09638288.2016.1212113; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vine Bernadette, 2004, GETTING THINGS DONE; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Willing K, 1992, TALKING IT THROUGH C; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	72	6	6	2	8	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	SEP	2019	62	9					3367	3380		10.1044/2019_JSLHR-L-18-0466			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IZ7CR	WOS:000487244000017	31398300	Green Published			2022-02-06	
J	Nagib, S; Linens, SW				Nagib, Steven; Linens, Shelley W.			Vestibular Rehabilitation Therapy Improves Perceived Disability Associated With Dizziness Postconcussion	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; recovery; sport medicine; survey	CONCUSSION	Clinical Scenario: Every year, millions of people suffer a concussion. A significant portion of these people experience symptoms lasting longer than 10 days and are diagnosed with postconcussion syndrome. Dizziness is the second most reported symptom associated with a concussion and may be a predictor of prolonged recovery. Clinicians are beginning to incorporate vestibular rehabilitation therapy (VRT) in their postconcussion treatment plan, in order to address the dysfunctional inner ear structures that could be causing this dizziness. Focused Clinical Question: Can VRT help postconcussion syndrome patients experiencing prolonged dizziness by improving their perceived disability? Summary of Key Findings: Three studies were included: 1 randomized control trial, 1 retrospective chart review, and 1 exploratory study. The randomized control trial compared cervical spine therapy alone to cervical spine therapy in conjunction with VRT to obtain medical clearance for sport. The chart review explored VRT as a treatment for reducing dizziness and improving balance and gait dysfunction. The exploratory study implemented VRT in conjunction with light aerobic exercise to improve perceived disability associated with dizziness postconcussion. All 3 studies found statistically significant decreases (improvements) in Dizziness Handicap Index scores. Clinical Bottom Line: There is preliminary evidence suggesting that VRT can improve perceived disability in patients with postconcussion syndrome experiencing prolonged dizziness. There is a decrease (improvement) in Dizziness Handicap Index scores across all 3 studies. VRT is a relatively safe treatment option, with no adverse reactions or case reports. Strength of Recommendation: There is level 2 and level 3 evidence supporting the use of VRT to treat patients suffering from dizziness postconcussion.	[Nagib, Steven; Linens, Shelley W.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA		Nagib, S (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	snagib@uorcgon.cdu					Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Howick J, 2011, 2011 OXFORD CEBM EVI, P1; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Moore Brian M, 2016, J Allied Health, V45, pe59; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Treleaven J, 2006, AUST J PHYSIOTHER, V52, P67, DOI 10.1016/S0004-9514(06)70070-8; Zanotto D, 2017, OTOL NEUROTOL, V38, P1490, DOI 10.1097/MAO.0000000000001586	14	6	6	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2019	28	7					764	768		10.1123/jsr.2018-0021			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	IW7SN	WOS:000485194400017	30040008	Bronze			2022-02-06	
J	Nekrosius, D; Kaminskaite, M; Jokubka, R; Pranckeviciene, A; Lideikis, K; Tamasauskas, A; Bunevicius, A				Nekrosius, Deividas; Kaminskaite, Migle; Jokubka, Ramunas; Pranckeviciene, Aiste; Lideikis, Karolis; Tamasauskas, Arimantas; Bunevicius, Adomas			Association of COMT Val(158)Met Polymorphism With Delirium Risk and Outcomes After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MONTREAL COGNITIVE ASSESSMENT; MILD; DISCHARGE; SCALE; GENE	Objective: The authors investigated the association of the catechol-O-methyltransferase (COMT) gene Val(158)Met polymorphism with delirium risk and functional and cognitive outcomes among patients with complicated mild to moderate traumatic brain injury (TBI). Methods: In a prospective observational cohort study, patients were monitored for occurrence of delirium during the first 4 days of admission by using the Confusion Assessment Method. Functional and cognitive outcomes were evaluated with the Glasgow Outcome on Discharge Scale and the Montreal Cognitive Assessment test, respectively. Eighty-nine patients were included in the study; of these, 17 (19%) were diagnosed with delirium. Results: The COMT Val(158)/Val(158) polymorphism was associated with increased risk of delirium in multivariable regression analyses adjusted for alcohol misuse, history of neurological disorder, age, and admission Glasgow Coma Scale score (odds ratio=4.57, 95% CI=1.11, 18.9, p=0.036). The COMT Met(158) allele was associated with better functional outcomes in univariate analysis (odds ratio=2.82, 95% CI=1.10, 7.27, p=0.031) but not in multivariable analysis (odds ratio=2.33, 95% CI=0.89, 6.12, p=0.085). Cognitive outcomes were not associated with the COMT Val(158)Met polymorphism in univariate regression analysis (p=0.390). Delirium was a significant predictor of worse functional and cognitive outcomes in multivariable regression analyses adjusted for other risk factors (odds ratio=0.04, 95% CI=0.01, 0.16, p<0.001, and beta=-3.889, 95% CI=-7.55, -0.23, p=0.038, respectively). Conclusions: The COMT genotype is important in delirium risk and functional outcomes of patients with mild to moderate TBI. Whether the COMT genotype is associated with outcomes through incident delirium remains to be determined in larger studies.	[Nekrosius, Deividas; Lideikis, Karolis] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Kaminskaite, Migle; Jokubka, Ramunas; Pranckeviciene, Aiste; Tamasauskas, Arimantas; Bunevicius, Adomas] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania; [Tamasauskas, Arimantas; Bunevicius, Adomas] Lithuanian Univ Hlth Sci, Dept Neurosurg Kauno Klinikos, Kaunas, Lithuania		Bunevicius, A (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania.; Bunevicius, A (corresponding author), Lithuanian Univ Hlth Sci, Dept Neurosurg Kauno Klinikos, Kaunas, Lithuania.	adomas.bunevicius@lsmuni.lt	Bunevicius, Adomas/I-3394-2019	Bunevicius, Adomas/0000-0003-0446-6898	Lithuanian University of Health SciencesResearch Council of Lithuania (LMTLT)	Supported by the Lithuanian University of Health Sciences.	Ali Shahid, 2011, Innov Clin Neurosci, V8, P25; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Babor T.F., 2001, AUDIT THE ALCOHOL US; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Clark KL, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00033; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Dewan M.C., 2018, J NEUROSURG; Grover S, 2012, WORLD J PSYCHIATR, V2, P58, DOI 10.5498/wjp.v2.i4.58; He QH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00677; Ira E, 2013, J PSYCHIATR NEUROSCI, V38, P366, DOI 10.1503/jpn.120178; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; Kim H, 2016, NEUROPSYCH DIS TREAT, V12, P1787, DOI 10.2147/NDT.S112017; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Maneewong J, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S128138; Mangusan RF, 2015, AM J CRIT CARE, V24, P156, DOI 10.4037/ajcc2015137; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Neufeld KJ, 2013, ANESTH ANALG, V117, P471, DOI 10.1213/ANE.0b013e3182973650; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Oliveira RARA, 2012, ARQ NEURO-PSIQUIAT, V70, P604, DOI 10.1590/S0004-282X2012000800009; Popp J, 2013, CURR OPIN NEUROL, V26, P634, DOI 10.1097/WCO.0000000000000030; Regal PJ, 2017, CLIN INTERV AGING, V12, P377, DOI 10.2147/CIA.S129255; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Stein DJ, 2006, CNS SPECTRUMS, V11, P745, DOI 10.1017/S1092852900014863; Stoicea N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00075; Sun ZL, 2018, PSYCHIAT GENET, V28, P47, DOI 10.1097/YPG.0000000000000194; Tanaka S, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-17; van Munster BC, 2011, DEMENT GERIATR COGN, V31, P358, DOI 10.1159/000327353; Veiga Fernandez Fernando, 2008, Rev Esp Geriatr Gerontol, V43 Suppl 3, P4; Vercammen A, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.125; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Xiao TT, 2017, TRANSL NEURODEGENER, V6, DOI [10.1186/s40035-017-0072-x, 10.1186/s40035-017-0081-9]	39	6	6	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2019	31	4					298	305		10.1176/appi.neuropsych.18080195			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	JD7SI	WOS:000490181300003	31046593	Bronze			2022-02-06	
J	Rieger, B; Lewandowski, L; Potts, H; Shea, N				Rieger, Brian; Lewandowski, Lawrence; Potts, Heather; Shea, Nicole			Effects of Concussion in Adolescent Students: Perceptions and Performance	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Pediatric; Psychological; Neuropsychological; Academic; Self-awareness	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; EXECUTIVE FUNCTION; CHILDREN; RECOVERY; OUTCOMES; YOUTH; SYMPTOMS	Objective: The purpose of this study was to compare adolescent students with and without concussion on a battery of academic, neurocognitive, and socioemotional measures and assess the aftereffects of concussion across domains of functioning. Methods: Twenty-four adolescents (ages 13-17) reporting postconcussion symptoms were compared to 24 controls matched for age and gender across a battery of tests and surveys. Results: After correcting for multiple comparisons, there were no significant differences on any neuropsychological measures. Similarly, there were no significant group differences on academic measures of vocabulary, word recognition, or reading comprehension. Self-reported concussion symptoms were much greater for students with concussion, as were self-reports of anxiety, depression, and somatization symptoms. Parents also rated those with concussion as having greater depression and somatization symptoms, but not to a degree that survived Bonferroni correction. Lastly, those with concussion reported a significantly greater number of school problems and academic concerns. Conclusions: Results indicated that adolescents who reported postconcussion symptoms do not perform differently from peers on most neurocognitive and academic tasks, yet they showed considerably more worry, somatization, academic concerns, and feelings of inadequacy than matched controls. The findings suggest that interventions to address psychological and academic stress may be indicated for adolescents symptomatic from concussion.	[Rieger, Brian] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA; [Lewandowski, Lawrence; Potts, Heather; Shea, Nicole] Syracuse Univ, Dept Psychol, Syracuse, NY USA		Rieger, B (corresponding author), SUNY Upstate Med Univ, Concuss Ctr, 505 Irving Ave Suite 1249, Syracuse, NY 13210 USA.	riegerb@upstate.edu					Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baker R.H., 2016, THESIS; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barr WB, 2001, J ATHL TRAINING, V36, P297; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2013, SPORT PSYCHOL, V27, P372, DOI 10.1123/tsp.27.4.372; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Glang A, 2008, NEUROREHABILITATION, V23, P477; Green P, 2004, GREENS MED SYMPTOM V; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kontos AP, 2013, RES SPORTS MED, V21, P367, DOI 10.1080/15438627.2013.825801; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Lewandowski L, 2015, J ATTEN DISORD, V19, P27, DOI 10.1177/1087054712449183; Lewandowski L, 2013, J PSYCHOEDUC ASSESS, V31, P41, DOI 10.1177/0734282912446304; Lewandowski LJ, 2016, J PSYCHOEDUC ASSESS, V34, P566, DOI 10.1177/0734282915622854; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Lovell M., 2002, IMMEDIATE POSTCONCUS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Makki Ali Y, 2016, Glob Pediatr Health, V3, p2333794X16630493, DOI 10.1177/2333794X16630493; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Newlin Elizabeth, 2015, N C Med J, V76, P107; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reed N, 2016, INT J SPORTS MED, V37, P708, DOI 10.1055/s-0042-104199; Reitan R, 1985, HALSTEAD REITAN NEUR; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sandel N, 2015, APPL NEUROPSYCH-CHIL, V4, P211, DOI 10.1080/21622965.2013.850692; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Smith, 1973, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154	62	6	6	8	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2019	25	8					777	786	PII S1355617719000468	10.1017/S1355617719000468			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IV9ZE	WOS:000484621400001	31134869				2022-02-06	
J	Saunders, RN; Tan, XG; Qidwai, SM; Bagchi, A				Saunders, Robert N.; Tan, X. Gary; Qidwai, Siddiq M.; Bagchi, Amit			Towards Identification of Correspondence Rules to Relate Traumatic Brain Injury in Different Species	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element; Blast analysis; Biomechanics; Porcine; Interspecies; Scaling; Injury analysis	CRITERION; ACCURATE; ELEMENT; MODEL; RISK	Traumatic brain injury analysis in humans is exceedingly difficult due to the intrusive methods by which data can be collected; thus, many researchers commonly implement animal surrogates. However, ethical concerns and cost limit the scope of these tests on animal subjects too. Computational models, which provide an alternative method to data collection, are not constrained by these concerns and are able to generate significant amounts of data in relatively short time. This paper shows how the data generated from models of a human and pig head can be used towards developing interspecies correspondence rules for blast overpressure effects. The blast overpressure is simulated using an explosive of known weight and standoff distance and injury is evaluated using criteria in published literature. Results indicate that equivalent blasts in the human and pig produce significantly different injuries, and when equating total injured brain volume, the locations of injury in the brain vary between the species. Charge weight and total injured brain volume are related using a linear regression of the data such that a known injury in the pig or known blast can be used to predict injury or the blast experienced by a human, thus creating a correspondence between the species.	[Saunders, Robert N.; Tan, X. Gary; Bagchi, Amit] US Naval Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA; [Qidwai, Siddiq M.] Natl Sci Fdn, 2415 Eisenhower Ave, Alexandria, VA 22314 USA		Bagchi, A (corresponding author), US Naval Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA.	robert.saunders@nrl.navy.mil; gary.tan@nrl.navy.mil; sqidwai@nsf.gov; amit.bagchi@nrl.navy.mil			Office of Naval Research (ONR)Office of Naval Research [N001415WX00531]; U.S. Army Corps of Engineers Research and Development Center (ERDC) Major Shared Resource Center (MSRC) [416]; Department of Defense (DoD) High Performance Computing Modernization Program (HPCMP); National Science Foundation under Internal Research & Development Program	This work was supported by the Office of Naval Research (ONR) under contract number N001415WX00531 and the Department of Defense (DoD) High Performance Computing Modernization Program (HPCMP) using the Air Force Research Laboratory (AFRL) and U.S. Army Corps of Engineers Research and Development Center (ERDC) Major Shared Resource Center (MSRC) under project 416, subproject 572. The authors acknowledge Dr. Ross Cotton from Simpleware (R) for the generation of the human head FE meshes. The authors acknowledge Dr. Tim Bentley from ONR for his support and technical discussions as well as Dr. Thomas O'Shaughnessy from NRL for technical discussions. The authors also acknowledge Drs. Kirubel Teferra and Patrick Brewick for their revisions and feedback. SMQ acknowledges the support of the National Science Foundation under the Internal Research & Development Program.	Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bonet J, 1998, COMMUN NUMER METH EN, V14, P437, DOI 10.1002/(SICI)1099-0887(199805)14:5<437::AID-CNM162>3.3.CO;2-N; Bonet J, 2001, INT J NUMER METH ENG, V50, P119, DOI 10.1002/1097-0207(20010110)50:1<119::AID-NME24>3.0.CO;2-C; Brewick P, 2017, NRL FR 6350 17 10304; Brewick PT, 2018, J MECH BEHAV BIOMED, V85, P237, DOI 10.1016/j.jmbbm.2018.05.037; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Deck C, 2009, International Journal of Vehicle Safety, V4, P85, DOI 10.1504/IJVS.2009.028921; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kang HS, 1997, SAE TECHN PAP, V41, P315; Kingery C.N, 1966, AIR BLAST PARAMETERS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Saunders R, 2018, NRLMR6350189807 DEF; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Tan X. G, 2017, P ASME 2017 INT MECH; Tan X. G, 2018, P ASME 2018 INT MECH; Teferra K, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3109; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656	30	6	6	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		2005	2018		10.1007/s10439-018-02157-1			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300013	30465151				2022-02-06	
J	Won, SY; Dubinski, D; Sautter, L; Hattingen, E; Seifert, V; Rosenow, F; Freiman, T; Strzelczyk, A; Konczalla, J				Won, Sae-Yeon; Dubinski, Daniel; Sautter, Lisa; Hattingen, Elke; Seifert, Volker; Rosenow, Felix; Freiman, Thomas; Strzelczyk, Adam; Konczalla, Juergen			Seizure and status epilepticus in chronic subdural hematoma	ACTA NEUROLOGICA SCANDINAVICA			English	Article						chronic subdural hematoma; EEG; functional outcome; predictors; seizures; status epilepticus	LATE POSTTRAUMATIC SEIZURES; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SURGICAL-TREATMENT; HEAD-INJURY; EPILEPSY; MULTICENTER; PHENYTOIN; LEVETIRACETAM; EVACUATION	Background Acute symptomatic seizure (ASz) and status epilepticus (SE) are serious conditions associated with poor quality of life, with unfavorable psychosocial and functional outcome. Chronic subdural hematoma (cSDH) is a common neurosurgical disease related to those complications; therefore, we aimed to evaluate incidence, predictors of ASz/SE, and outcome in this cohort. Methods We retrospectively analyzed patient diagnosed cSDH between 2010 and 2017. Beside their incidence of ASz/SE, patient characteristics, symptoms at admission, comorbidities, and all previously published relevant parameters were assessed. Recurrence rate and functional outcome were analyzed at hospital discharge and 90-day follow-up. Results A total of 375 patients were included; incidence of ASz was 15.2% and of SE, 1.9%. In the univariate analysis, drainage insertion (P = 0.004; OR = 0.3) was a significant negative predictor for ASz/SE and multivariate analysis, including all significant parameters, designated GCS <= 13 at admission (P = 0.09; OR = 1.9), remote stroke (P = 0.009; OR = 2.9), and recurrence rate within 14 days (P = 0.001; OR = 3.3; with an incidence of 13%) as independent predictors for ASz/SE. Overall, patients with ASz/SE had significantly unfavorable outcome at discharge (54.7%; P < 0.001) and follow-up (39.5%; P < 0.001) with only slight improvement. Late seizures occurred in 3.8% within follow-up period. Any patient with SE had an unfavorable outcome at discharge without any improvement at follow-up having a mortality rate of 14.2%. Conclusion Independent predictors for ASz/SE are GCS <= 13 at admission, remote stroke, and recurrent hematoma in patients with cSDH, which is associated with worse functional outcome, particularly those with SE. Due to the higher rate of seizures than recurrence rate, a routine pre- and postoperative EEG besides CT is recommended.	[Won, Sae-Yeon; Dubinski, Daniel; Sautter, Lisa; Seifert, Volker; Freiman, Thomas; Konczalla, Juergen] Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Hattingen, Elke] Goethe Univ, Univ Hosp, Inst Neuroradiol, Frankfurt, Germany; [Rosenow, Felix; Strzelczyk, Adam] Goethe Univ, Univ Hosp, Dept Neurol, Frankfurt, Germany; [Rosenow, Felix; Strzelczyk, Adam] Goethe Univ, Univ Hosp, Epilepsy Ctr Frankfurt Rhine Main, Frankfurt, Germany		Won, SY (corresponding author), Goethe Univ, Dept Neurosurg, Frankfurt, Germany.	sae-yeon.won@kgu.de	Konczalla, Juergen/AAJ-8528-2021; Won, Sae-Yeon/AAK-3408-2020; Freiman, Thomas/AAV-8494-2021; Dubinski, Daniel/AAH-2910-2021	Freiman, Thomas/0000-0002-2591-2829; Dubinski, Daniel/0000-0001-5568-8429; Konczalla, Juergen/0000-0001-9771-7806; Hattingen, Elke/0000-0002-8392-9004			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; Beleza P, 2012, NEUROLOGIST, V18, P109, DOI 10.1097/NRL.0b013e318251e6c3; Branco PM, 2017, CURR PHARM DESIGN, V23, P6442, DOI 10.2174/1381612823666171024144318; Brennan PM, 2017, J NEUROSURG, V127, P732, DOI 10.3171/2016.8.JNS16134; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen CW, 2004, J CLIN NEUROSCI, V11, P706, DOI 10.1016/j.jocn.2004.03.019; COLE M, 1961, NEW ENGL J MED, V265, P628, DOI 10.1056/NEJM196109282651304; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fernandez-Menendez A, 2014, REV NEUROLOGIA, V58, P548, DOI 10.33588/rn.5812.2013461; Firsching R, 2017, J NEUROL SURG PART A, V78, P478, DOI 10.1055/s-0037-1599239; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Glancz LJ, 2018, NEUROSURGERY, DOI [10.1093/neuros/nyy366/5086667, DOI 10.1093/NEUROS/NYY366/5086667]; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hamasaki T, 2013, CLIN NEUROL NEUROSUR, V115, P2336, DOI 10.1016/j.clineuro.2013.08.016; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hirakawa K, 1972, Neurol Med Chir (Tokyo), V12, P71, DOI 10.2176/nmc.12.71; Huang KT, 2016, NEUROCRIT CARE, V24, P294, DOI 10.1007/s12028-015-0194-x; Kolakowsky-Hayner SA, 2013, BRAIN INJURY, V27, P578, DOI 10.3109/02699052.2013.765595; Kortland LM, 2016, EPILEPSIA, V57, P2056, DOI 10.1111/epi.13584; KOTWICA Z, 1991, ACTA NEUROCHIR, V113, P118, DOI 10.1007/BF01403195; Kumar R, 2007, INDIAN J PEDIATR, V74, P1046, DOI 10.1007/s12098-007-0196-6; Lee Kwang Jin, 2015, Korean J Neurotrauma, V11, P144, DOI 10.13004/kjnt.2015.11.2.144; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; LUXON LM, 1979, Q J MED, V48, P43; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schucht P, 2018, NEUROSURGERY, V65, P108; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Strzelczyk A, 2017, EPILEPSIA, V58, P1533, DOI 10.1111/epi.13837; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Won SY, 2017, WORLD NEUROSURG, V101, P416, DOI 10.1016/j.wneu.2017.02.024; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	49	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	SEP	2019	140	3					194	203		10.1111/ane.13131			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IN5SP	WOS:000478737200004	31102548				2022-02-06	
J	Yang, X; Wang, CD; Zhang, XD; Chen, SQ; Chen, LP; Lu, SS; Lu, S; Yan, XS; Xiong, K; Liu, FX; Yan, J				Yang, Xue; Wang, Chudong; Zhang, Xudong; Chen, Siqi; Chen, Liangpei; Lu, Shanshan; Lu, Shuang; Yan, Xisheng; Xiong, Kun; Liu, Fengxia; Yan, Jie			Redox regulation in hydrogen sulfide action: From neurotoxicity to neuroprotection	NEUROCHEMISTRY INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; SENSITIVE POTASSIUM CHANNELS; CYSTATHIONINE-BETA-SYNTHASE; NF-KAPPA-B; NEUROLOGICAL SEQUELAE; INDUCED CYTOTOXICITY; OXIDATIVE STRESS; NITRIC-OXIDE; PC12 CELLS; GLUTAMATE		[Yang, Xue; Wang, Chudong; Chen, Siqi; Chen, Liangpei; Lu, Shanshan; Lu, Shuang; Yan, Jie] Dept Forens Sci, Changsha 410013, Hunan, Peoples R China; [Lu, Shuang; Xiong, Kun] Cent S Univ, Sch Basic Med Sci, Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China; [Zhang, Xudong] Municipal Secur Bur, Narcot Div, Changsha 410013, Hunan, Peoples R China; [Yan, Xisheng] Wuhan Third Hosp, Dept Cardiovasc Med, Wuhan 430060, Hubei, Peoples R China; [Liu, Fengxia; Yan, Jie] Xinjiang Med Univ, Sch Basic Med Sci, Dept Human Anat, Urumqi 830001, Peoples R China		Yan, J (corresponding author), Dept Forens Sci, Changsha 410013, Hunan, Peoples R China.	wills212156@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772024, 81871088]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2017JJ2339]; Hubei Province Natural Science Fund for Young Scholars [2016CFB120]; Hubei Province Health and Family Planning Scientific Research Project [WJ2017Q033]	This research was supported by the National Natural Science Foundation of China (81772024, 81871088), Natural Science Foundation of Hunan Province (2017JJ2339), Hubei Province Natural Science Fund for Young Scholars (2016CFB120), and Hubei Province Health and Family Planning Scientific Research Project (WJ2017Q033). We would like to thank Mrs. Tang Qiu and Mrs. Xiaojuan Zhao for the kind support and constructive suggestions.	Abe K, 1996, J NEUROSCI, V16, P1066; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; Anantharam P, 2017, ANN NY ACAD SCI, V1400, P46, DOI 10.1111/nyas.13419; Garcia-Bereguiain MA, 2008, ANTIOXID REDOX SIGN, V10, P31, DOI 10.1089/ars.2007.1656; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Biermann J, 2011, MOL VIS, V17, P1275; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Cao L, 2018, BRAIN BEHAV IMMUN, V73, P603, DOI 10.1016/j.bbi.2018.07.005; Cao X, 2018, MOL NEUROBIOL, V55, P3789, DOI 10.1007/s12035-017-0617-0; Chen HB, 2017, PHARMACOL BIOCHEM BE, V155, P16, DOI 10.1016/j.pbb.2017.03.002; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chenuel B, 2015, CLIN TOXICOL, V53, P93, DOI 10.3109/15563650.2014.996570; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Doujaiji B, 2010, ANN SAUDI MED, V30, P76, DOI [10.5144/0256-4947.59379, 10.4103/0256-4947.59379]; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Franco R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8020046; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Ghanbari F, 2019, J MOL NEUROSCI, V67, P133, DOI 10.1007/s12031-018-1218-8; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Giuliani D, 2013, NEUROBIOL LEARN MEM, V104, P82, DOI 10.1016/j.nlm.2013.05.006; Godinez-Rubi M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297357; Haouzi P, 2016, ANN NY ACAD SCI, V1374, P29, DOI 10.1111/nyas.13015; Haouzi P, 2015, CLIN TOXICOL, V53, P28, DOI 10.3109/15563650.2014.990976; HAWKINS RD, 1994, J NEUROBIOL, V25, P652, DOI 10.1002/neu.480250607; Henstridge CM, 2019, NAT REV NEUROSCI, V20, P94, DOI 10.1038/s41583-018-0113-1; Hertz L, 2006, NEUROCHEM INT, V48, P416, DOI 10.1016/j.neuint.2005.12.021; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Insko MA, 2009, BRIT J PHARMACOL, V157, P944, DOI 10.1111/j.1476-5381.2009.00248.x; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI 10.1089/ARS.2008.2132; Jezek P, 2004, PHYSIOL RES, V53, pS199; Jiang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20831; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Kilburn KH, 2003, SOUTH MED J, V96, P639, DOI 10.1097/01.SMJ.0000072361.86796.56; Kim DS, 2018, TOXICOL APPL PHARM, V355, P28, DOI 10.1016/j.taap.2018.06.001; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Koike S, 2016, MOLECULES, V21, DOI 10.3390/molecules21121753; Koike S, 2013, FEBS LETT, V587, P3548, DOI 10.1016/j.febslet.2013.09.013; Kolluru GK, 2013, NITRIC OXIDE-BIOL CH, V35, P5, DOI 10.1016/j.niox.2013.07.002; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kumar M, 2018, NEUROMOL MED, V20, P475, DOI 10.1007/s12017-018-8505-y; Kurokawa Y, 2011, BIOCHEM BIOPH RES CO, V414, P727, DOI 10.1016/j.bbrc.2011.09.144; Lan AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025921; Lee M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0488-8; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Li X, 2018, ACS APPL MATER INTER, V10, P39544, DOI 10.1021/acsami.8b16818; Li XH, 2016, INT J MOL MED, V38, P1152, DOI 10.3892/ijmm.2016.2701; Liu WB, 2010, NEUROCHEM INT, V57, P206, DOI 10.1016/j.neuint.2010.05.011; Lu M, 2012, ANTIOXID REDOX SIGN, V17, P849, DOI 10.1089/ars.2011.4507; Lu M, 2010, NEUROSCI RES, V66, P92, DOI 10.1016/j.neures.2009.09.1713; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Maher P, 1996, J NEUROSCI, V16, P6394; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Mikami Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101652; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nogue S, 2011, OCCUP MED-OXFORD, V61, P212, DOI 10.1093/occmed/kqr021; Pattison DJ, 2008, NAT CLIN PRACT RHEUM, V4, P590, DOI 10.1038/ncprheum0920; Paul BD, 2015, ANTIOXID REDOX SIGN, V22, P411, DOI 10.1089/ars.2014.5917; Paul BD, 2014, NATURE, V509, P96, DOI 10.1038/nature13136; Polhemus DJ, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/768607; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; RAJPUT DR, 1993, J NEUROL NEUROSUR PS, V56, P938, DOI 10.1136/jnnp.56.8.938; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pharmtox.32.1.109; Ren XY, 2017, ANTIOXID REDOX SIGN, V27, P989, DOI 10.1089/ars.2016.6925; Rumbeiha W, 2016, ANN NY ACAD SCI, V1378, P5, DOI 10.1111/nyas.13148; Sarukhani M, 2018, NEUROL RES, V40, P525, DOI 10.1080/01616412.2017.1390903; Schneider JS, 1998, OCCUP MED-OXFORD, V48, P255, DOI 10.1093/occmed/48.4.255; Seifert HA, 2014, TRANSL STROKE RES, V5, P543, DOI 10.1007/s12975-014-0349-7; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; SMITH L, 1977, BIOCHEM PHARMACOL, V26, P2247, DOI 10.1016/0006-2952(77)90287-8; SMITH RP, 1979, J OCCUP ENVIRON MED, V21, P93, DOI 10.1097/00043764-197902000-00008; SNYDER JW, 1995, AM J EMERG MED, V13, P199, DOI 10.1016/0735-6757(95)90094-2; Sommer O, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00501; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1982, DOI 10.1111/j.1471-4159.2007.04883.x; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902; Stein A, 2013, REDOX BIOL, V1, P32, DOI 10.1016/j.redox.2012.11.006; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Sun XL, 2008, NEUROPSYCHOPHARMACOL, V33, P1336, DOI 10.1038/sj.npp.1301501; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tang XQ, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-20; Tang XQ, 2010, NEUROSCI RES, V68, P241, DOI 10.1016/j.neures.2010.07.2039; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tsugane M, 2007, ANTIOXID REDOX SIGN, V9, P257, DOI 10.1089/ars.2007.9.257; TVEDT B, 1991, AM J IND MED, V20, P91, DOI 10.1002/ajim.4700200109; Tyagi N, 2009, ANTIOXID REDOX SIGN, V11, P25, DOI 10.1089/ars.2008.2073; Wang FF, 2019, BIOSENS BIOELECTRON, V126, P96, DOI 10.1016/j.bios.2018.10.056; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wintner EA, 2010, BRIT J PHARMACOL, V160, P941, DOI 10.1111/j.1476-5381.2010.00704.x; Woods JJ, 2018, J AM CHEM SOC, V140, P12383, DOI 10.1021/jacs.8b08695; Xiao F, 2016, EXP CELL RES, V348, P106, DOI 10.1016/j.yexcr.2016.09.006; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060200; Xie ZZ, 2014, ANTIOXID REDOX SIGN, V21, P2531, DOI 10.1089/ars.2013.5604; Xiong K, 2017, TOXICOL IN VITRO, V44, P1, DOI 10.1016/j.tiv.2017.06.009; Xiong K, 2016, TOXICOL IN VITRO, V35, P163, DOI 10.1016/j.tiv.2016.06.002; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang X, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00186; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Yin WL, 2017, NEUROSCI LETT, V657, P45, DOI 10.1016/j.neulet.2017.07.019; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Yuan YQ, 2018, BRAIN BEHAV IMMUN, V67, P77, DOI 10.1016/j.bbi.2017.07.159; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327; Zhang JY, 2017, MED GAS RES, V7, P113, DOI 10.4103/2045-9912.208517; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhang XZ, 2014, ACS CHEM NEUROSCI, V5, P876, DOI 10.1021/cn500185g; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0	136	6	6	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2019	128						58	69		10.1016/j.neuint.2019.04.011			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IK4TZ	WOS:000476580600007	31015021				2022-02-06	
J	Zhang, ZS; Zhao, GS; Liu, L; He, JC; Darwazeh, R; Liu, H; Chen, H; Zhou, C; Guo, ZD; Sun, XC				Zhang, Zhaosi; Zhao, Guosheng; Liu, Liu; He, Junchi; Darwazeh, Rami; Liu, Han; Chen, Hong; Zhou, Chao; Guo, Zongduo; Sun, Xiaochuan			Bexarotene Exerts Protective Effects Through Modulation of the Cerebral Vascular Smooth Muscle Cell Phenotypic Transformation by Regulating PPAR gamma/FLAP/LTB4 After Subarachnoid Hemorrhage in Rats	CELL TRANSPLANTATION			English	Article						Bexarotene; subarachnoid hemorrhage; vascular smooth muscle cells; PPAR gamma; FLAP	TRAUMATIC BRAIN-INJURY; PPAR-GAMMA; 5-LIPOXYGENASE; ROSIGLITAZONE; ATHEROSCLEROSIS; DIFFERENTIATION; INFLAMMATION; VASOSPASM; DISEASE; MODELS	Vascular smooth muscle cells (VSMCs) play an important role after a subarachnoid hemorrhage (SAH). The changes in VSMCs following bexarotene treatment after SAH are unknown. In the present study, neurological impairment, decreased cerebral cortical blood flow and transformation of cerebral VSMCs from a contractile to a synthetic phenotype were observed after SAH. Bexarotene reduced neurological impairment, improved cerebral cortical blood flow, inhibited VSMC phenotypic transformation and suppressed the expression of 5-lipoxygenase-activating protein (FLAP) and leukotriene B4 (LTB4), which was partly reversed by GW9662, an inhibitor of peroxisome proliferator-activated receptor gamma (PPAR gamma). Mechanistically, sh-PPAR gamma-mediated phenotypic transformation of VSMCs was partially suppressed by MK886, an antagonist of FLAP. Therefore, we conclude that bexarotene reduced neurological impairment, improved cerebral cortical blood flow and inhibited the VSMC phenotypic transformation after SAH, which was achieved by activating PPAR gamma-mediated inhibition of FLAP/LTB4 in VSMCs	[Zhang, Zhaosi; Liu, Liu; He, Junchi; Darwazeh, Rami; Liu, Han; Chen, Hong; Zhou, Chao; Guo, Zongduo; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Zhao, Guosheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing, Peoples R China		Guo, ZD (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.	stonegzd@163.com	Darwazeh, Rami/AAT-7891-2020; Zhao, Guo-sheng/Q-5928-2019; He, Junchi/AAD-8482-2019	Darwazeh, Rami/0000-0003-3099-8257; Zhao, Guo-sheng/0000-0003-0609-2789; Zhang, Zhaosi/0000-0002-4988-501X			Adrian TE, 2008, PPAR RES, V2008, DOI 10.1155/2008/827096; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexis JD, 2009, CIRC RES, V104, P69, DOI 10.1161/CIRCRESAHA.108.188409; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Ballesteros I, 2014, J LEUKOCYTE BIOL, V95, P587, DOI 10.1189/jlb.0613326; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Duvic M, 2001, J CLIN ONCOL, V19, P2456, DOI 10.1200/JCO.2001.19.9.2456; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gu C, 2015, BRAIN RES, V1624, P199, DOI 10.1016/j.brainres.2015.07.025; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Maddahi A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-274; Marbacher S, 2008, INTENS CARE MED, V34, P932, DOI 10.1007/s00134-008-0995-x; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Miller D, 2005, J APPL PHYSIOL, V98, P329, DOI 10.1152/japplphysiol.00514.2004; Muroi Carl, 2015, Acta Neurochir Suppl, V120, P315, DOI 10.1007/978-3-319-04981-6_54; Ohkuma H, 2003, NEUROSCI LETT, V344, P193, DOI 10.1016/S0304-3940(03)00464-6; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Riancho J, 2016, J NEUROL SCI, V360, P115, DOI 10.1016/j.jns.2015.11.058; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Teng ZP, 2016, STROKE, V47, P196, DOI 10.1161/STROKEAHA.115.011701; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Tunctan B, 2018, INFLAMMATION, V41, P337, DOI 10.1007/s10753-017-0691-5; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Wan W, 2018, J CEREB BLOOD FLOW M; Willis A I, 2004, Vasc Endovascular Surg, V38, P11, DOI 10.1177/153857440403800102; Xie ZY, 2018, BRAIN BEHAV IMMUN, V69, P190, DOI 10.1016/j.bbi.2017.11.012; Yang HM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.112; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yu Z, 2013, CIRC RES, V112, P432, DOI 10.1161/CIRCRESAHA.112.300755; Zhang HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep45234; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang LL, 2010, J BIOL CHEM, V285, P13666, DOI 10.1074/jbc.M109.087718; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033	45	6	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	SEP	2019	28	9-10					1161	1172		10.1177/0963689719842161			12	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	JA5VZ	WOS:000487912200009	31010302	gold, Green Published			2022-02-06	
J	Ramos, PL; Nascimento, DC; Ferreira, PH; Weber, KT; Santos, TEG; Louzada, F				Ramos, Pedro L.; Nascimento, Diego C.; Ferreira, Paulo H.; Weber, Karina T.; Santos, Taiza E. G.; Louzada, Francisco			Modeling traumatic brain injury lifetime data: Improved estimators for the Generalized Gamma distribution under small samples	PLOS ONE			English	Article							LIKELIHOOD; PARAMETER; MODERATE; FAMILY	In this paper, from the practical point of view, we focus on modeling traumatic brain injury data considering different stages of hospitalization, related to patients' survival rates following traumatic brain injury caused by traffic accidents. From the statistical point of view, the primary objective is related to overcoming the limited number of traumatic brain injury patients available for studying by considering different estimation methods to obtain improved estimators of the model parameters, which can be recommended to be used in the presence of small samples. To have a general methodology, at least in principle, we consider the very flexible Generalized Gamma distribution. We compare various estimation methods using extensive numerical simulations. The results reveal that the penalized maximum likelihood estimators have the smallest mean square errors and biases, proving to be the most efficient method among the investigated ones, mainly to be used in the presence of small samples. The Simulated Annealing technique is used to avoid numerical problems during the optimization process, as well as the need for good initial values. Overall, we considered an amount of three real data sets related to traumatic brain injury caused by traffic accidents to demonstrate that the Generalized Gamma distribution is a simple alternative to be used in this type of applications for different occurrence rates and risks, and in the presence of small samples.	[Ramos, Pedro L.; Nascimento, Diego C.; Louzada, Francisco] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil; [Ferreira, Paulo H.] Univ Fed Bahia, Inst Math & Stat, Salvador, BA, Brazil; [Weber, Karina T.; Santos, Taiza E. G.] Univ Sao Paulo, Med Sch Ribeirao Preto, Ribeirao Preto, Brazil		Ramos, PL (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil.	pedrolramos@usp.br	Santos, Taiza EG/F-9214-2012; Ramos, Pedro L/U-3270-2017; Nascimento, Diego/AAV-9709-2021	Santos, Taiza EG/0000-0003-3033-2981; Ramos, Pedro L/0000-0002-5387-2457; Nascimento, Diego/0000-0002-3406-4518; Ferreira, Paulo Henrique/0000-0001-6312-6098	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	The research was partially supported by the Brazilian organizations CNPq, FAPESP, and CAPES, and was carried out using the computational resources of the Center for Mathematical Sciences Applied to Industry (CeMEAI) funded by FAPESP.	Aarts E., 1989, SIMULATED ANNEALING; Akaike H., 1977, APPL STAT, P27; Bagheri SF, 2014, J STAT COMPUT SIM, V84, P2345, DOI 10.1080/00949655.2013.793342; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Burnham KP., 2002, MODEL SELECTION MULT; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Cheng R. C. H., 1979, 791 U WAL IST; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; DICICCIO TJ, 1987, TECHNOMETRICS, V29, P33, DOI 10.2307/1269881; DiCiccio TJ, 1996, STAT SCI, V11, P189; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; GLASER RE, 1980, J AM STAT ASSOC, V75, P667; HAARIO H, 1991, ADV APPL PROBAB, V23, P866, DOI 10.2307/1427681; Hager H.W., 1970, J AM STAT ASS, V65, P1601, DOI [10.1080/01621459.1970.10481190, DOI 10.2307/2284343, DOI 10.1080/01621459.1970.10481190]; Huang PH, 2006, TAIWAN J MATH, V10, P1083, DOI 10.11650/twjm/1500403894; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Izquierdo-Marquez I, 2018, INFORM SCIENCES, V460, P172, DOI 10.1016/j.ins.2018.05.047; Jeffreys H., 1998, THEORY PROBABILITY; Khodabina M, 2010, MATH SCI QJ, V4, P9; Kim JK, 2013, ACCIDENT ANAL PREV, V50, P1073, DOI 10.1016/j.aap.2012.08.011; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lehmann E. L., 2006, THEORY POINT ESTIMAT; Louzada F, 2020, COMMUN STAT-SIMUL C, V49, P1024, DOI 10.1080/03610918.2018.1491988; Louzada F, 2018, J STAT COMPUT SIM, V88, P1134, DOI 10.1080/00949655.2017.1422503; Louzada F, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8727951; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall AW, 1997, BIOMETRIKA, V84, P641, DOI 10.1093/biomet/84.3.641; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mudholkar GS, 1996, J AM STAT ASSOC, V91, P1575, DOI 10.2307/2291583; MUDHOLKAR GS, 1995, TECHNOMETRICS, V37, P436, DOI 10.2307/1269735; Noufaily A, 2013, COMPUTATION STAT, V28, P505, DOI 10.1007/s00180-012-0314-4; Owens PW, 2018, BRAIN INJURY, V32, P900, DOI 10.1080/02699052.2018.1466366; Peden, 2004, GUIDELINES ESSENTIAL; PRENTICE RL, 1974, BIOMETRIKA, V61, P539, DOI 10.1093/biomet/61.3.539; R Core Team, 2018, STATS PACK LANG ENV; Ramos PL, 2020, J APPL STAT, V47, P306, DOI 10.1080/02664763.2019.1644488; RANNEBY B, 1984, SCAND J STAT, V11, P93; Rodrigues GC, 2018, J APPL STAT, V45, P128, DOI 10.1080/02664763.2016.1268571; Salter LA, 2001, SYST BIOL, V50, P7, DOI 10.1080/106351501750107413; STACY EW, 1962, ANN MATH STAT, V33, P1187, DOI 10.1214/aoms/1177704481; STACY EW, 1965, TECHNOMETRICS, V7, P349, DOI 10.2307/1266594; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Teimouri M, 2013, STATISTICS-ABINGDON, V47, P93, DOI 10.1080/02331888.2011.559657; Torres-Jimenez J, 2015, INFORM SCIENCES, V303, P33, DOI 10.1016/j.ins.2014.12.041; Torres-Jimenez J, 2012, INFORM SCIENCES, V185, P137, DOI 10.1016/j.ins.2011.09.020; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; WINGO DR, 1987, IEEE T RELIAB, V36, P586, DOI 10.1109/TR.1987.5222478	49	6	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221332	10.1371/journal.pone.0221332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	WOS:000485062200018	31469851	Green Published, Green Submitted, gold			2022-02-06	
J	Mayer, AR; Stephenson, DD; Wertz, CJ; Dodd, AB; Shaff, NA; Ling, JM; Park, G; Oglesbee, SJ; Wasserott, BC; Meier, TB; Witkiewitz, K; Campbell, RA; Yeo, RA; Phillips, JP; Quinn, DK; Pottenger, A				Mayer, Andrew R.; Stephenson, David D.; Wertz, Christopher J.; Dodd, Andrew B.; Shaff, Nicholas A.; Ling, Josef M.; Park, Grace; Oglesbee, Scott J.; Wasserott, Ben C.; Meier, Timothy B.; Witkiewitz, Katie; Campbell, Richard A.; Yeo, Ronald A.; Phillips, John P.; Quinn, Davin K.; Pottenger, Amy			Proactive inhibition deficits with normal perfusion after pediatric mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						blood oxygen-level dependent response; cerebral blood flow; pediatric mild traumatic brain injury; response inhibition	CEREBRAL-BLOOD-FLOW; SPORTS-RELATED CONCUSSION; RESPONSE-INHIBITION; POSTCONCUSSIVE SYMPTOMS; WORKING-MEMORY; CHILDREN; RECOVERY; FMRI; ABNORMALITIES; EVOLUTION	Although much attention has been generated in popular media regarding the deleterious effects of pediatric mild traumatic brain injury (pmTBI), a paucity of empirical evidence exists regarding the natural course of biological recovery. Fifty pmTBI patients (12-18 years old) were consecutively recruited from Emergency Departments and seen approximately 1 week and 4 months post-injury in this prospective cohort study. Data from 53 sex- and age-matched healthy controls (HC) were also collected. Functional magnetic resonance imaging was obtained during proactive response inhibition and at rest, in conjunction with independent measures of resting cerebral blood flow. High temporal resolution imaging enabled separate modeling of neural responses for preparation and execution of proactive response inhibition. A priori predictions of failed inhibitory responses (i.e., hyperactivation) were observed in motor circuitry (pmTBI>HC) and sensory areas sub-acutely and at 4 months post-injury. Paradoxically, pmTBI demonstrated hypoactivation (HC>pmTBI) during target processing, along with decreased activation within prefrontal cognitive control areas. Functional connectivity within motor circuitry at rest suggested that deficits were limited to engagement during the inhibitory task, whereas normal resting cerebral perfusion ruled out deficits in basal perfusion. In conclusion, current results suggest blood oxygen-level dependent deficits during inhibitory control may exceed commonly held beliefs about physiological recovery following pmTBI, potentially lasting up to 4 months post-injury.	[Mayer, Andrew R.; Stephenson, David D.; Wertz, Christopher J.; Dodd, Andrew B.; Shaff, Nicholas A.; Ling, Josef M.; Wasserott, Ben C.; Phillips, John P.] Mind Res Network LBERI, Albuquerque, NM 87106 USA; [Mayer, Andrew R.; Witkiewitz, Katie; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Phillips, John P.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Campbell, Richard A.; Quinn, Davin K.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Park, Grace; Oglesbee, Scott J.; Pottenger, Amy] Univ New Mexico, Emergency Med, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Mayer, AR (corresponding author), Mind Res Network LBERI, Albuquerque, NM 87106 USA.	amayer@mrn.org	Witkiewitz, Katie/AAE-5346-2019	Witkiewitz, Katie/0000-0002-1086-3067	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS098494-03S1A1, NIH 01 R01 NS098494-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098494] Funding Source: NIH RePORTER	National Institutes of Health, Grant/Award Numbers: R01 NS098494-03S1A1, NIH 01 R01 NS098494-01A1	Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Galgano M., 2015, J NEUROL NEUROBIOL, V2, P117, DOI [10. 16966/2379-7150.117, DOI 10.16966/2379-7150.117, 10.16966/2379-7150.117]; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Jang H, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.045007; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Li JY, 2013, J NEUROPHYSIOL, V109, P659, DOI 10.1152/jn.01044.2011; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2019, HUM BRAIN MAPP, V40, P3843, DOI 10.1002/hbm.24635; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; Mayer AR, 2016, J PSYCHIATR NEUROSCI, V41, P312, DOI 10.1503/jpn.150097; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; PAUS T, 2007, UNDERST COMPLEX SYST, P463; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Talairach J., 1988, COPLANAR STEREOTAXIC; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	55	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC 15	2019	40	18					5370	5381		10.1002/hbm.24778		AUG 2019	12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	JK4FM	WOS:000483950900001	31456319	hybrid, Green Published, Green Accepted			2022-02-06	
J	Robertsen, A; Helseth, E; Laake, JH; Forde, R				Robertsen, Annette; Helseth, Eirik; Laake, Jon Henrik; Forde, Reidun			Neurocritical care physicians' doubt about whether to withdraw life-sustaining treatment the first days after devastating brain injury: an interview study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Decision-making; Ethics; Severe traumatic brain injury; Devastating brain injury; Potentially inappropriate treatment	POTENTIALLY INAPPROPRIATE TREATMENTS; DECISION-MAKING; POLICY STATEMENT; VARIABILITY; ICU; MANAGEMENT; CONSENSUS; SOCIETY; IMPACT; ETHICS	Background Multilevel uncertainty exists in the treatment of devastating brain injury and variation in end-of-life decision-making is a concern. Cognitive and emotional doubt linked to making challenging decisions have not received much attention. The aim of this study was to explore physicians ' doubt related to decisions to withhold or withdraw life-sustaining treatment within the first 72 h after devastating brain injury and to identify the strategies used to address doubt. Method Semi-structured interviews were conducted with 18 neurocritical care physicians in a Norwegian trauma centre (neurosurgeons, intensivists and rehabilitation specialists) followed by a qualitative thematic analysis. Result All physicians described feelings of doubt. The degree of doubt and how they dealt with it varied. Institutional culture, ethics climate and individual physicians ' values, experiences and emotions seemed to impact judgements and decisions. Common strategies applied by physicians across specialities when dealing with uncertainty and doubt were: 1. Provision of treatment trials 2. Using time as a coping strategy 3. Collegial counselling and interdisciplinary consensus seeking 4. Framing decisions as purely medical. Conclusion Decisions regarding life-sustaining treatment after devastating brain injury are crafted in a stepwise manner. Feelings of doubt are frequent and seem to be linked to the recognition of fallibility. Doubt can be seen as positive and can foster open-mindedness towards the view of others, which is one of the prerequisites for a good ethical climate. Doubt in this context tends to be mitigated by open interdisciplinary discussions acknowledging doubt as rational and a normal feature of complex decision-making.	[Robertsen, Annette; Laake, Jon Henrik] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway; [Robertsen, Annette; Helseth, Eirik] Univ Oslo, Dept Clin Med, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Forde, Reidun] Univ Oslo, Ctr Med Eth, Oslo, Norway		Robertsen, A (corresponding author), Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Anaesthesiol, Oslo, Norway.; Robertsen, A (corresponding author), Univ Oslo, Dept Clin Med, Oslo, Norway.	anerob@ous-hf.no	Helseth, Eirik/AAH-2466-2020; Laake, Jon Henrik/L-3224-2019	Laake, Jon Henrik/0000-0001-6157-5359			Benoit DD, 2018, INTENS CARE MED, V44, P1039, DOI 10.1007/s00134-018-5231-8; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Cook D, 2014, NEW ENGL J MED, V370, P2506, DOI 10.1056/NEJMra1208795; D'Lima DM, 2018, CRIT CARE MED, V46, P60, DOI 10.1097/CCM.0000000000002773; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Hoel H, 2014, ACTA ANAESTH SCAND, V58, P329, DOI 10.1111/aas.12246; JENNETT B, 1992, BRIT J HOSP MED, V47, P354; Kon AA, 2016, CRIT CARE MED, V44, P1769, DOI 10.1097/CCM.0000000000001965; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Laurent A, 2017, CRIT CARE MED, V45, P2023, DOI 10.1097/CCM.0000000000002710; Lazaridis C, 2018, NEUROCRIT CARE; Long AC, 2016, INTENS CARE MED, V42, P1043, DOI 10.1007/s00134-016-4336-1; Manara Alex R, 2016, J Intensive Care Soc, V17, P295, DOI 10.1177/1751143716647980; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; MOEN K, 2015, RES MED BIOL SCI PLA, P321; Norwegian Directorate of Health, 2013, IS2091 NORW DIR HLTH; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Rohaut B, 2018, BRIT J ANAESTH, V120, P5, DOI 10.1016/j.bja.2017.11.007; Rubin MA, 2016, AM J RESP CRIT CARE, V193, P466, DOI 10.1164/rccm.201510-2086LE; Schutz REC, 2018, J NEUROL SCI, V385, P232, DOI 10.1016/j.jns.2017.12.007; Smith M, 2012, ANAESTHESIA, V67, P941, DOI 10.1111/j.1365-2044.2012.07304.x; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2015, INTENS CARE MED, V41, P1679, DOI 10.1007/s00134-015-3868-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Trevick S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0699-5; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Van den Bulcke B, 2018, BMJ QUAL SAF, V27, P781, DOI 10.1136/bmjqs-2017-007390; Wilkinson D, 2016, BIOETHICS, V30, P109, DOI 10.1111/bioe.12162; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Wilson ME, 2013, INTENS CARE MED, V39, P1009, DOI 10.1007/s00134-013-2896-x	35	6	6	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 28	2019	27	1							81	10.1186/s13049-019-0648-9			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IT7OR	WOS:000483065900001	31462245	Green Published, gold			2022-02-06	
J	Maeda, Y; Ichikawa, R; Misawa, J; Shibuya, A; Hishiki, T; Maeda, T; Yoshino, A; Kondo, Y				Maeda, Yukihiro; Ichikawa, Rie; Misawa, Jimpei; Shibuya, Akiko; Hishiki, Teruyoshi; Maeda, Takeshi; Yoshino, Atsuo; Kondo, Yoshiaki			External validation of the TRISS, CRASH, and IMPACT prognostic models in severe traumatic brain injury in Japan	PLOS ONE			English	Article							MORTALITY PREDICTION MODEL; INTERNATIONAL MISSION; CLINICAL-TRIALS; HEAD-INJURY; SCORE; CLASSIFICATION; PROGESTERONE; MODERATE	In Japan, a range of patients with traumatic brain injury (TBI) has been recorded in a nationwide database (Japan Neurotrauma Data Bank; JNTDB). This study aimed to externally validate three international prediction models using JNTDB data: Trauma and Injury Severity Score (TRISS), Corticosteroid Randomization After Significant Head Injury (CRASH), and International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT). We also aimed to validate the applicability of these models in the Japanese population. Of 1,091 patients registered in the JNTDB from July 2009 to June 2011, we analyzed data for 635 patients. We examined factors associated with mortality in-hospital and unfavorable outcomes 6 months after TBI by applying the TRISS, CRASH, and IMPACT models. We also conducted an external validation of these models based on these data. The patients' mean age was 60.1 +/- 21.1 years, and 342 were alive at the time of discharge (53.9%). Univariate analysis revealed eight major risk factors for mortality in-hospital: age, Glasgow Coma Scale (GCS), Injury Severity Score (ISS), systolic blood pressure, heart rate, mydriasis, acute epidural hematoma (AEDH), and traumatic subarachnoid hemorrhage. A similar analysis identified five risk factors for unfavorable outcomes at 6 months: age, GCS, ISS, mydriasis, and AEDH. For mortality in-hospital, the TRISS had a satisfactory area under the curve value (0.75). For unfavorable outcomes at 6 months, the CRASH (basic and computed tomography) and IMPACT (core and core extended) models had satisfactory area under the curve values (0.86, 0.86, 0.81, and 0.85, respectively). The TRISS, CRASH, and IMPACT models were suitable for application to the JNTDB population, indicating these models had high value in Japanese patients with neurotrauma.	[Maeda, Yukihiro; Ichikawa, Rie; Misawa, Jimpei; Shibuya, Akiko; Kondo, Yoshiaki] Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Tokyo, Japan; [Ichikawa, Rie] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Shibuya, Akiko] Toyama Prefectural Univ, Sch Nursing, Dept Nursing, Toyama, Japan; [Hishiki, Teruyoshi] Toho Univ, Dept Informat Sci, Fac Sci, Chiba, Japan; [Maeda, Takeshi; Yoshino, Atsuo] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo, Japan		Ichikawa, R (corresponding author), Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Tokyo, Japan.; Ichikawa, R (corresponding author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan.	ichikawa.rie@nihon-u.ac.jp	Misawa, Jimpei/V-6855-2019	Misawa, Jimpei/0000-0003-3987-8251			Akay S, 2017, AM J EMERG MED, V35, P1056, DOI 10.1016/j.ajem.2017.02.035; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Ichikawa R, 2018, PEDIATR EMERG CARE, V34, P825, DOI 10.1097/PEC.0000000000001321; Jinadasa Sayuri, 2016, Anesthesiol Clin, V34, P557, DOI 10.1016/j.anclin.2016.04.008; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kunitz S. C., 1980, Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, P1333; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maegele M, 2017, EUR J TRAUMA EMERG S, V43, P439, DOI 10.1007/s00068-017-0771-0; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mathis S, 2014, ANAESTHESIST, V63, P387, DOI 10.1007/s00101-014-2315-x; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; States JD, 1969, ABBREVIATED COMPREHE; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Voskresensky IV, 2009, J SURG RES, V154, P105, DOI 10.1016/j.jss.2008.04.010; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221791	10.1371/journal.pone.0221791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	WOS:000485044000034	31449548	Green Published, Green Submitted, gold			2022-02-06	
J	Stuart, S; Parrington, L; Martini, DN; Kreter, N; Chesnutt, JC; Fino, PC; King, LA				Stuart, Samuel; Parrington, Lucy; Martini, Douglas N.; Kreter, Nicholas; Chesnutt, James C.; Fino, Peter C.; King, Laurie A.			Analysis of Free-Living Mobility in People with Mild Traumatic Brain Injury and Healthy Controls: Quality over Quantity	JOURNAL OF NEUROTRAUMA			English	Article						concussion; free-living; mTBI; physical activity; turning; wearable sensor	SPORTS-RELATED CONCUSSION; GAIT BALANCE CONTROL; DUAL-TASK; PARKINSONS-DISEASE; PHYSICAL-ACTIVITY; BLAST EXPOSURE; DETECTING GAIT; OF-LIFE; SYMPTOMS; PERFORMANCE	Balance and mobility issues are common non-resolving symptoms following mild traumatic brain injury (mTBI). Current approaches for evaluating balance and mobility following an mTBI can be subjective and suboptimal as they may not be sensitive to subtle deficits, particularly in those with chronic mTBI. Wearable inertial measurement units (IMU) allow objective quantification of continuous mobility outcomes in natural free-living environments. This study aimed to explore free-living mobility (physical activity and turning) of healthy and chronic mild traumatic brain injury (mTBI) participants using a single IMU. Free-living mobility was examined in 23 healthy control (48.56 +/- 23.07 years) and 29 symptomatic mTBI (40.2 +/- 12.1 years) participants (average 419 days post-injury, persistent balance complaints) over 1 week, using a single IMU placed at the waist. Free-living mobility was characterized in terms of macro (physical activity volume, pattern and variability) and micro-level (discrete measures of turning) features. Macro-level outcomes showed those with chronic mTBI had similar quantities of mobility compared with controls. Micro-level outcomes within walking bouts showed that chronic mTBI participants had impaired quality of mobility. Specifically, people with chronic mTBI made larger turns, had longer turning durations, slower average and peak velocities (all p < 0.001), and greater turn variability compared with controls. Results highlighted that the quality rather than quantity of mobility differentiated chronic mTBI from controls. Our findings support the use of free-living IMU continuous monitoring to enhance understanding of specific chronic mTBI-related mobility deficits. Future work is required to develop an optimal battery of free-living measures across the mTBI spectrum to aid application within clinical practice.	[Stuart, Samuel; Parrington, Lucy; Martini, Douglas N.; Kreter, Nicholas; Chesnutt, James C.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Stuart, Samuel; Parrington, Lucy; Martini, Douglas N.; Kreter, Nicholas; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Fino, Peter C.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA		Stuart, S (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.	stuarts@ohsu.edu	Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Fino, Peter/0000-0002-8621-3706; Parrington, Lucy/0000-0001-8507-9974	 [W81XWH-15-1-0620]	This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Godfrey A, 2018, MATURITAS, V113, P40, DOI 10.1016/j.maturitas.2018.04.012; Godfrey A, 2015, MED ENG PHYS, V37, P400, DOI 10.1016/j.medengphy.2015.02.003; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hickey A, 2017, J EPIDEMIOL COMMUN H, V71, P624, DOI 10.1136/jech-2016-208752; Hickey A, 2017, PHYSIOL MEAS, V38, pN1, DOI 10.1088/1361-6579/38/1/N1; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Johnston William, 2017, Concussion, V2, pCNC28, DOI 10.2217/cnc-2016-0025; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mancini M., 2018, FRONT NEUROL, P9; Mancini M, 2016, J GERONTOL A-BIOL, V71, P1102, DOI 10.1093/gerona/glw019; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McCamley J, 2012, GAIT POSTURE, V36, P316, DOI 10.1016/j.gaitpost.2012.02.019; Mellone S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0147-4; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Olson E, 2016, J NEUROTRAUM, V33, P734, DOI 10.1089/neu.2015.4085; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Quinn B, 2000, BRAIN INJURY, V14, P1063; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stewart GW, 2012, INT J SPORTS PHYS TH, V7, P433; Storzbach D., 2013, VA EVIDENCE BASED SY; Stuart S., 2018, PHYS THER SPORT; Stuart S, 2017, J SPORT HEALTH SCI, V6, P299, DOI 10.1016/j.jshs.2017.03.009; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Taft S.J., 2017, HIGH SCH RUGBY HOCKE; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vienne A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00817; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d	72	6	6	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2020	37	1					139	145		10.1089/neu.2019.6450		AUG 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KA2YK	WOS:000482678600001	31354032	Green Accepted			2022-02-06	
J	King, NS				King, Nigel S.			'Mild Traumatic Brain Injury' and 'Sport-related Concussion': Different languages and mixed messages?	BRAIN INJURY			English	Article						Mild traumatic brain injury; post concussional syndrome; sport-related concussion	COGNITIVE-BEHAVIORAL THERAPY; RECURRENT CONCUSSION; HEAD-INJURY; SYMPTOMS; RISK; ENCEPHALOPATHY; DEPRESSION; MODERATE; HETEROGENEITY; OUTCOMES	The last 20 years has seen the emergence of a sub-category of the mild traumatic brain injury literature termed 'sport-related concussion'. Some important differences now exist between this sub-category and the wider findings in the field and these could be detrimental to patients with persisting post-concussion symptoms (PCS). Sport-related studies often emphasize the cerebral risks associated with concussive injuries whilst the broader literature typically focuses on the relatively benign organic implications and the role of psychological factors in persisting symptoms. Clinically, anxiety caused by these mixed messages could lead to an exacerbation of PCS. This paper summarizes the commonalities and differences between the literatures and addresses the key clinical implications.	[King, Nigel S.] Univ Oxford, Warneford Hosp, Oxford Inst Clin Psychol Training, Oxford OX3 7JX, England; [King, Nigel S.] Bucks Healthcare NHS Trust, Camborne Ctr, Community Head Injury Serv, Aylesbury, Bucks, England		King, NS (corresponding author), Univ Oxford, Warneford Hosp, Oxford Inst Clin Psychol Training, Oxford OX3 7JX, England.	nigel.king@hmc.ox.ac.uk					[Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; National Institute for Health and Care Excellence, HEAD INJ ASS EARL MA; Neidecker J, 2017, ASS RINGSIDE PHYS CO; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Powell GE, 2013, CLIN NEUROPSYCHOLOGY, P413; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; SEKINO H, 1981, Neurologia Medico-Chirurgica, V21, P677; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Si B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00606; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	61	6	6	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1556	1563		10.1080/02699052.2019.1655794		AUG 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000481650800001	31418597				2022-02-06	
J	Dai, Y; Sun, FF; Zhu, H; Liu, QQ; Xu, XD; Gong, PP; Jiang, R; Jin, GH; Qin, JB; Chen, J; Zhang, XH; Shi, W				Dai, Yong; Sun, Feifan; Zhu, Hui; Liu, Qianqian; Xu, Xide; Gong, Peipei; Jiang, Rui; Jin, Guohua; Qin, Jianbing; Chen, Jian; Zhang, Xinghua; Shi, Wei			Effects and Mechanism of Action of Neonatal Versus Adult Astrocytes on Neural Stem Cell Proliferation After Traumatic Brain Injury	STEM CELLS			English	Article						Neural stem cells; Astrocytes; Proliferation; Differentiation; Microenvironment	STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; IN-VITRO; NEUROGENESIS; DIFFERENTIATION; CULTURES; NEURONS; REPAIR; GLIA	Due to the limited capacity of brain tissue to self-regenerate after traumatic brain injury (TBI), the mobilization of endogenous neural stem cells (NSCs) is a popular research topic. In the clinic, the neurogenic abilities of adults versus neonates vary greatly, which is likely related to functional differences in NSCs. Recent studies have demonstrated that the molecules secreted from astrocytes play important roles in NSC fate determination. In this study, conditioned media (CM) derived from neonatal or adult rat astrocytes, which were unstimulated or stimulated by lipopolysaccharide (LPS), were prepared to treat NSCs. Our results revealed that neonatal rat astrocytes can significantly promote the proliferation of NSCs, compared with adult rat astrocytes, regardless of whether or not they were stimulated by LPS. Furthermore, we used mass spectrometry to detect the constituents of the CM from each group. We analyzed and screened for a protein, Tenascin-C (TNC), which was highly expressed in the neonatal group but poorly expressed in the adult group. We found that TNC can bind to the NSC surface epidermal growth factor receptor and promote proliferation through the PI3K-AKT pathway in vitro. Additionally, we confirmed in vivo that TNC can promote damage repair in a rat model of TBI, through enhancing the proliferation of endogenous NSCs. We believe that these findings provide a mechanistic understanding of why neonates show better neuroregenerative abilities than adults. This also provides a potential future therapeutic target, TNC, for injury repair after TBI.	[Dai, Yong; Sun, Feifan; Zhu, Hui; Liu, Qianqian; Xu, Xide; Gong, Peipei; Jiang, Rui; Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury, Nantong 226001, Peoples R China; [Dai, Yong] Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nantong, Jiangsu, Peoples R China; [Jin, Guohua; Qin, Jianbing; Zhang, Xinghua] Nantong Univ, Sch Med, Dept Anat & Neurobiol, Nantong 226001, Peoples R China		Chen, J; Shi, W (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury, Nantong 226001, Peoples R China.; Zhang, XH (corresponding author), Nantong Univ, Sch Med, Dept Anat & Neurobiol, Nantong 226001, Peoples R China.	ntfychenjian@126.com; zhangxinhua@ntu.edu.cn; fysw@ntu.edu.cn			Jiangsu Provincial Key Medical Center; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771335]; Chinese Projects for Postdoctoral Science Funds [2014M561698]; Chinese Special Projects for Postdoctoral Science Funds [2015T80573]; Application Research Project of Nantong City [HS2017001, MS12017001-1, MS12017015-3]; Jiangsu "333" program [BRA2016450]	This work was supported by the Jiangsu Provincial Key Medical Center; the National Natural Science Foundation of China (Grant No. 81771335); Chinese Projects for Postdoctoral Science Funds (No. 2014M561698); Chinese Special Projects for Postdoctoral Science Funds (No. 2015T80573); Application Research Project of Nantong City (Grant Nos. HS2017001, MS12017001-1, MS12017015-3); and Jiangsu "333" program funding (Grant No. BRA2016450).	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bazan E, 2004, HISTOL HISTOPATHOL, V19, P1261, DOI 10.14670/HH-19.1261; Bizy Alexandra, 2015, Methods Mol Biol, V1212, P103, DOI 10.1007/7651_2014_91; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Forraz N, 2013, J TISSUE ENG REGEN M, V7, P523, DOI 10.1002/term.552; Grade S, 2013, INT J DEV NEUROSCI, V31, P692, DOI 10.1016/j.ijdevneu.2013.01.004; Gu J, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00282; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Hao P, 2017, BIOMATERIALS, V140, P88, DOI 10.1016/j.biomaterials.2017.04.014; Huang YX, 2015, BIOCHEM BIOPH RES CO, V466, P214, DOI 10.1016/j.bbrc.2015.09.011; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Johnson KM, 2015, NEUROSCI LETT, V600, P104, DOI 10.1016/j.neulet.2015.06.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Li M, 2014, NEUROCHEM RES, V39, P1440, DOI 10.1007/s11064-014-1333-z; LINDSAY RM, 1982, BRAIN RES, V243, P329, DOI 10.1016/0006-8993(82)90257-8; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Pei D, 2017, BRAIN RES BULL, V134, P121, DOI 10.1016/j.brainresbull.2017.06.020; Pekcec A, 2008, AGING CELL, V7, P368, DOI 10.1111/j.1474-9726.2008.00392.x; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Salmin VV, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00245; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Shetty AK, 2013, INT J DEV NEUROSCI, V31, P646, DOI 10.1016/j.ijdevneu.2013.05.006; Shirazi HA, 2015, EXP MOL PATHOL, V98, P240, DOI 10.1016/j.yexmp.2015.02.004; Skytt DM, 2010, NEUROCHEM RES, V35, P2043, DOI 10.1007/s11064-010-0329-6; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Teschemacher AG, 2015, NEUROCHEM RES, V40, P2386, DOI 10.1007/s11064-015-1562-9; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Yao MH, 2014, J NEUROSCI, V34, P12039, DOI 10.1523/JNEUROSCI.0486-14.2014; Zelentsova K, 2017, STEM CELLS, V35, P679, DOI 10.1002/stem.2522	41	6	7	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	OCT	2019	37	10					1344	1356		10.1002/stem.3060		AUG 2019	13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	JF3CP	WOS:000478986900001	31287930	hybrid			2022-02-06	
J	Banky, M; Clark, RA; Mentiplay, BF; Olver, JH; Kahn, MB; Williams, G				Banky, Megan; Clark, Ross A.; Mentiplay, Benjamin F.; Olver, John H.; Kahn, Michelle B.; Williams, Gavin			Toward Accurate Clinical Spasticity Assessment: Validation of Movement Speed and Joint Angle Assessments Using Smartphones and Camera Tracking	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Muscle spasticity; Outcome assessment (health care); Rehabilitation; Technology	BOTULINUM TOXIN ASSESSMENT; TRAUMATIC BRAIN-INJURY; MODIFIED TARDIEU SCALE; LOWER-LIMB SPASTICITY; STROKE SURVIVORS; RELIABILITY; WALKING; ADULTS; INTERVENTION; MANAGEMENT	Objective: To investigate whether a three-dimensional (3-D) camera (Microsoft Kinect) and a smartphone can be used to accurately quantify the joint angular velocity and range of motion (ROM) compared to a criterion-standard 3-D motion analysis system during a lower limb spasticity assessment. Design: Observational, criterion-standard comparison study. Setting: Large rehabilitation center. Participants: A convenience sample of 35 controls, 35 patients with a neurologic condition, and 34 rehabilitation professionals (physiotherapists and rehabilitation doctors) participated (N = 104). Interventions: Not applicable. Main Outcome Measures: The Modified Tardieu Scale was used to assess spasticity of the quadriceps, hamstrings, soleus, and gastrocnemius. Data for each trial were collected concurrently using the criterion-standard Optitrack 3-D motion analysis (3DMA) system, Microsoft Kinect, and a smartphone. Each healthy control participant was assessed by 1 health professional and each patient with a neurological condition was assessed by 3 health professionals. Spearman correlation coefficient and intraclass correlation coefficient with 95% confidence intervals were used to report the strength of the relationships investigated. Results: The smartphone and Microsoft Kinect demonstrated excellent concurrent validity with the 3DMA system. Overall, 74.8% of the relationships investigated demonstrated a very strong (>= 0.80) correlation across all of the testing parameters. The Microsoft Kinect was superior to the smartphone for measuring joint start and end angle, the smartphone was superior for measuring joint angular velocity, and the 2 systems were comparable for measuring total joint ROM. Conclusions: These findings provide preliminary evidence that user-friendly, low-cost technologies can be used to facilitate accurate measurements of joint angular velocity and angles during a lower limb spasticity assessment in a clinical setting. (C) 2019 by the American Congress of Rehabilitation Medicine	[Banky, Megan; Mentiplay, Benjamin F.; Kahn, Michelle B.; Williams, Gavin] Epworth HealthCare, Dept Physiotherapy, Melbourne, Vic, Australia; [Banky, Megan; Clark, Ross A.; Kahn, Michelle B.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [Mentiplay, Benjamin F.] La Trobe Univ, La Trobe Sport & Exercise Med Res Ctr, Melbourne, Vic, Australia; [Mentiplay, Benjamin F.] Murdoch Childrens Res Inst, Victorian Infant Brain Studies, Melbourne, Vic, Australia; [Olver, John H.] Epworth Monash Rehabil Med Unit, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia		Banky, M (corresponding author), Epworth Rehabil, Physiotherapy Dept, 29 Erin St, Richmond, Vic 3121, Australia.	megan.banky@epworth.org.au	Mentiplay, Benjamin/A-2279-2019; Clark, Ross/R-5664-2018	Mentiplay, Benjamin/0000-0002-4360-8310; Olver, John/0000-0001-7069-1191; Clark, Ross/0000-0002-7291-8553	Royal Automobile Club of Victoria, Epworth Research Institute, and Physiotherapy Research Fund	Supported by the Royal Automobile Club of Victoria, Epworth Research Institute, and Physiotherapy Research Fund.	Akpinar P, 2017, SPINAL CORD, V55, P944, DOI 10.1038/sc.2017.48; Banky M, 2019, J REHABIL MED, V51, P54, DOI 10.2340/16501977-2496; Banky M, 2017, BRAIN INJURY, V31, P440, DOI 10.1080/02699052.2016.1271455; Ben-Shabat E, 2013, ARCH PHYS MED REHAB, V94, P2494, DOI 10.1016/j.apmr.2013.06.026; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Charlton PC, 2015, J SCI MED SPORT, V18, P262, DOI 10.1016/j.jsams.2014.04.008; Clark RA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0006-8; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Evans JD, 1996, STRAIGHTFORWARD STAT; Held JP, 1969, MOTOR REHABILITATION; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lundstrom E, 2010, STROKE, V41, P319, DOI 10.1161/STROKEAHA.109.558619; Mentiplay BF, 2018, GAIT POSTURE, V65, P190, DOI 10.1016/j.gaitpost.2018.06.162; Mentiplay BF, 2018, J SPORT SCI, V36, P2202, DOI 10.1080/02640414.2018.1445439; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Nalysnyk L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-118; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Parag V, 2008, CEREBROVASC DIS, V25, P548, DOI 10.1159/000131673; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Platz T, 2005, DISABIL REHABIL, V27, P7, DOI 10.1080/09638280400014634; Quek J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-65; Radensky PW, 2001, NEUROREHAB NEURAL RE, V15, P57, DOI 10.1177/154596830101500108; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Sheean GL, 2001, CURR OPIN NEUROL, V14, P771, DOI 10.1097/00019052-200112000-00015; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Vernon S, 2015, NEUROREHAB NEURAL RE, V29, P48, DOI 10.1177/1545968314529475; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE49, DOI 10.1097/HTR.0000000000000094; Zorowitz RD, 2013, NEUROLOGY, V80, pS45, DOI 10.1212/WNL.0b013e3182764c86	34	6	6	1	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2019	100	8					1482	1491		10.1016/j.apmr.2018.11.026			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IR6QG	WOS:000481563200012	30684484				2022-02-06	
J	Dattilo, M; Read, AT; Samuels, BC; Ethier, CR				Dattilo, Michael; Read, A. Thomas; Samuels, Brian C.; Ethier, C. Ross			Detection and characterization of tree shrew retinal venous pulsations: An animal model to study human retinal venous pulsations	EXPERIMENTAL EYE RESEARCH			English	Article						Spontaneous retinal venous pulsations; Intracranial pressure; Intraocular pressure; Translaminar pressure gradient; Tree shrews	CEREBROSPINAL-FLUID PRESSURE; TRAUMATIC BRAIN-INJURY; HUMAN LAMINA-CRIBROSA; OPEN-ANGLE GLAUCOMA; INTRACRANIAL-PRESSURE; NONINVASIVE ASSESSMENT; INTRAOCULAR-PRESSURE; CEREBRAL PERFUSION; LUMBAR PUNCTURE; OPTIC-NERVE	Spontaneous retinal venous pulsations (SRVPs), pulsations of branches of the central retinal vein, are affected by intraocular pressure (IOP) and intracranial pressure (ICP) and thus convey potentially-useful information about ICP. However, the exact relationship between SRVPs, IOP, and ICP is unknown. It is not easily feasible to study this relationship in humans, necessitating the use of an animal model. We here propose tree shrews as a suitable animal model to study the complex relationship between SRVPs, IOP, and ICP. Tree shrew SRVP incidence was determined in a population of animals. Following validation of a modified IOP control system to accurately and quickly control IOP, IOP and/or ICP were manipulated in two tree shrews with SRVPs and the effects on SRVP properties were quantified. SRVPs were present in 75% of tree shrews at physiologic IOP and ICP. Altering IOP or ICP produced changes in tree shrew SRVP properties; specifically, increasing IOP caused SRVP amplitude to increase, while increasing ICP caused SRVP amplitude to decrease. In addition, a higher IOP was necessary to generate SRVPs at a higher ICP than at a lower ICP. SRVPs occur with a similar incidence in tree shrews as in humans, and tree shrew SRVPs are affected by changes in IOP and ICP in a manner qualitatively similar to that reported in humans. In view of anatomic similarities, tree shrews are a promising animal model system to further study the complex relationship between SRVPs, IOP, and ICP.	[Dattilo, Michael; Ethier, C. Ross] Emory Univ, Sch Med, Dept Ophthalmol, 1365-B Clifton Rd, Atlanta, GA 30322 USA; [Dattilo, Michael; Read, A. Thomas; Ethier, C. Ross] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr NW, Atlanta, GA 30332 USA; [Dattilo, Michael; Read, A. Thomas; Ethier, C. Ross] Emory Univ, 313 Ferst Dr NW, Atlanta, GA 30332 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, 1670 Univ Blvd, Birmingham, AL 35294 USA		Ethier, CR (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	Michael.dattilo@emory.edu; tom.read@bme.gatech.edu; bsamuels@uabmc.edu; ross.ethier@bme.gatech.edu			National Institutes of Health/National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32-EY007092, R21-EY026218]; Georgia Research Alliance; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32EY007092, R21EY026218] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/National Eye Institute grant numbers T32-EY007092 (MD) and R21-EY026218 (BCS); and the Georgia Research Alliance (CRE).	Adler MD, 2001, PEDIATR EMERG CARE, V17, P184, DOI 10.1097/00006565-200106000-00008; Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Albon J, 2007, INVEST OPHTH VIS SCI, V48, P2134, DOI 10.1167/iovs.06-0084; Alstadhaug Karl Bjornar, 2012, Tidsskr Nor Laegeforen, V132, P818, DOI 10.4045/tidsskr.11.0832; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bershad EM, 2014, NEUROSURGERY, V75, P445, DOI 10.1227/NEU.0000000000000449; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153; Burkett JG, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0839-1; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; del-Rio-Vellosillo M, 2017, REGION ANESTH PAIN M, V42, P1, DOI 10.1097/AAP.0000000000000504; Donnelly SJ, 2009, AM J OPHTHALMOL, V147, P51, DOI 10.1016/j.ajo.2008.07.035; Egede L E, 1999, Md Med J, V48, P15; ELKINGTON AR, 1990, EYE, V4, P42, DOI 10.1038/eye.1990.5; Engelborghs Sebastiaan, 2017, Alzheimers Dement (Amst), V8, P111, DOI 10.1016/j.dadm.2017.04.007; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Ficarrotta KR, 2018, INVEST OPHTH VIS SCI, V59, P2529, DOI 10.1167/iovs.17-22915; Firsching R, 2000, J NEUROSURG, V93, P33, DOI 10.3171/jns.2000.93.1.0033; Firsching R, 2011, J NEUROSURG, V115, P371, DOI 10.3171/2011.3.JNS101275; Gibbs FA, 1936, ARCH NEURO PSYCHIATR, V35, P292, DOI 10.1001/archneurpsyc.1936.02260020086006; Golzan SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128433; Golzan SM, 2011, CURR EYE RES, V36, P53, DOI 10.3109/02713683.2010.530731; Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341; HASAN D, 1991, STROKE, V22, P190, DOI 10.1161/01.STR.22.2.190; Holdgate A, 2001, Emerg Med (Fremantle), V13, P351, DOI 10.1046/j.1035-6851.2001.00239.x; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Jenkins K.S., 2017, ACTA OPHTHALMOL, V95; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 2008, GRAEF ARCH CLIN EXP, V246, P1059, DOI 10.1007/s00417-008-0780-0; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lee E, 2017, J GLAUCOMA, V26, P896, DOI 10.1097/IJG.0000000000000759; Legler U, 2007, CLIN EXP OPHTHALMOL, V35, P870, DOI 10.1111/j.1442-9071.2007.01641.x; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; LEVIN BE, 1978, ARCH NEUROL-CHICAGO, V35, P37, DOI 10.1001/archneur.1978.00500250041009; Levine DN, 2016, MICROVASC RES, V106, P67, DOI 10.1016/j.mvr.2016.03.005; LORENTZEN SE, 1970, ACTA OPHTHALMOL, V48, P765; Madekurozwa M, 2017, EXP EYE RES, V162, P129, DOI 10.1016/j.exer.2017.07.008; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Morgan WH, 2016, PROG RETIN EYE RES, V55, P82, DOI 10.1016/j.preteyeres.2016.06.003; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; Motschmann M, 2001, Strabismus, V9, P13, DOI 10.1076/stra.9.1.13.711; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Odden MC, 2014, ACTA OPHTHALMOL, V62, P1692, DOI DOI 10.1111/j.1755-3768.2012.02472.x; Oliver WJ, 2003, PEDIATRICS, V112, pE174, DOI 10.1542/peds.112.3.e174; Querfurth HW, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-106; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; RIOSMONTENEGRO EN, 1973, ARCH OPHTHALMOL-CHIC, V89, P52; Samuels BC, 2018, INVEST OPHTH VIS SCI, V59, P3136, DOI 10.1167/iovs.18-24261; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; Sherwood JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150694; Stockslager MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147020; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Thurtell Matthew J, 2010, Rev Neurol Dis, V7, pe56; Verslegers L, 2017, CLIN NEUROL NEUROSUR, V152, P95, DOI 10.1016/j.clineuro.2016.12.003; Vickers A, 2017, ANN EMERG MED, V70, pS104, DOI 10.1016/j.annemergmed.2017.07.241; Wall M, 2000, SEMIN NEUROL, V20, P89; WALSH TJ, 1969, AM J OPHTHALMOL, V67, P954, DOI 10.1016/0002-9394(69)90094-4; Zhan W., 2015, INVESTIG OPHTHALMOL, V56, P2428; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	68	6	6	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	AUG	2019	185								107689	10.1016/j.exer.2019.06.003			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	IT8NU	WOS:000483140000023	31175860	Green Accepted			2022-02-06	
J	Holliday, R; Rozek, DC; Smith, NB; McGarity, S; Jankovsky, M; Monteith, LL				Holliday, Ryan; Rozek, David C.; Smith, Noelle B.; McGarity, Suzanne; Jankovsky, Molly; Monteith, Lindsey L.			Safety Planning to Prevent Suicidal Self-Directed Violence Among Veterans With Posttraumatic Stress Disorder: Clinical Considerations	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						veterans; suicide prevention; Safety Planning; posttraumatic stress disorder	THERAPEUTIC RISK-MANAGEMENT; TRAUMATIC BRAIN-INJURY; MEANS RESTRICTION; SMARTPHONE APP; SUBSTANCE USE; PTSD; MILITARY; BEHAVIORS; SYMPTOMS; IDEATION	Veterans with posttraumatic stress disorder (PTSD) are at elevated risk for engaging in suicidal self-directed violence (S-SDV). Safety Planning has been widely implemented in the Veterans Health Administration to prevent S-SDV; however, limited guidelines exist regarding considerations for Safety Planning with veterans with PTSD. In this article, we discuss clinical considerations to guide health care providers in customizing each step of Safety Planning for veterans with PTSD. Proposed considerations include challenges establishing an appropriate baseline (Step 1); risky behaviors and substance use (Step 2); PTSD-related avoidance, beliefs, distrust, and isolation (Steps 3 and 4); stigma and distrust of providers and institutions (Step 5); and hypervigilance, safety beliefs, firearms, substances, and numbing (Step 6). Strategies for addressing these are provided for each step of the Safety Plan, such as delineating trauma-related warning signs, anticipating avoidance, and incorporating PTSD-related resources. In addition, methods of implementing the Safety Plan into evidence-based PTSD treatments disseminated within the Department of Veterans Affairs (e.g., cognitive processing therapy, prolonged exposure therapy) are discussed. Continued examination of Safety Planning in veterans with PTSD, including empirical investigation, is needed.	[Holliday, Ryan; McGarity, Suzanne; Jankovsky, Molly; Monteith, Lindsey L.] Rocky Mt Mental Illness Res Educ & Clin Ctr Suici, Aurora, CO 80045 USA; [Holliday, Ryan; McGarity, Suzanne; Monteith, Lindsey L.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Rozek, David C.] Univ Utah, Salt Lake City, UT 84112 USA; [Smith, Noelle B.] VA Northeast Program Evaluat Ctr, West Haven, CT USA; [Smith, Noelle B.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA		Holliday, R (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr Suici, Rocky Mt Reg Vet Affairs Med Ctr, 1700 North Wheeling St,G-3-116M, Aurora, CO 80045 USA.	ryan.holliday@va.gov	Monteith, Lindsey L./X-3658-2019	Monteith, Lindsey L./0000-0002-8104-5280	Department of Veterans AffairsUS Department of Veterans Affairs; Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs; Rocky Mountain Mental Illness Research, Education, and Clinical Center for Suicide Prevention; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002538, KL2TR002539]	THIS WORK WAS SUPPORTED in part by the Department of Veterans Affairs; Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs; the Rocky Mountain Mental Illness Research, Education, and Clinical Center for Suicide Prevention; and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002538 and KL2TR002539 (David C. Rozek). The content is solely the responsibility of the authors and does not necessarily represent the views or policy of the U.S. Government, Department of Veterans Affairs, or the National Institutes of Health.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Bakhiyi CL, 2016, J PSYCHIATR RES, V77, P92, DOI 10.1016/j.jpsychires.2016.02.019; Barber CW, 2014, AM J PREV MED, V47, pS264, DOI 10.1016/j.amepre.2014.05.028; Barnes SM, 2019, SUICIDE LIFE-THREAT, V49, P1094, DOI 10.1111/sltb.12511; Blanchard M, 2020, PSYCHOTHER RES, V30, P124, DOI 10.1080/10503307.2018.1543977; Britton PC, 2016, COGN BEHAV PRACT, V23, P51; Britton PC, 2012, PSYCHIAT RES, V200, P395, DOI 10.1016/j.psychres.2012.06.036; Bryan CJ, 2018, CURR OPIN PSYCHOL, V22, P27, DOI 10.1016/j.copsyc.2017.07.022; Bryan CJ, 2018, DEPRESS ANXIETY, V35, P619, DOI 10.1002/da.22753; Bryan CJ, 2018, PSYCHIAT SERV, V69, P108, DOI 10.1176/appi.ps.201700157; Bryan CJ, 2017, J AFFECT DISORDERS, V212, P64, DOI 10.1016/j.jad.2017.01.028; Bryan CJ, 2013, DEPRESS ANXIETY, V30, P55, DOI 10.1002/da.22002; Bush NE, 2017, PSYCHIAT SERV, V68, P330, DOI 10.1176/appi.ps.201600283; Crosby AE, 2011, SELF DIRECTED VIOLEN; Cunningham KC, 2019, J AFFECT DISORDERS, V243, P216, DOI 10.1016/j.jad.2018.09.040; Currier GW, 2015, CONTEMP CLIN TRIALS, V43, P179, DOI 10.1016/j.cct.2015.05.003; Department of Veterans Affairs (VA, 2018, VA NAT SUIC DAT REP; Finnegan HA, 2018, J AMBUL CARE MANAG, V41, P114, DOI 10.1097/JAC.0000000000000225; Freeman TW, 2001, J NERV MENT DIS, V189, P317, DOI 10.1097/00005053-200105000-00008; Gamarra JM, 2015, CRISIS, V36, P433, DOI 10.1027/0227-5910/a000345; Ganzini L, 2013, J GEN INTERN MED, V28, P1215, DOI 10.1007/s11606-013-2412-6; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Goodnight JRM, 2019, PROG NEURO-PSYCHOPH, V88, P418, DOI 10.1016/j.pnpbp.2018.05.006; Gradus J.L., 2017, EPIDEMIOLOGY PTSD; Gradus JL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0965-0; Green JD, 2018, BEHAV THER, V49, P931, DOI 10.1016/j.beth.2017.11.005; Gutierrez, 2012, J MENTAL HLTH COUNSE, V34, P95, DOI [10.17744/mehc.34.2.a77036631424nmq7, DOI 10.17744/MEHC.34.2.A77036631424NMQ7]; Hoffmire CA, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041029; Holliday Ryan, 2018, Fed Pract, V35, P24; Holliday R, 2019, J TRAUMA DISSOCIATIO, V20, P340, DOI 10.1080/15299732.2019.1571888; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jobes D., 2006, MANAGING SUICIDAL RI; Kimbrel NA, 2017, J PSYCHIATR RES, V89, P1, DOI 10.1016/j.jpsychires.2017.01.002; Kleiman EM, 2014, ARCH SUICIDE RES, V18, P144, DOI 10.1080/13811118.2013.826155; Knox KL, 2012, AM J PUBLIC HEALTH, V102, pS33, DOI 10.2105/AJPH.2011.300501; Kuhn E, 2014, MIL MED, V179, P12, DOI 10.7205/MILMED-D-13-00271; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Legarreta M, 2015, PSYCHOL TRAUMA-US, V7, P277, DOI 10.1037/tra0000026; Lehavot K, 2018, AM J PREV MED, V54, pE1, DOI 10.1016/j.amepre.2017.09.008; Lento RM, 2019, CRISIS, V40, P62, DOI 10.1027/0227-5910/a000532; Linehan M. M., 1993, COGNITIVE BEHAV THER; Lusk JD, 2017, J TRAUMA STRESS, V30, P270, DOI 10.1002/jts.22182; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Matarazzo BB, 2014, J PSYCHIATR PRACT, V20, P220, DOI 10.1097/01.pra.0000450321.06612.7a; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Mcmyler C, 2008, J PSYCHIATR MENT HLT, V15, P512, DOI 10.1111/j.1365-2850.2008.01286.x; Mittal D, 2013, PSYCHIATR REHABIL J, V36, P86, DOI 10.1037/h0094976; Monteith LL, 2017, J CLIN PSYCHOL, V73, P1655, DOI 10.1002/jclp.22462; Monteith LL, 2016, J CLIN PSYCHOL, V72, P743, DOI 10.1002/jclp.22292; Nishith P, 2002, J CONSULT CLIN PSYCH, V70, P880, DOI 10.1037/0022-006X.70.4.880; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Ouimette PC, 1998, ADDICT BEHAV, V23, P785, DOI 10.1016/S0306-4603(98)00064-1; Owen Jason E, 2018, Mhealth, V4, P28, DOI 10.21037/mhealth.2018.05.07; Paris J, 2004, J PERS DISORD, V18, P240, DOI 10.1521/pedi.18.3.240.35443; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pigeon WR, 2012, AM J PUBLIC HEALTH, V102, pS93, DOI 10.2105/AJPH.2011.300470; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rozek DC, 2019, EARLY INTERV PSYCHIA, V13, P682, DOI 10.1111/eip.12699; Rudd M.D., 2006, ASSESSMENT MANAGEMEN; Ruderman L, 2016, DEPRESS ANXIETY, V33, P606, DOI 10.1002/da.22494; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Smith CP, 2014, AM PSYCHOL, V69, P575, DOI 10.1037/a0037564; Smith NB, 2016, J AFFECT DISORDERS, V197, P66, DOI 10.1016/j.jad.2016.02.069; Stanley B., 2018, SAFETY PLANNING INTE; Stanley B, 2018, JAMA PSYCHIAT, V75, P894, DOI 10.1001/jamapsychiatry.2018.1776; Stanley IH, 2017, ARCH SUICIDE RES, V21, P237, DOI 10.1080/13811118.2016.1175395; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; The Assessment and Management of Risk for Suicide Working Group, 2013, VA DOD CLIN PRACT GU; Wortzel HS, 2014, J PSYCHIATR PRACT, V20, P63, DOI 10.1097/01.pra.0000442940.46328.63; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	73	6	6	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	AUG	2019	50	4					215	227		10.1037/pro0000239			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	IS9TL	WOS:000482490700002		Bronze			2022-02-06	
J	Jeanmonod, R; Asher, S; Roper, J; Vera, L; Winters, J; Shah, N; Reiter, M; Bruno, E; Jeanmonod, D				Jeanmonod, Rebecca; Asher, Shellie; Roper, Jamie; Vera, Luis; Winters, Josephine; Shah, Nirali; Reiter, Mark; Bruno, Eric; Jeanmonod, Donald			History and physical exam predictors of intracranial injury in the elderly fall patient: A prospective multicenter study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Geriatric trauma; Intracranial injuly; Head trauma; Neuroimaging in trauma	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY CT; EMERGENCY-DEPARTMENT; CLINICAL INDICATIONS; OLDER PATIENTS; WARFARIN USE; RISK; HEMORRHAGE; ANTICOAGULATION	Objectives: A prior single-center study clemonsfraled historical and exam features predicting intracranial injury (ICI) in geriatric patients with low-risk falls. We sought to prospectively validate these findings in a multicenter population. Methods: This is a prospective observational study of patients >= 65 years presenting after a fall to three EDs. Patients were eligible if they were al baseline mental status and were nor triaged to the trauma bay. Fall mechanism, head strike history, headache, loss of consciousness (LOC), anlicoagulanls/anliplateler use, dementia, and signs of head trauma were recorded. Radiographic imaging was obtained at the discretion of treating physicians. Patients were called at 30 days to determine outcome in non-imaged patients. Results: 723 patients (median age 83, interquartile range 74-88) were enrolled. Although all patients were at baseline mental status, 76 had GCS <15, and 154 had dementia. 406 patients were on anticoagulationlantiplatelet agents. Fifty-two (7.31%) patients had traumatic ICI. Two study variables were helpful in predicting ICI: LOC (odds ratio (OR) 2.02) and signs of head trauma (OR 2.6). The sensitivity of these items was 86.5% (CI 73.6-94) with a specificity of 38.8% (CI 35.1-42.7). The positive predictive value in this population was 10% (CI 7.5-13.3) with a negative predictive value of 97.3% (CI 94.4-98.8). Had these items been applied as a decision rule, 273 patients would not have undergone CT scanning, but 7 injuries would have been missed. Conclusion: In low-risk geriatric fall patients, the best predictors of ICI were physical findings of head trauma and history of LOC. (C) 2018 Published by Elsevier Inc.	[Jeanmonod, Rebecca; Roper, Jamie; Vera, Luis; Jeanmonod, Donald] St Lukes Univ Hlth Network, Dept Emergency Med, Bethlehem, PA 18015 USA; [Asher, Shellie; Winters, Josephine] Albany Med Ctr, Dept Emergency Med, Albany, NY USA; [Shah, Nirali; Reiter, Mark; Bruno, Eric] Univ Tennessee, Hlth Sci Ctr, Dept Emergency Med, Murfreesboro, TN USA		Jeanmonod, R (corresponding author), St Lukes Univ Hlth Network, Dept Emergency Med, Bethlehem, PA 18015 USA.	Rebecca.jeanmonod@sluhn.org					Adams ML, 2013, MMWR-MORBID MORTAL W, V62, P345; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Borade A, 2017, INJURY, V48, P1594, DOI 10.1016/j.injury.2017.04.051; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Brinjikji W, 2015, AM J ROENTGENOL, V204, P558, DOI 10.2214/AJR.14.13107; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dusenberry MW, 2017, AM J EMERG MED, V35, P260, DOI 10.1016/j.ajem.2016.10.065; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Government Accountability Office (GAO), 2008, MED B; Gray LC, 2013, ANN EMERG MED, V62, P467, DOI 10.1016/j.annemergmed.2013.05.008; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hruska K, 2018, EMERG MED CLIN N AM, V36, P219, DOI 10.1016/j.emc.2017.08.014; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Maniar H, 2015, INJURY, V46, P2185, DOI 10.1016/j.injury.2015.06.036; Marion DW, 2006, NEUROSURGERY, V58, P655; Meldon SW, 2000, SUBDURAL HEMATOMAS E; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013; Yokobori S, 2016, WORLD NEUROSURG, V86, P127, DOI 10.1016/j.wneu.2015.09.105	43	6	6	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2019	37	8					1470	1475		10.1016/j.ajem.2018.10.049			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IM3WT	WOS:000477927100014	30415981				2022-02-06	
J	King, D; Hume, PA; Hardaker, N; Cummins, C; Gissane, C; Clark, T				King, Doug; Hume, Patria A.; Hardaker, Natalie; Cummins, Cloe; Gissane, Conor; Clark, Trevor			Sports-related injuries in New Zealand: National Insurance (Accident Compensation Corporation) claims for five sporting codes from 2012 to 2016	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PREVENTION	Objectives To provide epidemiological data and related costs for sport-related injuries of five sporting codes (cricket, netball, rugby league, rugby union and football) in New Zealand for moderate-to-serious and serious injury claims. Methods A retrospective analytical review using detailed descriptive epidemiological data obtained from the Accident Compensation Corporation (ACC) for 2012-2016. Results Over the 5 years of study data, rugby union recorded the most moderate-to-serious injury entitlement claims (25 226) and costs (New Zealand dollars (NZD$) 267 359 440 (139 pound 084 749)) resulting in the highest mean cost (NZD$ 10 484 ( pound 5454)) per moderateto-serious injury entitlement claim. Rugby union recorded more serious injury entitlement claims (n=454) than cricket (t((4))=-66.6; P<0.0001); netball (t((4))=-45.1; P<0.0001); rugby league (t((4))=-61.4; P<0.0001) and football (t((4))=66.6; P<0.0001) for 2012-2016. There was a twofold increase in the number of female moderate-to-serious injury entitlement claims for football (RR 2.6 (95% CI 2.2 to 2.9); P<0.0001) compared with cricket, and a threefold increase when compared with rugby union (risk ratio (RR) 3.1 (95% CI 2.9 to 3.3); P<0.0001). Moderate-to-serious concussion claims increased between 2012 and 2016 for netball (RR 3.7 (95% CI 1.9 to 7.1); P<0.0001), rugby union (RR 2.0 (95% CI 1.6 to 2.4); P<0.0001) and football (RR 2.3 (95% CI 1.6 to 3.2); P<0.0001). Nearly a quarter of moderate-to-serious entitlement claims (23%) and costs (24%) were to participants aged 35 years or older. Conclusions Rugby union and rugby league have the highest total number and costs associated with injury. Accurate sport exposure data are needed to enable injury risk calculations.	[King, Doug; Hume, Patria A.; Hardaker, Natalie] Auckland Univ Technol, SPRINZ, Fac Hlth & Environm Sci, Auckland, New Zealand; [King, Doug; Cummins, Cloe] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Hume, Patria A.] Auckland Univ Technol, NISAN, Fac Hlth & Environm Sci, Auckland, New Zealand; [Hardaker, Natalie] Accid Compensat Corp, Wellington, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, New Zealand; [Clark, Trevor] Australian Coll Phys Educ, Dept Sport Performance, Sydney, NSW, Australia		King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Lower Hutt 5010, New Zealand.	doug.king35@gmail.com	Gissane, Conor/I-3661-2019; Hume, Patria Anne/P-1084-2017; Cummins, Cloe/AAA-5169-2019; Hume, Patria/AAN-5514-2021	Gissane, Conor/0000-0003-4677-3853; Hume, Patria Anne/0000-0003-1847-8128; Cummins, Cloe/0000-0003-1960-8916; Hume, Patria/0000-0003-1847-8128; Clark, Dr Trevor/0000-0002-2853-0068			Caldwell O, 2017, DOMINION POST; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; COUSINS SO, 1992, EDUC GERONTOL, V18, P461; Finch C, 2006, J SCI MED SPORT, V9, P490, DOI 10.1016/j.jsams.2006.03.002; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Gianotti S, 2008, BRIT J SPORT MED, V42, P427, DOI 10.1136/bjsm.2008.046987; Gianotti S, 2008, BRIT J SPORT MED, V39, P386; GIANOTTI S, 2005, BRIT J SPORT MED, V39, P386; Gianotti S, 2007, J SCI MED SPORT, V10, P436, DOI 10.1016/j.jsams.2006.10.006; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gianotti S, 2010, J SCI MED SPORT, V13, P32, DOI 10.1016/j.jsams.2008.07.010; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Hurley O., 2007, SPORT EXERCISE PSYCH, V3, P14; King D, 2011, INT J SPORTS MED, V32, P287, DOI 10.1055/s-0030-1270486; King D, 2009, NZ J SPORTS MED, V36, P48; King DA, 2010, BRIT J SPORT MED, V44, P1016, DOI 10.1136/bjsm.2009.064683; King DA, 2009, BRIT J SPORT MED, V43, P595, DOI 10.1136/bjsm.2009.061481; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; King DA, 2011, J SCI MED SPORT, V14, P126, DOI 10.1016/j.jsams.2010.10.001; Leung FT, 2017, J SPORT SCI, V35, P2088, DOI 10.1080/02640414.2016.1255771; Love Robert M., 1998, New Zealand Dental Journal, V94, P146; Lythe M, 1992, NZ J SPORTS MED, V20, P6; Marshall SW., 1994, NZ J SPORTS MED, V22, P18; Newsham-West R, 2009, PHYS THER SPORT, V10, P63, DOI 10.1016/j.ptsp.2009.01.002; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; Reeves J, 2015, SPORTS, V3, P77, DOI 10.3390/sports3020077; Twellaar M, 1996, AM J SPORT MED, V24, P528, DOI 10.1177/036354659602400419; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Welch Cara L., 2010, New Zealand Dental Journal, V106, P137; [No title captured]	32	6	6	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2019	53	16					1026	1033		10.1136/bjsports-2017-098533			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IT0BD	WOS:000482510800011	29530942	Green Published, Green Accepted			2022-02-06	
J	Kornblith, LZ; Robles, AJ; Conroy, AS; Redick, BJ; Howard, BM; Hendrickson, CM; Moore, S; Nelson, MF; Moazed, F; Callcut, RA; Calfee, CS; Cohen, MJ				Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Redick, Brittney J.; Howard, Benjamin M.; Hendrickson, Carolyn M.; Moore, Sara; Nelson, Mary F.; Moazed, Farzad; Callcut, Rachael A.; Calfee, Carolyn S.; Cohen, Mitchell Jay			Predictors of postinjury acute respiratory distress syndrome: Lung injury persists in the era of hemostatic resuscitation	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	89th Annual Scientific Meeting of the Pacific-Coast-Surgical-Association	FEB 17-19, 2018	Napa, CA	Pacific Coast Surg Assoc		ARDS; Berlin criteria; hemostatic resuscitation; platelet transfusion	MULTIPLE ORGAN FAILURE; CARE SAFETY NETWORK; TRAUMA DEATHS; DECREASING INCIDENCE; EARLY COAGULOPATHY; BLOOD-TRANSFUSION; MORTALITY; PLASMA; IMPACT; RISK	BACKGROUND Acute respiratory distress syndrome (ARDS) following trauma is historically associated with crystalloid and blood product exposure. Advances in resuscitation have occurred over the last decade, but their impact on ARDS is unknown. We sought to investigate predictors of postinjury ARDS in the era of hemostatic resuscitation. METHODS Data were prospectively collected from arrival to 28 days for 914 highest-level trauma activations who required intubation and survived more than 6 hours from 2005 to 2016 at a Level I trauma center. Patients with ratio of partial pressure of oxygen to fraction of inspired oxygen of 300 mmHg or less during the first 8 days were identified. Two blinded expert clinicians adjudicated all chest radiographs for bilateral infiltrates in the first 8 days. Those with left-sided heart failure detected were excluded. Multivariate logistic regression was used to define predictors of ARDS. RESULTS Of the 914 intubated patients, 63% had a ratio of partial pressure of oxygen to fraction of inspired oxygen of 300 or less, and 22% developed ARDS; among the ARDS cases, 57% were diagnosed early (in the first 24 hours), and 43% later. Patients with ARDS diagnosed later were more severely injured (ISS 32 vs. 20, p = 0.001), with higher rates of blunt injury (84% vs. 72%, p = 0.008), chest injury (58% vs. 36%, p < 0.001), and traumatic brain injury (72% vs. 48%, p < 0.001) compared with the no ARDS group. In multivariate analysis, head/chest Abbreviated Injury Score scores, crystalloid from 0 to 6 hours, and platelet transfusion from 0 to 6 hours and 7 to 24 hours were independent predictors of ARDS developing after 24 hours. CONCLUSIONS Blood and plasma transfusion were not independently associated with ARDS. However, platelet transfusion was a significant independent risk factor. The role of platelets warrants further investigation but may be mechanistically explained by lung injury models of pulmonary platelet sequestration with peripheral thrombocytopenia.	[Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Redick, Brittney J.; Howard, Benjamin M.; Nelson, Mary F.] Zuckerberg San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave,Room 3C-38, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hendrickson, Carolyn M.; Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Moore, Sara] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Cohen, Mitchell Jay] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Denver, CO 80202 USA		Kornblith, LZ (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave,Room 3C-38, San Francisco, CA 94110 USA.	lucy.kornblith@ucsf.edu	Callcut, Rachael/ABE-1484-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877, K23HL133495, R35HL140026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM130892] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL110969, R35 HL140026, K23 HL133495, UM1 HL120877] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01 ES026834] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23 GM130892] Funding Source: Medline		Alam HB, 2001, J AM COLL SURGEONS, V193, P255, DOI 10.1016/S1072-7515(01)01004-3; Allen-Bridson K, 2013, AM J INFECT CONTROL, V41, P1085, DOI 10.1016/j.ajic.2013.05.010; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Blaisdell WFLF, 1977, RESP DISTRESS SYNDRO; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; Croce MA, 2005, J TRAUMA, V59, P19, DOI 10.1097/01.TA.0000171459.21450.DC; Croce MA, 1999, J TRAUMA, V46, P361, DOI 10.1097/00005373-199903000-00001; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holena DN, 2012, J TRAUMA ACUTE CARE, V73, P825, DOI 10.1097/TA.0b013e318256de38; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Magill SS, 2014, CURR OPIN INFECT DIS, V27, P394, DOI 10.1097/QCO.0000000000000083; Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Martin M, 2005, J TRAUMA, V59, P1107, DOI 10.1097/01.ta.0000188633.94766.d0; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Miller PR, 2002, AM SURGEON, V68, P845; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Plurad D, 2007, J TRAUMA, V63, P1, DOI 10.1097/TA.0b013e318068b1ed; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reilly John P, 2014, Ann Am Thorac Soc, V11, P728, DOI 10.1513/AnnalsATS.201308-280OC; Reilly JPBS, 2012, AM J RESP CRIT CARE; ROBB HJ, 1972, SURG GYNECOL OBSTETR, V135, P777; Robinson BRH, 2017, SHOCK; Robinson BRH, 2013, J TRAUMA ACUTE CARE, V75, pS61, DOI 10.1097/TA.0b013e31828fa408; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Shah CV, 2010, CHEST, V138, P1054, DOI 10.1378/chest.09-2697; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watkins TR, 2012, CRIT CARE MED, V40, P2295, DOI 10.1097/CCM.0b013e3182544f6a; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	46	6	6	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2019	87	2					371	378		10.1097/TA.0000000000002331			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IN3WF	WOS:000478606400015	31033882	Green Accepted			2022-02-06	
J	MacWhinney, B				MacWhinney, Brian			Understanding spoken language through TalkBank	BEHAVIOR RESEARCH METHODS			English	Article						Child language; Aphasia; Conversation analysis; Bilingualism; Second language acquisition; Phonology; Computational linguistics; Corpora	PATTERNS; PLATFORM; CHILDES	Ongoing advances in computer technology have opened up a deluge of new datasets for understanding human behavior (Goldstone & Lupyan, 2016). Many of these datasets provide information on the use of written language. However, data on naturally occurring spoken-language conversations are much more difficult to obtain. A major exception to this is the TalkBank system, which provides online multimedia data for 14 types of spoken-language data: language in aphasia, child language, stuttering, child phonology, autism spectrum disorder, bilingualism, Conversation Analysis, classroom discourse, dementia, right hemisphere damage, Danish conversation, second language learning, traumatic brain injury, and daylong recordings in the home. The present report reviews these resources and describes the ways they are being used to further our understanding of human language and communication.	[MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA		MacWhinney, B (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	macw@cmu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD051698, R01HD082736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC008524, R01DC015494] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD023998, R01 HD051698, R01 HD082736] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC015494, R01 DC008524, R01HD082736] Funding Source: Medline		Baroni M, 2006, 11 C EUR CHAPT ASS C; Brown C, 2008, BEHAV RES METHODS, V40, P540, DOI 10.3758/BRM.40.2.540; Byun TM, 2012, J CHILD LANG, V39, P1043, DOI 10.1017/S0305000911000468; CLAHSEN H, 1992, COGNITION, V45, P225, DOI 10.1016/0010-0277(92)90018-D; Costa Teresa, 2010, THESIS; Donoho DL, 2010, BIOSTATISTICS, V11, P385, DOI 10.1093/biostatistics/kxq028; Freudenthal D, 2010, J CHILD LANG, V37, P643, DOI 10.1017/S0305000909990523; Garfinkel Harold., 1967, STUDIES ETHNOMETHODO; Givon T., 2005, CONTEXT OTHER MINDS; Goldstone RL, 2016, TOP COGN SCI, V8, P548, DOI 10.1111/tops.12212; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Le Franc A., 2018, INT 2018 MUMB IND; Lee L., 1974, DEV SENTENCE ANAL; Lehrer R., 2000, TEACHING CHILDREN MA, V6, P324; LEONARD LB, 1991, J CHILD LANG, V18, P261, DOI 10.1017/S0305000900011053; Lubetich S, 2014, 25 INT C COMP LING C; MACWHINNEY B, 1991, COGNITION, V40, P121, DOI 10.1016/0010-0277(91)90048-9; MacWhinney B, 2014, PORTUGUES PLATAFORMA, P9; MacWhinney B, 2017, LANG LEARN, V67, P254, DOI 10.1111/lang.12220; MacWhinney B, 2015, BLACKW HBK LINGUIST, P1; MacWhinney B, 2016, SEMIN SPEECH LANG, V37, P10, DOI 10.1055/s-0036-1571357; MacWhinney B, 2008, TRENDS LANG ACQUIS R, V6, P165; Malvern D, 2004, LEXICAL DIVERSITY AND LANGUAGE DEVELOPMENT: QUANTIFICATION AND ASSESSMENT, P1, DOI 10.1057/9780230511804; MARCUS GF, 1992, MONOGR SOC RES CHILD, V57, pR5; McCauley S.M., 2015, HDB LANGUAGE EMERGEN, P415, DOI [DOI 10.1002/9781118346136.CH19, 10.1002/9781118346136.ch19]; Metze F, 2016, INTERSPEECH, P1603, DOI 10.21437/Interspeech.2016-997; Miller J., 1983, SALT SYSTEMATIC ANAL; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Myers-Scotton C. M., 2005, HDB BILINGUALISM PSY, P326; Ngon C, 2013, DEVELOPMENTAL SCI, V16, P24, DOI 10.1111/j.1467-7687.2012.01189.x; Parisse C, 2000, BEHAV RES METH INS C, V32, P468, DOI 10.3758/BF03200818; Pennebaker J. W., 2012, OPENING HEALING POWE; Pine JM, 1997, APPL PSYCHOLINGUIST, V18, P123, DOI 10.1017/S0142716400009930; Ratner NB, 2018, J FLUENCY DISORD, V56, P69, DOI 10.1016/j.jfludis.2018.03.002; REDEKER G, 1984, DISCOURSE PROCESS, V7, P43, DOI 10.1080/01638538409544580; Rochon E, 2000, BRAIN LANG, V72, P193, DOI 10.1006/brln.1999.2285; Rose Y., 2014, OXFORD HDB CORPUS PH, P380; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sagae K, 2010, J CHILD LANG, V37, P705, DOI 10.1017/S0305000909990407; SCARBOROUGH HS, 1990, APPL PSYCHOLINGUIST, V11, P1, DOI 10.1017/S0142716400008262; Fernandez KDS, 2007, REV CONTEMP EDUC, V2; Skehan P, 2016, IRAL-INT REV APPL LI, V54, P97, DOI 10.1515/iral-2016-9992; Stigler JW, 2000, EDUC PSYCHOL, V35, P87, DOI 10.1207/S15326985EP3502_3; Thompson C.K., 1995, BRAIN LANG, V51, P124; Valian V, 2009, J CHILD LANG, V36, P743, DOI 10.1017/S0305000908009082; VanDam M, 2016, SEMIN SPEECH LANG, V37, P128, DOI 10.1055/s-0036-1580745; Vihman M, 2007, LINGUISTICS, V45, P683, DOI 10.1515/LING.2007.021; Wexler K, 1998, LINGUA, V106, P23, DOI 10.1016/S0024-3841(98)00029-1	48	6	6	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	AUG	2019	51	4			SI		1919	1927		10.3758/s13428-018-1174-9			9	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	IS0WT	WOS:000481874200028	30511153	Green Accepted, Bronze			2022-02-06	
J	Rajagopalan, V; Das, A; Zhang, LD; Hillary, F; Wylie, GR; Yue, GH				Rajagopalan, Venkateswaran; Das, Abhijit; Zhang, Luduan; Hillary, Frank; Wylie, Glenn R.; Yue, Guang H.			Fractal dimension brain morphometry: a novel approach to quantify white matter in traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Fractal dimension; DTI; TBI; Cognitive domain scores	DIFFUSE AXONAL INJURY; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; STRUCTURAL COMPLEXITY; COGNITIVE IMPAIRMENT; SERVICE MEMBERS; IMAGE-ANALYSIS; SEGMENTATION; COMA; IMPLEMENTATION	Traumatic brain injury (TBI) is the main cause of disability in people younger than 35 in the United States. The mechanisms of TBI are complex resulting in both focal and diffuse brain damage. Fractal dimension (FD) is a measure that can characterize morphometric complexity and variability of brain structure especially white matter (WM) structure and may provide novel insights into the injuries evident following TBI. FD-based brain morphometry may provide information on WM structural changes after TBI that is more sensitive to subtle structural changes post injury compared to conventional MRI measurements. Anatomical and diffusion tensor imaging (DTI) data were obtained using a 3T MRI scanner in subjects with moderate to severe TBI and in healthy controls (HC). Whole brain WM volume, grey matter volume, cortical thickness, cortical area, FD and DTI metrics were evaluated globally and for the left and right hemispheres separately. A neuropsychological test battery sensitive to cognitive impairment associated with traumatic brain injury was performed. TBI group showed lower structural complexity (FD) bilaterally (p<0.05). No significant difference in either grey matter volume, cortical thickness or cortical area was observed in any of the brain regions between TBI and healthy controls. No significant differences in whole brain WM volume or DTI metrics between TBI and HC groups were observed. Behavioral data analysis revealed that WM FD accounted for a significant amount of variance in executive functioning and processing speed beyond demographic and DTI variables. FD therefore, may serve as a sensitive marker of injury and may play a role in outcome prediction in TBI.	[Rajagopalan, Venkateswaran] Birla Inst Technol & Sci, Dept Elect & Elect Engn, Hyderabad Campus, Hyderabad, India; [Rajagopalan, Venkateswaran; Das, Abhijit; Wylie, Glenn R.; Yue, Guang H.] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Das, Abhijit; Wylie, Glenn R.] Kessler Fdn, Neurosci & Neuropsychol Res, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA; [Zhang, Luduan] LZ Biomed Inc, Westminster, CO 80021 USA; [Hillary, Frank] Penn State Univ, Dept Psychol, 313 Moore Bldg, University Pk, PA 16801 USA; [Yue, Guang H.] Kessler Fdn, Human Performance & Engn Res, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA		Yue, GH (corresponding author), Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA.; Yue, GH (corresponding author), Kessler Fdn, Human Performance & Engn Res, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	gyue@kesslerfoundation.org	Hillary, Frank/AAN-8622-2021; Das, Abhijit/AAQ-1729-2020		New Jersey Commission on Brain Injury Research [CBIR15MIG004]	This study was partially supported by a grant of New Jersey Commission on Brain Injury Research (CBIR15MIG004).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P113, DOI 10.1097/HTR.0000000000000379; BULLMORE E, 1994, PSYCHOL MED, V24, P771, DOI 10.1017/S0033291700027926; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Esteban FJ, 2007, NEUROIMAGE, V36, P543, DOI 10.1016/j.neuroimage.2007.03.057; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Graham D.I., 2000, HEAD INJ, P133; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mandelbrot BB., 1982, FRACTAL GEOMETRY NAT; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Mustafa N, 2012, NEUROIMAGE, V61, P694, DOI 10.1016/j.neuroimage.2012.03.088; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rajagopalan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073614; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SCOLDING, 1999, J Neurol Neurosurg Psychiatry, V66, P696, DOI 10.1136/jnnp.66.5.696; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wen W, 2004, STROKE, V35, P2813, DOI 10.1161/01.STR.0000147034.25760.3d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhang LD, 2006, J NEUROSCI METH, V150, P242, DOI 10.1016/j.jneumeth.2005.06.021; Zhang LD, 2008, BRAIN RES, V1228, P229, DOI 10.1016/j.brainres.2008.06.008; Zhang L, 2007, NEUROBIOL AGING, V28, P1543, DOI 10.1016/j.neurobiolaging.2006.06.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	6	6	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2019	13	4					914	924		10.1007/s11682-018-9892-2			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ3CU	WOS:000475782100004	29909586				2022-02-06	
J	Robbins, EM; Jaquins-Grstl, A; Fine, DF; Leong, CL; Dixon, CE; Wagner, AK; Boutelle, MG; Michael, AC				Robbins, Elaine M.; Jaquins-Grstl, Andrea; Fine, David F.; Leong, Chi Leng; Dixon, C. Edward; Wagner, Amy K.; Boutelle, Martyn G.; Michael, Adrian C.			Extended (10-Day) Real-Time Monitoring by Dexamethasone-Enhanced Microdialysis in the Injured Rat Cortex	ACS CHEMICAL NEUROSCIENCE			English	Article						Microdialysis; dexamethasone; biosensor; microfluidic; spreading depolarization; controlled cortical impact	TRAUMATIC BRAIN-INJURY; CORTICAL SPREADING DEPRESSION; DYNAMIC NEUROMETABOLIC CHANGES; ONLINE MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; PERIINFARCT DEPOLARIZATIONS; DOPAMINE RELEASE; GLUCOSE; LACTATE; ISCHEMIA	Intracerebral microdialysis has proven useful for chemical monitoring in patients following traumatic brain injury. Recent studies in animals, however, have documented that insertion of microdialysis probes into brain tissues initiates a foreign-body response. Within a few days after probe insertion, the foreign body response impedes the use of microdialysis to monitor the K+ and glucose transients associated with spreading depolarization, a potential mechanism for secondary brain injury. Herein, we show that perfusing microdialysis probes with dexamethasone, a potent anti-inflammatory glucocorticoid, suppresses the foreign body response and facilitates the monitoring of spontaneous spreading depolarizations for at least 10 days following controlled cortical injury in the rat. In addition to spreading depolarizations, results of this study suggest that a progressive, apparently permanent, decline in pericontusional interstitial glucose may be an additional sequela of brain injury. This study establishes extended dexamethasone-enhanced microdialysis in the injured rodent cortex as a new paradigm for investigating trauma-induced metabolic crisis.	[Robbins, Elaine M.; Jaquins-Grstl, Andrea; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Fine, David F.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Leong, Chi Leng; Boutelle, Martyn G.] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Sch Med, Pittsburgh, PA 15213 USA		Michael, AC (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	amichael@pitt.edu		Leong, Chi Leng/0000-0002-2654-1345	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102725, R21NS109875]; University of Pittsburgh Center for Biological ImagingUniversity of Pittsburgh [1S10RR028478-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS109875, R01NS102725] Funding Source: NIH RePORTER	This work was funded by the National Institutes of Health (R01NS102725, R21NS109875) and the University of Pittsburgh Center for Biological Imaging (1S10RR028478-01).	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Bhatia R, 2006, NEUROSURGERY, V58, P313, DOI 10.1227/01.NEU.0000208963.42378.83; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chuang YJ, 2014, J NANOMATER, V2014, DOI 10.1155/2014/968098; Corcoles E. P., 2013, BIOSENSORS INVASIVE; DiChiara G, 1996, BEHAV PHARMACOL, V7, P640; Ding M., 2011, DYNAMIC BRAIN EXPLOR; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Faul M, 2010, TRAUMATIC BRAIN INJU; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Guiou M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852556; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Howard B R, 2002, ILAR J, V43, P194; Jaquins-Gerstl A., 2017, COMPENDIUM IN VIVO M, V2, P375; Jaquins-Gerstl A, 2015, ANALYST, V140, P3696, DOI 10.1039/c4an02065k; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Jaquins-Gerstl A, 2009, J NEUROSCI METH, V183, P127, DOI 10.1016/j.jneumeth.2009.06.023; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Papadimitriou KI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00212; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; Seule M, 2015, NEUROCRIT CARE, V23, P108, DOI 10.1007/s12028-015-0111-3; Shain W, 2003, IEEE T NEUR SYS REH, V11, P186, DOI 10.1109/TNSRE.2003.814800; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2005, CRIT CARE MED, V33, P2147, DOI 10.1097/01.CCM.0000179029.95415.51; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Varner EL, 2017, ACS CHEM NEUROSCI, V8, P1779, DOI 10.1021/acschemneuro.7b00148; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r	57	6	6	0	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	AUG	2019	10	8					3521	3531		10.1021/acschemneuro.9b00145			21	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	IT0OS	WOS:000482546100025	31246409	Green Accepted			2022-02-06	
J	Suarez-Pierre, A; Crawford, TC; Zhou, X; Lui, C; Fraser, CD; Etchill, E; Sharma, K; Higgins, RS; Whitman, GJ; Kilic, A; Choi, CW				Suarez-Pierre, Alejandro; Crawford, Todd C.; Zhou, Xun; Lui, Cecillia; Fraser, Charles D., III; Etchill, Eric; Sharma, Kavita; Higgins, Robert S.; Whitman, Glenn J.; Kilic, Ahmet; Choi, Chun W.			Impact of Traumatically Brain-Injured Donors on Outcomes After Heart Transplantation	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	14th Annual Academic Surgical Congress (ASC)	FEB 05-07, 2019	Houston, TX			Heart transplantation; Traumatic brain injury; Organ allocation; Organ donation; Cardiac allograft vasculopathy; Propensity matching	DEATH; DYSFUNCTION	Background: Heart transplant recipients of traumatically brain-injured (TBI) donors have been reported to have inferior survival and increased rates of cardiac allograft vasculopathy in single-center studies. This study sought to examine the impact of TBI donors on outcomes after heart transplantation across all transplantation centers. Methods: We identified all adult heart transplants performed during 2007-2016 in the OPTN database. Recipients were dichotomized based on donor cause of death (TBI versus non-TBI), propensity-scored across 22 variables with known associations with mortality, and matched 1: 1 without replacement. The primary endpoint was all-cause mortality. Secondary endpoints were conditional survival and rates of cardiac allograft vasculopathy. Results: In total, 20,244 patients underwent heart transplantation. TBI was the primary cause of death in 53.4% of donors (10,816/20,244), and among TBI donors, blunt injury (59.6%; 6443/10,816) and gunshot wound (35%; 3781/10,816) were the most common mechanisms of injury. Propensity matching generated 6919 pairs (all absolute mean differences < 0.07). Risk-adjusted survival was similar between recipients of TBI donors and non-TBI donors at 5 y (78.1% versus 77.5%, log-rank P = 0.34). Risk-adjusted survival conditional on 1-y survival was also similar at 5 y (86.2% versus 86.1%, log-rank P = 0.74). The 5-y risk-adjusted rates of cardiac allograft vasculopathy did not differ either (30.6% versus 30.4%; log-rank P = 0.78). Conclusions: In the largest analysis of TBI donors in heart transplantation, we found similar survival and rates of cardiac allograft vasculopathy to those who received hearts from non-TBI donors out to 5 y. These findings should allay concerns over continued transplantation with this unique donor population. (C) 2019 Elsevier Inc. All rights reserved.	[Suarez-Pierre, Alejandro; Crawford, Todd C.; Zhou, Xun; Lui, Cecillia; Fraser, Charles D., III; Etchill, Eric; Higgins, Robert S.; Whitman, Glenn J.; Kilic, Ahmet; Choi, Chun W.] Johns Hopkins Univ, Sch Med, Div Cardiac Surg, Baltimore, MD USA; [Sharma, Kavita] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA		Choi, CW (corresponding author), Johns Hopkins Univ Hosp, 1800 Orleans St,Zayed Tower 7107, Baltimore, MD 21287 USA.	cchoi40@jhmi.edu	Zhou, Xun/AAK-7578-2020	Zhou, Xun/0000-0001-5179-5032; Suarez-Pierre, Alejandro/0000-0003-1821-6240; Etchill, Eric/0000-0002-5381-648X			Cohen O, 2007, TRANSPL P, V39, P2964, DOI 10.1016/j.transproceed.2007.08.102; Colvin M, 2018, AM J TRANSPLANT, V18, P291, DOI 10.1111/ajt.14561; Goel Radha, 2005, Congest Heart Fail, V11, P99; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Leppke S, 2013, TRANSPLANT REV-ORLAN, V27, P50, DOI 10.1016/j.trre.2013.01.002; McMurry TL, 2015, J THORAC CARDIOV SUR, V150, P14, DOI 10.1016/j.jtcvs.2015.03.057; Mehra MR, 2004, J AM COLL CARDIOL, V43, P806, DOI 10.1016/j.jacc.2003.08.059; NOVITZKY D, 1988, TRANSPLANTATION, V45, P964, DOI 10.1097/00007890-198805000-00025; Palac Robert T, 2003, Prog Transplant, V13, P42; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; R Core Team, 2018, STATS PACK LANG ENV; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Szabo G, 2000, Ann Transplant, V5, P45; Szabo G, 2002, TRANSPLANTATION, V73, P1846, DOI 10.1097/00007890-200206150-00027; WAHLERS T, 1991, J HEART LUNG TRANSPL, V10, P22; Yeh T, 1999, J THORAC CARDIOV SUR, V117, P365, DOI 10.1016/S0022-5223(99)70435-6	18	6	6	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2019	240						40	47		10.1016/j.jss.2019.02.049			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	HZ3IE	WOS:000468740900004	30909064				2022-02-06	
J	Tefertiller, C; Hays, K; Natale, A; O'Dell, D; Ketchum, J; Sevigny, M; Eagye, CB; Philippus, A; Harrison-Felix, C				Tefertiller, Candace; Hays, Kaitlin; Natale, Audrey; O'Dell, Denise; Ketchum, Jessica; Sevigny, Mitch; Eagye, C. B.; Philippus, Angela; Harrison-Felix, Cynthia			Results From a Randomized Controlled Trial to Address Balance Deficits After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Balance; Evidence based medicine; Rehabilitation; Traumati brain injuries; Virtual reality	VIRTUAL-REALITY; PARKINSONS-DISEASE; EXERCISE PROGRAMS; REHABILITATION; TASK; STROKE; INDIVIDUALS; PERFORMANCE; METAANALYSIS; RELIABILITY	Objective: To evaluate the efficacy of an in-home 12-week physical therapy (PT) intervention that utilized a virtual reality (VR) gaming system to improve balance in individuals with traumatic brain injury (TBI). Setting: Home-based exercise program (HEP). Participants: Individuals (N=63; traditional HEP n=32; VR n=31) at least 1 year post-TBI, ambulating independently within the home, not currently receiving PT services. Main Outcome Measures: Primary: Community Balance and Mobility Scale (CB & M); Secondary: Balance Evaluation Systems Test (BESTest), Activities-Specific Balance Confidence Scale (ABC), Participation Assessment with Recombined Tools-Objective (PART-O). Results: No significant between-group differences were observed in the CB&M over the study duration (P = .9983) for individuals who received VR compared to those who received a HEP to address balance deficits after chronic TBI nor in any of the secondary outcomes: BESTest (P = .8822); ABC (P = .4343) and PART-O (P= .8822). However, both groups demonstrated significant improvements in CB&M and BESTest from baseline to 6, 12, and at 12 weeks follow-up (all P's <.001). Regardless of treatment group, 52% of participants met or exceeded the minimal detectable change of 8 points on the CB&M at 24 weeks and 38% met or exceeded the minimal detectable change of 7.81 points on the BESTest. Conclusion: This study did not find that VR training was more beneficial than a traditional HEP for improving balance. However, individuals with chronic TBI in both treatment groups demonstrated improvements in balance in response to these interventions which were completed independently in the home environment. (C) 2019 by the American Congress of Rehabilitation Medicine	[Tefertiller, Candace; Hays, Kaitlin; Natale, Audrey] Craig Hosp, Dept Phys Therapy, Englewood, CO USA; [O'Dell, Denise] Regis Univ, Dept Phys Therapy, Denver, CO USA; [Ketchum, Jessica; Sevigny, Mitch; Eagye, C. B.; Philippus, Angela; Harrison-Felix, Cynthia] Craig Hosp, Dept Res, Englewood, CO USA		Tefertiller, C (corresponding author), 3425 S Clarkson St, Englewood, CO 80113 USA.	Ctefertiller@craighospital.org	Ketchum, Jessica/AAE-8200-2020	Philippus, Angela/0000-0001-7427-8660	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0034]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant no. 90DP0034). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Cameirao MS, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-48; Chinsongkram B, 2014, PHYS THER, V94, P1632, DOI 10.2522/ptj.20130558; Cikajlo I, 2012, DISABIL REHABIL, V34, P13, DOI 10.3109/09638288.2011.583308; Cuthbert JP, 2014, BRAIN INJURY, V28, P181, DOI 10.3109/02699052.2013.860475; Dodd KJ, 2003, DEV MED CHILD NEUROL, V45, P652, DOI 10.1017/S0012162203001221; Esculier JF, 2012, J REHABIL MED, V44, P144, DOI 10.2340/16501977-0922; Flynn Sheryl, 2007, J Neurol Phys Ther, V31, P180, DOI 10.1097/NPT.0b013e31815d00d5; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Hillier SL, 1997, BRAIN INJURY, V11, P661; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kim JH, 2009, AM J PHYS MED REHAB, V88, P693, DOI 10.1097/PHM.0b013e3181b33350; Kim N, 2015, J PHYS THER SCI, V27, P655, DOI 10.1589/jpts.27.655; Kizony R, 2005, J REHABIL RES DEV, V42, P595, DOI 10.1682/JRRD.2005.01.0023; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Lee HY, 2015, J PHYS THER SCI, V27, P1883, DOI 10.1589/jpts.27.1883; Liao HF, 2007, ARCH PHYS MED REHAB, V88, P25, DOI 10.1016/j.apmr.2006.10.006; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mirelman A, 2010, GAIT POSTURE, V31, P433, DOI 10.1016/j.gaitpost.2010.01.016; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Padgett PK, 2012, PHYS THER, V92, P1197, DOI 10.2522/ptj.20120056; Peirone E, 2014, CLIN REHABIL, V28, P329, DOI 10.1177/0269215513501527; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rizzo AA, 1997, ST HEAL T, V44, P123; Roy A, 2011, J REHABIL RES DEV, V48, P417, DOI 10.1682/JRRD.2010.04.0078; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Simek EM, 2012, PREV MED, V55, P262, DOI 10.1016/j.ypmed.2012.07.007; Straudi S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0871-9; Suarez H, 2011, BRAZ J OTORHINOLAR, V77, P651, DOI 10.1590/S1808-86942011000500019; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; van den Berg M, 2016, J PHYSIOTHER, V62, P20, DOI 10.1016/j.jphys.2015.11.005; Walker ML, 2010, ARCH PHYS MED REHAB, V91, P115, DOI 10.1016/j.apmr.2009.09.009; Wang CY, 2011, ARCH PHYS MED REHAB, V92, P1238, DOI 10.1016/j.apmr.2011.03.014; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Yang SW, 2011, AM J PHYS MED REHAB, V90, P969, DOI 10.1097/PHM.0b013e3182389fae; Yang YR, 2008, GAIT POSTURE, V28, P201, DOI 10.1016/j.gaitpost.2007.11.007; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	48	6	6	3	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2019	100	8					1409	1416		10.1016/j.apmr.2019.03.015			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IR6QG	WOS:000481563200003	31009598	Green Accepted			2022-02-06	
J	Theis, V; Theiss, C				Theis, Verena; Theiss, Carsten			Progesterone Effects in the Nervous System	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						progesterone; progesterone receptor; miRNA; nervous system; neuroprotection	TRAUMATIC BRAIN-INJURY; NEUROACTIVE STEROID-LEVELS; DEVELOPING PURKINJE-CELL; DIFFUSE AXONAL INJURY; BINDING-PROTEIN; NEUROSTEROID BIOSYNTHESIS; INTRANASAL DELIVERY; RECEPTOR ISOFORMS; DOWN-REGULATION; CLINICAL-TRIAL	The sex hormone progesterone is mainly known as a key factor in establishing and maintaining pregnancy. In addition, progesterone has been shown to induce morphological changes in the central and peripheral nervous system by increasing dendrito-, spino-, and synaptogenesis in Purkinje cells (Wessel et al.: Cell Mol Life Sci (2014a) 1723-1740) and increasing axonal outgrowth in dorsal root ganglia (Olbrich et al.: Endocrinology (2013) 3784-3795). These effects mediated mainly by the classical progesterone receptors (PRs) A and B seem to be limited to young neurons. It may be assumed that microRNAs (miRNAs), which are potent regulators of nervous system maturation and degeneration, are also involved in the regulation of progesterone-mediated neuronal plasticity by altering the expression patterns of the corresponding PR A/B receptors (Theis and Theiss: Neural Regen Res (2015) 547-549, Pieczora et al.: Cerebellum (2017) 376-387). This review critically discusses current data on the neuroprotective effect of progesterone and its corresponding receptors in the nervous system, with possible regulatory processes by miRNAs. Preclinical studies on stroke and traumatic brain injury revealed neuroprotective and neuroregenerative effects of progesterone in the treatment of severe neurological diseases in animal models, but have so far failed in humans. In this context, the identification of specific miRNAs that regulate the expression of progesterone and PR could help to exploit the neuroprotective potential of progesterone for the treatment of various neurological disorders. Anat Rec, 302:1276-1286, 2019. (c) 2019 Wiley Periodicals, Inc.	[Theis, Verena; Theiss, Carsten] Ruhr Univ Bochum, Dept Cytol, Inst Anat, Bochum, Germany		Theiss, C (corresponding author), Ruhr Univ Bochum, Fac Med, Inst Anat, Dept Cytol, D-44780 Bochum, Germany.	carsten.theiss@rub.de		Theiss, Carsten/0000-0001-7983-0143			Allitt BJ, 2017, CELL TRANSPLANT, V26, P1202, DOI 10.1177/0963689717714326; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Atif F, 2017, NEUROSCIENCE, V350, P1, DOI 10.1016/j.neuroscience.2017.03.007; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Barrow Jack W, 2018, Surg Neurol Int, V9, P150, DOI 10.4103/sni.sni_88_18; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Caracciolo D, 2018, EXPERT REV HEMATOL, V11, P793, DOI 10.1080/17474086.2018.1517041; Castelnovo LF, 2019, STEROIDS, V142, P6, DOI 10.1016/j.steroids.2017.09.009; Catenaccio E, 2016, BRAIN STRUCT FUNCT, V221, P3845, DOI 10.1007/s00429-016-1197-x; Cermenati G, 2010, J NEUROSCI, V30, P11896, DOI 10.1523/JNEUROSCI.1898-10.2010; Rubio AEC, 2018, J ENDOCRINOL, V237, pR65, DOI 10.1530/JOE-18-0129; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Coronel MF, 2017, PEPTIDES, V88, P189, DOI 10.1016/j.peptides.2017.01.001; Croset M, 2018, CANCER RES, V78, P5259, DOI 10.1158/0008-5472.CAN-17-3058; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; De Nicola AF, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12502; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Derkow K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200602; Dong SY, 2018, EXP NEUROL, V306, P190, DOI 10.1016/j.expneurol.2018.05.013; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Fabris V, 2017, J PATHOL CLIN RES, V3, P227, DOI 10.1002/cjp2.83; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Coronel MF, 2011, PAIN MED, V12, P1249, DOI 10.1111/j.1526-4637.2011.01178.x; Frechou M, 2015, NEUROPHARMACOLOGY, V97, P394, DOI 10.1016/j.neuropharm.2015.06.002; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Ghasabi M., 2018, J CELLULAR PHYSL, V234, P2152; Giatti S, 2015, STEROIDS, V103, P23, DOI 10.1016/j.steroids.2015.03.014; Gilam A, 2017, ONCOTARGET, V8, P25963, DOI 10.18632/oncotarget.15657; Giretti MS, 2008, STEROIDS, V73, P895, DOI 10.1016/j.steroids.2008.01.011; Godbole M, 2017, CANCER BIOL THER, V18, P801, DOI 10.1080/15384047.2017.1373216; Guennoun R, 2019, NEUROPHARMACOLOGY, V145, P283, DOI 10.1016/j.neuropharm.2018.06.006; Herrfurth L, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00002; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Huh JW, 2019, NEUROPHARMACOLOGY, V145, P153, DOI 10.1016/j.neuropharm.2018.06.025; Inquimbert P, 2018, CELL REP, V23, P2678, DOI 10.1016/j.celrep.2018.04.107; Jacobsen BM, 2012, MOL CELL ENDOCRINOL, V357, P18, DOI 10.1016/j.mce.2011.09.016; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Jie F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00562; Jimenez PT, 2016, MOL ENDOCRINOL, V30, P977, DOI 10.1210/me.2016-1050; Kabe Y, 2018, J CLIN BIOCHEM NUTR, V63, P12, DOI 10.3164/jcbn.17-132; Kaneko T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30119-z; Kasubuchi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05423-9; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Krauss Sybille, 2019, Microrna, V8, P76, DOI 10.2174/2211536607666180821162403; Kurozumi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201846; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2010, NEUROIMMUNOMODULAT, V17, P146, DOI 10.1159/000258709; Li XH, 2019, NEUROCHEM RES, V44, P531, DOI 10.1007/s11064-018-2614-8; Li Y, 2017, CNS NEUROSCI THER, V23, P779, DOI 10.1111/cns.12723; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Liu C, 2017, EXP BRAIN RES, V235, P3375, DOI 10.1007/s00221-017-5056-7; Locci A, 2017, BRIT J PHARMACOL, V174, P3226, DOI 10.1111/bph.13843; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Ma JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub4; Magnaghi V, 2001, BRAIN RES REV, V37, P360, DOI 10.1016/S0165-0173(01)00140-0; McKinnon B, 2018, TRENDS ENDOCRIN MET, V29, P535, DOI 10.1016/j.tem.2018.05.006; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi RC, 1999, J NEUROBIOL, V40, P471, DOI 10.1002/(SICI)1097-4695(19990915)40:4<471::AID-NEU5>3.3.CO;2-G; Melcangi RC, 2000, PROG NEUROBIOL, V60, P291, DOI 10.1016/S0301-0082(99)00028-3; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Melfi S, 2017, SRC PHOSPHO FAK KINA; Meyfroidt G, 2016, MINERVA ANESTESIOL, V82, P486; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Olbrich L, 2013, ENDOCRINOLOGY, V154, P3784, DOI 10.1210/en.2013-1175; Palliser HK, 2015, J DEV ORIG HLTH DIS, V6, P350, DOI 10.1017/S2040174415001075; Panda H, 2012, ENDOMETRIAL MIR 181A; Panda H, 2012, J CLIN ENDOCR METAB, V97, pE1316, DOI 10.1210/jc.2012-1018; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Pei TJ, 2018, ENDOCRINOLOGY, V159, P2554, DOI 10.1210/en.2018-00374; Pieczora L, 2017, CEREBELLUM, V16, P376, DOI 10.1007/s12311-016-0814-9; Pineles SL, 2018, PSYCHONEUROENDOCRINO, V93, P133, DOI 10.1016/j.psyneuen.2018.04.024; Qu WL, 2019, CLIN CHIM ACTA, V489, P225, DOI 10.1016/j.cca.2018.08.013; Vazquez-Martinez ER, 2014, MOL CELL ENDOCRINOL, V392, P115, DOI 10.1016/j.mce.2014.05.011; Robertson CL, 2015, PEDIATR CRIT CARE ME, V16, P236, DOI 10.1097/PCC.0000000000000323; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; Sakamoto H, 2008, CEREBELLUM, V7, P18, DOI 10.1007/s12311-008-0007-2; Sarabia-Estrada R, 2015, J NEUROSURG, V123, P270, DOI 10.3171/2014.12.JNS132519; Schlau M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020384; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Sharma C, 2018, J BIOMOL STRUCT DYN, V36, P139, DOI 10.1080/07391102.2016.1269687; Sinha S, 2017, NEUROL INDIA, V65, P1304, DOI 10.4103/0028-3886.217973; Sitruk-Ware R, 2018, CLIMACTERIC, V21, P315, DOI 10.1080/13697137.2018.1463982; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soltani Z, 2017, BRAIN INJURY, V31, P16, DOI 10.1080/02699052.2016.1213421; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sugawara T, 2017, P NATL ACAD SCI USA, V114, pE5256, DOI 10.1073/pnas.1617270114; Sun T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080104; Tameh AA, 2018, J STROKE CEREBROVASC, V27, P3066, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.041; Theis V, 2018, CURR PROTEIN PEPT SC, V19, P589, DOI 10.2174/1389203719666180104113937; Theis V, 2015, NEURAL REGEN RES, V10, P547, DOI 10.4103/1673-5374.155417; Tjaden J, 2018, CELL MOL NEUROBIOL, V38, P1399, DOI 10.1007/s10571-018-0606-5; Toms D, 2015, MOL CELL ENDOCRINOL, V399, P95, DOI 10.1016/j.mce.2014.07.022; Trotter A, 2012, J CLIN ENDOCR METAB, V97, P1041, DOI 10.1210/jc.2011-2612; Tsutsui K, 2008, MOL NEUROBIOL, V37, P116, DOI 10.1007/s12035-008-8024-1; Tsutsui Kazuyoshi, 2011, Front Endocrinol (Lausanne), V2, P61, DOI 10.3389/fendo.2011.00061; Tsutsui K, 2012, CEREBELLUM, V11, P414, DOI 10.1007/s12311-011-0341-7; Tuomarila M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109508; Ukena K, 1999, ENDOCRINOLOGY, V140, P805, DOI 10.1210/en.140.2.805; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; Van Asten K, 2019, ONCOLOGIST, V24, P165, DOI 10.1634/theoncologist.2018-0176; Wali B, 2017, J NEUROTRAUM, V34, P2183, DOI 10.1089/neu.2016.4845; Wang L, 2018, SHOCK, V50, P308, DOI 10.1097/SHK.0000000000001018; Wang Y, 2018, CELL PHYSIOL BIOCHEM, V48, P919, DOI 10.1159/000491959; Wang Z, 2016, MOL NEUROBIOL, V53, P7070, DOI 10.1007/s12035-015-9614-3; Wessel L, 2014, J HISTOCHEM CYTOCHEM, V62, P835, DOI 10.1369/0022155414550691; Wessel L, 2014, CELL MOL LIFE SCI, V71, P1723, DOI 10.1007/s00018-013-1448-4; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Wnuk A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112394; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu QJ, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0357-8; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Xu MQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195562; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Yousuf S, 2017, HORM BEHAV, V96, P21, DOI 10.1016/j.yhbeh.2017.08.004; Yu P, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12362; Yuan C, 2017, IUBMB LIFE, V69, P877, DOI 10.1002/iub.1686; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhu HG, 2017, BIOMED PHARMACOTHER, V92, P879, DOI 10.1016/j.biopha.2017.05.143; Zhu XY, 2019, J STEROID BIOCHEM, V185, P90, DOI 10.1016/j.jsbmb.2018.07.014	137	6	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	AUG	2019	302	8			SI		1276	1286		10.1002/ar.24121			11	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	IJ1NH	WOS:000475664800005	30951258	Bronze			2022-02-06	
J	Tomov, N; Surchev, L; Wiedenmann, C; Dobrossy, M; Nikkhah, G				Tomov, Nikola; Surchev, Lachezar; Wiedenmann, Clemens; Doebroessy, Mate; Nikkhah, Guido			Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts	EXPERIMENTAL NEUROLOGY			English	Article						Roscovitine; Parkinson's disease; Transplantation; CDK5; Microglia; Astroglia	CYCLIN-DEPENDENT KINASE-5; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PARKINSONS-DISEASE; CELL-CYCLE; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; SCAR FORMATION; SERTOLI-CELLS	Inhibitors of cell cycle proteins are known to reduce glial activation and to be neuroprotective in a number of settings. In the context of intracerebral grafting, glial activation is documented to correlate with graft rejection. However, the effects of modification of glial reactivity following grafting in the CNS are poorly understood. Moreover, it is not completely clear if the glial cells themselves trigger the rejection process, or are they secondarily activated. The present study investigated the effect of microglial inhibition by the cyclin-dependant kinase 5 (CDK5) inhibitor roscovitine following intracerebral transplantation in the rodent model of Parkinson's disease. Single cell suspension of rat 814 ventral mesencephalic tissue was transplanted to the dopamine-depleted striatum of unilaterally 6-hydroxydopamine (6-OHDA) lesioned male Sprague-Dawley rats. Experimental animals received injections of roscovitine (20 mg/kg) or a vehicle solution three times following the procedure. Immunohistochemistry was carried out on Day 7 and Day 28 to quantitatively describe the glial reaction adjacent to grafts. The data confirm that systemic roscovitine treatment significantly reduced microglial recruitment adjacent to the grafts on Day 28, without exhibiting significant effects on astroglia. However, this was not found to correlate with elevated numbers of neurons in the grafts. Moreover, microglial reaction surrounding grafts was less pronounced compared to control animals, subjected to the mechanical influence only, even without roscovitine treatment. Our results are the first to show the effect of cell cycle inhibition in the context of neuronal transplantation. The findings suggest that microglial activation around intracerebral grafts can be modified pharmacologically. However, the results do not confirm direct neuroprotective effects of cell cycle inhibition after intracerebral transplantation. Reducing microglial recruitment around grafts could be beneficial by reducing inflammation related degenerative processes. Sparing astrocytes in the same time provides transplanted cells with essential trophies and support. We consider microglial inhibition to be a possible approach for reducing later graft-related complications.	[Tomov, Nikola] Heidelberg Univ, Med Fac Mannheim, Dept Anat & Dev Biol, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany; [Tomov, Nikola; Surchev, Lachezar] Trakia Univ, Fac Med, Dept Anat, Armeyska 11, Stara Zagora 6000, Bulgaria; [Surchev, Lachezar] Univ Med Ctr Gottingen, Inst Anat & Embryol, Kreuzbergring 36, D-37075 Gottingen, Germany; [Wiedenmann, Clemens; Doebroessy, Mate] Univ Med Ctr Freiburg, Neuroctr, Lab Stereotaxy & Intervent Neurosci, Breisacher Str 64, D-79106 Freiburg, Germany; [Wiedenmann, Clemens] Ortenau Klinikum Offenburg Kehl, Clin Emergency Hand & Restorat Surg, Ebertpl 12, D-77654 Offenburg, Germany; [Nikkhah, Guido] Klinikum Stuttgart, Neurosurg Clin, Kriegsbergstr 60, D-70174 Stuttgart, Germany		Tomov, N (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anat & Dev Biol, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany.; Tomov, N (corresponding author), Trakia Univ, Fac Med, Dept Anat, Armeyska 11, Stara Zagora 6000, Bulgaria.	tomovmd@gmail.com	Tomov, Nikola/AAD-9327-2020; Dobrossy, Mate/AAL-7897-2021	Tomov, Nikola/0000-0002-7072-3832; Wiedenmann, Clemens/0000-0002-3301-2687	Department of Stereotactic Neurosurgery at the University Medical Centre Freiburg	This research was internally funded by the Department of Stereotactic Neurosurgery at the University Medical Centre Freiburg. It did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AKALAN N, 1994, SURG NEUROL, V42, P517, DOI 10.1016/0090-3019(94)90082-5; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Basu A, 2005, BIOCHEM BIOPH RES CO, V334, P1068, DOI 10.1016/j.bbrc.2005.06.199; Borlongan CV, 1996, NEUROL RES, V18, P297; Borlongan CV, 1996, SURG NEUROL, V46, P384, DOI 10.1016/S0090-3019(96)00190-5; BORLONGAN CV, 1999, LANCET S1, V353, pS129, DOI DOI 10.1016/s0140-6736(99)90229-5; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; DUSART I, 1989, DEV BRAIN RES, V48, P215, DOI 10.1016/0165-3806(89)90077-1; Furlanetti LL, 2015, NEUROREHAB NEURAL RE, V29, P1001, DOI 10.1177/1545968315581419; Garcia J, 2011, NEUROBIOL DIS, V43, P576, DOI 10.1016/j.nbd.2011.05.004; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Henchcliffe C, 1997, NEUROSCI LETT, V230, P41, DOI 10.1016/S0304-3940(97)00472-2; Henning J, 2008, NEUROSCI RES, V62, P246, DOI 10.1016/j.neures.2008.09.001; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hyun HW, 2017, NEUROSCI RES, V119, P24, DOI 10.1016/j.neures.2017.01.006; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Kim JH, 2012, NEUROBIOL AGING, V33, P2145, DOI 10.1016/j.neurobiolaging.2011.08.011; Kordower JH, 1997, CELL TRANSPLANT, V6, P213, DOI 10.1016/S0963-6897(97)00019-5; Lee JH, 2007, J CELL PHYSIOL, V210, P784, DOI 10.1002/jcp.20899; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Marchionini DM, 2004, CELL TRANSPLANT, V13, P273, DOI 10.3727/000000004783983972; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Moore AH, 2010, PHARMACEUTICALS, V3, P1812, DOI 10.3390/ph3061812; Neystat M, 2001, J NEUROCHEM, V77, P1611, DOI 10.1046/j.1471-4159.2001.00376.x; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; NIKKHAH G, 1993, NEUROSCIENCE, V56, P33, DOI 10.1016/0306-4522(93)90559-X; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Paxinos G, 1997, THE RAT BRAIN IN STE; Price DA, 2009, MOL PHARMACOL, V76, P812, DOI 10.1124/mol.109.056978; Pruszak Jan, 2009, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d05s11; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rousselet E, 2018, J CEREBR BLOOD F MET, V38, P1070, DOI 10.1177/0271678X17712163; Saltykow S, 1905, ARCH PSYCHIAT NERVEN, V40, P329, DOI 10.1007/BF02071085; Sanberg PR, 1996, NAT BIOTECHNOL, V14, P1692, DOI 10.1038/nbt1296-1692; Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129; Shinoda M, 1996, EXP NEUROL, V141, P173, DOI 10.1006/exnr.1996.0151; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tomov N, 2018, BALK MED J, V35, P141, DOI 10.4274/balkanmedj.2016.1911; TSAI LH, 1993, DEVELOPMENT, V119, P1029; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vita M, 2005, EUR J PHARM SCI, V25, P91, DOI 10.1016/j.ejps.2005.02.001; Wang T, 2014, J NEUROTRAUM, V31, P370, DOI 10.1089/neu.2013.2917; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Zawada WM, 2001, BRAIN RES, V891, P185; Zhang P, 2016, MOVEMENT DISORD, V31, P366, DOI 10.1002/mds.26488; Zheng YL, 2007, MOL BIOL CELL, V18, P404, DOI 10.1091/mbc.E06-09-0851	60	6	6	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2019	318						135	144		10.1016/j.expneurol.2019.04.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IG1MA	WOS:000473554500013	31028828				2022-02-06	
J	Yadollahi, M				Yadollahi, Mahnaz			A study of mortality risk factors among trauma referrals to trauma center, Shiraz, Iran, 2017	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Risk factor; Fetal mortality; Wounds and injuries	BRAIN-INJURY; PREDICTORS; EPIDEMIOLOGY; MORBIDITY; AUSTRALIA; SURVIVAL; OUTCOMES; BURDEN; SYSTEM; DEATH	Purpose: Trauma is well known as one of the main causes of death and disability throughout the world. Identifying the risk factors for mortality in trauma patients can significantly improve the quality of care and patient outcomes, as well as reducing mortality rates. Methods: In this retrospective cohort study, systematic randomization was used to select 849 patients referred to the main trauma center of south of Iran during a period of six months (February 2017-July 2017); the patients' case files were evaluated in terms of demographic information, pre- and post-accident conditions, clinical conditions at the time of admission and finally, accident outcomes. A logistic regression model was used to analyze the role of factors affecting mortality among subjects. Results: Among subjects, 60.4% were in the age-group of 15-39 years. There was a 10.4% mortality rate among patients and motor-vehicle accidents were the most common mechanism of injury (66.7%). Aging led to increased risk of fatality in this study. For each unit increase in Glasgow coma scale (GCS), risk of death decreased by about 40% (odds ratio (OR) = 0.63, 95% confidence interval (CI): 0.59-0.67). For each unit increase in injury severe score (ISS), risk of death increased by 10% (OR = 1.11%, 95% CI: 1.08-1.14) and for each unit increase in trauma revised injury severity score (TRISS), there was 18% decrease in the risk of fatality (OR = 0.82, 95% CI: 0.71-0.88). Conclusion: The most common cause of trauma and the most common cause of death from trauma was traffic accidents. It was also found that an increase in the ISS index increases the risk of death in trauma patients, but the increase in GCS, revised trauma score (RTS) and TRISS indices reduces the risk of death in trauma patients. The TRISS indicator is better predictor of traumatic death than other indicators. (C) 2019 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association.	[Yadollahi, Mahnaz] Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Emtiaz Trauma Hosp, Shiraz, Iran		Yadollahi, M (corresponding author), Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Emtiaz Trauma Hosp, Shiraz, Iran.	yadollahim@sums.ac.ir			Shiraz University of Medical Sciences in Shiraz, Iran [98-01-38-19738]	This research has been supported with grant number of 98-01-38-19738 by Shiraz University of Medical Sciences in Shiraz, Iran.	AlEassa EM, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-57; Alimohammadi H, 2014, EMERGENCY, V2, P30; Amani F, 2009, J ARDABIL U MED SCI, V9, P13; Araqi E, 2007, HORIZON MED SCI, V13, P34; Ay N, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0014-9; Azizi A, 2003, J KERMAN U MED SCI, P7; Bhalla K, 2009, INJURY PREV, V15, P150, DOI 10.1136/ip.2008.020826; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; Curtis K, 2012, AUSTRALAS EMERG NURS, V15, P45, DOI 10.1016/j.aenj.2011.12.001; Farzandipour M, 2007, J KERMAN U MED SCI, P11; Fazel MR, 2012, ARCH TRAUMA RES, V1, P63, DOI 10.5812/atr.6770; Goel A, 2004, NATL MED J INDIA, V17, P186; Golshani K, 2014, IRAN J EMERG MED, V1, P22; Haghparast-Bidgoli H, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-20; Hasler R, 2012, ACAD EMERG MED, V19, P712; Karbakhsh M, 2009, East Mediterr Health J, V15, P57; Khatami SM, 2003, J MIL MED, V5, P13; Krug, 2002, INJURY LEADING CAUSE; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lakeh M Moradi, 2002, RJMS, V9, P129; Lichtveld RA, 2007, EUR J TRAUMA EMERG S, V33, P46, DOI 10.1007/s00068-007-6097-6; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Magruder KM, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.29715; Mina M, 2014, J CRITICAL CARE NURS, V7, P41; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Mohammad A, 2014, WORLD J SURG, V38, P322, DOI 10.1007/s00268-013-2294-0; Mohseni M, 2015, SURVEYING CONDITION; Murlidhar V, 2004, INJURY, V35, P386, DOI 10.1016/S0020-1383(03)00214-6; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Paydar S, 2014, EMERGENCY, V2, P125; Peden, 2004, GUIDELINES ESSENTIAL; Rao D, 2014, EMERGENCY, V2, P12; Rasouli MR, 2011, PUBLIC HEALTH, V125, P727, DOI 10.1016/j.puhe.2011.07.006; Rogers A, 2013, EUR J TRAUMA EMERG S, V39, P599, DOI 10.1007/s00068-013-0289-z; Sanaei-Zadeh H, 2002, J Clin Forensic Med, V9, P74, DOI 10.1054/jcfm.2002.0547; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schluter PJ, 2011, INJURY, V42, P90, DOI 10.1016/j.injury.2010.08.040; Sim J, 2015, ANN SURG TREAT RES, V89, P215, DOI 10.4174/astr.2015.89.4.215; Solagberu B A, 2003, West Afr J Med, V22, P177; Thanapaisal Chaiyut, 2012, J Med Assoc Thai, V95 Suppl 11, pS25; Ulvik A, 2007, ACTA ANAESTH SCAND, V51, P171, DOI 10.1111/j.1399-6576.2006.01207.x; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wong ZH, 2009, ANN ACAD MED SINGAP, V38, P594; Worley H, 2006, ROAD TRAFFIC ACCIDEN; Yadollahi M, 2015, RAZAVI INT J MED, V3; Yadollahi M, 2017, IRAN RED CRESCENT ME, V19, DOI 10.5812/ircmj.33559; Yadollahi M, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.26028; Yousefzadeh S, 2007, J FACULTY ENG TECHNO, P11; Zafar H, 2002, EMERG MED J, V19, P391, DOI 10.1136/emj.19.5.391; Zargar M, 2011, CHIN J TRAUMATOL, V14, P131, DOI 10.3760/cma.j.issn.1008-1275.2011.03.001	53	6	6	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2019	22	4					212	218		10.1016/j.cjtee.2019.01.012			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	IM1PY	WOS:000477764500005	31239216	Green Published, gold			2022-02-06	
J	Champagne, AA; Coverdale, NS; Germuska, M; Cook, DJ				Champagne, Allen A.; Coverdale, Nicole S.; Germuska, Michael; Cook, Douglas J.			Multi-parametric analysis reveals metabolic and vascular effects driving differences in BOLD-based cerebrovascular reactivity associated with a history of sport concussion	BRAIN INJURY			English	Article						Cerebrovascular reactivity; calibrated MRI; sport-related concussion; cerebral blood flow; neuroimaging	CEREBRAL-BLOOD-FLOW; HEAD IMPACT EXPOSURES; HIGH-SCHOOL; FUNCTIONAL CONNECTIVITY; RECURRENT CONCUSSION; CO2 REACTIVITY; WORKING-MEMORY; BRAIN-INJURY; FMRI; MRI	Objective: Identify alterations in cerebrovascular reactivity (CVR) based on the history of sport-related concussion (SRC). Further explore possible mechanisms underlying differences in vascular physiology using hemodynamic parameters modeled using calibrated magnetic resonance imaging (MRI). Method: End-tidal targeting and dual-echo MRI were combined to probe hypercapnic and hyperoxic challenges in athletes with (n = 32) and without (n = 31) a history of SRC. Concurrent blood oxygenation level dependent (BOLD) and arterial spin labeling (ASL) data were used to compute BOLD-CVR, ASL-CVR, and other physiological parameters including resting oxygen extraction fraction (OEF0) and cerebral blood volume (CBV0). Multiple linear and logistic regressions were then used to identify dominant parameters driving group-differences in BOLD-CVR. Results: Robust evidence for elevated BOLD-CVR were found in athletes with SRC history spreading over parts of the cortical hemispheres. Follow-up analyses showed co-localized differences in ASL-CVR (representing modulation of cerebral blood flow) and hemodynamic factors representing static vascular (i.e., CBV0) and metabolic (i.e., OEF0) effects suggesting that group-based differences in BOLD-CVR may be driven by a mixed effect from factors with vascular and metabolic origins. Conclusion: These results emphasize that while BOLD-CVR offers promises as a surrogate non-specific biomarker for cerebrovascular health following SRC, multiple hemodynamic parameters can affect its relative measurements.	[Champagne, Allen A.; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Germuska, Michael] Cardiff Univ, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	dj.cook@queensu.ca		Germuska, Michael/0000-0003-0580-4350	Southeastern Ontario Academic Medical Organization (SEAMO); Southeastern Ontario Academic Medical Organization [6021315]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/K020404/1] Funding Source: UKRI	This work was supported by the Southeastern Ontario Academic Medical Organization (SEAMO); Southeastern Ontario Academic Medical Organization [6021315].	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andersson JLR, 2007, PRACT, P22; [Anonymous], 2013, Br J Sports Med, V47, P259; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blockley NP, 2013, NEUROIMAGE, V72, P33, DOI 10.1016/j.neuroimage.2013.01.039; Borich M, 2014, J NEUROTRAUM, V271, P1; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Bulte D, 2007, J MAGN RESON IMAGING, V26, P894, DOI 10.1002/jmri.21096; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Cantu RC, 2011, YB SPORT MED, V2011, P20, DOI [10.1016/j.yspm.2011.01.008, DOI 10.1016/J.YSPM.2011.01.008]; Champagne AA, 2017, NEUROIMAGE, V11, P44; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cox R.W., 2016, BIORXIV; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; De Vis JB, 2015, J CEREBR BLOOD F MET, V35, P1015, DOI 10.1038/jcbfm.2015.14; Donahue MJ, 2016, J CEREBR BLOOD F MET, V36, P1767, DOI 10.1177/0271678X15608643; Duffin J, 2015, NEUROIMAGE, V114, P207, DOI 10.1016/j.neuroimage.2015.04.029; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Fierstra J, 2010, J NEUROL NEUROSUR PS, V81, P290, DOI 10.1136/jnnp.2009.188078; Fisher JA, 2018, STROKE, V49, P2011, DOI 10.1161/STROKEAHA.118.021012; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Germuska M, 2016, NEUROIMAGE, V139, P313, DOI 10.1016/j.neuroimage.2016.06.004; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Hammeke TA, 2013, J INT NEUROPSYCH SOC, P1; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Lajoie I, 2017, NEUROIMAGE-CLIN, V15, P348, DOI 10.1016/j.nicl.2017.05.009; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Liu PY, 2013, HUM BRAIN MAPP, V34, P2078, DOI 10.1002/hbm.22053; Liu P, 2018, 2018 4TH INTERNATIONAL CONFERENCE ON EDUCATION, MANAGEMENT AND INFORMATION TECHNOLOGY (ICEMIT 2018), P1; Ma Y., 2014, P 22 SCI M INT SOC M, P3099; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Mutch W, 2016, J NEUROSURG, V125, P525; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Para AE, 2017, J MAGN RESON IMAGING, V46, P1448, DOI 10.1002/jmri.25639; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Slessarev M, 2007, J PHYSIOL-LONDON, V581, P1207, DOI 10.1113/jphysiol.2007.129395; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; van Niftrik CHB, 2018, MAGN RESON IMAGING, V49, P123, DOI 10.1016/j.mri.2018.02.002; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang YQ, 2019, B ENG GEOL ENVIRON, V78, P2851, DOI 10.1007/s10064-018-1278-6; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Wojtowicz M, 2016, J NEUROTRAUMA, V34; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Wu WC, 2007, IEEE T MED IMAGING, V26, P1319, DOI 10.1109/TMI.2007.898554; Zhang XF, 2014, MULTIDIM SYST SIGN P, V25, P67, DOI 10.1007/s11045-012-0186-3; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	94	6	6	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1479	1489		10.1080/02699052.2019.1644375		JUL 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000478418200001	31354054	Green Accepted			2022-02-06	
J	Bender, H; Noyes, N; Annis, JL; Hitpas, A; Mollnow, L; Croak, K; Kane, S; Wagner, K; Dow, S; Zabel, M				Bender, Heather; Noyes, Noelle; Annis, Jessica L.; Hitpas, Amanda; Mollnow, Luke; Croak, Kendra; Kane, Sarah; Wagner, Kaitlyn; Dow, Steven; Zabel, Mark			PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; EARLY SOCIAL ENRICHMENT; PROTEIN ACCUMULATION; ANTITUMOR-ACTIVITY; INCUBATION PERIOD; SULFATED GLYCANS; RNA INTERFERENCE; COPPER-BINDING; AMPHOTERICIN-B; REPEAT REGION	Prion diseases are members of neurodegenerative protein misfolding diseases (NPMDs) that include Alzheimer's, Parkinson's and Huntington diseases, amyotrophic lateral sclerosis, tauopathies, traumatic brain injuries, and chronic traumatic encephalopathies. No known therapeutics extend survival or improve quality of life of humans afflicted with prion disease. We and others developed a new approach to NPMD therapy based on reducing the amount of the normal, host-encoded protein available as substrate for misfolding into pathologic forms, using RNA interference, a catabolic pathway that decreases levels of mRNA encoding a particular protein. We developed a therapeutic delivery system consisting of small interfering RNA (siRNA) complexed to liposomes and addressed to the central nervous system using a targeting peptide derived from rabies virus glycoprotein. These liposome-siRNA-peptide complexes (LSPCs) cross the blood-brain barrier and deliver PrP siRNA to neuronal cells to decrease expression of the normal cellular prion protein, PrPC, which acts as a substrate for prion replication. Here we show that LSPCs can extend survival and improve behavior of prion-infected mice that remain immunotolerant to treatment. LSPC treatment may be a viable therapy for prion and other NPMDs that can improve the quality of life of patients at terminal disease stages.	[Bender, Heather; Noyes, Noelle; Annis, Jessica L.; Hitpas, Amanda; Mollnow, Luke; Croak, Kendra; Kane, Sarah; Wagner, Kaitlyn; Dow, Steven; Zabel, Mark] Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bender, Heather] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Noyes, Noelle] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Dow, Steven] Colorado State Univ, Dept Clin Sci, Ctr Immune & Regenerat Med, Ft Collins, CO 80523 USA		Zabel, M (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mzabel@colostate.edu		Zabel, Mark/0000-0002-2666-9197	National Institutes of Health Institute for Neurological Disorders and Stroke [R01NS075214]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075214] Funding Source: NIH RePORTER	The National Institutes of Health Institute for Neurological Disorders and Stroke grant R01NS075214 to MZ funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Belay ED, 2016, INT ENCY PUBLIC HLTH, DOI [10.1016/B978-0-12-803678-5.00469-0, DOI 10.1016/B978-0-12-803678-5.00469-0]; Bender HR, 2016, JOVE-J VIS EXP, DOI 10.3791/54106; Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boado RJ, 2010, J BIOTECHNOL, V146, P84, DOI 10.1016/j.jbiotec.2010.01.011; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Branchi I, 2006, J NEUROSCI RES, V83, P965, DOI 10.1002/jnr.20789; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caspi S, 1998, J BIOL CHEM, V273, P3484, DOI 10.1074/jbc.273.6.3484; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; COCHRAN KW, 1971, J GEN VIROL, V13, P353, DOI 10.1099/0022-1317-13-2-353; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Andrea I, 2007, BEHAV BRAIN RES, V183, P60, DOI 10.1016/j.bbr.2007.05.029; Daude N, 2003, J CELL SCI, V116, P2775, DOI 10.1242/jcs.00494; Dow SW, 1999, J IMMUNOL, V163, P1552; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gaskill BN, 2013, JOVE-J VIS EXP, DOI 10.3791/51012; Georgieva Julia V, 2014, Pharmaceutics, V6, P557, DOI 10.3390/pharmaceutics6040557; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; HAIG DA, 1968, J GEN VIROL, V3, P281, DOI 10.1099/0022-1317-3-2-281; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V214, P993, DOI 10.1006/bbrc.1995.2384; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-493; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; KIMBERLIN RH, 1983, ARCH VIROL, V78, P9, DOI 10.1007/BF01310854; KIMBERLIN RH, 1986, ANTIMICROB AGENTS CH, V30, P409, DOI 10.1128/AAC.30.3.409; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lemke A, 2010, NANOMED-NANOTECHNOL, V6, P597, DOI 10.1016/j.nano.2009.12.004; Leske H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170503; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; Lotscher M, 2003, J IMMUNOL, V170, P6040, DOI 10.4049/jimmunol.170.12.6040; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; MANSON J, 1992, DEVELOPMENT, V115, P117; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pang ZQ, 2008, J CONTROL RELEASE, V128, P120, DOI 10.1016/j.jconrel.2008.03.007; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; POCCHIARI M, 1989, J INFECT DIS, V160, P795, DOI 10.1093/infdis/160.5.795; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Pulford B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011085; Ragnarsson EGE, 2008, LAB INVEST, V88, P1215, DOI 10.1038/labinvest.2008.86; Regina A, 2008, BRIT J PHARMACOL, V155, P185, DOI 10.1038/bjp.2008.260; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Shiraishi N, 2000, BIOCHEM BIOPH RES CO, V267, P398, DOI 10.1006/bbrc.1999.1944; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Solassol J, 2004, J GEN VIROL, V85, P1791, DOI 10.1099/vir.0.19726-0; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Stewart LA, 2008, NEUROLOGY, V70, P1272, DOI 10.1212/01.wnl.0000308955.25760.c2; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, BRANCHED POLYAMINES; Tagliavini F, 1997, SCIENCE, V278, P1404; TATEISHI J, 1981, J NEUROL NEUROSUR PS, V44, P723, DOI 10.1136/jnnp.44.8.723; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Torres-Lista V, 2013, BEHAV BRAIN RES, V247, P153, DOI 10.1016/j.bbr.2013.03.021; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Wyckoff AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058630; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144; Zabel MD, 2010, STROMAL COMPLEMENT R; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	103	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2019	14	7							e0219995	10.1371/journal.pone.0219995			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4UB	WOS:000484974100036	31329627	Green Published, gold, Green Submitted			2022-02-06	
J	Tham, SW; Aaron, RV; Palermo, TM				Tham, See Wan; Aaron, Rachel V.; Palermo, Tonya M.			The role of sleep deficiency in the trajectory of postconcussive symptoms in adolescents	BRAIN INJURY			English	Article						Postconcussive symptoms; sleep; adolescents; insomnia; actigraphy	COGNITIVE-BEHAVIORAL THERAPY; INSOMNIA SEVERITY INDEX; ACUTE CONCUSSION; RISK-FACTORS; CHILDREN; DISTURBANCES; VALIDATION; ACTIGRAPHY; QUALITY; RECOVERY	Objective: To investigate the trajectory of sleep deficiency after concussion and examine its role as a predictor of postconcussive symptoms (PCS) over 3 weeks and at 3 months post-concussion. Design: This was a prospective pilot study of 29 adolescents recruited from a pediatric Emergency Department (69% female, mean age = 14.0 years, SD = 1.8) following a concussion. Methods: Adolescents completed questionnaire assessments at baseline, Weeks 1, 2, and 3 on PCS and sleep patterns. Concurrently, adolescents also completed a daily diary and wore an actigraph continuously to monitor sleep activity. At 3 months post-concussion, adolescents repeated questionnaire measures. Results: At enrollment, 53.6% reported severe PCS, and 12% maintained severe symptoms at 3 months. Over the first 3 weeks, sleep duration and daytime sleepiness gradually declined; however, insomnia symptoms remained unchanged. After accounting for age, sex and time since concussion, greater insomnia symptoms at enrollment were associated with more severe PCS at 3 weeks and 3 months (beta = 1.17, p < .001). In contrast, sleep duration, efficiency, and waketime after sleep onset were not predictors. Conclusions: Study findings suggest that insomnia symptoms after concussion may provide a target for early intervention to reduce prolonged severity and duration of PCS.	[Tham, See Wan; Palermo, Tonya M.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Tham, See Wan; Palermo, Tonya M.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Washington, DC USA; [Aaron, Rachel V.] John Hopkins Med, Dept Phys Med & Rehabil, Baltimore, MD USA		Tham, SW (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	see.tham@seattlechildrens.org			Seattle Children's Research Institute Center for Child Health Behavior and Development	This work was supported by the Seattle Children's Research Institute Center for Child Health Behavior and Development.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Bonvanie IJ, 2016, PAIN, V157, P957, DOI 10.1097/j.pain.0000000000000466; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Chung KF, 2011, SLEEP MED, V12, P463, DOI 10.1016/j.sleep.2010.09.019; de Bruin EJ, 2015, SLEEP, V38, P1913, DOI 10.5665/sleep.5240; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fatima Y, 2018, SLEEP HEALTH, V4, P154, DOI 10.1016/j.sleh.2018.01.002; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Janssen KC, 2017, SLEEP MED, V33, P30, DOI 10.1016/j.sleep.2017.01.014; Jansson-Frojmark M, 2019, J BEHAV MED, V42, P128, DOI 10.1007/s10865-018-9949-0; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Law EF, 2018, HEADACHE, V58, P1060, DOI 10.1111/head.13355; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meltzer LJ, 2012, SLEEP MED REV, V16, P463, DOI 10.1016/j.smrv.2011.10.002; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Palermo TM, 2017, J CLIN SLEEP MED, V13, P401, DOI 10.5664/jcsm.6490; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schlarb AA, 2018, BEHAV SLEEP MED, V16, P380, DOI 10.1080/15402002.2016.1228642; Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005; Strand LB, 2016, INT J CARDIOL, V223, P534, DOI 10.1016/j.ijcard.2016.08.119; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Toon E, 2016, J CLIN SLEEP MED, V12, P343, DOI 10.5664/jcsm.5580; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Wang M., 2014, ADV STAT, P1, DOI [10.1155/2014/303728, DOI 10.1155/2014/303728]; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	48	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1413	1419		10.1080/02699052.2019.1643921		JUL 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000477547000001	31322003	Green Accepted			2022-02-06	
J	Vander Werff, KR; Rieger, B				Vander Werff, Kathy R.; Rieger, Brian			Impaired auditory processing and neural representation of speech in noise among symptomatic post-concussion adults	BRAIN INJURY			English	Article						Mild traumatic brain injury; cortical auditory evoked potential; auditory processing; speech in noise	EVENT-RELATED POTENTIALS; EVOKED-POTENTIALS; HEAD-INJURY; T-COMPLEX; VETERANS; WAVE; DIFFICULTIES; PERCEPTION; COMPLAINTS; P1-N1-P2	Background: The purpose of the study was to examine auditory event-related potential (AERP) evidence of changes in earlier and later stages of auditory processing in individuals with long-term post-concussion problems compared to healthy controls, with a secondary aim of comparing AERPs by functional auditory behavioral outcomes. Methods: P1-N1-P2 complex and P300 components recorded to speech in quiet and background noise conditions were completed in individuals with ongoing post-concussion symptoms following mTBI and healthy controls. AERPs were also examined between sub-groups with normal or impaired auditory processing by behavioral tests. Results: Group differences were present for later stages of auditory processing (P300). Earlier components did not significantly differ by group overall but were more affected by noise in the mTBI group. P2 amplitude in noise differed between mTBI sub-groups with normal or impaired auditory processing. Conclusion: AERPs revealed differences between healthy controls and those with chronic post-concussion symptoms following mTBI at a later stage of auditory processing (P300). Neural processing at the earlier stage (P1-N1-P2) was more affected by noise in the mTBI group. Preliminary evidence suggested that it may be only the proportion of individuals with functional evidence of central auditory dysfunction with changes in AERPs at earlier stages of processing.	[Vander Werff, Kathy R.] Syracuse Univ, Dept Commun Sci & Disorders, Syracuse, NY 13244 USA; [Rieger, Brian] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA		Vander Werff, KR (corresponding author), Syracuse Univ, Commun Sci & Disorders, 621 Skytop Rd,Suite 1200, Syracuse, NY 13244 USA.	kvander@syr.edu		Vander Werff, Kathy/0000-0003-0526-9490	National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC010246]	This work was supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders (NIH/NIDCD) under grant number R03DC010246, awarded to the first author.	Alberti A, 2001, HEADACHE, V41, P579, DOI 10.1046/j.1526-4610.2001.041006579.x; American National Standards Institute, 2004, S362004 ANSI; Anderson S, 2010, EUR J NEUROSCI, V32, P1407, DOI 10.1111/j.1460-9568.2010.07409.x; Bennett KO, 2012, EAR HEARING, V33, P243, DOI 10.1097/AUD.0b013e31823173fd; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Billings CJ, 2013, JARO-J ASSOC RES OTO, V14, P891, DOI 10.1007/s10162-013-0415-y; Billings CJ, 2011, EAR HEARING, V32, P53, DOI 10.1097/AUD.0b013e3181ec5c46; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burger M, 2009, EAR HEARING, V30, P16, DOI 10.1097/AUD.0b013e31818fbb9d; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Elangovan S, 2011, NEUROSCI LETT, V490, P140, DOI 10.1016/j.neulet.2010.12.044; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Green P, 2004, GREENS MED SYMPTOM V; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Martin BA, 2000, J ACOUST SOC AM, V107, P2155, DOI 10.1121/1.428556; Martin BA, 2008, EAR HEARING, V29, P285, DOI 10.1097/AUD.0b013e3181662c0e; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 1992, ATTENTION BRAIN FUNC; Nandrajog Puneet, 2017, Asian J Neurosurg, V12, P447, DOI 10.4103/1793-5482.180921; Niemczak CE, 2019, EAR HEARING, V40, P156, DOI 10.1097/AUD.0000000000000604; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Ostroff JM, 1998, EAR HEARING, V19, P290, DOI 10.1097/00003446-199808000-00004; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; Papesh MA, 2015, CLIN NEUROPHYSIOL, V126, P1319, DOI 10.1016/j.clinph.2014.10.017; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Reitan R, 1985, HALSTEAD REITAN NEUR; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Sharma A, 2000, J ACOUST SOC AM, V107, P2697, DOI 10.1121/1.428655; Sharma M, 2014, NEUROREPORT, V25, P312, DOI 10.1097/WNR.0000000000000089; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Smith A., 1982, SYMBOL DIGITS MODALI; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686; Tremblay KL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00028; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vander Werff KR, 2019, J SPEECH LANG HEAR R, V62, P2501, DOI 10.1044/2019_JSLHR-H-18-0281; Wagner M, 2017, J SPEECH LANG HEAR R, V60, P2105, DOI 10.1044/2017_JSLHR-H-16-0056; Wagner M, 2016, NEUROSCI LETT, V614, P119, DOI 10.1016/j.neulet.2015.12.020; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; Weschler D., 2008, WESCHLER ADULT INTEL	66	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2019	33	10					1320	1331		10.1080/02699052.2019.1641624		JUL 2019	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM5YC	WOS:000476284300001	31317775	Green Accepted			2022-02-06	
J	Van Deynse, H; Van Belleghem, G; Lauwaert, D; Moen, M; Pien, K; Devos, S; Hubloue, I; Putman, K				Van Deynse, Helena; Van Belleghem, Griet; Lauwaert, Door; Moen, Maarten; Pien, Karen; Devos, Stefanie; Hubloue, Ives; Putman, Koen			The incremental cost of traumatic brain injury during the first year after a road traffic accident	BRAIN INJURY			English	Article						Brain injury; head injury; craniocerebral trauma; cost; traffic accident	ADMINISTRATIVE DATA; HOSPITAL COSTS; HEALTH-CARE; DISABILITY; DATABASES; OUTCOMES; PEOPLE; SCORE; RISK	This study aims to determine the incremental cost of TBI during the first year after a traffic accident, compared to other patients with similar non-TBI injuries. Secondly, identification of factors associated with medical costs of TBI is pursued. Analyses were performed on administrative data for traffic victims hospitalised in Belgium between 2009 and 2011. Medical costs attributable to the accident are estimated over one year post-injury. Cases with TBI were matched to controls with similar non-TBI injuries to determine the incremental cost of TBI. Both aims of this research were assessed using regression analysis. The incremental cost of TBI is estimated to range between euro 10 042 (95%CI [euro8198; euro11 887]) and euro21 715 (95%CI [euro13 5889; euro29 540]). Age, problems with self-reliance, survival status, the occurrence of acute events and severity of TBI are significant predictors of medical costs. As to healthcare utilisation, MRI usage, inpatient rehabilitation facilities, nursing homes and readmissions to acute hospital stand out as having most influence on costs. This study reveals a considerable incremental cost of TBI. Policy-making bodies should be made aware of this phenomenon and a diversified policy should be considered when financing programs are discussed.	[Van Deynse, Helena; Van Belleghem, Griet; Devos, Stefanie; Putman, Koen] Vrije Univ Brussel, Fac Med & Pharm, Interuniv Ctr Hlth Econ Res, Dept Publ Hlth, Laarbeeklaan 103,Bldg K, B-1090 Brussels, Belgium; [Lauwaert, Door; Hubloue, Ives] Univ Ziekenhuis Brussel, Dept Emergency Med, Emergency & Disaster Med, Brussels, Belgium; [Moen, Maarten] Univ Ziekenhuis Brussel, Dept Neurosurg, Brussels, Belgium; [Moen, Maarten] Univ Ziekenhuis Brussel, Dept Radiol, Brussels, Belgium; [Pien, Karen] Univ Ziekenhuis Brussel, Dept Med Registrat, Brussels, Belgium		Van Deynse, H (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, Interuniv Ctr Hlth Econ Res, Dept Publ Hlth, Laarbeeklaan 103,Bldg K, B-1090 Brussels, Belgium.	Helena.van.deynse@vub.be	Putman, Koen/ABG-6361-2021	Putman, Koen/0000-0002-7235-3759; Van Deynse, Helena/0000-0001-7744-1478	Belgian Road Safety Institute (BRSI)	This study is part of the REKOVER project, supported by the Belgian Road Safety Institute (BRSI). The authors would like to thank FPS Health (Ingrid Mertens, Eveline Depuijdt, Nathalie Terryn), the Department Data Management and the Technical Cell of the National Institute for Health and Disability Insurance (Yves Parmentier), and Intermutualistic Agency (Ragna Preal and Birgit Gielen) for their cooperation and support in the data extraction, data storage, and data security. Finally, our gratitude goes to Elisabeth Versailles from SAS Belgium for the provision of and assistance with the SAS-software.	Akobundu E, 2006, PHARMACOECONOMICS, V24, P869, DOI 10.2165/00019053-200624090-00005; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Bergstrahl E, 2007, GMATCH; Brooks MJ, 2005, BRIT J SURG, V92, P1288, DOI 10.1002/bjs.5058; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Devos S, 2017, INJURY, V48, P2132, DOI 10.1016/j.injury.2017.08.009; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; European Road Safety Observatory, 2017, ANN ACC REP; Gosho M, 2014, J STAT SOFTW, V57, P1; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jimenez-Martin S, 2012, EUR J HEALTH ECON, V13, P461, DOI 10.1007/s10198-011-0317-z; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parsons LS., 2001, SAS SUGI, V26, P214, DOI DOI 10.1016/J.MICINF.2011.07.011; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Van Belleghem G, 2016, INJURY, V47, P141, DOI 10.1016/j.injury.2015.08.025; Van de Sande S, 2006, D20061027314 KCE; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Welk B, 2017, CUAJ-CAN UROL ASSOC, V11, P136, DOI 10.5489/cuaj.4101; Welke KF, 2008, CARDIOL YOUNG, V18, P137, DOI 10.1017/S1047951108002837	39	6	6	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1234	1244		10.1080/02699052.2019.1641224		JUL 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000476368400001	31298587				2022-02-06	
J	Norman, RS; Shah, MN; Turkstra, LS				Norman, Rocio S.; Shah, Manish N.; Turkstra, Lyn S.			Reaction time and cognitive-linguistic performance in adults with mild traumatic brain injury	BRAIN INJURY			English	Article						Adult; brain injuries; cognitive-linguistic; mild traumatic brain injury	WORD RETRIEVAL; HEAD-INJURY; DEFICITS; DISCOURSE; COMMUNICATION; SPEED; CONCUSSION; NORMS; TBI; IMPAIRMENTS	Objective: The purpose of this study was to characterize cognitive-linguistic performance in adults with mild traumatic brain injury (mTBI) to advance assessment and treatment practices. We hypothesized that individuals with mTBI would demonstrate longer reaction times (RTs) and greater error rates when compared to an orthopedic injury (OI) group on a category-naming task. Method: Participants were age and education-matched adults with mTBI (n = 20; 12 females) and adults with OI (n = 21; 5 females) who were discharged to home after an Emergency Department visit. Our primary task was a category-naming task shown to be sensitive to language deficits after mTBI. The task was adapted and administered under speeded and unspeeded conditions. Results: There was a significant main effect of condition on RT (speeded faster than unspeeded) and accuracy (more errors in the speeded condition). There was a marginally significant effect of group on errors, with more errors in the mTBI group than the OI group. Naming RT and accuracy in both conditions were moderately correlated with injury variables and symptom burden. Conclusions: Our data showed a marginal effect of group on accuracy of performance. Correlations found between naming and neurobehavioural symptoms, including sleep quality, suggest that the latter should be considered in future research.	[Norman, Rocio S.; Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Shah, Manish N.] Univ Wisconsin, Sch Med & Publ Hlth, BerbeeWalsh Dept Emergency Med, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Surg, Madison, WI USA		Norman, RS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Speech Language Pathol Program, Sch Hlth Profess, 7703 Floyd Curl Dr,Mail Code 6243, San Antonio, TX 78229 USA.	normanr@uthscsa.edu	Turkstra, Lyn/ABC-5831-2021	Shah, Manish/0000-0001-6331-1074; Turkstra, Lyn/0000-0002-6948-6921	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GMO83252]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD071089]; National Institute of General Medical Sciences [R25GMO83252].	Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Beukelman D.R., 1984, ASSESSMENT INTELLIGI; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Buysse D J, 1989, Psychiatry Res, V28, P193; CARROLL JB, 1973, J VERB LEARN VERB BE, V12, P563, DOI 10.1016/S0022-5371(73)80036-2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dymowski A., 2015, J CLIN EXP NEUROPSYC, V37, P1, DOI DOI 10.1080/13803395.2014.983465; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gron G, 1996, J CLIN EXP NEUROPSYC, V18, P406, DOI 10.1080/01688639608408997; IBM Corp, REL 2015 IBM SPSS ST; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Key-DeLyria SE, 2016, J SPEECH LANG HEAR R, V59, P759, DOI 10.1044/2016_JSLHR-L-15-0104; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Montgomery JW, 2016, APPL PSYCHOLINGUIST, V37, P1281, DOI 10.1017/S0142716415000570; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Troyanskaya M, 2016, J CLIN EXP NEUROPSYC, V38, P811, DOI 10.1080/13803395.2016.1167172; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Wechsler D., 2008, WECHSLER ADULT INTEL; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P3, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6; Wright JM, 2014, SEMIN SPEECH LANG, V35, P155, DOI 10.1055/s-0034-1384676; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	75	6	6	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1173	1183		10.1080/02699052.2019.1632487		JUL 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000474916500001	31291747	hybrid, Green Accepted			2022-02-06	
J	Alkhachroum, A; Megjhani, M; Terilli, K; Rubinos, C; Ford, J; Wallace, BK; Roh, DJ; Agarwal, S; Connolly, ES; Boehme, AK; Claassen, J; Park, S				Alkhachroum, Ayham; Megjhani, Murad; Terilli, Kalijah; Rubinos, Clio; Ford, Jenna; Wallace, Brendan K.; Roh, David J.; Agarwal, Sachin; Connolly, E. Sander; Boehme, Amelia K.; Claassen, Jan; Park, Soojin			Hyperemia in subarachnoid hemorrhage patients is associated with an increased risk of seizures	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Seizures; ictal-interictal continuum; electroencephalogram; cerebral perfusion; subarachnoid hemorrhage	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; SPREADING DEPOLARIZATION; TISSUE HYPOXIA; BLOOD-FLOW; AUTOREGULATION; REACTIVITY; ISCHEMIA; PREDICTORS; MANAGEMENT	The association between impaired brain perfusion, cerebrovascular reactivity status and the risk of ictal events in patients with subarachnoid hemorrhage is unknown. We identified 13 subarachnoid hemorrhage (SAH) patients with seizures and 22 with ictal-interictal continuum (IIC), and compared multimodality physiological recordings to 38 similarly poor-grade SAH patients without ictal activity. We analyzed 10,179 cumulative minutes of seizure and 12,762 cumulative minutes of IIC. Cerebrovascular reactivity (PRx) was not different between subjects with seizures, IIC, or controls. Cerebral perfusion pressure (CPP) was higher in patients with seizures [99 +/- 6.5, p = .005] and IIC [97 +/- 8.5, p = .007] when compared to controls [89 +/- 12.3]. DeltaCPP, defined as actual CPP minus optimal CPP (CPPopt), was also higher in the seizure group [8.3 +/- 7.9, p = .0003] and IIC [8.1 +/- 10.3, p = .0006] when compared to controls [-0.1 +/- 5]. Time spent with supra-optimal CPP was higher in the seizure group [342 +/- 213 min/day, p = .002] when compared to controls [154 +/- 120 min/day]. In a temporal examination, a supra-optimal CPP preceded increased seizures and IIC in SAH patients, an hour before and continued to increase during the events [p < .0001].	[Alkhachroum, Ayham; Megjhani, Murad; Terilli, Kalijah; Rubinos, Clio; Ford, Jenna; Wallace, Brendan K.; Roh, David J.; Agarwal, Sachin; Boehme, Amelia K.; Claassen, Jan; Park, Soojin] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Connolly, E. Sander] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA; [Boehme, Amelia K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA		Park, S (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, NY Presbyterian Hosp, New York, NY 10032 USA.	sp3291@cumc.columbia.edu	Alkhachroum, Ayham/V-6050-2019; Rubinos, Clio/ABA-9937-2021; Claassen, Jan/AAA-5451-2020	Alkhachroum, Ayham/0000-0003-0352-5913; Rubinos, Clio/0000-0002-1680-2302; Terilli, Kalijah/0000-0003-2198-5147	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01 ES026833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026833] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Dr. Soojin Park NIH K01 ES026833.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; CUNNINGHAM FG, 1992, NEW ENGL J MED, V326, P927; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Geneslaw AS, 2011, J CEREBR BLOOD F MET, V31, P1394, DOI 10.1038/jcbfm.2011.16; Hill J., 2006, DATA ANAL USING REGR; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; INGVAR M, 1983, ACTA NEUROL SCAND, V68, P129, DOI 10.1111/j.1600-0404.1983.tb05339.x; Karapanayiotides T, 2005, STROKE, V36, P21, DOI 10.1161/01.STR.0000149946.86087.e5; Kim JA, 2017, CLIN NEUROPHYSIOL, V128, P1091, DOI 10.1016/j.clinph.2017.01.016; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Megjhani M, 2018, ACTA NEUROCHIR SUPPL, V126, P179, DOI 10.1007/978-3-319-65798-1_37; MELDRUM BS, 1976, BRAIN, V99, P523, DOI 10.1093/brain/99.3.523; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zhao MR, 2011, J NEUROSCI, V31, P13292, DOI 10.1523/JNEUROSCI.2597-11.2011; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	40	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2020	40	6					1290	1299	0271678X19863028	10.1177/0271678X19863028		JUL 2019	10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	LN5EH	WOS:000479487100001	31296131	Green Published			2022-02-06	
J	Arai, M; Imamura, O; Kondoh, N; Dateki, M; Takishima, K				Arai, Masaaki; Imamura, Osamu; Kondoh, Nobuo; Dateki, Minori; Takishima, Kunio			Neuronal Ca2+-dependent activator protein 1 (NCDAP1) induces neuronal cell death by activating p53 pathway following traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; Ca2+; NCDAP1; NMDA; p53; traumatic brain injury	NMDA RECEPTOR; MITOCHONDRIAL DYSFUNCTION; MOLECULAR-BASIS; IN-VITRO; MECHANISMS; CALCIUM; PATHOPHYSIOLOGY; EXPRESSION; EPILEPSY; PROFILE	Overactivation of N-methyl-d-aspartate glutamate receptors (NMDARs) after traumatic brain injury (TBI) contributes to excitotoxic cell death. The hyperactivation of NMDARs results in toxic levels of intracellular Ca2+ and in the activation of p53-mediated apoptosis pathway. Neuronal Ca2+-dependent activator protein 1 (NCDAP1) was identified as an epileptogenic gene of unknown function in our laboratory. In this study, we investigated the expression and cellular localization of NCDAP1 in rat models of fluid percussion-induced TBI. NCDAP1 expression increased in the ipsilateral cortex and hippocampus adjacent to the lesion of the TBI rats compared with that in the sham-operated controls. In addition, NCDAP1 was co-expressed with neuronal marker (NeuN), and the results of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining suggest that NCDAP1 is involved in neuronal apoptosis that occurs after brain injury. In addition, the expression levels of p53, Bax, and active caspase-3 correlated with those of NCDAP1. To further investigate the function of NCDAP1, primary cultured neurons were employed to establish an apoptosis model. The expression of NCDAP1 was induced by NMDA-induced Ca2+ influx, and the knockdown of NCDAP1 by siRNA decreased apoptosis caused by treatment with NMDA. Silencing of NCDAP1 also reduced p53 expression, whereas the over-expression of NCDAP1 induced cell death and up-regulated the expression of p53. The inhibition of p53 with pifithrin alpha or siRNA counteracted the effects of NCDAP1. Based on our data, we suggest that NCDAP1 plays an important role in p53-mediated neuronal apoptosis following TBI.	[Arai, Masaaki; Imamura, Osamu; Dateki, Minori; Takishima, Kunio] Natl Def Med Coll, Dept Biochem, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan; [Kondoh, Nobuo] Asahi Univ, Dept Oral Biochem, Sch Dent, Mizuho, Japan		Arai, M (corresponding author), Natl Def Med Coll, Dept Biochem, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	jin@ndmc.ac.jp			research expense of national defense medical college	The authors appreciate Dr. Atsushi Ohsumi for providing excellent technical support. No external funding was utilized as the study was funding by the research expense of national defense medical college. The authors have no conflict of interest to declare.	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arai M, 2003, MOL BRAIN RES, V118, P147, DOI 10.1016/S0169-328X(03)00329-2; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Gurkoff GG, 2013, BRAIN RES, V1515, P98, DOI 10.1016/j.brainres.2013.03.043; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hughes PE, 1997, NEUROREPORT, V8, pR5; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; Jordan J, 2003, NEUROSCIENCE, V122, P707, DOI 10.1016/j.neuroscience.2003.08.030; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Qin ZH, 1999, J NEUROSCI, V19, P4023; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012	45	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2019	151	6					795	809		10.1111/jnc.14803		JUL 2019	15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	OA2FZ	WOS:000475012500001	31237956				2022-02-06	
J	Kroshus, E; Chrisman, SPD				Kroshus, Emily; Chrisman, Sara P. D.			A New Game Plan for Concussion Education	HEALTH EDUCATION & BEHAVIOR			English	Article						behavioral theories; community health promotion; health disparities; health equity; health promotion; injury prevention; safety; physical activity; exercise	SOCIAL COGNITIVE THEORY; DECISION-MAKING; INJURY PREVENTION; HEALTH; SPORT; ADOLESCENT; IMPLEMENTATION; INEQUALITIES; RATIONALITY; DISCLOSURE	Despite state laws requiring concussion education for youth sport stakeholders and a proliferation of educational programs, there has been little demonstrated impact on concussion reporting behaviors. We propose that this is because of four key limitations to existing approaches to concussion education: (1) deliberative decision making by the injured athlete is assumed, (2) interventions are often targeted at individuals rather than social systems, (3) education occurs once during preseason and is forgotten, and (4) dissemination challenges exacerbate health inequalities. Addressing these limitations, we propose a novel theoretic framework that situates individual behavior within a sport system's culture and their broader structural context. Concussion education programs should seek to facilitate safety-supportive interpersonal communication within and between stakeholder groups and influence attributes of groups that drive behavior, including shared values. Addressing the limitations outlined and drawing on the proposed conceptual framework, we describe a novel approach to concussion education: pregame safety huddles.	[Kroshus, Emily; Chrisman, Sara P. D.] Seattle Childrens Res Inst, Seattle, WA USA; [Kroshus, Emily; Chrisman, Sara P. D.] Univ Washington, Seattle, WA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Kroshus, Emily/0000-0002-7484-2601; Chrisman, Sara/0000-0001-5373-7223	 [CDC U01];  [RFA-CD-17-002]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: CDC U01, RFA-CD-17-002 Development and Evaluation of Sports Concussion Research Strategies (co-Principal Investigators: Kroshus & Chrisman).	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bandura A, 2002, APPL PSYCHOL-INT REV, V51, P269, DOI 10.1111/1464-0597.00092; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A, 1986, SOCIAL FDN THOUGHT A; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; Boer D, 2013, PSYCHOL BULL, V139, P1113, DOI 10.1037/a0031347; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Cialdini RB, 1998, SOCIAL INFLUENCE SOC; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Fenoglio R, 2014, PHYS EDUC SPORT PEDA, V19, P191, DOI 10.1080/17408989.2012.748737; Figner B., 2004, POLISH PSYCHOL B, V35, P135; Finch CF, 2011, BRIT J SPORT MED, V45, P1253, DOI 10.1136/bjsports-2011-090230; Fleig L, 2013, REHABIL PSYCHOL, V58, P323, DOI 10.1037/a0033885; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Gerrard M, 2008, DEV REV, V28, P29, DOI 10.1016/j.dr.2007.10.001; Glymph Derrick C, 2015, AANA J, V83, P183; Graham R, 2013, SPORTS RELATED CONCU; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Jones K, 2014, SEX TRANSM DIS, V41, P413, DOI 10.1097/OLQ.0000000000000146; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kowash MB, 2000, BRIT DENT J, V188, P201, DOI 10.1038/sj.bdj.4800431a; Kroshus E, 2017, J ATHL TRAINING, V52, P1041, DOI 10.4085/1062-6050-52.11.17; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McBride N, 2003, HEALTH EDUC RES, V18, P729, DOI 10.1093/her/cyf050; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Montano DE., 2008, HLTH BEHAV HLTH ED T, V1, P67; Olweus D, 2010, AM J ORTHOPSYCHIAT, V80, P124, DOI 10.1111/j.1939-0025.2010.01015.x; Ostroff C, 2013, HDB PSYCHOL, V12, P643, DOI DOI 10.1002/0471264385.WEI1222; Provost SM, 2015, HEALTH CARE MANAGE R, V40, P2, DOI 10.1097/HMR.0000000000000009; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Rohan MJ, 2000, PERS SOC PSYCHOL REV, V4, P255, DOI 10.1207/S15327957PSPR0403_4; SCHEIN EH, 1990, AM PSYCHOL, V45, P109, DOI 10.1037/0003-066X.45.2.109; Shier V, 2014, GERONTOLOGIST, V54, pS6, DOI 10.1093/geront/gnt147; Shunk R, 2014, ACAD MED, V89, P244, DOI 10.1097/ACM.0000000000000104; Vast RL, 2010, AUST PSYCHOL, V45, P132, DOI 10.1080/00050060903261538; Verplanken B, 2002, J PERS SOC PSYCHOL, V82, P434, DOI 10.1037/0022-3514.82.3.434	53	6	6	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	DEC	2019	46	6					916	921	1090198119859414	10.1177/1090198119859414		JUL 2019	6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JU0MF	WOS:000476238200001	31296053				2022-02-06	
J	Oyesanya, TO; Arulselvam, K; Thompson, N; Norelli, J; Seel, RT				Oyesanya, Tolu O.; Arulselvam, Karthik; Thompson, Nicole; Norelli, Jenna; Seel, Ronald T.			Health, wellness, and safety concerns of persons with moderate-to-severe traumatic brain injury and their family caregivers: a qualitative content analysis	DISABILITY AND REHABILITATION			English	Article						Family caregiver; health; person; traumatic brain injury; safety; wellness	TRANSITION; INDIVIDUALS; EXPERIENCES; PEOPLE; NEEDS; HOME; TBI; REHABILITATION; RECOVERY; OUTCOMES	Background: Persons with moderate-to-severe traumatic brain injury (TBI) face issues with health, wellness, and safety that affect their ability to independently manage their care, even for individuals who are >= 75% independent in activities of daily living. These issues often lead to increased family involvement in managing the person's condition after discharge home. Purpose: We explored health, wellness, and safety concerns after discharge home from inpatient rehabilitation from the perspectives of persons with TBI who are >= 75% independent in activities of daily living and their family caregivers. Materials and methods: We interviewed 27 persons with TBI and family caregivers and used conventional content analysis to analyse the data. Results: Seven themes related to health, wellness, and safety encompassed participants' experience. Health themes included: (1) attempting to manage medications and (2) navigating mental health difficulties. Wellness themes included: (1) working to stay physically active, (2) dealing with sleep and sleeplessness, and (3) adjusting to changing social relationships. Safety themes were: (1) addressing mobility challenges and (2) compensating for complications with cognitive functioning. Conclusions: Findings can guide the development of tools, supports, and resources to promote health, wellness, and safety of persons with TBI as they recover after discharge home.	[Oyesanya, Tolu O.; Arulselvam, Karthik; Thompson, Nicole; Norelli, Jenna; Seel, Ronald T.] Crawford Res Inst, Shepherd Ctr, Atlanta, GA USA; [Oyesanya, Tolu O.] Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27710 USA; [Seel, Ronald T.] VCU Sch Med, Ctr Rehabil Sci & Engn, Dept Phys Med & Rehabil, Richmond, VA USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27710 USA.	Tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510	National Institute for Disability, Independent Living, and Rehabilitation Research, Rehabilitation Engineering Research Center [90RE5023-01-00]	This research was supported by the National Institute for Disability, Independent Living, and Rehabilitation Research, Rehabilitation Engineering Research Center (PI, F. DeRuyter) (Grant #90RE5023-01-00).	Adams T, 1997, AM J HEALTH PROMOT, V11, P208, DOI 10.4278/0890-1171-11.3.208; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bezner JR, 2015, PHYS THER, V95, P1433, DOI 10.2522/ptj.20140271; BLACK N, 1994, J EPIDEMIOL COMMUN H, V48, P425, DOI 10.1136/jech.48.5.425-a; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Callahan D, 1973, Stud Hastings Cent, V1, P77; Cayne BS, 1991, NEW WEBSTERS DICT TH; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hart T, 2017, BRAIN INJURY, V31, P297, DOI 10.1080/02699052.2016.1251612; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huggins JM, 2011, AM J HEALTH-SYST PH, V68, P254, DOI 10.2146/ajhp090629; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kolakowsky-Hayner SA, 2016, NEUROREHABILITATION, V39, P363, DOI 10.3233/NRE-161368; Kreutzer JS, 2009, PM&R, V1, P723, DOI 10.1016/j.pmrj.2009.07.005; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lefebvre H, 2006, BRAIN INJURY, V20, P711, DOI 10.1080/02699050600744244; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Liddle J, 2014, AUST OCCUP THER J, V61, P215, DOI [10.1111/1440-1630.12153, 10.1111/1440-1630.12119]; Liu VC, 2018, J AGING HEALTH; Malec JF, 2011, ENCY CLIN NEUROPSYCH, P1526; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Man DWK, 2001, BRAIN INJURY, V15, P961, DOI 10.1080/02699050110065664; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Ponniah A, 2007, J CLIN PHARM THER, V32, P343, DOI 10.1111/j.1365-2710.2007.00827.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Seel RT, 2016, NEUROREHABILITATION, V39, P371, DOI 10.3233/NRE-161369; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Tyson BT, 2012, PHYS MED REH CLIN N, V23, P315, DOI 10.1016/j.pmr.2012.02.007; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weiss ME, 2006, J NURS MEAS, V14, P163, DOI 10.1891/jnm-v14i3a002; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434	68	6	6	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 27	2021	43	5					685	695		10.1080/09638288.2019.1638456		JUL 2019	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	QS7HG	WOS:000476079400001	31298958				2022-02-06	
J	da Costa, BBS; Windlin, IC; Koterba, E; Yamaki, VN; Rabelo, NN; Solla, DJF; Teixeira, MJ; Figueiredo, EG				Sisnando da Costa, Bruno Braga; Windlin, Isabela Costola; Koterba, Edwin; Yamaki, Vitor Nagai; Rabelo, Nicollas Nunes; Fontoura Solla, Davi Jorge; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha			Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial	TRIALS			English	Article						Subarachnoid hemorrhage; Brain aneurysms; Glibenclamide	DOUBLE-BLIND; RECEPTOR ANTAGONIST; PRAVASTATIN; INJURY	Background: Recent findings on the benefits of glibenclamide as a neuroprotective drug have started a new era for prospective studies on sulfonylureas. The effect of glibenclamide blocking the Sur1-Trpm4 channel was examined in models of subarachnoid hemorrhage and stroke, with findings of significantly reduced tight-junction abnormalities, resulting in less edema formation and considerably reduced transsynaptic apoptosis of hippocampal neurons and significantly ameliorated impairments in spatial learning. Based on these data, we plan a clinical trial to establish evidence of glibenclamide as an adjunct treatment in aneurysmal subarachnoid hemorrhage. Methods: An estimated 80 patients meeting the inclusion criteria of radiological confirmatory evidence of an aneurysmal subarachnoid hemorrhage, age 18-70 years, and presentation of less than 96 h from the ictus will be allocated randomly into two groups, one receiving 5 mg daily oral intake of glibenclamide for 21 days and another control group receiving a placebo. The study's primary outcome is the modified Rankin scale (mRS) after 6 months, as favorable (mRS 0-2) or unfavorable (mRS 3-6). The secondary outcomes will be late cognitive status, assessed after 6 months by psychological tests (the Short Form Health Survey Questionnaire and the Montreal Cognitive Assessment), as well as death at 6 months, delayed cerebral ischemia and occurrence of serious adverse events due to study medication. Discussion: There is a growing interest in the scientific community regarding glibenclamide in brain edema and traumatic brain injury, but with very little of this interest targeting spontaneous brain hemorrhage, especially aneurism rupture. Positive outcomes are expected for the treatment patients, especially in language and memory preservation, as has been shown in experimental models.	[Sisnando da Costa, Bruno Braga; Windlin, Isabela Costola; Koterba, Edwin; Yamaki, Vitor Nagai; Rabelo, Nicollas Nunes; Fontoura Solla, Davi Jorge; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha] Univ Sao Paulo, Neurosurg Dept, Sao Paulo, SP, Brazil		da Costa, BBS; Figueiredo, EG (corresponding author), Univ Sao Paulo, Neurosurg Dept, Sao Paulo, SP, Brazil.	neurobraga@hotmail.com; ebgadelha@yahoo.com.br	Figueiredo, Eberval Gadelha/H-3488-2012; Solla, Davi/E-6988-2013	Araujo Barbosa, Breno/0000-0003-1459-4957; Solla, Davi/0000-0002-5092-6595			[Anonymous], 2000, Stroke, V31, P1843; Dhar R, 2012, CURR TREAT OPTION NE, V14, P164, DOI 10.1007/s11940-012-0163-z; Eisenberg E, GLYBURIDE RP 1127 TR; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; Kurland DB, 2013, PHARMACEUTICALS, V6, P1287, DOI 10.3390/ph6101287; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Shaw MDM, 2000, J NEUROSURG, V93, P992, DOI 10.3171/jns.2000.93.6.0992; Sheth KN, GLYBURIDE ADVANTAGE; Sheth KN, SAFETY STUDY RP 1127; Siasios I, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/571328; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Tseng MY, 2007, J NEUROSURG, V107, P1092, DOI 10.3171/JNS-07/12/1092; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275	25	6	6	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 9	2019	20								413	10.1186/s13063-019-3517-y			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IK3XR	WOS:000476522200006	31288831	Green Published, gold			2022-02-06	
J	Bergeron, MF; Landset, S; Maugans, TA; Williams, VB; Collins, CL; Wasserman, EB; Khoshgoftaar, TM				Bergeron, Michael F.; Landset, Sara; Maugans, Todd A.; Williams, Vernon B.; Collins, Christy L.; Wasserman, Erin B.; Khoshgoftaar, Taghi M.			Machine Learning in Modeling High School Sport Concussion Symptom Resolve	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						ADOLESCENT; AUGMENTED INTELLIGENCE; RECOVERY; SPORTS MEDICINE; TRAUMATIC BRAIN INJURY	NATIONAL ATHLETIC TREATMENT; OUTCOMES NETWORK NATION; PROLONGED RECOVERY; INJURIES; TIME; EPIDEMIOLOGY; STATEMENT; MEDICINE; AGE	Introduction Concussion prevalence in sport is well recognized, so too is the challenge of clinical and return-to-play management for an injury with an inherent indeterminant time course of resolve. A clear, valid insight into the anticipated resolution time could assist in planning treatment intervention. Purpose This study implemented a supervised machine learning-based approach in modeling estimated symptom resolve time in high school athletes who incurred a concussion during sport activity. Methods We examined the efficacy of 10 classification algorithms using machine learning for the prediction of symptom resolution time (within 7, 14, or 28 d), with a data set representing 3 yr of concussions suffered by high school student-athletes in football (most concussion incidents) and other contact sports. Results The most prevalent sport-related concussion reported symptom was headache (94.9%), followed by dizziness (74.3%) and difficulty concentrating (61.1%). For all three category thresholds of predicted symptom resolution time, single-factor ANOVA revealed statistically significant performance differences across the 10 classification models for all learners at a 95% confidence interval (P = 0.000). Naive Bayes and Random Forest with either 100 or 500 trees were the top-performing learners with an area under the receiver operating characteristic curve performance ranging between 0.656 and 0.742 (0.0-1.0 scale). Conclusions Considering the limitations of these data specific to symptom presentation and resolve, supervised machine learning demonstrated efficacy, while warranting further exploration, in developing symptom-based prediction models for practical estimation of sport-related concussion recovery in enhancing clinical decision support.	[Bergeron, Michael F.] SIVOTEC Analyt, Boca Raton Innovat Campus,4800 T Rex Ave, Boca Raton, FL 33431 USA; [Landset, Sara; Khoshgoftaar, Taghi M.] Florida Atlantic Univ, Dept Comp & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA; [Maugans, Todd A.] Nemours Childrens Hosp, Div Neurosurg, Orlando, FL USA; [Williams, Vernon B.] Kerlan Jobe Ctr Sports Neurol, Los Angeles, CA USA; [Collins, Christy L.; Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA		Bergeron, MF (corresponding author), SIVOTEC Analyt, Boca Raton Innovat Campus,4800 T Rex Ave, Boca Raton, FL 33431 USA.	mbergeron@sivotecanalytics.com			National Athletic Trainers' Association Research and Education Foundation; National Athletic Trainers' Central Indiana Corporate Partnership Foundation; BioCrossroads	The authors thank the Datalys Center for Sports Injury Research and Prevention for providing the NATION data for us to conduct this research and examine SRC in a new way. This study would not be possible without the assistance of the many high school AT who participated in the original data collection. The NATION project was funded by the National Athletic Trainers' Association Research and Education Foundation and Central Indiana Corporate Partnership Foundation in cooperation with BioCrossroads. The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of any of the funding organizations.	Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dabek F, 2015, PROCEDIA COMPUT SCI, V53, P265, DOI 10.1016/j.procs.2015.07.303; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Falcone M, 2013, INT CONF ACOUST SPEE, P7577, DOI 10.1109/ICASSP.2013.6639136; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hall M, 2009, SIGKDD EXPLOR, V11, P10, DOI 10.1145/1656274.1656278; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kampakis S, 2013, MLSA13, P46; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lopez-Valenciano A, 2018, MED SCI SPORT EXER, V50, P915, DOI 10.1249/MSS.0000000000001535; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Ruddy JD, 2018, MED SCI SPORT EXER, V50, P906, DOI 10.1249/MSS.0000000000001527; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.33.0210; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	33	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2019	51	7					1362	1371		10.1249/MSS.0000000000001903			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ID4WK	WOS:000471676800002	30694980				2022-02-06	
J	Bohnert, S; Ondruschka, B; Bohnert, M; Schuhmann, MK; Monoranu, CM				Bohnert, Simone; Ondruschka, Benjamin; Bohnert, Michael; Schuhmann, Michael K.; Monoranu, Camelia-Maria			Post-mortem cerebrospinal fluid diagnostics: cytology and immunocytochemistry method suitable for routine use to interpret pathological processes in the central nervous system	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						CSF; Cerebrospinal fluid; Forensic neuropathology; Forensic neurotraumatology; Cytology; Immunocytochemistry	TRAUMATIC BRAIN-INJURY; TIME-COURSE; DEATH; NSE; S100B	Due to its protected anatomical location, cerebrospinal fluid (CSF) is a very stable fluid which undergoes comparatively little change in the early post-mortem phase. While many immunohistochemical markers already established for clinical diagnostic issues in tissue samples obtained by biopsy could meanwhile be translated also to post-mortem tissue, no systematic immunocytochemical investigations have generally been conducted on post-mortem body fluids and for CSF specifically, have not been established at all. CSF as the fluid directly surrounding the brain should also be examined to allow a more detailed characterization of processes in the central nervous system. Comparing traumatized tissue and CSF can complete forensic assessment and complement neuropathological evaluation.	[Bohnert, Simone; Bohnert, Michael] Univ Wuerzbtug, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany; [Ondruschka, Benjamin] Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany; [Schuhmann, Michael K.] Univ Hosp Wuerzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Monoranu, Camelia-Maria] Univ Wurzburg, Inst Pathol, Dept Neuropathol, Josef Scimeider Str 2, D-97080 Wuerzbtug, Germany		Bohnert, S (corresponding author), Univ Wuerzbtug, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany.	simone.bohnert@uni-wuerzburg.de					Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Bayer R, 2015, DRUG ALCOHOL DEPEN, V156, P139, DOI 10.1016/j.drugalcdep.2015.09.005; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Dettmeyer R.B., 2018, FORENSIC HISTOPATHOL; Deutschen Gesellschaft fur Rechtsmedizin, 2017, RECHTSM LEICH; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Friedrich G, 1986, PRAXIS RECHTSMEDIZIN, P789; Garland J, 2018, AM J FOREN MED PATH, V39, P304, DOI 10.1097/PAF.0000000000000420; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Hausmann Roland, 2002, Leg Med (Tokyo), V4, P79, DOI 10.1016/S1344-6223(02)00003-2; Jones KL, 2003, PEDIATRICS, V111, P358, DOI 10.1542/peds.111.2.358; KERNBACH G, 1983, PATHOLOGE, V4, P235; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; MANGIN P, 1983, FORENSIC SCI INT, V22, P143, DOI 10.1016/0379-0738(83)90007-5; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Quan L, 2011, LEGAL MED-TOKYO, V13, P75, DOI 10.1016/j.legalmed.2010.11.003; Rognum IJ, 2014, J NEUROPATH EXP NEUR, V73, P115, DOI 10.1097/NEN.0000000000000034; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Swain R, 2015, J FORENSIC LEG MED, V36, P144, DOI 10.1016/j.jflm.2015.09.017; Trautz F, 2018, INT J LEGAL MED, V132, P1103, DOI 10.1007/s00414-017-1767-3; Weber M, 2013, BRAIN RES, V1500, P72, DOI 10.1016/j.brainres.2012.12.048; Weis S, 2018, HAND CLINIC, V145, P181, DOI 10.1016/B978-0-12-802395-2.00014-6; WYLER D, 1994, INT J LEGAL MED, V106, P194, DOI 10.1007/BF01371336	31	6	6	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2019	133	4					1141	1146		10.1007/s00414-019-02050-z			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	IG3EQ	WOS:000473685700022	30927078				2022-02-06	
J	Caplan, HW; Cox, CS				Caplan, Henry W.; Cox, Charles S., Jr.			Resuscitation Strategies for Traumatic Brain Injury	CURRENT SURGERY REPORTS			English	Article						Traumatic brain injury; Secondary brain injury; Intracranial pressure; Intracranial hypertension; Cerebral perfusion pressure; Lund concept	RESPIRATORY-DISTRESS-SYNDROME; PROGENITOR-CELL THERAPY; END-EXPIRATORY PRESSURE; FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; HYPERTONIC SALINE; EARLY PROPRANOLOL	Purpose of ReviewTraumatic brain injury (TBI) is a leading cause of morbidity and mortality; however, little definitive evidence exists about most clinical management strategies. Here, we highlight important differences between two major guidelines, the 2016 Brain Trauma Foundation guidelines and the Lund Concept, along with recent preclinical and clinical data.Recent FindingsWhile intracranial pressure (ICP) monitoring has been questioned, the majority of literature demonstrates benefit in severe TBI. The optimal cerebral perfusion pressure and ICP are yet unknown, but likely as important is the concept of ICP burden. The evidence for antihypertensive therapy is strengthening. Decompressive craniectomy improves mortality, but at the cost of increased morbidity. Plasma-based resuscitation has demonstrated benefit in multiple preclinical TBI studies.SummaryThe management of hemodynamics and intravascular volume are crucial in TBI. Based on recent evidence, ICP monitoring, antihypertensive therapy, minimal use of vasopressors/inotropes, and plasma resuscitation may improve outcomes.	[Caplan, Henry W.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St,Suite 258, Houston, TX 77030 USA		Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St,Suite 258, Houston, TX 77030 USA.	charles.s.cox@uth.tmc.edu		Caplan, Henry/0000-0003-0012-1606	Coagulex, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	Henry W. Caplan declares no potential conflicts of interest. Charles S. Cox Jr holds equity and royalty interests in Cellvation Inc. as well as a sponsored research agreement and scientific advisory board position. Dr. Cox Jr has sponsored research and holds a scientific advisory board position for CBR, Inc. He also sponsored research for Hope Bio, Inc., as well as Sponsored research and received equity/royalty interest from Coagulex, Inc.	Ahl R, 2017, EUR J TRAUMA EMERG S, V43, P783, DOI 10.1007/s00068-017-0779-5; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Albert Venencia, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010005; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Andresen M, 2018, NEUROCRIT CARE, V28, P162, DOI 10.1007/s12028-017-0438-z; [Anonymous], 2000, J NEUROTRAUM, V17, P507, DOI DOI 10.1089/neu.2000.17.507; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Bible LE, 2014, J TRAUMA ACUTE CARE, V77, P54, DOI 10.1097/TA.0000000000000264; Bogert JN, 2016, J INTENSIVE CARE MED, V31, P177, DOI 10.1177/0885066614558018; Boone MD, 2017, NEUROCRIT CARE, V26, P174, DOI 10.1007/s12028-016-0328-9; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cardenas JC, 2016, SHOCK, V45, P166, DOI 10.1097/SHK.0000000000000504; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carr KR, 2016, NEUROCRIT CARE, V25, P185, DOI 10.1007/s12028-016-0273-7; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Faul M, 2010, TRAUMATIC BRAIN INJU; Finfer S, 2004, VOX SANG, V87, P123, DOI 10.1111/j.1741-6892.2004.00468.x; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; HOFFMAN WE, 1991, ANESTH ANALG, V73, P460; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Ko A, 2017, AM SURGEON, V83, P1447; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mangat HS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1963-7; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Nordstrom CH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00274; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Oernbo EK, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0111-8; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roquilly A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018035; Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Schreibman DL, 2018, NEUROCRIT CARE, V29, P253, DOI 10.1007/s12028-018-0535-7; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Sharma D, 2011, J NEUROSURG ANESTH, V23, P363, DOI 10.1097/01.ana.0000405613.27980.ea; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Wang J, 2010, J NEUROIMMUNOL, V223, P77, DOI 10.1016/j.jneuroim.2010.04.006; Wen MY, 2018, BIOCHEM BIOPH RES CO, V499, P345, DOI 10.1016/j.bbrc.2018.03.161; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020; Zeng WX, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0351-6; Zhang DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08959-y; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	114	6	6	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2167-4817			CURR SURG REP	Curr. Surg. Rep.	JUL	2019	7	7							14	10.1007/s40137-019-0237-x			14	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	HY5EN	WOS:000468150500002	31205819	Green Accepted			2022-02-06	
J	Chen, T; Smith, K; Jiang, SY; Zhang, TY; Gan, RZ				Chen, Tao; Smith, Kyle; Jiang, Shangyuan; Zhang, Tianyu; Gan, Rong Z.			Progressive hearing damage after exposure to repeated low-intensity blasts in chinchillas	HEARING RESEARCH			English	Article; Proceedings Paper	8th International Symposium on Middle Ear Mechanics in Research and Otology (MEMRO)	JUL 05-09, 2018	Shanghai, PEOPLES R CHINA			Repetitive low-intensity blast; Progressive hearing damage; Hearing protection devices	TRAUMATIC BRAIN-INJURY; TYMPANIC MEMBRANE; AUDITORY-SYSTEM; STEM RESPONSE; OVERPRESSURE; PHARMACOLOGY; PHYSIOLOGY; RATS; NEED	Hearing damage caused by blast waves is a frequent and common injury for Service members. However, most studies have focused on high-intensity blast exposures that are known to cause moderate to severe traumatic brain injury (TBI), and fewer studies have investigated the progressive hearing damage caused by low-intensity blast exposures (below mild TBI). In this paper, we report our recent study in chinchillas to investigate the auditory function changes over the time course after repetitive exposures to low intensity blast. Two groups of chinchillas (N = 7 each) were used in this study. Group 1 was for an acute study with 2 blasts and Group 2 for progressive study with 3 blasts on Day 1 and observed for 7 days. Animals in both groups were exposed to blast overpressures of 21-35 kPa (3-5 psi or 180-185 dB SPL) at which the eardrum was usually not ruptured. One ear was left open while another ear was protected with an earplug. Blast overpressures were monitored at the entrance of the ear canal (PO) and near the eardrum in the canal (P1). Auditory brainstem responses (ABRs), distortion product otoacoustic emissions (DPOAEs), and middle latency responses (MLRs) were measured after each blast series in the acute group and on Days 1, 4, and 7 in the progressive group. Results show that hearing damage was induced in both ears after blast exposure on Day 1 and more damage was observed in open ears than plugged ears. Seven days after the three-blast series, the ABR threshold in open ears was still 7-20 dB higher on average than prior to the blasts. The MLR wave amplitude shifts were observed in both open and protected ears, which indicated central auditory damage. With the protection of an earplug, hearing thresholds had recovered to the pre-blast level by Day 7. Using this chinchilla blast model, acute and progressive hearing damages were quantified in both open and protected ears following repeated low intensity blast exposures. (C) 2019 Elsevier B.V. All rights reserved.	[Chen, Tao; Smith, Kyle; Jiang, Shangyuan; Gan, Rong Z.] Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave,Room 200, Norman, OK 73019 USA; [Chen, Tao; Zhang, Tianyu] Fudan Univ, Eye & ENT Hosp, Dept Facial Plast & Reconstruct Surg, Shanghai, Peoples R China		Gan, RZ (corresponding author), Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave,Room 200, Norman, OK 73019 USA.	rgan@ou.edu			US DoDUnited States Department of Defense [W81XWH-14-1-0228]; NSF-ChinaNational Natural Science Foundation of China (NSFC) [81570934]	The authors thank Dr. Junfeng Liang and Zachary Yokell in the Biomedical Engineering Lab at the University of Oklahoma for assistance in histology and animal studies. This work was supported by the US DoD W81XWH-14-1-0228 and NSF-China 81570934.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abel SM, 2006, AVIAT SPACE ENVIR MD, V77, P899; Ahlers ST, 2012, FRONT NEUROL, V3, P1; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Arnold S. A., 2000, AUDIOLOGY DIAGNOSIS, V1, P451; Biessels GJ, 1999, BRAIN, V122, P757, DOI 10.1093/brain/122.4.757; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Daniel SJ, 2007, LARYNGOSCOPE, V117, P2201, DOI 10.1097/MLG.0b013e318148b275; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Engles WG, 2017, ANN BIOMED ENG, V45, P2383, DOI 10.1007/s10439-017-1870-0; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gan RZ, 2018, MIL MED, V183, P245, DOI 10.1093/milmed/usx149; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Guan XY, 2011, HEARING RES, V277, P96, DOI 10.1016/j.heares.2011.03.003; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hawa T, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4027141; HEFFNER RS, 1991, HEARING RES, V52, P13, DOI 10.1016/0378-5955(91)90183-A; Henry KS, 2011, HEARING RES, V280, P236, DOI 10.1016/j.heares.2011.06.002; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Li C. J., 2006, CHONGQING MED, V5; Liang JF, 2017, HEARING RES, V354, P48, DOI 10.1016/j.heares.2017.08.003; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Munjal SK, 2010, J NEUROTRAUM, V27, P309, DOI 10.1089/neu.2009.0957; Norrix LW, 2017, J AM ACAD AUDIOL, V28, P950, DOI 10.3766/jaaa.16112; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Phillips DJ, 2011, SLEEP, V34, P1527, DOI 10.5665/sleep.1392; Puel JL, 2002, AUDIOL NEURO-OTOL, V7, P49, DOI 10.1159/000046864; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Saunders GH, 2009, NOISE HEALTH, V11, P14, DOI 10.4103/1463-1741.45308; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Smith K., 2018, J MIL MED; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Stuhmiller J.H., 1991, CONVENTIONAL WARFARE, P241; Suta D, 2011, EXP GERONTOL, V46, P739, DOI 10.1016/j.exger.2011.05.004; TEASDALE G, 1974, LANCET, V2, P81; Torre P, 2000, HEARING RES, V142, P131, DOI 10.1016/S0378-5955(00)00025-3; Zhong ZW, 2014, HEARING RES, V309, P55, DOI 10.1016/j.heares.2013.11.006	47	6	6	2	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUL	2019	378				SI		33	42		10.1016/j.heares.2019.01.010			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	IE2VZ	WOS:000472244000005	30686544				2022-02-06	
J	Crawford, AM; Yang, SM; Hu, P; Li, Y; Lozanova, P; Scalea, TM; Stein, DM				Crawford, Angela M.; Yang, Shiming; Hu, Peter; Li, Yao; Lozanova, Petya; Scalea, Thomas M.; Stein, Deborah M.			Concomitant chest trauma and traumatic brain injury, biomarkers correlate with worse outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; biomarkers; cytokines; critical care; chest trauma	PULMONARY CONTUSION; COMPUTED-TOMOGRAPHY; HEAD TRAUMA; EPIDEMIOLOGY; IMPACT; SERUM; LUNG; MANAGEMENT; LESIONS; MODEL	BACKGROUND Clinical data are lacking on the influence of chest trauma on the secondary injury process after traumatic brain injury (TBI), with some data suggesting that multiple trauma may worsens brain injury. Blunt chest trauma and TBI represent the two major single injury entities with the highest risk of complications and are potential biomarker targets. METHODS Trauma patients with severe TBI were enrolled. Serum biomarker levels were obtained every 6 hours for 72 hours. Baseline, 6 hours and 24 hours CT head scans were evaluated. Neurologic worsening was defined as increased contusions, ischemia, compression of basal cisterns, and/or midline shift. The TBI patients with chest injury (Abbreviated Injury Scale chest score >= 1) and those without chest injury were compared. Wilcoxon rank sum test, univariate logistic regression and receiver operating characteristic were reported. RESULTS Fifty-seven patients. Mean age of 40.5 years. Median motor Glasgow Coma Scale score at admission and 24 hours was 3 (interquartile range, 1-5) and 5 (interquartile range, 3-5). Of the patients enrolled, 12.2% patients underwent craniotomy within 6 hours from the time of admission and 22.8% within 12 hours. Patients with chest trauma, 24.5% had a chest Abbreviated Injury Scale score of 3 or greater, and 73.6% sustained blunt chest trauma. Stratifying TBI patients with and without chest injury revealed higher mean levels of IL-4, IL-5, IL-8, and IL-10 and lower mean IFN-gamma and IL-7 levels in patient with chest injury. IL-7 levels adjusted for chest injury predicted neurological worsening with area under the receiver operating characteristic of 0.59 (p value = 0.011). The TBI and chest trauma patients' IL-4 and neuron-specific enolase levels were predictive of mortality (area under the receiver operating characteristic of 0.67 and 0.63, p = 0.0001, 0.003), respectively. CONCLUSION Utilizing biomarkers for early identification of patients with TBI and chest trauma has the capability of modifying adverse factors affecting morbidity and mortality in this subset of TBI patients. LEVEL OF EVIDENCE Level III.	[Crawford, Angela M.; Lozanova, Petya; Scalea, Thomas M.; Stein, Deborah M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Yang, Shiming; Hu, Peter; Li, Yao] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA		Crawford, AM (corresponding author), Univ Maryland, R Adams Cowley Shock Trauma Ctr, 11 S Paca St, Baltimore, MD 21201 USA.	acrawford@som.umaryland.edu			USAF [FA8650-13-2-6D09]	This study was supported in part by USAF grant FA8650-13-2-6D09 (Fit-to-Fly).	Bradley MJ, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0170-7; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention (CDC) United States Department of Defense (DOD) VA Leadership Panel Report to Congress on Traumatic Brain Injury in the United States, VA LEAD PAN REP C TR; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Couret D, 2013, AM J EMERG MED, V31, P1220, DOI 10.1016/j.ajem.2013.05.028; Dai D, 2013, IMPACT THORACIC INJU; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; LOCICERO J, 1989, SURG CLIN N AM, V69, P15; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Michelet P, 2010, J TRAUMA, V68, P395, DOI 10.1097/TA.0b013e3181a601cb; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pape HC, 2010, DAMAGE CONTROL MANAGEMENT IN THE POLYTRAUMA PATIENT, P1, DOI 10.1007/978-0-387-89508-6; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; Peng W, 2014, J NEUROSURG; Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI 10.1586/ERS.10.92; Seitz DH, 2011, J TRAUMA, V70, P189, DOI 10.1097/TA.0b013e3181d7693c; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; STELLIN G, 1991, AM SURGEON, V57, P780; Trupka A., 1996, POSTTRAUMATISCHES MU, P11; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zhu H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-58	42	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2019	87			1			S146	S151		10.1097/TA.0000000000002256			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	KB6AV	WOS:000506576600022	31246919				2022-02-06	
J	Frosen, J; Frisk, O; Raj, R; Hernesniemi, J; Tukiainen, E; Barner-Rasmussen, I				Frosen, Juhana; Frisk, Oskari; Raj, Rahul; Hernesniemi, Juha; Tukiainen, Erkki; Barner-Rasmussen, Ian			Outcome and rational management of civilian gunshot injuries to the brainretrospective analysis of patients treated at the Helsinki University Hospital from 2000 to 2012	ACTA NEUROCHIRURGICA			English	Article						Gunshot wound; Brain injury; Mortality; Survival; Treatment indications	TRAUMATIC BRAIN-INJURY; WOUNDS; BALLISTICS; FINLAND; HEAD	BackgroundTreatment of gunshot wounds of the brain (GSWB) remains controversial and there is high variation in reported survival rates (from <10 to >90%) depending on the etiology and country. We retrospectively analyzed the outcome of a series of consecutive GSWB patients admitted alive to a level 1 trauma center in a safe high-income welfare country with a low rate of homicidal gun violence.MethodsPatients admitted due to a GSWB to the HUS Helsinki University Hospital during 2000-2012 were identified from hospital discharge registry and log books of the emergency room and ICU. CT scans and medical records of these patients were reviewed. Univariate analysis and backward logistic regression were performed, and their results compared with that of a systematic literature review of factors related to the outcome of GSWB patients.ResultsSixty-four patients admitted alive after GSWB were identified. Eighty percent had self-inflicted GSWB, 81% were contact shots, and 70% were caused by handguns. In-hospital mortality was 72%. Factors associated with mortality in our series were low GCS (8) at admission, transventricular bullet trajectory, and associated damage to deep brain structures, as reported before in the literature. Of the 64 patients admitted alive, 42% (27/64) were admitted to ICU, 34% (22/64) underwent surgery, and in 25% (16/64), craniotomy and hematoma evacuation was performed. Mortality in the surgically treated group was 32% but near 100% without surgery and ICU treatment. Median GOS in the surgically treated patients was 3 (range 1-5).ConclusionsGSWB caused by contact shot from handguns has a high mortality rate, but can be survived with reasonable outcome if limited to lobar injury without significant damage to deep brain structures or brain stem. In such GSWB patients, initial aggressive resuscitation, ICU admission, and surgery seem indicated.	[Frosen, Juhana] Kuopio Univ Hosp, Dept Neurosurg, Kuopio, Finland; [Frosen, Juhana] Univ Eastern Finland, Kuopio, Finland; [Frisk, Oskari; Tukiainen, Erkki; Barner-Rasmussen, Ian] HUS Helsinki Univ Hosp, Dept Plast Surg, Helsinki, Finland; [Frisk, Oskari; Raj, Rahul; Tukiainen, Erkki; Barner-Rasmussen, Ian] Univ Helsinki, Helsinki, Finland; [Raj, Rahul] HUS Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Hernesniemi, Juha] Henan Prov Peoples Hosp, Juha Hernesniemi Int Ctr Neurosurg, Zhengzhou, Henan, Peoples R China		Frosen, J (corresponding author), Kuopio Univ Hosp, Dept Neurosurg, Kuopio, Finland.; Frosen, J (corresponding author), Univ Eastern Finland, Kuopio, Finland.	Juhana.frosen@kuh.fi	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	University of Eastern Finland (UEF) including Kuopio University Hospital	Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital.	[Anonymous], 2001, J TRAUMA, V51, pS12; BOSTMAN O, 1993, ANN CHIR GYNAECOL FE, V82, P47; Boyd LR, 2017, J ROY ARMY MED CORPS, V163, P342, DOI 10.1136/jramc-2016-000743; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Croezen DH, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1034/j.1399-0012.2001.00002.x; Doan N, 2016, J SURG CASE REP, V2016, P2016; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hazama A, 2018, WORLD NEUROSURG, V117, P309, DOI 10.1016/j.wneu.2018.06.132; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Kong V, 2017, ANZ J SURG, V87, P186, DOI 10.1111/ans.13846; Lichte P, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-35; LILLARD PL, 1978, SURG NEUROL, V9, P79; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; Marczak Laurie, 2016, JAMA, V316, P2347, DOI 10.1001/jama.2016.16676; Mattila VM, 2006, J TRAUMA, V61, P1222, DOI 10.1097/01.ta.0000197179.50226.1d; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Ospina-Delgado D, 2018, NEUROCIRUGIA, V29, P217, DOI 10.1016/j.neucir.2018.04.001; Patil R, 2015, J CRANIOVERTEBRAL JU, V6, P149, DOI 10.4103/0974-8237.167855; Rainio J, 2005, AM J FOREN MED PATH, V26, P70, DOI 10.1097/01.paf.0000154334.43260.82; Rhee PM, 2016, J TRAUMA ACUTE CARE, V80, P853, DOI 10.1097/TA.0000000000001037; RIDAH S, 1988, J APPL PHYS, V64, P152, DOI 10.1063/1.341448; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; University of Sydney School of Public Health, 2019, GUNS FINL FACTS FIG; Valadka AB, 2000, J TRAUMA, V48, P296, DOI 10.1097/00005373-200002000-00017; Wikipedia, 2019, WELF FINL	36	6	6	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2019	161	7					1285	1295		10.1007/s00701-019-03952-y			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ID9JZ	WOS:000472004700003	31129782	Green Published, hybrid			2022-02-06	
J	Howell, DR; Potter, MN; Kirkwood, MW; Wilson, PE; Provence, AJ; Wilson, JC				Howell, David R.; Potter, Morgan N.; Kirkwood, Michael W.; Wilson, Pamela E.; Provence, Aaron J.; Wilson, Julie C.			Clinical predictors of symptom resolution for children and adolescents with sport-related concussion	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric concussion; mild traumatic brain injury; trauma; Romberg test; postural balance; recovery	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL CONSULTATION; POSTCONCUSSION SYMPTOMS; RECOVERY; BALANCE; DURATION; MANAGEMENT; SEVERITY	OBJECTIVE The goal of this study was to determine which variables assessed during an initial clinical evaluation for concussion are independently associated with time until symptom resolution among pediatric patients. METHODS Data collected from a prospective clinical registry of pediatric patients with concussion were analyzed. The primary outcome variable was time from injury until symptom resolution. Predictor variables assessed within 10 days after injury included preinjury factors, Health and Behavior Inventory scores, headache severity, and balance, vestibular, and oculomotor test performances. The researchers used univariate Cox proportional models to identify potential predictors of symptom resolution time and constructed a multivariate Cox proportional hazards model in which total duration of concussion symptoms remained the outcome variable. RESULTS The sample consisted of 351 patients (33% female, mean age 14.6 +/- 2.2 years, evaluated 5.6 +/- 2.6 days after concussion). Univariate Cox proportional hazards models indicated that several variables were associated with a longer duration of symptoms, including headache severity (hazard ratio [HR] 0.90 [95% CI 0.85-0.96]), headache frequency (HR 0.83 [95% CI 0.71-0.96]), confusion (HR 0.79 [95% CI 0.69-0.92]), forgetfulness (HR 0.79 [95% CI 0.68-0.92]), attention difficulties (HR 0.83 [95% Cl 0.72-0.96]), trouble remembering (HR 0.84 [95% CI 0.72-0.98]), getting tired often (HR 0.86 [95% CI 0.76-0.97]), getting tired easily (HR 0.86 [95% CI 0.76-0.98]), dizziness (HR 0.86 [95% Cl 0.75-0.99]), and abnormal performance on the Romberg test (HR 0.59 [95% CI 0.40-0.85]). A multivariate Cox proportional hazards model indicated that an abnormal performance on the Romberg test was independently associated with a longer duration of symptoms (HR 0.65 [95% CI 0.44-0.98]; p = 0.038). CONCLUSIONS For children and adolescents evaluated within 10 days after receiving a concussion, abnormal performance on the Romberg test was independently associated with a longer duration of symptoms during recovery. In line with findings of other recent studies investigating predictors of symptom resolution, postural stability tests may provide useful prognostic information for sports medicine clinicians.	[Howell, David R.; Potter, Morgan N.; Provence, Aaron J.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Kirkwood, Michael W.; Wilson, Pamela E.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO USA; [Howell, David R.; Potter, Morgan N.; Provence, Aaron J.; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Kirkwood, Michael W.; Wilson, Pamela E.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.	david.howell@ucdenver.edu					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Chase D, 2018, DEV NEUROPSYCHOL, V43, P345, DOI 10.1080/87565641.2018.1428326; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Filippi CG, 2016, J PEDIATR NEURORADIO, V5, P32, DOI 10.1055/s-0036-1584416; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, J PEDIAT, V174; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Iverson GL, 2003, BRIT J SPORT MED, V51, P941; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Jacobson GP, 2011, EAR HEARING, V32, pE1, DOI 10.1097/AUD.0b013e31822802bb; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Provance AJ, 2016, SPORTS HEALTH, V6, P410; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	47	6	6	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2019	24	1					54	61		10.3171/2018.11.PEDS18626			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	IF8HV	WOS:000473331600009	30994475	Bronze			2022-02-06	
J	Konan, LM; Song, HL; Pentecost, G; Fogwe, D; Ndam, T; Cui, JK; Johnson, CE; Grant, D; White, T; Chen, M; Xia, WM; Cernak, I; DePalma, RG; Gu, ZZ				Konan, Landry M.; Song, Hailong; Pentecost, Genevieve; Fogwe, Delvise; Ndam, Tina; Cui, Jiankun; Johnson, Catherine E.; Grant, DeAna; White, Tommi; Chen, Mei; Xia, Weiming; Cernak, Ibolja; DePalma, Ralph G.; Gu, Zezong			Multi-Focal Neuronal Ultrastructural Abnormalities and Synaptic Alterations in Mice after Low-Intensity Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						axonal microtubule injury; low-intensity open-field blast; synaptic alterations; tau; transmission electron microscopy	TRAUMATIC BRAIN-INJURY; STRETCH-INJURY; AMYLOID-BETA; CELL-DEATH; STRESS; TAU; PLASTICITY; SYNAPSES; MODEL; MICROTUBULES	Service members during military actions or combat training are exposed frequently to primary blast generated by explosive weaponry. The majority of military-related neurotrauma are classified as mild and designated as "invisible injuries" that are prevalent during current conflicts. While the previous experimental blast injury studies using moderate- to high-intensity exposures focused mainly on gross and microscopic neuropathology, our previous studies have shown that low-intensity blast (LIB) exposures resulted in nanoscale subcellular myelin and mitochondrial damages and subsequent behavioral disorders in the absence of gross or detectable cellular damage. In this study, we used transmission electron microscopy to delineate the LIB effects at the ultrastructural level specifically focusing on the neuron perikaryon, axons, and synapses in the cortex and hippocampus of mice at seven and 30 days post-injury (DPI). We found dysmorphic dark neuronal perikaryon and "cytoplasmic aeration" of dendritic processes, as well as increased microtubular fragmentation of the myelinated axons along with biochemically measured elevated tau/phosphorylated tau/A beta levels. The number of cortical excitatory synapses decreased along with a compensatory increase of the post-synaptic density (PSD) thickness both at seven and 30 DPI, while the amount of hippocampal CA1 synapses increased with the reduced PSD thickness. In addition, we observed a significant increase in protein levels of PSD95 and synaptophysin mainly at seven DPI indicating potential synaptic reorganization. These results demonstrated that a single LIB exposure can lead to ultrastructural brain injury with accompanying multi-focal neuronal organelle alterations. This pre-clinical study provides key insights into disease pathogenesis related to primary blast exposure.	[Konan, Landry M.; Song, Hailong; Pentecost, Genevieve; Fogwe, Delvise; Ndam, Tina; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Johnson, Catherine E.] Missouri Univ Sci & Technol, Dept Min & Nucl Engn, Rolla, MO 65409 USA; [Grant, DeAna; White, Tommi] Univ Missouri, Electron Microscopy Core Facil, Columbia, MO USA; [Chen, Mei; Xia, Weiming] Bedford VA Med Ctr, Bedford, MA USA; [Chen, Mei; Xia, Weiming] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA USA; [Cernak, Ibolja] STARR C Stress Trauma & Resilience Res Consulting, Philadelphia, PA USA; [DePalma, Ralph G.] Uniformed Univ Hlth Sci, Norman Rich Dept Surg, Bethesda, MD USA; [DePalma, Ralph G.] Dept Vet Affairs, Off Res & Dev, Washington, DC USA; [Cui, Jiankun; Gu, Zezong] Truman VA Hosp, Res Serv, Columbia, MO USA		Gu, ZZ (corresponding author), Univ Missouri Columbia, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA.	guze@health.missouri.edu	Song, Hailong/I-9418-2018	Song, Hailong/0000-0002-4204-6459; Ibolja, Cernak/0000-0003-3214-698X; Fogwe, Delvise/0000-0001-8296-5735; Konan, Landry/0000-0003-2679-3785	DoD Congressionally Directed Medical Research Programs (CDMRP) for the Peer Reviewed Alzheimer's Research Program Convergence Science Research Award (PRARP-CSRA) [AZ140109]; Electron Microscopy Core (EMC) Excellence in Electron Microscopy; EMC Fellowship; Department of Pathology and Anatomical Sciences from the University of Missouri School of Medicine; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I21BX002215, I01BX003527, I21BX003807]; Cure Alzheimer's Fund	This publication was made possible by funding from the DoD Congressionally Directed Medical Research Programs (CDMRP) for the Peer Reviewed Alzheimer's Research Program Convergence Science Research Award (PRARP-CSRA; AZ140109). We also appreciate the support from the Electron Microscopy Core (EMC) Excellence in Electron Microscopy and EMC Fellowship awards (LK and HS) and the research funds from Department of Pathology and Anatomical Sciences from the University of Missouri School of Medicine (ZG). This study was also supported by the award I21BX002215, I01BX003527 and I21BX003807 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development and the Cure Alzheimer's Fund (WX). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the United States government, the DoD, the United States Army or the Department of Veterans Affairs.	Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Chaudhury S, 2009, SYNAPSE, V63, P152, DOI 10.1002/syn.20585; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Csabai D, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00024; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Du X, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2069-8; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elsworth JD, 2013, INT J NEUROPSYCHOPH, V16, P905, DOI 10.1017/S1461145712000892; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Fournier AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131617; Fukunaga Y, 2015, NEUROSCI RES, V101, P6, DOI 10.1016/j.neures.2015.07.003; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Harris KM, 2012, COLD SPRING HARB PER, V4, P5, DOI DOI 10.1101/CSHPERSPECT.A005587; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Marques SA, 2003, BRAIN RES, V969, P1, DOI 10.1016/S0006-8993(02)03834-9; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Parisian C.M., 2017, J NAT SCI, V3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Reist NE, 1998, J NEUROSCI, V18, P7662; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Smith M, 2016, EXP NEUROL, V286, P107, DOI 10.1016/j.expneurol.2016.10.002; Song H., 2018, TRANSL STROKE RES; Song H., 2019, J NEUROTRAUMA; Song HL, 2018, NEURAL REGEN RES, V13, P1516, DOI 10.4103/1673-5374.237110; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Timmermans W, 2013, NEUROSCIENCE, V248, P626, DOI 10.1016/j.neuroscience.2013.05.043; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016	65	6	7	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2117	2128		10.1089/neu.2018.6260			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600433	30667346				2022-02-06	
J	Ledwidge, PS; Patterson, JN; Molfese, DL; Honaker, JA				Ledwidge, Patrick S.; Patterson, Jessie N.; Molfese, Dennis L.; Honaker, Julie A.			Clinical Utility of Oculomotor and Electrophysiological Measures in Identifying Concussion History	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports-related concussion; electrophysiology; oculomotors; neuropsychology; postural control	SPORTS-RELATED CONCUSSION; WORKING-MEMORY; DEFICITS; STATEMENT; RECOVERY; RELIABILITY; INJURY	Objective: To examine whether oculomotor and electrophysiological measures improve the clinical performance of the typical concussion protocol for classifying collegiate athletes with a history of concussion. Design: Cross-sectional. Setting: University Athletic Medicine and Research Facility. Participants: Forty-five varsity collegiate athletes. Independent Variables: Collegiate varsity athletes with or without a history of a diagnosed concussion. Main Outcome Measures: Multivariate receiver operating curve and area under the curve (AUC) analyses tested the clinical performance of the typical concussion protocol (symptoms, postural control, neuropsychological abilities). We examined differences in clinical performance between this protocol and after adding reflexive saccade and event-related potential (ERP) indices. Hypotheses were formed after data collection. Results: Significant AUCs were demonstrated for the typical concussion protocol (model 1: AUC = 0.75, P = 0.007), after adding reflexive saccade eye excursion gain (model 2: AUC = 0.80, P = 0.001), and ERPs (model 3: AUC = 0.79, P = 0.002). The AUC for reflexive saccades and ERPs was significant (model 4: AUC = 0.70, P = 0.030). Model 2's increased clinical performance compared with model 1 was nonsignificant, chi(2)(2) = 1.871, P = 0.171. Conclusions: All 4 models demonstrated adequate sensitivity and specificity for classifying athletes with a previous concussion. Adding reflexive saccades and ERPs did not significantly increase clinical performance of the typical concussion protocol. Future research should determine the clinical utility of saccades and ERPs for acute postconcussion assessments.	[Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska Lincoln, Dept Psychol, Lincoln, NE USA; [Ledwidge, Patrick S.; Patterson, Jessie N.; Molfese, Dennis L.; Honaker, Julie A.] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE USA; [Ledwidge, Patrick S.] Baldwin Wallace Univ, Dept Psychol, 275 Eastland Rd, Berea, OH 44017 USA; [Patterson, Jessie N.; Honaker, Julie A.] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Honaker, Julie A.] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44106 USA		Ledwidge, PS (corresponding author), Baldwin Wallace Univ, Dept Psychol, 275 Eastland Rd, Berea, OH 44017 USA.	pledwidg@bw.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIHR01 HD073202]; Nebraska Tobacco Settlement Biomedical Enhancement funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD073202] Funding Source: NIH RePORTER	Supported partially by the National Institutes of Health, NIHR01 HD073202, and the Nebraska Tobacco Settlement Biomedical Enhancement funds.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Reitan R, 1985, HALSTEAD REITAN NEUR; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Shepard NT, 2015, BALANCE FUNCTION ASS, P209; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; TURNER RG, 1984, EAR HEARING, V5, P125, DOI 10.1097/00003446-198405000-00002; Wechsler D., 2008, WECHSLER ADULT INTEL	35	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2019	29	4					292	297		10.1097/JSM.0000000000000512			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	IQ4RL	WOS:000480737900008	31241531	Green Accepted			2022-02-06	
J	Manickam, V; Dhakshinamoorthy, V; Perumal, E				Manickam, Vijayprakash; Dhakshinamoorthy, Vasanth; Perumal, Ekambaram			Iron Oxide Nanoparticles Affects Behaviour and Monoamine Levels in Mice	NEUROCHEMICAL RESEARCH			English	Article						Brain markers; Demyelination; Energy depletion; Fe2O3-NPs; Monoamines; Neurobehaviour	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; TYROSINE-HYDROXYLASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; SODIUM-FLUORIDE; EXPRESSION; CALCIUM; DEFICIENCY; TOXICITY	Iron oxide (Fe2O3) nanoparticles (NPs) attract the attention of clinicians for its unique magnetic and paramagnetic properties, which are exclusively used in neurodiagnostics and therapeutics among the other biomedical applications. Despite numerous research findings has already proved neurotoxicity of Fe2O3-NPs, factors affecting neurobehaviour has not been elucidated. In this study, mice were exposed to Fe2O3-NPs (25 and 50mg/kg body weight) by oral intubation daily for 30days. It was observed that Fe2O3-NPs remarkably impair motor coordination and memory. In the treated brain regions, mitochondrial damage, depleted energy level and decreased ATPase (Mg2+, Ca2+ and Na+/K+) activities were observed. Disturbed ion homeostasis and axonal demyelination in the treated brain regions contributes to poor motor coordination. Increased intracellular calcium ([Ca2+](i)) and decreased expression of growth associated protein 43 (GAP43) impairs vesicular exocytosis could result in insufficient signal between neurons. In addition, levels of dopamine (DA), norepinephrine (NE) and epinephrine (EP) were found to be altered in the subjected brain regions in correspondence to the expression of monoamine oxidases (MAO). Along with all these factors, over expression of glial fibrillary acidic protein (GFAP) confirms the neuronal damage, suggesting the evidences for behavioural changes.	[Manickam, Vijayprakash; Dhakshinamoorthy, Vasanth; Perumal, Ekambaram] Bharathiar Univ, Dept Biotechnol, Mol Toxicol Lab, Coimbatore 641046, Tamil Nadu, India		Perumal, E (corresponding author), Bharathiar Univ, Dept Biotechnol, Mol Toxicol Lab, Coimbatore 641046, Tamil Nadu, India.	ekas2009@buc.edu.in	Perumal, Ekambaram/R-9319-2018	Perumal, Ekambaram/0000-0003-2159-8198	UGC-BSR, New Delhi, India [F.7-25/2007]; UGC-SAP DRS II, New Delhi, India [F-3-30/2013]; DST FIST, New Delhi, IndiaDepartment of Science & Technology (India) [SR/FST/LSI-618/2014]; DST-SERB, New Delhi, India [EMR/2014/000600]	The authors would like to acknowledge Sophisticated Analytical Instrument Facility, All India Institute of Medical science (AIIMS), New Delhi, for the technical assistance in transmission electron microscopy. The authors are also grateful to Mr. Monojit Bhattacharjee, Bharathiar University, Coimbatore, for his assistance in HPLC analysis. Vijayprakash Manickam acknowledges the UGC-BSR fellowship (UGC-BSR-No.F.7-25/2007) funded by UGC-BSR, New Delhi, India. We also thank the UGC-SAP DRS II (F-3-30/2013), DST FIST (SR/FST/LSI-618/2014) and DST-SERB (EMR/2014/000600), New Delhi, India for their partial financial assistance.	Barbelivien A, 2001, PHARMACOL TOXICOL, V88, P304; Batra J, 2005, INDIAN J CLIN BIOCHE, V20, P119, DOI 10.1007/BF02867410; Bezem MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep30390; BONTING SL, 1963, ARCH BIOCHEM BIOPHYS, V101, P47, DOI 10.1016/0003-9861(63)90532-0; Bortolato M, 2011, INT REV NEUROBIOL, V100, P13, DOI 10.1016/B978-0-12-386467-3.00002-9; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Coggan JS, 2015, INT J MOL SCI, V16, P21215, DOI 10.3390/ijms160921215; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; DEVASAGAYAM TPA, 1987, BIOCHEM BIOPH RES CO, V145, P134, DOI 10.1016/0006-291X(87)91297-6; Dhakshinamoorthy V, 2017, NEUROTOX RES, V32, P187, DOI 10.1007/s12640-017-9721-1; Dribben WH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.39; EISENHOFER G, 1994, J PHARMACOL EXP THER, V268, P1242; Ekambaram P, 2003, FLUORIDE, V36, P189; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Estelrich J, 2015, INT J NANOMED, V10, P1727, DOI 10.2147/IJN.S76501; Fredriksson A, 2000, DEV BRAIN RES, V119, P65, DOI 10.1016/S0165-3806(99)00160-1; Guo C, 2003, NEURAL REGEN RES, V8, P2003, DOI DOI 10.3969/J.ISSN.1673-5374.2013.21.009; HAHN PF, 1990, RADIOLOGY, V175, P695, DOI 10.1148/radiology.175.3.2343116; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; HJERTEN S, 1983, BIOCHIM BIOPHYS ACTA, V728, P281, DOI 10.1016/0005-2736(83)90480-7; Johnson WK, 1996, MAGN RESON IMAGING, V14, P43, DOI 10.1016/0730-725X(95)02044-T; KADEKARO M, 1985, P NATL ACAD SCI USA, V82, P6010, DOI 10.1073/pnas.82.17.6010; Kim JJ, 1997, P NATL ACAD SCI USA, V94, P5929, DOI 10.1073/pnas.94.11.5929; Kumari M, 2012, J NANOSCI NANOTECHNO, V12, P2149, DOI 10.1166/jnn.2012.5796; Latchney SE, 2014, DEV NEUROSCI-BASEL, V36, P44, DOI 10.1159/000357840; Lee HY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03398; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lovinger DM, 2008, ALCOHOL RES HEALTH, V31, P196; Maaroufi K, 2014, BEHAV BRAIN RES, V258, P80, DOI 10.1016/j.bbr.2013.10.016; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Manickam V, 2018, J MOL NEUROSCI, V64, P352, DOI 10.1007/s12031-018-1030-5; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Nakashima A, 2012, J NEUROCHEM, V120, P199, DOI 10.1111/j.1471-4159.2011.07562.x; Nylen K, 2002, J NEUROSCI RES, V67, P844, DOI 10.1002/jnr.10180; OHNISHI T, 1982, BIOCHIM BIOPHYS ACTA, V684, P67, DOI 10.1016/0005-2736(82)90050-5; Oloche JJ, 2012, ASIAN J BIOCH, V10, P180, DOI [10.3923/ajb.2015.180.189, DOI 10.3923/AJB.2015.180.189]; Paul V, 1998, ENVIRON TOXICOL PHAR, V6, P187, DOI 10.1016/S1382-6689(98)00033-7; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Prakash D, 2013, NEUROMOL MED, V15, P192, DOI 10.1007/s12017-012-8210-1; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; ROSENGREN LE, 1995, J NEUROL SCI, V133, P61, DOI 10.1016/0022-510X(95)00152-R; Sasaki M, 2008, NEUROREPORT, V19, P1649, DOI 10.1097/WNR.0b013e328315a637; Sheng L, 2015, J BIOMED MATER RES A, V103, P1141, DOI 10.1002/jbm.a.35263; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Shi HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13327; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Singh C, 2013, P NATL ACAD SCI USA, V110, P12816, DOI 10.1073/pnas.1308037110; Sun C, 2008, NANOMEDICINE-UK, V3, P495, DOI 10.2217/17435889.3.4.495; Sundarraj K, 2017, TOXICOL APPL PHARM, V317, P12, DOI 10.1016/j.taap.2017.01.002; Tabrez S, 2012, CNS NEUROL DISORD-DR, V11, P395, DOI 10.2174/187152712800792785; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Thanawala MS, 2013, J NEUROSCI, V33, P4625, DOI 10.1523/JNEUROSCI.4031-12.2013; Tzschentke TM, 2001, PROG NEUROBIOL, V63, P241, DOI 10.1016/S0301-0082(00)00033-2; Vargas MR, 2010, NEUROTHERAPEUTICS, V7, P471, DOI 10.1016/j.nurt.2010.05.012; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang B, 2009, J NANOPART RES, V11, P41, DOI 10.1007/s11051-008-9452-6; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang P, 2014, EUR NEUROL, V72, P249, DOI 10.1159/000363515; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Wenk Gary L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805as26; Winer JL, 2012, WORLD NEUROSURG, V78, P709, DOI 10.1016/j.wneu.2011.08.013; Wu J, 2013, NEUROTOXICOLOGY, V34, P243, DOI 10.1016/j.neuro.2012.09.006; Wu W, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/2/023501; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Yang JH, 2013, BIOMETALS, V26, P43, DOI 10.1007/s10534-012-9593-z; Yang YL, 2008, BEHAV SCI LAW, V26, P65, DOI 10.1002/bsl.788; Yarjanli Z, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0369-9; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Yu ZF, 2002, J ETHNOPHARMACOL, V83, P161, DOI 10.1016/S0378-8741(02)00211-8	76	6	6	5	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2019	44	7					1533	1548		10.1007/s11064-019-02774-9			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IC1VR	WOS:000470748000002	30941547				2022-02-06	
J	Marque, P; Denis, A; Gasq, D; Chaleat-Valayer, E; Yelnik, A; Colin, C; Perennou, D; Bensmail, D; Bussel, B; Courtois-Jacquin, S; Fournier-Mehouas, M; Gallien, P; Luaute, J; de Boissezon, X; Maupas, E; Parratte, B; Perrouin-Verbe, B; Pelissier, J; Pellas, F; Rome, J; Rousseau, M; Simonetta-Moreau, M; Vial, C				Marque, Philippe; Denis, Angelique; Gasq, David; Chaleat-Valayer, Emmanuelle; Yelnik, Alain; Colin, Cyrille; Perennou, Dominic; Bensmail, Djamel; Bussel, Bernard; Courtois-Jacquin, Sophie; Fournier-Mehouas, Manuella; Gallien, Philippe; Luaute, Jacques; de Boissezon, Xavier; Maupas, Eric; Parratte, Bernard; Perrouin-Verbe, Brigitte; Pelissier, Jacques; Pellas, Frederic; Rome, Johana; Rousseau, Marc; Simonetta-Moreau, Marion; Vial, Christophe		Botuloscope Grp	Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; GOAL ATTAINMENT; UPPER-EXTREMITY; ARM FUNCTION; A DYSPORT; STROKE; EFFICACY; SAFETY; RECOVERY	Background: Botuloscope is a cohort study supported by a French public grant and aiming to evaluate a 1-year treatment of the post-stroke spastic upper limb with botulinum toxin type A (BoNT-A) in terms of individual satisfaction with respect to personalized goals and quality of life. Methods: This was an open-label prospective, multicentric study (11 French centres) that followed 330 adults [mean (SD) age 53.7 (13.7) years] over 1 year; participants had ranked 5 therapeutic goals at inclusion [mean (SD) 5.1 (7.3) years post-stroke], had severe hemiparesis [median motricity index (MI) 40 (Q1-Q3 24 to 60)], and were assessed at inclusion (M0) and at month 3 (M3) and M12. Outcome criteria were: spasticity, range of motion, pain [visual analog scale (VAS)], motor function [Modified Ashworth Scale (MAS)] and activities (MI; Frenchay Arm Test), and overall satisfaction with the achievement of each goal (VAS) and quality of life (Reintegration to Normal Life Index). Criteria at M0 and M12 were compared. Adverse effects were also collected, as were medication changes. Results: The primary goal was comfort and activities for 63% of participants and motor function for 36%. Participants underwent amean of 2.4 injection sessions, 19% causing adverse effects. The greatest spasticity attenuation occurredwith wrist flexors (median decrease in MAS-2 [Q1-Q3; -2 to -1], P < 10(-3)). Fewer individuals took oral anti-spastic drugs (56% at M12 vs 50% at M0; P < 10(-2)). Range of motion increased by 16 degrees, on average(13 to 19; P < 10(-3)) for wrist extension. Pain prevalence decreases at rest (29% at M0 vs. 19% at M12; P < 10(-4)) and during mobilization (64% vs. 43%; P < 10(-4)), and fewer participants took analgesics (25% vs. 17%; P < 10(-3)). Satisfaction was high for the goals "hand hygiene'' and "pain release'' and moderate for "improvement in upper limb function''. However, function was more improved for participants who selected this goal as the first priority than others (P < 10(-2)). Overall, 22% had the goal "improving gait and balance'', which was reasonably achieved at M12. Quality of life improved markedly [median 8 (4 to 11) vs. 6 (3 to 10); P < 10(-4)]. Prevalence of complete dissatisfaction with the first objective was 10% to 15%. Conclusion: This is the first long-term follow-up of BoNT-A treatment for upper limb spasticity involving a large cohort independent of industry. Quality of life was improved by treating upper limb spasticity with BoNT-A, even at 5 years post-stroke. Personalizing objectives of the treatment amplified its efficacy. BoNT-A was a powerful analgesic when pain was spasticity-related. Treating the spastic upper limb also improved balance and gait abilities. (C) 2019 Elsevier Masson SAS. All rights reserved.	[Marque, Philippe; Gasq, David] CHU Purpan Pavillon Baudot, UMR Inserm 1214, UPS ToNIc Toulouse Neurolmaging Ctr, Pl Dr Baylac, F-31024 Toulouse 3, France; [Marque, Philippe] CHU Rangueil, Serv Med Phys & Readaptat, 1 Ave Pr Poulhes, F-31059 Toulouse 9, France; [Denis, Angelique; Colin, Cyrille] Hosp Civil Lyon, Dept Informat Med, 162 Ave Lacassagne, F-69000 Lyon, France; [Gasq, David] CHU Rangueil, Serv Explorat Fonct, 1 Ave Pr Poulhes, F-31059 Toulouse 9, France; [Chaleat-Valayer, Emmanuelle] Ctr Med Chirurg Readaptat Massues, 92 Ave Edmond Locard, F-69322 Lyon 05, France; [Yelnik, Alain] Paris Diderot Univ, AP HP, GH St Louis Lariboisiere F Widal, Dept Med Phys & Readaptat, 200 Rue Fbg St Denis, F-75010 Paris, France; [Perennou, Dominic] CHU Grenoble Alpes, Dept Med Phys & Readaptat, Site SUD,Ave Kimberley, F-38130 Echirolles, France; [Perennou, Dominic] Univ Grenoble Alpes, LPNC, CNRS, F-38000 Grenoble, France		Marque, P (corresponding author), CHU Purpan Pavillon Baudot, UMR Inserm 1214, UPS ToNIc Toulouse Neurolmaging Ctr, Pl Dr Baylac, F-31024 Toulouse 3, France.	marque.ph@chu-toulouse.fr	MARQUE, Philippe/AAC-4798-2019	GASQ, David/0000-0002-1339-370X	program "Support for innovative therapeuthics'' (STIC) from the health ministry of the French government	Botuloscope was an observational study funded by the program "Support for innovative therapeuthics'' (STIC) from the health ministry of the French government.	Armstrong AD, 1998, J SHOULDER ELB SURG, V7, P573, DOI 10.1016/S1058-2746(98)90003-9; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Chaleat-Valayer E, 2011, EUR J PAEDIATR NEURO, V15, P439, DOI 10.1016/j.ejpn.2010.04.006; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Cousins E, 2010, CLIN REHABIL, V24, P501, DOI 10.1177/0269215509358945; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Dong Y, 2017, EUR J PHYS REHAB MED, V53, P256, DOI 10.23736/S1973-9087.16.04329-X; Elovic EP, 2008, ARCH PHYS MED REHAB, V89, P799, DOI 10.1016/j.apmr.2008.01.007; Esquenazi A, 2017, AM J PHYS MED REHAB, V96, P881, DOI 10.1097/PHM.0000000000000781; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Fheodoroff K, 2015, TOXINS, V7, P1192, DOI 10.3390/toxins7041192; Foley N, 2013, ARCH PHYS MED REHAB, V94, P977, DOI 10.1016/j.apmr.2012.12.006; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; Higgins J, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2003.10.0156; Jost WH, 2014, J NEUROL SCI, V337, P86, DOI 10.1016/j.jns.2013.11.022; Kaji R, 2010, CURR MED RES OPIN, V26, P1983, DOI 10.1185/03007995.2010.497103; Kaya T, 2011, INT J REHABIL RES, V34, P59, DOI 10.1097/MRR.0b013e32833d6cdf; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Kwakkel G, 2015, LANCET NEUROL, V14, P969, DOI 10.1016/S1474-4422(15)00222-7; Levy J, 2019, ANN PHYS REHABIL MED, V62, P234, DOI 10.1016/j.rehab.2018.05.1320; Marciniak C, 2017, PM&R, V9, P1181, DOI 10.1016/j.pmrj.2017.06.007; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Muir Susan W, 2010, N Am J Sports Phys Ther, V5, P98; Olvey EL, 2010, CLIN THER, V32, P2282, DOI 10.1016/j.clinthera.2011.01.005; Picelli A, 2017, FUNCT NEUROL, V32, P89; Rosales RL, 2012, NEUROREHAB NEURAL RE, V26, P812, DOI 10.1177/1545968311430824; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Turner-Stokes L, 2013, BMJ OPEN, V3; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011157; Wissel J, 2017, NEUROLOGY, V88, P1321, DOI 10.1212/WNL.0000000000003789; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005; Yelnik AP, 2007, J NEUROL NEUROSUR PS, V78, P845, DOI 10.1136/jnnp.2006.103341	38	6	6	1	5	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	JUL	2019	62	4			SI		207	213		10.1016/j.rehab.2019.06.003			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	II6KL	WOS:000475302700002	31229700	Bronze			2022-02-06	
J	Martin, M; Lobo, D; Bitot, V; Couffin, S; Escalard, S; Mounier, R; Cook, F				Martin, Mathieu; Lobo, David; Bitot, Valerie; Couffin, Severine; Escalard, Simon; Mounier, Roman; Cook, Fabrice			Prediction of Early Intracranial Hypertension After Severe Traumatic Brain Injury: A Prospective Study	WORLD NEUROSURGERY			English	Article						Computed tomography; Intracranial pressure; Optic nerve sheath diameter; Transcranial Doppler; Traumatic brain injury	OPTIC-NERVE SHEATH; PRESSURE; MANAGEMENT; DIAMETER; ULTRASONOGRAPHY; GUIDELINES; CARE	OBJECTIVE: This study aimed to assess the reliability of clinical features, noninvasive transcranial Doppler-related pulsatility index (PI) calculation, and optic nerve sheath diameter (ONSD) measured by ultrasound (US) and initial computed tomography (CT) scan (Marshall CT scan classification) in predicting the occurrence of early (<24 hours) high intracranial pressure (EHICP) (>20 mm Hg) after severe traumatic brain injury (TBI). METHODS: We conducted an observational prospective study in a level 1 trauma center. Patients were measured simultaneously for PI and US ONSD in the triage zone. Patients were categorized into 2 groups: those who had EHICP after TBI (EHICP+) and those who did not (EHICP-). RESULTS: Fifty-four patients were included; 32 were categorized as EHICP+ and 22 as EHICP-. PI >1.4 did not correlate with EHICP+ patients (69% vs. 46%, P = 0.09). US ONSD measurement was higher in the EHICP+ group (6.25; range, 6-6.95 vs. 5.7; range, 5.2-6.4; P = 0.005). The area under the receiver operating characteristic curve for US ONSD as a predictor of developing EHICP was 0.73 (95% confidence interval [CI], 0.59-0.86). CT ONSD measurement was higher in the EHICP+ group (6.71; range, 6.35-7.87 vs. 6.25; range, 5.8-6.93; P = 0.04). The area under the receiver operating characteristic curve for CT ONSD measurement as a predictor for EHICP+ was 0.67 (95% CI, 0.53-0.81). The diffuse injury III and IV categories in the Marshall CT scan classification were associated with the occurrence of EHICP (P = 0.004). CONCLUSIONS: None of the clinical features or noninvasive tools assessed in this study enabled clinicians to strictly ascertain EHICP. Further studies are needed to establish their potential role before intracranial pressure probe insertion.	[Martin, Mathieu; Lobo, David; Bitot, Valerie; Couffin, Severine; Mounier, Roman; Cook, Fabrice] Paris Est Creteil Univ, Surg Intens Care Unit, Trauma Ctr, Dept Anaesthesiol & Crit Care Med, Creteil, France; [Escalard, Simon] Paris Est Creteil Univ, Dept Neuroradiol, Creteil, France; [Escalard, Simon] Henri Mondor Univ Hosp, AP HP, Creteil, France		Martin, M (corresponding author), Paris Est Creteil Univ, Surg Intens Care Unit, Trauma Ctr, Dept Anaesthesiol & Crit Care Med, Creteil, France.	mathieu.martin@aphp.fr		Bitot, Valerie/0000-0002-8447-2296			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Bremmer R, 2010, NEUROCRIT CARE, V12, P362, DOI 10.1007/s12028-009-9329-2; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Glaser J, 2016, TRAUMA SURG ACUTE CA, V1, P1; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meyfroidt G, 2017, NEUROSURGERY, V81, pE1, DOI 10.1093/neuros/nyx144; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Wang LJ, 2018, JAMA OPHTHALMOL, V136, P250, DOI 10.1001/jamaophthalmol.2017.6560	29	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						E1242	E1248		10.1016/j.wneu.2019.04.121			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300157	31009774				2022-02-06	
J	McLeod, TCV; Kostishak, N; Anderson, BE; Bacon, CEW; Lam, KC				McLeod, Tamara C. Valovich; Kostishak, Nicholas, Jr.; Anderson, Barton E.; Bacon, Cailee E. Welch; Lam, Kenneth C.			Patient, Injury, Assessment, and Treatment Characteristics and Return-to-Play Timelines After Sport-Related Concussion: An Investigation from the Athletic Training Practice-Based Research Network	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; brain concussion; balance; cognition; symptoms; documentation; adolescent	ASSOCIATION POSITION STATEMENT; HIGH-SCHOOL; MANAGEMENT; RECOVERY; REHABILITATION; SERVICES; TRENDS; CARE	Objectives: To describe the patient, injury, assessment and treatment characteristics, as well as return-to-play timelines and clinical findings at discharge for adolescent patients after sport-related concussion. Design: Retrospective analysis of electronic medical records. Setting: Athletic training facilities of secondary school members of the Athletic Training Practice-Based Research Network (AT-PBRN). Patients: In total, 1886 patient records were reviewed. [1204 (63.8%) male, 682 (36.2%) female, age = 15.3 +/- 1.9 years, height = 169.5 +/- 13.5 cm, mass = 70.3 +/- 17.0 kg]. Patients were diagnosed with a concussion by an athletic trainer or team/directing physician. Interventions: None. Main Outcome Measures: Descriptive analysis of patient, injury, assessment, treatment, and participation status characteristics, as well as discharge information. Results: Injury demographic forms were completed for 1886 concussion cases. A concussion-specific evaluation form was completed for 55.9% (n = 1054) of cases. Treatment documentation was completed on 829 patients (44.0% of initial documented cases). Discharge forms were completed for 750 patients (40.0% of initial documented cases). Most cases were coded as 850.9-Concussion (85.5%, n = 642) and occurred during an in-season game (49.4%, n = 308). Time lost from competition was 24.9 +/- 39.9 days. Conclusions: Most concussion cases documented in this study were not on-field emergencies, as indicated by their normal clinical examinations and the lack of immediate referral to an emergency department. However, certain aspects of the clinical examination were often not assessed during the initial evaluation. These findings describe concussion assessment and recovery in adolescents and reinforce the need for a standardized approach to concussion assessment and appropriate documentation.	[McLeod, Tamara C. Valovich; Kostishak, Nicholas, Jr.; Anderson, Barton E.; Bacon, Cailee E. Welch; Lam, Kenneth C.] AT Still Univ, Arizona Sch Hlth Sci, Postprofess Athlet Training Program, Mesa, AZ USA; [McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA; [Kostishak, Nicholas, Jr.] Profess Phys Therapy & Holy Trinity Diocesan High, Garden City, NY USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020; Lam, Kenny/ABB-9733-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Lam, Kenneth/0000-0002-2185-0990	National Operating Committee on Standards for Athletic Equipment (NOCSAE)	Funding provided by a grant from the National Operating Committee on Standards for Athletic Equipment (NOCSAE).	American Medical Association, 1998, H 470 995 ATHL SPORT; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Bacon CEW, 2017, J ATHL TRAINING, V52, P667, DOI 10.4085/1062-6050-52.3.15; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Lam KC, 2016, J ATHL TRAINING, V51, P435, DOI 10.4085/1062-6050-51.8.03; Lam KC, 2015, SPORTS HEALTH, V7, P67, DOI 10.1177/1941738114555842; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2012, J ATHL TRAINING, V47, P557, DOI 10.4085/1062-6050-47.5.05; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Nottingham SL, 2017, J ATHL TRAINING, V52, P656, DOI 10.4085/1062-6050-52.3.14; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612	36	6	6	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2019	29	4					298	305		10.1097/JSM.0000000000000530			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	IQ4RL	WOS:000480737900009	31241532				2022-02-06	
J	Morris, DM; Taub, E; Mark, VW; Liu, W; Brenner, L; Pickett, T; Stearns-Yoder, K; Bishop-McKay, S; Taylor, A; Reder, L; Adams, T; Rimmer, J; Dew, D; Szaflarski, J; Womble, B; Stevens, L; Rothman, D; Uswatte, G				Morris, David M.; Taub, Edward; Mark, Victor W.; Liu, Wei; Brenner, Lisa; Pickett, Treven; Stearns-Yoder, Kelly; Bishop-McKay, Staci; Taylor, Andrea; Reder, Laura; Adams, Terrie; Rimmer, James; Dew, Dustin; Szaflarski, Jerzy; Womble, Brent; Stevens, Lillian; Rothman, David; Uswatte, Gitendra			Protocol for a Randomized Controlled Trial of CI Therapy for Rehabilitation of Upper Extremity Motor Deficit: The Bringing Rehabilitation to American Veterans Everywhere Project	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						carryover effects; CI therapy; motor deficit; transfer package; traumatic brain injury; upper extremity	INDUCED MOVEMENT THERAPY; UPPER-LIMB HEMIPARESIS; BRAIN; RELIABILITY; STROKE; ARM; VALIDITY; PLASTICITY; SPASTICITY; RECOVERY	Constraint-induced movement therapy (CI therapy) has been shown to reduce disability for individuals with upper extremity (UE) hemiparesis following different neurologic injuries. This article describes the study design and methodological considerations of the Bringing Rehabilitation to American Veterans Everywhere (BRAVE) Project, a randomized controlled trial of CI therapy to improve the motor deficit of participants with chronic and subacute traumatic brain injury. Our CI therapy protocol comprises 4 major components: (1) intensive training of the more-affected UE for target of 3 hour/day for 10 consecutive weekdays, (2) a behavioral technique termed shaping during training, (3) a "transfer package," 0.5 hour/day, of behavioral techniques to transfer therapeutic gains from the treatment setting to the life situation, and (4) prolonged restraint of use of the UE not being trained. The primary endpoint is posttreatment change on the Motor Activity Log, which assesses the use of the more-affected arm outside the laboratory in everyday life situations. Data from a number of secondary outcome measures are also being collected and can be categorized as physical, genomic, biologic, fitness, cognitive/behavioral, quality of life, and neuroimaging measures.	[Taub, Edward; Mark, Victor W.; Bishop-McKay, Staci; Taylor, Andrea; Reder, Laura; Adams, Terrie; Womble, Brent; Uswatte, Gitendra] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Morris, David M.; Uswatte, Gitendra] Univ Alabama Birmingham, Dept Phys Therapy, 383 Sch Hlth Profess Bldg, Birmingham, AL 35294 USA; [Mark, Victor W.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Mark, Victor W.; Szaflarski, Jerzy] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Rimmer, James] Univ Alabama Birmingham, Dept Occupat Therapy, Birmingham, AL USA; [Rimmer, James; Dew, Dustin] Univ Alabama Birmingham, UAB Lakeshore Res Collaborat, Birmingham, AL USA; [Liu, Wei] Edward Via Coll Osteopath Med, Auburn, AL USA; [Pickett, Treven] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brenner, Lisa] Univ Colorado, Dept Psychiat, Denver, CO USA; [Brenner, Lisa] Univ Colorado, Dept Neurol, Denver, CO USA; [Brenner, Lisa] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO USA; [Brenner, Lisa] Denver Vet Med Ctr, Denver, CO USA; [Stearns-Yoder, Kelly] Rocky Mt MIRECC, Denver, CO USA; [Stevens, Lillian; Rothman, David] Virginia Commonwealth Univ, Dept Phys Med, Richmond, VA USA; [Rothman, David] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian] Virginia Commonwealth Univ, Dept Rehabil, Richmond, VA USA		Morris, DM (corresponding author), Univ Alabama Birmingham, Dept Phys Therapy, 383 Sch Hlth Profess Bldg, Birmingham, AL 35294 USA.	morrisd@uab.edu	Brenner, Lisa A./AAG-2442-2019; Mark, Victor/AAT-3772-2020		Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-14-2-0167]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NSFNational Science Foundation (NSF); Shor Foundation for Epilepsy Research, Department of Defense; UCB Biosciences; SAGE Therapeutics Inc; Eisai Inc.Eisai Co Ltd; NeuroPace, Inc; Medical Association of the State of Alabama; LivaNova Inc	This work was supported by the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program under Award No. W81XWH-14-2-0167. ClinicalTrails. gov Identifier: NCT02339220. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.r Dr Szaflarski reports funding from the NIH, NSF, Shor Foundation for Epilepsy Research, Department of Defense, UCB Biosciences, NeuroPace Inc, SAGE Therapeutics Inc, Serina Therapeutics Inc, Greenwich Biosciences Inc, State of Alabama, and Eisai Inc. Dr Szaflarski reports serving as a consultant or on advisory boards of SAGE Therapeutics Inc, GW Pharmaceuticals Inc, NeuroPace, Inc, Upsher-Smith Laboratories, Inc, Medical Association of the State of Alabama, Serina Therapeutics Inc, LivaNova Inc, Lundbeck, and Elite Medical Experts LLC. He serves on editorial board for Epilepsy & Behavior, Journal of Epileptology (associate editor), Journal of Medical Science, Epilepsy Currents (contributing editor), and Folia Medica Copernicana.	Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; Andersson AG, 2006, J REHABIL MED, V38, P186, DOI 10.1080/16501970500478023; [Anonymous], 1999, JAMA-J AM MED ASSOC, V10, P974; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Cho YW, 2005, NEUROREHABILITATION, V20, P71; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuhrer MJ, 2003, AM J PHYS MED REHAB, V82, pS8, DOI 10.1097/01.PHM.0000086995.80644.D7; Fulk GD, 2007, PHYS REHABILITATION, P895; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Henderson CA, 2012, DISABIL REHABIL, V34, P2177, DOI 10.3109/09638288.2012.673686; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mark VW, 2015, MULT SCLER J, V21, P213; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P270, DOI 10.1123/jsep.16.3.270; Microsoft Corporation, 2013, ON MICR WAY; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; Morris D M, 2006, Eura Medicophys, V42, P257; Morris DM, 2006, NEUROREHABILITATION, V21, P131; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; National Institute on Disability and Rehabilitation Research, 2014, TBI MOD SYST FORM 2; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160; Razumovsky A, 2013, STROKE, V44; Rubin DB, 1995, CLIN PHARMACOL THER, V57, P93; SAS Institute Inc, 2017, 100 SAS CAMP DRIV; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sterr A, 2004, NEUROLOGY, V63, P2176, DOI 10.1212/01.WNL.0000145605.20476.07; Sterr A, 2002, BRAIN INJURY, V16, P1093, DOI 10.1080/02699050210155267; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Taub E, 2005, STROKE, V36, P1301, DOI 10.1161/01.STR.0000166043.27545.e8; Taub E, 2004, AM PSYCHOL, V59, P692, DOI 10.1037/0003-066X.59.8.692; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; Tryon WW, 1996, BEHAV RES METH INS C, V28, P392, DOI 10.3758/BF03200519; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2000, STROKE, V31, P662, DOI 10.1161/01.STR.31.3.662; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Weschler D., 1997, WECHLER MEMORY SCALE; Winkler PA, NEUROLOGICAL REHABIL, V200, P416; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2005, NEUROREHAB NEURAL RE, V19, P194, DOI 10.1177/1545968305276663; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	54	6	6	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					268	279		10.1097/HTR.0000000000000460			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400015	30608308				2022-02-06	
J	O'Brien, KH; Schellinger, SK; Hwang, BL; LaPlaca, MC				O'Brien, Katy H.; Schellinger, Sarah K.; Hwang, Brenda L.; LaPlaca, Michelle C.			A Comparison of Student and Parent Knowledge and Perceived Confidence About Brain Injury and Concussion	TOPICS IN LANGUAGE DISORDERS			English	Article						brain injury; concussion; confidence; health knowledge; misconceptions; pediatric; prevention; public education; public knowledge; sports	SCHOOL FOOTBALL PLAYERS; COMMON MISCONCEPTIONS; COGNITIVE IMPAIRMENT; ATTITUDES; EDUCATION; MILD; PROFESSIONALS; PERCEPTIONS; BEHAVIORS; AWARENESS	Purpose: The public has long had misconceptions about traumatic brain injury (TBI) and its effects. Concussion education targeted toward athletes has been increasing with passage of return-to-play laws in all 50 states. The current study examined differences in public knowledge about TBI and concussion, and the extent to which students and parents in the general public may have benefited from increased availability of education around concussion. Methods: At a public fair, 246 students, parents, and other adults completed a survey adapted from existing TBI and concussion knowledge surveys. Participants also rated their confidence in accuracy of their responses. Results: There were no group differences on TBI knowledge or confidence. Parents scored slightly higher on concussion knowledge than students, and knowing someone with a TBI or concussion was also associated with higher scores. Confidence was only weakly related to concussion knowledge. Overall concussion knowledge scores were higher than TBI knowledge scores. Knowledge and confidence were not associated with sports participation. Discussion: Given similarities in TBI knowledge across groups, but that parents outpace students in concussion knowledge, parents may have greater exposure or heightened awareness of concussion information education opportunities. Lower confidence in students suggests an openness to education and opportunities for prevention of injuries.	[O'Brien, Katy H.; Hwang, Brenda L.] Univ Georgia, Commun Sci & Special Educ, 540 Aderhold Hall,110 Carlton St, Athens, GA 30602 USA; [Schellinger, Sarah K.] St Xavier Univ, Commun Sci & Disorders, Chicago, IL USA; [LaPlaca, Michelle C.] Emory Univ, Georgia Tech, Translat Neurotrauma Lab, Biomed Engn, Atlanta, GA 30322 USA		O'Brien, KH (corresponding author), Univ Georgia, Commun Sci & Special Educ, 540 Aderhold Hall,110 Carlton St, Athens, GA 30602 USA.	khobrien@uga.edu			Brain Injury Association of Georgia	The authors gratefully acknowledge the Brain Injury Association of Georgia for their support of this project. Special thanks also to the research assistants in the Cognitive-Communication Rehabilitation Lab at the University of Georgia, and in particular, Desiree Pena for her efforts in training and coordinating the research team.	Ahmed Osman Hassan, 2017, Concussion, V2, pCNC27, DOI 10.2217/cnc-2016-0026; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Atlanta Science Festival, 2017, ATL SCI FEST 2017 AN; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Bjork RA, 1999, ATTENTION PERFORM, V17, P435; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Centers for Disease Control and Prevention, 2017, HEADS; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Ehrlinger J, 2008, ORGAN BEHAV HUM DEC, V105, P98, DOI 10.1016/j.obhdp.2007.05.002; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hildenbrand K, 2018, RES Q EXERCISE SPORT, V89, P361, DOI 10.1080/02701367.2018.1472735; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KELLEY CM, 1993, J MEM LANG, V32, P1, DOI 10.1006/jmla.1993.1001; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McAvoy K, 2009, REAP BENEFITS GOOD C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Patel DR, 2017, TRANSL PEDIATR, V6, P114, DOI 10.21037/tp.2017.03.08; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schellinger SK, 2018, BRAIN INJURY, V32, P1377, DOI 10.1080/02699052.2018.1492737; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; United States Census Bureau, 2019, US CENS BUR QUICKFAC; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wallace J, 2019, HEALTH EDUC J, V78, P315, DOI 10.1177/0017896918806935; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	73	6	6	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2019	39	3			SI		313	334		10.1097/TLD.0000000000000190			22	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	IM3IN	WOS:000477887000007					2022-02-06	
J	Schwab, N; Tator, C; Hazrati, LN				Schwab, Nicole; Tator, Charles; Hazrati, Lili-Naz			DNA damage as a marker of brain damage in individuals with history of concussions	LABORATORY INVESTIGATION			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; MILD COGNITIVE IMPAIRMENT; DOUBLE-STRAND BREAKS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CEREBRAL-CORTEX; HEAD-INJURY; REPAIR; GAMMA-H2AX; DEMENTIA	Mild traumatic brain injury (mTBI) is common in many populations, including athletes, veterans, and domestic abuse victims. mTBI can cause chronic symptoms, including depression, irritability, memory problems, and attention deficits. A history of repetitive mTBI has been epidemiologically associated with developing early-onset dementia and neurodegenerative diseases and, in particular, is thought to be the underlying cause of chronic traumatic encephalopathy (CTE)-a progressive tauopathy diagnosed by the presence of perivascular hyperphosphorylated tau protein (p-tau) in the depths of cortical sulci. However, the scarce and focal pathology often seen in CTE does not correlate with the severity of symptoms experienced by patients. This paper proposes accumulation of gamma H2AX, a marker of double-stranded DNA damage, as a novel pathological marker to identify brain damage post-mTBI. We present two cases of men with history of mTBI. Immunohistochemistry revealed extensive DNA damage throughout the frontal cortex, hippocampus, and brainstem areas. Furthermore, gene expression profiling showed increases of ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHEK2), two serine/threonine kinases recruited in response to double-strand breaks in the DNA damage response pathway. These cases highlight the complex pathophysiology of head trauma, and suggest DNA damage as the molecular mechanism behind mTBI-induced pathology and symptoms.	[Schwab, Nicole; Hazrati, Lili-Naz] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Schwab, Nicole; Hazrati, Lili-Naz] Hosp Sick Children, Toronto, ON, Canada; [Schwab, Nicole; Tator, Charles; Hazrati, Lili-Naz] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Tator, Charles] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada		Hazrati, LN (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Hazrati, LN (corresponding author), Hosp Sick Children, Toronto, ON, Canada.; Hazrati, LN (corresponding author), Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada.	lili-naz.hazrati@sickkids.ca	Lang, Steven/AAE-8102-2021; hazrati, lili-naz/AAE-7785-2020	Lang, Steven/0000-0003-1669-9146; hazrati, lili-naz/0000-0003-2715-1485	Canadian Concussion Centre	We would like to thank Road2Recovery and the Canadian Concussion Centre for funding of this research.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; [Anonymous], 2015, SEATTLE TIMES; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.c100466200; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CNN, 2017, CNN; Coburn K, 1992, AACN Clin Issues Crit Care Nurs, V3, P9; Coppe JP, ANN REV PATHOL, V5, P99; Coppede F, 2009, CURR ALZHEIMER RES, V6, P36, DOI 10.2174/156720509787313970; Fielder E, 2017, J ALZHEIMERS DIS, V60, pS107, DOI 10.3233/JAD-161221; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Francois M, 2016, DNA REPAIR, V46, P29, DOI 10.1016/j.dnarep.2016.08.001; Gao A. F., 2017, INT J PATHOL CLIN RE, V3, P50, DOI [10.23937/2469-5807/1510050, DOI 10.23937/2469-5807/1510050]; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Garwood CJ, 2014, NEUROPATH APPL NEURO, V40, P802, DOI 10.1111/nan.12156; Gomperts Stephen N, 2016, Continuum (Minneap Minn), V22, P435, DOI 10.1212/CON.0000000000000309; Heymann D, 2016, CURR ALZHEIMER RES, V13, P1356, DOI 10.2174/1567205013666160603005035; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Ishiai Masamichi, 2012, Methods Mol Biol, V920, P39, DOI 10.1007/978-1-61779-998-3_4; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Liu SJ, 2003, ACTA PHARMACOL SIN, V24, P512; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Marachal A, 2013, COLD SPRING HARB PER, V5; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Mei L, 2015, INT J CLIN EXP PATHO, V8, P5597; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Myung NH, 2008, AGE DORDR, V30, P109; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishioka N, 2004, AM J GERIAT PSYCHIAT, V12, P167, DOI 10.1176/appi.ajgp.12.2.167; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Roman P, 2017, REV CLIN ESP, V217, P229, DOI 10.1016/j.rce.2017.01.007; Schwab N, 2018, J ALZHEIMERS DIS, V64, P1067, DOI 10.3233/JAD-180373; Sepe S, 2016, CELL REP, V15, P1866, DOI 10.1016/j.celrep.2016.04.071; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Siddiqui MS, 2018, MUTAT RES-GEN TOX EN, V829, P6, DOI 10.1016/j.mrgentox.2018.03.001; Simpson JE, 2016, NEUROPATH APPL NEURO, V42, P167, DOI 10.1111/nan.12252; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Tan RH, 2015, BRAIN, V138, P3110, DOI 10.1093/brain/awv220; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Villar-Pique A, 2016, J NEUROCHEM, V139, P240, DOI 10.1111/jnc.13249; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Yu H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23644-4; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045	77	6	6	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JUL	2019	99	7					1008	1018		10.1038/s41374-019-0199-8			11	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	IG3XK	WOS:000473738500008	30760862	Bronze			2022-02-06	
J	Shendell, DG; Gonzalez, L; Listwan, TA; Pancella, J; Blackborow, M; Boyd, J				Shendell, Derek G.; Gonzalez, Lauren; Listwan, Tracy A.; Pancella, Joseph; Blackborow, Mary; Boyd, Joanna			Developing and Piloting a School-Based Online Adolescent Student-Athlete Concussion Surveillance System	JOURNAL OF SCHOOL HEALTH			English	Article						adolescents; concussions; high schools; injury surveillance; injury control and prevention	STATES HIGH-SCHOOL; SPORTS INJURY; EPIDEMIOLOGY; MANAGEMENT; GUIDELINES; SYMPTOMS; PLAYERS; YOUTH; COLLEGIATE; KNOWLEDGE	BACKGROUND Despite increased awareness of concussions, epidemiologic surveillance efforts have been scarce, especially among adolescents. This project, which was developed with school stakeholders (certified athletic trainers [ATCs], nurses, athletic directors), piloted a public secondary school-based online surveillance tool for interscholastic and intramural sports and physical education-related concussions in New Jersey during 2014-2017 school years (SY). METHODS Participating public high schools (5 within 4 districts) and career-technical-vocational education districts (2 with 5 campuses) completed forms anonymously online via PsychData within 5 days. RESULTS There were 208 concussions reported, 115 in 2015-2016 SY and 93 in 2016-2017 SY. In fall 2015, 86 concussions were reported, including 16 from summer preseason. In fall 2016, 56 concussions were reported; 3 occurred during preseason. There were 7 concussions reported in winter 2016 and 16 in winter 2017. Twenty-two concussions were reported in spring of both 2016 and 2017. Most online forms were completed in <10 minutes, usually using either desktop computers or tablets/iPads. School nurses followed by ATCs were primary sources of data entered online, usually by ATCs. CONCLUSIONS Cooperation of nurses and ATCs at participating schools suggested online surveillance was valued and viable. Data inform future concussion prevention education and ongoing injury surveillance.	[Shendell, Derek G.; Listwan, Tracy A.] Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, 683 Hoes Lane West,3rd Floor SPH Bldg,Suite 399, Piscataway, NJ 08854 USA; [Gonzalez, Lauren] Rutgers Sch Publ Hlth, NJ Safe Sch Program, Piscataway, NJ USA; [Pancella, Joseph] West Deptford High Sch, Athlet Dept, W Deptford, NJ USA; [Blackborow, Mary; Boyd, Joanna] Brain Injury Alliance NJ Concuss Youth Sports Com, North Brunswick, NJ USA; [Blackborow, Mary] North Brunswick High Sch, North Brunswick, NJ USA		Shendell, DG (corresponding author), Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, 683 Hoes Lane West,3rd Floor SPH Bldg,Suite 399, Piscataway, NJ 08854 USA.	shendedg@sph.rutgers.edu; lng45@sph.rutgers.edu; tracylistwan@gmail.com; jpanchella@wdeptford.k12.nj.us; MBLACKBOROW@nbtschools.org; Jboyd@bianj.org	Shendell, Derek/AAF-2950-2021	Gonzalez, Lauren/0000-0003-4085-3932	Kessler Foundation, Special Projects Program mechanism, 2014-2017	This project was funded by Kessler Foundation, Special Projects Program mechanism, 2014-2017.	Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Blake T, 2014, BRIT J SPORT MED, V48, P569, DOI [10.1136/bjsports-2014-093494.26, DOI 10.1136/BJSPORTS-2014-093494.26]; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Brooks MA, 2009, CLIN PEDIATR, V48, P548, DOI 10.1177/0009922808330777; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Chachad S, 2006, CLIN PEDIATR, V45, P285, DOI 10.1177/000992280604500314; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Comstock RD, 2016, INJURY PEDIAT ADOLES, P51; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Ekegren CL, 2015, SCAND J MED SCI SPOR, V25, P315, DOI 10.1111/sms.12216; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hanson E, 2014, CLIN PEDIATR, V53, P1221, DOI 10.1177/0009922813518429; Herrmann A, 2018, NJ PEDIAT J NJAAP, V43, P30; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2014, AUST FAM PHYSICIAN, V43, P94; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mularoni P Patrick, 2014, FP Essent, V417, P11; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Shendell DG, 2018, INT J ATHL THER TRAI, V23, P162, DOI 10.1123/ijatt.2017-0083; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shim J, 2015, J SPORT REHABIL, V24, P72, DOI 10.1123/jsr.2013-0058; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543	43	6	6	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	JUL	2019	89	7					527	535		10.1111/josh.12775			9	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	IC3ZM	WOS:000470902300002	31016753				2022-02-06	
J	Slusarczyk, W; Olakowska, E; Larysz-Brysz, M; Woszczycka-Korczynska, I; Gendosz de Carrillo, D; Weglarz, WP; Lewin-Kowalik, J; Marcol, W				Slusarczyk, Wojciech; Olakowska, Edyta; Larysz-Brysz, Magdalena; Woszczycka-Korczynska, Izabella; Gendosz de Carrillo, Daria; Weglarz, Wladyslaw P.; Lewin-Kowalik, Joanna; Marcol, Wieslaw			Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury	NEURAL REGENERATION RESEARCH			English	Article						ebselen; antioxidant; neuroprotection; neuroregeneration; spinal cord injury; spinal cord repair; functional recovery	ISCHEMIA/REPERFUSION INJURY; OXIDATIVE DAMAGE; WHITE-MATTER; ANTIOXIDANT; MODEL; BRAIN; MORPHOLOGY; ISCHEMIA; EFFICACY; STRESS	Spinal cord injury (SCI) causes disturbances of motor skills. Free radicals have been shown to be essential for the development of spinal cord trauma. Despite some progress, until now no effective pharmacological therapies against SCI have been verified. The purpose of our experiment was to investigate the neuroprotective effects of ebselen on experimental SCI. Twenty-two rats subjected to SCI were randomly subjected to SCI with no further treatment (n = 10) or intragastric administration of ebselen (10 mg/kg) immediately and 24 hours after SCI. Behavioral changes were assessed using the Basso, Beattie, and Bresnahan locomotor scale and foot-print test during 12 weeks after SCI. Histopathological and immunohistochemical analyses of spinal cords and brains were performed at 12 weeks after SCI. Magnetic resonance imaging analysis of spinal cords was also performed at 12 weeks after SCI. Rats treated with ebselen presented only limited neurobehavioral progress as well as reduced spinal cord injuries compared with the control group, namely length of lesions (cysts/scars) visualized histopathologically in the spinal cord sections was less but cavity area was very similar. The same pattern was found in T2-weighted magnetic resonance images (cavities) and diffusion-weighted images (scars). The number of FluoroGold retrogradely labeled neurons in brain stem and motor cortex was several-fold higher in ebselen-treated rats than in the control group. The findings suggest that ebselen has only limited neuroprotective effects on injured spinal cord. All exprimental procedures were approved by the Local Animal Ethics Committee for Experiments on Animals in Katowice (Katowice, Poland) (approval No. 19/2009).	[Slusarczyk, Wojciech; Olakowska, Edyta; Larysz-Brysz, Magdalena; Woszczycka-Korczynska, Izabella; Gendosz de Carrillo, Daria; Lewin-Kowalik, Joanna; Marcol, Wieslaw] Med Univ Silesia, Dept Physiol, Katowice, Poland; [Weglarz, Wladyslaw P.] Polish Acad Sci, Inst Nucl Phys, Krakow, Poland		Marcol, W (corresponding author), Med Univ Silesia, Dept Physiol, Katowice, Poland.	wmarcol@o2.pl	Weglarz, Wladyslaw P./W-5770-2018	Weglarz, Wladyslaw P./0000-0002-3390-3615; Lewin-Kowalik, Joanna/0000-0002-7971-449X; GENDOSZ DE CARRILLO, DARIA/0000-0001-5090-8365			Aras M, 2014, INT J NEUROSCI, V124, P771, DOI 10.3109/00207454.2013.879581; Azad GK, 2014, MOL BIOL REP, V41, P2717, DOI 10.1007/s11033-014-3181-y; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; DAWSON DA, 1995, NEUROSCI LETT, V185, P65, DOI 10.1016/0304-3940(94)11226-9; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; Filipp ME, 2019, NEURAL REGEN RES, V14, P7, DOI 10.4103/1673-5374.243694; Fujisawa S, 2005, ANTICANCER RES, V25, P3989; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gul S, 2010, J CLIN NEUROSCI, V17, P608, DOI 10.1016/j.jocn.2009.07.115; Hafize U., 2002, TURKISH NEUROSURG, V12, P9; He MX, 2007, BRAIN RES, V1181, P83, DOI 10.1016/j.brainres.2007.08.072; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Jia ZQ, 2018, NEUROSCI LETT, V678, P110, DOI 10.1016/j.neulet.2018.05.007; Kalayci M, 2005, NEUROCHEM RES, V30, P403, DOI 10.1007/s11064-005-2615-2; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Liu CB, 2018, NEURAL REGEN RES, V13, P877, DOI 10.4103/1673-5374.232485; Liu XZ, 1997, J NEUROSCI, V17, P5395; Marcol W, 2017, EXP THER MED, V14, P4869, DOI 10.3892/etm.2017.5130; Marcol W, 2012, J RECONSTR MICROSURG, V28, P561, DOI 10.1055/s-0032-1315779; Minati L, 2007, CONCEPT MAGN RESON A, V30A, P278, DOI 10.1002/cmr.a.20094; MULLER A, 1984, BIOCHEM PHARMACOL, V33, P3235, DOI 10.1016/0006-2952(84)90083-2; Noguchi N, 2016, ARCH BIOCHEM BIOPHYS, V595, P109, DOI 10.1016/j.abb.2015.10.024; Ozyigit F, 2015, BOSNIAN J BASIC MED, V15, P36, DOI 10.17305/bjbms.2015.521; Parnham MJ, 2013, BIOCHEM PHARMACOL, V86, P1248, DOI 10.1016/j.bcp.2013.08.028; Saito I, 1998, NEUROSURGERY, V42, P269, DOI 10.1097/00006123-199802000-00038; Santofimia-Castano P, 2016, TOXICOLOGY, V357, P74, DOI 10.1016/j.tox.2016.06.002; Satoh T, 2004, NEUROSCI LETT, V371, P1, DOI 10.1016/j.neulet.2004.04.055; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Seo JY, 2009, J NEUROL SCI, V285, P88, DOI 10.1016/j.jns.2009.05.029; Takasago T, 1997, BRIT J PHARMACOL, V122, P1251, DOI 10.1038/sj.bjp.0701426; Takazawa A, 2018, NEURAL REGEN RES, V13, P536, DOI 10.4103/1673-5374.228759; Watanabe T, 1997, NEUROL RES, V19, P563, DOI 10.1080/01616412.1997.11740859; Wei L, 2014, CLIN EXP PHARMACOL P, V41, P134, DOI 10.1111/1440-1681.12186; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Zhang D, 2015, NEURAL REGEN RES, V10, P412, DOI 10.4103/1673-5374.153689; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399	41	6	6	3	19	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUL	2019	14	7					1255	1261	PMID 30804257	10.4103/1673-5374.251334			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HN2ZA	WOS:000460052200026	30804257	Green Published, gold			2022-02-06	
J	Wabl, R; Williamson, CA; Pandey, AS; Rajajee, V				Wabl, Rafael; Williamson, Craig A.; Pandey, Aditya S.; Rajajee, Venkatakrishna			Long-term and delayed functional recovery in patients with severe cerebrovascular and traumatic brain injury requiring tracheostomy	JOURNAL OF NEUROSURGERY			English	Article						acute brain injury; traumatic brain injury; stroke; tracheostomy; activities of daily living; trauma; vascular disorders	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; TIME-COURSE; STROKE; TRIAL; DISABILITY; IMPROVEMENT; POPULATION; WITHDRAWAL	OBJECTIVE Data on long-term functional recovery (LFR) following severe brain injury are essential for counseling of surrogates and for appropriate timing of outcome assessment in clinical trials. Delayed functional recovery (DFR) beyond 3-6 months is well documented following severe traumatic brain injury (sTBI), but there are limited data on DFR following severe cerebrovascular brain injury. The objective of this study was to assess LFR and DFR in patients with sTBI and severe stroke dependent on tracheostomy and tube feeding at the time of discharge from the intensive care unit (ICU). METHODS The authors identified patients entered into their tracheostomy database 2008-2013 with sTBI and severe stroke, encompassing SAH, intracerebral hemorrhage (ICH), and acute ischemic stroke (AIS). Eligibility criteria included disease-specific indicators of severity, Glasgow Coma Scale score < 9 at time of tracheostomy, and need for tracheostomy and tube feeding at ICU discharge. Assessment was at 1-3 months, 6-12 months, 12-24 months, and 24-36 months after initial injury for presence of tracheostomy, ability to walk, and ability to perform basic activities of daily living (B-ADLs). Long-term functional recovery (LFR) was defined as recovery of the ability to walk or perform B-ADLs by the 24- to 36-month follow-up. Delayed functional recovery (DFR) was defined as progression in functional milestones between any 2 time points beyond the 1- to 3-month follow-up. RESULTS A total of 129 patients met the eligibility criteria. Functional outcomes were available for 129 (100%), 97 (75%), 83 (64%), and 80 (62%) patients, respectively, from assessments at 1-3, 6-12, 12-24 and 24-36 months; 33 (26%) died by 24-36 months. Fifty-nine (46%) regained the ability to walk and 48 (37%) performed B-ADLs at some point during their recovery. Among survivors who had not achieved the respective milestone at 1-3 months, 29/58 (50%) were able to walk and 28/74 (38%) performed B-ADLs at 6-12 months. Among survivors who had not achieved the respective milestone at 6-12 months, 5/16 (31%) were able to walk and 13/30 (43%) performed B-ADLs at 12-24 months. There was no significant difference in rates of LFR or DFR between patients with sTBI and those with severe stroke. CONCLUSIONS Among patients with severe brain injury requiring tracheostomy and tube feeding at ICU discharge, 46% regained the ability to walk and 37% performed B-ADLs 2-3 years after injury. DFR beyond 1-3 and 6-12 months was seen in over 30% of survivors, with no significant difference between sTBI and severe stroke.	[Williamson, Craig A.; Pandey, Aditya S.; Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Wabl, Rafael; Williamson, Craig A.; Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA		Rajajee, V (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com					Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Furlan JC, 2011, J NEUROTRAUM, V28, P1413, DOI 10.1089/neu.2009.1148; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Honeybul S, 2018, CURR OPIN CRIT CARE, V24, P97, DOI 10.1097/MCC.0000000000000481; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Mocco J, 2006, J NEUROL, V253, P1278, DOI 10.1007/s00415-006-0179-y; Navi BB, 2012, NEUROCRIT CARE, V17, P343, DOI 10.1007/s12028-012-9772-3; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Rajajee V, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0924-7; Ransom ER, 2007, NEUROCRIT CARE, V6, P174, DOI 10.1007/s12028-007-0019-7; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang AC, 2016, J NEUROSURG, V124, P296, DOI 10.3171/2015.3.JNS15336; Wilson DA, 2013, J NEUROSURG, V119, P606, DOI 10.3171/2013.4.JNS121287; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	36	6	6	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2019	131	1					114	121		10.3171/2018.2.JNS173247			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	IJ3XR	WOS:000475838400015	29979120	Bronze			2022-02-06	
J	Williams, KA; Lawson, RM; Perurena, OH; Coppin, JD				Williams, Karen A.; Lawson, Robin M.; Perurena, Osvaldo H.; Coppin, John D.			Management of Chronic Migraine and Occipital Neuralgia in Post 9/11 Combat Veterans	MILITARY MEDICINE			English	Article						Chronic Migraine; occipital neuralgia; TBI; combat veteran	TRAUMATIC BRAIN-INJURY; SERVICE MEMBERS; NERVE BLOCKADE; HEADACHE; PREVALENCE; CONCUSSION; HISTORY; IRAQ; ONABOTULINUMTOXINA; SOLDIERS	Introduction: The rate of chronic migraine (CM) has been shown to be 20% or greater in the post 9/11 combat veteran population with a history of traumatic brain injury, while the rate is much lower at 3-5% in the general population. Studies have shown that medications such as oral topiramate or intramuscular injections of onabotulinum toxin A (Botox) have been used for CM prevention, and occipital blocks have been shown to be helpful in treating occipital neuralgia and short-term relief of CM. However, there are no known studies that have specifically evaluated the use of Botox and occipital blocks for reducing headache frequency in the US veteran population. The purpose of this study was to evaluate the effectiveness of using occipital blocks and Botox as dual therapy for reducing headache frequency in post 9/11 combat veterans with CM, occipital neuralgia, and a history of TBI or neck trauma. Materials and Methods: Following Institutional Review Board approval, a retrospective chart review was completed on post 9/11 combat veterans treated in a headache clinic located at the Central Texas Veteran Health Care System. The electronic medical record was used to retrieve the charts of post 9/11 combat veterans who (1) had a confirmed deployment-related history of TBI or neck trauma; (2) were diagnosed with CM and occipital neuralgia; and (3) were treated in the headache clinic between January 1, 2014 and December 31, 2015 with the administration of occipital blocks and Botox within the first six months. Of 282 charts that were reviewed, a total of 30 (N = 30) veterans fit the criteria. The mean number of self-reported headache days per month (28 days) for the month prior to starting treatment was compared to the number of headache days per month (28 days) 6 months after initiation of therapy. Results: Results revealed that the mean number of headache days in the month prior to treatment was 24.1 (22.0, 25.7). The mean number of headache days in the month post-treatment (6 months after the initiation of dual therapy with occipital blocks and Botox) was 12.9 (9.7, 16.4). The mean difference in the number of headache days from pre- to post-treatment (pre-treatment minus post-treatment) was 11.2 (8.2, 14.2). Conclusion: This study evaluated the effectiveness of using occipital blocks and Botox as dual therapy for reducing headache frequency for post 9/11 combat veterans with CM, occipital neuralgia, and a history of TBI or neck trauma. Results revealed a statistically significant reduction in the number of headache days per month after the dual therapy. There were multiple limitations to the study to include a small sample size, lack of a control group, self-reported headaches for only 1 month pre-and post-treatment, and no control for other interventions or events which may have influenced the outcome. There is a strong need for randomized, double blinded, placebo-controlled studies involving dual therapy in this population. This study, though small, may be helpful in stimulating additional studies and treatments in this veteran population.	[Williams, Karen A.] Cent Texas Vet Hlth Care Syst, Med Serv, 1901 Vet Mem Dr, Temple, TX 76504 USA; [Lawson, Robin M.] Univ Alabama, Capstone Coll Nursing, 650 Univ Blvd E, Tuscaloosa, AL 35401 USA; [Perurena, Osvaldo H.] Cent Texas Vet Hlth Care Syst, 1901 Vet Mem Dr, Temple, TX 76504 USA; [Coppin, John D.] Cent Texas Vet Hlth Care Syst, Res Serv, 1901 Vet Mem Dr, Temple, TX 76504 USA		Williams, KA (corresponding author), Cent Texas Vet Hlth Care Syst, Med Serv, 1901 Vet Mem Dr, Temple, TX 76504 USA.						Allen SM, 2018, J AM BOARD FAM MED, V31, P211, DOI 10.3122/jabfm.2018.02.170188; Altalib HH, 2017, CEPHALALGIA, V37, P3, DOI 10.1177/0333102416631959; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blumenfeld A, 2015, HEADACHE, V55, P682, DOI 10.1111/head.12579; Blumenfeld A, 2010, HEADACHE, V50, P1406, DOI 10.1111/j.1526-4610.2010.01766.x; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Cuadrado ML, 2016, CEPHALALGIA, V37, P1; Dougherty C, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0411-x; Ducic I, 2015, MICROSURG, V35, P603, DOI 10.1002/micr.22503; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Gul HL, 2017, ACTA NEUROL SCAND, V136, P138, DOI 10.1111/ane.12716; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Inan LE, 2015, ACTA NEUROL SCAND, V132, P270, DOI 10.1111/ane.12393; Lipton RB, 2016, CEPHALALGIA, V36, P899, DOI 10.1177/0333102416652092; Lipton RB, 2015, HEADACHE, V55, P103, DOI 10.1111/head.12505_2; Munakata J, 2009, HEADACHE, V49, P498, DOI 10.1111/j.1526-4610.2009.01369.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Sahai-Srivastava S, 2011, HEADACHE, V51, P124, DOI 10.1111/j.1526-4610.2010.01788.x; Tassorelli C, 2018, CEPHALALGIA, P1; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495; Zaremski JL, 2015, CURR SPORT MED REP, V14, P16, DOI 10.1249/JSR.0000000000000121	30	6	6	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2019	184	7-8					E207	E211		10.1093/milmed/usy405			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IK4FQ	WOS:000476542900012	30690565				2022-02-06	
J	Kawoos, U; Abutarboush, R; Zarriello, S; Qadri, A; Ahlers, ST; McCarron, RM; Chavko, M				Kawoos, Usmah; Abutarboush, Rania; Zarriello, Sydney; Qadri, Aasheen; Ahlers, Stephen T.; McCarron, Richard M.; Chavko, Mikulas			N-acetylcysteine Amide Ameliorates Blast-Induced Changes in Blood-Brain Barrier Integrity in Rats	FRONTIERS IN NEUROLOGY			English	Article						repetitive blast; blood-brain barrier; N-acetylcysteine amide; intravital microscopy; fluorescent imaging	INDUCED OXIDATIVE STRESS; INJURY; MODEL; EXPOSURE; DAMAGE; PERMEABILITY; INFLAMMATION; MECHANISMS; JUNCTIONS; OCCLUDIN	Traumatic brain injury resulting from exposure to blast overpressure (BOP) is associated with neuropathology including impairment of the blood-brain barrier (BBB). This study examined the effects of repeated exposure to primary BOP and post-blast treatment with an antioxidant, N-acetylcysteine amide (NACA) on the integrity of BBB. Anesthetized rats were exposed to three 110 kPa BOPs separated by 0.5 h. BBB integrity was examined in vivo via a cranial window allowing imaging of pial microcirculation by intravital microscopy. Tetramethylrhodamine isothiocyanate Dextran (TRITC-Dextran, mw = 40 kDa or 150 kDa) was injected intravenously 2.5 h after the first BOP exposure and the leakage of TRITC-Dextran from pial microvessels into the brain parenchyma was assessed. The animals were randomized into 6 groups (n = 5/group): four groups received 40 kDa TRITC-Dextran (BOP-40, sham-40, BOP-40 NACA, and sham-40 NACA), and two groups received 150 kDa TRITC-Dextran (BOP-150 and sham-150). NACA treated groups were administered NACA 2 h after the first BOP exposure. The rate of TRITC-Dextran leakage was significantly higher in BOP-40 than in sham-40 group. NACA treatment significantly reduced TRITC-Dextran leakage in BOP-40 NACA group and sham-40 NACA group presented the least amount of leakage. The rate of leakage in BOP-150 and sham-150 groups was comparable to sham-40 NACA and thus these groups were not assessed for the effects of NACA. Collectively, these data suggest that BBB integrity is compromised following BOP exposure and that NACA treatment at a single dose may significantly protect against blast-induced BBB breakdown.	[Kawoos, Usmah; Abutarboush, Rania; Chavko, Mikulas] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD 20817 USA; [Kawoos, Usmah; Abutarboush, Rania; Ahlers, Stephen T.; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [Zarriello, Sydney] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Qadri, Aasheen] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Ahlers, Stephen T.; McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Kawoos, U (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD 20817 USA.; Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	usmah.kawoos.ctr@mail.mil			Office of Naval ResearchOffice of Naval Research [601152N.0000.001, A1308]	This work was supported/funded by the Office of Naval Research, work unit number 601152N.0000.001.A1308.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agarwal R, 1999, NEUROCHEM RES, V24, P1507, DOI 10.1023/A:1021191729865; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Covey Dana C, 2010, J Surg Orthop Adv, V19, P8; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kerksick Chad, 2005, J Int Soc Sports Nutr, V2, P38, DOI 10.1186/1550-2783-2-2-38; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; KUROIWA T, 1988, ACTA NEUROPATHOL, V76, P62, DOI 10.1007/BF00687681; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; Vorbrodt AW, 2004, FOLIA HISTOCHEM CYTO, V42, P67; Waring W Stephen, 2012, Ther Adv Drug Saf, V3, P305, DOI 10.1177/2042098612464265; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008	46	6	6	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 26	2019	10								650	10.3389/fneur.2019.00650			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF5IG	WOS:000473113900002	31297080	gold, Green Published			2022-02-06	
J	Luo, P; Li, X; Wu, XQ; Dai, SH; Yang, YF; Xu, HX; Jing, D; Rao, W; Xu, HY; Gao, XY; Fei, Z; Lu, HB				Luo, Peng; Li, Xin; Wu, Xiuquan; Dai, Shuhui; Yang, Yuefan; Xu, Haoxiang; Jing, Da; Rao, Wei; Xu, Hongyu; Gao, Xiangyu; Fei, Zhou; Lu, Hongbing			Preso regulates NMDA receptor-mediated excitotoxicity via modulating nitric oxide and calcium responses after traumatic brain injury	CELL DEATH & DISEASE			English	Article							GLUTAMATE RECEPTORS; DOWN-REGULATION; PSD-95; PHOSPHORYLATION; GLUN2B; CDK5; INHIBITOR; S1284; NNOS	Traumatic brain injury (TBI) has become a major health concern worldwide, and the poor outcome of TBI increases the need for therapeutic improvement. Secondary injuries following TBI, including excitotoxicity, lead to synaptic dysfunction and provide potential targets for intervention. Postsynaptic scaffold proteins, which are involved in the regulation of excitotoxicity after neuronal injury, play a crucial role in modulating synaptic function. Therefore, exploring the role of postsynaptic scaffold proteins in TBI might uncover new treatments. In this study, we demonstrated that downregulated expression of the postsynaptic scaffold protein Preso protects against neuronal injury after TBI in vitro and in vivo, and these effects are related to the inhibition of N-methyl-D-aspartate receptor (NMDAR) function. Further study showed that Preso facilitates signaling from NMDAR to nitric oxide (NO) and calcium (Ca2+) responses. First, the complex constituting NMDAR, postsynaptic density-95 (PSD-95), and neuronal nitric oxide synthase (nNOS) was shown to be involved in the Preso regulation of the NO response. Uncoupling the linkage between Preso and PSD-95 attenuated the stability of this complex and suppressed the regulatory effect of Preso on the NO response. In addition, phosphorylation of NMDAR by cyclin-dependent kinase 5 (CDK5) was shown to be responsible for the Preso-mediated Ca2+ response, which was dependent on the interaction between Preso and CDK5. These results suggested that the association of Preso with NMDAR signaling can serve as a target for neuroprotection against TBI.	[Luo, Peng; Wu, Xiuquan; Dai, Shuhui; Yang, Yuefan; Xu, Haoxiang; Rao, Wei; Xu, Hongyu; Gao, Xiangyu; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Luo, Peng; Xu, Haoxiang; Jing, Da; Lu, Hongbing] Fourth Mil Med Univ, Dept Biomed Engn, Xian, Shaanxi, Peoples R China; [Li, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China.; Lu, HB (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian, Shaanxi, Peoples R China.	zhoufei@fmmu.edu.cn; luhb@fmmu.edu.cn	Yang, Yuefan/AAJ-9136-2020	Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771322, 81601149, 81601077, 81771239, 81430043]; Military Youth talent lifting project [17-JCJQ-QT-037]; Youth talent lifting project of Shaanxi province [20180305]; Natural Science Foundation of Shaanxi provinceNatural Science Foundation of Shaanxi Province [2017JQ8038]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M572683]	This work was supported by the National Natural Science Foundation of China (nos. 81771322, 81601149, 81601077, 81771239, 81430043), the Military Youth talent lifting project (no. 17-JCJQ-QT-037), the Youth talent lifting project of Shaanxi province (20180305), the Natural Science Foundation of Shaanxi province (2017JQ8038), and a project funded by the China Postdoctoral Science Foundation (2015M572683).	Al H, 2017, NEUROSCIENCE, V351, P24, DOI 10.1016/j.neuroscience.2017.03.029; Bach A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12157; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hu JH, 2017, J PHARMACOL EXP THER, V361, P122, DOI 10.1124/jpet.116.238394; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Kucharz K, 2017, J CEREBR BLOOD F MET, V37, P1820, DOI 10.1177/0271678X16645595; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu W, 2015, EXP NEUROL, V271, P251, DOI 10.1016/j.expneurol.2015.06.016; Luo CX, 2014, J NEUROSCI, V34, P13535, DOI 10.1523/JNEUROSCI.1305-14.2014; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2013, FEBS J, V280, P6114, DOI 10.1111/febs.12531; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mo J, 2012, EUR J NEUROSCI, V36, P1960, DOI 10.1111/j.1460-9568.2012.08124.x; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Sommer JB, 2017, NEUROCHEM RES, V42, P3401, DOI 10.1007/s11064-017-2381-y; Sommer JB, 2017, EUR J NEUROSCI, V45, P238, DOI 10.1111/ejn.13483; Yousuf MA, 2016, J NEUROCHEM, V138, P317, DOI 10.1111/jnc.13620; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	31	6	6	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUN 24	2019	10								496	10.1038/s41419-019-1731-x			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	IF2YQ	WOS:000472947100005	31235685	Green Published, gold			2022-02-06	
J	Gerbatin, RR; Dobrachinski, F; Cassol, G; Soares, FAA; Royes, LFF				Gerbatin, Rogerio R.; Dobrachinski, Fernando; Cassol, Gustavo; Soares, Felix A. A.; Royes, Luiz Fernando F.			A(1) rather than A(2A) adenosine receptor as a possible target of Guanosine effects on mitochondrial dysfunction following Traumatic Brain Injury in rats	NEUROSCIENCE LETTERS			English	Article						Fluid percussion injury; Adenosinergic system; Purinergic nucleoside; Reactive oxygen species; Mitochondrial membrane potential	OXIDATIVE STRESS; PROTECTS; SYSTEM; MODEL; NEUROPROTECTION; OXYGEN; DAMAGE; CELLS	Traumatic brain injury (TBI) represents one of the leading causes of death worldwide. Its pathophysiology involves several neurochemical events including mitochondrial dysfunction. Since mitochondrial respiration plays a key role in cell survival, pharmacological interventions targeting mitochondrial function have been highlighted as a powerful tool against the neurodegenerative process triggered by TBI. Guanosine (GUO), a neuroprotective molecule in different neurological disorders involving neurotoxicity, has shown protective properties after TBI, however its mechanism of action is not well understood in the central nervous system (CNS). Therefore, the aim of this study is to evaluate the possible target receptor involved in the protective GUO effects on TBI-induced mitochondrial dysfunction in the cerebral cortex of rats. Results show that a single dose of GUO (7.5 mg/kg) injected 40 min after a fluid percussion injury (FPI) protects against loss of mitochondrial membrane potential and increase of reactive oxygen species 8 h post-TBI. These effects were specifically blocked by a pretreatment (10 min after TBI) with an A(1) adenosine receptor antagonist (DPCPX 1 mg/kg). In contrast, pretreatment with an A(2A) adenosine receptor antagonist (SCH 58261 0.05 mg/kg) did not alter GUO effects. These findings suggest that acute GUO neuroprotection following TBI involves the modulation of the adenosinergic system, especially A(1) adenosine receptor.	[Gerbatin, Rogerio R.; Cassol, Gustavo; Royes, Luiz Fernando F.] Univ Fed Santa Maria, Ctr Phys Educ & Sports, Lab Exercise Biochem, Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Soares, Felix A. A.] Univ Fed Santa Maria, Dept Biochem & Mol Biol, Ctr Nat & Exact Sci, Santa Maria, RS, Brazil; [Gerbatin, Rogerio R.] RCSI, Dept Physiol & Med Phys, FutureNeuro Res Ctr, Dublin 2, Ireland		Gerbatin, RR (corresponding author), Univ Fed Santa Maria, Ctr Phys Educ & Sports, Lab Exercise Biochem, Santa Maria, RS, Brazil.; Gerbatin, RR (corresponding author), RCSI, Dept Physiol & Med Phys, FutureNeuro Res Ctr, Dublin 2, Ireland.	rogeriodarosagerbatin@rcsi.com	Dobrachinski, Fernando/C-4316-2014; Soares, Felix/AAE-6251-2020	Dobrachinski, Fernando/0000-0002-3948-1273; Soares, Felix/0000-0002-6453-7902; Cassol, Gustavo/0000-0003-1343-7001	INCT for excitotoxicity and neuroprotection-MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);  [FAPERGS/PRONEM11/2029-1]	This study was supported by INCT for excitotoxicity and neuroprotection-MCT/CNPq. L.F.R. and F.A.A.S. received a fellowship by CNPq; F.D., R.R.G., and G.C. received a fellowship by CAPES. Additional support was given by FAPERGS/PRONEM11/2029-1.	AKERMAN KEO, 1979, BIOCHIM BIOPHYS ACTA, V546, P341, DOI 10.1016/0005-2728(79)90051-3; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Di Liberto V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00158; Dobrachinski F., 2018, MOL NEUROBIOL, V55; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Dobrachinski F, 2014, NEUROTOX RES, V26, P317, DOI 10.1007/s12640-014-9463-2; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gerbatin RR, 2019, PROG NEURO-PSYCHOPH, V92, P328, DOI 10.1016/j.pnpbp.2019.02.004; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Lakatos RK, 2016, BRAIN RES BULL, V124, P172, DOI 10.1016/j.brainresbull.2016.05.001; Lanznaster D, 2016, AGING DIS, V7, P657, DOI 10.14336/AD.2016.0208; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001; Quincozes-Santos A, 2014, J NEUROCHEM, V130, P61, DOI 10.1111/jnc.12694; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007	29	6	6	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 21	2019	704						141	144		10.1016/j.neulet.2019.04.014			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH4ZX	WOS:000474501800023	30974229				2022-02-06	
J	Morris, TP; Munoz, JMT; Cattaneo, G; Solana-Sanchez, J; Bartres-Faz, D; Pascual-Leone, A				Morris, Timothy P.; Tormos Munoz, Jose-Maria; Cattaneo, Gabriele; Solana-Sanchez, Javier; Bartres-Faz, David; Pascual-Leone, Alvaro			Traumatic Brain Injury Modifies the Relationship Between Physical Activity and Global and Cognitive Health: Results From the Barcelona Brain Health Initiative	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						physical activity; cognition; global health; traumatic brain injury; health-related quality of life	QUALITY-OF-LIFE; ACTIVITY PARTICIPATION; OLDER-ADULTS; EXERCISE; RISK; IMPAIRMENT; FITNESS; DETERMINANTS; INDIVIDUALS; MAINTENANCE	Physical activity has many health benefits for individuals with and without history of brain injury. Here, we evaluated in a large cohort study the impact of physical activity on global and cognitive health as measured by the PROMIS global health and NeuroQoL cognitive function questionnaires. A nested case control study assessed the influence of a history of traumatic brain injury (TBI) on the effects of physical activity since underlying pathophysiology and barriers to physical activity in individuals with TBI may mean the effects of physical activity on perceived health outcomes differ compared to the general population. Those with a history of TBI (n = 81) had significantly lower Global health (beta = -1.66, p = 0.010) and NeuroQoL cognitive function (beta = -2.65, p = 0.006) compared to healthy adults (n = 405). A similar proportion of individuals in both groups reported being active compared to being insufficiently active (chi(2)((1)) = 0.519 p = 0.471). Furthermore, the effect of physical activity on global health (beta = 0.061, p = 0.076) and particularly for NeuroQoL (beta = 0.159, p = 0.002) was greater in those with a history of TBI. Individuals with a history of TBI can adhere to a physically active lifestyle, and if so, that is associated with higher global and cognitive health perceptions. Adhering to a physically active lifestyle is non-trivial, particularly for individuals with TBI, and therefore adapted strategies to increase participation in physical activity is critical for the promotion of public health.	[Morris, Timothy P.; Tormos Munoz, Jose-Maria; Cattaneo, Gabriele; Solana-Sanchez, Javier; Bartres-Faz, David; Pascual-Leone, Alvaro] UAB, Inst Univ Neurorehabil Adscrit, Inst Guttmann, Badalona, Spain; [Morris, Timothy P.; Tormos Munoz, Jose-Maria; Solana-Sanchez, Javier] Univ Autonoma Barcelona, Bellaterra, Spain; [Morris, Timothy P.; Tormos Munoz, Jose-Maria; Solana-Sanchez, Javier] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain; [Morris, Timothy P.; Pascual-Leone, Alvaro] Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Div Cognit Neurol, Dept Neurol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Cattaneo, Gabriele; Bartres-Faz, David] Univ Barcelona, Fac Med & Ciencies Salut, Dept Med, Barcelona, Spain; [Cattaneo, Gabriele; Bartres-Faz, David] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain		Morris, TP (corresponding author), UAB, Inst Univ Neurorehabil Adscrit, Inst Guttmann, Badalona, Spain.; Morris, TP (corresponding author), Univ Autonoma Barcelona, Bellaterra, Spain.; Morris, TP (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain.; Morris, TP (corresponding author), Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Div Cognit Neurol, Dept Neurol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	tpmorris@bidmc.harvard.edu	Bartres-Faz, David/C-8997-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Bartres-Faz, David/0000-0001-6020-4118; Pascual-Leone, Alvaro/0000-0001-8975-0382; Tormos Munoz, Jose Maria/0000-0002-8764-2289	Sidney R. Baer Jr. Foundation; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH100186, R01HD069776, R01NS073601, R21 NS082870, R21 MH099196, R21 NS085491, R21 HD07616]; Football Players Health Study at Harvard University; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCATS NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR025758]; Obra Social La CaixaLa Caixa Foundation [LCF/PR/PR16/11110004]; Abertis foundation; Institut Guttmann; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH100186] Funding Source: NIH RePORTER	AP-L was partly supported by the Sidney R. Baer Jr. Foundation, the National Institutes of Health (NIH; R01MH100186, R01HD069776, R01NS073601, R21 NS082870, R21 MH099196, R21 NS085491, R21 HD07616), the Football Players Health Study at Harvard University, and Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, the National Institutes of Health, the Sidney R. Baer Jr. Foundation. The BBHI receives funding from "Obra Social La Caixa" (grant agreement no LCF/PR/PR16/11110004) and the Abertis foundation, as well as internal funding from the Institut Guttmann (Institut Guttmann and Fundacio Abertis).	Amireault S, 2015, PERCEPT MOTOR SKILL, V120, P604, DOI 10.2466/03.27.PMS.120v19x7; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bartres-Faz D, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0381-z; Bauman Adrian, 2005, Int J Behav Nutr Phys Act, V2, P10; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Brill P, 2012, ACT ADAPT AGING, V36, P182, DOI 10.1080/01924788.2012.677794; Brown DW, 2003, PREV MED, V37, P520, DOI 10.1016/S0091-7435(03)00179-8; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Carroll DD, 2014, MMWR-MORBID MORTAL W, V63, P407; Cattaneo G, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00321; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen FT, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090279; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Devine JM, 2016, ARCH PHYS MED REHAB, V97, P1392, DOI 10.1016/j.apmr.2016.04.015; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Godin G, 2011, HLTH FITNESS J CANAD, V4, P18, DOI DOI 10.14288/HFJC.V4I1.82; Gomes-Osman J, 2018, NEUROL-CLIN PRACT, V8, P257, DOI 10.1212/CPJ.0000000000000460; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McKinney J, 2016, B C MED J, V58, P131; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Pescatello L., 2014, J CAN CHIROPR ASS, V58, P328; Pinto Shanti M, 2018, J Funct Morphol Kinesiol, V3, DOI 10.3390/jfmk3030047; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Vidoni ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131647; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weng Timothy B, 2017, Brain Plast, V2, P171, DOI 10.3233/BPL-160039; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; [WHO WHO], 2018, PHYS ACT AD; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; World Health Organization, 2019, PHYS ACTIVITY; World Health Organization, 2019, GLOB REC PHYS ACT HL	54	6	6	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 19	2019	13								135	10.3389/fnbeh.2019.00135			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	IE2HF	WOS:000472204500001	31275124	Green Published, gold			2022-02-06	
J	Albayram, O; Maciver, B; Mathai, J; NeVerstegen, A; Baxley, S; Qiu, CX; Bell, C; Caldarone, BJ; Zhou, XZ; Lu, KP; Zeidel, M				Albayram, Onder; Maciver, Bryce; Mathai, John; NeVerstegen, An; Baxley, Sean; Qiu, Chenxi; Bell, Carter; Caldarone, Barbara J.; Zhou, Xiao Zhen; Lu, Kun Ping; Zeidel, Mark			Traumatic Brain Injury-related voiding dysfunction in mice is caused by damage to rostral pathways, altering inputs to the reflex pathways	SCIENTIFIC REPORTS			English	Article							PONTINE MICTURITION CENTER; ANTI-TAU ANTIBODIES; PASSIVE-IMMUNIZATION; NEURAL-CONTROL; BARRINGTONS NUCLEUS; ALZHEIMERS-DISEASE; RISK-FACTORS; MOUSE MODEL; HEAD-INJURY; PATHOLOGY	Brain degeneration, including that caused by traumatic brain injury (TBI) often leads to severe bladder dysfunction, including incontinence and lower urinary tract symptoms; with the causes remaining unknown. Male C57BL/6J mice underwent repetitive moderate brain injury (rmdTBI) or sham injury, then mice received either cis P-tau monoclonal antibody (cis mAb), which prevents brain degeneration in TBI mice, or control (IgG). Void spot assays revealed age-dependent incontinence in IgG controls 8 months after injury, while cis mAb treated or sham mice showed no dysfunction. No obvious bladder pathology occurred in any group. Urodynamic cystometry in conscious mice revealed overactive bladder, reduced maximal voiding pressures and incontinence in IgG control, but not sham or cis mAb treated mice. Hyperphosphorylated tau deposition and neural tangle-like pathology occurred in cortical and hippocampal regions only of IgG control mice accompanied with post-traumatic neuroinflammation and was not seen in midbrain and hindbrain regions associated with bladder filling and voiding reflex arcs. In this model of brain degeneration bladder dysfunction results from rostral, and not hindbrain damage, indicating that rostral brain inputs are required for normal bladder functioning. Detailed analysis of the functioning of neural circuits controlling bladder function in TBI should lead to insights into how brain degeneration leads to bladder dysfunction, as well as novel strategies to treat these disorders.	[Albayram, Onder] Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Albayram, Onder; Baxley, Sean; Qiu, Chenxi; Bell, Carter; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Hematol & Oncol Div, Boston, MA 02215 USA; [Albayram, Onder; Baxley, Sean; Qiu, Chenxi; Bell, Carter; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Translat Therapeut, Boston, MA 02215 USA; [Albayram, Onder; Baxley, Sean; Qiu, Chenxi; Bell, Carter; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Maciver, Bryce; Mathai, John; NeVerstegen, An; Zeidel, Mark] Harvard Med Sch, Dept Med, Div Nephrol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Qiu, Chenxi; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Qiu, Chenxi; Zhou, Xiao Zhen; Lu, Kun Ping] MIT, Cambridge, MA 02142 USA; [Caldarone, Barbara J.] Harvard Med Sch, Harvard NeuroDiscovery Ctr, NeuroBehav Lab, Boston, MA 02115 USA		Albayram, O (corresponding author), Med Univ South Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA.; Albayram, O (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Hematol & Oncol Div, Boston, MA 02215 USA.; Albayram, O (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Translat Therapeut, Boston, MA 02215 USA.; Albayram, O (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.; Maciver, B (corresponding author), Harvard Med Sch, Dept Med, Div Nephrol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	albayram@musc.edu; imaciver@bidmc.harvard.edu		Albayram, Onder/0000-0002-2028-1458; Qiu, Chenxi/0000-0002-0314-5307	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS096835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG055559] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG055559] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS096835] Funding Source: Medline		Albayram O, 2018, J ALZHEIMERS DIS PAR, V8; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Albayram O, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0124-4; Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Befeler AR, 2016, J NEUROSURG, V124, P703, DOI 10.3171/2015.4.JNS141257; Bilkei-Gerzo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202566; Bilkei-Gorzo A, 2017, NAT MED, V23, P782, DOI 10.1038/nm.4311; Bjorling DE, 2015, AM J PHYSIOL-RENAL, V308, pF1369, DOI 10.1152/ajprenal.00072.2015; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLOK BFM, 1994, NEUROSCI LETT, V166, P93, DOI 10.1016/0304-3940(94)90848-6; Blok BFM, 1997, NEUROSCI LETT, V222, P195, DOI 10.1016/S0304-3940(97)13384-5; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cohen EV, 2016, PARKINSONISM RELAT D, V22, P21, DOI 10.1016/j.parkreldis.2015.11.001; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; DAGG A I, 1971, Laboratory Animals (London), V5, P163, DOI 10.1258/002367771781006456; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Groat WC, 2013, ACTA PHYSIOL, V207, P66, DOI 10.1111/apha.12014; de Groat WC, 2015, COMPR PHYSIOL, V5, P327, DOI 10.1002/cphy.c130056; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Griffiths D, 2015, NAT REV UROL, V12, P695, DOI 10.1038/nrurol.2015.266; Griffiths Derek, 2015, Handb Clin Neurol, V130, P121, DOI 10.1016/B978-0-444-63247-0.00007-9; Gu JP, 2013, J BIOL CHEM, V288, P33081, DOI 10.1074/jbc.M113.494922; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hou XH, 2016, CELL, V167, P73, DOI 10.1016/j.cell.2016.08.073; Jiang HH, 2013, EXP NEUROL, V240, P57, DOI 10.1016/j.expneurol.2012.11.012; Kadow BT, 2015, CURR BLADDER DYSFUNC, V10, P325, DOI 10.1007/s11884-015-0331-6; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lu PJ, 1999, NATURE, V399, P784; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller G, 2011, SCIENCE, V333, P514, DOI 10.1126/science.333.6042.514; Moody BJ, 2014, NEUROUROL URODYNAM, V33, P1159, DOI 10.1002/nau.22470; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nemani SK, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0643-9; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Sakakibara Ryuji, 2015, Handb Clin Neurol, V130, P269, DOI 10.1016/B978-0-444-63247-0.00015-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith PP, 2012, AM J PHYSIOL-REG I, V302, pR577, DOI 10.1152/ajpregu.00508.2011; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; VALENTINO RJ, 1994, NEUROSCIENCE, V62, P125, DOI 10.1016/0306-4522(94)90320-4; Verstegen AMJ, 2017, J COMP NEUROL, V525, P2287, DOI 10.1002/cne.24215; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Winge Kristian, 2015, Handb Clin Neurol, V130, P335, DOI 10.1016/B978-0-444-63247-0.00019-5; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3	81	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 14	2019	9								8646	10.1038/s41598-019-45234-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ID3OO	WOS:000471586300005	31201348	gold, Green Published			2022-02-06	
J	Sekar, S; Zhang, YB; Mahabadi, HM; Parvizi, A; Taghibiglou, C				Sekar, Sathiya; Zhang, Yanbo; Mahabadi, Hajar Miranzadeh; Parvizi, Amirhassan; Taghibiglou, Changiz			Low-Field Magnetic Stimulation Restores Cognitive and Motor Functions in the Mouse Model of Repeated Traumatic Brain Injury: Role of Cellular Prion Protein	JOURNAL OF NEUROTRAUMA			English	Article						cellular prion protein; circadian rhythm proteins; low-field magnetic stimulation; motor and cognitive functions; repeated traumatic brain injury	ELECTROMAGNETIC-FIELDS; CIRCADIAN-RHYTHM; DEPRESSION; CONNECTIVITY; SLEEP; DISORDERS; MEMORY; STMS	Traumatic brain injury (TBI)/concussion is a growing epidemic throughout the world. Memory and neurobehavioral dysfunctions are among the sequelae of TBI. Dislodgement of cellular prion protein (PrPc) and disruption of circadian rhythm have been linked to TBI. Low-field magnetic stimulation (LFMS) is a new noninvasive repetitive transcranial magnetic stimulation (rTMS) technique that generates diffused and low-intensity magnetic stimulation to deep cortical and subcortical areas. The role of LFMS on PrPc, proteins related to the circadian rhythm, and behavior alterations in a repeated TBI mouse model were studied in the present study. TBI was induced to the mice (right hemisphere) using weight-drop method, once daily for 3 days. LFMS treatment was given for 20 min once daily for 4 days (immediately after each TBI induction). The results showed that LFMS-treated TBI mice significantly improved cognitive and motor function as evidenced by open field exploration, rotarod, and novel location recognition tasks. In addition, a significant increase in PrPc and decreased glial fibrillary acidic protein levels were observed in cortical and hippocampal regions of LFMS-treated TBI mice brain compared with sham-treated TBI mice, while neuronal nuclei level was significantly increased in cortical region. In LFMS-treated mice, a decrease in proteins related to circadian rhythm were observed, compared with sham-treated TBI mice. The results obtained from the study demonstrated the neuroprotective effect of LFMS, which may be through regulating PrPc and/or proteins related to circadian rhythm. Thus, the present study suggests that LFMS may improve the subject's neurological condition following TBI.	[Sekar, Sathiya; Mahabadi, Hajar Miranzadeh; Parvizi, Amirhassan; Taghibiglou, Changiz] Univ Saskatchewan, Coll Med, Dept Anat, Physiol,Pharmacol, Saskatoon, SK, Canada; [Zhang, Yanbo] Univ Saskatchewan, Coll Med, Dept Psychiat, Saskatoon, SK, Canada		Taghibiglou, C (corresponding author), Univ Saskatchewan, Coll Med, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	changiz.taghibiglou@usask.ca	Sekar, Sathiya/AAN-7175-2020	Zhang, Yanbo/0000-0002-2421-157X	Defence Research and Development Canada, (Suffield Research Center, Ralston, Alberta, Canada); College of Medicine COMRAD funding; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); Saskatchewan Institute for Health Research (SHRF); Iver and Joyce Graham Indiana Small Professorship; University of Saskatchewan; Saskatchewan Health Research Foundation (SHRF) Establisment Grant	The authors thank Dr. Yushan Wang and the Defence Research and Development Canada, (Suffield Research Center, Ralston, Alberta, Canada) as well as the College of Medicine COMRAD funding for providing the fund for mTBI research in CT's laboratory. CT was also supported by the NSERC discovery grant. We also thank Saskatchewan Institute for Health Research (SHRF) for awarding the post-doctoral fellowship to SS. YZ was supported by the Iver and Joyce Graham Indiana Small Professorship and startup fund from the University of Saskatchewan and the Saskatchewan Health Research Foundation (SHRF) Establisment Grant. We thank Dr. Stan Bardal, Professor, Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Canada for assisting us in English language editing. Finally, We thank our honors students (Margaret Sutherland, Rudi Kerlis, Saleha Shahid, and Zohe Rafid-Hamed) in CT laboratory for assisting with blinded processing and scoring immunohistochemistry experiments.	Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Benca R, 2009, BRAIN RES REV, V62, P57, DOI 10.1016/j.brainresrev.2009.09.005; Biessels GJ, 2006, J NEUROL NEUROSUR PS, V77, P304, DOI 10.1136/jnnp.2005.069583; Blume C, 2017, NEUROLOGY, V88, P1933, DOI 10.1212/WNL.0000000000003942; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Carballosa G. M. M., 2013, J NEUROTRAUM, V30, P119, DOI DOI 10.1089/neu.2012.2499; Castle AR, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00019; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hoshino S, 2003, ACT NEUR S, V86, P297; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Jin Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-13; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lee SA, 2018, MED SCI MONITOR, V24, P8789, DOI 10.12659/MSM.911385; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Leuchter AF, 2015, BRAIN STIMUL, V8, P787, DOI 10.1016/j.brs.2015.05.005; Li XY, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/931058; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; Martiny K, 2010, BIOL PSYCHIAT, V68, P163, DOI 10.1016/j.biopsych.2010.02.017; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Namad T, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.156.4948; Neville IS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0944-2; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Roguski A, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040058; Rohan M, 2004, AM J PSYCHIAT, V161, P93, DOI 10.1176/appi.ajp.161.1.93; Rohan ML, 2014, BIOL PSYCHIAT, V76, P186, DOI 10.1016/j.biopsych.2013.10.024; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Salas R, 2003, J NEUROSCI, V23, P6255; Sanchez-Alavez M, 2007, BRAIN RES, V1158, P71, DOI 10.1016/j.brainres.2007.05.010; Shafi M, 2014, BIOL PSYCHIAT, V76, P170, DOI 10.1016/j.biopsych.2014.05.017; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Straaso B, 2014, ACTA NEUROPSYCHIATR, V26, P272, DOI 10.1017/neu.2014.5; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Taylor R, 2018, AUSTRALAS PSYCHIATRY, V26, P189, DOI 10.1177/1039856217748249; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vogel-Ciernia A., 2014, CURRENT PROTOCOLS NE, V69, P8, DOI 10.1002/0471142301.ns0831s69; Wang C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00571; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Zhang ZC, 2015, NEURAL REGEN RES, V10, P916, DOI 10.4103/1673-5374.158356; Zhen Junli, 2017, Alzheimers Dement (N Y), V3, P487, DOI 10.1016/j.trci.2017.07.002	60	6	6	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3103	3114		10.1089/neu.2018.5918		JUN 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000470867400001	31020907				2022-02-06	
J	Taghdiri, F; Multani, N; Tarazi, A; Naeimi, SA; Khodadadi, M; Esopenko, C; Green, R; Colella, B; Wennberg, R; Mikulis, D; Davis, KD; Goswami, R; Tator, C; Levine, B; Tartaglia, MC				Taghdiri, Foad; Multani, Namita; Tarazi, Apameh; Naeimi, Seyed Ali; Khodadadi, Mozghan; Esopenko, Carrie; Green, Robin; Colella, Brenda; Wennberg, Richard; Mikulis, David; Davis, Karen Deborah; Goswami, Ruma; Tator, Charles; Levine, Brian; Tartaglia, Maria Carmela			Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; CSF BIOMARKERS; BRAIN-INJURY; BETA; DIAGNOSIS; PROTEIN; AGE; DISCRIMINATION	Objective To identify CSF biomarkers that are related to decreased white matter (WM) integrity and poor cognitive performance in former professional athletes with a history of multiple concussions. Methods Concentrations of phosphorylated tau181, total tau (t-tau), and beta-amyloid in the CSF were measured in 3 groups: 22 former professional athletes with multiple concussions (mean +/- SD age 55.9 +/- 12.2 years), 5 healthy controls (age 57.4 +/- 5.2 years), and 12 participants (age 60.0 +/- 6.6 years) diagnosed with Alzheimer disease (AD). All participants in the former athletes group underwent diffusion tensor imaging to determine WM tract integrity and completed neuropsychological testing. We divided the former athletes group into those with normal (< 300 pg/mL) and high (>300 pg/mL) CSF t-tau. Results CSF t-tau in the former athletes group was significantly higher than in the healthy control group (349.3 +/- 182.6 vs 188.8 +/- 39.9 pg/mL, p = 0.003) and significantly lower than in the patients with AD (349.3 +/- 182.6 vs 857.0 +/- 449.3 pg/mL, p = 0.007). Fractional anisotropy values across all the tracts were significantly lower in the high CSF t-tau group compared to the normal CSF t-tau group (p = 0.036). Participants in the high CSF t-tau group scored significantly lower on the Trail Making Test (TMT) Part B compared to the normal CSF t-tau group (t scores 45.6 +/- 18.8 vs 62.3 +/- 10.1, p = 0.017). Conclusion Our findings indicate that former athletes with multiple concussions are at increased risk of elevated levels of CSF t-tau and that high CSF t-tau is associated with reduced WM integrity and worse scores on the TMT Part B.	[Taghdiri, Foad; Multani, Namita; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Green, Robin; Colella, Brenda] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; [Green, Robin; Wennberg, Richard; Mikulis, David; Davis, Karen Deborah; Tator, Charles; Levine, Brian; Tartaglia, Maria Carmela] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Davis, Karen Deborah] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol & Neurol, Toronto, ON, Canada; [Taghdiri, Foad; Tarazi, Apameh; Naeimi, Seyed Ali; Khodadadi, Mozghan; Green, Robin; Colella, Brenda; Wennberg, Richard; Mikulis, David; Davis, Karen Deborah; Goswami, Ruma; Tator, Charles; Tartaglia, Maria Carmela] Univ Hlth Network, Canadian Concuss Ctr, Toronto, ON, Canada; [Tator, Charles] Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurosurg, Toronto, ON, Canada; [Tarazi, Apameh; Naeimi, Seyed Ali; Wennberg, Richard; Tartaglia, Maria Carmela] Univ Hlth Network, Div Neurol, Toronto, ON, Canada; [Mikulis, David] Univ Hlth Network, Div Neuroradiol, Joint Dept Med Imaging, Toronto, ON, Canada; [Esopenko, Carrie] Rotman Res Inst Baycrest, Toronto, ON, Canada		Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.; Tartaglia, MC (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Tartaglia, MC (corresponding author), Univ Hlth Network, Canadian Concuss Ctr, Toronto, ON, Canada.; Tartaglia, MC (corresponding author), Univ Hlth Network, Div Neurol, Toronto, ON, Canada.	carmela.tartaglia@uhn.ca	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Taghdiri, Foad/0000-0002-3280-2804; Esopenko, Carrie/0000-0001-8607-5633; Green, Robin/0000-0001-9451-3963; Mikulis, David/0000-0003-3956-0892	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Toronto General and Western Hospital Foundation; PSI Foundation	Funded by the Toronto General and Western Hospital Foundation, PSI Foundation, and Canadian Institute of Health Research.	Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Amlien IK, 2013, RADIOLOGY, V266, P295, DOI 10.1148/radiol.12120319; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1007/BF03206605; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Caprelli MT, 2019, NEUROSCIENTIST, V25, P8, DOI 10.1177/1073858417742125; Caprelli MT, 2018, J NEUROTRAUM, V35, P1929, DOI 10.1089/neu.2017.5495; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kapaki EN, 2007, EUR J NEUROL, V14, P168, DOI 10.1111/j.1468-1331.2006.01593.x; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maddalena A, 2003, ARCH NEUROL-CHICAGO, V60, P1202, DOI 10.1001/archneur.60.9.1202; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rajyaguru, 2015, INT J NEW TECHNOL SC, V2, P22, DOI DOI 10.1109/ISIT.2014.6875215; Rosenthal SL, 2014, THESIS; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Sjogren M, 2001, CLIN CHEM, V47, P1776; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	50	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUN 4	2019	92	23					E2717	E2726		10.1212/WNL.0000000000007608			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IQ5EG	WOS:000480774000010	31068482	Green Published			2022-02-06	
J	Anthonymuthu, TS; Kenny, EM; Hier, ZE; Clark, RSB; Kochanek, PM; Kagan, VE; Bayir, H				Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Hier, Zachary E.; Clark, Robert S. B.; Kochanek, Patrick M.; Kagan, Valerian E.; Bayir, Huelya			Detection of brain specific cardiolipins in plasma after experimental pediatric head injury	EXPERIMENTAL NEUROLOGY			English	Article						Mitochondrial dysfunction; Plasma biomarker; Brain-specific cardiolipin; Phospholipidomics	LIPID-PEROXIDATION; BIOMARKERS; MODEL; REVEALS; PATHWAY; STRESS; GENDER; ACTS	Cardiolipin (CL) is a mitochondria-specific phospholipid that is central to maintenance and regulation of mitochondrial bioenergetic and metabolic functions. CL molecular species display great tissue variation with brain exhibiting a distinct, highly diverse CL population. We recently showed that the appearance of unique brain-type CLs in plasma could serve as a brain-specific marker of mitochondrial/tissue injury in patients after cardiac arrest. Mitochondrial dysfunction has been increasingly implicated as a critical mechanism underlying the pathogenesis of traumatic brain injury (TBI). Therefore, we hypothesized that unique, brain-specific CL species from the injured brain are released to the peripheral circulation after TBI. To test this hypothesis, we performed a high-resolution mass spectrometry based phospholipidomics analysis of post-natal day (PND)17 rat brain and plasma after controlled cortical impact. We found a time-dependent increase in plasma CLs after TBI including the aforementioned brain-specific CL species early after injury, whereas CLs were significantly decreased in the injured brain. Compositional and quantitative correlational analysis suggested a possible release of CL into the systemic circulation following TBI. The identification of brain-type CLs in systemic circulation may indicate underlying mitochondrial dysfunction/loss after TBI. They may have potential as pharmacodynamics response biomarkers for targeted therapies.	[Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Hier, Zachary E.; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Hier, Zachary E.; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Hier, Zachary E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA USA; [Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Hier, Zachary E.; Kagan, Valerian E.; Bayir, Huelya] Childrens Hosp Pittsburgh, Childrens Neurosci Inst, Pittsburgh, PA 15213 USA; [Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Kagan, Valerian E.] IM Sechenov Moscow Med State Univ, Lab Nav Redox Lipid, Moscow, Russia		Bayir, H (corresponding author), Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.	bayihx@ccm.upmc.edu		Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL114453, AI068021, NS076511, NS084604, NS061817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076511, R01NS084604] Funding Source: NIH RePORTER	Supported by NIH (HL114453, AI068021, NS076511, NS084604 and NS061817).	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Acaz-Fonseca E, 2017, SCI REP-UK, V7, DOI 10.1038/srep43878; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Anthonymuthu TS, 2019, CRIT CARE MED, V47, pE292, DOI 10.1097/CCM.0000000000003636; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Anthonymuthu TS, 2017, BBA-MOL BASIS DIS, V1863, P2601, DOI 10.1016/j.bbadis.2017.03.015; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Balasubramanian K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6179; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Chakraborty K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13944; Chao HL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97677; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Chua EW, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00001; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Goetzl L, 2018, ANN CLIN TRANSL NEUR, V5, P4, DOI 10.1002/acn3.499; Gonzalez-Dominguez R, 2014, J PROTEOMICS, V104, P37, DOI 10.1016/j.jprot.2014.01.014; Graham EM, 2018, CURR OPIN PEDIATR, V30, P199, DOI 10.1097/MOP.0000000000000591; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maeda A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.277; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stovell MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29255-3; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; 2015, ANTIOXID REDOX SIGN, V22, P1667, DOI DOI 10.1089/ARS.2014.6219; 2015, BLOOD, V125, P2151, DOI DOI 10.1182/BLOOD-2014-09-598805	48	6	6	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2019	316						63	73		10.1016/j.expneurol.2019.04.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX8NV	WOS:000467663500007	30981805	Green Accepted			2022-02-06	
J	Cummiskey, B; Sankaran, GN; McIver, KG; Shyu, D; Markel, J; Talavage, TM; Leverenz, L; Meyer, JJ; Adams, D; Nauman, EA				Cummiskey, Brian; Sankaran, Goutham N.; McIver, Kevin G.; Shyu, Daniel; Markel, Justin; Talavage, Thomas M.; Leverenz, Larry; Meyer, Janette J.; Adams, Douglas; Nauman, Eric A.			Quantitative evaluation of impact attenuation by football helmets using a modal impulse hammer	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Protective equipment; head impact; helmet evaluation; dimensional analysis; Hybrid III headform	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; HEAD-INJURY; BIOMECHANICS; ACCELERATION; PERFORMANCE; ABILITY; STATE	Concussions and changes in neurophysiology due to sub-concussive blows are common in contact sports, motivating a need for improved safety systems. While there have been attempts to determine whether or not new helmet designs influence the incidence of concussion, the results to date have been inconclusive. Consequently, the goal of this study was to evaluate the ability of modern football helmets to mitigate linear impacts directed normal, as well as oblique, to the surface of the helmeted head using a system that quantifies both the input load and the resulting accelerations of a Hybrid III headform. The transfer function connecting the inputs and outputs of the system was developed using dimensional analysis to provide a means of comparing helmets across brands and sports. For translational accelerations, increased helmet mass and a secondary layer of padding helped mitigate the impacts. The attenuation of angular accelerations depended substantially on helmet model and impact location.	[Cummiskey, Brian; Sankaran, Goutham N.; Markel, Justin; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA; [McIver, Kevin G.; Shyu, Daniel; Talavage, Thomas M.; Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47906 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47906 USA; [Leverenz, Larry] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47906 USA; [Meyer, Janette J.; Adams, Douglas] Vanderbilt Univ, Dept Civil & Environm Engn, Nashville, TN 37235 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	enauman@purdue.edu		Talavage, Thomas/0000-0003-4977-6398	Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; Indiana Clinical and Translational Sciences Institute; Purdue's College of Engineering Dean's Office	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, a Core Facility Grant from the Indiana Clinical and Translational Sciences Institute, and Purdue's College of Engineering Dean's Office.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barenblatt, 1996, SCALING SELF SIMILAR; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; MILLS NJ, 1991, ACCIDENT ANAL PREV, V23, P153, DOI 10.1016/0001-4575(91)90045-7; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Newman J.A., 2007, MODERN SPORTS HELMET; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2013, STAND TEST METH EQ U; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1	34	6	6	2	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2019	233	2					301	311		10.1177/1754337118823603			11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA9LX	WOS:000469879800013					2022-02-06	
J	de l'Escalopier, N; Salga, M; Gatin, L; Genet, F; Denormandie, P				de l'Escalopier, Nicolas; Salga, Marjorie; Gatin, Laure; Genet, Francois; Denormandie, Philippe			Resection of heterotopic ossification around the hip after trauma	EFORT OPEN REVIEWS			English	Article						neurogenic heterotopic ossification; osteoma hip; surgery; trauma	BRAIN-INJURY; EXCISION; REMOVAL; CT	Traumatic neurological lesions may lead to development of heterotopic ossification. These cases are classified as 'neurogenic heterotopic ossifications' (NHOs). The associated neurological lesions can be caused by cranial trauma or spinal cord injury and may sometimes include a local trauma. NHOs that form around the hip joints are of particular interest because they often cause the patient to avoid the sitting position or the resumption of walking. Whilst NHO can involve the knee, shoulder and elbow joints, hip-involving NHOs are more numerous, and sometimes develop in close contact with vascular or neurological structures. Multi-disciplinary clinical examination is fundamental to evaluate patients for surgical intervention and to define the objectives of the surgery. The best investigation to define an NHO mass is a computerized tomography (CT) scan. Resection is performed to liberate a fused joint to provide functionality, and this need not be exhaustive if it is not necessary to increase the range of motion. While recurrence does occur post-surgery, a partial resection does not pose a greater risk of recurrence and there are no adjuvant treatments available to reduce this risk. The greatest risks associated with NHO surgical resection are infection and haematoma; these risks are very high and must be considered when evaluating patients for surgery.	[de l'Escalopier, Nicolas; Gatin, Laure; Denormandie, Philippe] Hop Raymond Poincare, Serv Chirurg Orthoped, Garches, France; [de l'Escalopier, Nicolas] Hop Instruct Armees Percy, Serv Chirurg Orthoped Traumatol & Chirurg Reparat, 101 Ave Henri Barbusse, F-92141 Clamart, France; [Salga, Marjorie; Genet, Francois] Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France		de l'Escalopier, N (corresponding author), Hop Instruct Armees Percy, Serv Chirurg Orthoped Traumatol & Chirurg Reparat, 101 Ave Henri Barbusse, F-92141 Clamart, France.	ndelescalopier@gmail.com		de l'Escalopier, Nicolas/0000-0001-6333-7311			Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Arduini M, 2015, BONE JOINT J, V97B, P899, DOI 10.1302/0301-620X.97B7.35031; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cipriano Cara, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-33; Denormandie P, 2018, ORTHOP TRAUMATOL-SUR, V104, pS121, DOI 10.1016/j.otsr.2017.04.015; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Foley KL, 2018, BONE, V109, P65, DOI 10.1016/j.bone.2017.12.006; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Gacon G, REV CHIR ORTHOP REPA, V64, P375; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Gatin L, 2017, ORTHOP TRAUMATOL-SUR, V103, P357, DOI 10.1016/j.otsr.2017.02.001; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2015, BRAIN INJURY, V29, P866, DOI 10.3109/02699052.2015.1005133; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Honore T., 2016, PLACE RADIOTHERAPIE; Hoyt BW, 2018, BONE, V109, P3, DOI 10.1016/j.bone.2018.02.009; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152	30	6	6	0	1	BRITISH EDITORIAL SOC BONE & JOINT SURGERY	LONDON	22 BUCKINGHAM ST, LONDON, WC2N 6ET, ENGLAND	2058-5241			EFORT OPEN REV	EFORT Open Rev.	JUN	2019	4	6					263	268		10.1302/2058-5241.4.180098			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	IB2KF	WOS:000470097500006	31210967	gold, Green Published, Green Submitted			2022-02-06	
J	Driver, S; Juengst, S; McShan, EE; Bennett, M; Bell, K; Dubiel, R				Driver, Simon; Juengst, Shannon; McShan, Evan Elizabeth; Bennett, Monica; Bell, Kathleen; Dubiel, Rosemary			A randomized controlled trial protocol for people with traumatic brain injury enrolled in a healthy lifestyle program (GLB-TBI)	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Physical activity; Nutrition; Weight loss; Rehabilitation; Intervention	DIABETES-PREVENTION-PROGRAM; MONTREAL COGNITIVE ASSESSMENT; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; WEIGHT-LOSS; ACUTE REHABILITATION; LIVING PARTNERSHIPS; SCREENING TOOL; ADULT PATIENTS; WALKING SPEED	Weight gain is prevalent among people with traumatic brain injury (TBI) and may be attributable to environmental or injury-specific factors such as mobility impairment, endocrine dysfunction, behavioral and emotional disorders, and sensory loss. Few weight management programs exist to meet the unique needs of this population. Researchers modified a nationally recognized, evidence-based weight-loss program, Group Lifestyle Balance (TM) (GLB), to address the needs of over-weight and obese people post TBI (GLB-TBI). This current randomized controlled trial (RCT) examines the efficacy of the GLB-TBI on weight and secondary outcomes compared to an attention control educational support group. Furthermore, researchers have developed a mobile technology app to further engage participants in the program. This RCT will enroll and randomize 66 participants over a two-year period. It is anticipated that findings from this current RCT will contribute to the knowledge and evidence for an effective weight-loss intervention among this underserved population, with a goal of achieving full recognition by the Centers for Disease Control and Prevention-National Diabetes Prevention Program and subsequent Center for Medicare and Medicaid Services reimbursement for participation.	[Driver, Simon; Juengst, Shannon; McShan, Evan Elizabeth; Bennett, Monica; Bell, Kathleen; Dubiel, Rosemary] North Texas Traumat Brain Injury Model Syst, Dallas, TX USA; [Driver, Simon; McShan, Evan Elizabeth; Dubiel, Rosemary] Baylor Scott & White Inst Rehabil, 909 N Washington, Dallas, TX 75246 USA; [Juengst, Shannon; Bell, Kathleen] Univ Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bennett, Monica] Baylor Scott & White Hlth, 8080 N Cent Expy, Dallas, TX 75206 USA		Driver, S (corresponding author), Baylor Scott & White Inst Rehabil, 909 N Washington, Dallas, TX 75246 USA.	sjdriver@bswrehab.com; shannon.juengst@utsouthwestern.edu; evan.mcshan@bswhealth.org; monica.bennett@bswhealth.org; kathleen.bell@utsouthwestern.edu; rdubiel@bswrehab.com	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; driver, simon/0000-0003-2356-432X; Bell, Kathleen/0000-0002-0928-2046	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0013-01-00]	The contents of this publication were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPTB0013-01-00). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Amundson HA, 2009, DIABETES EDUCATOR, V35, P209, DOI 10.1177/0145721709333269; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Baranowski T, 2009, INT J BEHAV NUTR PHY, V6, DOI [10.1186/1479-5868-6-6, 10.1186/1479-5868-6-32]; Becker H., 1993, J HLTH BEHAV ED PROM; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Block G, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4897; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Brown RM, 2018, BRAIN INJURY, V32, P986, DOI 10.1080/02699052.2018.1468575; Brown SC, 2013, AM J PREV MED, V45, P202, DOI 10.1016/j.amepre.2013.03.021; Centers for Disease C Prevention, 2016, TBI GET FACTS OCT; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Davis-Smith M, 2007, J NATL MED ASSOC, V99, P440; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE49, DOI 10.1097/HTR.0000000000000372; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Driver S, 2017, BRAIN INJURY, V31, P1612, DOI 10.1080/02699052.2017.1346286; Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003; Enders C. K., 2010, APPL MISSING DATA AN; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Faul M, 2010, TRAUMATIC BRAIN INJU; Gidding SS, 2009, CIRCULATION, V119, P1161, DOI 10.1161/CIRCULATIONAHA.109.191856; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Greenwood DA, 2014, DIABETES EDUCATOR, V40, P299, DOI 10.1177/0145721714524281; Hamilton M, 2016, BRAIN INJURY, V30, P819, DOI 10.3109/02699052.2016.1146962; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hinnant L, 2015, EVALUATION HLTH CARE; Hochbaum G., 1952, HLTH BELIEF MODEL; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2011, DIABETES EDUCATOR, V37, P659, DOI 10.1177/0145721711411930; Kramer MK, 2010, DIABETES RES CLIN PR, V90, pE60, DOI 10.1016/j.diabres.2010.08.013; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Kramer SF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460482; Kriska A, 2003, EXERC SPORT SCI REV, V31, P132, DOI 10.1097/00003677-200307000-00006; Kriska AM, 2006, MED SCI SPORT EXER, V38, P826, DOI 10.1249/01.mss.0000218138.91812.f9; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; Luxton DD, 2011, TELEMED E-HEALTH, V17, P50, DOI 10.1089/tmj.2010.0091; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieman DC, 2003, J AM DIET ASSOC, V103, P588, DOI 10.1053/jada.2003.50116; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; REYNOLDS RG, 2018, BRAIN INJURY, P13, DOI DOI 10.1007/978-3-319-74171-0_2; Rimmer JH, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0100-5; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; SAS Institute, 2002, SAS STAT 9 3 US GUID; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schwarzer R., 2010, ANXIETY STRESS COPIN, V12, P329; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Tomlinson M, 2009, LANCET, V374, P1857, DOI 10.1016/S0140-6736(09)61910-3; Vadheim LM, 2010, J RURAL HEALTH, V26, P266, DOI 10.1111/j.1748-0361.2010.00288.x; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wing RR, 2004, OBES RES, V12, P1426; World Health Organization, 2000, WHO TECHN REP SER	79	6	6	2	9	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA		2451-8654		CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	JUN	2019	14								100328	10.1016/j.conctc.2019.100328			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	IM0FB	WOS:000477660500013	30775611	Green Published, gold			2022-02-06	
J	Eiden, M; Christinat, N; Chakrabarti, A; Sonnay, S; Miroz, JP; Cuenoud, B; Oddo, M; Masoodi, M				Eiden, Michael; Christinat, Nicolas; Chakrabarti, Anirikh; Sonnay, Sarah; Miroz, John-Paul; Cuenoud, Bernard; Oddo, Mauro; Masoodi, Mojgan			Discovery and validation of temporal patterns involved in human brain ketometabolism in cerebral microdialysis fluids of traumatic brain injury patients	EBIOMEDICINE			English	Article						Traumatic brain injury; Cerebral microdialysis; Ketometabolism; Metabolic state	CHAIN AMINO-ACIDS; INTRACRANIAL-PRESSURE; KETOGENIC DIET; METABOLISM; LACTATE; EXPRESSION; KEGG; CATECHOLAMINES; PHENYLALANINE; GLYCOLYSIS	Background: Traumatic brain injury (TBI) is recognized as a metabolic disease, characterized by acute cerebral glucose hypo-metabolism. Adaptive metabolic responses to TBI involve the utilization of alternative energy substrates, such as ketone bodies. Cerebral microdialysis (CMD) has evolved as an accurate technique allowing continuous sampling of brain extracellular fluid and assessment of regional cerebral metabolism. We present the successful application of a combined hypothesis- and data-driven metabolomics approach using repeated CMD sampling obtained routinely at patient bedside. Investigating two patient cohorts (n = 26 and n = 12), we identified clinically relevant metabolic patterns at the acute post-TBI critical care phase. Methods: Clinical and CMD metabolomics data were integrated and analysed using in silico and data modelling approaches. We used both unsupervised and supervised multivariate analysis techniques to investigate structures within the time series and associations with patient outcome. Findings: The multivariate metabolite time series exhibited two characteristic brain metabolic states that were attributed to changes in key metabolites: valine, 4-methyl-2-oxovaleric acid (4-MOV), isobeta-hydroxybutyrate (iso-bHB), tyrosyine, and 2-ketoisovaleric add (2-KIV). These identified cerebral metabolic states differed significantly with respect to standard clinical values. We validated our findings in a second cohort using a classification model trained on the cerebral metabolic states. We demonstrated that short-term (therapeutic intensity level (TIL)) and mid-term patient outcome (6-month Glasgow Outcome Score (GOS)) can be predicted from the time series characteristics. Interpretation: We identified two specific cerebral metabolic patterns that are closely linked to ketometabolism and were associated with both TIL and GOS. Our findings support the view that advanced metabolomics approaches combined with CMD may be applied in real-time to predict short-term treatment intensity and long-term patient outcome. (C) 2019 The Authors. Published by Elsevier B.V.	[Christinat, Nicolas; Chakrabarti, Anirikh; Sonnay, Sarah; Masoodi, Mojgan] Ecole Polytech Fed Lausanne, Nestle Res, Lipid Metab, Innovat Pk, Lausanne, Switzerland; [Eiden, Michael] Eidea Biosci Ltd, Cambridge, England; [Miroz, John-Paul; Oddo, Mauro] CHUV Univ Hosp, Fac Biol & Med, Neurosci Crit Care Res Grp, Dept Intens Care Med, Lausanne, Switzerland; [Cuenoud, Bernard] Nestle Hlth Sci, Lausanne, Switzerland; [Masoodi, Mojgan] Bern Univ Hosp, Inselspital, Inst Clin Chem, Freiburgstr, CH-3010 Bern, Switzerland		Masoodi, M (corresponding author), Bern Univ Hosp, Inselspital, Inst Clin Chem, Freiburgstr, CH-3010 Bern, Switzerland.	mojgan.masoodi@insel.ch	MIROZ, John-Paul/AAR-7445-2020	Chakrabarti, Anirikh/0000-0001-7804-209X; Cuenoud, Bernard/0000-0001-5120-1740; MASOODI, MOJGAN/0000-0001-9840-1731	Nestle Health ScienceNestle SA	This study was sponsored by Nestle Health Science.	Alexander JJ, 1998, NEUROCHEM RES, V23, P227, DOI 10.1023/A:1022441211177; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8; Banerjee A, 2016, J NEUROCHEM, V138, P265, DOI 10.1111/jnc.13638; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; BRAND K, 1981, BIOCHIM BIOPHYS ACTA, V677, P126, DOI 10.1016/0304-4165(81)90153-7; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Desagher S, 1997, J NEUROSCI, V17, P9060; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Elamin M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00377; Endres M, 2005, STROKE, V36, P321, DOI 10.1161/01.STR.0000153008.60517.ab; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martens H, 2001, CHEMOMETR INTELL LAB, V58, P85, DOI 10.1016/S0169-7439(01)00153-8; Massieu L, 2003, NEUROSCIENCE, V120, P365, DOI 10.1016/S0306-4522(03)00266-5; Murin R, 2008, J NEUROCHEM, V105, P1176, DOI 10.1111/j.1471-4159.2008.05298.x; Murin R, 2009, NEUROCHEM RES, V34, P1195, DOI 10.1007/s11064-008-9895-2; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; Oddo M, 2018, INTENS CARE MED, V44, P1945, DOI 10.1007/s00134-017-5031-6; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Pinheiro JL, 2018, J CLIN NUTR METABO, V2, P1; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Sharma B, 2018, J HEAD TRAUMA REHAB, V33, P33, DOI 10.1097/HTR.0000000000000280; Sharma Deepak, 2012, Anesthesiol Clin, V30, P333, DOI 10.1016/j.anclin.2012.04.003; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stovell MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29255-3; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; White H, 2017, NEUROL RES, V39, P1, DOI 10.1080/01616412.2016.1251695; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	67	6	7	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-3964			EBIOMEDICINE	EBioMedicine	JUN	2019	44						607	617		10.1016/j.ebiom.2019.05.054			11	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	IF0LQ	WOS:000472768900061	31202815	Green Published, gold			2022-02-06	
J	Griffiths, BB; Sahbaie, P; Rao, A; Arvola, O; Xu, LJ; Liang, DY; Ouyang, YB; Clark, DJ; Giffard, RG; Stary, CM				Griffiths, Brian B.; Sahbaie, Peyman; Rao, Anand; Arvola, Oiva; Xu, Lijun; Liang, Deyong; Ouyang, Yibing; Clark, David J.; Giffard, Rona G.; Stary, Creed M.			Pre-treatment with microRNA-181a Antagomir Prevents Loss of Parvalbumin Expression and Preserves Novel Object Recognition Following Mild Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Mild traumatic brain injury; Parvalbumin; MicroRNA; Hippocampus; Novel object	C-FOS; DENTATE GYRUS; NEURONAL LOSS; MIR-181A; HIPPOCAMPUS; MODEL; MICE; INHIBITION; RECEPTOR; DEFICITS	Mild traumatic brain injury (mTBI) can result in permanent impairment in memory and learning and may be a precursor to other neurological sequelae. Clinical treatments to ameliorate the effects of mTBI are lacking. Inhibition of microRNA-181a (miR-181a) is protective in several models of cerebral injury, but its role in mTBI has not been investigated. In the present study, miR-181a-5p antagomir was injected intracerebroventricularly 24h prior to closed-skull cortical impact in young adult male mice. Paw withdrawal, open field, zero maze, Y maze, object location and novel object recognition tests were performed to assess neurocognitive dysfunction. Brains were assessed immunohistologically for the neuronal marker NeuN, the perineuronal net marker wisteria floribunda lectin (WFA), cFos, and the interneuron marker parvalbumin. Protein quantification was performed with immunoblots for synaptophysin and postsynaptic density 95 (PSD95). Fluorescent in situ hybridization was utilized to localize hippocampal miR-181a expression. MiR-181a antagomir treatment reduced neuronal miR-181a expression after mTBI, restored deficits in novel object recognition and increased hippocampal parvalbumin expression in the dentate gyrus. These changes were associated with decreased dentate gyrus hyperactivity indicated by a relative reduction in PSD95 and cFos expression. These results suggest that miR-181a inhibition may be a therapeutic approach to reduce hippocampal excitotoxicity and prevent cognitive dysfunction following mTBI.	[Griffiths, Brian B.; Sahbaie, Peyman; Rao, Anand; Arvola, Oiva; Xu, Lijun; Liang, Deyong; Ouyang, Yibing; Clark, David J.; Giffard, Rona G.; Stary, Creed M.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA; [Sahbaie, Peyman; Liang, Deyong; Clark, David J.] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, Palo, CA USA		Griffiths, BB; Stary, CM (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	griffiths@stanford.edu; cstary@stanford.edu		Griffiths, Brian/0000-0003-2930-983X; Arvola, Oiva/0000-0001-7151-0348	American Heart AssociationAmerican Heart Association [FTF-19970029, 18POST33990395]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science [00171200]; VA Merit Review GrantUS Department of Veterans Affairs [RX001776-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS053898]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053898] Funding Source: NIH RePORTER	This study was funded in part by American Heart Association Grants FTF-19970029 to CMS and #18POST33990395 to BBG, the Finnish Cultural Foundation grant #00171200 to OA, NIH #5R01NS053898 to RG, and VA Merit Review Grant #RX001776-01 to DJC.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bhushan R, 2013, INT J BIOCHEM CELL B, V45, P696, DOI 10.1016/j.biocel.2012.12.008; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Czigner A, 2004, INT J MOL MED, V14, P247; Datta Chaudhuri A, 2013, FRONTIERS CELLULAR N; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fasulo L, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00020; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hayes RL, 2009, COLLECTIONS, V116, P252; Hegarty Shane V, 2018, Neuronal Signal, V2, pNS20170181, DOI 10.1042/NS20170181; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huang YQ, 2015, INT J CLIN EXP PATHO, V8, P12861; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunsaker MR, 2007, BEHAV NEUROSCI, V121, P742, DOI 10.1037/0735-7044.121.4.742; Hylin MJ, 2013, LEARN MEMORY, V20, P267, DOI 10.1101/lm.030197.112; Jackson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035557; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JOHANSEN FF, 1990, NEUROSCI LETT, V120, P171, DOI 10.1016/0304-3940(90)90030-D; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Keith DJ, 2008, FRONTIERS MOL NEUROS; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo J, 2014, FRONTIERS NEUROLOGY; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Ren L, 2016, GENETICS MOL RES GMR; Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002; Sahbaie P, 2018, J PAIN; Sahbaie P, 2014, ANESTH ANALG, V118, P1336, DOI 10.1213/ANE.0000000000000189; Stary CM, 2017, MOL CELL NEUROSCI, V82, P118, DOI 10.1016/j.mcn.2017.05.004; Tajerian M, 2015, NEUROBIOL LEARN MEM, V123, P100, DOI 10.1016/j.nlm.2015.06.004; Tajerian M, 2014, ANESTHESIOLOGY, V121, P852, DOI 10.1097/ALN.0000000000000403; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Thompson EH, 2018, P NATL ACAD SCI USA, V115, P607, DOI 10.1073/pnas.1713530115; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Xu LJ, 2015, EXP NEUROL, V264, P1, DOI 10.1016/j.expneurol.2014.11.007; Xu XF, 2018, CEREB CORTEX, V28, P3309, DOI 10.1093/cercor/bhx201; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; Zhang S. Y., 2017, IEEE T COMPON PACK T, V7, P1; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976; Zou YN, 2012, P NATL ACAD SCI USA, V109, P21522, DOI 10.1073/pnas.1216913110	63	6	7	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	JUN	2019	21	2					170	181		10.1007/s12017-019-08532-y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HY2FL	WOS:000467933200008	30900118	Green Accepted			2022-02-06	
J	Hoffman, H; Jalal, MS; Chin, LS				Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.			The Incidence of Meningitis in Patients with Traumatic Brain Injury Undergoing External Ventricular Drain Placement: A Nationwide Inpatient Sample Analysis	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Ventriculostomy; Cross-infection	INTRACRANIAL-PRESSURE MONITORS; ANTIBIOTIC-PROPHYLAXIS; RISK-FACTORS; INFECTIONS; COMPLICATIONS; MANAGEMENT; EFFICACY; IMPACT; COST	Background/ObjectiveInfection is the most common complication of external ventricular drain (EVD) placement. National trends in the annual incidence of meningitis among patients with traumatic brain injury (TBI) who have undergone EVD placement have not been reported.MethodsThe Nationwide Inpatient Sample was used to select adults with a primary diagnosis of TBI who underwent EVD placement between 2002 and 2011. Annual rates of meningitis among patients who underwent EVD placement were determined. We also calculated mortality rates and length of stay (LOS). Potential factors associated with meningitis were evaluated in a binary logistic regression analysis.ResultsOut of 1,571,927 adult discharges with a primary diagnosis of TBI between 2002 and 2011, 39,029 (2.5%) underwent EVD placement. Of these, 1544 (4.3%) patients developed meningitis. There was no significant trend in the annual incidence of meningitis (p=0.88), mortality (p=0.55), or mean LOS (p=0.13) during the study period. Meningitis and mortality rates remained stable when stratifying patients by hospital volume. In the binary logistic regression, acquired immunodeficiency syndrome, sepsis, and cerebrospinal fluid leak were associated with meningitis.ConclusionsThe incidence of meningitis in patients who underwent EVD placement remained stable between 2002 and 2011. Further prospective studies are needed to identify approaches for preventing these infections.	[Hoffman, Haydn; Jalal, Muhammad S.; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	hoffmanh@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Akbik OS, 2017, J NEUROTRAUM, V34, P3153, DOI 10.1089/neu.2016.4912; Alleyne CH, 2000, NEUROSURGERY, V47, P1124, DOI 10.1097/00006123-200011000-00020; Alotaibi NM, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17426; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Baram Daniel, 2008, Clin Med Circ Respirat Pulm Med, V2, P19; Baum GR, 2017, J NEUROSURG, V127, P1190, DOI 10.3171/2016.9.JNS16367; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chi H, 2010, INT J INFECT DIS, V14, pE216, DOI 10.1016/j.ijid.2009.04.006; CLARK WC, 1989, NEUROSURGERY, V25, P20; Cui ZW, 2015, AM J INFECT CONTROL, V43, pE23, DOI 10.1016/j.ajic.2015.03.015; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; EDWARDS N, 1994, HEALTH CARE FINANC R, V16, P45; Edwards NC, 2015, J NEUROSURG, V122, P139, DOI 10.3171/2014.9.JNS131277; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Guyot LL, 1998, ACT NEUR S, V71, P47; Hoffman H, 2018, WORLD NEUROSURG, V118, pE880, DOI 10.1016/j.wneu.2018.07.089; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Jha RM, 2018, NEUROPHARMACOLOGY; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Luerssen TG, 1991, 8 INT S INTR PRESS; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; Murphy RKJ, 2015, J NEUROSURG, V122, P1120, DOI 10.3171/2014.9.JNS132882; Murthy SB, 2016, NEUROCRIT CARE, V24, P389, DOI 10.1007/s12028-015-0199-5; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Poblete R, 2017, WORLD NEUROSURG, V99, P599, DOI 10.1016/j.wneu.2016.12.073; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Ramanan M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0712-z; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Schultz M, 1993, J Neurosci Nurs, V25, P158; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; Stevens EA, 2010, J NEUROSURG, V113, P86, DOI 10.3171/2009.10.JNS09565; Stoikes NF, 2008, SURG INFECT, V9, P503, DOI 10.1089/sur.2007.032; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Thompson DR, 2018, ACTA NEUROCHIR, V160, P1089, DOI 10.1007/s00701-018-3508-x; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	43	6	6	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30	3					666	674		10.1007/s12028-018-0656-z			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HY2EM	WOS:000467930300022	30523540				2022-02-06	
J	Lenell, S; Nyholm, L; Lewen, A; Enblad, P				Lenell, Samuel; Nyholm, Lena; Lewen, Anders; Enblad, Per			Clinical outcome and prognostic factors in elderly traumatic brain injury patients receiving neurointensive care	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Elderly; Outcome; Quality register; Neurointensive care; Prognostic factors	SEVERE HEAD-INJURY; PREINJURY WARFARIN; AGGRESSIVE TREATMENT; OLDER-ADULTS; MORTALITY; AGE; ANTIPLATELET; LEVEL; ANTICOAGULATION; MANAGEMENT	BackgroundThe probability of favorable outcome after traumatic brain injury (TBI) decreases with age. Elderly, 60years, are an increasing part of our population. Recent studies have shown an increase of favorable outcome in elderly over time. However, the optimal patient selection and neurointensive care (NIC) treatments may differ in the elderly and the young. The aims of this study were to examine outcome in a larger group of elderly TBI patients receiving NIC and to identify demographic and treatment related prognostic factors.MethodsPatients with TBI60years receiving NIC at our department between 2008 and 2014 were included. Demographics, co-morbidity, admission characteristics, and type of treatments were collected. Clinical outcome at around 6months was assessed. Potential prognostic factors were included in univariate and multivariate regression analysis with favorable outcome as dependent variable.ResultsTwo hundred twenty patients with mean age 70years (median 69; range 60-87) were studied. Overall, favorable outcome was 46% (Extended Glasgow Outcome Scale (GOSE) 5-8), unfavorable outcome 27% (GOSE 2-4), and mortality 27% (GOSE 1). Significant independent negative prognostic variables were high age (p<0.05), multiple injuries (p<0.05), GCS M3 on admission (p<0.05), and mechanical ventilation (p<0.001).ConclusionsOverall, the elderly TBI patients >60years receiving modern NIC in this study had a fair chance of favorable outcome without large risks for severe deficits and vegetative state, also in patients over 75years of age. High age, multiple injuries, GCS M3 on admission, and mechanical ventilation proved to be independent negative prognostic factors. The results underline that a selected group of elderly with TBI should have access to NIC.	[Lenell, Samuel; Nyholm, Lena; Lewen, Anders; Enblad, Per] Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci Neurosurg, SE-75185 Uppsala, Sweden		Lenell, S (corresponding author), Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci Neurosurg, SE-75185 Uppsala, Sweden.	samuel.lenell@neuro.uu.se		Lenell, Samuel/0000-0001-8914-5086	Uppsala university hospital	The study was supported by grants from the Uppsala university hospital.	ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Barnato AE, 2011, AM J RESP CRIT CARE, V183, P1037, DOI 10.1164/rccm.201002-0301OC; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Cheng C, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12208; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iaccarino C, 2018, J NEUROSURG SCI, V62, P765, DOI 10.23736/S0390-5616.16.03721-8; Karni A, 2001, AM SURGEON, V67, P1098; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lenell S, 2015, ACTA NEUROCHIR, V157, P417, DOI 10.1007/s00701-014-2329-9; Lennartsson C, 2012, SCAND J PUBLIC HEALT, V40, P95, DOI 10.1177/1403494812459468; Li Lai-Fung, 2017, Asian J Neurosurg, V12, P37, DOI 10.4103/1793-5482.148787; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Merzo A, 2016, ACTA NEUROCHIR, V158, P125, DOI 10.1007/s00701-015-2639-6; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Sjorgen H, 1991, J AGING HEALTH, V3, P107, DOI DOI 10.1177/089826439100300106; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Unterhofer C, 2017, ACTA NEUROCHIR, V159, P1547, DOI 10.1007/s00701-017-3240-y; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; World Population Prospects, 2017, STESASERA400 UN WORL; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013	48	6	8	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2019	161	6					1243	1254		10.1007/s00701-019-03893-6			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HY6FJ	WOS:000468224800028	30980243	Green Published, hybrid			2022-02-06	
J	Takagi, M; Babl, FE; Anderson, N; Bressan, S; Clarke, CJ; Crichton, A; Dalziel, K; Davis, GA; Doyle, M; Dunne, K; Godfrey, C; Hearps, SJC; Ignjatovic, V; Parkin, G; Rausa, V; Seal, M; Thompson, EJ; Truss, K; Anderson, V				Takagi, Michael; Babl, Franz E.; Anderson, Nicholas; Bressan, Silvia; Clarke, Cathriona J.; Crichton, Ali; Dalziel, Kim; Davis, Gavin A.; Doyle, Melissa; Dunne, Kevin; Godfrey, Celia; Hearps, Stephen J. C.; Ignjatovic, Vera; Parkin, Georgia; Rausa, Vanessa; Seal, Marc; Thompson, Emma Jane; Truss, Katie; Anderson, Vicki			Protocol for a prospective, longitudinal, cohort study of recovery pathways, acute biomarkers and cost for children with persistent postconcussion symptoms: the Take CARe Biomarkers study	BMJ OPEN			English	Article							QUALITY-OF-LIFE; UNITED-STATES; RELIABILITY; CONCUSSION; SCALE; PERFORMANCE; SPORT	Introduction The majority of children who sustain a concussion will recover quickly, but a significant minority will experience ongoing postconcussive symptoms, known as postconcussion syndrome (PCS). These symptoms include emotional, behavioural, cognitive and physical symptoms and can lead to considerable disability. The neurobiological underpinnings of PCS are poorly understood, limiting potential clinical interventions. As such, patients and families frequently re-present to clinical services, who are often ill equipped to address the multifactorial nature of PCS. This contributes to the high cost of concussion management and the disability of children experiencing PCS. The aims of the present study are: (1) to plot and contrast recovery pathways for children with concussion from time of injury to 3 months postinjury, (ii) evaluate the contribution of acute biomarkers (ie, blood, MRI) to delayed recovery postconcussion and (3) estimate financial costs of child concussion to patients attending the emergency department (ED) of a tertiary children's hospital and factors predicting high cost. Methods and analysis Take C.A. Re is a prospective, longitudinal study at a tertiary children's hospital, recruiting and assessing 525 patients aged 5-<18 years (400 concussion, 125 orthopaedic injury) who present to the ED with a concussion and following them at 1-4 days, 2 weeks, 1 month and 3 months postinjury. Multiple domains are assessed: preinjury and postinjury, clinical, MRI, blood samples, neuropsychological, psychological and economic. PCS is defined as the presence of >= 2 symptoms on the Post Concussive Symptoms Inventory rated as worse compared with baseline 1 month postinjury. Main analyses comprise longitudinal Generalised Estimating Equation models and regression analyses of predictors of recovery and factors predicting high economic costs. Ethics and dissemination Ethical approval has been obtained through the Royal Children's Hospital Melbourne Human Research Ethics Committee (33122). We aim to disseminate the findings through international conferences, international peer-reviewed journals and social media.	[Takagi, Michael; Babl, Franz E.; Anderson, Nicholas; Bressan, Silvia; Clarke, Cathriona J.; Crichton, Ali; Davis, Gavin A.; Doyle, Melissa; Dunne, Kevin; Godfrey, Celia; Hearps, Stephen J. C.; Ignjatovic, Vera; Parkin, Georgia; Rausa, Vanessa; Seal, Marc; Thompson, Emma Jane; Truss, Katie; Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Takagi, Michael; Doyle, Melissa; Truss, Katie; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Dunne, Kevin; Godfrey, Celia; Ignjatovic, Vera; Anderson, Vicki] Univ Melbourne, Dept Paediat, Carlton, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dalziel, Kim] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hosp, Dept Neurosurg, Parkville, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Dept Neurosurg, Parkville, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia.; Babl, FE (corresponding author), Univ Melbourne, Dept Paediat, Carlton, Vic, Australia.; Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Seal, Marc/0000-0002-8396-140X; Hearps, Stephen/0000-0003-2984-1172; Visser, Melissa/0000-0002-5313-3347; Parkin, Georgia/0000-0002-0588-2239; Takagi, Michael/0000-0003-2903-7598	Royal Children's Hospital Research Foundation	This work was supported by the Royal Children's Hospital Research Foundation.	Achenbach T. M., 2001, CHILD BEHAV CHECKLIS; Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Kessler R, 2002, PSYCHOL MED, V32, P949; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liebenberg L, 2013, CAN J PUBLIC HEALTH, V104, pE131, DOI 10.1007/BF03405676; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Lugones M, 2018, NEUROSCI BIOBEHAV R, V87, P206, DOI 10.1016/j.neubiorev.2018.02.006; McCrory P, 2016, BR J SPORTS MED, V11; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Narrow WE, 2013, AM J PSYCHIAT, V170, P71, DOI 10.1176/appi.ajp.2012.12071000; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rice KG, 2002, MEAS EVAL COUNS DEV, V34, P210, DOI 10.1080/07481756.2002.12069038; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Sobell L, 1996, CALENDAR METHOD ASSE; Stevens K, 2011, APPL HEALTH ECON HEA, V9, P157, DOI 10.2165/11587350-000000000-00000; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wechsler D., 2012, WECHSLER PRESCHOOL P; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	43	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	2							e022098	10.1136/bmjopen-2018-022098			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC7AO	WOS:000471124600016	30804026	gold, Green Published			2022-02-06	
J	Tobieson, L; Rossitti, S; Zsigmond, P; Hillman, J; Marklund, N				Tobieson, Lovisa; Rossitti, Sandro; Zsigmond, Peter; Hillman, Jan; Marklund, Niklas			Persistent Metabolic Disturbance in the Perihemorrhagic Zone Despite a Normalized Cerebral Blood Flow Following Surgery for Intracerebral Hemorrhage	NEUROSURGERY			English	Article						Cerebral blood flow; Energy metabolism; Intracerebral hemorrhage; Microdialysis; Xenon-enhanced computed tomography	TRAUMATIC BRAIN-INJURY; INITIAL CONSERVATIVE TREATMENT; MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; BEDSIDE DIAGNOSIS; PERFUSION CT; XENON-CT; MICRODIALYSIS; ISCHEMIA; STROKE	BACKGROUND We hypothesized that reduced cerebral blood flow (CBF) and/or energy metabolic disturbances exist in the tissue surrounding a surgically evacuated intracerebral hemorrhage (ICH). If present, such CBF and/or metabolic impairments may contribute to ongoing tissue injury and the modest clinical efficacy of ICH surgery. OBJECTIVE To conduct an observational study of CBF and the energy metabolic state in the perihemorrhagic zone (PHZ) tissue and in seemingly normal cortex (SNX) by microdialysis (MD) following surgical ICH evacuation. METHODS We evaluated 12 patients (median age 64; range 26-71 yr) for changes in CBF and energy metabolism following surgical ICH evacuation using Xenon-enhanced computed tomography (n = 10) or computed tomography perfusion (n = 2) for CBF and dual MD catheters, placed in the PHZ and the SNX at ICH surgery. RESULTS CBF was evaluated at a mean of 21 and 58 h postsurgery. In the hemisphere ipsilateral to the ICH, CBF improved between the investigations (36.6 20 vs 40.6 +/- 20 mL/100 g/min; P < .05). In total, 1026 MD samples were analyzed for energy metabolic alterations including glucose and the lactate/pyruvate ratio (LPR). The LPR was persistently elevated in the PHZ compared to the SNX region (P < .05). LPR elevations in the PHZ were predominately type II (pyruvate normal-high; indicating mitochondrial dysfunction) as opposed to type I (pyruvate low; indicating ischemia) at 4 to 48 h (70% vs 30%) and at 49 to 84 h (79% vs 21%; P < .05) postsurgery. CONCLUSION Despite normalization of CBF following ICH evacuation, an energy metabolic disturbance suggestive of mitochondrial dysfunction persists in the perihemorrhagic zone.	[Tobieson, Lovisa; Rossitti, Sandro; Zsigmond, Peter; Hillman, Jan] Linkoping Univ, Dept Clin & Expt Med, Dept Neurosurg, Linkoping, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Neurosurg, Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Dept Clin Sci, Div Neurosur, Univ Sjukhuset EA Blocket Plan 2,Barngatan 2B, S-22185 Lund, Sweden.	niklas.marklund@med.lu.se			STROKE-Riksforbundet (Skarholmen, Sweden); local hospital ALF-funds (Region Ostergotland, Linkoping, Sweden); Anaesthesia, Operations and Specialty Surgery Centre	This study was supported by STROKE-Riksforbundet (Skarholmen, Sweden), and the Anaesthesia, Operations and Specialty Surgery Centre, and local hospital ALF-funds (Region Ostergotland, Linkoping, Sweden). None of the financing agencies had any influence on the design or implementation of the study, the analysis and interpretation of results, or the writing of the manuscript. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; Carhuapoma JR, 2000, STROKE, V31, P726, DOI 10.1161/01.STR.31.3.726; Carlson AP, 2011, AM J NEURORADIOL, V32, P1315, DOI 10.3174/ajnr.A2522; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Cour M, 2014, J APPL PHYSIOL, V117, P930, DOI 10.1152/japplphysiol.00495.2014; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Etminan N, 2012, STROKE, V43, P759, DOI 10.1161/STROKEAHA.111.616730; FATOUROS PP, 1987, INVEST RADIOL, V22, P705, DOI 10.1097/00004424-198709000-00003; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Field A., 2018, DISCOVERING STAT USI, V5th ed.; GOOD WF, 1987, MED PHYS, V14, P867, DOI 10.1118/1.596014; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hillered L, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00245; Hillman J, 2006, ACTA NEUROCHIR, V148, P319, DOI 10.1007/s00701-005-0670-8; Hillman J, 2005, BRIT J NEUROSURG, V19, P395, DOI 10.1080/02688690500389898; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hirano T, 1999, NEUROLOGY, V53, P2179, DOI 10.1212/WNL.53.9.2179; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Honda Mitsuru, 2013, Acta Neurochir Suppl, V118, P259, DOI 10.1007/978-3-7091-1434-6_49; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; KAWAKAMI H, 1974, STROKE, V5, P207, DOI 10.1161/01.STR.5.2.207; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Maurer MH, 2008, PROTEOM CLIN APPL, V2, P437, DOI 10.1002/prca.200780044; Mayer SA, 1998, STROKE, V29, P1791, DOI 10.1161/01.STR.29.9.1791; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Miyazawa N, 1998, AM J NEURORADIOL, V19, P1741; NEHLS DG, 1990, NEUROSURGERY, V27, P674, DOI 10.1227/00006123-199011000-00002; NEHLS DG, 1988, NEUROSURGERY, V23, P439, DOI 10.1227/00006123-198810000-00006; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Poulsen FR, 2015, NEUROCRIT CARE, V22, P221, DOI 10.1007/s12028-014-0057-x; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2002, NEUROSURG CLIN N AM, V13, P355, DOI 10.1016/S1042-3680(02)00012-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; Siddique MS, 2002, J NEUROSURG, V96, P736, DOI 10.3171/jns.2002.96.4.0736; Siddique MS, 2000, ACT NEUR S, V76, P517; Sturnegk P, 2007, BRIT J NEUROSURG, V21, P332, DOI 10.1080/02688690701411574; TANIZAKI Y, 1988, ACTA NEUROCHIR, V90, P103, DOI 10.1007/BF01560562; Tayal AH, 2007, STROKE, V38, P319, DOI 10.1161/01.STR.0000254492.35504.db; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	62	6	6	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2019	84	6					1269	1278		10.1093/neuros/nyy179			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IC8QQ	WOS:000471247000038	29788388	Green Published, Green Submitted, hybrid			2022-02-06	
J	Vanden Berg, RW; Davidsson, J; Lidin, E; Angeria, M; Risling, M; Gunther, M				Vanden Berg, Rand Wilcox; Davidsson, Johan; Lidin, Erik; Angeria, Maria; Risling, Marten; Gunther, Mattias			Brain tissue saving effects by single-dose intralesional administration of Neuroprotectin D1 on experimental focal penetrating brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Neuroprotectin D1; NPD1; Focal penetrating TBI; Traumatic brain injury	N-ACETYLCYSTEINE; CELL-DEATH; NEURODEGENERATION; INFLAMMATION; EXPRESSION; MODEL; MOTOR	Traumatic brain injury (TBI) is followed by a secondary inflammation in the brain. Neuroprotectin D1 (NPD1) is synthesized from docosahexaenoic acid (DHA) and has anti-inflammatory and antiapoptotic effects in experimental models of neurodegenerative disease and brain ischemia-reperfusion. It is not known whether intralesional administration of NPD1 ameliorates inflammation and cell death after severe TBI. We therefore investigated the effects of NPD1 following a severe form of focal penetrating TBI. A total of 30 male Sprague-Dawley rats weighing between 350 and 450 g were exposed to focal penetrating TBI or sham surgery. The rats were randomized to NPD1 treatment (50 ng intralesionally, immediately following TBI) or no treatment. The rats were sacrificed at 24 or 72 h. All subgroups consisted of 5 rats. Brains were removed, fresh frozen, cut in 14-mu m coronal sections and subjected to Fluoro-Jade, TUNEL, MnSOD, 3-NT, COX-2. Ox-42 and NF-kappa B immuno-staining and lesion size analyses. NPD1 decreased the lesion area at 72 h compared to no treatment with a mean change 42% (NPD1 14.1 mm(2); no treatment 24.5 mm(2)) (p < 0.01). No difference was detected in markers for neuronal degeneration, apoptosis, anti-inflammatory or antioxidative enzymes, or immune cells. In conclusion, single-dose intralesional administration of NPD1 had brain tissue sparing effects after focal penetrating TBI, which may be beneficial in preventing brain tissue damage, making NPD1 a potential candidate for further clinical applications. Exact mechanisms of action could not be determined and it is possible that continuous or multiple administration regimens may increase efficacy in sequential preclinical studies. (C) 2019 Elsevier Ltd. All rights reserved.	[Vanden Berg, Rand Wilcox] Weill Cornell Med Coll, New York Presbyterian Hosp, Dept Urol, New York, NY USA; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety Mech & Maritime Sci, Gothenburg, Sweden; [Lidin, Erik; Angeria, Maria; Risling, Marten; Gunther, Mattias] Karolinska Inst, Sect Expt Traumatol, Dept Neurosci, Biomedicum B8, SE-17177 Stockholm, Sweden		Gunther, M (corresponding author), Karolinska Inst, Sect Expt Traumatol, Dept Neurosci, Biomedicum B8, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	Davidsson, Johan/A-3229-2016; , Mattias/A-4442-2013	Davidsson, Johan/0000-0002-1717-1514; , Mattias/0000-0003-2372-6114; Lidin, Erik/0000-0001-6800-6677	Swedish Defense	This study was funded by the Swedish Defense.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bains M, 2011, BIOCHIM BIOPHYS ACTA, V1822, P675; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Keller JN, 1998, J NEUROSCI, V18, P687; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Meyer K, 2008, J TRAUMA NURS, V15, P90; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	38	6	6	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2019	64						227	233		10.1016/j.jocn.2019.03.032			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC6LJ	WOS:000471083300052	30948313				2022-02-06	
J	Wachholz, F; Kockum, T; Haid, T; Federolf, P				Wachholz, Felix; Kockum, Tove; Haid, Thomas; Federolf, Peter			Changed Temporal Structure of Neuromuscular Control, Rather Than Changed Intersegment Coordination, Explains Altered Stabilographic Regularity after a Moderate Perturbation of the Postural Control System	ENTROPY			English	Article						temporal regularity; coordinative complexity; motor control; center of pressure COP; principal component analysis PCA; balance; perturbation; neuroscience	OF-PRESSURE TRAJECTORIES; CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; BALANCE CONTROL; MUSCLE FATIGUE; SWAY; VARIABILITY; COMPLEXITY; STRATEGIES; MOVEMENTS	Sample entropy (SaEn) applied on center-of-pressure (COP) data provides a measure for the regularity of human postural control. Two mechanisms could contribute to altered COP regularity: first, an altered temporal structure (temporal regularity) of postural movements (H1); or second, altered coordination between segment movements (coordinative complexity; H2). The current study used rapid, voluntary head-shaking to perturb the postural control system, thus producing changes in COP regularity, to then assess the two hypotheses. Sixteen healthy participants (age 26.5 +/- 3.5; seven females), whose postural movements were tracked via 39 reflective markers, performed trials in which they first stood quietly on a force plate for 30 s, then shook their head for 10 s, finally stood quietly for another 90 s. A principal component analysis (PCA) performed on the kinematic data extracted the main postural movement components. Temporal regularity was determined by calculating SaEn on the time series of these movement components. Coordinative complexity was determined by assessing the relative explained variance of the first five components. H1 was supported, but H2 was not. These results suggest that moderate perturbations of the postural control system produce altered temporal structures of the main postural movement components, but do not necessarily change the coordinative structure of intersegment movements.	[Wachholz, Felix; Kockum, Tove; Haid, Thomas; Federolf, Peter] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria		Wachholz, F (corresponding author), Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria.	felix.wachholz@student.uibk.ac.at; tove.kockum@student.uibk.ac.at; thomas.haid@uibk.ac.at; peter.federolf@uibk.ac.at	Federolf, Peter/H-4481-2019; Wachholz, Felix/AAZ-8226-2021	Federolf, Peter/0000-0002-0266-6813; Wachholz, Felix/0000-0002-7421-9852	University of Innsbruck; Leopold-Franzens University Innsbruck [2017/2/PSY/SPORT-23]	This research was funded by the University of Innsbruck. The corresponding author currently holds a scholarship by the Leopold-Franzens University Innsbruck (funding-code: 2017/2/PSY/SPORT-23).	Bockemuhl T, 2010, HUM MOVEMENT SCI, V29, P73, DOI 10.1016/j.humov.2009.03.003; Busa MA, 2016, GAIT POSTURE, V45, P7, DOI 10.1016/j.gaitpost.2015.12.007; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Derlich M, 2011, RES DEV DISABIL, V32, P1808, DOI 10.1016/j.ridd.2011.03.009; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Ella K., 2001, ACTA OTO-LARYNGOL, V121, P481; Estrada L, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19090460; Federolf P, 2015, EXP BRAIN RES, V233, P3507, DOI 10.1007/s00221-015-4420-8; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Federolf PA, 2016, J BIOMECH, V49, P364, DOI 10.1016/j.jbiomech.2015.12.030; Federolf PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078689; Galli M, 2008, DISABIL REHABIL, V30, P1274, DOI 10.1080/09638280701610353; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Gloersen O, 2018, J SPORT SCI, V36, P229, DOI 10.1080/02640414.2017.1298826; Gloersen O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152616; Gow BJ, 2015, ENTROPY-SWITZ, V17, P7926, DOI 10.3390/e17127849; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Gribble PA, 2004, J ELECTROMYOGR KINES, V14, P641, DOI 10.1016/j.jelekin.2004.05.001; Gruber AH, 2011, GAIT POSTURE, V34, P13, DOI 10.1016/j.gaitpost.2011.02.015; Guo LY, 2014, CHIN J INTEGR MED, V20, P409, DOI 10.1007/s11655-013-1533-4; Haid T, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20010030; Haid TH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00022; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Manor B, 2010, NEUROLOGY, V74, P458, DOI 10.1212/WNL.0b013e3181cef647; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; McCamley JD, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20100764; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; Memari Amir Hossein, 2014, Asian J Sports Med, V5, pe22963, DOI 10.5812/asjsm.22963; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Promsri A, 2018, HUM MOVEMENT SCI, V58, P165, DOI 10.1016/j.humov.2018.02.003; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rhea CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017696; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Sabatini AM, 2000, MED BIOL ENG COMPUT, V38, P617, DOI 10.1007/BF02344866; Tasseel-Ponche S, 2015, NEUROPHYSIOL CLIN, V45, P327, DOI 10.1016/j.neucli.2015.09.003; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; Wayne PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114731; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Zandiyeh P, 2013, PHYSICA A, V392, P6265, DOI 10.1016/j.physa.2013.08.023	53	6	6	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1099-4300		ENTROPY-SWITZ	Entropy	JUN	2019	21	6								10.3390/e21060614			14	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physics	II6LA	WOS:000475304200075	33267328	Green Submitted, Green Published, gold			2022-02-06	
J	Yeates, KO; Tang, K; Barrowman, N; Freedman, SB; Gravel, J; Gagnon, I; Sangha, G; Boutis, K; Beer, D; Craig, W; Burns, E; Farion, KJ; Mikrogianakis, A; Barlow, K; Dubrovsky, AS; Meeuwisse, W; Gioia, G; Meehan, WP; Beauchamp, MH; Kamil, Y; Grool, AM; Hoshizaki, B; Anderson, P; Brooks, BL; Vassilyadi, M; Klassen, T; Keightley, M; Richer, L; DeMatteo, C; Osmond, MH; Zemek, R; Xie, JL; Chatfield, J; Dow, N; Papadimitropoulos, R; Levesque, T; Langford, C; Tran, TT; McGahern, C; DiGirolamo, V; Mazza, J; Lagace, M; Cook, R; Fitzpatrick, E; MacIntyre, J; Moore, J				Yeates, Keith Owen; Tang, Kenneth; Barrowman, Nick; Freedman, Stephen B.; Gravel, Jocelyn; Gagnon, Isabelle; Sangha, Gurinder; Boutis, Kathy; Beer, Darcy; Craig, William; Burns, Emma; Farion, Ken J.; Mikrogianakis, Angelo; Barlow, Karen; Dubrovsky, Alexander S.; Meeuwisse, Willem; Gioia, Gerard; Meehan, William P., III; Beauchamp, Miriam H.; Kamil, Yael; Grool, Anne M.; Hoshizaki, Blaine; Anderson, Peter; Brooks, Brian L.; Vassilyadi, Michael; Klassen, Terry; Keightley, Michelle; Richer, Lawrence; DeMatteo, Carol; Osmond, Martin H.; Zemek, Roger; Xie, Jialing; Chatfield, Jennifer; Dow, Nadia; Papadimitropoulos, Rena; Levesque, Tracey; Langford, Cindy; Tinh Trung Tran; McGahern, Candice; DiGirolamo, Vanessa; Mazza, Joanna; Lagace, Maryse; Cook, Ramona; Fitzpatrick, Eleanor; MacIntyre, Jessica; Moore, Jill		Pediat Emergency Res Canada PERC P	Derivation and Initial Validation of Clinical Phenotypes of Children Presenting with Concussion Acutely in the Emergency Department: Latent Class Analysis of a Multi-Center, Prospective Cohort, Observational Study	JOURNAL OF NEUROTRAUMA			English	Article						concussion; latent class; outcomes; pediatric; phenotypes	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; PREDICTORS; NUMBER; SPORT	The identification of clinical phenotypes may help parse the substantial heterogeneity that characterizes children with concussion. This study used latent class analysis (LCA) to identify discernible phenotypes among children with acute concussion and examine the association between phenotypes and persistent post-concussive symptoms (PPCS) at 4 and 12 weeks post-injury. We conducted LCA of variables representing pre-injury history, clinical presentation, and parent symptom ratings, derived from a prospective cohort, observational study that recruited participants from August 2013 until June 2015 at nine pediatric emergency departments within the Pediatric Emergency Research Canada network. This substudy included 2323 children from the original cohort ages 8.00-17.99 years who had data for at least 80% of all variables included in each LCA. Concussion was defined according to Zurich consensus statement diagnostic criteria. The primary outcome was PPCS at 4 and 12 weeks after enrollment. Participants were 39.5% female and had a mean age of 12.8 years (standard deviation = 2.6). Follow-up was completed by 1980 (85%) at 4 weeks and 1744 (75%) at 12 weeks. LCA identified four groups with discrete pre-injury histories, four groups with discrete clinical presentations, and seven groups with discrete profiles of acute symptoms. Clinical phenotypes based on the profile of group membership across the three LCAs varied significantly in their predicted probability of PPCS at 4 and 12 weeks. The results indicate that children with concussion can be grouped into distinct clinical phenotypes, based on pre-injury history, clinical presentation, and acute symptoms, with markedly different risks of PPCS. With further validation, clinical phenotypes may provide a useful heuristic for clinical assessment and management.	[Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Tang, Kenneth; Barrowman, Nick; Kamil, Yael; Grool, Anne M.; Vassilyadi, Michael; Osmond, Martin H.; Zemek, Roger] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Alberta Childrens Hosp Res Inst, Dept Pediat, Calgary, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Hosp St Justine, Dept Pediat, Montreal, PQ, Canada; [Gagnon, Isabelle; Dubrovsky, Alexander S.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Hlth Ctr, Montreal, PQ, Canada; [Sangha, Gurinder] Western Univ, Childrens Hosp Western Ontario, Dept Pediat, London, ON, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Beer, Darcy; Klassen, Terry] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Craig, William] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Emergency Med, Halifax, NS, Canada; [Farion, Ken J.; Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Mikrogianakis, Angelo; Barlow, Karen] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Gioia, Gerard] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Dept Neuropsychol, Rockville, MD USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Beauchamp, Miriam H.] Univ Montreal, Ste Justine Res Ctr, Montreal, PQ, Canada; [Hoshizaki, Blaine] Univ Ottawa, Dept Kinesiol, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Dept Psychol, Ottawa, ON, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Surg, Div Neurosurg, Ottawa, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Richer, Lawrence] Stollery Childrens Hosp, Dept Neurol, Edmonton, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Xie, Jialing; Chatfield, Jennifer] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Dow, Nadia] Stollery Childrens Hosp, Edmonton, AB, Canada; [Papadimitropoulos, Rena; Levesque, Tracey] Winnipeg Childrens Hosp, Winnipeg, MB, Canada; [Langford, Cindy] Childrens Hosp Western Ontario, London, ON, Canada; [Tinh Trung Tran] Hosp Sick Children, Toronto, ON, Canada; [McGahern, Candice] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [DiGirolamo, Vanessa; Mazza, Joanna] Montreal Childrens Hosp, Montreal, PQ, Canada; [Lagace, Maryse; Cook, Ramona] Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Fitzpatrick, Eleanor; MacIntyre, Jessica; Moore, Jill] IWK Childrens Hosp, Halifax, NS, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, Ad 254,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Barlow, Karen/I-6492-2019; Mikrogianakis, Angelo/AAW-5929-2021; Richer, Lawrence/D-3622-2009; Barrowman, Nick/AAL-3166-2020; Freedman, Stephen/H-9102-2012	Barlow, Karen/0000-0003-2612-8507; Mikrogianakis, Angelo/0000-0002-8854-0620; Richer, Lawrence/0000-0002-6897-8668; Barrowman, Nick/0000-0002-4704-9595; Klassen, Terry/0000-0002-5309-7091; Freedman, Stephen/0000-0003-2319-6192; Yeates, Keith/0000-0001-7680-2892; Craig, William/0000-0002-4804-194X; Gagnon, Isabelle/0000-0003-2043-1644; Burns, Emma/0000-0001-8042-7124; Osmond, Martin/0000-0001-8275-8381	Canadian Institutes of Health Research (CIHR) Operating Grant MOPCanadian Institutes of Health Research (CIHR) [126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant TM1 [127047]; CIHR planning grant MRP [119829]	This study was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP: #126197; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant TM1: #127047; and CIHR planning grant MRP: #119829. The funders had no roles in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. K.O.Y., R.Z., and K.T. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. K. T. conducted the data analysis. K.Y. had final responsibility for the decision to submit for publication.	[Anonymous], 2013, Br J Sports Med, V47, P263; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cosio BG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160770; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hosmer DW, 1997, STAT MED, V16, P965; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCutcheon AL, 1987, LATENT CLASS ANAL; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Muthen B., 2017, MPLUS USERS GUIDE; Muthen B. O., 2001, NEW DEV TECHNIQUES S, P21, DOI DOI 10.4324/9781410601858; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	35	6	6	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1758	1767		10.1089/neu.2018.6009			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600006	30618356				2022-02-06	
J	Zhang, M; Radford, KD; Driscoll, M; Purnomo, S; Kim, J; Choi, KH				Zhang, Michael; Radford, Kennett D.; Driscoll, Mercedes; Purnomo, Salsabila; Kim, Jean; Choi, Kwang H.			Effects of subanesthetic intravenous ketamine infusion on neuroplasticity-related proteins in the prefrontal cortex, amygdala, and hippocampus of Sprague-Dawley rats	IBRO REPORTS			English	Article						Intravenous ketamine; Fear conditioning; Brain-derived neurotrophic factor; c-Fos; Extracellular signal-regulated kinase; Prefrontal cortex		Ketamine, a multimodal dissociative anesthetic, is a powerful analgesic administered following trauma due to its hemodynamic and respiratory stability. However, ketamine can cause hallucination and dissociation which may adversely impact traumatic memory after an injury. The effects of ketamine on proteins implicated in neural plasticity are unclear due to different doses, routes, and timing of drug administration in previous studies. Here, we investigated the effects of a single intravenous (IV) ketamine infusion on protein levels in three brain regions of rats. Adult male Sprague-Dawley rats with indwelling IV catheters underwent an auditory fear conditioning (three pairings of tone and mild footshock 0.8 mA, 0.5 s) and received a high dose of IV ketamine (0 or 40 mg/kg/2 h) infusion (Experiment 1). In a follow-up study, animals received a low dose of IV ketamine (0 or 10 mg/kg/2 h) infusion (Experiment 2). Two hours after the infusion, brain tissue from the medial prefrontal cortex (mPFC), hippocampus, and amygdala were collected for western blot analyses. Protein levels of a transcription factor (c-Fos), brain-derived neurotrophic factor (BDNF), and phosphorylated extracellular signal-regulated kinase (pERK) were quantified in these regions. The 40 mg/kg ketamine infusion increased c-Fos levels in the mPFC and amygdala as well as pERK levels in the mPFC and hippocampus. The 10 mg/kg ketamine infusion increased BDNF levels in the amygdala, but decreased pERK levels in the mPFC and hippocampus. These findings suggest that a clinically relevant route of ketamine administration produces dose-dependent and brain region-specific effects on proteins involved in neuroplasticity.	[Zhang, Michael; Purnomo, Salsabila; Kim, Jean; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Zhang, Michael; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Radford, Kennett D.; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Daniel K Inouye Grad Sch Nursing, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Driscoll, Mercedes] Walter Reed Natl Mil Med Ctr, Natl Capital Consortium Psychiat Residency Progra, Bethesda, MD 20814 USA		Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	kwang.choi@usuhs.edu			American Association of Nurse Anesthetist Foundation [2016-G-1]; USUHS Intramural Grant [T0613801]	American Association of Nurse Anesthetist Foundation [2016-G-1] and USUHS Intramural Grant [T0613801].	Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Akinfiresoye L, 2013, PSYCHOPHARMACOLOGY, V230, P291, DOI 10.1007/s00213-013-3153-2; ARNOLD FJL, 1992, NEUROSCIENCE, V51, P377, DOI 10.1016/0306-4522(92)90322-S; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Bland ST, 2005, BRAIN RES, V1051, P90, DOI 10.1016/j.brainres.2005.05.065; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Caffino L, 2016, PHARMACOL RES, V104, P22, DOI 10.1016/j.phrs.2015.12.014; Choi M, 2017, BIOCHEM BIOPH RES CO, V489, P420, DOI 10.1016/j.bbrc.2017.05.157; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Fernandes A, 2017, BRAIN RES, V1670, P86, DOI 10.1016/j.brainres.2017.05.008; Fraga DB, 2013, REV BRAS PSIQUIATR, V35, P262, DOI 10.1590/1516-4446-2012-0858; Garcia LS, 2008, BASIC CLIN PHARMACOL, V103, P502, DOI 10.1111/j.1742-7843.2008.00210.x; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Girgenti MJ, 2017, NEUROBIOL DIS, V100, P1, DOI 10.1016/j.nbd.2016.12.026; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; Honsberger MJ, 2015, SCHIZOPHR RES, V164, P227, DOI 10.1016/j.schres.2015.02.009; Ibla JC, 2009, CURR DRUG SAF, V4, P11, DOI 10.2174/157488609787354495; Juven-Wetzler A, 2014, EUR NEUROPSYCHOPHARM, V24, P469, DOI 10.1016/j.euroneuro.2013.08.007; Ke XY, 2014, DRUG ALCOHOL DEPEN, V142, P290, DOI 10.1016/j.drugalcdep.2014.06.043; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; Koike H, 2011, BEHAV BRAIN RES, V224, P107, DOI 10.1016/j.bbr.2011.05.035; Le Nedelec M., 2018, DRUG DELIV TRANSL RE; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu RJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2268, DOI 10.1038/npp.2013.128; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; McGhee LL, 2014, MIL MED, V179, P41, DOI 10.7205/MILMED-D-13-00481; Mion G, 2017, ANAESTHESIA, V72, P1476, DOI 10.1111/anae.14079; Morris C, 2009, ANAESTHESIA, V64, P532, DOI 10.1111/j.1365-2044.2008.05835.x; Nakao S, 2002, BRAIN RES, V926, P191, DOI 10.1016/S0006-8993(01)03338-8; Nowak K, 2012, ACTA NEUROBIOL EXP, V72, P207; Palenicek T, 2011, NEUROPSYCHOBIOLOGY, V63, P202, DOI 10.1159/000321803; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peng S, 2011, MOL BIOL REP, V38, P2401, DOI 10.1007/s11033-010-0374-x; Pietersen CY, 2006, PROG NEURO-PSYCHOPH, V30, P1209, DOI 10.1016/j.pnpbp.2006.02.019; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Radford Cdr Kennett D, 2018, AANA J, V86, P393; Radford KD, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0310-8; Radford KD, 2017, PHARMACOL BIOCHEM BE, V153, P130, DOI 10.1016/j.pbb.2016.12.014; Radvansky BM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/749837; Reus GZ, 2011, BEHAV BRAIN RES, V221, P166, DOI 10.1016/j.bbr.2011.02.024; Salort G, 2019, PROG NEURO-PSYCHOPH, V88, P121, DOI 10.1016/j.pnpbp.2018.07.006; Saur L, 2017, NEUROSCI LETT, V658, P6, DOI 10.1016/j.neulet.2017.08.026; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schonenberg M, 2005, PSYCHOPHARMACOLOGY, V182, P420, DOI 10.1007/s00213-005-0094-4; Shen L, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0379-2; Su SS, 2015, PSYCHIAT RES, V229, P365, DOI 10.1016/j.psychres.2015.06.038; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tulogdi A, 2012, BRAIN RES BULL, V88, P359, DOI 10.1016/j.brainresbull.2012.04.001; Villarreal JS, 2006, NEUROBIOL LEARN MEM, V85, P44, DOI 10.1016/j.nlm.2005.08.005; Wang XB, 2011, PSYCHIAT RES, V185, P248, DOI 10.1016/j.psychres.2010.04.046; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Yang C, 2013, UPSALA J MED SCI, V118, P3, DOI 10.3109/03009734.2012.724118; Zhou W, 2014, EUR PSYCHIAT, V29, P419, DOI 10.1016/j.eurpsy.2013.10.005	57	6	6	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	JUN	2019	6									10.1016/j.ibror.2019.01.006			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VJ5SI	WOS:000608621700009	30723838	Green Published, gold			2022-02-06	
J	Ranson, J; Magnus, BE; Temkin, N; Dikmen, S; Giacino, JT; Okonkwo, DO; Valadka, AB; Manley, GT; Nelson, LD; Cooper, SR; Dams-O'Connor, K; Gordon, WA; Maas, AIR; Menon, DK; Mukherjee, P; Puccio, AM; Vassar, MJ; Yue, JK; Yuh, EL				Ranson, Jana; Magnus, Brooke E.; Temkin, Nancy; Dikmen, Sureyya; Giacino, Joseph T.; Okonkwo, David O.; Valadka, Alex B.; Manley, Geoffrey T.; Nelson, Lindsay D.; Cooper, Shelly R.; Dams-O'Connor, Kristen; Gordon, Wayne A.; Maas, Andrew I. R.; Menon, David K.; Mukherjee, Pratik; Puccio, Ava M.; Vassar, Mary J.; Yue, John K.; Yuh, Esther L.		TRACK-TBI Investigators	Diagnosing the GOSE: Structural and Psychometric Properties Using Item Response Theory, a TRACK-TBI Pilot Study	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Outcome Scale-Extended; item response theory; outcome assessment; psychometrics; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GLASGOW-OUTCOME-SCALE; SEVERE HEAD-INJURY; CLINICAL-TRIALS; FIT INDEXES; MULTICENTER; DISABILITY; HEALTH; LONG; MISCLASSIFICATION	The Glasgow Outcome Scale-Extended (GOSE) was designed to assess global outcome after traumatic brain injury (TBI). Since its introduction, several empirically founded criticisms of the GOSE have been raised, including poor reliability; an insensitivity to small, but potentially meaningful, changes; a tendency to produce ceiling effects; inconsistent associations with neurocognitive, psychological, and quality-of-life measures; and an inability to assess the multi-dimensional nature of TBI outcome. The current project took a diagnostic approach to identifying the underlying causes of reported limitations by exploring the internal construct validity of the GOSE at 3 and 6 months post-injury using item response theory (IRT) techniques. Data were from the TRACK-TBI Pilot Study, a large (N = 586), prospective, multi-site project that included TBI cases of all injury severity levels. To assess the level of latent functional "impairment" captured by GOSE items independent of the assigned outcome category or GOSE total score, items were modified so that higher scores reflected greater impairment. Results showed that although the GOSE's items capture varying levels of impairment across a broad disability spectrum at 3 and 6 months, there was also evidence at each time point of item redundancy (multiple items capturing similar levels of impairment), item deficiency (lack of items capturing lower levels of impairment), and item inefficiency (items only capturing minimal impairment information). The findings illustrate the value of IRT to illuminate strengths and weaknesses of clinical outcome assessment measures and provide a framework for future measure refinement.	[Ranson, Jana; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Magnus, Brooke E.] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Giacino, Joseph T.] Spaulding Rehabil Ctr, Dept Rehabil Neuropsychol, Charlestown, MA USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol Surg, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Cooper, Shelly R.; Vassar, Mary J.; Yue, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Dams-O'Connor, Kristen; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Maas, Andrew I. R.] Univ Hosp Antwerp, Dept Neurol Surg, Antwerp, Belgium; [Menon, David K.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Menon, David K.] Univ Cambridge, Dept Neurocrit Care, Cambridge, England; [Mukherjee, Pratik] Univ Calif San Francisco, Dpet Radiol, San Francisco, CA USA; [Yuh, Esther L.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	Maas, Andrew IR/C-5584-2013; Yue, John K/P-1348-2015; Giacino, Joseph/AAF-1952-2021	Maas, Andrew IR/0000-0003-1612-1264; Yue, John K/0000-0001-9694-7722; Giacino, Joseph/0000-0002-7916-9698; Ranson, PhD, Jana/0000-0003-0967-192X; Magnus, Brooke/0000-0001-6905-972X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC2 NS0694909, RC2 NS069409-02S1, R03 NS100691-01]; Department of DefenseUnited States Department of Defense [USAMRAA W81XWH-13-1-0441]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS100691] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grant nos. RC2 NS0694909 [to G.T.M.], RC2 NS069409-02S1 [to G.T.M.], and R03 NS100691-01 [to L.D.N.]) and the Department of Defense (USAMRAA W81XWH-13-1-0441; to G.T.M.). Registry: ClinicalTrials.gov Identifier NCT01565551. Editorial support was provided by Amy J. Markowitz, JD.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Alves WM., 2017, HDB NEUROMERGENCY CL, P167; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; [Anonymous], 2013, R LANG ENV STAT COMP; [Anonymous], 2017, IRTPRO WIND; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Birbeck GL, 2000, NEUROLOGY, V54, P1822, DOI 10.1212/WNL.54.9.1822; BOCK RD, 1982, APPL PSYCH MEAS, V6, P431, DOI 10.1177/014662168200600405; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Cai L., 2011, IRTPRO SOFTWARE MANU; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.3102/10769986022003265; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Furr RM., 2007, PSYCHOMETRICS INTRO, V1st; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hays RD, 2000, MED CARE, V38, P28; Hellawell DJ, 1997, INT J REHABIL RES, V20, P345, DOI 10.1097/00004356-199712000-00001; Holgado-Tello F. P., 2013, INT J SOC SCI STUD, V1, P54, DOI DOI 10.11114/IJSSS.V1I1.27; Hong I, 2016, OTJR-OCCUP PART HEAL, V36, P65, DOI 10.1177/1539449216632449; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; IBM Corp, 2016, IBM SPSS STAT WIND; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kahraman N, 2013, J EDUC MEAS, V50, P227, DOI 10.1111/jedm.12012; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kumar R., 2005, RES METHODOLOGY STEP, V2nd; Lecointe D. A., 1995, ANNU M AM EDUC RES; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marmarou A., 2001, AM BRAIN INJURY CONS; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; McHorney CA, 1997, J CLIN EPIDEMIOL, V50, P451, DOI 10.1016/S0895-4356(96)00424-6; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Muthen L.K., 2015, MPLUS USERS GUIDE, V5th; Nandakumar R., 2004, SAGE HDB QUANTITATIV, P93, DOI DOI 10.4135/9781412986311.N5; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; SMITH E, 1974, J NEUROL NEUROSUR PS, V37, P719, DOI 10.1136/jnnp.37.6.719; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thorpe G, 2012, DATA ANAL USING ITEM; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Weiss D. J., 2011, J METHODS MEASUREMEN, V2, P1, DOI [10.2458/v2i1.12351, DOI 10.2458/jmm.v2i1.12351]; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	76	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2493	2505		10.1089/neu.2018.5998		MAY 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000470629300001	30907261	Green Published, Green Accepted			2022-02-06	
J	Tee, JC; Till, K; Jones, B				Tee, Jason C.; Till, Kevin; Jones, Ben			Incidence and characteristics of injury in under-19 academy level rugby league match play: A single season prospective cohort study	JOURNAL OF SPORTS SCIENCES			English	Article						Injury; incidence; burden; team sport; position; tackle	TIME-LOSS INJURIES; TACKLING ABILITY; DATA-COLLECTION; ELITE; STRENGTH; UNION; RISK; DEFINITIONS; FOOTBALL; POSITION	Academy rugby league competition is an important step along the pathway to professional status, but little is known about injury at this level of the game. The aim of this research was to establish the nature, incidence and burden of injury in English academy rugby league. Using an observational prospective cohort study design, and a time-loss injury definition, the injury outcomes of three professional rugby league academies were recorded during the 2017 season. A total of 87 injuries occurred in 59 matches for an overall injury incidence of 85 (95%CI 67-103) injuries per 1000 hours played. The mean severity of injury was 22 +/- 19 days resulting in an overall injury burden of 1898 (95%CI 1813-1983) days lost per 1000 hours. The tackle event was the most common cause of injury (77% of all injuries). Forwards sustained a greater proportion of injuries than backs (forwards 67% vs. backs 33% of injuries). Concussion (13 (6-20) per 1000 hours) and ankle sprains (11 (4-17) per 1000 hours) were the most commonly diagnosed injuries. The shoulder joint was the most commonly injured site (17 (9-25) per 1000 hours). The incidence of injury for academy rugby league is similar to senior professional rugby league.	[Tee, Jason C.; Till, Kevin; Jones, Ben] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Jones, Ben] Rugby Football League, Leeds, W Yorkshire, England; [Jones, Ben] Yorkshire Carnegie Rugby Union Club, Leeds, W Yorkshire, England		Tee, JC (corresponding author), Leeds Beckett Univ, Ctr Sports Performance, Inst Sport Phys Act & Leisure, Room 107a,Cavendish Hall,Headingley Campus, Leeds LS6 3QS, W Yorkshire, England.	j.c.tee@leedsbeckett.ac.uk	Tee, Jason/J-7445-2019; Till, Kevin/AAP-7379-2021	Tee, Jason/0000-0002-7275-2928; Jones, Ben/0000-0002-4274-6236; Till, Kevin/0000-0002-9686-0536			Bahr R, 2018, BRIT J SPORT MED, V52, P1018, DOI 10.1136/bjsports-2017-098160; Barden C, 2018, J ATHL TRAINING, V53, P514, DOI 10.4085/1062-6050-311-16; Booth M, 2017, J SPORT SCI MED, V16, P295; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Drawer S, 2002, BRIT J SPORT MED, V36, P446, DOI 10.1136/bjsm.36.6.446; Estell J, 1995, Aust J Sci Med Sport, V27, P95; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Fletcher BD, 2016, J SPORT SCI, V34, P1067, DOI 10.1080/02640414.2015.1088166; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Gabbett T, 2008, SPORTS MED, V38, P119, DOI 10.2165/00007256-200838020-00003; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2012, J SCI MED SPORT, V15, P496, DOI 10.1016/j.jsams.2012.03.017; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gabbett TJ, 2001, J SPORT SCI, V19, P341, DOI 10.1080/02640410152006117; Gissane C, 2003, OCCUP MED-OXFORD, V53, P512, DOI 10.1093/occmed/kqg103; Gissane C, 2002, SPORTS MED, V32, P211, DOI 10.2165/00007256-200232030-00004; Gissane C, 2012, CLIN J SPORT MED, V22, P414, DOI 10.1097/JSM.0b013e318261cace; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Johnston RD, 2014, J SCI MED SPORT, V17, P535, DOI 10.1016/j.jsams.2013.07.018; Johnston RD, 2014, SPORTS MED, V44, P1087, DOI 10.1007/s40279-014-0190-x; King D, 2006, NZ J SPORTS MED, V34, P21; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King DA, 2009, NZ J SPORTS MED, V36, P6; Meir RA, 1997, BRIT J SPORT MED, V31, P132, DOI 10.1136/bjsm.31.2.132; Orr R, 2016, J SCI MED SPORT, V19, P212, DOI 10.1016/j.jsams.2015.03.007; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Powell JW, 2004, J ATHL TRAINING, V39, P56; Sobue S, 2018, BRIT J SPORT MED, V52, P353, DOI 10.1136/bjsports-2017-098135; Speranza MJA, 2017, J STRENGTH COND RES, V31, P3311, DOI 10.1519/JSC.0000000000001540; Speranza MJ, 2016, J STRENGTH COND RES, V30, P336, DOI 10.1519/JSC.0000000000001058; Sterne, 2003, ESSENTIAL MED STAT; Tee J C, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1532; Till K, 2016, J SCI MED SPORT, V19, P585, DOI 10.1016/j.jsams.2015.07.001; Williams S, 2016, BRIT J SPORT MED, V50, P651, DOI 10.1136/bjsports-2015-094798; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	40	6	6	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	MAY 19	2019	37	10					1181	1188		10.1080/02640414.2018.1547100			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HS3VP	WOS:000463790900012	30430907	Green Accepted			2022-02-06	
J	King, R; Kirton, A; Zewdie, E; Seeger, TA; Ciechanski, P; Barlow, KM				King, Regan; Kirton, Adam; Zewdie, Ephrem; Seeger, Trevor A.; Ciechanski, Patrick; Barlow, Karen M.			Longitudinal Assessment of Cortical Excitability in Children and Adolescents With Mild Traumatic Brain Injury and Persistent Post-concussive Symptoms	FRONTIERS IN NEUROLOGY			English	Article						transcranial magnetic stimulation; mild traumatic brain injury; pediatrics; persistent post-concussive symptoms; cortical silent period	POSTCONCUSSION SYNDROME; MAGNETIC STIMULATION; SPORTS CONCUSSION; PLASTICITY; EPIDEMIOLOGY; INHIBITION; BIOMECHANICS; INDUCTION	Introduction: Symptoms following a mild traumatic brain injury (mTBI) usually resolve quickly but may persist past 3 months in up to 15% of children. Mechanisms of mTBI recovery are poorly understood, but may involve alterations in cortical neurophysiology. Transcranial Magnetic Stimulation (TMS) can non-invasively investigate such mechanisms, but the time course of neurophysiological changes in mTBI are unknown. Objective/Hypothesis: To determine the relationship between persistent post-concussive symptoms (PPCS) and altered motor cortex neurophysiology over time. Methods: This was a prospective, longitudinal, controlled cohort study comparing children (8-18 years) with mTBI (symptomatic vs. asymptomatic) groups to controls. Cortical excitability was measured using TMS paradigms at 1 and 2 months post injury. The primary outcome was the cortical silent period (cSP). Secondary outcomes included short interval intracortical inhibition (SICI) and facilitation (SICF), and long-interval cortical inhibition (UCI). Generalized linear mixed model analyses were used to evaluate the effect of group and time on neurophysiological parameters. Results: One hundred seven participants (median age 15.1, 57% female) including 78 (73%) with symptomatic PPCS and 29 with asymptomatic mTBI, were compared to 26 controls. Cortical inhibition (cSP and SICI) was reduced in the symptomatic group compared to asymptomatic group and tended to increase over time. Measures of cortical facilitation (SICF and ICF) were increased in the asymptomatic group and decreased over time. TMS was well tolerated with no serious adverse events. Conclusions: TMS-assessed cortical excitability is altered in children following mild TBI and is dependent on recovery trajectory. Our findings support delayed return to contact sports in children even where clinical symptoms have resolved.	[King, Regan; Kirton, Adam; Zewdie, Ephrem; Seeger, Trevor A.; Ciechanski, Patrick; Barlow, Karen M.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [King, Regan; Kirton, Adam; Zewdie, Ephrem; Seeger, Trevor A.; Ciechanski, Patrick; Barlow, Karen M.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [King, Regan; Kirton, Adam; Zewdie, Ephrem; Ciechanski, Patrick; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Kirton, Adam; Barlow, Karen M.] Dept Pediat, Calgary, AB, Canada; [Kirton, Adam; Barlow, Karen M.] Dept Clin Neurosc, Calgary, AB, Canada; [Kirton, Adam; Barlow, Karen M.] Dept Community Hlth Sci, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Dept Pediat, Fac Med, Brisbane, Qld, Australia		Barlow, KM (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.; Barlow, KM (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Barlow, KM (corresponding author), Alberta Childrens Prov Gen Hosp, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.; Barlow, KM (corresponding author), Dept Pediat, Calgary, AB, Canada.; Barlow, KM (corresponding author), Univ Queensland, Dept Pediat, Fac Med, Brisbane, Qld, Australia.	k.barlow@uq.edu.au	Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Faculty of Medicine, University of Calgary; Alberta Children's Hospital Research Institue (Neurotrauma initiative)	This study was funded by the Canadian Institutes of Health Research (grant number: 293375); the Faculty of Medicine, University of Calgary; and the Alberta Children's Hospital Research Institue (Neurotrauma initiative). These funding sources had no role in the design of this study and did not have any role during its execution, analyses, interpretation of the data, or decision to submit results.	Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Cantu D, 2014, EPILEPSY CURR, V14, P472; Ciechanski P, 2017, J NEUROPHYSIOL, V118, P140, DOI 10.1152/jn.00076.2017; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Faul M, 2010, TRAUMATIC BRAIN INJU; Garvey MA, 2001, J CHILD NEUROL, V16, P891, DOI 10.1177/088307380101601205; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kirton A, 2010, P 1 INT WORKSH SYN P; Kirton A, 2008, PEDIATR NEUROL, V39, P196, DOI 10.1016/j.pediatrneurol.2008.06.004; Kirton A, 2010, CLIN NEUROPHYSIOL, V121, P1922, DOI 10.1016/j.clinph.2010.04.021; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lao Y, 2015, PROCSPIE INTSOCOPTEN, V9287, P1, DOI DOI 10.1117/12.20; Livingston S, 2012, J HEAD TRAUMA REHAB, V27, pE12; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider LA, 2016, NEUROSCIENCE, V312, P19, DOI 10.1016/j.neuroscience.2015.10.057; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Tremblay S, 2011, CLIN NEUROPHYSIOL, V122, pS185; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Valzania F, 1997, ELECTROMYOGR MOTOR C, V105, P37, DOI 10.1016/S0924-980X(96)96517-0; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zewdie E, 2017, NEUROREHAB NEURAL RE, V31, P261, DOI 10.1177/1545968316680485; Ziemann U, 2015, BRAIN STIMUL, V8, P662, DOI 10.1016/j.brs.2015.01.409	48	6	6	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 17	2019	10								451	10.3389/fneur.2019.00451			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HY5OK	WOS:000468177200001	31156530	gold, Green Published			2022-02-06	
J	Mallott, JM; Palacios, EM; Maruta, J; Ghajar, J; Mukherjee, P				Mallott, Jacob M.; Palacios, Eva M.; Maruta, Jun; Ghajar, Jamshid; Mukherjee, Pratik			Disrupted White Matter Microstructure of the Cerebellar Peduncles in Scholastic Athletes After Concussion	FRONTIERS IN NEUROLOGY			English	Article						magnetic resonance; diffusion weighted imaging; acquired brain injury; fractional anisotropy; tract-based spatial statistics	TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR; TIME; CHILDHOOD; PATHWAYS; FOOTBALL; CHILDREN	Concussion, or mild traumatic brain injury (mTBI), is a major public health concern, linked with persistent post-concussive syndrome, and chronic traumatic encephalopathy. At present, standard clinical imaging fails to reliably detect traumatic axonal injury associated with concussion and post-concussive symptoms. Diffusion tensor imaging (DTI) is an MR imaging technique that is sensitive to changes in white matter microstructure. Prior studies using DTI did not jointly investigate white matter microstructure in athletes, a population at high risk for concussive and subconcussive head traumas, with those in typical emergency room (ER) patients. In this study, we determine DTI scalar metrics in both ER patients and scholastic athletes who suffered concussions and compared them to those in age-matched healthy controls. In the early subacute post-concussion period, athletes demonstrated an elevated rate of regional decreases in axial diffusivity (AD) compared to controls. These regional decreases of AD were especially pronounced in the cerebellar peduncles, and were more frequent in athletes compared to the ER patient sample. The group differences may indicate differences in the mechanisms of the concussive impacts as well as possible compound effects of cumulative subconcussive impacts in athletes. The prevalence of white matter abnormality in cerebellar tracts lends credence to the hypothesis that post-concussive symptoms are caused by shearing of axons within an attention network mediated by the cerebellum, and warrant further study of the correlation between cerebellar DTI findings and clinical, neurocognitive, oculomotor, and vestibular outcomes in mTBI patients.	[Mallott, Jacob M.; Palacios, Eva M.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Maruta, Jun] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Maruta, Jun] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA		Mukherjee, P (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Mukherjee, P (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	pratik.mukherjee@ucsf.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of DefenseUnited States Department of Defense [W911QY-12-C-0005, W911QY-14-C-0086]	This work was supported by U.S. Department of Defense contracts W911QY-12-C-0005 and W911QY-14-C-0086.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bruckert L, 2019, CEREBELLUM, V18, P372, DOI 10.1007/s12311-018-1003-9; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leitner Y, 2015, CEREBELLUM, V14, P613, DOI 10.1007/s12311-015-0652-1; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mori S, 2005, MRI ATLAS HUMAN WHIT; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Palacios E., 2018, NODDI STUDY BIORXIV, DOI [10.1101/345629, DOI 10.1101/345629]; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Travis KE, 2015, HUM BRAIN MAPP, V36, P1536, DOI 10.1002/hbm.22721; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	46	6	6	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 15	2019	10								518	10.3389/fneur.2019.00518			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HY2TP	WOS:000467976100002	31156545	Green Published, gold			2022-02-06	
J	Santhanam, P; Wilson, SH; Oakes, TR; Weaver, LK				Santhanam, Priya; Wilson, Steffanie H.; Oakes, Terrence R.; Weaver, Lindell K.			Effects of mild traumatic brain injury and post-traumatic stress disorder on resting-state default mode network connectivity	BRAIN RESEARCH			English	Article						Traumatic brain injury; Post-traumatic stress disorder; Default mode network; Independent component analysis; Medial prefrontal cortex; Posterior cingulate cortex	FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; SUSTAINED ATTENTION; ALZHEIMERS-DISEASE; HYPERBARIC-OXYGEN; MEMORY RETRIEVAL; CINGULATE CORTEX; PARIETAL CORTEX; SYMPTOMS; IRAQ	Mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) are common outcomes for service members. Abnormal connectivity within neural networks has been reported in the resting brain of mTBI and PTSD patients, respectively; however, the potential role of PTSD in changes to neural networks following injury has not been studied in detail. Using a data-driven approach, the present analysis aimed to elucidate resting state functional connectivity in the default mode network (DMN) in those with mTBI only and those with comorbid mTBI and PTSD. A secondary analysis focused on distinct contributions by the anterior and posterior DMN components. Group-level independent component analysis was used to identify the DMN, and a dual-regression method was utilized to measure connectivity within the overall network and its anterior (medial prefrontal cortex) and posterior (posterior cingulate cortex) nodes. Connectivity within the overall DMN was significantly higher for the mTBI only group (p = 0.001), as compared to controls and mTBI + PTSD. For all subjects with mTBI, network connectivity correlated inversely with PTSD checklist score (p < 0.05). Additionally, distinct associations (p < 0.05) between medial prefrontal cortex connectivity and PTSD symptoms and, separately, posterior cingulate cortex connectivity and mTBI-related cognitive deficits were found. To our knowledge, this is the first study to report a differential relationship between DMN components and both post-traumatic symptoms and cognitive outcomes.	[Santhanam, Priya] Lovelace Biomed Res, Albuquerque, NM USA; [Wilson, Steffanie H.] Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA; [Oakes, Terrence R.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Div Hyperbar Med, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake, CT USA		Santhanam, P (corresponding author), Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA.	psanthanam@lrri.org			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	This work is supported by the US Army Medical Research and Material Command under Contract No. W81XWH-15-D-0039-0003. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beckmann CF, 2009, GROUP COMP RESTING S; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Mostert JC, 2016, PROG NEURO-PSYCHOPH, V67, P82, DOI 10.1016/j.pnpbp.2016.01.011; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Piccoli T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123354; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	48	6	6	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2019	1711						77	82		10.1016/j.brainres.2019.01.015			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HS7ZP	WOS:000464088100010	30641036	hybrid			2022-02-06	
J	Toth, A; Berente, Z; Bogner, P; Kornyei, B; Balogh, B; Czeiter, E; Amrein, K; Doczi, T; Buki, A; Schwarcz, A				Toth, Arnold; Berente, Zoltan; Bogner, Peter; Kornyei, Balint; Balogh, Bendeguz; Czeiter, Endre; Amrein, Krisztina; Doczi, Tamas; Buki, Andras; Schwarcz, Attila			Cerebral Microbleeds Temporarily Become Less Visible or Invisible in Acute Susceptibility Weighted Magnetic Resonance Imaging: A Rat Study	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; microbleed; MRI; rat; susceptibility weighted imaging (SWI)	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; MR APPEARANCE; BLOOD; LESIONS; COLLAGENASE; HISTOLOGY; MODELS; IMAGES	Previously, we reported human traumatic brain injury cases demonstrating acute to subacute microbleed appearance changes in susceptibility-weighted imaging (SWI-magnetic resonance imaging [MRI]). This study aims to confirm and characterize such temporal microbleed appearance alterations in an experimental model. To elicit microbleed formation, brains of male Sprague Dawley rats were pierced in a depth of 4 mm, in a parasagittal position bilaterally using 159 mu m and 474 mu m needles, without the injection of autologous blood or any agent. Rats underwent 4.7 T MRI immediately, then at multiple time points until 125 h. Volumes of hypointensities consistent with microbleeds in SWI were measured using an intensity threshold-based approach. Microbleed volumes across time points were compared using repeated measures analysis of variance. Microbleeds were assessed by Prussian blue histology at different time points. Hypointensity volumes referring to microbleeds were significantly decreased (corrected p < 0.05) at 24 h compared with the immediate or the 125 h time points. By visual inspection, microbleeds were similarly detectable at the immediate and 125 h imaging but were decreased in extent or completely absent at 24 h or 48 h. Histology confirmed the presence of microbleeds at all time points and in all animals. This study confirmed a general temporary reduction in visibility of microbleeds in the acute phase in SWI. Such short-term appearance dynamics of microbleeds should be considered when using SWI as a diagnostic tool for microbleeds in traumatic brain injury and various diseases.	[Toth, Arnold; Kornyei, Balint; Czeiter, Endre; Amrein, Krisztina; Doczi, Tamas; Buki, Andras; Schwarcz, Attila] Pecs Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Toth, Arnold; Bogner, Peter; Balogh, Bendeguz] Pecs Med Sch, Dept Radiol, Pecs, Hungary; [Toth, Arnold; Czeiter, Endre; Doczi, Tamas] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Berente, Zoltan] Pecs Med Sch, Dept Biochem & Med Chem, Pecs, Hungary; [Berente, Zoltan; Czeiter, Endre; Amrein, Krisztina; Buki, Andras] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Berente, Zoltan] Pecs Med Sch, Res Grp Expt Diagnost Imaging, Pecs, Hungary; [Doczi, Tamas] Diagnost Ctr Pecs, Pecs, Hungary		Toth, A (corresponding author), Pecs Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary.	prsarn@gmail.com	Kornyei, Balint/AAK-7548-2020	Czeiter, Endre/0000-0002-9578-6944			Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Barnes S, 2009, J MAGN RESON IMAGING, V29, P1465, DOI 10.1002/jmri.21791; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; BRADLEY WG, 1985, RADIOLOGY, V156, P99, DOI 10.1148/radiology.156.1.4001427; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brown M S, 1995, J Neuroimaging, V5, P23; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chang SX, 2016, J MAGN RESON IMAGING, V44, P420, DOI 10.1002/jmri.25143; CLARK RA, 1990, RADIOLOGY, V175, P201, DOI 10.1148/radiology.175.1.2315481; de Haan S, 2017, NEURORADIOLOGY, V59, P963, DOI 10.1007/s00234-017-1898-8; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; ENZMANN DR, 1981, AM J NEURORADIOL, V2, P517; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; HAYMAN LA, 1991, AM J NEURORADIOL, V12, P899; HAYMAN LA, 1988, RADIOLOGY, V168, P489, DOI 10.1148/radiology.168.2.3393669; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; JANICK PA, 1991, AM J NEURORADIOL, V12, P891; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Knight RA, 2008, STROKE, V39, P2596, DOI 10.1161/STROKEAHA.107.506683; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; RIPOLL M, 2007, ACTA RADIOL, V44, P199; Ritzenthaler T, 2016, NEUROLOGY, V87, pE83, DOI 10.1212/WNL.0000000000003007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoonjans F, 1995, COMPUT METH PROG BIO, V48, P257, DOI 10.1016/0169-2607(95)01703-8; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Sumbria RK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0693-5; Taber KH, 1996, JMRI-J MAGN RESON IM, V6, P878, DOI 10.1002/jmri.1880060607; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825; Watanabe J, 2016, ACTA NEUROCHIR, V158, P1247, DOI 10.1007/s00701-016-2805-5	49	6	7	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1670	1677		10.1089/neu.2018.6004			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900017	30421664	Green Published, Green Accepted, hybrid, Green Submitted			2022-02-06	
J	Zuo, ZZ; Ji, X				Zuo, Zhizhi; Ji, Xiang			Prognostic value of copeptin in patients with aneurysmal subarachnoid hemorrhage	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Copeptin; Aneurysmal subarachnoid hemorrhage; Prognosis; Mortality	DELAYED CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; PLASMA COPEPTIN; INDEPENDENT PREDICTOR; MULTIPLE BIOMARKERS; NT-PROBNP; ALL-CAUSE; VASOPRESSIN; STROKE; MORTALITY	Background: Recently, copeptin has been identified as a plasma prognosis marker in acute ischemic stroke and intracerebral hemorrhage (ICH). This study investigated the prognostic value of copeptin in the patients with aneurysmal subarachnoid hemorrhage(aSAH). Methods: In this retrospective study, 243 consecutive patients were included. Upon admission, plasma copeptin levels were measured by enzyme-linked immunosorbent assay. The end points were mortality and poor functional outcome (Glasgow Outcome Scale score of 1-3) after 3 months. Results: In 243 patients, 112 (46.1%) were male and median age was 58 years (IQR 49-68). Median copeptin plasma levels were 21.0 pmol/1 (IQR 13.2-31.2). Copeptin levels increased with increasing severity of aSAH as defined by the World Federation of Neurological Surgeons (WFNS) score. Patients with a poor outcome and nonsurvivors had significantly increased copeptin levels on admission (P < .001 both). In the multivariate analysis, for each 1 pmol/l increase of plasma concentration of copeptin, the adjusted risk of poor outcomes and mortality would be increased by and 6% (1.06 [1.02-1.10], P < .001) and 9% (1.09 [1.03-1.13], P < .001), respectively. Receiver operating characteristics to predict functional outcome and mortality demonstrated areas under the curve of copeptin of 0.74 (95% confidence interval [CI], 0.67-0.81) and 0.81 (95% CI, 0.74-0.87), which was comparable with the WFNS score(P > .05) but superior to C-reactive protein and IL-6 (P < .01). Conclusions: The data shows that copeptin levels may reliably predict short-term prognosis at its onset in aSAH patients.	[Zuo, Zhizhi; Ji, Xiang] Tianjin Huanhu Hosp, Emergency Dept, Tianjin 300350, Peoples R China		Ji, X (corresponding author), 6 Jizhao Rd, Tianjin 300350, Peoples R China.	koobesholes@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; Assaad S.N., 2016, EGYPT J OBES DIABETE, V2, P131; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; CACH R, 1989, BRAIN RES, V483, P221, DOI 10.1016/0006-8993(89)90166-2; Choi KS, 2017, AM J EMERG MED, V35, P1444, DOI 10.1016/j.ajem.2017.04.038; Crobeddu E, 2012, STROKE, V43, P697, DOI 10.1161/STROKEAHA.111.638403; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Doi K., 2004, J NEUROENDOCRINOL, V16, P348; DRAKE CG, 1988, J NEUROSURG, V68, P985; Duan WY, 2018, NEUROEPIDEMIOLOGY, V50, P128, DOI 10.1159/000487325; Engelbertz C, 2016, INT J CARDIOL, V221, P327, DOI 10.1016/j.ijcard.2016.07.058; Enhorning S, 2015, AM HEART J, V169, P549, DOI 10.1016/j.ahj.2014.11.020; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053191; Galea J, 2018, J NEUROSURG, V128, P515, DOI 10.3171/2016.9.JNS16615; Itoi K, 1998, ENDOCR J, V45, P13, DOI 10.1507/endocrj.45.13; JENNETT B, 1975, LANCET, V1, P480; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Juvela S, 2012, ACTA NEUROCHIR, V154, P397, DOI 10.1007/s00701-011-1243-7; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Lagares A, 2001, ACTA NEUROCHIR, V143, P665, DOI 10.1007/s007010170044; Lattuca B, 2019, INT J CARDIOL, V274, P337, DOI 10.1016/j.ijcard.2018.09.022; Llull L, 2017, MOL NEUROBIOL, V54, P6572, DOI 10.1007/s12035-016-0180-0; Molnar AH, 2008, ACTA NEUROCHIR, V150, P265, DOI 10.1007/s00701-007-1400-1; Morawiec B, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/6597387; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Pozsonyi Z, 2015, HEART LUNG CIRC, V24, P359, DOI 10.1016/j.hlc.2014.10.008; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sun H, 2015, PEPTIDES, V69, P9, DOI 10.1016/j.peptides.2015.03.023; Tamargo RJ, 2012, CRIT CARE, V16, DOI 10.1186/cc10594; Tang WZ, 2017, NEUROTOX RES, V32, P420, DOI 10.1007/s12640-017-9754-5; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Tu WJ, 2013, J NEUROENDOCRINOL, V25, P771, DOI 10.1111/jne.12052; Tu WJ, 2017, STROKE, V48, P1531, DOI 10.1161/STROKEAHA.117.017128; Tu WJ, 2017, NEUROLOGY, V88, P1899, DOI 10.1212/WNL.0000000000003937; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Xu Q, 2017, HYPERTENS RES, V40, P465, DOI 10.1038/hr.2016.165; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Zeng XW, 2016, J AM COLL CARDIOL, V68, P2710, DOI 10.1016/j.jacc.2016.09.954; Zhang JL, 2013, ACTA NEUROL SCAND, V128, P372, DOI 10.1111/ane.12132; Zhang RY, 2017, MOL NEUROBIOL, V54, P169, DOI 10.1007/s12035-015-9626-z; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011; Zheng YK, 2017, CLIN CHIM ACTA, V475, P64, DOI 10.1016/j.cca.2017.10.009; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	47	6	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAY 15	2019	330						116	122		10.1016/j.jneuroim.2019.03.007			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HU1UK	WOS:000465057100021	30875611				2022-02-06	
J	Bosco, FM; Berardinelli, L; Parola, A				Bosco, Francesca M.; Berardinelli, Laura; Parola, Alberto			The Ability of Patients With Schizophrenia to Comprehend and Produce Sincere, Deceitful, and Ironic Communicative Intentions: The Role of Theory of Mind and Executive Functions	FRONTIERS IN PSYCHOLOGY			English	Article						schizophrenic pathology; pragmatics; theory of mind; executive function; schizophrenia	TRAUMATIC BRAIN-INJURY; COGNITIVE PRAGMATIC TREATMENT; LANGUAGE; IMPAIRMENTS; DEFICITS; PEOPLE; CHILDREN; SKILLS; SYMPTOMATOLOGY; DISORDERS	Patients with schizophrenia are often described as impaired in several cognitive domains. Specifically, patients with schizophrenia often exhibit problems in solving tasks requiring theory of mind (ToM), i.e., the ability to ascribe mental states to oneself and others, communicative-pragmatic ability, i.e., the ability to use language and non-verbal expressive means to convey meaning in a given context, and executive functions (EF). This study aims to investigate the role of cognitive functions, such as general intelligence, selective attention, processing speed, and especially EF (working memory, cognitive flexibility, inhibition, and planning), and ToM in explaining the performance of individual with schizophrenia in comprehending and producing communicative acts expressed with different communicative intentions (i.e., sincere, deceitful, and ironic), and realized through linguistic and extralinguistic/non-verbal expressive means. Thirty-two patients with schizophrenia and an equal number of healthy controls performed tasks aiming to investigate their capacity to comprehend and produce sincere, deceitful, and ironic communicative acts in addition to a series of cognitive tasks evaluating EF and ToM. The results indicated that individuals with schizophrenia performed worse than the controls in the comprehension and production of all pragmatic phenomena investigated, as well as in all the cognitive functions examined. The patients with schizophrenia also exhibited an increasing trend of difficulty in comprehending and producing sincere, deceitful, and ironic communicative acts expressed through either linguistic or extralinguistic means. Furthermore, a multiple regression analysis of the patients' performance on the pragmatic tasks revealed that overall, the role of attention, general intelligence, and processing speed did not appear to significantly explain the patients' communicative-pragmatic performance. The inclusion of EF into the analysis did not contribute to increase the explained variance of the patients' ability to comprehend and produce the various pragmatic phenomena investigated. Only the addition of ToM could significantly increase the explained variance, but only in the comprehension and production of deceit expressed by language and the production of sincere communicative acts, also limited to linguistic production. We conclude that neither EF nor ToM are able to explain the decreasing trend detected in the patients' pragmatic performance.	[Bosco, Francesca M.; Parola, Alberto] Univ Turin, Dept Psychol, Turin, Italy; [Bosco, Francesca M.] Inst Neurosci, Turin, Italy; [Berardinelli, Laura] ASL Citta Torino, Dept Mental Hlth, Turin, Italy		Bosco, FM (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.; Bosco, FM (corresponding author), Inst Neurosci, Turin, Italy.	francesca.bosco@unito.it	bosco, francesca marina/B-6746-2013; Parola, alberto/AAK-3748-2020	bosco, francesca marina/0000-0001-6101-8587; PAROLA, ALBERTO/0000-0002-6039-0907	MIUR: Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN)Ministry of Education, Universities and Research (MIUR) [201577HA9M]	This research was supported by MIUR: Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) 2017. Project 'The interpretative brain: Understanding and promoting pragmatic abilities across lifespan and in mental illness' project code 201577HA9M.	Abu-Akel A., 1999, PRAGMAT COGN, V7, P247, DOI DOI 10.1075/PC.7.2.02ABU; AIRENTI G, 1993, COGNITIVE SCI, V17, P197, DOI 10.1207/s15516709cog1702_2; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bara B. G., 2010, COGNITIVE PRAGMATCIS; Bara BG, 1999, P 3 EUR C COGN SCI E; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bechi M, 2018, NEUROPSYCHOLOGY, V32, P746, DOI 10.1037/neu0000456; Bliksted V, 2014, SCHIZOPHR RES, V153, P9, DOI 10.1016/j.schres.2014.01.010; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco FM, 2018, ARCH CLIN NEUROPSYCH, V33, P875, DOI 10.1093/arclin/acy041; Bosco FM, 2008, J PRAGMATICS, V40, P583, DOI 10.1016/j.pragma.2007.05.004; Bosco FM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01453; Bosco FM, 2017, PERSP PRAGMAT PHILO, V11, P267, DOI 10.1007/978-3-319-47489-2_11; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Bosco FM, 2017, APPL PSYCHOLINGUIST, V38, P57, DOI 10.1017/S0142716416000047; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Bosco FM, 2009, CONSCIOUS COGN, V18, P323, DOI 10.1016/j.concog.2008.12.007; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Bucca A., 2018, INDIRECT REPORTS PRA, P439; Champagne-Lavau M, 2010, J NEUROLINGUIST, V23, P285, DOI 10.1016/j.jneuroling.2009.08.009; Cohen AS, 2014, SCHIZOPHR RES, V159, P533, DOI 10.1016/j.schres.2014.09.013; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Corcoran CM, 2018, WORLD PSYCHIATRY, V17, P67, DOI 10.1002/wps.20491; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Corcoran Rhiannon, 2003, Cogn Neuropsychiatry, V8, P223, DOI 10.1080/13546800244000319; Csukly G, 2014, COMPR PSYCHIAT, V55, P349, DOI 10.1016/j.comppsych.2013.08.025; Cummings L., 2017, RES CLIN PRAGMATICS, V11; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith C.D., 1992, COGN NEUROPSYCHOL; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Grice H. P., 1975, SYNTAX SEMANTICS; Haas MH, 2015, J PSYCHOLINGUIST RES, V44, P469, DOI 10.1007/s10936-014-9298-2; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Harrington Leigh, 2005, Cogn Neuropsychiatry, V10, P249, DOI 10.1080/13546800444000056; Holland A., 1999, COMMUNICATION ACTIVI; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Huber W, 1984, Adv Neurol, V42, P291; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Laghi F, 2014, BRIT J PSYCHOL, V105, P509, DOI 10.1111/bjop.12054; Langdon R, 2002, MIND LANG, V17, P68, DOI 10.1111/1468-0017.00189; Le TP, 2017, PSYCHIAT RES, V248, P98, DOI 10.1016/j.psychres.2016.12.025; Levinson Stephen., 1983, PRAGMATICS; Linscott RJ, 2005, SCHIZOPHR RES, V75, P225, DOI 10.1016/j.schres.2004.10.007; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Moro A, 2015, NEUROPSYCHOLOGIA, V79, P147, DOI 10.1016/j.neuropsychologia.2015.10.030; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Orellana Gricel, 2013, Front Psychiatry, V4, P35, DOI 10.3389/fpsyt.2013.00035; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parola A., 2019, BIORXIV, DOI [10.1101/583815, DOI 10.1101/583815]; Parola A, 2019, J NEUROLINGUIST, V51, P53, DOI 10.1016/j.jneuroling.2018.12.003; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Pauselli L, 2018, PSYCHIAT RES, V263, P74, DOI 10.1016/j.psychres.2018.02.037; Pawelczyk A, 2018, PSYCHIAT RES, V267, P63, DOI 10.1016/j.psychres.2018.05.070; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Peskin J, 1996, CHILD DEV, V67, P1735, DOI 10.2307/1131728; Pickup GJ, 2008, PSYCHOPATHOLOGY, V41, P206, DOI 10.1159/000125554; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sacco K, 2008, J COGN SCI, V9, P111; Sarfati Y, 1999, PSYCHOL MED, V29, P613, DOI 10.1017/S0033291799008326; Schettino A, 2010, NEUROPSYCHOLOGIA, V48, P1032, DOI 10.1016/j.neuropsychologia.2009.11.030; Searle J.R., 1979, EXPRESSION MEANING; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P5; Sponheim SR, 2003, SCHIZOPHR RES, V65, P117, DOI 10.1016/S0920-9964(02)00525-X; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Thoma P, 2009, PSYCHIAT RES, V170, P132, DOI 10.1016/j.psychres.2009.01.026; Varga E, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00247; Vaskinn A, 2018, COMPR PSYCHIAT, V85, P1, DOI 10.1016/j.comppsych.2018.05.002; Wampers M, 2018, SCHIZOPHR RES, V195, P97, DOI 10.1016/j.schres.2017.08.053; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257, DOI 10.1111/j.2044-835X.1991.tb00875.x	99	6	6	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 8	2019	10								827	10.3389/fpsyg.2019.00827			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HX4KA	WOS:000467362700001	31139103	Green Published, gold			2022-02-06	
J	Villasana, LE; Peters, A; McCallum, R; Liu, C; Schnell, E				Villasana, Laura E.; Peters, Austin; McCallum, Raluca; Liu, Chang; Schnell, Eric			Diazepam Inhibits Post-Traumatic Neurogenesis and Blocks Aberrant Dendritic Development	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; diazepam; models of injury; neurogenesis; regeneration; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GRANULE CELLS; COGNITIVE RECOVERY; NEURONAL DIFFERENTIATION; ENHANCES NEUROGENESIS; UP-REGULATION; BORN NEURONS; PROLIFERATION	Traumatic brain injury (TBI) triggers a robust increase in neurogenesis within the dentate gyrus of the hippocampus, but these new neurons undergo aberrant maturation and dendritic outgrowth. Because gamma-aminobutyric acid (GABA)(A) receptors (GABA(A)Rs) modulate dendritic outgrowth during constitutive neurogenesis and GABA(A)R-modulating sedatives are often administered to human patients after TBI, we investigated whether the benzodiazepine, diazepam (DZP), alters post-injury hippocampal neurogenesis. We used a controlled cortical impact (CCI) model of TBI in adult mice, and administered DZP or vehicle continuously for 1 week after injury via osmotic pump. Although DZP did not affect the neurogenesis rate in control mice, it almost completely prevented the TBI-induced increase in hippocampal neurogenesis as well as the aberrant dendritic growth of neurons born after TBI. DZP did not reduce cortical injury, reactive gliosis, or cell proliferation early after injury, but decreased c-Fos activation in the dentate gyrus at both early and late time-points after TBI, suggesting an association between neuronal activity and post-injury neurogenesis. Because DZP blocks post-injury neurogenesis, further studies are warranted to assess whether benzodiazepines alter cognitive recovery or the development of complications after TBI.	[Villasana, Laura E.; Peters, Austin; Liu, Chang; Schnell, Eric] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [McCallum, Raluca; Schnell, Eric] VA Portland Hlth Care Syst, Operat Care Div, Portland, OR 97239 USA		Schnell, E (corresponding author), VA Portland Hlth Care Syst, P3ANES 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and DevelopmentUS Department of Veterans Affairs [005-10S]; Department of Veterans Affairs Merit Review AwardUS Department of Veterans Affairs [I01-BX002949]; Department of Defense CDMRP AwardUnited States Department of Defense [W81XWH-18-1-0598]; Oregon Clinical and Translational Research Institute (OCTRI) NIH from the National Center for Advancing Translational Sciences at the National Institutes of Health [TL1TR000129]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32NS083109]; BIRCWH [K12HD043488]; Office of Research on Women's HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH) [P30NS061800]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002949] Funding Source: NIH RePORTER	This material was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development CDA-2 Award 005-10S (ES), a Department of Veterans Affairs Merit Review Award I01-BX002949 (ES), a Department of Defense CDMRP Award W81XWH-18-1-0598 (ES), the Oregon Clinical and Translational Research Institute (OCTRI) NIH TL1TR000129 from the National Center for Advancing Translational Sciences at the National Institutes of Health (RM), the NIH F32NS083109 (LEV), a BIRCWH K12HD043488 Award made possible through the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of Research on Women's Health (LEV), and P30NS061800 (OHSU) Awards. We thank Dr. Gary Westbrook of the Vollum Institute for comments on our manuscript, Dr. Stefanie Kaech-Petrie of the OHSU Advanced Light Microscopy Core for assistance with imaging, and our lab volunteer Khanh Doan and research assistants Sarah Mader and Alexandria Wilson for outstanding technical support. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arnot MI, 2001, J NEUROSCI RES, V64, P617, DOI 10.1002/jnr.1115; BACKUS KH, 1988, GLIA, V1, P132, DOI 10.1002/glia.440010205; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; BOURIN M, 1992, J PSYCHIATR NEUROSCI, V17, P72; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; CDC, RAT TBI REL EM DEP V; Chatzi C, 2015, ELIFE, V4, DOI 10.7554/eLife.08722; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chohan M. O., 2014, NEUROSURGERY, V76, P214; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Depino AM, 2008, BRAIN RES, V1210, P189, DOI 10.1016/j.brainres.2008.03.006; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; FRIEDMAN H, 1986, PSYCHOPHARMACOLOGY, V88, P267; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; GASTAUT H, 1965, Epilepsia, V6, P167, DOI 10.1111/j.1528-1157.1965.tb03786.x; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, J NEUROSCI, V17, P2492; Hernandez TD, 2006, J NEUROTRAUM, V23, P1211, DOI 10.1089/neu.2006.23.1211; Ho NF, 2013, MOL PSYCHIATR, V18, P404, DOI 10.1038/mp.2013.8; Hsieh J, 2010, NEUROBIOL DIS, V39, P73, DOI 10.1016/j.nbd.2010.01.008; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kitamura T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-13; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; KLOTZ U, 1976, J PHARMACOL EXP THER, V199, P67; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Krzisch M, 2013, ANESTHESIOLOGY, V118, P602, DOI 10.1097/ALN.0b013e3182815948; Larson TA, 2014, J NEUROSCI, V34, P13066, DOI 10.1523/JNEUROSCI.3316-13.2014; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Li Y, 2012, P NATL ACAD SCI USA, V109, P4290, DOI 10.1073/pnas.1120754109; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Nochi R, 2013, J NEUROSCI RES, V91, P1429, DOI 10.1002/jnr.23264; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Pallotto M, 2012, J NEUROSCI, V32, P9103, DOI 10.1523/JNEUROSCI.0214-12.2012; Parent JM, 2007, EPILEPSIA, V48, P69, DOI 10.1111/j.1528-1167.2007.01355.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/NCHEMBIO.917, 10.1038/nchembio.917]; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stefovska VG, 2008, ANN NEUROL, V64, P434, DOI 10.1002/ana.21463; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Taylor SR, 2013, J NEUROSURG-PEDIATR, V12, P545, DOI 10.3171/2013.8.PEDS13154; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	108	6	6	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2454	2467		10.1089/neu.2018.6162		MAY 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000468181700001	30794026	Green Published			2022-02-06	
J	Montes, P; Vigueras-Villasenor, RM; Rojas-Castaneda, JC; Monfil, T; Cervantes, M; Morali, G				Montes, Pedro; Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio; Monfil, Tomas; Cervantes, Miguel; Morali, Gabriela			Progesterone treatment in rats after severe global cerebral ischemia promotes hippocampal dentate gyrus neurogenesis and functional recovery	NEUROLOGICAL RESEARCH			English	Article						Global cerebral ischemia; neurogenesis; progesterone; brain plasticity; functional recovery	TRAUMATIC BRAIN-INJURY; CELL-DEATH; ADULT NEUROGENESIS; NEWBORN NEURONS; ALLOPREGNANOLONE; STROKE; DAMAGE; PROLIFERATION; EXPRESSION; PLASTICITY	Objective: Rats treated with progesterone (P4) after ischemia show an adequate functional performance despite a significant loss of hippocampal pyramidal neurons, suggesting that P4 could favour a permissive microenvironment for cerebral plasticity mechanisms. The possibility of P4 treatment promoting the survival of newly generated hippocampal neurons, in relation to the performance of ischemic rats in a spatial learning task, was assessed in this study. Methods: Adult male rats were subjected to a severe global cerebral ischemia episode (30 min) and treated with P4 or its vehicle at 15 min, 2, 6, 24, 48 and 72 h of reperfusion. From day 4 to 8 post-ischemia 5-bromo-2-deoxyuridine (BrdU) was administered to label proliferating cells. Twenty-one days post-ischemia, the rats were exposed to the Morris water maze to assess behavioral parameters of spatial learning and memory. Subsequently, the brain was perfusion-fixed and immunofluorescence procedures were performed to quantify the number of new mature neurons (BrdU(+)/NeuN(+)) in the dentate gyrus (DG) of the hippocampus. Results: Rats subjected to severe global cerebral ischemia and treated with P4 had a significantly better performance in spatial learning-memory tests, than those treated with vehicle, and a significantly higher number of new mature neurons (BrdU(+)/NeuN(+)) in the DG. Conclusion: These findings show that post-ischemia P4 treatment, following an episode of severe global cerebral ischemia, promotes the survival of newly generated hippocampal neurons in the DG, which may be one of the mechanisms of cerebral plasticity induced by the hormone, that underlie a successful functional performance in learning and memory tests.	[Montes, Pedro; Monfil, Tomas; Morali, Gabriela] IMSS, CMN Siglo XXI, Unidad Invest Med Farmacol CMN, Mexico City, DF, Mexico; [Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio] Inst Nacl Pediat, Subdirecc Med Expt, Mexico City, DF, Mexico; [Cervantes, Miguel] UMSNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico		Morali, G (corresponding author), IMSS, Ctr Med Nacl Siglo XXI, Unidad Invest Media Farmacol, Av Cuauhtemoc 330, Mexico City 06720, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Morali, Gabriela/0000-0002-7504-9365; Montes, Pedro/0000-0003-1630-5047; Cervantes, Miguel/0000-0002-0509-3977	Instituto Mexicano del Seguro Social (IMSS) [2005/1/I/042]; IMSS [99091245]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [172697]	This work was supported by the Instituto Mexicano del Seguro Social (IMSS) [2005/1/I/042]. Pedro Montes was recipient of fellowships from the IMSS [99091245] and CONACYT [172697].	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aydin K, 2011, INT J DEV NEUROSCI, V29, P717, DOI 10.1016/j.ijdevneu.2011.05.013; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Cheatwood JL, 2008, TOP STROKE REHABIL, V15, P42, DOI 10.1310/tsr1501-42; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Espinosa-Garcia C, 2017, BRAIN BEHAV IMMUN, V66, P177, DOI 10.1016/j.bbi.2017.06.012; Espinosa-Garcia C, 2014, BRAIN RES, V1545, P23, DOI 10.1016/j.brainres.2013.11.030; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Foscarin S, 2012, CELL TISSUE RES, V349, P161, DOI 10.1007/s00441-011-1293-4; Frye CA, 2011, DEV NEUROBIOL, V71, P142, DOI 10.1002/dneu.20832; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Hansberg-Pastor V, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00165; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jiang C, 2017, MOL NEUROBIOL, V54, P571, DOI 10.1007/s12035-015-9651-y; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Perez-Alvarez MJ, 2016, CURR PHARM DESIGN, V22, P1334, DOI 10.2174/138161282210160304112834; Kato T, 2014, ADV EXP MED BIOL, V812, P203, DOI 10.1007/978-1-4939-0620-8_27; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Lee RJ, 2015, J NEUROCHEM, V132, P32, DOI 10.1111/jnc.12990; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Li XJ, 2015, INT J CLIN EXP MED, V8, P8197; Lieberwirth C, 2016, BRAIN RES, V1644, P127, DOI 10.1016/j.brainres.2016.05.015; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Ma CL, 2017, BEHAV BRAIN RES, V317, P332, DOI 10.1016/j.bbr.2016.09.067; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2012, RESTOR NEUROL NEUROS, V30, P1, DOI 10.3233/RNN-2011-0605; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neumann JT, 2013, CURR DRUG TARGETS, V14, P20; Ohline SM, 2019, NEUROPHARMACOLOGY, V145, P3, DOI 10.1016/j.neuropharm.2018.04.007; Okada T, 2003, EUR J NEUROSCI, V17, P341, DOI 10.1046/j.1460-9568.2003.02458.x; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Sadelli K, 2017, NEUROBIOL LEARN MEM, V141, P168, DOI 10.1016/j.nlm.2017.04.004; Sandvig I, 2018, EUR J NEUROSCI, V47, P1414, DOI 10.1111/ejn.13959; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanaka M, 2018, EXP GERONTOL, V113, P29, DOI 10.1016/j.exger.2018.09.012; Toni N., 2015, COLD SPRING HARB PER, V8, DOI 10.1101/cshperspect.a018903.; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhang Z, 2010, NEUROPHARMACOLOGY, V58, P930, DOI 10.1016/j.neuropharm.2010.01.002; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915	54	6	6	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY 4	2019	41	5					429	436		10.1080/01616412.2019.1576356			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ3LE	WOS:000462311700005	30762490				2022-02-06	
J	Kalita-de Croft, P; Straube, J; Lim, M; Al-Ejeh, F; Lakhani, SR; Saunus, JM				Kalita-de Croft, Priyakshi; Straube, Jasmin; Lim, Malcolm; Al-Ejeh, Fares; Lakhani, Sunil R.; Saunus, Jodi M.			Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						brain metastasis; proteomics; tumour microenvironment; metabolism	CELLS; IDENTIFICATION; ASTROCYTES; LANDSCAPE; AUTOPHAGY; JUNCTIONS; NETWORKS; BARRIER; PROTEIN; CNS	Patients with brain-metastatic breast cancer face a bleak prognosis marked by morbidity and premature death. A deeper understanding of molecular interactions in the metastatic brain tumour microenvironment may inform the development of new therapeutic strategies. In this study, triple-negative MDA-MB-231 breast cancer cells or PBS (modelling traumatic brain injury) were stereotactically injected into the cerebral cortex of NOD/SCID mice to model metastatic colonization. Brain cells were isolated from five tumour-associated samples and five controls (pooled uninvolved and injured tissue) by immunoaffinity chromatography, and proteomic profiles were compared using the Sequential Window Acquisition of All Theoretical Mass Spectra (SWATH-MS) discovery platform. Ontology and cell type biomarker enrichment analysis of the 125 differentially abundant proteins (p < 0.05) showed the changes largely represent cellular components involved in metabolic reprogramming and cell migration (min q = 4.59 x 10(-5)), with high-throughput PubMed text mining indicating they have been most frequently studied in the contexts of mitochondrial dysfunction, oxidative stress and autophagy. Analysis of mouse brain cell type-specific biomarkers suggested the changes were paralleled by increased proportions of microglia, mural cells and interneurons. Finally, we orthogonally validated three of the proteins in an independent xenograft cohort, and investigated their expression in craniotomy specimens from triple-negative metastatic breast cancer patients, using a combination of standard and fluorescent multiplex immunohistochemistry. This included 3-Hydroxyisobutyryl-CoA Hydrolase (HIBCH), which is integral for gluconeogenic valine catabolism in the brain, and was strongly induced in both graft-associated brain tissue (13.5-fold by SWATH-MS; p = 7.2 x 10(-4)), and areas of tumour-associated, reactive gliosis in human clinical samples. HIBCH was also induced in the tumour compartment, with expression frequently localized to margins and haemorrhagic areas. These observations raise the possibility that catabolism of valine is an effective adaptation in metastatic cells able to access it, and that intermediates or products could be transferred from tumour-associated glia. Overall, our findings indicate that metabolic reprogramming dominates the proteomic landscape of graft-associated brain tissue in the intracranial MDA-MB-231 xenograft model. Brain-derived metabolic provisions could represent an exploitable dependency in breast cancer brain metastases.	[Kalita-de Croft, Priyakshi; Lim, Malcolm; Lakhani, Sunil R.; Saunus, Jodi M.] Univ Queensland, Clin Res Ctr, Fac Med, Herston, Qld 4029, Australia; [Straube, Jasmin; Al-Ejeh, Fares] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Herston, Qld 4029, Australia		Saunus, JM (corresponding author), Univ Queensland, Clin Res Ctr, Fac Med, Herston, Qld 4029, Australia.	p.kalita@uq.edu.au; jasmin.straube@qimrberghofer.edu.au; m.lim@uq.edu.au; fares.al-ejeh@qimrberghofer.edu.au; s.lakhani@uq.edu.au; j.saunus@uq.edu.au	Straube, Jasmin/Y-1355-2018; Saunus, Jodi/AAE-5291-2020; Saunus, Jodi M/C-6657-2011; Kalita-de Croft, Priyakshi/M-8790-2016; Al-Ejeh, Fares/M-7032-2016	Straube, Jasmin/0000-0002-1748-0659; Saunus, Jodi/0000-0002-4604-4709; Saunus, Jodi M/0000-0002-4604-4709; Lim, Malcolm/0000-0003-3691-4368; Kalita-de Croft, Priyakshi/0000-0001-8877-7655; Al-Ejeh, Fares/0000-0002-1553-0077	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1017028]	This research was funded by the Australian National Health and Medical Research Council (Program grant APP1017028).	Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Arvanitis CD, 2018, P NATL ACAD SCI USA, V115, pE8717, DOI 10.1073/pnas.1807105115; Bavisotto CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020434; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bronstein JM, 2000, J NEUROSCI RES, V59, P706, DOI 10.1002/(SICI)1097-4547(20000315)59:6<706::AID-JNR2>3.0.CO;2-D; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Chen JY, 2015, CANCER RES, V75, P554, DOI 10.1158/0008-5472.CAN-14-2268; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Denninger AR, 2015, BIOPHYS J, V109, P1387, DOI 10.1016/j.bpj.2015.08.012; Doron H, 2019, CANCER RES, V79, P423, DOI 10.1158/0008-5472.CAN-18-1805; Dun MD, 2015, MOL CELL PROTEOMICS, V14, P2316, DOI 10.1074/mcp.M114.046110; Dupont N, 2014, METHOD ENZYMOL, V543, P73, DOI 10.1016/B978-0-12-801329-8.00004-0; Gril B, 2013, AM J PATHOL, V182, P2368, DOI 10.1016/j.ajpath.2013.02.043; Hohensee I, 2013, AM J PATHOL, V183, P83, DOI 10.1016/j.ajpath.2013.03.023; Jeong HK, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-28; Kim Y, 2013, J BIOL CHEM, V288, P29453, DOI 10.1074/jbc.M113.468801; Li F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021977; Lim M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061280; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lin QT, 2010, NEOPLASIA, V12, P748, DOI 10.1593/neo.10602; Lyle LT, 2016, CLIN CANCER RES, V22, P5287, DOI 10.1158/1078-0432.CCR-15-1836; Meijer AJ, 2015, AMINO ACIDS, V47, P2037, DOI 10.1007/s00726-014-1765-4; Nakazawa T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10594; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Reed AEM., 2018, OPEN J BIORESOUR, V5, P5, DOI DOI 10.5334/OJB.33; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sartorius CA, 2016, ONCOGENE, V35, P2881, DOI 10.1038/onc.2015.353; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; Sperringer JE, 2017, NEUROCHEM RES, V42, P1697, DOI 10.1007/s11064-017-2261-5; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tabouret E, 2012, ANTICANCER RES, V32, P4655; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wu JX, 2016, MOL CELL PROTEOMICS, V15, P2501, DOI 10.1074/mcp.M115.055558; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	41	6	6	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAY 2	2019	20	10							2524	10.3390/ijms20102524			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	IC5IP	WOS:000471001400155	31121957	gold, Green Submitted, Green Published			2022-02-06	
J	Ahmed, OZ; Holubkov, R; Dean, JM; Bennett, TD; Meert, KL; Berg, RA; Newth, CJL; Carcillo, JA; Burd, RS; Pollack, MM				Ahmed, Omar Z.; Holubkov, Richard; Dean, J. Michael; Bennett, Tellen D.; Meert, Kathleen L.; Berg, Robert A.; Newth, Christopher J. L.; Carcillo, Joseph A.; Burd, Randall S.; Pollack, Murray M.			Change in functional status among children treated in the intensive care unit after injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Functional Status Scale; pediatric trauma; domain morbidity; critically ill children; pediatric critical care	QUALITY-OF-LIFE; STATUS SCALE; OUTCOMES; MORTALITY; IMPACT	BACKGROUND Because pediatric trauma-related mortality continues to decline, metrics assessing morbidity are needed to evaluate the impact of treatment after injury. Based on its value for assessing children with traumatic brain injuries and other critical illnesses, Functional Status Scale (FSS), a tool that measures function in six domains (communication, feeding, mental, motor, sensory, and respiratory), was evaluated as an outcome measure for the overall population of injured children. METHODS Children with at least one injury (Abbreviated Injury Scale [AIS] severity >= 1) surviving to discharge between December 2011 and April 2013 were identified in a previous study of intensive care unit admissions. Morbidity was defined as additional morbidity in any domain (domain FSS change >= 2 or "new domain morbidity") and additional overall morbidity (total FSS change >= 3) between preinjury status and discharge. Associations between injury profiles and the development of morbidity were analyzed. RESULTS We identified 553 injured children, with a mean of 2.0 +/- 1.9 injuries. New domain and overall morbidity were observed in 17.0% and 11.0% of patients, respectively. New domain morbidity was associated with an increasing number of body regions with an injury with AIS >= 2 (p < 0.001), with severe (AIS >= 4) head (p = 0.04) and spine (p = 0.01) injuries and with at moderately severe (AIS >= 2) lower extremity injuries (p = 0.01). New domain morbidity was more common among patients with severe spine and lower extremity injuries (55.6% and 48.7%, respectively), with greatest impact in the motor domain (55.6% and 43.6%, respectively). New domain morbidity was associated with increasing injury severity score, number of moderately severe injuries and number of body regions with more than a moderately severe injury (p < 0.001 for all). CONCLUSIONS Higher morbidity measured by the FSS is associated with increasing injury severity. These findings support the use of the FSS as a metric for assessing outcome after pediatric injury.	[Ahmed, Omar Z.; Burd, Randall S.; Pollack, Murray M.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Holubkov, Richard; Dean, J. Michael] Univ Utah, Sch Med, Salt Lake City, UT 84108 USA; [Bennett, Tellen D.] Childrens Hosp Colorado, Aurora, CO USA; [Meert, Kathleen L.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Newth, Christopher J. L.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Carcillo, Joseph A.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Burd, RS (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Trauma & Burn Surg, Childrens Natl Med Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	rburd@cnmc.org		Bennett, Tellen/0000-0003-1483-4236	Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN), National Institutes of Health, Department of Health and Human Services [U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, U01HD049934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [UG1HD049981, U01HD049934] Funding Source: NIH RePORTER	Research reported in this article was supported, in part, by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN), National Institutes of Health, Department of Health and Human Services: U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114 and U01HD049934. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Burd RS, 2009, ACAD EMERG MED, V16, P639, DOI 10.1111/j.1553-2712.2009.00446.x; Centers for Disease Prevention and Control, 2014, HLTH US INJ; Cooper CG, 2013, PEDIATR CRIT CARE ME, V14, pE365, DOI 10.1097/PCC.0b013e3182917a4c; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; Gabbe BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113467; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Institute for Health Metrics and Evaluation, GBD COMP WEBS; McCarthy A, 2016, INJURY, V47, P574, DOI 10.1016/j.injury.2015.12.028; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121552; Rios-Diaz AJ, 2016, JAMA SURG, V151, P1101, DOI 10.1001/jamasurg.2016.2343; Schweer Lynn H, 2006, J Trauma Nurs, V13, P6; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Stelfox HT, 2010, CRIT CARE MED, V38, P1187, DOI 10.1097/CCM.0b013e3181d455fe; Tomaszewski R, 2014, J ORTHOP, V11, P78, DOI 10.1016/j.jor.2014.04.005; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7	24	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2019	86	5					810	816		10.1097/TA.0000000000002120			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HW6KW	WOS:000466799900007	30444861	Green Accepted			2022-02-06	
J	Buckley, TA; Bryk, KN; Van Pelt, KL; Broglio, SP; East, SA; Zuckerman, SL; Kuhn, AW				Buckley, Thomas A.; Bryk, Kelsey N.; Van Pelt, Kathryn L.; Broglio, Steven P.; East, Stephen A.; Zuckerman, Scott L.; Kuhn, Andrew W.			Concussion and National Hockey League Player Performance: An Advanced Hockey Metrics Analysis	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; sports performance; ice hockey	CRUCIATE LIGAMENT RECONSTRUCTION; SYSTEMATIC VIDEO ANALYSIS; NHL; RETURN; INJURY; GAIT	Context: Postconcussion deficits in neurocognitive performance and postural control may persist at the time of return to sport participation. How these deficits, if present, affect athletic performance is largely unknown, with prior studies showing mixed results. Objective: To evaluate postconcussion National Hockey League player performance using advanced hockey metrics over short- (5 games), medium- (10 games), and long-term (remainder of the season) seasonal performance. Design: Retrospective cohort study. Patients or Other Participants: National Hockey League players who sustained a sport-related concussion (SRC; n = 93) and returned during the same season and players (n = 51) who missed time for non-injury-related reasons. Main Outcome Measure(s): Six performance metrics were used: (1) points per 60 minutes, (2) Corsi percentage, (3) personal Fenwick shooting percentage, (4) scoring chances per 60 minutes, (5) penalty difference, and (6) PDO (not an acronym but sometimes referred to as SVSP% [save percentage shooting percentage]). Performance was compared using 2 (group) x 2 (time) repeated-measures analyses of variance for 3 time windows: (1) +/- 5 games, (2) +/- 10 games, and (3) the remainder of the season postconcussion. Alpha values were set at a conservative .01 to account for the lack of independence among dependent variables. Results: No significant interactions were present for any of the 6 dependent variables at any of the 3 time windows. Overall, none of the secondary variables differed. Conclusions: Using advanced, sport-specific metrics, we found that National Hockey League players did not display worse seasonal performance during 3 postinjury time frames after they sustained an SRC. Whereas laboratory studies have identified lingering neurologic deficits after concussion, our results suggest that these deficits, if present, either do not translate to worse athletic performance or were not captured by these 44 metrics. Further, prospective efforts are needed to accurately quantify performance after SRC among professional hockey players.	[Buckley, Thomas A.; Bryk, Kelsey N.; East, Stephen A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave,150 Human Performance Lab, Newark, DE 19716 USA; [Buckley, Thomas A.; Bryk, Kelsey N.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE 19716 USA; [Van Pelt, Kathryn L.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Van Pelt, Kathryn L.; Broglio, Steven P.] Univ Michigan, Injury Ctr, Ann Arbor, MI 48109 USA; [Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Kuhn, Andrew W.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 541 South Coll Ave,150 Human Performance Lab, Newark, DE 19716 USA.	TBuckley@UDel.edu	Kuhn, Andrew W/AAM-4820-2020; Buckley, Thomas A/B-7525-2016	Kuhn, Andrew W/0000-0003-1836-7575; Buckley, Thomas A/0000-0002-0515-0150; Van Pelt, Kathryn/0000-0002-5494-2357			Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gao J, 2011, PLOS ONE, V6; Hardy R, 2017, PHYS EDUC-US, V74, P150, DOI 10.18666/TPE-2017-V74-I1-6830; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kuhn AW, 2015, CONCUSSION, V1; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Longstaffe R, CLIN J SPORT MED, DOI [10.1097/JSM.000000000000584, DOI 10.1097/JSM.000000000000584]; Mai HT, 2017, AM J SPORT MED, V45, P2226, DOI 10.1177/0363546517704834; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mehran N, 2016, ORTHOP J SPORTS MED, V4; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; NHL, SAP PARTN LEAD STAT; Orchard JW, 2009, BRIT J SPORT MED, V43, P963, DOI 10.1136/bjsm.2009.058404; Read CR, 2017, AM J SPORT MED, V45, P1815, DOI 10.1177/0363546517703361; Servatius RJ, 2018, J NEUROTRAUM, V35, P1008, DOI 10.1089/neu.2017.5314; Sikka R, 2016, AM J SPORT MED, V44, P378, DOI 10.1177/0363546515616802; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	34	6	6	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2019	54	5					527	533		10.4085/1062-6050-200-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ID7OX	WOS:000471873300009	30933609	Green Published, gold			2022-02-06	
J	Ilmaniemi, S; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM				Ilmaniemi, Sarianna; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija			Incidence of head injury and traumatic brain injury among people with Alzheimer's disease	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							OLDER-PEOPLE; DEMENTIA; RISK; OUTCOMES; FALLS	Background Injuries caused by falling are a major health concern among older population. For older people, falls are the leading cause of head injuries; especially, persons with cognitive disorders have an increased risk of falling. Objective To compare the incidence of head injury and traumatic brain injury (TBI) among persons with Alzheimer's disease (AD) with persons without AD. Methods This register-based study was conducted on a nationwide cohort, which includes all communitydwelling persons diagnosed with AD in Finland in 2005-2011. Persons with previous head injuries were excluded, leaving 67 172 persons with AD. For each person with AD, a matching person without AD and previous head injury were identified with respect to age, sex and university hospital district. The Cox proportional hazard model and competing risk analyses were used to estimate HR for head injury and TBI. Results Persons with AD had 1.34-fold (95% CI 1.29 to 1.40) risk of head injuries and 1.49-fold (95% CI 1.40 to 1.59) risk of TBIs after accounting for competing risks of death and full adjustment by socioeconomic status, drug use and comorbidities. Conclusion Persons with AD are more likely to have a head injury or TBI incident than persons without AD.	[Ilmaniemi, Sarianna; Taipale, Heidi; Hartikainen, Sirpa; Tolppanen, Anna-Maija] Univ Eastern Finland, Sch Pharm, Kuopio 70210, Finland; [Taipale, Heidi; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Karolinska Inst, Department Clin Neurosci, Stockholm, Sweden; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Tanskanen, Antti; Tiihonen, Jari] Natl Inst Hlth & Welf, Helsinki, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland		Ilmaniemi, S (corresponding author), Univ Eastern Finland, Sch Pharm, Kuopio 70210, Finland.	sariilm@uef.fi		Taipale, Heidi/0000-0002-3281-934X; Ilmaniemi, Sarianna/0000-0002-0211-4816	Academy of FinlandAcademy of FinlandEuropean Commission [307232, 295334]; University of Eastern Finland	A-MT is funded by the Academy of Finland (grants 307232 and 295334). HT and A-MT acknowledge strategic funding from the University of Eastern Finland. The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; de Vries M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.013; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Harvey L, 2016, ARCH GERONTOL GERIAT, V67, P61, DOI 10.1016/j.archger.2016.06.014; Harvey L, 2016, INJURY, V47, P226, DOI 10.1016/j.injury.2015.09.021; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kallin K, 2005, AM J GERIAT PSYCHIAT, V13, P501, DOI 10.1176/appi.ajgp.13.6.501; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lonnroos E, 2013, J ALZHEIMERS DIS, V33, P157, DOI 10.3233/JAD-2012-120808; Seppala LJ, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.099; Solomon A, 2014, ALZHEIMERS DEMENT, V10, P303, DOI 10.1016/j.jalz.2013.03.004; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Tolppanen AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012100; TRICK GL, 1995, NEUROLOGY, V45, P68, DOI 10.1212/WNL.45.1.68; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; World Health Organization (WHO-Eur), 2012, STRAT ACT PLAN HLTH	19	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	MAY	2019	73	5					451	454		10.1136/jech-2018-211960			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	ID7GA	WOS:000471849100012	30782855				2022-02-06	
J	Inness, EL; Sweeny, M; Perez, OH; Danells, C; Chandra, T; Foster, E; Saverino, C; Comper, P; Bayley, M; Mochizuki, G				Inness, Elizabeth L.; Sweeny, Michelle; Perez, Olinda Habib; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Saverino, Cristina; Comper, Paul; Bayley, Mark; Mochizuki, George			Self-reported Balance Disturbance and Performance-Based Balance Impairment After Concussion in the General Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; concussion; mild traumatic brain injury; postural control	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; GAIT STABILITY; INTERNATIONAL-CONFERENCE; DIVIDED ATTENTION; POSTURAL CONTROL; NORMATIVE DATA; RECOVERY	Objective: To characterize the prevalence of, and relationship between, self-reported balance disturbance and performance-based balance impairment in the general population with concussion. Setting: Rehabilitation hospital outpatient concussion clinic. Participants: One hundred six individuals with concussion (49 males, mean age = 32.4; SD = 11.5 years), mean (SD) = 5 (1.8) days postinjury. Design: Cross-sectional observational study. Main Measures: SCAT3 Symptoms Subscale, Balance Error Scoring System, modified Balance Error Scoring System, and center-of-pressure root-mean-square amplitude and velocity in eyes open and closed conditions. Results: The majority of participants reported balance or dizziness symptoms (54% and 63%, respectively) and demonstrated balance impairment on the Balance Error Scoring System and modified Balance Error Scoring System (66% and 58%, respectively). The prevalence of balance impairment across center-of-pressure measures varied from 32% to 48%. There was no effect of balance or dizziness symptom severity on any of the balance measures (F-2,F-103 = 1.02; P = .44) and (F-2,F-103 = 1.45; P = .10), respectively. There was poor agreement between self-report of balance/dizziness symptoms and identified balance impairment across all balance measures (all kappa <= 0.26 and kappa <= 0.20, respectively). Conclusions: There was no clear relationship between the subjective experience of balance disturbance and objective measures of balance impairment in the general population. These results have implications for clinical evaluation of postconcussive deficits and determination of recovery.	[Inness, Elizabeth L.; Sweeny, Michelle; Perez, Olinda Habib; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Saverino, Cristina; Comper, Paul; Bayley, Mark; Mochizuki, George] Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave,Room 5-200, Toronto, ON M5G 2A2, Canada; [Inness, Elizabeth L.; Danells, Cynthia; Mochizuki, George] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON, Canada; [Sweeny, Michelle; Comper, Paul; Mochizuki, George] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Fac Med, Div Phys Med & Rehabil, Toronto, ON, Canada; [Mochizuki, George] Sunnybrook Res Inst, Toronto, ON, Canada		Inness, EL (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave,Room 5-200, Toronto, ON M5G 2A2, Canada.	liz.inness@uhn.ca		Mochizuki, George/0000-0003-2308-1643; Inness, Elizabeth L./0000-0002-9217-4619; Bayley, Mark/0000-0001-7860-9463	Toronto Rehab Foundation of the University Health Network	This research was supported by the Toronto Rehab Foundation of the University Health Network.	Altman D.G., 1990, PRACTICAL STAT MED R; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Martin RK, 2017, SPORTS HEALTH, V9, P312, DOI 10.1177/1941738117695777; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Willer BS, 2016, ACAD EMERG MED, V23, P495, DOI 10.1111/acem.12940; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543	43	6	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E37	E46		10.1097/HTR.0000000000000431			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100005	30169435				2022-02-06	
J	Kersey, J; Juengst, SB; Skidmore, E				Kersey, Jessica; Juengst, Shannon B.; Skidmore, Elizabeth			Effect of Strategy Training on Self-Awareness of Deficits After Stroke	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; PARTICIPATION; IMPAIRMENTS	Importance: Self-awareness of deficits, or the ability to understand the effects of impairments on daily life, is often diminished after a stroke. Diminished self-awareness influences participation in rehabilitation and functional outcomes. Objective: To examine whether self-awareness of deficits changed over time after a stroke (N = 43) and whether metacognitive strategy training (n = 21) resulted in improved self-awareness compared with direct skill training (n = 22). Design: Secondary analysis of data collected from a randomized controlled trial. Setting: Inpatient stroke rehabilitation. Participants: Adults with cognitive impairments after an acute stroke. Intervention: Metacognitive strategy training is an approach in which clients are guided through a process of selfassessment and develop solutions for barriers to task performance. This approach was compared with direct skill training, in which the therapist provides specific instructions for task completion, removing the client-initiated assessment and problem-solving components. Outcomes and Measures: Self-awareness measures included the Self-Regulation Skills Interview and SelfAwareness of Deficits Interview at baseline and 3 mo and 6 mo after the intervention. We used a one-way analysis of variance (ANOVA) to analyze change in self-awareness and a two-way ANOVA to examine differences between groups over time. Results: There was a statistically significant and potentially meaningful difference over time in the self-awareness domain of strategy behavior, F(2) = 3.35, p =.039, but there were no differences in improvements between the metacognitive strategy and direct skill training groups. Conclusions and Relevance: Self-awareness warrants further investigation to determine whether it improves naturally over time or through both interventions after stroke. What This Article Adds: Self-awareness of deficits, and the use of strategies in particular, may improve in the early stages of stroke recovery, but the optimal approach for intervention remains unclear.	[Kersey, Jessica; Skidmore, Elizabeth] Univ Pittsburgh, Sch Hlth & Rehabil Serv, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA		Kersey, J (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Serv, Dept Occupat Therapy, Pittsburgh, PA 15260 USA.	jmk286@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD073770, UL1 TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Grants R03 HD073770 and UL1 TR000005). This study is registered at ClinicalTrials.gov (NCT02766400).	Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Engel L, 2019, NEUROPSYCHOL REHABIL, V29, P163, DOI 10.1080/09602011.2017.1292923; Fleming JM, 1996, BRAIN INJURY, V10, P1; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Richardson C, 2014, BRAIN INJURY, V28, P1711, DOI 10.3109/02699052.2014.954270; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Skidmore ER, 2017, ARCH PHYS MED REHAB, V98, P673, DOI 10.1016/j.apmr.2016.10.004; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858	17	6	6	1	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2019	73	3							7303345020	10.5014/ajot.2019.031450			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HY5HJ	WOS:000468158500014	31120846	Green Published			2022-02-06	
J	Lu, LY; Li, FF; Ma, YH; Chen, HY; Wang, P; Peng, MY; Chen, YC; Yin, XD				Lu, Liyan; Li, Fengfang; Ma, Yuehu; Chen, Huiyou; Wang, Peng; Peng, Mingyang; Chen, Yu-Chen; Yin, Xindao			Functional connectivity disruption of the substantia nigra associated with cognitive impairment in acute mild traumatic brain injury	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Mild traumatic brain injury; Substantia nigra; Functional connectivity; Cognitive impairment; fMRI	CONCUSSION; SINGLE	Purpose: Mild traumatic brain injury is known to have frequent cognitive impairment. Accumulating evidence is pointing to the malfunctioning of the substantia nigra (SN) as an important factor for head trauma. However, it remains unknown whether changes in the SN-based resting state functional connectivity following mTBI at acute stage and its relationship with cognitive function. Materials and methods: 58 patients with mTBI and 30 age-, gender-, and years of education-matched healthy controls were enrolled in the current study. All of participants received resting state functional magnetic resonance imaging as well as neuropsychological assessment. The resting state functional MR imaging data were analyzed by using a standard seed-based whole-brain correlation method to characterize SN resting state networks. Student t tests were used to perform comparisons. The association between SN resting state networks and performance on neuropsychological measures was also investigated in patients with mTBI by using Pearson rank correlation. Results: Patients with mTBI at acute stage exhibited reduced left SN-based functional connectivity with right insula and caudate and increased left SN-based functional connectivity with left precuneus and left middle occipital gyrus, and reduced right SN-based functional connectivity with left insula. Increased functional connectivity of left precuneus was negatively associated with neurocognitive functions as well (r = -0.266; P = 0.049). Conclusion: The present study indicated that patients with acute mTBI suffer from disruption in their SN resting state networks. Moreover, abnormal functional connectivity significantly correlated with cognitive function. Taking together, these results may better improve our understanding of the neuropathological mechanism underlying the neurocognitive symptoms associated with acute mTBI.	[Lu, Liyan; Li, Fengfang; Ma, Yuehu; Chen, Huiyou; Wang, Peng; Peng, Mingyang; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Dept Radiol, Nanjing Hosp 1, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Dept Radiol, Nanjing Hosp 1, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	chenyuchen1989@126.com; y.163yy@163.com		Chen, Yu-Chen/0000-0002-8539-7224	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870563]; Nanjing Medical University [2017NJMU123]	This study was supported by the National Natural Science Foundation of China (No, 81870563) and Nanjing Medical University grant (No, 2017NJMU123). LL and FL designed the experiment, collected the data, performed the analysis, and wrote the paper. YM, HC, PW, and MP helped collect the data and perform the analysis. XY and Y-C C contributed to the discussion and manuscript revision.	Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Ekman U, 2012, LANCET NEUROL, V11, P679, DOI 10.1016/S1474-4422(12)70138-2; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Lai JH, 2019, J NEUROTRAUM, V36, P1054, DOI 10.1089/neu.2018.5949; Livny A, 2017, J NEUROTRAUM, V34, P1466, DOI 10.1089/neu.2016.4598; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rosenthal S, 2018, NEUROIMAG CLIN N AM, V28, P107, DOI 10.1016/j.nic.2017.09.008; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Xu H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00467; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhang HY, 2015, NEUROSCI LETT, V606, P36, DOI 10.1016/j.neulet.2015.08.029; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	29	6	7	2	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAY	2019	114						69	75		10.1016/j.ejrad.2019.03.002			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HU0TI	WOS:000464983700011	31005180				2022-02-06	
J	Merck, LH; Yeatts, SD; Silbergleit, R; Manley, GT; Pauls, Q; Palesch, Y; Conwit, R; Le Roux, P; Miller, J; Frankel, M; Wright, DW				Merck, Lisa H.; Yeatts, Sharon D.; Silbergleit, Robert; Manley, Geoffrey T.; Pauls, Qi; Palesch, Yuko; Conwit, Robin; Le Roux, Peter; Miller, Joseph; Frankel, Michael; Wright, David W.			The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial	CRITICAL CARE MEDICINE			English	Article							BLOOD-PRESSURE; HEAD-INJURY; HYPOTENSION; OUTCOMES; MANAGEMENT	Objectives: To estimate the impact of goal-directed therapy on outcome after traumatic brain injury, our team applied goal-directed therapy to standardize care in patients with moderate to severe traumatic brain injury, who were enrolled in a large multicenter clinical trial. Design: Planned secondary analysis of data from Progesterone for the Treatment of Traumatic Brain Injury III, a large, prospective, multicenter clinical trial. Setting: Forty-two trauma centers within the Neurologic Emergencies Treatment Trials network. Patients: Eight-hundred eighty-two patients were enrolled within 4 hours of injury after nonpenetrating traumatic brain injury characterized by Glasgow Coma Scale score of 4-12. Measurements and Main Results: Physiologic goals were defined a priori in order to standardize care across 42 sites participating in Progesterone for the Treatment of Traumatic Brain Injury III. Physiologic data collection occurred hourly; laboratory data were collected according to local ICU protocols and at a minimum of once per day. Physiologic transgressions were predefined as substantial deviations from the normal range of goal-directed therapy. Each hour where goal-directed therapy was not achieved was classified as a " transgression." Data were adjudicated electronically and via expert review. Six-month outcomes included mortality and the stratified dichotomy of the Glasgow Outcome ScaleExtended. For each variable, the association between outcome and either: 1) the occurrence of a transgression or 2) the proportion of time spent in transgression was estimated via logistic regression model. Results: For the 882 patients enrolled in Progesterone for the Treatment of Traumatic Brain Injury III, mortality was 12.5%. Prolonged time spent in transgression was associated with increased mortality in the full cohort for hemoglobin less than 8 gm/dL (p =0.0006), international normalized ratio greater than 1.4 (p < 0.0001), glucose greater than 180 mg/dL (p =0.0003), and systolic blood pressure less than 90 mm Hg (p < 0.0001). In the patient subgroup with intracranial pressure monitoring, prolonged time spent in transgression was associated with increased mor-tality for intracranial pressure greater than or equal to 20 mm Hg (p < 0.0001), glucose greater than 180 mg/dL (p = 0.0293), hemoglobin less than 8 gm/dL (p = 0.0220), or systolic blood pressure less than 90 mm Hg (p = 0.0114). Covariates inversely related to mortality included: a single occurrence of mean arterial pressure less than 65 mm Hg (p = 0.0051) or systolic blood pressure greater than 180 mm Hg (p = 0.0002). Conclusions: The Progesterone for the Treatment of Traumatic Brain Injury III clinical trial rigorously monitored compliance with goal-directed therapy after traumatic brain injury. Multiple significant associations between physiologic transgressions, morbidity, and mortality were observed. These data suggest that effective goal-directed therapy in traumatic brain injury may provide an opportunity to improve patient outcomes.	[Merck, Lisa H.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Merck, Lisa H.] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Merck, Lisa H.] Brown Univ, Warren Alpert Med Sch, Dept Diagnost Imaging, Providence, RI 02912 USA; [Yeatts, Sharon D.; Pauls, Qi; Palesch, Yuko] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Conwit, Robin] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Le Roux, Peter] Main Line Hlth, Dept Neurosurg, Philadelphia, PA USA; [Miller, Joseph] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI USA; [Frankel, Michael] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA		Merck, LH (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA.; Merck, LH (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA.; Merck, LH (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Diagnost Imaging, Providence, RI 02912 USA.	lisa_merck@brown.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032] Funding Source: NIH RePORTER	Work by the authors on the Progesterone for the Treatment of Traumatic Brain Injury III clinical trial was supported, in part, by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and was conducted through the Neurological Emergencies Treatment Trials network.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bershad EM, 2008, COAGULOPATHY INHOSPI, DOI [10.3171/JNS/2008/109/10/0664, DOI 10.3171/JNS/2008/109/10/0664]; Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cnossen MC, 2016, J NEUROTRAUM; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cryer HG, ACS TQIP BEST PRACTI; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Edwards P, 2005, LANCET, V365, P1957; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ngwenya LB, 2018, J NEUROSURG, V128, P1530, DOI 10.3171/2017.1.JNS162234; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Rossi AF, 2005, INTENS CARE MED, V31, P98, DOI 10.1007/s00134-004-2504-1; Rowan KM, 2017, NEW ENGL J MED, V376, P2223, DOI 10.1056/NEJMoa1701380; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wilms H, 2014, J CRIT CARE, V29, P204, DOI 10.1016/j.jcrc.2013.10.019; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	37	6	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2019	47	5					623	631		10.1097/CCM.0000000000003680			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IA2JQ	WOS:000469387900017	30730438	Green Accepted			2022-02-06	
J	Narad, ME; Raj, S; Yeates, KO; Taylor, HG; Kirkwood, MW; Stancin, T; Wade, SL				Narad, Megan E.; Raj, Stacey; Yeates, Keith O.; Taylor, H. Gerry; Kirkwood, Michael W.; Stancin, Terry; Wade, Shari L.			Randomized Controlled Trial of an Online Problem-Solving Intervention Following Adolescent Traumatic Brain Injury: Family Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent; Brain injuries, traumatic; Family; Problem solving; Rehabilitation; Single-parent family	BEHAVIORAL OUTCOMES; INITIAL YEAR; PARENT; CHILD; TEEN; THERAPY; ADAPTATION; DEPRESSION; DISORDERS; EFFICACY	Objective: To examine parent and family outcomes of a randomized controlled trial (RCT) comparing Teen Online Problem-Solving with Family (TOPS-F), Teen Online Problem-Solving-Teen Only (TOPS-TO), or access to Internet resources alone (Internet resource comparison [IRC]). Design: Three-arm RCT. Setting: Four children's hospitals and 1 general medical center in Ohio and Colorado. Participants: Children and adolescents (N=152), 11-18 years old, hospitalized for complicated mild to severe traumatic brain injury in the previous 18 months. Interventions: Intervention groups: TOPS-F, TOPS-TO, and IRC. Main Outcome Measure: Parental depression (CES-D), parental psychological distress (SCL-90-GSI), family functioning (FAD-GF), cohesiveness (PARQ), and conflict (IBQ) were assessed pre- and post-treatment. Treatment effects and the moderating effect of the number of parents in the home (single vs 2-parent families). Results: Number of parents moderated treatment effects with effects ranging from trending to statistically significant for depression, family functioning, cohesion, and conflict. Among single parents, TOPS-TO reported better family functioning than TOPS-F and greater cohesion and less conflict than IRC. Among 2-parent families, TOPS-F reported less depression than IRC and less depression and greater cohesion than TOPS-TO. The effect of family composition was also noted within TOPS-TO and TOPS-F. In TOPS-F, 2-parent families reported less depression than single-parent families. In TOPS-TO single parents reported greater cohesion and better family functioning than 2-parent families. Conclusions: Findings support the TOPS intervention improves family outcomes, with differential effects noted for single vs 2-parent households. The TOPS-TO format appeared more beneficial for single-parent households, while TOPS-F was more beneficial for 2-parent households, highlighting the importance of considering family composition when determining the best treatment modality. (C) 2019 by the American Congress of Rehabilitation Medicine	[Narad, Megan E.; Raj, Stacey; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst,Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Biobehav Hlth Ctr, Nationwide Childrens Hosp Res Inst, Columbus, OH 43210 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Stancin, Terry] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave MLC 4009, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]; NIH grant from the National Institute on Child Health and Human Development [IF32HD088011]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant no. H133B090010). Megan Narad was supported by NIH grant no. IF32HD088011 from the National Institute on Child Health and Human Development. This material does not necessarily represent the policy of these agencies, nor is the material necessarily endorsed by the federal government.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Bagner DM, 2003, J CLIN CHILD ADOLESC, V32, P599, DOI 10.1207/S15374424JCCP3204_13; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Cunningham CE, 2000, J CONSULT CLIN PSYCH, V68, P928, DOI 10.1037/0022-006X.68.5.928; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Kazdin AE, 1997, J CONSULT CLIN PSYCH, V65, P453, DOI 10.1037/0022-006X.65.3.453; KAZDIN AE, 1994, J CONSULT CLIN PSYCH, V62, P1069, DOI 10.1037/0022-006X.62.5.1069; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; NEZU AM, 1986, J CONSULT CLIN PSYCH, V54, P196, DOI 10.1037/0022-006X.54.2.196; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Nezu AM, 2006, PROBLEM SOLVING THER; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, P158, DOI 10.1097/HTR.0000000000000331; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Robin AL, 2009, PARENT ADOLESCENT RE; Robin AL, 1989, NEGOTIATING PARENT A; Ronzio CR, 2006, AM J ORTHOPSYCHIAT, V76, P37, DOI 10.1037/0002-9432.76.1.37; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WEINRAUB M, 1983, CHILD DEV, V54, P1297, DOI 10.2307/1129683; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; 1990, BEHAV THER, V21, P319; 2014, DEV MED CHILD NEUROL, V56, P19, DOI DOI 10.1111/DMCN.12237	42	6	6	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2019	100	5					811	820		10.1016/j.apmr.2019.01.010			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HW3UV	WOS:000466619100002	30738021				2022-02-06	
J	Orlando, A; Levy, AS; Rubin, BA; Tanner, A; Carrick, MM; Lieser, M; Hamilton, D; Mains, CW; Bar-Or, D				Orlando, Alessandro; Levy, A. Stewart; Rubin, Benjamin A.; Tanner, Allen; Carrick, Matthew M.; Lieser, Mark; Hamilton, David; Mains, Charles W.; Bar-Or, David			Isolated subdural hematomas in mild traumatic brain injury. Part 2: a preliminary clinical decision support tool for neurosurgical intervention	JOURNAL OF NEUROSURGERY			English	Article						mild; traumatic brain injury; neurosurgical intervention; subdural hematoma; predictive modeling	CT HEAD RULE; NEW-ORLEANS CRITERIA; INTRACRANIAL LESIONS; EXTERNAL VALIDATION; COMPUTED-TOMOGRAPHY; TELERADIOLOGY; PREDICTION; MANAGEMENT; MODELS	OBJECTIVE A paucity of studies have examined neurosurgical interventions in the mild traumatic brain injury (mTBI) population with intracranial hemorrhage (ICH). Furthermore, it is not understood how the dimensions of an ICH relate to the risk of a neurosurgical intervention. These limitations contribute to a lack of treatment guidelines. Isolated subdural hematomas (iSDHs) are the most prevalent ICH in mTBI, carry the highest neurosurgical intervention rate, and account for an overwhelming majority of all neurosurgical interventions. Decision criteria in this population could benefit from understanding the risk of requiring neurosurgical intervention. The aim of this study was to quantify the risk of neurosurgical intervention based on the dimensions of an iSDH in the setting of mTBI. METHODS This was a 3.5-year, retrospective observational cohort study at a Level I trauma center. All adult (>= 18 years) trauma patients with mTBI and iSDH were included in the study. Maximum length and thickness (in mm) of acute SDHs, the presence of acute-on-chronic (AOC) SDH, mass effect, and other hemorrhage-related variables were double-data entered; discrepant results were adjudicated after a maximum of 4 reviews. Patients with coagulopathy, skull fractures, no acute hemorrhage, a non-SDH ICH, or who did not undergo imaging on admission were excluded. Tentorial SDHs were not measured. The primary outcome was neurosurgical intervention (craniotomy, burr holes, intracranial pressure monitor placement, shunt, ventriculostomy, or SDH evacuation). Multivariate stepwise logistic regression was used to identify significant covariates, to assess interactions, and to create the scoring system. RESULTS There were a total of 176 patients included in our study: 28 patients did and 148 did not receive a neurosurgical intervention. There were no significant differences between neurosurgical intervention groups in 11 demographic and 22 comorbid variables. Patients with neurosurgical intervention had significantly longer and thicker SDHs than nonsurgical controls. Logistic regression identified thickness and AOC hemorrhage as being the most important variables in predicting neurosurgical intervention; SDH length was not. Risk of neurosurgical intervention was calculated based on the SDH thickness and presence of an AOC hemorrhage from a multivariable logistic regression model (area under the receiver operating characteristic curve 0.94, 95% CI 0.90-0.97; p < 0.001). With a decision point of 2.35% risk, we predicted neurosurgical intervention with 100% sensitivity, 100% negative predictive value, and 53% specificity. CONCLUSIONS This is the first study to quantify the risk of neurosurgical intervention based on hemorrhage characteristics in patients with mTBI and iSDH. Once validated in a second population, these data can be used to inform the necessity of interhospital transfers and neurosurgical consultations.	[Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA; [Rubin, Benjamin A.] Swedish Med Ctr, Dept Neurosurg, Englewood, CO 80110 USA; [Levy, A. Stewart] St Anthony Hosp, Dept Neurosurg, Lakewood, CO USA; [Orlando, Alessandro; Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Orlando, Alessandro; Carrick, Matthew M.; Bar-Or, David] Med City Plano, Trauma Res Dept, Plano, TX USA; [Orlando, Alessandro; Tanner, Allen; Hamilton, David; Bar-Or, David] Penrose Community Hosp, Trauma Res Dept, Colorado Springs, CO USA; [Lieser, Mark] Res Med Ctr, Trauma Serv Dept, Kansas City, MO USA; [Bar-Or, David] Rocky Vista Univ Coll Osteopath Med, Parker, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Englewood, CO 80110 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Faul M, 2010, TRAUMATIC BRAIN INJU; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Kreutzer J, 2008, J TELEMED TELECARE, V14, P67, DOI 10.1258/jtt.2007.060605; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Orlando A, 2019, J NEUROSURG, V130, P1616, DOI 10.3171/2018.1.JNS171884; Orlando A, 2017, WORLD NEUROSURG, V107, P94, DOI [10.1016/j.wneu.2017.07.130, 10.1016/J.WNEU.2017.07.130]; Overton TL, 2014, AM J SURG, V208, P806, DOI 10.1016/j.amjsurg.2014.02.012; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Weinberg AM, 2010, EUR J TRAUMA EMERG S, V36, P318, DOI 10.1007/s00068-010-1120-8; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011; 2006, J CLIN EPIDEMIOL, V59, P132, DOI DOI 10.1016/J.JCLINEPI.2005.06.009; 2014, J TRAUMA ACUTE CARE, V76, P965, DOI DOI 10.1097/TA.0000000000000161; 2002, EUR J NEUROL, V9, P207	38	6	6	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1626	1633		10.3171/2018.1.JNS171906			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100026	29905511	Bronze			2022-02-06	
J	Pons, E; Foks, KA; Dippel, DWJ; Hunink, MGM				Pons, Ewoud; Foks, Kelly A.; Dippel, Diederik W. J.; Hunink, M. G. Myriam			Impact of guidelines for the management of minor head injury on the utilization and diagnostic yield of CT over two decades, using natural language processing in a large dataset	EUROPEAN RADIOLOGY			English	Article						Craniocerebral trauma; Natural language processing; Data mining; Validation studies; Quality assurance; health care	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; COST-EFFECTIVENESS; MILD; STRATEGIES; RULE; RADIOLOGY; SUPPORT	ObjectivesWe investigated the impact of clinical guidelines for the management of minor head injury on utilization and diagnostic yield of head CT over two decades.MethodsRetrospective before-after study using multiple electronic health record data sources. Natural language processing algorithms were developed to rapidly extract indication, Glasgow Coma Scale, and CT outcome from clinical records, creating two datasets: one based on all head injury CTs from 1997 to 2009 (n=9109), for which diagnostic yield of intracranial traumatic findings was calculated. The second dataset (2009-2014) used both CT reports and clinical notes from the emergency department, enabling selection of minor head injury patients (n=4554) and calculation of both CT utilization and diagnostic yield. Additionally, we tested for significant changes in utilization and yield after guideline implementation in 2011, using chi-square statistics and logistic regression.ResultsThe yield was initially nearly 60%, but in a decreasing trend dropped below 20% when CT became routinely used for head trauma. Between 2009 and 2014, of 4554 minor head injury patients overall, 85.4% underwent head CT. After guideline implementation in 2011, CT utilization significantly increased from 81.6 to 87.6% (p=7x10(-7)), while yield significantly decreased from 12.2 to 9.6% (p=0.029).ConclusionsThe number of CTs performed for head trauma gradually increased over two decades, while the yield decreased. In 2011, despite implementation of a guideline aiming to improve selective use of CT in minor head injury, utilization significantly increased.	[Pons, Ewoud; Hunink, M. G. Myriam] Erasmus Univ, Med Ctr Rotterdam, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Pons, Ewoud] Erasmus Univ, Med Ctr Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [Foks, Kelly A.] Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus Univ, Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Erasmus Univ, Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA		Foks, KA (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Foks, KA (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515	Open Technology Programme of Technology Foundation STW	This study was supported by the Open Technology Programme of Technology Foundation STW.	af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Bellolio MF, 2017, WEST J EMERG MED, V18, P835, DOI 10.5811/westjem.2017.5.34152; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brinjikji W, 2015, AM J ROENTGENOL, V204, P558, DOI 10.2214/AJR.14.13107; Dreyer KJ, 2005, RADIOLOGY, V234, P323, DOI 10.1148/radiol.2341040049; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydon NB, 2013, J MED IMAG RADIAT ON, V57, P161, DOI 10.1111/1754-9485.12007; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Kreimeyer K, 2017, J BIOMED INFORM, V73, P14, DOI 10.1016/j.jbi.2017.07.012; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Van den Brand CL, 2017, EUR J EMERG MED; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	30	6	6	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	MAY	2019	29	5					2632	2640		10.1007/s00330-018-5954-5			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HR4ZV	WOS:000463157200052	30643942	hybrid, Green Published			2022-02-06	
J	Rubiano, AM; Maldonado, M; Montenegro, J; Restrepo, CM; Khan, AA; Monteiro, R; Faleiro, RM; Carreno, JN; Amorim, R; Paiva, W; Munoz, E; Paranhos, J; Soto, A; Armonda, R; Rosenfeld, JV				Rubiano, Andres M.; Maldonado, Miguel; Montenegro, Jorge; Restrepo, Claudia M.; Khan, Ahsan Ali; Monteiro, Ruy; Faleiro, Rodrigo M.; Carreno, Jose N.; Amorim, Robson; Paiva, Wellingson; Munoz, Erick; Paranhos, Jorge; Soto, Alvaro; Armonda, Rocco; Rosenfeld, Jeffrey V.			The Evolving Concept of Damage Control in Neurotrauma: Application of Military Protocols in Civilian Settings with Limited Resources	WORLD NEUROSURGERY			English	Article						Damage control; Global surgery; Low resources; Military neurotrauma; Neurotrauma; Severe TBI	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT; MORTALITY; OUTCOMES; SURGERY; ETHICS	OBJECTIVE: The aim of the present review was to describe the evolution of the damage control concept in neurotrauma, including the surgical technique and medical postoperative care, from the lessons learned from civilian and military neurosurgeons who have applied the concept regularly in practice at military hospitals and civilian institutions in areas with limited resources. METHODS: The present narrative review was based on the experience of a group of neurosurgeons who participated in the development of the concept from their practice working in military theaters and low-resources settings with an important burden of blunt and penetrating cranial neurotrauma. RESULTS: Damage control surgery in neurotrauma has been described as a sequential therapeutic strategy that supports physiological restoration before anatomical repair in patients with critical injuries. The application of the concept has evolved since the early definitions in 1998. Current strategies have been supported by military neurosurgery experience, and the concept has been applied in civilian settings with limited resources. CONCLUSION: Damage control in neurotrauma is a therapeutic option for severe traumatic brain injury management in austere environments. To apply the concept while using an appropriate approach, lessons must be learned from experienced neurosurgeons who use this technique regularly.	[Rubiano, Andres M.] El Bosque Univ, Inst Neurosci & Neurosurg, Bogota, Colombia; [Rubiano, Andres M.; Montenegro, Jorge; Restrepo, Claudia M.; Khan, Ahsan Ali] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Rubiano, Andres M.] MEDITECH Fdn, INUB MEDITECH Res Grp, Cali, Colombia; [Rubiano, Andres M.] MEDITECH Fdn, Cali Valle, Colombia; [Maldonado, Miguel] Nueva Granada Mil Univ, Sch Med, Cent Mil Hosp, Bogota, Colombia; [Montenegro, Jorge; Restrepo, Claudia M.; Khan, Ahsan Ali] MEDITECH Fdn, Dept Res, INUB MEDITECH Res Grp, Cali, Colombia; [Montenegro, Jorge] Puerto Asis Hosp, Puerto Asis, Colombia; [Restrepo, Claudia M.] Nueva Granada Mil Univ, Cent Mil Hosp, Bogota, Colombia; [Khan, Ahsan Ali] Univ Cambridge, Dept Neurosurg Neurotrauma & Global Sury, MEDITECH Fdn, Barrow Neurol Inst, Cambridge, England; [Monteiro, Ruy] Hosp Municipal Miguel Couto, Neurol Surg Serv, Rio De Janeiro, Brazil; [Faleiro, Rodrigo M.] Hosp Sao Joao XXIII, Dept Neurosurg, Belo Horizonte, MG, Brazil; [Carreno, Jose N.] Santa Fe Fdn Univ Hosp, Neurointens Care Unit, Bogota, Colombia; [Carreno, Jose N.] Nueva Granada Mil Univ, Cent Mil Hosp, Bogota, Colombia; [Amorim, Robson] Univ Sao Paulo, Emergency Neurosurg Serv, Hosp Clin, Sch Med, Manaus, Amazonas, Brazil; [Paiva, Wellingson] Univ Sao Paulo, Neurosurg Intens Care Unit, Dept Neurol, Sao Paulo, Brazil; [Munoz, Erick] Nueva Granada Mil Univ, Neurol Surg Serv, Cent Mil Hosp, Bogota, Colombia; [Paranhos, Jorge] Santa Casa de Misericordia Hosp, Intens Care Unite, Sao Joao Del Rei, MG, Brazil; [Paranhos, Jorge] Santa Casa de Misericordia Hosp, Neuroemergency Serv, Sao Joao Del Rei, MG, Brazil; [Soto, Alvaro] San Antonio Hosp, Neurosurg Serv, Pitalito, Huila, Colombia; [Armonda, Rocco] Med Star Georgetown Univ Hosp, Dept Neuroendovasc Surg, Med Star Washington Hosp Ctr, Washington, DC USA; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, Dept Surg, F Edward Hebert Sch Med, Bethesda, MD USA		Rubiano, AM (corresponding author), El Bosque Univ, Inst Neurosci & Neurosurg, Bogota, Colombia.; Rubiano, AM (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.; Rubiano, AM (corresponding author), MEDITECH Fdn, INUB MEDITECH Res Grp, Cali, Colombia.; Rubiano, AM (corresponding author), MEDITECH Fdn, Cali Valle, Colombia.	andresrubiano@aol.com	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021; RUBIANO, ANDRES M/K-6704-2012	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; RUBIANO, ANDRES M/0000-0001-8931-3254; Maldonado Moran, Miguel Angel/0000-0001-8315-4109	National Institute for Health Research (NIHR) Global Health Research Group on NeurotraumaNational Institute for Health Research (NIHR); NIHRNational Institute for Health Research (NIHR) [16/137/105]	Dr. Rubiano and Dr. Khan are supported by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma. The Group was commissioned by the NIHR using Official Development Assistance funding (project 16/137/105). The views expressed in this manuscript are those of the authors and are not necessarily those of the UK National Health Service, NIHR, or the UK Department of Health.	Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P3; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Charry JD, 2016, J NEUROSCI RURAL PRA, V7, P7, DOI 10.4103/0976-3147.172151; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dulou R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1016; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Fuller G, 2014, PREHOSP EMERG CARE, V18, P60, DOI 10.3109/10903127.2013.831507; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; GILLON R, 1994, BRIT MED J, V309, P184, DOI 10.1136/bmj.309.6948.184; Godat L, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-53; Griswold D, 2016, WORLD NEUROSURG, V93, P474, DOI 10.1016/j.wneu.2016.06.044; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Holcomb JB, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002339; Honeybul S, 2012, MED J AUSTRALIA, V196, P531, DOI 10.5694/mja11.11485; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kotwal RS, 2018, MIL MED, V183, P134, DOI 10.1093/milmed/usx211; Lamb CM, 2014, BRIT J ANAESTH, V113, P242, DOI 10.1093/bja/aeu233; Larsen Morten Schultz, 2011, Ugeskr Laeger, V173, P1273; Limpastan Kriengsak, 2013, Journal of the Medical Association of Thailand, V96, P678; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MacGoey P, 2016, TRAUMA, V18, P165, DOI 10.1177/1460408616629507; Maciunas Robert J, 2006, Clin Neurosurg, V53, P267; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Marshall SA, 2015, ENCY TRAUMA CARE; Moore JM, 2016, CLIN NEUROL NEUROSUR, V148, P13, DOI 10.1016/j.clineuro.2016.06.012; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; Ojo O A, 2015, Niger Postgrad Med J, V22, P45; Pitts LH, 1998, J TRAUMA, V44, P989; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rosenfeld JV, 2015, ANZ J SURG, V85, P600, DOI 10.1111/ans.13207; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Rotondo MF, 1997, SURG CLIN N AM, V77, P761, DOI 10.1016/S0039-6109(05)70582-X; Rubiano AM, 2004, NEUROLOGICAL SURG PR, P1; Rubiano AM, 2007, NEUROTRAUMA NEURO IN, P211; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Shackelford SA, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18404; Shchedrenok V V, 2013, Vestn Khir Im I I Grek, V172, P11; Shenai MB, 2014, J NEUROSURG, V121, P277, DOI 10.3171/2014.4.JNS131805; Sinha Virendra Deo, 2012, Asian J Neurosurg, V7, P75, DOI 10.4103/1793-5482.98648; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Teff RJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1017; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954; World Federation of Neurosurgical Societies, BOG DECL; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Ziaeirad M, 2018, IRAN J NURS MIDWIFE, V23, P211, DOI 10.4103/ijnmr.IJNMR_65_17; 1998, J TRAUMA, V44, P984; 2017, CURR OPIN CRIT CARE, V23, P498, DOI DOI 10.1097/MCC.0000000000000455; 2018, ANAESTH CRIT CARE PA, V37, P171, DOI DOI 10.1016/J.ACCPM.2017.12.001	60	6	7	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E82	E93		10.1016/j.wneu.2019.01.005			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700013	30659971				2022-02-06	
J	Van Pelt, KL; Lapointe, AP; Galdys, MC; Dougherty, LA; Buckley, TA; Broglio, SP				Van Pelt, Kathryn L.; Lapointe, Andrew P.; Galdys, Michelle C.; Dougherty, Lauren A.; Buckley, Thomas A.; Broglio, Steven P.			Evaluating Performance of National Hockey League Players After a Concussion Versus Lower Body Injury	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; orthopaedic injuries; recovery; outcomes; professional athletes	COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RECOVERY; DEFICITS; TIME	Context: Concussions elicit changes in brain function that may extend well beyond clinical symptom recovery. Whether these changes produce meaningful deficits outside the laboratory environment is unclear. The results of player performance postconcussion within professional sports have been mixed. Objective: To determine whether National Hockey League (NHL) players with concussions performed worse after returning to sport than players with lower body injuries or uninjured players. Design: Cohort study. Setting: Publicly available Web sites that compiled injury and player statistics of NHL players. Patients or Other Participants: Male NHL players who missed games due to a concussion (n =22), lower body injury (n = 21), or noninjury (ie, personal reason or season break; n = 13) during the 2013-2014 and 2014-2015 regular seasons. Data on concussed athletes were used to identify similar players with lower body injury and noninjury based on (1) position, (2) time loss, (3) time on the ice, and (4) team. Main Outcome Measure(s): The primary performance metric was a modified plus-minus statistic calculated by weighting the players' plus-minus metric by their team's simple rating system to account for varying team performances. Linear mixed models assessed the relationship between injury type (concussion, lower body, or noninjury) and performance (plusminus score). Results: We observed a quadratic effect for a time x group interaction (chi(2)(2) = 8.85, P= .01). This interaction revealed that the concussion and lower body injury groups had similar patterns of an initial decrease (ie, 2 weeks after return to play), followed by an increase in performance compared with the uninjured group in weeks 5 and 6. Meanwhile, the uninjured group had an initial increase in performance. We observed no group x linear time interaction (P= .47) or overall group effect (P= .57). Conclusions: The NHL players in the concussion and lower body injury groups displayed similar performance impairments. Both injured cohorts experienced an initial decrease in performance at weeks 1 to 2 after return to play, followed by improved performance at weeks 5 to 6 after return to play, suggesting that the performance implications of concussion may be short lived.	[Van Pelt, Kathryn L.; Lapointe, Andrew P.; Galdys, Michelle C.; Dougherty, Lauren A.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA		Van Pelt, KL (corresponding author), Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	kloconn@umich.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Van Pelt, Kathryn/0000-0002-5494-2357			[Anonymous], EST PROB COMP COLL A; [Anonymous], 2008, NONF OCC INJ ILLN RE, P4; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hackel S, NY TIMES; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130	31	6	6	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2019	54	5					534	540		10.4085/1062-6050-218-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ID7OX	WOS:000471873300010	31084502	gold, Green Published			2022-02-06	
J	Vassallo, J; Webster, M; Barnard, EBG; Lyttle, MD; Smith, JE				Vassallo, James; Webster, Melanie; Barnard, Edward B. G.; Lyttle, Mark D.; Smith, Jason E.		PERUKI Paediat Emergency Res UK	Epidemiology and aetiology of paediatric traumatic cardiac arrest in England and Wales	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							RESUSCITATION COUNCIL GUIDELINES; MELBOURNE	Objective To describe the epidemiology and aetiology of paediatric traumatic cardiac arrest (TCA) in England and Wales. Design Population-based analysis of the UK Trauma Audit and Research Network (TARN) database. Patients and setting All paediatric and adolescent patients with TCA recorded on the TARN database for a 10-year period (2006-2015). Measures Patient demographics, Injury Severity Score (ISS), location of TCA ('prehospital only', ' in-hospital only' or ' both'), interventions performed and outcome. Results 21 710 paediatric patients were included in the database; 129 (0.6%) sustained TCA meeting study inclusion criteria. The majority, 103 (79.8%), had a prehospital TCA. 62.8% were male, with a median age of 11.7 (3.4-16.6) years, and a median ISS of 34 (25-45). 110 (85.3%) had blunt injuries, with roadtraffic collision the most common mechanism (n= 73, 56.6%). 123 (95.3%) had severe haemorrhage and/ or traumatic brain injury. Overall 30-day survival was 5.4% ((95% CI 2.6 to 10.8), n= 7). ' Pre-hospital only' TCA was associated with significantly higher survival (n= 6) than those with TCA in both ' pre-hospital and in-hospital' (n= 1)-13.0% (95% CI 6.1% to 25.7%) and 1.2% (95% CI 0.1% to 6.4%), respectively, p< 0.05. The greatest survival (n= 6, 10.3% (95% CI 4.8% to 20.8%)) was observed in those transported to a paediatric major trauma centre (MTC) (defined as either a paediatric-only MTC or combined adult-paediatric MTC). Conclusions Survival is possible from the resuscitation of children in TCA, with overall survival comparable to that reported in adults. The highest survival was observed in those with a pre-hospital only TCA, and those who were transported to an MTC. Early identification and aggressive management of paediatric TCA is advocated.	[Vassallo, James] Univ Cape Town, Div Emergency Med, Cape Town, South Africa; [Vassallo, James] Inst Naval Med, Gosport PO12 2DL, Hants, England; [Vassallo, James; Barnard, Edward B. G.; Smith, Jason E.] Royal Ctr Def Med Res & Academia, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England; [Webster, Melanie; Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Fac Hlth & Appl Sci, Bristol, Avon, England		Vassallo, J (corresponding author), Inst Naval Med, Gosport PO12 2DL, Hants, England.	vassallo@doctors.org.uk	Smith, Jason Edward/H-9380-2013	Smith, Jason Edward/0000-0002-6143-0421; Lyttle, Mark/0000-0002-8634-7210			Barnard E, 2017, RESUSCITATION, V110, P90, DOI 10.1016/j.resuscitation.2016.11.001; Barnard EBG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002349; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Crewdson K, 2007, RESUSCITATION, V75, P29, DOI 10.1016/j.resuscitation.2007.02.018; Deasy C, 2012, RESUSCITATION, V83, P471, DOI 10.1016/j.resuscitation.2011.11.009; Deasy C, 2010, RESUSCITATION, V81, P1095, DOI 10.1016/j.resuscitation.2010.04.029; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Hillman CM, 2016, J ROY ARMY MED CORPS, V162, P276, DOI 10.1136/jramc-2015-000464; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Lockey DJ, 2013, RESUSCITATION, V84, P738, DOI 10.1016/j.resuscitation.2012.12.003; Morrison JJ, 2014, SHOCK, V41, P388, DOI 10.1097/SHK.0000000000000136; Sherren PB, 2013, CRIT CARE, V17, DOI 10.1186/cc12504; Smith JE, 2015, J ROY SOC MED, V108, P11, DOI 10.1177/0141076814560837; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Truhlar A, 2015, RESUSCITATION, V95, P148, DOI 10.1016/j.resuscitation.2015.07.017; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007; Wolfe I, 2014, WHY CHILDREN DIE DEA; Zwingmann J, 2012, CRIT CARE, V16, DOI 10.1186/cc11410	19	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	MAY	2019	104	5					437	+		10.1136/archdischild-2018-314985			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IC6KD	WOS:000471079900009	30262513				2022-02-06	
J	Wasicek, PJ; Li, Y; Yang, SM; Teeter, WA; Scalea, TM; Hu, P; Brenner, ML				Wasicek, Philip J.; Li, Yao; Yang, Shiming; Teeter, William A.; Scalea, Thomas M.; Hu, Peter; Brenner, Megan L.			Examination of hemodynamics in patients in hemorrhagic shock undergoing Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Resuscitative Endovascular Balloon; Occlusion of the Aorta; REBOA; Aortic occlusion; Hemodynamics; Blood pressure	LETHAL MODEL; INJURY; TRAUMA	Background: The objective of this study was to investigate the hemodynamic effects of aortic occlusion (AO) during Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) using a sophisticated continuous vital sign (CVS) monitoring tool. Methods: Patients admitted between February 2013 and May 2017 at a tertiary center that received REBOA were included. Patients in cardiac arrest before or at the time of REBOA were excluded. Time of AO was documented by time-stamped videography and correlated with CVS data. Results: 28 patients were included, mean (standard deviation) ISS was 38 (11). 18 received Zone 1 (distal thoracic aorta) and 10 received Zone 3 (distal abdominal aorta) AO. Among Zone 1 patients the pre-AO systolic blood pressure (SBP) nadir was 64 (19) mmHg, which increased to a mean of 124 (29) mmHg within 5 min after AO (p < 0.01). Among Zone 3 patients the pre-AO SBP nadir was 75 (19) mmHg, which increased to a mean of 98 (14) mmHg within 5 min after AO (p < 0.01). 72% of Zone 1 patients had episodes during AO where SBP was less than 90 mmHg as compared to 80% of Zone 3 patients (p = 0.51). 100% of Zone 1 patients had periods during AO where SBP was greater than 140 mmHg as compared to 70% Zone 3 patients (p = 0.04). The overall mean decrease in SBP after balloon deflation was 13 (20) mmHg (p < 0.01), with similar decreases among groups (14 (21) mmHg vs 12 (18) mmHg for Zone 1 and 3 patients, respectively (p = 0.85)). Patients undergoing Zone 1 AO were more likely to have an acute change (increase or decrease) in their heart rate immediately after AO as compared to Zone 3 AO (p = 0.048). Conclusions: Significant hemodynamic alterations occur before, during, and after AO. The effects of Zone 1 AO on blood pressure and heart rate appear different than Zone 3 AO. This may have important implications for cardiac or cerebral function and perfusion goals, particularly with concomitant injuries such as cardiac contusion or traumatic brain injury. (C) 2018 Elsevier Ltd. All rights reserved.	[Wasicek, Philip J.; Li, Yao; Yang, Shiming; Teeter, William A.; Scalea, Thomas M.; Hu, Peter; Brenner, Megan L.] Univ Maryland, Sch Med, Program Trauma Crit Care RA Cowley Shock Trauma C, 22 S Greene St, Baltimore, MD 21201 USA		Wasicek, PJ (corresponding author), 22 S Greene St, Baltimore, MD 21201 USA.	pwasicek@som.umaryland.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Teeter, William/0000-0001-9584-0579	United States Department of DefenseUnited States Department of Defense [W81XWH-15-1-0025]	This study was funded in part by a grant from the United States Department of Defense, grant number W81XWH-15-1-0025.	Brenner M, 2018, JAMA SURG, V153, P130, DOI 10.1001/jamasurg.2017.3549; Brenner M, 2014, J TRAUMA ACUTE CARE, V77, P286, DOI 10.1097/TA.0000000000000310; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; DUNN E, 1977, J SURG RES, V22, P463, DOI 10.1016/0022-4804(77)90028-2; Fortuna G, 2016, J TRAUMA ACUTE CARE, V81, P63, DOI 10.1097/TA.0000000000000996; GELMAN S, 1994, ANESTH ANALG, V78, P219, DOI 10.1213/00000539-199402000-00005; GELMAN S, 1988, J THORAC CARDIOV SUR, V96, P387; Hu PF, 2017, J MED SYST, V41, DOI 10.1007/s10916-016-0648-5; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Johnston WE, 2002, ANESTHESIOLOGY, V97, P875, DOI 10.1097/00000542-200210000-00019; Lallemand MS, 2017, J TRAUMA ACUTE CARE, V83, P230, DOI 10.1097/TA.0000000000001548; Madurska MJ, 2017, J TRAUMA ACUTE CARE, V83, P557, DOI 10.1097/TA.0000000000001574; Matsumura Y, 2018, EUR J EMERG MED; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; Morrison JJ, 2012, J SURG RES, V177, P341, DOI 10.1016/j.jss.2012.04.035; ROIZEN MF, 1984, J VASC SURG, V1, P300, DOI 10.1067/mva.1984.avs0010300; Romagnoli A, 2017, J TRAUMA ACUTE CARE, V83, P1161, DOI 10.1097/TA.0000000000001665; Russo RM, 2016, J AM COLL SURGEONS, V223, P359, DOI 10.1016/j.jamcollsurg.2016.04.037; Sadeghi M, 2018, EUR J TRAUMA EMERG S; Sadek S, 2016, RESUSCITATION, V107, P135, DOI 10.1016/j.resuscitation.2016.06.029; SPARGO PM, 1988, ANN ROY COLL SURG, V70, P64; STOKLAND O, 1980, AM J PHYSIOL, V238, pH423, DOI 10.1152/ajpheart.1980.238.4.H423; Uchino H, 2016, AM J CASE REP, V17, P810, DOI 10.12659/AJCR.900267; Wasicek PJ, 2018, J AM COLL SURGEONS, V226, P294, DOI 10.1016/j.jamcollsurg.2017.12.005; Williams TK, 2016, J TRAUMA ACUTE CARE, V81, P294, DOI 10.1097/TA.0000000000001075	25	6	6	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2019	50	5					1042	1048		10.1016/j.injury.2018.12.030			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HX6UG	WOS:000467538200007	30591227				2022-02-06	
J	Areas, FZ; Schwarzbold, ML; Diaz, AP; Rodrigues, IK; Sousa, DS; Ferreira, CL; Quevedo, J; Lin, K; Kupek, E; Ritter, C; Dal Pizzol, F; Walz, R				Areas, Fernando Zanela; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Rodrigues, Igor Kunze; Sousa, Daniel Santos; Ferreira, Camila Leite; Quevedo, Joao; Lin, Katia; Kupek, Emil; Ritter, Cristiane; Dal Pizzol, Felipe; Walz, Roger			Predictors of Hospital Mortality and the Related Burden of Disease in Severe Traumatic Brain Injury: A Prospective Multicentric Study in Brazil	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; mortality; prognosis; burden of disease; Brazil		Traumatic brain injury (TBI) is a worldwide social, economic, and health problem related to premature death and long-term disabilities. There were no prospective and multicentric studies analyzing the predictors of TBI related mortality and estimating the burden of TBI in Brazil. To address this gap, we investigated prospectively: (1) the hospital mortality and its determinants in patients admitted with severe TBI we analyzed in three reference centers; (2) the burden of TBI estimated by the years of life lost (YLLs) due to premature death based on the hospital mortality considering the hospital mortality. Between April 2014 and January 2016 (22 months), all the 266 patients admitted with Glasgow coma scale (GCS), <= 8 admitted in three TBI reference centers were included in the study. These centers cover a population of 1,527,378 population of the Santa Catarina state, Southern Brazil. Most patients were male (n = 230, 86.5%), with a mean (SD) age of 38 (17) years. Hospital mortality was 31.1% (n = 83) and independently associated with older age, worse cranial CT injury by the Marshall classification, the presence of subarachnoid hemorrhage in the CT, lower GCS scores and abnormal pupils at admission. The final multiple logistic regression model including these variables showed an overall accuracy for hospital mortality of 77.9% (specificity 88.6%, sensitivity 53.8%, PPV 67.7%, and NPV 81.1%). The estimated annual incidence of hospitalizations and mortality due to severe TBI were 9.5 cases and 5.43 per 100,000 inhabitants, respectively. The estimated YLLs in 22 months, in the 2 metropolitan areas were 2,841, corresponding to 1,550 YLLs per year and 101.5 YLLs per 100,000 people every year. The hospital mortality did not change significantly since the end of the 1990s and was similar to other centers in Brazil and Latin America. Significant predictors of hospital mortality were the same as those of studies worldwide, but their strength of association seemed to differ according to countries income. Present study results question the extrapolation of TBI hospital mortality models for high income to lower- and middle-income countries and therefore have implications for TBI multicentric trials including countries with different income levels.	[Areas, Fernando Zanela; Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim; Lin, Katia; Walz, Roger] Univ Fed Santa Catarina, Hosp Univ, Ctr Neurociencias Aplicadas, Florianopolis, SC, Brazil; [Areas, Fernando Zanela; Schwarzbold, Marcelo Liborio; Walz, Roger] Univ Fed Santa Catarina, Programa Posgrad Neurociencias, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo Liborio; Rodrigues, Igor Kunze; Sousa, Daniel Santos; Lin, Katia; Kupek, Emil; Dal Pizzol, Felipe; Walz, Roger] Univ Fed Santa Catarina, Programa Posgrad Ciencias Med, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo Liborio; Diaz, Alexandre Paim] Univ Fed Santa Catarina, HU, Dept Clin Med, Serv Psiquiatria, Florianopolis, SC, Brazil; [Rodrigues, Igor Kunze] Univ Fed Santa Catarina, HU, Serv Neurocirurgia, Florianopolis, SC, Brazil; [Rodrigues, Igor Kunze] Hosp Reg Sao Jose Homero de Miranda Gomes, Serv Neurocirurgia, Sao Jose, Brazil; [Sousa, Daniel Santos] Hosp Governado Celso Ramos, Serv Neurocirurgia, Florianopolis, SC, Brazil; [Ferreira, Camila Leite; Quevedo, Joao] Univ Extremo Sul Catarinense, Lab Neurociencias, Programa Posgrad Ciencias Saude, Criciuma, Brazil; [Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Lin, Katia; Walz, Roger] Univ Fed Santa Catarina, HU, Serv Neurol, Dept Clin Med, Florianopolis, SC, Brazil; [Kupek, Emil] Univ Fed Santa Catarina, Dept Saude Publ, Florianopolis, SC, Brazil; [Ritter, Cristiane; Dal Pizzol, Felipe] Hosp Sao Jose, Criciuma, Brazil; [Ritter, Cristiane; Dal Pizzol, Felipe] Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, Programa Posgrad Ciencias Saude, Criciuma, Brazil		Walz, R (corresponding author), Univ Fed Santa Catarina, Hosp Univ, Ctr Neurociencias Aplicadas, Florianopolis, SC, Brazil.; Walz, R (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Neurociencias, Florianopolis, SC, Brazil.; Walz, R (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ciencias Med, Florianopolis, SC, Brazil.; Walz, R (corresponding author), Univ Fed Santa Catarina, HU, Serv Neurol, Dept Clin Med, Florianopolis, SC, Brazil.	rogerwalz@hotmail.com	Lin, Katia/G-4891-2012; Diaz, Alexandre Paim/J-9042-2014; Areas, Fernando/AAX-5070-2020; Diaz, Alexandre Paim/AAD-8323-2019; de Quevedo, Joao Luciano/E-5491-2013; Walz, Roger/K-9096-2013	Lin, Katia/0000-0002-5401-7524; Areas, Fernando/0000-0002-2068-2606; Diaz, Alexandre Paim/0000-0002-6591-6648; de Quevedo, Joao Luciano/0000-0003-3114-6611; Walz, Roger/0000-0002-9875-6687	PRONEX Program (NENASC Project) [56802/2010]; PPSUS Program of FAPESC-CNPq-MS, Santa Catarina, Brazil [TO 201302248]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)	This work was supported by PRONEX Program (NENASC Project, process 56802/2010) and PPSUS Program (TO 201302248) of FAPESC-CNPq-MS, Santa Catarina, Brazil. RW, KL, EK, CR, and FD are Research Fellows from CNPq (Brazilian Council for Science and Technology Development). FA received a fellowship for his Ph.D. degree from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM).	Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; da Costa LGV, 2017, CLINICS, V72, P461, DOI 10.6061/clinics/2017(08)02; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; de Souza RL, 2015, ACTA ANAESTH SCAND, V59, P392, DOI 10.1111/aas.12447; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hohl A, 2014, BRAIN INJURY, V28, P1262, DOI 10.3109/02699052.2014.915986; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P1012, DOI 10.1590/S0004-27302009000800016; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Murray C., 1996, GLOBAL BURDEN DIS; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosi J, 2017, J CLIN NEUROSCI, V42, P122, DOI 10.1016/j.jocn.2017.03.012; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwarzbold ML, 2014, REV BRAS PSIQUIATR, V36, P206, DOI 10.1590/1516-4446-2013-1308; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; 2014, J NEUROPSYCHOL, V8, P125, DOI DOI 10.1111/JNP.12000; 2007, J NEUROTRAUM, V24, P329, DOI DOI 10.1089/NEU.2006.0035	25	6	7	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 25	2019	10								432	10.3389/fneur.2019.00432			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV7SZ	WOS:000466182200002	31105642	Green Published, gold			2022-02-06	
J	Rubin, ML; Yamal, JM; Chan, WY; Robertson, CS				Rubin, M. Laura; Yamal, Jose-Miguel; Chan, Wenyaw; Robertson, Claudia S.			Prognosis of Six-Month Glasgow Outcome Scale in Severe Traumatic Brain Injury Using Hospital Admission Characteristics, Injury Severity Characteristics, and Physiological Monitoring during the First Day Post-Injury	JOURNAL OF NEUROTRAUMA			English	Article						first day post-injury; Glasgow Outcome Scale; prognostic model; secondary injury; traumatic brain injury	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; HYPERTENSION; VALIDATION; PREDICTION	Gold standard prognostic models for long-term outcome in patients with severe traumatic brain injury (TBI) use admission characteristics and are considered useful in some areas but not for clinical practice. In this study, we aimed to build prognostic models for 6-month Glasgow Outcome Score (GOS) in patients with severe TBI, combining baseline characteristics with physiological, treatment, and injury severity data collected during the first 24 h after injury. We used a training dataset of 472 TBI subjects and several data mining algorithms to predict the long-term neurological outcome. Performance of these algorithms was assessed in an independent (test) sample of 158 subjects. The least absolute shrinkage and selection operator (LASSO) led to the highest prediction accuracy (area under the receiving operating characteristic curve = 0.86) in the test set. The most important post-baseline predictor of GOS was the best motor Glasgow Coma Scale (GCS) recorded in the first day post-injury. The LASSO model containing the best motor GCS and baseline variables as predictors outperformed a model with baseline data only. TBI patient physiology of the first day-post-injury did not have a major contribution to patient prognosis six months after injury. In conclusion, 6-month GOS in patients with TBI can be predicted with good accuracy by the end of the first day post-injury, using hospital admission data and information on the best motor GCS achieved during those first 24 h post-injury. Passed the first day after injury, important physiological predictors could emerge from landmark analyses, leading to prediction models of higher accuracy than the one proposed in the current research.	[Rubin, M. Laura] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Yamal, Jose-Miguel; Chan, Wenyaw] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, 1200 Pressler,RAS E809, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Yamal, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, 1200 Pressler,RAS E809, Houston, TX 77030 USA.	Jose-Miguel.Yamal@uth.tmc.edu			National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS38660]; National Institute of General Medical Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM074902]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074902] Funding Source: NIH RePORTER	This study was supported in part by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (Grant No. P01NS38660), and by the National Institute of General Medical Sciences, National Institutes of Health (T32 GM074902).	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Friedman J., 2001, SPRINGER SERIES STAT, pNY; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; JENNETT B, 1975, LANCET, V1, P480; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kalpakis K, 2015, COMPUT BIOL MED, V56, P167, DOI 10.1016/j.compbiomed.2014.11.007; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rubin ML, 2017, STAT MED, V36, P4570, DOI 10.1002/sim.7387; Steyerberg EW, 2008, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	28	6	7	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2417	2422		10.1089/neu.2018.6217		APR 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000465473900001	30860434	Green Published			2022-02-06	
J	Brown, AW; Pretz, CR; Bell, KR; Hammond, FM; Arciniegas, DB; Bodien, YG; Dams-O'Connor, K; Giacino, JT; Hart, T; Johnson-Greene, D; Kowalski, RG; Walker, WC; Weintraub, A; Zafonte, R				Brown, Allen W.; Pretz, Christopher R.; Bell, Kathleen R.; Hammond, Flora M.; Arciniegas, David B.; Bodien, Yelena G.; Dams-O'Connor, Kristen; Giacino, Joseph T.; Hart, Tessa; Johnson-Greene, Douglas; Kowalski, Robert G.; Walker, William C.; Weintraub, Alan; Zafonte, Ross			Predictive utility of an adapted Marshall head CT classification scheme after traumatic brain injury	BRAIN INJURY			English	Article						Clinical decision-making; computed tomography; craniocerebral trauma; forecasting; neuroimaging	GLASGOW OUTCOME SCALE	Objective: To study the predictive relationship among persons with traumatic brain injury (TBI) between an objective indicator of injury severity (the adapted Marshall computed tomography [CT] classification scheme) and clinical indicators of injury severity in the acute phase, functional outcomes at inpatient rehabilitation discharge, and functional and participation outcomes at 1 year after injury, including death. Participants: The sample involved 4895 individuals who received inpatient rehabilitation following acute hospitalization for TBI and were enrolled in the Traumatic Brain Injury Model Systems National Database between 1989 and 2014. Design: Head CT variables for each person were fit into adapted Marshall CT classification categories I through IV. Main Measures: Prediction models were developed to determine the amount of variability explained by the CT classification categories compared with commonly used predictors, including a clinical indicator of injury severity. Results: The adapted Marshall classification categories aided only in the prediction of craniotomy or craniectomy during acute hospitalization, otherwise making no meaningful contribution to variance in the multivariable models predicting outcomes at any time point after injury. Conclusion: Results suggest that head CT findings classified in this manner do not inform clinical discussions related to functional prognosis or rehabilitation planning after TBI.	[Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA; [Pretz, Christopher R.] Craig Hosp, Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [Arciniegas, David B.] Ctr Mental Hlth, Gunnison, CO USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Arciniegas, David B.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Bodien, Yelena G.] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Bodien, Yelena G.; Giacino, Joseph T.; Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Johnson-Greene, Douglas] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Kowalski, Robert G.] Craig Hosp, Res Dept, Englewood, CO USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Weintraub, Alan] Craig Hosp, Craig Hosp Rocky Mt Reg Brain Injury Syst, Englewood, CO USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA		Brown, AW (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903; Bell, Kathleen/0000-0002-0928-2046	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0030, 90DP0036, 90DP0039, 90DP0037, 90DP0038, 90DP0034, 90DP0060, 90DP0046, 90DP0045, 90DP0033]	The contents of this report were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant numbers 90DP0030, 90DP0036, 90DP0039, 90DP0037, 90DP0038, 90DP0034, 90DP0060, 90DP0046, 90DP0045, and 90DP0033). NIDILRR is a center within the Administration for Community Living (ACL), US Department of Health and Human Services (DHHS). This report is solely the responsibility of the authors and does not necessarily represent the official views of the NIDILRR, the ACL, or the DHHS and should not be assumed an endorsement by the US Federal Government.	Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chesnut RM, 2009, J NEUROTRAUM, V17, P555, DOI [10.1089/neu.2000.17.555, DOI 10.1089/NEU.2000.17.555]; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hellawell DJ, 1997, INT J REHABIL RES, V20, P345, DOI 10.1097/00004356-199712000-00001; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Lee Bruce, 2005, NeuroRx, V2, P372; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAS, 2010, EFF SIZ MEAS F TEST; SERVADEI F, 2005, PUBMED, V46, P70; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; WARDLAW JM, 1992, PUBMED, V72, P188; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	29	6	7	4	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					610	617		10.1080/02699052.2019.1566970			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200008	30663426	Green Submitted, Green Accepted			2022-02-06	
J	Weber, ML; Suggs, DW; Bierema, L; Miller, LS; Reifsteck, F; Schmidt, JD				Weber, Michelle L.; Suggs, David Welch; Bierema, Laura; Miller, L. Stephen; Reifsteck, Fred; Schmidt, Julianne D.			Collegiate student-athlete sex, years of sport eligibility completed, and sport contact level influence on concussion reporting intentions and behaviours	BRAIN INJURY			English	Article						Sport-related concussion; sex; years sport eligibility completed; sport contact level	STATES HIGH-SCHOOL; EPIDEMIOLOGY; IMPACT; MOTIVATIONS; KNOWLEDGE; EDUCATION; INJURY; NORMS	Primary Objective: The objective of this study was to determine whether sex, years of sport eligibility completed, and sport contact level influenced student-athletes' concussion reporting intentions and behaviours. Research Design: Cross-sectional. Methods and Procedures: Student-athletes (n = 828) reported their sex, years of sport eligibility completed, sport, and completed concussion reporting intentions and behaviours surveys. Nonparametric statistics were conducted to compare intentions and behaviours between groups (alpha = 0.05). Main Outcomes and Results: Females had higher indirect intentions to report concussion than males (p = 0.035), but did not differ in direct intentions (p = 0.258) or behaviours (indirect: p = 0.756; direct: p = 0.686). Intentions (indirect: p = 0.383; direct: p = 0.397) and behaviours (indirect: p = 0.154; direct: p = 0.999) did not differ between years of sport eligibility completed. Limited/non-contact sport student-athletes intended to report more concussions than those in collision/contact sports (indirect: p = 0.001; direct: p = 0.021), but did not differ in behaviours (indirect: p = 0.184; direct: p = 0.497). Conclusions: Data suggest that female and limited/non-contact sport student-athletes intended to report more concussions, however differences did not translate to reporting behaviours.	[Weber, Michelle L.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA 30602 USA; [Suggs, David Welch] Univ Georgia, Grady Coll Journalism & Mass Commun, Athens, GA 30602 USA; [Bierema, Laura] Dept Lifelong Educ Adm & Policy, Athens, GA USA; [Bierema, Laura; Miller, L. Stephen] Dept Psychol, Athens, GA USA; [Bierema, Laura; Miller, L. Stephen; Reifsteck, Fred] Univ Georgia, Athens, GA 30602 USA; [Reifsteck, Fred] Univ Hlth Ctr, Athens, GA USA		Weber, ML (corresponding author), 330 River Rd, Athens, GA 30602 USA.	michelle.weber25@uga.edu		Suggs, Jr., David Welch/0000-0002-0133-9191	National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults; National Collegiate Athletic Association [FP00004605]; U.S. Department of DefenseUnited States Department of Defense [AWD00004388]	This project was conducted with support from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: Changing Attitudes about Concussions in Young and Emerging Adults; National Collegiate Athletic Association [FP00004605]; U.S. Department of Defense [AWD00004388];	Ajzen I., 1985, ACTION CONTROL COGNI, V1st ed., P11, DOI 10.1007/978-3-642-69746-3_2; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field A., 2017, DISCOVERING STAT USI, V5th; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2014, BRIT J SPORT MED, V48, P1, DOI [10.1136/bjsports-2013-093253, DOI 10.1136/BJSPORTS-2013-093253]; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lempke L, ATH TRAIN SPORTS HLT; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Walsh-Buhi ER, 2016, J ADOLESCENT HEALTH, V59, P283, DOI 10.1016/j.jadohealth.2016.05.007; Weber M, EXAMINATION COLLEGIA	30	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					592	597		10.1080/02699052.2019.1568573			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200006	30704294				2022-02-06	
J	Tamas, V; Kocsor, F; Gyuris, P; Kovacs, N; Czeiter, E; Buki, A				Tamas, Viktoria; Kocsor, Ferenc; Gyuris, Petra; Kovacs, Noemi; Czeiter, Endre; Buki, Andras			The Young Male Syndrome-An Analysis of Sex, Age, Risk Taking and Mortality in Patients With Severe Traumatic Brain Injuries	FRONTIERS IN NEUROLOGY			English	Article						severe traumatic brain injury; young male syndrome; risk taking behavior; age groups; day-of-injury alcohol intoxication	GENDER-DIFFERENCES; ALCOHOL; EPIDEMIOLOGY; ACCIDENTS; OUTCOMES; PREVALENCE; PERCEPTION; HOMICIDE	Higher risk taking is particularly characteristic for males between 15 and 35 years, the age when intrasexual competition is the strongest. This fitness-maximizing strategy, however, also has negative consequences; previous data revealed that males have a significantly higher tendency to die in accidents. This retrospective study aimed to assess whether age-related risk taking, often associated with the reproductive competition between males, and referred to as the Young Male Syndrome (YMS), may play a role in the high incidence of severe traumatic brain injury (sTBI) in young males. Derived from the available evidence and the main assumptions of the YMS, we expected that men, especially when they are in the age when their reproductive potential peaks, are more likely to suffer sTBI from highly risky behaviors that also lead to higher mortality. It was also expected that alcohol intoxication makes the demographic pattern of sTBI even more similar to what previous research on the YMS implies. We analyzed demographic data of patients with sTBI (N = 365) registered in a clinical database. To this end, we built Generalized Linear Mixed Models (GLMM) to reveal which of the demographic characteristics are the best predictors for risky behaviors leading to sTBI and death as a consequence of the injury. The data suggest that younger people acquired sTBI from riskier behaviors compared to members of older age groups, irrespective of their sex. Moreover, being male and being alcohol intoxicated also contributed significantly to risk-taking behavior. Mortality rate after the injury, however, increased with the age of the patient and did not depend on the riskiness of the behavior. The results indicate that the demographic distribution of the specific patient population in our focus cannot be simply explained by the YMS. However, higher incidence rates of males among the patients are in line with the core assumptions of the YMS. These data indicate that epidemiological studies should also take into consideration evolutionary theories and highlight the importance of age and sex specific prevention strategies.	[Tamas, Viktoria; Kovacs, Noemi; Czeiter, Endre; Buki, Andras] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary; [Kocsor, Ferenc; Gyuris, Petra] Univ Pecs, Inst Psychol, Fac Humanities, Pecs, Hungary; [Czeiter, Endre; Buki, Andras] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Czeiter, Endre; Buki, Andras] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Tamas, V (corresponding author), Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary.	tamas.viktoria@pte.hu		Czeiter, Endre/0000-0002-9578-6944	Hungarian Brain Research Program 2.0 [2017-1.2.1-NKP-2017-00002]; Higher Education Institutional Excellence Programme [20765-3/2018/FEKUTSTRAT]; Hungarian Economic Development and Innovation Operational Programme [GINOP-2.3.2-15-2016-00048, GINOP-2.3.3-15-2016-00032]; European UnionEuropean Commission; European Social Fund (Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs) [EFOP-3.6.1.-16-2016-00004];  [EFOP-3.6.2.-16-2017-00008]	This work is financially supported by Hungarian Brain Research Program 2.0-Grant Nos. 2017-1.2.1-NKP-2017-00002; Higher Education Institutional Excellence Programme-Grant No. 20765-3/2018/FEKUTSTRAT; EFOP-3.6.2.-16-2017-00008. The role of neuro-inflammation in neurodegeneration: from molecules to clinics as well as Hungarian Economic Development and Innovation Operational Programme Grant Nos. GINOP-2.3.2-15-2016-00048 and GINOP-2.3.3-15-2016-00032 supported the present work. The project has also been supported by the European Union, co-financed by the European Social Fund (EFOP-3.6.1.-16-2016-00004-Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs).	Alexander RD, 1979, DARWINISM HUMAN AFFA, P317; Bereczkei T., 2003, EVOLUTIONAL PSYCHOL; Buckley L., 2005, AUSTRALASIAN ROAD SA; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Champion A.J., 2006, NEUROPSYCHOLOGICAL R; CHEREK DR, 1985, J STUD ALCOHOL, V46, P321, DOI 10.15288/jsa.1985.46.321; Clarke DD, 2006, ACCIDENT ANAL PREV, V38, P871, DOI 10.1016/j.aap.2006.02.013; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Csepregi Gyula, 2007, Orvosi Hetilap, V148, P771, DOI 10.1556/OH.2007.27879; Daly M, 2001, Nebr Symp Motiv, V47, P1; Datta Gupta N, 2005, IZA DISCUSSION PAPER, V1833; Farsang P, 2016, HUM ETHOL B, V2, P17, DOI [10.22330/heb/312/017-029, DOI 10.22330/HEB/312/017-029]; Farthing GW, 2005, EVOL HUM BEHAV, V26, P171, DOI 10.1016/j.evolhumbehav.2004.08.004; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; HOLINGER PC, 1987, AM J PSYCHIAT, V144, P215; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kelly S, 2001, HUM NATURE-INT BIOS, V12, P89, DOI 10.1007/s12110-001-1018-6; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kumpula H., 2008, INJURIES RISK TAKING; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee K. K., 2006, SMJ Singapore Medical Journal, V47, P31; Liguori A, 1999, ALCOHOL CLIN EXP RES, V23, P815, DOI 10.1097/00000374-199905000-00008; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Marx B P, 1999, Sex Abuse, V11, P131; Mealey L., 2000, SEX DIFFERENCES DEV; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pennings JL, 1993, ARCH SURG-CHICAGO, V128, P93; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Sohlberg M., 2001, COGNITIVE REHABILITA; Stawicki Stanislaw P, 2017, Int J Crit Illn Inj Sci, V7, P23, DOI 10.4103/IJCIIS.IJCIIS_2_17; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tieves Kelly S, 2005, WMJ, V104, P22; TRANKLE U, 1990, ACCIDENT ANAL PREV, V22, P119, DOI 10.1016/0001-4575(90)90063-Q; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; ZUCKERMAN M, 1971, J CONSULT CLIN PSYCH, V36, P45, DOI 10.1037/h0030478	46	6	6	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2019	10								366	10.3389/fneur.2019.00366			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HT3BE	WOS:000464437700001	31031696	gold, Green Published			2022-02-06	
J	Kaltiainen, H; Liljestrom, M; Helle, L; Salo, A; Hietanen, M; Renvall, H; Forss, N				Kaltiainen, Hanna; Liljestrom, Mia; Helle, Liisa; Salo, Anne; Hietanen, Marja; Renvall, Hanna; Forss, Nina			Mild Traumatic Brain Injury Affects Cognitive Processing and Modifies Oscillatory Brain Activity during Attentional Tasks	JOURNAL OF NEUROTRAUMA			English	Article						alpha frequency modulation; cognitive task; magnetoencephalography; mild traumatic brain injury	SERIAL ADDITION TEST; MINOR HEAD-INJURY; TEST-RETEST RELIABILITY; INTRAINDIVIDUAL VARIABILITY; SUSTAINED ATTENTION; ALPHA-ACTIVITY; EEG SPECTRA; MEMORY; LOCALIZATION; PERFORMANCE	Despite the high prevalence of mild traumatic brain injury (mTBI), current diagnostic tools to objectively assess cognitive complaints after mTBI continue to be inadequate. Our aim was to identify neuronal correlates for cognitive difficulties in mTBI patients by evaluating the possible alterations in oscillatory brain activity during a behavioral task known to be sensitive to cognitive impairment after mTBI. We compared oscillatory brain activity during rest and cognitive tasks (Paced Auditory Serial Addition Test [PASAT] and a vigilance test [VT]) with magnetoencephalography between 25 mTBI patients and 20 healthy controls. Whereas VT induced no significant differences compared with resting state in either group, patients exhibited stronger attenuation of 8- to 14-Hz oscillatory activity during PASAT than healthy controls in the left parietotemporal cortex (p <= 0.05). Further, significant task-related modulation in the left superior frontal gyrus and right prefrontal cortex was detected only in patients. The similar to 10-Hz (alpha) peak frequency declined in frontal, temporal, and parietal regions during PASAT compared with rest (p < 0.016) in patients, whereas in controls it remained the same or showed a tendency to increase. In patients, the similar to 10-Hz peak amplitude was negatively correlated with behavioral performance in the Trail Making Test. The observed alterations in the cortical oscillatory activity during cognitive load may provide measurable neurophysiological correlates of cognitive difficulties in mTBI patients, even at the individual level.	[Kaltiainen, Hanna; Liljestrom, Mia; Helle, Liisa; Renvall, Hanna; Forss, Nina] Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, POB 12200, FI-00076 Espoo, Finland; [Kaltiainen, Hanna; Liljestrom, Mia; Helle, Liisa; Renvall, Hanna; Forss, Nina] Aalto Univ, MEG Core, Aalto Neuroimaging, Espoo, Finland; [Kaltiainen, Hanna] Lohja Dist Hosp, Dept Neurol, Lohja, Finland; [Helle, Liisa] MEGIN Elekta Oy, Helsinki, Finland; [Kaltiainen, Hanna; Salo, Anne; Hietanen, Marja; Renvall, Hanna; Forss, Nina] Univ Helsinki, Clin Neurosci, Helsinki, Finland; [Kaltiainen, Hanna; Salo, Anne; Hietanen, Marja; Renvall, Hanna; Forss, Nina] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Renvall, Hanna] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Renvall, Hanna] Helsinki Univ Hosp, Helsinki, Finland		Kaltiainen, H (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, POB 12200, FI-00076 Espoo, Finland.	hanna-leena.kaltiainen@aalto.fi	Liljestrom, Mia/ABE-5251-2021	Liljestrom, Mia/0000-0002-9110-6788; Forss, Nina/0000-0002-1620-8573; Helle, Liisa/0000-0002-0001-9292	TEKES, the Finnish Funding for Innovation, Seamless patient care project funding; Paulo Foundation; Finnish Medical Society Duodecim; Academy of FinlandAcademy of FinlandEuropean Commission [277655]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Maud Kuistila Memorial Foundation; Swedish cultural foundation;  [1988/31/2015]	This research has been funded by TEKES, the Finnish Funding for Innovation, Seamless patient care project funding (H.K., N.F.), State Research funding grant number 1988/31/2015 (H.K., N.F.), The Paulo Foundation (H.K.), The Finnish Medical Society Duodecim (H.K.), Academy of Finland grant number 277655 (H.R.), the Finnish Cultural Foundation (H.R.), Maud Kuistila Memorial Foundation (M.L.), and The Swedish cultural foundation (M.L.).	[Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; Arico P, 2015, IEEE ENG MED BIO, P7242, DOI 10.1109/EMBC.2015.7320063; Audoin B, 2005, MAGN RESON MATER PHY, V18, P96, DOI 10.1007/s10334-004-0098-9; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Backer KC, 2015, J NEUROSCI, V35, P1307, DOI 10.1523/JNEUROSCI.1487-14.2015; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bonnefond M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0153-16.2017; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cardinal KS, 2008, MULT SCLER, V14, P465, DOI 10.1177/1352458507084263; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gutmann B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/717312; Haegens S, 2014, NEUROIMAGE, V92, P46, DOI 10.1016/j.neuroimage.2014.01.049; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hanslmayr S, 2014, NEUROIMAGE, V85, P648, DOI 10.1016/j.neuroimage.2013.05.121; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; Kondacs A, 1999, CLIN NEUROPHYSIOL, V110, P1708, DOI 10.1016/S1388-2457(99)00122-4; Kostyunina M B, 1996, Neurosci Behav Physiol, V26, P340, DOI 10.1007/BF02359037; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; Lockwood AH, 2004, J INT NEUROPSYCH SOC, V10, P26, DOI 10.1017/S1355617740410145; Long NM, 2014, NEUROIMAGE, V84, P488, DOI 10.1016/j.neuroimage.2013.08.052; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maurer U, 2015, BRAIN TOPOGR, V28, P127, DOI 10.1007/s10548-014-0361-y; Mierau A, 2017, NEUROSCIENCE, V360, P146, DOI 10.1016/j.neuroscience.2017.07.037; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Napflin M, 2008, NEUROIMAGE, V43, P687, DOI 10.1016/j.neuroimage.2008.08.028; Neuper C, 2005, CLIN NEUROPHYSIOL, V116, P1681, DOI 10.1016/j.clinph.2005.03.013; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Puce A, 2017, MEG EEG PRIMER; Rogers JM, 2015, NEUROREPORT, V26, P903, DOI 10.1097/WNR.0000000000000445; Rogers JM, 2015, BRAIN INJURY, V29, P343, DOI 10.3109/02699052.2014.976273; Saggar M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00256; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Valdes-Hernandez PA, 2010, NEUROIMAGE, V49, P2328, DOI 10.1016/j.neuroimage.2009.10.030; van Harskamp NJ, 2001, CORTEX, V37, P363, DOI 10.1016/S0010-9452(08)70579-3; van Vliet M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00586; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; VONBIERBRAUER A, 1992, EEG-EMG-Z ELEK ELEKT, V23, P151; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wilson S.M., 1996, BEHAV ASSESSMENT DYS	79	6	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2222	2232		10.1089/neu.2018.6306		APR 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000464547000001	30896274	Green Published, hybrid			2022-02-06	
J	Nesari, A; Mansouri, MT; Khodayar, MJ; Rezaei, M				Nesari, Ali; Mansouri, Mohammad Taghi; Khodayar, Mohammad Javad; Rezaei, Mohsen			Preadministration of high-dose alpha-tocopherol improved memory impairment and mitochondrial dysfunction induced by proteasome inhibition in rat hippocampus	NUTRITIONAL NEUROSCIENCE			English	Article						Rat; Proteasome; Mitochondria; Alpha-tocopherol; Memory; Reactive Oxygen Species	ENDOPLASMIC-RETICULUM STRESS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; VITAMIN-E; OXIDATIVE STRESS; CELL-DEATH; THERAPEUTIC STRATEGY; POSSIBLE INVOLVEMENT; LIVER-MITOCHONDRIA; LIPID-PEROXIDATION	Objective: The ubiquitin-proteasome system plays a key role in memory consolidation. Proteasome inhibition and free radical-induced neural damage were implicated in neurodegenerative states. In this study, it was tested whether alpha-tocopherol (alpha T) in low and high doses could improve the long-term memory impairment induced by proteasome inhibition and protects against hippocampal oxidative stress. Methods: Alpha-tocopherol (alpha T) (60, 200 mg/kg, i.p. for 5 days) was administered to rats with memory deficit and hippocampal oxidative stress induced by bilateral intra-hippocampal injection of lactacystin (32 ng/mu l) and mitochondrial evaluations were performed for improvement assessments. Results: The results showed that lactacystin significantly reduced the passive avoidance memory performance and increased the level of malondialdehyde (MDA), reactive oxygen species (ROS) and diminished the mitochondrial membrane potential (MMP) in the rat hippocampus. Furthermore, Intraperitoneal administration of alpha T significantly increased the passive avoidance memory, glutathione content and reduced ROS, MDA levels and impaired MMP. Conclusions: The results suggested that alpha T has neuroprotective effects against lactacystin-induced oxidative stress and memory impairment via the enhancement of hippocampal antioxidant capacity and concomitant mitochondrial sustainability. This finding shows a way to prevent and also to treat neurodegenerative diseases associated with mitochondrial impairment.	[Nesari, Ali; Khodayar, Mohammad Javad] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Toxicol, Ahwaz, Iran; [Mansouri, Mohammad Taghi] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Pharmacol, Ahwaz, Iran; [Mansouri, Mohammad Taghi] Columbia Univ, Irving Med Ctr, Dept Anesthesiol, New York, NY USA; [Khodayar, Mohammad Javad; Rezaei, Mohsen] Ahvaz Jundishapur Univ Med Sci, Toxicol Res Ctr, Ahwaz, Iran; [Rezaei, Mohsen] Tarbiat Modares Univ, Fac Med Sci, Dept Toxicol, POB 14115-331, Tehran, Iran		Rezaei, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Toxicol, POB 14115-331, Tehran, Iran.	rezaei.m@modares.ac.ir	Rezaei, Mohsen/V-5497-2019; Mansouri, Seyed Mohammad Taghi/F-3847-2014; Khodayar, Mohammad Javad/D-2779-2018	Rezaei, Mohsen/0000-0001-6823-2463; Mansouri, Seyed Mohammad Taghi/0000-0002-7549-0708; Khodayar, Mohammad Javad/0000-0001-9518-1286; nesari, ali/0000-0003-3260-7846	Ahvaz Jundishapur University of Medical Sciences [TRC_9310]	This work was supported by the Ahvaz Jundishapur University of Medical Sciences [grant number TRC_9310].	ANDERSSON BS, 1987, AM J PHYSIOL, V252, pC349, DOI 10.1152/ajpcell.1987.252.4.C349; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Ataie A, 2010, DARU, V18, P128; Bakhshi J, 2008, APOPTOSIS, V13, P904, DOI 10.1007/s10495-008-0221-x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Behl C, 2000, J NEURAL TRANSM, V107, P393, DOI 10.1007/s007020070082; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Butterfield DA, 2002, DRUG DEVELOP RES, V56, P428, DOI 10.1002/ddr.10095; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chun J, 2006, J FOOD COMPOS ANAL, V19, P196, DOI 10.1016/j.jfca.2005.08.001; DAHLMANN B, 1995, BIOCHEM J, V309, P195, DOI 10.1042/bj3090195; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Das K, 2001, BBA-MOL BASIS DIS, V1537, P1, DOI 10.1016/S0925-4439(01)00048-5; Demasi M, 2015, BBA-GEN SUBJECTS, V1850, P1594, DOI 10.1016/j.bbagen.2014.10.031; Dong YL, 2013, CLINICS, V68, P1255, DOI 10.6061/clinics/2013(09)13; dos Santos PS, 2011, EUR J PHARMACOL, V668, P65, DOI 10.1016/j.ejphar.2011.06.035; Dreher ML, 2012, NUTR REV, V70, P234, DOI 10.1111/j.1753-4887.2011.00467.x; Drexler HCA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004161; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Eidi A, 2006, EUR NEUROPSYCHOPHARM, V16, P101, DOI 10.1016/j.euroneuro.2005.06.006; Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Figueiredo-Pereira ME, 2014, FRONT MOL NEUROSCI, V7, P1; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Foley AG, 2000, J NEUROCHEM, V74, P2607, DOI 10.1046/j.1471-4159.2000.0742607.x; Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003; Goudarzi M, 2018, HUM EXP TOXICOL, V37, P532, DOI 10.1177/0960327117715900; Goudarzi M, 2018, LIFE SCI, V198, P38, DOI 10.1016/j.lfs.2018.02.022; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Guo C, 2003, NEURAL REGEN RES, V8, P2003, DOI DOI 10.3969/J.ISSN.1673-5374.2013.21.009; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huseby NE, PROTEASOME INHIBITOR; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Kaang BK, 2009, NEUROSCIENTIST, V15, P430, DOI 10.1177/1073858408331374; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Keshtzar E, 2016, HUM EXP TOXICOL, V35, P1060, DOI 10.1177/0960327115618247; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Lass A, 1998, ARCH BIOCHEM BIOPHYS, V352, P229, DOI 10.1006/abbi.1997.0606; Lebold KM, 2013, COMP BIOCHEM PHYS C, V157, P382, DOI 10.1016/j.cbpc.2013.03.007; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liang LP, 2006, FREE RADICAL BIO MED, V40, P316, DOI 10.1016/j.freeradbiomed.2005.08.026; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ling QH, 2015, BBA-BIOENERGETICS, V1847, P939, DOI 10.1016/j.bbabio.2015.02.017; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Lu ZB, 2006, NEUROCHEM INT, V48, P263, DOI 10.1016/j.neuint.2005.10.010; Magalhaes J, 2005, EUR J APPL PHYSIOL, V93, P726, DOI 10.1007/s00421-004-1222-2; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896; Mansouri MT, 2013, FOOD CHEM, V138, P1028, DOI 10.1016/j.foodchem.2012.11.022; Mansouri S. M. T., 2005, Iranian Biomedical Journal, V9, P181; MARCUS SR, 1993, J NUTR BIOCHEM, V4, P336, DOI 10.1016/0955-2863(93)90078-B; Maria DA, 2013, INVEST NEW DRUG, V31, P493, DOI 10.1007/s10637-012-9871-1; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Masaki H, 2002, FREE RADICAL RES, V36, P705, DOI 10.1080/10715760210873; MCLAUGHLIN PJ, 1979, J AM DIET ASSOC, V75, P647; Mecocci P, 2012, BBA-MOL BASIS DIS, V1822, P631, DOI 10.1016/j.bbadis.2011.10.006; MEYDANI M, 1995, LANCET, V345, P170, DOI 10.1016/S0140-6736(95)90172-8; Mishima K, 2001, JPN J PHARMACOL, V87, P297, DOI 10.1254/jjp.87.297; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nash KM, 2015, NANOMED-NANOTECHNOL, V11, P2033, DOI 10.1016/j.nano.2015.07.003; Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Park SK, 2008, J NUTR, V138, P1010, DOI 10.1093/jn/138.6.1010; Perez-Alvarez S, 2009, BRIT J PHARMACOL, V158, P1121, DOI 10.1111/j.1476-5381.2009.00388.x; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Rahigude A, 2012, NEUROSCIENCE, V226, P62, DOI 10.1016/j.neuroscience.2012.09.026; Reis DS, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00150; Reiter E, 2007, MOL ASPECTS MED, V28, P668, DOI 10.1016/j.mam.2007.01.003; Rezaei M, 2016, JUNDISHAPUR J NAT PH, V11, DOI 10.17795/jjnpp-33433; Rodriguez-Ortiz CJ, 2011, NEUROBIOL LEARN MEM, V95, P311, DOI 10.1016/j.nlm.2010.12.010; Romero-Granados R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028927; Ross JM, 2015, INT J MOL SCI, V16, P19458, DOI 10.3390/ijms160819458; Safaei F, 2018, ACTA CHIR BELG, V118, P152, DOI 10.1080/00015458.2017.1394672; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; SUKALSKI KA, 1993, FREE RADICAL BIO MED, V14, P57, DOI 10.1016/0891-5849(93)90509-S; Sultana R, 2006, ANTIOXID REDOX SIGN, V8, P2021, DOI 10.1089/ars.2006.8.2021; Sung S, 2003, FASEB J, V17, P323, DOI 10.1096/fj.03-0961fje; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Ulatowski LM, 2015, NEUROBIOL DIS, V84, P78, DOI 10.1016/j.nbd.2015.04.002; Vianna MRM, 2000, NEUROCHEM RES, V25, P621, DOI 10.1023/A:1007502918282; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Yamamoto N, PROTEASOME INHIBITIO; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Yoshida Y, 2010, J NUTR BIOCHEM, V21, P66, DOI 10.1016/j.jnutbio.2008.10.006; Zhong Q, 2008, ARCH BIOCHEM BIOPHYS, V474, P119, DOI 10.1016/j.abb.2008.03.008; Zhu W, COMP NEUROPROTECTIVE	102	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.	FEB 1	2021	24	2					119	129		10.1080/1028415X.2019.1601888		APR 2019	11	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	QF3VY	WOS:000471474600001	31084475				2022-02-06	
J	Caswell, SV; Kelshaw, P; Lincoln, AE; Hepburn, L; Dunn, R; Cortes, N				Caswell, Shane, V; Kelshaw, Patricia; Lincoln, Andrew E.; Hepburn, Lisa; Dunn, Reginald; Cortes, Nelson			Game-Related Impacts in High School Boys' Lacrosse	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						helmet contact; defenseless player; collisions; wearable sensors; video analysis	VIDEO INCIDENT ANALYSIS; HEAD-IMPACT; MENS LACROSSE; INJURIES; GIRLS; PLAYERS; EPIDEMIOLOGY; CONCUSSIONS; EXPOSURE	Background: The rate of concussions in boys' lacrosse is reported to be the third highest among high school sports in the United States, but no studies have described game-related impacts among boys' lacrosse players. Purpose: To characterize verified game-related impacts, both overall and those directly to the head, in boys' varsity high school lacrosse. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A total of 77 male participants (mean age, 16.6 +/- 1.2 years; mean height, 1.77 +/- 0.05 m; mean weight, 73.4 +/- 12.2 kg) were instrumented with sensors and were videotaped during 39 games. All verified game-related impacts >= 20g were summarized in terms of frequency, peak linear acceleration (PLA), and peak rotational velocity (PRV). Descriptive statistics and impact rates per player-game (PG) with corresponding 95% CIs were calculated. Results: Overall, 1100 verified game-related impacts were recorded (PLA: median, 33.5g [interquartile range (IQR), 25.7-51.2]; PRV: median, 1135.5 deg/s [IQR, 790.0-1613.8]) during 795 PGs. The rate for all verified game-related impacts was 1.38 impacts per PG (95% CI, 1.30-1.47). Of these, 680 (61.8%) impacts (PLA: median, 35.9g [IQR, 26.7-55.5]; PRV: 1170.5 deg/s [IQR, 803.2-1672.8]) were directly to the head (impact rate, 0.86 impacts/PG [95% CI, 0.79-0.92]). Overall, midfielders (n = 514; 46.7%) sustained the most impacts, followed by attackers (n = 332; 30.2%), defenders (n = 233; 21.2%), and goalies (n = 21; 1.9%). The most common mechanisms for overall impacts and direct head impacts were contact with player (overall: n = 706 [64.2%]; head: n = 397 [58.4%]) and stick (overall: n = 303 [27.5%]; head: n = 239 [35.1%]), followed by ground (overall: n = 73 [6.6%]; head: n = 26 [3.8%]) and ball (overall: n = 15 [1.4%]; head: n = 15 [2.2%]). Direct head impacts were associated with a helmet-to-helmet collision 31.2% of the time, and they were frequently (53.7%) sustained by the players delivering the impact. Nearly half (48.8%) of players delivering contact used their helmets to initiate contact that resulted in a helmet-to-helmet impact. Players receiving a head impact from player contact were most often unprepared (75.9%) for the collision. Conclusion: The helmet is commonly used to initiate contact in boys' high school lacrosse, often targeting defenseless opponents. Interventions to reduce head impacts should address rules and coaching messages to discourage intentional use of the helmet and encourage protection of defenseless opponents.	[Caswell, Shane, V; Kelshaw, Patricia; Lincoln, Andrew E.; Hepburn, Lisa; Dunn, Reginald; Cortes, Nelson] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10900 Univ Blvd,MS 4E5, Manassas, VA 20110 USA; [Lincoln, Andrew E.; Hepburn, Lisa; Dunn, Reginald] MedStar Sports Med, Baltimore, MD USA; [Lincoln, Andrew E.] Georgetown Univ, Med Ctr, Dept Rehabil Med, Washington, DC 20007 USA		Caswell, SV (corresponding author), George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, 10900 Univ Blvd,MS 4E5, Manassas, VA 20110 USA.	scaswell@gmu.edu	Kelshaw, Patricia/AAC-7220-2021	Cortes, Nelson/0000-0001-8762-3144	US Lacrosse Sports Science and Safety Committee; George Mason University Libraries Open Access Publishing Fund; AOSSM	Financial support was received via a grant from the US Lacrosse Sports Science and Safety Committee; funding was primarily used to support equipment and personnel. Publication of this study was funded in part by the George Mason University Libraries Open Access Publishing Fund. S.V.C. and A.E.L. are nonpaid volunteer members of the US Lacrosse Sports Science and Safety Committee. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kindschi Kari, 2017, BMJ Open Sport Exerc Med, V3, pe000165, DOI 10.1136/bmjsem-2016-000165; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; National Federation of State High School Associations, PART STAT; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	33	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 4	2019	7	4							2325967119835587	10.1177/2325967119835587			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HS1BL	WOS:000463595500001	31058198	gold, Green Published			2022-02-06	
J	Visscher, RMS; Feddermann-Demont, N; Romano, F; Straumann, D; Bertolini, G				Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni			Artificial intelligence for understanding concussion: Retrospective cluster analysis on the balance and vestibular diagnostic data of concussion patients	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SELF-ORGANIZING MAP; POSTCONCUSSION SYNDROME; CLASSIFICATION	Objectives We propose a bottom-up, machine-learning approach, for the objective vestibular and balance diagnostic data of concussion patients, to provide insight into the differences in patients' phenotypes, independent of existing diagnoses (unsupervised learning). Methods Diagnostic data from a battery of validated balance and vestibular assessments were extracted from the database of the Swiss Concussion Center. The desired number of clusters within the patient database was estimated using Calinski-Harabasz criteria. Complex (self-organizing map, SOM) and standard (k-means) clustering tools were used, and the formed clusters were compared. Results A total of 96 patients (81.3% male, age (median [IQR]): 25.0[10.8]) who were expected to suffer from sports-related concussion or post-concussive syndrome (52[140] days between diagnostic testing and the concussive episode) were included. The cluster evaluation indicated dividing the data into two groups. Only the SOM gave a stable clustering outcome, dividing the patients in group-1 (n = 38) and group-2 (n = 58). A large significant difference was found for the caloric summary score for the maximal speed of the slow phase, where group-1 scored 30.7% lower than group-2 (27.6[18.2] vs. 51.0[31.0]). Group-1 also scored significantly lower on the sensory organisation test composite score (69.0[22.3] vs. 79.0 [10.5]) and higher on the visual acuity (-0.03[0.33] vs. -0.14[0.12]) and dynamic visual acuity (0.38[0.84] vs. 0.20[0.20]) tests. The importance of caloric, SOT and DVA, was supported by the PCA outcomes. Group-1 tended to report headaches, blurred vision and balance problems more frequently than group-2 (>10% difference). Conclusion The SOM divided the data into one group with prominent vestibular disorders and another with no clear vestibular or balance problems, suggesting that artificial intelligence might help improve the diagnostic process.	[Visscher, Rosa M. S.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Visscher, Rosa M. S.; Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, Nina; Romano, Fausto; Straumann, Dominik; Bertolini, Giovanni] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland		Visscher, RMS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Visscher, RMS (corresponding author), Univ Zurich, Univ Hosp Zurich, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland.	rosa.visscher@hest.ethz.ch	Bertolini, Giovanni/W-4117-2019	Bertolini, Giovanni/0000-0003-2428-9454; Visscher, Rosa/0000-0003-2817-9359; Romano, Fausto/0000-0002-6166-7461			Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Arthur D, 2007, SODA 07 P 18 ANN ACM, P1027, DOI [10.5555/1283383.1283494, DOI 10.5555/1283383.1283494, DOI 10.1145/1283383.1283494]; Ben Slama A, 2016, IEEE IND ELEC, P5165, DOI 10.1109/IECON.2016.7793010; Bohmer A, 1995, J Vestib Res, V5, P35; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Costello A, 2005, PRACT ASSESS RES EVA, V10, P7; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Ding C, 2004, SIAM PROC S, P497; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Fujimoto C, 2018, CLIN NEUROPHYSIOL, V129, P238, DOI 10.1016/j.clinph.2017.11.006; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Incorporated NM, 2016, NEUROCOM BAL MAN SEN; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Kelly KM, 2018, J HEAD TRAUMA REHAB, DOI [10.1097/HTR, DOI 10.1097/HTR]; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kononenko I, 2001, ARTIF INTELL MED, V23, P89, DOI 10.1016/S0933-3657(01)00077-X; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Landry AP, 2019, J NEUROSURG, V131, P1235, DOI 10.3171/2018.6.JNS18607; Lin FR, 2005, ANN OTO RHINOL LARYN, V114, P777, DOI 10.1177/000348940511401007; Liu YG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003117; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes L, 2018, 180203426 ARXIV; Minaee Shervin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1267, DOI 10.1109/EMBC.2018.8512556; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Oh JH, 2016, METHOD INFORM MED, V55, P431, DOI 10.3414/ME16-01-0035; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Polla M., 2009, TKK REPORTS INFORM C; Polzlbauer G., 2004, WORKSH DAT AN SLIEZS; Randolph C, 2005, CONCUSSION SYMPTOMS; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakai K, 2019, JPN J RADIOL, V37, P34, DOI 10.1007/s11604-018-0794-4; Schmid-Priscoveanu A, 1999, ACTA OTO-LARYNGOL, V119, P750, DOI 10.1080/00016489950180379; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Si B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00606; Si B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198741; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sun Y, 2000, NEUROCOMPUTING, V34, P169, DOI 10.1016/S0925-2312(00)00292-7; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; van de Berg R, 2018, CURR OPIN NEUROL, V31, P111, DOI 10.1097/WCO.0000000000000526; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; VANEGMOND AAJ, 1954, ACTA OTO-LARYNGOL, V44, P589, DOI 10.3109/00016485409127671; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5; Voutilainen A, 2018, GERONTOLOGIST, V58, pE138, DOI 10.1093/geront/gnw251; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Zhao Xinyu, 2018, Front Appl Math Stat, V4, DOI 10.3389/fams.2018.00025; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	68	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2019	14	4							e0214525	10.1371/journal.pone.0214525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HR2UW	WOS:000462993900031	30939164	Green Published, gold, Green Accepted, Green Submitted			2022-02-06	
J	Xiao, L; Saiki, C; Okamura, H				Xiao, Li; Saiki, Chikako; Okamura, Hisashi			Oxidative Stress-Tolerant Stem Cells from Human Exfoliated Deciduous Teeth Decrease Hydrogen Peroxide-Induced Damage in Organotypic Brain Slice Cultures from Adult Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						oxidative stress-tolerant stem cells; brain damage; brain slice culture; stem cells from human exfoliated deciduous teeth; neuronal protection	DNA-DAMAGE; GLIAL-CELLS; INTERLEUKIN-6; THERAPIES; PROMOTES; SURVIVAL; COPPER	Oxidative stress causes severe tissue injury of the central nervous system in ischemic brain damage (IBD), traumatic brain injury (TBI) and neurodegenerative disorders. In this study, we used hydrogen peroxide (H2O2) to induce oxidative stress in organotypic brain slice cultures (OBSCs), and investigated the protective effects of oxidative stress-tolerant (OST) stem cells harvested from human exfoliated deciduous teeth (SHED) which were co-cultivated with OBSCs. Using presto blue assay and immunostaining, we demonstrated that both normal SHED and OST-SHED could prevent H2O2-induced cell death, and increase the numbers of mature neuron and neuronal progenitors in the hippocampus of OBSCs. During co-cultivation, OST-SHED, but not normal SHED, exhibited neuronal cell morphology and expressed neuronal markers. Results from ELISA showed that both normal SHED and OST-SHED significantly decreased oxidative DNA damage in H2O2-treated OBSCs. SHED could also produce neurotrophic factor BDNF (brain derived neurotrophic factor) and promoted the production of IL-6 in OBSCs. Although OST-SHED had lower cell viability, the neuronal protection of OST-SHED was significantly superior to that of normal SHED. Our findings suggest that SHED, especially OST-SHED, could prevent oxidative stress induced brain damage. OST-SHED can be explored as a new therapeutic tool for IBD, TBI and neurodegenerative disorders.	[Xiao, Li] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pharmacol, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1020071, Japan; [Saiki, Chikako] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Physiol, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1020071, Japan; [Okamura, Hisashi] Nippon Dent Univ Hosp, Dept Oral & Maxillofacial Surg, Chiyoda Ku, 2-3-16 Fujimi, Tokyo 1028158, Japan		Xiao, L (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Pharmacol, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1020071, Japan.	xiaoli@tky.ndu.ac.jp; chikako@tky.ndu.ac.jp; hisashi124@gmail.com	Saiki, Chikako/AAW-6132-2020; Xiao, Li/AAX-7766-2020	Xiao, Li/0000-0002-3053-4930	Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [17K11813]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (17K11813).	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Chen F, 2017, CELL TRANSPLANT, V26, P1483, DOI 10.1177/0963689717735407; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Feeney CJ, 2008, BRAIN RES, V1198, P1, DOI 10.1016/j.brainres.2007.12.049; Fu S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00022; Gelain DP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/895153; Goudarzi F, 2018, FREE RADICAL RES, V52, P763, DOI 10.1080/10715762.2018.1466121; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hellwig S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14624; Humpel C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00047; Jiao Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/356415; Lee DH, 2002, NUCLEIC ACIDS RES, V30, P3566, DOI 10.1093/nar/gkf478; Lee HS, 2015, CRYOBIOLOGY, V71, P374, DOI 10.1016/j.cryobiol.2015.10.146; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Park HH, 2016, NEUROTOXICOLOGY, V55, P131, DOI 10.1016/j.neuro.2016.05.022; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Riviere J, 2006, FREE RADICAL BIO MED, V40, P2071, DOI 10.1016/j.freeradbiomed.2006.02.003; Saez DM, 2015, CELLS TISSUES ORGANS, V202, P269, DOI 10.1159/000447055; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shirley R, 2014, ANTIOXIDANTS-BASEL, V3, P472, DOI 10.3390/antiox3030472; Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang Y, 2017, AGEING RES REV, V34, P39, DOI 10.1016/j.arr.2016.11.002; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Xiao L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081745; Xiao L, 2014, NEURAL REGEN RES, V9, P1253, DOI 10.4103/1673-5374.137570	34	6	6	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR 2	2019	20	8							1858	10.3390/ijms20081858			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HX8ID	WOS:000467648700056	30991705	gold, Green Published, Green Submitted			2022-02-06	
J	Beynon, C; Brenner, S; Younsi, A; Rizos, T; Neumann, JO; Pfaff, J; Unterberg, AW				Beynon, Christopher; Brenner, Steffen; Younsi, Alexander; Rizos, Timolaos; Neumann, Jan-Oliver; Pfaff, Johannes; Unterberg, Andreas W.			Management of Patients with Acute Subdural Hemorrhage During Treatment with Direct Oral Anticoagulants	NEUROCRITICAL CARE			English	Article						Intracranial hemorrhages; Trauma; Subdural hematoma; Subdural hemorrhage; Oral anticoagulants	PROTHROMBIN COMPLEX CONCENTRATE; VITAMIN-K ANTAGONISTS; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; RADIOLOGICAL COURSE; PRACTICAL GUIDE; RABBIT MODEL; REVERSAL	BackgroundAnticoagulation therapy is a major risk factor for unfavorable patient outcomes following (traumatic) intracranial hemorrhage. Direct oral anticoagulants (DOAC) are increasingly used for the prevention and treatment of thromboembolic diseases. Data on patients treated for acute subdural hemorrhage (SDH) during anticoagulation therapy with DOAC are limited.MethodsWe analyzed the medical records of consecutive patients treated at our institution for acute SDH during anticoagulation therapy with DOAC or vitamin K antagonists (VKA) during a period of 30months. Patient characteristics such as results of imaging and laboratory studies, treatment modalities and short-term patient outcomes were included.ResultsA total of 128 patients with preadmission DOAC (n=65) or VKA (n=63) intake were compared. The overall 30-day mortality rate of this patient cohort was 27%, and it did not differ between patients with DOAC or VKA intake (26% vs. 27%; p=1.000). Similarly, the rates of neurosurgical intervention (65%) and intracranial re-hemorrhage (18%) were comparable. Prothrombin complex concentrates were administered more frequently in patients with VKA intake than in patients with DOAC intake (90% vs. 58%; p<0.0001). DOAC treatment in patients with acute SDH did not increase in-hospital and 30-day mortality rates compared to VKA treatment.ConclusionsThese findings support the favorable safety profile of DOAC in patients, even in the setting of intracranial hemorrhage. However, the availability of specific antidotes to DOAC may further improve the management of these patients.	[Beynon, Christopher; Brenner, Steffen; Younsi, Alexander; Neumann, Jan-Oliver; Unterberg, Andreas W.] Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Rizos, Timolaos] Heidelberg Univ Hosp, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Rizos, Timolaos] Alfried Krupp Krankenhaus Essen, Dept Neurol, Alfried Krupp Str 21, D-45131 Essen, Germany; [Pfaff, Johannes] Heidelberg Univ Hosp, Dept Neuroradiol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany		Beynon, C (corresponding author), Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	christopher.beynon@med.uni-heidelberg.de	Younsi, Alexander/AAW-7869-2020; Pfaff, Johannes Alex Rolf/P-6272-2019	Younsi, Alexander/0000-0002-8218-9243; Pfaff, Johannes Alex Rolf/0000-0003-0672-5718			Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Batey M, 2018, SURGERY, V164, P814, DOI 10.1016/j.surg.2018.05.060; Becattini C, 2017, INT J CARDIOL, V227, P261, DOI 10.1016/j.ijcard.2016.11.117; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Beynon C, 2017, SEMIN THROMB HEMOST, V43, P416, DOI 10.1055/s-0037-1599159; Beynon C, 2015, THROMB RES, V136, P560, DOI 10.1016/j.thromres.2015.07.001; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Boulouis G, 2018, J NEUROL NEUROSUR PS, V89, P263, DOI 10.1136/jnnp-2017-316631; Burnett AE, 2016, J THROMB THROMBOLYS, V41, P206, DOI 10.1007/s11239-015-1310-7; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Douxfils J, 2018, J THROMB HAEMOST, V16, P209, DOI 10.1111/jth.13912; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gerner ST, 2018, ANN NEUROL, V83, P186, DOI 10.1002/ana.25134; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Heidbuchel H, 2013, EUR HEART J, V34, P2094, DOI 10.1093/eurheartj/eht134; Henskens YMC, 2018, THROMB J, V16, DOI 10.1186/s12959-017-0160-2; Herzog E, 2015, J THROMB HAEMOST, V13, P2220, DOI 10.1111/jth.13165; Huang KT, 2016, NEUROCRIT CARE, V24, P294, DOI 10.1007/s12028-015-0194-x; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Karni A, 2001, AM SURGEON, V67, P1098; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Laible M, 2016, CEREBROVASC DIS, V42, P446, DOI 10.1159/000448815; Lin LM, 2017, INTERDISCIP NEUROSUR, V8, P35, DOI 10.1016/j.inat.2017.01.011; Martin AC, 2013, INT J CARDIOL, V168, P4228, DOI 10.1016/j.ijcard.2013.07.152; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; Pozzessere A, 2015, AM SURGEON, V81, P1039; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Purrucker JC, 2016, JAMA NEUROL, V73, P169, DOI 10.1001/jamaneurol.2015.3682; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sanden P, 2017, THROMB HAEMOSTASIS, V117, P27, DOI 10.1160/TH16-06-0489; Senger S, 2016, WORLD NEUROSURG, V88, P132, DOI 10.1016/j.wneu.2015.11.086; von der Brelie C, 2017, ACTA NEUROCHIR, V159, P101, DOI 10.1007/s00701-016-3026-7; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Zeeshan M, 2018, J TRAUMA ACUTE CARE	47	6	6	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					322	333		10.1007/s12028-018-0635-4			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900014	30382531				2022-02-06	
J	Bhatti, JA; Thiruchelvam, D; Redelmeier, DA				Bhatti, Junaid A.; Thiruchelvam, Deva; Redelmeier, Donald A.			Traumatic brain injury as an independent risk factor for problem gambling: a matched case-control study	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article						Concussion; Head injury; Pathological gambling	IMPAIRED DECISION-MAKING; UNITED-STATES; PREVALENCE; BEHAVIOR; IMPACT; ADDICTION; SUICIDE; CANADA; WOMEN; TASK	PurposeTo assess whether traumatic brain injury (TBI) increases the risks of subsequent problem gambling.MethodsWe conducted a matched case-control analysis of adults in Ontario, Canada. The study included those who self-reported their gambling activities in the Canadian Community Health Survey 2007-2008. Using Problem Gambling Severity Index, we defined cases as those who were problem gamblers and controls who were recreational gamblers. Cases were matched to controls 1:2 using propensity scores based on demographics, prior mental health, and self-reported behaviours. The main predictor was prior TBI defined as requiring emergency care and identified using ICD-10 codes from administrative health databases. We estimated the likelihood of prior TBI in problem gamblers compared to controls using conditional logistic regression.ResultsOf 30,652 survey participants, 16,002 (53%) reported gambling activity of whom 14,910 (49%) were recreational gamblers and 4% (n=1092) were problem gamblers. A total of 1469 respondents (5%) had a prior TBI. Propensity score matching yielded 2038 matched pairs with 1019 cases matched to 2037 controls. Case-control analysis showed a significant association between prior TBI and subsequent problem gambling (odds ratio 1.27, 95% confidence interval 1.07-1.51, P=0.007). The increased risk was mostly apparent in men aged 35 to 64years who reported alcohol use or smoking. The relative risk of problem gambling in those with two or more TBIs equated to an odds ratio of 2.04 (95% confidence interval 1.05-3.99).ConclusionsWe found that a prior TBI was associated with an increased subsequent risk of problem gambling. Our findings support more awareness, screening, and treating problem gambling risks among TBI patients.	[Bhatti, Junaid A.; Redelmeier, Donald A.] Sunnybrook Res Inst, Evaluat Clin Sci, Toronto, ON, Canada; [Bhatti, Junaid A.; Redelmeier, Donald A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Bhatti, Junaid A.; Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bhatti, Junaid A.; Thiruchelvam, Deva; Redelmeier, Donald A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Bhatti, Junaid A.] Sunnybrook Hlth Sci Ctr, Dept Surg, 2075 Bayview Ave,G106, Toronto, ON M4N 3M5, Canada		Bhatti, JA (corresponding author), Sunnybrook Res Inst, Evaluat Clin Sci, Toronto, ON, Canada.; Bhatti, JA (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.; Bhatti, JA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Bhatti, JA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Bhatti, JA (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Surg, 2075 Bayview Ave,G106, Toronto, ON M4N 3M5, Canada.	junaid.bhatti@ices.on.ca					Afifi TO, 2010, PSYCHIAT RES, V178, P395, DOI 10.1016/j.psychres.2009.10.003; Afifi TO, 2010, CAN J PSYCHIAT, V55, P21, DOI 10.1177/070674371005500104; Allen S, 2016, SUBST USE MISUSE, V2, P1; [Anonymous], 2009, FACTS PROBL GAMBL; [Anonymous], 2014, SCHED BEN PHYS SERV; [Anonymous], 2014, NAT VIT STAT SYST NV; Bina M, 2006, ACCIDENT ANAL PREV, V38, P472, DOI 10.1016/j.aap.2005.11.003; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bouchard SM, 2012, ACCIDENT ANAL PREV, V45, P580, DOI 10.1016/j.aap.2011.09.012; Burden A, 2017, PRAGMAT OBS RES, V8, P15, DOI 10.2147/POR.S122563; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; Cox BJ, 2005, CAN J PSYCHIAT, V50, P213, DOI 10.1177/070674370505000404; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; El-Guebaly N, 2006, J GAMBL STUD, V22, P275, DOI 10.1007/s10899-006-9016-6; Farmer CF., 2016, UNDERSTANDING TREATM; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Ferris J. A., 2001, CANADIAN PROBLEM GAM; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Holden C, 2010, SCIENCE, V327, P935, DOI 10.1126/science.327.5968.935; Huang JH, 2007, CAN J PSYCHIAT, V52, P657, DOI 10.1177/070674370705201006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Kelly M, 2014, J CLIN EXP NEUROPSYC, V36, P897, DOI 10.1080/13803395.2014.955784; King G., 2016, WHY PROPENSITY SCORE; Korn DA, 2000, CAN MED ASSOC J, V163, P61; Kuentzel JG, 2008, J GAMBL STUD, V24, P307, DOI 10.1007/s10899-008-9094-8; Ledgerwood DM, 2004, J NERV MENT DIS, V192, P711, DOI 10.1097/01.nmd.0000142021.71880.ce; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Marr A., 2004, CENTRAL NERVOUS SYST; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mun P., 2006, GAMBLING PROBLEM GAM; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Redelmeier DA, 2012, NEW ENGL J MED, V367, P1228, DOI 10.1056/NEJMsa1114310; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Romanczuk-Seiferth N, 2014, NEUROPSYCHOBIOLOGY, V70, P95, DOI 10.1159/000362839; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Shaffer HJ, 1999, AM J PUBLIC HEALTH, V89, P1369, DOI 10.2105/AJPH.89.9.1369; Shaffer HJ, 2001, CAN J PUBLIC HEALTH, V92, P168, DOI 10.1007/BF03404298; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Statistics Canada, 2014, POP YEAR PROV TERR; Statistics Canada, 2008, CAN COMM HLTH SURV C; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Volberg R.A, 2013, GAMBLING PROBLEM GAM; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Walker M., 2011, CLIN ASSESSMENT PROB; Waters-Wood SM, 2012, J INT NEUROPSYCH SOC, V18, P927, DOI 10.1017/S135561771200063X; Whiting SW, 2016, J BEHAV ADDICT, V5, P213, DOI 10.1556/2006.5.2016.027; Wiebe J., 2004, GAMBLING PROBLEM GAM; WILLIAMS R.J., 2012, PREVENTION PROBLEM G; Wittwer A, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.2016.00640, 10.3389/fpsyd.2016.00640]; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005	56	6	6	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	APR	2019	54	4					517	523		10.1007/s00127-018-1583-1			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	HR3HC	WOS:000463026400012	30232507				2022-02-06	
J	Candanedo, C; Doron, O; Hemphill, JC; de Noriega, FR; Manley, GT; Patal, R; Rosenthal, G				Candanedo, Carlos; Doron, Omer; Hemphill, J. Claude; de Noriega, Fernando Ramirez; Manley, Geoffrey T.; Patal, Rani; Rosenthal, Guy			Characterizing the Response to Cerebrospinal Fluid Drainage in Patients with an External Ventricular Drain: The Pressure Equalization Ratio	NEUROCRITICAL CARE			English	Article						Pressure equalization ratio; Intracranial pressure; External ventricular drain; Traumatic brain injury; Intracranial compliance	BRAIN; SPACE	BackgroundAn external ventricular drain (EVD) is the gold standard for measurement of intracranial pressure (ICP) and allows for drainage of cerebrospinal fluid (CSF). Different causes of elevated ICP, such as CSF outflow obstruction or cerebral swelling, respond differently to CSF drainage. This is a widely recognized but seldom quantified distinction. We sought to define an index to characterize the response to CSF drainage in neurocritical care patients.MethodsWe studied consecutive patients admitted to the neurointensive care unit who had an EVD. The EVD was closed for 30min prior to assessment. We documented pre-drainage ICP, opened EVD to drainage allowing CSF to drain until it ceased, and recorded post-drainage ICP at EVD closure. We calculated the pressure equalization (PE) ratio as the difference between pre-drainage ICP and post-drainage ICP divided by the difference between pre-drainage ICP and EVD height.ResultsWe studied 60 patients (36 traumatic brain injury [TBI], 24 non-TBI). As expected, TBI patients had more signs of cerebral swelling on CT and smaller ventricles. Although TBI patients had significantly higher pre-drainage ICP (2610mm Hg) than non-TBI patients (19 +/- 5mm Hg, p<0.001) they drained less CSF (7cc vs. 4cc, p<0.01). PE ratio was substantially higher in non-TBI than in TBI patients (0.86 +/- 0.36 vs. 0.43 +/- 0.31, p<0.0001), indicating that non-TBI patients were better able to equalize pressure with EVD height than TBI patients.Conclusions p id=Par4 PE ratio reflects the ability to equalize pressure with the preset height of the EVD and differs substantially between TBI and non-TBI patients. A high PE ratio likely indicates CSF outflow obstruction effectively treated by CSF diversion, while a lower PE ratio occurs when cerebral swelling predominates. Further studies could assess whether the PE ratio would be useful as a surrogate marker for cerebral edema or the state of intracranial compliance.	[Candanedo, Carlos; Doron, Omer; de Noriega, Fernando Ramirez; Patal, Rani; Rosenthal, Guy] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, Jerusalem, Israel; [Hemphill, J. Claude] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Rosenthal, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, Jerusalem, Israel.	rosenthalg@hadassah.org.il	Hemphill, Claude/AAY-5630-2021	Hemphill, Claude/0000-0003-4019-7525; Candanedo, Carlos/0000-0002-0499-8264			Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GUILLAUME J, 1951, PRESSE MED, V59, P953; GUILLAUME J, 1951, REV NEUROL, V84, P131; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HOSSMANN KA, 1971, EXP NEUROL, V32, P163, DOI 10.1016/0014-4886(71)90060-4; Hrabetova S, 2004, NEUROCHEM INT, V45, P467, DOI 10.1016/j.neuint.2003.11.011; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Lai HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164263; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MATSUOKA Y, 1982, EXP NEUROL, V77, P599, DOI 10.1016/0014-4886(82)90231-X; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Servadei F, 2015, WORLD NEUROSURG, V83, P732, DOI 10.1016/j.wneu.2015.01.031; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010; Valadka AB, 2015, WORLD NEUROSURG, V84, P211, DOI 10.1016/j.wneu.2015.02.013	26	6	6	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					340	347		10.1007/s12028-018-0612-y			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900016	30251075				2022-02-06	
J	Casillas-Espinosa, PM; Sargsyan, A; Melkonian, D; O'Brien, TJ				Casillas-Espinosa, Pablo M.; Sargsyan, Armen; Melkonian, Dmitri; O'Brien, Terence J.			A universal automated tool for reliable detection of seizures in rodent models of acquired and genetic epilepsy	EPILEPSIA			English	Article						automated seizure detection; genetic absence epilepsy rats from Strasbourg; post-status epilepticus model; posttraumatic epilepsy; traumatic brain injury; Wistar Albino Glaxo from Rijswijk	ABSENCE EPILEPSY; ELECTRICAL-STIMULATION; WAVE DISCHARGES; BRAIN-INJURY; RATS; SPIKE; EEG	Objective Prolonged electroencephalographic (EEG) monitoring in chronic epilepsy rodent models has become an important tool in preclinical drug development of new therapies, in particular those for antiepileptogenesis, disease modification, and treating drug-resistant epilepsy. We have developed an easy-to-use, reliable, computational tool for automated detection of electrographic seizures from prolonged EEG recordings in rodent models of epilepsy. Methods We applied a novel method based on advanced time-frequency analysis that detects EEG episodes with excessive activity in certain frequency bands. The method uses an innovative technique of short-term spectral analysis, the Similar Basis Function algorithm. The method was applied for offline seizure detection from long-term EEG recordings from four spontaneously seizing, chronic epilepsy rat models: the fluid percussion injury (n = 5 rats, n = 49 seizures) and post-status epilepticus models (n = 119 rats, n = 993 seizures) of acquired epilepsy, and two genetic models of absence epilepsy, Genetic Absence Epilepsy Rats from Strasbourg and Wistar Albino Glaxo from Rijswijk (n = 41 and 14 rats, n = 8733 and 825 seizures, respectively). Results Our comparative analysis revealed that the EEG amplitude spectra of these four rat models are remarkably similar during epileptiform activity and have a single expressed peak within the 17- to 25-Hz frequency range. Focusing on this band, our computer program detected all seizures in the 179 rats. A quick semiautomated user inspection of the EEGs for the period of each identified event allowed quick rejection of artifact events. The overall processing time for 12-day-long recordings varied from a few minutes (5-10) to 30 minutes, depending on the number of artifact events, which was strongly correlated with the signal quality of the raw EEG data. Significance Our automated seizure detection tool provides high sensitivity, with acceptable specificity, for long- and short-term EEG recordings from both acquired and genetic chronic epilepsy rat models. This tool has the potential to improve the efficiency and rigor of preclinical research and therapy development using these models.	[Casillas-Espinosa, Pablo M.; O'Brien, Terence J.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Casillas-Espinosa, Pablo M.; O'Brien, Terence J.] Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic, Australia; [Casillas-Espinosa, Pablo M.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Sargsyan, Armen; Melkonian, Dmitri] KaosKey, Sydney, NSW, Australia; [O'Brien, Terence J.] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia		O'Brien, TJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.	terence.obrien@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Sargsyan, Armen/0000-0002-0293-3539; O'Brien, Terence/0000-0002-7198-8621			Aghazadeh R, 2015, GEN PHYSIOL BIOPHYS, V34, P285, DOI 10.4149/gpb_2015010; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Barker-Haliski ML, 2015, DRUGS, V75, P749, DOI 10.1007/s40265-015-0395-9; Bhandare AM, 2017, NEUROSCIENCE, V350, P23, DOI 10.1016/j.neuroscience.2017.03.012; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Casillas-Espinosa PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179924; COENEN AML, 1992, EPILEPSY RES, V12, P75, DOI 10.1016/0920-1211(92)90029-S; Dheer Puneet, 2017, Neurosci J, V2017, P9606213, DOI 10.1155/2017/9606213; DRINKENBURG WHIM, 1991, EPILEPSY RES, V9, P218, DOI 10.1016/0920-1211(91)90055-K; Galanopoulou Aristea S, 2016, Epilepsia Open, V1, P86, DOI 10.1002/epi4.12021; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Galanopoulou AS, 2013, EPILEPSIA S4, V54, P783; Islam MK, 2016, NEUROPHYSIOL CLIN, V46, P287, DOI 10.1016/j.neucli.2016.07.002; Islam MK, 2016, IEEE J BIOMED HEALTH, V20, DOI 10.1109/JBHI.2015.2457093; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Koren JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00454; Lee J, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00052; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Melkonian D, 2010, NUMER ALGORITHMS, V54, P73, DOI 10.1007/s11075-009-9324-x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Niknazar M, 2013, EPILEPSY BEHAV, V27, P355, DOI 10.1016/j.yebeh.2013.01.028; Ovchinnikov A, 2010, J NEUROSCI METH, V194, P172, DOI 10.1016/j.jneumeth.2010.09.017; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Rao KR, 2010, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6629-0; Richard CD, 2015, J NEUROSCI METH, V242, P127, DOI 10.1016/j.jneumeth.2014.12.016; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Ulate-Campos A, 2016, SEIZURE-EUR J EPILEP, V40, P88, DOI 10.1016/j.seizure.2016.06.008; Van Hese P, 2003, PHYS MED BIOL, V48, P1685; van Luijtelaar G, 2016, J NEUROSCI METH, V260, P144, DOI 10.1016/j.jneumeth.2015.07.010; Van Nieuwenhuyse B, 2015, BRAIN RES, V1627, P1, DOI 10.1016/j.brainres.2015.08.016; White AM, 2006, J NEUROSCI METH, V152, P255, DOI 10.1016/j.jneumeth.2005.09.014; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Xanthopoulos P, 2009, IEEE ENG MED BIO, P2184, DOI 10.1109/IEMBS.2009.5334941	39	6	6	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2019	60	4					783	791		10.1111/epi.14691			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR6MX	WOS:000463267500020	30866062	Green Published			2022-02-06	
J	Das, M; Tang, XL; Mohapatra, SS; Mohapatra, S				Das, Mahasweta; Tang, Xiaolan; Mohapatra, Shyam S.; Mohapatra, Subhra			Vision impairment after traumatic brain injury: present knowledge and future directions	REVIEWS IN THE NEUROSCIENCES			English	Article						gene therapy; nanomedicine; optic nerve; optic neuropathy; retina; traumatic brain injury (TBI); visual impairment	RETINAL GANGLION-CELLS; NEURAL STEM-CELLS; OPTIC-NERVE; OCULOMOTOR NERVE; COMPUTED-TOMOGRAPHY; VISUAL-SYSTEM; AXONAL INJURY; GENE-THERAPY; DAMAGE; NEUROPATHY	Traumatic brain injury (TBI) is a major cause of mortality and morbidity in the USA as well as in the world. As a result of TBI, the visual system is also affected often causing complete or partial visual loss, which in turn affects the quality of life. It may also lead to ocular motor dysfunction, defective accommodation, and impaired visual perception. As a part of the therapeutic strategy, early rehabilitative optometric intervention is important. Orthoptic therapy, medication, stem cell therapy, motor and attention trainings are the available treatment options. Gene therapy is one of the most promising emerging strategies. Use of state-of-the-art nanomedicine approaches to deliver drug(s) and/or gene(s) might enhance the therapeutic efficacy of the present and future modalities. More research is needed in these fields to improve the outcome of this debilitating condition. This review focuses on different visual pathologies caused by TBI, advances in pre-clinical and clinical research, and available treatment options.	[Das, Mahasweta; Tang, Xiaolan; Mohapatra, Shyam S.; Mohapatra, Subhra] James A Haley Vet Adm Hosp, Tampa, FL 33612 USA; [Das, Mahasweta; Tang, Xiaolan; Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA; [Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Coll Med, Tampa, FL 33612 USA		Mohapatra, S (corresponding author), James A Haley Vet Adm Hosp, Tampa, FL 33612 USA.; Mohapatra, S (corresponding author), Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA.	smohapa2@health.usf.edu		Das, Mahasweta/0000-0003-3809-5861	Veterans Affairs Merit Review grantUS Department of Veterans Affairs [BX002668]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs;  [IK6BX004212];  [IK6 BX003778]	This work is supported by Veterans Affairs Merit Review grant (BX002668) to Subhra Mohapatra, and Research Career Scientist Awards to Dr. Subhra Mohapatra (IK6BX004212) and Dr. Shyam Mohapatra (IK6 BX003778). Though this report is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, the contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ARIAS MJ, 1985, NEUROSURGERY, V16, P232, DOI 10.1227/00006123-198502000-00020; ASNR, 2018, TRAUM BRAIN INJ TBI; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bertram JP, 2009, J MICROENCAPSUL, V26, P18, DOI 10.1080/02652040802095250; Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; BURGER LJ, 1970, BRAIN, V93, P567, DOI 10.1093/brain/93.3.567; Caesar R, 2003, EYE, V17, P661, DOI 10.1038/sj.eye.6700420; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Cockerham GC, 2014, OPHTHALMOLOGY, V121, P2165, DOI 10.1016/j.ophtha.2014.06.009; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cohen AH, 2013, NEUROREHABILITATION, V32, P483, DOI 10.3233/NRE-130871; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; FDA, 2017, FDA APPR NOV GEN THE; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Gauguet Jean-Marc, 2008, Radiol Case Rep, V3, P124, DOI 10.2484/rcr.v3i1.124; Gerbino G, 2005, INT J ORAL MAX SURG, V34, P127, DOI 10.1016/j.ijom.2004.05.001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172928; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; HEINZE J, 1969, MED J AUSTRALIA, V2, P1246, DOI 10.5694/j.1326-5377.1969.tb103371.x; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Houston KE, 2017, AM J PHYS MED REHAB, V96, pE70, DOI 10.1097/PHM.0000000000000592; Jackson R. S., 2016, TRAUMATIC OPTIC NEUR; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Johnson TV, 2014, BRAIN, V137, P503, DOI 10.1093/brain/awt292; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kasten E, 2007, J CLIN EXP NEUROPSYC, V29, P569, DOI 10.1080/13803390600878919; Khatib TZ, 2017, EYE, V31, P218, DOI 10.1038/eye.2016.299; Kim Ju Young, 2017, Retin Cases Brief Rep, V11, P227, DOI 10.1097/ICB.0000000000000327; Kumaran AM, 2015, CRANIOMAX TRAUM REC, V8, P31, DOI 10.1055/s-0034-1393734; Kurimoto Y, 2001, NEUROSCI LETT, V306, P57, DOI 10.1016/S0304-3940(01)01857-2; Kwon HG, 2013, J NEUROL NEUROSUR PS, V84, P1073, DOI 10.1136/jnnp-2013-305111; Laha B, 2017, SCIENCE, V356, P1031, DOI 10.1126/science.aal5060; Lee Bruce, 2005, NeuroRx, V2, P372; Lee KF, 2010, INT J OPHTHALMOL-CHI, V3, P175, DOI 10.3980/j.issn.2222-3959.2010.02.20; Levin Leonard A, 2004, Ophthalmol Clin North Am, V17, P455, DOI 10.1016/j.ohc.2004.05.008; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Magharious MM, 2011, JOVE-J VIS EXP, V12, P1; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCann J D, 1994, Curr Opin Ophthalmol, V5, P3, DOI 10.1097/00055735-199412000-00002; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Miller NR, 1996, CURR OPIN NEUROL, V9, P21, DOI 10.1097/00019052-199602000-00005; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Moreau F, 2013, CEREBROVASC DIS EXTR, V3, P130, DOI 10.1159/000355024; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; Neitz J, 2008, CURR BIOL, V18, pR700, DOI 10.1016/j.cub.2008.06.062; Nkansah MK, 2008, BIOTECHNOL BIOENG, V100, P1010, DOI 10.1002/bit.21822; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; Pease ME, 2009, INVEST OPHTH VIS SCI, V50, P2194, DOI 10.1167/iovs.08-3013; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Prow TW, 2008, NANOMED-NANOTECHNOL, V4, P340, DOI 10.1016/j.nano.2008.06.003; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; SAAD N, 1992, AUST NZ J OPHTHALMOL, V20, P121, DOI 10.1111/j.1442-9071.1992.tb00723.x; Salunke P, 2012, INDIAN J OPHTHALMOL, V60, P149, DOI 10.4103/0301-4738.90491; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Sawhney R, 2003, EYE, V17, P667, DOI 10.1038/sj.eye.6700411; Schumann P, 2013, CRANIOMAX TRAUM REC, V6, P75, DOI 10.1055/s-0033-1343783; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G., 2014, GCS 40 EYES VERBAL M; Tiffin PAC, 1996, EYE, V10, P377, DOI 10.1038/eye.1996.77; Tzameret A, 2014, EXP EYE RES, V118, P135, DOI 10.1016/j.exer.2013.10.023; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uzan M, 1996, Eur Spine J, V5, P275, DOI 10.1007/BF00301333; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; WARNER JEA, 1995, INT OPHTHALMOL CLIN, V35, P57, DOI 10.1097/00004397-199503510-00007; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Zampieri T. P. D., 2007, BLINDED VETERANS ASS, P1	104	6	7	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2019	30	3					305	315		10.1515/revneuro-2018-0015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ9HS	WOS:000462738600007	30226209				2022-02-06	
J	Donders, J; Kim, E				Donders, Jacobus; Kim, Eunice			Effect of Cognitive Reserve on Children With Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Assessment; Cognition; Education; Patient outcomes; Protective factors; Risk factors	MILD; PREDICTORS; RECOVERY; SYMPTOMS; VALIDITY; IQ	Objectives: Traumatic brain injury can result in cognitive impairments in children. The objective of this retrospective study was to determine to what extent such outcomes are moderated by cognitive reserve, as indexed by parental education. Methods: Sixty 6- to 16-year-old children completed the Wechsler Intelligence Scale for ChildrenFifth Edition (WISC-V) within 30-360 days after having sustained a traumatic brain injury (TBI). Their Full-Scale IQ and factor index scores were compared to those of demographically matched controls. In addition, regression analysis was used to investigate in the TBI group the influence of injury severity in addition to parental education on WISC-V factor index scores. Results: Cognitive reserve moderated the effect of TBI on WISC-V Full Scale IQ, Verbal Comprehension, and Visual Spatial. In the TBI group, it also had a protective effect with regard to performance on the Verbal Comprehension, Visual Spatial, and Fluid Reasoning indices. At the same time, greater injury severity was predictive of lower Visual Spatial and Processing Speed index scores in the TBI group. Conclusions: Cognitive reserve as reflected in parental education has a moderating effect with regard to children's performance on the WISC-V after TBI, such that higher cognitive reserve is associated with greater preservation of acquired word knowledge and understanding of visual relationships. Measures that emphasize speed of processing remain affected by severity of TBI, even after accounting for the protective effect associated with cognitive reserve. (JINS, 2019, 25, 355-361)	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Kim, Eunice] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Catroppa C., 2016, NEW FRONTIERS PEDIAT; Dennis M., 2006, COGNITIVE RESERVE TH, P53; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fuentes A, 2010, BRAIN INJURY, V24, P995, DOI 10.3109/02699052.2010.489791; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Murphy KR, 2004, STAT POWER ANAL; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ris MD, 2013, PEDIAT NEUROPSYCHOLO, P395; Roebuck-Spencer T, 2018, NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN, P139; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th	28	6	6	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2019	25	4					355	361		10.1017/S1355617719000109			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IC9LS	WOS:000471304800003	31050332				2022-02-06	
J	Dreer, LE; Cox, MK; McBrayer, A; Neumeier, WH; Herman, C; Malone, LA				Dreer, Laura E.; Cox, Molly K.; McBrayer, Alexandra; Neumeier, William H.; Herman, Cassandra; Malone, Laurie A.			Resilience Among Caregivers of Injured Service Members: Finding the Strengths in Caregiving	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregivers; Integrative medicine; Military personnel; Problem solving; Rehabilitation; Resilence; Spirituality	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; CONNOR-DAVIDSON RESILIENCE; FAMILY RESILIENCE; PSYCHOMETRIC PROPERTIES; COMMUNITY INTEGRATION; NATIONAL-HEALTH; PTSD CHECKLIST; VETERANS	Objective: To examine the relationships between caregiver resilience and a comprehensive set of sociodemographic and health-related quality of life (HRQOL) predictors among both caregivers and injured service members. Design: Cross-sectional analysis of an observational cohort. Setting: Community dwelling. Participants: Caregivers (n=87) who provide instrumental or emotional support to injured service members (n=73)(N=160). Interventions: Not applicable. Main outcome measure: The Connor-Davidson Resilience Scale 25-item version. Results: Higher caregiver resilience scores were related to lower depressive symptom severity, greater health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, stress management, and problem-solving orientation. A multivariable regression model showed that spiritual growth and aspects of problem-solving orientation were significantly related to resilience. Conclusions: Results highlight the relationships between resilience and spirituality, problem-solving orientation, and aspects of HRQOL among caregivers of injured service members. These findings have important implications for caregiver behavioral health programs designed to promote resilience and draw upon caregiver strengths when taking on a caregiver role. Approaches that include a more integrative medicine or strengths-based emphasis may be particularly beneficial when working with families of injured military. (C) 2019 by the American Congress of Rehabilitation Medicine	[Dreer, Laura E.; Cox, Molly K.; McBrayer, Alexandra] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL USA; [Neumeier, William H.; Herman, Cassandra; Malone, Laurie A.] Univ Alabama Birmingham, UAB, Lakeshore Res Collaborat, Sch Hlth Profess, Birmingham, AL USA; [Herman, Cassandra] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA		Dreer, LE (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Callahan Eye Hosp, H-405,1720 Univ Blvd, Birmingham, AL 35233 USA.	lauradreer@uabmc.edu	Neumeier, William/R-2850-2017	Neumeier, William/0000-0002-5588-0477	Lakeshore Foundation; National Institute for Disability, Independent Living, and Rehabilitation Research [90IF0039]; Wise Up! Concussion Initiative of the Al and Sharyne Wallace Foundation	Supported in part by clinical research funds and private donations, Lakeshore Foundation, the National Institute for Disability, Independent Living, and Rehabilitation Research (grant no. #90IF0039) and the Wise Up! Concussion Initiative of the Al and Sharyne Wallace Foundation.	Ahmadi K., 2011, J AGGRESSION MALTREA, V20, P636, DOI DOI 10.1080/10926771.2011.595761; Aiken LJ, 2010, DIMENS CRIT CARE NUR, V29, P13, DOI 10.1097/DCC.0b013e3181be4a1a; Bass DM, 2012, AM J GERIAT PSYCHIAT, V20, P239, DOI 10.1097/JGP.0b013e31824108ca; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Black K, 2008, J FAM NURS, V14, P33, DOI 10.1177/1074840707312237; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bobo WV, 2004, MIL MED, V169, P648, DOI 10.7205/MILMED.169.8.648; Bormann J, 2009, FAM COMMUNITY HEALTH, V32, P345, DOI 10.1097/FCH.0b013e3181b91fd6; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Chapin M, 2011, SOC WORK HEALTH CARE, V50, P527, DOI 10.1080/00981389.2011.588130; Christensen EW, 2013, J DISABIL POLICY STU, V23, P235, DOI 10.1177/1044207311432314; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Conforte AM, 2017, MIL MED, V182, pE1871, DOI 10.7205/MILMED-D-17-00016; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Dreer LE, 2016, CURR EYE RES, V41, P50, DOI 10.3109/02713683.2014.1002045; Dreer LE, 2013, OPTOMETRY VISION SCI, V90, P883, DOI 10.1097/OPX.0000000000000009; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Folstein M., 2003, TELEPHONE INTERVIEW; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Husaini B, 1980, J COMMUNITY PSYCHOL, V36, P531; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kozminski M, 2010, J AM OSTEOPATH ASSOC, V110, P514; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V304, P1427, DOI 10.1001/jama.2010.1327; Lee HB, 2012, AGING MENT HEALTH, V16, P372, DOI 10.1080/13607863.2011.609533; Lin CY, 2017, ARCH GERONTOL GERIAT, V68, P8, DOI 10.1016/j.archger.2016.08.005; Link PE, 2013, CLIN CHILD FAM PSYCH, V16, P376, DOI 10.1007/s10567-013-0145-z; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; MCCUBBIN HI, 1988, FAM RELAT, V37, P247, DOI 10.2307/584557; Melvin KC, 2012, RES NURS HEALTH, V35, P164, DOI 10.1002/nur.21459; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Monin JK, 2014, AM J GERIAT PSYCHIAT, V22, P570, DOI 10.1016/j.jagp.2012.11.023; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; OBERST MT, 1989, CANCER NURS, V12, P209; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramchand R, 2014, HIDDEN HEROS AM MILI; Roberts R, 1983, APPL PSYCH MEAS, V1, P385; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saltzman WR, 2013, CLIN CHILD FAM PSYCH, V16, P294, DOI 10.1007/s10567-013-0142-2; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Sharma V, 2017, J AFFECT DISORDERS, V217, P197, DOI 10.1016/j.jad.2017.03.071; Shinopulos N M, 1999, Urol Nurs, V19, P249; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Tanielian Terri, 2013, Rand Health Q, V3, P3; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Terri Tanielian, 2018, Rand Health Q, V7, P9; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WALKER SN, 1987, NURS RES, V36, P76; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilks SE, 2018, GERIATR NURS, V39, P663, DOI 10.1016/j.gerinurse.2018.05.002	81	6	6	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S76	S84		10.1016/j.apmr.2018.12.027			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900009	30684488				2022-02-06	
J	Dunn, EC; Humberstone, CE; Iredale, KF; Blazevich, AJ				Dunn, Emily C.; Humberstone, Clare E.; Iredale, K. Fiona; Blazevich, Anthony J.			A damaging punch: Assessment and application of a method to quantify punch performance	TRANSLATIONAL SPORTS MEDICINE			English	Article						boxing; fighting; force production; punch; reliability		Measurement of punch performance in a reliable, quantitative manner is relevant to combat sport, military, and concussion research. A punching protocol (3MPT) was developed, based on performance demands of amateur boxing, and evaluated on a custom-built punch integrator (PI). PI reliability and accuracy were assessed by calculating TE and CV for a range of known masses. A within-subject, repeated-measures design assessed the test-retest reliability of 3MPT. Fifteen male boxers (17.5 +/- 0.5 years; 177.5 +/- 9.5 cm; 73.0 +/- 14.0 kg) were familiarized and then completed two 3MPT trials 90 minutes apart on 2 days (total of four tests). Peak punch force (N), relative punch force (N/kg), impulse (N.s), and rate of force development calculated to various time points were compared using a linear mixed model. Smallest worthwhile change (SWC) was also computed. PI data were reliable and accurate (CV <0.1%). TE and SWC comparisons revealed that 3MPT can detect moderate and large changes in performance; however, within-day reliability improved from day 1 (3.1%-13.8%) to 2 (2.3%-5.1%) indicating a possible learning effect. Likewise, differences between test one and two were greater on day 1 than 2. Numerous punch-related variables can be accurately and reliably measured using the 3MPT but repeat-trial familiarization is suggested to reduce between-test variability.	[Dunn, Emily C.; Iredale, K. Fiona; Blazevich, Anthony J.] Edith Cowan Univ, Ctr Exercise & Sport Sci Res, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Dunn, Emily C.; Humberstone, Clare E.] Australian Inst Sport, Bruce, ACT, Australia		Dunn, EC (corresponding author), Edith Cowan Univ, Ctr Exercise & Sport Sci Res, Sch Med & Hlth Sci, Joondalup, WA, Australia.	ecdunn@our.ecu.edu.au	Blazevich, Anthony J/D-1713-2016	Blazevich, Anthony J/0000-0003-1664-1614; Dunn, Emily/0000-0002-9068-8501; Iredale, Fiona/0000-0003-4186-2574	Australian Government Research Training ProgramAustralian Government	The authors would like to acknowledge the contributions of Mr Jamie Plowman and Mr Michael Steinebronn for their continued technical support throughout this project. Additionally, the authors thank Dr Marijke Welvaert for her statistical support, Boxing Australia for endorsing this research and Miss Ella Bloor for help with the graphics published in this paper. No specific funding was received for this research; however, Ms Emily Dunn was supported by the Australian Government Research Training Program scheme at the time of this research.	BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chaabene H, 2015, SPORTS MED, V45, P337, DOI 10.1007/s40279-014-0274-7; Cohen J, 1998, STAT POWER ANAL BEHA; Davis P, 2018, J STRENGTH COND RES, V32, P3441, DOI 10.1519/JSC.0000000000001864; Davis P, 2015, INT J SPORT PHYSIOL, V10, P53, DOI 10.1123/ijspp.2013-0474; Dunn EC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188675; Dyson R, 2005, 23 INT S BIOM SPORTS; Dyson R, 2007, 25 INT S BIOM SPORTS; El Ashker S, 2011, INT J PERF ANAL SPOR, V11, P356; Halperin I, 2017, J SPORT SCI, V35, P500, DOI 10.1080/02640414.2016.1175651; Hickey K., 1980, BOXING AMATEUR BOXIN; Hopkins W.G., 2015, SPREADSHEETS ANAL VA; International Boxing Association, 2017, AIBA TECHN RUL, P146; Joch W, 1981, 7 INT C BIOM WARS PO; Loturco I, 2016, J STRENGTH COND RES, V30, P109, DOI 10.1519/JSC.0000000000001075; PARKINSON D, 1988, SURG NEUROL, V30, P102, DOI 10.1016/0090-3019(88)90094-8; Pierce JD, 2006, J QUANT ANAL SPORTS, V2, DOI [10.2202/1559-0410.1030, 10.2202/1559-0410.1004]; Piorkowski BA, 2011, SPORT BIOMECH, V10, P1, DOI 10.1080/14763141.2010.547590; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith M, 2001, INT J SPORT NUTR EXE, V11, P238, DOI 10.1123/ijsnem.11.2.238; Smith MS, 2006, J SPORT SCI MED, V5, P74; Smith MS, 2000, EUR J APPL PHYSIOL, V83, P34, DOI 10.1007/s004210000251; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; Turner A, 2015, STRENGTH COND J, V37, P76, DOI 10.1519/SSC.0000000000000113; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207	27	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	APR	2019	2	3					146	152		10.1002/tsm2.71			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ9QO	WOS:000647611700007					2022-02-06	
J	Epstein, EL; Martindale, SL; Miskey, HM; Brancu, M; Beckham, JC; Calhoun, PS; Dedert, E; Elbogen, EB; Fairbank, JA; Hurley, RA; Kilts, JD; Kimbrel, NA; Kirby, A; Marx, CE; McDonald, SD; Moore, SD; Morey, RA; Naylor, JC; Pickett, TC; Rowland, J; Swinkels, C; Szabo, ST; Taber, KH; Tupler, LA; Van Voorhees, EE; Yoash-Gantz, RE				Epstein, Erica L.; Martindale, Sarah L.; Miskey, Holly M.; Brancu, Mira; Beckham, Jean C.; Calhoun, Patrick S.; Dedert, Eric; Elbogen, Eric B.; Fairbank, John A.; Hurley, Robin A.; Kilts, Jason D.; Kimbrel, Nathan A.; Kirby, Angela; Marx, Christine E.; McDonald, Scott D.; Moore, Scott D.; Morey, Rajendra A.; Naylor, Jennifer C.; Pickett, Treven C.; Rowland, Jared; Swinkels, Cindy; Szabo, Steven T.; Taber, Katherine H.; Tupler, Larry A.; Van Voorhees, Elizabeth E.; Yoash-Gantz, Ruth E.		VA Mid-Atlantic MIRECC Workgrp	Posttraumatic stress disorder and traumatic brain Injury: Sex differences in veterans	PSYCHIATRY RESEARCH			English	Article						Female; Veterans; Combat; Mental health	MENTAL-HEALTH DIAGNOSES; OEF/OIF VA PATIENTS; GENDER-DIFFERENCES; IRAQI FREEDOM; SAMPLE; EXPOSURE; SCALE; PTSD; TBI	Around half of Iraq and Afghanistan war veterans with traumatic brain injury (TBI) have co-occurring post traumatic stress disorder (PTSD). Research on the differences between male and female veterans with co-occurring PTSD/TBI is sparse. This study evaluated behavioral health differences between sexes with these conditions. Veterans (N = 1577) completed a structured psychiatric interview, TBI interview, and self-report interviews assessing sleep quality, alcohol use, substance use, pain, depression symptoms, PTSD symptoms, and combat exposure. Groups depended on the presence/absence of a lifetime PTSD diagnosis and history of TBI. Among veterans with PTSD and TBI, males and females were equally likely to meet criteria for current PTSD, and in the PTSD only group, male veterans were more likely to have current PTSD. Male veterans with PTSD were also more likely to meet criteria for lifetime alcohol and substance use disorders (AUD and SUD), and mild TBI. Although TIM severity did not differ between sexes in the TBI only group, female veterans were more likely to have a moderate/severe TBI among veterans with co-occurring PTSD. Female veterans without PTSD and TBI were more likely to have major depressive disorder (MDD). Significant sex differences were found for AUD, MDD, current PTSD, and TBI severity.	[Epstein, Erica L.; Martindale, Sarah L.; Miskey, Holly M.] Salisbury VA Hlth Care Syst, 1601 Brenner Ave, Salisbury, NC 28144 USA; [Epstein, Erica L.; Martindale, Sarah L.; Miskey, Holly M.; VA Mid-Atlantic MIRECC Workgrp] VA Midatlant Mental Illness Res Educ & Clin Ctr M, 508 Fulton St, Durham, NC 27705 USA; [Epstein, Erica L.; Martindale, Sarah L.; Miskey, Holly M.] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA		Epstein, EL; Martindale, SL; Miskey, HM (corresponding author), Salisbury VA Hlth Care Syst, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Erica.Epstein@va.gov; Sarah.Martindale-Supak@va.gov; Holly.Miskey@va.gov	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454; Miskey, Holly/0000-0002-5139-4586	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and TreatmentUS Department of Veterans Affairs; Salisbury VA Health Care System, Durham Veterans Affairs Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center; VA Mid -Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) of the Department of Veterans Affairs Office of Mental Health and Suicide Prevention; Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000525]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [11K2RX000703-01, 11K2RX000908, 1K2RX001298]	This research was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment, the Salisbury VA Health Care System, Durham Veterans Affairs Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, and the VA Mid -Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) of the Department of Veterans Affairs Office of Mental Health and Suicide Prevention.; The VA Mid -Atlantic MIRECC Workgroup contributors for this paper include: Mira Brancu, PhD, Jean C. Beckham, PhD, Patrick S. Calhoun, PhD, Eric Dedert, PhD, Eric B. Elbogen, PhD, John A. Fairbank, PhD, Robin A. Hurley, MD, Jason D. Kilts, PhD, Nathan A. Kimbrel, PhD, Angela Kirby, MS, Christine E. Marx, MD, MS, Scott D. McDonald, PhD, Scott D. Moore, MD, PhD, Rajendra A. Morey, MD, MS, Jennifer C. Naylor, PhD, Treven C. Pickett, PsyD, Jared Rowland, PhD, Cindy Swinkels, PhD, Steven T. Szabo, MD, PhD, Katherine H. Taber, PhD, Larry A. Tupler, PhD, Elizabeth E. Van Voorhees, PhD, and Ruth E. Yoash-Gantz, PsyD. Kimbrel is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000525). McDonald completed funding (2017) by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000703-01). Naylor is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000908). Van Voorhees is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1K2RX001298).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arbisi PA, 2012, PSYCHOL ASSESSMENT, V24, P1034, DOI 10.1037/a0028014; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bagalman, 2013, TRAUMATIC BRAIN INJU; Bean-Mayberry B, 2011, WOMEN HEALTH ISS, V21, pS84, DOI 10.1016/j.whi.2011.04.022; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; DVBIC, 2018, PROGR RET ACT FOLL A; First M.B., 1996, STRUCTURED CLIN INTE; Gaudiano BA, 2014, J PSYCHIAT INTENSIVE, V10, P23; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Harris P., 2013, GUARDIAN; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; LUND M, 1984, J CLIN PSYCHOL, V40, P1323, DOI 10.1002/1097-4679(198411)40:6<1323::AID-JCLP2270400607>3.0.CO;2-I; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; McSally ME, 2011, DAEDALUS-US, V140, P148, DOI 10.1162/DAED_a_00105; Miles SR, 2015, MIL MED, V180, P45, DOI 10.7205/MILMED-D-14-00187; Miskey H.M., 2017, CURR TREAT OPTIONS P, V4, P254, DOI [10.1007/s40501-017-0120-2, DOI 10.1007/S40501-017-0120-2]; National Center for Veterans Analysis and Statistics, 2016, VET POP; Newman JL, 1999, J COUNS DEV, V77, P198, DOI 10.1002/j.1556-6676.1999.tb02440.x; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramsey C, 2017, AM J PUBLIC HEALTH, V107, P329, DOI 10.2105/AJPH.2016.303574; Silove D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171879; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Skopp NA, 2011, J TRAUMA STRESS, V24, P277, DOI 10.1002/jts.20632; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Wang JM, 2015, WOMEN HEALTH ISS, V25, P35, DOI 10.1016/j.whi.2014.09.003; Wilker S, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.28306	44	6	6	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	APR	2019	274						105	111		10.1016/j.psychres.2019.01.097			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	HU1VG	WOS:000465059300015	30784779				2022-02-06	
J	Ferrazzano, PA; Rosario, BL; Wisniewski, SR; Shafi, NI; Siefkes, HM; Miles, DK; Alexander, AL; Bell, MJ; Agrawal, S; Mahoney, S; Gupta, D; Beca, J; Loftis, L; Morris, K; Piper, L; Slater, A; Walson, K; Bennett, T; Kilbaugh, T; O'Meara, AMI; Dean, N; Chima, RS; Biagas, K; Wildschut, E; Peters, M; LaRovere, K; Balcells, J; Robertson, C; Gertz, S; Deep, A; Cooper, S; Wainwright, M; Murphy, S; Kuluz, J; Butt, W; O'Brien, N; Thomas, N; Buttram, S; Erickson, S; Samuel, JM; Agbeko, R; Edwards, R; Ramakrishnan, KA; Winkler, M; Borasino, S; Natale, J; Giza, C; Hilfiker, M; Shellington, D; Figaji, A; Newell, E; Truemper, E; Clark, R; Newth, K; Shafi, N; Miles, D; Schober, M; Zimmerman, J; Ferrazzano, P; Pineda, J; Sarnaik, A				Ferrazzano, Peter A.; Rosario, Bedda L.; Wisniewski, Stephen R.; Shafi, Nadeem, I; Siefkes, Heather M.; Miles, Darryl K.; Alexander, Andrew L.; Bell, Michael J.; Agrawal, Shruti; Mahoney, Sarah; Gupta, Deepak; Beca, John; Loftis, Laura; Morris, Kevin; Piper, Lauren; Slater, Anthony; Walson, Karen; Bennett, Tellen; Kilbaugh, Todd; O'Meara, A. M. Iqbal; Dean, Nathan; Chima, Ranjit S.; Biagas, Katherine; Wildschut, Enno; Peters, Mark; LaRovere, Kerri; Balcells, Joan; Robertson, Courtney; Gertz, Shira; Deep, Akash; Cooper, Sian; Wainwright, Mark; Murphy, Sarah; Kuluz, John; Butt, Warwick; O'Brien, Nicole; Thomas, Neal; Buttram, Sandra; Erickson, Simon; Samuel, J. Mahil; Agbeko, Rachel; Edwards, Richard; Ramakrishnan, Kesava Ananth; Winkler, Margaret; Borasino, Santiago; Natale, Joanne; Giza, Christopher; Hilfiker, Mary; Shellington, David; Figaji, Anthony; Newell, Elizabeth; Truemper, Edward; Clark, Robert; Newth, Kit; Shafi, Nadeem; Miles, Darryl; Schober, Michelle; Zimmerman, Jerry; Ferrazzano, Peter; Pineda, Jose; Sarnaik, Ajit		Investigators ADAPT Trial	Use of magnetic resonance imaging in severe pediatric traumatic brain injury: assessment of current practice	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						magnetic resonance imaging; pediatric traumatic brain injury; survey; trauma	DIFFUSE AXONAL INJURY; GLASGOW COMA SCALE; SEVERE HEAD-INJURY; OUTCOME PREDICTION; PROGNOSTIC VALUE; CHILDREN; LESION; MODERATE; MRI; DISABILITY	OBJECTIVE There is no consensus on the optimal timing and specific brain MRI sequences in the evaluation and management of severe pediatric traumatic brain injury (TBI), and information on current practices is lacking. The authors performed a survey of MRI practices among sites participating in a multicenter study of severe pediatric TBI to provide information for designing future clinical trials using MRI to assess brain injury after severe pediatric TBI. METHODS Information on current imaging practices and resources was collected from 27 institutions participating in the Approaches and Decisions after Pediatric TBI Trial. Multiple-choice questions addressed the percentage of patients with TBI who have MRI studies, timing of MRI, MRI sequences used to investigate TBI, as well as the magnetic field strength of MR scanners used at the participating institutions and use of standardized MRI protocols for imaging after severe pediatric TBI. RESULTS Overall, the reported use of MRI in pediatric patients with severe TBI at participating sites was high, with 40% of sites indicating that they obtain MRI studies in > 95% of this patient population. Differences were observed in the frequency of MRI use between US and international sites, with the US sites obtaining MRI in a higher proportion of their pediatric patients with severe TBI (94% of US vs 44% of international sites reported MRI in at least 70% of patients with severe TBI). The reported timing and composition of MRI studies was highly variable across sites. Sixty percent of sites reported typically obtaining an MRI study within the first 7 days postinjury, with the remainder of responses distributed throughout the first 30-day postinjury period. Responses indicated that MRI sequences sensitive for diffuse axonal injury and ischemia are frequently obtained in patients with TBI, whereas perfusion imaging and spectroscopy techniques are less common. CONCLUSIONS Results from this survey suggest that despite the lack of consensus or guidelines, MRI is commonly obtained during the acute clinical setting after severe pediatric TBI. The variation in MRI practices highlights the need for additional studies to determine the utility, optimal timing, and composition of clinical MRI studies after TBI. The information in this survey describes current clinical MRI practices in children with severe TBI and identifies important challenges and objectives that should be considered when designing future studies.	[Ferrazzano, Peter A.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Rosario, Bedda L.; Wisniewski, Stephen R.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Shafi, Nadeem, I] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Siefkes, Heather M.] Univ Tennessee, Dept Epidemiol, Memphis, TN USA; [Miles, Darryl K.] Univ Tennessee, Dept Pediat, Memphis, TN USA; [Alexander, Andrew L.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Alexander, Andrew L.] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Bell, Michael J.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Agrawal, Shruti] Addenbrookes Hosp, Cambridge, England; [Mahoney, Sarah] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Gupta, Deepak] All India Inst Med Sci, New Delhi, India; [Beca, John] Starship Childrens Hosp, Auckland DHB Charitable Trust, Auckland, New Zealand; [Loftis, Laura] Baylor Coll Med, Houston, TX 77030 USA; [Morris, Kevin] Birmingham Childrens Hosp MIS Fdn Trust, Birmingham, W Midlands, England; [Piper, Lauren] Levine Childrens Hosp, Charlotte, NC USA; [Slater, Anthony] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Qld, Australia; [Walson, Karen] Childrens Healthcare Atlanta, Atlanta, GA USA; [Bennett, Tellen] Childrens Hosp Colorado, Aurora, CO USA; [Kilbaugh, Todd] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [O'Meara, A. M. Iqbal] Childrens Hosp Richmond, Richmond, VA USA; [Dean, Nathan] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Chima, Ranjit S.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, MA USA; [Biagas, Katherine] Columbia Univ, New York, NY USA; [Wildschut, Enno] Erasmus MC, Rotterdam, Netherlands; [Peters, Mark] Great Ormond St Hosp NHS Fdn Trust, London, England; [LaRovere, Kerri] Boston Childrens Hosp, Boston, MA USA; [Balcells, Joan] Hosp Valle De Hebron, Barcelona, Spain; [Robertson, Courtney] Johns Hopkins Univ, Baltimore, MD USA; [Gertz, Shira] Hackensack Univ, Med Ctr, Joseph M Sanzari Childrens Hosp, Hackensack, NJ USA; [Deep, Akash] Kings Coll Hosp NHS Fdn Trust, London, England; [Cooper, Sian] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Wainwright, Mark] Lurie Childrens Hosp, Chicago, IL USA; [Murphy, Sarah] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kuluz, John] Miami Childrens Hosp, Miami, FL USA; [Butt, Warwick] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [O'Brien, Nicole] Nationwide Childrens Hosp, Columbus, OH USA; [Thomas, Neal] Penn State Univ, Hershey, PA USA; [Buttram, Sandra] Phoenix Childrens Hosp, Phoenix, AZ USA; [Erickson, Simon] Princess Margaret Hosp, Perth, WA, Australia; [Samuel, J. Mahil] Royal Manchester Childrens Hosp NHS Fdn Trust, Manchester, Lancs, England; [Agbeko, Rachel] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle, NSW, Australia; [Edwards, Richard] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England; [Ramakrishnan, Kesava Ananth] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Winkler, Margaret; Borasino, Santiago] Univ Alabama Birmingham, Birmingham, AL USA; [Natale, Joanne] Univ Calif Davis, Sacramento, CA 95817 USA; [Giza, Christopher] Univ Calif Los Angeles, Los Angeles, CA USA; [Hilfiker, Mary; Shellington, David] Univ Calif San Diego, San Diego, CA 92103 USA; [Figaji, Anthony] Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Newell, Elizabeth] Univ Iowa Childrens Hosp, Iowa City, IA USA; [Truemper, Edward] Univ Nebraska Med Ctr, Omaha, NE USA; [Truemper, Edward] Nebraska Med Ctr, Omaha, NE USA; [Clark, Robert] Univ Pittsburgh, Pittsburgh, PA USA; [Newth, Kit] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Shafi, Nadeem] LeBonheur Childrens Hosp, Memphis, TN USA; [Miles, Darryl] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Schober, Michelle] Univ Utah, Salt Lake City, UT USA; [Zimmerman, Jerry] Univ Washington, Seattle, WA 98195 USA; [Ferrazzano, Peter] Univ Wisconsin, Madison, WI USA; [Pineda, Jose] Washington Univ, St Louis, MO USA; [Sarnaik, Ajit] Wayne State Univ, Detroit, MI USA		Ferrazzano, PA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	ferrazzano@pediatrics.wisc.edu	Gertz, Shira J/AAT-2711-2020; Alexander, Andrew/ABA-2806-2020; Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808; Edwards, Richard/0000-0001-8415-2180; Bennett, Tellen/0000-0003-1483-4236; Kilbaugh, Todd/0000-0002-4959-3092	NINDS section of the NIH [U01 NS081041, K08NS078113, R01NS092870]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092870, U01NS081041, K08NS078113] Funding Source: NIH RePORTER	Research reported in this publication was supported by the NINDS section of the NIH under award no. U01 NS081041 (Bell), award no. K08NS078113 (Ferrazzano), and R01NS092870 (Ferrazzano and Alexander), and also supported in part by core grant no. U54HD090256 to the University of Wisconsin Waisman Center from the National Institute of Child Health and Human Development (Ferrazzano and Alexander). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Faul M, 2010, TRAUMATIC BRAIN INJU; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1994, RADIOLOGY, V191, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Larsen GY, 2016, NEUROCRIT CARE, V24, P353, DOI 10.1007/s12028-015-0218-6; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shakir A, 2016, J NEUROIMAGING, V26, P103, DOI 10.1111/jon.12286; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Soman S, 2013, AM J NEURORADIOL, V34, P2092, DOI 10.3174/ajnr.A3595; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	36	6	7	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2019	23	4					471	479		10.3171/2018.10.PEDS18374			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HR1GE	WOS:000462877000009	30738383	Green Accepted, Green Submitted			2022-02-06	
J	Heetderks-Fong, E				Heetderks-Fong, Elizabeth			Appropriateness Criteria for Neuroimaging of Adult Headache Patients in the Emergency Department How Are We Doing?	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						ACR-AC; emergency department; headaches; imaging; neuroimaging in ED; nurse practitioner; overuse	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; UNITED-STATES; KNOWLEDGE; TRENDS; CT; PHYSICIANS; EDUCATION; COSTS	The American College of Radiology (ACR) developed Appropriateness Criteria (ACR-AC) for diagnostic imaging to reduce overuse and promote high-yield, cost-effective, evidence-based decision-making. For adult headaches, there are 16 variants with specific imaging recommendations. Headache accounts for 4.5% of emergency department (ED) visits, and 61% are chronic. Imaging for headaches has increased in the past 2 decades, with intracranial pathology diagnoses going down. Evidence suggests that there is poor knowledge of the ACR-AC among advanced practice nurses (APNs) and nonradiologist physicians. The ACR-AC recommendations were examined using the Health Care Cost and Utilization Project State Emergency Department Data (HCUP SEDD) from Maryland in 2013. Imaging proportions were examined, as well as differences between residency program hospitals and hospitals that have APNs in the ED. Of the 11,109 chronic headache visits, a quarter underwent computed tomography ([CT]; 26.9%) and 3.6% underwent magnetic resonance imaging (MRI); the ACR-AC does not recommend use of either of these in patients with chronic headache. There were significant practice differences related to hospital teaching and whether APNs were employed in the ED or not. For patients with posttraumatic headache, there were no significant differences in practice. Computed tomography was used in 76.4% of posttraumatic headache visits. It is unknown whether the ACR-AC are being used in the ED, and there is variability in following the recommendations. Posttraumatic headache protocol is well established in the ED, but chronic headache continues to be a problem in imaging overuse despite recommendations. Radiological education, including the ACR-AC, as well as radiation dosing and exposure information should be part of APN, physician, and registered nurse education, as well as continuing education. Continuing education is critical for adherence to the ACR-AC, as the recommendations are complex and continuously evolving. In addition, to minimize overuse of CT in headaches, the ACR-AC should be integrated into clinical decision support to promote best imaging practices.	[Heetderks-Fong, Elizabeth] Univ Maryland, Sch Nursing, 655 W Lombard St, Baltimore, MD 21201 USA		Heetderks-Fong, E (corresponding author), Univ Maryland, Sch Nursing, 655 W Lombard St, Baltimore, MD 21201 USA.	elizabeth.heetderks@umaryland.edu					Agency for Health Research and Quality (AHRQ), 2017, HCUPNET; Agency for Health Research and Quality (AHRQ) Healthcare Cost and Utilization Project, 2013, HCUP STAT EM DEP DAT; American College of Radiology (ACR), 2017, ACR APPR CRIT; American Hospital Association (AHA), 2012, AHA ANN SURV DAT; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Boone JM, 2012, RADIOLOGY, V265, P544, DOI 10.1148/radiol.12112201; Callaghan BC, 2014, JAMA INTERN MED, V174, P819, DOI 10.1001/jamainternmed.2014.173; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casalino E, 2014, EMERG MED J, V31, P361, DOI 10.1136/emermed-2012-202155; Chiunda AB, 2012, ACAD RADIOL, V19, P635, DOI 10.1016/j.acra.2012.01.003; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Costello JE, 2013, AM J ROENTGENOL, V201, P1283, DOI 10.2214/AJR.12.9720; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Douglas AC, 2014, J AM COLL RADIOL, V11, P657, DOI 10.1016/j.jacr.2014.03.024; Gilbert JW, 2012, EMERG MED J, V29, P576, DOI 10.1136/emermed-2011-200088; Griffey RT, 2014, ACAD EMERG MED, V21, P768, DOI 10.1111/acem.12410; HAWASH K, 2016, NEUROLOGY SUPPL, V3; Hobbs JB, 2018, J AM COLL RADIOL, V15, P34, DOI 10.1016/j.jacr.2017.08.034; Insinga RP, 2011, CEPHALALGIA, V31, P1570, DOI 10.1177/0333102411425960; Kanaan Y, 2013, ACAD RADIOL, V20, P1107, DOI 10.1016/j.acra.2013.05.005; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Krille L, 2010, EUR J RADIOL, V76, P36, DOI 10.1016/j.ejrad.2010.08.025; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leschied JR, 2013, ACAD RADIOL, V20, P1168, DOI 10.1016/j.acra.2013.05.011; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Logsdon R, 2015, ADV EMERG NURS J, V37, P233, DOI 10.1097/TME.0000000000000071; Lucas S, 2013, NEUROLOGY, V80; Mafi JN, 2015, J GEN INTERN MED, V30, P548, DOI 10.1007/s11606-014-3107-3; Messali A, 2016, HEADACHE, V56, P306, DOI 10.1111/head.12755; Moriarity AK, 2015, J AM COLL RADIOL, V12, P358, DOI 10.1016/j.jacr.2014.11.013; Powell DK, 2015, CLIN IMAG, V39, P334, DOI 10.1016/j.clinimag.2014.10.011; Puri S, 2012, AM J ROENTGENOL, V199, P1328, DOI 10.2214/AJR.12.8581; Rosenkrantz AB, 2017, J AM COLL RADIOL, V14, P1282, DOI 10.1016/j.jacr.2017.03.004; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Saha A, 2013, ACAD RADIOL, V20, P284, DOI 10.1016/j.acra.2012.10.006; Sheng AY, 2016, J AM COLL RADIOL, V13, P131, DOI 10.1016/j.jacr.2015.08.026; Shinagare AB, 2014, AM J ROENTGENOL, V202, pW277, DOI 10.2214/AJR.13.10986	38	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	APR-JUN	2019	41	2					172	182		10.1097/TME.0000000000000240			11	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	HW8ZX	WOS:000466981500011	31033665				2022-02-06	
J	Jalin, AMAA; Jin, R; Wang, M; Li, GH				Jalin, Angela Melinda A. Anthony; Jin, Rong; Wang, Min; Li, Guohong			EPPS treatment attenuates traumatic brain injury in mice by reducing A beta burden and ameliorating neuronal autophagic flux	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Neuroprotection; Axonal injury; Beta-amyloid; Autophagy	PATHOLOGY; EXPRESSION; DEFICITS; MODERATE; DEATH	Beta-amyloid (A beta) burden and impaired neuronal autophagy contribute to secondary brain injury after traumatic brain injury (TBI). 4-(2-hydroxyethyl)-1-piperazinepropanesulphonic acid (EPPS) treatment has been reported to reduce A beta aggregation and rescue behavioral deficits in Alzheimer's disease-like mice. Here, we investigated neuroprotective effects of EPPS in a mouse model of TBI. Mice subjected to controlled cortical impact (CCI) were treated with EPPS (120 mg/kg, orally) immediately after CCI and thereafter once daily for 3 or 7 days. We found that EPPS treatment profoundly reduced the accumulation of beta-amyloid precursor protein (beta-APP) and A beta over a widespread area detected in the pericontusional cortex, external capsule (EC), and hippocampal CA1 and CA3 at 3 days after TBI, accompanied by significant reduction in the TBI-induced diffuse axonal injury identified by increased immunoreactivity of SMI-32 (an indicator for axonal damage). We also found that EPPS treatment ameliorated the TBI-induced synaptic damage (as reflected by enhanced postsynaptic density 95, PSD-95), and impairment of autophagy flux in the neurons as reflected by reduced autophagy markers (LC3-II/LC3-I ratio and p62/SQSTM1) and increased lysosomal enzyme cathepsin D (CTSD) in neurons detected in the cortex and hippocampal CA1. As a result, EPPS treatment significantly reduced the TBI-induced early neuronal apoptosis (assessed by active caspase-3), and eventually prevented cortical tissue loss and hippocampal neuronal loss at 28 days after TBI. Additionally, we found that inhibition of autophagic flux with chloroquine by decreasing autophagosome-lysosome fusion significantly reversed the decreased expressions of neuronal p62/SQSTM1 and apoptosis by EPPS treatment. These data suggest that the neuroprotection by EPPS is, at least in part, related to improved autophagy flux. Finally, we found that EPPS treatment significantly improved the cortex-dependent motor and hippocampal-dependent cognitive deficits associated with TBI. Taken together, these findings support the further investigation of EPPS as a treatment for TBI.	[Jalin, Angela Melinda A. Anthony; Jin, Rong; Wang, Min; Li, Guohong] Penn State Hershey Med Ctr, Neurosci Inst, Dept Neurosurg, Hershey, PA 17033 USA		Li, GH (corresponding author), Penn State Hershey Med Ctr, Neurosci Inst, Dept Neurosurg, Hershey, PA 17033 USA.	aanthonyjalin@pennstatehealth.psu.edu; rjin@pennstatehealth.psu.edu; mwang2@pennstatehealth.psu.edu; guohongli@pennstatehealth.psu.edu		Anthony Jalin, Angela Melinda/0000-0002-2831-7996	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088719, NS089991]; Louisiana State University Health Sciences Foundation Fund for Schumpert Endowed Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089991, R01NS088719] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants NS088719 and NS089991 (G.L.) and the Louisiana State University Health Sciences Foundation Fund for Schumpert Endowed Chair (G.L.).	Akwa Y, 2018, MOL PSYCHIATR, V23, P1530, DOI 10.1038/mp.2017.142; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Button RW, 2017, AUTOPHAGY, V13, P1797, DOI 10.1080/15548627.2017.1358850; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Faul M, 2010, TRAUMATIC BRAIN INJU; Forner S, 2017, TRENDS NEUROSCI, V40, P347, DOI 10.1016/j.tins.2017.04.002; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kim HY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9997; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Piras A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0292-9; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Yin Y., 2017, MOL NEUROBIOL, V55, P2454; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang MT, 2017, J NEUROCHEM, V143, P244, DOI 10.1111/jnc.14154	50	6	6	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2019	314						20	33		10.1016/j.expneurol.2019.01.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN1MX	WOS:000459952400003	30639321	Bronze, Green Accepted			2022-02-06	
J	Leibowitz, A; Brotfain, E; Koyfman, L; Klein, M; Hess, S; Zlotnik, A; Boyko, M				Leibowitz, Akiva; Brotfain, Evgeni; Koyfman, Leonid; Klein, Moti; Hess, Shmuel; Zlotnik, Alexander; Boyko, Matthew			Treatment of combined traumatic brain injury and hemorrhagic shock with fractionated blood products versus fresh whole blood in a rat model	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Hemorrhage; Neurological outcomes; Resuscitation	SOLUTION RESUSCITATION; FLUID RESUSCITATION; IMPROVED SURVIVAL; TRANSFUSION; HYPOTENSION; MANAGEMENT; MORTALITY; COAGULOPATHY; CONSEQUENCES; PARAMETERS	IntroductionTreatment of combined traumatic brain injury and hemorrhagic shock, poses a particular challenge due to the possible conflicting consequences. While restoring diminished volume is the treatment goal for hypovolemia, maintaining adequate cerebral perfusion pressure and avoidance of secondary damage remains a treatment goal for the injured brain. Various treatment modalities have been proposed, but the optimal resuscitation fluid and goals have not yet been clearly defined. A growing body of evidence suggests that in hypovolemic shock, resuscitation with fresh whole blood (FWB) may be superior to component therapy without platelets (which are likely to be unavailable in the pre-hospital setting). Nevertheless, the effects of this approach have not been studied in the combined injury. Previously, in a rat model of combined injury we have found that mild resuscitation to MABP of 80mmHg with FWB is superior to fluid resuscitation or aggressive resuscitation with FWB. In this study, we investigate the physiological and neurological outcomes in a rat model of combined traumatic brain injury (TBI) and hypovolemic shock, submitted to treatment with varying amounts of FWB, compared to similar resuscitation goals with fractionated blood productsred blood cells (RBCs) and plasma in a 1:1 ratio regimen.Materials and methods40 male Lewis rats were divided into control and treatment groups. TBI was inflicted by a free-falling rod on the exposed cranium. Hypovolemia was induced by controlled hemorrhage of 30% blood volume. Treatment groups were treated either with fresh whole blood or with RBC+plasma in a 1:1 ratio, achieving a resuscitation goal of a mean arterial blood pressure (MAP) of 80mmHg at 15min. MAP was assessed at 60min, and neurological outcomes and mortality in the subsequent 24h.ResultsAt 60min, hemodynamic parameters were improved compared to controls, but not significantly different between treatment groups. Survival rates at 48h were 100% for both of the mildly resuscitated groups (MABP 80mmHg) with FWB and RBC+plasma. The best neurological outcomes were found in the group mildly resuscitated with FWB and were better when compared to resuscitation with RBC+plasma to the same MABP goal (FWB: Neurological Severity Score (NSS) 62, RBC+plasma: NSS 10 +/- 2, p=0.02).ConclusionsIn this study, we find that mild resuscitation with goals of restoring MAP to 80mmHg (which is lower than baseline) with FWB, provided better hemodynamic stability and survival. However, the best neurological outcomes were found in the group resuscitated with FWB. Thus, we suggest that resuscitation with FWB is a feasible modality in the combined TBI+hypovolemic shock scenario, and may result in improved outcomes compared to platelet-free component blood products.	[Leibowitz, Akiva] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Leibowitz, Akiva; Brotfain, Evgeni; Koyfman, Leonid; Klein, Moti; Hess, Shmuel; Zlotnik, Alexander; Boyko, Matthew] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Gen Intens Care Unit, Beer Sheva, Israel		Brotfain, E (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Gen Intens Care Unit, Beer Sheva, Israel.	bem1975@gmail.com	klein, moti/AAR-6552-2021; Boyko, Matthew/AAC-7341-2021	Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Auten JD, 2015, J TRAUMA ACUTE CARE, V79, P790, DOI 10.1097/TA.0000000000000842; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barret JP, 1999, J TRAUMA, V47, P526, DOI 10.1097/00005373-199909000-00016; Bassett Aaron K, 2016, J Spec Oper Med, V16, P5; BECKETT A, 2003, CAN J SURG, V58, pS153; Borgman MA, 2011, VOX SANG, V101, P44, DOI 10.1111/j.1423-0410.2011.01466.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brotfain E, 2012, SHOCK, V38, P630, DOI 10.1097/SHK.0b013e318272d59f; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; COUNTS RB, 1979, ANN SURG, V190, P91, DOI 10.1097/00000658-197907000-00020; Dar DE, 2010, SHOCK, V34, P75, DOI 10.1097/SHK.0b013e3181ce2cbc; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Esnault P, 2013, ANN FR ANESTH, V32, P670, DOI 10.1016/j.annfar.2013.06.007; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Goforth CW, 2016, CRIT CARE NURSE, V36, P50, DOI 10.4037/ccn2016780; Hallet J, 2013, CRIT CARE MED, V41, P2800, DOI 10.1097/CCM.0b013e31829a6ecb; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Ho AMH, 2012, ANESTHESIOLOGY, V116, P716, DOI 10.1097/ALN.0b013e318245c47b; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Krausz Michael M, 2006, World J Emerg Surg, V1, P14, DOI 10.1186/1749-7922-1-14; Krausz MM, 2000, SHOCK, V13, P230, DOI 10.1097/00024382-200003000-00010; LAVEE J, 1989, J THORAC CARDIOV SUR, V97, P204; Losiniecki A, 2010, CURR TREAT OPTION NE, V12, P142, DOI 10.1007/s11940-010-0063-z; MacLennan S, 2001, CLIN LAB HAEMATOL, V23, P391, DOI 10.1046/j.1365-2257.2001.00419.x; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; MANNO CS, 1991, BLOOD, V77, P930, DOI 10.1182/blood.V77.5.930.930; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MCLEAN JA, 1969, MED J AUSTRALIA, V1, P43, DOI 10.5694/j.1326-5377.1969.tb49677.x; MCLEAN JA, 1967, BRIT MED J, V4, P78, DOI 10.1136/bmj.4.5571.78; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Meledeo MA, 2017, J TRAUMA ACUTE CARE, V82, pS26, DOI 10.1097/TA.0000000000001435; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Park PK, 2013, J TRAUMA ACUTE CARE, V75, pS238, DOI 10.1097/TA.0b013e31829a8c71; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Perveev V I, 1981, Vestn Khir Im I I Grek, V126, P124; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; Popovsky MA, 2006, TRANSFUS APHER SCI, V34, P243, DOI 10.1016/j.transci.2006.01.005; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Rajasekhar A, 2011, CRIT CARE MED, V39, P1507, DOI 10.1097/CCM.0b013e31820eb517; Repine TB, 2006, J TRAUMA, V60, pS59, DOI 10.1097/01.ta.0000219013.64168.b2; Revskoi A K, 1975, Klin Med (Mosk), V53, P99; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Schmoker JD, 1996, J NEUROTRAUM, V13, P67, DOI 10.1089/neu.1996.13.67; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sicard B, 2016, INT MARIT HEALTH, V67, P79, DOI 10.5603/IMH.2016.0016; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; van den Elsen MJLJ, 2010, CURR OPIN ANESTHESIO, V23, P269, DOI 10.1097/ACO.0b013e328336b8d0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1993, J NEUROTRAUM, V10, P307, DOI 10.1089/neu.1993.10.307; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	81	6	6	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2019	45	2					263	271		10.1007/s00068-018-0908-9			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HS2US	WOS:000463718800011	29344708				2022-02-06	
J	Lele, AV; Watanitanon, A; Lakireddy, V; Clark-Bell, C; Moore, A; Zimmerman, JJ; Chesnut, RM; Armstead, W; Vavilala, MS				Lele, Abhijit, V; Watanitanon, Arraya; Lakireddy, Viharika; Clark-Bell, Crystalyn; Moore, Anne; Zimmerman, Jerry J.; Chesnut, Randall M.; Armstead, William; Vavilala, Monica S.			Prevalence, Evolution, and Extent of Impaired Cerebral Autoregulation in Children Hospitalized With Complex Mild Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						autoregulation; children; mild; pediatrics; transcranial Doppler; traumatic brain injury	DIABETIC-KETOACIDOSIS; HEAD-INJURY; MODERATE	Objectives: To examine cerebral autoregulation in children with complex mild traumatic brain injury. Design: Prospective observational convenience sample. Setting: PICU at a level I trauma center. Patients: Children with complex mild traumatic brain injury (trauma, admission Glasgow Coma Scale score 13-15 with either abnormal head CT, or history of loss of consciousness). Interventions: Cerebral autoregulation was tested using transcranial Doppler ultrasound between admission day 1 and 8. Measurements and Main Results: The primary outcome was prevalence of impaired cerebral autoregulation (autoregulation index < 0.4), determined using transcranial Doppler ultrasonography and tilt testing. Secondary outcomes examined factors associated with and evolution and extent of impairment. Cerebral autoregulation testing occurred in 31 children 10 years (sd, 5.2 yr), mostly male (59%) with isolated traumatic brain injury (91%), median admission Glasgow Coma Scale 15, Injury Severity Scores 14.2 (sd, 7.7), traumatic brain injury due to fall (50%), preadmission loss of consciousness (48%), and abnormal head CT scan (97%). Thirtyone children underwent 56 autoregulation tests. Impaired cerebral autoregulation occurred in 15 children (48.4%) who underwent 19 tests; 68% and 32% of tests demonstrated unilateral and bilateral impairment, respectively. Compared with children on median day 6 of admission after traumatic brain injury, impaired autoregulation was most common in the first 5 days after traumatic brain injury (day 1: relative risk, 3.7; 95% CI, 1.9-7.3 vs day 2: relative risk, 2.7; 95% CI, 1.1-6.5 vs day 5: relative risk, 1.33; 95% CI, 0.7-2.3). Children with impaired autoregulation were older (12.3 yr [sd, 1.3 yr] vs 8.7 yr [sd, 1.1 yr]; p = 0.04) and tended to have subdural hematoma (64% vs 44%), epidural hematoma (29% vs 17%), and subarachnoid hemorrhage (36% vs 28%). Eight children (53%) were discharged home with ongoing impaired cerebral autoregulation. Conclusions: Impaired cerebral autoregulation is common in children with complex mild traumatic brain injury, despite reassuring admission Glasgow Coma Scale 13-15. Children with complex mild traumatic brain injury have abnormal cerebrovascular hemodynamics, mostly during the first 5 days. Impairment commonly extends to the contralateral hemisphere and discharge of children with ongoing impaired cerebral autoregulation is common.	[Lele, Abhijit, V] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA; [Lele, Abhijit, V; Moore, Anne; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Watanitanon, Arraya; Lakireddy, Viharika; Clark-Bell, Crystalyn] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Zimmerman, Jerry J.] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Armstead, William] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA USA		Lele, AV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA.; Lele, AV (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	abhijit2@uw.edu		Chesnut, Randall/0000-0001-6377-3666	National Institutes of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Neurological Diseases and Stroke (R21NS095321-02: to Dr. Vavilala).	[Anonymous], 2017, STAT IC COMP PROGR V; Bergman DA, 1999, PEDIATRICS, V104, P1407; Centers for Disease Control and Prevention, 2016, REP PED MILD TRAUM B; Chandee T, 2017, PEDIATR CRIT CARE ME, V18, P1166, DOI 10.1097/PCC.0000000000001350; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; Nagel C, 2016, ACTA NEUROCHIR SUPPL, V122, P239, DOI 10.1007/978-3-319-22533-3_48; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TEASDALE G, 1974, LANCET, V2, P81; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2018, BRAIN INJURY, V32, P269, DOI 10.1080/02699052.2017.1408145; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F	23	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2019	20	4					372	378		10.1097/PCC.0000000000001824			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	IA2HW	WOS:000469383200016	30575699				2022-02-06	
J	Moman, RN; Kor, DJ; Chandran, A; Hanson, AC; Schroeder, DR; Rabinstein, AA; Warner, MA				Moman, Rajat N.; Kor, Daryl J.; Chandran, Arun; Hanson, Andrew C.; Schroeder, Darrell R.; Rabinstein, Alejandro A.; Warner, Matthew A.			Red blood cell transfusion in acute brain injury subtypes: An observational cohort study	JOURNAL OF CRITICAL CARE			English	Article						Red blood cell transfusion; Anemia; Acute brain injury; Length of stay; Mortality	HEMOGLOBIN CONCENTRATION; CEREBRAL OXYGENATION; ANEMIA; INCREASES; METABOLISM; MORTALITY; COMPLICATIONS; HEMODILUTION; HEMORRHAGE; DELIVERY	Purpose: Optimal red blood cell (RBC) transfusion thresholds in acute brain injury (ABI) are poorly defined. Materials and methods: We conducted a retrospective cohort study of adult patients with ABI and moderate anemia (Hb 7-10 g/dL) in a neurological intensive care unit (ICU) at an academic medical center between 2008 and 2015. Transfused and non-transfused patients were matched based on age, ABI subtype, pre-transfusion hemoglobin, and ICU length of stay (LOS) at the time of RBC transfusion. Multivariable regression analyses were performed to assess the relationship between RBC transfusion and hospital LOS, hospital mortality, ICU LOS, ICU mortality, and 24 h change in sequential organ failure assessment (SOFA) scores. Results: 2638 patients met inclusion criteria, with 225 (8.5%) receiving RBC transfusion. Acute ischemic stroke was the most prevalent ABI diagnosis (433%) then intracranial hemorrhage (25.6%), subarachnoid hemorrhage (165%), and traumatic brain injury (TBI) (14.6%). In multivariable analyses, RBC transfusion was associated with longer hospital and ICU LOS, and higher SOFA scores. Each ABI subtype had similar results, except for TBI which showed no difference in hospital LOS. Mortality was not significantly different. Conclusions: In moderately anemic patients with ABI, RBC transfusion was associated with longer hospital and ICU LOS. Prospective investigations are necessary to further assess these relationships. (C) 2018 Elsevier Inc. All rights reserved.	[Moman, Rajat N.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Kor, Daryl J.; Warner, Matthew A.] Mayo Clin, Div Crit Care Med, Dept Anesthesiol & Perioperat Med, 200 1st St SW, Rochester, MN 55905 USA; [Chandran, Arun] Harvard Med Sch, Dept Internal Med, Mt Auburn Hosp, Cambridge, MA USA; [Hanson, Andrew C.; Schroeder, Darrell R.] Mayo Clin, Biostat, Dept Biomed Stat & Informat, Rochester, MN USA; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, Rochester, MN USA		Warner, MA (corresponding author), Mayo Clin, Div Crit Care Med, Dept Anesthesiol & Perioperat Med, 200 1st St SW, Rochester, MN 55905 USA.	warner.matthew@mayo.edu	Moman, Rajat/ABD-5535-2020; Moman, Rajat N/H-2468-2016	Moman, Rajat/0000-0001-6551-7009; Moman, Rajat N/0000-0001-6551-7009	Mayo Clinic Department of Anesthesiology and Perioperative Medicine; Critical Care Integrated Multidisciplinary Practice, Rochester, Minnesota; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL121232]; CTSA grant from the National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR002379]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002379] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL121232] Funding Source: NIH RePORTER	This study was made possible by funding from the Mayo Clinic Department of Anesthesiology and Perioperative Medicine and the Critical Care Integrated Multidisciplinary Practice, Rochester, Minnesota. In addition, this study was supported by an NIH R01 grant (HL121232) to Dr. Kor and by CTSA grant number KL2 TR002379 to Dr. Warner from the National Center for Advancing Translational Sciences (NCATS). The manuscript has been read and approved by all authors. There are no actual or potential conflicts of interest capable of influencing the judgement on the part of any author.	BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; Broessner G, 2009, CRIT CARE MED, V37, P1886, DOI 10.1097/CCM.0b013e31819ffd7f; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chang TR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-379; Chute CG, 2010, J AM MED INFORM ASSN, V17, P131, DOI 10.1136/jamia.2009.002691; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Dexter F, 1997, BRIT J ANAESTH, V79, P346, DOI 10.1093/bja/79.3.346; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Festic E, 2013, NEUROCRIT CARE, V18, P209, DOI 10.1007/s12028-012-9777-y; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Herasevich Vitaly, 2011, Healthc Inform, V28, P44; Kellert L, 2014, J CRIT CARE, V29, P236, DOI 10.1016/j.jcrc.2013.11.008; Kellert L, 2011, STROKE, V42, P2832, DOI 10.1161/STROKEAHA.110.606665; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Kuramatsu JB, 2013, CRIT CARE, V17, DOI 10.1186/cc12827; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Reasoner DK, 1996, ANESTH ANALG, V82, P61, DOI 10.1097/00000539-199601000-00011; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sheth KN, 2011, NEUROSURGERY, V68, P1286, DOI 10.1227/NEU.0b013e31820cccb2; Sico JJ, 2013, J STROKE CEREBROVASC, V22, P271, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.003; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Tu YK, 1997, J NEUROL SCI, V150, P115, DOI 10.1016/S0022-510X(97)00111-1; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	38	6	6	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2019	50						44	49		10.1016/j.jcrc.2018.11.006			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL0HO	WOS:000458375800007	30471560	Green Accepted			2022-02-06	
J	Moran, RN; Covassin, T; Wallace, J				Moran, Ryan N.; Covassin, Tracey; Wallace, Jessica			Premorbid migraine history as a risk factor for vestibular and oculomotor baseline concussion assessment in pediatric athletes	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; migraine; vestibular; vision; pediatrics; trauma	TRAUMATIC BRAIN-INJURY; CHILDREN; RELIABILITY; STATEMENT; SYMPTOMS; HEADACHE; VERTIGO; SPORT; TOOL	OBJECTIVE Migraine history has recently been identified as a risk factor for concussion and recovery. The authors performed a cross-sectional study examining baseline outcome measures on newly developed and implemented concussion assessment tools in pediatrics. The purpose of this study was to examine the effects of premorbid, diagnosed migraine headaches as a risk factor on vestibular and oculomotor baseline assessment in pediatric athletes. METHODS Pediatric athletes between the ages of 8 and 14 years with a diagnosed history of migraine headache (n = 28) and matched controls without a history of diagnosed migraine headache (n = 28) were administered a baseline concussion assessment battery, consisting of the Vestibular/Ocular Motor Screening (VOMS), near point of convergence (NPC), and the King-Devick (K-D) tests. Between-groups comparisons were performed for vestibular symptoms and provocation scores on the VOMS (smooth pursuit, saccades, convergence, vestibular/ocular reflex, visual motion sensitivity), NPC (average distance), and K-D (time). RESULTS Individuals diagnosed with migraine headaches reported greater VOMS smooth pursuit scores (p = 0.02), convergence scores (p = 0.04), vestibular ocular reflex scores (p value range 0.002-0.04), and visual motion sensitivity scores (p = 0.009). Differences were also observed on K-D oculomotor performance with worse times in those diagnosed with migraine headache (p = 0.02). No differences were reported on NPC distance (p = 0.06) or headache symptom reporting (p = 0.07) prior to the VOMS assessment. CONCLUSIONS Pediatric athletes diagnosed with migraine headaches reported higher baseline symptom provocation scores on the VOMS. Athletes with migraine headaches also performed worse on the K-D test, further illustrating the influence of premorbid migraine headaches as a risk factor for elevated concussion assessment outcomes at baseline. Special consideration may be warranted for post-concussion assessment in athletes with migraine headaches.	[Moran, Ryan N.] Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, Tuscaloosa, AL USA; [Covassin, Tracey] Michigan State Univ, Sport Injury Res Lab, Dept Kinesiol, E Lansing, MI 48824 USA; [Wallace, Jessica] Youngstown State Univ, Dept Kinesiol & Sport Sci, Youngstown, OH 44555 USA		Moran, RN (corresponding author), Univ Alabama, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University College of Education; Michigan State University Graduate School Research Fellowship Award	This study was funded by the Michigan State University College of Education and the Graduate School Research Fellowship Award (R.N.M. and T.C.).	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T., 2014, ATHL TRAIN SPORT HLT, DOI [10.3928/19425864-20140916-01, DOI 10.3928/19425864-20140916-01]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Furman Joseph M, 2012, Continuum (Minneap Minn), V18, P1102, DOI 10.1212/01.CON.0000421621.18407.96; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Genizi J, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0625-x; Gil-Gouveia R, 2015, CEPHALALGIA, V35, P662, DOI 10.1177/0333102414553823; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Heyer GL, 2018, CLIN J SPORT MED, V28, P272, DOI 10.1097/JSM.0000000000000445; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Humphriss RL, 2011, INT J PEDIATR OTORHI, V75, P395, DOI 10.1016/j.ijporl.2010.12.015; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; Kirchmann M, 2006, NEUROLOGY, V66, P880, DOI 10.1212/01.wnl.0000203647.48422.dd; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Marcelli V, 2010, HEADACHE, V50, P71, DOI 10.1111/j.1526-4610.2009.01454.x; McCaslin DL, 2011, OTOLARYNG CLIN N AM, V44, P291, DOI 10.1016/j.otc.2011.01.003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Terry DP, 2018, J NEUROTRAMA; Terry DP, 2018, CLIN J SPORT MED	35	6	6	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2019	23	4					465	470		10.3171/2018.10.PEDS18425			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HR1GE	WOS:000462877000008	30641840				2022-02-06	
J	Peris, A; Lazzeri, C; D'Antonio, L; Bombardi, M; Bonizzoli, M; Guetti, C; Maccherini, M; Migliaccio, ML				Peris, Adriano; Lazzeri, Chiara; D'Antonio, Lorenzo; Bombardi, Marco; Bonizzoli, Manuela; Guetti, Cristiana; Maccherini, Massimo; Migliaccio, Maria Luisa			Epidemiological changes in potential heart donors after brain death: a retrospective 15 year cohort study	INTERNAL AND EMERGENCY MEDICINE			English	Article						Causes of brain death; Transplantation system; Potential heart donor; Heart procurement	ORGAN; STATISTICS	Changes in the causes of brain death may influence the numbers of hearts that can be procured and transplanted. We retrospectively investigated whether the distribution of causes responsible for brain death have changed over a 15-year period in a cohort of 1286 potential heart donor (aged <= 60), and whether it influenced heart procurement. Between 2001 and 2016, the age of potential donors significantly increased (p<0.0001) as well as the relative proportion of postanoxic brain death, while that of traumatic brain injury decreased (p=0.0007). A significant increase in the use of norepinephrine was detectable. The number of transplanted hearts did not significantly change, with no differences in the age of donors or in the causes of brain death. According to our data, in our 15-year study period, significant changes in the causes of brain death occurred (indicated by a reduction in potential donors following traumatic brain injury) together with an increase in donor age. Nevertheless, the number of transplanted hearts did not change probably thanks to a modified donor management (as inferred by a different use of vasoactive drugs).	[Peris, Adriano; Lazzeri, Chiara; Bonizzoli, Manuela; Guetti, Cristiana] Univ Careggi, Emergency Dept, Intens Care Unit, Azienda Osped, Largo Brambilla 1, I-50134 Florence, Italy; [Peris, Adriano; Lazzeri, Chiara; Bonizzoli, Manuela; Guetti, Cristiana] Univ Careggi, Reg ECMO Referral Ctr, Azienda Osped, Largo Brambilla 1, I-50134 Florence, Italy; [Peris, Adriano; D'Antonio, Lorenzo; Bombardi, Marco; Migliaccio, Maria Luisa] Tuscany Author Transplantat, CRAOT, Florence, Italy; [Maccherini, Massimo] Univ Siena, Dept Cardiovasc Dis, Siena, Italy		Peris, A (corresponding author), Univ Careggi, Emergency Dept, Intens Care Unit, Azienda Osped, Largo Brambilla 1, I-50134 Florence, Italy.; Peris, A (corresponding author), Univ Careggi, Reg ECMO Referral Ctr, Azienda Osped, Largo Brambilla 1, I-50134 Florence, Italy.; Peris, A (corresponding author), Tuscany Author Transplantat, CRAOT, Florence, Italy.	aperis@libero.it					Callahan DS, 2014, J AM COLL SURGEONS, V219, P752, DOI 10.1016/j.jamcollsurg.2014.04.017; Cohen J, 2015, ISR MED ASSOC J, V17, P365; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Desschans B, 2014, TRANSPL P, V46, P3124, DOI 10.1016/j.transproceed.2014.09.170; Frontera JA, 2010, NEUROCRIT CARE, V12, P103, DOI 10.1007/s12028-009-9292-y; Kramer Andreas H, 2017, CMAJ Open, V5, pE19, DOI 10.9778/cmajo.20160093; Lazzeri C, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13094; Saidi RF, 2012, WORLD J SURG, V36, P2909, DOI 10.1007/s00268-012-1748-0; Van Gelder F, 2009, TRANSPL P, V41, P569, DOI 10.1016/j.transproceed.2009.01.039; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	11	6	6	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1828-0447	1970-9366		INTERN EMERG MED	Intern. Emerg. Med.	APR	2019	14	3					371	375		10.1007/s11739-018-1897-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS3BE	WOS:000463736600008	29943077				2022-02-06	
J	Putukian, M; D'Alonzo, BA; Campbell-McGovern, CS; Wiebe, DJ				Putukian, Margot; D'Alonzo, Bernadette A.; Campbell-McGovern, Carolyn S.; Wiebe, Douglas J.			The Ivy League-Big Ten Epidemiology of Concussion Study A Report on Methods and First Findings	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sport-related concussion; epidemiology; surveillance system; symptoms	SPORTS-RELATED CONCUSSION; RECOVERY-TIME; INJURY; PREDICTOR; SEX	Background: Little is known about the nature of concussion injury among university student-athletes, including concussion incidence and rates across sports, the mechanisms of injury, the type of activity during competition or practice, and the time to return to academics, return to sport, and symptom resolution. Purpose: To describe methods of the Ivy League-Big Ten Epidemiology of Concussion Study and first epidemiologic findings. Study Design: Descriptive epidemiology study. Methods: A prospective cohort study was conducted with data accrued through a surveillance system that was launched in the 2013-2014 athletic season. Surveillance continues to operate by detecting and collecting sport-related concussion (SRC) cases and non-SRC cases in addition to outcomes among university student-athletes. Results: A total of 1922 cases of SRC (649 women, 1004 men) among athletes from 27 sports, including varsity sports and club rugby, were enrolled during the 5 athletic seasons from 2013-2014 through 2017-2018. American football had the most cases (n = 495, 25.8%), followed by women's rugby (n = 199, 6.2%), men's ice hockey (n = 106, 5.5%), men's lacrosse (n = 105, 5.5%), women's soccer (n = 103, 5.4%), wrestling (n = 93, 4.8%), and men's soccer (n = 89, 4.6%), and women's ice hockey (n = 78, 4.1%). The highest overall concussion rates occurred in women's lacrosse (1.35 concussions per 1000 athletic exposures [ AEs]) and football (1.26 per 1000 AEs). Rates of concussion were generally higher during competition than practice and were highest during wrestling competition (4.06 per 1000 AEs) and second highest during football competition (3.68 per 1000 AEs). The median number of concussion symptoms was 7. Time to symptom resolution was longer for athletes with 7 symptoms versus\ 7 (P\.001) but did not differ across the 4 sports with rules comparable by sex and did not differ significantly between women and men (median, 8 vs 9 days, respectively). Women and men did not differ in days to return to academics, exertion activities, or competition. Conclusion: This multisite collaborative endeavor has produced a robust database yielding novel opportunities to better understand the epidemiology of concussion among university student-athletes participating in a variety of sports. Given the setting and number of cases, these findings add to our understanding of SRC and are the first of many that will be generated over the coming years from this large study that continues in its sixth year.	[Putukian, Margot; D'Alonzo, Bernadette A.; Campbell-McGovern, Carolyn S.; Wiebe, Douglas J.] Univ Penn, Philadelphia, PA 19104 USA; [Putukian, Margot] Princeton Univ, Athlet Med, Princeton, NJ 08544 USA; [D'Alonzo, Bernadette A.; Wiebe, Douglas J.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Campbell-McGovern, Carolyn S.] Ivy League, Princeton, NJ USA		Wiebe, DJ (corresponding author), Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Blockley Hall Room 902,423 Guardian Dr, Philadelphia, PA 19104 USA.	dwiebe@upenn.edu		D'Alonzo, Bernadette/0000-0002-3760-2158	Ivy League; Big Ten	D.J.W. and B.A.D. were supported through a contract from the Ivy League and Big Ten. C.S.C.M. is employed by the Ivy League. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	[Anonymous], 1988, PEDIATRICS, V81, P737; [Anonymous], 2009, BR J SPORTS MED S1, V43, pi85; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Campbell-McGovern C, 2018, INJURY PREV, V24, P319, DOI 10.1136/injuryprev-2018-042831; Dick R, 2007, J ATHL TRAINING, V42, P173; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; 2016, J ATHL TRAINING, V51, P189, DOI DOI 10.4085/1062-6050-51.3.05; 2018, EXP NEUROL, V300, P121, DOI DOI 10.1016/J.EXPNEUROL.2017.11.001	26	6	6	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2019	47	5					1236	1247		10.1177/0363546519830100			12	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HY0SA	WOS:000467821500034	30943078				2022-02-06	
J	Rakholia, MV; Kumar, RG; Oh, BM; Ranganathan, PR; Berga, SL; Kochanek, PM; Wagner, AK				Rakholia, Milap V.; Kumar, Raj G.; Oh, Byung-Mo; Ranganathan, Prerna R.; Berga, Sarah L.; Kochanek, Patrick M.; Wagner, Amy K.			Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality	JOURNAL OF NEUROTRAUMA			English	Article						aromatase; estradiol; estrone; inflammation; TBI	CEREBRAL-ARTERY OCCLUSION; TUMOR-NECROSIS-FACTOR; LENGTH-OF-STAY; INFLAMMATORY RESPONSE; CRITICALLY-ILL; SEPTIC SHOCK; AROMATASE CYTOCHROME-P450; SERUM; PROGESTERONE; TISSUE	Extensive pre-clinical studies suggest that sex steroids are neuroprotective in experimental traumatic brain injury (TBI). However, clinical trials involving sex hormone administration have not shown beneficial results, and our observational cohort studies show systemic estradiol (E2) production to be associated with adverse outcomes. Systemic E2 is produced via aromatization of testosterone (T) or reduction of estrone (E1). E1, also produced via aromatization of androstenedione (Andro) and is a marker of T-independent E2 production. We hypothesized that E1 would be (1) associated with TBI-related mortality, (2) the primary intermediate for E2 production, and (3) associated with adipose tissue-specific aromatase transcription. We assessed 100 subjects with severe TBI and 8 healthy controls. Serum levels were measured on days 0-3 post-TBI for key steroidogenic precursors (progesterone), aromatase pathway intermediates (E1, E2, T, Andro), and the adipose tissue-specific aromatase transcription factors cortisol, tumor necrosis factor-alpha (TNF-), and interleukin-6 (IL-6). E1 was elevated after TBI versus controls. High E1 was associated with higher progesterone, cortisol, and IL-6 (p<0.05). Multivariable logistic regression demonstrated that those in the highest E1 tertile had increased odds for mortality (adjusted OR=5.656, 95% CI=1.102-29.045, p=0.038). Structural equation models show that early serum E2 production is largely T independent, occurring predominantly through E1 metabolism. Acute serum E1 functions as a mortality marker for TBI through aromatase-dependent E1 production and T-independent E2 production. Further work should evaluate risk factors for high E2 production and how systemic E2 and its key intermediate E1 contribute to the extracerebral consequences of severe TBI.	[Rakholia, Milap V.; Kumar, Raj G.; Ranganathan, Prerna R.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Kochanek, Patrick M.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Berga, Sarah L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27103 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318, TL1 TR0001858]; Centers for Disease Control (CDC) R49 Consumer Confidence Report (CCR) [323155]; Department of Defense (DOD)United States Department of Defense [W81XWH-071-0701]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001858] Funding Source: NIH RePORTER	The authors acknowledge the University of Pittsburgh Medical Center (UPMC) Trauma Registry team for their role in clinical data collection. This work was supported in part by National Institutes of Health (NIH) 5P01NS030318 and TL1 TR0001858, Centers for Disease Control (CDC) R49 Consumer Confidence Report (CCR) 323155, Department of Defense (DOD) W81XWH-071-0701, and National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) 90DP0041.	Angstwurm MWA, 2005, CRIT CARE MED, V33, P2786, DOI 10.1097/01.CCM.0000190242.24410.17; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bulun SE, 1999, SEMIN REPROD ENDOCR, V17, P349, DOI 10.1055/s-1999-7720; Cadagan D, 2014, MOL GENET METAB REP, V1, P254, DOI 10.1016/j.ymgmr.2014.05.002; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; CHRISTEFF N, 1992, CIRC SHOCK, V36, P249; CHRISTEFF N, 1988, J STEROID BIOCHEM, V29, P435, DOI 10.1016/0022-4731(88)90254-3; CID M, 2001, J CLIN INVEST, V93, P17; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CLELAND WH, 1985, J CLIN ENDOCR METAB, V60, P174, DOI 10.1210/jcem-60-1-174; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Crago EA, 2015, BIOL RES NURS, V17, P558, DOI 10.1177/1099800414561632; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Dubal DB, 1999, J NEUROSCI, V19, P6385; Egami R, 2005, EUR J PHARMACOL, V520, P142, DOI 10.1016/j.ejphar.2005.07.028; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; FOURRIER F, 1994, CIRC SHOCK, V43, P171; Garban HJ, 2004, J CARDIOVASC PHARM, V43, P638, DOI 10.1097/00005344-200405000-00005; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Green PS, 1997, J NEUROSCI, V17, P511; Gregoric Pavle D, 2003, Srp Arh Celok Lek, V131, P118; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; Hawkins ML, 2005, AM SURGEON, V71, P920; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jha RM, 2017, LANCET NEUROL, V16, P578, DOI 10.1016/S1474-4422(17)30225-9; Kajta M, 2002, POL J PHARMACOL, V54, P727; Kemp CD, 2008, AM SURGEON, V74, P866; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Khan N, 2004, ARCH BIOCHEM BIOPHYS, V429, P50, DOI 10.1016/j.abb.2004.05.023; Kumar R.G., 2015, J NEUROTRAUM, V32, pA92; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Li J, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/7405797; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Liu F, 2012, J NEUROENDOCRINOL, V24, P319, DOI 10.1111/j.1365-2826.2011.02248.x; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manwani B, 2015, J CEREBR BLOOD F MET, V35, P221, DOI 10.1038/jcbfm.2014.186; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; McCullough LD, 2003, J NEUROSCI, V23, P8701; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; SALT PJ, 1972, NATURE-NEW BIOL, V238, P91, DOI 10.1038/newbio238091a0; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Schneider CP, 2003, J APPL PHYSIOL, V95, P104, DOI 10.1152/japplphysiol.00182.2003; Schneider CP, 2000, SHOCK, V14, P347, DOI 10.1097/00024382-200014030-00019; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Selles J, 2005, STEROIDS, V70, P251, DOI 10.1016/j.steroids.2004.10.012; SIMON D, 1992, AM J EPIDEMIOL, V135, P783, DOI 10.1093/oxfordjournals.aje.a116365; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; SIMPSON E, 1985, RECENT PROG HORM RES, V52, P185; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; SIMPSON ER, 1993, J STEROID BIOCHEM, V44, P321, DOI 10.1016/0960-0760(93)90235-O; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SPOONER CE, 1992, CLIN IMMUNOL IMMUNOP, V62, pS11, DOI 10.1016/0090-1229(92)90036-N; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1542, DOI 10.1210/jc.76.6.1542; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Swainson MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177175; Tahsili-Fahadan P, 2017, CIRC RES, V120, P559, DOI 10.1161/CIRCRESAHA.116.308446; Tanamas Stephanie K, 2015, BMC Obes, V3, P4, DOI 10.1186/s40608-016-0085-5; Taniguchi T, 1999, AM J EMERG MED, V17, P548, DOI 10.1016/S0735-6757(99)90194-8; TEASDALE G, 1974, LANCET, V2, P81; Tep-areenan P, 2003, EUR J PHARMACOL, V476, P139, DOI 10.1016/S0014-2999(03)02152-6; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Tsang G., 2016, CRIT CARE, P20; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Van den Berghe G, 2001, J CLIN ENDOCR METAB, V86, P3217, DOI 10.1210/jc.86.7.3217; van der Jagt Mathieu, 2012, Recent Pat Cardiovasc Drug Discov, V7, P141; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340; ZHAO Y, 1995, J BIOL CHEM, V270, P16449, DOI 10.1074/jbc.270.27.16449; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350; Zhou KW, 2013, MOL HUM REPROD, V19, P169, DOI 10.1093/molehr/gas044; Zolin SJ, 2015, J TRAUMA ACUTE CARE, V78, P451, DOI 10.1097/TA.0000000000000550; ZUCKERMAN SH, 1995, IMMUNOLOGY, V86, P18	104	6	6	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1156	1167		10.1089/neu.2018.5782			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000463235900003	29947289	Green Published			2022-02-06	
J	Richter, DL; Bankhead, CP; Wascher, DC; Treme, GP; Veitch, A; Schenck, RC				Richter, Dustin L.; Bankhead, Christopher P.; Wascher, Daniel C.; Treme, Gehron P.; Veitch, Andrew; Schenck, Robert C., Jr.			Knee Dislocation (KD) IV Injuries of the Knee	CLINICS IN SPORTS MEDICINE			English	Article						KDIV; Dislocation; Multiligamentous knee injury; MLI	PERONEAL NERVE INJURY; VASCULAR INJURIES; PATTERNS; LIGAMENT; TRAUMA	KDIV ligamentous injuries of the knee are frequently high-energy injuries with significant soft tissue disruption, gross knee instability, and rarely are treated nonoperatively. KDIVs frequently require external fixation, but when presenting in an isolated fashion can be reconstructed in one setting. Five presentations of KDIV injury are described: closed with multitrauma/closed head injury requiring external fixation, irreducible KDIV requiring semi-emergent open reduction , and repair, isolated KDIV without arterial injury undergoing 4-ligament reconstruction after regaining motion, KDIV with varus and slight thrust undergoing medial opening osteotomy before ligament reconstruction, and KDIV with failed ligaments requiring revision and posterior tibial tendon transfer.	[Richter, Dustin L.; Bankhead, Christopher P.; Wascher, Daniel C.; Treme, Gehron P.; Veitch, Andrew; Schenck, Robert C., Jr.] Univ New Mexico, Dept Orthopaed Surg, MSC10 5600,1 Univ New Mexico, Albuquerque, NM 87131 USA		Schenck, RC (corresponding author), Univ New Mexico, Dept Orthopaed Surg, MSC10 5600,1 Univ New Mexico, Albuquerque, NM 87131 USA.	RSchenck@salud.unm.edu		Richter, Dustin/0000-0001-9935-6493	Arthrex	The authors disclose Educational Grants from Arthrex.	Abou-Sayed H, 2002, ARCH SURG-CHICAGO, V137, P585, DOI 10.1001/archsurg.137.5.585; Azar FM, 2011, AM J SPORT MED, V39, P2170, DOI 10.1177/0363546511414855; Becker EH, 2013, J ORTHOP TRAUMA, V27, P226, DOI 10.1097/BOT.0b013e318270def4; Cook S, 2015, KNEE SURG SPORT TR A, V23, P2983, DOI 10.1007/s00167-014-3451-1; Cruz RS, 2016, ARTHROSC TEC, V5, pE563, DOI 10.1016/j.eats.2016.02.006; Cush G, 2011, SPORTS MED ARTHROSC, V19, P139, DOI 10.1097/JSA.0b013e3182191897; Everhart JS, 2018, ARTHROSCOPY, V1, P1; GREEN NE, 1977, J BONE JOINT SURG AM, V59, P236, DOI 10.2106/00004623-197759020-00017; Johnson ME, 2008, AM J SPORT MED, V36, P2448, DOI 10.1177/0363546508325669; Kane PW, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118770170; KENNEDY JC, 1963, J BONE JOINT SURG AM, V45, P889, DOI 10.2106/00004623-196345050-00001; Krych AJ, 2014, CLIN ORTHOP RELAT R, V472, P2630, DOI 10.1007/s11999-014-3542-9; LaPrade RF, 1997, AM J SPORT MED, V25, P433, DOI 10.1177/036354659702500403; LaPrade RF, 2008, J BONE JOINT SURG AM, V90A, P2069, DOI 10.2106/JBJS.G.00979; LaPrade RF, 2010, AM J SPORT MED, V38, P330, DOI 10.1177/0363546509349347; Levy BA, 2009, ARTHROSCOPY, V25, P430, DOI 10.1016/j.arthro.2009.01.008; Levy NM, 2015, KNEE SURG SPORT TR A, V23, P3003, DOI 10.1007/s00167-015-3750-1; Lustig S, 2009, ORTHOP TRAUMATOL-SUR, V95, P614, DOI 10.1016/j.otsr.2009.10.005; MEYERS MH, 1971, J BONE JOINT SURG AM, VA 53, P16, DOI 10.2106/00004623-197153010-00002; Mills WJ, 2004, J TRAUMA, V56, P1261, DOI 10.1097/01.TA.0000068995.63201.0B; Moatshe G, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117706521; Montgomery T J, 1995, Am J Knee Surg, V8, P97; Peskun CJ, 2012, CLIN ORTHOP RELAT R, V470, P774, DOI 10.1007/s11999-011-1981-0; Rihn JA, 2004, J AM ACAD ORTHOP SUR, V12, P334, DOI 10.5435/00124635-200409000-00008; SCHENCK RC, 1994, AAOS INSTR COURS LEC, V43, P127; Stannard JP, 2004, J BONE JOINT SURG AM, V86A, P910, DOI 10.2106/00004623-200405000-00004; Tocci Stephen L, 2010, J Knee Surg, V23, P201, DOI 10.1055/s-0031-1271888; TREIMAN GS, 1992, ARCH SURG-CHICAGO, V127, P1056; Walker DN., 1994, AM J KNEE SURG, V7, P117; Wascher DC, 1997, J ORTHOP TRAUMA, V11, P525, DOI 10.1097/00005131-199710000-00011; Wascher DC, 2000, CLIN SPORT MED, V19, P457, DOI 10.1016/S0278-5919(05)70218-0	31	6	6	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2019	38	2					247	+		10.1016/j.csm.2018.11.007			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HT5UR	WOS:000464629300009	30878047				2022-02-06	
J	Spader, HS; Dean, DC; LaFrance, WC; Raukar, NP; Cosgrove, GR; Eyerly-Webb, SA; Ellermeier, A; Correia, S; Deoni, SCL; Rogg, J				Spader, Heather S.; Dean, Douglas C., III; LaFrance, W. Curt, Jr.; Raukar, Neha P.; Cosgrove, G. Rees; Eyerly-Webb, Stephanie A.; Ellermeier, Anna; Correia, Stephen; Deoni, Sean C. L.; Rogg, Jeffrey			Prospective study of myelin water fraction changes after mild traumatic brain injury in collegiate contact sports	JOURNAL OF NEUROSURGERY			English	Article						mild traumatic brain injury; concussion; sports; myelin	WHITE-MATTER DEVELOPMENT; SPATIAL STATISTICS; REGISTRATION; RELAXATION; COMPONENTS; INTEGRITY; PATHOLOGY; COGNITION; MODERATE; ROBUST	OBJECTIVE Mild traumatic brain injury (mTBI) in athletes, including concussion, is increasingly being found to have long-term sequelae. Current imaging techniques have not been able to identify early damage caused by mTBI that is predictive of long-term symptoms or chronic traumatic encephalopathy. In this preliminary feasibility study, the authors investigated the use of an emerging magnetic resonance imaging (MRI) technique, multicomponent driven equilibrium single pulse observation of T1 and T2 (mcDESPOT), in visualizing acute and chronic white matter changes after mTBI in collegiate football and rugby players. METHODS This study was a nonrandomized, nonblinded prospective trial designed to quantify changes in the myelin water fraction (MWF), used as a surrogate MRI measure of myelin content, in a group of male collegiate football and rugby players, classified here as a contact sport player (CSP) cohort, at the time of mTBI diagnosis and 3 months after injury when the acute symptoms of the injury had resolved. In addition, differences in the MWF between the CSP cohort and a control cohort of noncontact sport players (NCSPs) were quantified. T-tests and a threshold-free cluster enhancement (TFCE) statistical analysis technique were used to identify brain structures with significant changes in the MWF between the CSP and NCSP cohorts and between immediately postinjury and follow-up images obtained in the CSP cohort. RESULTS Brain MR images of 12 right-handed male CSPs were analyzed and compared with brain images of 10 righthanded male NCSPs from the same institution. A comparison of CSP and NCSP baseline images using TFCE showed significantly higher MWFs in the bilateral basal ganglia, anterior and posterior corpora callosa, left corticospinal tract, and left anterior and superior temporal lobe (p < 0.05). At the 3-month follow-up examination, images from the CSP cohort still showed significantly higher MWFs than those identified on baseline images from the NCSP cohort in the bilateral basal ganglia, anterior and posterior corpora callosa, and left anterior temporal lobe, and also in the bilateral corticospinal tracts, parahippocampal gyrus, and bilateral juxtapositional (previously known as supplemental motor) areas (p < 0.05). In the CSP cohort, a t-test comparing the MWF at the time of injury and 3 months later showed a significant increase in the overall MWF at follow-up (p < 0.005). These increases were greatest in the bilateral basal ganglia and deep white matter. MWF decreases were seen in more superficial white matter (p < 0.005). CONCLUSIONS In this preliminary study, MWF was found to be increased in the brains of CSPs compared with the brains of controls, suggesting acute/chronic MWF alterations in CSPs from previous injuries. Increases in the MWF were also demonstrated in the brains of CSPs 3 months after the players sustained an mTBI. The full clinical significance of an increased MWF and whether this reflects axon neuropathology or disorderly remyelination leading to hypermyelination has yet to be determined.	[Spader, Heather S.] Joe DiMaggio Childrens Hosp, Div Pediat Neurosurg, Hollywood, FL USA; [Eyerly-Webb, Stephanie A.] Mem Healthcare Syst, Off Human Res, Hollywood, FL USA; [Dean, Douglas C., III] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Div Neuropsychiat & Behav Neurol, Providence, RI USA; [Raukar, Neha P.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Ellermeier, Anna; Rogg, Jeffrey] Rhode Isl Hosp, Dept Diagnost Imaging, Providence, RI USA; [LaFrance, W. Curt, Jr.; Correia, Stephen] Brown Univ, Dept Psychiat & Human Behav, Sch Engn, Providence, RI 02912 USA; [LaFrance, W. Curt, Jr.] Brown Univ, Dept Neurol, Sch Engn, Providence, RI 02912 USA; [Deoni, Sean C. L.] Brown Univ, Sch Engn, Adv Baby Imaging Lab, Providence, RI 02912 USA; [Correia, Stephen] Providence VA Med Ctr, Providence, RI USA; [Deoni, Sean C. L.] Mem Hosp Rhode Isl, Dept Pediat, Pawtucket, RI USA; [Cosgrove, G. Rees] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA		Spader, HS (corresponding author), Joe DiMaggio Childrens Hosp, Hollywood, FL 33021 USA.	hspader@mhs.net	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852; Eyerly-Webb, Stephanie/0000-0002-0377-1148	Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI; National Institutes for Mental Health [K99MH110596]; Eunice Kennedy Shriver National Institute of Child Health & Human Development under the National Institutes of Health [T32HD007489, U54 HD090256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007489, U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K99MH110596] Funding Source: NIH RePORTER	This study was funded by a grant from the Department of Diagnostic Imaging, Rhode Island Hospital, Providence, RI. This work was additionally supported in part by the National Institutes for Mental Health (K99MH110596 to DCD) and the Eunice Kennedy Shriver National Institute of Child Health & Human Development under the National Institutes of Health (T32HD007489 to DCD and U54 HD090256 to the Waisman Center).	[Anonymous], 2015, C TRAUM BRAIN INJ US; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Combes AJE, 2017, NEUROIMAGE-CLIN, V16, P17, DOI 10.1016/j.nicl.2017.06.019; Dean DC, 2017, JAMA NEUROL, V74, P41, DOI 10.1001/jamaneurol.2016.3232; Dean DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163774; Dean DC, 2016, NEUROIMAGE, V132, P225, DOI 10.1016/j.neuroimage.2016.02.040; Dean DC, 2015, BRAIN STRUCT FUNCT, V220, P1921, DOI 10.1007/s00429-014-0763-3; Deoni SCL, 2008, J MAGN RESON IMAGING, V27, P1421, DOI 10.1002/jmri.21079; Deoni SCL, 2013, MAGN RESON MED, V70, P147, DOI 10.1002/mrm.24429; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Hurley SA, 2010, ISMRM ESMRMB JOINT A; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lotocki G, 2012, NEUROSCI LETT, V516, P166, DOI 10.1016/j.neulet.2012.03.085; MacKay Alex L, 2016, Brain Plast, V2, P71, DOI 10.3233/BPL-160033; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Muircheartaigh J, 2014, HUM BRAIN MAPP, V35, P4475, DOI 10.1002/hbm.22488; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spader HS, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.1.FOCUS12426; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Weber AM, 2018, NEUROIMAG CLIN N AM, V28, P83, DOI 10.1016/j.nic.2017.09.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	48	6	6	2	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2019	130	4					1321	1329		10.3171/2017.12.JNS171597			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR1CV	WOS:000462866700030	29712487	Green Accepted, Bronze			2022-02-06	
J	Stolla, M; Zhang, FY; Meyer, MR; Zhang, JN; Dong, JF				Stolla, Moritz; Zhang, Fangyi; Meyer, Michael R.; Zhang, Jianning; Dong, Jing-Fei			Current state of transfusion in traumatic brain injury and associated coagulopathy	TRANSFUSION			English	Article; Proceedings Paper	Annual Symposium on Remote Damage Control Resuscitation (RDCR)	JUN, 2018	Bergen, NORWAY				RED-BLOOD-CELLS; PLATELET ADENOSINE-DIPHOSPHATE; FRESH-FROZEN PLASMA; HEMORRHAGIC-SHOCK; MURINE MODEL; HEAD-INJURY; IN-VIVO; DYSFUNCTION; MORTALITY; STORAGE	Traumatic brain injury (TBI)-induced coagulopathy has long been recognized as a significant risk for poor outcomes in patients with TBI, but its pathogenesis remains poorly understood. As a result, current treatment options for the condition are limited and ineffective. The lack of information is most significant for the impact of blood transfusions on patients with isolated TBI and in the absence of confounding influences from trauma to the body and limbs and the resultant hemorrhagic shock. Here we discuss recent progress in understanding the pathogenesis of TBI-induced coagulopathy and the current state of blood transfusions for patients with TBI and associated coagulopathy.	[Stolla, Moritz; Dong, Jing-Fei] Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA; [Stolla, Moritz; Dong, Jing-Fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Zhang, Fangyi; Meyer, Michael R.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Zhang, Jianning] Tianjin Inst Neurol, Tianjin, Peoples R China; [Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China		Dong, JF (corresponding author), Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA.; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	jianningzhang@hotmail.com; jfdong@psbc.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087296, HL119391]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81271361, 81271359]	This study is supported by NIH grants NS087296 and HL119391 (JFD), Natural Science Foundation of China State Key Program Grant 81330029 (JNZ) and Research Grants 81271361, 81271359 (JNZ).	Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Al-Dorzi HM, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/672639; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Baraniuk S, 2014, INJURY, V45, P1287, DOI 10.1016/j.injury.2014.06.001; Bartels AN, 2016, SURGERY, V160, P954, DOI 10.1016/j.surg.2016.07.012; BEUTLER E, 1969, J LAB CLIN MED, V74, P300; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Bouchard BA, 2018, J TRAUMA ACUTE CARE, V84, P598, DOI 10.1097/TA.0000000000001759; Brasel KJ, 2011, J TRAUMA S3, V71, pS343; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chaudhary R, 2012, BLOOD TRANSFUS-ITALY, V10, P59, DOI 10.2450/2011.0107-10; Daley MJ, 2017, EUR J TRAUMA EMERG S, V43, P105, DOI 10.1007/s00068-016-0643-z; Danesh A, 2014, BLOOD, V123, P687, DOI 10.1182/blood-2013-10-530469; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Downey DM, 2009, AM SURGEON, V75, P1100; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Haltmeier T, 2018, INJURY, V49, P62, DOI 10.1016/j.injury.2017.07.035; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jokar TO, 2016, AM SURGEON, V82, P271; Kannan M, 2010, TRANSFUSION, V50, P1581, DOI 10.1111/j.1537-2995.2010.02585.x; Kim Y, 2018, SURGERY, V163, P423, DOI 10.1016/j.surg.2017.09.028; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P12, DOI 10.1097/TA.0000000000001836; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maani CV, 2009, CURR OPIN ANESTHESIO, V22, P255, DOI 10.1097/ACO.0b013e32832922be; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Mitra B, 2012, EMERG MED J, V29, P622, DOI 10.1136/emj.2011.113167; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Noulsri E, 2018, TRANSFUS APHER SCI, V57, P587, DOI 10.1016/j.transci.2018.07.018; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Prodan CI, 2016, J NEUROTRAUM, V33, P818, DOI 10.1089/neu.2014.3846; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowell SE, 2014, J TRAUMA ACUTE CARE, V77, P846, DOI 10.1097/TA.0000000000000459; Sadallah S, 2008, J LEUKOCYTE BIOL, V84, P1316, DOI 10.1189/jlb.0108013; Said AS, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01120; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; VALERI CR, 1969, J LAB CLIN MED, V73, P722; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Yang CJ, 2011, J TRAUMA, V71, pE132, DOI 10.1097/TA.0b013e31820ea36b; Zecher D, 2014, ARTERIOSCL THROM VAS, V34, P313, DOI 10.1161/ATVBAHA.113.302378; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738; Zielinski MD, 2013, TRANSFUSION, V53, p59S, DOI 10.1111/trf.12037	86	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	APR	2019	59			2	SI		1522	1528		10.1111/trf.15169			7	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	IA3SF	WOS:000469482400017	30980753	Bronze			2022-02-06	
J	Yaramothu, C; Greenspan, LD; Scheiman, M; Alvarez, TL				Yaramothu, Chang; Greenspan, Lynn D.; Scheiman, Mitchell; Alvarez, Tara L.			Vergence Endurance Test: A Pilot Study for a Concussion Biomarker	JOURNAL OF NEUROTRAUMA			English	Article						concussion biomarker; objective concussion metric; post-concussion syndrome; vergence distractors; vergence eye movements	TRAUMATIC BRAIN-INJURY; OCULAR MOTOR-ASSESSMENT; DISPARITY VERGENCE; EYE-MOVEMENTS; CONVERGENCE INSUFFICIENCY; PEAK VELOCITY; MILD; VISION; PHORIA; SACCADES	The Vergence Endurance Test (VET), a quantitative and objective eye movement assessment, was utilized to differentiate control from concussed subjects. Nine symptomatic concussed (2 male; 30.8 +/- 11 years) and 9 asymptomatic control (6 male; 25.1 +/- 1.4 years) subjects participated in the VET. Symmetrical disparity vergence step targets were presented with and without visual distractors. A masked data analyst measured vergence latency, peak velocity, response amplitude, settling time, and the percentage of trials which contained blinks. A Binocular Precision Index (BPI) and a Binocular Accuracy Index (BAI) were calculated to quantify the changes that occur in the vergence parameters over the duration of the VET. Convergence and divergence peak velocity, divergence response amplitude, the percentage of trials that contained blinks during the transient portion of the response, and the BAI were significantly (p < 0.05) different between the concussed and the control subjects. For these parameters, the BAI and divergence response amplitude yielded the greatest accuracy, 78%, in their ability to discriminate between the groups. The VET objectively measures the change in vergence performance over time and shows promise as a method to diagnose a concussion. Future studies will determine whether the VET can be used to assess the extent of natural recovery and the effectiveness of therapeutic interventions.	[Yaramothu, Chang; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, 323 Dr Martin Luther King Jr Blvd, Newark, NJ 07102 USA; [Greenspan, Lynn D.; Scheiman, Mitchell] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA		Alvarez, TL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, 323 Dr Martin Luther King Jr Blvd, Newark, NJ 07102 USA.	tara.l.alvarez@njit.edu	Greenspan, Lynn/ABG-5360-2021	Scheiman, Mitchell/0000-0002-9274-5696; Alvarez, Tara/0000-0002-8797-1613; Yaramothu, Chang/0000-0003-4442-5409	NSF MRINational Science Foundation (NSF)NSF - Office of the Director (OD) [CBET 1428425]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EY023261]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023261] Funding Source: NIH RePORTER	This research was supported by NSF MRI CBET 1428425 and NIH 1R01EY023261 to T.L.A.	Alvarez TL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02851-5; Alvarez TL, 2017, VISION RES, V133, P1, DOI 10.1016/j.visres.2017.01.002; Alvarez TL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00419; Alvarez TL, 2013, INVEST OPHTH VIS SCI, V54, P4122, DOI 10.1167/iovs.13-11797; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Alvarez TL, 2000, VISION RES, V40, P341, DOI 10.1016/S0042-6989(99)00175-3; Alvarez TL, 1998, J NEUROPHYSIOL, V79, P37, DOI 10.1152/jn.1998.79.1.37; Alvarez TL, 1999, ANN BIOMED ENG, V27, P380, DOI 10.1114/1.162; BAHILL AT, 1982, BIOL CYBERN, V45, P1, DOI 10.1007/BF00387207; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Berthold-Lindstedt M, 2017, J REHABIL MED, V49, P327, DOI 10.2340/16501977-2218; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; BlueCross BlueShield, 2016, STEEP RIS CONC DIAGN; Boutis K, 2018, J EMERG MED, V54, P757, DOI 10.1016/j.jemermed.2018.02.041; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Chen YF, 2010, J MED BIOL ENG, V30, P1; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Coubard OA, 2008, GRAEF ARCH CLIN EXP, V246, P521, DOI 10.1007/s00417-007-0714-2; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; DWYER P, 1995, OPTOMETRY VISION SCI, V72, P224, DOI 10.1097/00006324-199504000-00002; Fletcher GF, 2006, AM FAM PHYSICIAN, V74, P1749; Gottschalk AW, 2011, SPORTS MED ARTHROSC, V19, P2, DOI 10.1097/JSA.0b013e31820b95fc; Guo Y, 2011, JOVE-J VIS EXP, V49, P2530; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaschinski W, 2008, VISION RES, V48, P253, DOI 10.1016/j.visres.2007.11.004; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Khazali MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17229-w; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim EH, 2012, CURR EYE RES, V37, P1054, DOI 10.3109/02713683.2012.694551; Kim EH, 2012, VISION RES, V63, P9, DOI 10.1016/j.visres.2012.04.013; Kim EH, 2011, EXP BRAIN RES, V212, P267, DOI 10.1007/s00221-011-2727-7; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Lee YY, 2008, J VISION, V8, DOI 10.1167/8.12.5; Lee YY, 2009, VISION RES, V49, P2960, DOI 10.1016/j.visres.2009.09.013; Leigh RJ, 2016, NEUROLOGY EYE MOVEME; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matta M, 2009, NEUROLOGY, V73, P798, DOI 10.1212/WNL.0b013e3181b6bbf4; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munoz P, 1999, VISION RES, V39, P1695, DOI 10.1016/S0042-6989(98)00206-5; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Paprocki R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00620; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pillai C, 2017, SEMIN OPHTHALMOL, V32, P144, DOI 10.1080/08820538.2016.1228412; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00012; Samadani U., 2015, CONCUSSION, V1, pCNC2; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Semmlow JL, 2002, CAH PSYCHOL COGN, V21, P343; SEMMLOW JL, 1993, OPHTHAL PHYSL OPT, V13, P48, DOI 10.1111/j.1475-1313.1993.tb00426.x; Semmlow JL, 2007, J EYE MOVEMENT RES, V1; Semmlow JL, 2009, J EYE MOVEMENT RES, V2; Servatius RJ, 2018, J NEUROTRAUM, V35, P1008, DOI 10.1089/neu.2017.5314; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Talasan H, 2016, J VISION, V16, DOI 10.1167/16.1.7; TenHave TR, 1996, STAT MED, V15, P2573, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2573::AID-SIM389>3.0.CO;2-O; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yaramothu C, 2018, J VISION, V18, DOI 10.1167/18.6.2; Younger D.S., 2018, WORLD J NEUROSCI, V8, P10; Yuan WH, 2000, VISION RES, V40, P3089, DOI 10.1016/S0042-6989(00)00162-0	85	6	6	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2200	2212		10.1089/neu.2018.6075		MAR 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000462599700001	30829134	Green Published			2022-02-06	
J	Meyers, MC				Meyers, Michael C.			Incidence, Mechanisms, and Severity of Game-Related High School Football Injuries Across Artificial Turf Systems of Various Infill Weights	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						artificial surface; knee; turf; trauma	CRUCIATE LIGAMENT RECONSTRUCTION; NATURAL GRASS SURFACES; PLAYING SURFACES; SOCCER INJURIES; SPORTS INJURIES; SHOE TYPE; RISK; COLLEGIATE; FIELDTURF; EPIDEMIOLOGY	Background: Artificial turf surfaces are developed to duplicate playing characteristics of natural grass. With the newer generations of sand and rubber infill systems, the infill is a common component that varies between fields and is a critical factor that could influence the player-surface interaction. Because the influence of infill weight on sport trauma is unknown, this study quantified football trauma in high schools in the United States across artificial turf systems of various infill weights. Hypothesis: Athletes would not experience differences in game-related injuries across artificial turf systems of various infill weights. Study Design: Cohort study; Level of evidence, 2. Methods: Artificial turf systems were divided into 4 sand/rubber infill weight groups by pounds per square foot: >= 9.0, 6.0-8.9, 3.0-5.9, and 0.0-2.9. A total of 57 high schools in 4 states participated over the course of 5 seasons. Outcomes of interest included injury severity, as a function of infill weight, across head, knee, and shoulder traumas; injury category; primary type of injury; tissue type; specific body location of injury; cleat design; environmental factors; and turf age. Data were subject to multivariate analyses of variance (MANOVAs) and Wilks lambda criteria through use of general linear model procedures. Results: Of 1837 games documented, 528 games were played on infill weights of >= 9.0 lb/ft(2), 521 on 6.0-8.9 lb/ft(2), 525 on 3.0-5.9 lb/ft(2), and 263 on 0.0-2.9 lb/ft(2), with 4655 total injuries reported. MANOVAs indicated significant infill weight effects across injury severity (F-2,F-4648 = 5.087; P = .0001), with significant main effects also observed by injury category, tissue injured, lower extremity joint and muscle, cleat design, environmental factors, and turf age. Post hoc analyses indicated significantly lower (P < .05 to .0001) total and substantial traumas, concussions, shoe-surface interaction during contact trauma, surface impacts, muscle-tendon overload, cleat design influence, adverse weather trauma, lower extremity injuries, and turf age effect while athletes were competing on the 6.0 to >= 9.0 lb/ft(2) infill weight systems compared with the lighter infill weight systems. Conclusion: As infill surface weight decreased, football trauma significantly increased across numerous playing conditions. Based on findings, high school football fields should minimally contain 6.0 pounds of infill per square foot.	[Meyers, Michael C.] Idaho State Univ, Pocatello, ID 83209 USA; [Meyers, Michael C.] Idaho State Univ, Dept Sport Sci & Phys Educ, Pocatello, ID 83209 USA		Meyers, MC (corresponding author), Dept Sport Sci & Phys Educ, 921 South 8th Ave,Stop 8105, Pocatello, ID 83209 USA.	meyersgroupinc@gmail.com	FACSM, Michael C Meyers PhD/AAH-9728-2019	FACSM, Michael C Meyers PhD/0000-0003-3108-7279	FieldTurf USA, Calhoun, Georgia	One or more of the authors has declared the following potential conflict of interest or source of funding: This research was partially funded by FieldTurf USA, Calhoun, Georgia. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	American College of Sports Medicine, 2006, GUID EX TEST PRESCR, p[19, 115]; Ardern CL, 2015, AM J SPORT MED, V43, P848, DOI 10.1177/0363546514563282; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Balazs GC, 2015, AM J SPORT MED, V43, P1798, DOI 10.1177/0363546514545864; Bjorneboe J, 2010, BRIT J SPORT MED, V44, P794, DOI 10.1136/bjsm.2010.073783; Blackburn JT, 2016, MED SCI SPORT EXER, V48, P1664, DOI 10.1249/MSS.0000000000000963; Bradley JP, 2002, ARTHROSCOPY, V18, P502, DOI 10.1053/jars.2002.30649; Brophy RH, 2007, MED SCI SPORT EXER, V39, P22, DOI 10.1249/01.mss.0000241637.52231.18; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dodson CC, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116631949; Drakos MC, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000118; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hart NH, 2016, MED SCI SPORT EXER, V48, P1379, DOI 10.1249/MSS.0000000000000897; Hewett TE, 2017, AM J SPORT MED, V45, P2654, DOI 10.1177/0363546516686080; Iacovelli JN, 2013, BRIT J SPORT MED, V47, P789, DOI 10.1136/bjsports-2012-092113; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Johnston JT, 2018, AM J SPORT MED, V46, P862, DOI 10.1177/0363546518756328; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Junge A, 2000, AM J SPORT MED, V28, pS40; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Lawrence DW, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116639222; Lee AJ, 2001, BRIT J SPORT MED, V35, P412, DOI 10.1136/bjsm.35.6.412; Lindenfeld T N, 1988, Am J Sports Med, V16 Suppl 1, pS69; Livesay GA, 2006, AM J SPORT MED, V34, P415, DOI 10.1177/0363546505284182; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; McCloskey J W, 1988, Am J Sports Med, V16 Suppl 1, pS63; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; McLean SG, 2010, EXERC SPORT SCI REV, V38, P192, DOI 10.1097/JES.0b013e3181f450b4; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Meyers MC, 2017, AM J SPORT MED, V45, P708, DOI 10.1177/0363546516671715; Meyers MC, 2013, AM J SPORT MED, V41, P2409, DOI 10.1177/0363546513498994; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Milne C, 2011, BRIT J SPORT MED, V45, P945, DOI 10.1136/bjsm.2010.076943; Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Orchard JW, 2013, OPEN ACCESS J SPORTS, V4, P251, DOI 10.2147/OAJSM.S52417; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; Parkkari J, 2001, SPORTS MED, V31, P985, DOI 10.2165/00007256-200131140-00003; POWELL JW, 1992, AM J SPORT MED, V20, P686, DOI 10.1177/036354659202000609; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Rudicel S, 1988, Am J Sports Med, V16 Suppl 1, pS48; Shelbourne KD, 2017, AM J SPORT MED, V45, P2730, DOI 10.1177/0363546517718827; Synthetic Turf Council, 2011, GUID SYNTH TURF PERF; Tabachnick B. G., 1989, USING MULTIVARIATE S; The National Federation of State High School Associations, 2014 15 HIGH SCH ATH; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Villwock MR, 2009, AM J SPORT MED, V37, P518, DOI 10.1177/0363546508328108; Wannop JW, 2013, MED SCI SPORT EXER, V45, P2137, DOI 10.1249/MSS.0b013e318299ac56	57	6	6	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR 25	2019	7	3							2325967119832878	10.1177/2325967119832878			12	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HQ3KK	WOS:000462309600001	30937317	Green Published, gold			2022-02-06	
J	Schofield, PW; Mason, R; Nelson, PK; Kenny, D; Butler, T				Schofield, Peter W.; Mason, Racquel; Nelson, Paul K.; Kenny, Dianna; Butler, Tony			Traumatic brain injury is highly associated with self-reported childhood trauma within a juvenile offender cohort	BRAIN INJURY			English	Article						Traumatic brain injury; offending; childhood trauma	YOUNG OFFENDERS; PREVALENCE; ABUSE; POPULATION; BEHAVIOR; SCALES	Primary objective: To identify correlates of past traumatic brain injury (TBI) in a population of young offenders. Research design: Cross-sectional analyses were conducted on available data from a sample derived from the NSW Young People on Community Orders Health Survey. Procedures: Study participants were administered questionnaires to collect history relating to past TBI, childhood trauma, substance abuse, and psychological/psychiatric symptoms and underwent assessments of intellectual functioning. Information on offending history was accessed through Juvenile Justice administrative records. Outcomes and results: Analyses were undertaken on data from 788 young offenders (672 males and 116 females). A past TBI was reported in 39%. Symptoms of psychological distress were more prevalent in females. A history of TBI was associated with more symptoms on a Childhood Trauma Questionnaire, as well as higher psychological distress (K-10), and higher levels on standardized measures of anger/violence, post-traumatic stress, and substance abuse. Conclusions: The experience of early life trauma warrants further consideration as an antecedent to both childhood TBI and offending which might account for some of the previously observed association of mild TBI with subsequent offending behavior.	[Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peter W.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Schofield, Peter W.; Mason, Racquel] Univ Newcastle, Psychol Dept, Newcastle, NSW, Australia; [Nelson, Paul K.] NSW Bur Crime Stat & Res, Sydney, NSW, Australia; [Kenny, Dianna] Univ Sydney, Fac Arts & Social Sci, Sydney, NSW, Australia; [Butler, Tony] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia		Schofield, PW (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.; Schofield, PW (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia.; Schofield, PW (corresponding author), Univ Newcastle, Psychol Dept, Newcastle, NSW, Australia.	peter.schofield@hnehealth.nsw.gov.au		Schofield, Peter/0000-0001-8298-8590; Butler, Tony/0000-0002-2679-2769	Australian Research CouncilAustralian Research Council [LP0347017]; NSW Department of Juvenile Justice, and Justice Health & Forensic Mental Health Network	The survey was supported by a grant from the Australian Research Council (Project LP0347017)], the NSW Department of Juvenile Justice, and Justice Health & Forensic Mental Health Network. We acknowledge the young people who participated in the study and their willingness to share their personal stories, provide information on their mental and physical health, and their aspirations so that we may better understand how to break the juvenile crime cycle.	Bernstein D., 1998, MANUAL CHILDHOOD TRA; Bick J, 2016, NEUROPSYCHOPHARMACOL, V41, P177, DOI 10.1038/npp.2015.252; Carswell K, 2004, J ADOLESCENCE, V27, P415, DOI 10.1016/j.adolescence.2004.04.003; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Elwert F, 2014, ANNU REV SOCIOL, V40, P31, DOI 10.1146/annurev-soc-071913-043455; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Forrest CB, 2000, PEDIATRICS, V105, P286; FRIEDRICH WN, 1976, AM J ORTHOPSYCHIAT, V46, P580, DOI 10.1111/j.1939-0025.1976.tb00957.x; Haapasalo J, 1999, AGGRESS VIOLENT BEH, V4, P107, DOI 10.1016/S1359-1789(97)00027-X; HERRENKOHL EC, 1979, J AM ACAD CHILD PSY, V18, P260, DOI 10.1016/S0002-7138(09)61041-4; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux D, 1998, BRAIN INJURY, V12, P667; IBM Corp, 2015, IBM SPSS STAT WIND V; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kenny D., 2006, NSW YOUNG PEOPLE COM; Kenny DT, 2006, PSYCHOL PUBLIC POL L, V12, P86, DOI 10.1037/1076-8971.12.1.86; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; LEVINE MD, 1985, AM J DIS CHILD, V139, P50, DOI 10.1001/archpedi.1985.02140030052028; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Olson-Madden JH, 2012, REHABILITATION RES P, V2012, P6; PALFREY JS, 1983, PUBLIC HEALTH REP, V98, P449; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Reynolds W.M., 2000, ADOLESCENT PSYCHOPAT; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Velleman R., 2016, BJPSYCH ADV, V22, P108, DOI [DOI 10.1192/APT.BP.114.014449, 10.1192/apt.bp.114.014449]; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wechsler D., 2011, WECHSLER ABBREVIATED; WESCHLER D, 2005, WECHSLER INDIVIDUAL; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	37	6	6	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					412	418		10.1080/02699052.2018.1552020			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100003	30501422				2022-02-06	
J	Lange, RT; Yeh, PH; Brickell, TA; Lippa, SM; French, LM				Lange, Rael T.; Yeh, Ping-Hong; Brickell, Tracey A.; Lippa, Sara. M.; French, Louis M.			Postconcussion symptom reporting is not associated with diffusion tensor imaging findings in the subacute to chronic phase of recovery in military service members following mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Military; white matter integrity; postconcussion symptoms; traumatic brain injury	WHITE-MATTER INTEGRITY; POST-CONCUSSION SYNDROME; GOOD OLD DAYS; POSTTRAUMATIC-STRESS; AXONAL INJURY; CORPUS-CALLOSUM; MODERATE; DISORDER; PTSD; ABNORMALITIES	Introduction: The purpose of this study was to examine the relation between white matter integrity of the brain and postconcussion symptom reporting following mild traumatic brain injury (MTBI). Method: Participants were 109 U.S. military service members (91.7% male) who had sustained a MTBI (n = 88) or orthopedic injury without TBI (trauma controls, TC, n = 21), enrolled from the Walter Reed National Military Medical Center, Bethesda, Maryland. Participants completed a battery of neurobehavioral symptom measures and underwent diffusion tensor imaging (DTI; General Electric 3T) of the whole brain, on average 44.9 months post injury (SD = 42.3). Measures of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were generated for 18 regions of interest (ROIs). Participants in the MTBI group were divided into two subgroups based on International Classification of Diseases-10th Revision (ICD-10) Category C criteria for postconcussion syndrome (PCS): PCS-present (n = 41) and PCS-absent (n = 47). Results: The PCS-present group had significantly worse scores on all 13 neurobehavioral measures than the PCS-absent group (p < .001, d = 0.87-2.50) and TC group (p < .003, d = 0.84-2.06). For all ROIs, there were no significant main effects across the three groups for FA, MD, AD, and RD (all ps >.03). Pairwise comparisons revealed no significant differences for all ROIs when using FA and RD, and only two significant pairwise differences were found between PCS-present and PCS-absent groups when using MD and AD [i.e., anterior thalamic radiation and cingulate gyrus (supracallosal) bundle]. Conclusions: Consistent with past research, but not all studies, postconcussion symptom reporting was not associated with white matter integrity in the subacute to chronic phase of recovery following MTBI.	[Lange, Rael T.; Brickell, Tracey A.; Lippa, Sara. M.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lange, Rael T.; Yeh, Ping-Hong; Brickell, Tracey A.; Lippa, Sara. M.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rlange@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2017, BRAIN IMAGING BEHAV, V11, P1548, DOI 10.1007/s11682-016-9594-6; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davenport ND, 2015, BRAIN IMAGING BEHAV, V9, P472, DOI 10.1007/s11682-015-9371-y; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jiang J, 2017, J PSYCHIATR NEUROSCI, V42, P150, DOI 10.1503/jpn.150341; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lieberman G, 2014, J PAIN, V15, P1110, DOI 10.1016/j.jpain.2014.08.002; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; MCCRAE MA, 2008, MILD TRAUMATIC BRAIN, DOI DOI 10.1017/S1355617710000093; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; O'Doherty DCM, 2018, HUM BRAIN MAPP, V39, P1327, DOI 10.1002/hbm.23920; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teepker M, 2012, HEADACHE, V52, P274, DOI 10.1111/j.1526-4610.2011.02000.x; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Wang W, 2016, BEHAV BRAIN RES, V314, P159, DOI 10.1016/j.bbr.2016.08.017; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zeineh MM, 2015, RADIOLOGY, V274, P517, DOI 10.1148/radiol.14141079	85	6	6	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 28	2019	41	5					497	511	UNSP 1585518	10.1080/13803395.2019.1585518		MAR 2019	15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HY1MF	WOS:000461967500001	30871410				2022-02-06	
J	Wang, YY; Chen, LY; Xu, DG; Chen, TN; Feng, H; Yao, JQ				Wang Yuye; Chen Linyu; Xu Degang; Chen Tunan; Feng Hua; Yao Jianquan			Three-Dimensional Reconstruction of Rat Brain Trauma Based on Terahertz Imaging	ACTA OPTICA SINICA			Chinese	Article						medical optics; biomedical imaging; traumatic brain injury; terahertz wave; three-dimensional reconstruction	INJURY; PATHOPHYSIOLOGY	The rat brain trauma model is established with Feeney's method. The rat brain tissue slices arc imaged with the terahertz transmission imaging system, which shows that the rat brain traumatic region has lower transmittance than the normal region. The three-dimensional modeling of rat brain is realized by the three-dimensional reconstruction technique. The model clearly reflects the spatial distribution of the traumatic region inside the rat brain. This study suggests that the three-dimensional reconstruction technique based on terahertz multi-depth slices imaging has great potential in the precise and accurate biomedical diagnosis.	[Wang Yuye; Chen Linyu; Xu Degang; Yao Jianquan] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin 300072, Peoples R China; [Wang Yuye; Chen Linyu; Xu Degang; Yao Jianquan] Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin 300072, Peoples R China; [Wang Yuye; Chen Tunan; Feng Hua] Army Med Univ, Hosp Affiliated 1, Inst Neurosurg, Chongqing 400038, Peoples R China		Wang, YY (corresponding author), Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin 300072, Peoples R China.; Wang, YY (corresponding author), Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin 300072, Peoples R China.; Wang, YY (corresponding author), Army Med Univ, Hosp Affiliated 1, Inst Neurosurg, Chongqing 400038, Peoples R China.	yuyewang@tju.edu.cn					Bajwa N, 2017, BIOMED OPT EXPRESS, V8, P460, DOI 10.1364/BOE.8.000460; Bin Ji Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36040; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grootendorst MR, 2017, BIOMED OPT EXPRESS, V8, P2932, DOI 10.1364/BOE.8.002932; Joseph CS, 2014, J BIOPHOTONICS, V7, P295, DOI 10.1002/jbio.201200111; Li M Q, 2017, ACTA OPTICA SINICA, V37; Li W J, 2017, ACTA OPTICA SINICA, V37; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Sim YC, 2013, BIOMED OPT EXPRESS, V4, P1413, DOI 10.1364/BOE.4.001413; Wang YY, 2011, PHYS MED BIOL, V56, P4517, DOI 10.1088/0031-9155/56/14/018; Wang YK, 2016, 2016 IEEE/CSAA INTERNATIONAL CONFERENCE ON AIRCRAFT UTILITY SYSTEMS (AUS), P1, DOI 10.1109/AUS.2016.7748011; Wang YY, 2010, OPT EXPRESS, V18, P15504, DOI 10.1364/OE.18.015504; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610	16	6	6	0	1	CHINESE LASER PRESS	SHANGHAI	PO BOX 800-211, SHANGHAI, 201800, PEOPLES R CHINA	0253-2239			ACTA OPT SIN	Acta Opt. Sin.	MAR 10	2019	39	3							0317002	10.3788/AOS201939.0317002			6	Optics	Emerging Sources Citation Index (ESCI)	Optics	VJ7IU	WOS:000620023400028					2022-02-06	
J	Barry, S; Knox, L; Douglas, JM				Barry, Sandra; Knox, Lucy; Douglas, Jacinta M.			"Time's Up": The Experience of Entering Residential Aged Care for Young People with Acquired Neurological Disorders and Their Families	BRAIN IMPAIRMENT			English	Article						qualitative; brain injuries; nursing home; residential aged care; accommodation	TRAUMATIC BRAIN-INJURY; LONG-TERM-CARE; HEALTH; CHOICE; ADULTS; OUTCOMES; HOMES; NEEDS; HOPE	Background and aims: Previous research has highlighted that living in residential aged care (RAC) is associated with a range of negative outcomes for adults with acquired neurological disorders. This study sought to understand the lived experience of entering RAC for young people and their family members and characterise their needs during this process. Method: Data included 64 written and verbal submissions to the 2015 Senate Inquiry into the Adequacy of existing residential care arrangements available for young people with severe physical, mental or intellectual disabilities in Australia. In line with hermeneutic tradition, text was analysed using thematic analysis. Results: Entry to RAC was experienced as a complex process that coalesced around three key events: an unexpected health crisis, a directive that time's up and the individual is required to leave the healthcare setting, with a subsequent decision to move into RAC. This decision was made in the absence of time, knowledge of options or adequate support. Conclusions: Findings suggest that there are both immediate practice changes and longer term policy responses that can support the health and disability systems to uphold the rights of people with acquired disability to choose where and how they will live their lives.	[Barry, Sandra; Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Living Disabil Res Ctr, Bundoora, Vic 3086, Australia; [Barry, Sandra; Knox, Lucy; Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia		Douglas, JM (corresponding author), La Trobe Univ, Living Disabil Res Ctr, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia.	J.Douglas@latrobe.edu.au	Douglas, Jacinta M/C-2380-2009	Douglas, Jacinta/0000-0003-0940-6624			[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Appleton JV, 1997, ADV NURS SCI, V20, P13, DOI 10.1097/00012272-199712000-00003; Australian Institute of Health and Welfare, 2016, RES AG CAR HOM CAR 2; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cameron C, 2001, AUST NZ J PUBL HEAL, V25, P261, DOI 10.1111/j.1467-842X.2001.tb00574.x; Colantonio A, 2015, J HEAD TRAUMA REHAB, V30, pE18, DOI 10.1097/HTR.0000000000000112; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Crotty M., 1998, FDN SOCIAL RES MEANI; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dorsett P, 2010, AUST SOC WORK, V63, P83, DOI 10.1080/03124070903464293; Foster M, 2015, HEALTH SOC CARE COMM, V23, P292, DOI 10.1111/hsc.12146; Fries BE, 2005, J CLIN EPIDEMIOL, V58, P198, DOI 10.1016/j.jclinepi.2004.07.001; Harrington R, 2015, BRAIN INJURY, V29, P1561, DOI 10.3109/02699052.2015.1075142; Knox L, 2018, BRAIN INJURY, V32, P1000, DOI 10.1080/02699052.2018.1468924; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Liamputtong P., 2009, QUALITATIVE RES METH; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McIntyre D, 2017, DISABIL REHABIL, V39, P1829, DOI 10.1080/09638288.2016.1212108; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; Muenchberger H, 2011, DISABIL REHABIL, V33, P1190, DOI 10.3109/09638288.2010.524275; O'Reilly Kate, 2002, Aust Health Rev, V25, P46; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Presson DI, 2009, J GERONTOL NURS, V35, P22, DOI 10.3928/00989134-20090903-02; Productivity Commission, 2011, 54 ACT PROD COMM; Ryan R., 2010, MIDTERM REV YOUNGER; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Smith M, 2004, CONTEMP NURSE, V16, P188, DOI [10.5172/conu.16.3.187, DOI 10.5172/CONU.16.3.187]; Summer Foundation, 2017, NDIS REP CARD OUTC Y; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Van Manen M., 2016, RES LIVED EXPERIENCE; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler D., 2012, EVALUATION QUALITY L; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Winkler D, 2015, BRAIN IMPAIR, V16, P221, DOI 10.1017/BrImp.2015.32; Winkler DF, 2011, AUST HEALTH REV, V35, P320, DOI 10.1071/AH10889; Wright CJ, 2017, J HOUS BUILT ENVIRON, V32, P339, DOI 10.1007/s10901-016-9517-2; Wright CJ, 2015, DISABIL SOC, V30, P834, DOI 10.1080/09687599.2015.1038336	42	6	6	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2019	20	1					37	48		10.1017/BrImp.2018.13			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	HL2WZ	WOS:000458571400004					2022-02-06	
J	Favorov, OV; Francisco, E; Holden, J; Kursun, O; Zai, L; Tommerdahl, M				Favorov, Oleg V.; Francisco, Eric; Holden, Jameson; Kursun, Olcay; Zai, Laila; Tommerdahl, Mark			Quantification of Mild Traumatic Brain Injury via Cortical Metrics: Analytical Methods	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			mTBI; tactile; cortical metrics; concussion assessments	NEUROSENSORY ASSESSMENTS	Mild traumatic brain injuries are difficult to diagnose or assess with commonly used diagnostic methods. However, the functional state of cerebral cortical networks can be rapidly and effectively probed by measuring tactile-based sensory percepts (called cortical metrics), which are designed to exercise various components of cortical machinery. In this study, such cortical metrics were obtained from 52 college students before and after they experienced sports-related concussions by delivering vibrotactile stimuli to the index and middle fingertips. Performance on four of the sensory test protocols is described: reaction time, amplitude discrimination, temporal order judgment, and duration discrimination. The collected test performance data were analyzed using methods of uni- and multivariate statistics, receiver operated characteristic (ROC) curves, and discriminant analysis. While individual cortical metrics vary extensively in their ability to discriminate between control and concussed subjects, their combined discriminative performance greatly exceeds that of any individual metric, achieving cross-validated 93.0% sensitivity, 92.3% specificity, 93.0% positive predictive value, and 92.3% negative predictive value. The cortical metrics vector can be used to track an individual's recovery from concussion. The study thus establishes that cortical metrics can be used effectively as a quantitative indicator of central nervous system health status.	[Favorov, Oleg V.; Tommerdahl, Mark] Univ N Carolina, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA; [Francisco, Eric; Holden, Jameson; Tommerdahl, Mark] Cort Metr LLC, 209 Lloyd St,Suite 360, Carrboro, NC 27510 USA; [Kursun, Olcay] Univ Cent Arkansas, Lewis Sci Ctr, Dept Comp Sci, Room 176, Conway, AR 72035 USA; [Zai, Laila] Appl Res Associates Inc, 4300 San Mateo Blvd NE,Suite A-220, Albuquerque, NM 87110 USA		Favorov, OV (corresponding author), Univ N Carolina, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA.		Kursun, Olcay/AAU-7777-2021	Kursun, Olcay/0000-0001-7153-2061; Favorov, Oleg V./0000-0002-8963-8339	Office of Naval ResearchOffice of Naval Research; Office of the Secretary of Defense for Health Affairs	This study was supported, in part, by the Office of Naval Research. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Cole Wesley R, 2017, J Int Neuropsychol Soc, P1, DOI 10.1017/S1355617717000856; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; Francisco EM, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00077; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Kursun O, 2011, PATTERN RECOGN LETT, V32, P134, DOI 10.1016/j.patrec.2010.09.025; Mahalanobis PC., 1936, P NATL I SCI INDIA, V2, P49; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Nguyen RH, 2013, BRAIN RES, V1492, P53, DOI 10.1016/j.brainres.2012.11.021; Puts NAJ, 2017, AUTISM RES, V10, P608, DOI 10.1002/aur.1691; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; Tommerdahl M, 2010, NEUROSCI BIOBEHAV R, V34, P160, DOI 10.1016/j.neubiorev.2009.08.009; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec	18	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			228	236		10.1093/milmed/usy411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100034	30901467	Bronze			2022-02-06	
J	Fino, PC; Wilhelm, J; Parrington, L; Stuart, S; Chesnutt, JC; King, LA				Fino, Peter C.; Wilhelm, Jennifer; Parrington, Lucy; Stuart, Samuel; Chesnutt, James C.; King, Laurie A.			Inertial Sensors Reveal Subtle Motor Deficits When Walking With Horizontal Head Turns After Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						gait; mild traumatic brain injury; rehabilitation; vestibular; wearable sensors	DUAL-TASK GAIT; ERROR SCORING SYSTEM; POSTURAL-CONTROL; VESTIBULAR REHABILITATION; ORGANIZATION TEST; BALANCE PROBLEMS; SPORT; TRANSLATION; STABILITY; ROTATION	Objective: To examine whether horizontal head turns while seated or while walking, when instrumented with inertial sensors, were sensitive to the acute effects of concussion and whether horizontal head turns had utility for concussion management. Setting: Applied field setting, athletic training room. Participants: Twenty-four collegiate athletes with sports-related concussion and 25 healthy control athletes. Design: Case-control; longitudinal. Main Measures: Peak head angular velocity and peak head angle (range of motion) when performing head turns toward an auditory cue while seated or walking. Gait speed when walking with and without head turns. Results: Athletes with acute sports-related concussion turned their head slower than healthy control subjects initially (group beta = -49.47; SE = 16.33; P = .003) and gradually recovered to healthy control levels within 10 days postconcussion (group x time beta = 4.80; SE = 1.41; P < .001). Peak head velocity had fair diagnostic accuracy in differentiating subjects with acute concussion compared with controls (areas under the receiver operating characteristic curve [AUC] = 0.71-0.73). Peak head angle (P = .17) and gait speed (P = .64) were not different between groups and showed poor diagnostic utility (AUC = 0.57-0.62). Conclusion: Inertial sensors can improve traditional clinical assessments by quantifying subtle, nonobservable deficits in people following sports-related concussion.	[Fino, Peter C.; Wilhelm, Jennifer; Parrington, Lucy; Stuart, Samuel; Chesnutt, James C.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk,Mail Code OP-32, Portland, OR 97239 USA; [Fino, Peter C.; Wilhelm, Jennifer; Parrington, Lucy; Stuart, Samuel; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Wilhelm, Jennifer] Oregon Hlth & Sci Univ, Dept Phys Therapy & Rehabil, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthoped, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Rehabil, Portland, OR 97201 USA		Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk,Mail Code OP-32, Portland, OR 97239 USA.	fino@ohsu.edu	Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Fino, Peter/0000-0002-8621-3706; Parrington, Lucy/0000-0001-8507-9974	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R21HD080398]; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health/Complex Traumatic Brain Injury Rehabilitation Research Program [W81XWH-17-1-0424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD080398] Funding Source: NIH RePORTER	This project was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Award Number R21HD080398) and by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health/Complex Traumatic Brain Injury Rehabilitation Research Program under Award No. W81XWH-17-1-0424. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the NIH or the Department of Defense.	Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chien JH, 2014, ANN BIOMED ENG, V42, P2512, DOI 10.1007/s10439-014-1112-7; Crane BT, 1997, J NEUROPHYSIOL, V78, P2129, DOI 10.1152/jn.1997.78.4.2129; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Doherty C, 2017, HUM MOVEMENT SCI, V52, P160, DOI 10.1016/j.humov.2017.02.005; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; HECHT H, 1993, PERCEPTION, V22, P917, DOI 10.1068/p220917; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Paul SS, 2017, JAMA OTOLARYNGOL, V143, P1008, DOI 10.1001/jamaoto.2017.1443; Raphan T, 2001, ANN NY ACAD SCI, V942, P128; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Toro B., 2003, Physiotherapy Theory and Practice, V19, P137, DOI 10.1080/09593980307964; Weiss A, 2011, PHYSIOL MEAS, V32, P2003, DOI 10.1088/0967-3334/32/12/009; Whitney SL, 2000, J VESTIBUL RES-EQUIL, V10, P99; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	33	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		E74	E81		10.1097/HTR.0000000000000418			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400009	30045224	Green Accepted			2022-02-06	
J	Gauvin-Lepage, J; Friedman, D; Grilli, L; Gagnon, I				Gauvin-Lepage, Jerome; Friedman, Debbie; Grilli, Lisa; Gagnon, Isabelle			Effect of Sex on Recovery From Persistent Postconcussion Symptoms in Children and Adolescents Participating in an Active Rehabilitation Intervention	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children and adolescent; concussion; exercise-based intervention; postconcussion symptoms; sex; trauma	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; GENDER-DIFFERENCES; PROTRACTED RECOVERY; ACUTE CONCUSSION; MILD; SLOW; LIFE	Objective: To estimate the extent to which biologic sex contributes to the severity of postconcussion symptoms (PCSs) in concussed youth, who are slow to recover and who receive an active rehabilitation intervention (ARI) as part of their standard care. Setting: The concussion clinic of a pediatric trauma center in Canada. Participants: A total of 355 youth with persistent PCS (188 girls and 167 boys) as per the following criteria: (1) diagnosed with a concussion (or mild traumatic brain injury) as per the 2004 World Health Organization definition; (2) aged 8 to 17 years (mean = 14.34, standard deviation [SD] = 2.22 years); (3) presenting with at least 1 PCS interfering with daily activities (mean total PCS score at initial assessment = 24.50, SD = 18.88); and (4) on ARI 4 weeks postinjury (mean = 30.46, SD = 3.74 days). Design: A retrospective analysis of a prospective cohort. Main Measures: PCS severity, measured by the PCS Scale (PCSS) included in the Sports Concussion Assessment Tool-3, was the dependent variable. PCSs were assessed 3 times over a 4-week period. Results: Boys presented with significantly fewer symptoms than girls 4 weeks postinjury, at initiation of the ARI (PCSS total score mean: male = 19.9, female = 28.5, P < .001, confidence interval = -14.8 to -6.4), at 2 and 4 weeks of follow-up, but the rate of recovery was slightly faster for girls over the follow-up period. Conclusion: Despite differences between the PCSS score reduction after 4 weeks of intervention, our results favored to a slightly faster recovery for girls over the follow-up period. Although our findings are not strong enough to suggest distinct sex-specific intervention, both boys and girls benefit from participating in an ARI.	[Gauvin-Lepage, Jerome] Univ Montreal, Fac Nursing, Pavillon Marguerite Youville,Off 5088,POB 6128, Montreal, PQ H3C 3J7, Canada; [Gauvin-Lepage, Jerome] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Friedman, Debbie; Grilli, Lisa; Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Trauma Ctr, Ctr Hlth, Montreal, PQ, Canada; [Friedman, Debbie; Gagnon, Isabelle] McGill Univ, Fac Med, Montreal, PQ, Canada		Gauvin-Lepage, J (corresponding author), Univ Montreal, Fac Nursing, Pavillon Marguerite Youville,Off 5088,POB 6128, Montreal, PQ H3C 3J7, Canada.	jerome.gauvin-lepage@umontreal.ca	Gauvin-Lepage, Jerome/AAD-6699-2020	Gagnon, Isabelle/0000-0003-2043-1644			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bisegger C, 2005, SOZ PRAVENTIV MED, V50, P281, DOI 10.1007/s00038-005-4094-2; Bourque C, 2001, CADRE REFERENCE CLIN; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Imhoff S, 2016, J SPORTS MED, V2016, P5127374, DOI DOI 10.1155/2016/5127374; Institut National de Sante Publique du Quebec, 2012, EV HOSP ATTR TRAUM C; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Levy F, 2005, J AM ACAD CHILD PSY, V44, P368, DOI 10.1097/01.chi.0000153232.64968.c1; Lumba-Brown A, 2016, REPORT PEDIAT MILD T; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Luoto TM, 2015, BRAIN INJURY, V29, P565, DOI 10.3109/02699052.2014.1002421; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Pardini D., 2004, BR J SPORTS MED, V38, P661; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; The Montreal Children's Hospital, 2011, MCH TRAUM CONC KIT; Thoma RJ, 2015, BRAIN INJURY, V29, P633, DOI 10.3109/02699052.2014.999352; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Urkin J, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00021; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	45	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		96	102		10.1097/HTR.0000000000000402			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400012	30045216				2022-02-06	
J	Glass, NE; Vadlamani, A; Hwang, F; Sifri, ZC; Kunac, A; Bonne, S; Pentakota, SR; Yonclas, P; Mosenthal, AC; Livingston, DH; Albrecht, JS				Glass, Nina E.; Vadlamani, Aparna; Hwang, Franchesca; Sifri, Ziad C.; Kunac, Anastasia; Bonne, Stephanie; Pentakota, Sri Ram; Yonclas, Peter; Mosenthal, Anne C.; Livingston, David H.; Albrecht, Jennifer S.			Bleeding and Thromboembolism After Traumatic Brain Injury in the Elderly: A Real Conundrum	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; Elderly; Anticoagulation; Stroke; Thromboembolic event	CLINICAL CLASSIFICATION SCHEMES; ATRIAL-FIBRILLATION; NATIONAL REGISTRY; PREDICTING STROKE; RISK; ANTICOAGULATION; ENCEPHALOPATHY; POPULATION; HEMORRHAGE; WARFARIN	Background: Elderly patients presenting with a traumatic brain injury (TBI) often have comorbidities that increase risk of thromboembolic (TE) disease and recurrent TBI. A significant number are on anticoagulant therapy at the time of injury and studies suggest that continuing anticoagulation can prevent TE events. Understanding bleeding, recurrent TBI, and TE risk after TBI can help to guide therapy. Our objectives were to 1) evaluate the incidence of bleeding, recurrent TBI, and TE events after an initial TBI in older adults and 2) identify which factors contribute to this risk. Methods: Retrospective analysis of Medicare claims between May 30, 2006 and December 31, 2009 for patients hospitalized with TBI was performed. We defined TBI for the index admission, and hemorrhage (gastrointestinal bleeding or hemorrhagic stroke), recurrent TBI, and TE events (stroke, myocardial infarction, deep venous thrombosis, or pulmonary embolism) over the following year using ICD-9 codes. Unadjusted incidence rates and 95% confidence intervals (CIs) were calculated. Risk factors of these events were identified using logistic regression. Results: Among beneficiaries hospitalized with TBI, incidence of TE events (58.6 events/1000 person-years; 95% CI 56.2, 60.8) was significantly higher than bleeding (23.6 events/1000 person-years; 95% CI 22.2, 25.1) and recurrentTBI events (26.0 events/1000 person-years; 95% CI 24.5, 27.6). Several common factors predisposed to bleeding, recurrent TBI, and TE outcomes. Conclusions: Among Medicare patients hospitalized with TBI, the incidence of TE was significantly higher than that of bleeding or recurrent TBI. Specific risk factors of bleeding and TE events were identified which may guide care of older adults after TBI. (C) 2018 Elsevier Inc. All rights reserved.	[Glass, Nina E.; Hwang, Franchesca; Sifri, Ziad C.; Kunac, Anastasia; Bonne, Stephanie; Pentakota, Sri Ram; Yonclas, Peter; Mosenthal, Anne C.; Livingston, David H.] Rutgers New Jersey Med Sch, Dept Surg, Div Trauma & Crit Care, Newark, NJ USA; [Vadlamani, Aparna; Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA		Glass, NE (corresponding author), Rutgers New Jersey Med Sch, Univ Hosp, Dept Surg, Div Trauma & Crit Care, M237A 150 Bergen St, Newark, NJ 07103 USA.	nina.glass@rutgers.edu	Pentakota, Sri Ram/ABB-8001-2020	Pentakota, Sri Ram/0000-0001-6872-1507; Glass, Nina/0000-0002-6821-4289; Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER	Dr Albrecht was supported by Agency for Healthcare Quality and Research grant K01HS024560.	Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Perez-Gomez Francisco, 2014, Neurology, V83, P1220, DOI [10.1212/WNL.0000000000000831, 10.1212/01.wnl.0000454881.48113.78]; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Di Bartolomeo S, 2014, J TRAUMA ACUTE CARE, V76, P437, DOI 10.1097/TA.0b013e3182aa80f9; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; January CT, 2014, CIRCULATION, V130, pE272, DOI 10.1161/CIR.0000000000000143; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Marr A., 2004, CENTRAL NERVOUS SYST; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rogers SO, 2007, J AM COLL SURGEONS, V204, P1211, DOI 10.1016/j.jamcollsurg.2007.02.072; Sauter TC, 2016, J NEGAT RESULTS BIOM, V15, DOI 10.1186/s12952-016-0055-y; Seddighi AS, 2013, BRAIN INJURY, V27, P1666, DOI 10.3109/02699052.2013.830333; Son HJ, 2010, J VASC SURG, V51, P667, DOI 10.1016/j.jvs.2009.09.048; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	35	6	6	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2019	235						615	620		10.1016/j.jss.2018.10.021			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	HI9LL	WOS:000456777000076	30691850	Bronze			2022-02-06	
J	Hill, T; Orchard, J; Kountouris, A				Hill, Thomas; Orchard, John; Kountouris, Alex			Incidence of Concussion and Head Impacts in Australian Elite-Level Male and Female Cricketers After Head Impact Protocol Modifications	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; cricket; trauma; neurology; sports medicine	INJURY SURVEILLANCE; CONSENSUS STATEMENT; MANAGEMENT; SPORT	Background: Concussion in sport is a topic of growing interest in Australia and worldwide. To date, relatively few studies have examined the true incidence of concussion in cricket. Hypothesis: Concussion in cricket is more common than current literature suggests. Study Design: Descriptive epidemiology study. Level of Evidence: Level 4. Methods: This is a prospective registry and subsequent analysis of head impacts and concussions in elite-level male and female cricketers in Australia over 2 seasons (2015-2016 and 2016-2017). A total of 172 male and 106 female domestic and international players in 2015-2016 and 179 males and 98 females in 2016-2017 were included. Results: There were 92 head impacts (29 concussions) in men's matches and 15 head impacts (8 concussions) in women's matches. Match incidence rates per 1000 player days were 7.2 head impacts (2.3 concussions) in elite male cricket and 3.7 head impacts (2.0 concussions) in elite female cricket. This equates to a head impact every 2000 balls and concussion every 9000 balls in male domestic cricket. Concussion rates per 1000 player-match hours were 0.4 for elite males and 0.5 for elite females; 53% of head impacts in females were diagnosed as concussions compared with 32% in males, and 83% of concussions resulted in missing no more than 1 game. Conclusion: The rate of concussion in cricket is higher than previously appreciated; however, the majority of patients recovered quickly, and players generally did not miss much playing time as a result. The institution of concussion policies after head impact, including player substitution, appears to have had an effect on increasing reporting of symptoms, resulting in an increase in diagnosis of concussion. Clinical Relevance: Concussion in cricket is not as infrequent as previously assumed. Ongoing review of the rules and regulations is required to ensure that protection of player welfare lies in parallel with other sporting codes.	[Hill, Thomas; Orchard, John; Kountouris, Alex] Cricket Australia, Melbourne, Vic, Australia; [Kountouris, Alex] La Trobe Univ, Sports Med Res Ctr, Melbourne, Vic, Australia		Hill, T (corresponding author), Western Australian Cricket Assoc, 77 Sackville Terrace, Scarborough, WA 6019, Australia.	hillt32@gmail.com	Orchard, John W/AAY-7216-2020	Orchard, John W/0000-0003-3530-1711			Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2014, AUST FAM PHYSICIAN, V43, P94; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Health and Medical Research Council, NAT STAT ETH COND HU; Orchard JW, 2016, OPEN ACCESS J SPORTS, V7, P187, DOI 10.2147/OAJSM.S117497; Orchard JW, 2016, BRIT J SPORT MED, V50, P1245, DOI 10.1136/bjsports-2016-096125; Orchard JW, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012732; Orchard JW, 2012, SPORTS PHYSIO, V4, P19; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959	19	6	6	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2019	11	2					180	185		10.1177/1941738118811315			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HM5DT	WOS:000459496000009	30444677	Green Published			2022-02-06	
J	Torres-Prioris, MJ; Lopez-Barroso, D; Roe-Vellve, N; Paredes-Pacheco, J; Davila, G; Berthier, ML				Jose Torres-Prioris, Maria; Lopez-Barroso, Diana; Roe-Vellve, Nuria; Paredes-Pacheco, Jose; Davila, Guadalupe; Berthier, Marcelo L.			Repetitive verbal behaviors are not always harmful signs: Compensatory plasticity within the language network in aphasia	BRAIN AND LANGUAGE			English	Article							WORD-MEANING DEAFNESS; SHORT-TERM-MEMORY; ARCUATE FASCICULUS; SPEECH PRODUCTION; NAMING ERRORS; LESION LOAD; BRAIN; DISCONNECTION; IMPAIRMENT; DORSAL	Repetitive verbal behaviors such as conduite d'approche (CdA) and mitigated echolalia (ME) are well-known phenomena since early descriptions of aphasia. Nevertheless, there is no substantial fresh knowledge on their clinical features, neural correlates and treatment interventions. In the present study we take advantage of three index cases of chronic fluent aphasia showing CdA, ME or both symptoms to dissect their clinical and neural signatures. Using multimodal neuroimaging (structural magnetic resonance imaging and [18]-fluorodeoxyglucose positron emission tomography during resting state), we found that despite of the heterogeneous lesions in terms of etiology (stroke, traumatic brain injury), volume and location, CdA was present when the lesion affected in greater extent the left dorsal language pathway, while ME resulted from preferential damage to the left ventral stream. The coexistence of CdA and ME was associated with involvement of areas overlapping with the structural lesions and metabolic derangements described in the subjects who showed one of these symptoms (CdA or ME). These findings suggest that CdA and ME represent the clinical expression of plastic changes that occur within the spared language network and its interconnected areas in order to compensate for the linguistic functions that previously relied on the activity of the damaged pathway. We discuss the results in the light of this idea and consider alternative undamaged neural networks that may support CdA and ME.	[Jose Torres-Prioris, Maria; Lopez-Barroso, Diana; Davila, Guadalupe; Berthier, Marcelo L.] Univ Malaga, Cognit Neurol & Aphasia Unit, Ctr Invest Med Sanitarias, Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Jose Torres-Prioris, Maria; Lopez-Barroso, Diana; Davila, Guadalupe] Univ Malaga, Area Psychobiol, Fac Psychol & Speech Therapy, Malaga, Spain; [Jose Torres-Prioris, Maria; Lopez-Barroso, Diana; Davila, Guadalupe; Berthier, Marcelo L.] Univ Malaga, Res Lab Neurosci Language, Fac Psychol & Speech Therapy, Malaga, Spain; [Roe-Vellve, Nuria; Paredes-Pacheco, Jose] Univ Malaga, Mol Imaging Unit, Ctr Invest Med Sanitarias, Gen Fdn, Malaga, Spain; [Roe-Vellve, Nuria] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Paredes-Pacheco, Jose] Univ Compostela, Mol Imaging & Med Phys Grp, Dept Psychiat Radiol & Publ Hlth, Galicia, Spain		Torres-Prioris, MJ; Lopez-Barroso, D (corresponding author), Univ Malaga, Unidad Neurol Cognit & Afasia, Ctr Invest Med Sanitarias CIMES, CMarques de Beccaria 3, Malaga 29010, Spain.	mjprioris@uma.es; dlopbarroso@uma.es	Davila, Guadalupe/D-3050-2011; Torres-Prioris, Maria Jose/AAA-1944-2020; Lopez-Barroso, Diana/AAH-6830-2019	Davila, Guadalupe/0000-0002-3297-4243; Torres-Prioris, Maria Jose/0000-0003-3795-8151; Lopez-Barroso, Diana/0000-0002-8938-1959; Paredes-Pacheco, Jose/0000-0002-4982-2422	Spanish Ministry of Education, Culture and Sport under the FPU program [FPU14/04021, FPU16/05108]; University of Malaga	MJTP and JPP have been funded by PhD scholarships from the Spanish Ministry of Education, Culture and Sport under the FPU program (MJTP: FPU14/04021; JPP: FPU16/05108). DLB has been supported by a postdoctoral grant from the University of Malaga.	Albert M. L., 1981, CLIN ASPECTS DYSPHAS; Axer H, 2001, BRAIN LANG, V76, P317, DOI 10.1006/brln.2000.2425; Baldo JV, 2008, BRAIN LANG, V105, P134, DOI 10.1016/j.bandl.2007.12.007; Basilakos A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00845; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Berthier M.L., 2018, APHASIA REHABILITATI APHASIA REHABILITATI, P143; Berthier ML, 2018, APHASIOLOGY, V32, P784, DOI 10.1080/02687038.2016.1274875; Berthier ML, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00164; Berthier ML, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00873; Berthier ML, 2012, CORTEX, V48, P133, DOI 10.1016/j.cortex.2011.06.014; Bormann T, 2012, CORTEX, V48, P294, DOI 10.1016/j.cortex.2011.06.003; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; BROWN J W, 1975, Cortex, V11, P37; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2014, CURR OPIN NEUROBIOL, V28, P165, DOI 10.1016/j.conb.2014.07.018; Christman Sarah S., 2004, Seminars in Speech and Language, V25, P295, DOI 10.1055/s-2004-837243; Cloutman LL, 2013, BRAIN LANG, V127, P251, DOI 10.1016/j.bandl.2012.08.003; DAMASIO AR, 1992, SCI AM, V267, P89; Dell GS, 2013, COGNITION, V128, P380, DOI 10.1016/j.cognition.2013.05.007; Druks J., 2000, OBJECT ACTION NAMING; Fisher W., 2008, J INTELL DISABIL RES, V32, P357, DOI [10.1111/j.1365-2788.1988.tb01426.x, DOI 10.1111/J.1365-2788.1988.TB01426.X]; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; Foulon C, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy004; Franklin S, 1996, COGNITIVE NEUROPSYCH, V13, P1139, DOI 10.1080/026432996381683; Fridriksson J, 2016, P NATL ACAD SCI USA, V113, P15108, DOI 10.1073/pnas.1614038114; Fridriksson J, 2013, BRAIN, V136, P3451, DOI 10.1093/brain/awt267; Fridriksson J, 2012, NEUROIMAGE, V60, P854, DOI 10.1016/j.neuroimage.2011.12.057; Fridriksson J, 2009, HUM BRAIN MAPP, V30, P2487, DOI 10.1002/hbm.20683; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friston KJ, 2003, TRENDS COGN SCI, V7, P151, DOI 10.1016/S1364-6613(03)00054-8; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Geva S, 2015, BRAIN LANG, V150, P117, DOI 10.1016/j.bandl.2015.09.001; Gierhan SME, 2013, BRAIN LANG, V127, P205, DOI 10.1016/j.bandl.2012.11.002; Gleichgerrcht E, 2017, NEUROIMAGE-CLIN, V16, P461, DOI 10.1016/j.nicl.2017.08.018; Gvion A, 2012, APHASIOLOGY, V26, P579, DOI 10.1080/02687038.2011.643759; Halai AD, 2018, NEUROIMAGE-CLIN, V17, P465, DOI 10.1016/j.nicl.2017.10.037; Hartwigsen G, 2019, NEUROIMAGE, V190, P14, DOI 10.1016/j.neuroimage.2017.11.056; Hickok G., 2016, NEUROBIOLOGY LANGUAG, P299, DOI [DOI 10.1016/B978-0-12-407794-2.00025-0, 10.1016/B978-0-12-407794-2.00025-0]; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok Gregory, 2015, Handb Clin Neurol, V129, P149, DOI 10.1016/B978-0-444-62630-1.00008-1; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hope TMH, 2016, NEUROIMAGE, V125, P1169, DOI 10.1016/j.neuroimage.2015.09.025; Hope TMH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00246; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; JOANETTE Y, 1980, BRAIN LANG, V11, P30, DOI 10.1016/0093-934X(80)90107-8; Kay J, 1992, PALPA PSYCHOLINGUIST; Kertesz A., 1990, BATERFA AFASFAS W W; Kertesz A., 1982, W APHASIA BATTERY; Kleist R., 1931, EUR NEUROL, V80, P188; KOHN SE, 1986, COGNITIVE NEUROPSYCH, V3, P291, DOI 10.1080/02643298608253361; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; Lee YS, 2017, NEUROPSYCHOLOGIA, V94, P52, DOI 10.1016/j.neuropsychologia.2016.11.010; Lopez-Barroso D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00476; Lopez-Barroso D, 2015, NEUROIMAGE, V110, P182, DOI 10.1016/j.neuroimage.2014.12.085; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Makris N, 2009, BRAIN STRUCT FUNCT, V213, P343, DOI 10.1007/s00429-008-0199-8; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; McKinnon ET, 2017, ANN NEUROL, V82, P147, DOI 10.1002/ana.24983; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mirman D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7762; Nadeau SE, 2001, BRAIN LANG, V79, P511, DOI 10.1006/brln.2001.2566; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Nozari N, 2013, BRAIN LANG, V126, P327, DOI 10.1016/j.bandl.2013.07.005; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Papagno C, 2017, HUM BRAIN MAPP, V38, P3011, DOI 10.1002/hbm.23569; PATE DS, 1987, LANG COGNITIVE PROC, V2, DOI DOI 10.1080/01690968708406351; Pick A, 1924, BRAIN, V47, P417, DOI 10.1093/brain/47.4.417; Postman-Caucheteux WA, 2010, J COGNITIVE NEUROSCI, V22, P1299, DOI 10.1162/jocn.2009.21261; Rauschecker AM, 2009, NEUROPSYCHOLOGIA, V47, P180, DOI 10.1016/j.neuropsychologia.2008.08.011; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Restle J, 2012, NEUROPSYCHOLOGIA, V50, P2026, DOI 10.1016/j.neuropsychologia.2012.05.001; Riddoch M. J., 1993, BIRMINGHAM OBJECT RE; Rijntjes Michel, 2012, Front Evol Neurosci, V4, P9, DOI 10.3389/fnevo.2012.00009; Rojkova K, 2016, BRAIN STRUCT FUNCT, V221, P1751, DOI 10.1007/s00429-015-1001-3; Rolheiser T, 2011, J NEUROSCI, V31, P16949, DOI 10.1523/JNEUROSCI.2725-11.2011; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rosso C, 2015, NEUROREHAB NEURAL RE, V29, P287, DOI 10.1177/1545968314543926; Rubens AB, 1983, LOCALIZATION NEUROPS, P245; Sarasso S, 2014, NEUROREHAB NEURAL RE, V28, P129, DOI 10.1177/1545968313498651; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; Sierpowska J, 2017, J NEUROSURG, V126, P435, DOI 10.3171/2016.2.JNS151592; Sollereder S, 2013, PROCD SOC BEHV, V94, P125, DOI 10.1016/j.sbspro.2013.09.060; Spielmann K, 2018, STROKE, V49, P1018, DOI 10.1161/STROKEAHA.117.020197; Spielmann K, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4806492; Stengel E., 1947, DISORDERS LANGUAGE; Suzuki T, 2009, NEUROCASE, V15, P384, DOI 10.1080/13554790902842037; Thiebaut de Schotten M, 2015, CEREB CORTEX, V25, P4812, DOI 10.1093/cercor/bhv173; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P771, DOI 10.1016/j.neuropsychologia.2004.07.020; Ueno T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00422; Valle F., 1995, EPLA EVALUACION PROC EPLA EVALUACION PROC; WALLESCH CW, 1990, APHASIOLOGY, V4, P133, DOI 10.1080/02687039008249066; Wechsler D., 1988, WAIS ESCALA INTELIGE; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Welbourne SR, 2011, COGN NEUROPSYCHOL, V28, P65, DOI 10.1080/02643294.2011.621937; Yeatman JD, 2013, CORTEX, V49, P301, DOI 10.1016/j.cortex.2011.08.006	102	6	6	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	MAR	2019	190						16	30		10.1016/j.bandl.2018.12.004			15	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	HM1TF	WOS:000459235200003	30665003				2022-02-06	
J	Kerr, ZY; Cortes, N; Ambegaonkar, JP; Caswell, AM; Prebble, M; Rommt, K; Caswell, SV				Kerr, Zachary Y.; Cortes, Nelson; Ambegaonkar, Jatin P.; Caswell, Amanda M.; Prebble, Matt; Rommt, Kaitlin; Caswell, Shane, V			The Epidemiology of Injuries in Middle School Football, 2015-2017: The Advancing Healthcare Initiatives for Underserved Students Project	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						youth sports; concussion; contact; head injuries	LIFE COGNITIVE IMPAIRMENT; SPORTS-RELATED CONCUSSION; RECURRENT CONCUSSION; UNITED-STATES; RISK-FACTORS; YOUTH; ASSOCIATION; PLAYERS; RATES; PATTERNS	Background: Although data exist on injuries in youth football leagues, there are limited recent data on injury incidence in middle school football. Updated injury incidence estimates can help drive the development of injury prevention strategies. Purpose: Describe the epidemiology of injuries in middle school football during school years 2015-2016 to 2017-2018. Study Design: Descriptive epidemiology study. Methods: Data originated from 9 public middle schools in Virginia during school years 2015-2016 to 2017-2018. Certified athletic trainers collected injury and athlete-exposure (AE) data from school-sanctioned games and practices in boys', football. Injury counts and rates per 1000 AEs were calculated. Injury rate ratios with 95% CIs compared rates between games and practices. Results: Overall, 664 middle school boys', football injuries were reported, leading to an overall injury rate of 20.54 per 1000 AEs (95% CI, 18.98-22.11). The time loss injury rate (inclusive of injuries with participation restriction time >= 24 hours) was 9.28 per 1000 AEs (95% CI, 8.23-10.33). The injury rate was higher in competition than practice (36.19 vs 17.97 per 1000 AEs; injury rate ratio, 2.01; 95% CI, 1.69-2.40). Most injuries were to the head/face (competition, 20.6%; practice, 15.8%) and hand/wrist (competition, 18.8%; practice, 16.4%) and were diagnosed as contusions (competition, 30.9%; practice, 25.9%) and sprains (competition, 19.4%; practice, 12.6%). Competitions also had a large proportion of concussions (10.3%). Overall, 80.0% and 66.9% of injuries were due to contact in competition and practice, respectively; of these contact-related injuries, 62.1% and 41.6% were specifically player contact. Conclusion: Injury distributions parallel those found in previous research from middle school and other sport settings. Injury rates in middle school football were higher than those reported in previous findings in high school and college. However, caution must be taken when interpreting findings in relation to other surveillance systems with varying methodologies. Still, the findings highlight the need for injury prevention strategies within middle school football, particularly as related to contact-related mechanisms.	[Kerr, Zachary Y.; Cortes, Nelson; Ambegaonkar, Jatin P.; Caswell, Amanda M.; Prebble, Matt; Rommt, Kaitlin; Caswell, Shane, V] George Mason Univ, Manassas, VA 20110 USA; [Cortes, Nelson; Ambegaonkar, Jatin P.; Caswell, Amanda M.; Prebble, Matt; Rommt, Kaitlin; Caswell, Shane, V] George Mason Univ, Res & Testing Lab, Sports Med Assessment, 9100 Freedom Ctr Blvd, Manassas, VA 20110 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Caswell, SV (corresponding author), George Mason Univ, Res & Testing Lab, Sports Med Assessment, 9100 Freedom Ctr Blvd, Manassas, VA 20110 USA.	scaswell@gmu.edu		Cortes, Nelson/0000-0001-8762-3144; Ambegaonkar, Jatin/0000-0002-3790-915X	Potomac Health Foundation; AOSSM	The ACHIEVES Project (Advancing Healthcare Initiatives for Underserved Students) is made possible with grant funding from the Potomac Health Foundation. All authors work on the ACHIEVES Project. Z.Y.K. is a member of the Medical Advisory Committee for the Korey Stringer Institute. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Caswell SV, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662251; Clarke Kenneth S., 1975, AM J SPORTS MED, V3, P292; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, CONVENIENCE SAMPLE S; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; ESPN, 2011, IVY LEAG LIM FULL CO; ESPN, 2013, PAC 12 LIM CONT PRAC; Farrey T, 2016, YOUTH FOOTBALL PARTI; Finch CF, 2015, OSTEOARTHR CARTILAGE, V23, P1138, DOI 10.1016/j.joca.2015.02.165; Green L., LEGAL PERSPECTIVES R; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jones B., 2015, STATES ADOPT PLANS L; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2017, NEUROL CLIN, V35, P409, DOI 10.1016/j.ncl.2017.03.001; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kreck Carol, 2014, STATES ADDRESS CONCU; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; Little League, 2016, CONC YOUTH ATHL; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKeon PO, 2013, SPORTS MED, V43, P385, DOI [10.1007/s40279-013-0043-z, DOI 10.1007/s40279-013-0043-z]; National Collegiate Athletic Association, 2018, YEAR ROUND FOOTB PRA; National Collegiate Athletic Association, NCAA SPORTS SPONS PA; National Federation of High Schools, 2017, 2016 17 HIGH SCH ATH; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell JW, 2004, J ATHL TRAINING, V39, P56; Schussler E, 2018, INT J SPORTS PHYS TH, V13, P229, DOI 10.26603/ijspt20180229; Simon JE, 2016, J ATHL TRAINING, V51, P205, DOI 10.4085/1062-6050-51.4.05; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	48	6	6	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2019	47	4					933	941		10.1177/0363546518825361			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HP0XX	WOS:000461391000022	30802146				2022-02-06	
J	Konkor, I; Kansanga, M; Sano, Y; Atuoye, K; Luginaah, I				Konkor, Irenius; Kansanga, Moses; Sano, Yujiro; Atuoye, Kilian; Luginaah, Isaac			Risk-taking behaviours and timing to first motorbike collision in the Upper West Region of Ghana	JOURNAL OF TRANSPORT & HEALTH			English	Article						Road traffic collisions; Risk-taking behaviours; Timing to first motorbike collision; Upper West Region; Ghana	TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC INJURIES; MOTORCYCLE HELMET USE; ALCOHOL; DRUGS; PERCEPTIONS; FATALITIES; ACCIDENTS; DRIVERS	Introduction: Road traffic collisions kill more than many diseases in Sub-Saharan Africa with the youth, particularly those between 15-29 years, being the most vulnerable group due to their risktaking behaviours. In Ghana, about six people die daily from road traffic collisions. This study examines the relationship between risky behaviours and time to first motorbike collision in northern Ghana with the aim of informing policy and contributing to the Sustainable Development Goals (SDGs). Methods: We collected data from a representative sample of 818 respondents aged 18 years and older from three districts in the Upper West Region of Ghana. We fitted log-normal models to estimate time ratios and hazard graphs, which identified the most at risk group in timing to first collision. Results: The results show that limited knowledge of speed limit (TR=0.75, P<0.001), ever had alcoholic beverage (TR=0.62, P<0.01), know someone died of collision (TR<0.64, P<0.05), and male (TR=0.37, P<0.001) were significant predictors of time to first motorbike collision. Those in the 25-30 age group (TR=0.41, P<0.001) were more at risk compared with those less than 20 years. Conclusion: The implications of the study findings are that for Ghana to achieve target 3.6 of the SDGs, there is the need to intensify existing road safety campaigns on speed limits and alcohol abuse, while enforcing regulations against use of motorbike by unlicensed/under aged riders. It is also crucial to enforce helmet use, particularly among third party riders, who are often not the priority for road safety.	[Konkor, Irenius; Kansanga, Moses; Atuoye, Kilian; Luginaah, Isaac] Univ Western Ontario, Dept Geog, Room 2322 Social Sci Ctr,1151 Richmond St, London, ON, Canada; [Sano, Yujiro] Univ Western Ontario, Dept Sociol, London, ON, Canada		Konkor, I (corresponding author), Univ Western Ontario, Dept Geog, Room 2322 Social Sci Ctr,1151 Richmond St, London, ON, Canada.	ikonkor@uwo.ca	Atuoye, Kilian Nasung/I-4602-2019	Atuoye, Kilian Nasung/0000-0002-6003-980X; Kansanga, Moses Mosonsieyiri/0000-0001-8566-396X	Department of Geography, University of Western Ontario, Canada	The fieldwork for this study was funded by the Department of Geography, University of Western Ontario, Canada.	Adam A, 2016, J MED BIOMED SCI, V5, P5, DOI 10.4314/jmbs.v5i2.2; Afukaar F. K., 2003, ROAD TRAFFIC ACCIDEN; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Akaateba MA, 2015, TRAFFIC INJ PREV, V16, P809, DOI 10.1080/15389588.2015.1024833; Anastasopoulos PC, 2012, TRANSPORT RES REC, P12, DOI 10.3141/2279-02; Barnes TD, 2018, GOVERNANCE, V31, P143, DOI 10.1111/gove.12281; Bawah Ayaga, 2014, Inj Epidemiol, V1, P22; Baxter J, 2005, CAN GEOGR-GEOGR CAN, V49, P61, DOI 10.1111/j.0008-3658.2005.00080.x; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Broughton J., 2007, TRENDS FATAL CAR ACC; Damsere-Derry J, 2018, TRAFFIC INJ PREV, V19, P118, DOI 10.1080/15389588.2017.1369533; Das A, 2012, TRAFFIC INJ PREV, V13, P544, DOI 10.1080/15389588.2012.663518; del Rio MC, 2002, FORENSIC SCI INT, V127, P63; Fell JC, 2016, TRAFFIC INJ PREV, V17, P771, DOI 10.1080/15389588.2016.1157592; Foltz J. D., 2015, UNPUB; Ghana Statistical Service, 2014, 2010 POP HOUS CENS D; Glanz K., 2008, HLTH BEHAV HLTH ED T; GNRSC, 2018, 2076 PEOPL DIED ROAD; GNRSC N. R. S. C., 2017, NRSC 61 ROAD CRASH U; Green E., 2014, WILEY BLACKWELL ENCY, P766, DOI DOI 10.1002/9781118410868.WBEHIBS410; Gupta S, 2018, TRAFFIC INJ PREV, V19, P66, DOI 10.1080/15389588.2017.1342821; Haqverdi MQ, 2015, ACCIDENT ANAL PREV, V85, P102, DOI 10.1016/j.aap.2015.09.007; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Herslund MB, 2003, ACCIDENT ANAL PREV, V35, P885, DOI 10.1016/S0001-4575(02)00095-7; Hochbaum G., 1952, HLTH BELIEF MODEL; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kansanga MM, 2018, INT J HEALTH PLAN M, V33, pE531, DOI 10.1002/hpm.2505; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; Kolb AY, 2005, ACAD MANAG LEARN EDU, V4, P193, DOI 10.5465/AMLE.2005.17268566; Kuo SCH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4649-1; Li LP, 2008, ACCIDENT ANAL PREV, V40, P1937, DOI 10.1016/j.aap.2008.06.019; Liu B., 2003, HELMETS PREVENTING I; Luginaah I, 2003, SOC SCI MED, V57, P1747, DOI 10.1016/S0277-9536(03)00014-5; Manan MMA, 2017, TRANSPORT RES F-TRAF, V50, P109, DOI 10.1016/j.trf.2017.08.006; Moller M, 2016, ACCIDENT ANAL PREV, V87, P1, DOI 10.1016/j.aap.2015.11.008; Nanga S, 2017, ACCIDENT ANAL PREV, V103, P92, DOI 10.1016/j.aap.2017.04.003; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; OROURKE D, 1983, J MARKETING RES, V20, P428, DOI 10.2307/3151446; Peden M., 2004, WORLD REPORT ROAD TR; Razmara A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5300-5; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Shams M, 2011, ACCIDENT ANAL PREV, V43, P646, DOI 10.1016/j.aap.2010.10.007; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Siddiqui TR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005129; Simsekoglu O, 2013, SAFETY SCI, V59, P187, DOI 10.1016/j.ssci.2013.05.014; Teye-Kwadjo E., 2011, RISK PERCEPTION TRAF; World Health Organization, 2016, WORLD HLTH STAT 2016; World Health Organization, 2015, GLOB STAT REP ROAD S	50	6	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2214-1405			J TRANSP HEALTH	J. Transp. Health	MAR	2019	12						105	114		10.1016/j.jth.2019.01.001			10	Public, Environmental & Occupational Health; Transportation	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	HT4KE	WOS:000464531700011					2022-02-06	
J	Lever, K; Peng, J; Lundine, JP; Caupp, S; Wheeler, KK; Sribnick, EA; Xiang, H				Lever, Kimberly; Peng, Jin; Lundine, Jennifer P.; Caupp, Sarah; Wheeler, Krista K.; Sribnick, Eric A.; Xiang, Henry			Attending Follow-up Appointments After Pediatric Traumatic Brain Injury: Caregiver-Perceived Barriers and Facilitators	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						barriers; facilitators; follow-up; pediatric; traumatic brain injury (TBI)	HEALTH-CARE; POSTCONCUSSIVE SYMPTOMS; INTENSIVE-CARE; CHILDREN; MILD; REHABILITATION; PARENT; COORDINATION; ADOLESCENTS; PERCEPTIONS	Objective: To examine barriers and facilitators for follow-up care of children with traumatic brain injury (TBI). Setting: Urban children's hospital. Participants: Caregivers of children (aged 2-18 years) discharged from an inpatient unit with a TBI diagnosis in 2014-2015. Design: Survey of caregivers. Main Measures: Caregiver-reported barriers and facilitators to follow-up appointment attendance. Results: The sample included 159 caregivers who completed the survey. The top 3 barriers were "no need" (38.5%), "schedule conflicts" (14.1%), and "lack of resources" (10.3%). The top 5 identified facilitators were "good hospital experience" (68.6%), "need" (37.8%), "sufficient resources" (35.8%), "well-coordinated appointments" (31.1%), and "provision of counseling and support" (27.6%). Caregivers with higher income were more likely to report "no need" as a barrier; females were less likely to do so. Nonwhite caregivers and those without private insurance were more likely to report "lack of resources" as a barrier. Females were more likely to report "good hospital experience" and "provision of counseling and support" as a facilitator. Nonwhite caregivers were more likely to report "need" but less likely to report "sufficient resources" as facilitators. Conclusions: Care coordination, assistance with resources, and improvements in communication and the hospital experience are ways that adherence might be enhanced.	[Lever, Kimberly; Lundine, Jennifer P.; Caupp, Sarah; Wheeler, Krista K.; Sribnick, Eric A.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH USA; [Lever, Kimberly; Caupp, Sarah; Wheeler, Krista K.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Peng, Jin] Nationwide Childrens Hosp, Res Inst, Res Informat Solut & Innovat, Columbus, OH USA; [Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Neurosurg, Columbus, OH USA; [Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Xiang, Henry] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	Henry.Xiang@NationwideChildrens.org	Sribnick, Eric/AAH-6693-2020; Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	Ohio Department of Public Safety Emergency Medical Services grant program; US Department of Health [R40/MC 30759]; US Human Service Health Resources and Services Administration (HRSA) [R40/MC 30759]	This study was funded by a grant from the Ohio Department of Public Safety Emergency Medical Services grant program and a US Department of Health and Human Service Health Resources and Services Administration (HRSA) grant (R40/MC 30759). The authors thank the patients of Nationwide Children's Hospital and their families for their contributions to this project.	Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Alexander J, 2005, PEDIATRICS, V116, P1238, DOI 10.1542/peds.2005-2070; Antonelli RC, 2008, PEDIATRICS, V122, pE209, DOI 10.1542/peds.2007-2254; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Chard Sarah E, 2006, NeuroRx, V3, P525, DOI 10.1016/j.nurx.2006.07.002; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Faul M, 2010, TRAUMATIC BRAIN INJU; Figueroa JF, 2016, HEALTH AFFAIR, V35, P1391, DOI 10.1377/hlthaff.2015.1426; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Glasow P.A., 2005, FUNDAMENTALS SURVEY; Gordon M, 2010, PSYCHIAT SERV, V61, P657, DOI 10.1176/ps.2010.61.7.657; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Harmon SL, 2013, CLIN PEDIATR, V52, P389, DOI 10.1177/0009922813477237; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Howitt MJ, 2011, J PEDIATR ONCOL NURS, V28, P107, DOI 10.1177/1043454210377331; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; IRWIN CE, 1993, PEDIATRICS, V92, P20; Izadi N, 2017, ANN ALLERG ASTHMA IM, V118, P577, DOI 10.1016/j.anai.2017.02.024; Janevic MR, 2017, J ASTHMA, V54, P514, DOI 10.1080/02770903.2016.1242136; Jhanjee I, 2004, J AM BOARD FAM PRACT, V17, P324, DOI 10.3122/jabfm.17.5.324; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lyles AA, 2017, J PEDIATR HEALTH CAR, V31, P555, DOI 10.1016/j.pedhc.2017.01.012; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKay MM, 2001, J BEHAV HEALTH SER R, V28, P475, DOI 10.1007/BF02287777; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; McPherson ML, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e94; Otani Koichiro, 2016, J Patient Exp, V3, P145, DOI 10.1177/2374373516685953; Parkes A, 2015, J FAM PSYCHOL, V29, P907, DOI 10.1037/fam0000129; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; SCHULTZ EM, 2001, COORDINATION, V17, P5, DOI DOI 10.1177/2053435414540615; Siegal MD, 2005, AM J PUBLIC HEALTH, V95, P1352, DOI 10.2105/AJPH.2004.054858; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Tajeu GS, 2015, AM J PUBLIC HEALTH, V105, P2076, DOI 10.2105/AJPH.2015.302721; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Wang NE, 2006, ACAD EMERG MED, V13, P840, DOI 10.1197/j.aem.2006.04.021; Weier RC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2786E; Willis GB, 1999, SHORT COURSE REDUCIN; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; Youngblut JoAnne M, 2005, Pediatr Crit Care Med, V6, P550, DOI 10.1097/01.PCC.0000163283.27419.E9	57	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		E21	E34		10.1097/HTR.0000000000000433			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400003	30169437				2022-02-06	
J	Lindsey, A; Hurley, E; Mozeiko, J; Coelho, C				Lindsey, Andre; Hurley, Erin; Mozeiko, Jennifer; Coelho, Carl			Follow-Up on the Story Goodness Index for Characterizing Discourse Deficits Following Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	47th Clinical Aphasiology Conference (CAC)	2017	UT				HEAD-INJURY; ADULTS; NARRATIVES; LANGUAGE	Purpose: The Story Goodness Index (SGI) is a hybrid analysis of narrative discourse combining 2 macrostructural measures: story grammar and story completeness. Initially proposed by Le and colleagues (Le, Coelho, Mozeiko, & Grafman, 2011), the SGI is intended to characterize the discourse performance of individuals with cognitive-communication disorders. In this study, the SGI was utilized to examine the discourse of 2 groups, one with closed head injuries and another with non-brain injured (NBI) peers. The intent of this study was to ascertain whether the SGI could differentiate the discourse performance of the 2 groups, as was previously reported for individuals with penetrating traumatic brain injury and an NBI comparison group (Le, Coelho, Mozeiko, Krueger, & Grafman, 2012). Because of the retrospective nature of this study, the wordless visual narrative used to elicit discourse was different from the narrative used by Le and colleagues (2012). Method: A retrospective analysis of discourse was performed on 55 individuals with a history of closed head injury and 47 NBI socioeconomically matched peers. During the initial assessment, participants were engaged in a narrative retell task. Each participant was shown a wordless picture story and then asked to retell the story to the examiner. Story narratives were reanalyzed for story grammar (organization) and completeness (critical content). Results: A significant group difference was noted for the story grammar measure, but not for story completeness. Although the SGI plots depicted the heterogeneity in discourse performance of the 2 groups, a chi-square test of independence revealed no significant association between group membership and SGI quadrant. Conclusions: Findings from this study were inconsistent with those of Le and colleagues. The studies did not use identical SGI protocols; specifically, different picture stimuli were used to elicit the story retells. Therefore, this study cannot be considered a replication. The story used by Le and colleagues was judged to be more complex, requiring more inference for story interpretation. Future studies should interpret findings within the context of the story stimuli presented.	[Lindsey, Andre; Mozeiko, Jennifer; Coelho, Carl] Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT 06269 USA; [Lindsey, Andre] Univ Connecticut, Neurobiol Language Training Program, Storrs, CT 06269 USA; [Hurley, Erin; Coelho, Carl] Univ Connecticut, Cognit Sci Program, Storrs, CT USA; [Mozeiko, Jennifer; Coelho, Carl] Univ Connecticut, Connecticut Inst Brain & Cognit Sci, Storrs, CT USA		Lindsey, A (corresponding author), Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT 06269 USA.; Lindsey, A (corresponding author), Univ Connecticut, Neurobiol Language Training Program, Storrs, CT 06269 USA.	andre.lindsey@uconn.edu		Lindsey, Andre/0000-0002-2489-0808	National Science Foundation Integrative Graduate Education and Research Traineeship ProgramNational Science Foundation (NSF) [DGE-1144399]	A researcher for this study (Andre Lindsey) was supported by National Science Foundation Integrative Graduate Education and Research Traineeship Program Grant DGE-1144399.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Cherney L. R., 1998, ANAL DISCOURSE COMMU, P1; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Hagen C., 1980, RANCHO LOS AMIGOS LE; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hunt K., 1965, 3 NCTE; Kemmerer D., 2015, COGNITIVE NEUROSCIEN; Kertesz A., 1982, W APHASIA BATTERY; Le K, 2014, AM J SPEECH-LANG PAT, V23, P271, DOI 10.1044/2014_AJSLP-13-0095; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); Lindsey A., 2016, CLIN APH C CHARL VA; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; SCHWARTZCOWLEY R, 1989, TOP LANG DISORD, V9, P1, DOI 10.1097/00011363-198903000-00003; Scott, 2013, PICTUREBOOKS WORK; Stein NL., 1979, NEW DIRECTIONS DISCO; Winter P., 1976, THE BEAR AND THE FLY; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	28	6	6	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAR	2019	28	1		S	SI		330	340		10.1044/2018_AJSLP-17-0151			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HQ3UL	WOS:000462335900009	30054625				2022-02-06	
J	Mee, H; Kolias, AG; Chari, A; Ercole, A; Lecky, F; Turner, C; Tudur-Smith, C; Coles, J; Anwar, F; Belli, A; Manford, M; Ham, T; McMahon, C; Bulters, D; Uff, C; Duncan, JS; Wilson, MH; Marson, AG; Hutchinson, PJ				Mee, Harry; Kolias, Angelos G.; Chari, Aswin; Ercole, Ari; Lecky, Fiona; Turner, Carole; Tudur-Smith, Catrin; Coles, Jonathan; Anwar, Fahim; Belli, Antonio; Manford, Mark; Ham, Timothy; McMahon, Catherine; Bulters, Diederik; Uff, Chris; Duncan, John S.; Wilson, Mark H.; Marson, Anthony G.; Hutchinson, Peter J.			Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland	ACTA NEUROCHIRURGICA			English	Article						Post-traumatic seizures; Traumatic brain injury; Anti-epileptic medication; Seizure prophylaxis	PHENYTOIN; LEVETIRACETAM; PREVENTION; EPILEPSY	BackgroundPatient selection for seizure prophylaxis after traumatic brain injury (TBI) andduration of anti-epileptic drug treatmentfor patients with early post-traumatic seizures (PTS), remain plagued with uncertainty. In early 2017, a collaborative group of neurosurgeons, neurologists, neurointensive care and rehabilitation medicine physicians was formed in the UK with the aim of assessing variability in current practice and gauging the degree of uncertainty to inform the design of future studies. Here we present the results of a survey of clinicians managing patients with TBI in the UK and Ireland.Materials and methodsAn online survey was developed and piloted. Following approval by the Academic Committee of the Society of British Neurological Surgeons, it was distributed via appropriate electronic mailing lists.ResultsOne hundred and seventeen respondents answered the questionnaire, predominantly neurosurgeons (76%) from 30 (of 32) trauma-receiving hospitals in the UK and Ireland. Fifty-three percent of respondents do not routinely use seizure prophylaxis, but 38% prescribe prophylaxis for one week. Sixty percent feel there is uncertainty regarding the use of seizure prophylaxis, and 71% would participate in further research to address this question. Sixty-two percent of respondents use levetiracetam for treatment of seizures during the acute phase, and 42% continued for a total of 3months. Overall, 90% were uncertain about the duration of treatment for seizures, and 78% would participate in further research to address this question.ConclusionThe survey results demonstrate the variation in practice and uncertainty in both described aspects of management of patients who have suffered a TBI. The majority of respondents would want to participate in future research to help try and address this critical issue, and this shows the importance and relevance of these two clinical questions.	[Mee, Harry; Kolias, Angelos G.; Turner, Carole; Anwar, Fahim; Manford, Mark; Ham, Timothy; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Mee, Harry; Kolias, Angelos G.; Ercole, Ari; Turner, Carole; Coles, Jonathan; Anwar, Fahim; Manford, Mark; Ham, Timothy; Hutchinson, Peter J.] Addenbrookes Hosp, Cambridge, England; [Mee, Harry; Kolias, Angelos G.; Turner, Carole; Hutchinson, Peter J.] Surg Theme, Cambridge Clin Trials Unit, Cambridge, England; [Chari, Aswin; Uff, Chris] Royal London Hosp, Dept Neurosurg, London, England; [Ercole, Ari; Coles, Jonathan] Univ Cambridge, Neurosci Crit Care Unit, Cambridge, England; [Ercole, Ari; Coles, Jonathan] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Tudur-Smith, Catrin] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Belli, Antonio] Queen Elizabeth Hosp, Dept Neurosurg, Birmingham, W Midlands, England; [McMahon, Catherine] Walton Ctr, Dept Neurosurg, Liverpool, Merseyside, England; [Bulters, Diederik] Univ Hosp Southampton, Dept Neurosurg, Southampton, Hants, England; [Duncan, John S.] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Wilson, Mark H.] Imperial Coll, Imperial Neurotrauma Ctr, Dept Surg & Canc, London, England; [Marson, Anthony G.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England		Mee, H (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Mee, H (corresponding author), Addenbrookes Hosp, Cambridge, England.; Mee, H (corresponding author), Surg Theme, Cambridge Clin Trials Unit, Cambridge, England.	harrymee@nhs.net	Marson, Anthony/AAW-9776-2020; Anwar, Fahim/ABH-5525-2020; Bulters, Diederik/ABH-3573-2020; Belli, Antonio/I-3799-2015; Ercole, Ari/B-6288-2009	Marson, Anthony/0000-0002-6861-8806; Anwar, Fahim/0000-0002-1176-0975; Belli, Antonio/0000-0002-3211-9933; Ercole, Ari/0000-0001-8350-8093; Bulters, Diederik/0000-0001-9884-9050; Kolias, Angelos/0000-0003-3992-0587; Mee, Harry/0000-0002-1314-3962; Coles, Jonathan/0000-0003-4013-679X; Hutchinson, Peter/0000-0002-2796-1835; Duncan, John S/0000-0002-1373-0681; Chari, Aswin/0000-0003-0053-147X	School of Clinical Medicine, University of CambridgeUniversity of Cambridge; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Royal College of Surgeons of England; European Union Seventh Framework Program grant (CENTER-TBI) [602150]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0601025, G0502030, G1002277, G0600986] Funding Source: UKRI	Angelos Kolias is supported by a Clinical Lectureship, School of Clinical Medicine, University of Cambridge. Peter Hutchinson is supported by a Research Professorship from the National Institute for Health Research (NIHR), the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150) and the Royal College of Surgeons of England.	Carney N, 2016, INJURY, V1, P1; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Huijben JA, 2018, VARIATION GEN SUPPOR, P1, DOI [10.1186/s13054-018-2000-6, DOI 10.1186/S13054-018-2000-6]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nadkarni Siddhartha, 2005, Epilepsy Curr, V5, P176, DOI 10.1111/j.1535-7511.2005.00056.x; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; St Louis EK, 2009, CURR NEUROPHARMACOL, V7, P106, DOI 10.2174/157015909788848857; Szaflarski JP, 2015, EPILEPSY CURR, V15, P94, DOI 10.5698/1535-7597-15.2.94; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, V26, P1; Thompson K, 1996, PHARM TREATMENTS PRE, P1, DOI [10.1002/14651858.CD009900.pub2, DOI 10.1002/14651858.CD009900.PUB2]	14	6	6	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2019	161	3					457	464		10.1007/s00701-018-3683-9			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HO0PZ	WOS:000460607500004	30276544	Green Published, Green Accepted, hybrid			2022-02-06	
J	Sturges, BK; Dickinson, PJ; Tripp, LD; Udaltsova, I; LeCouteur, RA				Sturges, Beverly K.; Dickinson, Peter J.; Tripp, Linda D.; Udaltsova, Irina; LeCouteur, Richard A.			Intracranial pressure monitoring in normal dogs using subdural and intraparenchymal miniature strain-gauge transducers	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						canine; Codman; intracranial hypertension; microsensor	CEREBRAL PERFUSION PRESSURES; CEREBROSPINAL-FLUID PRESSURE; TRAUMATIC BRAIN-INJURY; CLINICAL-EXPERIENCE; ICP; VENTILATION; SYSTEM; COMPLICATIONS; PLACEMENT; VENTRICLE	Background: Monitoring of intracranial pressure (ICP) is a critical component in the management of intracranial hypertension. Safety, efficacy, and optimal location of microsensor devices have not been defined in dogs. Hypothesis/Objective: Assessment of ICP using a microsensor transducer is feasible in anesthetized and conscious animals and is independent of transducer location. Intraparenchymal transducer placement is associated with more adverse effects. Animals: Seven adult, bred-for-research dogs. Methods: In a prospective investigational study, microsensor ICP transducers were inserted into subdural and intraparenchymal locations at defined rostral or caudal locations within the rostro-tentorial compartment under general anesthesia. Mean arterial pressure and ICP were measured continuously during physiological maneuvers, and for 20 hours after anesthesia. Results: Baseline mean +/- SD values for ICP and cerebral perfusion pressure were 7.2 +/- 2.3 and 78.9 +/- 7.6 mm Hg, respectively. Catheter position did not have a significant effect on ICP measurements. There was significant variation from baseline ICP accompanying physiological maneuvers (P < .001) and with normal activities, especially with changes in head position (P < .001). Pathological sequelae were more evident after intraparenchymal versus subdural placement. Conclusions and Clinical Importance: Use of a microsensor ICP transducer was technically straightforward and provided ICP measurements within previously reported reference ranges. Results support the use of an accessible dorsal location and subdural positioning. Transient fluctuations in ICP are normal events in conscious dogs and large variations associated with head position should be accounted for when evaluating animals with intracranial hypertension.	[Sturges, Beverly K.; Dickinson, Peter J.; LeCouteur, Richard A.] Univ Calif Davis, Sch Vet Med, Dept Surg, Davis, CA 95616 USA; [Sturges, Beverly K.; Dickinson, Peter J.; LeCouteur, Richard A.] Univ Calif Davis, Sch Vet Med, Dept Radiol Sci, Davis, CA 95616 USA; [Tripp, Linda D.] Univ Calif Davis, Off Res, Davis, CA 95616 USA; [Udaltsova, Irina] Univ Calif Davis, Sch Vet Med, Populat Hlth & Reprod, Davis, CA 95616 USA		Sturges, BK (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	bksturges@ucdavis.edu	LeCouteur, Richard/AAJ-9983-2021		Center for Companion Animal Health, University of California, DavisUniversity of California System [CCAH-99-10F]	Center for Companion Animal Health, University of California, Davis, Grant/Award Number: CCAH-99-10F	Adrianov O. S., 1964, ATLAS CANINE BRAIN; Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; Bagley RS, 1996, AM J VET RES, V57, P116; BAGLEY RS, 1995, J AM VET MED ASSOC, V207, P588; BAGLEY RS, 1995, AM J VET RES, V56, P1475; BARLOW P, 1985, J NEUROSURG, V63, P578, DOI 10.3171/jns.1985.63.4.0578; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bekar A, 2008, NEUROL RES, V30, P465, DOI 10.1179/174313208X284269; Berlin T, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-10; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Brosnan RJ, 2004, AM J VET RES, V65, P1042, DOI 10.2460/ajvr.2004.65.1042; Brosnan RJ, 2003, AM J VET RES, V64, P1444, DOI 10.2460/ajvr.2003.64.1444; Brosnan RJ, 2003, AM J VET RES, V64, P21, DOI 10.2460/ajvr.2003.64.21; Brosnan RJ, 2002, AM J VET RES, V63, P1252, DOI 10.2460/ajvr.2002.63.1252; Brosnan RJ, 2002, J APPL PHYSIOL, V92, P2542, DOI 10.1152/japplphysiol.00055.2002; Brosnan RJ, 2008, AM J VET RES, V69, P737, DOI 10.2460/ajvr.69.6.737; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; Dewey C. W., 1997, Journal of Veterinary Emergency & Critical Care, V7, P20; Lopes PCF, 2014, ARQ BRAS MED VET ZOO, V66, P1351, DOI 10.1590/1678-6519; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; GRASBERGER RC, 1984, J NEUROSURG, V60, P1214, DOI 10.3171/jns.1984.60.6.1214; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Guyot LL, 1998, ACT NEUR S, V71, P47; Harrington ML, 1996, AM J VET RES, V57, P1659; Hong WC, 2006, SURG NEUROL, V66, pS8, DOI 10.1016/j.surneu.2006.07.006; Ilie LA, 2015, AM J VET RES, V76, P724, DOI 10.2460/ajvr.76.8.724; JAKOBSSON KE, 1990, ACTA NEUROCHIR, V104, P126, DOI 10.1007/BF01842830; Jallo J, 1997, J NEUROSCI METH, V75, P155, DOI 10.1016/S0165-0270(97)00064-2; Jiang Y, 2015, J ADV NURS, V71, P2237, DOI 10.1111/jan.12679; KEEGAN RD, 1995, AM J VET RES, V56, P193; KORTZ GD, 1995, AM J VET RES, V56, P1351; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Kroin JS, 2000, J NEUROSURG, V93, P852, DOI 10.3171/jns.2000.93.5.0852; LEONARD JL, 1973, AM J VET RES, V34, P213; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Lim R.K.S., 1960, STEREOTAXIC ATLAS DO; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Macmillan CSA, 1999, NEUROSURGERY, V45, P188, DOI 10.1097/00006123-199907000-00047; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; NOVAK G, 1974, Laboratory Animals (London), V8, P85, DOI 10.1258/002367774780943779; Packer RA, 2011, AM J VET RES, V72, P103, DOI 10.2460/ajvr.72.1.103; PALAFOX BA, 1981, J TRAUMA, V21, P55, DOI 10.1097/00005373-198101000-00012; Pluhar GE, 1996, VET SURG, V25, P480, DOI 10.1111/j.1532-950X.1996.tb01447.x; RAHIMIFAR M, 1989, J NEUROSURG, V70, P932, DOI 10.3171/jns.1989.70.6.0932; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schmitt M, 2012, ACTA NEUROCHIR SUPPL, V113, P109, DOI 10.1007/978-3-7091-0923-6_22; SIMPSON ST, 1987, J AM ANIM HOSP ASSOC, V23, P629; Tanaka R, 2012, J NEUROSURG, V117, P1100, DOI 10.3171/2012.9.JNS12738; VERDURA J, 1964, J NEUROSURG, V21, P1047, DOI 10.3171/jns.1964.21.12.1047; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; YANO M, 1987, NEUROSURGERY, V21, P688, DOI 10.1227/00006123-198711000-00015; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256; Zwienenberg M, 1999, J NEUROTRAUM, V16, P1095, DOI 10.1089/neu.1999.16.1095	60	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	MAR-APR	2019	33	2					708	716		10.1111/jvim.15333			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	HS4MR	WOS:000463838000043	30575120	gold, Green Published			2022-02-06	
J	Tarimala, A; Singichetti, B; Yi, HG; Huang, LH; Doerschuk, R; Tiso, M; Yang, JZ				Tarimala, Anirudh; Singichetti, Bhavna; Yi, Honggang; Huang, Lihong; Doerschuk, Rachel; Tiso, Michael; Yang, Jingzhen			Initial Emergency Department Visit and Follow-Up Care for Concussions among Children with Medicaid	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; UNITED-STATES; PEDIATRIC CONCUSSION; HEALTH-CARE; TRENDS; MANAGEMENT; YOUTH; LAWS	Objective To describe the rates and patterns of initial emergency department (ED) encounters and follow-up care for concussions among Medicaid-insured children before and after the 2013 enactment of Ohio concussion law. Study design Using a time-series design. this study analyzed concussion claim data obtained from Partners for Kids. a pediatric accountable-care organization in Ohio. A total of 12 512 concussions and 48 238 associated claims for services between January 1, 2008. and June 30. 2017, with an initial ED encounter among Medicaid-insured children (ages 0-18 years) were analyzed. The effect of the law on the odds of follow-up care were assessed using generalized estimating equations models, adjusted for sex, age group, and residence location. Results Of the total 12 512 concussions, 63.9% occurred in male patients, 70.1% in patients ages 10-18 years. and 65.2% in patients from urban areas. The rate of initial ED encounters for concussions increased from 2008 to 2014 (2.8 to 4.9 per 10 000 members), followed by a decrease in 2016 (4.2 per 10 000 members). A significant increase in follow-up care after the initial ED encounter was observed from pre-law to post-law (OR 1.73, 95% CI 1.61. 1.86). A shift in follow-up care was observed from radiology and ambulance services in pre-law to primary care providers in post-law. Conclusions The Ohio concussion law may have influenced the patterns of initial ED visit and follow-up care for concussions among Medicaid-insured children. Future studies evaluating the impact of the law should analyze the utilization patterns among children with various insurance/payment types.	[Tarimala, Anirudh; Singichetti, Bhavna; Yi, Honggang; Huang, Lihong; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RBIII, Columbus, OH 43205 USA; [Tarimala, Anirudh; Tiso, Michael; Yang, Jingzhen] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Doerschuk, Rachel] Nationwide Childrens Hosp, Partners Kids, Columbus, OH USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr RBIII, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org		Singichetti, Bhavna/0000-0002-2188-3979	Centers for Disease Control PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [3 R49 CE002106-05S1]; Ohio State University College of Medicine Roessler Research Scholarship	Supported in part by funding from the Centers for Disease Control & Prevention (3 R49 CE002106-05S1 [to B.S., L.H., and J.Y.]), and by The Ohio State University College of Medicine Roessler Research Scholarship (to A.T.). The authors declare no conflicts of interest.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Fieldston ES, 2012, PEDIATR EMERG CARE, V28, P220, DOI 10.1097/PEC.0b013e318248b431; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gleeson S, 2016, JAMA PEDIATR, V170, P259, DOI 10.1001/jamapediatrics.2015.3809; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hubbard ME, 2016, APPL NEUROPSYCH-ADUL, P1; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marsh AM, 2013, J PEDIATR HEALTH CAR, V27, P499, DOI 10.1016/j.pedhc.2012.12.014; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nationwide Children's Hospital (NCH), PARTN KIDS PED ACC C; Owens PL, 2008, AMBUL PEDIATR, V8, P219, DOI 10.1016/j.ambp.2008.03.032; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Sports and Fitness Industry Association, 2018, 2018 SPORTS FITN LEI; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	28	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAR	2019	206						178	183		10.1016/j.jpeds.2018.10.021			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HN0FE	WOS:000459860100031	30442410	Bronze			2022-02-06	
J	Wang, SN; Guo, XY; Tang, J; Ding, SQ; Shen, L; Wang, R; Ma, SF; Hu, JG; Lu, HL				Wang, Sai-Nan; Guo, Xue-Yan; Tang, Jie; Ding, Shu-Qin; Shen, Lin; Wang, Rui; Ma, Shan-Feng; Hu, Jian-Guo; Lu, He-Luo			Expression and localization of absent in melanoma 2 in the injured spinal cord	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; absent in melanoma 2; spatio-temporal expression; neurons; astrocytes; oligodendrocytes; infiltrated leukocytes; activated microglia; western blot assay; immunohistochemistry; neural regeneration	INFLAMMASOME ACTIVATION; AIM2 INFLAMMASOME; TEMPORAL KINETICS; CELL-DEATH; MECHANISMS; PROTEIN; ASC; RECOGNITION; ASTROCYTES; MORPHOLOGY	In traumatic brain injury, absent in melanoma 2 (AIM2) has been demonstrated to be involved in pyroptotic neuronal cell death. Although the pathophysiological mechanism of spinal cord injury is similar to that of brain injury, the expression and cellular localization of AIM2 after spinal cord injury is still not very clear. In the present study, we used a rat model of T9 spinal cord contusive injury, produced using the weight drop method. The rats were randomly divided into 1-hour, 6-hour, 1-day, 3-day and 6-day (post-injury time points) groups. Sham-operated rats only received laminectomy at T9 without contusive injury. Western blot assay revealed that the expression levels of AIM2 were not significantly different among the 1-hour, 6-hour and 1-day groups. The expression levels of AIM2 were markedly higher in the 1-hour, 6-hour and 1-day groups compared with the sham, 3-day and 7-day groups. Double immunofluorescence staining demonstrated that AIM2 was expressed by NeuN(+) (neurons), GFAP(+) (astrocytes), CNPase(+) (oligodendrocytes) and CD11b(+) (microglia) cells in the sham-operated spinal cord. In rats with spinal cord injury, AIM2 was also found in CD45(+) (leukocytes) and CD68(+) (activated microglia/macrophages) cells in the spinal cord at all time points. These findings indicate that AIM2 is mainly expressed in neurons, astrocytes, microglia and oligodendrocytes in the normal spinal cord, and that after spinal cord injury, its expression increases because of the infiltration of leukocytes and the activation of astrocytes and microglia/macrophages.	[Wang, Sai-Nan; Guo, Xue-Yan; Ding, Shu-Qin; Hu, Jian-Guo; Lu, He-Luo] Bengbu Med Coll, Affiliated Hosp 1, Clin Lab, Bengbu, Anhui, Peoples R China; [Wang, Sai-Nan; Guo, Xue-Yan; Shen, Lin; Wang, Rui; Ma, Shan-Feng; Hu, Jian-Guo; Lu, He-Luo] Bengbu Med Coll, Affiliated Hosp 1, Anhui Key Lab Tissue Transplantat, Bengbu, Anhui, Peoples R China; [Wang, Sai-Nan; Tang, Jie; Lu, He-Luo] Bengbu Med Coll, Dept Immunol, Bengbu, Anhui, Peoples R China; [Wang, Sai-Nan; Tang, Jie; Lu, He-Luo] Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China		Hu, JG; Lu, HL (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Clin Lab, Bengbu, Anhui, Peoples R China.; Hu, JG; Lu, HL (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Anhui Key Lab Tissue Transplantat, Bengbu, Anhui, Peoples R China.; Lu, HL (corresponding author), Bengbu Med Coll, Dept Immunol, Bengbu, Anhui, Peoples R China.; Lu, HL (corresponding author), Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China.	jghu9200@163.com; lhz233003@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772321, 81571194, 81471277]; Key Program of Anhui Province for Outstanding Talents in Universities in China [gxbjZD2016071, 2014H012]	This study was supported by the National Natural Science Foundation of China, No. 81772321 (to HZL), 81571194 (to HZL), 81471277 (to JGH); a grant from the Key Program of Anhui Province for Outstanding Talents in Universities in China, No. gxbjZD2016071 (to HZL), 2014H012 (to HZL).	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Barclay W, 2017, BRAIN PATHOL, V27, P213, DOI 10.1111/bpa.12477; Barradas PC, 1998, BRAZ J MED BIOL RES, V31, P257, DOI 10.1590/S0100-879X1998000200009; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Bernier LP, 2012, J GEN PHYSIOL, V140, P571, DOI 10.1085/jgp.201210875; Chen YJ, 2015, J NEUROSCI RES, V93, P1526, DOI 10.1002/jnr.23612; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Cruz CD, 2015, ADV DRUG DELIVER REV, V82-83, P153, DOI 10.1016/j.addr.2014.11.007; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Drury JA, 2011, HISTOPATHOLOGY, V59, P1156, DOI 10.1111/j.1365-2559.2011.04046.x; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; Franklin BS, 2018, IMMUNOL REV, V281, P74, DOI 10.1111/imr.12611; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Greaves DR, 2002, INT J HEMATOL, V76, P6, DOI 10.1007/BF02982713; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hansen JD, 2011, DEV COMP IMMUNOL, V35, P886, DOI 10.1016/j.dci.2011.01.008; Hendrickx DAE, 2017, J NEUROIMMUNOL, V309, P12, DOI 10.1016/j.jneuroim.2017.04.007; Hu JG, 2016, EXP NEUROL, V277, P190, DOI 10.1016/j.expneurol.2016.01.002; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kesavardhana S, 2017, INT IMMUNOL, V29, P201, DOI 10.1093/intimm/dxx018; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Korzhevskiy D E, 2015, Morfologiia, V147, P37; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lang Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1549549; Lin YH, 2018, NEUROCHEM INT, V113, P23, DOI 10.1016/j.neuint.2017.11.015; Lugrin J, 2018, IMMUNOL REV, V281, P99, DOI 10.1111/imr.12618; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; PATARROYO M, 1990, IMMUNOL REV, V114, P67, DOI 10.1111/j.1600-065X.1990.tb00562.x; Rosenzweig ES, 2004, CURR OPIN NEUROL, V17, P121, DOI 10.1097/00019052-200404000-00007; Saghazadeh A, 2017, BIOMED PHARMACOTHER, V92, P128, DOI 10.1016/j.biopha.2017.05.048; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sarnat HB, 2015, CELL TISSUE RES, V359, P279, DOI 10.1007/s00441-014-1988-4; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Slowik A, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12482; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang B, 2017, J STRUCT BIOL, V200, P279, DOI 10.1016/j.jsb.2017.08.001; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wang Y, 2018, J HISTOCHEM CYTOCHEM, V66, P175, DOI 10.1369/0022155417749491; Wu DL, 2013, HUM IMMUNOL, V74, P514, DOI 10.1016/j.humimm.2013.01.022; Wu PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32405; Wu Y, 2017, J NEUROSCI RES, V95, P1666, DOI 10.1002/jnr.23993; Yogarajah T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05589-2; Zhang AS, 2015, MOL IMMUNOL, V66, P253, DOI 10.1016/j.molimm.2015.03.009; Zhang Y, 2018, ZHONGGUO ZUZHI GONGC, V22, P3824	56	6	6	0	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2019	14	3					542	552		10.4103/1673-5374.245481			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HE5UF	WOS:000453454800025	30539825	Green Published, gold			2022-02-06	
J	Yilmaz, I; Ertem, DH; Kilic, M; Altas, K; Mirhasilova, M; Ozdemir, B; Tanriverdi, O; Yilmaz, A				Yilmaz, Ilhan; Ertem, Devrimsel Harika; Kilic, Mustafa; Altas, Kadir; Mirhasilova, Muyassar; Ozdemir, Burak; Tanriverdi, Osman; Yilmaz, Adem			Factors associated with mortality in acute subdural hematoma: Is decompressive craniectomy effective?	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Acute subdural hematoma; decompressive craniectomy; mortality; outcome	TRAUMATIC BRAIN-INJURY; MANAGEMENT; OUTCOMES; EVACUATION; ADULTS	BACKGROUND: Despite rapid diagnosis and aggressive neurosurgical intervention, acute subdural hematoma (ASDH) is a severe type of head injury that can result in high morbidity and mortality. Although surgical procedures, such as craniotomy and decompressive craniectomy (DC), can be effective, the preferred approach for treating an ASDH remains controversial. The aim of this report was to evaluate factors associated with mortality in patients with ASDH and determinants of outcome in those with ASDH who underwent DC. METHODS: The demographic details and clinical and radiological characteristics of a total of 93 patients with ASDH who underwent DC during a 60-month period from 2012 to 2017 were evaluated to determine the effect on mortality and any association with the Glasgow Coma Scale (GCS) score recorded on arrival. RESULTS: Sixty-five male and 28 female subjects with a mean age of 59.82 +/- 19.49 years (range: 16-88 years) were included in the stud y. Sixteen patients (17.2%) died following the surgery. Older age (p=0.007) and lower GCS scores (p=0.022) were statistically significantly associated with the mortality rate. The mean hematoma thickness was 15.46 +/- 5.73 mm, and the mean midline shift was 9.90 +/- 4.84 mm. The mortality rate was positively correlated with an excessive midline shift (p=0.011; r=0.262) and age (p=0.022; r=0.237) in patients with ADSH. A midline shift of >= 10 mm and a hematoma thickness of >= 15 mm was significantly associated with mortality (p=0.014; p=0.039). The etiology of the trauma; comorbidities of subarachnoid, epidural, or intracranial hemorrhage; compression fractures; or contusions were not significantly correlated. CONCLUSION: The results indicated that there was a higher mortality rate among older patients and those with a GCS score of <6 on arrival. A midline shift of >= 10 mm and a hematoma thickness of >= 15 mm were significantly related to mortality. Our study supports the conclusion that DC may help prevent further midline shift and be associated with a lower mortality rate compared with a craniotomy.	[Yilmaz, Ilhan; Kilic, Mustafa; Altas, Kadir; Mirhasilova, Muyassar; Ozdemir, Burak; Yilmaz, Adem] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Ertem, Devrimsel Harika] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Neurol, Istanbul, Turkey; [Tanriverdi, Osman] Univ Hlth Sci, Dept Neurosurg, Bakirkoy Training & Res Hosp Neurol Neurosurg & P, Istanbul, Turkey		Ertem, DH (corresponding author), SBU Hamidiye Etfal Egitim & Arastirma Hastanesi, Norol Klin, Istanbul, Turkey.	hkaozhan@gmail.com	/ABA-8648-2021	/0000-0002-4846-4213			Alagoz F, 2017, TURK NEUROSURG, V27, P187, DOI 10.5137/1019-5149.JTN.15177-15.2; Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Demetriades AK, 2017, ACTA NEUROCHIR, V159, P623, DOI 10.1007/s00701-017-3119-y; Hanif S, 2009, Ir Med J, V102, P255; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Kaptanoglu E, 2001, Ulus Travma Derg, V7, P246; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Kinoshita T, 2016, WORLD NEUROSURG, V89, P187, DOI 10.1016/j.wneu.2016.01.071; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Marion DW, 2006, NEUROSURGERY, V58, P655; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Shabani S, 2016, WORLD NEUROSURG, V96, P66, DOI 10.1016/j.wneu.2016.08.075; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	25	6	6	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2019	25	2					147	153		10.5505/tjtes.2018.48079			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HP2DT	WOS:000461479100010	30892670	Bronze			2022-02-06	
J	Keilhoff, G; Mbou, RP; Lucas, B; Schild, L				Keilhoff, Gerburg; Mbou, Ricardo Pirex; Lucas, Benjamin; Schild, Lorenz			The Differentiation of Spinal Cord Motor Neurons is Associated with Changes of the Mitochondrial Phospholipid Cardiolipin	NEUROSCIENCE			English	Article						cardiolipin; mitochondria; neurite sprouting; oleic acid; palmitic acid; PPAR alpha expression	ACTIVATED RECEPTOR-ALPHA; OLEIC-ACID; FATTY-ACIDS; PPAR-GAMMA; CELL-LINE; BRAIN; ROLES; PALMITOYLATION; AXON; GROWTH	Motor neuron damage caused by diseases, traumatic insults or de-afferentation of the spinal cord is often incurable due to the poor intrinsic regenerative capacity. Moreover, regenerated peripheral nerves often do not reach normal functionality. Here, we investigated cardiolipin in the process of neuro-differentiation, since cardiolipin is closely linked to the mitochondrial energy supply in cells. The NSC-34 hybrid cell line, produced by fusing neuroblastoma cells with primary spinal cord motor neurons, was used, since it shares several morphological and physiological characteristics with mature primary motor neurons. Their neuro-differentiation was supported by switching from normal to differentiation medium or by fatty acid supplementation. Differentiation was evaluated by measuring neurite-sprouting parameters and PPAR alpha expression. Cellular fatty acid distribution was analyzed to indicate changes in lipid metabolism during differentiation. Cardiolipin was characterized by acylchain composition and the distribution of molecular cardiolipin species. Both, the switch from normal to differentiation medium as well as the administration of palmitic and oleic acid promoted neuro-differentiation. Stimulated differentiation was accompanied by changes in cardiolipin content and composition. The positive correlation between neuro-differentiation and concentration of those molecular cardiolipin species containing palmitic and oleic acid implied a link between differentiation of NSC-34 cells and cardiolipin metabolism. We further demonstrated the impact of cellular lipid metabolism, and particularly cardiolipin metabolism, during and NSC-34 neuritogenesis. Thus, cardiolipin may represent a new therapeutic target for axon regeneration after peripheral nerve injuries or when axon sprouting is required to compensate for motor neuron loss in response to aging and/or disease. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Keilhoff, Gerburg; Mbou, Ricardo Pirex] Univ Magdeburg, Inst Biochem & Cell Biol, Med Fac, Leipziger Str 44,Haus 1, D-39120 Magdeburg, Germany; [Lucas, Benjamin] Univ Magdeburg, Med Fac, Dept Trauma Surg, Magdeburg, Germany; [Schild, Lorenz] Univ Magdeburg, Med Fac, Dept Pathol Biochem, Magdeburg, Germany		Keilhoff, G (corresponding author), Univ Magdeburg, Inst Biochem & Cell Biol, Med Fac, Leipziger Str 44,Haus 1, D-39120 Magdeburg, Germany.	gerburg.keilhoff@med.ovgu.de					Aleshin S, 2013, BIOL CHEM, V394, P1553, DOI 10.1515/hsz-2013-0215; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Avila-Martin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026107; Barth PG, 2011, BRAIN DEV-JPN, V33, P621, DOI 10.1016/j.braindev.2011.02.008; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Chuang YC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-184; Cimini A, 2008, STEM CELL REV, V4, P293, DOI 10.1007/s12015-008-9024-2; Cortie CH, 2012, INT J MOL SCI, V13, P15447, DOI 10.3390/ijms131115447; Dell'Anno MT, 2017, NEUROSCI LETT, V652, P25, DOI 10.1016/j.neulet.2016.12.002; DESOUZA RJ, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H3978; Di Giacomo E, 2017, CELL CYCLE, V16, P59, DOI 10.1080/15384101.2016.1252881; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gaspard GJ, 2015, CHEM PHYS LIPIDS, V193, P1, DOI 10.1016/j.chemphyslip.2015.09.005; Gauthier-Kemper A, 2014, MOL BIOL CELL, V25, P3284, DOI 10.1091/mbc.E13-12-0737; Guan XM, 2011, SCI CHINA CHEM, V54, P1888, DOI 10.1007/s11426-011-4428-2; Ha EEJ, 2014, BIOFACTORS, V40, P419, DOI 10.1002/biof.1169; Holland SM, 2017, J NEUROSCI RES, V95, P1528, DOI 10.1002/jnr.24003; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Keilhoff G, 2016, MOL CELL BIOCHEM, V421, P41, DOI 10.1007/s11010-016-2782-2; Khairallah RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034402; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; Kimura T, 2016, PROG LIPID RES, V62, P75, DOI 10.1016/j.plipres.2016.02.001; Knauf C, 2006, ENDOCRINOLOGY, V147, P4067, DOI 10.1210/en.2005-1536; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Krivickas Lisa S, 2003, Phys Med Rehabil Clin N Am, V14, P327, DOI 10.1016/S1047-9651(02)00119-5; Leenhouts JM, 1995, BIOCHEM SOC T, V23, P968, DOI 10.1042/bst0230968; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Martens JC, 2015, MOL CELL BIOCHEM, V400, P253, DOI 10.1007/s11010-014-2282-1; Martensson CU, 2017, BBA-MOL CELL BIOL L, V1862, P102, DOI 10.1016/j.bbalip.2016.06.015; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Meldolesi J, 2011, BRAIN RES REV, V66, P246, DOI 10.1016/j.brainresrev.2010.06.004; Metcalf RG, 2007, AM J CLIN NUTR, V85, P1222, DOI 10.1093/ajcn/85.5.1222; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Murad H, 2011, MOL MED REP, V4, P575, DOI 10.3892/mmr.2011.463; Nango H, 2017, J PHARMACOL SCI, V135, P64, DOI 10.1016/j.jphs.2017.09.001; Nourooz-Zadeh J, 1999, J NEUROCHEM, V72, P734, DOI 10.1046/j.1471-4159.1999.0720734.x; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Pointer CB, 2017, CELL MOL NEUROBIOL, V37, P1161, DOI 10.1007/s10571-016-0458-9; Polo-Hernandez E, 2014, BRAIN RES, V1570, P13, DOI 10.1016/j.brainres.2014.04.038; Quintanilla RA, 2014, PPAR RES, V2014, DOI 10.1155/2014/768594; Raches D, 2012, J DEV BEHAV PEDIATR, V33, P328, DOI 10.1097/DBP.0b013e31824c4090; Ruthel G, 2003, J NEUROSCI, V23, P8618; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Safiulina D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001755; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Sheng ZH, 2017, TRENDS CELL BIOL, V27, P403, DOI 10.1016/j.tcb.2017.01.005; Siri-Tarino PW, 2010, CURR ATHEROSCLER REP, V12, P384, DOI 10.1007/s11883-010-0131-6; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Stump M, 2016, ENDOCRINOLOGY, V157, P4266, DOI 10.1210/en.2016-1524; Tabernero A, 2001, J NEUROCHEM, V79, P606, DOI 10.1046/j.1471-4159.2001.00598.x; Tai EKK, 2013, FOOD FUNCT, V4, P1767, DOI 10.1039/c3fo60298b; Tam SL, 2008, ENCY NEUROSCIENCE; Tortosa E, 2017, NEURON, V94, P809, DOI 10.1016/j.neuron.2017.04.042; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; Wang SH, 2011, TOXICOL LETT, V206, P339, DOI 10.1016/j.toxlet.2011.07.026; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101; Zhou B, 2014, METHOD ENZYMOL, V547, P75, DOI 10.1016/B978-0-12-801415-8.00005-9; Zolezzi JM, 2017, BIOL REV, V92, P2046, DOI 10.1111/brv.12320	74	6	6	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 21	2019	400						169	183		10.1016/j.neuroscience.2019.01.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ6FM	WOS:000457280300014	30639394				2022-02-06	
J	Zhang, J; Knight, R; Wang, YS; Sawyer, TW; Martyniuk, CJ; Langlois, VS				Zhang, Jing; Knight, Rosalinda; Wang, Yushan; Sawyer, Thomas W.; Martyniuk, Christopher J.; Langlois, Valerie S.			Hair follicle miRNAs: a novel biomarker for primary blast Induced-Mild traumatic brain injury	BIOMARKERS			English	Article						mTBI; sub-network enrichment analysis; gene set enrichment analysis; transcriptomics; head trauma	CIRCULATING MICRORNAS; MESSENGER-RNAS; CANCER; EXPRESSION; COMPONENTS; COMPLEXES; TARGETS; MODELS; SERUM	Context: Due to the wide use of improvised explosive devices during modern warfare, primary blast-derived mild traumatic brain injury (mTBI) has become a major medical condition in the military. With minimal visually identifiable symptoms, an effective molecular biomarker system is desirable. Objective: We assessed the potential of mammalian hair follicle miRNAs as an mTBI biomarker. Materials and methods: Due to their well-established roles in mTBI molecular pathology, the expression level of miR-183, miR-26a, miR-181c, miR-29a, miR-34a and miR-27b was determined using qRT-PCR in whisker hair follicles from rats subject to head-only exposure to a single-pulse shock wave. Based on established transcriptomics profiles, sub-network enrichment analysis (SNEA) was also conducted. Results: The results revealed that molecular networks involving miR-183, miR-26a and miR-181c were enriched in multiple treatments, whereas sub-networks of miR-29a, miR-34a and miR-27b were unique to individual exposure groups. Discussion: Our study showed that all six miRNAs were reflective of the mTBI signature involved in cellular responses. Noteworthy was that the decrease in the transcript levels of miR-181c was correlated with shockwave exposure severity. Conclusion: This study demonstrates for the first time that mammalian hair follicles are capable of housing miRNA biomarkers for TBI.	[Zhang, Jing; Langlois, Valerie S.] Royal Mil Coll Canada, Dept Chem & Chem Engn, Kingston, ON, Canada; [Knight, Rosalinda; Martyniuk, Christopher J.] Univ New Brunswick, Canadian River Inst, Fredericton, NB, Canada; [Wang, Yushan; Sawyer, Thomas W.] Def Res & Dev Canada, Suffield Res Ctr, Medicine Hat, ON, Canada; [Langlois, Valerie S.] Inst Natl Rech Sci, Ctr Eau Terre Environm INRS ETE, 490 Rue Couronne, Quebec City, PQ G1K 9A9, Canada; [Zhang, Jing] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Martyniuk, Christopher J.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Martyniuk, Christopher J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA		Langlois, VS (corresponding author), Inst Natl Rech Sci, Ctr Eau Terre Environm INRS ETE, 490 Rue Couronne, Quebec City, PQ G1K 9A9, Canada.	jzhangc@gmail.com; valerie.langlois@inrs.ca		Martyniuk, Christopher J./0000-0003-0921-4796; Langlois, Valerie S./0000-0003-4031-6838	Technology Investment Fund by Defense Research and Development Canada (DRDC)	This study is funded through the Technology Investment Fund by Defense Research and Development Canada (DRDC), to VSL (PI), CJM and YW. VSL holds a Canadian Research Chair.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ahmed MI, 2014, J CELL BIOL, V207, P549, DOI 10.1083/jcb.201404001; Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096820; Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176532; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gu QH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7789; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Hochfeld LM, 2017, BMC DERMATOL, V17, DOI 10.1186/s12895-017-0054-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lefort K, 2013, EMBO J, V32, P2248, DOI 10.1038/emboj.2013.156; Lezina L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.483; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ouyang YB, 2013, GLIA, V61, P1784, DOI 10.1002/glia.22556; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Rizos E, 2012, ONCOL REP, V28, P2200, DOI 10.3892/or.2012.2052; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; SCHULZE C, 1993, J CELL SCI, V104, P773; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tak H, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.73; Torres-Aleman I, 2008, ENDOCRINOLOGY, V149, P5952, DOI 10.1210/en.2008-0905; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WEICKMANN JL, 1982, J BIOL CHEM, V257, P8705; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Zhang J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13534; Zhang J, 2018, BRAIN INJURY, V32, P123, DOI 10.1080/02699052.2017.1342000; Zhang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104388; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09401; Zhou XH, 2015, J PHYSIOL BIOCHEM, V71, P753, DOI 10.1007/s13105-015-0439-3	56	6	8	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers	FEB 17	2019	24	2					166	179		10.1080/1354750X.2018.1531929			14	Biotechnology & Applied Microbiology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Toxicology	HU3FU	WOS:000465158700010	30280938	Green Accepted			2022-02-06	
J	Shanan, N; Ghasemigharagoz, A; Abdel-Kader, R; Breitinger, HG				Shanan, Nagwan; Ghasemigharagoz, Alireza; Abdel-Kader, Reham; Breitinger, Hans-Georg			The effect of Pyrroloquinoline quinone and Resveratrol on the Survival and Regeneration of Cerebellar Granular Neurons	NEUROSCIENCE LETTERS			English	Article						Pyrroloquinoline quinone; Resveratrol; Cerebellar granular neurons; Neuroprotection; Neurite outgrowth; Neuroregeneration	SPINAL-CORD-INJURY; HIPPOCAMPAL-NEURONS; PERIPHERAL-NERVE; SCIATIC-NERVE; GROWTH CONE; CELL-DEATH; INHIBITION; APOPTOSIS; DIFFERENTIATION; POTASSIUM	The inability of central nervous system (CNS) to regenerate following traumatic brain injury (TBI) can be attributed to apoptotic cell death, inhibitory extrinsic environment, and the limited ability of neurons to regenerate. Thus, fostering the intrinsic regenerative potential and minimizing neuronal cell death could be a promising therapeutic approach. Pyrroloquinoline quinone (PQQ) was previously reported for its neuroprotective and regenerative potential on peripheral nerves. Here, we investigated the ability of PQQ to induce neurite re-growth in a wound healing model on cultured cerebellar granular neurons (CGNs), an integral part of cerebellar circuitry, as one of the most affected areas following TBI. The neuroprotective effect was also examined utilizing K+/FCS deprivation-induced apoptosis model in CGNs. Resveratrol (RVT), an effective promoter of neuroprotection and regeneration both centrally and peripherally was also investigated separately and in combination with PQQ to establish a possible synergistic effect. RVT (5 mu M) and PQQ (0.5 mu M) showed a tendency to promote neurite re-growth in the wound healing assay, however the effect observed was statistically insignificant. Higher concentrations of PQQ (1 and 2 mu M) were found to be less effective. Resveratrol did not affect neurite length in CGNs culture; however, it did significantly increase the number of viable CGNs. For the neuroprotective effect; PQQ and RVT showed a significant increase in the survival of CGNs following K+/FCS deprivation of culture. Thus, both compounds showed a tendency to support neurite outgrowth in addition to a significant neuroprotective effect, but no synergistic effect was detected.	[Shanan, Nagwan; Abdel-Kader, Reham] German Universiy Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt; [Ghasemigharagoz, Alireza] Klinikum Univ Munchen, Inst Stroke & Dementia Res ISD, Munich, Germany; [Breitinger, Hans-Georg] German Univ Cairo, Dept Biochem, Cairo, Egypt		Breitinger, HG (corresponding author), German Univ, Dept Biochem, Cairo, Egypt.; Abdel-Kader, R (corresponding author), German Univ, Dept Pharmacol & Toxicol, Cairo, Egypt.	reham.abdelkader@guc.edu.eg; hans.breitinger@guc.edu.eg	Breitinger, Hans-Georg/ABD-3247-2021	Breitinger, Hans-Georg/0000-0003-0111-3528	German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD)	This work was supported by German Academic Exchange Service (DAAD) support to N.N.S. We are thankful to Prof. Dr. Simone Di Giovanni and Dr. Yashashree S. Joshi from the Laboratory of Neuroregeneration and Repair, Hertie Institute for Clinical Brain Research, University of Tiibingen, Germany, and Dr. Ali Ertiirk, The Institute for Stroke and Dementia, Ludwig-Maximilian-University, Munich, Germany, for experimental assistance and helpful discussions. We also would like to thank Mitsubishi Gas, Tokyo, Japan, for kindly providing the Pyrroloquinoline quinone.	Ates O, 2006, ACTA PHARMACOL SIN, V27, P1317, DOI 10.1111/j.1745-7254.2006.00416.x; Azizi A, 2014, INT J SURG, V12, P76, DOI 10.1016/j.ijsu.2013.10.002; Bagriyanik HA, 2014, NEUROSCI LETT, V561, P123, DOI 10.1016/j.neulet.2013.12.056; Bora-Tatar G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/709108; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097; Cristofol R, 2012, J PINEAL RES, V52, P271, DOI 10.1111/j.1600-079X.2011.00939.x; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; GALLO V, 1987, J NEUROSCI, V7, P2203; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gong QH, 2007, ACTA PHARMACOL SIN, V28, P1724, DOI 10.1111/j.1745-7254.2007.00666.x; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; Hirakawa A, 2009, BIOCHEM BIOPH RES CO, V378, P308, DOI 10.1016/j.bbrc.2008.11.045; Kara H, 2015, BOSNIAN J BASIC MED, V15, P38, DOI 10.17305/bjbms.2015.1.119; Kilpatrick DL, 2012, CEREBELLUM, V11, P41, DOI 10.1007/s12311-010-0227-0; LASHER RS, 1972, BRAIN RES, V41, P482, DOI 10.1016/0006-8993(72)90521-5; Li Hao-huan, 2011, Zhonghua Zheng Xing Wai Ke Za Zhi, V27, P298; Liu SQ, 2005, MICROSURG, V25, P329, DOI 10.1002/micr.20126; Luo LH, 2015, BIOCHEM BIOPH RES CO, V457, P507, DOI 10.1016/j.bbrc.2014.12.121; Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Paterniti I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015937; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Sun AY, 2001, NEUROTOX RES, V3, P167, DOI 10.1007/BF03033189; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034999; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Ye YQ, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4782820; Zhang JJ, 2009, NEUROSCI LETT, V464, P165, DOI 10.1016/j.neulet.2009.08.037; Zhang Q, 2014, NEUROSCIENCE, V270, P183, DOI 10.1016/j.neuroscience.2014.04.022; Zhang Q, 2012, GENET MOL RES, V11, P2652, DOI 10.4238/2012.June.27.3; Zhang Q, 2011, TOXICOL APPL PHARM, V252, P62, DOI 10.1016/j.taap.2011.02.006; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027; Zuo L, 2013, INVEST OPHTH VIS SCI, V54, P5097, DOI 10.1167/iovs.13-12157	44	6	7	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 16	2019	694						192	197		10.1016/j.neulet.2018.12.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM7FS	WOS:000459643800031	30528876				2022-02-06	
J	Gottshall, JL; Adams, ZM; Forgacs, PB; Schiff, ND				Gottshall, Jackie L.; Adams, Zoe M.; Forgacs, Peter B.; Schiff, Nicholas D.			Daytime Central Thalamic Deep Brain Stimulation Modulates Sleep Dynamics in the Severely Injured Brain: Mechanistic Insights and a Novel Framework for Alpha-Delta Sleep Generation	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; minimally conscious state; deep brain stimulation; synaptic homeostasis hypothesis; alpha-delta sleep; sleep spindles; slow wave sleep	GRAY-MATTER ABNORMALITIES; MAJOR DEPRESSIVE DISORDER; SLOW-WAVE ACTIVITY; SODIUM OXYBATE; FUNCTIONAL CONNECTIVITY; SYNAPTIC HOMEOSTASIS; PREFRONTAL CORTEX; LATE RECOVERY; CONSCIOUSNESS; PATTERNS	Loss of organized sleep electrophysiology is a characteristic finding following severe brain injury. The return of structured elements of sleep architecture has been associated with positive prognosis across injury etiologies, suggesting a role for sleep dynamics as biomarkers of wakeful neuronal circuit function. In a continuing study of one minimally conscious state patient studied over the course of similar to 81/2 years, we sought to investigate whether changes in daytime brain activation induced by central thalamic deep brain stimulation (CT-DBS) influenced sleep electrophysiology. In this patient subject, we previously reported significant improvements in sleep electrophysiology during 51/2 years of CT-DBS treatment, including increased sleep spindle frequency and SWS delta power. We now present novel findings that many of these improvements in sleep electrophysiology regress following CT-DBS discontinuation; these regressions in sleep features correlate with a significant decrease in behavioral responsiveness. We also observe the re-emergence of alpha-delta sleep, which had been previously suppressed by daytime CT-DBS in this patient subject. Importantly, CT-DBS was only active during the daytime and has been proposed to mediate recovery of consciousness by driving synaptic activity across frontostriatal systems through the enhancement of thalamocortical output. Accordingly, the improvement of sleep dynamics during daytime CT-DBS and their subsequent regression following CT-DBS discontinuation implicates wakeful synaptic activity as a robust modulator of sleep electrophysiology. We interpret these findings in the context of the "synaptic homeostasis hypothesis," whereby we propose that daytime upregulation of thalamocortical output in the severely injured brain may facilitate organized frontocortical circuit activation and yield net synaptic potentiation during wakefulness, providing a homeostatic drive that reconstitutes sleep dynamics over time. Furthermore, we consider common large-scale network dynamics across several neuropsychiatric disorders in which alpha-delta sleep has been documented, allowing us to formulate a novel mechanistic framework for alpha-delta sleep generation. We conclude that the bi-directional modulation of sleep electrophysiology by daytime thalamocortical activity in the severely injured brain: (1) emphasizes the cyclical carry-over effects of state-dependent circuit activation on large-scale brain dynamics, and (2) further implicates sleep electrophysiology as a sensitive indicator of wakeful brain activation and covert functional recovery in the severely injured brain.	[Gottshall, Jackie L.; Forgacs, Peter B.; Schiff, Nicholas D.] Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10065 USA; [Adams, Zoe M.; Forgacs, Peter B.; Schiff, Nicholas D.] Weill Cornell Med, Dept Neurol, New York, NY USA; [Forgacs, Peter B.; Schiff, Nicholas D.] Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA		Gottshall, JL (corresponding author), Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10065 USA.	jag2037@med.cornell.edu	Gottshall, Jackie/AAM-9485-2021	Gottshall, Jackie/0000-0002-8336-1383	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD51912, HL135465]; James S. McDonnell Foundation; Jerold B. Katz Foundation; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS096222]; Leon Levy Neuroscience Fellowship Award; Stavros Niarchos Foundation; NCATS Rockefeller CTSA Program [NIH UL1 TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL135465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS096222] Funding Source: NIH RePORTER	This work was supported by NIH grants #HD51912 & #HL135465, the James S. McDonnell Foundation, and the Jerold B. Katz Foundation. PF is supported by NIH NINDS K23 NS096222, Leon Levy Neuroscience Fellowship Award, NIH UL1 TR000043 NCATS Rockefeller CTSA Program, and The Stavros Niarchos Foundation.	Adams ZM, 2016, CLIN NEUROPHYSIOL, V127, P3086, DOI 10.1016/j.clinph.2016.06.028; Allada R, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027730; Anaclet C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9744; Arnaldi D, 2016, CLIN NEUROPHYSIOL, V127, P1445, DOI 10.1016/j.clinph.2015.10.042; Avantaggiato P, 2015, J HEAD TRAUMA REHAB, V30, P334, DOI 10.1097/HTR.0000000000000122; Blumenfeld H, 2000, J NEUROSCI, V20, P5153; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Ceko M, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/585419; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; Cirelli C, 2017, CURR OPIN NEUROBIOL, V44, P72, DOI 10.1016/j.conb.2017.03.016; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; De Tanti A, 2016, BRAIN INJURY, V30, P1029, DOI 10.3109/02699052.2016.1147078; Dolsen MR, 2017, J AFFECT DISORDERS, V212, P160, DOI 10.1016/j.jad.2017.01.025; Drewes AM, 1998, BRIT J RHEUMATOL, V37, P71; Drewes AM, 1997, SLEEP, V20, P632, DOI 10.1093/sleep/20.8.632; Ducharme-Crevier L, 2017, PEDIATR CRIT CARE ME, V18, P452, DOI 10.1097/PCC.0000000000001137; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Ferrarelli F, 2017, SCHIZOPHR RES, V180, P36, DOI 10.1016/j.schres.2016.05.023; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giraldo-Chica M, 2017, SCHIZOPHR RES, V180, P58, DOI 10.1016/j.schres.2016.08.005; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; Gottshall JL, 2017, COGN NEUR SOC 24 ANN; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; HAURI P, 1973, ELECTROEN CLIN NEURO, V34, P233, DOI 10.1016/0013-4694(73)90250-2; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Huber R, 2013, CEREB CORTEX, V23, P1, DOI 10.1093/cercor/bhs014; Jaimchariyatam Nattapong, 2011, Innov Clin Neurosci, V8, P35; Kantrowitz J, 2009, CNS DRUGS, V23, P681, DOI 10.2165/00023210-200923080-00005; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kothare SV, 2007, NEUROLOGY, V68, P1157, DOI 10.1212/01.wnl.0000258658.00692.36; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Kuhn M, 2016, NAT COMMUN, V7; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Lorincz ML, 2008, J NEUROSCI, V28, P660, DOI 10.1523/JNEUROSCI.4468-07.2008; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Ly JQM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11828; Mahowald ML, 2000, SLEEP MED, V1, P195, DOI 10.1016/S1389-9457(00)00028-9; Maitre M, 2016, MED RES REV, V36, P363, DOI 10.1002/med.21382; MANU P, 1994, SOUTHERN MED J, V87, P465, DOI 10.1097/00007611-199404000-00008; Maremmani AGI, 2015, ADDICT DISORD TREAT, V14, P198, DOI 10.1097/ADT.0000000000000055; Markello RD, 2018, NEUROIMAGE, V173, P287, DOI 10.1016/j.neuroimage.2018.02.042; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Meisel C, 2015, P NATL ACAD SCI USA, V112, P14694, DOI 10.1073/pnas.1513716112; Miyawaki H, 2016, CURR BIOL, V26, P893, DOI 10.1016/j.cub.2016.02.024; Moldofsky H, 2010, J RHEUMATOL, V37, P2156, DOI 10.3899/jrheum.091041; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Mouthon AL, 2016, NEUROIMAGE-CLIN, V11, P468, DOI 10.1016/j.nicl.2016.03.012; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nava F, 2001, EUR J PHARMACOL, V430, P261, DOI 10.1016/S0014-2999(01)01163-3; Nofzinger EA, 2005, ARCH GEN PSYCHIAT, V62, P387, DOI 10.1001/archpsyc.62.4.387; PARENT A, 1988, J COMP NEUROL, V277, P281, DOI 10.1002/cne.902770209; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Rains JC, 2003, J PSYCHOSOM RES, V54, P77, DOI 10.1016/S0022-3999(02)00545-7; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; REIHER J, 1977, CAN J NEUROL SCI, V4, P39, DOI 10.1017/S0317167100120396; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Rodriguez AV, 2016, J NEUROSCI, V36, P12436, DOI 10.1523/JNEUROSCI.1614-16.2016; Roehrs JD, 2015, J CLIN SLEEP MED, V11, P277, DOI 10.5664/jcsm.4546; Roizenblatt S, 2001, ARTHRITIS RHEUM-US, V44, P222, DOI 10.1002/1529-0131(200101)44:1<222::AID-ANR29>3.0.CO;2-K; Rudolph M, 2005, J NEUROPHYSIOL, V94, P2805, DOI 10.1152/jn.01313.2004; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Scharf MB, 2003, J RHEUMATOL, V30, P1070; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff N.D., 2016, BRAIN FUNCTION RESPO, P195, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schwartz TL, 2007, CNS SPECTRUMS, V12, P884; Sebastiano DR, 2018, CLIN NEUROPHYSIOL, V129, P687, DOI 10.1016/j.clinph.2017.12.012; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Sloan EP, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-20; STERIADE M, 1987, BRAIN RES, V408, P372, DOI 10.1016/0006-8993(87)90408-2; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; TANAKA ZENRYU, 1966, FOLIA PSYCHIAT NEUROL JAP, V20, P9; Tatum William O, 2016, Neurodiagn J, V56, P285, DOI 10.1080/21646821.2016.1245576; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Vertkin I, 2015, P NATL ACAD SCI USA, V112, pE3291, DOI 10.1073/pnas.1424810112; Vijayan S, 2015, J NEUROPHYSIOL, V114, P1923, DOI 10.1152/jn.00280.2015; Vijayan S, 2012, P NATL ACAD SCI USA, V109, P18553, DOI 10.1073/pnas.1215385109; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157	98	6	6	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 4	2019	10								20	10.3389/fneur.2019.00020			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HK1SH	WOS:000457686200001	30778326	Green Published, gold			2022-02-06	
J	Balakrishnan, B; Flynn-O'Brien, KT; Simpson, PM; Dasgupta, M; Hanson, SJ				Balakrishnan, Binod; Flynn-O'Brien, Katherine T.; Simpson, Pippa M.; Dasgupta, Mahua; Hanson, Sheila J.			Enteral Nutrition Initiation in Children Admitted to Pediatric Intensive Care Units After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Children; Pediatric intensive care; Enteral nutrition; Outcomes; Trauma; Pediatric	CRITICALLY-ILL CHILDREN; LENGTH-OF-STAY; OUTCOMES; SUPPORT; DISCHARGE; MORTALITY	BackgroundTraumatic brain injury (TBI) is the leading cause of death and long-term disability among injured children. Early feeding has been shown to improve outcomes in adults, with some similar evidence in children with severe TBI. We aimed to examine the current practice of initiation of enteral nutrition in children with TBI and to evaluate the risk factors associated with delayed initiation of enteral nutrition.MethodsThis retrospective, multicenter study used the Pediatric Trauma Assessment and Management Database including all children with head trauma discharged from five pediatric intensive care units (PICU) at pediatric trauma centers between January 1, 2013 and December 31, 2013. We compared demographics, injury and procedure data, time to initiation of nutrition, and injury and illness severity scores between patients who received enteral nutrition early (48h) and late (>48h). Fisher's exact and Mann-Whitney U tests compared discrete and continuous variables. Univariate and multivariable analyses evaluated variables associated with delayed initiation of feeding. Outcomes of interest included mortality, complications, ventilator days, hospital and ICU length of stay, and functional status at ICU discharge.ResultsIn the 416 patients in the study, the overall mortality was 2.6%. The majority of patients (83%; range 69-88% between five sites, p=0.0008) received enteral nutrition within 48h of PICU admission. Lower Glasgow Coma Scale scores and higher Injury Severity Score (ISS) were independently associated with delayed initiation of enteral nutrition. Delayed enteral nutrition was independently associated with worse functional status at PICU discharge (p=0.02) but was not associated with mortality or increased length of stay.ConclusionsChildren with severe TBI and higher ISS were more likely to have delayed initiation of enteral nutrition. Delayed enteral nutrition was an independent risk factor for worse functional status at ICU discharge for the entire cohort, but not for the severe TBI group.	[Balakrishnan, Binod; Hanson, Sheila J.] Med Coll Wisconsin, Childrens Hosp Wisconsin, Dept Pediat, Div Crit Care, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Flynn-O'Brien, Katherine T.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Simpson, Pippa M.; Dasgupta, Mahua] Med Coll Wisconsin, Div Quantitat Hlth Sci, Dept Pediat, Milwaukee, WI 53226 USA		Balakrishnan, B (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, Dept Pediat, Div Crit Care, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA.	SHanson@mcw.edu	Balakrishnan, Binod/AAU-4660-2021		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32-HD057822]; 2014 Childress Foundation grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	This project was, in part, supported by a 2014 Childress Foundation grant. Dr. Katherine T Flynn-O'Brien received fellowship support from the National Institute of Child Health and Human Development (T32-HD057822) during the preparation of this paper. VPS data were provided from the VPS, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Childress Institute, or VPS, LLC.	ACS TQIP, 2015, BEST PRACT MAN TRAUM; Canarie MF, 2015, PEDIATR CRIT CARE ME, V16, pE283, DOI 10.1097/PCC.0000000000000527; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Keehn A, 2015, JPEN-PARENTER ENTER, V39, P211, DOI 10.1177/0148607113513800; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS72, DOI 10.1097/PCC.0b013e31823f681d; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Malakouti A, 2012, PEDIATR CRIT CARE ME, V13, pE18, DOI 10.1097/PCC.0b013e31820aba1f; Mehta NM, 2015, AM J CLIN NUTR, V102, P199, DOI 10.3945/ajcn.114.104893; Mehta NM, 2010, JPEN-PARENTER ENTER, V34, P38, DOI 10.1177/0148607109348065; Meinert E, 2018, PEDIATR CRIT CARE ME, V19, P345, DOI 10.1097/PCC.0000000000001471; Mikhailov TA, 2014, JPEN-PARENTER ENTER, V38, P459, DOI 10.1177/0148607113517903; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Sangkhathat S, 2003, J PEDIATR SURG, V38, P1516, DOI 10.1016/S0022-3468(03)00506-2; Shinnick JK, 2016, J SURG RES, V202, P165, DOI 10.1016/j.jss.2015.12.051; Stylianos S, 2008, SEMIN PEDIATR SURG, V17, P110, DOI 10.1053/j.sempedsurg.2008.02.006; Taha AA, 2011, J NEUROSCI NURS, V43, P291, DOI 10.1097/JNN.0b013e318234e9b2; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vrecenak JD, 2014, J PEDIATR SURG, V49, P99, DOI 10.1016/j.jpedsurg.2013.09.038	24	6	7	4	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					193	200		10.1007/s12028-018-0597-6			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700023	30171446	Bronze			2022-02-06	
J	Bjarko, VV; Skandsen, T; Moen, KG; Gulati, S; Helseth, E; Nilsen, TIL; Vik, A				Bjarko, Vera Vik; Skandsen, Toril; Moen, Kent Goran; Gulati, Sasha; Helseth, Eirik; Nilsen, Tom I. L.; Vik, Anne			Time of Injury and Relation to Alcohol Intoxication in Moderate-to-Severe Traumatic Brain Injury: A Decade-Long Prospective Study	WORLD NEUROSURGERY			English	Article						Alcohol; Epidemiology; Prevention; TBI; Time of injury	EPIDEMIOLOGY; DRINKING; TRENDS	BACKGROUND: Knowledge about the causes and time of injury for traumatic brain injury (TBI) is important for the development of efficient prevention policies. We aimed to study time of injury and relation to alcohol intoxication for moderate-to-severe TBI in a level 1 trauma center in Norway. METHODS: From October 2004 to September 2014, 493 consecutive patients (>= 16 years) with moderate (Glasgow Coma Scale [GCS] score 9-13) and severe TBI (GCS score 3-8) were prospectively included in the Trondheim TBI Study (222 patients with moderate and 270 patients with severe TBI). RESULTS: Mean age was 47 years (standard deviation 21 years). Positive blood alcohol concentration (BAC) was found in 29%, and median BAC was 41.5 mmol/L (inter-quartile range 28.7-54.3), equal to 1.91 parts per thousand. Admissions were more frequent on Saturdays (relative risk [RR] 2.67, 95% confidence interval [CI] 1.87-3.80) and Sundays (RR 2.10, 95% CI 1.45-3.03) compared with Mondays, and positive BAC was more common on weekends than weekdays (43% vs. 16%). Furthermore, admissions were more frequent in June (RR 2.26, 95% CI 1.44-3.55), July (RR 2.07, 95% CI 1.31-3.28), and December (RR 2.07, 95% CI 1.31-3.28) compared with January. The number of patients with positive BAC was greatest in December (RR 5.75, 95% CI 1.99-16.63), and 70% of these were caused by falls. CONCLUSIONS: Our findings demonstrate that moderate-to-severe TBI admissions display a clear weekly and seasonal variation and that alcohol is an important modifiable risk factor for moderate-to-severe TBI.	[Bjarko, Vera Vik; Helseth, Eirik] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Skandsen, Toril; Moen, Kent Goran; Gulati, Sasha; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Nilsen, Tom I. L.] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Gulati, Sasha; Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Nilsen, Tom I. L.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Anesthesia & Intens Care, Trondheim, Norway; [Moen, Kent Goran] Levanger Hosp, Dept Med Imaging, Levanger, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway		Bjarko, VV (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	vbjarko@gmail.com	Helseth, Eirik/AAH-2466-2020				Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cantwell K, 2015, PREHOSP EMERG CARE, V19, P425, DOI 10.3109/10903127.2014.995843; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Khorshidi A, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.27894; Knudsen AK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1533-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makela P, 2001, ADDICTION, V96, P1575; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Reich RR, 2015, J ABNORM PSYCHOL, V124, P635, DOI 10.1037/abn0000061; Rossow I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1076; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Siliquini R, 2012, J PUBLIC HEALTH RES, V1, P83, DOI 10.4081/jphr.2012.e15; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Strand Bjorn Heine, 2003, Tidsskr Nor Laegeforen, V123, P2849; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099	22	6	6	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2019	122						E684	E689		10.1016/j.wneu.2018.10.122			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HJ6UM	WOS:000457328100083	30385362	Green Published, hybrid			2022-02-06	
J	Brands, IMH; Verlinden, I; Ribbers, GM				Brands, Ingrid M. H.; Verlinden, Inge; Ribbers, Gerard M.			A study of the influence of cognitive complaints, cognitive performance and symptoms of anxiety and depression on self-efficacy in patients with acquired brain injury	CLINICAL REHABILITATION			English	Article						Self-efficacy; neuropsychological rehabilitation; cognitive impairment; emotional distress; brain injury	QUALITY-OF-LIFE; COPING SKILLS GROUP; SOCIAL-PARTICIPATION; ADAPTATION PROCESS; HOSPITAL ANXIETY; REHABILITATION; SUPPORT; STROKE; ASSOCIATIONS; STYLES	Objective: To examine the relationship between self-efficacy for managing brain injury-specific symptoms and cognitive performance, subjective cognitive complaints and anxiety and depression symptoms in patients with acquired brain injury (ABI). Design: Clinical cohort study. Setting: General hospitals, rehabilitation centres. Subjects: A total of 122 patients with newly ABI (mean age = 54.4 years (SD, 12.2)) were assessed at discharge home from inpatient neurorehabilitation or at start of outpatient neurorehabilitation after discharge home from acute hospital. Mean time since injury was 14.1 weeks (SD, 8.6). Main measures: Self-efficacy was measured using the Traumatic Brain Injury (TBI) Self-Efficacy Questionnaire (SEsx), mean score = 82.9 (SD, 21.8). Objective cognitive performance was measured with the Symbol Digit Modalities Test (SDMT), mean z-score = -1.36 (SD, 1.31). Anxiety and depression symptoms were measured with the Hospital Anxiety and Depression Scale (HADS), cognitive complaints with the self-rating form of the Dysexecutive Questionnaire (DEX-P). Results: Higher levels of subjective cognitive complaints and higher levels of anxiety and depression symptoms were significantly associated with lower self-efficacy (beta = -0.35; P = .001 and beta =-0.43; P < .001, respectively). Objective cognitive performance was not significantly associated with self-efficacy (beta = 0.04, P = .53). DEX-P scores accounted for 42% and HADS scores for 7% of the total 57% variance explained. Objective cognitive performance did not correlate significantly with subjective cognitive complaints (r = -.13, P = .16). Conclusion: Control over interfering emotions and mastery over brain injury-associated symptoms seems important in the development of self-efficacy for managing brain injury-specific symptoms.	[Brands, Ingrid M. H.; Verlinden, Inge] Libra Rehabil & Audiol, Dept Neurorehabil, POB 1355, NL-5602 BJ Eindhoven, Netherlands; [Ribbers, Gerard M.] Erasmus MC, Dept Rehabil, Rotterdam, Netherlands; [Ribbers, Gerard M.] Rijndam Rehabil Ctr, Dept Neurorehabil, Rotterdam, Netherlands		Brands, IMH (corresponding author), Libra Rehabil & Audiol, Dept Neurorehabil, POB 1355, NL-5602 BJ Eindhoven, Netherlands.	i.brands@libranet.nl	Ribbers, Gerard M/C-1454-2014	Ribbers, Gerard M/0000-0002-6114-349X			Aben L, 2011, CEREBROVASC DIS, V31, P566, DOI 10.1159/000324627; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus S, 2016, ARCH PHYS MED REHAB, V97, P281, DOI 10.1016/j.apmr.2015.10.097; Bandura A., 1997, SELF EFFICACY EXERCI; Brands I, 2017, NEUROREHABILITATION, V40, P587, DOI 10.3233/NRE-171446; Brands I, 2015, CLIN REHABIL, V29, P611, DOI 10.1177/0269215514549484; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands I, 2014, J REHABIL MED, V46, P869, DOI 10.2340/16501977-1849; Brands IMH, 2014, PSYCHOL ASSESSMENT, V26, P848, DOI 10.1037/a0036275; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Brock K, 2009, DISABIL REHABIL, V31, P880, DOI 10.1080/09638280802356179; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; De Bie S. E., 1987, STANDAARDVRAGEN 1987; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Genis M, 2016, NEUROPSYCHOL REHABIL, V26, P191, DOI 10.1080/09602011.2015.1009473; Gregorio GW, 2015, BRIT J CLIN PSYCHOL, V54, P291, DOI 10.1111/bjc.12074; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Jongen PJ, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/960282; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; Lewin A, 2013, NEUROPSYCHOL REHABIL, V23, P546, DOI 10.1080/09602011.2013.794742; Longworth C, 2018, NEUROPSYCHOL REHABIL, V28, P1078, DOI 10.1080/09602011.2016.1226185; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lowe R, 2008, PSYCHOL HEALTH, V23, P155, DOI 10.1080/14768320601139160; Mole JA, 2020, NEUROPSYCHOL REHABIL, V30, P346, DOI 10.1080/09602011.2018.1464934; Nijsse B, 2017, NEUROPSYCHOL REHABIL, V27, P99, DOI 10.1080/09602011.2015.1065280; Peter C, 2015, REHABIL PSYCHOL, V60, P67, DOI 10.1037/rep0000021; Rakers SE, 2018, NEUROPSYCHOLOGY, V32, P213, DOI 10.1037/neu0000399; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Simblett SK, 2017, JMIR MENT HEALTH, V4, DOI 10.2196/mental.6022; Smith A., 1982, SYMBOL DIGIT MODALIT; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stulemeijer M, 2008, THESIS; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tam HMK, 2015, APPL NEUROPSYCH-ADUL, V22, P94, DOI 10.1080/23279095.2013.860602; Tang WK, 2013, ARCH PHYS MED REHAB, V94, P2535, DOI 10.1016/j.apmr.2013.07.012; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Volz M, 2016, J AFFECT DISORDERS, V206, P252, DOI 10.1016/j.jad.2016.07.041; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	6	6	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2019	33	2					327	334		10.1177/0269215518795249			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HJ0XS	WOS:000456887100018	30168362				2022-02-06	
J	Foletti, JM; Martinez, V; Graillon, N; Godio-Raboutet, Y; Thollon, L; Guyot, L				Foletti, J. M.; Martinez, V; Graillon, N.; Godio-Raboutet, Y.; Thollon, L.; Guyot, L.			Development and validation of an optimized finite element model of the human orbit	JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY			English	Article						Finite element analysis; Maxillofacial; Trauma; Orbit; Biomechanics	STRESS-ANALYSIS; HUMAN HEAD; HUMAN EYE; DEFORMATION; MECHANISMS; FRACTURES; INJURY	Introduction: The authors' main purpose was to develop a detailed finite element model (FEM) of the human orbit and to validate it by analyzing its behavior under the stress of blunt traumas. Materials and methods: A pre-existing 3D FEM of a human head was modified and used in this study. Modifications took into account preliminary research carried out on PubMed database. Data from a CT scan of the head were computed with Mimics (R) software to re-create the skull geometry. The mesh production, the model's properties and the simulations of blunt orbital traumas were conducted on Hyperworks (R) software. Results: The resulting 3D FEM was composed of 640 000 elements and was used to perform blunt trauma simulations on an intact orbit. A total of 27 tests were simulated. Fifteen tests were realized with a metallic cylinder impactor; 12 tests simulated a hit by a closed fist. In all the tests conducted (27/27), the orbital floor was fractured. Fracture patterns were similar to those found in real clinical situations according to the buckling and hydraulic theories of orbital floor fractures. Discussion: The similitude between the fracture patterns produced on the model and those observed in vivo allows for a validation of the model. This model constitutes, at the authors knowledge, the most sophisticated one ever developed. (C) 2018 Published by Elsevier Masson SAS.	[Foletti, J. M.; Graillon, N.] Aix Marseille Univ, AP HM, IFSTTAR, LBA,Hop Concept,Serv Chirurg Maxillofaciale, F-13005 Marseille, France; [Martinez, V; Godio-Raboutet, Y.; Thollon, L.] Aix Marseille Univ, IFSTTAR, LBA, F-13005 Marseille, France; [Guyot, L.] Aix Marseille Univ, AP HM, CNRS, EFS,Hop Concept,Serv Chirurg Maxillofaciale, F-13005 Marseille, France		Foletti, JM (corresponding author), Aix Marseille Univ, IFSTTAR, LBA UMR T24, Fac Med Sect Nord, Blvd Pierre Dramard, F-13916 Marseille 20, France.	jean-marc.foletti@ap-hm.fr; valentine.martinez4@gmail.com; nicolas.graillon@ap-hm.fr; yves.godio@ifsttar.fr; lionel.thollon@ifsttar.fr; Laurent.guyot@ap-hm.fr					Ahmad F, 2006, J CRANIOFAC SURG, V17, P438, DOI 10.1097/00001665-200605000-00009; Al-Sukhun J, 2006, J R SOC INTERFACE, V3, P255, DOI 10.1098/rsif.2005.0084; Al-Sukhun J, 2006, J ORAL MAXIL SURG, V64, P434, DOI 10.1016/j.joms.2005.11.015; Al-sukhun J, 2012, J CRANIOFAC SURG, V23, P669, DOI 10.1097/SCS.0b013e31824db8a0; Al-Sukhun J, 2012, J CRANIOFAC SURG, V23, P126, DOI 10.1097/SCS.0b013e318240fc92; Al-Sukhun J, 2011, J CRANIOFAC SURG, V22, P1299, DOI 10.1097/SCS.0b013e31821c6ae9; Al-Sukhun J, 2011, J CRANIOFAC SURG, V22, P1294, DOI 10.1097/SCS.0b013e31821c6afd; Armentani E, 2010, OPEN MECH ENG J, V4, P8, DOI DOI 10.2174/1874155X010040100008; Arnoux P J, 2005, Traffic Inj Prev, V6, P288, DOI 10.1080/15389580590969463; Bege T, 2015, MED BIOL ENG COMPUT, V53, P187, DOI 10.1007/s11517-014-1212-4; Behr M., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P263, DOI 10.1080/10255840310001606080; Esposito L, 2015, COMPUT METHOD BIOMEC, V18, P107, DOI 10.1080/10255842.2013.779684; Foletti JM, 2017, BRIT J ORAL MAX SURG, V55, P836, DOI 10.1016/j.bjoms.2017.06.011; Joseph D, 1999, T ORTHOP RES SOC, V24, P642; Karimi A, 2016, INJURY, V47, P1042, DOI 10.1016/j.injury.2016.01.030; Ramesh S, 2018, OPHTHAL PLAST RECONS, V34, P456, DOI 10.1097/IOP.0000000000001049; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Rossi T, 2012, INVEST OPHTH VIS SCI, V53, P8057, DOI 10.1167/iovs.12-10591; Schaller A, 2012, INT J ORAL MAX SURG, V41, P66, DOI 10.1016/j.ijom.2011.09.004; Schaller A, 2013, J CRANIO MAXILL SURG, V41, P710, DOI 10.1016/j.jcms.2012.02.008; Schoemaker I, 2006, INVEST OPHTH VIS SCI, V47, P4819, DOI 10.1167/iovs.05-1497; Schutte S, 2006, VISION RES, V46, P1724, DOI 10.1016/j.visres.2005.11.022; Tuchtan L, 2015, FORENSIC SCI INT, V252, P22, DOI 10.1016/j.forsciint.2015.04.017; Versluis A, 2004, DENT MATER, V20, P554, DOI 10.1016/j.dental.2003.05.007; Wang RZ, 1998, J BIOMECH, V31, P135; Weaver AA, 2011, J BIOMECH, V44, P1296, DOI 10.1016/j.jbiomech.2011.01.004; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wong RCW, 2011, INT J ORAL MAX SURG, V40, P393, DOI 10.1016/j.ijom.2010.11.023	29	6	7	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-8509	2468-7855		J STOMATOL ORAL MAXI	J. Stomatol. Oral Maxillofac. Surg.	FEB	2019	120	1					16	20		10.1016/j.jormas.2018.09.002			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	HN3GW	WOS:000460072800005	30287407	Green Published			2022-02-06	
J	Kienzler, JC; Zakelis, R; Babler, S; Remonda, E; Ragauskas, A; Fandino, J				Kienzler, Jenny C.; Zakelis, Rolandas; Babler, Sabrina; Remonda, Elke; Ragauskas, Arminas; Fandino, Javier			Validation of Noninvasive Absolute Intracranial Pressure Measurements in Traumatic Brain Injury and Intracranial Hemorrhage	OPERATIVE NEUROSURGERY			English	Article						ICP; Noninvasive; Traumatic brain injury; Intracranial hemorrhage	TYMPANIC MEMBRANE DISPLACEMENT; DOPPLER PULSATILITY INDEX; OPTIC-NERVE SHEATH; TRANSCRANIAL DOPPLER; CLINICAL-ASSESSMENT; HYPERTENSION; ICP; ULTRASOUND; CHILDREN; MR	BACKGROUND: Increased intracranial pressure (ICP) causes secondary damage in traumatic brain injury (TBI), and intracranial hemorrhage (ICH). Current methods of ICP monitoring require surgery and carry risks of complications. OBJECTIVE: To validate a new instrument for noninvasive ICP measurement by comparing values obtained from noninvasive measurements to those from commercial implantable devices through this pilot study. METHODS: The ophthalmic artery (OA) served as a natural ICP sensor. ICP measurements obtained using noninvasive, self-calibrating device utilizing Doppler ultrasound to evaluate OA flow were compared to standard implantable ICP measurement probes. RESULTS: A total of 78 simultaneous, paired, invasive, and noninvasive ICP measurements were obtained in 11 ICU patients over a 17-mo period with the diagnosis of TBI, SAH, or ICH. A total of 24 paired data points were initially excluded because of questions about data independence. Analysis of variance was performed first on the 54 remaining data points and then on the entire set of 78 data points. There was no difference between the 2 groups nor was there any correlation between type of sensor and the patient (F[10, 43] = 1.516, P = .167), or the accuracy and precision of noninvasive ICP measurements (F[1, 43] = 0.511, P = .479). Accuracy was [-1.130; 0.539] mm Hg (CL = 95%). Patient-specific calibration was not needed. Standard deviation (precision) was [1.632; 2.396] mm Hg (CL = 95%). No adverse events were encountered. CONCLUSION: This pilot study revealed no significant differences between invasive and noninvasive ICP measurements (P < .05), suggesting that noninvasive ICP measurements obtained by this method are comparable and reliable.	[Kienzler, Jenny C.; Zakelis, Rolandas; Babler, Sabrina; Remonda, Elke; Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Zakelis, Rolandas; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania		Kienzler, JC (corresponding author), Kantonsspital Aarau, Dept Neurosurg, Editorial Off, Tellstr, CH-5001 Aarau, Switzerland.	jenny.kienzler@ksa.ch			Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_1733421]; Vittamed Neurosciences, Boston, Massachusett; Swiss Agency for Development and Cooperation (SDS); Research Fund Kantonsspital Aarau, Switzerland	This study was supported in part by the Swiss National Science Foundation (Grant No. 32003B_1733421), Vittamed Neurosciences, Boston, Massachusetts; Swiss Agency for Development and Cooperation (SDS), and the Research Fund Kantonsspital Aarau, Switzerland. Rolandas Zakelis and Arminas Ragauskas received financial support from Vittamed Neurosciences. Arminas Ragauskas is a co-owner of Vittamed Neurosciences.	Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Buki B, 1996, HEARING RES, V94, P125, DOI 10.1016/0378-5955(96)00015-9; Burges CJC, 2010, FOUND TRENDS MACH LE, V2, P275, DOI 10.1561/2200000002; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Citerio G, 2008, NEUROSURGERY, V63, P1152, DOI 10.1227/01.NEU.0000335148.87042.D7; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Ganslandt O, 2018, J NEUROSURG, V128, P1653, DOI 10.3171/2016.11.JNS152268; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Harris AJI, 2013, VP131SMM07K03080; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Kamel H, 2012, NEUROCRIT CARE, V17, P172, DOI 10.1007/s12028-012-9744-7; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Lv YH, 2015, NEUROL SCI, V36, P1203, DOI 10.1007/s10072-015-2073-9; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; MARCHBANKS RJ, 1984, ACTA OTO-LARYNGOL, V98, P119, DOI 10.3109/00016488409107543; Marshall I, 2008, BRIT J NEUROSURG, V22, P389, DOI 10.1080/02688690801911598; Michel E, 1998, ULTRASOUND MED BIOL, V24, P597, DOI 10.1016/S0301-5629(98)00024-6; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Morton R, 2012, NEUROSURGERY, V71, pE193, DOI 10.1227/NEU.0b013e318232e250; Motschmann M, 2001, Strabismus, V9, P13, DOI 10.1076/stra.9.1.13.711; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Querfurth HW, 2002, ACTA NEUROL SCAND, V105, P431, DOI 10.1034/j.1600-0404.2002.01273.x; Ragauskas A, 2005, ACT NEUR S, V95, P357; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Ragauskas A, 2014, NEUROL RES, V36, P607, DOI 10.1179/1743132813Y.0000000308; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Raksin PB, 2003, NEUROSURG FOCUS, V14, P1; REID A, 1989, J NEUROL NEUROSUR PS, V52, P610, DOI 10.1136/jnnp.52.5.610; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Samuel M, 1998, EUR J PEDIATR SURG, V8, P200, DOI 10.1055/s-2008-1071154; Samuel M, 1998, J NEUROSURG, V88, P983, DOI 10.3171/jns.1998.88.6.0983; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Shen QM, 1999, J CLIN MONIT COMPUT, V15, P179, DOI 10.1023/A:1009925811965; Shimbles S, 2005, ACTA NEUROCHIR SUPPL, V95, P197; Shofty B, 2012, AM J NEURORADIOL, V33, P366, DOI 10.3174/ajnr.A2779; Skoloudik D, 2011, BRIT J OPHTHALMOL, V95, P217, DOI 10.1136/bjo.2009.172890; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stuart RM, 2011, NEUROCRIT CARE, V15, P146, DOI 10.1007/s12028-009-9264-2; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; YORK D, 1984, NEUROSURGERY, V14, P456, DOI 10.1227/00006123-198404000-00011; Zhang B, 2012, MED HYPOTHESES, V78, P227, DOI 10.1016/j.mehy.2011.10.031; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	67	6	6	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	FEB	2019	16	2					186	195		10.1093/ons/opy088			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IT9DU	WOS:000483181700047	29726988				2022-02-06	
J	Ledoux, AA; Barrowman, NJ; Boutis, K; Davis, A; Reid, S; Sangha, G; Farion, KJ; Belanger, K; Tremblay, MS; Yeates, KO; DeMatteo, C; Reed, N; Zemek, R				Ledoux, Andree-Anne; Barrowman, Nicholas J.; Boutis, Kathy; Davis, Adrienne; Reid, Sarah; Sangha, Gurinder; Farion, Ken J.; Belanger, Kevin; Tremblay, Mark S.; Yeates, Keith Owen; DeMatteo, Carol; Reed, Nick; Zemek, Roger		Pediat Emergency Res Canada	Multicentre, randomised clinical trial of paediatric concussion assessment of rest and exertion (PedCARE): a study to determine when to resume physical activities following concussion in children	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; ACTIVE REHABILITATION; POSTURAL STABILITY; MANAGEMENT; RETURN; ADOLESCENTS; GUIDELINES; PLAY	Introduction Rest until symptom-free, followed by a progressive stepwise return to activities, is often prescribed in the management of paediatric concussions. Recent evidence suggests prolonged rest may hinder recovery, and early resumption of physical activity may be associated with more rapid recovery postconcussion. The primary objective is to determine whether the early reintroduction of non-contact physical activity beginning 72 hours postinjury reduces postconcussive symptoms at 2 weeks in children following an acute concussion as compared with a rest until asymptomatic protocol. Methods and analysis This study is a randomised clinical trial across three Canadian academic paediatric emergency departments. A total of 350 participants, aged 10-17.99 years, who present within 48 hours of an acute concussion, will be recruited and randomly assigned to either the study intervention protocol (resumption of physical activity 72 hours postconcussion even if experiencing symptoms) or physical rest until fully asymptomatic. Participants will document their daily physical and cognitive activities. Follow-up questionnaires will be completed at 1, 2 and 4 weeks postinjury. Compliance with the intervention will be measured using an accelerometer (24 hours/day for 14 days). Symptoms will be measured using the validated Health and Behaviour Inventory. A linear multivariable model, adjusting for site and prognostically important covariates, will be tested to determine differences between groups. The proposed protocol adheres to the RCT-CONSORT guidelines. Discussion This trial will determine if early resumption of non-contact physical activity following concussion reduces the burden of concussion and will provide healthcare professionals with the evidence by which to recommend the best timing of reintroducing physical activities.	[Ledoux, Andree-Anne; Barrowman, Nicholas J.; Reid, Sarah; Farion, Ken J.; Belanger, Kevin; Tremblay, Mark S.; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Boutis, Kathy; Davis, Adrienne] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Reid, Sarah; Farion, Ken J.; Zemek, Roger] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Sangha, Gurinder] Childrens Hosp London, Pediat Emergency Med, Hlth Sci Ctr, London, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Dept Psychol, Res Inst, Calgary, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada		Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Tremblay, Mark/ABI-5477-2020; Tremblay, Mark/AAF-2981-2019; Barrowman, Nick/AAL-3166-2020; Yeates, Keith/AAJ-4223-2020	Barrowman, Nick/0000-0002-4704-9595; Yeates, Keith/0000-0001-7680-2892	Ontario SPOR Support Unit - IMPACT-Child Health Award; Ontario Neurotrauma Foundation; CHEO Foundation	This work was supported by Ontario SPOR Support Unit - IMPACT-Child Health Award, the Ontario Neurotrauma Foundation, and the CHEO Foundation.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Burton LJ, 1997, PEDIATR EMERG CARE, V13, P1, DOI 10.1097/00006565-199702000-00001; Carey S, 2013, CONCUSSIONS ONTARIO; Carroll L J, 2011, CONCUSSION CRISIS AN; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Institute of Medicine (IOM) and National Research Council (NRC), 2013, SPORTS RELATED CONCU; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Maulden SA, 2005, ARCH PHYS MED REHAB, V86, pS34, DOI 10.1016/j.apmr.2005.08.119; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Roemmich JN, 2006, MED SCI SPORT EXER, V38, P1014, DOI 10.1249/01.mss.0000218123.81079.49; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sampson MR, 2012, EXPERT REV CLIN PHAR, V5, P525, DOI [10.1586/ECP.12.52, 10.1586/ecp.12.52]; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tremblay Mark, 2007, Health Rep, V18 Suppl, P7; Tremblay Mark S, 2010, Health Rep, V21, P7; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, pE113; Tudor-Locke C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0172-x; Varni JW, 2013, QUAL LIFE RES, V22, P2581, DOI 10.1007/s11136-013-0370-4; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2004, J RHEUMATOL, V31, P2494; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2013, BMJ OPEN, V3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	88	6	6	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2019	53	3					195	+		10.1136/bjsports-2017-097981			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HK9EQ	WOS:000458292900013	28701360	Green Published			2022-02-06	
J	Santos, J; Milthorpe, BK; Padula, MP				Santos, Jerran; Milthorpe, Bruce Kenneth; Padula, Matthew Paul			Proteomic Analysis of Cyclic Ketamine Compounds Ability to Induce Neural Differentiation in Human Adult Mesenchymal Stem Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						adult stem cells; adipose; neural; proteomics; cytokines; cyclic ketamine	LANTHIONINE KETIMINE; BOVINE BRAIN; FILAMIN-A; EXPRESSION; GELSOLIN; BINDING; ACTIVATION; RECEPTORS; MIGRATION; TOXICITY	Neural regeneration is of great interest due to its potential to treat traumatic brain injuries and diseases that impact quality of life. Growth factor mediated differentiation can take up to several weeks to months to produce the cell of interest whereas chemical stimulation may be as minimal as a few hours. The smaller time scale is of great clinical relevance. Adipose derived stem cells (ADSCs) were treated for up to 24 h with a novel differentiation media containing the cyclic ketamine compounds to direct neurogenic induction. The extent of differentiation was investigated by proteome changes occurring during the process. The treatments indicated the ADSCs responded favorably to the neurogenic induction media by presenting a number of morphological cues of neuronal phenotype previously seen and a higher cell population post induction compared to previous studies. Furthermore, approximately 3500 proteins were analyzed and identified by mass spectrometric iTRAQ analyses. The bioinformatics analyses revealed hundreds of proteins whose expression level changes were statistically significant and biologically relevant to neurogenesis and annotated as being involved in neurogenic development. Complementing this, the Bioplex cytokine assay profiles present evidence of decreased panel of stress response cytokines and a relative increase in those involved in neurogenesis.	[Santos, Jerran; Milthorpe, Bruce Kenneth] Univ Technol Sydney, Sch Life Sci, Adv Tissue Regenerat & Drug Delivery Grp, POB 123, Broadway, Ultimo 2007, Australia; [Santos, Jerran; Padula, Matthew Paul] Univ Technol Sydney, Fac Sci, Prote Core Facil, POB 123, Broadway, Ultimo 2007, Australia; [Santos, Jerran; Padula, Matthew Paul] Univ Technol Sydney, Fac Sci, Sch Life Sci, POB 123, Broadway, Ultimo 2007, Australia; [Santos, Jerran] Univ Toulouse 3 INPT, CIRIMAT, 118 Route Narbonne, F-31062 Toulouse, France		Santos, J (corresponding author), Univ Technol Sydney, Sch Life Sci, Adv Tissue Regenerat & Drug Delivery Grp, POB 123, Broadway, Ultimo 2007, Australia.; Santos, J (corresponding author), Univ Technol Sydney, Fac Sci, Prote Core Facil, POB 123, Broadway, Ultimo 2007, Australia.; Santos, J (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, POB 123, Broadway, Ultimo 2007, Australia.; Santos, J (corresponding author), Univ Toulouse 3 INPT, CIRIMAT, 118 Route Narbonne, F-31062 Toulouse, France.	Jerran.Santos@uts.edu.au; Bruce.Milthorpe@uts.edu.au; Matthew.Padula@uts.edu.au	Padula, Matthew P/R-6150-2016; Milthorpe, Bruce/Z-1153-2019; Santos, Jerran/P-7868-2016	Padula, Matthew P/0000-0002-8283-0643; Milthorpe, Bruce/0000-0002-0867-9586; Santos, Jerran/0000-0003-4067-220X	UTS; MQU	We would like to acknowledge UTS and MQU for internal project funding. Special thanks to Prof Jim Piper for R&D internal funding for patent development, Bill Russell and Tim Dably for Patent Management, the Australian Proteome Analysis facility (APAF), Macquarie University, Thiri Zaw for technical support and Andre Hallen for providing chemicals.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Amagai M, 2004, J INVEST DERMATOL, V123, pXIV, DOI 10.1111/j.0022-202X.2004.23432.x; Barnabe GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005222; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Biber K, 2002, CURR OPIN PHARMACOL, V2, P63, DOI 10.1016/S1471-4892(01)00122-9; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bilby CR, 1999, THERIOGENOLOGY, V51, P1285, DOI 10.1016/S0093-691X(99)00072-2; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Carro E, 2010, EXPERT OPIN THER TAR, V14, P585, DOI 10.1517/14728222.2010.488222; CAVALLINI D, 1991, EUR J BIOCHEM, V202, P217, DOI 10.1111/j.1432-1033.1991.tb16365.x; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dejda A, 2005, PHARMACOL REP, V57, P307; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Estrada CP, 2014, STEM CELLS DEV, V23, P2311, DOI 10.1089/scd.2013.0452; FONTANA M, 1990, BIOCHEM BIOPH RES CO, V171, P480, DOI 10.1016/0006-291X(90)91418-R; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Gualdoni S, 2007, BIOL CELL, V99, P455, DOI 10.1042/BC20060119; Guo CJ, 2003, J NEUROCHEM, V84, P997, DOI 10.1046/j.1471-4159.2003.01609.x; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; Hensley K., 2010, U.S. Patent, Patent No. [7683055B2, 7683055]; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hensley K, 2010, MOLECULES, V15, P5581, DOI 10.3390/molecules15085581; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Hu SX, 2000, J PSYCHOPHARMACOL, V14, P238, DOI 10.1177/026988110001400307; Huang YS, 2009, BRAIN RES, V1304, P38, DOI 10.1016/j.brainres.2009.09.009; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; MARCOUX FW, 1988, BRAIN RES, V452, P329, DOI 10.1016/0006-8993(88)90037-6; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; Nada SE, 2012, NEUROCHEM INT, V61, P1357, DOI 10.1016/j.neuint.2012.09.013; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; NARDINI M, 1988, BIOCHIM BIOPHYS ACTA, V957, P286, DOI 10.1016/0167-4838(88)90285-3; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Pease JE, 2006, BRIT J PHARMACOL, V149, P460, DOI 10.1038/sj.bjp.0706910; Pesheva P, 1998, J NEUROSCI RES, V54, P639, DOI 10.1002/(SICI)1097-4547(19981201)54:5<639::AID-JNR9>3.0.CO;2-2; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; RICCI G, 1989, BIOCHIM BIOPHYS ACTA, V990, P211, DOI 10.1016/S0304-4165(89)80036-4; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Santos J, 2017, INT J STEM CELLS, V10, P193, DOI 10.15283/ijsc17036; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Simzar S, 2000, NEUROCHEM RES, V25, P1613, DOI 10.1023/A:1026670620633; SOLINAS SP, 1992, BIOCHEM BIOPH RES CO, V183, P481, DOI 10.1016/0006-291X(92)90507-H; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; Taverner T, 2012, BIOINFORMATICS, V28, P2404, DOI 10.1093/bioinformatics/bts449; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C	59	6	6	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB 1	2019	20	3							523	10.3390/ijms20030523			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HQ4WR	WOS:000462412500067	30691166	Green Submitted, Green Accepted, Green Published, gold			2022-02-06	
J	Wang, PB; Li, T				Wang, Pengbo; Li, Ting			Which wavelength is optimal for transcranial low-level laser stimulation?	JOURNAL OF BIOPHOTONICS			English	Article						low-level laser therapy (LLLT); Monte Carlo modeling; photon fluence distribution; transcranial low-level laser stimulation; visible human	TRAUMATIC BRAIN-INJURY; BIPHASIC DOSE-RESPONSE; ACUTE ISCHEMIC-STROKE; OPTICAL-PROPERTIES; LIGHT THERAPY; RANGE; SKIN; TEMPERATURE; DATASETS; TISSUES	One of the challenges in transcranial low-level laser therapy (LLLT) is to optimally choose illumination parameters, such as wavelength. However, there is sparse study on the wavelengths comparison especially on human transcranial LLLT. Here, we employed Monte Carlo modeling and visible human phantom to compute the penetrated photon fluence distribution within cerebral cortex. By comparing the fluence distribution, penetration depth and the intensity of laser-tissue-interaction within brain among all candidate wavelengths, we found that 660, 810 nm performed much better than 980, 1064 nm with much stronger, deeper and wider photon penetration into cerebral tissue; 660 nm was shown to be the best and slightly better than 810 nm. Our computational finding was in a surprising accordance with previous LLLT-neurobehavioral studies on mice. This study not only offered quantitative comparison among wavelengths in the effect of LLLT light penetration effectiveness but also anticipated a delightful possibility of online, precise and visible optimization of LLLT illumination parameters.	[Wang, Pengbo; Li, Ting] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China; [Wang, Pengbo; Li, Ting] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China; [Wang, Pengbo; Li, Ting] Peking Union Med Coll, Tianjin 300192, Peoples R China		Li, T (corresponding author), Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.; Li, T (corresponding author), Peking Union Med Coll, Tianjin 300192, Peoples R China.	liting@bme.cams.cn			National Natural Science Fund ProjectNational Natural Science Foundation of China (NSFC) [61675039]; Key research and development projects by Ministry of science and technology [2017YFB1302305, 2017YFB1300301]; Tianjin Key Project [18JCZDJC32700]	National Natural Science Fund Project, Grant Award Number: 61675039; Key research and development projects by Ministry of science and technology, Grant Award Numbers: 2017YFB1302305, 2017YFB1300301; Tianjin Key Project, Grant Award Number: (18JCZDJC32700)	Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen CX, 2010, INT CONF BIOMED, P286, DOI 10.1109/BMEI.2010.5639485; Chow RT, 2010, LANCET, V375, P894; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; FIRBANK M, 1993, PHYS MED BIOL, V38, P503, DOI 10.1088/0031-9155/38/4/002; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Huang YY, 2014, J BIOPHOTONICS, V7, P656, DOI 10.1002/jbio.201300125; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Hwang J, 2016, LASER MED SCI, V31, P1151, DOI 10.1007/s10103-016-1962-3; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kim S, 2014, LASER MED SCI, V29, P637, DOI 10.1007/s10103-013-1376-4; Lapchak P. A., 2010, P SPIE INT SOC OPTIC, V7552, P18; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Li AA, 2008, CHINESE SCI BULL, V53, P1848, DOI 10.1007/s11434-008-0244-2; Li T., 2015, J INNOV OPT HEAL SCI, V8; Li T, 2017, J INNOV OPT HEAL SCI, V10, DOI 10.1112/S1793515817130027; Li T, 2015, J INNOV OPT HEAL SCI, V8, DOI 10.1142/S1793545815500248; Li T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3567085; Li T, 2010, J INNOV OPT HEAL SCI, V3, P91, DOI 10.1142/S1793545810000927; Litscher D., 2013, INT J PHOTOENERGY, V2013, P1; Litscher G, 2015, INTEGR MED INT, V2, P80; Naeser M. A., 2010, SPIE INT SOC OPT ENG, V1, P7552; Roggan A, 1999, J BIOMED OPT, V4, P36, DOI 10.1117/1.429919; Salehpour F., 2018, MOL NEUROBIOL, V1, P1; Stadler I, 2004, PHOTOMED LASER SURG, V22, P227, DOI 10.1089/1549541041438560; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Wu LH, 2017, IEEE PHOTONICS J, V9, DOI 10.1109/JPHOT.2017.2743048; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yue L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.088001; Zaidi M, 2013, PHOTOCHEM PHOTOBIOL, V89, P709, DOI 10.1111/php.12024; Zhang GZ, 2007, PHYS MED BIOL, V52, P7367, DOI 10.1088/0031-9155/52/24/011; Zhang GZ, 2008, HEALTH PHYS, V94, P118, DOI 10.1097/01.HP.0000285256.48498.b4; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	41	6	7	4	20	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	FEB	2019	12	2							e201800173	10.1002/jbio.201800173			7	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	HL7HM	WOS:000458910500001	30043500				2022-02-06	
J	Wu, XB; Qu, WR; Bakare, AA; Zhang, YP; Fry, CME; Shields, LBE; Shields, CB; Xu, XM				Wu, Xiangbing; Qu, Wenrui; Bakare, Adewale A.; Zhang, Yi Ping; Fry, Collin M. E.; Shields, Lisa B. E.; Shields, Christopher B.; Xu, Xiao-Ming			A Laser-Guided Spinal Cord Displacement Injury in Adult Mice	JOURNAL OF NEUROTRAUMA			English	Article						behavioral test; contusion; mouse; SCI; tissue displacement	THERMAL NOCICEPTION; RECOVERY; DEFICIENT; RATS; PRECISE; DAMAGE; SCALE; PAIN	Mouse models are unique for studying molecular mechanisms of neurotrauma because of the availability of various genetic modified mouse lines. For spinal cord injury (SCI) research, producing an accurate injury is essential, but it is challenging because of the small size of the mouse cord and the inconsistency of injury production. The Louisville Injury System Apparatus (LISA) impactor has been shown to produce precise contusive SCI in adult rats. Here, we examined whether the LISA impactor could be used to create accurate and graded contusive SCIs in mice. Adult C57BL/6 mice received a T10 laminectomy followed by 0.2, 0.5, and 0.8mm displacement injuries, guided by a laser, from the dorsal surface of the spinal cord using the LISA impactor. Basso Mouse Scale (BMS), grid-walking, TreadScan, and Hargreaves analyses were performed for up to 6 weeks post-injury. All mice were euthanized at the 7th week, and the spinal cords were collected for histological analysis. Our results showed that the LISA impactor produced accurate and consistent contusive SCIs corresponding to mild, moderate, and severe injuries to the cord. The degree of injury severities could be readily determined by the BMS locomotor, grid-walking, and TreadScan gait assessments. The cutaneous hyperalgesia threshold was also significantly increased as the injury severity increased. The terminal lesion area and the spared white matter of the injury epicenter were strongly correlated with the injury severities. We conclude that the LISA device, guided by a laser, can produce reliable graded contusive SCIs in mice, resulting in severity-dependent behavioral and histopathological deficits.	[Wu, Xiangbing; Qu, Wenrui; Bakare, Adewale A.; Fry, Collin M. E.; Xu, Xiao-Ming] Indiana Univ Sch Med, Indiana Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Wu, Xiangbing; Qu, Wenrui; Bakare, Adewale A.; Fry, Collin M. E.; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Neurol Surg, 320 West 15th St,NB 500E, Indianapolis, IN 46202 USA; [Wu, Xiangbing; Qu, Wenrui; Bakare, Adewale A.; Fry, Collin M. E.; Xu, Xiao-Ming] Indiana Univ Sch Med, Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA; [Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Zhang, Yi Ping; Shields, Lisa B. E.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY USA; [Shields, Christopher B.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40202 USA		Xu, XM (corresponding author), Indiana Univ Sch Med, Dept Neurol Surg, 320 West 15th St,NB 500E, Indianapolis, IN 46202 USA.; Shields, CB (corresponding author), Univ Louisville, Dept Neurol Surg, Louisville, KY 40202 USA.	cbshields1@gmail.com; xu26@iupui.edu	吉大二院手足重建, 瞿文瑞/AAL-9639-2020	Qu, Wenrui/0000-0002-0178-3698	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS103481, R01 NS100531]; Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX002356-01, I01 BX003705-01A1]; Craig H Neilsen Foundation [296749, ISDH 019919, ISDH13679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100531, R01NS103481] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003705, I01BX002356] Funding Source: NIH RePORTER	We thank Dr. Naikui Liu for assistance with statistical analysis and the Laboratory Animal Resources Center (LARC) staff at the Indiana University School of Medicine for veterinary care. This work was supported in part by National Institutes of Health (NIH) R01 NS103481, and R01 NS100531; Department of Veterans Affairs I01 RX002356-01, and I01 BX003705-01A1; and Craig H Neilsen Foundation 296749, ISDH 019919 (to X.M.X.), and ISDH13679 (to X.W.).	Abe Y, 2003, J NEUROTRAUM, V20, P43, DOI 10.1089/08977150360517173; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Center NSCIS, 2018, FACTS FIG GLANC; Chao OY, 2012, NEUROSCIENCE, V202, P318, DOI 10.1016/j.neuroscience.2011.11.016; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Dittgen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029880; Eide PK, 1998, SPINAL CORD, V36, P601, DOI 10.1038/sj.sc.3100737; Farooque M, 2001, J NEUROTRAUM, V18, P105, DOI 10.1089/089771501750055811; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hill RL, 2009, J NEUROTRAUM, V26, P1, DOI 10.1089/neu.2008.0543; Jakeman Lyn B., 2009, P433, DOI 10.1007/978-1-60327-185-1_37; Ju G, 2014, NEURAL REGEN RES, V9, P789, DOI 10.4103/1673-5374.131591; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Liu NK, 2007, J NEUROPATH EXP NEUR, V66, P932, DOI 10.1097/nen.0b013e3181567d59; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lourbopoulos A, 2008, J NEUROSCI METH, V173, P225, DOI 10.1016/j.jneumeth.2008.06.018; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Ma ZW, 2015, FUNCT NEUROL, V30, P229; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Nicholson BD, 2004, NEUROLOGY, V62, pS30, DOI 10.1212/WNL.62.5_suppl_2.S30; Onifer SM, 2005, EXP NEUROL, V192, P25, DOI 10.1016/j.expneurol.2004.10.016; Sandhir R, 2011, NEUROCHEM RES, V36, P856, DOI 10.1007/s11064-011-0414-5; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Scheff Stephen, 2009, P423, DOI 10.1007/978-1-60327-185-1_36; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; STOKES BT, 1992, J NEUROTRAUM, V9, P129, DOI 10.1089/neu.1992.9.129; Wu XB, 2017, JOVE-J VIS EXP, DOI 10.3791/54988; Young W, 2002, PROG BRAIN RES, V137, P231; Young Wise, 2009, P411, DOI 10.1007/978-1-60327-185-1_35; Zhang N, 2014, NEURAL REGEN RES, V9, P2008, DOI 10.4103/1673-5374.143436; Zhang YP, 2008, J NEUROTRAUM, V25, P1227, DOI 10.1089/neu.2007.0388	39	6	6	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	3					460	468		10.1089/neu.2018.5756			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MG	WOS:000459447200005	29893166	Green Submitted, Green Published			2022-02-06	
J	Yang, XP; Chen, YS; Li, JX; Chen, LJ; Ren, HF; Liu, Y; Zhang, XY				Yang, Xiping; Chen, Yisheng; Li, Jianxin; Chen, Lijun; Ren, Hefei; Liu, Yang; Zhang, Xinyu			Hypertonic saline maintains coagulofibrinolytic homeostasis following moderate-to-severe traumatic brain injury by regulating monocyte phenotype via expression of lncRNAs	MOLECULAR MEDICINE REPORTS			English	Article						hypertonic saline; coagulofibrinolytic homeostasis; monocyte phenotype; lncRNAs; traumatic brain injury	LONG NONCODING RNA; GENE-EXPRESSION; IMMUNE-RESPONSE; NEUROINFLAMMATION; ACTIVATION; MICROGLIA; RELEASE; LEUKOCYTES; FLUID	Traumatic brain injury (TBI) is the most common cause of death and permanent disability in people aged <45, and is associated with secondary brain injury and bleed progression, resulting in increased morbidity and mortality. TBI may also induce innate host defense responses characterized by activation of resident microglia and astrocytes, brain microvascular endothelial cells and peripheral blood monocytes. In the present study, 34 patients with moderate-to-severe traumatic brain injury were randomly divided into two groups, including a 7.5% hypertonic saline (HS) treatment group (4 ml/kg) and 3% HS treatment group (4 ml/kg). The results demonstrated that treatment with 7.5% HS decreased the intracranial pressure and improved coagulofibrinolytic homeostasis. Analysis of the monocyte subsets revealed significant reduction in the proportion of cluster of differentiation (CD)14(++)CD16(+) circulating inflammatory monocytes in the 7.5% HS group. In addition, 7.5% HS treatment downregulated the expression of long non-coding (lnc) RNA2448-11 and lncRNA1403 in the peripheral blood mononuclear cells of patients with TBI. Using reverse transcription-quantitative polymerase chain reaction, it was determined that 7.5% HS regulated the expression of tumor necrosis factor-, interleukin-1, transforming growth factor- and thrombomodulin, which are the target genes of lncRNA2448-11 and lncRNA1403. These results indicated that 7.5% HS improved the intracranial pressure and coagulofibrinolytic homeostasis by modulating the phenotype of monocytes through lncRNA2448-11 and lncRNA1403. These findings provided evidence that initial resuscitation with HS imparts functional changes to inflammatory cells following TBI, thereby reducing potential neuroinflammatory events associated with secondary brain injury.	[Yang, Xiping; Chen, Yisheng; Li, Jianxin] Logist Univ Chinese Peoples Armed Police Force, Affiliated Hosp, Dept Neurosurg, Tianjin 300162, Peoples R China; [Yang, Xiping; Chen, Yisheng; Li, Jianxin] Logist Univ Chinese Peoples Armed Police Force, Affiliated Hosp, Inst Traumat Brain Injury & Neurol, Tianjin 300162, Peoples R China; [Yang, Xiping] Pingjin Hosp, Dept Neurosurg, Tianjin 300162, Peoples R China; [Chen, Lijun; Zhang, Xinyu] Logist Univ Chinese Peoples Armed Police Force, Dept Biochem & Physiol, 1 Huizhi Rd, Tianjin 300309, Peoples R China; [Ren, Hefei] Logist Univ Chinese Peoples Armed Police Force, Grad Management Team, Tianjin 300309, Peoples R China; [Liu, Yang] Shanghai Fourth Peoples Hosp, Dept Neurol, 1878 Sichuan Rd, Shanghai 200000, Peoples R China; [Zhang, Xinyu] Logist Univ Chinese Peoples Armed Police Force, Affiliated Hosp, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin 300162, Peoples R China		Zhang, XY (corresponding author), Logist Univ Chinese Peoples Armed Police Force, Dept Biochem & Physiol, 1 Huizhi Rd, Tianjin 300309, Peoples R China.; Liu, Y (corresponding author), Shanghai Fourth Peoples Hosp, Dept Neurol, 1878 Sichuan Rd, Shanghai 200000, Peoples R China.	cardiolab2016@outlook.com; zhxy_vivian@163.com			Scientific Fund of Logistic University of Chinese People's Armed Police Force [WHJ2015021]	The present study was supported by the Scientific Fund of Logistic University of Chinese People's Armed Police Force (grant no. WHJ2015021).	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Carpenter S, 2016, VIRUS RES, V212, P137, DOI 10.1016/j.virusres.2015.08.019; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chu AJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/367284; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rasslan R, 2014, INT J SURG, V12, P594, DOI 10.1016/j.ijsu.2014.04.007; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stojkovic S, 2017, THROMB HAEMOSTASIS, V117, P1379, DOI 10.1160/TH16-10-0784; Summy-Long JY, 2009, AM J PHYSIOL-REG I, V297, pR1532, DOI 10.1152/ajpregu.00340.2009; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	39	6	6	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	FEB	2019	19	2					1083	1091		10.3892/mmr.2018.9748			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	HH3TB	WOS:000455641200037	30569101	hybrid, Green Published, Green Submitted			2022-02-06	
J	Yu, J; Zhu, H; Taheri, S; Monday, WL; Perry, S; Kindy, MS				Yu, Jin; Zhu, Hong; Taheri, Saeid; Monday, William L.; Perry, Stephen; Kindy, Mark S.			Reduced Neuroinflammation and Improved Functional Recovery after Traumatic Brain Injury by Prophylactic Diet Supplementation in Mice	NUTRIENTS			English	Article						diet; traumatic brain injury; inflammation; mitochondrial biogenesis; behavior	OXIDATIVE STRESS; ENTERAL NUTRITION; RAT HIPPOCAMPUS; CATHEPSIN-B; DEFICITS; OPTIMIZATION; INFLAMMATION; MANAGEMENT; BEHAVIOR; OUTCOMES	Currently, there are no approved therapeutic drugs for the treatment of traumatic brain injury (TBI), and new targets and approaches are needed to provide relief from the long-term effects of TBI. Recent studies suggest that nutrition plays a critical role in improving the outcome from TBI in both civilians and military personnel. We have previously shown that GrandFusion((R)) (GF) diets improved recovery from cerebral ischemia and enhanced physical activity and endurance in rodent models. We, therefore, sought to determine the impact of a prophylactic diet enriched in fruits and vegetables on recovery from TBI in the controlled cortical impact rodent model. Results demonstrated that mice fed the diets had improved neuromotor function, reduced lesion volume, increased neuronal density in the hippocampus and reduced inflammation. As previously shown, TBI increases cathepsin B as part of the inflammasome complex resulting in elevated inflammatory markers like interleukin-1 (IL-1). Consumption of the GF diets attenuated the increase in cathepsin B levels and prevented the increase in the proapoptotic factor Bax following TBI. These data suggest that prior consumption of diets enriched in fruits and vegetables either naturally or through powdered form can provide protection from the detrimental effects of TBI.	[Yu, Jin; Zhu, Hong; Taheri, Saeid; Monday, William L.; Kindy, Mark S.] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA; [Perry, Stephen] NutriFusion LLC, Naples, FL 34109 USA; [Kindy, Mark S.] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Mol Pharmacol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Physiol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] Univ S Florida, Dept Neurol, Coll Med, Tampa, FL 33620 USA; [Kindy, Mark S.] James A Haley VA Med Ctr, Tampa, FL 33612 USA; [Kindy, Mark S.] Shriners Hosp Children, Tampa, FL 33612 USA		Kindy, MS (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Mol Pharmacol, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Physiol, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Pathol & Cell Biol, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), Univ S Florida, Dept Neurol, Coll Med, Tampa, FL 33620 USA.; Kindy, MS (corresponding author), James A Haley VA Med Ctr, Tampa, FL 33612 USA.; Kindy, MS (corresponding author), Shriners Hosp Children, Tampa, FL 33612 USA.	jinyu@health.usf.edu; hongzhu@health.usf.edu; taheris@health.usf.edu; wmondy@health.usf.edu; sperry@consealint.com; kindym@health.usf.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 ES016774-01, R21AG043718, 1P20GM109091, 2P20GM103444, 5P30GM103342]; VA Merit AwardUS Department of Veterans Affairs; National Science FoundationNational Science Foundation (NSF) [IIP-0903795]; AHA SFRN grant; VA Merit ReviewUS Department of Veterans Affairs	The authors wish to acknowledge NutriFusion, LLC for providing the GrandFusion (R) diets for the studies. We thank Mr. William Grand for reviewing the manuscript prior to submission. GrandFusion (R) is a patent pending product of NutriFusion, LLC. This work was partially supported by grants from the National Institutes of Health (R01 ES016774-01, R21AG043718, 1P20GM109091, 2P20GM103444, and 5P30GM103342), VA Merit Award, a grant from the National Science Foundation (IIP-0903795), an AHA SFRN grant and VA Merit Review (M.S.K.). Dr Kindy is a Senior Research Career Scientist in the VA.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Carriere CH, 2017, EXP TOXICOL PATHOL, V69, P109, DOI 10.1016/j.etp.2016.12.007; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Daradkeh Ghazi, 2014, Pak J Biol Sci, V17, P1089, DOI 10.3923/pjbs.2014.1089.1097; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elvington A, 2012, J IMMUNOL, V189, P4640, DOI 10.4049/jimmunol.1201904; Fan Ming-chao, 2016, Chinese Medical Sciences Journal, V31, P213; Faul M, 2010, TRAUMATIC BRAIN INJU; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Royes LFF, 2016, MINI-REV MED CHEM, V16, P29, DOI 10.2174/1389557515666150722101926; Guseva MV, 2013, B EXP BIOL MED+, V155, P197; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hatton J, 2006, J NEUROSURG, V105, P843, DOI 10.3171/jns.2006.105.6.843; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Jones S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010043; Kawashita E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097947; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lee SH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122510; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Redmond Carrie, 2006, Nutr Clin Pract, V21, P450, DOI 10.1177/0115426506021005450; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saiki Robin L, 2009, Crit Care Nurs Clin North Am, V21, P549, DOI 10.1016/j.ccell.2009.07.009; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Simon DW, 2016, METHODS MOL BIOL, V1462, P393, DOI 10.1007/978-1-4939-3816-2_22; Steenerson K, 2017, NEUROL CLIN, V35, P403, DOI 10.1016/j.ncl.2017.03.011; Stover KR, 2015, BEHAV BRAIN RES, V281, P16, DOI 10.1016/j.bbr.2014.11.046; Strnad M, 2017, WIEN KLIN WOCHENSCHR, V129, P110, DOI 10.1007/s00508-016-0974-0; Taha AA, 2011, J NEUROSCI NURS, V43, P291, DOI 10.1097/JNN.0b013e318234e9b2; Wang D, 2015, J NEUROSURG, V123, P1194, DOI 10.3171/2014.11.JNS141109; Wang LG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170942; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yu J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081101; Yu J, 2017, AGING-US, V9, P1041, DOI 10.18632/aging.101209; Yu J, 2016, NUTR NEUROSCI, V19, P290, DOI 10.1179/1476830515Y.0000000021	67	6	6	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	FEB	2019	11	2							299	10.3390/nu11020299			16	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	HO3NH	WOS:000460829700090	30708954	Green Published, gold, Green Submitted			2022-02-06	
J	Zhang, DN; Xiao, M; Wang, L; Jia, W				Zhang, Dainan; Xiao, Meng; Wang, Long; Jia, Wang			Blood-Based Glutamate Scavengers Reverse Traumatic Brain Injury-Induced Synaptic Plasticity Disruption by Decreasing Glutamate Level in Hippocampus Interstitial Fluid, but Not Cerebral Spinal Fluid, In Vivo	NEUROTOXICITY RESEARCH			English	Article						Traumatic brain injury; Hippocampus; Glutamate-oxaloacetate transaminase; Synaptic plasticity; Long-term potentiation	EXCITATORY AMINO-ACIDS; OXALOACETATE TRANSAMINASE; CEREBROSPINAL-FLUID; CLINICAL-TRIALS; NEUROPROTECTION; TRANSPORTERS; MECHANISM; NETWORK; RAT	Excessive glutamate release has been implicated as a major contributor to multiple post-traumatic brain injury (TBI) deficits, including neurodegeneration and cognitive impairment. Prior to the presence of behavior change, synaptic plasticity is rapidly and potently disrupted by TBI, which is believed to be relevant to inappropriately increased extracellular glutamate concentration and glutamatergic receptor activation. Acutely promoting brain glutamate clearance with a blood-based scavenging system, glutamate oxaloacetate transaminase (GOT), prevents the delayed inhibition of LTP post-TBI. Here, we report that repeated dosing of recombinant GOT type 1, with the glutamate co-substrate oxaloacetate, could induce a persistent enhancement of serum level of GOT and reverse the disruption of synaptic plasticity 4days after the induction of TBI in rats. Moreover, the change of glutamate level post-TBI presents a different timeframe in ventricular CSF and hippocampus interstitial fluid (ISF), and the application of rGOT may reverse the inhibition of LTP by decreasing the glutamate level in hippocampus ISF, but not ventricular CSF. Lastly, we found that the intervention did not significantly affect the total level of glutamate in the hippocampus as well as the expression of major glutamate transporters, EAAT1 and EAAT2. Overall, the present findings support the importance of clearance of glutamate post-TBI and provide new evidence of the mechanism of glutamate-induced LTP inhibition which leads to a development of evaluations, intervention, and reversion for post-TBI cognitive deficit.	[Zhang, Dainan; Jia, Wang] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Dainan; Xiao, Meng; Wang, Long] Xinxiang Med Univ, Henan Key Lab Neural Regenerat & Repairment, Affiliated Hosp 1, Weihui, Henan, Peoples R China; [Jia, Wang] China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China		Jia, W (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Jia, W (corresponding author), China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China.	noanswear@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701085]; Henan Key Laboratory of Neural Regeneration [HNSJXF-2018-020]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M620833, 2018T110121]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2017-zz-121]	This study was supported by the National Natural Science Foundation of China (no. 81701085), Henan Key Laboratory of Neural Regeneration and Repairment (no. HNSJXF-2018-020), China Postdoctoral Science Foundation (no. 2017M620833 and no. 2018T110121), and Beijing Postdoctoral Research Foundation (no. 2017-zz-121).	BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Brotfain E, 2018, NEUROTOX RES, V33, P300, DOI 10.1007/s12640-017-9791-0; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Castillo J, 2016, J CEREBR BLOOD F MET, V36, P292, DOI 10.1177/0271678X15606721; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Goldshmit Y, 2018, J NEUROTRAUM, V35, P2581, DOI 10.1089/neu.2017.5524; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Koola MM, 2018, PRIM CARE COMPANION, V20; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lee A, 2012, J CHEM NEUROANAT, V43, P64, DOI 10.1016/j.jchemneu.2011.09.006; Liraz-Zaltsman S, 2018, J NEUROTRAUM, V35, P1667, DOI 10.1089/neu.2017.5561; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagy D, 2009, CELL MOL NEUROBIOL, V29, P827, DOI 10.1007/s10571-009-9364-8; Nakada T, 2018, NEUROSCIENTIST; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; Perez-Mato M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.507; Piao C. S., 2017, J CEREB BLOOD FLOW M, DOI 10.1177/0271678X17742792.271678X17742792; Ruban A, 2015, NEURODEGENER DIS, V15, P233, DOI 10.1159/000382034; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vieites-Prado A, 2015, J CEREB BLOOD FLOW M; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Wang CC, 2018, WORLD NEUROSURG, V112, pE719, DOI 10.1016/j.wneu.2018.01.140; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhang DN, 2017, CEREB CORTEX, V27, P3724, DOI 10.1093/cercor/bhw193; Zhang DN, 2017, NEUROPHARMACOLOGY, V121, P231, DOI 10.1016/j.neuropharm.2017.03.036; Zhang H, 2001, CLIN CHEM, V47, P1458	36	6	6	2	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2019	35	2					360	372		10.1007/s12640-018-9961-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH3ZW	WOS:000455660400008	30255425				2022-02-06	
J	Langhammer, B; Stanghelle, JK				Langhammer, Birgitta; Stanghelle, Johan K.			Senior fitness test; a useful tool to measure physical fitness in persons with acquired brain injury	BRAIN INJURY			English	Article						Acquired brain injury; cerebral insult; senior fitness test; traumatic brain injury	CARDIORESPIRATORY FITNESS; OLDER-ADULTS; RISK-FACTORS; STROKE; MULTIMORBIDITY; EPIDEMIOLOGY; EXERCISE	Objectives: To evaluate the feasibility and usability of the senior fitness test (SFT) in persons with acquired brain injury (ABI). Methods: A pilot cohort design with a convenience sample of persons with ABI was used. Results: Persons with ABIs (n = 47) were younger than their healthy counterparts (n = 172) were but performed significantly worse on sit to stand, 6-min walk test (6MWT) and 2.45-m up and go. This difference was accentuated in the age groups >60 years of age. Persons with ABIs, divided into subgroups traumatic brain injury (TBI; n = 12) and cerebral insult (CI; n = 35), showed significant differences in leg strength, upper extremity flexibility and walking capacity. Persons with CI were weaker, less flexible in upper and lower extremities, walked shorter distance and were less mobile. CI but not TBI performed significantly worse when compared to healthy elderly persons. Conclusion: This study indicates that SFT is feasible, safe and useful tool for persons with ABI, to evaluate physical capacity, endurance, strength and flexibility. The submaximal test was well tolerated and could be performed by all participants irrespective of age or diagnosis. The distribution of test scores indicates responsiveness to change and no ceiling or floor effects.	[Langhammer, Birgitta] Oslo Metropolitan Univ, Sunnaas Rehabil Hosp, Fac Hlth Sci, Oslo, Norway; [Stanghelle, Johan K.] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Stanghelle, Johan K.] Univ Oslo, Fac Med, Nesoddtangen, Norway		Langhammer, B (corresponding author), Oslo Metropolitan Univ, Sunnaas Rehabil Hosp, Fac Hlth Sci, Oslo, Norway.	Birgitta.Langhammer@oslomet.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570			Baert I, 2012, ARCH PHYS MED REHAB, V93, P669, DOI 10.1016/j.apmr.2011.09.022; Bell SP, 2016, CLIN GERIATR MED, V32, P215, DOI 10.1016/j.cger.2016.01.013; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Brovold T, 2013, J AM GERIATR SOC, V61, P1580, DOI 10.1111/jgs.12400; Butler AA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-31; Dunn A, 2017, TOP STROKE REHABIL, V24, P163, DOI 10.1080/10749357.2016.1236482; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Gallacher KI, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0151-0; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Hesseberg K, 2015, PHYSIOTHER RES INT, V20, P37, DOI 10.1002/pri.1594; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Jakovljevic DG, 2012, STROKE, V43, P1422, DOI 10.1161/STROKEAHA.111.649434; Kunkel D, 2014, DISABIL REHABIL, P1; Langhammer B, 2011, EUR J PHYSIOTHER, V13, P137, DOI 10.3109/14038196.2011.616913; Loureiro APC, 2017, J REHABIL MED, V49, P558, DOI 10.2340/16501977-2255; MAHONEY F I, 1965, Md State Med J, V14, P61; Moore SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055263; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Pandey A, 2016, STROKE, V47, P1720, DOI 10.1161/STROKEAHA.115.011532; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P162, DOI 10.1123/japa.7.2.162; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Rikli RE, 2004, PHYS FITNESS OLDER A; Rikli RE., 2001, SENIOR FITNESS TEST; Todde F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7639842	24	6	6	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					183	188		10.1080/02699052.2018.1540796			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300008	30403880	Green Accepted, Green Submitted			2022-02-06	
J	Savulich, G; Thorp, E; Piercy, T; Peterson, KA; Pickard, JD; Sahakian, BJ				Savulich, George; Thorp, Emily; Piercy, Thomas; Peterson, Katie A.; Pickard, John D.; Sahakian, Barbara J.			Improvements in Attention Following Cognitive Training With the Novel "Decoder" Game on an iPad	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						enhancement of attention; problems of attention/concentration; maintaining flow; cognitive training; Decoder game	INFERIOR FRONTAL GYRUS; SUSTAINED ATTENTION; DEFICIT/HYPERACTIVITY DISORDER; ENHANCING COGNITION; WORKING-MEMORY; NEURAL BASIS; ADULT ADHD; INHIBITION; NEUROSCIENCE; CHILDREN	Work and study increasingly rely on the use of technologies requiring individuals to switch attention rapidly between emails, texts and tasks. This has led to healthy people having problems of attention and concentration and difficulties getting into the "flow," which impedes goal attainment and task completion. Possibly related to this, there is an increasing diagnosis of attention deficit hyperactivity disorder (ADHD) and prescriptions of drugs such as methylphenidate. In addition to ADHD, attention is impaired in other neuropsychiatric disorders, such as schizophrenia and in traumatic brain injury (TBI). Based on neuropsychological and neuroimaging evidence, we developed "Decoder," a novel game for targeted cognitive training of visual sustained attention on an iPad. We aimed to investigate the effects of cognitive training in 75 healthy young adults randomly assigned to a Cognitive Training (8 h of playing Decoder over 4 weeks; n = 25), Active Control (8 h of playing Bingo over 4 weeks; n = 25) or Passive Control (continuation of activities of daily living; n = 25) group. Results indicated that cognitive training with Decoder was superior to both control groups in terms of increased target sensitivity (A') on the Cambridge Neuropsychological Test Automated Battery Rapid Visual Information processing (CANTAB RVP) test, indicating significantly improved sustained visual attention. Individuals playing Decoder also showed significantly better performance on the Trail Making Test (TMT) compared with those playing Bingo. Significant differences in visual analogue scales were also found between the two gaming groups, such that Decoder received higher ratings of enjoyment, task-related motivation and alertness across all hours of game play. These data suggest that cognitive training with Decoder is an effective non-pharmacological method for enhancing attention in healthy young adults, which could be extended to clinical populations in which attentional problems persist.	[Savulich, George; Thorp, Emily; Piercy, Thomas; Sahakian, Barbara J.] Univ Cambridge, Sch Clin Med, Dept Psychiat & Behav, Cambridge, England; [Savulich, George; Thorp, Emily; Piercy, Thomas; Sahakian, Barbara J.] Univ Cambridge, Sch Clin Med, Clin Neurosci Inst, Cambridge, England; [Peterson, Katie A.; Pickard, John D.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England		Sahakian, BJ (corresponding author), Univ Cambridge, Sch Clin Med, Dept Psychiat & Behav, Cambridge, England.; Sahakian, BJ (corresponding author), Univ Cambridge, Sch Clin Med, Clin Neurosci Inst, Cambridge, England.	bjs1001@medschl.cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Savulich, George/O-1376-2018	Sahakian, Barbara/0000-0001-7352-1745; Savulich, George/0000-0002-6513-5454	NIHR Brain Injury Health Care Technology Co-operative (HTC); NIHR MedTech and in vitro diagnostic Co-operative (MIC); Wallitt Foundation; Eton College; NIHR Cambridge Biomedical Research Centre (BRC) Mental Health theme; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI	This research was supported by the NIHR Brain Injury Health Care Technology Co-operative (HTC) and the NIHR MedTech and in vitro diagnostic Co-operative (MIC). GS is funded by the Wallitt Foundation and Eton College, with support from the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health theme. TP is funded by the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health theme. BS received funding from the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health theme.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Barratt E. S, 1994, IMPULSIVE CLIENT THE, P39; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bruhl AB, 2016, ANN NY ACAD SCI, V1369, P195, DOI 10.1111/nyas.13040; Bul KCM, 2015, GAMES HEALTH J, V4, P502, DOI 10.1089/g4h.2015.0021; Care Quality Commission, 2016, SAF MAN CONTR DRUGS; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chamberlain SR, 2017, CNS SPECTRUMS, V22, P22, DOI 10.1017/S1092852915000875; Chamberlain SR, 2011, BIOL PSYCHIAT, V69, P1192, DOI 10.1016/j.biopsych.2010.08.019; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Commodari E, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517718557; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; d'Angelo LSC, 2017, BRIT J PHARMACOL, V174, P3257, DOI 10.1111/bph.13813; del Campo N, 2013, BRAIN, V136, P3252, DOI 10.1093/brain/awt263; Epstein JN, 2013, NEUROPSYCHIATRY-LOND, V3, P455, DOI 10.2217/npy.13.59; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Fan LY, 2018, HUM BRAIN MAPP, V39, P3827, DOI 10.1002/hbm.24214; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Gau SSF, 2014, PSYCHOL MED, V44, P435, DOI 10.1017/S0033291713000640; Gazzaley A, 2016, DISTRACTED MIND ANCI; Glenn M, 2005, APATHY EVALUATION SC; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Keshavan MS, 2014, AM J PSYCHIAT, V171, P510, DOI 10.1176/appi.ajp.2013.13081075; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kirchhoff BA, 2012, NEUROIMAGE, V62, P1956, DOI 10.1016/j.neuroimage.2012.06.017; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; KOLIN EA, 1964, J CONSULT PSYCHOL, V28, P477; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lustig C, 2016, CURR TOP BEHAV NEURO, V28, P327, DOI 10.1007/7854_2015_5009; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Maier LJ, 2018, INT J DRUG POLICY, V58, P104, DOI 10.1016/j.drugpo.2018.05.009; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Merritt P, 2007, PERS INDIV DIFFER, V43, P597, DOI 10.1016/j.paid.2007.01.016; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Nelson, 1982, NATL ADULT HEADING T; Parasuraman R, 1998, ATTENTIVE BRAIN, P3; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pironti VA, 2014, BIOL PSYCHIAT, V76, P639, DOI 10.1016/j.biopsych.2013.09.025; Pletzer B, 2017, PHYSIOL BEHAV, V179, P384, DOI 10.1016/j.physbeh.2017.07.012; Pletzer B, 2014, HORM BEHAV, V66, P257, DOI 10.1016/j.yhbeh.2014.05.004; Prins PJM, 2013, GAMES HEALTH J, V2, P44, DOI 10.1089/g4h.2013.0004; Reitan R, 1985, HALSTEAD REITAN NEUR; Sahakian B. J, 2018, DARWIN COLL LECT, P101; Sahakian BJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0214; Sahakian BJ, 2014, NEUROSCI BIOBEHAV R, V43, P240, DOI 10.1016/j.neubiorev.2014.04.002; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Savulich G, 2017, CLIN PHARMACOL THER, V101, P170, DOI 10.1002/cpt.457; Savulich G, 2018, PSYCHOL MED, V48, P1397, DOI 10.1017/S0033291718000892; Savulich G, 2017, INT J NEUROPSYCHOPH, V20, P624, DOI 10.1093/ijnp/pyx040; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Strenziok M, 2014, NEUROIMAGE, V85, P1027, DOI 10.1016/j.neuroimage.2013.07.069; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	62	6	7	1	17	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JAN 21	2019	13								2	10.3389/fnbeh.2019.00002			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	HI1CB	WOS:000456180200001	30719000	gold, Green Published			2022-02-06	
J	von Leden, RE; Moritz, KE; Bermudez, S; Jaiswal, S; Wilson, CM; Dardzinski, BJ; Byrnes, KR				von Leden, Ramona E.; Moritz, Kasey E.; Bermudez, Sara; Jaiswal, Shalini; Wilson, Colin M.; Dardzinski, Bernard J.; Byrnes, Kimberly R.			Aging alters glucose uptake in the naive and injured rodent spinal cord	NEUROSCIENCE LETTERS			English	Article						Aging; FDG-PET imaging; Inflammation; Glucose metabolism; Glucose transporter; Spinal cord injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; NADPH OXIDASE; EXPRESSION; AGE; TRANSPORTERS; GLUT4; MACROPHAGES; ACTIVATION; DEFICITS	Aging results in increased activation of inflammatory glial cells and decreased neuronal viability following spinal cord injury (SCI). Metabolism and transport of glucose is also decreased with age, although the influence of age on glucose transporter (GLUT) expression or glucose uptake in SCI is currently unknown. We therefore performed [F-18]Fluorodeoxyglucose (FDG) PET imaging of young (3 month) and middle-aged (12 month) rats. Glucose uptake in middle-aged rats was decreased compared to young rats at baseline, followed by increased uptake 14 days post contusion SCI. qRT-PCR and protein analysis revealed an association between 14 day glucose uptake and 14 day post-injury inflammation. Further, gene expression analysis of neuron-specific GLUT3 and non-specific GLUT4 (present on glial cells) revealed an inverse relationship between GLUT3/4 gene expression and glucose uptake patterns. Protein expression revealed increased GLUT3 in 3 month rats only, consistent with age related decreases in glucose uptake, and increased GLUT4 in 12 month rats only, consistent with age related increases in inflammatory activity and glucose uptake. Inconsistencies between gene and protein suggest an influence of age-related impairment of translation and/or protein degradation. Overall, our findings show that age alters glucose uptake and GLUT3/4 expression profiles before and after SCI, which may be dependent on level of inflammatory response, and may suggest a therapeutic avenue in addressing glucose uptake in the aging population.	[von Leden, Ramona E.; Moritz, Kasey E.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Bermudez, Sara; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room C2115, Bethesda, MD 20814 USA; [Jaiswal, Shalini] Ctr Neurosci & Regenerat Med, Translat Imaging Core, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Wilson, Colin M.; Dardzinski, Bernard J.; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD USA; [Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [von Leden, Ramona E.] Univ Texas Austin, Dept Neurol, 1701 Trinitiy St, Austin, TX 78712 USA; [Bermudez, Sara] McGill Univ, Dept Biochem, Goodman Canc Ctr, 1160 Pine Ave West,Room 614, Montreal, PQ H3A 1A3, Canada; [Wilson, Colin M.] Univ New Mexico, Sch Med, Dept Radiol, Reginald Heber Fitz Hall 211,Room B07, Albuquerque, NM 87131 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room C2115, Bethesda, MD 20814 USA.	ramona.von-leden@austin.utexas.edu; kasey.moritz.ctr@usuhs.edu; sarabers88@gmail.com; shalini.jaiswal.ctr@usuhs.edu; cmwilson@salud.unm.edu; bernard.dardzinski@usuhs.edu; kimberly.byrnes@usuhs.edu		Dardzinski, Bernard/0000-0001-7098-9131; Byrnes, Kimberly/0000-0002-7501-7734	Uniformed Services University; NINDS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1F31NS090737-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS090737] Funding Source: NIH RePORTER	This work was supported by a pilot grant from the Uniformed Services University. R. von Leden was supported by the NINDS/NIH (Grant number 1F31NS090737-01A1).	Calder PC, 2007, CURR OPIN CLIN NUTR, V10, P531, DOI 10.1097/MCO.0b013e3281e72ad4; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; dos Santos JM, 2012, CELL BIOCHEM FUNCT, V30, P191, DOI 10.1002/cbf.1834; Duelli R, 2001, NEWS PHYSIOL SCI, V16, P71; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; El Messari S, 2002, J CHEM NEUROANAT, V24, P225, DOI 10.1016/S0891-0618(02)00058-3; Fattoretti P, 2002, ANN NY ACAD SCI, V973, P293, DOI 10.1111/j.1749-6632.2002.tb04653.x; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Frontera JE, 2017, PHYS MED REH CLIN N, V28, P821, DOI 10.1016/j.pmr.2017.06.013; Gomez O, 2011, J ANAT, V219, P525, DOI 10.1111/j.1469-7580.2011.01410.x; Gwak YS, 2004, J NEUROTRAUM, V21, P983, DOI 10.1089/0897715041650999; Gwak YS, 2004, NEUROSCI LETT, V362, P232, DOI 10.1016/j.neulet.2004.03.019; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jurcovicova J, 2014, Endocr Regul, V48, P35; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuang R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88815; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lu H, 2016, INT J OBESITY, V40, P121, DOI 10.1038/ijo.2015.137; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; NSCISC, 2016, FACTS FIG GLANC; OKA Y, 1992, GERONTOLOGY, V38, P3; Qin LY, 2013, GLIA, V61, P855, DOI 10.1002/glia.22479; Ronsyn MW, 2008, SPINAL CORD, V46, P532, DOI 10.1038/sc.2008.13; Roozbehi Amrollah, 2015, Acta Med Iran, V53, P281; RYDZEWSKI BZ, 1991, ADV EXP MED BIOL, V293, P397; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Siegenthaler MM, 2008, EXP NEUROL, V213, P363, DOI 10.1016/j.expneurol.2008.06.015; Takano M, 2017, STEM CELL REP, V8, P509, DOI 10.1016/j.stemcr.2017.01.013; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Leden RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0933-3; von Leden RE, 2016, NEUROSCI LETT, V621, P126, DOI 10.1016/j.neulet.2016.04.027; Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001	45	6	6	1	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 18	2019	690						23	28		10.1016/j.neulet.2018.10.004			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9CI	WOS:000456752500005	30296507	Green Accepted			2022-02-06	
J	Cohn, SM; Jimenez, JC; Khoury, L; Perez, JM; Panzo, M				Cohn, Stephen M.; Jimenez, Jean-Carlos; Khoury, Leen; Perez, Javier Martin; Panzo, Melissa			Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion	CUREUS			English	Article						platelet dysfunction; aspirin and clopidogrel effects; bleeding time; platelet transfusion; storage defect	BRAIN-INJURY PATIENTS; ANTIPLATELET THERAPY; HEMOSTATIC EFFECTIVENESS; INTRACRANIAL HEMORRHAGE; TRANSFUSION; STORAGE; TEMPERATURE; 4-DEGREES-C; OUTCOMES; FRESH	Background Platelets are commonly administered to trauma patients to reverse the effects of pre-injury anti-platelet drugs if these individuals are judged to be at risk for ongoing bleeding (i.e., traumatic brain injury). In the U.S. blood banks, platelets are maintained at room temperature and are not infused prior to 72 hours storage due to rigorous screening methods. Recent work suggested that cold refrigerated platelets may be effective at restoring platelet function. We hypothesized that refrigerated platelets might be superior to room temperature platelets in reversing aspirin and clopidogrel-induced platelet dysfunction. Methods Using a cross-over design, 10 healthy, adult subjects underwent platelet removal by apheresis, received anti-platelet drugs (aspirin 325 mg and clopidogrel 75 mg) daily for three days, and then had return of their own platelets (about 3 x 10(11 )platelets). Five subjects were randomly assigned to receive platelets stored at 4 degrees C, and five received platelets stored at room temperature. One month later, this entire process was repeated with each subject receiving platelets stored by the alternative method. Thus, subjects served as their own controls. At multiple time points during the study in vivo platelet function was assessed by bleeding times, which were measured by a single observer blinded to patient group. Results Bleeding times rose dramatically after anti-platelet drugs were given, but remained well above the normal range (seven minutes) despite reinfusion of platelets. There were no differences in platelet function according to the method of storage. Conclusions Transfusion with autologous platelets appears to be ineffective in reversing the anti-platelet effects of aspirin and clopidogrel. Cold refrigerated platelets were no more effective than room temperature stored platelets in restoring platelet function.	[Cohn, Stephen M.; Khoury, Leen] Staten Isl Univ Hosp, Surg, Staten Isl, NY 10305 USA; [Jimenez, Jean-Carlos] Staten Isl Univ Hosp, Northwell Hlth, Surg, Stamford, CT USA; [Perez, Javier Martin] Hackensack Meridian Hlth, Surg, Hackensack, NJ USA; [Panzo, Melissa] Staten Isl Univ Hosp, Emergency Med, Staten Isl, NY USA		Cohn, SM (corresponding author), Staten Isl Univ Hosp, Surg, Staten Isl, NY 10305 USA.	scohn1@northwell.edu					ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Blais N, 2009, THROMB HAEMOSTASIS, V102, P404, DOI 10.1160/TH09-02-0126; Cap AP, 2016, TRANSFUSION, V56, P13, DOI 10.1111/trf.13433; FILIP DJ, 1978, J LAB CLIN MED, V91, P618; HANDIN RI, 1971, NEW ENGL J MED, V285, P538, DOI 10.1056/NEJM197109022851003; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; MANNO CS, 1991, BLOOD, V77, P930, DOI 10.1182/blood.V77.5.930.930; MIELKE CH, 1969, BLOOD-J HEMATOL, V34, P204, DOI 10.1182/blood.V34.2.204.204; Mishkel GJ, 1999, J AM COLL CARDIOL, V34, P1884, DOI 10.1016/S0735-1097(99)00443-X; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; Nair PM, 2014, J TRAUMA ACUTE CARE, V77, pS88, DOI 10.1097/TA.0000000000000327; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pidcoke HF, 2014, SHOCK, V41, P51, DOI 10.1097/SHK.0000000000000078; Pruller F, 2011, J THROMB HAEMOST, V9, P1670, DOI 10.1111/j.1538-7836.2011.04392.x; Ramsey MT, 2016, J TRAUMA ACUTE CARE, V80, P726, DOI 10.1097/TA.0000000000001017; Reddoch KM, 2014, SHOCK, V41, P54, DOI 10.1097/SHK.0000000000000082; Valeri CR, 2007, TRANSFUSION, V47, p206S, DOI 10.1111/j.1537-2995.2007.01465.x; Valeri CR, 2002, TRANSFUSION, V42, P1206, DOI 10.1046/j.1537-2995.2002.00195.x; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Yende S, 2001, CRIT CARE MED, V29, P2271, DOI 10.1097/00003246-200112000-00006	30	6	6	0	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JAN 15	2019	11	1							e3889	10.7759/cureus.3889			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HP0OD	WOS:000461364500004	30911446	Green Published, gold			2022-02-06	
J	Tibaek, M; Kammersgaard, LP; Johnsen, SP; Dehlendorff, C; Forchhammer, HB				Tibaek, Maiken; Kammersgaard, Lars Peter; Johnsen, Soren P.; Dehlendorff, Christian; Forchhammer, Hysse B.			Long-Term Return to Work After Acquired Brain Injury in Young Danish Adults: A Nation-Wide Registry-Based Cohort Study	FRONTIERS IN NEUROLOGY			English	Article						brain injury; return to work; employment; prognosis; TBI; young adults	VOCATIONAL-REHABILITATION; FOLLOW-UP; EMPLOYMENT; STROKE; STABILITY; OUTCOMES; AGE; EPIDEMIOLOGY; QUALITY	Objective: (1) To determine patterns of return to work (RTW) after traumatic brain injury and other causes of acquired brain injury (ABI) among young adults aged 19-30 years and (2) to compare the stability of long-term labor-market attachment (LMA) to the background population. Method: Nationwide registry-based inception cohort study of 10 years weekly data of employment status. Patients (n = 8,496) aged 19-30 years with first-ever diagnosis of TBI, stroke, subarachnoid hemorrhage, encephalopathy, brain tumor, or CNS infections during 1999-2015. For comparison, a general population cohort (n = 206,025) individually matched on age, sex, and municipality was identified. The main outcome was RTW, which was defined as time to LMA, i.e., a week without public assistance benefits except education grants/leave. Stable labor-market attachment (sLMA) was defined as LMA for at least 75% over 52 weeks. The cumulative incidence proportions of RTW and stable RTW in the ABI cohort were estimated with the Aalen-Johansen estimator with death as a competing event. Results: Twelve weeks after diagnosis 46.9% of ABI cohort had returned to stable RTW, which increased to 57.4% 1 year after, and 69.7% 10 years after. However, compared to controls fewer had sLMA 1 year (OR: 0.25 [95% CI 0.24-0.27]) and 10 years after diagnosis (OR: 0.35 [95% CI: 0.33-0.38]). Despite significant variations, sLMA was lower compared to the control cohort for all subtypes of ABI and no significant improvements were seen after 2-5 years. Conclusion: Despite relatively fast RTW only a minor proportion of young patients with ABI achieves sLMA.	[Tibaek, Maiken; Forchhammer, Hysse B.] Univ Copenhagen, Dept Neurol, Rigshosp, Natl Study Young Survivors Brain Injury, Copenhagen, Denmark; [Kammersgaard, Lars Peter] Univ Copenhagen, Dept Neurorehabil, Res Unit Brain Injury Rehabil Copenhagen, TBI Unit,Rigshosp, Copenhagen, Denmark; [Johnsen, Soren P.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Dehlendorff, Christian] Danish Canc Soc Res Ctr, Stat & Pharmacoepidemiol, Copenhagen, Denmark		Tibaek, M (corresponding author), Univ Copenhagen, Dept Neurol, Rigshosp, Natl Study Young Survivors Brain Injury, Copenhagen, Denmark.	mtibaek@gmail.com	Dehlendorff, Christian/AAG-9421-2019	Dehlendorff, Christian/0000-0001-6161-4565	Danish Ministry of Health; Capital Region of Denmark	The study was funded by grants from the Danish Ministry of Health and The Capital Region of Denmark.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Biering K, 2013, J OCCUP REHABIL, V23, P400, DOI 10.1007/s10926-012-9405-x; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Grimaud O, 2011, STROKE, V42, P1201, DOI 10.1161/STROKEAHA.110.596429; Gzell C, 2014, J CANCER SURVIV, V8, P108, DOI 10.1007/s11764-013-0311-9; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; Knudsen LB, 1998, DAN MED BULL, V45, P221; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langhammer B, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1055; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; R Development Core Team, 2013, R LANG ENV STAT COMP; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Rusbridge SL, 2013, PSYCHO-ONCOLOGY, V22, P1907, DOI 10.1002/pon.3241; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Stapelfeldt CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-661; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Wildenschild C, 2014, CLIN EPIDEMIOL, V6, P27, DOI 10.2147/CLEP.S50449; [No title captured]; [No title captured]; [No title captured]	37	6	6	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 14	2019	9								1180	10.3389/fneur.2018.01180			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HH3YK	WOS:000455656200001	30692963	gold, Green Published			2022-02-06	
J	Wiseman-Hakes, C; Gosselin, N; Sharma, B; Langer, L; Gagnon, I				Wiseman-Hakes, Catherine; Gosselin, Nadia; Sharma, Bhanu; Langer, Laura; Gagnon, Isabelle			A Longitudinal Investigation of Sleep and Daytime Wakefulness in Children and Youth With Concussion	ASN NEURO			English	Article						concussion; sleep; daytime wakefulness; longitudinal; children; youth	TRAUMATIC BRAIN-INJURY; SYMPTOM SCALE; HIGH-SCHOOL; QUALITY; ADOLESCENTS; VALIDATION; INSTRUMENT; RISK	A high proportion of adults who sustain a concussion identify changes in their sleep during the acute stage, typically reporting an increased need for sleep or nonrestful sleep. Our understanding of sleep following concussion is less well understood within a pediatric population. In this study, we investigated the trajectory of sleep and daytime sleepiness in a prospective cohort of 40 children and youth (6-18 years old) with concussion, 40 age-and sex-matched healthy children and youth, and 40 with upper-extremity orthopedic injury. Evaluations occurred during the acute stage (<2 weeks) and at 3-, 6-, and 12-month postinjury using the Sleep Disturbance Scale for Children and the Postconcussion Symptom Scale. There were no significant differences within- or between-group differences in sleep across all four time points with analysis of the groups as a whole. When groups were divided by age (6-11 and 12- < 18 years), there was a significant difference in the ability to initiate sleep for the younger concussed group during the acute stage, compared with healthy controls, as well as significantly greater daytime nap duration that decreased over time. Significant correlations were also found between the frequency and duration of daytime naps and Postconcussion Symptom Scale total score and subscores (cognitive, physical/migraine, mood, and sleep) in the concussed group during the acute stage. Our results suggest that in a group with noncomplicated concussion, children and youth have transient alterations in daytime sleepiness that are related to concussion symptoms. Younger children may be more vulnerable to disturbances in sleep and daytime wakefulness.	[Wiseman-Hakes, Catherine] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Montreal, PQ, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Sharma, Bhanu] McMaster Univ, Hamilton, ON, Canada; [Langer, Laura] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada		Wiseman-Hakes, C (corresponding author), Univ Toronto, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	catherinew.hakes@utoronto.ca	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Gagnon, Isabelle/0000-0003-2043-1644; Langer, Laura/0000-0003-4408-355X	SickKids Foundation; Research Institute of the McGill University Health Center; Sleep and Biological Rhythms Toronto, a CIHR team	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a postdoctoral fellowship to Dr. Catherine Wiseman-Hakes through Sleep and Biological Rhythms Toronto, a CIHR team and training grant to the University of Toronto, as well as by the SickKids Foundation and the Research Institute of the McGill University Health Center.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Babcock L, 2016, JAMA-J AM MED ASSOC, V315, P987, DOI 10.1001/jama.2016.1276; Becker SP, 2017, SLEEP MED REV, V34, P94, DOI 10.1016/j.smrv.2016.07.004; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Eisenberg M, 2018, CURR OPIN PEDIATR, V30, P344, DOI 10.1097/MOP.0000000000000620; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eugene Andy R, 2015, MEDtube Sci, V3, P35; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Hinds Andrea, 2016, Concussion, V1, pCNC15, DOI 10.2217/cnc-2016-0002; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Ko P. R., 2015, NEUROLOGY S, V84, pI5; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Koo PC, 2016, CURR BIOL, V26, pR813, DOI 10.1016/j.cub.2016.07.027; Kostyun Regina, 2015, Conn Med, V79, P161; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wiseman-Hakes C., 2017, BRAIN INJURY, V31, P719, DOI [10.1080/02699052, DOI 10.1080/02699052]; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	31	6	6	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JAN 10	2019	11								1759091418822405	10.1177/1759091418822405			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI2ZL	WOS:000456315800001	30806074	Green Published, gold			2022-02-06	
J	Aggarwal, SS; Ott, SD; Padhye, NS; Meininger, JC; Armstrong, TS				Aggarwal, Seema S.; Ott, Summer D.; Padhye, Nikhil S.; Meininger, Janet C.; Armstrong, Terri S.			Clinical and demographic predictors of concussion resolution in adolescents: A retrospective study	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Adolescent; athletic injuries; concussion; recovery; return to play	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; HIGH-SCHOOL; BASE-LINE; PROTRACTED RECOVERY; HEALTH-INSURANCE; SYMPTOMS; CHILDREN; IMPACT	Concussions in adolescents are a growing public health concern. The aim of this study was to identify clinical (e.g., concussion history, migraine history, learning disabilities/ADHD) and demographic factors (e.g., age, sex, race, health insurance status, mechanism of injury, education) that predict concussion recovery times. In a retrospective cohort study of 118 adolescents 13-19 years old who were evaluated for an acute concussion (<= 10 days from injury), recovery times were calculated from the date of concussive injury to the date of clearance to return to play and/or normal activities. The median time to recovery was 17 days. Predictors of longer recovery included ADHD (HR = .221, 95% CI = .095 - .514, p < .001) and prior concussion (HR = .564, 95% CI = .332 - .959, p = .03). Student athletic insurance and public insurance were predictors of shorter recovery times (HR = 3.98, 95% CI = 1.25 - 12.65, p = .02 and HR = 3.33, 95% CI = 1.09 - 10.15, p = .03, respectively). In adolescents with prior concussion or ADHD, clearance to return to play/ normal activities may be delayed. Further research is needed to validate the impact of SES/health insurance on concussion recovery time.	[Aggarwal, Seema S.] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Acute & Continuing Care, 6901 Bertner Ave,678, Houston, TX 77030 USA; [Ott, Summer D.] Univ Texas Hlth Sci Ctr Houston, Med Sch, Dept Orthoped Surg, Houston, TX 77030 USA; [Padhye, Nikhil S.] Univ Texas Hlth Sci Ctr Houston, Ctr Nursing Res, Sch Nursing, Houston, TX 77030 USA; [Meininger, Janet C.] Univ Texas Hlth Sci Ctr Houston, Nursing Syst, Sch Nursing, Houston, TX 77030 USA; [Armstrong, Terri S.] NCI, NIH, Neurooncol Branch, CCR, Bethesda, MD 20892 USA		Aggarwal, SS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Acute & Continuing Care, 6901 Bertner Ave,678, Houston, TX 77030 USA.	seema.s.aggarwal@uth.tmc.edu		Padhye, Nikhil/0000-0001-5738-7486; Armstrong, Terri/0000-0002-2414-0492	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC011837] Funding Source: NIH RePORTER		Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control, 2010, TRAUMATIC BRAIN INJU; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Christino MA, 2015, J AM ACAD ORTHOP SUR, V23, P501, DOI 10.5435/JAAOS-D-14-00173; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Devoe JE, 2011, MED CARE, V49, P818, DOI 10.1097/MLR.0b013e3182159e4d; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; ImPACT Applications Inc, 2007, IMM POSTC ASS TEST I; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kreider AR, 2016, JAMA PEDIATR, V170, P43, DOI 10.1001/jamapediatrics.2015.3028; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Loder S, 2015, HEADACHE, V55, P214, DOI 10.1111/head.12506; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699Aq]volpge, DOI 10.1136/BJSPORTS-2017-097699AQ]VOLPGE]; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; R Development Core Team, 2012, R LANG ENV STAT COMP; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; U. S. Census Bureau, 2011, SEL EC CHAR 2006 201; Wallace J., 2017, J ATHL TRAINING, V52, P422, DOI [10.4085/1062-6050-52.3.05, DOI 10.4085/1062-6050-52.3.05]; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	64	6	6	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2019	8	1					50	60		10.1080/21622965.2017.1381099			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HS3VU	WOS:000463791400005	29058480				2022-02-06	
J	Beauchamp, MH; Vera-Estay, E; Morasse, F; Anderson, V; Dooley, J				Beauchamp, M. H.; Vera-Estay, E.; Morasse, F.; Anderson, V.; Dooley, J.			Moral reasoning and decision-making in adolescents who sustain traumatic brain injury	BRAIN INJURY			English	Article						Moral reasoning; social cognition; traumatic brain injury; adolescence	PROBLEM-SOLVING SKILLS; SOCIAL-ADJUSTMENT; CHILDREN; CHILDHOOD; EMOTION; EMPATHY; COGNITION; OUTCOMES; MIND; RECOGNITION	Objective: Emerging evidence suggests that moral processes are disrupted by traumatic brain injury (TBI). The objective of this study was to explore moral reasoning (MR) and decision-making in adolescents with TBI, and to examine potential associations with global manifestations of social competence. Design: This retrospective, cross-sectional research design compared MR and decision-making in adolescents with mild TBI (n = 20), moderate-severe TBI (n = 23) and typically developing controls (n = 93). Methods: Participants completed a visual task of socio-moral reasoning (SoMoral) and the Index of Empathy for Children and Adolescents. Their parents completed questionnaires documenting their child's behavior (Child Behavior Checklist) and adaptive functioning (Adaptive Behavior Assessment System-Second Edition). Main results: Adolescents with both mild and moderate-severe TBI displayed more immature MR than typically developing peers. Participants with TBI also provided fewer socially adapted decisions. Closer inspection revealed that this difference was apparent only in the mild TBI group. No significant group differences were observed for empathy, behavior or adaptive skills. Conclusions: Sustaining TBI appears to affect adolescents' ability to provide mature moral justifications when faced with moral dilemmas representative of everyday social conflicts. These difficulties do not appear to be associated with behavior problems, reduced empathy, or adaptive functioning.	[Beauchamp, M. H.; Vera-Estay, E.; Morasse, F.] Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Beauchamp, M. H.; Vera-Estay, E.; Morasse, F.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Anderson, V.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dooley, J.] Cuyahoga Cty Court Psychiat Clin, Cleveland, OH USA		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Victoria Neurotrauma Initiative; Fonds de la recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec; Government of Chile scholarship	This work was supported by the Victoria Neurotrauma Initiative; Fonds de la recherche en Sante du Quebec; and a Government of Chile scholarship to E.V-E.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Baird JA, 2004, NEW DIR CHILD ADOLES, V103, P37, DOI 10.1002/cd.96; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2011, DEV NEUROPSYCHOL, V36, P1; Beauchamp MH, 2017, NEUROPSYCHOLOGY, V31, P981, DOI 10.1037/neu0000395; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.2307/1128984; Chiasson V, 2017, BRAIN IMPAIR, V18, P102, DOI 10.1017/BrImp.2016.33; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Cohen J., 2013, STAT POWER ANAL BEHA; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; Cowell JM, 2015, P NATL ACAD SCI USA, V112, P12657, DOI 10.1073/pnas.1508832112; Cui LX, 2016, J ABNORM CHILD PSYCH, V44, P663, DOI 10.1007/s10802-015-0079-7; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Galvin J, 2009, DEV NEUROREHABIL, V12, P352, DOI 10.3109/17518420903087293; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; GIBBS JC, 2010, MORAL DEV REALITY TH; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hinnant JB, 2013, COGNITION EMOTION, V27, P1460, DOI 10.1080/02699931.2013.789792; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kohlberg Lawrence., 1983, MORAL STAGES CURRENT; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malti T, 2009, AGGRESSIVE BEHAV, V35, P90, DOI 10.1002/ab.20289; Martins AT, 2012, JUDGM DECIS MAK, V7, P478; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Overton W. F., 1983, RELATIONSHIP SOCIAL, P53; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rowley DA, 2018, J NEUROPSYCHOL, V12, P200, DOI 10.1111/jnp.12117; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; Sevinc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087427; Sirois K, 2019, NEUROPSYCHOL REHABIL, V29, P1383, DOI 10.1080/09602011.2017.1413987; Stams GJ, 2006, J ABNORM CHILD PSYCH, V34, P697, DOI 10.1007/s10802-006-9056-5; Stevens D, 2001, J GENET PSYCHOL, V162, P201, DOI 10.1080/00221320109597961; van Vugt E, 2012, INT J OFFENDER THER, V56, P986, DOI 10.1177/0306624X11420083; Vascello MGF, 2018, ARCH CLIN NEUROPSYCH, V33, P583, DOI 10.1093/arclin/acx099; Vera-Estay E, 2015, J MORAL EDUC, V44, P17, DOI 10.1080/03057240.2014.986077; Vera-Estay E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00227; Wade SL, 2017, ARCH PHYS MED REHAB, V98, P1614, DOI 10.1016/j.apmr.2017.03.006; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	71	6	6	2	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		32	39		10.1080/02699052.2018.1531307			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400005	30325212				2022-02-06	
